,molecule_chembl_id,canonical_smiles,standard_type,standard_units,standard_relation,standard_value,assay_description
0,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.0,Inhibition of hERG currents Kv11.1
1,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,~,3.0,Inhibitory concentration against hERG currents after prolonged depolarizing pulses
2,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.2,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
3,CHEMBL2368925,O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,IC50,nM,=,5950.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
4,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,143.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
5,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,196.0,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1
6,CHEMBL998,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,IC50,nM,=,173.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
7,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
8,CHEMBL370805,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,IC50,nM,=,4.4,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
9,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,152.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
10,CHEMBL472,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,IC50,nM,=,74000.0,K+ channel blocking activity in neuroblastoma cells expressing HERG Kv11.1
11,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1430.0,K+ channel blocking activity in COS-7 African green monkey kidney derived cells expressing HERG Kv11.1
12,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,100000.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
13,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,129000.0,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1
14,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,10000.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
15,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,130000.0,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1
16,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,550.0,K+ channel blocking activity in COS-7 African green monkey kidney derived cells expressing HERG Kv11.1
17,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,15.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
18,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,104000.0,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1
19,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,0.9,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
20,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,28.1,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
21,CHEMBL61301,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,IC50,nM,=,28.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
22,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,204.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
23,CHEMBL289469,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,IC50,nM,=,3730.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
24,CHEMBL75880,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,IC50,nM,=,7800.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
25,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,18.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
26,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,191.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
27,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,6.5,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
28,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,21570.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
29,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,7.7,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
30,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,34400.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
31,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1470.0,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1
32,CHEMBL219916,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,nM,=,162.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
33,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,nM,=,17300.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
34,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,163.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
35,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,350.0,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
36,CHEMBL123558,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,IC50,nM,=,560.0,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1
37,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,35.7,K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1
38,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3400.0,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1
39,CHEMBL338109,CN1C(=O)[C@H](NC(=O)C(N)Cc2ccccc2)N=C(c2ccccc2)c2ccccc21,IC50,nM,=,8800.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
40,CHEMBL16900,O=C(Cc1ccc(C(F)(F)F)cc1C(F)(F)F)N[C@@H]1N=C(c2ccccc2)c2ccccc2N(CC(F)(F)F)C1=O,IC50,nM,=,6000.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
41,CHEMBL340353,CN1C(=O)[C@H](NC(=O)CCC2CCCCC2)N=C(c2ccccc2)c2ccccc21,IC50,nM,=,1000.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
42,CHEMBL332826,CN1C(=O)[C@H](NC(=O)/C=C/c2ccc(Cl)cc2Cl)N=C(c2ccccc2)c2ccccc21,IC50,nM,=,1500.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
43,CHEMBL127701,O=C(Cc1ccc(Cl)cc1Cl)N[C@@H]1N=C(c2ccccc2)c2ccccc2N(CC(F)(F)F)C1=O,IC50,nM,=,2400.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
44,CHEMBL9387,Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1,IC50,nM,=,5000.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
45,CHEMBL339327,O=C(Cc1cc(Cl)cc(Cl)c1)N[C@@H]1N=C(c2ccccc2)c2ccccc2N(CC(F)(F)F)C1=O,IC50,nM,=,4000.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
46,CHEMBL70380,Cc1cccc(NC(=O)N[C@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1,IC50,nM,=,10000.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
47,CHEMBL128007,CN(C)CCN1C(=O)C(NC(=O)CCc2ccc(Cl)cc2Cl)N=C(c2ccccc2)c2ccccc21,IC50,nM,=,100.0,Inhibition of Ikr current in isolated guinea pig myocytes during a 0.5 s voltage clamp step from -50 to -10 mV.
48,CHEMBL443476,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,88.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
49,CHEMBL53661,O=C1NCCN1CCN1CCC(c2cn(C3CCCCC3)c3ccc(Cl)cc23)CC1,IC50,nM,=,137.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
50,CHEMBL299390,CCC(CC)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,1480.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
51,CHEMBL12186,O=C1NCCN1CCN1CC=C(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,10.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
52,CHEMBL299590,CC(C)(C)c1ccc2c(ccn2-c2ccc(F)cc2)c1,IC50,nM,>,10000.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
53,CHEMBL556312,O=C1NCCN1CCN1CCC(C2CN(c3ccc(F)cc3)c3ccccc32)CC1,IC50,nM,=,23.5,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
54,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,45.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
55,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,143.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
56,CHEMBL55835,O=C(O)Cc1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,579.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
57,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,56.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
58,CHEMBL298978,Fc1ccc(-n2cc(C3CCN(CCN4CCN=C4S)CC3)c3ccccc32)cc1,IC50,nM,=,6.2,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
59,CHEMBL53871,CCC(O)(CC)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,15700.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
60,CHEMBL300927,O=C(O)c1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,75000.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
61,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
62,CHEMBL301992,CC(=O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,>,10000.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
63,CHEMBL52348,CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,26000.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
64,CHEMBL53866,CCC(O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,2200.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
65,CHEMBL53089,CC(C)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,>,10000.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
66,CHEMBL301956,CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,11.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
67,CHEMBL53321,CCC(=O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,1947.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
68,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,23000.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
69,CHEMBL52794,CC(O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,4550.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
70,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,32.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
71,CHEMBL12780,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccccc23)CC1,IC50,nM,=,7.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
72,CHEMBL300907,CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,3500.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
73,CHEMBL415944,COC(=O)Cc1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,131.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
74,CHEMBL52627,CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(C3CCc4cc(C#N)ccc4C3)CC1)O2,IC50,nM,=,34.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
75,CHEMBL52832,CC(C)(O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,460.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
76,CHEMBL52999,COC(=O)c1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,36.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
77,CHEMBL273235,Fc1ccc(-n2cc(C3CCNCC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,204.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
78,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,3.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
79,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,18.0,Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1
80,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,47.0,Inhibitory activity against Potassium channel HERG
81,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,3.0,Inhibitory activity against Potassium channel HERG
82,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,50000.0,Inhibitory activity against Potassium channel HERG
83,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,18.0,Inhibitory activity against Potassium channel HERG
84,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,0.9,Inhibitory activity against Potassium channel HERG
85,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,56.0,Inhibitory activity against Potassium channel HERG
86,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,191.0,Inhibitory activity against Potassium channel HERG
87,CHEMBL193,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],IC50,nM,=,50118.72,Inhibition of human Potassium channel HERG expressed in mammalian cells
88,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
89,CHEMBL998,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,IC50,nM,=,169.82,Inhibition of human Potassium channel HERG expressed in mammalian cells
90,CHEMBL60796,Oc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,1.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
91,CHEMBL1110,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,3235.94,Inhibition of human Potassium channel HERG expressed in mammalian cells
92,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,549.54,Inhibition of human Potassium channel HERG expressed in mammalian cells
93,CHEMBL723,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,IC50,nM,=,10471.29,Inhibition of human Potassium channel HERG expressed in mammalian cells
94,CHEMBL2093896,CSc1ccc([C@H]2N=C(OCc3ccc(NS(C)(=O)=O)cc3)N(C)Cc3ccccc32)cc1.Cl,IC50,nM,=,21000.0,Blockade of the delayed rectifier K+ current (IKr) of guinea pig myocytes
95,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,912010.84,Inhibition of human Potassium channel HERG expressed in mammalian cells
96,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,199.53,Inhibition of human Potassium channel HERG expressed in mammalian cells
97,CHEMBL75880,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,IC50,nM,=,7762.47,Inhibition of human Potassium channel HERG expressed in mammalian cells
98,CHEMBL549,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,IC50,nM,=,3981.07,Inhibition of human Potassium channel HERG expressed in mammalian cells
99,CHEMBL3350235,CSc1ccc([C@@H]2N=C(OCc3ccc(NS(C)(=O)=O)cc3)N(C)Cc3ccccc32)cc1.Cl,IC50,nM,=,56000.0,Blockade of the delayed rectifier K+ current (IKr) of guinea pig myocytes
100,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,6.026,Inhibition of human Potassium channel HERG expressed in mammalian cells
101,CHEMBL319742,O=C(O[C@H]1C[C@@H]2C[C@@H]3C[C@@H](C1)N2CC3=O)C1CNc2ccccc21,IC50,nM,=,5888.44,Inhibition of human Potassium channel HERG expressed in mammalian cells
102,CHEMBL370805,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,IC50,nM,=,7244.36,Inhibition of human Potassium channel HERG expressed in mammalian cells
103,CHEMBL533,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
104,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1445.44,Inhibition of human Potassium channel HERG expressed in mammalian cells
105,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,39.81,Inhibition of human Potassium channel HERG expressed in mammalian cells
106,CHEMBL517,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,IC50,nM,=,91201.08,Inhibition of human Potassium channel HERG expressed in mammalian cells
107,CHEMBL4,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,1412537.54,Inhibition of human Potassium channel HERG expressed in mammalian cells
108,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,18197.01,Inhibition of human Potassium channel HERG expressed in mammalian cells
109,CHEMBL1788206,CN1Cc2ccccc2[C@@H](c2ccccc2)N=C1OCc1ccc(NS(C)(=O)=O)cc1.O=C(O)/C=C/C(=O)O,IC50,nM,=,38000.0,Blockade of the delayed rectifier K+ current (IKr) of guinea pig myocytes
110,CHEMBL1788304,CN1Cc2ccccc2[C@H](c2ccc(F)cc2F)N=C1CCc1ccc(NS(C)(=O)=O)cc1.Cl,IC50,nM,=,85000.0,Blockade of the delayed rectifier K+ current (IKr) of guinea pig myocytes
111,CHEMBL505,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,IC50,nM,=,20892.96,Inhibition of human Potassium channel HERG expressed in mammalian cells
112,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,30.2,Inhibition of human Potassium channel HERG expressed in mammalian cells
113,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,436.52,Inhibition of human Potassium channel HERG expressed in mammalian cells
114,CHEMBL17423,COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC,IC50,nM,=,1096.48,Inhibition of human Potassium channel HERG expressed in mammalian cells
115,CHEMBL535650,Cl.OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,IC50,nM,=,5623.41,Inhibition of human Potassium channel HERG expressed in mammalian cells
116,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,nM,=,954992.59,Inhibition of human Potassium channel HERG expressed in mammalian cells
117,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,323.59,Inhibition of human Potassium channel HERG expressed in mammalian cells
118,CHEMBL845,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,IC50,nM,=,4466.84,Inhibition of human Potassium channel HERG expressed in mammalian cells
119,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,363.08,Inhibition of human Potassium channel HERG expressed in mammalian cells
120,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1479.11,Inhibition of human Potassium channel HERG expressed in mammalian cells
121,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,1513.56,Inhibition of human Potassium channel HERG expressed in mammalian cells
122,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IC50,nM,=,10000.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
123,CHEMBL123558,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,IC50,nM,=,1412.54,Inhibition of human Potassium channel HERG expressed in mammalian cells
124,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human Potassium channel HERG expressed in mammalian cells
125,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,199.53,Inhibition of human Potassium channel HERG expressed in mammalian cells
126,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,50118.72,Inhibition of human Potassium channel HERG expressed in mammalian cells
127,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,3311.31,Inhibition of human Potassium channel HERG expressed in mammalian cells
128,CHEMBL22,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,IC50,nM,=,239883.29,Inhibition of human Potassium channel HERG expressed in mammalian cells
129,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,nM,=,17378.01,Inhibition of human Potassium channel HERG expressed in mammalian cells
130,CHEMBL1000,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,IC50,nM,=,30199.52,Inhibition of human Potassium channel HERG expressed in mammalian cells
131,CHEMBL657,CN(C)CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,26915.35,Inhibition of human Potassium channel HERG expressed in mammalian cells
132,CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,nM,=,1905.46,Inhibition of human Potassium channel HERG expressed in mammalian cells
133,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,141.25,Inhibition of human Potassium channel HERG expressed in mammalian cells
134,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,1513.56,Inhibition of human Potassium channel HERG expressed in mammalian cells
135,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,151.36,Inhibition of human Potassium channel HERG expressed in mammalian cells
136,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,44000.0,Blockade of the delayed rectifier K+ current (IKr) of guinea pig myocytes
137,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,10.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
138,CHEMBL3,CN1CCC[C@H]1c1cccnc1,IC50,nM,=,245470.89,Inhibition of human Potassium channel HERG expressed in mammalian cells
139,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,50.12,Inhibition of human Potassium channel HERG expressed in mammalian cells
140,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,10.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
141,CHEMBL1741,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,58884.37,Inhibition of human Potassium channel HERG expressed in mammalian cells
142,CHEMBL1741,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,33113.11,Inhibition of K+ channel activity in mammalian cells expressing HERG Kv11.1
143,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human Potassium channel HERG expressed in mammalian cells
144,CHEMBL475534,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,10000.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
145,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.36,Inhibition of human Potassium channel HERG expressed in mammalian cells
146,CHEMBL1088,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,IC50,nM,=,323.59,Inhibition of human Potassium channel HERG expressed in mammalian cells
147,CHEMBL96153,COc1ccc(C2CCN(CC[C@H]3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,251.19,Inhibition of human Potassium channel HERG expressed in mammalian cells
148,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,10000.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
149,CHEMBL94664,COc1ccc(C2CCN(CCC3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,199.53,Inhibition of human Potassium channel HERG expressed in mammalian cells
150,CHEMBL2092889,CN1Cc2ccccc2[C@H](c2ccccc2)N=C1OCc1ccc(NS(C)(=O)=O)cc1.O=C(O)/C=C/C(=O)O,IC50,nM,=,29000.0,Blockade of the delayed rectifier K+ current (IKr) of guinea pig myocytes
151,CHEMBL1106,NC1=NCC2c3ccccc3Cc3ccccc3N12,IC50,nM,=,100000.0,Inhibition of human Potassium channel HERG expressed in mammalian cells
152,CHEMBL46,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,812.83,Inhibition of human Potassium channel HERG expressed in mammalian cells
153,CHEMBL1294,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,IC50,nM,=,323.59,Inhibition of human Potassium channel HERG expressed in mammalian cells
154,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,181.97,Inhibition of human Potassium channel HERG expressed in mammalian cells
155,CHEMBL2092890,CN1Cc2ccccc2[C@@H](c2ccc(F)cc2F)N=C1CCc1ccc(NS(C)(=O)=O)cc1.Cl,IC50,nM,=,38000.0,Blockade of the delayed rectifier K+ current (IKr) of guinea pig myocytes
156,CHEMBL652,O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,IC50,nM,=,3890.45,Inhibition of human Potassium channel HERG expressed in mammalian cells
157,CHEMBL1712,Cl.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,120.23,Inhibition of human Potassium channel HERG expressed in mammalian cells
158,CHEMBL2368925,O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,IC50,nM,=,12022.64,Inhibition of human Potassium channel HERG expressed in mammalian cells
159,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,19.95,Inhibition of human Potassium channel HERG expressed in mammalian cells
160,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3388.44,Inhibition of human Potassium channel HERG expressed in mammalian cells
161,CHEMBL61301,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,IC50,nM,=,28.18,Inhibition of human Potassium channel HERG expressed in mammalian cells
162,CHEMBL368895,CN(C)CCCn1nc(C2=C(c3cn(-c4ccc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21,IC50,nM,=,28.0,Inhibition of Potassium channel HERG
163,CHEMBL180672,CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N,IC50,nM,=,194.0,Inhibitory concentration against human Kv11.1 ERG potassium channel
164,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,10000.0,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
165,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,0.912,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
166,CHEMBL537847,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1.Cl,IC50,nM,=,562.34,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
167,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,549.54,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
168,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,nM,=,17378.01,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
169,CHEMBL2368925,O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,IC50,nM,=,6025.6,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
170,CHEMBL219916,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,nM,=,162.18,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
171,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.36,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
172,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,21379.62,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
173,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
174,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,77624.71,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
175,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,199.53,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
176,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,28.18,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
177,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1445.44,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
178,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,117489.76,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
179,CHEMBL61301,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,IC50,nM,=,28.18,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
180,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,18.2,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
181,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,162.18,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
182,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.13,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
183,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,26302.68,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
184,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,144.54,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state
185,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1479.11,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
186,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,6.457,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
187,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,5754.4,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
188,CHEMBL370805,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,IC50,nM,=,5754.4,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
189,CHEMBL289469,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,IC50,nM,=,3801.89,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
190,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3388.44,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
191,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,354.81,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
192,CHEMBL75880,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,IC50,nM,=,7762.47,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
193,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,128.82,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
194,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,35.48,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
195,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,151.36,Inhibition of partially open human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel)
196,CHEMBL298475,CN([C@H]1c2cc(OCCCC(F)(F)F)ccc2OC(C)(C)[C@@H]1O)S(C)(=O)=O,IC50,nM,=,12600.0,Inhibitory concentration against IKr potassium channel
197,CHEMBL17423,COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC,IC50,nM,=,18000.0,Inhibitory concentration against IKr potassium channel
198,CHEMBL532,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,39000.0,Inhibitory concentration against IKr potassium channel
199,CHEMBL1264,CCCNCC(O)COc1ccc(O)cc1C(=O)CCc1ccccc1,IC50,nM,=,40000.0,Inhibitory concentration against IKr potassium channel
200,CHEMBL1365,NCC(O)COc1ccccc1C(=O)CCc1ccccc1,IC50,nM,=,44000.0,Inhibitory concentration against IKr potassium channel
201,CHEMBL1741,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,46000.0,Inhibitory concentration against IKr potassium channel
202,CHEMBL1000,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,IC50,nM,=,108000.0,Inhibitory concentration against IKr potassium channel
203,CHEMBL16,O=C1N=C(O)NC1(c1ccccc1)c1ccccc1,IC50,nM,=,240000.0,Inhibitory concentration against IKr potassium channel
204,CHEMBL40,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,IC50,nM,=,3000000.0,Inhibitory concentration against IKr potassium channel
205,CHEMBL284348,Nc1ccncc1,IC50,nM,=,4400000.0,Inhibitory concentration against IKr potassium channel
206,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,1.5,Inhibitory concentration against IKr potassium channel
207,CHEMBL129583,CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2,IC50,nM,=,8.0,Inhibitory concentration against IKr potassium channel
208,CHEMBL182977,CCCCCCCN(CC)CCCCc1ccc([N+](=O)[O-])cc1,IC50,nM,=,10.0,Inhibitory concentration against IKr potassium channel
209,CHEMBL533,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,20.0,Inhibitory concentration against IKr potassium channel
210,CHEMBL182646,COc1ccc(CCN(C)CCCN(C(=O)c2ccc([N+](=O)[O-])cc2)c2ccc(OC)c(OC)c2)cc1OC,IC50,nM,=,20.0,Inhibitory concentration against IKr potassium channel
211,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,20.0,Inhibitory concentration against IKr potassium channel
212,CHEMBL96153,COc1ccc(C2CCN(CC[C@H]3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,30.0,Inhibitory concentration against IKr potassium channel
213,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,30.0,Inhibitory concentration against IKr potassium channel
214,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,50.0,Inhibitory concentration against IKr potassium channel
215,CHEMBL9484,CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1,IC50,nM,=,150.0,Inhibitory concentration against IKr potassium channel
216,CHEMBL362103,CCC[S+]([O-])CCCN(CC)CC(O)COc1ccc(C#N)cc1,IC50,nM,=,250.0,Inhibitory concentration against IKr potassium channel
217,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,260.0,Inhibitory concentration against IKr potassium channel
218,CHEMBL723,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,IC50,nM,=,350.0,Inhibitory concentration against IKr potassium channel
219,CHEMBL123558,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,IC50,nM,=,400.0,Inhibitory concentration against IKr potassium channel
220,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,430.0,Inhibitory concentration against IKr potassium channel
221,CHEMBL363295,CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C,IC50,nM,=,500.0,Inhibitory concentration against IKr potassium channel
222,CHEMBL631,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,IC50,nM,=,800.0,Inhibitory concentration against IKr potassium channel
223,CHEMBL353985,COc1ccc(CCN(C)CCOc2ccc(NS(C)(=O)=O)cc2N)cc1OC,IC50,nM,=,1000.0,Inhibitory concentration against IKr potassium channel
224,CHEMBL505,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,IC50,nM,=,1100.0,Inhibitory concentration against IKr potassium channel
225,CHEMBL511,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,IC50,nM,=,1100.0,Inhibitory concentration against IKr potassium channel
226,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1400.0,Inhibitory concentration against IKr potassium channel
227,CHEMBL184412,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,IC50,nM,=,3000.0,Inhibitory concentration against IKr potassium channel
228,CHEMBL9387,Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1,IC50,nM,=,5000.0,Inhibitory concentration against IKr potassium channel
229,CHEMBL184014,COc1ccc(CCNC(C)COc2c(C)cccc2C)cc1OC,IC50,nM,=,6100.0,Inhibitory concentration against IKr potassium channel
230,CHEMBL87045,c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1,IC50,nM,=,8800.0,Inhibitory concentration against IKr potassium channel
231,CHEMBL360861,Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O,IC50,nM,=,10000.0,Inhibitory concentration against IKr potassium channel
232,CHEMBL185434,CCN(CC)CC#CCOC(=O)[C@](O)(c1ccccc1)C1CCCCC1,IC50,nM,=,12000.0,Inhibitory concentration against IKr potassium channel
233,CHEMBL517,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,IC50,nM,=,12000.0,Inhibitory concentration against IKr potassium channel
234,CHEMBL186873,COc1cc2c(cc1OC)C1Cc3ccc(OC)c(OC)c3C(Cc3ccccc3)N1CC2,IC50,nM,=,14000.0,Inhibitory concentration against IKr potassium channel
235,CHEMBL442717,COc1cc2c(cc1OC)[C@@H](Cc1ccc(Oc3cc(C[C@@H]4c5cc(OC)c(OC)cc5CCN4C)ccc3O)cc1)N(C)CC2,IC50,nM,=,16000.0,Inhibitory concentration against IKr potassium channel
236,CHEMBL1726,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],IC50,nM,=,23000.0,Inhibitory concentration against IKr potassium channel
237,CHEMBL1097,CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1,IC50,nM,=,100000.0,Inhibitory concentration against IKr potassium channel
238,CHEMBL193,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],IC50,nM,=,280000.0,Inhibitory concentration against IKr potassium channel
239,CHEMBL448,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,IC50,nM,=,22800000.0,Inhibitory concentration against IKr potassium channel
240,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,40.0,Inhibitory concentration against IKr potassium channel
241,CHEMBL362721,CN1Cc2ccccc2[C@@H](c2ccccc2)N=C1CCc1ccccc1,IC50,nM,=,90.0,Inhibitory concentration against IKr potassium channel
242,CHEMBL184461,COc1ccc(CCNCCCNC(=O)c2ccc([N+](=O)[O-])cc2)cc1OC,IC50,nM,=,420.0,Inhibitory concentration against IKr potassium channel
243,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,1400.0,Inhibitory concentration against IKr potassium channel
244,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,1700.0,Inhibitory concentration against IKr potassium channel
245,CHEMBL46516,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,IC50,nM,=,2300.0,Inhibitory concentration against IKr potassium channel
246,CHEMBL76,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,IC50,nM,=,2500.0,Inhibitory concentration against IKr potassium channel
247,CHEMBL416956,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,IC50,nM,=,2600.0,Inhibitory concentration against IKr potassium channel
248,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,3100.0,Inhibitory concentration against IKr potassium channel
249,CHEMBL16900,O=C(Cc1ccc(C(F)(F)F)cc1C(F)(F)F)N[C@@H]1N=C(c2ccccc2)c2ccccc2N(CC(F)(F)F)C1=O,IC50,nM,=,6000.0,Inhibitory concentration against IKr potassium channel
250,CHEMBL38827,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1,IC50,nM,=,8100.0,Inhibitory concentration against IKr potassium channel
251,CHEMBL183418,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)C(N)C2CCCCC2)cc1)C(=O)O.O=C(O)C(F)(F)F,IC50,nM,>,90000.0,Inhibition of human Potassium channel HERG
252,CHEMBL182223,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccc(F)c(F)c1.O=C(O)C(F)(F)F,IC50,nM,=,79000.0,Inhibition of human Potassium channel HERG
253,CHEMBL435882,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(F)(F)F)cc1)Cc1ccccc1F.O=C(O)C(F)(F)F,IC50,nM,=,870.0,Inhibition of human Potassium channel HERG
254,CHEMBL364102,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,IC50,nM,=,76000.0,Inhibition of human Potassium channel HERG
255,CHEMBL183289,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2c(F)c(F)c(F)c(F)c2F)cc1)C(=O)O.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Inhibition of human Potassium channel HERG
256,CHEMBL186482,COC(=O)Cc1ccc(CNC(=O)[C@@H]2CSCN2C(=O)CC(N)Cc2ccccc2F)cc1.O=C(O)C(F)(F)F,IC50,nM,=,9700.0,Inhibition of human Potassium channel HERG
257,CHEMBL186730,NCc1ccc(F)c(C2CCN(C(=O)c3cccc(-c4nc(-c5cccs5)no4)c3)CC2)c1,IC50,nM,=,800.0,Inhibitory activity against human Potassium channel HERG
258,CHEMBL185752,CCOC(=O)c1cc(C(=O)N2CCC(c3cc(CN)ccc3F)CC2)cc(-c2nc(-c3cccs3)no2)c1,IC50,,,,Inhibitory activity against human Potassium channel HERG; ND denotes not determined
259,CHEMBL188068,NCc1ccc(F)c(C2CCN(C(=O)c3cc(C(=O)O)cc(-c4nc(-c5cccs5)no4)c3)CC2)c1,IC50,nM,=,76800.0,Inhibitory activity against human Potassium channel HERG
260,CHEMBL362874,NCc1cccc(C2CCN(C(=O)c3cc(C(N)=O)cc(-c4nc(-c5cccs5)no4)c3)CC2)c1,IC50,nM,>,30000.0,Inhibitory activity against human Potassium channel HERG
261,CHEMBL365062,NCc1ccc(F)c(C2CCN(C(=O)c3cc(C(N)=O)cc(-c4nc(-c5cccs5)no4)c3)CC2)c1,IC50,nM,=,17100.0,Inhibitory activity against human Potassium channel HERG
262,CHEMBL195755,C[C@@H](c1ccc(-c2cccc(C(=O)O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Inhibitory concentration against Potassium channel HERG was determined
263,CHEMBL189881,C[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,=,1100.0,Inhibitory concentration against Potassium channel HERG was determined
264,CHEMBL2113086,O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1,IC50,nM,=,2700.0,Inhibitory activity against human Potassium channel HERG
265,CHEMBL195378,C[C@@H](c1ccc(-c2cccc(-c3nn[nH]n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,=,59000.0,Inhibitory concentration against Potassium channel HERG was determined
266,CHEMBL370072,C[C@@H](c1ccc(-c2cccc(-c3noc(O)n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,=,28000.0,Inhibitory concentration against Potassium channel HERG was determined
267,CHEMBL435886,O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(C(F)(F)F)cn34)CC2)[C@@H](c2cccc(F)c2)C1,IC50,nM,<,10000.0,Inhibitory activity against human Potassium channel HERG
268,CHEMBL196983,COc1ccc([C@@H](O)C[C@H]2c3cc(OC)c(OC)cc3CCN2C)cc1,IC50,nM,=,790.0,Mean inhibitory concentration against potassium channel HERG
269,CHEMBL197467,COc1cc2c(cc1OC)[C@H](C[C@H](O)c1ccc(Cl)cc1)N(C)CC2,IC50,nM,=,400.0,Mean inhibitory concentration against potassium channel HERG
270,CHEMBL197243,COc1cccc(CN2CCCCCCC2)c1OCc1csc(-c2ccccc2)n1,IC50,nM,=,180.0,In vitro inhibitory concentration against displacement of 35[S] MK-499 binding to hERG channel expressed in HEK293 cells
271,CHEMBL197304,COc1cccc(CN2CCCCCCC2)c1OCc1csc(-c2ccc(Cl)cc2)n1,IC50,nM,=,40.0,In vitro inhibitory concentration against displacement of 35[S] MK-499 binding to hERG channel expressed in HEK293 cells
272,CHEMBL195180,Clc1ccc(-c2nc(COc3ccccc3CN3CCCCCCC3)cs2)cc1,IC50,nM,=,30.0,In vitro inhibitory concentration against displacement of 35[S] MK-499 binding to hERG channel expressed in HEK293 cells
273,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,10.0,Inhibitory concentration against potassium channel HERG
274,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibitory concentration against potassium channel HERG
275,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,10.0,Inhibitory concentration against potassium channel HERG
276,CHEMBL533,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibitory concentration against potassium channel HERG
277,CHEMBL92870,Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,15.85,Inhibitory concentration against potassium channel HERG
278,CHEMBL1382,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,IC50,nM,=,16.98,Inhibitory concentration against potassium channel HERG
279,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,19.95,Inhibitory concentration against potassium channel HERG
280,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,30.2,Inhibitory concentration against potassium channel HERG
281,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.36,Inhibitory concentration against potassium channel HERG
282,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,39.81,Inhibitory concentration against potassium channel HERG
283,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,50.12,Inhibitory concentration against potassium channel HERG
284,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,120.23,Inhibitory concentration against potassium channel HERG
285,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,141.25,Inhibitory concentration against potassium channel HERG
286,CHEMBL364512,Cc1nc2n(c(=O)c1CCN1CCC(C3NOc4cc(F)ccc43)CC1)CCCC2,IC50,nM,=,151.36,Inhibitory concentration against potassium channel HERG
287,CHEMBL364912,COc1cccc(C(=O)N2CCCC2)c1OCc1csc(-c2ccc(Cl)cc2)n1,IC50,nM,=,7700.0,In vitro inhibitory concentration against displacement of 35[S] MK-499 binding to hERG channel expressed in HEK293 cells
288,CHEMBL195235,O=C(c1ccccc1OCc1csc(-c2ccc(Cl)cc2)n1)N1CCCC1,IC50,nM,=,9800.0,In vivo inhibitory concentration against displacement of 35[S] MK-499 binding to hERG channel expressed in HEK293 cells
289,CHEMBL219916,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,nM,=,162.18,Inhibitory concentration against potassium channel HERG
290,CHEMBL998,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,IC50,nM,=,169.82,Inhibitory concentration against potassium channel HERG
291,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,181.97,Inhibitory concentration against potassium channel HERG
292,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,190.55,Inhibitory concentration against potassium channel HERG
293,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,199.53,Inhibitory concentration against potassium channel HERG
294,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,199.53,Inhibitory concentration against potassium channel HERG
295,CHEMBL96153,COc1ccc(C2CCN(CC[C@H]3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,251.19,Inhibitory concentration against potassium channel HERG
296,CHEMBL1294,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,IC50,nM,=,323.59,Inhibitory concentration against potassium channel HERG
297,CHEMBL607,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,IC50,nM,=,323.59,Inhibitory concentration against potassium channel HERG
298,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,323.59,Inhibitory concentration against potassium channel HERG
299,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,436.52,Inhibitory concentration against potassium channel HERG
300,CHEMBL1088,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,IC50,nM,=,549.54,Inhibitory concentration against potassium channel HERG
301,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,549.54,Inhibitory concentration against potassium channel HERG
302,CHEMBL46,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,812.83,Inhibitory concentration against potassium channel HERG
303,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,1380.38,Inhibitory concentration against potassium channel HERG
304,CHEMBL123558,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,IC50,nM,=,1412.54,Inhibitory concentration against potassium channel HERG
305,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1445.44,Inhibitory concentration against potassium channel HERG
306,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1479.11,Inhibitory concentration against potassium channel HERG
307,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,1513.56,Inhibitory concentration against potassium channel HERG
308,CHEMBL2,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,IC50,nM,=,1584.89,Inhibitory concentration against potassium channel HERG
309,CHEMBL596,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,IC50,nM,=,1819.7,Inhibitory concentration against potassium channel HERG
310,CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,nM,=,1905.46,Inhibitory concentration against potassium channel HERG
311,CHEMBL1514,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1,IC50,nM,=,2187.76,Inhibitory concentration against potassium channel HERG
312,CHEMBL305660,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,3019.95,Inhibitory concentration against potassium channel HERG
313,CHEMBL1110,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,3235.94,Inhibitory concentration against potassium channel HERG
314,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,3311.31,Inhibitory concentration against potassium channel HERG
315,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3388.44,Inhibitory concentration against potassium channel HERG
316,CHEMBL289469,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,IC50,nM,=,3715.35,Inhibitory concentration against potassium channel HERG
317,CHEMBL652,O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,IC50,nM,=,3890.45,Inhibitory concentration against potassium channel HERG
318,CHEMBL549,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,IC50,nM,=,3981.07,Inhibitory concentration against potassium channel HERG
319,CHEMBL416956,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,IC50,nM,=,5623.41,Inhibitory concentration against potassium channel HERG
320,CHEMBL370805,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,IC50,nM,=,7244.36,Inhibitory concentration against potassium channel HERG
321,CHEMBL511142,CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,IC50,nM,=,7585.78,Inhibitory concentration against potassium channel HERG
322,CHEMBL651,CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,IC50,nM,=,9772.37,Inhibitory concentration against potassium channel HERG
323,CHEMBL475534,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,10000.0,Inhibitory concentration against potassium channel HERG
324,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IC50,nM,=,10000.0,Inhibitory concentration against potassium channel HERG
325,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,10000.0,Inhibitory concentration against potassium channel HERG
326,CHEMBL723,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,IC50,nM,=,10471.29,Inhibitory concentration against potassium channel HERG
327,CHEMBL2368925,O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,IC50,nM,=,12022.64,Inhibitory concentration against potassium channel HERG
328,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,nM,=,17378.01,Inhibitory concentration against potassium channel HERG
329,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,18197.01,Inhibitory concentration against potassium channel HERG
330,CHEMBL505,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,IC50,nM,=,20892.96,Inhibitory concentration against potassium channel HERG
331,CHEMBL657,CN(C)CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,26915.35,Inhibitory concentration against potassium channel HERG
332,CHEMBL1000,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,IC50,nM,=,30199.52,Inhibitory concentration against potassium channel HERG
333,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,50118.72,Inhibitory concentration against potassium channel HERG
334,CHEMBL193,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],IC50,nM,=,50118.72,Inhibitory concentration against potassium channel HERG
335,CHEMBL196431,C/C=C1/N(C)C(C)CC1(c1ccccc1)c1ccccc1,IC50,nM,=,50118.72,Inhibitory concentration against potassium channel HERG
336,CHEMBL1741,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,58884.37,Inhibitory concentration against potassium channel HERG
337,CHEMBL517,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,IC50,nM,=,91201.08,Inhibitory concentration against potassium channel HERG
338,CHEMBL1106,NC1=NCC2c3ccccc3Cc3ccccc3N12,IC50,nM,=,91201.08,Inhibitory concentration against potassium channel HERG
339,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibitory concentration against potassium channel HERG
340,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibitory concentration against potassium channel HERG
341,CHEMBL640,CCN(CC)CCNC(=O)c1ccc(N)cc1,IC50,nM,=,138038.43,Inhibitory concentration against potassium channel HERG
342,CHEMBL3,CN1CCC[C@H]1c1cccnc1,IC50,nM,=,245470.89,Inhibitory concentration against potassium channel HERG
343,CHEMBL485,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,IC50,nM,=,301995.17,Inhibitory concentration against potassium channel HERG
344,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,912010.84,Inhibitory concentration against potassium channel HERG
345,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,nM,=,954992.59,Inhibitory concentration against potassium channel HERG
346,CHEMBL70,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,IC50,nM,=,1000000.0,Inhibitory concentration against potassium channel HERG
347,CHEMBL4,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,1412537.54,Inhibitory concentration against potassium channel HERG
348,CHEMBL194564,O=c1cc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2o1,IC50,nM,=,2250.0,Inhibition of human potassium channel HERG
349,CHEMBL198387,CC(C)(C)C1CCC2(CC1)CCN(c1ccc(OC(F)(F)F)cc1)C(=O)N2Cc1ccc(C(=O)Nc2nn[nH]n2)cc1,IC50,nM,=,5400.0,Inhibitory concentration against Potassium channel hERG
350,CHEMBL201307,COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1,IC50,nM,>,10000.0,Inhibitory activity against human hERG receptor
351,CHEMBL381145,C[C@@H](c1ccc(-c2ccc(O)nc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,=,8300.0,Binding to human ERG potassium channel
352,CHEMBL203169,C[C@@H](c1ccc(-c2cn(C)c(=O)cc2CO)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Binding to human ERG potassium channel
353,CHEMBL205872,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Binding to human ERG potassium channel
354,CHEMBL206383,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Binding to human ERG potassium channel
355,CHEMBL191054,Cc1c(Cl)ccc2c1N1[C@H](CNC[C@H]1C)C2,IC50,nM,=,2500.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
356,CHEMBL203013,C[C@@H]1CNC[C@H]2Cc3ccc(COCC4CC4)nc3N12,IC50,nM,>,30000.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
357,CHEMBL206845,Cc1ccc2c(n1)N1[C@H](C)CNC[C@H]1C2,IC50,nM,=,21000.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
358,CHEMBL203230,C[C@@H]1CNC[C@H]2Cc3ccc(Cl)nc3N12,IC50,nM,=,40000.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
359,CHEMBL380905,Cc1cc2c(F)c(Oc3ncnn4cc(O)c(C)c34)ccc2[nH]1,IC50,,,,Inhibitory activity against hERG by patch-clamp assay
360,CHEMBL206545,Cc1cc2c(F)c(Oc3ncnn4cc(OCCCNS(C)(=O)=O)c(C)c34)ccc2[nH]1,IC50,,,,Inhibitory activity against hERG by patch-clamp assay
361,CHEMBL427202,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)O)c(C)c34)ccc2[nH]1,IC50,,,,Inhibitory activity against hERG by patch-clamp assay
362,CHEMBL206145,Cc1cc2c(F)c(Oc3ncnn4cc(OCCC5CCN(C)CC5)c(C)c34)ccc2[nH]1,IC50,,,,Inhibitory activity against hERG by patch-clamp assay
363,CHEMBL377300,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,IC50,nM,=,18000.0,Inhibitory activity against hERG by patch-clamp assay
364,CHEMBL205710,COC[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,IC50,nM,=,18000.0,Inhibitory activity against hERG by patch-clamp assay
365,CHEMBL383077,Cc1cc2c(F)c(Oc3ncnn4cc(OCCCS(C)(=O)=O)c(C)c34)ccc2[nH]1,IC50,nM,=,20000.0,Inhibitory activity against hERG by patch-clamp assay
366,CHEMBL204459,N[C@H](C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1)C1CC1,IC50,nM,=,6500.0,Inhibitory activity against human hERG receptor expressed in CHO cells by whole cell voltage clamp assay
367,CHEMBL205437,CN(C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1)C1CCNCC1,IC50,nM,=,1300.0,Inhibitory activity against human hERG receptor expressed in HEK cells
368,CHEMBL382165,O=C([C@@H](O)C1CC1)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,nM,=,11000.0,Inhibitory activity against human hERG receptor expressed in HEK cells
369,CHEMBL202788,CC(C)(C)[C@H](NC(=O)OCCO)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,nM,=,25000.0,Inhibitory activity against human hERG receptor expressed in HEK cells
370,CHEMBL204408,CC(C)(C)[C@H](N)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,nM,=,1500.0,Inhibitory activity against human hERG receptor expressed in HEK cells
371,CHEMBL204459,N[C@H](C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1)C1CC1,IC50,nM,=,3500.0,Inhibitory activity against human hERG receptor expressed in HEK cells
372,CHEMBL204369,CC(C)[C@@H](N)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,,,,Inhibitory activity against human hERG receptor expressed in HEK cells
373,CHEMBL379690,CC(C)[C@H](N)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,nM,=,2400.0,Inhibitory activity against human hERG receptor expressed in HEK cells
374,CHEMBL203045,CC(C)(CN)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,nM,=,2200.0,Inhibitory activity against human hERG receptor expressed in HEK cells
375,CHEMBL382587,CN(CCCN)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,nM,=,1300.0,Inhibitory activity against human hERG receptor expressed in HEK cells
376,CHEMBL208422,CC(=O)N1CCC(N(C)C(=O)N2CC(c3cc(F)ccc3F)=C[C@H]2c2ccccc2)CC1,IC50,nM,>,10000.0,Inhibitory activity against human hERG receptor expressed in HEK cells
377,CHEMBL378547,CC(C)(C)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(O)c1,IC50,nM,=,7800.0,Inhibitory activity against human hERG receptor expressed in HEK cells
378,CHEMBL206249,CN(C(=O)N1CC(c2cc(F)ccc2F)=CC1c1cccc(O)c1)C1CCNCC1,IC50,nM,=,6600.0,Inhibitory activity against human hERG receptor expressed in HEK cells
379,CHEMBL206798,CN(CCO)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(O)c1,IC50,nM,=,15000.0,Inhibitory activity against human hERG receptor expressed in HEK cells
380,CHEMBL381533,CN(C)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(O)c1,IC50,nM,=,33000.0,Inhibitory activity against human hERG receptor expressed in HEK cells
381,CHEMBL262736,CC(C)(C)[C@H](O)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(O)c1,IC50,nM,=,7800.0,Inhibitory activity against human hERG receptor expressed in HEK cells
382,CHEMBL377596,O=C([C@@H](O)C1CC1)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(O)c1,IC50,nM,=,18000.0,Inhibitory activity against human hERG receptor expressed in HEK cells
383,CHEMBL206115,N[C@H](C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(O)c1)C1CC1,IC50,nM,=,5600.0,Inhibitory activity against human hERG receptor expressed in HEK cells
384,CHEMBL381526,CC(C)[C@H](N)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(O)c1,IC50,nM,=,8500.0,Inhibitory activity against human hERG receptor expressed in HEK cells
385,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,0.9,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
386,CHEMBL209324,COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(C)cc2)CC1,IC50,nM,>,5000.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
387,CHEMBL210537,CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)c3ccc(C)cc3)CC2)c1,IC50,nM,=,300.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
388,CHEMBL207478,CC(=O)Nc1cccc(N2CCN(CCCCN(C)S(=O)(=O)CC(C)C)CC2)c1,IC50,nM,=,2200.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
389,CHEMBL207220,CC(=O)Nc1cccc(N2CCN(CCCCN(C)S(=O)(=O)CC3CCCCC3)CC2)c1,IC50,nM,=,4000.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
390,CHEMBL379984,CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC(C)C)CC2)c1,IC50,nM,=,3000.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
391,CHEMBL377697,O=C(Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1)C1CC1,IC50,nM,=,1500.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
392,CHEMBL209821,CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1,IC50,nM,=,3800.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
393,CHEMBL211012,CC(=O)Nc1cccc(N2CCN(CC3CCN(S(=O)(=O)CC4CCCCC4)CC3)CC2)c1,IC50,nM,=,2000.0,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
394,CHEMBL209064,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Inhibition of hERG
395,CHEMBL210829,CN(C)C(=O)[C@@H](c1ccc(-c2ccn3ncnc3c2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,IC50,nM,=,16000.0,Inhibition of hERG
396,CHEMBL208957,CN(C)C(=O)[C@@H](c1ccc(-c2ccn3nccc3n2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Inhibition of hERG
397,CHEMBL195232,CC(=O)N1N=C(c2cc(F)ccc2F)C[C@H]1c1cccc(O)c1,IC50,nM,=,26400.0,Inhibition of hERG expressed in HEK cells by radioligand binding assay
398,CHEMBL377566,CN(C)C(=O)N1N=C(c2cc(F)ccc2F)C[C@@]1(CCCN)c1ccccc1,IC50,nM,=,19300.0,Inhibition of hERG expressed in HEK cells by radioligand binding assay
399,CHEMBL207690,CCCc1c(OCCCN2C(=O)Cc3cc(CC(=O)O)ccc32)ccc2c(C(F)(F)F)noc12,IC50,nM,>,10000.0,Inhibition of IKr
400,CHEMBL439342,O=C([C@@H](OP(=O)(O)O)C1CC1)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1,IC50,,,,Inhibitory activity against human hERG receptor expressed in HEK cells
401,CHEMBL382994,O=C([C@@H](O)C1CC1)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(OP(=O)(O)O)c1,IC50,,,,Inhibitory activity against human hERG receptor expressed in HEK cells
402,CHEMBL202734,CC(C)(C)[C@H](O)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1cccc(OP(=O)(O)O)c1,IC50,,,,Inhibitory activity against human hERG receptor expressed in HEK cells
403,CHEMBL411941,CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O,IC50,,,,Inhibition of hERG potassium channel in HEK293 cells by patch clamp assay
404,CHEMBL212689,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1,IC50,nM,=,7300.0,Inhibition of hERG
405,CHEMBL377734,O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F,IC50,nM,=,16600.0,Inhibition of human ERG expressed in HEK293 cells
406,CHEMBL209534,CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N,IC50,nM,>,100000.0,Displacement of [3H]dofetilide from hERG
407,CHEMBL424872,CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N,IC50,nM,>,100000.0,Displacement of [3H]dofetilide from hERG
408,CHEMBL377241,CN[C@@H]1CCN(c2ccc(-n3ncc4cc(-c5ccc(C(F)(F)F)cc5)sc4c3=O)cn2)C1,IC50,nM,=,1800.0,Affinity for human ERG channel by patch clamp assay
409,CHEMBL446703,O=C1NCC(c2ccccc2)C12CCN(C1(c3ccccc3)CCCOC1)CC2,IC50,nM,>,11000.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
410,CHEMBL559007,I.O=C1NCC(c2ccccc2)C12CCN(C1(c3ccccc3)CCOCC1)CC2,IC50,nM,>,14000.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
411,CHEMBL377114,O=C1NCC(c2ccc(F)cc2)C12CCN(C1(c3ccc(F)cc3)CCCCC1)CC2,IC50,nM,=,1300.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
412,CHEMBL534723,CCOc1ccccc1C[C@H](c1ccccc1)N1CCNCC1.Cl,IC50,nM,=,16000.0,Binding affinity to hERG
413,CHEMBL214122,O=C1NCC(c2ccccc2)C12CCN(C1CCCCC1(O)c1ccc(F)cc1)CC2,IC50,nM,=,1800.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
414,CHEMBL378253,O=C1NCC(c2ccc(F)cc2)C12CCN(C1CCCCC1(O)c1ccccc1)CC2,IC50,nM,>,24000000.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
415,CHEMBL2096837,O=C1NC[C@@H](c2ccccc2)C12CCN(C1CCCCC1c1ccccc1)CC2,IC50,nM,=,1400.0,Inhibition of hERG potassium channel expressed in CHO cells by whole cell patch clamp method
416,CHEMBL205285,CN1CCN(CCCN(C(=O)Nc2ccc(F)c(C(F)(F)F)c2)[C@@H]2CC[C@]3(c4ccc(C#N)cc4)C[C@H]23)CC1,IC50,nM,=,52.0,Inhibition of hERG channel by voltage clamp assay
417,CHEMBL209964,CN1CCN(CCCN(C(=O)Nc2ccc(F)c(C(F)(F)F)c2)[C@@H]2CC[C@]3(c4ccc5c(N)noc5c4)C[C@H]23)CC1,IC50,nM,=,690.0,Inhibition of hERG channel by voltage clamp assay
418,CHEMBL382851,CN(C(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)[C@H]1CCN(C(=O)N2CC[C@@H](NCCC(C)(C)c3ccc(Cl)cc3)C2)C1,IC50,nM,=,2600.0,Inhibition of HERG potassium channel expressed in HEK cells by whole cell patch clamp method
419,CHEMBL375330,CN(C(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)[C@H]1CCN(C(=O)N(C)[C@@H]2CCN(CCCc3ccc(Cl)cc3)C2)C1,IC50,nM,=,170.0,Inhibition of HERG potassium channel expressed in HEK cells by whole cell patch clamp method
420,CHEMBL206081,COc1ccc2c(=O)cc(C(=O)NC3CCN(Cc4ccc5c(c4)OCO5)CC3)oc2c1,IC50,nM,=,11.5,Displacement of [3H]dofetilide from hERG
421,CHEMBL437341,N[C@H]1CC(C(=O)N2CCn3c(nnc3C(F)(F)F)C2)=CC[C@@H]1c1cc(F)c(F)c(F)c1.O=C(O)C(F)(F)F,IC50,nM,>,300000.0,Binding affinity to hERG in HEK293 cells by patch clamp assay
422,CHEMBL387417,N#Cc1ccc2c(=O)cc(C(=O)NC3CCN(Cc4ccc5c(c4)OCO5)CC3)oc2c1,IC50,nM,=,5.0,Displacement of [3H]dofetilide from hERG
423,CHEMBL214021,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,15.1,Displacement of [3H]dofetilide from hERG
424,CHEMBL217789,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(Cl)cc2o1,IC50,nM,=,3.6,Displacement of [3H]dofetilide from hERG
425,CHEMBL217706,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(Br)cc2o1,IC50,nM,=,2.5,Displacement of [3H]dofetilide from hERG
426,CHEMBL214377,CCc1ccc2c(=O)cc(C(=O)NC3CCN(Cc4ccc5c(c4)OCO5)CC3)oc2c1,IC50,nM,=,7.4,Displacement of [3H]dofetilide from hERG
427,CHEMBL213715,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(OC(F)F)cc2o1,IC50,nM,=,3.6,Displacement of [3H]dofetilide from hERG
428,CHEMBL215631,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(O)cc2o1,IC50,nM,=,63.7,Displacement of [3H]dofetilide from hERG
429,CHEMBL402868,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(C(F)(F)F)cc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
430,CHEMBL214413,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(F)c(F)c(F)c2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
431,CHEMBL2113245,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2c(Cl)c(Cl)ccc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
432,CHEMBL441542,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(F)cc(F)c2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
433,CHEMBL277531,Cc1c(C(=O)NC2CCN(Cc3ccc4c(c3)OCO4)CC2)oc2cc(Cl)ccc2c1=O,IC50,,,,Displacement of [3H]dofetilide from hERG
434,CHEMBL386021,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2c(Cl)cccc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
435,CHEMBL387219,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(OC(F)(F)F)ccc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
436,CHEMBL213658,Cc1ccc2oc(C(=O)NC3CCN(Cc4ccc5c(c4)OCO5)CC3)cc(=O)c2c1,IC50,,,,Displacement of [3H]dofetilide from hERG
437,CHEMBL217925,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(Br)ccc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
438,CHEMBL216577,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(C(F)(F)F)ccc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
439,CHEMBL216133,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(Cl)ccc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
440,CHEMBL214731,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(F)ccc2o1,IC50,nM,=,4.0,Displacement of [3H]dofetilide from hERG
441,CHEMBL387178,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(F)c(F)cc2o1,IC50,nM,=,6.2,Displacement of [3H]dofetilide from hERG
442,CHEMBL217442,COc1cc2oc(C(=O)NC3CCN(Cc4ccc5c(c4)OCO5)CC3)cc(=O)c2cc1F,IC50,nM,=,15.9,Displacement of [3H]dofetilide from hERG
443,CHEMBL387418,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(F)c(Cl)cc2o1,IC50,nM,=,10.5,Displacement of [3H]dofetilide from hERG
444,CHEMBL214767,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccccc2o1,IC50,nM,=,6.7,Displacement of [3H]dofetilide from hERG
445,CHEMBL204828,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(Cl)c(Cl)cc2o1,IC50,nM,=,1.4,Displacement of [3H]dofetilide from hERG
446,CHEMBL214278,O=C(NC1CCN(Cc2ccc(F)cc2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
447,CHEMBL214075,COc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1OC,IC50,,,,Displacement of [3H]dofetilide from hERG
448,CHEMBL214679,O=C(NC1CCN(Cc2cccc3c2OCO3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
449,CHEMBL213761,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,19.9,Displacement of [3H]dofetilide from hERG
450,CHEMBL217707,O=C(NC1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,5.6,Displacement of [3H]dofetilide from hERG
451,CHEMBL216680,CC(=O)Nc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1,IC50,nM,=,47.7,Displacement of [3H]dofetilide from hERG
452,CHEMBL384487,CC(=O)c1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1,IC50,nM,=,20.3,Displacement of [3H]dofetilide from hERG
453,CHEMBL214768,COc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1F,IC50,nM,=,8.5,Displacement of [3H]dofetilide from hERG
454,CHEMBL387309,COc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)c(F)c1,IC50,nM,=,14.7,Displacement of [3H]dofetilide from hERG
455,CHEMBL216225,O=C(NC1CCN(Cc2cccc(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,21.2,Displacement of [3H]dofetilide from hERG
456,CHEMBL216777,O=C(NC1CCN(Cc2ccccc2F)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG
457,CHEMBL217593,COc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1,IC50,nM,=,5.4,Displacement of [3H]dofetilide from hERG
458,CHEMBL217400,COc1cccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)c1,IC50,nM,=,10.4,Displacement of [3H]dofetilide from hERG
459,CHEMBL425448,O=C(NC1CCN(Cc2ccc3c(c2)OCCO3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,12.2,Displacement of [3H]dofetilide from hERG
460,CHEMBL217105,O=C(NC1CCN(Cc2cc3c(cc2Cl)OCO3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,13.5,Displacement of [3H]dofetilide from hERG
461,CHEMBL214021,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,1600.0,Activity at hERG expressed in HEK293 cells assessed as blockade of current at -50 mV by voltage clamp assay
462,CHEMBL214808,CN1CCN(Cc2ccc3cc(-n4cnc5cc(-c6ccc(Cl)cc6)sc5c4=O)ccc3n2)CC1,IC50,nM,=,21877.62,Inhibitory activity against hERG by patch-clamp assay
463,CHEMBL215023,COc1ccc2c(=O)n(CC(O)CO)c(C#N)c(-c3cccc(F)c3)c2c1,IC50,nM,=,33500.0,Binding affinity to hERG potassium channel
464,CHEMBL216168,COc1ccc2c(=O)n(CC(O)CO)c(C#N)c(-c3cccc(C(F)(F)F)c3)c2c1,IC50,nM,=,16000.0,Binding affinity to hERG potassium channel
465,CHEMBL217571,COc1ccc2c(=O)n(C[C@@H](O)CO)c(C#N)c(-c3ccccc3)c2c1,IC50,nM,=,76000.0,Binding affinity to hERG potassium channel
466,CHEMBL216894,COc1ccc2c(=O)n(C[C@H](O)CO)c(C#N)c(-c3ccccc3)c2c1,IC50,nM,=,135000.0,Binding affinity to hERG potassium channel
467,CHEMBL214553,COc1ccc2c(=O)n(CC(CO)NCc3cccnc3)c(C#N)c(-c3ccccc3)c2c1,IC50,nM,=,10000.0,Binding affinity to hERG potassium channel
468,CHEMBL215050,COCCN(C)CCn1c(C#N)c(-c2cccc(F)c2)c2cc(OC)ccc2c1=O,IC50,nM,=,1650.0,Binding affinity to hERG potassium channel
469,CHEMBL214969,COc1ccc2c(=O)n(CCO)c(C#N)c(-c3cccc(F)c3)c2c1,IC50,nM,=,62000.0,Binding affinity to hERG potassium channel
470,CHEMBL214578,COc1ccc2c(C(=O)NCCO)nc(C#N)c(-c3ccccc3)c2c1,IC50,nM,>,30000.0,Binding affinity to hERG potassium channel
471,CHEMBL215818,COc1ccc2c(-n3cnc(C)c3)nc(C#N)c(-c3cccc(F)c3)c2c1,IC50,nM,=,21000.0,Binding affinity to hERG potassium channel
472,CHEMBL214876,COc1ccc2c(NC[C@H](O)CO)nc(C#N)c(-c3ccccc3)c2c1,IC50,nM,=,15000.0,Binding affinity to hERG potassium channel
473,CHEMBL383997,COc1ccc2c(OC[C@H](O)CO)nc(C#N)c(-c3ccccc3)c2c1,IC50,nM,=,20500.0,Binding affinity to hERG potassium channel
474,CHEMBL214742,COc1ccc2c(=O)n(C)c(CN(C)C)c(-c3ccccc3)c2c1,IC50,nM,=,5300.0,Binding affinity to hERG potassium channel
475,CHEMBL385049,COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC[C@@H]1CO,IC50,nM,>,30000.0,activity against the human ether-a-go-go-related gene (hERG)-encoded potassium channel was determined using conventional or automated whole-cell electrophysiology
476,CHEMBL214849,CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC,IC50,nM,>,30000.0,activity against the human ether-a-go-go-related gene (hERG)-encoded potassium channel was determined using conventional or automated whole-cell electrophysiology
477,CHEMBL215022,O=C(Cc1cc(Nc2ncnc3cc(OCCCN4CCC[C@@H]4CO)ccc23)n[nH]1)Nc1cccc(F)c1F,IC50,nM,>,30000.0,activity against the human ether-a-go-go-related gene (hERG)-encoded potassium channel was determined using conventional or automated whole-cell electrophysiology
478,CHEMBL215152,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,IC50,nM,>,30000.0,activity against the human ether-a-go-go-related gene (hERG)-encoded potassium channel was determined using conventional or automated whole-cell electrophysiology
479,CHEMBL216228,Cc1nc(N2CCCC2)nc2ccc(NC(=O)COc3ccc(Cl)cc3)cc12,IC50,nM,=,10000.0,Inhibition of hERG in patch-clamp assay
480,CHEMBL214021,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,15100.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
481,CHEMBL216554,O=C(NC1CCN(Cc2ccc3occc3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,5280.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
482,CHEMBL216104,O=C(NC1CCN(Cc2ccc3sccc3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,1370.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
483,CHEMBL216180,O=C(NC1CCN(Cc2ccc3[nH]ccc3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,6080.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
484,CHEMBL274168,O=C(NC1CCN(Cc2ccc3cc[nH]c3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,2530.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
485,CHEMBL216524,O=C(NC1CCN(Cc2ccc3ncoc3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,34600.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
486,CHEMBL215457,CCc1nc2ccc(CN3CCC(NC(=O)c4cc(=O)c5ccc(F)cc5o4)CC3)cc2o1,IC50,nM,=,26700.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
487,CHEMBL384043,CCc1nc2cc(CN3CCC(NC(=O)c4cc(=O)c5ccc(F)cc5o4)CC3)ccc2o1,IC50,nM,=,20000.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
488,CHEMBL217435,O=C(NC1CCN(Cc2ccc3oc(=O)[nH]c3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,25000.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
489,CHEMBL216323,O=C(NC1CCN(Cc2ccc3oc(=O)oc3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,85200.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
490,CHEMBL217233,O=C1COc2ccc(CN3CCC(NC(=O)c4cc(=O)c5ccc(F)cc5o4)CC3)cc2N1,IC50,nM,=,5790.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
491,CHEMBL216482,O=C(NC1CCN(Cc2ccc3ccc(=O)[nH]c3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,85500.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
492,CHEMBL266725,Cn1c(=O)ccc2ccc(CN3CCC(NC(=O)c4cc(=O)c5ccc(F)cc5o4)CC3)cc21,IC50,nM,=,47400.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
493,CHEMBL386281,O=C(NC1CCN(Cc2ccc3ccc(=O)oc3c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,51100.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
494,CHEMBL216680,CC(=O)Nc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1,IC50,nM,=,47700.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
495,CHEMBL269352,CC(=O)Nc1cccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)c1,IC50,nM,=,60700.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
496,CHEMBL214731,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2cc(F)ccc2o1,IC50,nM,=,15000.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
497,CHEMBL214585,O=C(NC1CCN(C2CCc3cc4c(cc32)OCO4)CC1)c1cc(=O)c2cc(F)ccc2o1,IC50,nM,=,11200.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
498,CHEMBL425257,O=C(NC1CCN(C2CCc3c2ccc2c3OCO2)CC1)c1cc(=O)c2cc(F)ccc2o1,IC50,nM,=,5860.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
499,CHEMBL214585,O=C(NC1CCN(C2CCc3cc4c(cc32)OCO4)CC1)c1cc(=O)c2cc(F)ccc2o1,IC50,nM,=,9310.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
500,CHEMBL214585,O=C(NC1CCN(C2CCc3cc4c(cc32)OCO4)CC1)c1cc(=O)c2cc(F)ccc2o1,IC50,nM,=,7870.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
501,CHEMBL384111,O=C(NC1CCN(C2CCc3cc4oc(=O)[nH]c4cc32)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,25000.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
502,CHEMBL384919,O=C1COc2cc3c(cc2N1)C(N1CCC(NC(=O)c2cc(=O)c4ccc(F)cc4o2)CC1)CC3,IC50,nM,=,14600.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
503,CHEMBL215661,CC(=O)Nc1ccc2c(c1)C(N1CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC1)CC2,IC50,nM,=,34800.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
504,CHEMBL215661,CC(=O)Nc1ccc2c(c1)C(N1CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC1)CC2,IC50,nM,=,27200.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
505,CHEMBL215661,CC(=O)Nc1ccc2c(c1)C(N1CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC1)CC2,IC50,nM,=,15600.0,Displacement of 3H-dofetilide from hERG-expressing HEK membrane homogenates
506,CHEMBL216821,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(F)cc3)cc1)C2,IC50,nM,=,1800.0,Inhibition of binding to hERG
507,CHEMBL215278,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(Cl)cc3)cn1)C2,IC50,nM,=,2600.0,Inhibition of binding to hERG
508,CHEMBL217820,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(Cl)cc3)nc1)C2,IC50,nM,=,5100.0,Inhibition of binding to hERG
509,CHEMBL215660,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(F)cc3)cn1)C2,IC50,nM,=,5200.0,Inhibition of binding to hERG
510,CHEMBL216314,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(F)cc3)nc1)C2,IC50,nM,=,10000.0,Inhibition of binding to hERG
511,CHEMBL216741,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(Cl)cn3)cc1)C2,IC50,nM,=,14000.0,Inhibition of binding to hERG
512,CHEMBL216406,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccccc3)cn1)C2,IC50,nM,=,20000.0,Inhibition of binding to hERG
513,CHEMBL267320,CN(C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccccn3)cc1)C2,IC50,nM,=,30000.0,Inhibition of binding to hERG
514,CHEMBL214432,CN(CC(=O)N(C)C)Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(F)cc3)cc1)C2,IC50,nM,=,1800.0,Inhibition of binding to hERG
515,CHEMBL424895,CN(C)C(=O)[C@@H]1CCCN1Cc1ccc2c(c1)CC[C@H](N(C)C(=O)c1ccc(-c3ccc(F)cc3)cc1)C2,IC50,nM,=,5000.0,Inhibition of binding to hERG
516,CHEMBL437728,CN(C(=O)c1ccc(-c2ccc(F)cc2)cc1)[C@H]1CCc2cc(CN3CCN(C(N)=O)CC3)ccc2C1,IC50,nM,=,6700.0,Inhibition of binding to hERG
517,CHEMBL214629,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCc3ccc(F)cc3)CC1=O)C2,IC50,nM,=,8100.0,Inhibition of binding to hERG
518,CHEMBL384400,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCc3ccc(Cl)cc3)CC1=O)C2,IC50,nM,=,3300.0,Inhibition of binding to hERG
519,CHEMBL214323,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCc3cccc(C(F)(F)F)c3)CC1=O)C2,IC50,nM,=,1700.0,Inhibition of binding to hERG
520,CHEMBL384000,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCC3CCCCC3)CC1=O)C2,IC50,nM,=,3300.0,Inhibition of binding to hERG
521,CHEMBL215526,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCC3CCCS3)CC1=O)C2,IC50,nM,=,13200.0,Inhibition of binding to hERG
522,CHEMBL216486,O=C1CN(CCc2ccc(F)cc2)CCN1[C@H]1CCc2cc(CN3CCC(C(F)(F)F)CC3)ccc2C1,IC50,nM,=,2000.0,Inhibition of binding to hERG
523,CHEMBL214983,O=C1CN(CCc2ccc(F)cc2)CCN1[C@H]1CCc2cc(Cn3ccnc3)ccc2C1,IC50,nM,=,4000.0,Inhibition of binding to hERG
524,CHEMBL217875,O=C1CN(CCc2ccc(F)cc2)CCN1[C@H]1CCc2cc(CN3CCOCC3)ccc2C1,IC50,nM,=,11000.0,Inhibition of binding to hERG
525,CHEMBL384030,CS(=O)(=O)N1CCN(Cc2ccc3c(c2)CC[C@H](N2CCN(CCc4ccc(F)cc4)CC2=O)C3)CC1,IC50,nM,=,13000.0,Inhibition of binding to hERG
526,CHEMBL216959,O=C1CN(CCc2ccc(F)cc2)CCN1[C@H]1CCc2cc(CN3CCS(=O)(=O)CC3)ccc2C1,IC50,nM,=,24000.0,Inhibition of binding to hERG
527,CHEMBL386717,CC(=O)N1CCN(Cc2ccc3c(c2)CC[C@H](N2CCN(CCc4ccc(F)cc4)CC2=O)C3)CC1,IC50,nM,=,25000.0,Inhibition of binding to hERG
528,CHEMBL385710,CN(C)C(=O)C(CO)N(C)Cc1ccc2c(c1)CC[C@H](N1CCN(CCc3ccc(F)cc3)CC1=O)C2,IC50,nM,=,25000.0,Inhibition of binding to hERG
529,CHEMBL217133,CCc1c(C)[nH]c2c1/C(=N/NC(=O)Nc1ccccc1)CCC2,IC50,nM,=,21000.0,Inhibition of hERG expressed in HEK cells by whole cell patch clamp assay
530,CHEMBL217347,CCc1c(C)[nH]c2c1/C(=N/OC(=O)Nc1ccccc1)CCC2,IC50,nM,>,30000.0,Inhibition of hERG expressed in HEK cells by whole cell patch clamp assay
531,CHEMBL216281,CCc1c2c(n(C)c1CC)CCC/C2=N\OC(=O)Nc1ccccc1,IC50,nM,>,30000.0,Inhibition of hERG expressed in HEK cells by whole cell patch clamp assay
532,CHEMBL438992,C[C@H](c1nc(-c2ccc(Cl)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,IC50,nM,=,36700.0,Inhibition of hERG potassium channel
533,CHEMBL375745,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(=O)N3CC[C@H](F)C3)n2)c(F)c1.O=C(O)C(F)(F)F,IC50,nM,=,58500.0,Inhibition of hERG potassium channel
534,CHEMBL216835,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1,IC50,nM,>,100000.0,Inhibition of hERG potassium channel
535,CHEMBL375442,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(=O)N3CC[C@H](F)C3)n2)cc1.O=C(O)C(F)(F)F,IC50,nM,>,100000.0,Inhibition of hERG potassium channel
536,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,>,50000.0,Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assay
537,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,56000.0,Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assay
538,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,23000.0,Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assay
539,CHEMBL1000,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assay
540,CHEMBL48029,c1ccc(COc2ccc(CCNc3ccncc3)cc2)cc1,IC50,nM,=,130.0,Displacement of [35S]MK-499 from hERG potassium channel expressed in HEK293 cells
541,CHEMBL181350,CCN(CC)c1ccc(NC(=O)C2(N(C)C(=O)OCC(C)C)CCc3cccc(OC)c3C2)cc1,IC50,nM,=,6100.0,Inhibition of hERG receptor
542,CHEMBL223943,CC#Cc1cc(-c2n[nH]c3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)cs1,IC50,nM,=,1410.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
543,CHEMBL225240,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccc(CN6CCOCC6)cc5)c4)n[nH]c2-3)CC1,IC50,nM,=,2560.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
544,CHEMBL223997,CCCC#Cc1cc(-c2n[nH]c3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)cs1,IC50,nM,=,1800.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
545,CHEMBL225639,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCCO)c4)n[nH]c2-3)CC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
546,CHEMBL225036,COCC#Cc1cc(-c2n[nH]c3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)cs1,IC50,nM,=,5190.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
547,CHEMBL225090,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,450.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
548,CHEMBL225318,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5Cl)c4)n[nH]c2-3)CC1,IC50,nM,=,790.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
549,CHEMBL225319,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5cccc(Cl)c5)c4)n[nH]c2-3)CC1,IC50,nM,=,2590.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
550,CHEMBL387929,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccc(Cl)cc5)c4)n[nH]c2-3)CC1,IC50,nM,=,3590.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
551,CHEMBL224497,Cc1ccc(OCC#Cc2cc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)cs2)cc1C,IC50,nM,=,2500.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
552,CHEMBL223219,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5cccnc5)c4)n[nH]c2-3)CC1,IC50,nM,=,3390.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
553,CHEMBL223998,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCCc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,4800.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
554,CHEMBL426009,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,1750.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
555,CHEMBL225311,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNC(=O)c5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,7460.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
556,CHEMBL376779,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNS(=O)(=O)c5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,4870.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
557,CHEMBL224968,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNC(=O)Oc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,2750.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
558,CHEMBL225336,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCNC(=O)Nc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,7910.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
559,CHEMBL389499,C(#Cc1cc(-c2n[nH]c3c2Cc2ccccc2-3)cs1)COc1ccccc1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
560,CHEMBL224547,CN1CCN(c2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,1740.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
561,CHEMBL390353,CN1CCN(CCc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,5870.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
562,CHEMBL387972,CC1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,80.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
563,CHEMBL223999,CN1CCC(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,2100.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
564,CHEMBL225261,NC(=O)N1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,5360.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
565,CHEMBL225278,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1=O,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
566,CHEMBL225334,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)C(=O)C1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
567,CHEMBL390735,CN1CCN(C(=O)c2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1,IC50,nM,=,1720.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
568,CHEMBL224027,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(CN4CCSC4)ccc2-3)cs1)COc1ccccc1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
569,CHEMBL223604,COCCOc1ccc2c(c1)Cc1c(-c3csc(C#CCOc4ccccc4)c3)n[nH]c1-2,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
570,CHEMBL374690,CN(C)C(=O)COc1ccc2c(c1)Cc1c(-c3csc(C#CCOc4ccccc4)c3)n[nH]c1-2,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
571,CHEMBL224834,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4ccnc4)ccc2-3)cs1)COc1ccccc1,IC50,nM,=,1430.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
572,CHEMBL224889,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4cccn4)ccc2-3)cs1)COc1ccccc1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
573,CHEMBL224917,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4ccnn4)ccc2-3)cs1)COc1ccccc1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
574,CHEMBL224918,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4cncn4)ccc2-3)cs1)COc1ccccc1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
575,CHEMBL225192,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC(N)=O)c4)n[nH]c2-3)CC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
576,CHEMBL225193,COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)cs1,IC50,nM,=,9190.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
577,CHEMBL225335,COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(CN4CCN(C)CC4)cc2-3)cs1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
578,CHEMBL445404,COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4cncn4)ccc2-3)cs1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
579,CHEMBL223971,COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(Cn4cncn4)cc2-3)cs1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
580,CHEMBL225334,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)C(=O)C1,IC50,nM,=,53000.0,Inhibition of hERG expressed in HEK293 cells assessed as effect on ionic current by patch clamp assay
581,CHEMBL224918,C(#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4cncn4)ccc2-3)cs1)COc1ccccc1,IC50,nM,=,1700.0,Inhibition of hERG expressed in HEK293 cells assessed as effect on ionic current by patch clamp assay
582,CHEMBL445404,COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2cc(Cn4cncn4)ccc2-3)cs1,IC50,nM,>,150000.0,Inhibition of hERG expressed in HEK293 cells assessed as effect on ionic current by patch clamp assay
583,CHEMBL223971,COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(Cn4cncn4)cc2-3)cs1,IC50,nM,=,11600.0,Inhibition of hERG expressed in HEK293 cells assessed as effect on ionic current by patch clamp assay
584,CHEMBL387971,COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1,IC50,nM,=,9400.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells
585,CHEMBL387971,COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1,IC50,nM,=,5300.0,Inhibition of hERG expressed in HEK293 cells assessed as effect on ionic current by patch clamp assay
586,CHEMBL214629,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCc3ccc(F)cc3)CC1=O)C2,IC50,nM,=,8100.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
587,CHEMBL214323,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCc3cccc(C(F)(F)F)c3)CC1=O)C2,IC50,nM,=,1700.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
588,CHEMBL384400,CCN(CC)Cc1ccc2c(c1)CC[C@H](N1CCN(CCc3ccc(Cl)cc3)CC1=O)C2,IC50,nM,=,3300.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
589,CHEMBL425994,CN(C)Cc1cc(OCCCN2CCCCC2)ccc1Nc1ncnc2ccccc12,IC50,nM,>,10000.0,Inhibition of hERG at 10 uM
590,CHEMBL379218,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,IC50,nM,=,13400.0,Inhibition of hERG by patch clamp assay
591,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,9.2,Blockade of hERG expressed in HEK293 cells by whole-cell patch clamp method
592,CHEMBL227000,CC1(C)C2=C3CC4C5=[N+](CCC4OC3CCN2c2ccc(CC(=O)NCCCCCCN(CCOc3ccc(NS(C)(=O)=O)cc3)CCc3ccc(NS(C)(=O)=O)cc3)cc21)c1ccc(S(=O)(=O)[O-])cc1C5(C)C,IC50,nM,=,310.0,Blockade of hERG expressed in HEK293 cells by whole-cell patch clamp method
593,CHEMBL227134,CS(=O)(=O)Nc1ccc(CCN(CCOc2ccc(NS(C)(=O)=O)cc2)c2ccc([N+](=O)[O-])c3nonc23)cc1,IC50,nM,<,3.0,Blockade of hERG expressed in HEK293 cells by whole-cell patch clamp method
594,CHEMBL230984,N[C@H]1CN(c2ccncn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,IC50,nM,=,26100.0,Inhibition of human ERG potassium channel
595,CHEMBL231497,Cc1nnc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nn12.O=C(O)C(F)(F)F,IC50,nM,=,20300.0,Inhibition of human ERG potassium channel
596,CHEMBL231397,Cc1cc(=O)n2nc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ccc2n1.O=C(O)C(F)(F)F,IC50,nM,=,33200.0,Inhibition of human ERG potassium channel
597,CHEMBL231396,N[C@H]1CN(c2ccc3nc(=O)ccn3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,IC50,nM,=,100000.0,Inhibition of human ERG potassium channel
598,CHEMBL231294,N[C@H]1CN(c2ccn3cnnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,IC50,nM,=,100000.0,Inhibition of human ERG potassium channel
599,CHEMBL231293,N[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,IC50,nM,=,8100.0,Inhibition of human ERG potassium channel
600,CHEMBL231196,N[C@H]1CN(c2cnc3nccnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,IC50,nM,=,9900.0,Inhibition of human ERG potassium channel
601,CHEMBL229008,CCN1CCN(c2ccc(C(C)(C)NC(=O)c3cc4[nH]c5ccccc5c(=O)c4cc3F)cn2)CC1,IC50,nM,=,25000.0,Inhibition of hERG by patch clamp method
602,CHEMBL244347,CN(C(=O)CC[C@@H](C1CCCCC1)N1Cc2cc(Oc3ccccc3)ccc2N=C1N)C1CCCCC1,IC50,nM,=,140.0,Inhibition of hERG
603,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from hERG expressed in CHO cells
604,CHEMBL242603,Cc1ccc2c(-c3nnc(SCCC(C)N4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from hERG expressed in CHO cells
605,CHEMBL242602,Cc1cc(-c2ccc3c(c2)CCN(CCSc2nnc(-c4ccc(F)c(F)c4)n2C)CC3)n(C)n1,IC50,nM,=,501.19,Displacement of [3H]dofetilide from hERG expressed in CHO cells
606,CHEMBL242601,Cc1cnc(-c2nnc(SCCN3CCc4ccc(-c5cc(C)nn5C)cc4CC3)n2C)cn1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from hERG expressed in CHO cells
607,CHEMBL245120,Cc1ccc2c(-c3nnc(SCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from hERG expressed in CHO cells
608,CHEMBL245119,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ocnc4C)n2C)CC3)n(C)n1,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from hERG expressed in CHO cells
609,CHEMBL390649,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)n(C)n1,IC50,nM,=,31.62,Displacement of [3H]dofetilide from hERG expressed in CHO cells
610,CHEMBL245118,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(F)c(F)c4)n2C)CC3)n(C)n1,IC50,nM,=,251.19,Displacement of [3H]dofetilide from hERG expressed in CHO cells
611,CHEMBL244946,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from hERG expressed in CHO cells
612,CHEMBL244945,COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cn1,IC50,nM,=,158.49,Displacement of [3H]dofetilide from hERG expressed in CHO cells
613,CHEMBL242600,COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,IC50,nM,=,39.81,Displacement of [3H]dofetilide from hERG expressed in CHO cells
614,CHEMBL390429,COc1ccccc1-c1nnc(SCCCN2CCc3ccc(-c4cc(C)on4)cc3CC2)n1C,IC50,nM,=,39.81,Displacement of [3H]dofetilide from hERG expressed in CHO cells
615,CHEMBL242598,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCOCC4)n2C)CC3)no1,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from hERG expressed in CHO cells
616,CHEMBL243860,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCC(C)CC4)n2C)CC3)no1,IC50,nM,=,125.89,Displacement of [3H]dofetilide from hERG expressed in CHO cells
617,CHEMBL243859,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCCC4)n2C)CC3)no1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from hERG expressed in CHO cells
618,CHEMBL243474,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)(C)C)n2C)CC3)no1,IC50,nM,=,398.11,Displacement of [3H]dofetilide from hERG expressed in CHO cells
619,CHEMBL243901,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)C)n2C)CC3)no1,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from hERG expressed in CHO cells
620,CHEMBL243900,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(F)(F)F)n2C)CC3)no1,IC50,nM,=,316.23,Displacement of [3H]dofetilide from hERG expressed in CHO cells
621,CHEMBL243899,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C)n2C)CC3)no1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from hERG expressed in CHO cells
622,CHEMBL244280,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(F)c4)n2C)CC3)no1,IC50,nM,=,251.19,Displacement of [3H]dofetilide from hERG expressed in CHO cells
623,CHEMBL397222,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)c(Cl)c4)n2C)CC3)no1,IC50,nM,=,10.0,Displacement of [3H]dofetilide from hERG expressed in CHO cells
624,CHEMBL244279,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)cc4)n2C)CC3)no1,IC50,nM,=,25.12,Displacement of [3H]dofetilide from hERG expressed in CHO cells
625,CHEMBL244278,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(Cl)c4)n2C)CC3)no1,IC50,nM,=,79.43,Displacement of [3H]dofetilide from hERG expressed in CHO cells
626,CHEMBL244087,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4Cl)n2C)CC3)no1,IC50,nM,=,63.1,Displacement of [3H]dofetilide from hERG expressed in CHO cells
627,CHEMBL395743,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccn4C)n2C)CC3)no1,IC50,nM,=,251.19,Displacement of [3H]dofetilide from hERG expressed in CHO cells
628,CHEMBL244086,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)no1,IC50,nM,=,125.89,Displacement of [3H]dofetilide from hERG expressed in CHO cells
629,CHEMBL244085,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccncc4)n2C)CC3)no1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from hERG expressed in CHO cells
630,CHEMBL243898,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccn4)n2C)CC3)no1,IC50,nM,=,251.19,Displacement of [3H]dofetilide from hERG expressed in CHO cells
631,CHEMBL395742,Cc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,IC50,nM,=,25.12,Displacement of [3H]dofetilide from hERG expressed in CHO cells
632,CHEMBL243897,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)no1,IC50,nM,=,63.1,Displacement of [3H]dofetilide from hERG expressed in CHO cells
633,CHEMBL243896,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C#N)cc4)n2C)CC3)no1,IC50,nM,=,19.95,Displacement of [3H]dofetilide from hERG expressed in CHO cells
634,CHEMBL243709,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4)n2C)CC3)no1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from hERG expressed in CHO cells
635,CHEMBL243708,Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5nc(C)c(C)nc5c4)n2C)CC3)no1,IC50,nM,=,316.23,Displacement of [3H]dofetilide from hERG expressed in CHO cells
636,CHEMBL243707,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)cccc2n1,IC50,nM,=,501.19,Displacement of [3H]dofetilide from hERG expressed in CHO cells
637,CHEMBL244277,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccn4C)n2C)CC3)o1,IC50,nM,=,501.19,Displacement of [3H]dofetilide from hERG expressed in CHO cells
638,CHEMBL244276,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5[nH]ccc5c4)n2C)CC3)o1,IC50,nM,=,39.81,Displacement of [3H]dofetilide from hERG expressed in CHO cells
639,CHEMBL397429,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cc5ccccc5[nH]4)n2C)CC3)o1,IC50,nM,=,50.12,Displacement of [3H]dofetilide from hERG expressed in CHO cells
640,CHEMBL244275,Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)o1,IC50,nM,=,316.23,Displacement of [3H]dofetilide from hERG expressed in CHO cells
641,CHEMBL244084,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6ncc(C)o6)cc5CC4)n3C)cccc2n1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from hERG expressed in CHO cells
642,CHEMBL244083,Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from hERG expressed in CHO cells
643,CHEMBL243707,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)cccc2n1,IC50,nM,=,125.89,Binding affinity to hERG expressed in CHO cells by patch clamp assay
644,CHEMBL233047,CCN(CC)C(C)CCCNc1nccc(NCc2ccc(Cl)cc2Cl)n1.N,IC50,nM,=,300.0,Inhibition of hERG
645,CHEMBL233046,O=C([C@@H]1CCCCN1)N1CCN(c2nc(NCc3ccc(Cl)cc3Cl)c3cccnc3n2)CC1,IC50,nM,>,30000.0,Inhibition of hERG
646,CHEMBL377566,CN(C)C(=O)N1N=C(c2cc(F)ccc2F)C[C@@]1(CCCN)c1ccccc1,IC50,nM,=,19300.0,Inhibition of hERG expressed in CHO cells by cell voltage clamp assay
647,CHEMBL395034,CN(C)C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CC[C@H](N)C(F)F)c1ccccc1,IC50,nM,=,15900.0,Inhibition of hERG expressed in CHO cells by cell voltage clamp assay
648,CHEMBL395332,CN(C)C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CCCN)c1ccccc1,IC50,nM,=,7100.0,Inhibition of hERG expressed in CHO cells by cell voltage clamp assay
649,CHEMBL3392292,CS(=O)(=O)O.NC[C@H]1CC[C@]2(CC1)OOC1(O2)C2CC3CC(C2)CC1C3,IC50,nM,=,1800.0,Inhibition of hERG by patch clamp assay
650,CHEMBL233781,NC(=O)CNC[C@H]1CC[C@]2(CC1)OO[C@]1(O2)C2CC3CC(C2)CC1C3,IC50,nM,=,2700.0,Inhibition of hERG by patch clamp assay
651,CHEMBL239414,CC(=O)N1CCN(CCC[C@@]2(c3ccccc3)CC(c3cc(F)ccc3F)=NN2C(C)=O)CC1,IC50,nM,>,30000.0,Binding affinity to human ERG in HEK cells
652,CHEMBL236893,O=C(CCc1ccccc1)N[C@H]1CC[C@H](c2ccc(O)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
653,CHEMBL237533,O=C(CCc1ccccc1)N[C@H]1CC[C@](O)(c2ccc(O)c(F)c2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
654,CHEMBL237323,Cc1cc(O)ccc1[C@H]1CC[C@H](NC(=O)CCc2ccccc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
655,CHEMBL237320,O=C(CCc1ccccc1)N[C@H]1CC[C@](O)(c2ccc(O)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
656,CHEMBL237103,CN(C)C(Cc1ccccc1)C(=O)N[C@H]1CC[C@H](c2ccc(O)cc2)CC1,IC50,,,,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
657,CHEMBL237102,O=C(N[C@H]1CC[C@H](c2ccc(O)cc2)CC1)C1Cc2ccccc2CN1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
658,CHEMBL393609,Cn1c(CCC(=O)N[C@H]2CC[C@H](c3ccc(O)cc3)CC2)nc2ccccc21,IC50,,,,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
659,CHEMBL237101,Cc1cnc(CCC(=O)N[C@H]2CC[C@H](c3ccc(O)cc3)CC2)s1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
660,CHEMBL236895,O=C(CCc1ccccn1)N[C@H]1CC[C@H](c2ccc(O)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
661,CHEMBL236894,O=C(CCc1cccnc1)N[C@H]1CC[C@H](c2ccc(O)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
662,CHEMBL237751,O=C(CCc1ccccc1)N[C@H]1CC[C@](O)(c2ccc(O)cn2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
663,CHEMBL319706,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,IC50,nM,<,1000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
664,CHEMBL391122,O=C1CC(Cc2ccccc2)CCN1CC(O)c1ccc(O)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
665,CHEMBL237793,O=C1CCc2cc([C@@H](O)CN3CCC(O)(c4cccc(F)c4)CC3)ccc2N1,IC50,nM,=,1100.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
666,CHEMBL237321,Cc1cc([C@]2(O)CC[C@@H](NC(=O)CCc3ccccc3)CC2)ccc1O,IC50,ucm,>,10.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
667,CHEMBL395904,Cc1cc(O)ccc1[C@]1(O)CC[C@@H](NC(=O)CCc2ccccc2)CC1,IC50,ucm,>,10.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
668,CHEMBL237534,O=C(CCc1ccccc1)N[C@H]1CC[C@H](c2ccc(O)c(F)c2)CC1,IC50,ucm,>,10.0,Displacement of [3H]dofetilide from human HERG expressed in HEK293 cells
669,CHEMBL237119,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,IC50,nM,=,4600.0,Inhibition of human ERG
670,CHEMBL237547,CC(=O)N[C@H]1CC[C@H]([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
671,CHEMBL237337,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,IC50,nM,=,86000.0,Inhibition of human ERG
672,CHEMBL237336,C[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,IC50,nM,=,1100.0,Inhibition of human ERG
673,CHEMBL437557,CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2ccc3ncnn3c2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,IC50,nM,>,90000.0,Inhibition of human ERG
674,CHEMBL236587,CCOc1cc(CN2CCC(Nc3nc4ccccc4o3)CC2)ccc1OC,IC50,nM,<,100.0,Inhibition of hERG channel
675,CHEMBL393718,CCOc1cc(CN2CCC(Nc3nc4cc(S(N)(=O)=O)ccc4o3)CC2)ccc1OC,IC50,nM,=,3500.0,Inhibition of hERG channel
676,CHEMBL241330,CCOc1cc(CN2CCC(NC(=O)c3cccc(S(C)(=O)=O)c3)CC2)ccc1Cl,IC50,nM,=,1300.0,Binding affinity to human ERG channel
677,CHEMBL559206,Cl.O=C(c1ccccc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1,IC50,nM,=,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
678,CHEMBL392354,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1.O=CO,IC50,nM,=,25118.86,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
679,CHEMBL240567,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1.O=CO,IC50,nM,=,7943.28,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
680,CHEMBL240565,CS(=O)(=O)c1cccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCCC5)CC4)cc3)C(=O)C2)c1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
681,CHEMBL240178,CS(=O)(=O)c1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCCC5)CC4)cc3)C(=O)C2)cc1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
682,CHEMBL239964,N#Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCCC5)CC4)cc3)C(=O)C2)cc1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
683,CHEMBL239963,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1.O=CO,IC50,nM,=,19952.62,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
684,CHEMBL239744,O=C(c1ccc(Cl)cc1)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1.O=CO,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
685,CHEMBL400224,O=C(c1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1)N1CCC1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
686,CHEMBL239321,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
687,CHEMBL239101,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
688,CHEMBL398996,CS(=O)(=O)c1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
689,CHEMBL239099,N#Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1.O=CO,IC50,nM,=,9332.54,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
690,CHEMBL537219,Cl.O=C(c1ccc(F)cc1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1,IC50,nM,<,31622.78,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
691,CHEMBL540634,Cl.O=C(c1ccc(Cl)cc1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1,IC50,nM,=,31622.78,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
692,CHEMBL556782,Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1.Cl,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
693,CHEMBL540633,Cl.O=C(c1ccccc1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
694,CHEMBL392532,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4ccc(F)cc4F)CC3=O)cc2)CC1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
695,CHEMBL430368,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4cc(F)cc(F)c4)CC3=O)cc2)CC1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
696,CHEMBL238456,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4ccc(C#N)cc4)CC3=O)cc2)CC1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
697,CHEMBL239724,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3F)CC2=O)cc1.O=CO,IC50,nM,=,31622.78,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
698,CHEMBL392713,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3cc(F)cc(F)c3)CC2=O)cc1.O=CO,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
699,CHEMBL239510,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(C#N)cc3)CC2=O)cc1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
700,CHEMBL239300,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2=O)cc1.O=CO,IC50,nM,=,25118.86,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
701,CHEMBL239299,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3F)CC2=O)cc1.O=CO,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
702,CHEMBL239081,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3cc(F)cc(F)c3)CC2=O)cc1.O=CO,IC50,nM,=,501.19,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
703,CHEMBL239080,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(C#N)cc3)CC2=O)cc1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
704,CHEMBL394144,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2=O)cc1.O=CO,IC50,nM,=,19952.62,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
705,CHEMBL238872,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OCCCN3CCCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,=,50118.72,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
706,CHEMBL238871,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OCCCN3CCCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
707,CHEMBL400612,N#Cc1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCCC4)cc3)C(=O)C2)cc1.O=CO,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
708,CHEMBL238870,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
709,CHEMBL240352,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OCCCN3CCCC3)cc2)C(=O)C1,IC50,nM,<,15848.93,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
710,CHEMBL394015,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OCCCN3CCCC3)cc2)C(=O)C1,IC50,nM,=,7943.28,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
711,CHEMBL240141,N#Cc1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCC4)cc3)C(=O)C2)cc1.O=CO,IC50,nM,<,15848.93,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
712,CHEMBL429458,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCC3)cc2)C(=O)C1.O=CO,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
713,CHEMBL537218,CC(C)(C)C(=O)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1.Cl,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
714,CHEMBL238504,O=C(c1cnn2cccnc12)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
715,CHEMBL238503,O=C(c1ccncc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
716,CHEMBL240395,O=C(c1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1)N1CCC1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
717,CHEMBL398812,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
718,CHEMBL240394,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,=,39810.72,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
719,CHEMBL240393,CS(=O)(=O)c1cccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)c1.O=CO,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
720,CHEMBL240187,CS(=O)(=O)c1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1,IC50,nM,<,63095.73,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
721,CHEMBL240185,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1.O=CO,IC50,nM,=,50118.72,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
722,CHEMBL239975,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1,IC50,nM,<,31622.78,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
723,CHEMBL536991,Cc1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1.Cl,IC50,nM,=,31622.78,Displacement of [3H]dofetilide from hERG expressed in CHOK1 cells
724,CHEMBL245568,COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1,IC50,nM,=,1584.89,Inhibition of hERG
725,CHEMBL397395,COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1,IC50,nM,=,6309.57,Inhibition of hERG
726,CHEMBL247340,Cc1cccc(CN(C2CCOCC2)[C@H]2CCNC2)c1Cl,IC50,,,,Inhibition of hERG
727,CHEMBL245687,c1ccc(-c2ccccc2CN(C2CCOCC2)[C@H]2CCNC2)cc1,IC50,,,,Inhibition of hERG
728,CHEMBL247538,COc1cccc(CN(C2CCOCC2)[C@H]2CCNC2)c1C,IC50,,,,Inhibition of hERG
729,CHEMBL247341,Cc1c(Cl)cccc1CN(C1CCOCC1)[C@H]1CCNC1,IC50,,,,Inhibition of hERG
730,CHEMBL391143,Cc1c(CN(C2CCOCC2)[C@H]2CCNC2)cccc1C(F)(F)F,IC50,nM,=,2900.0,Inhibition of hERG
731,CHEMBL246519,Fc1ccc(CN(C2CCOCC2)[C@H]2CCNC2)c(F)c1F,IC50,nM,=,1200.0,Inhibition of hERG
732,CHEMBL442272,FC(F)(F)c1ccccc1CN(C1CCOCC1)[C@H]1CCNC1,IC50,nM,=,1100.0,Inhibition of hERG
733,CHEMBL397392,Cc1ccccc1CN(C1CCOCC1)[C@H]1CCNC1,IC50,nM,=,2400.0,Inhibition of hERG
734,CHEMBL245492,Fc1cccc(CN(C2CCOCC2)[C@H]2CCNC2)c1C(F)(F)F,IC50,nM,=,1600.0,Inhibition of hERG
735,CHEMBL214768,COc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1F,IC50,nM,=,8300.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
736,CHEMBL247283,O=C(NC1CCN(Cc2ccc(OCCN3CCOCC3)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
737,CHEMBL248295,O=C(NC1CCN(Cc2ccc(OCCN3CCCC3)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,,,,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
738,CHEMBL246464,O=C(CCN1CCCCC1)Nc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1F,IC50,nM,=,9180.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
739,CHEMBL246259,COc1cc(C(=O)NCCN2CCCC2)ccc1CN1CCC(NC(=O)c2cc(=O)c3ccc(F)cc3o2)CC1,IC50,nM,=,6600.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
740,CHEMBL246258,O=C(NCCN1CCCC1)c1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)c(Cl)c1,IC50,nM,=,11000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
741,CHEMBL246051,O=C(NCCN1CCC(F)(F)CC1)c1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1,IC50,nM,=,6300.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
742,CHEMBL246050,O=C(NCCN1CCCCC1)c1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1,IC50,nM,=,66000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
743,CHEMBL245846,O=C(NC1CCN(Cc2ccc(C(=O)NCCN3CCCC3)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,>,100000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
744,CHEMBL245844,O=C(NC1CCN(Cc2ccc(OCCCN3C(=O)CSC3=O)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,8500.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
745,CHEMBL394639,CC(C)CO/N=C/COc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1F,IC50,nM,=,450.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
746,CHEMBL245642,CO/N=C/COc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1F,IC50,nM,=,3200.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
747,CHEMBL247891,O=C(NC1CCN(Cc2ccc(OCCCN(C3CC3)C3CC3)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,740.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
748,CHEMBL247690,O=C(NC1CCN(Cc2ccc(OCCCN3CCOCC3)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,34000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
749,CHEMBL247689,O=C(NC1CCN(Cc2ccc(OCC(F)(F)F)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,1600.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
750,CHEMBL247688,COC(C)(C)CCOc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1,IC50,nM,=,4300.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
751,CHEMBL248297,O=C(NC1CCN(Cc2ccc(OCCCN3CCCCC3)c(F)c2)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,42000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
752,CHEMBL248296,CN(C)CCCOc1ccc(CN2CCC(NC(=O)c3cc(=O)c4ccc(F)cc4o3)CC2)cc1F,IC50,nM,=,65000.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
753,CHEMBL214021,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)CC1)c1cc(=O)c2ccc(F)cc2o1,IC50,nM,=,15100.0,Displacement of [3H]dofetilide from hERG expressed in HEK293 cell membrane
754,CHEMBL191067,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,=,4600.0,Inhibition of cardiac hERG
755,CHEMBL392825,C[C@@H](C1CCC(N(C)C(=O)C2CC2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,IC50,nM,=,39000.0,Inhibition of cardiac hERG
756,CHEMBL245545,CC(=O)N(C)C1CCC([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1.Cl,IC50,nM,>,90000.0,Inhibition of cardiac hERG
757,CHEMBL428747,CC(=O)N(C)C1CCC([C@H](C(=O)N(C)C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1.Cl,IC50,nM,>,90000.0,Inhibition of cardiac hERG
758,CHEMBL245379,C[C@@H](C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,IC50,nM,=,78000.0,Inhibition of cardiac hERG
759,CHEMBL246374,CN(C)C(=O)[C@@H](C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,IC50,nM,>,90000.0,Inhibition of cardiac hERG
760,CHEMBL395213,Cl.N[C@H](C(=O)N1CC[C@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,IC50,nM,=,49000.0,Inhibition of cardiac hERG
761,CHEMBL245969,CN(C)C(=O)[C@@H](c1ccc(N(C)C(=O)c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,IC50,nM,>,90000.0,Inhibition of cardiac hERG
762,CHEMBL246634,CC(C(O)c1ccc2[nH]c(=O)oc2c1)N1CCC(O)(c2ccc(F)cc2)CC1,IC50,nM,=,2600.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
763,CHEMBL404851,CC(C(O)c1ccc2c(c1)CCC(=O)N2)N1CCC(O)(c2ccc(F)cc2)CC1,IC50,nM,=,8600.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
764,CHEMBL246816,CC(C(O)c1ccc2c(c1)CN(C)C(=O)N2)N1CCC(O)(c2ccc(F)cc2)CC1,IC50,nM,=,3100.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
765,CHEMBL246815,CC(C(O)c1ccc2c(c1)CNC(=O)N2)N1CCC(O)(c2ccc(F)cc2)CC1,IC50,nM,=,7400.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
766,CHEMBL246635,CC(C(O)c1ccc2c(c1)OCC(=O)N2)N1CCC(O)(c2ccc(F)cc2)CC1,IC50,nM,=,1600.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
767,CHEMBL401407,CC(C(O)c1ccc2c(c1)COC(=O)N2)N1CCC(O)(c2ccc(F)cc2)CC1,IC50,nM,=,2400.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
768,CHEMBL246818,COc1cccc(C2(O)CCN(C(C)C(O)c3ccc4c(c3)CCC(=O)N4)CC2)c1,IC50,nM,=,11000.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
769,CHEMBL247842,CC(C(O)c1ccc2c(c1)CCC(=O)N2)N1CCC(O)(c2ccc(Cl)cc2)CC1,IC50,nM,<,1000.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
770,CHEMBL247841,CC(C(O)c1ccc2c(c1)CCC(=O)N2)N1CCC(O)(c2cccc(COc3ccccc3)c2)CC1,IC50,nM,<,1500.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
771,CHEMBL404852,CC(C(O)c1ccc2c(c1)CCC(=O)N2)N1CCC(O)(c2cccc(F)c2)CC1,IC50,nM,=,10000.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
772,CHEMBL247840,Cc1ccc(C2(O)CCN(C(C)C(O)c3ccc4c(c3)CCC(=O)N4)CC2)cc1,IC50,nM,=,3300.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
773,CHEMBL246817,CC(C(O)c1ccc2c(c1)CCC(=O)N2)N1CCC(O)(c2ccc3c(c2)COCC3)CC1,IC50,nM,=,16000.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
774,CHEMBL246819,O=C1CCc2cc(C(O)CN3CCC(O)(c4cccc(F)c4)CC3)ccc2N1,IC50,nM,=,21000.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
775,CHEMBL246819,O=C1CCc2cc(C(O)CN3CCC(O)(c4cccc(F)c4)CC3)ccc2N1,IC50,nM,=,9800.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
776,CHEMBL246819,O=C1CCc2cc(C(O)CN3CCC(O)(c4cccc(F)c4)CC3)ccc2N1,IC50,nM,=,13000.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
777,CHEMBL17350,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1,IC50,nM,=,10000.0,Displacement of [3H]bufuralol from hERG channel expressed in HEK293 cells
778,CHEMBL249093,O=C(NC[C@H]1CC[C@@H](CCOc2ccccc2)CC1)c1cn[nH]c1,IC50,nM,>,30000.0,Inhibition of hERG
779,CHEMBL400917,O=C(NCc1cccc(C(=O)NCc2ccccc2)c1)c1ccc(O)cc1,IC50,nM,>,30000.0,Inhibition of hERG
780,CHEMBL250125,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN1CCN(C(C)=O)CC1)c1ccccc1,IC50,nM,=,10000.0,Inhibition of hERG expressed in HEK cells
781,CHEMBL247044,CC(=O)C1=NN(c2cc(C)ccc2F)C[C@@]1(CCCN(C)C)c1ccccc1,IC50,nM,=,3036.0,Inhibition of hERG expressed in HEK cells
782,CHEMBL398612,Cc1[nH]nc2c1c(=O)n(C[C@H](F)CN)c1cc(C3CCCCC3)c(C3CCCCC3)cc21,IC50,nM,=,13200.0,Binding affinity at hERG expressed in human embryonic kidney cells
783,CHEMBL250481,Cc1[nH]nc2c1c(=O)n(CCCN)c1cc(C3CCCCC3)c(C3CCCCC3)cc21,IC50,nM,=,5300.0,Binding affinity at hERG expressed in human embryonic kidney cells
784,CHEMBL251142,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN1CCC(=O)N(C)CC1)c1ccccc1,IC50,nM,=,9600.0,Inhibition of hERG expressed in HEK cells
785,CHEMBL438876,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN1CCNC(=O)CC1)c1ccccc1,IC50,nM,=,17000.0,Inhibition of hERG expressed in HEK cells
786,CHEMBL401476,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN1CCNCC1)c1ccccc1,IC50,nM,=,4600.0,Inhibition of hERG expressed in HEK cells
787,CHEMBL250743,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCO)c1ccccc1,IC50,nM,=,18000.0,Inhibition of hERG expressed in HEK cells
788,CHEMBL250127,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN)c1ccccc1,IC50,nM,=,940.0,Inhibition of hERG expressed in HEK cells
789,CHEMBL250126,CC(=O)C1=NN2c3cc(Cl)ccc3OC[C@H]2[C@@]1(CCCN1CCN(C(C)=O)CC1)c1ccccc1,IC50,nM,=,5600.0,Inhibition of hERG expressed in HEK cells
790,CHEMBL250125,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN1CCN(C(C)=O)CC1)c1ccccc1,IC50,nM,=,10000.0,Inhibition of hERG expressed in HEK cells
791,CHEMBL399378,CC(=O)C1=NN2c3cc(C)ccc3OC[C@H]2[C@@]1(CCCN1CCOCC1)c1ccccc1,IC50,nM,=,6300.0,Inhibition of hERG expressed in HEK cells
792,CHEMBL250533,CC(=O)C1=NN2c3cc(Cl)ccc3OC[C@H]2C1(CCCN1CCOCC1)c1ccccc1,IC50,nM,=,3300.0,Inhibition of hERG expressed in HEK cells
793,CHEMBL398478,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN1CCOCC1)c1ccccc1,IC50,nM,=,6100.0,Inhibition of hERG expressed in HEK cells
794,CHEMBL250532,CC(=O)C1=NN2c3cc(C)ccc3OC[C@H]2[C@@]1(CCCN(C)C)c1ccccc1,IC50,nM,=,2400.0,Inhibition of hERG expressed in HEK cells
795,CHEMBL429553,CC(=O)C1=NN2c3cc(Cl)ccc3OC[C@H]2[C@@]1(CCCN(C)C)c1ccccc1,IC50,nM,=,2000.0,Inhibition of hERG expressed in HEK cells
796,CHEMBL250328,CC(=O)C1=NN2c3cc(F)ccc3OC[C@H]2[C@@]1(CCCN(C)C)c1ccccc1,IC50,nM,=,5940.0,Inhibition of hERG expressed in HEK cells
797,CHEMBL428936,N[C@H]1CN(C(=O)c2cnc3ccccc3n2)C(=O)[C@H]1C(=O)N1CCCC1,IC50,nM,>,300000.0,Inhibition of hERG by patch clamp assay
798,CHEMBL399791,Cc1cc(CN2C[C@H](N)[C@H](C(=O)C3CCC[C@H]3C#N)C2)cc(C)c1C#N,IC50,nM,=,28900.0,Inhibition of hERG by patch clamp assay
799,CHEMBL429115,Cc1cc(CN2C[C@H](N)[C@H](C(=O)C3CCC[C@H]3C#N)C2)ccc1C#N,IC50,nM,=,19600.0,Inhibition of hERG by patch clamp assay
800,CHEMBL249601,CC(c1ccc(C#N)cc1)N1C[C@H](N)[C@H](C(=O)N2CCC[C@H]2C#N)C1,IC50,nM,=,10000.0,Inhibition of hERG by patch clamp assay
801,CHEMBL399726,Cc1nnc(-c2ccc(CN3C[C@H](N)[C@H](C(=O)N4CCC[C@H]4C#N)C3)cc2)o1,IC50,nM,=,165000.0,Inhibition of hERG by patch clamp assay
802,CHEMBL399525,N#C[C@@H]1CCCN1C(=O)[C@@H]1CN(Cc2ccc(-n3cncn3)cc2)C[C@@H]1N,IC50,nM,=,1800.0,Inhibition of hERG by patch clamp assay
803,CHEMBL250689,CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1,IC50,nM,=,400.0,Inhibition of hERG
804,CHEMBL249854,CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C,IC50,nM,=,6000.0,Inhibition of hERG
805,CHEMBL429663,Cc1cccc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)c1,IC50,nM,=,27000.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
806,CHEMBL250877,CN1CCCc2cc(NC(=O)c3ccc(-c4ccc(Cl)cc4)o3)ccc21,IC50,nM,=,5300.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
807,CHEMBL539863,Cc1cccc(NC(=N)c2ccc(-c3ccc(Cl)cc3)o2)c1.Cl,IC50,nM,=,2100.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
808,CHEMBL250443,Cc1cccc(NC(=O)c2ccc(-c3ccc(OC(F)(F)F)cc3)o2)c1,IC50,nM,>,30000.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
809,CHEMBL401258,Cc1cccc(NC(=O)c2ccc(-c3ccc(C#N)cc3)o2)c1,IC50,nM,=,5800.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
810,CHEMBL250048,Cc1ccnc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)c1,IC50,nM,>,30000.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
811,CHEMBL250699,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1,IC50,nM,>,30000.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
812,CHEMBL255023,Cc1cccc(N/C(=N/C#N)c2ccc(-c3ccc(Cl)cc3)o2)c1,IC50,nM,>,30000.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
813,CHEMBL251241,C[C@@H](NC(=O)c1ccc(-c2ccc(Cl)cc2)o1)C(=O)N1CCN(CCCOc2ccc(C(=O)C3CC3)cc2)CC1,IC50,nM,=,800.0,Inhibition of hERG potassium channel expressed in CHO cells by isotope efflux assay
814,CHEMBL253868,Nc1ccc(-c2ccccc2)cc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,nM,=,3000.0,Displacement of [35S]MK-499 from ERG expressed in HEK293 cells
815,CHEMBL253869,Nc1ccc(-c2ccccc2)cc1NC(=O)c1ccc(CNC(=O)CCc2cccnc2)cc1,IC50,nM,=,3700.0,Displacement of [35S]MK-499 from ERG expressed in HEK293 cells
816,CHEMBL428594,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3ccc(F)cc3)CC2)C1,IC50,nM,=,16.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
817,CHEMBL255511,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cccc(C(=O)O)c3)CC2)C1,IC50,nM,=,600.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
818,CHEMBL256954,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3ccncn3)CC2)C1,IC50,nM,=,130.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
819,CHEMBL401608,CC(C)(O)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cc(Cl)ncn3)CC2)C1,IC50,nM,=,186.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
820,CHEMBL429849,CC(C)(O)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cncnc3)CC2)C1,IC50,nM,=,844.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
821,CHEMBL256154,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cncnc3)CC2)C1,IC50,nM,=,1800.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
822,CHEMBL256154,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cncnc3)CC2)C1,IC50,nM,=,1413.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
823,CHEMBL402624,CC(C)(O)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cccc(C(=O)O)c3)CC2)C1,IC50,nM,=,19720.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
824,CHEMBL255511,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cccc(C(=O)O)c3)CC2)C1,IC50,nM,=,2786.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
825,CHEMBL255312,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cccc(O)c3)CC2)C1,IC50,nM,=,67.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
826,CHEMBL403033,COc1cccc(C2CCN([C@@H]3CC[C@@](C(=O)NCc4cc(C(F)(F)F)cc(C(F)(F)F)c4)(C(C)C)C3)CC2)c1,IC50,nM,=,217.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
827,CHEMBL258246,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cccc(F)c3)CC2)C1,IC50,nM,=,45.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
828,CHEMBL428602,CC(C)(O)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3ccc(F)cc3)CC2)C1,IC50,nM,=,54.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
829,CHEMBL255513,CC(C)[C@]1(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC[C@@H](N2CCC(c3cccnc3)CC2)C1,IC50,nM,=,224.0,Displacement of [33S]MK499 from human ERG expressed in HEK cells
830,CHEMBL58004,Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1,IC50,nM,=,1200.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
831,CHEMBL255858,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
832,CHEMBL255857,Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1,IC50,nM,=,12200.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
833,CHEMBL255856,Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
834,CHEMBL255645,CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1,IC50,nM,=,4400.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
835,CHEMBL255644,CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
836,CHEMBL255431,Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1,IC50,nM,=,410.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
837,CHEMBL59511,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1,IC50,nM,=,1300.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
838,CHEMBL301454,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1,IC50,nM,=,670.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
839,CHEMBL62152,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1,IC50,nM,=,150.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
840,CHEMBL61536,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1,IC50,nM,=,550.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
841,CHEMBL58387,Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1,IC50,nM,=,570.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes
842,CHEMBL253968,O=C(Cn1cc(Nc2nncc3cc(OCCCN4CCC[C@@H]4CO)ccc23)cn1)Nc1cccc(F)c1F,IC50,nM,>,100000.0,Inhibition of human ERG by automated whole cell electrophysiology
843,CHEMBL250766,O=C(Cn1cc(Nc2nncc3cc(OCCCN4CCC[C@@H]4COP(=O)(O)O)ccc23)cn1)Nc1cccc(F)c1F,IC50,nM,>,100000.0,Inhibition of human ERG by automated whole cell electrophysiology
844,CHEMBL402011,C[C@@H](Oc1cccc2ncnc(Nc3ccc4c(cnn4Cc4ccccn4)c3)c12)C(=O)N(C)C,IC50,nM,=,25000.0,Inhibition of human ERG
845,CHEMBL401895,Cc1cc(C)n(-c2cc(NC(=O)COc3cccc(CN(C)C)c3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,1200.0,Inhibition of human ERG by patch clamp assay
846,CHEMBL193544,CN1CCC(Oc2cccc3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,IC50,nM,=,5000.0,Inhibition of human ERG
847,CHEMBL429760,Cc1ccc(Oc2ccc(Nc3ncnc4cccc(O[C@@H](C)C(=O)N(C)C)c34)cc2C)cn1,IC50,nM,=,11000.0,Inhibition of human ERG
848,CHEMBL256362,Cc1ccc(Oc2ccc(Nc3ncnc4cccc(O[C@H](C)C(=O)N(C)C)c34)cc2C)cn1,IC50,nM,=,8000.0,Inhibition of human ERG
849,CHEMBL257478,Cc1ccc(Oc2ccc(Nc3ncnc4cccc(O[C@H](C)C(=O)N(C)CCO)c34)cc2C)cn1,IC50,nM,=,12000.0,Inhibition of human ERG
850,CHEMBL403594,CNC(=O)[C@@H](C)Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,IC50,nM,=,32000.0,Inhibition of human ERG
851,CHEMBL255968,C[C@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)C,IC50,nM,=,10000.0,Inhibition of human ERG
852,CHEMBL428777,C[C@@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)C,IC50,nM,=,14000.0,Inhibition of human ERG
853,CHEMBL403774,C[C@@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N1CCOCC1,IC50,nM,=,10000.0,Inhibition of human ERG
854,CHEMBL256060,C[C@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)CCO,IC50,nM,=,11000.0,Inhibition of human ERG
855,CHEMBL258313,C[C@@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)CCO,IC50,nM,=,12000.0,Inhibition of human ERG
856,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,1995.26,Inhibition of human ERG
857,CHEMBL272297,Cc1cc(-c2nc3c4c(ccc3o2)CCN(CCCSc2nnc(-c3ocnc3C)n2C)CC4)n(C)n1,IC50,nM,=,794.33,Inhibition of human ERG
858,CHEMBL402853,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6oc(-c7cc(C)nn7C)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,794.33,Inhibition of human ERG
859,CHEMBL403815,Cc1ccc2c(-c3nnc(SCCCN4CCc5c(Cl)cc6oc(C)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,1584.89,Inhibition of human ERG
860,CHEMBL270376,Cc1nc(C)c(-c2nnc(SCCCN3CCc4ccc5oc(C(F)(F)F)nc5c4CC3)n2C)s1,IC50,nM,=,794.33,Inhibition of human ERG
861,CHEMBL270387,Cn1c(SCCCN2CCc3ccc4oc(C(F)(F)F)nc4c3CC2)nnc1-c1ccccc1,IC50,nM,=,251.19,Inhibition of human ERG
862,CHEMBL255158,Cc1ncccc1-c1nnc(SCCCN2CCc3ccc4oc(C(F)(F)F)nc4c3CC2)n1C,IC50,nM,=,3981.07,Inhibition of human ERG
863,CHEMBL404404,Cc1ccc(-c2nnc(SCCCN3CCc4ccc5oc(C(F)(F)F)nc5c4CC3)n2C)cn1,IC50,nM,=,1584.89,Inhibition of human ERG
864,CHEMBL270602,Cc1cnc(-c2nnc(SCCCN3CCc4ccc5oc(C(F)(F)F)nc5c4CC3)n2C)cn1,IC50,nM,=,1258.93,Inhibition of human ERG
865,CHEMBL402215,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4oc(C(F)(F)C(F)(F)F)nc4c3CC2)n1C,IC50,nM,=,316.23,Inhibition of human ERG
866,CHEMBL271034,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6oc(C(F)(F)C(F)(F)F)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,251.19,Inhibition of human ERG
867,CHEMBL437792,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4oc(C(C)(F)F)nc4c3CC2)n1C,IC50,nM,=,2511.89,Inhibition of human ERG
868,CHEMBL271449,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4oc(C(F)(F)F)nc4c3CC2)n1C,IC50,nM,=,1258.93,Inhibition of human ERG
869,CHEMBL272150,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6oc(C(F)(F)F)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Inhibition of human ERG
870,CHEMBL427836,CCc1nc2c3c(ccc2o1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,5011.87,Inhibition of human ERG
871,CHEMBL442456,CCc1nc2c3c(ccc2o1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,6309.57,Inhibition of human ERG
872,CHEMBL402422,Cc1nc2c3c(ccc2o1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,12589.25,Inhibition of human ERG
873,CHEMBL272511,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6oc(C)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Inhibition of human ERG
874,CHEMBL244946,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Inhibition of human ERG
875,CHEMBL271511,Cc1ncoc1-c1nnc(SCCCN2CCc3nc4ccc(C(F)(F)F)cn4c3CC2)n1C,IC50,nM,=,1995.26,Inhibition of human ERG
876,CHEMBL271729,Cc1ccc2c(-c3nnc(SCCCN4CCc5nc6ccc(C(F)(F)F)cn6c5CC4)n3C)cccc2n1,IC50,nM,=,5011.87,Inhibition of human ERG
877,CHEMBL272588,Cc1ncoc1-c1nnc(SCCCN2CCc3nc4cc(C(F)(F)F)ccn4c3CC2)n1C,IC50,nM,=,794.33,Inhibition of human ERG
878,CHEMBL411293,Cc1ccc2c(-c3nnc(SCCCN4CCc5nc6cc(C(F)(F)F)ccn6c5CC4)n3C)cccc2n1,IC50,nM,=,251.19,Inhibition of human ERG
879,CHEMBL406678,Cc1ccc2c(-c3nnc(SCCCN4CCc5nc6ccccn6c5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Inhibition of human ERG
880,CHEMBL257716,Cc1ccc2c(-c3nnc(SCCCN4CCc5nc6ccc(Cl)cn6c5CC4)n3C)cccc2n1,IC50,nM,=,1584.89,Inhibition of human ERG
881,CHEMBL256658,Cc1ccc2nc3c(n2c1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,2511.89,Inhibition of human ERG
882,CHEMBL257717,Cc1ccn2c3c(nc2c1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,251.19,Inhibition of human ERG
883,CHEMBL403804,CCc1nc2ccc3c(c2s1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,3162.28,Inhibition of human ERG
884,CHEMBL256442,CCc1nc2ccc3c(c2s1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,158.49,Inhibition of human ERG
885,CHEMBL255220,Cc1nc2ccc3c(c2s1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,12589.25,Inhibition of human ERG
886,CHEMBL271909,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6nc(C)sc6c5CC4)n3C)cccc2n1,IC50,nM,=,3162.28,Inhibition of human ERG
887,CHEMBL272775,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4nc(C(C)(F)F)oc4c3CC2)n1C,IC50,nM,=,5011.87,Inhibition of human ERG
888,CHEMBL256488,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6nc(C(C)(F)F)oc6c5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Inhibition of human ERG
889,CHEMBL256659,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4nc(C(F)(F)F)oc4c3CC2)n1C,IC50,nM,=,5011.87,Inhibition of human ERG
890,CHEMBL404363,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6nc(C(F)(F)F)oc6c5CC4)n3C)cccc2n1,IC50,nM,=,1000.0,Inhibition of human ERG
891,CHEMBL408479,CN(C)S(=O)(=O)N(C)[C@@H]1CCCn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,nM,=,20000.0,Inhibition of human ERG
892,CHEMBL408962,CN(C)C(=O)C(=O)N(C)[C@H]1CCCCn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O,IC50,nM,>,10000.0,Inhibition of human ERG
893,CHEMBL271066,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6c(cc5CC4)OCC(=O)N6)n3C)cccc2n1,IC50,nM,=,6.31,Displacement of [3H]Dofetilide from human ERG
894,CHEMBL408169,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6c(cc5CC4)OCCN6)n3C)cccc2n1,IC50,nM,=,398.11,Displacement of [3H]Dofetilide from human ERG
895,CHEMBL272702,CC(=O)N1CCOc2cc3c(cc21)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,10000.0,Displacement of [3H]Dofetilide from human ERG
896,CHEMBL272379,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6c(cc5CC4)N(S(C)(=O)=O)CCO6)n3C)cccc2n1,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG
897,CHEMBL257534,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4c(cc3CC2)N(C)C(=O)CO4)n1C,IC50,nM,=,25118.86,Displacement of [3H]Dofetilide from human ERG
898,CHEMBL256652,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6c(cc5CC4)N(C)C(=O)CO6)n3C)cccc2n1,IC50,nM,=,5011.87,Displacement of [3H]Dofetilide from human ERG
899,CHEMBL257536,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4c(cc3CC2)OCC(=O)N4)n1C,IC50,nM,=,63.1,Displacement of [3H]Dofetilide from human ERG
900,CHEMBL401576,Cc1noc2cc3c(cc12)CCN(CCCSc1nnc(-c2ccc(C(F)(F)F)cc2)n1C)CC3,IC50,nM,=,125.89,Displacement of [3H]Dofetilide from human ERG
901,CHEMBL403181,CCc1noc2cc3c(cc12)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,1000.0,Displacement of [3H]Dofetilide from human ERG
902,CHEMBL256475,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4onc(C)c4cc3CC2)n1C,IC50,nM,=,6309.57,Displacement of [3H]Dofetilide from human ERG
903,CHEMBL257946,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6onc(C)c6cc5CC4)n3C)cccc2n1,IC50,nM,=,794.33,Displacement of [3H]Dofetilide from human ERG
904,CHEMBL401728,Cc1cc(-c2nc3cc4c(cc3o2)CCN(CCCSc2nnc(-c3ocnc3C)n2C)CC4)n(C)n1,IC50,nM,=,1000.0,Displacement of [3H]Dofetilide from human ERG
905,CHEMBL270567,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(-c7cc(C)nn7C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,501.19,Displacement of [3H]Dofetilide from human ERG
906,CHEMBL271083,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4nc(C(F)(F)C(F)(F)F)oc4cc3CC2)n1C,IC50,nM,=,199.53,Displacement of [3H]Dofetilide from human ERG
907,CHEMBL270227,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C(F)(F)C(F)(F)F)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,100.0,Displacement of [3H]Dofetilide from human ERG
908,CHEMBL255620,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(N(C)C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,19952.62,Displacement of [3H]Dofetilide from human ERG
909,CHEMBL255826,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(N7CCCCC7)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,5011.87,Displacement of [3H]Dofetilide from human ERG
910,CHEMBL255619,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4nc(CC5CC5)oc4cc3CC2)n1C,IC50,nM,=,1000.0,Displacement of [3H]Dofetilide from human ERG
911,CHEMBL273166,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(CC7CC7)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,1258.93,Displacement of [3H]Dofetilide from human ERG
912,CHEMBL256472,COCc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,>,15848.93,Displacement of [3H]Dofetilide from human ERG
913,CHEMBL256473,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C(C)(F)F)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,1258.93,Displacement of [3H]Dofetilide from human ERG
914,CHEMBL258090,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(CC(F)(F)F)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Displacement of [3H]Dofetilide from human ERG
915,CHEMBL402016,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C(F)(F)F)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,1000.0,Displacement of [3H]Dofetilide from human ERG
916,CHEMBL256651,CCc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2ccc(F)c(F)c2)n1C)CC3,IC50,nM,=,1258.93,Displacement of [3H]Dofetilide from human ERG
917,CHEMBL271096,CCc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2ccc(C(F)(F)F)cc2)n1C)CC3,IC50,nM,=,251.19,Displacement of [3H]Dofetilide from human ERG
918,CHEMBL272302,CCc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2cccnc2)n1C)CC3,IC50,nM,=,15848.93,Displacement of [3H]Dofetilide from human ERG
919,CHEMBL270209,Cc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(C2CCOCC2)n1C)CC3,IC50,nM,>,63095.73,Displacement of [3H]Dofetilide from human ERG
920,CHEMBL269995,Cc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2ccc(F)c(F)c2)n1C)CC3,IC50,nM,=,10000.0,Displacement of [3H]Dofetilide from human ERG
921,CHEMBL439065,Cc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2ccc(C(F)(F)F)cc2)n1C)CC3,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG
922,CHEMBL256653,Cc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2cccnc2)n1C)CC3,IC50,nM,=,50118.72,Displacement of [3H]Dofetilide from human ERG
923,CHEMBL429132,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C(C)(C)C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,794.33,Displacement of [3H]Dofetilide from human ERG
924,CHEMBL271280,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4nc(C5CC5)oc4cc3CC2)n1C,IC50,nM,>,3981.07,Displacement of [3H]Dofetilide from human ERG
925,CHEMBL272695,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C7CC7)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,1000.0,Displacement of [3H]Dofetilide from human ERG
926,CHEMBL256016,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4nc(C(C)C)oc4cc3CC2)n1C,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG
927,CHEMBL256015,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C(C)C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]Dofetilide from human ERG
928,CHEMBL402826,CCCc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,630.96,Displacement of [3H]Dofetilide from human ERG
929,CHEMBL272546,CCc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,6309.57,Displacement of [3H]Dofetilide from human ERG
930,CHEMBL272545,CCc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,5011.87,Displacement of [3H]Dofetilide from human ERG
931,CHEMBL271844,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6ncoc6cc5CC4)n3C)cccc2n1,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG
932,CHEMBL255621,Cc1ncoc1-c1nnc(SCCCN2CCc3cc4ncoc4cc3CC2)n1C,IC50,nM,=,6309.57,Displacement of [3H]Dofetilide from human ERG
933,CHEMBL255827,Cc1nc2cc3c(cc2o1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,31622.78,Displacement of [3H]Dofetilide from human ERG
934,CHEMBL269959,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,>,10000.0,Displacement of [3H]Dofetilide from human ERG
935,CHEMBL255618,Cc1ccc2c(-c3nnc(SCCC(C)N4CCc5cc6nc(C(F)(F)F)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]Dofetilide from human ERG
936,CHEMBL255417,CCc1nc2cc3c(c(Br)c2o1)CCN(C(C)CCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,3162.28,Displacement of [3H]Dofetilide from human ERG
937,CHEMBL273165,Cc1ccc2c(-c3nnc(SCCC(C)N4CCc5cc6nc(C)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,10000.0,Displacement of [3H]Dofetilide from human ERG
938,CHEMBL257525,Cc1ccc2c(-c3nnc(SCCC(C)N4CCc5cc6nc(C(F)(F)F)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,1000.0,Displacement of [3H]Dofetilide from human ERG
939,CHEMBL257524,CCc1nc2cc3c(c(C)c2o1)CCN(C(C)CCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG
940,CHEMBL270239,Cc1ccc2c(-c3nnc(SCCC(C)N4CCc5cc6nc(C)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG
941,CHEMBL257900,Cc1ccc2c(-c3nnc(SCCN4CCc5cc6nc(C(F)(F)F)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,398.11,Displacement of [3H]Dofetilide from human ERG
942,CHEMBL401777,CCc1nc2cc3c(c(C)c2o1)CCN(CCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,2511.89,Displacement of [3H]Dofetilide from human ERG
943,CHEMBL257901,Cc1ccc2c(-c3nnc(SCCN4CCc5cc6nc(C)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG
944,CHEMBL408208,Cc1ccc2c(-c3nnc(SCCN4CCc5cc6nc(C(F)(F)F)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,630.96,Displacement of [3H]Dofetilide from human ERG
945,CHEMBL272378,CCc1nc2cc3c(c(Br)c2o1)CCN(CCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,2511.89,Displacement of [3H]Dofetilide from human ERG
946,CHEMBL402015,Cc1ccc2c(-c3nnc(SCCN4CCc5cc6nc(C)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,6309.57,Displacement of [3H]Dofetilide from human ERG
947,CHEMBL256650,Cc1ccc2c(-c3nnc(SCCN4CCc5cc6nc(C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,=,50118.72,Displacement of [3H]Dofetilide from human ERG
948,CHEMBL271097,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,251.19,Displacement of [3H]Dofetilide from human ERG
949,CHEMBL269994,CCc1nc2cc3c(c(C)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,1584.89,Displacement of [3H]Dofetilide from human ERG
950,CHEMBL256481,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,1584.89,Displacement of [3H]Dofetilide from human ERG
951,CHEMBL257369,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,251.19,Displacement of [3H]Dofetilide from human ERG
952,CHEMBL256482,CCc1nc2cc3c(c(Br)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,1584.89,Displacement of [3H]Dofetilide from human ERG
953,CHEMBL271072,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,5011.87,Displacement of [3H]Dofetilide from human ERG
954,CHEMBL271073,Cc1nc2cc3c(cc2o1)CCN(CCCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,50118.72,Displacement of [3H]Dofetilide from human ERG
955,CHEMBL402087,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C(C)(C)C)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,251.19,Displacement of [3H]Dofetilide from human ERG
956,CHEMBL401752,CCc1nc2cc3c(c(C)c2o1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,501.19,Displacement of [3H]Dofetilide from human ERG
957,CHEMBL272694,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C)oc6c(C)c5CC4)n3C)cccc2n1,IC50,nM,=,5011.87,Displacement of [3H]Dofetilide from human ERG
958,CHEMBL255566,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C(C)(C)C)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,398.11,Displacement of [3H]Dofetilide from human ERG
959,CHEMBL255778,CCc1nc2cc3c(c(Br)c2o1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,1258.93,Displacement of [3H]Dofetilide from human ERG
960,CHEMBL255806,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C)oc6c(Br)c5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Displacement of [3H]Dofetilide from human ERG
961,CHEMBL255567,CCc1nc2cc3c(cc2s1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,1258.93,Displacement of [3H]Dofetilide from human ERG
962,CHEMBL271631,CCc1nc2cc3c(cc2s1)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,251.19,Displacement of [3H]Dofetilide from human ERG
963,CHEMBL256471,Cc1nc2cc3c(cc2s1)CCN(CCCSc1nnc(-c2ocnc2C)n1C)CC3,IC50,nM,=,3162.28,Displacement of [3H]Dofetilide from human ERG
964,CHEMBL271632,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C)sc6cc5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Displacement of [3H]Dofetilide from human ERG
965,CHEMBL256477,CCc1nn(C)c2cc3c(cc12)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,IC50,nM,=,1000.0,Displacement of [3H]Dofetilide from human ERG
966,CHEMBL272086,Cc1ccc2c(-c3nnc(SCCC(C)N4CCc5cc6c(cc5CC4)C(=O)N(C(C)C)C6)n3C)cccc2n1,IC50,nM,=,2511.89,Displacement of [3H]Dofetilide from human ERG
967,CHEMBL272300,Cc1ccc2c(-c3nnc(SCCC(C)N4CCc5cc6c(cc5CC4)C(=O)N(C)C6)n3C)cccc2n1,IC50,nM,=,39810.72,Displacement of [3H]Dofetilide from human ERG
968,CHEMBL270852,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6c(cc5CC4)C(=O)N(C(C)C)C6)n3C)cccc2n1,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG
969,CHEMBL270853,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6c(cc5CC4)C(=O)N(C)C6)n3C)cccc2n1,IC50,nM,=,31622.78,Displacement of [3H]Dofetilide from human ERG
970,CHEMBL272478,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6c(cc5CC4)C(=O)N(C(C)C)C6)n3C)cccc2n1,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG
971,CHEMBL273199,Cc1cc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2cn1,IC50,nM,=,1995.26,Displacement of [3H]Dofetilide from human ERG
972,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,1995.26,Displacement of [3H]Dofetilide from human ERG
973,CHEMBL257670,COc1cc(CC(=O)Nc2cc(-n3nc(C)cc3C)nc(-c3ccc(C)o3)n2)cc(OC)c1,IC50,nM,>,3000.0,Inhibition of human ERG expressed in HEK cells assessed as effect on electric current by patch clamp assay
974,CHEMBL272241,OCc1ccc(OC2CCN(CC3CCNCC3)CC2)cc1Cl,IC50,nM,=,2951209.23,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
975,CHEMBL439304,O=C(c1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2)N1C[C@H](O)CO1,IC50,nM,=,25.12,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
976,CHEMBL411651,COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1,IC50,nM,=,15135.61,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
977,CHEMBL272022,COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1,IC50,nM,=,8511.38,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
978,CHEMBL409849,O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,14125.38,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
979,CHEMBL410885,O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,1412.54,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
980,CHEMBL271801,O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,363.08,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
981,CHEMBL409648,COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1,IC50,nM,=,100.0,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
982,CHEMBL429436,O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,81.28,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
983,CHEMBL270969,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2,IC50,nM,=,1905.46,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
984,CHEMBL270971,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2,IC50,nM,=,208.93,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
985,CHEMBL271128,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2,IC50,nM,=,30.2,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
986,CHEMBL271127,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2,IC50,nM,=,120.23,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
987,CHEMBL271768,O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1,IC50,nM,=,20.89,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
988,CHEMBL409224,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2,IC50,nM,=,2.512,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
989,CHEMBL259243,O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1,IC50,nM,=,6.457,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
990,CHEMBL429924,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccnc(N)c1)CC2,IC50,nM,=,158489319.25,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
991,CHEMBL271127,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2,IC50,nM,=,537031796.37,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
992,CHEMBL410862,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccc1-c1nnn[nH]1)CC2,IC50,nM,=,512861383.99,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
993,CHEMBL408483,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc(Cl)c(Cl)cc1C(=O)O)CC2,IC50,nM,=,954992586.02,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
994,CHEMBL409449,O=C(O)c1ccccc1N1CCC(CN2CCC(Oc3ccc(CO)c(Cl)c3)CC2)CC1,IC50,nM,=,645654229.03,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
995,CHEMBL270116,O=C(O)c1cccc(N2CCC(CN3CCC(Oc4ccc(CO)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,512861383.99,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
996,CHEMBL272842,O=C(O)[C@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(CO)c(Cl)c3)CC2)CC1,IC50,nM,=,758577575.03,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
997,CHEMBL271766,N#CCCN1CCC(CN2CCC(Oc3ccc(CO)c(Cl)c3)CC2)CC1,IC50,nM,=,251188643.15,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
998,CHEMBL272441,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccc1C(=O)O)CC2,IC50,nM,=,43651583.22,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
999,CHEMBL272846,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc(N)ccn1)CC2,IC50,nM,=,6165950.02,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1000,CHEMBL429763,Cc1ccc(C(=O)O)c(C(=O)N2CCC(CN3CCC(Oc4ccc(CO)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,100000000.0,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1001,CHEMBL272242,O=C(O)c1ccccc1C(=O)N1CCC(CN2CCC(Oc3ccc(CO)c(Cl)c3)CC2)CC1,IC50,nM,=,97723722.1,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1002,CHEMBL429581,CS(=O)(=O)c1ccc(CC(C(=O)O)N2CCC(CN3CCC(Oc4ccc(CO)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,85113803.82,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1003,CHEMBL271998,O=C(O)c1cccc(N2CCC(CN3CCC(Oc4ccc(CO)c(Cl)c4)CC3)CC2)n1,IC50,nM,=,66069344.8,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1004,CHEMBL406028,O=C(O)CN1CCC(CN2CCC(Oc3ccc(CO)c(Cl)c3)CC2)CC1,IC50,nM,=,64565422.9,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1005,CHEMBL411448,Cc1ncc(N2CCC(CN3CCC(Oc4ccc(CO)c(Cl)c4)CC3)CC2)cc1C(=O)O,IC50,nM,=,37153522.91,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1006,CHEMBL271405,O=C(O)[C@H](Cc1ccccn1)N1CCC(CN2CCC(Oc3ccc(CO)c(Cl)c3)CC2)CC1,IC50,nM,=,33113112.15,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1007,CHEMBL271971,CCC1C[C@H](N2CCC(CN3CCC(Oc4ccc(CO)c(Cl)c4)CC3)CC2)C(=O)O1,IC50,nM,=,28183829.31,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1008,CHEMBL402450,COC(=O)CCCN1CCC(CN2CCC(Oc3ccc(CO)c(Cl)c3)CC2)CC1,IC50,nM,=,20417379.45,Displacement of [3H]dofetilide from human recombinant ERG potassium channel expressed in HEK293 cells by patch clamp method
1009,CHEMBL270084,COc1ccc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c2c(N)noc12,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1010,CHEMBL430090,COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1011,CHEMBL271240,COc1ccc(N2C(=O)[C@@H](Cc3cccc(OCCc4nc(-c5ccccc5)oc4C)c3)[C@H]2C(=O)O)cc1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
1012,CHEMBL257891,COc1ccc(N2C(=O)[C@H](Cc3cccc(OCCc4nc(-c5ccccc5)oc4C)c3)[C@@H]2C(=O)O)cc1,IC50,,,,Inhibition of human ERG by FLIPR assay
1013,CHEMBL272962,COc1ccc(N2C(=O)C(Cc3cccc(OCCc4nc(-c5ccccc5)oc4C)c3)C2C(=O)O)cn1,IC50,,,,Inhibition of human ERG by FLIPR assay
1014,CHEMBL255388,Cc1oc(-c2ccccc2)nc1CCOc1cccc(CC2C(=O)N(c3ccc(Cl)cc3)C2C(=O)O)c1,IC50,,,,Inhibition of human ERG by FLIPR assay
1015,CHEMBL271739,Cc1oc(-c2ccccc2)nc1CCOc1cccc(CC2C(=O)N(c3ccc(F)cc3)C2C(=O)O)c1,IC50,,,,Inhibition of human ERG by FLIPR assay
1016,CHEMBL403847,COc1ccc(N2C(=O)C(Cc3cccc(OCCc4nc(-c5ccccc5)oc4C)c3)C2C(=O)O)cc1,IC50,,,,Inhibition of human ERG by FLIPR assay
1017,CHEMBL272336,Cc1oc(-c2ccc(Cl)cc2)nc1CCOc1cccc(C[C@@H]2C(=O)N(c3ccc(C(C)(C)C)cc3)[C@@H]2C(=O)O)c1,IC50,nM,=,1300.0,Inhibition of human ERG by FLIPR assay
1018,CHEMBL257517,COc1ccc(-c2nc(CCOc3cccc(C[C@@H]4C(=O)N(c5ccc(C(C)(C)C)cc5)[C@@H]4C(=O)O)c3)c(C)o2)cc1,IC50,nM,=,3200.0,Inhibition of human ERG by FLIPR assay
1019,CHEMBL429734,Cc1oc(-c2cccc(Cl)c2)nc1CCOc1cccc(C[C@@H]2C(=O)N(c3ccc(C(C)(C)C)cc3)[C@@H]2C(=O)O)c1,IC50,nM,=,1800.0,Inhibition of human ERG by FLIPR assay
1020,CHEMBL404646,COc1cccc(-c2nc(CCOc3cccc(C[C@@H]4C(=O)N(c5ccc(C(C)(C)C)cc5)[C@@H]4C(=O)O)c3)c(C)o2)c1,IC50,nM,=,2100.0,Inhibition of human ERG by FLIPR assay
1021,CHEMBL404451,Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H]2C(=O)N(c3ccc(C(C)(C)C)cc3)[C@H]2C(=O)O)cc1,IC50,,,,Inhibition of human ERG by FLIPR assay
1022,CHEMBL256468,Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@@H]2C(=O)N(c3ccc(C(C)(C)C)cc3)[C@@H]2C(=O)O)cc1,IC50,nM,=,18100.0,Inhibition of human ERG by FLIPR assay
1023,CHEMBL272963,Cc1oc(-c2ccccc2)nc1CCOc1cccc(C[C@H]2C(=O)N(c3ccc(C(C)(C)C)cc3)[C@H]2C(=O)O)c1,IC50,,,,Inhibition of human ERG by FLIPR assay
1024,CHEMBL255389,Cc1oc(-c2ccccc2)nc1CCOc1cccc(C[C@@H]2C(=O)N(c3ccc(C(C)(C)C)cc3)[C@@H]2C(=O)O)c1,IC50,nM,=,6200.0,Inhibition of human ERG by FLIPR assay
1025,CHEMBL272774,COc1ccc(N2C(=O)[C@H](Cc3ccc(OCCc4nc(-c5ccccc5)oc4C)cc3)[C@@H]2C(=O)O)cc1,IC50,,,,Inhibition of human ERG by FLIPR assay
1026,CHEMBL411118,COc1ccc(N2C(=O)[C@@H](Cc3ccc(OCCc4nc(-c5ccccc5)oc4C)cc3)[C@H]2C(=O)O)cc1,IC50,nM,=,54000.0,Inhibition of human ERG by FLIPR assay
1027,CHEMBL258132,CN(C)C(=O)C(N)c1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1,IC50,nM,=,6800.0,Inhibition of human ERG
1028,CHEMBL402911,CCOC(=O)C(N)c1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1,IC50,nM,=,5700.0,Inhibition of human ERG
1029,CHEMBL270467,Cc1cc(C)n(-c2cc(NC(=O)CN3CCN(C)CC3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,950.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1030,CHEMBL429575,CCN(CC)[C@H]1CCN(CC(=O)Nc2cc(-n3nc(C)cc3C)nc(-c3ccc(C)o3)n2)C1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1031,CHEMBL259038,CCN[C@@H]1CCN(CC(=O)Nc2cc(-n3nc(C)cc3C)nc(-c3ccc(C)o3)n2)C1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1032,CHEMBL409230,Cc1cc(C)n(-c2cc(NC(=O)CN3CC[C@H](OC(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1033,CHEMBL270355,Cc1cc(C)n(-c2cc(NC(=O)CN3CC[C@@H](N(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1034,CHEMBL406397,Cc1cc(C)n(-c2cc(NC(=O)CN3CCCC3)nc(-c3ccc(C)o3)n2)n1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1035,CHEMBL271786,COC1CCN(CC(=O)Nc2cc(-n3nc(C)cc3C)nc(-c3ccc(C)o3)n2)CC1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1036,CHEMBL406921,Cc1cc(C)n(-c2cc(NC(=O)CN3CCCOCC3)nc(-c3ccc(C)o3)n2)n1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1037,CHEMBL261176,Cc1cc(C)n(-c2cc(NC(=O)CN3CCOCC3)nc(-c3ccc(C)o3)n2)n1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1038,CHEMBL261177,CC(=O)N1CCN(CC(=O)Nc2cc(-n3nc(C)cc3C)nc(-c3ccc(C)o3)n2)CC1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1039,CHEMBL409460,Cc1cc(C)n(-c2cc(NC(=O)CN3CCC[C@@H](CN(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1040,CHEMBL429428,Cc1cc(C)n(-c2cc(NC(=O)CN3CCC[C@H](CN(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1041,CHEMBL409420,CCN1CCN(CC(=O)Nc2cc(-n3nc(C)cc3C)nc(-c3ccc(C)o3)n2)CC1,IC50,,,,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1042,CHEMBL270314,Cc1cc(C)n(-c2cc(NC(=O)CCN3CC[C@H](N(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,2280.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1043,CHEMBL410234,Cc1cc(C)n(-c2cc(NC(=O)CCN(C)C)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,650.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1044,CHEMBL272637,Cc1cc(C)n(-c2cc(NC(=O)CN3CC[C@@H](CN(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,1010.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1045,CHEMBL429761,Cc1cc(C)n(-c2cc(NC(=O)CN3CC[C@H](CN(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,1860.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1046,CHEMBL409229,CCN[C@H]1CCN(CC(=O)Nc2cc(-n3nc(C)cc3C)nc(-c3ccc(C)o3)n2)C1,IC50,nM,=,420.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1047,CHEMBL271606,Cc1cc(C)n(-c2cc(NC(=O)CN3CC[C@H](N(C)C)C3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,600.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1048,CHEMBL272679,Cc1cc(C)n(-c2cc(NC(=O)CC3CCN(C)CC3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,4170.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1049,CHEMBL409459,Cc1cc(C)n(-c2cc(NC(=O)CN3CCC(CN(C)C)CC3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,1670.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1050,CHEMBL409419,Cc1cc(C)n(-c2cc(NC(=O)CN3CCCN(C)CC3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,285.0,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique
1051,CHEMBL436673,CCc1ccccc1Oc1cc(C)ncc1CN(C)C,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG channel
1052,CHEMBL437206,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,IC50,nM,=,37000.0,Inhibition of human ERG
1053,CHEMBL402163,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1.O=C(O)C(F)(F)F,IC50,nM,=,7100.0,Inhibition of human ERG
1054,CHEMBL445674,CS(=O)(=O)c1ccc(-c2noc([C@@H](CCO)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1.O=C(O)C(F)(F)F,IC50,nM,=,47000.0,Inhibition of human ERG
1055,CHEMBL257023,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,IC50,nM,=,19000.0,Inhibition of human ERG
1056,CHEMBL410832,COC1OC2(CCN(Cc3ccccc3)CC2)c2cnn(-c3ccccc3)c21,IC50,nM,=,0.41,Inhibition of human ERG channel
1057,CHEMBL259732,CCCCN1CCC2(CC1)OC(OC)c1c2cnn1-c1ccccc1,IC50,nM,=,0.65,Inhibition of human ERG channel
1058,CHEMBL257176,N#Cc1cccnc1-c1ccc(C(=O)Nc2ccccc2N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG channel
1059,CHEMBL256998,CC(C)N1CCN(Cc2cnc(-c3ccc(C(=O)Nc4ccccc4N)cc3)c(F)c2)CC1,IC50,nM,<,31622.78,Inhibition of human ERG channel
1060,CHEMBL258175,CC(C)N1CCN(Cc2cnc(-c3ccc(C(=O)Nc4ccccc4N)cc3)c(Cl)c2)CC1,IC50,nM,=,7079.46,Inhibition of human ERG channel
1061,CHEMBL258177,CC(C)N1CCN(Cc2cnc(-c3ccc(C(=O)Nc4ccccc4N)cc3)c(C#N)c2)CC1,IC50,nM,=,19054.61,Inhibition of human ERG channel
1062,CHEMBL258176,Cc1cc(CN2CCN(C(C)C)CC2)cnc1-c1ccc(C(=O)Nc2ccccc2N)cc1,IC50,nM,<,25118.86,Inhibition of human ERG channel
1063,CHEMBL255925,CCN1CCN(Cc2cnc(-c3ccc(C(=O)Nc4ccccc4N)cc3)c(F)c2)CC1,IC50,nM,<,31622.78,Inhibition of human ERG channel
1064,CHEMBL402542,CCN1CCN(Cc2cnc(-c3ccc(C(=O)Nc4ccccc4N)cc3)c(Cl)c2)CC1,IC50,nM,=,8317.64,Inhibition of human ERG channel
1065,CHEMBL256985,CCN1CCN(Cc2cnc(-c3ccc(C(=O)Nc4ccccc4N)cc3)c(C#N)c2)CC1,IC50,nM,<,25118.86,Inhibition of human ERG channel
1066,CHEMBL255244,CCN1CCN(Cc2cnc(-c3ccc(C(=O)Nc4ccccc4N)cc3)c(C)c2)CC1,IC50,nM,<,25118.86,Inhibition of human ERG channel
1067,CHEMBL403812,Nc1ccccc1NC(=O)c1ccc(-c2ncc(CN3CCC3)cc2F)cc1,IC50,nM,<,25118.86,Inhibition of human ERG channel
1068,CHEMBL255245,Nc1ccccc1NC(=O)c1ccc(-c2ncc(CN3CCC3)cc2Cl)cc1,IC50,nM,=,22387.21,Inhibition of human ERG channel
1069,CHEMBL403813,N#Cc1cc(CN2CCC2)cnc1-c1ccc(C(=O)Nc2ccccc2N)cc1,IC50,nM,<,25118.86,Inhibition of human ERG channel
1070,CHEMBL402208,Cc1cc(CN2CCC2)cnc1-c1ccc(C(=O)Nc2ccccc2N)cc1,IC50,nM,<,25118.86,Inhibition of human ERG channel
1071,CHEMBL261592,Cc1cc2cc(Nc3ncnn4cc(-c5nnc(C)o5)c(C(C)C)c34)cnc2[nH]1,IC50,nM,=,6600.0,Inhibition of human ERG by patch clamp method
1072,CHEMBL262341,O=C1N=CC=C2N=C(c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)C(c3ccccc3)=CC12,IC50,nM,=,5610.0,Inhibition of human ERG
1073,CHEMBL472,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,IC50,nM,=,74000.0,Inhibition of human ERG potassium channel
1074,CHEMBL43,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,IC50,nM,=,210.0,Inhibition of human ERG potassium channel
1075,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,181.0,Inhibition of human ERG potassium channel
1076,CHEMBL428411,Cc1nccn1C[C@H]1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,810.0,Inhibition of human ERG potassium channel
1077,CHEMBL513608,CN(C)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,11.0,Inhibition of human ERG potassium channel
1078,CHEMBL362103,CCC[S+]([O-])CCCN(CC)CC(O)COc1ccc(C#N)cc1,IC50,nM,=,5.0,Inhibition of human ERG potassium channel
1079,CHEMBL540359,CC(C)OC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]2CCC[N+](C)(Cc3cccc(O)c3)C2)cc1.[I-],IC50,nM,=,2511.89,Inhibition of human ERG
1080,CHEMBL472363,O=C(COc1cccc(Cl)c1)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,560.0,Inhibition of human ERG expressed in CHO cells by Patch clamp assay
1081,CHEMBL512185,O=C(COc1cccc(Cl)c1)NC1CCN(Cc2ccn(-c3ccc(OC(F)(F)F)cc3)c2)CC1,IC50,nM,=,490.0,Inhibition of human ERG expressed in CHO cells by Patch clamp assay
1082,CHEMBL562668,CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1,IC50,nM,>,3000.0,Inhibition of human ERG
1083,CHEMBL496770,Clc1ccc(-n2c(-c3ccc(Cl)cc3Cl)nc3c(NN4CCCCC4)ncnc32)cc1,IC50,nM,=,2700.0,Inhibition of human ERG
1084,CHEMBL524087,Clc1ccc(-n2c(-c3ccc(Cl)cc3Cl)nc3c(NC4CCCCC4)ncnc32)cc1,IC50,nM,>,3000.0,Inhibition of human ERG
1085,CHEMBL496352,Clc1ccc(-n2c(-c3ccc(Cl)cc3Cl)nc3c(N4CCCCC4)ncnc32)cc1,IC50,nM,>,3000.0,Inhibition of human ERG
1086,CHEMBL522235,Clc1ccc(-n2c(-c3ccccc3Cl)nc3c(N4CCCCC4)ncnc32)cc1,IC50,nM,>,3000.0,Inhibition of human ERG
1087,CHEMBL498411,CN1CCN(c2ncnc3c2nc(-c2ccc(Cl)cc2Cl)n3-c2ccc(Cl)cc2)CC1,IC50,nM,=,350.0,Inhibition of human ERG
1088,CHEMBL496555,CN1CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1,IC50,nM,=,630.0,Inhibition of human ERG
1089,CHEMBL497999,CS(=O)(=O)c1ccc(OCC2CC2)c(C(=O)N2CCN(c3ccc(C#N)cc3F)CC2)c1,IC50,nM,=,600.0,Inhibition of human ERG potassium channel by patch-clamp assay
1090,CHEMBL497171,CCCCNc1nccc2[nH]c3ccccc3c12,IC50,nM,=,1584.89,Inhibition of human ERG
1091,CHEMBL480016,C[C@H]1CN(S(=O)(=O)C[C@]23CC[C@H](CC2=O)C3(C)C)CCN1c1ncc(C(F)(F)F)cc1F,IC50,nM,>,63000.0,Binding affinity to human ERG
1092,CHEMBL465955,C[C@@H]1CN(CC2(C(N)=O)CC2)CCN1S(=O)(=O)c1ccc(C(C)(O)C(F)(F)F)cc1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp technique
1093,CHEMBL454407,CN1C(=O)[C@@H](CN2CCCCC2)C[C@H]1C#Cc1ccccc1,IC50,nM,=,6850.0,Inhibition of human ERG by patch-clamp technique
1094,CHEMBL465956,C[C@@H]1CN(CC2(C(N)=O)CCC2)CCN1S(=O)(=O)c1ccc(C(C)(O)C(F)(F)F)cc1,IC50,nM,=,65000.0,Inhibition of human ERG by patch clamp technique
1095,CHEMBL516636,C[C@@H]1CN(CC2(c3ccc(C(N)=O)cc3)CC2)CCN1S(=O)(=O)c1ccc(C(C)(O)C(F)(F)F)cc1,IC50,nM,=,6400.0,Inhibition of human ERG by patch clamp technique
1096,CHEMBL460962,C[C@@H]1CN(CC2(C(N)=O)CC2)CCN1S(=O)(=O)c1ccc([C@](C)(O)C(F)(F)F)cc1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp technique
1097,CHEMBL489500,C[C@@H]1CN(CC2(C(N)=O)CC2)CCN1S(=O)(=O)c1ccc([C@@](C)(O)C(F)(F)F)cc1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp technique
1098,CHEMBL522964,C[C@@H]1CN(CC2(c3ccncc3)CC2)CCN1S(=O)(=O)c1ccc(C(C)(O)C(F)(F)F)cc1,IC50,nM,=,440.0,Inhibition of human ERG by patch clamp technique
1099,CHEMBL491679,Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1.Cl,IC50,nM,=,2300.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1100,CHEMBL491320,Cc1nnc(C(C)C)n1C1CCN([C@@H](C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1101,CHEMBL491319,Cc1nnc(C(C)C)n1C1CCN([C@H](C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1102,CHEMBL489324,Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1.Cl,IC50,nM,=,2100.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1103,CHEMBL526466,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CC3)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,80.0,Inhibition of human ERG channel
1104,CHEMBL209821,CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1,IC50,nM,=,3800.0,Inhibition of human ERG channel
1105,CHEMBL210537,CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)c3ccc(C)cc3)CC2)c1,IC50,nM,=,300.0,Inhibition of human ERG channel
1106,CHEMBL209324,COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(C)cc2)CC1,IC50,nM,=,5000.0,Inhibition of human ERG channel
1107,CHEMBL317520,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(C(=O)c3cccc(Cl)c3)C2)cc1,IC50,nM,=,5800.0,Inhibition of human ERG channel
1108,CHEMBL516874,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CCO3)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,150.0,Inhibition of human ERG channel
1109,CHEMBL525369,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CCC3)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,7000.0,Inhibition of human ERG channel
1110,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,33.2,Inhibition of human ERG channel
1111,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,26.8,Inhibition of human ERG channel
1112,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,54.6,Inhibition of human ERG channel
1113,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,320.0,Inhibition of human ERG channel
1114,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,148.0,Inhibition of human ERG channel
1115,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.7,Inhibition of human ERG channel
1116,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,125.0,Inhibition of human ERG channel
1117,CHEMBL1088,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,IC50,nM,=,320.0,Inhibition of human ERG channel
1118,CHEMBL1688,C[N+]1([O-])CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,133300.0,Inhibition of human ERG channel
1119,CHEMBL845,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,IC50,nM,=,4490.0,Inhibition of human ERG channel
1120,CHEMBL1621,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,IC50,nM,=,1300.0,Inhibition of human ERG channel
1121,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,1390.0,Inhibition of human ERG channel
1122,CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,nM,=,1900.0,Inhibition of human ERG channel
1123,CHEMBL3,CN1CCC[C@H]1c1cccnc1,IC50,nM,=,244300.0,Inhibition of human ERG channel
1124,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,213.0,Inhibition of human ERG channel
1125,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,6.7,Inhibition of human ERG channel
1126,CHEMBL1110,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,3200.0,Inhibition of human ERG channel
1127,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,18.1,Inhibition of human ERG channel
1128,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,231.3,Inhibition of human ERG channel
1129,CHEMBL1125,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1,IC50,nM,=,14200.0,Inhibition of human ERG channel
1130,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,3300.0,Inhibition of human ERG channel
1131,CHEMBL502560,N#Cc1ccc2cc1Oc1cccc(c1)CN1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,4700.0,Inhibition of human ERG channel
1132,CHEMBL524909,N#Cc1ccc2cc1Oc1cccc(c1)CN1CC[C@H](NCc3cncn3C2)C1=O,IC50,nM,=,11000.01,Inhibition of human ERG channel
1133,CHEMBL524352,N#Cc1ccc2cc1Oc1cc(Cl)cc(c1)CN1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,220.0,Inhibition of human ERG channel
1134,CHEMBL501480,N#Cc1ccc2cc1Oc1cccc(c1)C(c1ccccc1)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,320.0,Inhibition of human ERG channel
1135,CHEMBL501480,N#Cc1ccc2cc1Oc1cccc(c1)C(c1ccccc1)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,2900.0,Inhibition of human ERG channel
1136,CHEMBL525413,N#Cc1ccc2cc1Oc1cccc(c1)C(c1cccc(Cl)c1)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,82.0,Inhibition of human ERG channel
1137,CHEMBL525413,N#Cc1ccc2cc1Oc1cccc(c1)C(c1cccc(Cl)c1)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,530.0,Inhibition of human ERG channel
1138,CHEMBL498042,CC1c2ccc(C#N)c(c2)Oc2cccc(c2)CN2CC[C@@H](NCc3cncn31)C2=O,IC50,nM,=,20000.0,Inhibition of human ERG channel
1139,CHEMBL498042,CC1c2ccc(C#N)c(c2)Oc2cccc(c2)CN2CC[C@@H](NCc3cncn31)C2=O,IC50,nM,=,8399.99,Inhibition of human ERG channel
1140,CHEMBL524997,N#Cc1ccc2cc1Oc1ccc(Br)c(c1)CN1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,4600.0,Inhibition of human ERG channel
1141,CHEMBL524862,N#Cc1ccc2cc1Oc1cccc(c1)-c1ccccc1N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,2600.0,Inhibition of human ERG channel
1142,CHEMBL53821,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@H](NCc3cncn3C2)C1=O,IC50,nM,=,10499.99,Inhibition of human ERG channel
1143,CHEMBL496879,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,8300.0,Inhibition of human ERG channel
1144,CHEMBL497048,CN1Cc2cncn2Cc2ccc(C#N)c(c2)Oc2ccc3cccc(c3c2)N2CC[C@H]1C2=O,IC50,nM,=,4400.0,Inhibition of human ERG channel
1145,CHEMBL523080,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@H](NC(=O)Cc3cncn3C2)C1=O,IC50,nM,=,10000.0,Inhibition of human ERG channel
1146,CHEMBL524082,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@@H](NC(=O)Cc3cncn3C2)C1=O,IC50,nM,=,9900.0,Inhibition of human ERG channel
1147,CHEMBL55826,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@H](NCCc3cncn3C2)C1=O,IC50,nM,=,8100.0,Inhibition of human ERG channel
1148,CHEMBL498260,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@@H](NCCc3cncn3C2)C1=O,IC50,nM,=,210.0,Inhibition of human ERG channel
1149,CHEMBL525368,CN1CCc2cncn2Cc2ccc(C#N)c(c2)Oc2ccc3cccc(c3c2)N2CC[C@H]1C2=O,IC50,nM,=,4900.0,Inhibition of human ERG channel
1150,CHEMBL498100,CN1CCc2cncn2Cc2ccc(C#N)c(c2)Oc2ccc3cccc(c3c2)N2CC[C@@H]1C2=O,IC50,nM,=,180.0,Inhibition of human ERG channel
1151,CHEMBL526466,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CC3)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,80.0,Inhibition of human ERG channel
1152,CHEMBL498101,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CC3)N1CC[C@H](NCc3cncn3C2)C1=O,IC50,nM,=,4300.0,Inhibition of human ERG channel
1153,CHEMBL526656,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@H](CC3)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,4700.0,Inhibition of human ERG channel
1154,CHEMBL523570,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@H](CC3)N1CC[C@H](NCc3cncn3C2)C1=O,IC50,nM,=,2700.0,Inhibition of human ERG channel
1155,CHEMBL496065,CN1Cc2cncn2Cc2ccc(C#N)c(c2)Oc2ccc3c(c2)[C@@H](CC3)N2CC[C@@H]1C2=O,IC50,nM,=,2600.0,Inhibition of human ERG channel
1156,CHEMBL525369,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CCC3)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,7000.0,Inhibition of human ERG channel
1157,CHEMBL526521,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CCC3)N1CC[C@H](NCc3cncn3C2)C1=O,IC50,nM,=,11999.99,Inhibition of human ERG channel
1158,CHEMBL516874,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CCO3)N1CC[C@@H](NCc3cncn3C2)C1=O,IC50,nM,=,150.0,Inhibition of human ERG channel
1159,CHEMBL465417,N#Cc1ccc2cc1Oc1ccc3c(c1)[C@@H](CCO3)N1CC[C@H](NCc3cncn3C2)C1=O,IC50,nM,=,9099.99,Inhibition of human ERG channel
1160,CHEMBL316502,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(Cc3ccccc3)C2=O)cc1,IC50,nM,=,7199.99,Inhibition of human ERG channel
1161,CHEMBL312137,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(Cc3cccc(Cl)c3)C2=O)cc1,IC50,nM,=,440.0,Inhibition of human ERG channel
1162,CHEMBL99371,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(c3ccncc3)C2=O)cc1,IC50,nM,=,3200.0,Inhibition of human ERG channel
1163,CHEMBL100566,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(c3cccc4ncccc34)C2=O)cc1,IC50,nM,=,8200.0,Inhibition of human ERG channel
1164,CHEMBL483964,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(C(=O)c3cccc(Cl)c3)C2=O)cc1,IC50,nM,=,5800.0,Inhibition of human ERG channel
1165,CHEMBL483805,Cc1ncccc1C(=O)N1CC[C@H](NCc2cncn2Cc2ccc(C#N)cc2)C1=O,IC50,nM,=,10000.0,Inhibition of human ERG channel
1166,CHEMBL484816,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(C(=O)c3cccnc3N)C2=O)cc1,IC50,nM,=,50000.0,Inhibition of human ERG channel
1167,CHEMBL485161,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(C(=O)c3cccnc3O)C2=O)cc1,IC50,nM,=,50000.0,Inhibition of human ERG channel
1168,CHEMBL485162,COc1ncccc1C(=O)N1CC[C@H](NCc2cncn2Cc2ccc(C#N)cc2)C1=O,IC50,nM,=,20999.99,Inhibition of human ERG channel
1169,CHEMBL483810,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(C(=O)c3cccnc3S)C2=O)cc1,IC50,nM,=,11000.01,Inhibition of human ERG channel
1170,CHEMBL502288,CSc1ncccc1C(=O)N1CC[C@H](NCc2cncn2Cc2ccc(C#N)cc2)C1=O,IC50,nM,=,7800.01,Inhibition of human ERG channel
1171,CHEMBL500945,CCSc1ncccc1C(=O)N1CC[C@H](NCc2cncn2Cc2ccc(C#N)cc2)C1=O,IC50,nM,=,14000.0,Inhibition of human ERG channel
1172,CHEMBL500946,N#Cc1ccc(Cn2cncc2CN[C@H]2CCN(C(=O)c3cncc(Br)c3)C2=O)cc1,IC50,nM,=,6000.0,Inhibition of human ERG channel
1173,CHEMBL100415,CCCCN(Cc1cncn1Cc1ccc(C#N)cc1)[C@H]1CCN(Cc2ccccc2)C1=O,IC50,nM,=,190.0,Inhibition of human ERG channel
1174,CHEMBL327946,N#Cc1ccc(Cn2cncc2CN(Cc2cccnc2)[C@H]2CCN(Cc3ccccc3)C2=O)cc1,IC50,nM,=,870.0,Inhibition of human ERG channel
1175,CHEMBL329067,N#Cc1ccc(Cn2cncc2CN(CCCc2ccccc2)[C@H]2CCN(Cc3ccccc3)C2=O)cc1,IC50,nM,=,24.0,Inhibition of human ERG channel
1176,CHEMBL322007,N#Cc1ccc(Cn2cncc2CN(CCCN)[C@H]2CCN(Cc3ccccc3)C2=O)cc1,IC50,nM,=,480.0,Inhibition of human ERG channel
1177,CHEMBL526277,N#Cc1ccc(Cn2cncc2CN(CCN2CCOCC2)[C@H]2CCN(Cc3ccccc3)C2=O)cc1,IC50,nM,=,190.0,Inhibition of human ERG channel
1178,CHEMBL522568,N#Cc1ccc(Cn2cncc2CN(CCN2CCNCC2)[C@H]2CCN(Cc3ccccc3)C2=O)cc1,IC50,nM,=,1100.0,Inhibition of human ERG channel
1179,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,33.2,Inhibition of human ERG channel
1180,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,26.8,Inhibition of human ERG channel
1181,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,54.6,Inhibition of human ERG channel
1182,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,320.0,Inhibition of human ERG channel
1183,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,148.0,Inhibition of human ERG channel
1184,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.7,Inhibition of human ERG channel
1185,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,125.0,Inhibition of human ERG channel
1186,CHEMBL1088,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,IC50,nM,=,320.0,Inhibition of human ERG channel
1187,CHEMBL1688,C[N+]1([O-])CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,133299.95,Inhibition of human ERG channel
1188,CHEMBL845,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,IC50,nM,=,4490.0,Inhibition of human ERG channel
1189,CHEMBL1621,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,IC50,nM,=,1300.0,Inhibition of human ERG channel
1190,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,1390.0,Inhibition of human ERG channel
1191,CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,nM,=,1900.0,Inhibition of human ERG channel
1192,CHEMBL3,CN1CCC[C@H]1c1cccnc1,IC50,nM,=,244299.74,Inhibition of human ERG channel
1193,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,213.0,Inhibition of human ERG channel
1194,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,6.7,Inhibition of human ERG channel
1195,CHEMBL1110,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,3200.0,Inhibition of human ERG channel
1196,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,18.1,Inhibition of human ERG channel
1197,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,231.3,Inhibition of human ERG channel
1198,CHEMBL1125,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1,IC50,nM,=,14199.99,Inhibition of human ERG channel
1199,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,3300.0,Inhibition of human ERG channel
1200,CHEMBL98553,CC(C)(C)OC(=O)NCCCN(Cc1cncn1Cc1ccc(C#N)cc1)[C@H]1CCN(Cc2ccccc2)C1=O,IC50,nM,=,110.0,Inhibition of human ERG channel
1201,CHEMBL1110,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,3235.94,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1202,CHEMBL22,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,IC50,nM,=,239883.29,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1203,CHEMBL94664,COc1ccc(C2CCN(CCC3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,199.53,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1204,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,181.97,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1205,CHEMBL61301,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,IC50,nM,=,28.18,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1206,CHEMBL416956,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,IC50,nM,=,5623.41,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1207,CHEMBL498572,O=C(OC1CC2CC3CC(C1)N2CC3O)c1c[nH]c2ccccc12,IC50,nM,=,5888.44,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1208,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,1513.56,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1209,CHEMBL652,O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,IC50,nM,=,3890.45,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1210,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.36,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1211,CHEMBL60796,Oc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,1.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1212,CHEMBL549,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1213,CHEMBL17423,COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC,IC50,nM,=,1096.48,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1214,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,141.25,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1215,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,363.08,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1216,CHEMBL96153,COc1ccc(C2CCN(CC[C@H]3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,251.19,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1217,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,199.53,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1218,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,18197.01,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1219,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,3311.31,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1220,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,10.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1221,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,151.36,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1222,CHEMBL1294,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,IC50,nM,=,323.59,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1223,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,50.12,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1224,CHEMBL75880,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,IC50,nM,=,7762.47,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1225,CHEMBL46,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,812.83,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1226,CHEMBL4,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,1412537.54,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1227,CHEMBL845,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,IC50,nM,=,4466.84,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1228,CHEMBL475534,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1229,CHEMBL193,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],IC50,nM,=,50118.72,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1230,CHEMBL3,CN1CCC[C@H]1c1cccnc1,IC50,nM,=,245470.89,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1231,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1232,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,436.52,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1233,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1445.44,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1234,CHEMBL1088,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,IC50,nM,=,323.59,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1235,CHEMBL998,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,IC50,nM,=,169.82,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1236,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,912010.84,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1237,CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,nM,=,1905.46,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1238,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3388.44,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1239,CHEMBL533,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1240,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,30.2,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1241,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,199.53,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1242,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,50118.72,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1243,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1244,CHEMBL1106,NC1=NCC2c3ccccc3Cc3ccccc3N12,IC50,nM,=,100000.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1245,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,19.95,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1246,CHEMBL2368925,O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,IC50,nM,=,12022.64,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1247,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1248,CHEMBL517,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,IC50,nM,=,91201.08,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1249,CHEMBL657,CN(C)CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,26915.35,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1250,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,nM,=,17378.01,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1251,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,1380.38,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1252,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,120.23,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1253,CHEMBL370805,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,IC50,nM,=,7244.36,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1254,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,323.59,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1255,CHEMBL1741,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,58884.37,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1256,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,39.81,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1257,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,nM,=,954992.59,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1258,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1479.11,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1259,CHEMBL505,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,IC50,nM,=,20892.96,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1260,CHEMBL1000,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,IC50,nM,=,30199.52,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1261,CHEMBL723,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,IC50,nM,=,10471.29,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1262,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,549.54,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1263,CHEMBL123558,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,IC50,nM,=,1412.54,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1264,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,10.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1265,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1266,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique
1267,CHEMBL521851,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,nM,=,64000.0,Blockade of human ERG channel by whole cell patch clamp assay
1268,CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,nM,>,50000.0,Binding affinity to human ERG
1269,CHEMBL495331,CN(C)C(=O)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,IC50,nM,>,50000.0,Binding affinity to human ERG
1270,CHEMBL492447,C1=C(c2ccccc2)c2ccccc2OC12CCNCC2,IC50,nM,=,680.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1271,CHEMBL13470,C=CCN1C[C@H](C)N([C@H](c2ccc(C(=O)N(CC)CC)cc2)c2cccc(OC)c2)C[C@H]1C,IC50,,,,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1272,CHEMBL25230,C=CCN1C[C@H](C)N([C@H](c2ccc(C(=O)N(CC)CC)cc2)c2cccc(O)c2)C[C@H]1C,IC50,,,,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1273,CHEMBL494480,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cccc(O)c32)cc1,IC50,nM,=,78000.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1274,CHEMBL494479,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccc(O)cc32)cc1,IC50,nM,=,19750.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1275,CHEMBL495094,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cc(O)ccc32)cc1,IC50,nM,=,60000.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1276,CHEMBL523507,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3c(O)cccc32)cc1,IC50,nM,=,18310.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1277,CHEMBL494472,CCN1CCC2(C=C(c3ccc(C(=O)N(CC)CC)cc3)c3ccccc3O2)CC1,IC50,nM,=,1814.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1278,CHEMBL494275,CCN(CC)C(=O)c1ccc(C2=CC3(CCN(C)CC3)Oc3ccccc32)cc1,IC50,nM,=,766.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1279,CHEMBL494274,CCN(CC)C(=O)c1ccc(C2=CC3(CCN(C(C)=O)CC3)Oc3ccccc32)cc1,IC50,nM,=,47440.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1280,CHEMBL493454,CCN(CC)C(=O)c1ccccc1C1=CC2(CCNCC2)Oc2ccccc21,IC50,nM,=,6450.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1281,CHEMBL523204,CCN(CC)C(=O)c1cccc(C2=CC3(CCNCC3)Oc3ccccc32)c1,IC50,nM,=,303.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1282,CHEMBL494462,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,7900.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1283,CHEMBL494266,O=C(O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,>,100000.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1284,CHEMBL494265,COC(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,663.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1285,CHEMBL495278,N#Cc1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,<,100.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1286,CHEMBL495074,Oc1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,643.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1287,CHEMBL495073,COc1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,585.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1288,CHEMBL492449,FC(F)(F)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,379.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1289,CHEMBL492448,Cc1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,462.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1290,CHEMBL521523,C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CC5CCNCC5)c4)ccc3F)c2)CCN1,IC50,nM,=,10000.0,Inhibition of human ERG
1291,CHEMBL495087,CC(=O)Nc1ccc(CN2CCC3(CC2)C(NC2CCCCC2)=NC(=O)N3c2cccc(F)c2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG
1292,CHEMBL492438,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCc2ccc(Cl)c(Cl)c2)cc1,IC50,nM,=,730.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1293,CHEMBL493078,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CN(CCc2ccc(Cl)c(Cl)c2)Cc2ccc(F)c(F)c2F)cc1,IC50,nM,=,1700.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1294,CHEMBL495114,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CN(CCc2ccc(Cl)c(Cl)c2)Cc2ccccc2F)cc1,IC50,nM,=,1200.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1295,CHEMBL493712,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CN(CCc2ccc(Cl)c(Cl)c2)Cc2cccc(O)c2)cc1,IC50,nM,=,780.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1296,CHEMBL495328,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CN(CCc2ccc(Cl)c(Cl)c2)Cc2ccccc2O)cc1,IC50,nM,=,830.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1297,CHEMBL493087,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CN(CCc2ccc(Cl)c(Cl)c2)Cc2ccccc2)cc1,IC50,nM,=,430.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1298,CHEMBL494105,CC(C)CN(CCc1ccc(Cl)c(Cl)c1)C[C@H](O)COc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,730.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1299,CHEMBL494504,CCCCN(CCc1ccc(Cl)c(Cl)c1)C[C@H](O)COc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,70.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1300,CHEMBL524038,CCCN(CCc1ccc(Cl)c(Cl)c1)C[C@H](O)COc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,130.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1301,CHEMBL492620,CCN(CCc1ccc(Cl)c(Cl)c1)C[C@H](O)COc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,170.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1302,CHEMBL523167,CN(CCc1ccc(Cl)c(Cl)c1)C[C@H](O)COc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,370.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1303,CHEMBL494061,Cc1ccc(CCNC[C@H](O)COc2ccc(NS(C)(=O)=O)cc2)cc1C,IC50,nM,=,2400.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1304,CHEMBL523671,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCc2ccc(F)c(F)c2)cc1,IC50,nM,=,1630.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1305,CHEMBL493053,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCc2ccc(Cl)c(F)c2)cc1,IC50,nM,=,1910.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1306,CHEMBL492846,CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCc2ccc(Cl)cc2)cc1,IC50,nM,=,1390.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1307,CHEMBL523374,CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12,IC50,nM,=,13000.0,Inhibition of human ERG by manual electrophysiology
1308,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,806.0,Inhibition of human ERG
1309,CHEMBL521833,CC(C)(C)CCN1CC[C@@H](CNC(=O)c2cc(Cl)cc(Cl)c2)[C@H](F)C1,IC50,nM,=,3034.0,Inhibition of human ERG
1310,CHEMBL493677,CC(C)(C)CCN1CC[C@H](CNC(=O)c2cc(Cl)cc(Cl)c2)[C@H](F)C1,IC50,nM,=,4114.0,Inhibition of human ERG
1311,CHEMBL522843,CC(C)(C)OCCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,1260.0,Inhibition of human ERG
1312,CHEMBL493467,CC(C)(C)NC(=O)CN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG
1313,CHEMBL495303,CC(C)(C)C(F)CN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,4731.0,Inhibition of human ERG
1314,CHEMBL495302,CC(C)(C)C(O)CN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,4810.0,Inhibition of human ERG
1315,CHEMBL493061,CC(C)(C)C(=O)CN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,2047.0,Inhibition of human ERG
1316,CHEMBL523508,CC(C)(C)CCN1CCC(CNC(=O)Cc2ccc(C(C)(C)C)cc2)CC1,IC50,nM,=,1021.0,Inhibition of human ERG
1317,CHEMBL493060,CC(C)(C)CCN1CCC(CNC(=O)C2(c3ccc(F)cc3)CCCCC2)CC1,IC50,nM,=,3674.0,Inhibition of human ERG
1318,CHEMBL446911,CC(C)(C)CCN1CCC(CNC(=O)c2cc(C(F)(F)F)n[nH]2)CC1,IC50,,,,Inhibition of human ERG
1319,CHEMBL493879,CC(C)(C)CCN1CCC(CNC(=O)c2cncc(Br)c2)CC1,IC50,,,,Inhibition of human ERG
1320,CHEMBL493680,CC(C)(C)CCN1CCC(CNC(=O)c2cccc(Cl)c2)CC1,IC50,nM,=,4823.0,Inhibition of human ERG
1321,CHEMBL493679,CC(C)(C)CCN1CCC(CNC(=O)c2ccc(Cl)c(Cl)c2)CC1,IC50,nM,=,1047.0,Inhibition of human ERG
1322,CHEMBL493678,CC(C)(C)CCN1CCC(CNC(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC1,IC50,nM,=,1799.0,Inhibition of human ERG
1323,CHEMBL494682,CC(C)(O)CCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,,,,Inhibition of human ERG
1324,CHEMBL522697,CCC(C)C(C)CN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,883.0,Inhibition of human ERG
1325,CHEMBL494478,CC(CC(C)(C)C)N1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,2208.0,Inhibition of human ERG
1326,CHEMBL494477,O=C(NCC1CCN(CCC2CC2)CC1)c1cc(Cl)cc(Cl)c1,IC50,,,,Inhibition of human ERG
1327,CHEMBL523535,O=C(NCC1CCN(Cc2ccc(Br)nc2)CC1)c1cc(Cl)cc(Cl)c1,IC50,nM,=,655.0,Inhibition of human ERG
1328,CHEMBL493059,O=C(NCC1CCN(Cc2cccnc2)CC1)c1cc(Cl)cc(Cl)c1,IC50,,,,Inhibition of human ERG
1329,CHEMBL523525,O=C(NCC1CCN(Cc2cccc(C(F)(F)F)c2)CC1)c1cc(Cl)cc(Cl)c1,IC50,nM,=,483.0,Inhibition of human ERG
1330,CHEMBL488468,CC(C)(C)CCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,1934.0,Inhibition of human ERG
1331,CHEMBL488294,CC(C)(C)CCN1CCC(CNC(=O)Nc2cccc(Cl)c2)(c2ccccc2)CC1,IC50,nM,=,88.0,Inhibition of human ERG
1332,CHEMBL488295,Cc1ccc(CN2CCC(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)cc1,IC50,nM,=,135.0,Inhibition of human ERG
1333,CHEMBL488817,CC1(C)C[C@@H](CN2CCC(F)(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)CCO1,IC50,nM,=,3790.0,Inhibition of human ERG
1334,CHEMBL461571,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,IC50,nM,=,3230.0,Inhibition of human ERG
1335,CHEMBL473921,C[C@H]1CN(Cc2ccc(-c3cccnc3C(=O)N3CCC(Nc4ccc(F)cc4)CC3)cc2)C[C@@H](C)N1,IC50,nM,>,31622.78,Binding affinity to human ERG
1336,CHEMBL489095,C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)CCN1,IC50,nM,=,15848.93,Binding affinity to human ERG
1337,CHEMBL76,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,IC50,nM,=,2500.0,Inhibition of human cloned ERG
1338,CHEMBL1630,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl,IC50,nM,=,2400.0,Inhibition of human cloned ERG
1339,CHEMBL147587,CCN(CC)Cc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O,IC50,nM,=,3900.0,Inhibition of human cloned ERG
1340,CHEMBL147806,CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O,IC50,nM,=,7500.0,Inhibition of human cloned ERG
1341,CHEMBL1235,CCNCc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,IC50,nM,=,9500.0,Inhibition of human cloned ERG
1342,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,40.0,Inhibition of human cloned ERG
1343,CHEMBL257991,O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp method
1344,CHEMBL641,CNCC[C@@H](Oc1ccccc1C)c1ccccc1,IC50,nM,=,2100.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1345,CHEMBL471001,CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@H]1CN,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1346,CHEMBL469946,C=C(F)CN(CC)C(=O)[C@@]1(c2cccs2)C[C@H]1CN,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1347,CHEMBL512851,C=CCN(CC=C)C(=O)[C@@]1(c2cccs2)C[C@H]1CN,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1348,CHEMBL469947,C=CCN(C(=O)[C@@]1(c2cccs2)C[C@H]1CN)C1CC1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1349,CHEMBL507806,C=CCN(Cc1nccs1)C(=O)[C@@]1(c2cccs2)C[C@H]1CN,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1350,CHEMBL513248,C#CCN(CC#C)C(=O)[C@@]1(c2cccs2)C[C@H]1CN,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1351,CHEMBL259209,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1352,CHEMBL471002,C=CCN(CC)C(=O)[C@@]1(c2cccs2)C[C@H]1CN,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1353,CHEMBL472253,C#CCN(CC)C(=O)[C@@]1(c2cccs2)C[C@H]1CN,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1354,CHEMBL471211,NC[C@@H]1C[C@@]1(C(=O)N1Cc2ccccc2C1)c1cccs1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1355,CHEMBL458242,COc1cncc(-c2cc(NC(C)=O)nc(-n3nc(C)cc3C)n2)c1,IC50,nM,=,24000.0,Inhibition of human ERG by electrophysiology assay
1356,CHEMBL486162,CC(=O)Nc1cc(-c2cccc(N3CCN(C)CC3)n2)nc(-n2nc(C)cc2C)n1,IC50,nM,=,540.0,Inhibition of human ERG by electrophysiology assay
1357,CHEMBL487763,CNCCC(c1ccccc1)c1c[nH]c2ccccc12,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHO cells
1358,CHEMBL463585,CCCCC1(c2ccc3[nH]ccc3c2)CCNC1,IC50,nM,=,4400.0,Inhibition of human ERG expressed in CHO cells
1359,CHEMBL442924,CNC(=O)c1cc2cc(C3(Cc4ccccc4)CCNC3)ccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells
1360,CHEMBL457931,NC(=O)c1cc2cc(C3(Cc4ccccc4)CCNC3)ccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells
1361,CHEMBL457930,N#Cc1cc2cc(C3(Cc4ccccc4)CCNC3)ccc2[nH]1,IC50,nM,=,1400.0,Inhibition of human ERG expressed in CHO cells
1362,CHEMBL459176,Cn1ccc2cc(C3(Cc4ccccc4)CCNC3)ccc21,IC50,nM,=,7000.0,Inhibition of human ERG expressed in CHO cells
1363,CHEMBL513258,Fc1ccc(CC2(c3ccc4[nH]ccc4c3)CCNC2)cc1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in CHO cells
1364,CHEMBL456654,c1ccc(CC2(c3ccc4[nH]ccc4c3)CCNC2)nc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells
1365,CHEMBL486537,c1ccc(CC2(c3ccc4sccc4c3)CCNC2)cc1,IC50,nM,=,11000.0,Inhibition of human ERG expressed in CHO cells
1366,CHEMBL487355,c1ccc(CC2(c3ccc4[nH]ccc4c3)CCNC2)cc1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in CHO cells
1367,CHEMBL528995,Clc1ccc(C23CNCC2C3)cc1Cl,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells
1368,CHEMBL487355,c1ccc(CC2(c3ccc4[nH]ccc4c3)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1369,CHEMBL463389,CCCC1(c2ccc3[nH]ccc3c2)CCNC1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1370,CHEMBL463388,CC1(c2ccc3[nH]ccc3c2)CCNC1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1371,CHEMBL517305,N#Cc1c[nH]c2ccc(C3(Cc4ccccc4)CCNC3)cc12,IC50,,,,Inhibition of human ERG expressed in CHO cells
1372,CHEMBL463387,CN(C)C(=O)c1cc2cc(C3(Cc4ccccc4)CCNC3)ccc2[nH]1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1373,CHEMBL512551,CCOC(=O)c1cc2cc(C3(Cc4ccccc4)CCNC3)ccc2[nH]1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1374,CHEMBL504231,c1ccc(CCC2(c3ccc4[nH]ccc4c3)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1375,CHEMBL514759,COc1cccc(CC2(c3ccc4[nH]ccc4c3)CCNC2)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1376,CHEMBL514447,c1ccc(CC2(c3c[nH]c4ccccc34)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1377,CHEMBL459165,c1ccc(CC2(c3ccc4cc[nH]c4c3)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1378,CHEMBL459165,c1ccc(CC2(c3ccc4cc[nH]c4c3)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1379,CHEMBL459165,c1ccc(CC2(c3ccc4cc[nH]c4c3)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1380,CHEMBL486538,c1ccc(CC2(c3cnc4[nH]ccc4c3)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1381,CHEMBL520869,c1ccc(CC2(c3ccc4[nH]ncc4c3)CCNC2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells
1382,CHEMBL485123,Cc1ncc(C)c(C(=O)N2CCC([C@H](N)Cc3cc(F)c(F)cc3F)CC2)n1,IC50,nM,=,85000.0,Inhibition of human ERG by patch-clamp assay
1383,CHEMBL485124,Cc1nccnc1C(=O)N1CCC([C@H](N)Cc2cc(F)c(F)cc2F)CC1,IC50,nM,=,55000.0,Inhibition of human ERG by patch-clamp assay
1384,CHEMBL485125,N[C@H](Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2cnc3ncccn23)CC1,IC50,nM,=,59000.0,Inhibition of human ERG by patch-clamp assay
1385,CHEMBL484528,Cc1cc2ncc(C(=O)N3CCC([C@H](N)Cc4cc(F)c(F)cc4F)CC3)c(C)n2n1,IC50,nM,=,18000.0,Inhibition of human ERG by patch-clamp assay
1386,CHEMBL214957,COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OCCN1CCCC1,IC50,nM,=,1170.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1387,CHEMBL470633,COc1cc(-n2ccnc(NCCc3ccccc3)c2=O)ccc1OCCN1CCCC1,IC50,nM,=,6200.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1388,CHEMBL470840,COc1cc(-n2ccnc(CCCc3ccccc3)c2=O)ccc1OCCN1CCCC1,IC50,nM,=,7300.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1389,CHEMBL512873,COc1cc(-n2ccnc(OCCc3ccccc3)c2=O)ccc1OCCN1CCCC1,IC50,,,,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
1390,CHEMBL488730,Cc1nnc(-c2cc(C(F)(F)F)cc(S(=O)(=O)N3CCN(C(=O)[C@@H]4C[C@H]4c4ccc(C(F)(F)F)cc4)CC3)c2)[nH]1,IC50,nM,=,1300.0,Inhibition of human ERG by MK-0499 binding assay
1391,CHEMBL528997,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3cn[nH]n3)cc(C(F)(F)F)c2)CC1,IC50,nM,=,3500.0,Inhibition of human ERG by MK-0499 binding assay
1392,CHEMBL529214,O=C1CSC(c2cc(C(F)(F)F)cc(S(=O)(=O)N3CCN(C(=O)[C@@H]4C[C@H]4c4ccc(C(F)(F)F)cc4)CC3)c2)=N1,IC50,nM,=,4000.0,Inhibition of human ERG by MK-0499 binding assay
1393,CHEMBL519252,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3cn[nH]c3)cc(C(F)(F)F)c2)CC1,IC50,nM,=,500.0,Inhibition of human ERG by MK-0499 binding assay
1394,CHEMBL487708,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3ccn[nH]3)cc(C(F)(F)F)c2)CC1,IC50,nM,=,500.0,Inhibition of human ERG by MK-0499 binding assay
1395,CHEMBL487500,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3ncon3)cc(C(F)(F)F)c2)CC1,IC50,nM,=,1200.0,Inhibition of human ERG by MK-0499 binding assay
1396,CHEMBL520543,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(C(O)C(F)(F)F)cc(C(F)(F)F)c2)CC1,IC50,nM,=,60.0,Inhibition of human ERG by MK-0499 binding assay
1397,CHEMBL519389,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(C(F)(F)F)cc(C(F)(F)CO)c2)CC1,IC50,nM,=,2500.0,Inhibition of human ERG by MK-0499 binding assay
1398,CHEMBL490027,CC(C)(O)c1cc(C(F)(F)F)cc(S(=O)(=O)N2CCN(C(=O)[C@@H]3C[C@H]3c3ccc(C(F)(F)F)cc3)CC2)c1,IC50,nM,=,1200.0,Inhibition of human ERG by MK-0499 binding assay
1399,CHEMBL490026,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(CCO)cc(C(F)(F)F)c2)CC1,IC50,nM,=,900.0,Inhibition of human ERG by MK-0499 binding assay
1400,CHEMBL487912,Cc1n[nH]cc1-c1cc(C(F)(F)F)cc(S(=O)(=O)N2CCN(C(=O)[C@@H]3C[C@H]3c3ccc(C(F)(F)F)cc3)CC2)c1,IC50,nM,=,40.0,Inhibition of human ERG by MK-0499 binding assay
1401,CHEMBL529213,O=C([C@@H]1C[C@H]1c1ccc(C(F)(F)F)cc1)N1CCN(S(=O)(=O)c2cc(-c3nnc[nH]3)cc(C(F)(F)F)c2)CC1,IC50,nM,=,1000.0,Inhibition of human ERG by MK-0499 binding assay
1402,CHEMBL471299,Cc1nn(-c2c(Cl)cccc2NS(C)(=O)=O)cc1CN1CCC2(CC1)OCc1ccccc12,IC50,nM,=,17000.0,Displacement of [35S]MK499 from human ERG in HEK293 cell membrane
1403,CHEMBL470951,Cc1cccnc1-n1cc(CN2CCC3(CC2)OCc2ccccc23)c(C)n1,IC50,nM,=,13000.0,Displacement of [35S]MK499 from human ERG in HEK293 cell membrane
1404,CHEMBL512520,Cc1nn(-c2ncccc2Cl)cc1CN1CCC2(CC1)OCc1ccccc12,IC50,nM,=,7800.0,Displacement of [35S]MK499 from human ERG in HEK293 cell membrane
1405,CHEMBL460893,Cc1nn(-c2ccccc2)cc1CN1CCC2(CC1)OCc1ccccc12,IC50,nM,=,740.0,Displacement of [35S]MK499 from human ERG in HEK293 cell membrane
1406,CHEMBL488294,CC(C)(C)CCN1CCC(CNC(=O)Nc2cccc(Cl)c2)(c2ccccc2)CC1,IC50,nM,=,88.0,Antagonist activity at human ERG by voltage-clamp electrophysiology assay
1407,CHEMBL488817,CC1(C)C[C@@H](CN2CCC(F)(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)CCO1,IC50,nM,=,2900.0,Antagonist activity at human ERG by voltage-clamp electrophysiology assay
1408,CHEMBL488653,CC1(C)C[C@H](CN2CCC(F)(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)CCO1,IC50,nM,=,5010.0,Antagonist activity at human ERG by voltage-clamp electrophysiology assay
1409,CHEMBL529445,CC1(C)CC(CN2CCC(F)(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)CCO1,IC50,nM,=,8410.0,Antagonist activity at human ERG by voltage-clamp electrophysiology assay
1410,CHEMBL486247,CC(C)(C)CCN1CCC(F)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,2220.0,Antagonist activity at human ERG by voltage-clamp electrophysiology assay
1411,CHEMBL488468,CC(C)(C)CCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,1930.0,Antagonist activity at human ERG by voltage-clamp electrophysiology assay
1412,CHEMBL488295,Cc1ccc(CN2CCC(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)cc1,IC50,nM,=,135.0,Antagonist activity at human ERG by voltage-clamp electrophysiology assay
1413,CHEMBL487273,NC(=O)Nc1sc(-c2ccccc2)cc1C(=O)N[C@H]1CCCNC1,IC50,nM,>,31600.0,Inhibition of human ERG
1414,CHEMBL446134,O=C1NCCc2nc(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc21,IC50,nM,=,2500.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1415,CHEMBL452823,CN1CCN(c2ccc3nc(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)c(-c4ccccc4)nc3n2)CC1,IC50,nM,=,2143.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1416,CHEMBL447558,Nc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ccc6nc5-c5ccccc5)cc4)CC3)[nH]2)cn1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1417,CHEMBL499961,CN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(N)nc7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,4700.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1418,CHEMBL506827,CN(C)CCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1419,CHEMBL501612,OCCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1420,CHEMBL508098,CN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,8300.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1421,CHEMBL499554,CN(C)CCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,6000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1422,CHEMBL449989,OCCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1423,CHEMBL443620,CN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,9100.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1424,CHEMBL455071,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7cc[n+]([O-])cc7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,7900.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1425,CHEMBL449200,[O-][n+]1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ncc6cc5-c5ccccc5)cc4)CC3)[nH]2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1426,CHEMBL507204,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7cc[n+]([O-])cc7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,9800.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1427,CHEMBL503652,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(=O)[nH]c7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,800.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1428,CHEMBL502113,O=c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ncc6cc5-c5ccccc5)cc4)CC3)[nH]2)c[nH]1,IC50,nM,=,6800.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1429,CHEMBL503270,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(N)nc7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,3500.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1430,CHEMBL503810,Nc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ncc6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,IC50,nM,=,7400.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1431,CHEMBL445212,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(N)nc7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,6100.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1432,CHEMBL505848,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,4800.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1433,CHEMBL455226,OCCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1434,CHEMBL453288,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1435,CHEMBL446966,COc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,IC50,nM,=,1220.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1436,CHEMBL444136,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5nnc(-c6cnccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc12,IC50,nM,=,8428.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1437,CHEMBL502393,Nc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,IC50,nM,=,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1438,CHEMBL488428,O=c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)c[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1439,CHEMBL447114,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5nnc(-c6ncccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc12,IC50,nM,>,10000.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1440,CHEMBL443661,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,IC50,nM,=,2100.0,Inhibition of human ERG in embryonic kidney cells by radioligand-binding competition assay
1441,CHEMBL471371,CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1,IC50,nM,>,10000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1442,CHEMBL451761,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1,IC50,nM,>,30000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1443,CHEMBL451761,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1,IC50,nM,>,10000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1444,CHEMBL454086,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1,IC50,nM,>,30000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1445,CHEMBL454086,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1,IC50,nM,>,10000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1446,CHEMBL454086,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1,IC50,nM,>,10000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1447,CHEMBL454085,O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1,IC50,nM,=,8200.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1448,CHEMBL487445,O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1,IC50,nM,=,1000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1449,CHEMBL516783,CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2)cc1,IC50,nM,>,10000.0,Displacement of MK-499 from human ERG channel in HEK293 cells
1450,CHEMBL518148,CN(C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CO)c1ccccc1)C1CCNCC1,IC50,nM,=,19200.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1451,CHEMBL481932,CN1CC[C@H](N(C)C(=O)N2CC(c3cc(F)ccc3F)=C[C@@]2(CO)c2ccccc2)[C@@H](F)C1,IC50,nM,=,36900.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1452,CHEMBL481931,CN1CC[C@H](N(C)C(=O)N2CC(c3cc(F)ccc3F)=C[C@@]2(CO)c2ccccc2)[C@H](F)C1,IC50,nM,=,20500.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1453,CHEMBL520602,CN(C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CO)c1ccccc1)C1CCN(CC(F)F)CC1,IC50,,,,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1454,CHEMBL481921,CN(C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CO)c1ccccc1)C1CCN(C2CC2)CC1,IC50,nM,=,15200.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1455,CHEMBL481920,CN(C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CO)c1ccccc1)C1CCN(CCF)CC1,IC50,nM,=,13800.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1456,CHEMBL480777,CN(C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CO)c1ccccc1)C1CCN(CC2CC2)CC1,IC50,,,,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1457,CHEMBL479796,CN1CCC(N(C)C(=O)N2CC(c3cc(F)ccc3F)=C[C@@]2(CO)c2ccccc2)CC1,IC50,nM,=,14600.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1458,CHEMBL481959,CN1CCC(N(C)C(=O)N2CC(c3cc(F)ccc3F)=C[C@H]2c2ccccc2)CC1,IC50,nM,=,1200.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1459,CHEMBL240923,CN(C)C(=O)N1CC(c2cc(F)ccc2F)=C[C@@]1(CC[C@@H](N)C(F)F)c1ccccc1,IC50,nM,=,15900.0,Displacement of [35S]MK499 from human ERG expressed in HEL cells
1460,CHEMBL471994,Cc1ccccc1C1CCN(C[C@H]2CCc3cccnc3[C@@H](O)C2)CC1,IC50,nM,=,310.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1461,CHEMBL472168,Cc1ccccc1C1CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)CC1,IC50,nM,=,1500.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1462,CHEMBL471994,Cc1ccccc1C1CCN(C[C@H]2CCc3cccnc3[C@@H](O)C2)CC1,IC50,nM,=,220.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1463,CHEMBL513585,Cc1ccccc1C1CCN(C[C@@H]2CCc3c(C)cccc3[C@@H](O)C2)CC1,IC50,nM,=,86.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1464,CHEMBL472168,Cc1ccccc1C1CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)CC1,IC50,nM,=,2700.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1465,CHEMBL513423,O[C@H]1C[C@H](CN2CC[C@H](c3ccc(F)cc3Cl)[C@@H](O)C2)CCc2cccnc21,IC50,nM,=,13000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1466,CHEMBL472304,Cc1cc(F)ccc1[C@@H]1CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)C[C@H]1O,IC50,nM,=,13000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1467,CHEMBL512896,Cc1ccccc1[C@@H]1CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)C[C@H]1O,IC50,nM,=,40000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1468,CHEMBL472125,Cc1ccccc1[C@@H]1CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)C[C@H]1CO,IC50,nM,=,20000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1469,CHEMBL511658,Cc1ccccc1[C@@H]1CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)C[C@H]1C,IC50,nM,=,9200.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1470,CHEMBL518922,CC1(c2ccccc2)CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)CC1,IC50,nM,=,11000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1471,CHEMBL487827,O[C@H]1C[C@H](CN2CCC(c3ccccc3)CC2)CCc2cccnc21,IC50,nM,=,11000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1472,CHEMBL487826,Cc1ccccc1N1CCN(C[C@@H]2CCc3cccnc3[C@@H](O)C2)CC1,IC50,nM,=,2300.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1473,CHEMBL487485,O[C@H]1C[C@H](CN2CCC(c3ccccc3Cl)CC2)CCc2cccnc21,IC50,nM,=,1500.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1474,CHEMBL486644,O[C@H]1C[C@H](CN2CCC(c3c(Cl)cccc3Cl)CC2)CCc2cccnc21,IC50,nM,=,940.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1475,CHEMBL487458,O[C@H]1C[C@H](CN2CC[C@H](c3ccc(F)cc3Cl)[C@@H](O)C2)Cc2cccnc21,IC50,nM,>,50000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1476,CHEMBL487457,Cc1cc(F)ccc1[C@H]1CCN(C[C@@H]2Cc3cccnc3[C@@H](O)C2)C[C@@H]1O,IC50,,,,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1477,CHEMBL488655,Cc1ccccc1[C@H]1CCN(C[C@@H]2Cc3cccnc3[C@@H](O)C2)C[C@@H]1O,IC50,nM,>,50000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1478,CHEMBL471982,Cc1ccccc1C1CCN(C[C@@H]2Cc3cccnc3[C@@H](O)C2)CC1,IC50,nM,>,50000.0,Displacement of [35S]MK499 from human ERG K+ channel expressed in HEK293 cells
1479,CHEMBL480501,Cn1c(N(Cc2ccc(C(=O)Nc3nnn[nH]3)cc2)[C@H]2CC[C@H](C(C)(C)C)CC2)nc2cc(C(F)(F)F)ccc21,IC50,nM,>,10000.0,Inhibition of hERG potassium channel
1480,CHEMBL372575,Cc1noc(/C(=C/c2cccc(-c3cc(C(C)(C)S(C)(=O)=O)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)n1,IC50,nM,=,49900.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1481,CHEMBL456171,O=C(Nc1c(Cl)cncc1Cl)c1cn(-c2ccc(Cl)cc2)c2ncccc2c1=O,IC50,nM,=,198.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1482,CHEMBL499477,Cc1noc(/C(=C/c2cccc(-n3cc(C(=O)Nc4c(Cl)cncc4Cl)c(=O)c4cccnc43)c2)c2ccc(S(C)(=O)=O)cc2)n1,IC50,nM,=,680.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1483,CHEMBL464803,NC(=O)c1cn(-c2cccc(Br)c2)c2ncccc2c1=O,IC50,nM,>,94500.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1484,CHEMBL456173,CC(C)NC(=O)c1cn(-c2ccccc2)c2ncccc2c1=O,IC50,nM,=,71500.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1485,CHEMBL456172,CC(C)NC(=O)c1cn(-c2cccc(Br)c2)c2ncccc2c1=O,IC50,nM,=,31600.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1486,CHEMBL464600,CC(C)CNC(=O)c1cn(-c2cccc(Br)c2)c2ncccc2c1=O,IC50,nM,=,31800.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1487,CHEMBL464804,CC(=O)c1cccc(-c2cccc(-n3cc(C(=O)NC(C)C)c(=O)c4cccnc43)c2)c1,IC50,nM,=,6960.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1488,CHEMBL514564,CC(=O)c1cccc(-c2cccc(-n3cc(C(=O)Nc4nccc(Cl)c4Cl)c(=O)c4cccnc43)c2)c1,IC50,nM,=,740.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1489,CHEMBL456808,CCOc1cccc(-c2cccc(-n3cc(C(=O)NC(C)C)c(=O)c4cccnc43)c2)c1,IC50,nM,=,2700.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1490,CHEMBL485547,CSc1ccc(-c2cccc(-n3cc(C(=O)NC(C)C)c(=O)c4cccnc43)c2)cc1,IC50,nM,=,960.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1491,CHEMBL519193,CC(=O)c1ccc(-c2cccc(-n3cc(C(=O)NC(C)C)c(=O)c4cccnc43)c2)cc1,IC50,nM,=,8950.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1492,CHEMBL484753,CC(C)NC(=O)c1cn(-c2cccc(-c3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1=O,IC50,nM,=,23000.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1493,CHEMBL484754,O=C(NC1CC1)c1cn(-c2cccc(-c3ccncc3)c2)c2ncccc2c1=O,IC50,nM,=,18600.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1494,CHEMBL484931,CS(=O)(=O)c1ccc(-c2cccc(-n3cc(C(=O)NC4CC4)c(=O)c4cccnc43)c2)cn1,IC50,nM,=,13600.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1495,CHEMBL520502,CC(C)(O)c1ccc(-c2cccc(-n3cc(C(=O)NC4CC4)c(=O)c4cccnc43)c2)cn1,IC50,nM,=,36600.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1496,CHEMBL485620,CC(C)(O)c1ccc(-c2cccc(-n3cc(C(=O)NC4CC4)c(=O)c4cccnc43)c2)c[n+]1[O-],IC50,nM,=,50100.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1497,CHEMBL521509,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3cccnc3)c2)c2ncccc2c1=O,IC50,nM,=,16700.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1498,CHEMBL485629,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O,IC50,nM,=,65700.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1499,CHEMBL520463,CC(C)(O)c1ccc(C#Cc2cccc(-n3cc(C(=O)NC4CC4)c(=O)c4cccnc43)c2)c[n+]1[O-],IC50,nM,=,89400.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1500,CHEMBL511368,Cc1ccc(-n2cc(C(=O)NC(C)C)c(=O)c3cccnc32)cc1Br,IC50,,,,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1501,CHEMBL464802,Cc1ccc2c(=O)c(C(=O)NC(C)C)cn(-c3cccc(Br)c3)c2n1,IC50,,,,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1502,CHEMBL519355,O=C(NC1CC1)c1cn(-c2cccc(-c3cccnc3)c2)c2ncccc2c1=O,IC50,nM,=,34000.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
1503,CHEMBL476373,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1504,CHEMBL483199,Cc1nc2ccccc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1505,CHEMBL483366,Cc1nc2ccccc2c(=O)n1-c1ccc(OC2CCN(C3CCCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1506,CHEMBL485242,Cc1nc2ccccc2c(=O)n1-c1ccc(OC2CCCN(C3CCC3)CC2)cc1,IC50,nM,=,7300.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1507,CHEMBL519018,Cc1nc2ccccc2c(=O)n1-c1ccc(OC2CCCN(C3CCCC3)CC2)cc1,IC50,nM,=,6800.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1508,CHEMBL484740,Cc1nc2ccccc2c(=O)n1-c1ccc(OC2CCC(N3CCCC3)C2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1509,CHEMBL484740,Cc1nc2ccccc2c(=O)n1-c1ccc(OC2CCC(N3CCCC3)C2)cc1,IC50,nM,=,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1510,CHEMBL521022,Cc1nc2ccccc2c(=O)n1-c1ccc(O[C@H]2CC[C@@H](N3CCCC3)CC2)cc1,IC50,nM,=,8000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1511,CHEMBL483400,Cc1nc2cccc(F)c2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1512,CHEMBL517937,Cc1nc2ccc(F)cc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1513,CHEMBL464598,Cc1nc2cc(F)ccc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1514,CHEMBL464599,Cc1nc2c(F)cccc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1515,CHEMBL516697,Cc1nc2cc(F)c(F)cc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1516,CHEMBL458176,Cc1nc2cccc(Cl)c2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1517,CHEMBL458359,Cc1nc2ccc(Cl)cc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,=,5400.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1518,CHEMBL458953,Cc1nc2cc(Cl)ccc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,=,3900.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1519,CHEMBL458954,Cc1nc2c(Cl)cccc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,=,3300.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1520,CHEMBL520629,COc1cccc2nc(C)n(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)c(=O)c12,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1521,CHEMBL484189,COc1ccc2nc(C)n(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)c(=O)c2c1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1522,CHEMBL485388,COc1ccc2c(=O)n(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)c(C)nc2c1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1523,CHEMBL485389,COc1cccc2c(=O)n(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)c(C)nc12,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1524,CHEMBL483194,Cc1nc2cccnc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1525,CHEMBL484610,Cc1nc2ccncc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1526,CHEMBL521327,Cc1nc2cnccc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1527,CHEMBL484611,Cc1nc2ncccc2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1528,CHEMBL484946,Cc1cccc2nc(C)n(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)c(=O)c12,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1529,CHEMBL485543,Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,"Antagonist activity at human ERG in HEK293 cells assessed as inhibition of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide binding"
1530,CHEMBL514217,CN(CCN1CCCCC1)C(=O)[C@H]1CC[C@@]2(CC1)OC(=O)c1ccccc12,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1531,CHEMBL513893,COc1ccc2c(c1)C(=O)O[C@]21CC[C@H](C(=O)N(C)CCN2CCCCC2)CC1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1532,CHEMBL507921,COc1ccc2c(c1)[C@]1(CC[C@@H](C(=O)N(C)CCN3CCCCC3)CC1)OC2=O,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1533,CHEMBL478434,COc1cccc2c1[C@]1(CC[C@@H](C(=O)N(C)CCN3CCCCC3)CC1)OC2=O,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1534,CHEMBL478012,CNC(=O)c1c(NCCC2CCCC2)nc(C#N)nc1OCC1CCN(C)CC1,IC50,nM,=,360.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1535,CHEMBL478013,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCN(C(C)C)CC1,IC50,nM,=,540.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1536,CHEMBL514042,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCN(CCO)CC1,IC50,nM,=,890.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1537,CHEMBL478436,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCN(C(C)=O)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1538,CHEMBL478462,CNC(=O)c1c(NCC2CCC3(CCCC3)CC2)nc(C#N)nc1OCC1CCN(C)CC1,IC50,nM,=,1455.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1539,CHEMBL513921,CNC(=O)c1c(NCC2CCC3(CC2)OCCO3)nc(C#N)nc1OCC1CCN(C)CC1,IC50,nM,=,5770.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1540,CHEMBL478011,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCCC1CCN(C)CC1,IC50,nM,=,420.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1541,CHEMBL515025,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCN(C)CC1,IC50,nM,=,710.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1542,CHEMBL478224,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OC1CC(C)(C)NC(C)(C)C1,IC50,nM,=,5040.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1543,CHEMBL477600,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCCO,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1544,CHEMBL476130,CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCC1CCNCC1,IC50,nM,=,2340.0,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1545,CHEMBL477625,CNC(=O)c1c(NCC2OCC3(CCC3)CO2)nc(C#N)nc1OCC1CCN(C)CC1,IC50,,,,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1546,CHEMBL514545,CNC(=O)c1c(NCC2CCC3(CC2)CC3)nc(C#N)nc1OCCC1CCN(C)CC1,IC50,,,,Displacement of [3H]dofetilide from human ERG in HEK293 cells
1547,CHEMBL508861,ClCc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,IC50,nM,=,2018.0,Inhibition of human ERG expressed in HEK cells by competitive radioligand binding assay
1548,CHEMBL445464,Cc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,IC50,nM,=,2778.0,Inhibition of human ERG expressed in HEK cells by competitive radioligand binding assay
1549,CHEMBL447328,c1ccc(-c2cc3c(ccn4cnnc34)nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK cells by competitive radioligand binding assay
1550,CHEMBL506077,Oc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,IC50,nM,=,5312.0,Inhibition of human ERG expressed in HEK cells by competitive radioligand binding assay
1551,CHEMBL499555,Nc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,IC50,nM,=,5319.0,Inhibition of human ERG expressed in HEK cells by competitive radioligand binding assay
1552,CHEMBL507130,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)c(-c3ccccc3)cc12,IC50,nM,=,5610.0,Inhibition of human ERG expressed in HEK cells by competitive radioligand binding assay
1553,CHEMBL490153,CCC(=O)c1cc(-c2ccc(Cl)cc2)n(-c2ccc(S(N)(=O)=O)cc2)c1C,IC50,nM,>,20000.0,Inhibition of human ERG channel
1554,CHEMBL522456,N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1,IC50,nM,=,101.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1555,CHEMBL490937,Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cnccn3)=N2)cc1,IC50,nM,=,3400.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1556,CHEMBL523134,C[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,=,1730.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1557,CHEMBL491107,C[C@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1558,CHEMBL522793,CC[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,=,490.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1559,CHEMBL490949,CCC[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,=,490.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1560,CHEMBL523305,N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)[C@H](CO)N2)c1,IC50,nM,=,6100.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1561,CHEMBL491119,C[C@@H]1NC(c2cnccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1.Cl,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1562,CHEMBL491288,C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1563,CHEMBL490123,C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1564,CHEMBL521932,C[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)nc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1565,CHEMBL506163,COc1ccc([C@]2(c3ccc(F)cc3)N=C(c3cc(C#N)ccn3)N[C@H]2C)cn1.Cl,IC50,nM,=,6300.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1566,CHEMBL490901,C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(=O)[nH]c1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1567,CHEMBL521947,C[C@@H]1NC(c2cccc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,=,4330.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1568,CHEMBL491894,C[C@@H]1NC(c2cccc(S(C)(=O)=O)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1569,CHEMBL491895,C[C@@H]1NC(c2cncc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1570,CHEMBL523821,C[C@@H]1NC(c2cccc(C#N)n2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,=,6930.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1571,CHEMBL490561,C[C@@H]1NC(c2ccnc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1572,CHEMBL491567,C[C@@H]1NC(c2nccc(C#N)n2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1573,CHEMBL490902,COc1ccnc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)c1,IC50,nM,=,6330.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1574,CHEMBL490903,C[C@@H]1NC(c2cc(Cl)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1.Cl,IC50,nM,=,7800.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1575,CHEMBL489725,C[C@@H]1NC(c2cc(C(N)=O)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1576,CHEMBL523776,C[C@@H]1NC(c2cnccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1577,CHEMBL489726,C[C@@H]1NC(c2cccc(=O)[nH]2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1578,CHEMBL523945,C[C@@H]1NC(c2cnsn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1579,CHEMBL489732,C[C@@H]1NC(c2nccs2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
1580,CHEMBL474484,CC(C)CNc1nc(C#N)nc(N2CCNCC2)c1N,IC50,nM,=,52000.0,Inhibition of human ERG
1581,CHEMBL471757,CC(C)(C)CNc1nc(C#N)nc(N2CCOCC2)c1N,IC50,nM,=,70000.0,Inhibition of human ERG
1582,CHEMBL450061,CC(C)CNc1nc(C#N)nc(N2CCOCC2)c1N,IC50,nM,>,100000.0,Inhibition of human ERG
1583,CHEMBL514011,N#Cc1cccnc1N1CCN([C@@H]2CN[C@H](C(=O)N3CCC(F)(F)C3)C2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG by patch-clamp technique
1584,CHEMBL474421,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1C[C@H](F)[C@H](F)C1,IC50,nM,=,54000.0,Inhibition of human ERG by patch-clamp technique
1585,CHEMBL515387,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,IC50,nM,=,126000.0,Inhibition of human ERG by patch-clamp technique
1586,CHEMBL221906,CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)cc1,IC50,nM,=,330.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1587,CHEMBL512351,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,IC50,nM,=,8900.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1588,CHEMBL472967,CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c(F)c1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1589,CHEMBL515919,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2F)c(C(=O)Nc2ccc(Cl)cn2)c1,IC50,nM,=,4200.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method
1590,CHEMBL467114,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1.[Na+],IC50,nM,>,31622.78,Inhibition of human ERG channel
1591,CHEMBL467114,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1.[Na+],IC50,nM,>,32000.0,Inhibition of human ERG channel
1592,CHEMBL516725,CCN(CC)CCCOc1ccc(-n2c(C)nc3ccccc3c2=O)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1593,CHEMBL446516,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CC(C)CC(C)C2)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1594,CHEMBL477556,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCC(C)CC2)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1595,CHEMBL516126,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCC[C@@H](C)C2)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1596,CHEMBL478628,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2C)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1597,CHEMBL443958,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2[C@H](C)CC[C@H]2C)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1598,CHEMBL478621,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCCCC2)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1599,CHEMBL476373,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1600,CHEMBL487063,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,=,8600.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1601,CHEMBL478395,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCC[C@H](C)C2)cc1,IC50,nM,=,5300.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1602,CHEMBL515477,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCC(C)C2)cc1,IC50,nM,=,6400.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1603,CHEMBL477361,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCC[C@H]2C)cc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1604,CHEMBL477360,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCC[C@@H]2C)cc1,IC50,nM,=,6000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1605,CHEMBL476579,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCCC2)cc1,IC50,nM,=,6600.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1606,CHEMBL518431,O=c1c2ccccc2ncn1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,710.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1607,CHEMBL476322,Cc1nc2c(C(F)(F)F)cccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,350.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1608,CHEMBL477364,Cc1nc2cc(C(F)(F)F)ccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,2600.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1609,CHEMBL477363,Cc1nc2cccc(Cl)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,8100.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1610,CHEMBL515150,Cc1nc2c(F)cccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1611,CHEMBL476106,Cc1nc2cc(F)ccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,6000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1612,CHEMBL479252,Cc1nc2ccc(F)cc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,2500.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1613,CHEMBL477356,Cc1nc2cccc(F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1614,CHEMBL477152,COc1cccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc12,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1615,CHEMBL477201,COc1ccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc2c1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1616,CHEMBL477991,COc1ccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c2c1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1617,CHEMBL477990,COc1cccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c12,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1618,CHEMBL478616,Cc1cccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc12,IC50,nM,=,1600.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1619,CHEMBL478615,Cc1ccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc2c1,IC50,nM,=,6700.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1620,CHEMBL478406,Cc1ccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c2c1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1621,CHEMBL479242,Cc1cccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c12,IC50,nM,=,6600.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1622,CHEMBL479241,O=c1c2ccccc2nc(-c2ccccc2)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,1100.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1623,CHEMBL479036,CC(C)c1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,3900.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1624,CHEMBL515004,CCCc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,2800.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1625,CHEMBL476723,CCc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,5000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1626,CHEMBL476323,Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,10000.0,"Displacement of [35S]N-[(4R)-1'-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-6-yl]methanesulfonamide from human ERG in HEK293 cells"
1627,CHEMBL477567,Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)n2)n1C(C)C,IC50,nM,=,5500.0,Inhibition of human ERG
1628,CHEMBL515001,Cc1ncc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2F)n1C(C)C,IC50,nM,=,11000.0,Inhibition of human ERG
1629,CHEMBL476993,Cc1ncc(-c2nc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3)ncc2F)n1C(C)C,IC50,nM,=,18000.0,Inhibition of human ERG
1630,CHEMBL478241,Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)CN(C)C)CC4)cc3)n2)n1C(C)C,IC50,nM,>,32000.0,Inhibition of human ERG
1631,CHEMBL515311,Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)[C@H](C)O)CC4)cc3)n2)n1C(C)C,IC50,nM,>,24000.0,Inhibition of human ERG
1632,CHEMBL477786,Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3)n2)n1C(C)C,IC50,nM,>,24000.0,Inhibition of human ERG
1633,CHEMBL514384,COCCS(=O)(=O)N1CCN(c2ccc(Nc3nccc(-c4cnc(C)n4C(C)C)n3)cc2)CC1,IC50,nM,=,8400.0,Inhibition of human ERG
1634,CHEMBL477785,Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(S(=O)(=O)CCN(C)C)CC4)cc3)n2)n1C(C)C,IC50,nM,=,18000.0,Inhibition of human ERG
1635,CHEMBL468397,COC(=O)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(c1ccc(Br)cc1)C(C)C,IC50,nM,=,178.0,Inhibition of human ERG channel
1636,CHEMBL476954,CC(C)C(=O)N(Cc1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,=,24700.0,Inhibition of human ERG potassium channel
1637,CHEMBL477374,CC(C)C(=O)N(Cc1ccc(Cl)c(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,>,6870.0,Inhibition of human ERG potassium channel
1638,CHEMBL513139,CC(C)C(=O)N(Cc1ccc(Cl)cc1Cl)[C@H]1CCNC1,IC50,nM,=,40200.0,Inhibition of human ERG potassium channel
1639,CHEMBL468176,Fc1ccc(-c2noc(C3CCN(c4cnc5ccc(Cl)cc5c4)CC3)n2)c(Cl)c1,IC50,nM,=,500.0,Displacement of radiolabeled dofetilide from human ERG
1640,CHEMBL469169,CNC(=O)c1cccc(NC(=O)N2CCC(Oc3ccccc3Cl)CC2)c1,IC50,nM,>,100000.0,Displacement of [3H]dofetilide from human ERG channel
1641,CHEMBL470753,c1ccc2sc(Oc3ccc(CCN4CCCCC4)cc3)nc2c1,IC50,nM,=,2000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1642,CHEMBL481280,O=C(O)C1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1643,CHEMBL479383,O=C(CO)NC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,>,16000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1644,CHEMBL479382,CC(=O)OCC(=O)NC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,30000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1645,CHEMBL480131,CC(=O)NC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,20000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1646,CHEMBL518155,O=C1OCCN1C1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,24000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1647,CHEMBL480130,O=C1CCCN1C1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,15000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1648,CHEMBL517533,NC(=O)C1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1649,CHEMBL479752,OC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1650,CHEMBL454760,c1ccc2sc(Oc3ccc(CN4CCCCC4)cc3)nc2c1,IC50,nM,>,30000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1651,CHEMBL482057,CC(=O)OCC(=O)NC1CCN(CCc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,5000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1652,CHEMBL520942,CC(=O)NC1CCN(CCc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,9000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1653,CHEMBL482056,O=C1OCCN1C1CCN(CCc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,500.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1654,CHEMBL482058,O=C1CCCN1C1CCN(CCc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,1000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1655,CHEMBL511292,NC(=O)C1CCN(CCc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1656,CHEMBL446514,OC1CCN(CCc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,3000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1657,CHEMBL481863,c1ccc2oc(Oc3ccc(OCCN4CCCCC4)cc3)nc2c1,IC50,nM,=,1000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1658,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,2700.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1659,CHEMBL470929,O=C1CCCCN1C1CCN(CCOc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,1800.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1660,CHEMBL472138,O=C1OCCN1C1CCN(CCOc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,2700.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane
1661,CHEMBL452864,C1=C(CS/C(=N\C2CCCCC2)NC2CCCCC2)N2CCN=C2S1,IC50,nM,>,20000.0,Inhibition of human recombinant ERG in CHOK1 cells
1662,CHEMBL452864,C1=C(CS/C(=N\C2CCCCC2)NC2CCCCC2)N2CCN=C2S1,IC50,nM,=,8500.0,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells
1663,CHEMBL460491,CC1(C)CN2C(CS/C(=N\C3CCCCC3)NC3CCCCC3)=CSC2=N1,IC50,nM,>,20000.0,Inhibition of human recombinant ERG in CHOK1 cells
1664,CHEMBL460491,CC1(C)CN2C(CS/C(=N\C3CCCCC3)NC3CCCCC3)=CSC2=N1,IC50,nM,=,13240.0,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells
1665,CHEMBL488436,Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,IC50,nM,=,3200.0,Inhibition of human ERG by patch clamp assay
1666,CHEMBL488084,Cc1ncc(-c2ccnc(Nc3ccc(C(N)=O)cc3)n2)n1C(C)C,IC50,nM,=,17000.0,Inhibition of human ERG by patch clamp assay
1667,CHEMBL508129,CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
1668,CHEMBL488085,Cc1ncc(-c2ccnc(Nc3ccc(C(=O)N(C)C)cc3)n2)n1C(C)C,IC50,nM,=,18000.0,Inhibition of human ERG by patch clamp assay
1669,CHEMBL487066,Cc1ncc(-c2ccnc(Nc3ccc(C(=O)NC4CC4)cc3)n2)n1C(C)C,IC50,nM,=,7000.0,Inhibition of human ERG by patch clamp assay
1670,CHEMBL487067,Cc1ncc(-c2ccnc(Nc3ccc(C(=O)NCCO)cc3)n2)n1C(C)C,IC50,nM,>,32000.0,Inhibition of human ERG by patch clamp assay
1671,CHEMBL509881,Cc1ncc(-c2nc(Nc3ccc(C(N)=O)cc3)ncc2F)n1C(C)C,IC50,nM,=,20000.0,Inhibition of human ERG by patch clamp assay
1672,CHEMBL453655,CNC(=O)c1ccc(Nc2ncc(F)c(-c3cnc(C)n3C(C)C)n2)cc1,IC50,nM,=,12000.0,Inhibition of human ERG by patch clamp assay
1673,CHEMBL453862,Cc1ncc(-c2nc(Nc3ccc(C(=O)N(C)C)cc3)ncc2F)n1C(C)C,IC50,nM,=,11000.0,Inhibition of human ERG by patch clamp assay
1674,CHEMBL455427,Cc1ncc(-c2ccnc(Nc3ccc(C(N)=O)c(F)c3)n2)n1C(C)C,IC50,nM,=,10000.0,Inhibition of human ERG by patch clamp assay
1675,CHEMBL455428,CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1F,IC50,nM,=,16000.0,Inhibition of human ERG by patch clamp assay
1676,CHEMBL510436,Cc1ncc(-c2ccnc(Nc3ccc(C(=O)N(C)C)c(F)c3)n2)n1C(C)C,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp assay
1677,CHEMBL455429,Cc1ncc(-c2nc(Nc3ccc(C(N)=O)c(F)c3)ncc2F)n1C(C)C,IC50,nM,=,20000.0,Inhibition of human ERG by patch clamp assay
1678,CHEMBL455651,CNC(=O)c1ccc(Nc2ncc(F)c(-c3cnc(C)n3C(C)C)n2)cc1F,IC50,nM,=,19000.0,Inhibition of human ERG by patch clamp assay
1679,CHEMBL454648,Cc1ncc(-c2nc(Nc3ccc(C(=O)N(C)C)c(F)c3)ncc2F)n1C(C)C,IC50,nM,=,6000.0,Inhibition of human ERG by patch clamp assay
1680,CHEMBL508739,Cc1cc(Nc2ncc(F)c(-c3cnc(C)n3C(C)C)n2)ccc1C(=O)N(C)C,IC50,nM,>,32000.0,Inhibition of human ERG by patch clamp assay
1681,CHEMBL443922,CN(C)Cc1ccccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,2120.0,Displacement of [3H]dofetilide from human ERG channel
1682,CHEMBL488060,CNCc1cc(F)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,5570.0,Displacement of [3H]dofetilide from human ERG channel
1683,CHEMBL488912,CNCc1ccccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,3880.0,Displacement of [3H]dofetilide from human ERG channel
1684,CHEMBL450714,CSc1ccc(Oc2ccccc2CN(C)C)cc1,IC50,nM,=,3020.0,Displacement of [3H]dofetilide from human ERG channel
1685,CHEMBL487053,CC(c1ccccc1Oc1ccc(Cl)c(Cl)c1)N(C)C,IC50,nM,=,900.0,Displacement of [3H]dofetilide from human ERG channel
1686,CHEMBL488069,CN(C)Cc1ccc(C(F)(F)F)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,1120.0,Displacement of [3H]dofetilide from human ERG channel
1687,CHEMBL488021,CNCc1cc(F)ccc1Oc1ccc(C)c(C)c1,IC50,nM,=,20000.0,Displacement of [3H]dofetilide from human ERG channel
1688,CHEMBL488260,CNCc1ccc(C(F)(F)F)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,1190.0,Displacement of [3H]dofetilide from human ERG channel
1689,CHEMBL488261,CNCc1ccc(Cl)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,1240.0,Displacement of [3H]dofetilide from human ERG channel
1690,CHEMBL488437,CNC(C)c1cc(F)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,6830.0,Displacement of [3H]dofetilide from human ERG channel
1691,CHEMBL487223,CNCc1ccc(F)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,3010.0,Displacement of [3H]dofetilide from human ERG channel
1692,CHEMBL487221,CNC(C)c1ccccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,3850.0,Displacement of [3H]dofetilide from human ERG channel
1693,CHEMBL488434,CNCc1cc(F)ccc1Oc1ccc(Cl)cc1,IC50,nM,=,7390.0,Displacement of [3H]dofetilide from human ERG channel
1694,CHEMBL444203,CNC(C)c1cc(F)ccc1Oc1ccc(Cl)cc1,IC50,nM,=,5230.0,Displacement of [3H]dofetilide from human ERG channel
1695,CHEMBL455511,Cc1ccc(Oc2ccc(Cl)c(Cl)c2)c(CN(C)C)c1,IC50,nM,=,3390.0,Displacement of [3H]dofetilide from human ERG channel
1696,CHEMBL451137,CNCc1ccc(Br)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,974.0,Displacement of [3H]dofetilide from human ERG channel
1697,CHEMBL488435,CNCc1cc(Br)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,1620.0,Displacement of [3H]dofetilide from human ERG channel
1698,CHEMBL487188,CNCc1cc(OC)c(OC)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,10100.0,Displacement of [3H]dofetilide from human ERG channel
1699,CHEMBL455423,COc1ccc(CN(C)C)c(Oc2ccc(Cl)c(Cl)c2)c1,IC50,nM,=,234.0,Displacement of [3H]dofetilide from human ERG channel
1700,CHEMBL451076,CNCc1cc(C#N)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,4560.0,Displacement of [3H]dofetilide from human ERG channel
1701,CHEMBL455424,CNCc1cc(S(=O)(=O)NC)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,4800.0,Displacement of [3H]dofetilide from human ERG channel
1702,CHEMBL455425,CNCc1cc(C)c(C)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,1480.0,Displacement of [3H]dofetilide from human ERG channel
1703,CHEMBL510435,CNCc1ccc(C#N)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,1310.0,Displacement of [3H]dofetilide from human ERG channel
1704,CHEMBL455426,CNCc1cc(C(N)=O)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,5440.0,Displacement of [3H]dofetilide from human ERG channel
1705,CHEMBL507884,CNCc1cc(C(F)(F)F)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,1310.0,Displacement of [3H]dofetilide from human ERG channel
1706,CHEMBL455675,CNCc1cc(F)c(Cl)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,3210.0,Displacement of [3H]dofetilide from human ERG channel
1707,CHEMBL500329,CNCc1ccc(OC)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,692.0,Displacement of [3H]dofetilide from human ERG channel
1708,CHEMBL448461,CNCc1cc(F)ccc1Oc1ccc(Cl)c(F)c1,IC50,nM,=,4670.0,Displacement of [3H]dofetilide from human ERG channel
1709,CHEMBL442923,CNCc1cc(F)ccc1Oc1ccc(F)c(Cl)c1,IC50,nM,=,8290.0,Displacement of [3H]dofetilide from human ERG channel
1710,CHEMBL453630,CNC(C)c1cc(C(F)(F)F)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,3030.0,Displacement of [3H]dofetilide from human ERG channel
1711,CHEMBL453631,CNC(C)c1cc(C)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,2690.0,Displacement of [3H]dofetilide from human ERG channel
1712,CHEMBL527094,CNC(C)c1ccc(OC)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,785.0,Displacement of [3H]dofetilide from human ERG channel
1713,CHEMBL454657,CNCc1cc(F)c(OC)cc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,2150.0,Displacement of [3H]dofetilide from human ERG channel
1714,CHEMBL507075,CNCc1ccc(C(F)(F)F)cc1Oc1ccc(Cl)cc1,IC50,nM,=,5110.0,Displacement of [3H]dofetilide from human ERG channel
1715,CHEMBL472388,CNCc1cc(C(F)(F)F)ccc1Oc1ccc(C)cc1,IC50,nM,=,10400.0,Displacement of [3H]dofetilide from human ERG channel
1716,CHEMBL475121,CNCc1ccc(Cl)cc1Oc1ccc(C)c(C)c1,IC50,nM,=,1740.0,Displacement of [3H]dofetilide from human ERG channel
1717,CHEMBL447864,CNCc1ccc(Cl)cc1Oc1ccc(C)cc1,IC50,nM,=,1640.0,Displacement of [3H]dofetilide from human ERG channel
1718,CHEMBL507721,CCc1cc(Oc2ccc(F)cc2CNC)ccc1Cl,IC50,nM,=,4560.0,Displacement of [3H]dofetilide from human ERG channel
1719,CHEMBL449542,CCc1cc(Oc2cc(Cl)ccc2CNC)ccc1Cl,IC50,nM,=,1150.0,Displacement of [3H]dofetilide from human ERG channel
1720,CHEMBL462387,CNCc1ccc(Cl)cc1Oc1ccc(Cl)cc1,IC50,nM,=,645.0,Displacement of [3H]dofetilide from human ERG channel
1721,CHEMBL461631,CNC(C)c1ccc(Cl)cc1Oc1ccc(C)cc1,IC50,nM,=,3690.0,Displacement of [3H]dofetilide from human ERG channel
1722,CHEMBL513629,CNC(C)c1ccc(Cl)cc1Oc1ccc(C)c(C)c1,IC50,nM,=,2470.0,Displacement of [3H]dofetilide from human ERG channel
1723,CHEMBL462225,CNCc1cc(Cl)ccc1Oc1ccc(C)c(C)c1,IC50,nM,=,5230.0,Displacement of [3H]dofetilide from human ERG channel
1724,CHEMBL505091,CNCc1cc(Cl)ccc1Oc1ccc(Cl)c(Cl)c1,IC50,nM,=,3120.0,Displacement of [3H]dofetilide from human ERG channel
1725,CHEMBL462226,CNCc1cc(Cl)ccc1Oc1ccc(Cl)cc1,IC50,nM,=,4790.0,Displacement of [3H]dofetilide from human ERG channel
1726,CHEMBL451330,CNCc1ccc(Cl)cc1Oc1ccc(C)c(Cl)c1,IC50,nM,=,1060.0,Displacement of [3H]dofetilide from human ERG channel
1727,CHEMBL452091,CNCc1ccc(Cl)cc1Oc1ccc(Cl)c(C)c1,IC50,nM,=,1780.0,Displacement of [3H]dofetilide from human ERG channel
1728,CHEMBL449048,CNCc1ccc(Cl)cc1Oc1cccc(Cl)c1,IC50,nM,=,2110.0,Displacement of [3H]dofetilide from human ERG channel
1729,CHEMBL455184,CNCc1ccc(Cl)cc1Oc1ccc(F)c(C)c1,IC50,nM,=,3040.0,Displacement of [3H]dofetilide from human ERG channel
1730,CHEMBL453879,CNCc1ccc(Cl)cc1Oc1ccc(F)c(Cl)c1,IC50,nM,=,2110.0,Displacement of [3H]dofetilide from human ERG channel
1731,CHEMBL453880,CNCc1ccc(Cl)cc1Oc1ccc(F)c(C(F)(F)F)c1,IC50,nM,=,873.0,Displacement of [3H]dofetilide from human ERG channel
1732,CHEMBL445754,CNCc1ccc(Cl)cc1Oc1ccc(Cl)c(F)c1,IC50,nM,=,1230.0,Displacement of [3H]dofetilide from human ERG channel
1733,CHEMBL487063,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,=,7900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1734,CHEMBL507360,COc1nccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1735,CHEMBL454642,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O,IC50,nM,=,7900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1736,CHEMBL453894,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(C(F)(F)F)cccc2c1=O,IC50,nM,=,350.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1737,CHEMBL453893,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O,IC50,nM,=,1100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1738,CHEMBL508712,Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12,IC50,nM,=,2000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1739,CHEMBL453892,COc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1740,CHEMBL454879,COc1ccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc2c1,IC50,nM,=,4300.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1741,CHEMBL453654,COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1,IC50,nM,=,3800.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1742,CHEMBL453653,COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1743,CHEMBL455681,Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O,IC50,nM,=,2900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1744,CHEMBL488249,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O,IC50,nM,=,5600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1745,CHEMBL488248,Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,2900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1746,CHEMBL487060,O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1,IC50,nM,=,460.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1747,CHEMBL487059,O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1,IC50,nM,=,170.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1748,CHEMBL488251,CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,3000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1749,CHEMBL487230,CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,1800.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1750,CHEMBL519067,CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,1700.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1751,CHEMBL487064,Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,2800.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1752,CHEMBL473921,C[C@H]1CN(Cc2ccc(-c3cccnc3C(=O)N3CCC(Nc4ccc(F)cc4)CC3)cc2)C[C@@H](C)N1,IC50,nM,>,31622.78,Inhibition of human ERG binding
1753,CHEMBL480219,C[C@H]1CN(Cc2ccc(-n3ccnc3C(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)C[C@@H](C)N1,IC50,nM,>,25118.86,Inhibition of human ERG binding
1754,CHEMBL505914,CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O.Cl,IC50,nM,=,15700.0,Inhibition of human ERG by calcium-flux based assay
1755,CHEMBL495702,Nc1ccc(-c2cccs2)cc1N,IC50,nM,=,1600.0,Inhibition of human ERG
1756,CHEMBL473485,Nc1ccc(-c2ccsc2)cc1N,IC50,nM,=,1500.0,Inhibition of human ERG
1757,CHEMBL474890,Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(CN2CCC3(CCCN3)CC2)cc1,IC50,nM,=,1597.0,Inhibition of human ERG
1758,CHEMBL514304,Nc1ccc(-c2ccsc2)cc1NC(=O)c1ccc(CN2CCC3(CCCN3)CC2)cc1,IC50,nM,=,1492.0,Inhibition of human ERG
1759,CHEMBL473271,Nc1ccc(-c2ccccc2F)cc1NC(=O)c1ccc(CN2CCC3(CCCN3)CC2)cc1,IC50,nM,=,183.0,Inhibition of human ERG
1760,CHEMBL473475,Nc1ccc(-c2cccc(F)c2)cc1NC(=O)c1ccc(CN2CCC3(CCCN3)CC2)cc1,IC50,nM,=,167.0,Inhibition of human ERG
1761,CHEMBL473478,Nc1ccc(-c2ccc(F)cc2)cc1NC(=O)c1ccc(CN2CCC3(CCNC3)CC2)cc1,IC50,nM,=,237.0,Inhibition of human ERG
1762,CHEMBL473479,Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(C(=O)N2CCC3(CCCN3)CC2)cc1,IC50,nM,=,25090.0,Inhibition of human ERG
1763,CHEMBL473484,Nc1ccc(-c2ccccc2)cc1NC(=O)c1ccc(C(=O)N2CCC3(CCCN3)CC2)cc1,IC50,nM,=,12390.0,Inhibition of human ERG
1764,CHEMBL471623,Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1,IC50,nM,=,9800.0,Displacement of [3H]dofetilide form human ERG expressed in HEK239 cells
1765,CHEMBL472260,Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(Cc3ccccc3)C(=O)C3CCC3)CC2)CC1,IC50,nM,=,3410.0,Displacement of [3H]dofetilide form human ERG expressed in HEK239 cells
1766,CHEMBL237336,C[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,IC50,nM,=,1100.0,Inhibition of human ERG
1767,CHEMBL237119,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,IC50,nM,=,4600.0,Inhibition of human ERG
1768,CHEMBL459357,CN(C)C(=O)[C@@H](c1ccc(C2=CN3N=CNC3C=C2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,IC50,nM,=,86000.0,Inhibition of human ERG
1769,CHEMBL445949,CC(C)[C@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)ccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,IC50,nM,=,76000.0,Inhibition of human ERG
1770,CHEMBL257023,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,IC50,nM,=,19000.0,Inhibition of human ERG
1771,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,10.0,Inhibition of wild-type human ERG expressed in HEK293 cells by whole cell patch clamp method
1772,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,2690.0,Inhibition of human ERG Y652A mutant expressed in HEK293 cells by whole cell patch clamp method
1773,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,1710.0,Inhibition of human ERG F656A mutant expressed in HEK293 cells by whole cell patch clamp method
1774,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,20.0,Inhibition of wild-type human ERG expressed in HEK293 cells by whole cell patch clamp method
1775,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,30.0,Inhibition of wild-type human ERG expressed in HEK293 cells by whole cell patch clamp method
1776,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,6780.0,Inhibition of human ERG Y652A mutant expressed in HEK293 cells by whole cell patch clamp method
1777,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,350.0,Inhibition of human ERG Y652A mutant expressed in HEK293 cells by whole cell patch clamp method
1778,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,2950.0,Inhibition of human ERG F656A mutant expressed in HEK293 cells by whole cell patch clamp method
1779,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,960.0,Inhibition of human ERG F656A mutant expressed in HEK293 cells by whole cell patch clamp method
1780,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,120.0,Inhibition of human ERG S624A mutant expressed in HEK293 cells by whole cell patch clamp method
1781,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,690.0,Inhibition of human ERG S624A mutant expressed in HEK293 cells by whole cell patch clamp method
1782,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,30.0,Inhibition of human ERG S624A mutant expressed in HEK293 cells by whole cell patch clamp method
1783,CHEMBL60889,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
1784,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,65000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
1785,CHEMBL460009,CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(n2cc(-c3ccccc3)[nH]c2=O)CC1,IC50,nM,=,4.7,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1786,CHEMBL460217,CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2[nH]ncc2-c2ccncc2)CC1,IC50,nM,=,117.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1787,CHEMBL456019,CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1,IC50,nM,=,248.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1788,CHEMBL469542,Cc1nnc(C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1,IC50,nM,=,849.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1789,CHEMBL459600,CC(C)c1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1,IC50,nM,=,1650.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1790,CHEMBL459598,CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2nnc(CN(C)C)o2)CC1,IC50,nM,=,3100.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1791,CHEMBL469724,Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1,IC50,nM,=,4000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1792,CHEMBL516939,Cc1nnc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)o1,IC50,nM,<,5280.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1793,CHEMBL460630,COc1ccc(CC(=O)NC2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)cc1,IC50,,,,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1794,CHEMBL518794,CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1,IC50,,,,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1795,CHEMBL459599,Cc1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1,IC50,,,,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
1796,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.36,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1797,CHEMBL61301,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,IC50,nM,=,27.54,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1798,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,22.91,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1799,CHEMBL477015,CS(=O)(=O)Nc1ccc2c(c1)[C@H](O)CC1(CCN([C@@H]3CCc4cc(C#N)ccc4C3)CC1)O2,IC50,nM,=,21.38,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1800,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,3.02,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1801,CHEMBL60796,Oc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,1.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1802,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,48.98,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1803,CHEMBL219916,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,nM,=,57.54,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1804,CHEMBL40,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,IC50,nM,=,3019951.72,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1805,CHEMBL79,CCN(CC)CC(=O)Nc1c(C)cccc1C,IC50,nM,=,263026.8,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1806,CHEMBL3,CN1CCC[C@H]1c1cccnc1,IC50,nM,=,245470.89,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1807,CHEMBL741,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,IC50,nM,=,229086.77,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1808,CHEMBL451136,COC(=O)C1=CC[C@@H]2CC[C@H]1N2C,IC50,nM,=,169824.37,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1809,CHEMBL779,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,IC50,nM,=,100000.0,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1810,CHEMBL607,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,IC50,nM,=,75857.76,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1811,CHEMBL163238,Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2,IC50,nM,=,20417.38,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1812,CHEMBL1125,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1,IC50,nM,=,14125.38,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1813,CHEMBL100454,CN1CCN(C2=Nc3ccccc3Nc3sc(CO)cc32)CC1,IC50,nM,=,11481.54,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method
1814,CHEMBL467510,CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)[O-])n1.[Na+],IC50,nM,>,31622.78,Displacement of [3H]dofetilide from human ERG receptor by FLIPR method
1815,CHEMBL494230,Cc1c(CNC(C)C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,IC50,nM,=,23.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1816,CHEMBL512827,Cc1c(CNC2CCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,IC50,nM,=,23.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1817,CHEMBL468937,Cc1c(CNC2CCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1cccnc1,IC50,nM,=,2900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1818,CHEMBL492396,Cc1c(CNC2CCCC2)nn(-c2ncccc2Cl)c1-c1cccnc1,IC50,nM,=,23000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1819,CHEMBL492585,Cc1c(CNC2CCCC2)nn(-c2ncccc2Cl)c1-c1ccc(Cl)nc1,IC50,nM,=,2700.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1820,CHEMBL494767,Cc1ccc(-c2c(C)c(CNC3CCCC3)nn2-c2ncccc2Cl)cn1,IC50,nM,=,16000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1821,CHEMBL494406,Cc1cncc(-c2c(C)c(CNC3CCCC3)nn2-c2ncccc2Cl)c1,IC50,nM,=,9000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1822,CHEMBL468307,Cc1ccc(-c2c(C)c(CNC3CCCC3)nn2-c2ncc(Cl)cc2Cl)cn1,IC50,nM,=,1200.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1823,CHEMBL513855,Cc1ccc(-c2c(C)c(CNC3CCCC3F)nn2-c2ncccc2Cl)cn1,IC50,nM,=,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1824,CHEMBL468308,Cc1ccc(-c2c(C)c(CN[C@H]3CC[C@@H](F)C3)nn2-c2ncccc2Cl)cn1,IC50,nM,=,29000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1825,CHEMBL468518,Cc1ccc(-c2c(C)c(CNC3CCC(F)(F)C3)nn2-c2ncccc2Cl)cn1,IC50,nM,=,21000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1826,CHEMBL512975,Cc1ncc(-c2c(C)c(CNC3CCCC3)nn2-c2ncccc2Cl)cc1F,IC50,nM,=,23000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1827,CHEMBL466648,Cc1ncc(-c2c(C)c(CN[C@H]3CC[C@@H](F)C3)nn2-c2ncccc2Cl)cc1F,IC50,nM,=,41000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1828,CHEMBL444945,CNC[C@H](CC1CCCCC1)NC(=O)N1CCC[C@@H]([C@@](O)(CCCCOC)c2cccc(Cl)c2)C1.O=C(O)/C=C/C(=O)O,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
1829,CHEMBL2112075,CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N.Cl,IC50,nM,=,3000.0,Binding affinity to human ERG
1830,CHEMBL504479,COc1ccc(CC(C)(C)NCC(O)COc2ccccc2C#N)cc1,IC50,nM,=,3500.0,Binding affinity to human ERG
1831,CHEMBL523475,COc1ccc(CC(C)(C)NCC(O)COc2cccc(Cl)c2C#N)cc1,IC50,nM,=,3600.0,Binding affinity to human ERG
1832,CHEMBL486278,COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1,IC50,nM,=,11800.0,Binding affinity to human ERG
1833,CHEMBL466702,CCN1CCN(c2cc3[nH]c(C(=O)[C@]4(C)CC[C@@H](NC(=O)OC)CC4)nc3cc2Cl)CC1,IC50,nM,=,4900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1834,CHEMBL466112,CCN1CCN(c2cc3[nH]c(C(=O)[C@]4(C)CC[C@@H](NC(=O)OC)CC4)nc3cc2C)CC1,IC50,nM,=,3000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1835,CHEMBL466307,CCN1CCN(c2cc3[nH]c(C(=O)C4(C)CCC(=O)CC4)nc3cc2Cl)CC1,IC50,nM,=,8500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1836,CHEMBL466308,CCN1CCN(c2cc3[nH]c(C(=O)[C@]4(C)CC[C@@](C)(O)CC4)nc3cc2Cl)CC1,IC50,nM,=,20000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1837,CHEMBL511742,CCN1CCN(c2cc3[nH]c(C(=O)[C@]4(C)CC[C@](C)(O)CC4)nc3cc2Cl)CC1,IC50,nM,=,3100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1838,CHEMBL467533,CCN1CCN(c2cc3[nH]c(C(=O)[C@]4(CC)CC[C@@](C)(O)CC4)nc3cc2Cl)CC1,IC50,nM,=,11000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1839,CHEMBL494350,C[C@@H]1CN(CCO)CCN1c1cc2[nH]c(SC(C)(C)C)nc2cc1Cl,IC50,nM,=,1600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1840,CHEMBL468504,CCN1CCN(c2cc3[nH]c(SC(C)(C)C)nc3cc2Cl)[C@H](C)C1,IC50,nM,=,990.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1841,CHEMBL450887,C[C@@H]1CN(CC(F)F)CCN1c1cc2[nH]c(SC(C)(C)C)nc2cc1Cl,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1842,CHEMBL466427,C[C@@H]1CN(CC#N)CCN1c1cc2[nH]c(SC(C)(C)C)nc2cc1Cl,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1843,CHEMBL466630,C[C@@H]1CN(CCC#N)CCN1c1cc2[nH]c(SC(C)(C)C)nc2cc1Cl,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1844,CHEMBL466631,CC(=O)CN1CCN(c2cc3[nH]c(SC(C)(C)C)nc3cc2Cl)C(C)C1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1845,CHEMBL466222,CCOC(=O)N1CCC(C)(Sc2nc3cc(Cl)c(N4CCN(CC)CC4)cc3[nH]2)CC1,IC50,nM,=,3900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1846,CHEMBL468301,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@H](NC(=O)OC)CC4)nc3cc2Cl)CC1,IC50,nM,=,1500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1847,CHEMBL468302,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](NC(=O)OC)CC4)nc3cc2Cl)CC1,IC50,nM,=,3500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1848,CHEMBL467473,CCN1CCN(c2cc3[nH]c(SC4(C)CCC(NC(=O)OC)C4)nc3cc2Cl)CC1,IC50,nM,=,2000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1849,CHEMBL467677,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](NC(C)=O)CC4)nc3cc2Cl)CC1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1850,CHEMBL467057,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](N(C)C(C)=O)CC4)nc3cc2Cl)CC1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1851,CHEMBL467266,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](NS(C)(=O)=O)CC4)nc3cc2Cl)CC1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1852,CHEMBL506207,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](N5CCCC5=O)CC4)nc3cc2Cl)CC1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1853,CHEMBL468315,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](C(=O)NC)CC4)nc3cc2Cl)CC1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1854,CHEMBL468524,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](S(C)(=O)=O)CC4)nc3cc2Cl)CC1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1855,CHEMBL466448,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](c5nnn(C)n5)CC4)nc3cc2Cl)CC1,IC50,nM,=,4400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1856,CHEMBL511205,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](c5nnnn5C)CC4)nc3cc2Cl)CC1,IC50,nM,=,6300.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1857,CHEMBL466252,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](c5nc(C)no5)CC4)nc3cc2Cl)CC1,IC50,nM,=,380.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1858,CHEMBL467279,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](c5nnco5)CC4)nc3cc2Cl)CC1,IC50,nM,=,3400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1859,CHEMBL467280,CCN1CCN(c2cc3[nH]c(S[C@]4(C)CC[C@@H](c5nnc(C)o5)CC4)nc3cc2Cl)CC1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
1860,CHEMBL2368925,O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,IC50,nM,=,6025.6,Inhibition of human ERG in MCF7 cells
1861,CHEMBL289469,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,IC50,nM,=,3801.89,Inhibition of human ERG in MCF7 cells
1862,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3388.44,Inhibition of human ERG in MCF7 cells
1863,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1479.11,Inhibition of human ERG in MCF7 cells
1864,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1445.44,Inhibition of human ERG in MCF7 cells
1865,CHEMBL123558,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,IC50,nM,=,562.34,Inhibition of human ERG in MCF7 cells
1866,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,549.54,Inhibition of human ERG in MCF7 cells
1867,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,354.81,Inhibition of human ERG in MCF7 cells
1868,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,199.53,Inhibition of human ERG in MCF7 cells
1869,CHEMBL998,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,IC50,nM,=,173.78,Inhibition of human ERG in MCF7 cells
1870,CHEMBL219916,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,nM,=,162.18,Inhibition of human ERG in MCF7 cells
1871,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,144.54,Inhibition of human ERG in MCF7 cells
1872,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,128.82,Inhibition of human ERG in MCF7 cells
1873,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,35.48,Inhibition of human ERG in MCF7 cells
1874,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.36,Inhibition of human ERG in MCF7 cells
1875,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,28.18,Inhibition of human ERG in MCF7 cells
1876,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,18.2,Inhibition of human ERG in MCF7 cells
1877,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.13,Inhibition of human ERG in MCF7 cells
1878,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,12.3,Inhibition of human ERG in MCF7 cells
1879,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,7.762,Inhibition of human ERG in MCF7 cells
1880,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,6.457,Inhibition of human ERG in MCF7 cells
1881,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,0.912,Inhibition of human ERG in MCF7 cells
1882,CHEMBL75880,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,IC50,nM,=,7762.47,Inhibition of human ERG in MCF7 cells
1883,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,10000.0,Inhibition of human ERG in MCF7 cells
1884,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,nM,=,17378.01,Inhibition of human ERG in MCF7 cells
1885,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,26302.68,Inhibition of human ERG in MCF7 cells
1886,CHEMBL472,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,IC50,nM,=,74131.02,Inhibition of human ERG in MCF7 cells
1887,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,77624.71,Inhibition of human ERG in MCF7 cells
1888,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,100000.0,Inhibition of human ERG in MCF7 cells
1889,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,117489.76,Inhibition of human ERG in MCF7 cells
1890,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human ERG in MCF7 cells
1891,CHEMBL61301,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,IC50,nM,=,28.18,Inhibition of human ERG in MCF7 cells
1892,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,151.36,Inhibition of human ERG in MCF7 cells
1893,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,162.18,Inhibition of human ERG in MCF7 cells
1894,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,190.55,Inhibition of human ERG in MCF7 cells
1895,CHEMBL370805,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,IC50,nM,=,5754.4,Inhibition of human ERG in MCF7 cells
1896,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,21379.62,Inhibition of human ERG in MCF7 cells
1897,CHEMBL2308139,O=C(Nc1ccc(C(F)(F)F)cc1)N1[C@H]2CC[C@@H]1C[C@H](S(=O)(=O)c1ccccn1)C2,IC50,nM,>,10000.0,Inhibition of human ERG channel
1898,CHEMBL564840,Cl.O=c1n(C[C@@H](O)CO)c2ccccc2n1C1CCN(C[C@H]2[C@H]3CC[C@H](C3)C23CC3)CC1,IC50,nM,=,25000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells coexpressing IKr channel protein
1899,CHEMBL551223,Cc1ccc(C(=O)c2ccc(O[C@H](CCN(C)CC(=O)O)c3ccccc3)cc2)cc1,IC50,,,,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1900,CHEMBL392770,OCC1(N2CCN(C3CCc4ccc(OCc5noc(-c6ccc(Cl)cc6)n5)cc43)CC2)CCCC1,IC50,,,,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1901,CHEMBL564919,CCN1C[C@H]2[C@@H](C1)[C@@H]2CN(Cc1cccc(OC(F)(F)F)c1)C(=O)c1cn(C)cn1,IC50,nM,=,2200.0,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1902,CHEMBL560750,Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)C[C@@H]2[C@H]3CN(CC4CC4)C[C@H]32)c1,IC50,nM,=,530.0,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1903,CHEMBL556247,CN1C[C@H]2[C@@H](C1)[C@@H]2CN(Cc1cccc(OC(F)(F)F)c1)C(=O)c1cn(C)cn1,IC50,nM,=,3800.0,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1904,CHEMBL563220,Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)C[C@@H]2[C@H]3CN(CC4CCCC4)C[C@H]32)c1,IC50,nM,=,460.0,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1905,CHEMBL551424,CCN1C[C@H]2[C@@H](C1)[C@@H]2CN(Cc1cccc(Cl)c1)C(=O)c1cn(C)cn1,IC50,,,,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1906,CHEMBL537965,CN1C[C@H]2[C@@H](C1)[C@@H]2CN(Cc1cccc(Cl)c1)C(=O)c1cn(C)cn1,IC50,,,,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1907,CHEMBL563251,CN1C[C@H]2[C@@H](C1)[C@@H]2CN(Cc1ccc(F)c(Cl)c1)C(=O)c1cn(C)cn1,IC50,nM,=,8500.0,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1908,CHEMBL564650,Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)C[C@@H]2[C@H]3CNC[C@H]32)c1,IC50,,,,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1909,CHEMBL565142,Cn1cnc(C(=O)N(Cc2cccc(Cl)c2)C[C@@H]2[C@H]3CNC[C@H]32)c1,IC50,,,,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1910,CHEMBL560289,Cn1cnc(C(=O)N(Cc2ccc(F)c(Cl)c2)C[C@@H]2[C@H]3CNC[C@H]32)c1,IC50,nM,=,14600.0,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1911,CHEMBL563761,Cn1cnc(C(=O)N(Cc2cccc(Cl)c2)[C@H]2CC[C@@H](N)CC2)c1,IC50,nM,=,65600.0,Inhibition human ERG expressed in HEK293 cells assessed as blockade of membrane current by patch clamp method
1912,CHEMBL519266,CC[C@H]1CN2CC[C@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,IC50,nM,=,773000.0,Inhibition of human ERG channel
1913,CHEMBL559456,Clc1cccc(OC(c2cccnc2)C2CCNCC2)c1Cl,IC50,nM,=,5180.0,Inhibition of human ERG channel
1914,CHEMBL559456,Clc1cccc(OC(c2cccnc2)C2CCNCC2)c1Cl,IC50,nM,=,1970.0,Inhibition of human ERG channel
1915,CHEMBL549825,Clc1cccc(OC(c2cccnc2)[C@@H]2CCCNC2)c1Cl,IC50,nM,=,6610.0,Inhibition of human ERG channel
1916,CHEMBL563495,Clc1cccc(OC(c2ccccn2)[C@H]2CCNC2)c1Cl,IC50,nM,=,10000.0,Inhibition of human ERG channel
1917,CHEMBL563495,Clc1cccc(OC(c2ccccn2)[C@H]2CCNC2)c1Cl,IC50,nM,>,10000.0,Inhibition of human ERG channel
1918,CHEMBL150932,c1ccc(C(Oc2cccc3ccccc23)C2CCNCC2)cc1,IC50,,,,Inhibition of human ERG channel
1919,CHEMBL541226,Clc1cccc(OC(c2ccccc2)C2CCNCC2)c1Cl,IC50,nM,=,950.0,Inhibition of human ERG channel
1920,CHEMBL564975,O=C(NC1CC1c1ccccc1)N1CCC(n2ccnn2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1921,CHEMBL562869,Cn1cc(C2CCN(C(=O)NC3CC3c3ccccc3)CC2)nn1,IC50,nM,>,30000.0,Inhibition of IKr channel
1922,CHEMBL550652,Cn1cnnc1C1CCN(C(=O)NC2CC2c2ccccc2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1923,CHEMBL563732,O=C(NC1CC1c1ccccc1)N1CCC(n2cncn2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1924,CHEMBL559101,O=C(NC1CC1c1ccccc1)N1CCC(n2cccn2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1925,CHEMBL552196,Cc1c(O)noc1C1CCN(C(=O)NC2CC2c2ccccc2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1926,CHEMBL561379,O=C(NC1CC1c1ccccc1)N1CCC(c2nnco2)CC1,IC50,nM,=,27000.0,Inhibition of IKr channel
1927,CHEMBL561259,O=C(NC1CC1c1ccccc1)N1CCC(c2ncon2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1928,CHEMBL564547,Cc1noc(C2CCN(C(=O)NC3CC3c3ccccc3)CC2)n1,IC50,nM,>,30000.0,Inhibition of IKr channel
1929,CHEMBL552402,O=C(NC1CC1c1ccccc1)N1CCC(c2nc3ccccc3o2)CC1,IC50,nM,=,8200.0,Inhibition of IKr channel
1930,CHEMBL561788,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3ccccc3C(F)(F)F)no2)CC1,IC50,nM,=,6000.0,Inhibition of IKr channel
1931,CHEMBL551058,CS(=O)(=O)c1ccc(-c2noc(C3CCN(C(=O)NC4CC4c4ccccc4)CC3)n2)cc1,IC50,nM,=,9000.0,Inhibition of IKr channel
1932,CHEMBL559531,O=C(O)c1ccc(-c2noc(C3CCN(C(=O)NC4CC4c4ccccc4)CC3)n2)cc1,IC50,nM,>,30000.0,Inhibition of IKr channel
1933,CHEMBL552382,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3ccccn3)no2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1934,CHEMBL564757,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3cccnc3)no2)CC1,IC50,nM,=,2000.0,Inhibition of IKr channel
1935,CHEMBL556487,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3ccncc3)no2)CC1,IC50,nM,=,10000.0,Inhibition of IKr channel
1936,CHEMBL557032,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3cnccn3)no2)CC1,IC50,nM,=,27000.0,Inhibition of IKr channel
1937,CHEMBL551517,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3ncccn3)no2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1938,CHEMBL552061,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3nccc4ccccc34)no2)CC1,IC50,nM,=,7000.0,Inhibition of IKr channel
1939,CHEMBL551921,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3ccc4ccccc4n3)no2)CC1,IC50,nM,=,2600.0,Inhibition of IKr channel
1940,CHEMBL555347,O=C(Nc1ccc(C(F)(F)F)cc1)N1CCC(c2nc(-c3ccccn3)no2)CC1,IC50,nM,=,8000.0,Inhibition of IKr channel
1941,CHEMBL562926,O=C(NC1CCc2ccccc2CC1)N1CCC(c2nc(-c3ccccn3)no2)CC1,IC50,nM,=,25000.0,Inhibition of IKr channel
1942,CHEMBL550242,O=C(NC1CCc2ccccc2C1)N1CCC(c2nc(-c3ccccn3)no2)CC1,IC50,nM,=,6000.0,Inhibition of IKr channel
1943,CHEMBL562822,O=C(N[C@@H]1C[C@H]1c1ccccc1)N1CCC(c2nc(-c3ccccn3)no2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1944,CHEMBL552382,O=C(NC1CC1c1ccccc1)N1CCC(c2nc(-c3ccccn3)no2)CC1,IC50,nM,>,30000.0,Inhibition of IKr channel
1945,CHEMBL541944,O=C(CN1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cn3)c2)CC1)NC(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,=,800.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1946,CHEMBL538936,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cn3)c2)CC1)NC(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,=,800.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1947,CHEMBL560063,O=C(NCc1ccc(Cl)cc1Cl)C1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cn3)c2)CC1,IC50,nM,=,3500.0,Inhibition of human ERG activation expressed in CHO cells by rubidium efflux assay
1948,CHEMBL549635,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N(CCCO)Cc1ccc(F)cc1,IC50,nM,=,630.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1949,CHEMBL549636,COCC(O)CN(Cc1ccc(F)cc1)C(=O)CC1CCN(Cc2ccc(-c3ccc(Cl)cc3)o2)CC1,IC50,nM,=,1090.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1950,CHEMBL557306,O=C(CC1CCN(Cc2ccc(-c3ccc(Cl)cc3)o2)CC1)NCC(O)C(F)(F)F,IC50,nM,=,1020.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1951,CHEMBL564674,O=C(CC1CCN(Cc2ccc(-c3ccc(Cl)cc3)o2)CC1)N1CCCC(CO)C1,IC50,nM,=,2340.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1952,CHEMBL557715,O=C(NCC1(O)CCCCC1)C1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,11700.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1953,CHEMBL550308,O=C(NCc1ccc(O)cc1Cl)C1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,1550.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1954,CHEMBL558442,O=C(NCc1ccc(Cl)cc1O)C1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,1550.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1955,CHEMBL562788,O=C(NCc1c(O)cc(Cl)cc1Cl)C1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,4200.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1956,CHEMBL560584,O=C(NCCc1ccccn1)C1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1957,CHEMBL550455,Cn1cccc1CNC(=O)CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,2400.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1958,CHEMBL550513,CN(CCC(=O)N1CCCC1)C(=O)CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,28000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1959,CHEMBL561463,CCN(CC)C(=O)C1CCCN(C(=O)CC2CCN(Cc3ccn(-c4ccc(C(F)(F)F)cc4)c3)CC2)C1,IC50,nM,=,16000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1960,CHEMBL564032,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCC(C(=O)N2CCCC2)C1,IC50,nM,=,31000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1961,CHEMBL559237,O=C(C1CCCCN1C(=O)CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCC1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1962,CHEMBL563884,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCOC(C(=O)N2CCCC2)C1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1963,CHEMBL562905,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCN(C(=O)N2CCCC2)CC1,IC50,nM,=,14000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1964,CHEMBL559535,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccccc1)c1cnc[nH]1,IC50,nM,=,11400.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1965,CHEMBL561584,Cc1nccn1CC(NC(=O)CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)c1ccccc1,IC50,nM,=,26600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1966,CHEMBL561585,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccccc1)c1ccccn1,IC50,nM,=,2300.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1967,CHEMBL551924,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccncc1)c1ccc(Cl)cc1,IC50,nM,=,1700.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1968,CHEMBL565073,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccc(F)cc1)c1cccnc1,IC50,nM,=,2170.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1969,CHEMBL538993,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccc(F)cc1)c1ccc[n+]([O-])c1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1970,CHEMBL553196,COc1ccc(C(NC(=O)CC2CCN(Cc3ccn(-c4ccc(C(F)(F)F)cc4)c3)CC2)c2ccc(F)cc2)cn1,IC50,nM,=,1750.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1971,CHEMBL549984,CCCCC(NC(=O)CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)c1ccc(OC)nc1,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1972,CHEMBL540930,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccc(F)cc1)c1c[nH]c(=O)c(Cl)c1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1973,CHEMBL554332,O=C(CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccc(F)cc1)c1ccc(=O)[nH]c1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1974,CHEMBL562847,CCCCC(NC(=O)CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)c1ccc(=O)[nH]c1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1975,CHEMBL564413,CC(NC(=O)CC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)c1ccc(=O)[nH]c1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1976,CHEMBL558052,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccccc1)c1ccccc1,IC50,nM,=,3800.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1977,CHEMBL554511,O=C(NCc1ccc(Cl)cc1Cl)N1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,1600.0,Inhibition of human ERG activation expressed in CHO cells by rubidium efflux assay
1978,CHEMBL472363,O=C(COc1cccc(Cl)c1)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,560.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
1979,CHEMBL557853,C[C@@H]1Sc2ccccc2O[C@@H]1c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,5.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1980,CHEMBL549433,CC[C@@H]1Sc2ccccc2O[C@@H]1c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,11.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1981,CHEMBL564514,c1ccc([C@@H]2Sc3ccccc3O[C@@H]2c2ccc(OCCCN3CCCC3)cc2)cc1,IC50,nM,=,12.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1982,CHEMBL550393,C[C@H]1Sc2ccccc2O[C@@H]1c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,25.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1983,CHEMBL560923,CC1=C(c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1,IC50,nM,=,4.4,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1984,CHEMBL549908,C[C@H]1[C@@H](c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1(=O)=O,IC50,nM,=,440.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1985,CHEMBL558248,C[C@@H]1[C@@H](c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1(=O)=O,IC50,nM,=,1300.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1986,CHEMBL556100,CC1=C(c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1(=O)=O,IC50,nM,=,470.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1987,CHEMBL549639,COc1cccc2c1S(=O)(=O)C(C)C(c1ccc(OCCCN3CCCC3)cc1)O2,IC50,nM,=,6300.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1988,CHEMBL565007,COc1ccc2c(c1)S(=O)(=O)C(C)C(c1ccc(OCCCN3CCCC3)cc1)O2,IC50,nM,=,1000.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1989,CHEMBL561324,COc1ccc2c(c1)OC(c1ccc(OCCCN3CCCC3)cc1)C(C)S2(=O)=O,IC50,nM,=,1700.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1990,CHEMBL562722,COc1cccc2c1OC(c1ccc(OCCCN3CCCC3)cc1)C(C)S2(=O)=O,IC50,nM,=,7000.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1991,CHEMBL550050,COc1cccc2c1OC(c1ccc(OCCCN3CCCCC3)cc1)C(C)S2(=O)=O,IC50,nM,=,4800.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1992,CHEMBL560863,COc1cccc2c1OC(c1ccc(OCCCN3CCC[C@H]3C)cc1)C(C)S2(=O)=O,IC50,nM,=,2900.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1993,CHEMBL563779,COc1cccc2c1OC(c1ccc(OCCCN3CCC[C@@H]3C)cc1)C(C)S2(=O)=O,IC50,nM,=,3800.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1994,CHEMBL550517,COc1cccc2c1OC(c1ccc(OCCCN3CCC[C@H](C)C3)cc1)C(C)S2(=O)=O,IC50,nM,=,2500.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1995,CHEMBL562870,COc1cccc2c1OC(c1ccc(OC3CCN(C4CCC4)CC3)cc1)C(C)S2(=O)=O,IC50,nM,=,14000.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1996,CHEMBL560386,COc1cccc2c1O[C@@H](c1ccc(OCCCN3CCCC3)cc1)[C@H](C)S2(=O)=O,IC50,nM,=,4900.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1997,CHEMBL557718,COc1cccc2c1O[C@H](c1ccc(OCCCN3CCCC3)cc1)[C@@H](C)S2(=O)=O,IC50,nM,=,6200.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1998,CHEMBL562326,CC1C(c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1(=O)=O,IC50,nM,=,1300.0,Inhibition of [35S]MK499 binding to human ERG transfected in HEK293 cells by microscintillation counting
1999,CHEMBL551991,Cc1cc2cc(/N=C(/NC#N)N[C@H]3CCCCN(CC(=O)N4CCCC4)C3=O)ccc2o1,IC50,nM,>,80000.0,Inhibition of human ERG
2000,CHEMBL560177,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2001,CHEMBL559029,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(C(F)(F)F)c1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2002,CHEMBL540241,CC(C)c1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,IC50,nM,=,5011.87,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2003,CHEMBL561512,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)cc(Cl)c1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2004,CHEMBL562176,N#Cc1cc(N2CCN(CCN3Cc4ccccc4C3)C2=O)ccc1F,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2005,CHEMBL550502,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(Cl)c(Cl)c1,IC50,nM,=,1000.0,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2006,CHEMBL565017,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(OC(F)(F)F)c1,IC50,nM,=,630.96,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2007,CHEMBL562983,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(F)c(Cl)c1,IC50,nM,=,5011.87,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2008,CHEMBL559386,CC(C)Oc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2009,CHEMBL559856,N#Cc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2010,CHEMBL556272,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(F)cc(Cl)c1,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2011,CHEMBL565031,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)ccc1F,IC50,nM,=,19952.62,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2012,CHEMBL564298,CC(C)(C)c1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)cc1,IC50,nM,=,1000.0,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2013,CHEMBL556478,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2sccc2c1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2014,CHEMBL559780,Cc1nc2cc(N3CCN(CCN4Cc5ccccc5C4)C3=O)ccc2s1,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2015,CHEMBL552460,Cc1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)s1,IC50,nM,=,31622.78,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2016,CHEMBL563247,O=C1N(CCN2Cc3ccccc3C2)CCN1c1csc2ccccc12,IC50,nM,=,7943.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2017,CHEMBL559004,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2occc2c1,IC50,nM,=,7943.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2018,CHEMBL549759,CC(=O)n1ccc2cc(N3CCN(CCN4Cc5ccccc5C4)C3=O)ccc21,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2019,CHEMBL564477,Cc1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)cn1,IC50,nM,=,31622.78,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2020,CHEMBL554914,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1,IC50,nM,=,25118.86,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2021,CHEMBL571229,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(Cl)c1,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2022,CHEMBL552366,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(C(F)(F)F)c1,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2023,CHEMBL560650,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccc(Cl)c(Cl)c1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2024,CHEMBL552367,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cc(Cl)ccc1Cl,IC50,nM,=,398.11,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2025,CHEMBL553238,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccc(Cl)cc1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2026,CHEMBL551386,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1Cl,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2027,CHEMBL564741,CC(c1cccc(C(F)(F)F)c1)N1CCN(CCN2Cc3ccccc3C2)C1=O,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2028,CHEMBL552371,CC1CCCN(CCN2CCN(c3cccc(Cl)c3)C2=O)C1,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2029,CHEMBL561054,CC1CCCCN1CCN1CCN(c2cccc(Cl)c2)C1=O,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2030,CHEMBL551914,CC1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2031,CHEMBL569846,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(O)c1,IC50,nM,=,15848.93,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2032,CHEMBL560574,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(I)c1,IC50,nM,=,199.53,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2033,CHEMBL562624,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(Cl)c1,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2034,CHEMBL552373,N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,IC50,nM,=,7943.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2035,CHEMBL559919,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(OC(F)(F)F)c1,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2036,CHEMBL554073,N#Cc1cc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)ccc1F,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2037,CHEMBL559920,COc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,IC50,nM,=,25118.86,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2038,CHEMBL550849,O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(Cl)c1F,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2039,CHEMBL571456,CC(C)N1CCN(CCN2CCN(c3cccc(C#N)c3)C2=O)CC1,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2040,CHEMBL549894,CC(C)N1CCN(CCN2CCN(c3cccc(OC(F)(F)F)c3)C2=O)CC1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2041,CHEMBL564108,CC(C)N1CCN(CCN2CCN(c3ccc(F)c(C#N)c3)C2=O)CC1,IC50,nM,=,15848.93,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2042,CHEMBL570998,CC(C)N1CCN(CCN2CCN(c3cccc(Cl)c3F)C2=O)CC1,IC50,nM,=,19952.62,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2043,CHEMBL550358,COc1cccc(N2CCN(CCN3CCN(C(C)C)CC3)C2=O)c1,IC50,nM,=,63095.73,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2044,CHEMBL560715,CC(C)N1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2045,CHEMBL571221,CN1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2046,CHEMBL508368,C[C@@H](N[C@@H]1CCCc2c1[nH]c1ccc(Br)cc21)c1ccccc1,IC50,nM,=,1700.0,Inhibition of human ERG
2047,CHEMBL551308,Brc1ccc2[nH]c3c(c2c1)CCCC3Nc1ccccc1,IC50,nM,>,30000.0,Inhibition of human ERG
2048,CHEMBL550359,O=C(N[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccc1F,IC50,nM,>,20000.0,Inhibition of human ERG
2049,CHEMBL551051,O=C(N[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccn1,IC50,nM,>,20000.0,Inhibition of human ERG
2050,CHEMBL557502,COc1cccnc1C(=O)N1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1.Cl,IC50,nM,=,50118.72,Inhibition of human ERG
2051,CHEMBL564513,CCNc1cc(N2CCOCC2)cc(CCc2nc(C)c(CC)o2)n1,IC50,nM,=,400.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2052,CHEMBL571013,CCc1oc(CCc2cc(N3CCOCC3)cc(NC)n2)nc1C,IC50,nM,=,830.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2053,CHEMBL559593,CCCNc1cc(N2CCOCC2)cc(CCc2nc(C)c(CC)o2)n1,IC50,nM,=,480.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2054,CHEMBL557648,CCc1oc(CCc2cc(N3CCOCC3)cc(NC(C)C)n2)nc1C,IC50,nM,=,540.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2055,CHEMBL562677,CCc1oc(CCc2cc(N3CCOCC3)cc(NCCOC)n2)nc1C,IC50,nM,=,900.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2056,CHEMBL556183,CCc1oc(CCc2cc(N3CCOCC3)cc(NCC#N)n2)nc1C,IC50,nM,=,4300.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2057,CHEMBL560921,CCc1oc(CCc2cc(N3CCOCC3)cc(NCCC#N)n2)nc1C,IC50,nM,=,1600.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2058,CHEMBL562831,CCOC(=O)CNc1cc(N2CCOCC2)cc(CCc2nc(C)c(CC)o2)n1,IC50,nM,=,910.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2059,CHEMBL559987,CCc1oc(CCc2cc(N3CCOCC3)cc(NC(C)=O)n2)nc1C,IC50,nM,=,7000.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2060,CHEMBL560182,CCc1oc(CCc2cc(N3CCOCC3)cc(NCC(F)(F)F)n2)nc1C,IC50,nM,=,1600.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2061,CHEMBL551197,CCc1oc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)nc1C,IC50,nM,=,8300.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2062,CHEMBL563011,Cc1nc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)oc1C,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2063,CHEMBL560263,Cc1nc(OCc2cc(N3CCOCC3)cc(NCC#N)n2)oc1C,IC50,,,,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2064,CHEMBL549699,Cc1nc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)n(C)c1C,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2065,CHEMBL560382,Cc1nc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)sc1C,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2066,CHEMBL564536,CCc1sc(CCc2cc(N3CCOCC3)cc(NC(C)c3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C,IC50,nM,=,36.0,Displacement of [35S]MK499 from human ERG channel in HEK293 cells
2067,CHEMBL494462,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,7900.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2068,CHEMBL551412,CCNC(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,11989.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2069,CHEMBL550063,NC(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,11589.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2070,CHEMBL551413,CNC(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,>,100000.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2071,CHEMBL563137,CC(C)CNC(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,3190.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2072,CHEMBL561882,CC(C)N(C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1)C(C)C,IC50,nM,=,6809.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2073,CHEMBL561805,CN(C)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,23070.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2074,CHEMBL564922,O=C(c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1)N1CCCC1,IC50,nM,=,10566.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2075,CHEMBL550261,O=C(c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1)N1CCCCC1,IC50,nM,=,3027.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2076,CHEMBL551414,O=C(c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1)N1CCOCC1,IC50,nM,=,54256.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2077,CHEMBL551613,O=C(c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1)N1Cc2ccccc2C1,IC50,nM,=,3501.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2078,CHEMBL551536,CN(Cc1ccccc1)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,1571.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2079,CHEMBL551615,CCN1CCc2cc(C3=CC4(CCNCC4)Oc4ccccc43)ccc2C1=O,IC50,nM,=,13500.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2080,CHEMBL563893,CCN(CC)C(=O)c1ccc(C2=CC3(CCCNCC3)Oc3ccccc32)cc1,IC50,nM,=,11784.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2081,CHEMBL556439,CCN(CC)C(=O)c1ccc(C2=CC3(CCNC3)Oc3ccccc32)cc1,IC50,nM,=,6429.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2082,CHEMBL563700,CCN(CC)C(=O)c1ccc(C2=CC3(CCCNC3)Oc3ccccc32)cc1,IC50,nM,=,12653.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2083,CHEMBL556923,CCN(CC)C(=O)c1ccc(C2=CC3(CCOCC3)Oc3ccccc32)cc1,IC50,,,,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2084,CHEMBL557121,CCN(CC)C(=O)c1ccc(C2CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,5094.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2085,CHEMBL556648,CCN(CC)C(=O)c1ccc([C@H]2CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,2543.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2086,CHEMBL550471,CCN(CC)C(=O)c1ccc([C@@H]2CC3(CCNCC3)Oc3ccccc32)cc1,IC50,nM,=,18471.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2087,CHEMBL550472,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)s1,IC50,nM,=,1261.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2088,CHEMBL550669,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)o1,IC50,nM,=,5132.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2089,CHEMBL562898,CCN(CC)C(=O)c1cc(C2=CC3(CCNCC3)Oc3ccccc32)cs1,IC50,nM,=,3463.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2090,CHEMBL557054,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cn1,IC50,nM,=,44113.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2091,CHEMBL561138,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)nc1,IC50,nM,=,71666.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2092,CHEMBL562280,CCN(CC)C(=O)c1ncc(C2=CC3(CCNCC3)Oc3ccccc32)cn1,IC50,nM,>,100000.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2093,CHEMBL557257,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1C,IC50,nM,=,4485.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2094,CHEMBL562873,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1F,IC50,nM,=,3794.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2095,CHEMBL557458,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)cc1O,IC50,nM,=,21079.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2096,CHEMBL562478,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)c(C)c1,IC50,nM,=,4243.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2097,CHEMBL559414,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)c(F)c1,IC50,nM,=,418.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2098,CHEMBL561339,CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)c(O)c1,IC50,nM,=,56700.0,Inhibition of human ERG channel expressed in HEK293 cells by voltage clamp assay
2099,CHEMBL564226,C[C@H](C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,IC50,nM,=,900.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2100,CHEMBL560741,CN(C)CCC1=C(Cc2ccc(F)cc2)c2ccccc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2101,CHEMBL559251,CN(C)CCC1=C(Cc2cnccn2)c2ccccc2C1,IC50,nM,=,5500.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2102,CHEMBL556506,C[C@H](C1=C(CCN(C)C)Cc2ccccc21)c1cnccn1,IC50,nM,=,1400.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2103,CHEMBL564144,C[C@@H](c1ccccn1)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,1400.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2104,CHEMBL540982,CN(C)CCc1sc2ccccc2c1Cc1ccc(F)cc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2105,CHEMBL551340,CN(C)CCc1sc2ccccc2c1Cc1cnccn1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2106,CHEMBL563920,C[C@@H](c1ccccn1)c1c(CCN(C)C)oc2ccccc12,IC50,nM,=,1200.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
2107,CHEMBL551876,C[C@@H](N[C@@H]1CC[C@@H](C(=O)N2CCC(C(=O)N3CCCC3)(c3ccccc3)CC2)C(C)(C)C1)c1ccc(Cl)cc1,IC50,nM,=,1300.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2108,CHEMBL558133,Cc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2109,CHEMBL562532,COc1cccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)c1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2110,CHEMBL549377,COc1ccccc1[C@@H](C)N[C@@H]1CC[C@@H](C(=O)N2CCC(C(=O)N3CCCC3)(c3ccccc3)CC2)C(C)(C)C1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2111,CHEMBL564810,C[C@@H](N[C@@H]1CC[C@@H](C(=O)N2CCC(C(=O)N3CCCC3)(c3ccccc3)CC2)C(C)(C)C1)c1ccccc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2112,CHEMBL557932,COc1ccc(CN[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,=,900.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2113,CHEMBL563052,COc1ccc([C@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,=,4700.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2114,CHEMBL562000,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N(C)C)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2115,CHEMBL552762,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCCC4)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,=,9000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2116,CHEMBL561999,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2117,CHEMBL561594,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(N4CCCCC4)CC3)C(C)(C)C2)cc1,IC50,nM,=,6700.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2118,CHEMBL551933,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(N4CCCNC4=O)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2119,CHEMBL561332,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(N4CCCOC4=O)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2120,CHEMBL561392,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(N4CCCCC4=O)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2121,CHEMBL561193,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)C3CCC(c4ccccc4)(N(C)C(C)=O)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2122,CHEMBL556915,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)C3CCC(NC(C)=O)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2123,CHEMBL560795,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)C3CCC(c4ccccc4)(c4nnc(C)s4)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2124,CHEMBL551608,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(c4nnc(C)o4)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2125,CHEMBL551132,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(c4nnco4)CC3)C(C)(C)C2)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2126,CHEMBL551206,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(c4ccc(Cl)nc4)CC3)C(C)(C)C2)cc1,IC50,nM,=,2100.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2127,CHEMBL171377,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(c4ccc(OC)nc4)CC3)C(C)(C)C2)cc1,IC50,nM,=,520.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2128,CHEMBL559045,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(c4cccnc4)CC3)C(C)(C)C2)cc1,IC50,nM,=,9600.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2129,CHEMBL549851,COc1ccc([C@@H](C)N[C@@H]2CC[C@@H](C(=O)N3CCC(c4ccccc4)(c4ccccc4)CC3)C(C)(C)C2)cc1,IC50,nM,=,530.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2130,CHEMBL554299,Cc1ccc(-n2c(-c3ncccc3Cl)nc(CNC3CCCC3)c2C)cn1,IC50,nM,=,19000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2131,CHEMBL551208,Cc1ccc(-n2c(-c3ncccc3Cl)nc(CN[C@H]3CC[C@@H](F)C3)c2C)cn1,IC50,nM,=,31000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2132,CHEMBL564812,CCc1c(CN[C@H]2CC[C@@H](F)C2)nc(-c2ncccc2Cl)n1-c1ccc(C)nc1,IC50,nM,=,15000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2133,CHEMBL561396,Cc1ccc(-n2c(-c3ncccc3Cl)nc(CNC3CCCC3)c2C(C)C)cn1,IC50,nM,=,9900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2134,CHEMBL561397,Cc1ccc(-n2c(-c3ncccc3Cl)nc(CN[C@H]3CC[C@@H](F)C3)c2C(C)C)cn1,IC50,nM,=,15000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2135,CHEMBL556300,Cc1nc(CN[C@H]2CC[C@@H](F)C2)c(C(C)C)n1-c1cc(F)cc(F)c1,IC50,nM,=,34000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2136,CHEMBL562663,Cc1nc(CNC2CCCC2)n(C(C)C)c1-c1ccc(Cl)cc1,IC50,nM,=,3200.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2137,CHEMBL563593,COCCc1nc(CN[C@H]2CC[C@@H](F)C2)n(C(C)C)c1-c1ccc(Cl)cc1,IC50,nM,=,16000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2138,CHEMBL560669,N[C@H]1Cn2c(nc3ccc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,IC50,nM,=,17000.0,Inhibition of human ERG
2139,CHEMBL552479,N[C@H]1Cn2c(nc3cc(C(F)(F)F)ccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,IC50,nM,=,7500.0,Inhibition of human ERG
2140,CHEMBL559940,CS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,IC50,nM,=,38000.0,Inhibition of human ERG
2141,CHEMBL561793,CS(=O)(=O)Nc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,IC50,nM,=,2500.0,Inhibition of human ERG
2142,CHEMBL541438,N[C@H]1Cn2c(nc3cnc(C(F)(F)F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,IC50,nM,=,57000.0,Inhibition of human ERG
2143,CHEMBL562188,N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,IC50,nM,=,89000.0,Inhibition of human ERG
2144,CHEMBL559477,N[C@H]1Cn2c(nc3cnc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,IC50,nM,=,81000.0,Inhibition of human ERG
2145,CHEMBL562388,N[C@H]1Cn2c(nc3ncccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,IC50,nM,=,90000.0,Inhibition of human ERG
2146,CHEMBL476116,CC(C)C(=O)N(Cc1ccccc1-c1ccccc1)[C@H]1CCNC1,IC50,nM,=,3020.0,Displacement of [3H]dofetilide from human ERG
2147,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2148,CHEMBL244946,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2149,CHEMBL269959,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2150,CHEMBL272511,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6oc(C)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2151,CHEMBL563635,CCN(CC)CCN1CCN(c2cccc(Cl)c2)C1=O,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2152,CHEMBL555744,COC[C@@H]1CCCN1N1CCN(c2cccc(Cl)c2)C1=O,IC50,nM,=,5011.87,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2153,CHEMBL563563,CC1(C)C[C@@H]2C[C@@](C)(CN2CCN2CCN(c3cccc(Cl)c3)C2=O)C1,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2154,CHEMBL563860,O=C1N(CCN2C[C@H]3CC[C@@H]2C3)CCN1c1cccc(Cl)c1,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2155,CHEMBL541435,COCC1[C@@H]2CC[C@H]1CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,IC50,nM,=,1000.0,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2156,CHEMBL551927,C[C@@]12CC(c3ccccc3)C[C@@H](C1)N(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,IC50,nM,=,63.1,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2157,CHEMBL565075,O=C1N(CCN2C[C@H]3CC[C@H](CC3)C2)CCN1c1cccc(Cl)c1,IC50,nM,=,398.11,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2158,CHEMBL564930,CC1(C)[C@H]2CC[C@]1(C)CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2159,CHEMBL562464,O=C1N(CCN2C[C@@H]3CC[C@H]2Cc2ccccc2C3)CCN1c1cccc(Cl)c1,IC50,nM,=,63.1,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2160,CHEMBL563580,O=C1N(CCN2[C@H]3CCC[C@@H]2CC3)CCN1c1cccc(Cl)c1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2161,CHEMBL556496,COc1cccc(C2CCCN(CCN3CCN(c4cccc(Cl)c4)C3=O)C2)c1,IC50,nM,=,199.53,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2162,CHEMBL557110,O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1cccc(Cl)c1,IC50,nM,=,79.43,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2163,CHEMBL561128,O=C1N(CCN2CCC(c3ccc(Cl)cc3)CC2)CCN1c1cccc(Cl)c1,IC50,nM,=,7.943,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2164,CHEMBL563926,COc1cccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)c1,IC50,nM,=,630.96,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2165,CHEMBL554693,COc1ccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)cc1OC,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2166,CHEMBL561326,O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1cccc(Cl)c1,IC50,nM,=,251.19,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2167,CHEMBL554738,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)Cc1cc2ccccc2s1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2168,CHEMBL549438,Cc1cc(CN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)on1,IC50,nM,=,50118.72,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2169,CHEMBL559873,O=C1N(CCN2CCCc3sccc3C2)CCN1c1cccc(Cl)c1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2170,CHEMBL562833,CC1(C)[C@@H]2CC[C@]13CCN(CCN1CCN(c4cccc(Cl)c4)C1=O)C3C2,IC50,nM,=,794.33,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2171,CHEMBL560177,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2172,CHEMBL563274,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2173,CHEMBL558058,CN(CCN1CCN(c2cccc(C(F)(F)F)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2174,CHEMBL564948,Cc1ccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)cc1,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2175,CHEMBL563435,COc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2176,CHEMBL560270,Cc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2177,CHEMBL562948,CN(CCN1CCN(c2ccccc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2178,CHEMBL562836,CN(CCN1CCN(c2ccc(F)cc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2179,CHEMBL564347,CN(CCN1CCN(c2ccc3c(c2)OCO3)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay
2180,CHEMBL560667,Cc1c(CN[C@H]2CC[C@@H](F)C2)nn(CCC#N)c1-c1cc(F)cc(F)c1,IC50,nM,=,9500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells overexpressing Ikr channel protein
2181,CHEMBL273208,CNCc1cnc(C)cc1Oc1ccccc1Oc1ccccc1,IC50,nM,=,11200.0,Displacement of [3H]dofetilide from human ERG
2182,CHEMBL478834,CCOC(=O)N(Cc1ccccc1-c1ccccc1)[C@H]1CCNC1,IC50,nM,=,4980.0,Displacement of [3H]dofetilide from human ERG
2183,CHEMBL564071,CC(C)CN(C(=O)c1ccccc1-c1ccccc1)[C@H]1CCNC1,IC50,nM,=,1440.0,Displacement of [3H]dofetilide from human ERG
2184,CHEMBL551935,Cc1ccccc1C(=O)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2185,CHEMBL564059,CSc1ccccc1C(=O)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2186,CHEMBL551471,CCOc1ccccc1C(=O)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,>,16800.0,Displacement of [3H]dofetilide from human ERG
2187,CHEMBL564021,O=C(c1ccccc1Cl)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2188,CHEMBL552338,O=C(c1ccccc1C(F)(F)F)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2189,CHEMBL561739,CCc1ccccc1C(=O)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,>,16300.0,Displacement of [3H]dofetilide from human ERG
2190,CHEMBL556539,CCSc1ccccc1C(=O)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,=,7570.0,Displacement of [3H]dofetilide from human ERG
2191,CHEMBL556093,CC(C)c1ccccc1C(=O)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,>,18200.0,Displacement of [3H]dofetilide from human ERG
2192,CHEMBL562569,O=C(c1ccccc1C1CCCC1)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,=,2210.0,Displacement of [3H]dofetilide from human ERG
2193,CHEMBL549584,O=C(c1ccccc1Oc1ccccc1)N(CC1CCC1)[C@H]1CCNC1,IC50,nM,=,760.0,Displacement of [3H]dofetilide from human ERG
2194,CHEMBL541196,CSc1ccccc1C(=O)N(C1CCC1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2195,CHEMBL549509,CCCN(C(=O)c1ccccc1SC)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2196,CHEMBL549510,CSc1ccccc1C(=O)N(C1CCCC1)[C@H]1CCNC1,IC50,nM,>,18700.0,Displacement of [3H]dofetilide from human ERG
2197,CHEMBL557660,CSc1ccccc1C(=O)N(c1ccccc1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2198,CHEMBL553395,CSc1ccccc1C(=O)N(C1CCCCC1)[C@H]1CCNC1,IC50,nM,=,2270.0,Displacement of [3H]dofetilide from human ERG
2199,CHEMBL555121,CC(C)N(C(=O)c1ccccc1C(F)(F)F)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2200,CHEMBL560673,O=C(c1ccccc1C(F)(F)F)N(C1CCC1)[C@H]1CCNC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human ERG
2201,CHEMBL559802,O=C(c1ccccc1C(F)(F)F)N(CC1CC1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2202,CHEMBL562533,O=C(c1ccccc1C(F)(F)F)N(c1ccccc1)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2203,CHEMBL564934,O=C(c1ccccc1C(F)(F)F)N(CC1CCCC1)[C@H]1CCNC1,IC50,nM,>,13500.0,Displacement of [3H]dofetilide from human ERG
2204,CHEMBL570781,CC(C)c1ccccc1C(=O)N(C1CCC1)[C@H]1CCNC1,IC50,nM,>,19000.0,Displacement of [3H]dofetilide from human ERG
2205,CHEMBL571443,CC(C)c1ccccc1C(=O)N(CC1CC1)[C@H]1CCNC1,IC50,nM,>,17600.0,Displacement of [3H]dofetilide from human ERG
2206,CHEMBL569364,CCCN(C(=O)c1ccccc1C(C)C)[C@H]1CCNC1,IC50,nM,>,20000.0,Displacement of [3H]dofetilide from human ERG
2207,CHEMBL550401,CC(C)c1ccccc1C(=O)N(C1CCCC1)[C@H]1CCNC1,IC50,nM,>,18500.0,Displacement of [3H]dofetilide from human ERG
2208,CHEMBL550402,CC(C)c1ccccc1C(=O)N(CC1CCCC1)[C@H]1CCNC1,IC50,nM,=,2350.0,Displacement of [3H]dofetilide from human ERG
2209,CHEMBL554336,CN(C(=O)c1ccccc1Oc1ccccc1)[C@H]1CCNC1,IC50,nM,=,9210.0,Displacement of [3H]dofetilide from human ERG
2210,CHEMBL563117,CCN(C(=O)c1ccccc1Oc1ccccc1)[C@H]1CCNC1,IC50,nM,=,5030.0,Displacement of [3H]dofetilide from human ERG
2211,CHEMBL561878,O=C(c1ccccc1Oc1ccccc1)N(C1CCC1)[C@H]1CCNC1,IC50,nM,=,2950.0,Displacement of [3H]dofetilide from human ERG
2212,CHEMBL558651,CC(C)CN(C(=O)c1ccccc1Oc1ccccc1)[C@H]1CCNC1,IC50,nM,=,1080.0,Displacement of [3H]dofetilide from human ERG
2213,CHEMBL564935,O=C(c1ccccc1Oc1ccccc1)N(c1ccccc1)[C@H]1CCNC1,IC50,nM,=,2810.0,Displacement of [3H]dofetilide from human ERG
2214,CHEMBL562802,CSc1ccccc1C(=O)N(CC1CCC1)[C@@H]1CCNC1,IC50,,,,Displacement of [3H]dofetilide from human ERG
2215,CHEMBL563384,O=C(c1ccccc1C(F)(F)F)N(CC1CCC1)[C@@H]1CCNC1,IC50,,,,Displacement of [3H]dofetilide from human ERG
2216,CHEMBL559319,CC(C)c1ccccc1C(=O)N(CC1CCC1)[C@@H]1CCNC1,IC50,,,,Displacement of [3H]dofetilide from human ERG
2217,CHEMBL558853,O=C(c1ccccc1Oc1ccccc1)N(CC1CCC1)[C@@H]1CCNC1,IC50,,,,Displacement of [3H]dofetilide from human ERG
2218,CHEMBL560999,O=C(C1CCC1)N(Cc1ccccc1C(F)(F)F)[C@H]1CCNC1,IC50,nM,>,7460.0,Displacement of [3H]dofetilide from human ERG
2219,CHEMBL538380,COc1ccc([C@H](N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)C(F)(F)F)cc1,IC50,nM,=,7400.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2220,CHEMBL540466,COc1ccc([C@H](N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)C(F)F)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2221,CHEMBL549917,C[C@@H](N[C@@H]1CC[C@@H](C(=O)N2CCC(C(=O)N3CCCC3)(c3ccccc3)CC2)C(C)(C)C1)c1ccc(F)cc1,IC50,nM,>,10000.0,Displacement of [35S]MK499 from human ERG potassium channel expressed in HEK293 cells
2222,CHEMBL550410,O=C(NCc1cccc(F)c1)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,1200.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2223,CHEMBL550068,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCn2cccc2C1c1ccccc1,IC50,nM,=,1300.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2224,CHEMBL564501,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCC1Cc1cccnc1,IC50,nM,=,1730.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2225,CHEMBL550876,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCC1c1ccc(F)cc1,IC50,nM,=,1810.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2226,CHEMBL557873,COc1ccc(OC2CN(C(=O)NC3CCN(Cc4ccn(-c5ccc(C(F)(F)F)cc5)c4)CC3)C2)cc1,IC50,nM,=,2030.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2227,CHEMBL558863,CN(CC1(O)CCCCC1)C(=O)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,2160.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2228,CHEMBL539475,Cc1cc(C)n(CC(NC(=O)NC2CCN(Cc3ccn(-c4ccc(C(F)(F)F)cc4)c3)CC2)c2ccccc2)n1,IC50,nM,=,2840.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2229,CHEMBL551281,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CC(N2CCCOCC2)C1,IC50,nM,=,3000.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2230,CHEMBL560283,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCC1c1cccnc1,IC50,nM,=,3080.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2231,CHEMBL558928,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCCC1CCO,IC50,nM,=,3080.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2232,CHEMBL550943,O=C(Nc1ccc(Cl)cc1CO)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,3330.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2233,CHEMBL550535,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CC(N2CCC(C(F)(F)F)CC2)C1,IC50,nM,=,3870.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2234,CHEMBL559329,O=C(NC[C@H]1CCCC[C@H]1O)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,3960.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2235,CHEMBL556927,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(Cn1cccn1)c1ccccc1,IC50,nM,=,4040.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2236,CHEMBL551886,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCC(c2ccccc2O)CC1,IC50,nM,=,4120.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2237,CHEMBL558532,CN1CCN(C(=O)NC2CCN(Cc3ccn(-c4ccc(C(F)(F)F)cc4)c3)CC2)C(c2ccccc2)C1,IC50,nM,=,4700.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2238,CHEMBL551543,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCC(CO)C1,IC50,nM,=,4890.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2239,CHEMBL562285,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(Cc1cnccn1)c1ccccc1,IC50,nM,=,5340.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2240,CHEMBL550816,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(CN1CCOCC1)c1ccccc1,IC50,nM,=,6900.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2241,CHEMBL564243,O=C(NC[C@@H]1CCCC[C@H]1O)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,7330.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2242,CHEMBL558726,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCC(O)(Cc2ccccc2)CC1,IC50,nM,=,7930.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2243,CHEMBL551684,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CCCC(C(=O)N2CCCC2)C1,IC50,nM,=,11700.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2244,CHEMBL563791,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(c1ccccc1)c1ncc[nH]1,IC50,nM,=,12700.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2245,CHEMBL558533,O=C(NCc1nc2ccccc2[nH]1)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,14700.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2246,CHEMBL559691,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)c1c[nH]c(=O)c(Cl)c1,IC50,nM,=,19600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2247,CHEMBL561344,CC(C)C(Cn1ccnc1)NC(=O)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,20900.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2248,CHEMBL557329,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N[C@H](CO)c1ccccc1,IC50,nM,=,23900.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2249,CHEMBL563005,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N[C@@H](CO)c1ccccc1,IC50,nM,=,25800.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2250,CHEMBL555349,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NS(=O)(=O)c1ccc(F)cc1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2251,CHEMBL555135,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CC(N2CCS(=O)(=O)CC2)C1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2252,CHEMBL561083,CC(=O)NC1CCN(C(=O)NC2CCN(Cc3ccn(-c4ccc(C(F)(F)F)cc4)c3)CC2)C1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2253,CHEMBL551826,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CC[C@@H](O)C1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2254,CHEMBL552224,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N1CC[C@H](O)C1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2255,CHEMBL552143,O=C(NCC1(O)CCCCC1)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2256,CHEMBL552144,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC12CC3CC(CC(O)(C3)C1)C2,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2257,CHEMBL549595,Cc1nccn1CC(NC(=O)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)c1ccccc1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2258,CHEMBL557262,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(Cn1cncn1)c1ccccc1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2259,CHEMBL557263,O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)NC(Cn1ccnc1)c1ccccc1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2260,CHEMBL549930,CC(Cn1ccnc1)NC(=O)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2261,CHEMBL561546,O=C(O)CC(NC(=O)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)c1ccccc1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2262,CHEMBL472363,O=C(COc1cccc(Cl)c1)NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1,IC50,nM,=,560.0,Inhibition of human ERG expressed in CHO cells by patch-clamp assay
2263,CHEMBL550818,CN(CC1CCOCC1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,29.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
2264,CHEMBL556450,Cc1cnn(C2CCN(c3nc4ccccc4n3Cc3ccc(F)cc3)CC2)c1,IC50,nM,=,809.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
2265,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,441.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
2266,CHEMBL563341,CN1CC[C@@H](N(Cc2ccccc2C(F)(F)F)c2ccc(C#N)c(Cl)c2)C1,IC50,nM,=,780.0,Inhibition of human ERG by whole cell patch clamp assay
2267,CHEMBL552023,CCN1C[C@@H](N(Cc2cc(F)ccc2Cl)c2ccc(C#N)c(Cl)c2)CC1=O,IC50,nM,=,3100.0,Inhibition of human ERG by whole cell patch clamp assay
2268,CHEMBL563283,CN1C[C@@H](N(Cc2ccccc2F)c2ccc(C#N)c(Cl)c2)CC1=O,IC50,nM,=,6500.0,Inhibition of human ERG by whole cell patch clamp assay
2269,CHEMBL1136,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,IC50,nM,=,40000.0,Inhibition of human ERG by patch-clamp assay
2270,CHEMBL583090,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(C3CN(Cc4ccnc5cccnc45)C3)C(=O)O[C@]12C,IC50,nM,=,196000.0,Inhibition of human ERG by patch-clamp assay
2271,CHEMBL583091,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(C3CN(Cc4ccnc5ncccc45)C3)C(=O)O[C@]12C,IC50,nM,=,80000.0,Inhibition of human ERG by patch-clamp assay
2272,CHEMBL583093,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(C3CN([C@H](C)c4ccnc5ncccc45)C3)C(=O)O[C@]12C,IC50,nM,=,43000.0,Inhibition of human ERG by patch-clamp assay
2273,CHEMBL583298,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(C3CN(Cc4c(O)cnc5ncccc45)C3)C(=O)O[C@]12C,IC50,nM,=,140000.0,Inhibition of human ERG by patch-clamp assay
2274,CHEMBL583299,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(C3CN(Cc4c(O)cnc5cccnc45)C3)C(=O)O[C@]12C,IC50,nM,=,67000.0,Inhibition of human ERG by patch-clamp assay
2275,CHEMBL575448,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,nM,>,10000.0,Inhibition of human ERG
2276,CHEMBL584554,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1,IC50,nM,>,30000.0,Inhibition of human ERG
2277,CHEMBL1645462,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,IC50,nM,=,4000.0,Inhibition of human ERG expressed in HEK cells
2278,CHEMBL532,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,39.0,Inhibition of human ERG expressed in HEK cells
2279,CHEMBL572996,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](OCC(=O)NC)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,411.0,Inhibition of human ERG expressed in HEK cells
2280,CHEMBL584549,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,10.0,Inhibition of human ERG expressed in HEK cells
2281,CHEMBL1204009,CCOC(=O)CCc1ccc(OC[C@H](O)CNC(C)(C)Cc2ccc3ccccc3c2)c(C#N)c1.Cl,IC50,nM,=,1.7,Inhibition of human ERG
2282,CHEMBL180672,CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N,IC50,nM,=,3.0,Inhibition of human ERG
2283,CHEMBL382741,CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1ccccc1C#N,IC50,nM,=,3.2,Inhibition of human ERG
2284,CHEMBL486278,COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1,IC50,nM,=,11.8,Inhibition of human ERG
2285,CHEMBL570593,CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1ccc(CCC(=O)O)cc1C#N,IC50,nM,=,32.7,Inhibition of human ERG
2286,CHEMBL572163,CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1ccc(CCC(=O)O)cc1,IC50,nM,=,38.5,Inhibition of human ERG
2287,CHEMBL568957,COc1ccc(CCN2C(=O)N(NS(=O)(=O)Cc3cccnc3)C[C@@H]2c2ccc(OC)cc2)cc1,IC50,,,,Inhibition of human ERG by patch-clamp technique
2288,CHEMBL429436,O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,602.56,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2289,CHEMBL259243,O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1,IC50,nM,=,83.18,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2290,CHEMBL409224,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2,IC50,nM,=,87.1,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2291,CHEMBL567620,CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2,IC50,nM,=,4897.79,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2292,CHEMBL567419,CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2,IC50,nM,=,1905.46,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2293,CHEMBL566759,C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2,IC50,nM,=,2344.23,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2294,CHEMBL583212,O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1,IC50,nM,=,5128.61,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2295,CHEMBL271128,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2,IC50,nM,=,45.71,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2296,CHEMBL270971,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2,IC50,nM,=,218.78,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2297,CHEMBL573216,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2,IC50,nM,=,70.79,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2298,CHEMBL271801,O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,446.68,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2299,CHEMBL410885,O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,1949.84,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2300,CHEMBL574655,COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1,IC50,nM,=,1905.46,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2301,CHEMBL272022,COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1,IC50,nM,=,25703.96,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2302,CHEMBL566974,O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1,IC50,nM,=,229.09,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2303,CHEMBL583843,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2,IC50,nM,=,14125.38,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2304,CHEMBL568503,CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1,IC50,nM,=,11220.18,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2305,CHEMBL567202,CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1,IC50,nM,=,19498.45,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2306,CHEMBL568296,CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1,IC50,nM,=,20892.96,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2307,CHEMBL568522,CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1,IC50,nM,=,38018.94,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2308,CHEMBL568523,CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1,IC50,nM,=,43651.58,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2309,CHEMBL584087,CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1,IC50,nM,=,16595.87,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2310,CHEMBL566324,CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1,IC50,nM,=,4168.69,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2311,CHEMBL567627,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1,IC50,nM,=,28840.32,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2312,CHEMBL566543,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,IC50,nM,=,16595.87,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2313,CHEMBL583621,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1,IC50,nM,=,7079.46,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2314,CHEMBL568294,CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,IC50,nM,=,11220.18,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2315,CHEMBL567417,CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,IC50,nM,=,3467.37,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2316,CHEMBL579072,CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F,IC50,nM,=,30902.95,Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiology
2317,CHEMBL585163,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)CC2c2ccc(C)c(C)c2)cc1,IC50,nM,=,15800.0,Inhibition of human ERG by patch-clamp technique
2318,CHEMBL572153,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)CC2c2ccc(C)cc2)cc1,IC50,nM,=,11200.0,Inhibition of human ERG by patch-clamp technique
2319,CHEMBL583254,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)CC2c2ccc(C3CC3)cc2)cc1,IC50,nM,=,8400.0,Inhibition of human ERG by patch-clamp technique
2320,CHEMBL583465,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)CC2c2ccc(Cl)cc2)cc1,IC50,nM,=,8700.0,Inhibition of human ERG by patch-clamp technique
2321,CHEMBL571041,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)CC2c2ccc(C(F)(F)F)cc2)cc1,IC50,nM,=,9100.0,Inhibition of human ERG by patch-clamp technique
2322,CHEMBL569184,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)C[C@@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,26700.0,Inhibition of human ERG by patch-clamp technique
2323,CHEMBL569185,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)C[C@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,15100.0,Inhibition of human ERG by patch-clamp technique
2324,CHEMBL571952,COc1ccc(CCN2C(=O)N(NS(C)(=O)=O)CC2c2ccc(OC(C)C)cc2)cc1,IC50,nM,=,17000.0,Inhibition of human ERG by patch-clamp technique
2325,CHEMBL571953,COCCOc1ccc(C2CN(NS(C)(=O)=O)C(=O)N2CCc2ccc(OC)cc2)cc1,IC50,nM,=,33000.0,Inhibition of human ERG by patch-clamp technique
2326,CHEMBL583430,COc1ccc(CCCN2C(=O)N(NS(C)(=O)=O)C[C@@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,14100.0,Inhibition of human ERG by patch-clamp technique
2327,CHEMBL570360,COc1ccc(CCCN2C(=O)N(NS(C)(=O)=O)C[C@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,14300.0,Inhibition of human ERG by patch-clamp technique
2328,CHEMBL570805,CCOc1ccc(CCN2C(=O)N(NS(C)(=O)=O)C[C@@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,12200.0,Inhibition of human ERG by patch-clamp technique
2329,CHEMBL583047,COc1ccc([C@H]2CN(NS(C)(=O)=O)C(=O)N2CCc2ccc(OC(F)(F)F)cc2)cc1,IC50,nM,=,5600.0,Inhibition of human ERG by patch-clamp technique
2330,CHEMBL569628,COc1ccc(CCN2C(=O)N(NS(=O)(=O)Cc3ccccc3)C[C@@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,4400.0,Inhibition of human ERG by patch-clamp technique
2331,CHEMBL570815,COc1ccc(CCN2C(=O)N(NS(=O)(=O)CC#N)C[C@@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,33000.0,Inhibition of human ERG by patch-clamp technique
2332,CHEMBL571039,COc1ccc(CCN2C(=O)N(NS(=O)(=O)CF)C[C@@H]2c2ccc(OC)cc2)cc1,IC50,nM,=,28300.0,Inhibition of human ERG by patch-clamp technique
2333,CHEMBL429436,O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,81.28,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2334,CHEMBL259243,O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1,IC50,nM,=,6.457,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2335,CHEMBL409224,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2,IC50,nM,=,2.512,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2336,CHEMBL567620,CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2,IC50,nM,=,19054.61,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2337,CHEMBL567419,CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2,IC50,nM,=,15135.61,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2338,CHEMBL566759,C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2,IC50,nM,=,1096.48,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2339,CHEMBL583212,O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1,IC50,nM,=,16982.44,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2340,CHEMBL271128,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2,IC50,nM,=,30.2,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2341,CHEMBL270971,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2,IC50,nM,=,208.93,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2342,CHEMBL573216,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2,IC50,nM,=,120.23,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2343,CHEMBL271801,O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,363.08,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2344,CHEMBL410885,O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1,IC50,nM,=,1412.54,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2345,CHEMBL272022,COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1,IC50,nM,=,8511.38,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2346,CHEMBL583843,COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2347,CHEMBL567202,CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1,IC50,nM,=,32359.37,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2348,CHEMBL568296,CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1,IC50,nM,=,8128.31,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2349,CHEMBL572537,O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1,IC50,nM,=,7762.47,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2350,CHEMBL568523,CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1,IC50,nM,=,37153.52,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2351,CHEMBL584087,CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1,IC50,nM,=,758.58,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2352,CHEMBL566324,CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1,IC50,nM,=,32359.37,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2353,CHEMBL567627,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1,IC50,nM,=,16982.44,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2354,CHEMBL566543,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,IC50,nM,=,12882.5,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2355,CHEMBL583621,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1,IC50,nM,=,30199.52,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2356,CHEMBL568294,CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,IC50,nM,=,30902.95,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2357,CHEMBL567417,CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2358,CHEMBL579072,CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F,IC50,nM,=,47863.01,Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp method
2359,CHEMBL575966,Cc1onc(-c2ccccc2Cl)c1C(=O)N(C)c1ccc(Cl)cc1,IC50,nM,>,50118.72,Displacement of dofetilide from human ERG
2360,CHEMBL576138,Cc1ccc(N(C)C(=O)c2c(-c3ccccc3Cl)noc2C)cc1Cl,IC50,nM,>,50118.72,Displacement of dofetilide from human ERG
2361,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,312.0,Inhibition of human ERG in L929 cells at 10 uM by whole cell patch-clamp assay
2362,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG in L929 cells at 10 uM by whole cell patch-clamp assay
2363,CHEMBL571389,Cc1ccc(CCCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,396.0,Inhibition of human ERG in L929 cells at 10 uM by whole cell patch-clamp assay
2364,CHEMBL570033,O=C(O)c1ccc(CCCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,11000.0,Inhibition of human ERG in L929 cells at 10 uM by whole cell patch-clamp assay
2365,CHEMBL571174,CC1CCC(CCCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG in L929 cells at 10 uM by whole cell patch-clamp assay
2366,CHEMBL127508,OC(c1ccccc1)(c1ccccc1)C1CCNCC1,IC50,nM,>,100000.0,Inhibition of human ERG in L929 cells at 10 uM by whole cell patch-clamp assay
2367,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,312.0,Inhibition of human ERG in L929 cells by whole cell patch-clamp assay
2368,CHEMBL127508,OC(c1ccccc1)(c1ccccc1)C1CCNCC1,IC50,nM,>,100000.0,Inhibition of human ERG in L929 cells by whole cell patch-clamp assay
2369,CHEMBL571174,CC1CCC(CCCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG in L929 cells by whole cell patch-clamp assay
2370,CHEMBL570033,O=C(O)c1ccc(CCCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,11000.0,Inhibition of human ERG in L929 cells by whole cell patch-clamp assay
2371,CHEMBL571389,Cc1ccc(CCCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,396.0,Inhibition of human ERG in L929 cells by whole cell patch-clamp assay
2372,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,>,100.0,Inhibition of human ERG in L929 cells by whole cell patch-clamp assay
2373,CHEMBL571581,Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3o2)ccc2[nH]ccc12,IC50,nM,>,10000.0,Inhibition of human ERG
2374,CHEMBL571581,Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3o2)ccc2[nH]ccc12,IC50,nM,>,30000.0,Inhibition of human ERG
2375,CHEMBL570274,C[C@@H]1CNCCN1c1ccc(=O)n(CCOc2ccccc2C(F)(F)F)n1,IC50,nM,=,3700.0,Inhibition of human ERG
2376,CHEMBL565833,CCCNCc1ccc(CCn2ccc(OCc3ccc(F)cc3)cc2=O)nc1,IC50,nM,=,5100.0,Inhibition of human ERG potassium channel 1
2377,CHEMBL570296,CCCNCc1ccc(CCn2ccc(OCc3ccc(F)cc3)cc2=O)cc1,IC50,nM,=,4200.0,Inhibition of human ERG potassium channel 1
2378,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG
2379,CHEMBL244946,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG
2380,CHEMBL572270,CC1=NC2C=C3CCN(CCCSc4nnc(-c5cccc6nc(C)ccc56)n4C)CCC3=CC2O1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human ERG
2381,CHEMBL272511,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6oc(C)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG
2382,CHEMBL563635,CCN(CC)CCN1CCN(c2cccc(Cl)c2)C1=O,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG
2383,CHEMBL555744,COC[C@@H]1CCCN1N1CCN(c2cccc(Cl)c2)C1=O,IC50,nM,=,5011.87,Displacement of [3H]dofetilide from human ERG
2384,CHEMBL563563,CC1(C)C[C@@H]2C[C@@](C)(CN2CCN2CCN(c3cccc(Cl)c3)C2=O)C1,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG
2385,CHEMBL563860,O=C1N(CCN2C[C@H]3CC[C@@H]2C3)CCN1c1cccc(Cl)c1,IC50,nM,=,12589.25,Displacement of [3H]dofetilide from human ERG
2386,CHEMBL541435,COCC1[C@@H]2CC[C@H]1CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,IC50,nM,=,1000.0,Displacement of [3H]dofetilide from human ERG
2387,CHEMBL551927,C[C@@]12CC(c3ccccc3)C[C@@H](C1)N(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,IC50,nM,=,63.1,Displacement of [3H]dofetilide from human ERG
2388,CHEMBL565075,O=C1N(CCN2C[C@H]3CC[C@H](CC3)C2)CCN1c1cccc(Cl)c1,IC50,nM,=,398.11,Displacement of [3H]dofetilide from human ERG
2389,CHEMBL564930,CC1(C)[C@H]2CC[C@]1(C)CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG
2390,CHEMBL562464,O=C1N(CCN2C[C@@H]3CC[C@H]2Cc2ccccc2C3)CCN1c1cccc(Cl)c1,IC50,nM,=,63.1,Displacement of [3H]dofetilide from human ERG
2391,CHEMBL563580,O=C1N(CCN2[C@H]3CCC[C@@H]2CC3)CCN1c1cccc(Cl)c1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG
2392,CHEMBL556496,COc1cccc(C2CCCN(CCN3CCN(c4cccc(Cl)c4)C3=O)C2)c1,IC50,nM,=,199.53,Displacement of [3H]dofetilide from human ERG
2393,CHEMBL557110,O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1cccc(Cl)c1,IC50,nM,=,79.43,Displacement of [3H]dofetilide from human ERG
2394,CHEMBL561128,O=C1N(CCN2CCC(c3ccc(Cl)cc3)CC2)CCN1c1cccc(Cl)c1,IC50,nM,=,7.943,Displacement of [3H]dofetilide from human ERG
2395,CHEMBL563926,COc1cccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)c1,IC50,nM,=,630.96,Displacement of [3H]dofetilide from human ERG
2396,CHEMBL554693,COc1ccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)cc1OC,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG
2397,CHEMBL561326,O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1cccc(Cl)c1,IC50,nM,=,251.19,Displacement of [3H]dofetilide from human ERG
2398,CHEMBL554738,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)Cc1cc2ccccc2s1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG
2399,CHEMBL549438,Cc1cc(CN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)on1,IC50,nM,=,50118.72,Displacement of [3H]dofetilide from human ERG
2400,CHEMBL559873,O=C1N(CCN2CCCc3sccc3C2)CCN1c1cccc(Cl)c1,IC50,nM,=,794.33,Displacement of [3H]dofetilide from human ERG
2401,CHEMBL562833,CC1(C)[C@@H]2CC[C@]13CCN(CCN1CCN(c4cccc(Cl)c4)C1=O)C3C2,IC50,nM,=,794.33,Displacement of [3H]dofetilide from human ERG
2402,CHEMBL560177,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG
2403,CHEMBL563274,CN(CCN1CCN(c2cccc(Cl)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG
2404,CHEMBL558058,CN(CCN1CCN(c2cccc(C(F)(F)F)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from human ERG
2405,CHEMBL564948,Cc1ccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)cc1,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG
2406,CHEMBL563435,COc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,IC50,nM,=,1995.26,Displacement of [3H]dofetilide from human ERG
2407,CHEMBL560270,Cc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,IC50,nM,=,1584.89,Displacement of [3H]dofetilide from human ERG
2408,CHEMBL562948,CN(CCN1CCN(c2ccccc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,3981.07,Displacement of [3H]dofetilide from human ERG
2409,CHEMBL562836,CN(CCN1CCN(c2ccc(F)cc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,3162.28,Displacement of [3H]dofetilide from human ERG
2410,CHEMBL567919,CN(CCN1CCN(C2COOC2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,IC50,nM,=,6309.57,Displacement of [3H]dofetilide from human ERG
2411,CHEMBL593521,Fc1cc2c(cn1)C1(CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC1)OC2,IC50,nM,=,24.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2412,CHEMBL585509,Fc1cc2c(cn1)C1(CCN(Cc3ccc(Nc4ccc(F)c(F)c4)cc3)CC1)OC2,IC50,nM,=,23.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2413,CHEMBL585856,CN(c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,25.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2414,CHEMBL568572,OC(c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,520.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2415,CHEMBL568361,CC(O)(c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,530.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2416,CHEMBL566257,O=C(c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,17.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2417,CHEMBL582978,O/N=C(/c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,310.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2418,CHEMBL565614,O/N=C(\c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,280.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2419,CHEMBL566880,CO/N=C(/c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,250.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2420,CHEMBL568571,CCO/N=C(/c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cc1)c1ccc(F)c(F)c1,IC50,nM,=,140.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2421,CHEMBL582792,CCO/N=C(/c1ccc(F)c(F)c1)c1ccc(CN2CCC3(CC2)OCc2cc(F)ncc23)cn1,IC50,nM,=,1790.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2422,CHEMBL585880,CCO/N=C(/c1ccc(F)c(F)c1)c1ccc(CN2CCC3(CC2)OCc2cc(=O)n(C)cc23)cn1,IC50,nM,>,10000.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2423,CHEMBL585664,CCO/N=C(/c1ccc(F)c(F)c1)c1ccc(CN2CCC3(CC2)OCc2cn(C)c(=O)cc23)cn1,IC50,nM,=,3670.0,Displacement of [35S]MK-499 from human ERG expressed in HEK293 cells
2424,CHEMBL565829,CCc1n[nH]c(CC)c1Oc1cc(C#N)cc(C#N)c1,IC50,nM,=,9800.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
2425,CHEMBL567916,CCc1n[nH]c(CC)c1Oc1cc(Cl)cc(C#N)c1,IC50,nM,=,39000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
2426,CHEMBL576256,CCc1n[nH]c(CC)c1Oc1cc(C)cc(C#N)c1,IC50,nM,=,100000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
2427,CHEMBL567570,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2ccccc12,IC50,nM,>,80000.0,Inhibition of human ERG by channel flux assay
2428,CHEMBL585487,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2cccnc12,IC50,nM,>,80000.0,Inhibition of human ERG by channel flux assay
2429,CHEMBL585498,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2ccncc12,IC50,nM,>,80000.0,Inhibition of human ERG by channel flux assay
2430,CHEMBL583867,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2cnccc12,IC50,nM,>,80000.0,Inhibition of human ERG by channel flux assay
2431,CHEMBL442078,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2ncccc12,IC50,nM,>,80000.0,Inhibition of human ERG by channel flux assay
2432,CHEMBL337301,COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,IC50,nM,>,80000.0,Inhibition of human ERG by channel flux assay
2433,CHEMBL238103,COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12,IC50,nM,>,80000.0,Inhibition of human ERG by channel flux assay
2434,CHEMBL595944,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1,IC50,nM,=,10400.0,Inhibition of human ERG
2435,CHEMBL594717,Cc1ccc(F)cc1CO[C@H]1CCc2ccc(N3CCNC[C@H]3C)nc21,IC50,nM,=,3900.0,Inhibition of human ERG channel
2436,CHEMBL594534,Cc1cc(Nc2ccccc2)nc(NCc2ccccn2)n1,IC50,nM,=,15800.0,Inhibition of human ERG channel
2437,CHEMBL594752,Cc1cc(Nc2ccccc2)nc(NCc2ccc3c(c2)OCO3)n1,IC50,nM,=,9500.0,Inhibition of human ERG channel
2438,CHEMBL594979,FC(F)(F)c1cc(Nc2ccccc2)nc(NCc2ccccn2)n1,IC50,nM,=,40100.0,Inhibition of human ERG channel
2439,CHEMBL607259,FC(F)(F)c1cc(Nc2ccncc2)nc(NCc2ccc3c(c2)OCO3)n1,IC50,nM,=,135000.0,Inhibition of human ERG channel
2440,CHEMBL558664,CN1CC[C@H](N(Cc2ccccc2C(F)(F)F)c2ccc(C#N)c(Cl)c2)C1,IC50,nM,=,780.0,Inhibition of human ERG by patch clamp technique
2441,CHEMBL601500,Cc1ccccc1CN(c1ccc(C#N)c(Cl)c1)[C@H]1CCN(S(C)(=O)=O)C1,IC50,nM,=,2800.0,Inhibition of human ERG by patch clamp technique
2442,CHEMBL590593,C[C@H](O)C(=O)N1CC[C@H](N(Cc2cc(Cl)ccc2Cl)c2ccc(C#N)c(Cl)c2)C1,IC50,nM,=,2200.0,Inhibition of human ERG by patch clamp technique
2443,CHEMBL611369,Brc1cnc2nc(N3CCN4CCC3CC4)oc2c1,IC50,nM,=,2300.0,Inhibition of human ERG
2444,CHEMBL597241,Clc1cnc2nc(N3CCN4CCC3CC4)oc2c1,IC50,nM,=,3300.0,Inhibition of human ERG
2445,CHEMBL597440,Fc1cnc2nc(N3CCN4CCC3CC4)oc2c1,IC50,nM,=,8700.0,Inhibition of human ERG
2446,CHEMBL604798,Cc1ccc2oc(N3CCN4CCC3CC4)nc2n1,IC50,nM,=,40000.0,Inhibition of human ERG
2447,CHEMBL597276,Clc1cnc2oc(N3CCN4CCC3CC4)nc2c1,IC50,nM,=,2200.0,Inhibition of human ERG
2448,CHEMBL603052,Cc1nc2nc(N3CCN4CCC3CC4)oc2cc1Cl,IC50,nM,=,16200.0,Inhibition of human ERG
2449,CHEMBL598555,CCc1ccc2oc(N3CCN4CCC3CC4)nc2n1,IC50,nM,=,27700.0,Inhibition of human ERG
2450,CHEMBL597737,Fc1ccccc1-c1ccc2oc(N3CCN4CCC3CC4)nc2n1,IC50,nM,=,2800.0,Inhibition of human ERG
2451,CHEMBL601907,CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1,IC50,nM,>,90000.0,Inhibition of human ERG
2452,CHEMBL601906,CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1,IC50,nM,>,90000.0,Inhibition of human ERG
2453,CHEMBL600686,O=C(CN1C(C(=O)c2ccccc2)=C(O)c2ccccc2S1(=O)=O)c1ccccc1,IC50,nM,>,100000.0,Inhibition of human ERG
2454,CHEMBL597521,O=C(CN1C(C(=O)c2ccccc2)=C(O)c2ccccc2S1(=O)=O)c1ccc(-c2ccccc2)cc1,IC50,,,,Inhibition of human ERG
2455,CHEMBL597722,O=C(CN1C(C(=O)c2ccccc2)=C(O)c2ccccc2S1(=O)=O)c1ccc([N+](=O)[O-])cc1,IC50,,,,Inhibition of human ERG
2456,CHEMBL599159,COC(=O)c1ccc(C(=O)CN2C(C(=O)c3ccccc3)=C(O)c3ccccc3S2(=O)=O)cc1,IC50,,,,Inhibition of human ERG
2457,CHEMBL599160,N#Cc1ccc(C(=O)CN2C(C(=O)c3ccccc3)=C(O)c3ccccc3S2(=O)=O)cc1,IC50,,,,Inhibition of human ERG
2458,CHEMBL604936,O=C(O)c1ccc(C(=O)CN2C(C(=O)c3ccccc3)=C(O)c3ccccc3S2(=O)=O)cc1,IC50,,,,Inhibition of human ERG
2459,CHEMBL607982,Cn1cnc(C(=O)N(Cc2ccc(F)c(C(F)(F)F)c2)[C@H]2C[C@@H]3CNC[C@@H]3C2)c1,IC50,,,,Inhibition of human ERG by patch clamp study
2460,CHEMBL605744,Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@@H]2C[C@@H]3CN(CC(C)(C)O)C[C@@H]3C2)c1,IC50,,,,Inhibition of human ERG by patch clamp study
2461,CHEMBL597033,Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@@H]2C[C@@H]3CN(CC(O)c4ccccc4)C[C@@H]3C2)c1,IC50,,,,Inhibition of human ERG by patch clamp study
2462,CHEMBL597032,Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@@H]2C[C@@H]3CN(CCC(F)(F)F)C[C@@H]3C2)c1,IC50,,,,Inhibition of human ERG by patch clamp study
2463,CHEMBL605540,CC(F)CN1C[C@H]2C[C@@H](N(Cc3cccc(OC(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1,IC50,,,,Inhibition of human ERG by patch clamp study
2464,CHEMBL604805,CCN1C[C@H]2C[C@@H](N(Cc3cccc(OC(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1,IC50,,,,Inhibition of human ERG by patch clamp study
2465,CHEMBL599482,CN1C[C@H]2C[C@@H](N(Cc3ccc(F)c(OC4CCCC4)c3)C(=O)c3cn(C)cn3)C[C@H]2C1,IC50,,,,Inhibition of human ERG by patch clamp study
2466,CHEMBL603695,CN1C[C@H]2C[C@@H](N(Cc3ccc(F)c(C(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1,IC50,nM,=,1720.0,Inhibition of human ERG by patch clamp study
2467,CHEMBL599480,CCN1C[C@H]2C[C@@H](N(Cc3ccc(F)c(C(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1,IC50,nM,=,1540.0,Inhibition of human ERG by patch clamp study
2468,CHEMBL598659,CN1C[C@H]2C[C@@H](N(Cc3cccc(OC(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1,IC50,,,,Inhibition of human ERG by patch clamp study
2469,CHEMBL603893,COc1ccc(CN(C(=O)c2cn(C)cn2)[C@@H]2C[C@@H]3CNC[C@@H]3C2)cc1OC1CCCC1,IC50,,,,Inhibition of human ERG by patch clamp study
2470,CHEMBL603691,Cn1cnc(C(=O)N(Cc2cccc(OC3CCCC3)c2)[C@@H]2C[C@@H]3CNC[C@@H]3C2)c1,IC50,,,,Inhibition of human ERG by patch clamp study
2471,CHEMBL599264,CC(C)Oc1cccc(CN(C(=O)c2cn(C)cn2)[C@@H]2C[C@@H]3CNC[C@@H]3C2)c1,IC50,,,,Inhibition of human ERG by patch clamp study
2472,CHEMBL599060,Cn1cnc(C(=O)N(Cc2ccc(F)c(OC3CCCC3)c2)[C@@H]2C[C@@H]3CNC[C@@H]3C2)c1,IC50,,,,Inhibition of human ERG by patch clamp study
2473,CHEMBL596700,Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@@H]2C[C@@H]3CNC[C@@H]3C2)c1,IC50,nM,=,13200.0,Inhibition of human ERG by patch clamp study
2474,CHEMBL596699,Cn1cnc(C(=O)N(Cc2ccc(F)c(C(F)(F)F)c2)[C@@H]2C[C@@H]3CNC[C@@H]3C2)c1,IC50,nM,=,4330.0,Inhibition of human ERG by patch clamp study
2475,CHEMBL3217125,Cl.Cl.Cl.Cn1cnc(C(=O)N(Cc2cccc(Cl)c2)[C@H]2CC[C@@H](N)CC2)c1,IC50,nM,=,65600.0,Inhibition of human ERG by patch clamp study
2476,CHEMBL606029,O=C(c1cc(Cc2c[nH]c(=O)c3cc(Cl)c(Cl)n23)ccc1F)N1CCC2(CCCN2)CC1,IC50,nM,=,12000.0,Inhibition of human ERG
2477,CHEMBL590791,CNC(C)(C)C(=O)N1CCN(C(=O)c2cc(Cc3c[nH]c(=O)c4cc(Cl)c(Cl)n34)ccc2F)CC1,IC50,nM,=,11000.0,Inhibition of human ERG
2478,CHEMBL590791,CNC(C)(C)C(=O)N1CCN(C(=O)c2cc(Cc3c[nH]c(=O)c4cc(Cl)c(Cl)n34)ccc2F)CC1,IC50,nM,=,11000.0,Inhibition of human ERG
2479,CHEMBL589833,O=C(c1cc(Cc2c[nH]c(=O)c3cc(Cl)c(Cl)n23)ccc1F)N1CCC(N2CCCC2)CC1,IC50,nM,=,8000.0,Inhibition of human ERG
2480,CHEMBL606029,O=C(c1cc(Cc2c[nH]c(=O)c3cc(Cl)c(Cl)n23)ccc1F)N1CCC2(CCCN2)CC1,IC50,nM,=,12000.0,Inhibition of human ERG
2481,CHEMBL602875,COc1cc2c(c(N3CCN(C)CC3)c1)O[C@@H](C(=O)Nc1ccc(N3CCOCC3)cc1)CC2,IC50,nM,=,19000.0,Inhibition of human ERG
2482,CHEMBL605785,COC1(c2ccc(NC(=O)c3cc(=O)c4cc(F)cc(-c5c(C)nn(C)c5C)c4o3)cn2)CCOCC1,IC50,nM,=,95000.0,Inhibition of human ERG
2483,CHEMBL589766,CC(C)OC(=O)C1=CN(C(=O)c2ccc(OCCCN3CCOCC3)cc2)CC(C)(C)c2c1[nH]c1cc(F)ccc21,IC50,nM,>,30000.0,Inhibition of human ERG
2484,CHEMBL601221,CC(C)OC(=O)C1=CN(C(=O)c2ccc(OCCN3CCOCC3)cc2)CC(C)(C)c2c1[nH]c1cc(F)ccc21,IC50,nM,>,30000.0,Inhibition of human ERG
2485,CHEMBL601873,CC(C)OC(=O)C1=CN(C(=O)c2ccc(OCCCN3CCOCC3)cc2)CC(C)(C)c2c1[nH]c1ccccc21,IC50,nM,=,5740.0,Inhibition of human ERG
2486,CHEMBL591942,CCCOCCn1c(=O)c(N2CCN([C@H](C)[C@@H](C)O)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2487,CHEMBL589069,CCCOCCn1c(=O)c(N2CCN([C@@H](C)[C@@H](C)O)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,nM,=,54.0,Inhibition of human ERG by patch-clamp method
2488,CHEMBL590037,CCCOCCn1c(=O)c(N2CCN(CC(C)(C)O)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2489,CHEMBL590036,CCCOCCn1c(=O)c(N2CCN(C[C@@H](C)O)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,nM,=,230.0,Inhibition of human ERG by patch-clamp method
2490,CHEMBL589797,CCCOCCn1c(=O)c(N2CCN(C[C@H](C)O)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2491,CHEMBL590787,CCCOCCn1c(=O)c(N2CCCN(CCCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2492,CHEMBL590545,CCCOCCn1c(=O)c(N2CCCN(CCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2493,CHEMBL590544,CCCOCCn1c(=O)c(N2CCN(CCCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2494,CHEMBL591501,CCCOCCn1c(=O)c(N2CCN(CCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,nM,=,1790.0,Inhibition of human ERG by patch-clamp method
2495,CHEMBL590280,CCCOCCn1c(=O)c(N2CCN(CC)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,nM,=,320.0,Inhibition of human ERG by patch-clamp method
2496,CHEMBL602120,CCCOCCn1c(=O)c(N2C[C@H]3C[C@@H]2CN3)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2497,CHEMBL591477,CCCOCCn1c(=O)c(N2CCNCC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,nM,=,670.0,Inhibition of human ERG by patch-clamp method
2498,CHEMBL567252,CCCOCCn1c(=O)c(NCCNCCO)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,nM,=,4500.0,Inhibition of human ERG by patch-clamp method
2499,CHEMBL567469,CCCOCCn1c(=O)c(NCCN)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,,,,Inhibition of human ERG by patch-clamp method
2500,CHEMBL608151,CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1,IC50,nM,=,4200.0,Inhibition of human ERG assessed as blockade of channel current by electrophysiology assay
2501,CHEMBL1085672,O=C1N(CC2CCCCN2)CCN1c1cccc(Cl)c1,IC50,nM,=,7943.28,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
2502,CHEMBL1084132,c1ccc(N2CCN(CC3CCCCN3)C2)cc1,IC50,nM,=,15848.93,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
2503,CHEMBL447328,c1ccc(-c2cc3c(ccn4cnnc34)nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,IC50,nM,>,10000.0,Inhibition of ERG
2504,CHEMBL1084400,N#Cc1nc(CCCN2CCCCC2)cc(-c2cccc(C(F)(F)F)c2)n1,IC50,nM,=,160.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
2505,CHEMBL1084401,CCC(CC)NCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1,IC50,nM,=,320.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
2506,CHEMBL1084402,CC(C)(C)NCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1,IC50,nM,=,1100.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
2507,CHEMBL1081869,Cc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c(F)c1,IC50,nM,=,39810.72,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2508,CHEMBL1082111,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,IC50,nM,=,10000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2509,CHEMBL1081957,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,IC50,nM,=,7943.28,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2510,CHEMBL1080489,COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,IC50,nM,=,6309.57,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2511,CHEMBL1080189,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccccc3C(F)(F)F)C2)n1C,IC50,nM,=,6309.57,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2512,CHEMBL1081869,Cc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c(F)c1,IC50,nM,=,6309.57,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2513,CHEMBL1081203,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,IC50,nM,=,5011.87,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2514,CHEMBL1081687,Cc1ncccc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,5011.87,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2515,CHEMBL1081867,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,IC50,nM,=,3981.07,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2516,CHEMBL1080489,COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,IC50,nM,=,3981.07,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2517,CHEMBL1082111,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,IC50,nM,=,3981.07,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2518,CHEMBL1079938,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,IC50,nM,=,3981.07,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2519,CHEMBL1079494,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,IC50,nM,=,3981.07,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2520,CHEMBL1079475,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cncnc1,IC50,nM,=,3162.28,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2521,CHEMBL1081957,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,IC50,nM,=,3162.28,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2522,CHEMBL1079938,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,IC50,nM,=,3162.28,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2523,CHEMBL1079578,COc1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5nc(C)ccc45)n2C)C3)cc1,IC50,nM,=,2511.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2524,CHEMBL1079837,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,IC50,nM,=,2511.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2525,CHEMBL1081957,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,IC50,nM,=,2511.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2526,CHEMBL1081587,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,IC50,nM,=,2511.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2527,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2528,CHEMBL244946,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2529,CHEMBL272150,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc6oc(C(F)(F)F)nc6c5CC4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2530,CHEMBL1081203,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2531,CHEMBL1080117,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2532,CHEMBL1081746,Cc1nc(C)c(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)s1,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2533,CHEMBL1079837,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2534,CHEMBL1079462,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2535,CHEMBL1079462,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2536,CHEMBL1079980,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2537,CHEMBL1081587,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2538,CHEMBL1081868,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2539,CHEMBL1204409,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C.Cl,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2540,CHEMBL1079494,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,IC50,nM,=,1995.26,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2541,CHEMBL1081237,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,IC50,nM,=,1584.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2542,CHEMBL1080117,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,IC50,nM,=,1584.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2543,CHEMBL1079667,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccccc3)C2)n1C,IC50,nM,=,1584.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2544,CHEMBL1080489,COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,IC50,nM,=,1584.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2545,CHEMBL1079461,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,IC50,nM,=,1584.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2546,CHEMBL1079837,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,IC50,nM,=,1258.93,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2547,CHEMBL1079461,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,IC50,nM,=,1258.93,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2548,CHEMBL1082111,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,IC50,nM,=,1258.93,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2549,CHEMBL1081408,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,IC50,nM,=,1258.93,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2550,CHEMBL1081408,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,IC50,nM,=,1258.93,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2551,CHEMBL1081408,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,IC50,nM,=,1258.93,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2552,CHEMBL1081237,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2553,CHEMBL1079481,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2554,CHEMBL1079824,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(C)(C)C)cc3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2555,CHEMBL1079980,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2556,CHEMBL1079980,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2557,CHEMBL1080846,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2558,CHEMBL1080846,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2559,CHEMBL1081023,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2560,CHEMBL1079938,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2561,CHEMBL1081868,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2562,CHEMBL1081869,Cc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c(F)c1,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2563,CHEMBL1081747,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3F)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2564,CHEMBL1081934,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2565,CHEMBL1081934,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2566,CHEMBL1081203,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2567,CHEMBL1079640,Cc1ccc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2568,CHEMBL1079480,Cc1cnc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2569,CHEMBL1081409,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2570,CHEMBL1082106,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Br)cc3)C2)n1C,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2571,CHEMBL1080490,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2572,CHEMBL1080490,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2573,CHEMBL1081023,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2574,CHEMBL1079494,COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,IC50,nM,=,794.33,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2575,CHEMBL1081237,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2576,CHEMBL1079577,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C#N)cc5)C4)n3C)cccc2n1,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2577,CHEMBL1079578,COc1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5nc(C)ccc45)n2C)C3)cc1,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2578,CHEMBL1079578,COc1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5nc(C)ccc45)n2C)C3)cc1,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2579,CHEMBL1081686,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccc1,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2580,CHEMBL1081580,Cc1ncoc1-c1nnc(SCCCN2C[C@H]3C[C@@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2581,CHEMBL1079822,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(C)(C)C)cc3)C2)n1C,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2582,CHEMBL1080126,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2583,CHEMBL1080126,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2584,CHEMBL1081934,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,IC50,nM,=,630.96,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2585,CHEMBL1080164,Cc1ccc2c(-c3nnc(SCCCN4C[C@H]5C[C@@]5(c5ccc(Br)cc5)C4)n3C)cccc2n1,IC50,nM,=,501.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2586,CHEMBL1081685,Cc1ccc2c(-c3nnc(SCCCN4C[C@@H]5C[C@]5(c5ccc(C(F)(F)F)cc5)C4)n3C)cccc2n1,IC50,nM,=,501.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2587,CHEMBL1082106,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Br)cc3)C2)n1C,IC50,nM,=,501.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2588,CHEMBL1080846,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,IC50,nM,=,501.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2589,CHEMBL1081023,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,501.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2590,CHEMBL1081587,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,IC50,nM,=,501.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2591,CHEMBL1081747,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3F)C2)n1C,IC50,nM,=,501.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2592,CHEMBL1079823,Cc1ncoc1-c1nnc(SCCCN2C[C@H]3C[C@@]3(c3ccc(C(C)(C)C)cc3)C2)n1C,IC50,nM,=,398.11,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2593,CHEMBL1082106,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Br)cc3)C2)n1C,IC50,nM,=,398.11,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2594,CHEMBL1080490,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,IC50,nM,=,398.11,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2595,CHEMBL1079814,Cc1cc(C(F)(F)F)ccc1C12CC1CN(CCCSc1nnc(-c3ocnc3C)n1C)C2,IC50,nM,=,398.11,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2596,CHEMBL1080126,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,IC50,nM,=,398.11,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2597,CHEMBL1081747,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3F)C2)n1C,IC50,nM,=,398.11,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2598,CHEMBL1079461,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,IC50,nM,=,316.23,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2599,CHEMBL1079462,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,IC50,nM,=,316.23,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2600,CHEMBL1081966,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,IC50,nM,=,316.23,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2601,CHEMBL1081401,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,IC50,nM,=,251.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2602,CHEMBL1081401,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,IC50,nM,=,251.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2603,CHEMBL1081401,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,IC50,nM,=,251.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2604,CHEMBL1080165,Cc1ccc2c(-c3nnc(SCCCN4C[C@@H]5C[C@]5(c5ccc(Br)cc5)C4)n3C)cccc2n1,IC50,nM,=,251.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2605,CHEMBL1081966,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,IC50,nM,=,251.19,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2606,CHEMBL1080117,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,IC50,nM,=,199.53,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2607,CHEMBL1079639,Cc1ccoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,199.53,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2608,CHEMBL1081966,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,IC50,nM,=,199.53,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2609,CHEMBL1080293,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(F)(F)F)cc5)C4)n3C)cccc2n1,IC50,nM,=,158.49,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2610,CHEMBL1079497,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Br)cc5)C4)n3C)cccc2n1,IC50,nM,=,125.89,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2611,CHEMBL1080389,C[C@H]1CN(C(=O)c2ccc(-c3ccccc3F)cc2)CCN1C(=O)c1ccc2cc[nH]c2c1,IC50,nM,>,10000.0,Inhibition of human ERG
2612,CHEMBL269959,Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6nc(C)oc6cc5CC4)n3C)cccc2n1,IC50,nM,>,10000.0,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay
2613,CHEMBL1081687,Cc1ncccc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,390.0,Inhibition of human ERG by patch clamp electrophysiology assay
2614,CHEMBL1081867,Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,IC50,nM,=,470.0,Inhibition of human ERG by patch clamp electrophysiology assay
2615,CHEMBL1081746,Cc1nc(C)c(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)s1,IC50,nM,=,350.0,Inhibition of human ERG by patch clamp electrophysiology assay
2616,CHEMBL1081409,Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,200.0,Inhibition of human ERG by patch clamp electrophysiology assay
2617,CHEMBL1080490,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,IC50,nM,=,110.0,Inhibition of human ERG by patch clamp electrophysiology assay
2618,CHEMBL1081023,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,460.0,Inhibition of human ERG by patch clamp electrophysiology assay
2619,CHEMBL1087898,Cc1cnc(Nc2cncc(N[C@@H](C)c3ncc(F)cn3)n2)s1,IC50,,,,Inhibition of human ERG
2620,CHEMBL570899,Cc1cc(Nc2cncc(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1,IC50,nM,>,32000.0,Inhibition of human ERG
2621,CHEMBL1088029,COc1cc(Nc2ncc(C)s2)nc(N[C@@H](C)c2ncc(F)cn2)n1,IC50,nM,>,32000.0,Inhibition of human ERG
2622,CHEMBL1088030,Cc1cnc(Nc2cc(N3CCOCC3)nc(N[C@@H](C)c3ncc(F)cn3)n2)s1,IC50,nM,>,32000.0,Inhibition of human ERG
2623,CHEMBL1087268,Cc1cnc(Nc2cc(N3CCN(C)CC3)nc(N[C@@H](C)c3ccc(F)cn3)n2)s1,IC50,nM,=,13000.0,Inhibition of human ERG
2624,CHEMBL1087269,Cc1cnc(Nc2cc(N3CCOCC3)nc(N[C@@H](C)c3ccc(F)cn3)n2)s1,IC50,nM,=,12000.0,Inhibition of human ERG
2625,CHEMBL1087398,C[C@H](Nc1nc(Nc2ncc(C#N)s2)cc(N2CCOCC2)n1)c1ccc(F)cn1,IC50,nM,>,32000.0,Inhibition of human ERG
2626,CHEMBL1087399,C[C@H](Nc1nc(Nc2ncc(C#N)s2)cc(N2CCOCC2)n1)c1ncc(F)cn1,IC50,,,,Inhibition of human ERG
2627,CHEMBL393718,CCOc1cc(CN2CCC(Nc3nc4cc(S(N)(=O)=O)ccc4o3)CC2)ccc1OC,IC50,nM,=,3500.0,Inhibition of human ERG expressed in CHO cells by patch clamp technique
2628,CHEMBL236587,CCOc1cc(CN2CCC(Nc3nc4ccccc4o3)CC2)ccc1OC,IC50,nM,<,100.0,Inhibition of human ERG expressed in CHO cells by patch clamp technique
2629,CHEMBL1079313,CCOc1cc(CN2CCC(Nc3nc4cc(S(=O)(=O)CC)ccc4o3)CC2)ccc1OC,IC50,nM,=,180.0,Inhibition of human ERG expressed in CHO cells by patch clamp technique
2630,CHEMBL1080584,CCOc1cc(CN2CCC(Nc3nc4cc(C(N)=O)ccc4o3)CC2)cc(OCC)c1F,IC50,nM,=,430.0,Inhibition of human ERG expressed in CHO cells by patch clamp technique
2631,CHEMBL1080585,CCOc1cc(CN2CCC(Nc3nc4cc(C(=O)O)ccc4o3)CC2)cc(OCC)c1Cl,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp technique
2632,CHEMBL1080586,CCOc1cc(CN2CCC(Nc3nc4ccc(C(=O)O)cc4o3)CC2)ccc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp technique
2633,CHEMBL1080046,CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1,IC50,nM,=,2511.89,Inhibition of human ERG
2634,CHEMBL1078595,O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(N2CCOCC2)nc1,IC50,nM,>,15848.93,Inhibition of human ERG
2635,CHEMBL476954,CC(C)C(=O)N(Cc1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,=,24700.0,Inhibition of human ERG
2636,CHEMBL1078312,CCN(C(=O)c1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,>,20000.0,Inhibition of human ERG
2637,CHEMBL1080069,CCCN(C(=O)c1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,>,18600.0,Inhibition of human ERG
2638,CHEMBL1080787,CC(C)CN(C(=O)c1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,=,20000.0,Inhibition of human ERG
2639,CHEMBL1080788,O=C(c1cccc(Cl)c1Cl)N(CC(F)(F)F)[C@H]1CCNC1,IC50,nM,>,10000.0,Inhibition of human ERG
2640,CHEMBL1080789,O=C(c1cccc(Cl)c1Cl)N(CCC1CC1)[C@H]1CCNC1,IC50,nM,=,7140.0,Inhibition of human ERG
2641,CHEMBL1080790,CC(C)(C)CN(C(=O)c1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,=,16800.0,Inhibition of human ERG
2642,CHEMBL1080968,O=C(c1cccc(Cl)c1Cl)N(C1CCCC1)[C@H]1CCNC1,IC50,nM,=,10300.0,Inhibition of human ERG
2643,CHEMBL1080969,CCC(CC)N(C(=O)c1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,=,7740.0,Inhibition of human ERG
2644,CHEMBL1079263,O=C(c1cccc(Cl)c1Cl)N(C1=CCOC=C1)[C@H]1CCNC1,IC50,nM,>,40000.0,Inhibition of human ERG
2645,CHEMBL1079264,O=C(c1cccc(Cl)c1Cl)N(c1ccccc1)[C@H]1CCNC1,IC50,nM,=,7920.0,Inhibition of human ERG
2646,CHEMBL1079265,CC(C)CN(C(=O)c1ccc(Cl)cc1Cl)[C@H]1CCNC1,IC50,,,,Inhibition of human ERG
2647,CHEMBL1077647,CC(C)CN(C(=O)c1cc(Cl)ccc1Cl)[C@H]1CCNC1,IC50,nM,=,19800.0,Inhibition of human ERG
2648,CHEMBL1078741,CC(C)CN(C(=O)c1cc(Cl)cc(Cl)c1)[C@H]1CCNC1,IC50,nM,>,10000.0,Inhibition of human ERG
2649,CHEMBL1078742,CC(C)CN(C(=O)c1ccc(Cl)c(Cl)c1)[C@H]1CCNC1,IC50,nM,=,17200.0,Inhibition of human ERG
2650,CHEMBL1078743,CC(C)CN(C(=O)c1cccc(Cl)c1)[C@H]1CCNC1,IC50,,,,Inhibition of human ERG
2651,CHEMBL1077638,CC(C)CN(C(=O)c1cccc(C(F)(F)F)c1Cl)[C@H]1CCNC1,IC50,nM,=,4120.0,Inhibition of human ERG
2652,CHEMBL1078162,Cc1c(Cl)cccc1C(=O)N(CC(C)C)[C@H]1CCNC1,IC50,nM,=,52400.0,Inhibition of human ERG
2653,CHEMBL1078163,Cc1c(F)cccc1C(=O)N(CC(C)C)[C@H]1CCNC1,IC50,,,,Inhibition of human ERG
2654,CHEMBL1078164,CC(C)CN(C(=O)c1cccc(F)c1Cl)[C@H]1CCNC1,IC50,,,,Inhibition of human ERG
2655,CHEMBL1078073,CC(C)CN(C(=O)c1cccc(Cl)c1F)[C@H]1CCNC1,IC50,nM,>,10000.0,Inhibition of human ERG
2656,CHEMBL1078074,CC(C)CN(C(=O)c1cccc(F)c1C(F)(F)F)[C@H]1CCNC1,IC50,nM,>,10000.0,Inhibition of human ERG
2657,CHEMBL1078076,CC(C)CN(C(=O)c1ccc(F)cc1Cl)[C@H]1CCNC1,IC50,,,,Inhibition of human ERG
2658,CHEMBL1078169,CC(C)CN(C(=O)c1ccccc1C(C)C)[C@H]1CCNC1,IC50,nM,=,12900.0,Inhibition of human ERG
2659,CHEMBL1078170,CC(C)CN(C(=O)c1cccc(Cl)c1Cl)[C@@H]1CCNC1,IC50,,,,Inhibition of human ERG
2660,CHEMBL1078231,CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2,IC50,nM,=,11900.0,Inhibition of human ERG
2661,CHEMBL1093318,CCCN(C(C)C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,,,,Inhibition of human ERG by FLIPR assay
2662,CHEMBL1090893,CCN(C(C)C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,,,,Inhibition of human ERG by FLIPR assay
2663,CHEMBL1092941,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cc(F)cc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,nM,=,22000.0,Inhibition of human ERG by FLIPR assay
2664,CHEMBL1092748,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,nM,=,4000.0,Inhibition of human ERG by FLIPR assay
2665,CHEMBL1092940,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3ccccc3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
2666,CHEMBL1092678,Cc1ccc(S(=O)(=O)C[C@@H]2C[C@H](N(C)C(C)C)CC[C@@H]2N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)cc1,IC50,nM,=,3000.0,Inhibition of human ERG by FLIPR assay
2667,CHEMBL1091605,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,nM,=,30000.0,Inhibition of human ERG by FLIPR assay
2668,CHEMBL1091604,CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
2669,CHEMBL1091356,CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
2670,CHEMBL1092169,CC(C)(O)C(=O)c1oc2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)cc2c1NC(=O)CO,IC50,nM,=,6600.0,Inhibition of human ERG potassium channel
2671,CHEMBL1092901,CC(=O)N1CCC(c2[nH]nc(-c3ccc(F)cc3)c2-c2ccncc2)CC1,IC50,nM,=,790.0,Inhibition of human ERG by patch clamp technique
2672,CHEMBL1091863,OC(c1ccccc1)(c1ccccc1)C(c1ccccc1)N1CCOCC1,IC50,nM,>,65000.0,Inhibition of human ERG
2673,CHEMBL1090791,OCC(c1ccccc1)N1CCOCC1,IC50,nM,>,60000.0,Inhibition of human ERG
2674,CHEMBL1090792,CC(C)(O)C(c1ccccc1)N1CCOCC1,IC50,nM,>,60000.0,Inhibition of human ERG
2675,CHEMBL1090793,CC(C)C(N1CCOCC1)C(O)(c1ccccc1)c1ccccc1,IC50,nM,>,30000.0,Inhibition of human ERG
2676,CHEMBL1090794,OC(c1cccnc1)(c1cccnc1)C(c1ccccc1)N1CCOCC1,IC50,nM,>,60000.0,Inhibition of human ERG
2677,CHEMBL1090795,CC(N1CCOCC1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,>,60000.0,Inhibition of human ERG
2678,CHEMBL1091879,CC(C)C(N1CCOCC1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,=,75000.0,Inhibition of human ERG
2679,CHEMBL1091880,OC(c1cccnc1)(c1cccnc1)C(Cc1ccccc1)N1CCOCC1,IC50,nM,=,15190.0,Inhibition of human ERG
2680,CHEMBL1088803,CCCCC(N1CCOCC1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,=,36000.0,Inhibition of human ERG
2681,CHEMBL1088804,CCCCCCC(N1CCOCC1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,=,27500.0,Inhibition of human ERG
2682,CHEMBL1088805,OC(Cc1ccccc1)(c1cccnc1)c1cccnc1,IC50,nM,>,60000.0,Inhibition of human ERG
2683,CHEMBL1090816,NC(c1ccccc1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,>,60000.0,Inhibition of human ERG
2684,CHEMBL1090817,CN(C)C(c1ccccc1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,>,60000.0,Inhibition of human ERG
2685,CHEMBL1090818,OC(c1cccnc1)(c1cccnc1)C(c1ccccc1)N1CCC1,IC50,nM,=,15000.0,Inhibition of human ERG
2686,CHEMBL1091162,CCN(CC)C(c1ccccc1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,>,60000.0,Inhibition of human ERG
2687,CHEMBL1092574,COCCN(C)C(c1ccccc1)C(O)(c1cccnc1)c1cccnc1,IC50,nM,=,3450.0,Inhibition of human ERG
2688,CHEMBL1091163,OC(c1cccnc1)(c1cccnc1)C(c1ccccc1)N1CCCOCC1,IC50,nM,=,3550.0,Inhibition of human ERG
2689,CHEMBL1090159,OC(c1cccnc1)(c1cccnc1)C(c1ccccc1)N1CCNCC1,IC50,nM,=,2300.0,Inhibition of human ERG
2690,CHEMBL1090160,OC(c1cccnc1)(c1cccnc1)C(c1ccccc1)N1CCCCC1,IC50,nM,=,14000.0,Inhibition of human ERG
2691,CHEMBL1089159,OC(c1cccnc1)(c1cccnc1)C(c1ccccc1)N1CCCC1,IC50,nM,=,20000.0,Inhibition of human ERG
2692,CHEMBL559251,CN(C)CCC1=C(Cc2cnccn2)c2ccccc2C1,IC50,nM,=,5400.0,Inhibition of human ERG by patch clamp assay
2693,CHEMBL1088882,Cc1cncc(CC2=C(CCN(C)C)Cc3ccccc32)n1,IC50,,,,Inhibition of human ERG by patch clamp assay
2694,CHEMBL1088898,Cc1nccnc1CC1=C(CCN(C)C)Cc2ccccc21,IC50,,,,Inhibition of human ERG by patch clamp assay
2695,CHEMBL1088899,Cc1cnc(CC2=C(CCN(C)C)Cc3ccccc32)cn1,IC50,,,,Inhibition of human ERG by patch clamp assay
2696,CHEMBL1088900,COc1nccnc1CC1=C(CCN(C)C)Cc2ccccc21,IC50,nM,=,7600.0,Inhibition of human ERG by patch clamp assay
2697,CHEMBL1090197,CN(C)CCC1=C(Cc2cccnn2)c2ccccc2C1,IC50,,,,Inhibition of human ERG by patch clamp assay
2698,CHEMBL1090198,CN(C)CCC1=C(Cc2ncccn2)c2ccccc2C1,IC50,,,,Inhibition of human ERG by patch clamp assay
2699,CHEMBL556506,C[C@H](C1=C(CCN(C)C)Cc2ccccc21)c1cnccn1,IC50,nM,=,1400.0,Inhibition of human ERG by patch clamp assay
2700,CHEMBL1092597,COc1nccnc1[C@H](C)C1=C(CCN(C)C)Cc2ccccc21,IC50,nM,=,7600.0,Inhibition of human ERG by patch clamp assay
2701,CHEMBL1092598,C[C@H](C1=C(CCN(C)C)Cc2ccccc21)c1nccs1,IC50,nM,=,3700.0,Inhibition of human ERG by patch clamp assay
2702,CHEMBL1092599,Cc1csc([C@H](C)C2=C(CCN(C)C)Cc3ccccc32)n1,IC50,nM,=,1900.0,Inhibition of human ERG by patch clamp assay
2703,CHEMBL1092600,Cc1ccc2c(c1)CC(CCN(C)C)=C2Cc1cnccn1,IC50,nM,=,520.0,Inhibition of human ERG by patch clamp assay
2704,CHEMBL1092258,COc1ccc2c(c1)CC(CCN(C)C)=C2Cc1cnccn1,IC50,nM,=,2100.0,Inhibition of human ERG by patch clamp assay
2705,CHEMBL1092259,CN(C)CCC1=C(Cc2cnccn2)c2ccc(Cl)cc2C1,IC50,nM,=,110.0,Inhibition of human ERG by patch clamp assay
2706,CHEMBL1092649,CN(C)CCC1=C(Cc2cnccn2)c2ccc(F)cc2C1,IC50,nM,=,590.0,Inhibition of human ERG by patch clamp assay
2707,CHEMBL1092650,COc1nccnc1CC1=C(CCN(C)C)Cc2cc(Cl)ccc21,IC50,nM,=,230.0,Inhibition of human ERG by patch clamp assay
2708,CHEMBL1092651,COc1nccnc1CC1=C(CCN(C)C)Cc2cc(F)ccc21,IC50,,,,Inhibition of human ERG by patch clamp assay
2709,CHEMBL1092662,CN(C)CCC1=C(Cc2cccnn2)c2ccc(F)cc2C1,IC50,nM,=,890.0,Inhibition of human ERG by patch clamp assay
2710,CHEMBL1092663,Cc1ccc2c(c1)CC(CCN(C)C)=C2[C@@H](C)c1cnccn1,IC50,nM,=,360.0,Inhibition of human ERG by patch clamp assay
2711,CHEMBL1090175,COc1ccc2c(c1)CC(CCN(C)C)=C2[C@@H](C)c1cnccn1,IC50,nM,=,3400.0,Inhibition of human ERG by patch clamp assay
2712,CHEMBL1090176,COc1nccnc1[C@H](C)C1=C(CCN(C)C)Cc2cc(C)ccc21,IC50,nM,=,3800.0,Inhibition of human ERG by patch clamp assay
2713,CHEMBL1090186,COc1ccc2c(c1)CC(CCN(C)C)=C2[C@@H](C)c1nccnc1OC,IC50,nM,=,5000.0,Inhibition of human ERG by patch clamp assay
2714,CHEMBL1090526,COc1nccnc1[C@H](C)C1=C(CCN(C)C)Cc2cc(F)ccc21,IC50,nM,=,1800.0,Inhibition of human ERG by patch clamp assay
2715,CHEMBL1090527,C[C@H](C1=C(CCN(C)C)Cc2cc(F)ccc21)c1nccs1,IC50,,,,Inhibition of human ERG by patch clamp assay
2716,CHEMBL1090528,Cc1ccc2c(c1)CC(CCN(C)C)=C2[C@@H](C)c1nccs1,IC50,nM,=,620.0,Inhibition of human ERG by patch clamp assay
2717,CHEMBL1093623,COc1ccc2c(c1)CC(CCN(C)C)=C2[C@@H](C)c1nccs1,IC50,nM,=,22000.0,Inhibition of human ERG by patch clamp assay
2718,CHEMBL1092652,CN(C)CCC1=C(Cc2cccnn2)c2ccc(Cl)cc2C1,IC50,nM,=,220.0,Inhibition of human ERG by patch clamp assay
2719,CHEMBL1091919,CSc1nn2c3c(c(C)nc2c1S(=O)(=O)c1ccccc1)CCCC3,IC50,nM,=,8400.0,Inhibition of human recombinant ERG by patch clamp assay
2720,CHEMBL1091775,C[C@@H](c1ccccn1)c1c(CCN2CCC2)sc2ccccc12,IC50,nM,=,4200.0,Displacement of [3H]Dofetilide from human ERG
2721,CHEMBL1091778,C[C@@H](c1cccnc1)c1c(CCN(C)C)sc2ccccc12,IC50,nM,>,5000.0,Displacement of [3H]Dofetilide from human ERG
2722,CHEMBL1090433,C[C@H](c1ccccn1)c1c(CCN(C)C)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2723,CHEMBL1091774,C[C@@H](c1ccccn1)c1c(CCN2CCCC2)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2724,CHEMBL1091777,C[C@H](c1cccnc1)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,490.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2725,CHEMBL1091790,CC(c1ccncc1)c1c(CCN(C)C)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2726,CHEMBL1091791,Cc1ccnc(C(C)c2c(CCN(C)C)sc3ccccc23)c1,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2727,CHEMBL1091792,COc1cccc(C(C)c2c(CCN(C)C)sc3ccccc23)n1,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2728,CHEMBL1091793,CC(c1cccc(F)n1)c1c(CCN(C)C)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2729,CHEMBL1092126,Cc1cccnc1[C@H](C)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,910.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2730,CHEMBL1091069,COc1cccnc1[C@H](C)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,3000.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2731,CHEMBL1092377,C[C@@H](c1ncccc1F)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,330.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2732,CHEMBL1092494,C[C@@H](c1ncccc1Cl)c1c(CCN(C)C)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2733,CHEMBL1092495,C[C@@H](c1ccc(F)cn1)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,240.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2734,CHEMBL1092496,Cc1ccc(C(C)c2c(CCN(C)C)sc3ccccc23)cn1,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2735,CHEMBL1092812,COc1ccc(C(C)c2c(CCN(C)C)sc3ccccc23)cn1,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2736,CHEMBL1092813,Cc1ncccc1[C@@H](C)c1c(CCN(C)C)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2737,CHEMBL1093294,COc1ncccc1[C@@H](C)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,1800.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2738,CHEMBL1092765,C[C@H](c1cccnc1F)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,2300.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2739,CHEMBL1092766,C[C@H](c1cccnc1Cl)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,1500.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2740,CHEMBL1092767,CC(c1nccs1)c1c(CCN(C)C)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2741,CHEMBL1091782,C[C@@H](c1cscn1)c1c(CCN(C)C)sc2ccccc12,IC50,nM,=,1700.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2742,CHEMBL1092118,C[C@@H](c1cncs1)c1c(CCN(C)C)sc2ccccc12,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2743,CHEMBL1093607,CC(c1c(CCN(C)C)sc2ccccc12)n1ccnc1,IC50,,,,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2744,CHEMBL1093058,C[C@H](c1c(CCN(C)C)sc2ccccc12)n1cccn1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis
2745,CHEMBL1089681,O=C(NCc1cc(Cl)cc(Cl)c1)N(c1ccc(Br)cc1)C1CCN(C2CCCC2)CC1,IC50,nM,=,61.0,Inhibition of human ERG by ion works assay
2746,CHEMBL1094028,O=C(NCc1ccccc1)N(c1ccc(Br)cc1)C1CCN(C2CCCC2)CC1,IC50,nM,=,178.0,Inhibition of human ERG by ion works assay
2747,CHEMBL1094029,O=C(Nc1ccccc1)N(c1ccc(Br)cc1)C1CCN(C2CCCC2)CC1,IC50,nM,=,188.0,Inhibition of human ERG by ion works assay
2748,CHEMBL1094030,O=C(NCc1ccc(F)cc1)N(c1ccc(Br)cc1)C1CCN(C2CCCC2)CC1,IC50,nM,=,202.0,Inhibition of human ERG by ion works assay
2749,CHEMBL1092105,CCN1CCC(N(C(=O)NCc2ccc(F)cc2)c2ccc(Cl)cc2)CC1,IC50,nM,=,6650.0,Inhibition of human ERG by ion works assay
2750,CHEMBL1092106,CCN1CCC(N(C(=O)NCc2ccc(F)cc2)c2ccc(Cl)cn2)CC1,IC50,nM,=,9190.0,Inhibition of human ERG by ion works assay
2751,CHEMBL1093113,O=C(NCc1ccc(F)cc1)N(c1ccc(Cl)cc1)C1CCN(CCO)CC1,IC50,nM,=,12700.0,Inhibition of human ERG by ion works assay
2752,CHEMBL1089078,O=C(NCc1ccc(F)cc1)N(c1ccc(Br)cc1)C1CCN(CCO)CC1,IC50,nM,=,7880.0,Inhibition of human ERG by ion works assay
2753,CHEMBL1091834,O=C(NCc1ccc(F)cc1)N(c1ccc(Cl)cc1)C1CCN(Cc2ccncc2)CC1,IC50,nM,=,3810.0,Inhibition of human ERG by ion works assay
2754,CHEMBL1091836,Nc1cc(CN2CCC(N(C(=O)NCc3ccc(F)cc3)c3ccc(Cl)cc3)CC2)ccn1,IC50,nM,=,384.0,Inhibition of human ERG by ion works assay
2755,CHEMBL1093696,O=C(NCc1ccc(F)cc1)N(c1ccc(Cl)cc1)C1CCN(Cc2ccnnc2)CC1,IC50,nM,=,12000.0,Inhibition of human ERG by ion works assay
2756,CHEMBL1092108,O=C(NCc1ccccc1)N(c1ccc(Br)cc1)C1CCN(Cc2ccncc2)CC1,IC50,nM,=,2310.0,Inhibition of human ERG by ion works assay
2757,CHEMBL1092109,O=C(NCc1ccccc1)N(c1ccc(Br)cc1)C1CCN(Cc2ccnnc2)CC1,IC50,nM,=,13800.0,Inhibition of human ERG by ion works assay
2758,CHEMBL1089865,Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O,IC50,nM,=,36000.0,Inhibition of human ERG by electrophysiology assay
2759,CHEMBL1089210,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(Cl)cc4)oc3C)c2)cc1,IC50,nM,=,29300.0,Inhibition of human ERG by electrophysiology assay
2760,CHEMBL1090211,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3oc(-c4ccc(Cl)cc4)nc3C)c2)cc1,IC50,nM,=,20000.0,Inhibition of human ERG by electrophysiology assay
2761,CHEMBL1090212,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3sc(-c4ccc(Cl)cc4)nc3C)c2)cc1,IC50,nM,>,80000.0,Inhibition of human ERG by electrophysiology assay
2762,CHEMBL1091664,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(Cl)cc4)sc3C)c2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology assay
2763,CHEMBL1091980,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccccc4Cl)oc3C)c2)cc1,IC50,nM,>,80000.0,Inhibition of human ERG by electrophysiology assay
2764,CHEMBL1092931,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4cccc(Cl)c4)oc3C)c2)cc1,IC50,nM,=,7300.0,Inhibition of human ERG by electrophysiology assay
2765,CHEMBL1089164,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(F)cc4)oc3C)c2)cc1,IC50,nM,=,38000.0,Inhibition of human ERG by electrophysiology assay
2766,CHEMBL1090188,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C#N)cc4)oc3C)c2)cc1,IC50,nM,=,53000.0,Inhibition of human ERG by electrophysiology assay
2767,CHEMBL1090189,COc1ccc(-c2nc(COc3cccc(CN(CC(=O)O)C(=O)Oc4ccc(C)cc4)c3)c(C)o2)cc1,IC50,nM,=,8600.0,Inhibition of human ERG by electrophysiology assay
2768,CHEMBL1090877,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C)cc4)oc3C)c2)cc1,IC50,nM,=,25900.0,Inhibition of human ERG by electrophysiology assay
2769,CHEMBL1091218,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C(F)(F)F)cc4)oc3C)c2)cc1,IC50,nM,=,26000.0,Inhibition of human ERG by electrophysiology assay
2770,CHEMBL1092134,O=C(Nc1ccccc1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12,IC50,nM,>,10000.0,Inhibition of human ERG
2771,CHEMBL356066,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,IC50,nM,=,12200.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2772,CHEMBL1089343,Cc1[nH]c2ccccc2c1C1CCCN(Cc2ccc(/C=C/C(=O)NO)cc2)C1,IC50,nM,=,27600.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2773,CHEMBL1089344,Cc1[nH]c2ccccc2c1C1CCN(Cc2ccc(/C=C/C(=O)NO)cc2)C1,IC50,nM,=,13400.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2774,CHEMBL1089359,Cc1[nH]c2ccccc2c1CC1CCCCN1Cc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,9100.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2775,CHEMBL1089700,Cc1[nH]c2ccccc2c1CCN1CCCC1c1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,19400.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2776,CHEMBL1088949,Cc1[nH]c2ccccc2c1CCN1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2777,CHEMBL1089701,Cc1[nH]c2ccccc2c1CCN1CCc2cc(/C=C/C(=O)NO)ccc2C1,IC50,nM,=,14800.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2778,CHEMBL1093362,Cc1[nH]c2ccccc2c1CCN1CCc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,=,2700.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2779,CHEMBL1089301,Cc1[nH]c2ccccc2c1CCN1CCc2ccc(/C=C/C(=O)NO)cc2CC1,IC50,nM,=,3200.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2780,CHEMBL1094040,O=C(/C=C/c1ccc(CN2CCCC(c3c[nH]c4ccccc34)C2)cc1)NO,IC50,nM,=,29300.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2781,CHEMBL1094041,O=C(/C=C/c1ccc(CN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1)NO,IC50,nM,=,28400.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2782,CHEMBL1094042,CC(C)(C)c1[nH]c2ccccc2c1C1CCCN(Cc2ccc(/C=C/C(=O)NO)cc2)C1,IC50,nM,=,13500.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2783,CHEMBL1093051,O=C(/C=C/c1ccc(CN2CCCC(c3c[nH]c4ccccc34)C2)c(F)c1)NO,IC50,nM,=,15300.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2784,CHEMBL1093052,O=C(/C=C/c1ccc(CN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)c(F)c1)NO,IC50,nM,=,19300.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2785,CHEMBL1093053,CC(C)(C)c1[nH]c2ccccc2c1C1CCCN(Cc2ccc(/C=C/C(=O)NO)cc2F)C1,IC50,nM,=,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2786,CHEMBL1093351,CC(C)(C)c1[nH]c2ccccc2c1C1CCCN(Cc2ccc(/C=C/C(=O)NO)cc2Cl)C1,IC50,nM,=,9900.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay
2787,CHEMBL1092929,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3ccccc3)CC2)C1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
2788,CHEMBL1089881,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3ccccc3F)CC2)C1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
2789,CHEMBL1092921,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3cc(F)ccc3F)CC2)C1,IC50,nM,=,10000.0,Displacement of [3H]astemizole from human ERG
2790,CHEMBL1088874,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3ccccc3Cl)CC2)C1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
2791,CHEMBL1093469,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3ccccc3)CC2)C1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
2792,CHEMBL1092238,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3ccccc3Cl)CC2)C1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
2793,CHEMBL1093802,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3ccccc3F)CC2)C1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
2794,CHEMBL1089793,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3cc(F)ccc3F)CC2)C1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
2795,CHEMBL1095202,CCOCCn1c([C@@H]2CCCN(C3CCOCC3)C2)nc2ccccc21,IC50,nM,=,2100.0,Inhibition of human ERG channel by patch clamp assay
2796,CHEMBL1095819,CN1CCC[C@@H](c2nc3ccccc3n2Cc2ccc(F)cc2)C1,IC50,nM,=,721.0,Inhibition of human ERG channel by patch clamp assay
2797,CHEMBL1087493,CCOCCn1c(N2CC[C@H](N(C)C)C2)nc2ccccc21,IC50,nM,=,233.0,Inhibition of human ERG channel by electrophysiology assay
2798,CHEMBL1087367,COc1ccc(Cn2c(N3CC[C@@H](N(C)C)C3)nc3ccccc32)cc1,IC50,nM,=,492.0,Inhibition of human ERG channel by electrophysiology assay
2799,CHEMBL556450,Cc1cnn(C2CCN(c3nc4ccccc4n3Cc3ccc(F)cc3)CC2)c1,IC50,nM,=,809.0,Inhibition of human ERG channel by electrophysiology assay
2800,CHEMBL550818,CN(CC1CCOCC1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,29.0,Inhibition of human ERG channel by electrophysiology assay
2801,CHEMBL1094211,CCOCCn1nc(CC)c2nc(N3CCN(C)CC3)nc(Nc3cc(C)ccn3)c21,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
2802,CHEMBL1097783,CCOCCn1nc(C)c2nc(NC3CCNCC3)nc(Nc3cc(C)ccn3)c21,IC50,nM,=,2800.0,Inhibition of human ERG by patch clamp electrophysiology
2803,CHEMBL1094832,CCOCCn1nc(CC)c2nc(N3CCC(N)CC3)nc(Nc3cc(C)ccn3)c21,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
2804,CHEMBL1094365,CCOCCn1nc(CC)c2nc(N3CCC(C(=O)O)CC3)nc(Nc3cc(C)ccn3)c21,IC50,nM,=,1100.0,Inhibition of human ERG by patch clamp electrophysiology
2805,CHEMBL1099323,O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccccc3)cc(-c3ccccc3)c2)c1CCC(=O)O,IC50,nM,>,3000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction of current amplitude
2806,CHEMBL1099330,O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccccc3)cc(-c3ccccc3)n2)c1CCC(=O)O,IC50,nM,>,3000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction of current amplitude
2807,CHEMBL1098560,O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccsc3)cc(-c3ccc4c(c3)OCO4)c2)c1CCC(=O)O,IC50,nM,>,3000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction of current amplitude
2808,CHEMBL1094348,O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3cccc(F)c3)cc(-c3ccc4c(c3)OCO4)c2)c1CCC(=O)O,IC50,nM,>,3000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction of current amplitude
2809,CHEMBL1099326,O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccncc3)cc(-c3ccncc3)c2)c1CCC(=O)O,IC50,,,,Inhibition of human ERG expressed in CHO cells assessed as reduction of current amplitude
2810,CHEMBL1094349,O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccc4c(c3)OCO4)cc(-c3ccccc3F)c2)c1CCC(=O)O,IC50,,,,Inhibition of human ERG expressed in CHO cells assessed as reduction of current amplitude
2811,CHEMBL1095845,O=C([C@H]1C[C@H](Oc2cccc(F)c2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp assay
2812,CHEMBL1095846,O=C([C@H]1C[C@H](Oc2ccc(F)cc2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,7800.0,Inhibition of human ERG by patch clamp assay
2813,CHEMBL1096827,CC(=O)N1C[C@@H](Oc2cccc(F)c2)C[C@@H]1C(=O)N1CCCN(C2CCC2)CC1,IC50,nM,=,6000.0,Inhibition of human ERG by patch clamp assay
2814,CHEMBL1095845,O=C([C@H]1C[C@H](Oc2cccc(F)c2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of labeled dofetilide human ERG
2815,CHEMBL1095846,O=C([C@H]1C[C@H](Oc2ccc(F)cc2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of labeled dofetilide human ERG
2816,CHEMBL1095847,O=C([C@H]1C[C@H](Oc2ccc(Cl)cc2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,2000.0,Displacement of labeled dofetilide human ERG
2817,CHEMBL1095877,O=C([C@H]1C[C@H](Oc2cccc(Cl)c2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,7200.0,Displacement of labeled dofetilide human ERG
2818,CHEMBL1097881,N#Cc1ccc(O[C@@H]2CN[C@@H](C(=O)N3CCCN(C4CCC4)CC3)C2)cc1,IC50,nM,>,10000.0,Displacement of labeled dofetilide human ERG
2819,CHEMBL1097882,O=C([C@H]1C[C@H](Oc2ccc(F)cc2)CN1)N1CCCN(C2CCCC2)CC1,IC50,nM,=,4600.0,Displacement of labeled dofetilide human ERG
2820,CHEMBL1097883,N#Cc1ccc(O[C@@H]2CN[C@@H](C(=O)N3CCCN(C4CCCC4)CC3)C2)cc1,IC50,nM,=,2900.0,Displacement of labeled dofetilide human ERG
2821,CHEMBL1094562,CC(=O)N1C[C@@H](Oc2ccc(F)cc2)C[C@@H]1C(=O)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of labeled dofetilide human ERG
2822,CHEMBL1096827,CC(=O)N1C[C@@H](Oc2cccc(F)c2)C[C@@H]1C(=O)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of labeled dofetilide human ERG
2823,CHEMBL1097701,O=C(CN1CCCN(Cc2nc3ccccc3[nH]2)CC1)Nc1ccc(C(F)(F)F)cc1,IC50,nM,=,4970.0,Inhibition of human ERG
2824,CHEMBL1098851,O=C(CNc1ccccc1C(F)(F)F)N1CCCN(Cc2nc3ccccc3[nH]2)CC1,IC50,nM,=,1320.0,Inhibition of human ERG
2825,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1400.0,Inhibition of human ERG
2826,CHEMBL1097718,Cc1cccc(Nc2nc(N3CCNCC3)nc3c(C)nn(CCOCC(F)(F)F)c23)n1,IC50,nM,=,560.0,Inhibition of human ERG expressed by patch clam electrophysiology assay
2827,CHEMBL1099069,CCc1nn(CCOCC(F)(F)F)c2c(Nc3ccncn3)nc(N3CCNCC3)nc12,IC50,nM,=,5100.0,Inhibition of human ERG expressed by patch clam electrophysiology assay
2828,CHEMBL1098752,Cc1nn(CCOCC(F)(F)F)c2c(Nc3ccncn3)nc(N3CCN[C@H](C)C3)nc12,IC50,nM,=,900.0,Inhibition of human ERG expressed by patch clam electrophysiology assay
2829,CHEMBL1095121,CCc1nn(CCOCC(F)(F)F)c2c(Nc3ccncn3)nc(N3CCN[C@H](C)C3)nc12,IC50,nM,=,1400.0,Inhibition of human ERG expressed by patch clam electrophysiology assay
2830,CHEMBL1094521,C[C@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,120.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2831,CHEMBL1094847,CC1(C)CC(NC(=O)C(C)(C)O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,380.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2832,CHEMBL1095499,CC1(C)CC(NC(=O)C2(O)CC2)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,300.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2833,CHEMBL1169572,Cc1cc(Cl)ccc1-c1nc2c(cc1-c1ccc(Cl)cc1)C(NC(=O)C(O)C(F)(F)F)CC(C)(C)O2,IC50,nM,=,260.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2834,CHEMBL1169572,Cc1cc(Cl)ccc1-c1nc2c(cc1-c1ccc(Cl)cc1)C(NC(=O)C(O)C(F)(F)F)CC(C)(C)O2,IC50,nM,=,410.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2835,CHEMBL1097455,CC1(C)CC(NC(=O)C(C)(O)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2836,CHEMBL1097456,CC1(C)CC(NC(=O)CC(O)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,1460.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2837,CHEMBL1097456,CC1(C)CC(NC(=O)CC(O)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,2470.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2838,CHEMBL1095159,CC1(C)CC(NC(=O)C(F)(F)CO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,80.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2839,CHEMBL1094839,CC1(C)C[C@@H](NC(=O)c2ccccc2O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2840,CHEMBL1094840,CC1(C)C[C@@H](NC(=O)c2ccccc2N)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2841,CHEMBL1095789,CCc1cc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)n[nH]1,IC50,nM,=,1200.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2842,CHEMBL1095158,Cc1c[nH]nc1C(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,5300.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2843,CHEMBL1095476,Cc1[nH]nc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)c1C,IC50,nM,=,8700.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2844,CHEMBL1097840,CC1(C)C[C@@H](NC(=O)c2n[nH]c3c2CCC3)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2845,CHEMBL1097841,CC1(C)C[C@@H](NC(=O)c2cn[nH]c2)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,380.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2846,CHEMBL1095150,Cc1n[nH]cc1C(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,1100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2847,CHEMBL1095151,Cc1n[nH]c(C)c1C(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,1600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2848,CHEMBL1098876,Cc1nc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)n[nH]1,IC50,nM,=,2000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2849,CHEMBL1095553,CC1(C)C[C@@H](NC(=O)c2n[nH]c3ccccc23)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,4600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2850,CHEMBL1095554,CC1(C)C[C@@H](NC(=O)c2ccc3[nH]ncc3c2)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,630.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2851,CHEMBL1097795,CC1(C)C[C@@H](NC(=O)c2cccc3[nH]ncc23)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2852,CHEMBL1095990,CC(=O)N[C@@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,540.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2853,CHEMBL1098847,CC(=O)N[C@H]1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,2660.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2854,CHEMBL1095211,CC1(C)C[C@@H](NC(=O)CC(O)(C(F)(F)F)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2855,CHEMBL1096845,CC1(C)C[C@H](NC(=O)CC(O)(C(F)(F)F)C(F)(F)F)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,,,,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2856,CHEMBL1096182,Cc1cc(C(=O)N[C@@H]2CC(C)(C)Oc3nc(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)cc32)n[nH]1,IC50,nM,=,1000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2857,CHEMBL477015,CS(=O)(=O)Nc1ccc2c(c1)[C@H](O)CC1(CCN([C@@H]3CCc4cc(C#N)ccc4C3)CC1)O2,IC50,nM,=,670.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
2858,CHEMBL1094222,NC(=O)c1c(F)ccc(OCc2nc3cc(Cl)ccc3s2)c1F,IC50,,,,Inhibition of human ERG by single cell patch-clamp assay
2859,CHEMBL1094181,NC(=O)c1c(F)ccc(OCc2nc3ncc(Cl)cc3s2)c1F,IC50,nM,>,10000.0,Inhibition of human ERG by single cell patch-clamp assay
2860,CHEMBL1094209,OC(c1ccnc(Cl)c1)(c1ccc2c(cnn2-c2ccc(F)cc2)c1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp method
2861,CHEMBL1094231,OC(c1ccc(F)c(Cl)c1)(c1ccc2c(cnn2-c2ccc(F)cc2)c1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp method
2862,CHEMBL1096467,N#Cc1cc(C(O)(c2ccc3c(cnn3-c3ccc(F)cc3)c2)C(F)(F)F)ccc1F,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp method
2863,CHEMBL1094514,Cc1cc(C(O)(c2ccc3c(cnn3-c3ccc(F)cc3)c2)C(F)(F)F)ccc1F,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp method
2864,CHEMBL1094208,OC(c1ccc2c(cnn2-c2ccc(F)cc2)c1)(c1cccc(Cl)c1Cl)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp method
2865,CHEMBL1086579,Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1,IC50,nM,=,3000.0,Inhibition of human ERG
2866,CHEMBL1086582,Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1,IC50,nM,=,2300.0,Inhibition of human ERG
2867,CHEMBL1082458,CNC[C@@H](O)CCN1c2ccccc2N(c2ccccc2F)S1(=O)=O,IC50,nM,>,30000.0,Inhibition of human ERG
2868,CHEMBL1083409,CNC[C@@H](O)CCN1c2ccccc2N(c2ccccc2)S1(=O)=O,IC50,nM,=,8000.0,Inhibition of human ERG
2869,CHEMBL1083429,CNC[C@@H](O)CCN1c2ccccc2N(c2c(F)cccc2F)S1(=O)=O,IC50,nM,=,20000.0,Inhibition of human ERG
2870,CHEMBL1083118,CNC[C@@H](O)CCN1c2ccccc2N(c2cc(F)ccc2F)S1(=O)=O,IC50,nM,=,13000.0,Inhibition of human ERG
2871,CHEMBL1084762,O=C(O)C[C@@H]1c2ccccc2C[C@H]1NC(=O)c1cc2sc(Cl)c(Cl)c2[nH]1,IC50,nM,>,30000.0,Inhibition of human ERG
2872,CHEMBL1084328,COCCC(C(=O)O)[C@@H]1c2ccccc2C[C@H]1NC(=O)c1cc2sc(Cl)c(Cl)c2[nH]1,IC50,nM,>,30000.0,Inhibition of human ERG
2873,CHEMBL1083787,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1,IC50,nM,=,1300.0,Binding affinity to human ERG expressed in CHO cells
2874,CHEMBL1080787,CC(C)CN(C(=O)c1cccc(Cl)c1Cl)[C@H]1CCNC1,IC50,nM,=,20000.0,Displacement of [3H]dofetilide from human ERG
2875,CHEMBL403441,CCOc1ccccc1C[C@H](c1ccccc1)N1CCNCC1,IC50,nM,=,6950.0,Displacement of [3H]dofetilide from human ERG
2876,CHEMBL1084971,Oc1ccccc1C[C@H](c1ccccc1)N1CCNCC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human ERG
2877,CHEMBL214335,COc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,41000.0,Displacement of [3H]dofetilide from human ERG
2878,CHEMBL213754,CCCOc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,5840.0,Displacement of [3H]dofetilide from human ERG
2879,CHEMBL1083405,CC(C)Oc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,6370.0,Displacement of [3H]dofetilide from human ERG
2880,CHEMBL1083705,c1ccc(C(Cc2ccccc2OC2CC2)N2CCNCC2)cc1,IC50,nM,=,6400.0,Displacement of [3H]dofetilide from human ERG
2881,CHEMBL1083706,c1ccc(C(Cc2ccccc2OCC2CC2)N2CCNCC2)cc1,IC50,nM,=,2960.0,Displacement of [3H]dofetilide from human ERG
2882,CHEMBL1083707,c1ccc(C(Cc2cccc3c2OCC3)N2CCNCC2)cc1,IC50,nM,=,21400.0,Displacement of [3H]dofetilide from human ERG
2883,CHEMBL1083708,FC(F)Oc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,10700.0,Displacement of [3H]dofetilide from human ERG
2884,CHEMBL375131,FC(F)(F)Oc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,10900.0,Displacement of [3H]dofetilide from human ERG
2885,CHEMBL1086273,COc1c(F)cccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,20800.0,Displacement of [3H]dofetilide from human ERG
2886,CHEMBL1086274,COc1cccc(F)c1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,8550.0,Displacement of [3H]dofetilide from human ERG
2887,CHEMBL1086275,Fc1cccc(OC(F)F)c1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,10400.0,Displacement of [3H]dofetilide from human ERG
2888,CHEMBL1085959,COc1ccccc1CC(c1ccccc1F)N1CCNCC1,IC50,nM,=,40100.0,Displacement of [3H]dofetilide from human ERG
2889,CHEMBL1085321,COc1ccccc1CC(c1cccc(F)c1)N1CCNCC1,IC50,nM,>,22500.0,Displacement of [3H]dofetilide from human ERG
2890,CHEMBL1085567,COc1ccccc1CC(c1ccc(F)cc1)N1CCNCC1,IC50,nM,=,16000.0,Displacement of [3H]dofetilide from human ERG
2891,CHEMBL1084309,Fc1ccccc1C(Cc1ccccc1OC(F)F)N1CCNCC1,IC50,nM,=,6500.0,Displacement of [3H]dofetilide from human ERG
2892,CHEMBL1084577,Fc1cccc(C(Cc2ccccc2OC(F)F)N2CCNCC2)c1,IC50,nM,=,8240.0,Displacement of [3H]dofetilide from human ERG
2893,CHEMBL1083425,Fc1ccc(C(Cc2ccccc2OC(F)F)N2CCNCC2)cc1,IC50,nM,=,9120.0,Displacement of [3H]dofetilide from human ERG
2894,CHEMBL1083426,Fc1ccccc1C(Cc1ccccc1OC(F)(F)F)N1CCNCC1,IC50,nM,=,7600.0,Displacement of [3H]dofetilide from human ERG
2895,CHEMBL1083427,Fc1cccc(C(Cc2ccccc2OC(F)(F)F)N2CCNCC2)c1,IC50,nM,=,6110.0,Displacement of [3H]dofetilide from human ERG
2896,CHEMBL1084033,Fc1ccc(C(Cc2ccccc2OC(F)(F)F)N2CCNCC2)cc1,IC50,nM,=,8050.0,Displacement of [3H]dofetilide from human ERG
2897,CHEMBL214335,COc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,39000.0,Displacement of [3H]dofetilide from human ERG
2898,CHEMBL214335,COc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,22900.0,Displacement of [3H]dofetilide from human ERG
2899,CHEMBL1083708,FC(F)Oc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,12700.0,Displacement of [3H]dofetilide from human ERG
2900,CHEMBL1083708,FC(F)Oc1ccccc1CC(c1ccccc1)N1CCNCC1,IC50,nM,=,15300.0,Displacement of [3H]dofetilide from human ERG
2901,CHEMBL1083426,Fc1ccccc1C(Cc1ccccc1OC(F)(F)F)N1CCNCC1,IC50,nM,=,2050.0,Displacement of [3H]dofetilide from human ERG
2902,CHEMBL1083426,Fc1ccccc1C(Cc1ccccc1OC(F)(F)F)N1CCNCC1,IC50,nM,=,760.0,Displacement of [3H]dofetilide from human ERG
2903,CHEMBL1084033,Fc1ccc(C(Cc2ccccc2OC(F)(F)F)N2CCNCC2)cc1,IC50,nM,=,9640.0,Displacement of [3H]dofetilide from human ERG
2904,CHEMBL1084033,Fc1ccc(C(Cc2ccccc2OC(F)(F)F)N2CCNCC2)cc1,IC50,nM,=,4950.0,Displacement of [3H]dofetilide from human ERG
2905,CHEMBL1083766,C[C@H]1CCc2c([nH]c3ccccc23)[C@@]2(N1)C(=O)Nc1ccc(Br)cc12,IC50,nM,>,30000.0,Binding affinity to human ERG
2906,CHEMBL1082725,C[C@H]1Cc2c([nH]c3cc(F)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,>,30000.0,Binding affinity to human ERG
2907,CHEMBL1086475,C[C@H]1Cc2c([nH]c3cc(Cl)ccc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,>,30000.0,Binding affinity to human ERG
2908,CHEMBL1084349,C[C@H]1Cc2c([nH]c3ccc(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,>,30000.0,Binding affinity to human ERG
2909,CHEMBL1083769,C[C@H]1Cc2c([nH]c3ccccc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,>,30000.0,Binding affinity to human ERG
2910,CHEMBL1083025,CC1(C)CC(NC(=O)CCO)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1,IC50,nM,=,380.0,Inhibition of human ERG
2911,CHEMBL1094521,C[C@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,340.0,Inhibition of human ERG
2912,CHEMBL1082330,CN1c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc2C(C(=O)NCO)CC1(C)C,IC50,nM,=,40.0,Inhibition of human ERG
2913,CHEMBL1083646,C[C@@H](O)C(=O)NC1CC(C)(C)Oc2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc21,IC50,nM,=,120.0,Inhibition of human ERG
2914,CHEMBL1083750,Cn1nccc1-c1cc(NC(=O)c2ccc(F)cc2F)ccc1OCCN1CCOCC1,IC50,nM,=,4100.0,Inhibition of human ERG by patch clamp assay
2915,CHEMBL1086317,Cn1nccc1-c1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1OCCN1CCOCC1,IC50,nM,=,900.0,Inhibition of human ERG by patch clamp assay
2916,CHEMBL1084617,COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1,IC50,nM,=,11000.0,Inhibition of human ERG by patch clamp assay
2917,CHEMBL1085627,CC(=O)N1CCN(CCOc2ccc(NC(=O)c3cccc(F)c3)cc2-c2ccnn2C)CC1,IC50,nM,=,4100.0,Inhibition of human ERG by patch clamp assay
2918,CHEMBL1170725,Cc1ncccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1,IC50,nM,>,31622.78,Binding affinity to human ERG by fluorescence-polarization binding assay
2919,CHEMBL1169660,O=C(NCCO)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1,IC50,nM,>,63095.73,Binding affinity to human ERG by fluorescence-polarization binding assay
2920,CHEMBL1171008,O=C(O)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1,IC50,nM,>,31622.78,Binding affinity to human ERG by fluorescence-polarization binding assay
2921,CHEMBL1171786,O=C(O)c1ccccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1,IC50,nM,=,7943.28,Binding affinity to human ERG by fluorescence-polarization binding assay
2922,CHEMBL1170608,Cl.Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccccc2o1,IC50,nM,=,750.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
2923,CHEMBL1170953,O=C(c1ccc(Oc2ccc(F)cc2)cn1)N1CCCN(C2CCC2)CC1,IC50,nM,=,8400.0,Displacement of radiolabeled astemizole from human ERG
2924,CHEMBL1171886,O=C(c1ccc(Oc2ccc(Cl)cc2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of radiolabeled astemizole from human ERG
2925,CHEMBL1171002,O=C(c1ccc(Oc2cccc(Cl)c2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of radiolabeled astemizole from human ERG
2926,CHEMBL1171756,N#Cc1cccc(Oc2ccc(C(=O)N3CCCN(C4CCC4)CC3)cn2)c1,IC50,nM,>,10000.0,Displacement of radiolabeled astemizole from human ERG
2927,CHEMBL1171754,O=C(c1ccc(Oc2ccc(F)cc2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of radiolabeled astemizole from human ERG
2928,CHEMBL1170790,O=C(c1ccc(Oc2cccc(F)c2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of radiolabeled astemizole from human ERG
2929,CHEMBL1170790,O=C(c1ccc(Oc2cccc(F)c2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,=,3500.0,Inhibition of human ERG by patch clamp technique
2930,CHEMBL1171754,O=C(c1ccc(Oc2ccc(F)cc2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp technique
2931,CHEMBL1171756,N#Cc1cccc(Oc2ccc(C(=O)N3CCCN(C4CCC4)CC3)cn2)c1,IC50,nM,=,5400.0,Inhibition of human ERG by patch clamp technique
2932,CHEMBL1171002,O=C(c1ccc(Oc2cccc(Cl)c2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,=,1600.0,Inhibition of human ERG by patch clamp technique
2933,CHEMBL1171886,O=C(c1ccc(Oc2ccc(Cl)cc2)nc1)N1CCCN(C2CCC2)CC1,IC50,nM,=,1400.0,Inhibition of human ERG by patch clamp technique
2934,CHEMBL1170953,O=C(c1ccc(Oc2ccc(F)cc2)cn1)N1CCCN(C2CCC2)CC1,IC50,nM,=,900.0,Inhibition of human ERG by patch clamp technique
2935,CHEMBL497999,CS(=O)(=O)c1ccc(OCC2CC2)c(C(=O)N2CCN(c3ccc(C#N)cc3F)CC2)c1,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2936,CHEMBL1173634,CC(C)COc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ccc(C#N)cc2F)CC1,IC50,nM,=,700.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2937,CHEMBL1173635,CC(C)Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ccc(C#N)cc2F)CC1,IC50,nM,=,3300.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2938,CHEMBL1172998,CS(=O)(=O)c1ccc(OCC(F)(F)F)c(C(=O)N2CCN(c3ccc(C#N)cc3F)CC2)c1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2939,CHEMBL1172999,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ccc(C#N)cc2F)CC1)C(F)(F)F,IC50,nM,=,3000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2940,CHEMBL1171498,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ccc(C#N)cc2)CC1)C(F)(F)F,IC50,nM,=,1200.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2941,CHEMBL1171499,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ccc(C(F)(F)F)cc2)CC1)C(F)(F)F,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2942,CHEMBL1172199,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ccc(C(F)(F)F)cc2F)CC1)C(F)(F)F,IC50,nM,=,6900.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2943,CHEMBL1170071,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ccc(C(F)(F)F)cn2)CC1)C(F)(F)F,IC50,nM,=,20000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2944,CHEMBL1171470,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2cnc(C(F)(F)F)cn2)CC1)C(F)(F)F,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2945,CHEMBL1171471,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cn2)CC1)C(F)(F)F,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2946,CHEMBL1171472,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2cnc(C(F)(F)F)nc2)CC1)C(F)(F)F,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2947,CHEMBL1171649,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F,IC50,nM,=,20000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2948,CHEMBL1169701,CC(Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2Cl)CC1)C(F)(F)F,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2949,CHEMBL2021600,C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(C)(C)C,IC50,nM,=,17000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2950,CHEMBL2021601,C[C@@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(C)(C)C,IC50,nM,=,28000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
2951,CHEMBL1079481,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,1000.0,Inhibition of human ERG
2952,CHEMBL1210552,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,IC50,nM,=,501.19,Inhibition of human ERG
2953,CHEMBL1210552,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,IC50,nM,=,398.11,Inhibition of human ERG
2954,CHEMBL1210552,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,IC50,nM,=,794.33,Inhibition of human ERG
2955,CHEMBL1081957,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,IC50,nM,=,3162.28,Inhibition of human ERG
2956,CHEMBL1210614,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,IC50,nM,=,1000.0,Inhibition of human ERG
2957,CHEMBL1210614,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,IC50,nM,=,1995.26,Inhibition of human ERG
2958,CHEMBL1210614,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,IC50,nM,=,1258.93,Inhibition of human ERG
2959,CHEMBL1209217,O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1,IC50,nM,=,1995.26,Inhibition of human ERG
2960,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,3100.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2961,CHEMBL1086754,Cc1c(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(-c2ccccc2)n1C,IC50,nM,=,140.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2962,CHEMBL1086756,CCCn1c(-c2ccccc2)cc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C,IC50,nM,=,540.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2963,CHEMBL1214176,CCCn1c(-c2ccccc2)cc(C(=O)N(C)CCCN2CCN(c3cccc(C)c3C)CC2)c1C,IC50,nM,=,700.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2964,CHEMBL1214177,Cc1c(C(=O)N(C)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(-c2ccccc2)n1C,IC50,nM,=,500.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2965,CHEMBL1086626,Cc1[nH]c(-c2ccccc2)cc1C(=O)NCCCN1CCN(c2cccc(Cl)c2Cl)CC1,IC50,nM,=,100.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2966,CHEMBL3217141,Cc1[nH]c(-c2ccccn2)cc1C(=O)NCCCN1CCN(c2cccc(Cl)c2Cl)CC1.Cl.Cl.Cl.Cl,IC50,nM,=,900.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2967,CHEMBL3216259,Cc1c(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(-c2ccccn2)n1C.Cl.Cl.Cl.Cl,IC50,nM,=,1700.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2968,CHEMBL3216702,CCCn1c(-c2ccccn2)cc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C.Cl.Cl.Cl.Cl,IC50,nM,=,1000.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2969,CHEMBL1212957,Cc1c(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(-c2cccnc2)n1C,IC50,nM,=,6800.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2970,CHEMBL1214595,Cc1cccc(N2CCN(CCNC(=O)c3cc(C(C)(C)C)n(C)c3C)CC2)c1C,IC50,nM,=,11800.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2971,CHEMBL1214597,Cc1c(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(C(C)(C)C)n1C.Cl,IC50,nM,=,6900.0,Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
2972,CHEMBL1215689,O=[N+]([O-])c1ccc(N2N=C(c3ccc(O)cc3)CC2c2ccc(F)cc2)cc1,IC50,,,,Displacement of [3H]dofetilide from human ERG at 10 uM
2973,CHEMBL1215690,N#Cc1ccc(N2N=C(c3ccc4[nH]c(=O)oc4c3)CC2c2ccc(F)cc2)cc1,IC50,,,,Displacement of [3H]dofetilide from human ERG at 10 uM
2974,CHEMBL1215691,N#Cc1ccc(N2N=C(c3ccc4[nH]c(=O)oc4c3)C[C@@H]2c2ccc(F)cc2)cc1,IC50,nM,=,29.0,Displacement of [3H]dofetilide from human ERG at 10 uM
2975,CHEMBL1215692,N#Cc1ccc(N2N=C(c3ccc4[nH]c(=O)oc4c3)C[C@H]2c2ccc(F)cc2)cc1,IC50,,,,Displacement of [3H]dofetilide from human ERG at 10 uM
2976,CHEMBL1215693,Cc1nc(C)c(C2=NN(c3ccc(C#N)cc3)[C@@H](c3ccc(F)cc3)C2)s1,IC50,,,,Displacement of [3H]dofetilide from human ERG at 10 uM
2977,CHEMBL1215755,CN(C)CCN(C)C(=O)c1ccc(C2=NN(c3ccc(C#N)cc3)C(c3ccc(F)cc3)C2)cc1,IC50,nM,=,170.0,Displacement of [3H]dofetilide from human ERG at 10 uM
2978,CHEMBL1215756,N#Cc1ccc(N2N=C(c3ccc4[nH]c(=O)oc4c3)CC2c2ccc(C(=O)O)cc2)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG at 10 uM
2979,CHEMBL1215757,O=C(O)c1ccc(N2N=C(c3ccc4[nH]c(=O)oc4c3)CC2c2ccc(F)cc2)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG at 10 uM
2980,CHEMBL1215758,N#Cc1ccc(N2N=C(c3ccc(C(=O)O)cc3)CC2c2ccc(F)cc2)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG at 10 uM
2981,CHEMBL1214685,N#Cc1ccc(N2N=C(c3ccc(C(=O)O)cc3)C[C@@H]2c2ccc(F)cc2)cc1,IC50,,,,Displacement of [3H]dofetilide from human ERG at 10 uM
2982,CHEMBL1214686,N#Cc1ccc(N2N=C(c3ccc(C(=O)O)cc3)C[C@H]2c2ccc(F)cc2)cc1,IC50,,,,Displacement of [3H]dofetilide from human ERG at 10 uM
2983,CHEMBL1214402,NC(=O)c1cnc(-c2cnc3c(Nc4ccc(C(F)(F)F)cn4)ccnc3n2)c(C(F)(F)F)c1,IC50,nM,=,5900.0,Inhibition of human hERG
2984,CHEMBL1214731,Cn1cc(Br)c(C(=O)N2CCN(CC(=O)c3ccc(F)cc3)CC2)n1,IC50,nM,=,19000.0,Inhibition of human ERG by patch clamp electrophysiology assay
2985,CHEMBL1214946,Cn1cc(Cl)c(C(=O)N2CCN(CC(=O)c3ccc(F)cc3)CC2)n1,IC50,nM,=,30000.0,Inhibition of human ERG by patch clamp electrophysiology assay
2986,CHEMBL1214731,Cn1cc(Br)c(C(=O)N2CCN(CC(=O)c3ccc(F)cc3)CC2)n1,IC50,nM,=,19000.0,Inhibition of human ERG by patch clamp electrophysiology assay
2987,CHEMBL1224639,CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@@]34C[C@@H]3CN(C)C4)cc2)cc1,IC50,nM,=,1584.89,Inhibition of human ERG
2988,CHEMBL1224697,CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,IC50,nM,=,1258.93,Inhibition of human ERG
2989,CHEMBL1224698,C=CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,IC50,nM,=,100.0,Inhibition of human ERG
2990,CHEMBL1224699,COc1cc([C@]23CNC[C@H]2C3)ccc1NS(=O)(=O)c1ccc(C(C)C)cc1,IC50,nM,=,1258.93,Inhibition of human ERG
2991,CHEMBL1224700,O=S(=O)(Nc1ccc([C@]23CNC[C@H]2C3)cc1)c1ccc(C(F)(F)F)cc1,IC50,nM,=,794.33,Inhibition of human ERG
2992,CHEMBL1224701,O=S(=O)(Nc1ccc([C@]23CNC[C@H]2C3)cc1)c1ccc(OC(F)(F)F)cc1,IC50,nM,=,10000.0,Inhibition of human ERG
2993,CHEMBL1223598,CC(C)c1ccc(S(=O)(=O)Cc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,IC50,nM,=,1258.93,Inhibition of human ERG
2994,CHEMBL1223599,CN(c1ccc([C@]23CNC[C@H]2C3)cc1)S(=O)(=O)c1ccccc1,IC50,nM,>,63095.73,Inhibition of human ERG
2995,CHEMBL1223600,CC(C)c1ccc(CS(=O)(=O)c2ccc([C@]34CNC[C@H]3C4)cc2)cc1,IC50,nM,=,3162.28,Inhibition of human ERG
2996,CHEMBL1223601,CCCCc1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,IC50,nM,=,1995.26,Inhibition of human ERG
2997,CHEMBL1223602,CCC(C)(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,IC50,nM,=,1258.93,Inhibition of human ERG
2998,CHEMBL1223657,CC(C)c1ccc(S(=O)(=O)Nc2ccc(C34CNCC3C4)cc2)cc1,IC50,nM,=,5011.87,Inhibition of human ERG
2999,CHEMBL1223657,CC(C)c1ccc(S(=O)(=O)Nc2ccc(C34CNCC3C4)cc2)cc1,IC50,nM,=,1584.89,Inhibition of human ERG
3000,CHEMBL1223815,Cc1ccc(CN2[C@H]3CC[C@@H]2C[C@H](Oc2cccc(C(N)=O)c2)C3)s1,IC50,nM,=,260.0,Inhibition of human ERG by electrophysiology assay
3001,CHEMBL1223816,NC(=O)c1cccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3CC2CCCCC2)c1,IC50,nM,=,2000.0,Inhibition of human ERG by electrophysiology assay
3002,CHEMBL1223817,CN(C)C(=O)N[C@H]1CC[C@H](CN2[C@H]3CC[C@@H]2C[C@H](Oc2cccc(C(N)=O)c2)C3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3003,CHEMBL1223870,CN(C)C(=O)N[C@H]1CC[C@H](CCN2[C@H]3CC[C@@H]2C[C@H](Oc2cccc(C(N)=O)c2)C3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3004,CHEMBL1223871,CN(C)C(=O)N[C@H]1CC[C@@H](CN2[C@H]3CC[C@@H]2C[C@H](Oc2cccc(C(N)=O)c2)C3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3005,CHEMBL1223872,CN(C)C(=O)N[C@H]1CC[C@@H](CCN2[C@H]3CC[C@@H]2C[C@H](Oc2cccc(C(N)=O)c2)C3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3006,CHEMBL1223873,NC(=O)c1cccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,610.0,Inhibition of human ERG by electrophysiology assay
3007,CHEMBL1223951,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,3000.0,Inhibition of human ERG by electrophysiology assay
3008,CHEMBL1223952,NC(=O)c1cccc(C[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,1500.0,Inhibition of human ERG by electrophysiology assay
3009,CHEMBL1223953,NC(=O)c1cccc(C[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,250.0,Inhibition of human ERG by electrophysiology assay
3010,CHEMBL1223954,NC(=O)c1cccc(S[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,1100.0,Inhibition of human ERG by electrophysiology assay
3011,CHEMBL1223955,NC(=O)c1cccc([S+]([O-])[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,20000.0,Inhibition of human ERG by electrophysiology assay
3012,CHEMBL1224065,NC(=O)c1cccc(N[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,1100.0,Inhibition of human ERG by electrophysiology assay
3013,CHEMBL1224066,NC(=O)c1ccnc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,1000.0,Inhibition of human ERG by electrophysiology assay
3014,CHEMBL1224067,NC(=O)c1cc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)ccn1,IC50,nM,=,1600.0,Inhibition of human ERG by electrophysiology assay
3015,CHEMBL1224068,NC(=O)c1cncc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,1500.0,Inhibition of human ERG by electrophysiology assay
3016,CHEMBL1224069,NC(=O)c1cccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)n1,IC50,nM,=,1000.0,Inhibition of human ERG by electrophysiology assay
3017,CHEMBL1224138,NC(=O)c1cncc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)n1,IC50,nM,=,15000.0,Inhibition of human ERG by electrophysiology assay
3018,CHEMBL1224139,NC(=O)c1cc(F)cc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,680.0,Inhibition of human ERG by electrophysiology assay
3019,CHEMBL1224140,Cc1cc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)cc(C(N)=O)c1,IC50,nM,=,660.0,Inhibition of human ERG by electrophysiology assay
3020,CHEMBL1224141,Cc1ccc(C(N)=O)cc1O[C@@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccccc1,IC50,,,,Inhibition of human ERG by electrophysiology assay
3021,CHEMBL1224142,Cc1c(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)cccc1C(N)=O,IC50,nM,=,1100.0,Inhibition of human ERG by electrophysiology assay
3022,CHEMBL1224213,NC(=O)c1ccccc1O[C@@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccccc1,IC50,nM,=,340.0,Inhibition of human ERG by electrophysiology assay
3023,CHEMBL1224214,NC(=O)c1ccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)cc1,IC50,nM,=,680.0,Inhibition of human ERG by electrophysiology assay
3024,CHEMBL1224215,Cc1cc(C(N)=O)ccc1O[C@@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccccc1,IC50,nM,=,1000.0,Inhibition of human ERG by electrophysiology assay
3025,CHEMBL1224216,NC(=O)c1ccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c(F)c1,IC50,nM,=,1400.0,Inhibition of human ERG by electrophysiology assay
3026,CHEMBL1224217,NC(=O)c1ccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)nc1,IC50,nM,=,1300.0,Inhibition of human ERG by electrophysiology assay
3027,CHEMBL1224285,NC(=O)c1ccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)cn1,IC50,,,,Inhibition of human ERG by electrophysiology assay
3028,CHEMBL1224286,CNC(=O)c1cccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,,,,Inhibition of human ERG by electrophysiology assay
3029,CHEMBL1224287,CN(C)C(=O)c1cccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,,,,Inhibition of human ERG by electrophysiology assay
3030,CHEMBL1224288,Oc1cccc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,1600.0,Inhibition of human ERG by electrophysiology assay
3031,CHEMBL1224164,CCCC1(C(=O)c2ccc3[nH]ccc3c2)CCCN1,IC50,nM,>,10000.0,Inhibition of human ERG
3032,CHEMBL1224165,CCCC1(C(=O)c2cc(F)c3[nH]ccc3c2)CCCN1,IC50,nM,=,5900.0,Inhibition of human ERG
3033,CHEMBL1224024,CCCC1(C(=O)c2ccc(Cl)c(Cl)c2)CCCN1,IC50,nM,=,3100.0,Inhibition of human ERG
3034,CHEMBL1224089,CCCC1(C(=O)c2ccc(N)c(Cl)c2)CCCN1,IC50,nM,>,10000.0,Inhibition of human ERG
3035,CHEMBL1224091,CC(C)OCC1(C(=O)c2ccc(N)c(Cl)c2)CCCN1,IC50,nM,>,10000.0,Inhibition of human ERG
3036,CHEMBL1224092,CCCC1(C(=O)c2ccc3[nH]ncc3c2)CCCN1,IC50,nM,>,10000.0,Inhibition of human ERG
3037,CHEMBL1224093,CC(C)CC1(C(=O)c2ccc3[nH]ncc3c2)CCCN1,IC50,nM,>,10000.0,Inhibition of human ERG
3038,CHEMBL1224094,CC(C)(C)CCC1(C(=O)c2ccc3[nH]ncc3c2)CCCN1,IC50,nM,>,10000.0,Inhibition of human ERG
3039,CHEMBL1079481,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,1000.0,Inhibition of human ERG
3040,CHEMBL1224638,CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,IC50,nM,=,1000.0,Inhibition of human ERG
3041,CHEMBL1221852,CCS(=O)(=O)N1C[C@H](C(=O)Nc2ccc(Cl)cn2)[C@@H](C(=O)Nc2ccc(-n3ccccc3=O)cc2F)C1,IC50,nM,>,10000.0,Inhibition of human ERG
3042,CHEMBL1221913,O=C(Nc1ccc(Cl)cn1)[C@H]1CN(CC(F)F)C[C@@H]1C(=O)Nc1ccc(-n2ccccc2=O)cc1F,IC50,nM,>,10000.0,Inhibition of human ERG
3043,CHEMBL1221915,CC(C)N1C[C@H](C(=O)Nc2ccc(Cl)cn2)[C@@H](C(=O)Nc2ccc(-n3ccccc3=O)cc2F)C1,IC50,nM,=,12000.0,Inhibition of human ERG
3044,CHEMBL1221916,COC(=O)N1C[C@H](C(=O)Nc2ccc(Cl)cn2)[C@@H](C(=O)Nc2ccc(-n3ccccc3=O)cc2F)C1,IC50,nM,>,10000.0,Inhibition of human ERG
3045,CHEMBL1222240,CC[C@@H](CC(=O)NCC1CCCCC1)n1c(N)nc2cc(Cl)ccc21,IC50,nM,=,7500.0,Inhibition of human ERG
3046,CHEMBL111,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,IC50,nM,=,4800.0,Inhibition of human ERG at holding potential of -80 mV to +40 mV
3047,CHEMBL220360,C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1,IC50,nM,=,14200.0,Inhibition of human ERG at holding potential of -80 mV to +40 mV
3048,CHEMBL1223034,CC(C)(C)c1nnc(-c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Br)cc3)c2Cn2cncn2)s1,IC50,nM,>,10000.0,Inhibition of human ERG at holding potential of -80 mV to +40 mV
3049,CHEMBL1222969,FC(F)(F)C1(c2nnc(-c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)c3Cn3cncn3)s2)CCC1,IC50,nM,>,10000.0,Inhibition of human ERG at holding potential of -80 mV to +40 mV
3050,CHEMBL1223259,CC(C)(C)c1nnc(-c2nn(-c3ccccc3Cl)c(-c3ccc(Br)cc3)c2Cn2cncn2)s1,IC50,nM,=,10500.0,Inhibition of human ERG at holding potential of -80 mV to +40 mV
3051,CHEMBL1241913,Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1,IC50,nM,>,10000.0,Inhibition of human ERG tail current by patch clamp electrophysiology assay
3052,CHEMBL1242717,Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)N6CCOCC6)ncn4-5)CC3)cccc2n1,IC50,nM,=,1000.0,Inhibition of human ERG tail current by patch clamp electrophysiology assay
3053,CHEMBL1241912,CNC(=O)c1ncn2c1COc1c(CCN3CCN(c4cccc5nc(C)ccc45)CC3)cccc1-2,IC50,nM,=,1584.89,Inhibition of human ERG tail current by patch clamp electrophysiology assay
3054,CHEMBL1240967,CC(C)(Cc1cccc(CC(=O)NCc2cccc(-c3ccc(O)cc3)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp technique
3055,CHEMBL1082723,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,=,30440.0,Inhibition of human ERG
3056,CHEMBL1082723,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp method
3057,CHEMBL1223951,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccc2)c1,IC50,nM,=,0.61,Inhibition of human ERG
3058,CHEMBL1257577,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2cccs2)c1,IC50,nM,=,0.43,Inhibition of human ERG
3059,CHEMBL1257578,Cc1ccc(CN2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)s1,IC50,nM,=,0.26,Inhibition of human ERG
3060,CHEMBL1255595,Cc1ccc(CN2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)o1,IC50,nM,=,2.8,Inhibition of human ERG
3061,CHEMBL1257698,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3CCc2ccccc2)c1,IC50,nM,=,0.38,Inhibition of human ERG
3062,CHEMBL1257820,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3CCCc2ccccc2)c1,IC50,nM,=,0.25,Inhibition of human ERG
3063,CHEMBL1257821,Cc1ccc(CN2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)cc1,IC50,nM,=,0.14,Inhibition of human ERG
3064,CHEMBL1257937,Cc1cccc(CN2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)c1,IC50,nM,=,0.52,Inhibition of human ERG
3065,CHEMBL1257938,Cc1ccccc1CN1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,0.62,Inhibition of human ERG
3066,CHEMBL1258047,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccncc2)c1,IC50,nM,=,1.5,Inhibition of human ERG
3067,CHEMBL1258048,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2cccnc2)c1,IC50,nM,=,3.5,Inhibition of human ERG
3068,CHEMBL1258164,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccccn2)c1,IC50,nM,=,1.9,Inhibition of human ERG
3069,CHEMBL1258165,CN1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,>,33.0,Inhibition of human ERG
3070,CHEMBL1258166,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3CC2CC2)c1,IC50,nM,=,7.3,Inhibition of human ERG
3071,CHEMBL1258279,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3CC2CCCCC2)c1,IC50,nM,=,2.0,Inhibition of human ERG
3072,CHEMBL1258280,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccc3c(c2)OCO3)c1,IC50,nM,=,0.62,Inhibition of human ERG
3073,CHEMBL1258391,CS(=O)(=O)Cc1ccc(CN2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)cc1,IC50,nM,=,6.6,Inhibition of human ERG
3074,CHEMBL1258392,Cn1cc(CN2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)cn1,IC50,nM,>,33.0,Inhibition of human ERG
3075,CHEMBL1258502,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3CC(=O)N2CCCC2)c1,IC50,nM,>,33.0,Inhibition of human ERG
3076,CHEMBL1258503,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3CC(=O)Nc2ccccc2)c1,IC50,nM,=,0.72,Inhibition of human ERG
3077,CHEMBL1258615,CC(c1ccccc1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,6.0,Inhibition of human ERG
3078,CHEMBL1258616,Cc1ccc(C(C)N2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)s1,IC50,nM,=,1.6,Inhibition of human ERG
3079,CHEMBL1258724,Cc1ccccc1C(C)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,4.9,Inhibition of human ERG
3080,CHEMBL1258725,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3C2CCCc3ccccc32)c1,IC50,nM,=,0.95,Inhibition of human ERG
3081,CHEMBL1258845,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3C2CCCCC2)c1,IC50,nM,=,15.0,Inhibition of human ERG
3082,CHEMBL1258846,CC(C)(c1ccccc1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,4.7,Inhibition of human ERG
3083,CHEMBL1258961,NC(=O)c1cccc(O[C@H]2C[C@@H]3CC[C@H](C2)N3C2(c3ccccc3)CC2)c1,IC50,nM,=,4.8,Inhibition of human ERG
3084,CHEMBL1258962,CC(c1ccncc1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,3.7,Inhibition of human ERG
3085,CHEMBL1257226,C[C@H](c1ccccc1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,13.0,Inhibition of human ERG
3086,CHEMBL1257227,C[C@@H](c1ccccc1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,1.8,Inhibition of human ERG
3087,CHEMBL1257348,COc1cccc([C@@H](C)N2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)c1,IC50,nM,=,4.6,Inhibition of human ERG
3088,CHEMBL1257458,Cc1ccc([C@@H](C)N2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)cn1,IC50,nM,=,3.0,Inhibition of human ERG
3089,CHEMBL1257459,C[C@H](c1ccnc(Cl)c1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,13.0,Inhibition of human ERG
3090,CHEMBL1257579,C[C@H](c1ccc(Cl)nc1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1cccc(C(N)=O)c1)C2,IC50,nM,=,3.3,Inhibition of human ERG
3091,CHEMBL1257347,Cc1ccc([C@@H](C)N2[C@H]3CC[C@@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)s1,IC50,nM,=,2.8,Inhibition of human ERG
3092,CHEMBL1079481,Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3093,CHEMBL1257447,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccccc3)C2)n1C,IC50,nM,=,6309.57,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3094,CHEMBL1257565,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccccc4)CC3C2)n1C,IC50,nM,=,5011.87,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3095,CHEMBL1257566,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,1995.26,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3096,CHEMBL1257686,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccc(C(F)(F)F)cc4)CC3C2)n1C,IC50,nM,=,794.33,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3097,CHEMBL1257687,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,IC50,nM,=,1995.26,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3098,CHEMBL1257808,Cc1ncoc1-c1nnc(SCCCN2CCC3(c4cccc(C(F)(F)F)c4)CC3C2)n1C,IC50,nM,=,199.53,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3099,CHEMBL1257809,Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)n1C,IC50,nM,=,1584.89,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3100,CHEMBL1257925,Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)o1,IC50,nM,=,1258.93,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3101,CHEMBL1257926,Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)s1,IC50,nM,=,630.96,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3102,CHEMBL1258034,Cn1c(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)nnc1-c1ccnnc1,IC50,nM,=,5011.87,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3103,CHEMBL1258035,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4)CC23)n1C,IC50,nM,=,251.19,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3104,CHEMBL1258153,Cc1ncoc1-c1nnc(SCCCN[C@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4)CC23)n1C,IC50,nM,=,2511.89,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3105,CHEMBL1258035,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4)CC23)n1C,IC50,nM,=,630.96,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3106,CHEMBL1258268,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4F)CC23)n1C,IC50,nM,=,630.96,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3107,CHEMBL1258269,Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC3C[C@]3(c3ccc(C(F)(F)F)cc3F)C2)n1C.Cl,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3108,CHEMBL1258380,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4cc(Br)ccc43)C2)n1C,IC50,nM,=,630.96,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3109,CHEMBL1258381,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4ccc(Br)cc43)C2)n1C,IC50,nM,=,1258.93,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3110,CHEMBL1258492,COc1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,IC50,nM,=,1995.26,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3111,CHEMBL1258493,COc1cccc2c1CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,IC50,nM,=,1995.26,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3112,CHEMBL1258605,COc1ccc2c(c1)C1(CCC2)CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,IC50,nM,=,6309.57,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3113,CHEMBL1258606,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCOc4ccccc43)C2)n1C,IC50,nM,=,6309.57,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3114,CHEMBL1258712,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(Br)ccc43)C2)n1C,IC50,nM,=,316.23,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3115,CHEMBL1258713,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4c(Br)cccc43)C2)n1C,IC50,nM,=,630.96,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3116,CHEMBL1258833,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4ccc(Br)cc43)C2)n1C,IC50,nM,=,794.33,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3117,CHEMBL1258834,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(Cl)cc54)C3)n2C)s1,IC50,nM,=,2511.89,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3118,CHEMBL1258948,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5cc(Cl)ccc54)C3)n2C)s1,IC50,nM,=,2511.89,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3119,CHEMBL1258949,Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(F)ccc43)C2)n1C,IC50,nM,=,2511.89,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3120,CHEMBL1257214,Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(F)cc54)C3)n2C)s1,IC50,nM,=,6309.57,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3121,CHEMBL1257215,Cc1ncoc1-c1nnc(SCCCN2[C@H]3CC[C@@H]2C[C@H](c2ccc(C(C)(C)C)cc2)C3)n1C,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3122,CHEMBL1257336,Cc1ncoc1-c1nnc(SCCCN2[C@H]3CC[C@@H]2C[C@H](c2ccc(C(F)(F)F)cc2)C3)n1C,IC50,nM,=,158.49,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3123,CHEMBL1257337,Cc1ncoc1-c1nnc(SCCCN2[C@H]3CC[C@@H]2C[C@H](c2cccc(C(F)(F)F)c2)C3)n1C,IC50,nM,=,501.19,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3124,CHEMBL1257448,Cc1ncoc1-c1nnc(SCCCN2[C@H]3CC[C@@H]2C[C@H](c2ccc(C(F)(F)F)cc2F)C3)n1C,IC50,nM,=,501.19,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3125,CHEMBL1257335,Cc1ncoc1-c1nnc(SCCCNC2CC3CC3(c3ccccc3)C2)n1C,IC50,nM,=,7943.28,Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay
3126,CHEMBL512351,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,IC50,nM,=,8900.0,Inhibition of human ERG by patch clamp assay
3127,CHEMBL1271940,Cc1nc2ccccc2n1C1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC[S+]([O-])CC1)c1cccc(F)c1,IC50,nM,>,10000.0,Inhibition of human ERG
3128,CHEMBL1269335,Cc1nc2ccc(F)cc2n1C1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCS(=O)(=O)CC1)c1cccc(F)c1,IC50,nM,>,10000.0,Inhibition of human ERG
3129,CHEMBL1271606,Cc1nc2ccccc2n1C1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCSCC1)c1cccc(F)c1,IC50,nM,=,740.0,Inhibition of human ERG
3130,CHEMBL1270208,O=C(NCc1cccnc1OCC(F)(F)F)c1cncc(-c2ccc(Cl)cc2)c1,IC50,nM,=,19000.0,Inhibition of human ERG by Isotopic flux assay
3131,CHEMBL1271309,Cc1cc(C)cc(NC(=O)c2cncc(-c3ccc(C#N)cc3)c2)c1,IC50,nM,=,16000.0,Inhibition of human ERG by Isotopic flux assay
3132,CHEMBL1269885,Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1,IC50,nM,=,15400.0,Inhibition of human ERG
3133,CHEMBL1236391,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCNCC3)ccc12,IC50,nM,=,8130.0,Inhibition of human ERG
3134,CHEMBL3084761,CN1[C@H]2CCC[C@@H]1C[C@@H](NC(=O)c1cccc3oc(N4CCOCC4)nc13)C2,IC50,nM,=,1400.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3135,CHEMBL1271520,O=C(N[C@@H]1CN2CCC1CC2)c1cccc2oc(N3CCOCC3)nc12,IC50,nM,=,3200.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3136,CHEMBL3084776,C[C@H]1CNC[C@H](C)N1c1nc2c(C(=O)N[C@H]3C[C@@H]4CCC[C@H](C3)N4C)cccc2o1,IC50,nM,=,6400.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3137,CHEMBL1272016,COc1ccccc1-c1nc2c(C(=O)N[C@@H]3CN4CCC3CC4)cccc2o1,IC50,nM,=,200.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3138,CHEMBL3084777,COc1ccccc1-c1nc2c(C(=O)N[C@H]3C[C@@H]4CCC[C@H](C3)N4C)cccc2o1,IC50,nM,=,400.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3139,CHEMBL1272072,O=C(N[C@@H]1CN2CCC1CC2)c1cccc2oc(C3CC3)nc12,IC50,nM,=,700.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3140,CHEMBL3084778,CN1[C@H]2CCC[C@@H]1C[C@@H](NC(=O)c1cccc3oc(C4CC4)nc13)C2,IC50,nM,=,200.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3141,CHEMBL46,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,400.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3142,CHEMBL1110,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,2300.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3143,CHEMBL1272178,Nc1nc2c(C(=O)N[C@@H]3CN4CCC3CC4)cccc2o1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3144,CHEMBL1272232,Nc1nc2c(C(=O)N[C@@H]3CN4CCC3CC4)cc(Cl)cc2o1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in HEK cells by patch clamp technique
3145,CHEMBL1271930,CSc1nc(C)cc(C(=O)NCCN2CCN(c3cccc(C)c3C)CC2)n1.Cl,IC50,nM,>,10000.0,Inhibition of human ERG channel
3146,CHEMBL1271816,Cc1nc(C(=O)NCCCN2CCN(c3cccc(C)c3C)CC2)cc(C(C)(C)C)n1.Cl,IC50,nM,=,5900.0,Inhibition of human ERG channel
3147,CHEMBL1271698,Cc1cc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(C)n1.Cl,IC50,nM,>,10000.0,Inhibition of human ERG channel
3148,CHEMBL1271756,Cc1nc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(C(C)C)n1.Cl,IC50,nM,=,5400.0,Inhibition of human ERG channel
3149,CHEMBL1270139,O=C(NO)c1cnc(N2C[C@@H]3CN(Cc4ccc5ccccc5c4)C[C@@H]3C2)nc1,IC50,nM,=,4100.0,Inhibition of human ERG channel
3150,CHEMBL496430,CNC[C@H](CC1CCCCC1)NC(=O)N1CCC[C@@H]([C@@](O)(CCCCOC)c2cccc(Cl)c2)C1,IC50,nM,>,30000.0,Inhibition of human ERG
3151,CHEMBL1277312,O=C(O)C1CN(C2CCC3(Cc4ccccc4Oc4ccccc43)C2)C1,IC50,nM,>,50118.72,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3152,CHEMBL1276948,O=C(O)C1CN(C2CC[C@]3(Cc4ccccc4Cc4ccccc43)C2)C1,IC50,nM,>,50118.72,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3153,CHEMBL1276947,O=C(O)[C@]12C[C@H]1CN(C1CC[C@]3(Cc4ccccc4Cc4ccccc43)C1)C2,IC50,nM,>,39810.72,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3154,CHEMBL1277678,O=C(O)C1(F)CCN(C2CC[C@]3(Cc4ccccc4Cc4ccccc43)C2)CC1,IC50,nM,>,39810.72,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3155,CHEMBL1277770,O=C(O)C1CCN(C2CC[C@]3(Cc4ccccc4Cc4ccccc43)C2)CC1,IC50,nM,>,63095.73,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3156,CHEMBL1277935,O=C(O)C1=CCCN(C2CC[C@]3(Cc4ccccc4Cc4ccccc43)C2)C1,IC50,nM,>,39810.72,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3157,CHEMBL1278115,O=C(O)CCNC1CC[C@@]2(Cc3ccccc3Cc3ccccc32)C1,IC50,nM,>,63095.73,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3158,CHEMBL1278114,O=C(O)CCNC1CC[C@]2(Cc3ccccc3Cc3ccccc32)C1,IC50,nM,=,63095.73,Displacement of [3H]dofetilide from human ERG by scintillation proximity assay
3159,CHEMBL1290746,Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N,IC50,nM,>,160000.0,Inhibition of human ERG by flux assay
3160,CHEMBL1289313,CN(O)C(=O)c1cc2c(CN3CCC[C@H]3C(N)=O)cn(Cc3ccc(F)cc3)c2cn1,IC50,nM,>,30000.0,Inhibition of human ERG
3161,CHEMBL1290412,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@H]1CN([C@H]2CC[C@@H](c3ccccc3)CC2)C[C@@H]1O,IC50,nM,<,1000.0,Inhibition of human ERG
3162,CHEMBL1290636,CCO[C@H]1CN([C@H]2CC[C@@H](c3ccccc3)CC2)C[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,<,1000.0,Inhibition of human ERG
3163,CHEMBL1289083,CCO[C@H]1CN([C@H]2CC[C@@](O)(c3ccccc3)CC2)C[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,=,17000.0,Inhibition of human ERG
3164,CHEMBL1289203,CCO[C@H]1CN([C@H]2CC[C@@](O)(c3ccc(C)cc3)CC2)C[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,=,11000.0,Inhibition of human ERG
3165,CHEMBL1289316,CCO[C@H]1CN([C@H]2CC[C@@](O)(c3ccc4c(c3)OCO4)CC2)C[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,=,13000.0,Inhibition of human ERG
3166,CHEMBL1288673,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4c(F)cccc4F)CC3)CC2)cc1,IC50,nM,=,1200.0,Displacement of [3H]-dofetilide from human ERG
3167,CHEMBL1288674,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4c(Cl)cccc4Cl)CC3)CC2)cc1,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from human ERG
3168,CHEMBL1288675,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4ccc(F)cc4O)CC3)CC2)cc1,IC50,nM,=,800.0,Displacement of [3H]-dofetilide from human ERG
3169,CHEMBL1288676,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4ccc(C#N)cc4)CC3)CC2)cc1,IC50,nM,=,400.0,Displacement of [3H]-dofetilide from human ERG
3170,CHEMBL1288677,N#Cc1ccc(CNC(=O)N(c2cccc(F)c2)C2CCN(CCC3(c4cccc(F)c4)CCN(C(=O)c4cccc(C(N)=O)c4)CC3)CC2)cc1,IC50,nM,=,20000.0,Displacement of [3H]-dofetilide from human ERG
3171,CHEMBL1288689,CC(C)(O)C(=O)N1CCC(CCN2CCC(N(C(=O)NCc3ccc(C#N)cc3)c3cccc(F)c3)CC2)(c2cccc(F)c2)CC1,IC50,nM,=,10000.0,Displacement of [3H]-dofetilide from human ERG
3172,CHEMBL1289610,Cc1ncccc1N1C[C@]2(CC[C@@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)OC1=O,IC50,nM,=,50118.72,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3173,CHEMBL1289819,O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccnc1F,IC50,nM,=,15848.93,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3174,CHEMBL1290147,N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccccn3)C(=O)O4)nc2c1,IC50,nM,=,12589.25,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3175,CHEMBL1290037,N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccccc3)C(=O)O4)nc2c1,IC50,nM,=,10000.0,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3176,CHEMBL1289715,O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccnc1,IC50,nM,=,7943.28,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3177,CHEMBL1289268,O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F,IC50,nM,=,6309.57,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3178,CHEMBL1289714,O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1,IC50,nM,=,3981.07,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3179,CHEMBL1289820,O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1,IC50,nM,=,3981.07,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3180,CHEMBL1289936,O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1,IC50,nM,=,3981.07,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3181,CHEMBL1289267,O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1,IC50,nM,=,2511.89,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3182,CHEMBL1289503,O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1,IC50,nM,=,2511.89,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3183,CHEMBL1290706,O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1,IC50,nM,=,1995.26,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3184,CHEMBL1289609,Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1,IC50,nM,=,1995.26,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3185,CHEMBL1290038,N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccc(F)cc3)C(=O)O4)nc2c1,IC50,nM,=,1584.89,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3186,CHEMBL1290707,O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3187,CHEMBL1289386,O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1,IC50,nM,=,794.33,Displacement of [3H]-dofetilide in human ERG expressed in CHO cells
3188,CHEMBL1112,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,IC50,nM,<,1000.0,Inhibition of human ERG
3189,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,<,1000.0,Inhibition of human ERG
3190,CHEMBL1289097,CC(C)[C@@H](Nc1nc2cc[nH]c(=O)c2c2cc(F)ccc12)C(F)(F)F,IC50,nM,=,3500.0,Binding affinity to human ERG expressed in HEK cells by radioligand displacement assay
3191,CHEMBL1289218,CC(C)[C@@H](Nc1nc2cc[nH]c(=O)c2c2cnccc12)C(F)(F)F,IC50,nM,=,1400.0,Binding affinity to human ERG expressed in HEK cells by radioligand displacement assay
3192,CHEMBL1289960,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2cccc(NS(C)(=O)=O)c2)cc1,IC50,nM,=,31600.0,Displacement of [3H]-dofetilide from human hERG
3193,CHEMBL1290058,CCN1C[C@H](c2ccc(-c3cccc(NS(C)(=O)=O)c3)cc2)[C@@H](NS(=O)(=O)C(C)C)C1,IC50,nM,=,2500.0,Displacement of [3H]-dofetilide from human hERG
3194,CHEMBL1290059,CC(C)N1C[C@H](c2ccc(-c3cccc(NS(C)(=O)=O)c3)cc2)[C@@H](NS(=O)(=O)C(C)C)C1,IC50,nM,=,6300.0,Displacement of [3H]-dofetilide from human hERG
3195,CHEMBL1290165,CC(C)S(=O)(=O)N[C@H]1CN(c2ccccc2)C[C@@H]1c1ccc(-c2cccc(NS(C)(=O)=O)c2)cc1,IC50,nM,=,1300.0,Displacement of [3H]-dofetilide from human hERG
3196,CHEMBL1290166,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2ccc(C#N)cc2)cc1,IC50,nM,=,2000.0,Displacement of [3H]-dofetilide from human hERG
3197,CHEMBL1290275,CCN1C[C@H](c2ccc(-c3ccc(C#N)cc3)cc2)[C@@H](NS(=O)(=O)C(C)C)C1,IC50,nM,=,400.0,Displacement of [3H]-dofetilide from human hERG
3198,CHEMBL1290276,CC(C)N1C[C@H](c2ccc(-c3ccc(C#N)cc3)cc2)[C@@H](NS(=O)(=O)C(C)C)C1,IC50,,,,Displacement of [3H]-dofetilide from human hERG
3199,CHEMBL1290391,CC(C)S(=O)(=O)N[C@H]1CN(c2ccccc2)C[C@@H]1c1ccc(-c2ccc(C#N)cc2)cc1,IC50,nM,=,800.0,Displacement of [3H]-dofetilide from human hERG
3200,CHEMBL1290392,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1,IC50,nM,>,63000.0,Displacement of [3H]-dofetilide from human hERG
3201,CHEMBL1290503,CC(=O)Nc1cccc(-c2ccc([C@H]3CN(C)C[C@@H]3NS(=O)(=O)C(C)C)cc2)c1,IC50,nM,=,12600.0,Displacement of [3H]-dofetilide from human hERG
3202,CHEMBL1290504,CC(=O)c1cccc(-c2ccc([C@H]3CN(C)C[C@@H]3NS(=O)(=O)C(C)C)cc2)c1,IC50,nM,=,7900.0,Displacement of [3H]-dofetilide from human hERG
3203,CHEMBL1290612,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2cccc(C(F)(F)F)c2)cc1,IC50,nM,=,4000.0,Displacement of [3H]-dofetilide from human hERG
3204,CHEMBL1290613,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2ccccc2F)cc1,IC50,,,,Displacement of [3H]-dofetilide from human hERG
3205,CHEMBL1290731,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2cccnc2)cc1,IC50,nM,=,31600.0,Displacement of [3H]-dofetilide from human hERG
3206,CHEMBL1290732,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2cccnc2F)cc1,IC50,nM,=,6300.0,Displacement of [3H]-dofetilide from human hERG
3207,CHEMBL1289062,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2ccc(F)nc2)cc1,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from human hERG
3208,CHEMBL1289063,CC(C)S(=O)(=O)N[C@H]1CN(c2ccccc2)C[C@@H]1c1ccc(-c2ccc(F)nc2)cc1,IC50,nM,=,80.0,Displacement of [3H]-dofetilide from human hERG
3209,CHEMBL1289179,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2cccs2)cc1,IC50,nM,>,63000.0,Displacement of [3H]-dofetilide from human hERG
3210,CHEMBL1289180,CC(C)S(=O)(=O)N[C@H]1CN(C)C[C@@H]1c1ccc(-c2ccsc2)cc1,IC50,nM,=,4000.0,Displacement of [3H]-dofetilide from human hERG
3211,CHEMBL1289181,CC(C)S(=O)(=O)N[C@@H]1COC[C@@H]1c1ccc(-c2ccc(C#N)cc2)cc1,IC50,nM,=,12600.0,Displacement of [3H]-dofetilide from human hERG
3212,CHEMBL1289293,CC(=O)c1cccc(-c2ccc([C@H]3COC[C@H]3NS(=O)(=O)C(C)C)cc2)c1,IC50,nM,>,63000.0,Displacement of [3H]-dofetilide from human hERG
3213,CHEMBL1289294,CC(C)S(=O)(=O)N[C@@H]1COC[C@@H]1c1ccc(-c2ccc(F)nc2)cc1,IC50,nM,=,12600.0,Displacement of [3H]-dofetilide from human hERG
3214,CHEMBL1289408,CC(C)S(=O)(=O)N[C@@H]1COC[C@@H]1c1ccc(-c2cncc(F)c2)cc1,IC50,nM,>,63000.0,Displacement of [3H]-dofetilide from human hERG
3215,CHEMBL1289409,CC(C)S(=O)(=O)N[C@@H]1COC[C@@H]1c1ccc(-c2ccc(F)cn2)cc1,IC50,nM,>,63000.0,Displacement of [3H]-dofetilide from human hERG
3216,CHEMBL1289410,CC(C)S(=O)(=O)N[C@@H]1COC[C@@H]1c1ccc(-c2cccs2)cc1,IC50,nM,>,63000.0,Displacement of [3H]-dofetilide from human hERG
3217,CHEMBL1289523,CC(C)S(=O)(=O)N[C@@H]1COC[C@@H]1c1ccc(-c2ccsc2)cc1,IC50,nM,>,63000.0,Displacement of [3H]-dofetilide from human hERG
3218,CHEMBL1289170,CCCCn1ncc2cc(-n3ccc(OCc4ccccc4)cc3=O)ccc21,IC50,,,,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3219,CHEMBL1289282,CN(C)CCn1ncc2cc(-n3ccc(OCc4ccccc4)cc3=O)ccc21,IC50,nM,=,1800.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3220,CHEMBL1289283,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CCN2CCCC2)c1,IC50,nM,=,2500.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3221,CHEMBL1289399,CN(C)CCCn1ncc2cc(-n3ccc(OCc4ccccc4)cc3=O)ccc21,IC50,nM,=,1400.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3222,CHEMBL1289400,CN(C)CC(O)Cn1ncc2cc(-n3ccc(OCc4ccccc4)cc3=O)ccc21,IC50,nM,=,12100.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3223,CHEMBL1289515,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CCN2CC[C@H](O)C2)c1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3224,CHEMBL1289516,CO[C@H]1CCN(CCn2ncc3cc(-n4ccc(OCc5ccccc5)cc4=O)ccc32)C1,IC50,nM,=,1800.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3225,CHEMBL1289623,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2C[C@@H]2CCCN2)c1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3226,CHEMBL1289624,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CC2C[C@@H](O)CN2)c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3227,CHEMBL1289169,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CCN2CCC[C@@H]2CO)c1,IC50,nM,=,2300.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3228,CHEMBL1289054,COC[C@H]1CCCN1CCn1ncc2cc(-n3ccc(OCc4ccccc4)cc3=O)ccc21,IC50,nM,=,800.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3229,CHEMBL1289053,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CC2=NCCN2)c1,IC50,nM,=,8500.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3230,CHEMBL1289726,CN1CCN=C1Cn1ncc2cc(-n3ccc(OCc4ccccc4)cc3=O)ccc21,IC50,nM,=,3300.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3231,CHEMBL1289727,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CCN2CCOCC2)c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3232,CHEMBL1289833,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CCN2CC3CC2CO3)c1,IC50,nM,=,16000.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3233,CHEMBL1289834,O=c1cc(OCc2ccccc2)ccn1-c1ccc2c(cnn2CCN2CCNCC2)c1,IC50,nM,=,16400.0,Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay
3234,CHEMBL1642173,COc1cc(/C=C/c2nc3ccccc3[nH]2)ccc1-n1cnc(C)c1,IC50,nM,=,680.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3235,CHEMBL1642174,COc1cc(/C=C/c2nc3ccccc3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3236,CHEMBL1642175,COc1cc(/C=C/c2nc3cccc(F)c3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,,,,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3237,CHEMBL1642176,COc1cc(/C=C/c2nc3ccc(F)cc3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3238,CHEMBL1642177,COc1cc(/C=C/c2nc3cc(Cl)ccc3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3239,CHEMBL1642178,COc1cc(/C=C/c2nc3cc(Br)ccc3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3240,CHEMBL1642179,COc1cc(/C=C/c2nc3cc(S(C)(=O)=O)ccc3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3241,CHEMBL1642180,COc1cc(/C=C/c2nc3cc(C(F)(F)F)ccc3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,=,870.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3242,CHEMBL1642181,COc1cc(/C=C/c2nc3scc(C)c3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3243,CHEMBL1642182,COc1cc(/C=C/c2nc3sc(C)c(C)c3c(=O)[nH]2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3244,CHEMBL1642183,COc1cc(/C=C/c2nc3sc4c(c3c(=O)[nH]2)CCC4)ccc1-n1cnc(C)c1,IC50,nM,=,4730.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3245,CHEMBL1642184,COc1cc(/C=C/c2nc(N)c3ccccc3n2)ccc1-n1cnc(C)c1,IC50,nM,=,140.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3246,CHEMBL1642185,COc1cc(/C=C/c2nc3ccccc3c(=O)n2-c2ccccc2)ccc1-n1cnc(C)c1,IC50,nM,=,990.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3247,CHEMBL1642186,COc1cc(/C=C/c2nc3ccccc3c(=O)n2C)ccc1-n1cnc(C)c1,IC50,nM,=,310.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3248,CHEMBL1642187,COc1cc(/C=C/c2nc(N)nc(Nc3ccccc3)n2)ccc1-n1cnc(C)c1,IC50,nM,=,300.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3249,CHEMBL1642188,CCOC(=O)c1sc2nc(/C=C/c3ccc(-n4cnc(C)c4)c(OC)c3)nc(N)c2c1C,IC50,nM,=,980.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3250,CHEMBL1642189,COc1cc(/C=C/c2nc(N)c3c(n2)oc2ccccc23)ccc1-n1cnc(C)c1,IC50,nM,=,510.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3251,CHEMBL1642190,COc1cc(/C=C/c2nc(NCc3ccccc3)c3c4c(sc3n2)CCC4)ccc1-n1cnc(C)c1,IC50,nM,=,1120.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3252,CHEMBL1642191,COc1cc(/C=C/c2nc(N)c3c4c(sc3n2)CCCCC4)ccc1-n1cnc(C)c1,IC50,nM,=,390.0,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells
3253,CHEMBL1642471,O=c1cc(OCc2ccccc2F)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,4.3,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3254,CHEMBL1642472,O=c1cc(OCc2cccc(F)c2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,2.9,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3255,CHEMBL584538,O=c1cc(OCc2ccc(F)cc2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,9.0,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3256,CHEMBL1642473,O=c1cc(OCc2ccccc2Cl)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3257,CHEMBL1642474,O=c1cc(OCc2cccc(Cl)c2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,1.9,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3258,CHEMBL1642475,O=c1cc(OCc2ccc(Cl)cc2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,1.7,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3259,CHEMBL1642476,COc1ccc(COc2ccn(-c3ccc(OCCN4CCCC4)cc3)c(=O)c2)cc1,IC50,nM,=,1.2,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3260,CHEMBL1642477,O=c1cc(OCc2ccc(C(F)(F)F)cc2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,2.4,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3261,CHEMBL1642478,O=c1cc(OCc2ccc(-c3ccccc3)cc2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3262,CHEMBL1642479,O=c1cc(OCc2ccc3ccccc3c2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,0.67,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3263,CHEMBL1642482,O=c1cc(OCc2ccccc2)ccn1-c1ccc(OCCN2CCCCC2)cc1,IC50,nM,=,5.8,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3264,CHEMBL1641614,O=c1cc(OCc2ccccc2)ccn1-c1ccc(OCCN2CCCC2)cc1,IC50,nM,=,8.1,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3265,CHEMBL1642468,O=c1cc(OCc2ccccc2)ccn1-c1ccc(OCCN2CCOCC2)cc1,IC50,nM,>,10.0,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3266,CHEMBL1642484,CN(C)CCOc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,nM,>,10.0,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3267,CHEMBL1642485,CCN(CC)CCOc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,nM,=,9.8,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3268,CHEMBL1642486,CC(C)N(CCOc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1)C(C)C,IC50,nM,=,4.3,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3269,CHEMBL1642487,CN(CCOc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1)Cc1ccccc1,IC50,nM,=,0.81,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3270,CHEMBL1642488,CC(CN(C)C)Oc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3271,CHEMBL1642489,CN(C)CC(C)(C)Oc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3272,CHEMBL1642490,CN1CCCCC1COc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,nM,=,5.8,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3273,CHEMBL1642491,CN1CCCC1COc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,nM,=,9.3,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3274,CHEMBL1642470,CN1CCC(Oc2ccc(-n3ccc(OCc4ccccc4)cc3=O)cc2)C1,IC50,nM,>,10.0,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3275,CHEMBL1642492,CCN(CC)CCNc1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,nM,=,7.0,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3276,CHEMBL1642493,CCN(CC)CCN(C)c1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,nM,=,1.7,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3277,CHEMBL1642494,CCN(CC)CCN(C(=O)OC)c1ccc(-n2ccc(OCc3ccccc3)cc2=O)cc1,IC50,,,,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3278,CHEMBL1642258,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(=O)N(C)C)CC2,IC50,nM,=,3900.0,Inhibition of human ERG by patch clamp assay
3279,CHEMBL1645164,COC(=O)c1coc(CN2CCN(C(=O)CC(c3ccc(F)cc3)c3ccc(Br)cc3)CC2)n1,IC50,nM,=,2230.0,Inhibition of human hERG
3280,CHEMBL1645167,COC(=O)c1coc(CN2CCN(C(=O)CC(c3ccc(F)cc3)c3ccc(C(F)(F)F)cc3)CC2)n1,IC50,nM,=,3830.0,Inhibition of human hERG
3281,CHEMBL1645172,Cc1ccc2nc(CN3CCN(C(=O)CC(c4ccccc4)c4ccc(F)cc4)CC3)oc2c1,IC50,nM,=,2270.0,Inhibition of human hERG
3282,CHEMBL1645184,COc1ccc(C(CC(=O)N2CCN(Cc3nc4ccc(C)cc4o3)CC2)c2ccccc2)cc1,IC50,nM,=,1160.0,Inhibition of human hERG
3283,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1400.0,Inhibition of human hERG
3284,CHEMBL1644183,O=C(O)CCNC(=O)c1ccc(Cn2nc(-c3cc(Cl)cc(Cl)c3)cc2-c2ccc(OC(F)(F)F)cc2)cc1,IC50,nM,=,5100.0,Inhibition of human ERG
3285,CHEMBL809,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,IC50,,,,Inhibition of human ERG
3286,CHEMBL1642894,CN[C@H]1Cc2ccccc2[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,,,,Inhibition of human ERG
3287,CHEMBL1642895,CN[C@@H]1Cc2ccccc2[C@@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,2320.0,Inhibition of human ERG
3288,CHEMBL1642896,CN[C@@H]1Cc2ccccc2[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,5270.0,Inhibition of human ERG
3289,CHEMBL1642897,CN[C@H]1Cc2ccccc2[C@@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,1600.0,Inhibition of human ERG
3290,CHEMBL1642906,CNC[C@H]1Cc2ccccc2[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,1610.0,Inhibition of human ERG
3291,CHEMBL1642907,CNC[C@@H]1Cc2ccccc2[C@@H](c2ccc(Cl)c(Cl)c2)C1,IC50,,,,Inhibition of human ERG
3292,CHEMBL1642908,CNC[C@@H]1Cc2ccccc2[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,2000.0,Inhibition of human ERG
3293,CHEMBL1642912,NCC[C@@H]1Cc2ccccc2[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,13100.0,Inhibition of human ERG
3294,CHEMBL1642913,NCC[C@H]1Cc2ccccc2[C@@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,1510.0,Inhibition of human ERG
3295,CHEMBL1642914,CN[C@H]1CCc2ccccc2[C@@H]1c1ccc(Cl)c(Cl)c1,IC50,,,,Inhibition of human ERG
3296,CHEMBL1642915,CN[C@@H]1CCc2ccccc2[C@@H]1c1ccc(Cl)c(Cl)c1,IC50,,,,Inhibition of human ERG
3297,CHEMBL1642916,CN[C@@H]1CCc2ccccc2[C@H]1c1ccc(Cl)c(Cl)c1,IC50,,,,Inhibition of human ERG
3298,CHEMBL1642917,CN[C@H]1CCc2ccccc2[C@H]1c1ccc(Cl)c(Cl)c1,IC50,,,,Inhibition of human ERG
3299,CHEMBL1643512,N[C@@H]1CCN(c2ccc(Cl)c(Cl)c2)c2ccccc21,IC50,nM,=,3500.0,Inhibition of human ERG
3300,CHEMBL1643511,CNC1CCN(c2ccc(Cl)c(Cl)c2)c2ccccc21,IC50,nM,=,7800.0,Inhibition of human ERG
3301,CHEMBL1643513,CN[C@@H]1CCN(c2ccc(Cl)c(Cl)c2)c2ccccc21,IC50,nM,=,3250.0,Inhibition of human ERG
3302,CHEMBL1643514,CN(C)[C@@H]1CCN(c2ccc(Cl)c(Cl)c2)c2ccccc21,IC50,nM,=,8600.0,Inhibition of human ERG
3303,CHEMBL1643518,CN[C@H]1Cc2ccccc2N(c2ccc(Cl)c(Cl)c2)C1,IC50,,,,Inhibition of human ERG
3304,CHEMBL1650511,FC(F)(F)c1ccccc1-c1cc(C(F)(F)F)c2[nH]c(C3=NOC4(CCCCC4)C3)nc2c1,IC50,nM,=,16000.0,Displacement of [3H]astemizole from human ERG by whole cell patch-clamp technique
3305,CHEMBL1651717,O=C(O)C1CN(Cc2ccc(-c3cc4cc(Cc5ccccc5)ccc4o3)c(F)c2)C1,IC50,nM,=,17000.0,Inhibition of human ERG by patch-clamp method
3306,CHEMBL1649933,CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(C(=O)C(C)(C)C)C3)C2)c1cccc(F)c1,IC50,nM,=,5000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3307,CHEMBL1649931,CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1,IC50,nM,=,12000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3308,CHEMBL1649932,CCCC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(C)=O)c2cccc(F)c2)C1,IC50,nM,=,6000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3309,CHEMBL1649930,CCC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(C)=O)c2cccc(F)c2)C1,IC50,nM,=,5000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3310,CHEMBL1649911,CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(C(C)=O)C3)C2)c1cccc(F)c1,IC50,nM,=,5000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3311,CHEMBL1649910,COC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(C)=O)c2cccc(F)c2)C1,IC50,nM,=,2000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3312,CHEMBL1649928,CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(c1ccncn1)C3)C2)c1cccc(F)c1,IC50,nM,=,10.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3313,CHEMBL1649929,CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(c1cnccn1)C3)C2)c1cccc(F)c1,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3314,CHEMBL1649913,CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3ccccc31)C2)c1ccccc1,IC50,nM,=,1500.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3315,CHEMBL1649912,Cc1nc(C(C)C)n([C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1,IC50,nM,=,4230.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells
3316,CHEMBL1642362,O=C(NC1CCCCC1)[C@H](C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(Cl)cc21,IC50,nM,=,1600.0,Inhibition of human ERG expressed in CHO cells
3317,CHEMBL1668238,O=C(NC1CCCCC1)[C@H](C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(F)cc21,IC50,nM,=,1400.0,Inhibition of human ERG expressed in CHO cells
3318,CHEMBL1668239,O=C(N[C@H]1CC[C@H](O)CC1)[C@H](C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(F)cc21,IC50,nM,=,7300.0,Inhibition of human ERG expressed in CHO cells
3319,CHEMBL1668240,O=C(N[C@H]1CC[C@H](C(=O)O)CC1)[C@H](C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(F)cc21,IC50,nM,=,7600.0,Inhibition of human ERG expressed in CHO cells
3320,CHEMBL1615153,O=C(O)c1ccc(NC(=O)[C@H](C2CCCCC2)n2c(-c3ccc(Cl)cc3)nc3cc(F)c(F)cc32)cc1,IC50,nM,>,20000.0,Inhibition of human ERG expressed in CHO cells
3321,CHEMBL1615152,O=C(O)c1ccc(NC(=O)[C@H](C2CCCCC2)n2c(-c3ccc(Cl)cc3)nc3cc(F)c(F)cc32)c(F)c1,IC50,nM,>,20000.0,Inhibition of human ERG expressed in CHO cells
3322,CHEMBL1668243,O=C(O)c1ccc(NC(=O)[C@H](C2CCCCC2)n2c(-c3ccc(Cl)cc3)nc3cc(F)c(F)cc32)c(Cl)c1,IC50,nM,=,7800.0,Inhibition of human ERG expressed in CHO cells
3323,CHEMBL1615150,Cc1cc(C(=O)O)ccc1NC(=O)[C@H](C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(F)cc21,IC50,nM,=,700.0,Inhibition of human ERG expressed in CHO cells
3324,CHEMBL1668249,O=C(Nc1ccc(OC2(C(=O)O)CC2)cc1F)[C@H](C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(F)cc21,IC50,nM,>,20000.0,Inhibition of human ERG expressed in CHO cells
3325,CHEMBL1668257,O=C(Nc1ccc(-c2nnn[nH]2)cc1F)[C@H](C1CCCCC1)n1c(-c2ccc(Cl)cc2)nc2cc(F)c(F)cc21,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells
3326,CHEMBL1668259,O=C(O)c1ccc(NC(=O)[C@H](C2CCCCC2)n2c(-c3ccc(Cl)cc3)nc3ccccc32)c(C(F)(F)F)c1,IC50,nM,>,20000.0,Inhibition of human ERG expressed in CHO cells
3327,CHEMBL1668261,COc1ccc(-c2nc3cc(F)c(F)cc3n2[C@H](C(=O)N[C@H]2CC[C@H](C(=O)O)CC2)C2CCCCC2)c(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells
3328,CHEMBL1668262,COc1ccc(-c2nc3cc(F)c(F)cc3n2[C@H](C(=O)N[C@H]2CC[C@H](C(=O)O)CC2)C2CCCCC2)c(Cl)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells
3329,CHEMBL1091720,CCC(C)(C)Cc1c[nH]c(CCc2ccc(-c3ccccn3)cc2)n1,IC50,nM,=,1200.0,Inhibition of human ERG
3330,CHEMBL1672558,O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1,IC50,nM,>,10000.0,Inhibition of human ERG by electrophysiology assay
3331,CHEMBL40,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,IC50,nM,=,3019951.72,Inhibition of human ERG
3332,CHEMBL299390,CCC(CC)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,1479108.39,Inhibition of human ERG
3333,CHEMBL53321,CCC(=O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,1995262.31,Inhibition of human ERG
3334,CHEMBL300907,CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,3467368.5,Inhibition of human ERG
3335,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human ERG
3336,CHEMBL22,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,IC50,nM,=,239883.29,Inhibition of human ERG
3337,CHEMBL1673435,CC1=C2C3OC(=O)C(C)C3C(O)CC2(C)C=CC1=O,IC50,nM,=,109647.82,Inhibition of human ERG
3338,CHEMBL640,CCN(CC)CCNC(=O)c1ccc(N)cc1,IC50,nM,=,138038.43,Inhibition of human ERG
3339,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,nM,=,954992.59,Inhibition of human ERG
3340,CHEMBL440464,CN1CCCC1c1cccnc1,IC50,nM,=,245470.89,Inhibition of human ERG
3341,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,128824.96,Inhibition of human ERG
3342,CHEMBL603584,COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1,IC50,nM,=,17378.01,Inhibition of human ERG
3343,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,22908.68,Inhibition of human ERG
3344,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,50118.72,Inhibition of human ERG
3345,CHEMBL300927,O=C(O)c1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,74131.02,Inhibition of human ERG
3346,CHEMBL52348,CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,25703957.83,Inhibition of human ERG
3347,CHEMBL53871,CCC(O)(CC)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,15848.93,Inhibition of human ERG
3348,CHEMBL517,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,IC50,nM,=,91201.08,Inhibition of human ERG
3349,CHEMBL1673437,CCCC1NC(C)C2C(=O)N=C(c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)NN12,IC50,nM,=,12882.5,Inhibition of human ERG
3350,CHEMBL505,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,IC50,nM,=,20892.96,Inhibition of human ERG
3351,CHEMBL611,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,IC50,nM,=,17782.79,Inhibition of human ERG
3352,CHEMBL1000,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,IC50,nM,=,31622.78,Inhibition of human ERG
3353,CHEMBL1673438,CC(C)Oc1cc(C(C2=CCC(=O)N=C2)c2ccc(C(C)(C)O)nc2)ccc1OC(F)F,IC50,nM,=,56234.13,Inhibition of human ERG
3354,CHEMBL1125,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1,IC50,nM,=,12589.25,Inhibition of human ERG
3355,CHEMBL845,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,IC50,nM,=,31622.78,Inhibition of human ERG
3356,CHEMBL193,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],IC50,nM,=,50118.72,Inhibition of human ERG
3357,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,3311.31,Inhibition of human ERG
3358,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,1380.38,Inhibition of human ERG
3359,CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,nM,=,1905.46,Inhibition of human ERG
3360,CHEMBL1673440,CC1N=CN=C1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,3162.28,Inhibition of human ERG
3361,CHEMBL17423,COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC,IC50,nM,=,1096.48,Inhibition of human ERG
3362,CHEMBL75880,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,IC50,nM,=,7762.47,Inhibition of human ERG
3363,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1479.11,Inhibition of human ERG
3364,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,10000.0,Inhibition of human ERG
3365,CHEMBL416956,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,IC50,nM,=,5495.41,Inhibition of human ERG
3366,CHEMBL363295,CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C,IC50,nM,=,5754.4,Inhibition of human ERG
3367,CHEMBL52794,CC(O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,4570881.9,Inhibition of human ERG
3368,CHEMBL76,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,IC50,nM,=,2511.89,Inhibition of human ERG
3369,CHEMBL657,CN(C)CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,2570.4,Inhibition of human ERG
3370,CHEMBL652,O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,IC50,nM,=,3890.45,Inhibition of human ERG
3371,CHEMBL38827,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1,IC50,nM,=,8128.31,Inhibition of human ERG
3372,CHEMBL3706574,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2C1C(C)C,IC50,nM,=,1445.44,Inhibition of human ERG
3373,CHEMBL2,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,IC50,nM,=,1584.89,Inhibition of human ERG
3374,CHEMBL475534,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,10000.0,Inhibition of human ERG
3375,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,147.91,Inhibition of human ERG
3376,CHEMBL708,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,IC50,nM,=,125.89,Inhibition of human ERG
3377,CHEMBL1088,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,IC50,nM,=,316.23,Inhibition of human ERG
3378,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,213.8,Inhibition of human ERG
3379,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,141.25,Inhibition of human ERG
3380,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,194.98,Inhibition of human ERG
3381,CHEMBL123558,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1,IC50,nM,=,562.34,Inhibition of human ERG
3382,CHEMBL55835,O=C(O)Cc1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,575.44,Inhibition of human ERG
3383,CHEMBL53661,O=C1NCCN1CCN1CCC(c2cn(C3CCCCC3)c3ccc(Cl)cc23)CC1,IC50,nM,=,138.04,Inhibition of human ERG
3384,CHEMBL415944,COC(=O)Cc1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,131.83,Inhibition of human ERG
3385,CHEMBL52832,CC(C)(O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,457.09,Inhibition of human ERG
3386,CHEMBL273235,Fc1ccc(-n2cc(C3CCNCC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,204.17,Inhibition of human ERG
3387,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IC50,nM,=,1000.0,Inhibition of human ERG
3388,CHEMBL43,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,IC50,nM,=,208.93,Inhibition of human ERG
3389,CHEMBL219916,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,nM,=,162.18,Inhibition of human ERG
3390,CHEMBL305660,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,331.13,Inhibition of human ERG
3391,CHEMBL1673442,O=C(c1ccc(F)cc1)N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,IC50,nM,=,107.15,Inhibition of human ERG
3392,CHEMBL1673443,CC(=O)NC(=O)C1CCC(C2N=CC(c3cccc(Br)c3)=N2)CC1,IC50,nM,=,501.19,Inhibition of human ERG
3393,CHEMBL7463,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,IC50,nM,=,1000.0,Inhibition of human ERG
3394,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,54.95,Inhibition of human ERG
3395,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.79,Inhibition of human ERG
3396,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,95.5,Inhibition of human ERG
3397,CHEMBL443476,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,87.1,Inhibition of human ERG
3398,CHEMBL52999,COC(=O)c1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,IC50,nM,=,36.31,Inhibition of human ERG
3399,CHEMBL556312,O=C1NCCN1CCN1CCC(C2CN(c3ccc(F)cc3)c3ccccc32)CC1,IC50,nM,=,23.44,Inhibition of human ERG
3400,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,11.48,Inhibition of human ERG
3401,CHEMBL92870,Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,15.85,Inhibition of human ERG
3402,CHEMBL1671884,c1ccc(C2=Nc3ccccc3C2C2CCN(c3ccccc3)CC2)cc1,IC50,nM,=,79.43,Inhibition of human ERG
3403,CHEMBL1671885,CCCCCCCCC(=O)NCc1ccc(CC(O)CO)c(OC)c1,IC50,nM,=,100.0,Inhibition of human ERG
3404,CHEMBL298978,Fc1ccc(-n2cc(C3CCN(CCN4CCN=C4S)CC3)c3ccccc32)cc1,IC50,nM,=,6.166,Inhibition of human ERG
3405,CHEMBL12780,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccccc23)CC1,IC50,nM,=,6.918,Inhibition of human ERG
3406,CHEMBL16,O=C1N=C(O)NC1(c1ccccc1)c1ccccc1,IC50,nM,=,239883.29,Inhibition of human ERG
3407,CHEMBL448,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,IC50,nM,=,131825.67,Inhibition of human ERG
3408,CHEMBL124754,O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12,IC50,nM,=,12022.64,Inhibition of human ERG
3409,CHEMBL1671887,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O,IC50,nM,=,72443.6,Inhibition of human ERG
3410,CHEMBL163238,Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2,IC50,nM,=,20417.38,Inhibition of human ERG
3411,CHEMBL1671888,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)/C(=N/OCOCCOC)C(C)C(O)C1(C)O,IC50,nM,=,36307.81,Inhibition of human ERG
3412,CHEMBL498572,O=C(OC1CC2CC3CC(C1)N2CC3O)c1c[nH]c2ccccc12,IC50,nM,=,12022.64,Inhibition of human ERG
3413,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3388.44,Inhibition of human ERG
3414,CHEMBL716,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,IC50,nM,=,5754.4,Inhibition of human ERG
3415,CHEMBL53089,CC(C)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,10000.0,Inhibition of human ERG
3416,CHEMBL299590,CC(C)(C)c1ccc2c(ccn2-c2ccc(F)cc2)c1,IC50,nM,=,10000.0,Inhibition of human ERG
3417,CHEMBL301992,CC(=O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,10000.0,Inhibition of human ERG
3418,CHEMBL549,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,IC50,nM,=,3981.07,Inhibition of human ERG
3419,CHEMBL1671889,N#Cc1ccc(Cn2cncc2CNC2CCN(C(=O)c3cncc(Br)c3)C2=O)cc1,IC50,nM,=,6025.6,Inhibition of human ERG
3420,CHEMBL1671890,CC/N=C(\c1ccc(OC)c(OC)c1)N1CCCc2cc(C3=NNC(=O)SC3C)ccc21,IC50,nM,=,6606.93,Inhibition of human ERG
3421,CHEMBL138093,O=C1CCC(c2ccc(Nc3ccncc3)cc2)=NN1,IC50,nM,=,1047.13,Inhibition of human ERG
3422,CHEMBL42557,c1ccc(-c2[nH]c3ccccc3c2C2CCCNC2)cc1,IC50,nM,=,4897.79,Inhibition of human ERG
3423,CHEMBL19224,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,IC50,nM,=,7244.36,Inhibition of human ERG
3424,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,3981.07,Inhibition of human ERG
3425,CHEMBL412663,COC(=O)C1=CCC2CCC1N2C,IC50,nM,=,8912.51,Inhibition of human ERG
3426,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,229.09,Inhibition of human ERG
3427,CHEMBL46,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,IC50,nM,=,812.83,Inhibition of human ERG
3428,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,457.09,Inhibition of human ERG
3429,CHEMBL94454,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,436.52,Inhibition of human ERG
3430,CHEMBL707,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,IC50,nM,=,588.84,Inhibition of human ERG
3431,CHEMBL167779,CCN(CC)CCOc1ccc(/C(=C(\Cl)c2ccccc2)c2ccccc2)cc1,IC50,nM,=,181.97,Inhibition of human ERG
3432,CHEMBL1671892,O=C(NCCO)C1CCC(c2ncc(-c3cccc(C(F)(F)F)c3)[nH]2)CC1,IC50,nM,=,501.19,Inhibition of human ERG
3433,CHEMBL1671893,COc1ccc(C2CCN(CCN3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,251.19,Inhibition of human ERG
3434,CHEMBL94664,COc1ccc(C2CCN(CCC3CCOc4ccccc43)CC2)cc1OC,IC50,nM,=,199.53,Inhibition of human ERG
3435,CHEMBL1671894,c1ccc(-c2[nH]c3ccccc3c2C2CC3CCC(C2)N3c2ccccc2)cc1,IC50,nM,=,17.78,Inhibition of human ERG
3436,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,12.02,Inhibition of human ERG
3437,CHEMBL12186,O=C1NCCN1CCN1CC=C(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,10.0,Inhibition of human ERG
3438,CHEMBL289469,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,IC50,nM,=,3801.89,Inhibition of human ERG
3439,CHEMBL1671895,CN1C2CCC1C(C(=O)O)C(OC(=O)c1ccccc1)C2,IC50,nM,=,3981071.71,Inhibition of human ERG
3440,CHEMBL295124,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2,IC50,nM,=,66069.34,Inhibition of human ERG
3441,CHEMBL1439973,CC(C)(O)C(Cl)(Cl)Cl,IC50,nM,=,4365158.32,Inhibition of human ERG
3442,CHEMBL1671896,CCNCCc1cccc(C(F)(F)F)c1,IC50,nM,=,537031.8,Inhibition of human ERG
3443,CHEMBL184412,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,IC50,nM,=,316.23,Inhibition of human ERG
3444,CHEMBL412663,COC(=O)C1=CCC2CCC1N2C,IC50,nM,=,169824.37,Inhibition of human ERG
3445,CHEMBL83,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,IC50,nM,=,1584.89,Inhibition of human ERG
3446,CHEMBL300117,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,IC50,nM,=,2754.23,Inhibition of human ERG
3447,CHEMBL1671897,COc1ccc(CC(=O)NCc2ccccc2-c2ccccc2C(=O)NCCc2cccnc2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG
3448,CHEMBL70099,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,IC50,nM,=,2398.83,Inhibition of human ERG
3449,CHEMBL1112,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,IC50,nM,=,630.96,Inhibition of human ERG
3450,CHEMBL441472,CC(C)(C)c1ccc(NC(=O)N2CCN(c3ncccc3Cl)CC2)cc1,IC50,nM,=,1000.0,Inhibition of human ERG
3451,CHEMBL511099,Cc1ccc(C23CNCC2C3)cc1,IC50,nM,=,44668.36,Inhibition of human ERG
3452,CHEMBL811,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,IC50,nM,=,891.25,Inhibition of human ERG
3453,CHEMBL49,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,IC50,nM,=,3981.07,Inhibition of human ERG
3454,CHEMBL1671898,Cc1cn2c(N)c(Cl)cc(C(=O)NCC3CCN(CC(C)C)CC3)c2n1,IC50,nM,=,2570.4,Inhibition of human ERG
3455,CHEMBL108,NC(=O)N1c2ccccc2C=Cc2ccccc21,IC50,nM,=,104712.85,Inhibition of human ERG
3456,CHEMBL325109,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1,IC50,nM,=,602.56,Inhibition of human ERG
3457,CHEMBL1671899,CO/N=C1\CN(c2nc3c(cc2F)C(=O)C(C(=O)O)CN3C2CC2)CC12CNC2,IC50,nM,=,218776.16,Inhibition of human ERG
3458,CHEMBL502,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,IC50,nM,=,1995.26,Inhibition of human ERG
3459,CHEMBL101740,CN(C)CC/C=C1/c2ccccc2COc2ccccc21,IC50,nM,=,6456.54,Inhibition of human ERG
3460,CHEMBL1671900,CCOP(=O)(Sc1ccccc1)Sc1ccccc1,IC50,nM,=,50118.72,Inhibition of human ERG
3461,CHEMBL311663,O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,nM,=,6025.6,Inhibition of human ERG
3462,CHEMBL1232472,COC(=O)[C@H]1[C@@H](O)C[C@@H]2CC[C@H]1N2C,IC50,nM,=,416869.38,Inhibition of human ERG
3463,CHEMBL290242,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](N)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,316227.77,Inhibition of human ERG
3464,CHEMBL1671901,CC(C)(CN1CCC(=C2c3ccc(F)cc3COc3ccccc32)CC1)C(=O)O,IC50,nM,=,10000.0,Inhibition of human ERG
3465,CHEMBL6,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,IC50,nM,=,301995.17,Inhibition of human ERG
3466,CHEMBL1513,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,IC50,nM,=,194984.46,Inhibition of human ERG
3467,CHEMBL1671902,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2c1NON2,IC50,nM,=,50118.72,Inhibition of human ERG
3468,CHEMBL1671903,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C\C=C\C[C@@H](C)OC(=O)C[C@H]1OC(C)=O,IC50,nM,=,102329.3,Inhibition of human ERG
3469,CHEMBL182977,CCCCCCCN(CC)CCCCc1ccc([N+](=O)[O-])cc1,IC50,nM,=,2.188,Inhibition of human ERG
3470,CHEMBL1201193,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,IC50,nM,=,20892.96,Inhibition of human ERG
3471,CHEMBL561,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21,IC50,nM,=,2398832.92,Inhibition of human ERG
3472,CHEMBL1087,Cc1cccc(C)c1NC(=O)C1CCCCN1C,IC50,nM,=,154881.66,Inhibition of human ERG
3473,CHEMBL558,Cc1cccc(C)c1OCC(C)N,IC50,nM,=,10000.0,Inhibition of human ERG
3474,CHEMBL86304,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,IC50,nM,=,79432.82,Inhibition of human ERG
3475,CHEMBL60889,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,IC50,nM,=,4786.3,Inhibition of human ERG
3476,CHEMBL1494,NCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,2290.87,Inhibition of human ERG
3477,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,204.17,Inhibition of human ERG
3478,CHEMBL900,Cc1ccccc1C(OCCN(C)C)c1ccccc1,IC50,nM,=,851.14,Inhibition of human ERG
3479,CHEMBL1621,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,IC50,nM,=,1288.25,Inhibition of human ERG
3480,CHEMBL531,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,IC50,nM,=,120.23,Inhibition of human ERG
3481,CHEMBL607,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,IC50,nM,=,74131.02,Inhibition of human ERG
3482,CHEMBL4,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,1412537.54,Inhibition of human ERG
3483,CHEMBL53866,CCC(O)c1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,2187761.62,Inhibition of human ERG
3484,CHEMBL1671904,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,IC50,nM,=,33113.11,Inhibition of human ERG
3485,CHEMBL472,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,IC50,nM,=,74131.02,Inhibition of human ERG
3486,CHEMBL1671905,CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2ccc3c(c2)OCO3)C1=O,IC50,nM,=,100000.0,Inhibition of human ERG
3487,CHEMBL723,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,IC50,nM,=,12589.25,Inhibition of human ERG
3488,CHEMBL1671906,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(C)c2cc1OC,IC50,nM,=,83176.38,Inhibition of human ERG
3489,CHEMBL32363,COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1N2C,IC50,nM,=,7244.36,Inhibition of human ERG
3490,CHEMBL998,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,IC50,nM,=,173.78,Inhibition of human ERG
3491,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,26.92,Inhibition of human ERG
3492,CHEMBL301956,CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12,IC50,nM,=,10.96,Inhibition of human ERG
3493,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,22.91,Inhibition of human ERG
3494,CHEMBL533,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,15.14,Inhibition of human ERG
3495,CHEMBL52627,CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(C3CCc4cc(C#N)ccc4C3)CC1)O2,IC50,nM,=,20.89,Inhibition of human ERG
3496,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,6.761,Inhibition of human ERG
3497,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,32.36,Inhibition of human ERG
3498,CHEMBL284348,Nc1ccncc1,IC50,nM,=,4365158.32,Inhibition of human ERG
3499,CHEMBL334491,CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1,IC50,nM,=,851.14,Inhibition of human ERG
3500,CHEMBL9484,CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1,IC50,nM,=,12.59,Inhibition of human ERG
3501,CHEMBL104,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,IC50,nM,=,3019.95,Inhibition of human ERG
3502,CHEMBL127457,CCOC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1N2C,IC50,nM,=,1202.26,Inhibition of human ERG
3503,CHEMBL1671908,CCC1=C(C)CC(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O,IC50,nM,=,74131.02,Inhibition of human ERG
3504,CHEMBL511142,CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,IC50,nM,=,7943.28,Inhibition of human ERG
3505,CHEMBL305187,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,IC50,nM,=,100.0,Inhibition of human ERG
3506,CHEMBL79,CCN(CC)CC(=O)Nc1c(C)cccc1C,IC50,nM,=,263026.8,Inhibition of human ERG
3507,CHEMBL729,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,IC50,nM,=,8511.38,Inhibition of human ERG
3508,CHEMBL1671910,COc1ccc(CC(=O)Nc2cc3c(cc2[N+](=O)[O-])OC(C)(C)[C@H](O)[C@H]3NC2CC2)cc1,IC50,nM,=,43651.58,Inhibition of human ERG
3509,CHEMBL1683444,C[C@@H](C[C@@H](CS(=O)(=O)N1CCC(OCc2ccc(Cl)cc2Cl)CC1)N(O)C=O)c1ncc(F)cn1,IC50,nM,=,5000.0,Inhibition of human ERG
3510,CHEMBL1615186,C[C@@H](C[C@@](C)(CS(=O)(=O)N1CCC(OCc2ccc(Cl)cc2Cl)CC1)N(O)C=O)c1ncc(F)cn1,IC50,nM,=,8000.0,Inhibition of human ERG
3511,CHEMBL1683445,C[C@@H](C[C@@](C)(CS(=O)(=O)N1CCN(c2ccc(F)cc2)CC1)N(O)C=O)c1ncc(F)cn1,IC50,nM,=,21000.0,Inhibition of human ERG
3512,CHEMBL1683443,C[C@@H](C[C@@H](CS(=O)(=O)N1CCN(c2ccc(F)cc2)CC1)N(O)C=O)c1ncc(F)cn1,IC50,nM,=,26000.0,Inhibition of human ERG
3513,CHEMBL1684045,CNC(C)C1(c2ccc(Cl)c(Cl)c2)CCCCC1,IC50,nM,=,23000.0,Inhibition of human ERG
3514,CHEMBL1684047,CC(N(C)C)C1(c2ccc(Cl)c(Cl)c2)CCCCC1,IC50,nM,=,40000.0,Inhibition of human ERG
3515,CHEMBL1684055,CC(N(C)C)C1(c2ccc3ccccc3c2)CCCCC1,IC50,nM,=,4300.0,Inhibition of human ERG
3516,CHEMBL1684057,CNC(C)C1(c2ccc(Cl)c(Cl)c2)CCCCC1.Cl,IC50,nM,=,23000.0,Inhibition of human ERG
3517,CHEMBL1684058,CC(N(C)C)C1(c2ccc(Cl)c(Cl)c2)CCCCC1.Cl,IC50,nM,=,40000.0,Inhibition of human ERG
3518,CHEMBL1684059,CC(N(C)C)C1(c2ccc3ccccc3c2)CCCCC1.Cl,IC50,nM,=,4300.0,Inhibition of human ERG
3519,CHEMBL1683577,Cc1c(C(=O)Nc2ccn(C)n2)ncn1Cc1cccc(C(F)(F)F)c1,IC50,nM,=,28900.0,Inhibition of human ERG by patch clamp assay
3520,CHEMBL1683074,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1,IC50,nM,=,1700.0,Displacement of dofetilide from human ERG
3521,CHEMBL3084348,Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC(CNS(=O)(=O)c1ccccc1)c1ccccc1,IC50,nM,>=,10000.0,Displacement of labeled dofetilide from human ERG
3522,CHEMBL3084348,Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC(CNS(=O)(=O)c1ccccc1)c1ccccc1,IC50,nM,>=,10000.0,Displacement of labeled dofetilide from human ERG
3523,CHEMBL3084349,Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC(CNC(=O)C1CCC(F)(F)CC1)c1ccccc1,IC50,nM,>=,10000.0,Displacement of labeled dofetilide from human ERG
3524,CHEMBL3084349,Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC(CNC(=O)C1CCC(F)(F)CC1)c1ccccc1,IC50,nM,>=,10000.0,Displacement of labeled dofetilide from human ERG
3525,CHEMBL3084350,Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC(CNC(=O)C1CC(F)(F)C1)c1ccccc1,IC50,nM,>=,10000.0,Displacement of labeled dofetilide from human ERG
3526,CHEMBL3084351,Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC(CNC(=O)c1ccccc1)c1ccccc1,IC50,nM,>=,10000.0,Displacement of labeled dofetilide from human ERG
3527,CHEMBL1684932,COc1ccc([C@@H](C)NC(=O)Cc2ccc(C(C)(C)C)cc2)nc1,IC50,nM,>,10000.0,Inhibition of human ERG
3528,CHEMBL1684954,C[C@@H](NC(=O)Cc1ccc(C2CC2)cc1)c1ccc(OCC(F)(F)F)cn1,IC50,nM,>,10000.0,Inhibition of human ERG
3529,CHEMBL1684585,Nc1nc(CC(=O)Nc2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1,IC50,nM,=,11200.0,Inhibition of human ERG
3530,CHEMBL1683074,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1,IC50,nM,=,1700.0,Inhibition of human ERG by patch clamp assay
3531,CHEMBL1688243,CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,IC50,nM,=,4500.0,Inhibition of human hERG
3532,CHEMBL1668584,CNc1nn2c(C)cc(C)nc2c1S(=O)(=O)c1ccccc1,IC50,nM,>,30000.0,Antagonist activity at human ERG by patch clamp method
3533,CHEMBL447183,N#Cc1ccc(C(=O)N2CCC3(CC2)N=C(N)c2c(F)ccc(F)c2N3)cn1,IC50,nM,=,100.0,Inhibition of human ERG
3534,CHEMBL1762470,NCC(Oc1cc(Cl)ccc1Cl)c1ccccc1,IC50,,,,Inhibition of human ERG
3535,CHEMBL1762471,CNCC[C@@H](Oc1cc(Cl)ccc1Cl)c1ccccc1.O=C(O)/C=C/C(=O)O,IC50,,,,Inhibition of human ERG
3536,CHEMBL1762472,CNCC[C@@H](Oc1cc(Cl)ccc1C#N)c1ccccc1.Cl,IC50,nM,=,10000.0,Inhibition of human ERG
3537,CHEMBL1762473,N#Cc1ccc(Cl)cc1O[C@H](CCN)c1ccccc1.O=C(O)C(=O)O,IC50,,,,Inhibition of human ERG
3538,CHEMBL1762474,N#Cc1ccc(Cl)cc1S[C@H](CCN)c1ccccc1.O=C(O)/C=C/C(=O)O,IC50,,,,Inhibition of human ERG
3539,CHEMBL1762475,CNCC[C@@H](Oc1cc(C(F)(F)F)ccc1C#N)c1ccccc1.Cl,IC50,,,,Inhibition of human ERG
3540,CHEMBL1762476,CNCC[C@@H](Oc1cc(OC)ccc1C#N)c1ccccc1.O=C(O)C(=O)O,IC50,,,,Inhibition of human ERG
3541,CHEMBL1762477,N#Cc1cc(Cl)ccc1O[C@H](CCN)c1ccccc1.O=C(O)/C=C/C(=O)O,IC50,,,,Inhibition of human ERG
3542,CHEMBL1762478,CCC(CCNC)Oc1cc(Cl)ccc1C#N.Cl,IC50,,,,Inhibition of human ERG
3543,CHEMBL1762479,N#Cc1cc(F)c(Cl)cc1O[C@H](CCN)c1ccccc1.O=C(O)C(=O)O,IC50,nM,>,10000.0,Inhibition of human ERG
3544,CHEMBL1762480,Cc1ccc(C#N)c(S[C@H](CCN)c2ccccc2)n1.O=C(O)/C=C/C(=O)O,IC50,,,,Inhibition of human ERG
3545,CHEMBL1762481,N#Cc1ccc(C(F)(F)F)nc1O[C@H](CCN)c1ccno1.O=C(O)C(=O)O,IC50,nM,>,10000.0,Inhibition of human ERG
3546,CHEMBL1760059,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,160.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3547,CHEMBL1760222,COc1ccc([C@H]2CN(Cc3ccc(OC)c(OC)c3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,600.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3548,CHEMBL1760223,COc1ccc([C@H]2CN(CCCc3ccc(OC)c(OC)c3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,200.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3549,CHEMBL1760226,COc1ccc([C@H]2CN(CCc3cccc(OC)c3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,47.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3550,CHEMBL1760227,COc1ccc(CCN2C[C@H](CNC(=O)c3cccc(Cl)c3)[C@@H](c3ccc(OC)cc3)C2)cc1,IC50,nM,=,28.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3551,CHEMBL1760229,COc1ccc([C@H]2CN(CCC3CCOCC3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,1960.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3552,CHEMBL1760003,COc1ccc([C@H]2CN(CCCC3CCOCC3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,1030.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3553,CHEMBL1760230,COc1ccc([C@H]2CN(CCCC3CCNCC3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,20300.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3554,CHEMBL1760234,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,66.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3555,CHEMBL1760235,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CC(=O)N(C)c2cccc(Cl)c2)cc1,IC50,nM,=,29.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3556,CHEMBL1760236,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CC(=O)NCc2cccc(Cl)c2)cc1,IC50,nM,=,34.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3557,CHEMBL1760237,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CCNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,56.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3558,CHEMBL1760242,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2Cc2nc3ccc(Cl)cc3[nH]2)cc1,IC50,nM,=,28.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3559,CHEMBL1760243,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CCc2nc3ccc(Cl)cc3[nH]2)cc1,IC50,nM,=,16.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3560,CHEMBL1760244,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CCc2cc3ccc(Cl)cc3[nH]2)cc1,IC50,nM,=,45.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3561,CHEMBL1760234,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,2.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3562,CHEMBL1760245,COc1ccc([C@H]2CN(CCCC3CCOCC3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,370.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3563,CHEMBL1760246,COc1ccc([C@H]2CN(CCC3CCOCC3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,120.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3564,CHEMBL1760247,COc1ccc([C@H]2CN(CCC3CCS(=O)(=O)CC3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,290.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3565,CHEMBL1760248,COc1ccc([C@H]2CN(CCC3(O)CCOCC3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,8240.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3566,CHEMBL1760249,COc1ccc([C@H]2CN(CCCN(C)S(C)(=O)=O)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,4620.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3567,CHEMBL1760250,COc1ccc([C@H]2CN(CCCN(C)S(=O)(=O)c3ccccc3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,140.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3568,CHEMBL1760251,COc1ccc([C@H]2CN(CCCN3CCCC3=O)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1,IC50,nM,=,1260.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3569,CHEMBL1760059,COc1ccc([C@H]2CN(CCc3ccc(OC)c(OC)c3)C[C@@H]2CNC(=O)c2cccc(Cl)c2)cc1,IC50,nM,=,110.0,Displacement of [3H]-dofetilide from human ERG expressed in human HEK293 cells after 90 mins by scintillation counting
3570,CHEMBL1761103,CC(=O)Nc1cccc(C2CCN(CCCn3c(-c4ccc(Cl)cc4)nc4ccccc43)CC2)c1,IC50,nM,=,3.0,Inhibition hERG by patch clamp method
3571,CHEMBL1170367,CCN(C(C)=O)c1ccc(OC)c2nc(NC(=O)c3ccnn3C)sc12,IC50,nM,>,100000.0,Inhibition of human ERG
3572,CHEMBL639,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,IC50,nM,=,100.0,Displacement of labeled dofetilide human ERG
3573,CHEMBL1767164,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1,IC50,nM,=,50.12,Displacement of labeled dofetilide human ERG
3574,CHEMBL1771457,CCc1cccc(NC(=O)N2CCc3nc(-c4cnccc4C#N)nc(-c4ccccc4C)c3C2)c1,IC50,nM,<,200.0,Displacement of [35S]MK-0499 from human ERG
3575,CHEMBL1771459,CCc1cccc(NC(=O)N2CCc3nc(-c4cnc(C#N)nc4)nc(-c4ccccc4C)c3C2)c1,IC50,nM,<,200.0,Displacement of [35S]MK-0499 from human ERG
3576,CHEMBL1771456,CCc1cccc(NC(=O)N2CCc3nc(-c4ccc5c(c4)OCO5)nc(-c4ccccc4C)c3C2)c1,IC50,nM,>,5000.0,Displacement of [35S]MK-0499 from human ERG
3577,CHEMBL1771460,CCc1cccc(NC(=O)N2CCc3nc(-c4c(C)noc4C)nc(-c4ccccc4C)c3C2)c1,IC50,nM,>,5000.0,Displacement of [35S]MK-0499 from human ERG
3578,CHEMBL1771458,CCc1cccc(NC(=O)N2CCc3nc(-c4cncnc4)nc(-c4ccccc4C)c3C2)c1,IC50,nM,>,5000.0,Displacement of [35S]MK-0499 from human ERG
3579,CHEMBL1770373,c1ccc(Cc2ncc3c(n2)CCNCC3)cc1,IC50,nM,>,100000.0,Inhibition of human ERG by patch-clamp method
3580,CHEMBL1770373,c1ccc(Cc2ncc3c(n2)CCNCC3)cc1,IC50,nM,>,22300.0,Binding affinity to human ERG
3581,CHEMBL1770720,O=C1Nc2ncccc2C2(CCN(C(=O)N[C@@H]3CC[C@@H](c4cccc(F)c4F)Cn4c(CC(F)(F)F)cnc43)CC2)O1,IC50,nM,=,3300.0,Inhibition of human ERG
3582,CHEMBL1771123,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@@H](c5ccc(C(C)(C)C)cc5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3583,CHEMBL1771124,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@H](c5ccc(C(C)(C)C)cc5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3584,CHEMBL1771125,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@@H](c5ccc(C(F)(F)F)cc5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3585,CHEMBL1771126,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@H](c5ccc(C(F)(F)F)cc5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3586,CHEMBL1771127,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@@H](c5cccc(C(F)(F)F)c5)CC4)cc3)oc12,IC50,nM,=,2372.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3587,CHEMBL1771128,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@H](c5cccc(C(F)(F)F)c5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3588,CHEMBL1771129,Cc1cccc([C@H]2CC[C@@H](CNC(=O)c3ccc(-c4nc5cc(C#N)cc(C(C)C)c5o4)cc3)CC2)c1,IC50,nM,=,11330.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3589,CHEMBL1771130,Cc1cccc([C@H]2CC[C@H](CNC(=O)c3ccc(-c4nc5cc(C#N)cc(C(C)C)c5o4)cc3)CC2)c1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3590,CHEMBL1771131,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@@H](c5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3591,CHEMBL1771132,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@H](c5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3592,CHEMBL1771133,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CC[C@H](c5ccc(Cl)cc5)CC4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3593,CHEMBL1771134,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NCC4CN(c5ccc(Cl)cn5)C(=O)O4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3594,CHEMBL1771135,C=C(C)c1ccc(N2CC(CNC(=O)c3ccc(-c4nc5cc(C#N)cc(C(C)C)c5o4)cc3)OC2=O)nc1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3595,CHEMBL1771136,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NCC4CN(c5ccc(-c6ccccc6C#N)cn5)C(=O)O4)cc3)oc12,IC50,nM,=,1188.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3596,CHEMBL1771137,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NCC4CN(c5ccc(-c6ccccc6C(N)=O)cn5)C(=O)O4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3597,CHEMBL1771138,Cc1ccc(-c2ccc(N3CC(CNC(=O)c4ccc(-c5nc6cc(C#N)cc(C(C)C)c6o5)cc4)OC3=O)nc2)s1,IC50,nM,=,12650.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3598,CHEMBL1771139,Cc1ccc(OC(C)C)c(-c2ccc(N3CC(CNC(=O)c4ccc(-c5nc6cc(C#N)cc(C(C)C)c6o5)cc4)OC3=O)nc2)c1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3599,CHEMBL1771140,CC(C)Oc1ccc(F)cc1-c1ccc(N2CC(CNC(=O)c3ccc(-c4nc5cc(C#N)cc(C(C)C)c5o4)cc3)OC2=O)nc1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3600,CHEMBL1771141,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NCC4CN(c5ccc(-c6ccccc6OC(F)(F)F)cn5)C(=O)O4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3601,CHEMBL1771142,CC(C)Oc1ccc(F)cc1-c1ccc(N2C[C@@H](CNC(=O)c3ccc(-c4nc5cc(C#N)cc(C(C)C)c5o4)cc3)OC2=O)nc1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3602,CHEMBL1771143,CC(C)Oc1ccc(F)cc1-c1ccc(N2C[C@H](CNC(=O)c3ccc(-c4nc5cc(C#N)cc(C(C)C)c5o4)cc3)OC2=O)nc1,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3603,CHEMBL1771144,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@@H]4CN(c5ccc(-c6ccccc6OC(F)(F)F)cn5)C(=O)O4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3604,CHEMBL1771145,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@H]4CN(c5ccc(-c6ccccc6OC(F)(F)F)cn5)C(=O)O4)cc3)oc12,IC50,nM,=,3580.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3605,CHEMBL1771146,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@]4(C)CN(c5ccc(-c6ccccc6OC(F)(F)F)cn5)C(=O)O4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3606,CHEMBL1771147,CC(C)c1cc(C#N)cc2nc(-c3ccc(C(=O)NC[C@@]4(C)CN(c5ccc(-c6ccccc6OC(F)(F)F)cn5)C(=O)O4)cc3)oc12,IC50,nM,>,30000.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3607,CHEMBL1682748,CC(C)Oc1ccc(F)cc1-c1ccc(N2CCC(CNC(=O)c3ccc(-c4nc5cc(C#N)cc(C(C)C)c5o4)cc3)CC2)nc1,IC50,nM,=,56.0,Displacement of [35S]MK499 from human ERG expressed in HEK cells
3608,CHEMBL1771093,Cc1cc(N2CCC(C3CCN(c4ncc(Cl)cn4)CC3)CC2)nc(C#N)n1,IC50,nM,=,277.0,Inhibition of human ERG
3609,CHEMBL1771094,Cc1cnc(N2CCC(C3CCN(c4cc(C#N)nc(C)n4)CC3)CC2)nc1,IC50,nM,=,1800.0,Inhibition of human ERG
3610,CHEMBL1771095,Cc1cnc(N2CCC(C3CCN(c4cc(C#N)nc(C)n4)CC3)CC2)cn1,IC50,nM,=,5400.0,Inhibition of human ERG
3611,CHEMBL1771096,Cc1cnc(N2CCC(C3CCN(c4cc(C)nc(C#N)n4)CC3)CC2)cn1,IC50,nM,=,10600.0,Inhibition of human ERG
3612,CHEMBL1771097,O=C(NC1CC1)c1ccc(OCC2CC2C2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,=,1500.0,Inhibition of human ERG
3613,CHEMBL1771097,O=C(NC1CC1)c1ccc(OCC2CC2C2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,=,1900.0,Inhibition of human ERG
3614,CHEMBL1771098,O=C(NC1CC1)c1ccc(OCCC2CC2C2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,>,30000.0,Inhibition of human ERG
3615,CHEMBL1771098,O=C(NC1CC1)c1ccc(OCCC2CC2C2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,>,30000.0,Inhibition of human ERG
3616,CHEMBL1771098,O=C(NC1CC1)c1ccc(OCCC2CC2C2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,=,2600.0,Inhibition of human ERG
3617,CHEMBL1771099,O=C(NC1CC1)c1ccc(OCC2CC2CC2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,=,1200.0,Inhibition of human ERG
3618,CHEMBL1771099,O=C(NC1CC1)c1ccc(OCC2CC2CC2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,>,30000.0,Inhibition of human ERG
3619,CHEMBL1771100,CS(=O)(=O)c1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)nc1,IC50,nM,=,19000.0,Inhibition of human ERG by patch clamp technique
3620,CHEMBL1771101,Clc1cnc(N2CCC([C@H]3C[C@H]3CCOc3ccc(-n4ccnn4)cc3)CC2)nc1,IC50,nM,=,19000.0,Inhibition of human ERG by patch clamp technique
3621,CHEMBL1771102,Clc1cnc(N2CCC([C@H]3C[C@H]3CCOc3ccc(-n4ccnn4)cn3)CC2)nc1,IC50,nM,=,44000.0,Inhibition of human ERG by patch clamp technique
3622,CHEMBL1771103,Cc1cnc(N2CCC([C@H]3C[C@H]3CCOc3nc(C)cc(C#N)n3)CC2)nc1,IC50,nM,=,4000.0,Inhibition of human ERG by patch clamp technique
3623,CHEMBL1771104,O=C(NC1CC1)c1ccc(OCCCC2CC2CCCC2CCN(c3ncc(Cl)cn3)CC2)cc1F,IC50,nM,>,30000.0,Inhibition of human ERG
3624,CHEMBL1775179,CC(C)OC(=O)N1CCC(Oc2ncnc3c2cnn3-c2ccc(S(C)(=O)=O)cc2F)CC1,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp assay
3625,CHEMBL1779710,CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,IC50,nM,=,79600.0,Inhibition of human ERG by patch clamp method
3626,CHEMBL1778033,CCN1C(=O)c2nc(Cc3ccccc3)n(Cc3ccccc3)c2N2CC3(CCc4ccccc43)N=C12,IC50,nM,=,2300.0,Inhibition of human ERG by voltage-clamp electrophysiology
3627,CHEMBL1778052,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)C[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](OCC(=O)NC)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,30000.0,Inhibition of human ERG
3628,CHEMBL572996,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](OCC(=O)NC)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,nM,=,411000.0,Inhibition of human ERG
3629,CHEMBL1777861,CC#CC(CC(=O)O)c1ccc(Oc2ccc(C(F)(F)F)cc2OC(F)F)cc1,IC50,nM,>,60000.0,Inhibition of human ERG
3630,CHEMBL1777855,CC#CC(CC(=O)O)c1ccc(Oc2ccc(C(F)(F)F)cc2OC(F)F)cc1F,IC50,nM,=,25000.0,Inhibition of human ERG
3631,CHEMBL1777878,CC#C[C@@H](c1ccc(Oc2ccc(C(F)(F)F)cc2OC(F)F)cc1)[C@H]1OC(=O)NC1=O,IC50,nM,=,3400.0,Inhibition of human ERG
3632,CHEMBL1778190,Cc1c2c(n3c1CCCN[C@H](C)CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,=,3200.0,Inhibition of human ERG by patch clamp method
3633,CHEMBL1778208,Cc1c2c(n3c1CCCNC(=O)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,>,33000.0,Inhibition of human ERG by patch clamp method
3634,CHEMBL1779003,COc1cc(F)ccc1-c1cncc(CNC2CCCC2)c1,IC50,nM,=,1890.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3635,CHEMBL1779004,COc1cc(F)ccc1-c1cccc(CNC2CCCC2)c1,IC50,nM,=,2150.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3636,CHEMBL1778867,COc1cc(F)ccc1-c1cncc(CNC2CCCC2)n1,IC50,nM,=,16000.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3637,CHEMBL1779005,COc1cc(F)ccc1-c1cccc(CNC2CCCC2)n1,IC50,nM,=,6230.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3638,CHEMBL1779006,COc1cc(F)ccc1-c1cc(CNC2CCCC2)ccn1,IC50,nM,=,3850.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3639,CHEMBL1779007,COc1cc(F)ccc1-c1cncc(CNC2CCCCC2)c1,IC50,nM,=,2180.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3640,CHEMBL1779008,COc1cc(F)ccc1-c1cncc(CNC(C)C)c1,IC50,nM,=,6670.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3641,CHEMBL1779009,COc1cc(F)ccc1-c1cncc(C2CCCN2)c1,IC50,nM,=,8620.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3642,CHEMBL1779010,COc1cc(F)ccc1-c1cncc(NCc2ccccc2)c1,IC50,nM,=,5200.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3643,CHEMBL1779011,COc1cc(F)ccc1-c1cncc(NC2CCCOC2)c1,IC50,nM,=,9400.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3644,CHEMBL1779012,COc1cc(F)ccc1-c1cncc(CNC(=O)c2cnccn2)c1,IC50,nM,=,7110.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3645,CHEMBL1779013,COc1cc(F)ccc1-c1cncc(CNC(=O)c2ccccn2)c1,IC50,nM,=,27000.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3646,CHEMBL1779014,COc1cc(F)ccc1-c1cncc(CNC(=O)c2ccccc2)c1,IC50,nM,=,18800.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3647,CHEMBL1779015,COc1cc(F)ccc1-c1cncc(CNC(=O)N2CCCC2)c1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3648,CHEMBL1779016,COc1cc(F)ccc1-c1cncc(CNC(=O)C2CCC2)c1,IC50,nM,=,18600.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3649,CHEMBL1779017,COc1cc(F)ccc1-c1cncc(CNC(=O)N(C)C)c1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3650,CHEMBL1779018,CCCC(=O)NCc1cncc(-c2ccc(F)cc2OC)c1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3651,CHEMBL1779019,COc1cc(F)ccc1-c1cncc(CNC(=O)C2CC2)c1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3652,CHEMBL1779020,CCOC(=O)C(=O)NCc1cncc(-c2ccc(F)cc2OC)c1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3653,CHEMBL1778865,COc1cc(F)ccc1-c1cncc(CNCC2CC2)n1,IC50,nM,=,1890.0,Inhibition of human ERG expressed in CHOK1 cells electrophysiology study
3654,CHEMBL278315,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3655,CHEMBL1738703,Cc1c2c(n3c1CCCNC[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3656,CHEMBL1778208,Cc1c2c(n3c1CCCNC(=O)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3657,CHEMBL1738705,Cc1c2c(n3c1CCCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,=,2600.0,Inhibition of human ERG by HT patch clamp assay
3658,CHEMBL1779531,Cc1c2c(n3c1CCCN1CCC[C@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3659,CHEMBL1779532,Cc1c2c(n3c1CCCN1CCCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,=,900.0,Inhibition of human ERG by HT patch clamp assay
3660,CHEMBL1779533,Cc1c2c(n3c1CCCN1CCOC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,=,12500.0,Inhibition of human ERG by HT patch clamp assay
3661,CHEMBL1779534,Cc1c2c(n3c1CCCN1CCNC[C@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3662,CHEMBL1779535,CC(=O)N1CCN2CCCc3c(C)c4c(n3-c3ccc(C(N)=O)c(c3)NC[C@H]2C1)CC(C)(C)CC4=O,IC50,nM,=,24400.0,Inhibition of human ERG by HT patch clamp assay
3663,CHEMBL1779536,Cc1c2c(n3c1CCCN1CC[C@H](CNc4cc-3ccc4C(N)=O)C1)CC(C)(C)CC2=O,IC50,nM,=,440.0,Inhibition of human ERG by HT patch clamp assay
3664,CHEMBL1779537,Cc1c2c(n3c1CCCN1CC[C@@H](CNc4cc-3ccc4C(N)=O)C1)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3665,CHEMBL1779538,Cc1c2c(n3c1CCCN1C[C@H](O)C[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3666,CHEMBL1779539,Cc1c2c(n3c1CCCN1C[C@@H](F)C[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,=,16400.0,Inhibition of human ERG by HT patch clamp assay
3667,CHEMBL1779540,CC(=O)N[C@H]1C[C@@H]2CNc3cc(ccc3C(N)=O)-n3c(c(C)c4c3CC(C)(C)CC4=O)CCCN2C1,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3668,CHEMBL1779541,Cc1c2c(n3c1CCCN1C[C@@H](N4CCCC4)C[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3669,CHEMBL1779542,Cc1c2c(n3c1CCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3670,CHEMBL1779543,Cc1c2c(n3c1CCCCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3671,CHEMBL1779544,Cc1c2c(n3c1CCC(=O)N1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3672,CHEMBL1779545,Cc1c2c(n3c1CCCN1CCCC[C@@H]1[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,=,1500.0,Inhibition of human ERG by HT patch clamp assay
3673,CHEMBL1779546,Cc1c2c(n3c1CCCN1CC[C@@H](C1)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,,,,Inhibition of human ERG by HT patch clamp assay
3674,CHEMBL1779547,Cc1c2c(n3c1CCCN1CCC[C@@H](C1)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,=,3400.0,Inhibition of human ERG by HT patch clamp assay
3675,CHEMBL1683074,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1,IC50,nM,=,1700.0,Displacement of labeled dofetilide from human ERG
3676,CHEMBL1782566,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cncc(C(F)(F)F)c3)CC2)(C(C)C)C1,IC50,nM,=,2100.0,Displacement of labeled dofetilide from human ERG
3677,CHEMBL1782567,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3ccnc(C(F)(F)F)c3)CC2)(C(C)C)C1,IC50,nM,>,90000.0,Displacement of labeled dofetilide from human ERG
3678,CHEMBL1683073,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)n3)CC2)(C(C)C)C1,IC50,nM,=,3900.0,Displacement of labeled dofetilide from human ERG
3679,CHEMBL1683075,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nccc(C(F)(F)F)n3)CC2)(C(C)C)C1,IC50,nM,=,4900.0,Displacement of labeled dofetilide from human ERG
3680,CHEMBL1782568,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cncc(C(F)(F)F)n3)CC2)(C(C)C)C1,IC50,nM,=,7600.0,Displacement of labeled dofetilide from human ERG
3681,CHEMBL1782569,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3ccnc(C(F)(F)F)n3)CC2)(C(C)C)C1,IC50,nM,=,35900.0,Displacement of labeled dofetilide from human ERG
3682,CHEMBL1782570,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ncn3)CC2)(C(C)C)C1,IC50,nM,=,42600.0,Displacement of labeled dofetilide from human ERG
3683,CHEMBL1782571,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nncc(C(F)(F)F)n3)CC2)(C(C)C)C1,IC50,nM,=,8900.0,Displacement of labeled dofetilide from human ERG
3684,CHEMBL1782572,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)cnn3)CC2)(C(C)C)C1,IC50,nM,=,31300.0,Displacement of labeled dofetilide from human ERG
3685,CHEMBL1782573,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3ncc(C(F)(F)F)s3)CC2)(C(C)C)C1,IC50,,,,Displacement of labeled dofetilide from human ERG
3686,CHEMBL1782574,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nc(C(F)(F)F)cs3)CC2)(C(C)C)C1,IC50,nM,=,3900000.0,Displacement of labeled dofetilide from human ERG
3687,CHEMBL1782575,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nc(C(F)(F)F)ns3)CC2)(C(C)C)C1,IC50,,,,Displacement of labeled dofetilide from human ERG
3688,CHEMBL1782576,CCO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1,IC50,nM,=,6500.0,Displacement of labeled dofetilide from human ERG
3689,CHEMBL1782577,CCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1,IC50,nM,=,8600.0,Displacement of labeled dofetilide from human ERG
3690,CHEMBL1782578,CCC1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1,IC50,nM,=,1200.0,Displacement of labeled dofetilide from human ERG
3691,CHEMBL1782579,CC(C)[C@]1(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)CC[C@@H](NC2CCOCC2)C1,IC50,nM,<,300.0,Displacement of labeled dofetilide from human ERG
3692,CHEMBL1782580,CC(C)[C@]1(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)CC[C@@H](N[C@H]2CCOC[C@H]2O)C1,IC50,nM,=,300.0,Displacement of labeled dofetilide from human ERG
3693,CHEMBL1782376,CC(C)[C@]1(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)CC[C@@H](NC2C3CCCC2COC3)C1,IC50,nM,=,1200.0,Displacement of labeled dofetilide from human ERG
3694,CHEMBL1782376,CC(C)[C@]1(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)CC[C@@H](NC2C3CCCC2COC3)C1,IC50,nM,=,1300.0,Displacement of labeled dofetilide from human ERG
3695,CHEMBL1782377,CO[C@@H]1COCC[C@@H]1N(C)[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1,IC50,nM,=,17000.0,Displacement of labeled dofetilide from human ERG
3696,CHEMBL1782375,CC(C)[C@]1(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)CC[C@@H](N2CCC3COCCC32)C1,IC50,nM,=,1100.0,Displacement of labeled dofetilide from human ERG
3697,CHEMBL1782375,CC(C)[C@]1(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)CC[C@@H](N2CCC3COCCC32)C1,IC50,nM,=,1100.0,Displacement of labeled dofetilide from human ERG
3698,CHEMBL1782378,CO[C@@H]1COCC[C@@H]1N(C)[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)cnn3)CC2)(C(C)C)C1,IC50,nM,=,52800.0,Displacement of labeled dofetilide from human ERG
3699,CHEMBL1784340,Cc1noc(C)c1CCC1CCN(S(=O)(=O)CC2(N(O)C=O)CCOCC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
3700,CHEMBL1615187,Cc1noc(C)c1CCC1CCN(S(=O)(=O)C[C@](C)(C[C@H](C)c2ncc(F)cn2)N(O)C=O)CC1,IC50,nM,=,65000.0,Inhibition of human ERG
3701,CHEMBL1784384,Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1,IC50,nM,=,1995.26,Inhibition of human Erg by patch clamp assay
3702,CHEMBL1784385,Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1,IC50,nM,=,1000.0,Inhibition of human Erg by patch clamp assay
3703,CHEMBL1784405,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)C(C)(C)C)CC1,IC50,nM,=,1584.89,Inhibition of human Erg by patch clamp assay
3704,CHEMBL1784406,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)C(C)(C)C(=O)O)CC1,IC50,nM,=,56234.13,Inhibition of human Erg by patch clamp assay
3705,CHEMBL1784407,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)C2(C(=O)O)CCC2)CC1,IC50,nM,=,44668.36,Inhibition of human Erg by patch clamp assay
3706,CHEMBL1784408,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2C(=O)O)CC1,IC50,nM,=,125892.54,Inhibition of human Erg by patch clamp assay
3707,CHEMBL1784409,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(C(=O)O)c2)CC1,IC50,nM,=,50118.72,Inhibition of human Erg by patch clamp assay
3708,CHEMBL1784465,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)c2nnn[nH]2)CC1,IC50,nM,=,18197.01,Inhibition of human Erg by patch clamp assay
3709,CHEMBL1784466,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C(=O)NS(C)(=O)=O)CC1,IC50,nM,=,25118.86,Inhibition of human Erg by patch clamp assay
3710,CHEMBL1784467,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(-c3nnn[nH]3)c2)CC1,IC50,nM,=,31622.78,Inhibition of human Erg by patch clamp assay
3711,CHEMBL1784468,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(C(=O)NO)c2)CC1,IC50,nM,=,79432.82,Inhibition of human Erg by patch clamp assay
3712,CHEMBL1784469,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc3c(c2)CC(=O)NS3(=O)=O)CC1,IC50,nM,>,31622.78,Inhibition of human Erg by patch clamp assay
3713,CHEMBL1784470,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(-c3noc(=S)[nH]3)c2)CC1,IC50,nM,>,31622.78,Inhibition of human Erg by patch clamp assay
3714,CHEMBL1784471,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)CO)CC1,IC50,nM,=,6025.6,Inhibition of human Erg by patch clamp assay
3715,CHEMBL1784472,COC(=O)c1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1,IC50,nM,=,794.33,Inhibition of human Erg by patch clamp assay
3716,CHEMBL1784464,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(C(N)=O)c2)CC1,IC50,nM,=,25118.86,Inhibition of human Erg by patch clamp assay
3717,CHEMBL1784473,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(S(N)(=O)=O)c2)CC1,IC50,nM,=,63095.73,Inhibition of human Erg by patch clamp assay
3718,CHEMBL1784475,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1,IC50,nM,=,25118.86,Inhibition of human Erg by patch clamp assay
3719,CHEMBL1784476,CNS(=O)(=O)c1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1,IC50,nM,=,63095.73,Inhibition of human Erg by patch clamp assay
3720,CHEMBL1784477,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(S(=O)(=O)N(C)C)c2)CC1,IC50,nM,=,1995.26,Inhibition of human Erg by patch clamp assay
3721,CHEMBL1784509,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(N)(=O)=O)c(F)cc2Cl)CC1,IC50,nM,>,31622.78,Inhibition of human Erg by patch clamp assay
3722,CHEMBL1784510,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(N)(=O)=O)ccc2Cl)CC1,IC50,nM,>,50118.72,Inhibition of human Erg by patch clamp assay
3723,CHEMBL1784511,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(N)(=O)=O)ccc2F)CC1,IC50,nM,=,41686.94,Inhibition of human Erg by patch clamp assay
3724,CHEMBL1784512,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2F)CC1,IC50,nM,>,50118.72,Inhibition of human Erg by patch clamp assay
3725,CHEMBL1784513,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2c(Cl)ccc(S(N)(=O)=O)c2Cl)CC1,IC50,nM,=,52480.75,Inhibition of human Erg by patch clamp assay
3726,CHEMBL1784515,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(=O)(=O)NC3CCCC3)c(F)cc2Cl)CC1,IC50,nM,=,30902.95,Inhibition of human Erg by patch clamp assay
3727,CHEMBL1784516,CCNS(=O)(=O)c1cc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3cccc(F)c3)CC2)c(Cl)cc1F,IC50,nM,=,30199.52,Inhibition of human Erg by patch clamp assay
3728,CHEMBL1784517,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(=O)(=O)NC(C)C)c(F)cc2Cl)CC1,IC50,nM,=,12882.5,Inhibition of human Erg by patch clamp assay
3729,CHEMBL1784518,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(=O)(=O)NC3CC3)c(F)cc2Cl)CC1,IC50,nM,=,12022.64,Inhibition of human Erg by patch clamp assay
3730,CHEMBL1784519,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(S(=O)(=O)NCC(F)(F)F)c(F)cc2Cl)CC1,IC50,nM,=,7943.28,Inhibition of human Erg by patch clamp assay
3731,CHEMBL1784520,CCCNS(=O)(=O)c1cc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3cccc(F)c3)CC2)c(Cl)cc1F,IC50,nM,=,8912.51,Inhibition of human Erg by patch clamp assay
3732,CHEMBL1784521,CNS(=O)(=O)c1cc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3cccc(F)c3)CC2)c(Cl)cc1F,IC50,nM,=,19054.61,Inhibition of human Erg by patch clamp assay
3733,CHEMBL1784522,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2ccc(NS(C)(=O)=O)cc2Cl)CC1,IC50,nM,=,10000.0,Inhibition of human Erg by patch clamp assay
3734,CHEMBL1782081,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(C)(=O)=O)c(F)cc2Cl)CC1,IC50,nM,=,31622.78,Inhibition of human Erg by patch clamp assay
3735,CHEMBL1784523,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(C)(=O)=O)c(F)cc2F)CC1,IC50,nM,=,100000.0,Inhibition of human Erg by patch clamp assay
3736,CHEMBL1784524,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2c(F)ccc(NS(C)(=O)=O)c2F)CC1,IC50,nM,=,36307.81,Inhibition of human Erg by patch clamp assay
3737,CHEMBL1784526,Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2cccc(F)c2)CCN(C(=O)c2cc(NS(=O)(=O)C(C)C)c(F)cc2F)CC1,IC50,nM,=,8912.51,Inhibition of human Erg by patch clamp assay
3738,CHEMBL519418,CN(C)[C@@H]1CCC[C@H]1Nc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F,IC50,nM,=,4700.0,Inhibition of human ERG by cell based by patch clamp assay
3739,CHEMBL2029180,CN=[S+](C)([O-])c1ccc(Nc2ncc(C(F)(F)F)c(N[C@@H]3CCC[C@H]3N(C)C)n2)cc1,IC50,nM,=,20300.0,Inhibition of human ERG by cell based by patch clamp assay
3740,CHEMBL1784130,C[C@@H]1NC(c2ccc(=O)n(C(F)F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1,IC50,nM,>,10.0,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3741,CHEMBL1784131,COn1cc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)ccc1=O,IC50,nM,>,10.0,"Displacement of [35S]N-[(4R)-10-[(2R)-6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl]-3,4-dihydro-4-hydroxyspiro[2H-1-benzopyran-2,40-piperidin]-6-yl]methanesulfonamide from human ERG expressed in HEK293 cells"
3742,CHEMBL1797410,Cc1onc(-c2c(Cl)cccc2Cl)c1CC(=O)NCc1ccc(OCC(F)(F)F)nc1,IC50,nM,>,26302.68,Inhibition of human ERG
3743,CHEMBL1797387,Cc1onc(-c2c(Cl)cccc2Cl)c1NC(=O)OCc1c(F)cccc1Cl,IC50,nM,>,26302.68,Inhibition of human ERG
3744,CHEMBL1796298,O=C(NCc1ccncn1)c1ccc(Oc2ccc(C#C[C@]3(O)CN4CCC3CC4)cc2)cc1,IC50,nM,>,50118.72,Inhibition of human ERG
3745,CHEMBL1801188,Cc1nnc(N2CC[C@@H](F)C2)c2nn(-c3ccc(OCC(F)(F)F)cc3)c(C)c12,IC50,nM,=,316.0,Inhibition of human hERG
3746,CHEMBL1801191,COC1CN(c2nnc(C)c3c(C)n(-c4ccc(Cl)cc4OC(F)(F)F)nc23)C1,IC50,nM,=,4000.0,Inhibition of human hERG
3747,CHEMBL1801192,CCOc1ccc(-n2nc3c(N4CC(OC)C4)nnc(C)c3c2C)c(F)c1,IC50,nM,=,6000.0,Inhibition of human hERG
3748,CHEMBL1822792,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3749,CHEMBL1802915,CN(C[C@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3750,CHEMBL1802914,CN([C@H]1CCOC1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3751,CHEMBL1802913,COCCCN(C)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3752,CHEMBL1802912,Cn1cc(-c2cnc3ccc4ccc(NS(=O)(=O)N5CC(F)C5)cc4c(=O)c3c2)cn1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3753,CHEMBL1802911,Cn1cc(-c2cnc3ccc4ccc(NS(=O)(=O)N5CCC5)cc4c(=O)c3c2)cn1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3754,CHEMBL1802910,CN(Cc1ccccc1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3755,CHEMBL1802909,CN(Cc1cnccn1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,=,7100.0,Inhibition of Kv11.1 channel
3756,CHEMBL1802908,CCN(CC)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3757,CHEMBL1802907,CNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3758,CHEMBL1802906,Cn1cc(-c2cnc3ccc4ccc(NS(N)(=O)=O)cc4c(=O)c3c2)cn1,IC50,nM,=,4300.0,Inhibition of Kv11.1 channel
3759,CHEMBL1802829,CN(C)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,IC50,nM,>,30000.0,Inhibition of Kv11.1 channel
3760,CHEMBL1802602,Cn1cc(-c2cnc3ccc4ccc(NS(C)(=O)=O)cc4c(=O)c3c2)cn1,IC50,nM,=,10100.0,Inhibition of Kv11.1 channel
3761,CHEMBL1803004,CS(=O)(=O)Nc1ccc2ccc3ncc(-c4ccccc4)cc3c(=O)c2c1,IC50,nM,=,290.0,Inhibition of Kv11.1 channel
3762,CHEMBL601821,NCC(=O)N1CCn2c(nc(-c3ccccc3)c2Nc2ccc3c(c2)OCO3)C1,IC50,nM,=,19000.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3763,CHEMBL1800836,NCC(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)cc2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3764,CHEMBL1800137,CC(C)(N)C(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)cc2)C1,IC50,nM,=,5600.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3765,CHEMBL1800831,NCC(=O)N1CCn2c(nc(-c3cccc(F)c3)c2Nc2ccc(F)cc2)C1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3766,CHEMBL1800768,CC(C)(N)C(=O)N1CCn2c(nc(-c3cccc(F)c3)c2Nc2ccc(F)cc2)C1,IC50,nM,=,5700.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3767,CHEMBL1800769,Cc1ccc(Nc2c(-c3ccc(F)cc3)nc3n2CCN(C(=O)CN)C3)cc1,IC50,nM,=,11100.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3768,CHEMBL1800770,Cc1ccc(Nc2c(-c3ccc(F)cc3)nc3n2CCN(C(=O)C(C)(C)N)C3)cc1,IC50,nM,=,1500.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3769,CHEMBL1800771,NCC(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(Cl)cc2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3770,CHEMBL1800772,CC(C)(N)C(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(Cl)cc2)C1,IC50,nM,=,2300.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3771,CHEMBL1800773,NCC(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)c(F)c2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3772,CHEMBL1800774,CC(C)(N)C(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)c(F)c2)C1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3773,CHEMBL1800775,NCC(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(Cl)c(F)c2)C1,IC50,nM,=,21000.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3774,CHEMBL1800776,CC(C)(N)C(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(Cl)c(F)c2)C1,IC50,nM,=,5600.0,Inhibition of human ERG expressed in CHO cells by Q-patch assay
3775,CHEMBL1800168,CCS(=O)(=O)c1ccc2c(c1)nc(C(C)(C)C)n2CC1CC1,IC50,nM,=,2600.0,Inhibition of human ERG
3776,CHEMBL1683351,N#Cc1ccc(N2CCN(Cc3cc(C(=O)O)c(=O)n4ccccc34)CC2)cc1,IC50,nM,=,7400.0,Inhibition of human ERG
3777,CHEMBL1800285,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
3778,CHEMBL1807804,Cc1c2c(n3c1CCN(C(=O)[C@H](C)N)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,nM,>,33000.0,Inhibition of human ERG
3779,CHEMBL1809039,CN(C)CCn1cc2c3c(cccc31)C1=C[C@@H](C(=O)N3CCCC3)CN(C(=O)Nc3ccccc3)[C@@H]1C2,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3780,CHEMBL1809044,COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3781,CHEMBL1809045,COc1cc(C2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,12000.0,Inhibition of human ERG by electrophysiology assay
3782,CHEMBL1809046,COc1cc(C2CCNCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,9100.0,Inhibition of human ERG by electrophysiology assay
3783,CHEMBL1809047,COc1cc(N2CCNC(=O)C2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3784,CHEMBL1809048,COc1cc(N2CCCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,11000.0,Inhibition of human ERG by electrophysiology assay
3785,CHEMBL1809049,COc1cc(OC2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology assay
3786,CHEMBL1809050,COc1cc(OC2CCNCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,4800.0,Inhibition of human ERG by electrophysiology assay
3787,CHEMBL1809051,COc1cc(OC2CN(C(C)=O)C2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3788,CHEMBL1809052,COc1cc(OC2CNC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,5900.0,Inhibition of human ERG by electrophysiology assay
3789,CHEMBL1809053,COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,3200.0,Inhibition of human ERG by electrophysiology assay
3790,CHEMBL1809054,COc1cc(CN2CCOCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,9900.0,Inhibition of human ERG by electrophysiology assay
3791,CHEMBL1809055,COc1cc(C(=O)N2CCOCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,2700.0,Inhibition of human ERG by electrophysiology assay
3792,CHEMBL1809056,COc1cc(CC(=O)N2CCOCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,8800.0,Inhibition of human ERG by electrophysiology assay
3793,CHEMBL1809057,COc1cc(C(CO)CO)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3794,CHEMBL1809058,COc1cc(N2CC3CNCC(C2)O3)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,5300.0,Inhibition of human ERG by electrophysiology assay
3795,CHEMBL1809059,COc1cc(N2CC3CN(CCO)CC(C2)O3)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,1500.0,Inhibition of human ERG by electrophysiology assay
3796,CHEMBL1809060,COc1cc(N2CC3COCC(C2)N3)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology assay
3797,CHEMBL1809061,COc1cc(N2CCNCC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,4600.0,Inhibition of human ERG by electrophysiology assay
3798,CHEMBL1809062,COc1cc(N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,3700.0,Inhibition of human ERG by electrophysiology assay
3799,CHEMBL1809063,COc1cc(N2CCN(CC(=O)N(C)C)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,12000.0,Inhibition of human ERG by electrophysiology assay
3800,CHEMBL1809064,COc1cc(N2CCN(CCS(C)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,9400.0,Inhibition of human ERG by electrophysiology assay
3801,CHEMBL1809065,COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3802,CHEMBL1809066,COC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c(OC)c2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3803,CHEMBL1809067,COc1cc(N2CCN(C(N)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
3804,CHEMBL1809068,COc1cc(N2CCN(C(=O)N(C)C)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,16000.0,Inhibition of human ERG by electrophysiology assay
3805,CHEMBL1809069,COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,14000.0,Inhibition of human ERG by electrophysiology assay
3806,CHEMBL1809070,COc1cc(N2CCN(C(=O)[C@H](C)O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,8100.0,Inhibition of human ERG by electrophysiology assay
3807,CHEMBL1809071,COc1cc(N2CCN(C(=O)[C@@H](C)O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,15000.0,Inhibition of human ERG by electrophysiology assay
3808,CHEMBL1809072,COc1cc(N2CCN(C(=O)CN)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,16000.0,Inhibition of human ERG by electrophysiology assay
3809,CHEMBL1809073,CNCC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c(OC)c2)CC1,IC50,nM,=,9500.0,Inhibition of human ERG by electrophysiology assay
3810,CHEMBL1809074,COc1cc(N2CCN(C(=O)[C@H](C)N)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,9400.0,Inhibition of human ERG by electrophysiology assay
3811,CHEMBL1809075,COc1cc(N2CCN(C(=O)[C@@H](C)N)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,14000.0,Inhibition of human ERG by electrophysiology assay
3812,CHEMBL1809076,COc1ccc(N2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,4300.0,Inhibition of human ERG by electrophysiology assay
3813,CHEMBL1809077,COc1ccc(N2CCNCC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,4800.0,Inhibition of human ERG by electrophysiology assay
3814,CHEMBL1809078,COc1ccc(N2CCOCC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,5100.0,Inhibition of human ERG by electrophysiology assay
3815,CHEMBL1809079,COc1ccc(C(=O)N2CCOCC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,1300.0,Inhibition of human ERG by electrophysiology assay
3816,CHEMBL1809044,COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,>,30000.0,Inhibition of human ERG by electrophysiological assay
3817,CHEMBL1808625,Cc1[nH]c2ccccc2c1CC(=O)N1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Binding affinity to human ERG by radioligand binding assay
3818,CHEMBL98,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3819,CHEMBL408513,O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3820,CHEMBL27759,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3821,CHEMBL272980,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3822,CHEMBL356066,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,IC50,nM,=,10300.0,Inhibition of human ERG by automated patch clamp assay
3823,CHEMBL1808617,CC(C)(C)OC(=O)N1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3824,CHEMBL1808618,CC(C)(C)C(=O)N1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3825,CHEMBL1808619,O=C(/C=C/c1ccc2c(c1)CN(C(=O)C1CC1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3826,CHEMBL1808620,O=C(/C=C/c1ccc2c(c1)CN(C(=O)C1CCCC1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3827,CHEMBL1808621,O=C(/C=C/c1ccc2c(c1)CN(C(=O)C1CCCCC1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3828,CHEMBL1808622,O=C(/C=C/c1ccc2c(c1)CN(C(=O)c1cccc(C(F)(F)F)c1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3829,CHEMBL1808623,O=C(/C=C/c1ccc2c(c1)CN(C(=O)c1cccnc1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3830,CHEMBL1808624,O=C(/C=C/c1ccc2c(c1)CN(C(=O)Cc1ccccc1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3831,CHEMBL1808625,Cc1[nH]c2ccccc2c1CC(=O)N1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3832,CHEMBL1808626,CS(=O)(=O)N1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3833,CHEMBL1808627,CCCCS(=O)(=O)N1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3834,CHEMBL1808628,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)C1CC1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3835,CHEMBL1808629,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)Cc1ccccc1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3836,CHEMBL1808630,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)c1ccccc1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3837,CHEMBL1808631,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)c1cccs1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3838,CHEMBL1808632,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)c1ccncc1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3839,CHEMBL1808633,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)c1cccnc1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3840,CHEMBL1808634,Cn1cnc(S(=O)(=O)N2Cc3ccc(/C=C/C(=O)NO)cc3C2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3841,CHEMBL1808635,Cc1ccc(S(=O)(=O)N2Cc3ccc(/C=C/C(=O)NO)cc3C2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3842,CHEMBL1808636,Cc1cccc(S(=O)(=O)N2Cc3ccc(/C=C/C(=O)NO)cc3C2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3843,CHEMBL1808637,Cc1ccccc1S(=O)(=O)N1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3844,CHEMBL1808638,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3845,CHEMBL1808639,O=C(/C=C/c1ccc2c(c1)CN(S(=O)(=O)c1cccc(C(F)(F)F)c1)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3846,CHEMBL1808640,COc1ccc(S(=O)(=O)N2Cc3ccc(/C=C/C(=O)NO)cc3C2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3847,CHEMBL1808641,COc1cccc(S(=O)(=O)N2Cc3ccc(/C=C/C(=O)NO)cc3C2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3848,CHEMBL1808642,O=C(/C=C/c1ccc2c(c1)CN(Cc1ccccc1)C2)NO,IC50,nM,=,27500.0,Inhibition of human ERG by automated patch clamp assay
3849,CHEMBL1808643,O=C(/C=C/c1ccc2c(c1)CN(CCC1CCCCC1)C2)NO,IC50,nM,=,22000.0,Inhibition of human ERG by automated patch clamp assay
3850,CHEMBL1808644,O=C(/C=C/c1ccc2c(c1)CN(CCc1c[nH]c3ccccc13)C2)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3851,CHEMBL1808645,O=C(/C=C/c1ccc2c(c1)CN(CCc1cnn3ccccc13)C2)NO,IC50,nM,=,5200.0,Inhibition of human ERG by automated patch clamp assay
3852,CHEMBL1088949,Cc1[nH]c2ccccc2c1CCN1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,=,4800.0,Inhibition of human ERG by automated patch clamp assay
3853,CHEMBL1808646,Cc1noc(-c2ccccc2)c1CCN1Cc2ccc(/C=C/C(=O)NO)cc2C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
3854,CHEMBL1813314,CN1C[C@H]2CCCC[C@@]2(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,4140.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3855,CHEMBL1813315,CN1C[C@@H]2CCCC[C@]2(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,2320.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3856,CHEMBL1813471,Clc1ccc([C@]23CCCC[C@H]2CNC3)cc1Cl,IC50,nM,=,6480.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3857,CHEMBL1813472,Clc1ccc([C@@]23CCCC[C@@H]2CNC3)cc1Cl,IC50,nM,=,3640.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3858,CHEMBL1813316,CCN1C[C@H]2CCCC[C@@]2(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,4730.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3859,CHEMBL1813317,CCN1C[C@@H]2CCCC[C@]2(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,4330.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3860,CHEMBL1813313,CN1C[C@@H]2CCCC[C@]2(c2ccc3ccccc3c2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3861,CHEMBL1813470,CN1C[C@H]2CCCC[C@@]2(c2ccc3ccccc3c2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3862,CHEMBL1813487,CN1C[C@H]2CCCC[C@@]2(Cc2ccc(Cl)c(Cl)c2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3863,CHEMBL1813489,Clc1ccc(C[C@@]23CCCC[C@@H]2CNC3)cc1Cl,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3864,CHEMBL1813478,CN1C[C@@H]2CCC[C@]2(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,5640.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3865,CHEMBL1813484,CN1C[C@H]2CCC[C@@]2(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,5430.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3866,CHEMBL1813474,Clc1ccc([C@]23CCC[C@H]2CNC3)cc1Cl,IC50,nM,=,6400.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3867,CHEMBL1813475,Clc1ccc([C@@]23CCC[C@@H]2CNC3)cc1Cl,IC50,nM,=,5280.0,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3868,CHEMBL1813476,c1ccc2cc([C@]34CCC[C@H]3CNC4)ccc2c1,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3869,CHEMBL1813477,c1ccc2cc([C@@]34CCC[C@@H]3CNC4)ccc2c1,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3870,CHEMBL1813483,CN1C[C@@H]2CCC[C@]2(c2ccc3ccccc3c2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3871,CHEMBL1813485,CN1C[C@H]2CCC[C@@]2(c2ccc3ccccc3c2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by high throughput single cell planar patch clamp method
3872,CHEMBL111,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,IC50,nM,=,2790.0,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay
3873,CHEMBL1814154,CCc1c(C(=O)NC(C)(C)c2nnnn2C)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1,IC50,nM,=,22700.0,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay
3874,CHEMBL1814327,Cc1c(C(=O)NC(C)(C)c2nnc(C(F)(F)F)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay
3875,CHEMBL1814329,Cc1c(C(=O)NC2(c3noc(C(F)(F)F)n3)CC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay
3876,CHEMBL1814331,CC(C)(NC(=O)c1nn(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2)c1CO)c1noc(C(F)(F)F)n1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay
3877,CHEMBL1814333,O=C(NC1(c2noc(C(F)(F)F)n2)CC1)c1nn(-c2ccc(Cl)cc2Cl)c(-c2ccc(Cl)cc2)c1CO,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay
3878,CHEMBL1813048,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(OC(F)(F)F)cc4)CC3)n2)c1C,IC50,nM,>,10000.0,Inhibition of human Erg expressed in human HEK293 cells by patch-clamp electrophysiological assay
3879,CHEMBL1813042,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(C(F)(F)F)cc4)CC3)n2)c1C,IC50,nM,>,10000.0,Inhibition of human Erg expressed in human HEK293 cells by patch-clamp electrophysiological assay
3880,CHEMBL1813050,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)n2)c1C,IC50,nM,=,2600.0,Inhibition of human Erg expressed in human HEK293 cells by patch-clamp electrophysiological assay
3881,CHEMBL1813049,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(Oc4ccc(C(F)(F)F)cc4)CC3)n2)c1C,IC50,nM,=,4100.0,Inhibition of human Erg expressed in human HEK293 cells by patch-clamp electrophysiological assay
3882,CHEMBL1813015,CC(=O)Nc1cccc(Nc2ncnc(N3CCc4ccccc4C3)n2)c1,IC50,nM,=,3800.0,Inhibition of human Erg expressed in human HEK293 cells by patch-clamp electrophysiological assay
3883,CHEMBL1813043,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(C)cc4)CC3)n2)c1C,IC50,nM,=,1930.0,Inhibition of human Erg expressed in human HEK293 cells by patch-clamp electrophysiological assay
3884,CHEMBL1813044,CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccc(C(C)C)cc4)CC3)n2)c1C,IC50,nM,=,440.0,Inhibition of human Erg expressed in human HEK293 cells by patch-clamp electrophysiological assay
3885,CHEMBL1813057,C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)n(C)n2)cc1,IC50,nM,=,13000.0,Inhibition of recombinant human ERG channel expressed in human HEK 293 cells by patch clamp assay
3886,CHEMBL1813065,C[C@@H]1CCCN1CCCOc1ccc(-c2cn[nH]c(=O)c2)cc1,IC50,nM,=,9500.0,Inhibition of recombinant human ERG channel expressed in human HEK 293 cells by patch clamp assay
3887,CHEMBL1829335,C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1,IC50,nM,=,13800.0,Inhibition of recombinant human ERG channel expressed in human HEK 293 cells by patch clamp assay
3888,CHEMBL1814813,CN=[S+](C)([O-])c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of tail current at holding potential of -70 mV after 10 mins by whole-cell patch clamp method
3889,CHEMBL2029168,C[S+](=N)([O-])c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of tail current at holding potential of -70 mV after 10 mins by whole-cell patch clamp method
3890,CHEMBL1818296,CN(C)CCC1CCN(c2cc(C(=O)NC[C@H]3CC[C@H](CNC(=O)OC(C)(C)C)CC3)c3ccccc3n2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG
3891,CHEMBL1818300,CC(C)(C)OC(=O)NC[C@H]1CC[C@H](CNC(=O)c2cc(N3CCC(CCN4CC(O)C4)CC3)nc3ccccc23)CC1,IC50,nM,>,33000.0,Inhibition of human ERG
3892,CHEMBL1818303,CN(C)CCC1CCN(c2cc(C(=O)NC[C@H]3CC[C@H](CNC(=O)OCC(C)(C)C)CC3)c3ccccc3n2)CC1,IC50,nM,=,14000.0,Inhibition of human ERG
3893,CHEMBL1818218,CC(C)CNc1nc(N2CCN(CC3CCCOC3)CC2)ncc1C(=O)NCc1ccccc1,IC50,nM,=,580.0,Inhibition of human ERG expressed in human HEK293 cells by patch-clamp electrophysiology
3894,CHEMBL1818821,COc1cc(-c2cn(Cc3ccccc3F)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2490.0,Binding affinity to human ERG by radioligand displacement assay
3895,CHEMBL1818822,COc1cc(-c2cn(Cc3cccc(F)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2700.0,Binding affinity to human ERG by radioligand displacement assay
3896,CHEMBL1818823,COc1cc(-c2cn(Cc3ccc(F)cc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2190.0,Binding affinity to human ERG by radioligand displacement assay
3897,CHEMBL1818824,COc1cc(-c2cn(Cc3cccc(C(F)(F)F)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,1250.0,Binding affinity to human ERG by radioligand displacement assay
3898,CHEMBL1818825,COc1cc(-c2cn(Cc3cccc(OC(F)(F)F)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,720.0,Binding affinity to human ERG by radioligand displacement assay
3899,CHEMBL1818826,COc1cc(-c2cn(Cc3cc(C(C)(C)C)cc(C(C)(C)C)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,320.0,Binding affinity to human ERG by radioligand displacement assay
3900,CHEMBL1818827,COc1cc(-c2cn(Cc3cc(Br)cc(Br)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,100.0,Binding affinity to human ERG by radioligand displacement assay
3901,CHEMBL1818828,COc1cc(-c2cn(Cc3cc(C(F)(F)F)cc(C(F)(F)F)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,390.0,Binding affinity to human ERG by radioligand displacement assay
3902,CHEMBL1818829,COc1cc(-c2cn(Cc3ccc(C(C)(C)C)cc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,390.0,Binding affinity to human ERG by radioligand displacement assay
3903,CHEMBL1818830,COc1cc(-c2cn(Cc3cccc4cccnc34)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,5430.0,Binding affinity to human ERG by radioligand displacement assay
3904,CHEMBL1818831,COc1cc(-c2cn(Cc3cccc(-n4cccn4)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG by radioligand displacement assay
3905,CHEMBL1818832,COc1cc(-c2cn(Cc3cccc(-c4noc(C)n4)c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG by radioligand displacement assay
3906,CHEMBL1818833,COc1cc(-c2cn(Cc3ccc(-c4noc(C)n4)cc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,8100.0,Binding affinity to human ERG by radioligand displacement assay
3907,CHEMBL1818834,COc1cc(-c2cn(Cc3ccc(-c4noc(-c5ccncc5)n4)cc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG by radioligand displacement assay
3908,CHEMBL1818835,COc1cc(-c2cn(Cc3csc4ccccc34)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2150.0,Binding affinity to human ERG by radioligand displacement assay
3909,CHEMBL1818836,COc1cc(-c2cn(Cc3ccc4ccsc4c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG by radioligand displacement assay
3910,CHEMBL1818837,COc1cc(-c2cn(Cc3ccc(-c4nc5ccccc5o4)cc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG by radioligand displacement assay
3911,CHEMBL2447962,CCCCN1CCCC[C@@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,84000.0,Inhibition of wild-type human ERG channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3912,CHEMBL2447962,CCCCN1CCCC[C@@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,276000.0,Inhibition of human ERG Y652A mutant channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3913,CHEMBL2447962,CCCCN1CCCC[C@@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,758000.0,Inhibition of human ERG F656A mutant channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3914,CHEMBL2447962,CCCCN1CCCC[C@@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,,,,Inhibition of wild-type human ERG channel expressed in CHO cells by whole-cell patch clamp technique
3915,CHEMBL2447962,CCCCN1CCCC[C@@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,,,,Inhibition of human ERG Y652A mutant channel expressed in CHO cells by whole-cell patch clamp technique
3916,CHEMBL1200396,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,32000.0,Inhibition of wild-type human ERG channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3917,CHEMBL1200396,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,265000.0,Inhibition of human ERG Y652A mutant channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3918,CHEMBL1200396,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,866000.0,Inhibition of human ERG F656A mutant channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3919,CHEMBL1200396,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,22000.0,Inhibition of wild-type human ERG channel expressed in CHO cells by whole-cell patch clamp technique
3920,CHEMBL1200396,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,95000.0,Inhibition of human ERG Y652A mutant channel expressed in CHO cells by whole-cell patch clamp technique
3921,CHEMBL1200749,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,13000.0,Inhibition of wild-type human ERG channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3922,CHEMBL1200749,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,278000.0,Inhibition of human ERG Y652A mutant channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3923,CHEMBL1200749,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,1013000.0,Inhibition of human ERG F656A mutant channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique
3924,CHEMBL1200749,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,13000.0,Inhibition of wild-type human ERG channel expressed in CHO cells by whole-cell patch clamp technique
3925,CHEMBL1200749,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl,IC50,nM,=,83000.0,Inhibition of human ERG Y652A mutant channel expressed in CHO cells by whole-cell patch clamp technique
3926,CHEMBL356066,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,IC50,nM,=,10300.0,Inhibition of human ERG by radioligand binding assay
3927,CHEMBL344227,O=C(/C=C/c1ccc(CNCCc2c[nH]c3ccccc23)cc1)NO,IC50,nM,=,27460.0,Inhibition of human ERG by radioligand binding assay
3928,CHEMBL1819137,CCN(CCc1c[nH]c2ccccc12)Cc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,5920.0,Inhibition of human ERG by radioligand binding assay
3929,CHEMBL1819138,Cc1[nH]c2ccccc2c1CCN(CCF)Cc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,5770.0,Inhibition of human ERG by radioligand binding assay
3930,CHEMBL1819141,CCCN(CCc1c[nH]c2ccccc12)Cc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,6680.0,Inhibition of human ERG by radioligand binding assay
3931,CHEMBL1819255,O=C(/C=C/c1ccc(CNCCc2c(-c3ccccc3)[nH]c3ccccc23)cc1)NO,IC50,nM,=,1480.0,Inhibition of human ERG by radioligand binding assay
3932,CHEMBL1819256,O=C(/C=C/c1ccc(CNCCc2c(-c3ccccn3)[nH]c3ccccc23)cc1)NO,IC50,nM,=,1540.0,Inhibition of human ERG by radioligand binding assay
3933,CHEMBL1819257,COc1ccncc1-c1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,8480.0,Inhibition of human ERG by radioligand binding assay
3934,CHEMBL1819258,O=C(/C=C/c1ccc(CNCCc2c(-c3cccs3)[nH]c3ccccc23)cc1)NO,IC50,nM,=,480.0,Inhibition of human ERG by radioligand binding assay
3935,CHEMBL1819259,Cc1noc(C)c1-c1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,31240.0,Inhibition of human ERG by radioligand binding assay
3936,CHEMBL1819260,CC(C)(C)c1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,7450.0,Inhibition of human ERG by radioligand binding assay
3937,CHEMBL142992,CC(C)N(CCc1c[nH]c2ccccc12)Cc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,5870.0,Inhibition of human ERG by radioligand binding assay
3938,CHEMBL1819272,O=C(/C=C/c1ccc(CNCCc2c(-c3ccccc3)nn3ccccc23)cc1)NO,IC50,nM,=,10400.0,Inhibition of human ERG by radioligand binding assay
3939,CHEMBL1819273,Cc1nn2ccccc2c1CCN(Cc1ccc(/C=C/C(=O)NO)cc1)C(C)C,IC50,nM,=,10030.0,Inhibition of human ERG by radioligand binding assay
3940,CHEMBL1819274,CCc1nn2ccccc2c1CCN(Cc1ccc(/C=C/C(=O)NO)cc1)C(C)C,IC50,nM,=,7520.0,Inhibition of human ERG by radioligand binding assay
3941,CHEMBL1819275,CC(C)N(CCc1c(-c2ccccc2)nn2ccccc12)Cc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,=,8160.0,Inhibition of human ERG by radioligand binding assay
3942,CHEMBL356066,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,IC50,nM,=,10300.0,Inhibition of human ERG by patch clamp assay
3943,CHEMBL1819267,CC(C)(C)c1[nH]c2ncccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated Q-patch assay
3944,CHEMBL1819270,Cc1nn2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated Q-patch assay
3945,CHEMBL98,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated Q-patch assay
3946,CHEMBL408513,O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,IC50,nM,>,30000.0,Inhibition of human ERG by automated Q-patch assay
3947,CHEMBL272980,Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated Q-patch assay
3948,CHEMBL27759,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated Q-patch assay
3949,CHEMBL1819261,CC(C)N(CCc1c(C(C)(C)O)[nH]c2ccccc12)Cc1ccc(/C=C/C(=O)NO)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by manual patch clamp assay
3950,CHEMBL356066,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,IC50,nM,=,10300.0,Inhibition of human ERG by manual patch clamp assay
3951,CHEMBL1819090,Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2cc(F)ccc2C#N)n(C)c1=O,IC50,nM,=,30000.0,Inhibition of human ERG
3952,CHEMBL3216758,Cc1nc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1.Cl.Cl.Cl.Cl,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
3953,CHEMBL3216098,Cc1nc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1.Cl.Cl.Cl.Cl,IC50,nM,=,8110.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
3954,CHEMBL3217170,Cc1c(Cl)cccc1N1CCN(CCCNC(=O)c2nc(-c3ccccc3)n(-c3ccccc3)c2C)CC1.Cl.Cl.Cl,IC50,nM,=,1300.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
3955,CHEMBL3215850,Cc1c(Cl)cccc1N1CCN(CCCNC(=O)c2nc(-c3ccccc3)n(-c3ccccc3)c2Cn2cncn2)CC1.Cl.Cl.Cl,IC50,nM,=,9800.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
3956,CHEMBL3215864,Cc1cccc(N2CCN(CCCNC(=O)c3nc(C)n(-c4ccc5c(c4)OCCO5)c3C)CC2)c1C.Cl.Cl,IC50,nM,=,8700.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells
3957,CHEMBL1822302,O=C(NCC1(N2CCOCC2)CCCCC1)N1CCC(c2nc(-c3ccc4ccccc4n3)no2)CC1,IC50,nM,=,4300.0,Inhibition of human ERG
3958,CHEMBL1822442,O=C(NCC1(N2CCCCC2)CCCC1)N1CCC(c2nc(-c3ccc4ccccc4n3)no2)CC1,IC50,nM,=,5800.0,Inhibition of human ERG
3959,CHEMBL1822304,O=C(NCC1(N2CCCC2)CCCC1)N1CCC(c2nc(-c3ccc4ccccc4n3)no2)CC1,IC50,nM,=,7100.0,Inhibition of human ERG
3960,CHEMBL1822443,CCN(CC)C1(CNC(=O)N2CCC(c3nc(-c4ccc5ccccc5n4)no3)CC2)CCCC1,IC50,nM,=,9400.0,Inhibition of human ERG
3961,CHEMBL1822294,O=C(NCC1(N2CCOCC2)CCCC1)N1CCC(c2nc(-c3ccc4ccccc4n3)no2)CC1,IC50,nM,=,10000.0,Inhibition of human ERG
3962,CHEMBL1822458,CC(C)N1CCCC1CNC(=O)N1CCC(c2nc(-c3ccc4ccccc4n3)no2)CC1,IC50,nM,=,17000.0,Inhibition of human ERG
3963,CHEMBL1822446,CCNC1(CNC(=O)N2CCC(c3nc(-c4ccc5ccccc5n4)no3)CC2)CCCC1,IC50,nM,=,24000.0,Inhibition of human ERG
3964,CHEMBL1822301,CC(C)(CNC(=O)N1CCC(c2nc(-c3ccc4ccccc4n3)no2)CC1)N1CCOCC1,IC50,nM,=,28000.0,Inhibition of human ERG
3965,CHEMBL1822444,CN(C)C1(CNC(=O)N2CCC(c3nc(-c4ccc5ccccc5n4)no3)CC2)CCCC1,IC50,nM,=,38000.0,Inhibition of human ERG
3966,CHEMBL1823340,c1ccc(-c2ccc(OCCCN3CCCCC3)cc2)cc1,IC50,nM,=,420.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3967,CHEMBL375571,CC(C)N1CCN(C(=O)N2CC=C(c3ccccc3)CC2)CC1,IC50,nM,=,22258.06,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3968,CHEMBL374493,CC(C)N1CCN(C(=O)N2CCC(c3ccccc3)CC2)CC1,IC50,nM,=,52500.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3969,CHEMBL218992,COc1cc2c(cc1OC)CN(C(=O)N1CCN(C(C)C)CC1)CC2,IC50,nM,=,115000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3970,CHEMBL219803,CC(C)N1CCN(C(=O)N2CCc3ccccc3C2)CC1,IC50,nM,=,115000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3971,CHEMBL219128,CC(C)N1CCN(C(=O)N2CCC(C(C)(C)C)CC2)CC1,IC50,nM,=,66923.08,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3972,CHEMBL219074,CC(C)N1CCN(C(=O)N2CCC(Cc3ccccc3)CC2)CC1,IC50,nM,=,37619.05,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3973,CHEMBL218410,CC(C)N1CCN(C(=O)N2CCC(C(=O)OC(C)(C)C)CC2)CC1,IC50,nM,=,101111.11,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3974,CHEMBL218834,CC(C)N1CCN(C(=O)N2CCC(C(=O)N3CC4CCC(CC4)C3)CC2)CC1,IC50,nM,=,115000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3975,CHEMBL220407,CC(C)N1CCN(C(=O)N2CCC(NC(=O)C3CCCC3)CC2)CC1,IC50,nM,=,156666.67,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3976,CHEMBL441705,O=C(N1CCN(C2CCCC2)CC1)N1Cc2ccccc2C1,IC50,nM,=,12222.22,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3977,CHEMBL373860,O=C(N1CCN(C2CC2)CC1)N1Cc2ccccc2C1,IC50,nM,=,52500.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3978,CHEMBL219592,CC(C)N1CCN(C(=O)N2Cc3ccccc3C2)CC1,IC50,nM,=,19411.76,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3979,CHEMBL384427,O=C(N1Cc2ccccc2C1)N1CCC[C@H]1CN1CCCC1,IC50,nM,=,28461.54,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3980,CHEMBL1823339,C=C(N(C)Cc1ccc(-c2ccccc2)cc1)N1CCN(C(C)C)CC1,IC50,nM,=,8181.82,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3981,CHEMBL216666,CN(Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCC[C@H]1CN1CCCC1,IC50,nM,=,5151.52,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3982,CHEMBL218836,O=C(NCc1ccc(C(F)(F)F)cc1)N1CCC[C@H]1CN1CCCC1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3983,CHEMBL218790,O=C(/C=C/c1ccc(C(F)(F)F)cc1)N1CCC[C@H]1CN1CCCC1,IC50,nM,=,3698.63,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3984,CHEMBL507360,COc1nccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3985,CHEMBL454642,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O,IC50,nM,=,7900.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3986,CHEMBL453894,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(C(F)(F)F)cccc2c1=O,IC50,nM,=,350.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3987,CHEMBL453893,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O,IC50,nM,=,1100.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3988,CHEMBL508712,Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3989,CHEMBL453892,COc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3990,CHEMBL454879,COc1ccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc2c1,IC50,nM,=,4300.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3991,CHEMBL453654,COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1,IC50,nM,=,3800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3992,CHEMBL453653,COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3993,CHEMBL455681,Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O,IC50,nM,=,2900.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3994,CHEMBL488249,Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O,IC50,nM,=,5600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3995,CHEMBL488248,Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,2900.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3996,CHEMBL487059,O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1,IC50,nM,=,170.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3997,CHEMBL487060,O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1,IC50,nM,=,460.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3998,CHEMBL488251,CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,3000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
3999,CHEMBL487230,CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,1800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4000,CHEMBL519067,CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,1700.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4001,CHEMBL487064,Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O,IC50,nM,=,2800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4002,CHEMBL476322,Cc1nc2c(C(F)(F)F)cccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,350.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4003,CHEMBL477364,Cc1nc2cc(C(F)(F)F)ccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,2600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4004,CHEMBL476323,Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4005,CHEMBL477363,Cc1nc2cccc(Cl)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,8100.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4006,CHEMBL515150,Cc1nc2c(F)cccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4007,CHEMBL476106,Cc1nc2cc(F)ccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,6000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4008,CHEMBL479252,Cc1nc2ccc(F)cc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,2500.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4009,CHEMBL477356,Cc1nc2cccc(F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4010,CHEMBL477990,COc1cccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c12,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4011,CHEMBL477991,COc1ccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c2c1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4012,CHEMBL477201,COc1ccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc2c1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4013,CHEMBL477152,COc1cccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc12,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4014,CHEMBL478616,Cc1cccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc12,IC50,nM,=,1600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4015,CHEMBL478615,Cc1ccc2c(=O)n(-c3ccc(OCCCN4CCCC4)cc3)c(C)nc2c1,IC50,nM,=,6700.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4016,CHEMBL478406,Cc1ccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c2c1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4017,CHEMBL479242,Cc1cccc2nc(C)n(-c3ccc(OCCCN4CCCC4)cc3)c(=O)c12,IC50,nM,=,6600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4018,CHEMBL479241,O=c1c2ccccc2nc(-c2ccccc2)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,1100.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4019,CHEMBL479036,CC(C)c1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,3900.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4020,CHEMBL515004,CCCc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,2800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4021,CHEMBL476723,CCc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,5000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4022,CHEMBL476373,Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4023,CHEMBL518431,O=c1c2ccccc2ncn1-c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,710.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4024,CHEMBL557718,COc1cccc2c1O[C@H](c1ccc(OCCCN3CCCC3)cc1)[C@@H](C)S2(=O)=O,IC50,nM,=,6200.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4025,CHEMBL560386,COc1cccc2c1O[C@@H](c1ccc(OCCCN3CCCC3)cc1)[C@H](C)S2(=O)=O,IC50,nM,=,4900.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4026,CHEMBL562870,COc1cccc2c1OC(c1ccc(OC3CCN(C4CCC4)CC3)cc1)C(C)S2(=O)=O,IC50,nM,=,14000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4027,CHEMBL550517,COc1cccc2c1OC(c1ccc(OCCCN3CCC[C@H](C)C3)cc1)C(C)S2(=O)=O,IC50,nM,=,2500.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4028,CHEMBL563779,COc1cccc2c1OC(c1ccc(OCCCN3CCC[C@@H]3C)cc1)C(C)S2(=O)=O,IC50,nM,=,3800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4029,CHEMBL560863,COc1cccc2c1OC(c1ccc(OCCCN3CCC[C@H]3C)cc1)C(C)S2(=O)=O,IC50,nM,=,2900.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4030,CHEMBL550050,COc1cccc2c1OC(c1ccc(OCCCN3CCCCC3)cc1)C(C)S2(=O)=O,IC50,nM,=,4800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4031,CHEMBL562722,COc1cccc2c1OC(c1ccc(OCCCN3CCCC3)cc1)C(C)S2(=O)=O,IC50,nM,=,7000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4032,CHEMBL561324,COc1ccc2c(c1)OC(c1ccc(OCCCN3CCCC3)cc1)C(C)S2(=O)=O,IC50,nM,=,1700.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4033,CHEMBL565007,COc1ccc2c(c1)S(=O)(=O)C(C)C(c1ccc(OCCCN3CCCC3)cc1)O2,IC50,nM,=,1000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4034,CHEMBL549639,COc1cccc2c1S(=O)(=O)C(C)C(c1ccc(OCCCN3CCCC3)cc1)O2,IC50,nM,=,6300.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4035,CHEMBL556100,CC1=C(c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1(=O)=O,IC50,nM,=,470.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4036,CHEMBL1823180,C[C@H]1[C@H](c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1(=O)=O,IC50,nM,=,440.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4037,CHEMBL560923,CC1=C(c2ccc(OCCCN3CCCC3)cc2)Oc2ccccc2S1,IC50,nM,=,4.4,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4038,CHEMBL550393,C[C@H]1Sc2ccccc2O[C@@H]1c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,25.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4039,CHEMBL564514,c1ccc([C@@H]2Sc3ccccc3O[C@@H]2c2ccc(OCCCN3CCCC3)cc2)cc1,IC50,nM,=,12.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4040,CHEMBL549433,CC[C@@H]1Sc2ccccc2O[C@@H]1c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,11.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4041,CHEMBL557853,C[C@@H]1Sc2ccccc2O[C@@H]1c1ccc(OCCCN2CCCC2)cc1,IC50,nM,=,5.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4042,CHEMBL575453,Nc1cnc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,132857.14,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4043,CHEMBL575234,c1ncc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,6393.44,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4044,CHEMBL575693,CC(=O)Nc1ccc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,8518.52,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4045,CHEMBL575685,Nc1ccc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,190000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4046,CHEMBL578834,Oc1ccc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,190000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4047,CHEMBL572559,Cc1ccc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,8181.82,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4048,CHEMBL575483,COc1ccc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,1111.11,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4049,CHEMBL572737,N#Cc1cncc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)c1,IC50,nM,=,6666.67,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4050,CHEMBL582876,Fc1ncccc1-c1cc2sc(N3CCC(N4CCCCC4)CC3)nc2cn1,IC50,nM,=,1363.64,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4051,CHEMBL574826,Fc1cc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)ccn1,IC50,nM,=,1764.71,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4052,CHEMBL575022,COc1cc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)ccn1,IC50,nM,=,989.01,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4053,CHEMBL573034,COc1cc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)ccn1,IC50,nM,=,204.08,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4054,CHEMBL583582,Fc1cc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)ccn1,IC50,nM,=,204.08,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4055,CHEMBL575023,Fc1ccc(-c2cc3sc(N4CCC(N5CCCCC5)CC4)nc3cn2)cn1,IC50,nM,=,9607.84,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4056,CHEMBL573493,Nc1cnc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4057,CHEMBL575476,c1ncc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,23333.33,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4058,CHEMBL574387,CC(=O)Nc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4059,CHEMBL575241,Nc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,19411.76,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4060,CHEMBL574393,Oc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,323333.33,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4061,CHEMBL574180,Cc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,7543.86,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4062,CHEMBL573485,COc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,101.01,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4063,CHEMBL578862,N#Cc1cncc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)c1,IC50,nM,=,1235.96,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4064,CHEMBL575475,Fc1ncccc1-c1cnc2nc(N3CCC(N4CCCCC4)CC3)sc2c1,IC50,nM,=,2658.23,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4065,CHEMBL574837,Fc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1,IC50,nM,=,309.28,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4066,CHEMBL584766,N#Cc1cc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)ccc1F,IC50,nM,=,101.01,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4067,CHEMBL572558,N#Cc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cc1,IC50,nM,=,1111.11,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4068,CHEMBL575474,Clc1cc2sc(N3CCC(N4CCCCC4)CC3)nc2cn1,IC50,nM,=,6949.15,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4069,CHEMBL1823054,COCC1CCCN1S(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,1918.03,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4070,CHEMBL1823053,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)N3CCC(O)C3)cc2)cc1,IC50,nM,=,7000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4071,CHEMBL554506,COC1CCN(S(=O)(=O)c2ccc(-c3ccc(CCN4CCC[C@H]4C)cc3)cc2)CC1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4072,CHEMBL560140,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)N3CCS(=O)(=O)CC3)cc2)cc1,IC50,nM,=,9500.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4073,CHEMBL561279,CC1COCC(C)N1S(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,1166.67,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4074,CHEMBL564380,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)N3CCOCC3)cc2)cc1,IC50,nM,=,3666.67,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4075,CHEMBL558655,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)NCc3ccncc3)cc2)cc1,IC50,nM,=,8111.11,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4076,CHEMBL558456,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)NCc3ccccc3)cc2)cc1,IC50,nM,=,571.43,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4077,CHEMBL552279,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)Nc3ccccc3)cc2)cc1,IC50,nM,=,296.7,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4078,CHEMBL559118,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)NC3CCOCC3)cc2)cc1,IC50,nM,=,12789.47,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4079,CHEMBL563118,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)NC3CCC3)cc2)cc1,IC50,nM,=,750.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4080,CHEMBL558260,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)NCC3CC3)cc2)cc1,IC50,nM,=,2555.56,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4081,CHEMBL550405,COCCNS(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,7344.83,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4082,CHEMBL1823052,CCC(CO)NS(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,5108.11,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4083,CHEMBL558923,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(N)(=O)=O)cc2)cc1,IC50,nM,=,7714.29,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4084,CHEMBL562629,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)N3CCCCC3)cc2)cc1,IC50,nM,=,1109.59,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4085,CHEMBL1823051,CCCNS(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,1411.76,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4086,CHEMBL569832,CCNS(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,3382.98,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4087,CHEMBL1092108,O=C(NCc1ccccc1)N(c1ccc(Br)cc1)C1CCN(Cc2ccncc2)CC1,IC50,nM,=,2310.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4088,CHEMBL1092109,O=C(NCc1ccccc1)N(c1ccc(Br)cc1)C1CCN(Cc2ccnnc2)CC1,IC50,nM,=,13800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4089,CHEMBL1093696,O=C(NCc1ccc(F)cc1)N(c1ccc(Cl)cc1)C1CCN(Cc2ccnnc2)CC1,IC50,nM,=,12000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4090,CHEMBL1091836,Nc1cc(CN2CCC(N(C(=O)NCc3ccc(F)cc3)c3ccc(Cl)cc3)CC2)ccn1,IC50,nM,=,384.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4091,CHEMBL1091834,O=C(NCc1ccc(F)cc1)N(c1ccc(Cl)cc1)C1CCN(Cc2ccncc2)CC1,IC50,nM,=,3810.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4092,CHEMBL1089078,O=C(NCc1ccc(F)cc1)N(c1ccc(Br)cc1)C1CCN(CCO)CC1,IC50,nM,=,7880.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4093,CHEMBL1093113,O=C(NCc1ccc(F)cc1)N(c1ccc(Cl)cc1)C1CCN(CCO)CC1,IC50,nM,=,12700.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4094,CHEMBL1092106,CCN1CCC(N(C(=O)NCc2ccc(F)cc2)c2ccc(Cl)cn2)CC1,IC50,nM,=,9190.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4095,CHEMBL1092105,CCN1CCC(N(C(=O)NCc2ccc(F)cc2)c2ccc(Cl)cc2)CC1,IC50,nM,=,6650.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4096,CHEMBL1094029,O=C(Nc1ccccc1)N(c1ccc(Br)cc1)C1CCN(C2CCCC2)CC1,IC50,nM,=,188.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4097,CHEMBL1094030,O=C(NCc1ccc(F)cc1)N(c1ccc(Br)cc1)C1CCN(C2CCCC2)CC1,IC50,nM,=,202.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4098,CHEMBL1094028,O=C(NCc1ccccc1)N(c1ccc(Br)cc1)C1CCN(C2CCCC2)CC1,IC50,nM,=,178.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4099,CHEMBL1823050,COC(=O)N1CC(Oc2ccc(F)cc2)CC1C(=O)N1CCCN(C2CCC2)CC1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4100,CHEMBL1823049,COC(=O)N1CC(Oc2cccc(F)c2)CC1C(=O)N1CCCN(C2CCC2)CC1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4101,CHEMBL1823048,O=C(C1CC(Oc2ccc(F)cc2)CN1)N1CCCN(C2CCCC2)CC1,IC50,nM,=,4600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4102,CHEMBL1823047,N#Cc1ccc(OC2CNC(C(=O)N3CCCN(C4CCCC4)CC3)C2)cc1,IC50,nM,=,2900.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4103,CHEMBL1823046,N#Cc1ccc(OC2CNC(C(=O)N3CCCN(C4CCC4)CC3)C2)cc1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4104,CHEMBL1823045,O=C(C1CC(Oc2ccc(Cl)cc2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4105,CHEMBL1823044,O=C(C1CC(Oc2ccc(F)cc2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4106,CHEMBL1823043,O=C(C1CC(Oc2cccc(Cl)c2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,7200.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4107,CHEMBL1823042,O=C(C1CC(Oc2cccc(F)c2)CN1)N1CCCN(C2CCC2)CC1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4108,CHEMBL1084616,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccn4ncnc4n3)ccc2c1,IC50,nM,=,20800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4109,CHEMBL392573,Cc1cc2ncc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)c(C)n2n1,IC50,nM,=,8800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4110,CHEMBL1086074,C[C@@H]1CCCN1CCc1ccc2nc(-c3cnc4c(c3)OCO4)ccc2c1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4111,CHEMBL1086073,Cc1cc(-c2nc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)cs2)no1,IC50,nM,=,2840.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4112,CHEMBL1086072,Cc1nc(-c2nc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)cs2)cs1,IC50,nM,=,12400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4113,CHEMBL1085841,Cc1nc(-c2ccncc2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,4800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4114,CHEMBL1082496,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccccn3)ccc2c1,IC50,nM,=,18000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4115,CHEMBL1086534,CCOC(=N)c1ccc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)s1,IC50,nM,=,4800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4116,CHEMBL1086315,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(C#N)s3)ccc2c1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4117,CHEMBL1083448,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc4c(c3)COCO4)ccc2c1,IC50,nM,=,3600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4118,CHEMBL263101,Cc1nc2ncccc2cc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4119,CHEMBL1083447,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc4nccnc4c3)ccc2c1,IC50,nM,=,8400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4120,CHEMBL1084385,Cc1nc2ccccn2c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,8000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4121,CHEMBL1084384,C[C@@H]1CCCN1CCc1ccc2nc(-c3cn4c(n3)SCC4)ccc2c1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4122,CHEMBL1084383,Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)sc2ncnn12,IC50,nM,=,2800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4123,CHEMBL1085142,Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)sc2nc3ccccc3n12,IC50,nM,=,1720.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4124,CHEMBL1083562,C[C@@H]1CCCN1CCc1ccc2nc(-c3nc4ccccc4s3)ccc2c1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4125,CHEMBL1085398,Cc1onc(-c2ccccc2)c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,6400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4126,CHEMBL1085397,C[C@@H]1CCCN1CCc1ccc2nc(-c3c(-c4ccccc4)nn(C)c3Cl)ccc2c1,IC50,nM,=,6000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4127,CHEMBL1085396,Cc1onc(-c2ccc(Cl)cc2)c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,1600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4128,CHEMBL1085641,Cc1c(-c2ccc(Cl)cc2)noc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4129,CHEMBL1086098,Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)nnn1-c1ccc(F)cc1F,IC50,nM,=,2800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4130,CHEMBL1082606,Cc1nc(-c2cccnc2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,6000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4131,CHEMBL1085866,Cc1nc(-c2ccccn2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,11200.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4132,CHEMBL1086561,Cc1nc(N2CCOCC2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,20400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4133,CHEMBL1085592,Cc1nc(-c2cnccn2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,32000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4134,CHEMBL1086292,Cc1nc(-c2cccs2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,3720.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4135,CHEMBL1086513,C[C@@H]1CCCN1CCc1ccc2nc(-c3cnc(-c4ccccc4)s3)ccc2c1,IC50,nM,=,1360.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4136,CHEMBL1086514,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(-n4ccc(=O)cc4)cc3)ccc2c1,IC50,nM,=,20000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4137,CHEMBL1085336,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(N4CCCCC4)cc3)ccc2c1,IC50,nM,=,2800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4138,CHEMBL1085337,CC1CCN(c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)CC1,IC50,nM,=,22400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4139,CHEMBL1082488,Cc1cc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)nc(-c2ccccc2)n1,IC50,nM,=,120.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4140,CHEMBL237191,Cc1nc(N2CCCC2)ncc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,10400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4141,CHEMBL1082489,COc1ncc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cn1,IC50,nM,=,22400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4142,CHEMBL1085828,C[C@@H]1CCCN1CCc1ccc2nc(-c3cncnc3)ccc2c1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4143,CHEMBL1822869,CC1CCCN1CCc1ccc2nc(-c3cccs3)ccc2c1,IC50,nM,=,2480.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4144,CHEMBL1822868,CC1CCCN1CCc1ccc2nc(-c3ccsc3)ccc2c1,IC50,nM,=,4800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4145,CHEMBL1822867,CC1CCCN1CCc1ccc2nc(-c3ccoc3)ccc2c1,IC50,nM,=,8400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4146,CHEMBL1084826,Cc1n[nH]c(C)c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4147,CHEMBL442242,Cc1nn(C)cc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,24800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4148,CHEMBL1084827,Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1C,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4149,CHEMBL1084314,Cc1n[nH]cc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,17600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4150,CHEMBL1084582,C[C@@H]1CCCN1CCc1ccc2nc(-c3cn[nH]c3)ccc2c1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4151,CHEMBL1084581,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccn[nH]3)ccc2c1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4152,CHEMBL1822866,COC(=O)c1cc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)on1,IC50,nM,=,16800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4153,CHEMBL1822865,COC(=O)c1c(C)noc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,6000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4154,CHEMBL1086520,C[C@@H]1CCCN1CCc1ccc2nc(-c3cc(Br)no3)ccc2c1,IC50,nM,=,880.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4155,CHEMBL1083274,Cc1nc(C)c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)o1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4156,CHEMBL1083462,Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1-c1ccc(N(C)C)nn1,IC50,nM,=,18000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4157,CHEMBL237394,CCOc1ccc(-n2ncc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)c2C)nn1,IC50,nM,=,10400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4158,CHEMBL1084877,Cc1cc(C(F)(F)F)cc(-n2ncc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)c2C)n1,IC50,nM,=,16800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4159,CHEMBL1083463,Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1-c1ccc(Cl)c(Cl)c1,IC50,nM,=,600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4160,CHEMBL393581,Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1-c1ccccn1,IC50,nM,=,20000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4161,CHEMBL1085124,Cc1ccc(-c2ccc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)s2)s1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4162,CHEMBL1084879,C[C@@H]1CCCN1CCc1ccc2nc(-c3csc(-c4ccc(OCC(F)(F)F)nc4)n3)ccc2c1,IC50,nM,=,1520.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4163,CHEMBL1084294,C[C@@H]1CCCN1CCc1ccc2nc(-c3csc(-c4cc(Cl)nc(Cl)c4)n3)ccc2c1,IC50,nM,=,20400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4164,CHEMBL1084878,C[C@@H]1CCCN1CCc1ccc2nc(-c3csc(-c4ccccc4)n3)ccc2c1,IC50,nM,=,1600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4165,CHEMBL1085964,C[C@@H]1CCCN1CCc1ccc2nc(-c3cnccn3)ccc2c1,IC50,nM,=,24800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4166,CHEMBL1085783,C[C@@H]1CCCN1CCc1ccc2nc(-c3c(O)ccnc3C(F)(F)F)ccc2c1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4167,CHEMBL1083406,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccncc3)ccc2c1,IC50,nM,=,28000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4168,CHEMBL1822864,Cc1nc(C)c(-c2ccc3cc(CCN4CCCC4C)ccc3n2)cc1C(N)=O,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4169,CHEMBL1822863,Cc1nc(C)c(-c2ccc3cc(CCN4CCCC4C)ccc3n2)cc1C#N,IC50,nM,=,8400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4170,CHEMBL1082447,Cc1ccc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)c(C)n1,IC50,nM,=,20000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4171,CHEMBL1083407,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(Cl)nc3)ccc2c1,IC50,nM,=,3600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4172,CHEMBL1082781,Cc1ccc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cn1,IC50,nM,=,26400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4173,CHEMBL1084560,C[C@@H]1CCCN1CCc1ccc2nc(-c3cccnc3)ccc2c1,IC50,nM,=,12000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4174,CHEMBL1084559,Cc1nc(C)c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)s1,IC50,nM,=,20400.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4175,CHEMBL1086521,C[C@@H]1CCCN1CCc1ccc2nc(-c3nccs3)ccc2c1,IC50,nM,=,11600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4176,CHEMBL1085591,C[C@@H]1CCCN1CCc1ccc2nc(C3=NCCS3)ccc2c1,IC50,nM,=,25200.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4177,CHEMBL1085325,C[C@@H]1CCCN1CCc1ccc2nc(C(C)(C)C)ccc2c1,IC50,nM,=,6800.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4178,CHEMBL1086034,C[C@@H]1CCCN1CCc1ccc2nc(C3CC3)ccc2c1,IC50,nM,=,44000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4179,CHEMBL1086033,Cc1ccc2cc(CCN3CCC[C@H]3C)ccc2n1,IC50,nM,=,216000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4180,CHEMBL1085800,C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(C#N)cc3)ccc2c1,IC50,nM,=,3200.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4181,CHEMBL1086032,C[C@@H]1CCCN1CCc1ccc2ncccc2c1,IC50,nM,=,40000.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4182,CHEMBL351231,C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1,IC50,nM,=,1600.0,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay
4183,CHEMBL1822525,COc1cc(N2CCN(C[C@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1,IC50,nM,=,9100.0,Inhibition of human ERG channel by patch clamp assay
4184,CHEMBL1824045,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(-c6ccco6)cc54)CC3)nc2N1,IC50,nM,=,1300.0,Inhibition of human ERG by electrophysiological assay
4185,CHEMBL1824039,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(OC(F)(F)F)cc54)CC3)nc2N1,IC50,nM,=,1400.0,Inhibition of human ERG by electrophysiological assay
4186,CHEMBL1824031,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(Br)cc54)CC3)nc2N1,IC50,nM,=,2800.0,Inhibition of human ERG by electrophysiological assay
4187,CHEMBL1824042,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(Cl)cc54)CC3)nc2N1,IC50,nM,=,3000.0,Inhibition of human ERG by electrophysiological assay
4188,CHEMBL1824043,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(F)cc54)CC3)nc2N1,IC50,nM,=,8500.0,Inhibition of human ERG by electrophysiological assay
4189,CHEMBL1824044,COc1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,=,12900.0,Inhibition of human ERG by electrophysiological assay
4190,CHEMBL1824034,COC(=O)c1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,=,14800.0,Inhibition of human ERG by electrophysiological assay
4191,CHEMBL1824037,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc([N+](=O)[O-])cc54)CC3)nc2N1,IC50,nM,=,24300.0,Inhibition of human ERG by electrophysiological assay
4192,CHEMBL1824040,CC(=O)c1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,=,49100.0,Inhibition of human ERG by electrophysiological assay
4193,CHEMBL1824036,CS(=O)(=O)c1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,=,50700.0,Inhibition of human ERG by electrophysiological assay
4194,CHEMBL1824028,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(-n6cnnn6)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological assay
4195,CHEMBL1824029,CC(O)c1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological assay
4196,CHEMBL1824030,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(O)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological assay
4197,CHEMBL1824032,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(NC(=O)C(F)(F)F)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological assay
4198,CHEMBL1824033,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(C(=O)O)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological assay
4199,CHEMBL1824038,CCS(=O)(=O)c1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological assay
4200,CHEMBL1824041,N#Cc1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,>,44000.0,Inhibition of human ERG by electrophysiological assay
4201,CHEMBL1830693,c1ccc(Nc2nc(-c3cn[nH]c3)cs2)nc1,IC50,nM,=,33000.0,Inhibition of human ERG
4202,CHEMBL1830698,c1ccc(Nc2nc3c(s2)CCc2n[nH]cc2-3)nc1,IC50,nM,=,17000.0,Inhibition of human ERG
4203,CHEMBL1830707,c1ccc(Nc2nc3c(s2)CCCc2n[nH]cc2-3)nc1,IC50,nM,=,28000.0,Inhibition of human ERG
4204,CHEMBL1830711,c1cnc(Nc2nc3c(s2)CCCc2n[nH]cc2-3)nc1,IC50,nM,=,30000.0,Inhibition of human ERG
4205,CHEMBL391574,Cc1cc(C(=O)O)n[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell voltage patch clamp technique
4206,CHEMBL445990,Oc1noc2cc(Cl)ccc12,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell voltage patch clamp technique
4207,CHEMBL492591,O=C(O)c1cc2occc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell voltage patch clamp technique
4208,CHEMBL507614,O=C(O)c1cc2sccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell voltage patch clamp technique
4209,CHEMBL495187,O=c1[nH]c2cccc(Cl)c2cc1O,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell voltage patch clamp technique
4210,CHEMBL467660,O=c1[nH]c2ccc(F)c(Cl)c2cc1O,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell voltage patch clamp technique
4211,CHEMBL1829472,C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)n(-c3ncccn3)n2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG by patch express assay
4212,CHEMBL1829637,N[C@]1(c2ccccc2)CC[C@H](N2CC(NC(=O)CNC(=O)c3cccc(C(F)(F)F)c3)C2)CC1,IC50,nM,=,6200.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4213,CHEMBL1829636,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](F)(c3ccccc3)CC2)C1,IC50,nM,=,3300.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4214,CHEMBL1829635,Cc1cccc(C)c1[C@]1(O)CC[C@@H](N2CC(NC(=O)CNC(=O)c3cccc(C(F)(F)F)c3)C2)CC1,IC50,nM,=,7600.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4215,CHEMBL1829634,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](O)(c3ccc4c(c3)OCC4)CC2)C1,IC50,nM,=,11700.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4216,CHEMBL1829633,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](O)(c3ccc4c(c3)OCO4)CC2)C1,IC50,nM,=,13500.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4217,CHEMBL1829632,COc1ccc([C@]2(O)CC[C@@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cc1,IC50,nM,=,8900.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4218,CHEMBL1829631,CN(C)c1cccc([C@]2(O)CC[C@@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)c1,IC50,nM,=,25000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4219,CHEMBL1829630,N#Cc1cccc([C@]2(O)CC[C@@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)c1,IC50,nM,=,1500.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4220,CHEMBL1829629,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](O)(c3ccc(F)cc3)CC2)C1,IC50,nM,=,2800.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4221,CHEMBL1829628,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](O)(c3ccccc3)CC2)C1,IC50,nM,=,10000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4222,CHEMBL1829603,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](O)(c3cccnc3)CC2)C1,IC50,nM,=,35000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4223,CHEMBL1829627,Nc1ccc([C@H]2CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)nc1,IC50,nM,=,37000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4224,CHEMBL1829626,Nc1cccnc1[C@H]1CC[C@H](N2CC(NC(=O)CNC(=O)c3cccc(C(F)(F)F)c3)C2)CC1,IC50,nM,=,44000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4225,CHEMBL1829625,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3ccncc3O)CC2)C1,IC50,nM,=,23000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4226,CHEMBL1829624,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3ccc(O)cn3)CC2)C1,IC50,nM,=,10000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4227,CHEMBL1829623,CN(C)c1ncc([C@H]2CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,9800.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4228,CHEMBL1829622,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3cnccn3)CC2)C1,IC50,nM,=,12000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4229,CHEMBL1829621,COc1cc([C@H]2CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)ccn1,IC50,nM,=,6200.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4230,CHEMBL1829620,COc1cnccc1[C@H]1CC[C@H](N2CC(NC(=O)CNC(=O)c3cccc(C(F)(F)F)c3)C2)CC1,IC50,nM,=,8200.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4231,CHEMBL1829619,COc1ccc([C@H]2CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,2800.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4232,CHEMBL1829618,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3cccnc3)CC2)C1,IC50,nM,=,3800.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4233,CHEMBL1829617,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3ccc4[nH]cnc4c3)CC2)C1,IC50,nM,=,2500.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4234,CHEMBL1829616,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3ccc(N4CCCC4)cc3)CC2)C1,IC50,nM,=,7900.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4235,CHEMBL1829615,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3ccc(C(=O)O)cc3)CC2)C1,IC50,nM,=,23000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4236,CHEMBL1829614,COC(=O)c1ccc([C@H]2CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cc1,IC50,nM,=,1300.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4237,CHEMBL1829613,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3ccc(O)cc3)CC2)C1,IC50,nM,=,4100.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4238,CHEMBL1829612,COc1ccc([C@H]2CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cc1,IC50,nM,=,3000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4239,CHEMBL1829611,O=C(CNC(=O)c1ccc(C(F)(F)F)cc1)NC1CN([C@H]2CC[C@H](c3ccc4c(c3)OCO4)CC2)C1,IC50,nM,=,1500.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4240,CHEMBL1829610,O=C(CNC(=O)c1ccccc1)NC1CN([C@H]2CC[C@H](c3ccc4c(c3)OCO4)CC2)C1,IC50,nM,=,2800.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4241,CHEMBL1829609,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@H](c3ccccc3)CC2)C1,IC50,nM,=,4000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4242,CHEMBL1829605,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@H](c3ccc4c(c3)OCO4)CC2)C1,IC50,nM,=,2800.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4243,CHEMBL1829604,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN(C2CCC(c3c[nH]c4ccccc34)CC2)C1,IC50,nM,=,2400.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4244,CHEMBL1829638,N#C[C@]1(c2ccccc2)CC[C@H](N2CC(NC(=O)CNC(=O)c3cccc(C(F)(F)F)c3)C2)CC1,IC50,,,,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4245,CHEMBL1829639,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](C(=O)O)(c3ccccc3)CC2)C1,IC50,,,,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4246,CHEMBL1829640,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@](CO)(c3ccccc3)CC2)C1,IC50,,,,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells after 1 hr
4247,CHEMBL1829763,C[C@@H](c1ccc(-c2ccc(F)cc2F)cc1)N1CC[C@](CCO)(c2ccc(F)cc2)OC1=O,IC50,nM,>,10000.0,Inhibition of human ERG
4248,CHEMBL1830042,CN1CC(c2c[nH]c3cc(-n4ccc(OCc5ccccc5)cc4=O)ccc23)C1,IC50,nM,=,12000.0,Inhibition of human ERG
4249,CHEMBL1837037,CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1,IC50,nM,=,17900.0,Displacement of [3H]dofetilide from human ERG transfected in HEK293 cells by fluorescence polarization binding assay
4250,CHEMBL1837038,COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1,IC50,nM,=,47300.0,Displacement of [3H]dofetilide from human ERG transfected in HEK293 cells by fluorescence polarization binding assay
4251,CHEMBL1837040,CC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1,IC50,nM,=,35200.0,Displacement of [3H]dofetilide from human ERG transfected in HEK293 cells by fluorescence polarization binding assay
4252,CHEMBL1837041,CS(=O)(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1,IC50,nM,=,30700.0,Displacement of [3H]dofetilide from human ERG transfected in HEK293 cells by fluorescence polarization binding assay
4253,CHEMBL1834854,O=C(CNc1noc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3nccs3)CC2)C1,IC50,nM,=,11.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4254,CHEMBL1834853,O=C(CNc1noc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3cncs3)CC2)C1,IC50,nM,=,16.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4255,CHEMBL1834852,COc1ccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4noc5ccc(C(F)(F)F)cc45)C3)CC2)cn1,IC50,nM,=,8.7,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4256,CHEMBL1833983,C#C[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(C)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,>,50.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4257,CHEMBL1834851,Cn1ccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4nn(C)c5ccc(C(F)(F)F)cc45)C3)CC2)n1,IC50,nM,>,50.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4258,CHEMBL1834850,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4nccn4C)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,,,,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4259,CHEMBL1834849,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4ncco4)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,,,,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4260,CHEMBL1834799,CC(C)c1ncc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4nn(C)c5ccc(C(F)(F)F)cc45)C3)CC2)s1,IC50,nM,=,17000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4261,CHEMBL1834798,CCc1ncc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4nn(C)c5ccc(C(F)(F)F)cc45)C3)CC2)s1,IC50,nM,=,23000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4262,CHEMBL1834797,Cc1ncc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4nn(C)c5ccc(C(F)(F)F)cc45)C3)CC2)s1,IC50,nM,=,25000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4263,CHEMBL1834796,O=C(CNc1nn(CCO)c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3nccs3)CC2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4264,CHEMBL1834795,NC(=O)n1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4nccs4)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,31000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4265,CHEMBL1834794,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4nccs4)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,27000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4266,CHEMBL1834793,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4cncs4)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,44000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4267,CHEMBL1834792,O=C(CNc1n[nH]c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3cncs3)CC2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4268,CHEMBL1834791,Cc1ccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4nn(C)c5ccc(C(F)(F)F)cc45)C3)CC2)cn1,IC50,nM,=,18000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4269,CHEMBL1834790,COc1ccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4nn(C)c5ccc(C(F)(F)F)cc45)C3)CC2)cn1,IC50,nM,=,12000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4270,CHEMBL1834789,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4cccnc4)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,24000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4271,CHEMBL1834788,Cc1ccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4n[nH]c5ccc(C(F)(F)F)cc45)C3)CC2)cn1,IC50,nM,=,27000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4272,CHEMBL2092884,COc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNc4n[nH]c5ccc(C(F)(F)F)cc45)C3)CC2)cn1,IC50,nM,=,32000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4273,CHEMBL1834787,O=C(CNc1n[nH]c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3cccnc3)CC2)C1,IC50,nM,=,36000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4274,CHEMBL1834786,CN(C)c1cccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4nn(C)c5ccc(C(F)(F)F)cc45)C3)CC2)c1,IC50,nM,=,12000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4275,CHEMBL1834785,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4ccccc4)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,10000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4276,CHEMBL1834784,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(C4CCCC4)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,4100.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4277,CHEMBL1834783,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNC3=NC(Cc4ccccc4)c4ccc(C(F)(F)F)cc43)C2)CC1,IC50,nM,=,1400.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4278,CHEMBL1834782,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(S(C)(=O)=O)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,25000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4279,CHEMBL1834781,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(C(N)=O)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,20000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4280,CHEMBL1834780,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(CC(F)(F)F)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,2500.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4281,CHEMBL1834779,C=CCn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](C(=O)OCC)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,3700.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4282,CHEMBL1834721,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(CC)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,7600.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4283,CHEMBL1834720,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3noc4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,5600.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4284,CHEMBL1834719,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3n[nH]c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,9100.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4285,CHEMBL1834718,NC(=O)n1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4ccc5c(c4)OCO5)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,12000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4286,CHEMBL1834717,CC(C)(C)NC(=O)n1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4ccc5c(c4)OCO5)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,4700.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4287,CHEMBL1834652,O=C(CNc1nn(CCO)c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccc4c(c3)OCO4)CC2)C1,IC50,nM,=,7600.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4288,CHEMBL1834651,O=C(CNc1noc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccc4c(c3)OCO4)CC2)C1,IC50,nM,=,1900.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4289,CHEMBL1834650,CS(=O)(=O)N[C@H]1CC[C@@H](N2CC(NC(=O)CNc3n[nH]c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,23000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4290,CHEMBL1834649,N[C@H]1CC[C@@H](N2CC(NC(=O)CNc3n[nH]c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4291,CHEMBL1834648,C=CCO[C@H]1CC[C@@H](N2CC(NC(=O)CNc3n[nH]c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,7400.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4292,CHEMBL1834647,CCO[C@H]1CC[C@@H](N2CC(NC(=O)CNc3n[nH]c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,4500.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4293,CHEMBL1834646,O=C(CNc1n[nH]c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](O)CC2)C1,IC50,nM,=,30000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4294,CHEMBL1834645,C=CCOC[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(C)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,5000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4295,CHEMBL1834644,CCOC[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(C)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,5600.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4296,CHEMBL1834643,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](CO)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,32000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4297,CHEMBL1834642,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](C(N)=O)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,32000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4298,CHEMBL1834641,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](C(=O)O)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,25000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4299,CHEMBL1834640,CCOC(=O)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3nn(C)c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,8000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4300,CHEMBL1834639,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](C4CCCCC4)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,3100.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4301,CHEMBL1834638,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](C#N)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,24000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4302,CHEMBL1834637,CC(C)[C@H]1CC[C@@H](N2CC(NC(=O)CNc3n[nH]c4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,6200.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4303,CHEMBL1834636,O=C(CNc1n[nH]c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](n3ccccc3=O)CC2)C1,IC50,nM,=,34000.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4304,CHEMBL1834635,Cn1nc(NCC(=O)NC2CN([C@H]3CC[C@@H](c4ccc5c(c4)OCO5)CC3)C2)c2cc(C(F)(F)F)ccc21,IC50,nM,=,840.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4305,CHEMBL1834634,COc1ccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4n[nH]c5ccc(C(F)(F)F)cc45)C3)CC2)cn1,IC50,nM,=,2500.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4306,CHEMBL1834633,NC(=O)Cc1ccc([C@H]2CC[C@@H](N3CC(NC(=O)CNc4n[nH]c5ccc(C(F)(F)F)cc45)C3)CC2)cc1,IC50,nM,=,9500.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4307,CHEMBL1834632,O=C(CNc1n[nH]c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccc4c(c3)OCO4)CC2)C1,IC50,nM,=,1100.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4308,CHEMBL1834631,O=C(CNc1n[nH]c2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccccc3)CC2)C1,IC50,nM,=,1200.0,Displacement of [3H]-astemizole from human ERG in HEK293 cells after 1 hrs by scintillation counting
4309,CHEMBL1836317,CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1,IC50,nM,>,10000.0,Inhibition of human ERG by patch-clamp assay
4310,CHEMBL1834226,CCN/C(=N\S(=O)(=O)c1cccc(Cl)c1)N1CC(CC)C=N1,IC50,nM,>,10000.0,Inhibition of human ERG
4311,CHEMBL1834234,CCN/C(=N\S(=O)(=O)c1cccc(Cl)c1)N1N=CCC1c1ccccc1,IC50,nM,>,10000.0,Inhibition of human ERG
4312,CHEMBL1834350,CCN/C(=N\S(=O)(=O)c1cccc(Cl)c1)N1CC2(C=N1)CCNCC2,IC50,nM,=,7943.28,Inhibition of human ERG
4313,CHEMBL1834345,CCN/C(=N\S(=O)(=O)c1cccc(Cl)c1)N1CC(C)(C)C=N1,IC50,nM,>,10000.0,Inhibition of human ERG
4314,CHEMBL1836170,CC(C)Oc1ncc(-c2nc(-c3ccc4c(c3)CCNCC4)no2)cc1C#N,IC50,nM,=,3162.28,Inhibition of human ERG
4315,CHEMBL1836212,CC(C)Oc1ccc(-c2nc(-c3cccc4c3OCCN(C(CO)CO)C4)no2)cc1C#N,IC50,nM,=,6760.83,Inhibition of human ERG
4316,CHEMBL1836171,Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(CC(=O)N[C@@H](C)CO)C2,IC50,nM,>,10000.0,Inhibition of human ERG
4317,CHEMBL1836213,Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)cnc2c1CCN(C(CO)CO)C2,IC50,nM,=,12589.25,Inhibition of human ERG
4318,CHEMBL1836215,Cc1c(-c2noc(-c3ccc(OC(C)C)c(C#N)c3)n2)ccc2c1CCN(C(CO)CO)C2,IC50,nM,=,12882.5,Inhibition of human ERG
4319,CHEMBL1836172,CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)CC4)no2)cc1C#N,IC50,nM,=,17782.79,Inhibition of human ERG
4320,CHEMBL1836214,CC(C)Oc1ccc(-c2nc(-c3ccc4c(c3)CCN(C(CO)CO)C4)no2)cc1C#N,IC50,nM,=,19952.62,Inhibition of human ERG
4321,CHEMBL515757,Cc1cccc(Nc2nc(NCCN)ncc2C(N)=O)c1,IC50,nM,=,1995.26,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4322,CHEMBL1834757,Cc1cccc(Nc2nc(N[C@@H]3CCCNC3)ncc2C(N)=O)c1,IC50,nM,=,2511.89,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4323,CHEMBL1834758,Cc1cccc(Nc2nc(N[C@H]3CCCNC3)ncc2C(N)=O)c1,IC50,nM,=,1584.89,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4324,CHEMBL1835057,Cc1cccc(Nc2nc(N[C@@H]3CCNC3)ncc2C(N)=O)c1,IC50,nM,=,501.19,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4325,CHEMBL1835058,Cc1cccc(Nc2nc(N[C@H]3CCNC3)ncc2C(N)=O)c1,IC50,nM,=,2511.89,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4326,CHEMBL1835059,Cc1cccc(Nc2nc(NC3CNC3)ncc2C(N)=O)c1,IC50,nM,=,1584.89,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4327,CHEMBL1835060,Cc1cccc(Nc2nc(NCC3CCCCN3)ncc2C(N)=O)c1,IC50,nM,=,2511.89,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4328,CHEMBL1835061,Cc1cccc(Nc2nc(NC[C@@H]3CCCN3)ncc2C(N)=O)c1,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4329,CHEMBL1835062,Cc1cccc(Nc2nc(NC[C@H]3CCCN3)ncc2C(N)=O)c1,IC50,nM,=,2511.89,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4330,CHEMBL1835063,NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1,IC50,nM,=,794.33,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4331,CHEMBL1235110,Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)c1,IC50,nM,=,3162.28,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4332,CHEMBL1835064,Cc1cccc(Nc2nc(N[C@H]3CCCC[C@H]3N)ncc2C(N)=O)c1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4333,CHEMBL1835065,Cc1cccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)c1,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4334,CHEMBL1835066,Cc1cccc(Nc2nc(N[C@@H]3COCC[C@@H]3N)ncc2C(N)=O)c1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4335,CHEMBL1835067,Cc1cccc(Nc2nc(N[C@@H]3COC[C@@H]3N)ncc2C(N)=O)c1,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4336,CHEMBL1835068,Cc1cccc(Nc2nc(N[C@@H]3CCC(F)(F)C[C@@H]3N)ncc2C(N)=O)c1,IC50,nM,=,3162.28,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4337,CHEMBL1835069,Cc1cccc(Nc2nc(N[C@@H]3CC(F)(F)CC[C@@H]3N)ncc2C(N)=O)c1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4338,CHEMBL1835070,Cc1ccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)cc1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4339,CHEMBL1835071,Cc1ccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)cc1,IC50,nM,=,19952.62,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4340,CHEMBL1835072,COc1ccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)cc1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO-K1 cells after 2 hrs by Cy3b-Dofetilide-based fluorescence polarisation assay
4341,CHEMBL1836146,COc1cc(OC)cc(C(=O)NCC2(C#N)CCN(Cc3ccccc3OC)CC2)c1,IC50,nM,=,920.0,Inhibition of human ERG by patch clamp assay
4342,CHEMBL1836147,COc1cccc(CN2CCC(C#N)(CNC(=O)c3cc(OC)cc(OC)c3)CC2)c1,IC50,nM,=,1500.0,Inhibition of human ERG by patch clamp assay
4343,CHEMBL1836148,COc1ccc(CN2CCC(C#N)(CNC(=O)c3cc(OC)cc(OC)c3)CC2)cc1,IC50,nM,=,3210.0,Inhibition of human ERG by patch clamp assay
4344,CHEMBL1836149,COc1cc(OC)cc(C(=O)NCC2(C#N)CCN(Cc3ccccc3C(F)(F)F)CC2)c1,IC50,nM,=,4760.0,Inhibition of human ERG by patch clamp assay
4345,CHEMBL1836152,COc1cc(OC)cc(C(=O)NCC2(C#N)CCN(CC3=Cc4ccccc4OC3(C)C)CC2)c1,IC50,nM,=,4730.0,Inhibition of human ERG by patch clamp assay
4346,CHEMBL1836153,COc1cc(OC)cc(C(=O)NCC2(C#N)CCN(CCc3ccccc3)CC2)c1,IC50,nM,=,1570.0,Inhibition of human ERG by patch clamp assay
4347,CHEMBL1836161,N#CC1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(CCc2ccccc2)CC1,IC50,nM,=,360.0,Inhibition of human ERG by patch clamp assay
4348,CHEMBL1836162,COC(=O)C1(CNC(=O)c2cc(OC)cc(OC)c2)CCN(Cc2ccccc2OC)CC1,IC50,nM,=,1900.0,Inhibition of human ERG by patch clamp assay
4349,CHEMBL1836163,COC(=O)C1(CNC(=O)c2cc(OC)cc(OC)c2)CCN(Cc2cccc(OC)c2)CC1,IC50,nM,=,310.0,Inhibition of human ERG by patch clamp assay
4350,CHEMBL1836164,COC(=O)C1(CNC(=O)c2cc(OC)cc(OC)c2)CCN(Cc2ccc(OC)cc2)CC1,IC50,nM,=,480.0,Inhibition of human ERG by patch clamp assay
4351,CHEMBL1836165,COC(=O)C1(CNC(=O)c2cc(OC)cc(OC)c2)CCN(Cc2ccccc2C(F)(F)F)CC1,IC50,nM,=,4980.0,Inhibition of human ERG by patch clamp assay
4352,CHEMBL1836166,COC(=O)C1(CNC(=O)c2cc(OC)cc(OC)c2)CCN(Cc2cccc(C(F)(F)F)c2)CC1,IC50,nM,=,2800.0,Inhibition of human ERG by patch clamp assay
4353,CHEMBL1836167,COC(=O)C1(CNC(=O)c2cc(OC)cc(OC)c2)CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,2350.0,Inhibition of human ERG by patch clamp assay
4354,CHEMBL1836168,COC(=O)C1(CNC(=O)c2cc(OC)cc(OC)c2)CCN(CC2=Cc3ccccc3OC2(C)C)CC1,IC50,nM,=,1290.0,Inhibition of human ERG by patch clamp assay
4355,CHEMBL1836247,COC(=O)C1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(Cc2ccccc2OC)CC1,IC50,nM,=,160.0,Inhibition of human ERG by patch clamp assay
4356,CHEMBL1836248,COC(=O)C1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(Cc2cccc(OC)c2)CC1,IC50,nM,=,360.0,Inhibition of human ERG by patch clamp assay
4357,CHEMBL1836249,COC(=O)C1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(Cc2ccc(OC)cc2)CC1,IC50,nM,=,130.0,Inhibition of human ERG by patch clamp assay
4358,CHEMBL1836250,COC(=O)C1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(Cc2ccccc2C(F)(F)F)CC1,IC50,nM,=,460.0,Inhibition of human ERG by patch clamp assay
4359,CHEMBL1836251,COC(=O)C1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(Cc2cccc(C(F)(F)F)c2)CC1,IC50,nM,=,890.0,Inhibition of human ERG by patch clamp assay
4360,CHEMBL1836252,COC(=O)C1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,290.0,Inhibition of human ERG by patch clamp assay
4361,CHEMBL1836253,COC(=O)C1(CNC(=O)c2cc(Cl)cc(Cl)c2)CCN(CC2=Cc3ccccc3OC2(C)C)CC1,IC50,nM,=,13830.0,Inhibition of human ERG by patch clamp assay
4362,CHEMBL1836255,COc1ccccc1CN1CCC(C#N)(CNC(=O)c2cc(CC(C)C)n(-c3ccccc3)n2)CC1,IC50,nM,=,920.0,Inhibition of human ERG by patch clamp assay
4363,CHEMBL1836256,COc1cccc(CN2CCC(C#N)(CNC(=O)c3cc(CC(C)C)n(-c4ccccc4)n3)CC2)c1,IC50,nM,=,1500.0,Inhibition of human ERG by patch clamp assay
4364,CHEMBL1836257,COc1ccc(CN2CCC(C#N)(CNC(=O)c3cc(CC(C)C)n(-c4ccccc4)n3)CC2)cc1,IC50,nM,=,3210.0,Inhibition of human ERG by patch clamp assay
4365,CHEMBL1836258,CC(C)Cc1cc(C(=O)NCC2(C#N)CCN(Cc3ccccc3C(F)(F)F)CC2)nn1-c1ccccc1,IC50,nM,=,4760.0,Inhibition of human ERG by patch clamp assay
4366,CHEMBL1836261,CC(C)Cc1cc(C(=O)NCC2(C#N)CCN(CC3=Cc4ccccc4OC3(C)C)CC2)nn1-c1ccccc1,IC50,nM,=,4730.0,Inhibition of human ERG by patch clamp assay
4367,CHEMBL1836262,CC(C)Cc1cc(C(=O)NCC2(C#N)CCN(CCc3ccccc3)CC2)nn1-c1ccccc1,IC50,nM,=,1570.0,Inhibition of human ERG by patch clamp assay
4368,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1340.0,Inhibition of human ERG by patch clamp assay
4369,CHEMBL1836263,COc1cc(OC)cc(C(=O)NCC2(C(=O)O)CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c1.Cl,IC50,nM,=,12080.0,Inhibition of human ERG by patch clamp assay
4370,CHEMBL1836035,Cc1nc2ccccc2n1-c1ccc(C(=O)N(C)[C@@H]2CCN(C(C)C)C2)cc1,IC50,nM,=,45000.0,Inhibition of human ERG
4371,CHEMBL1836037,Cc1nc2ccccc2n1-c1ccc(C(=O)N(C)[C@@H]2CCN(C3CCC3)C2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG
4372,CHEMBL1836039,Cc1nc2ccccc2n1-c1ccc(C(=O)N(C)[C@@H]2CCN(C3CCCC3)C2)cc1,IC50,nM,=,2300.0,Inhibition of human ERG
4373,CHEMBL1836040,Cc1nc2ccccc2n1-c1ccc(C(=O)N(C)[C@@H]2CCN(C3CCCCC3)C2)cc1,IC50,nM,=,2800.0,Inhibition of human ERG
4374,CHEMBL1835992,Cc1nc2ccccc2n1Cc1ccc(C(=O)N(C)[C@@H]2CCN(C(C)C)C2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG
4375,CHEMBL1835993,Cc1nc2ccccc2n1Cc1ccc(C(=O)N(C)[C@@H]2CCN(C3CCC3)C2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG
4376,CHEMBL1835999,CN(C(=O)c1ccc(-n2cccn2)cc1)[C@@H]1CCN(C2CCC2)C1,IC50,nM,=,25000.0,Inhibition of human ERG
4377,CHEMBL1835153,NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3cnc(N)nc3)ccc12,IC50,nM,=,22000.0,Inhibition of human hERG
4378,CHEMBL1835150,NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3ccc(N)nc3)ccc12,IC50,nM,=,750.0,Inhibition of human hERG
4379,CHEMBL1835149,NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3cn[nH]c3)ccc12,IC50,nM,=,3000.0,Inhibition of human hERG
4380,CHEMBL1833986,NC(=O)c1cnc(NC(C2CC2)C2CC2)c2c1[nH]c1cc(-c3cnc(N)nc3)ccc12,IC50,nM,=,8200.0,Inhibition of human hERG
4381,CHEMBL1835148,NC(=O)c1cnc(NC(C2CC2)C2CC2)c2c1[nH]c1cc(-c3cnc(N)cn3)ccc12,IC50,nM,=,720.0,Inhibition of human hERG
4382,CHEMBL1835146,NC(=O)c1cnc(NC(C2CC2)C2CC2)c2c1[nH]c1cc(-c3cn[nH]c3)ccc12,IC50,nM,=,990.0,Inhibition of human hERG
4383,CHEMBL1835142,Cn1cc(-c2ccc3c(c2)[nH]c2c(C(N)=O)cnc(N[C@H](C4CC4)C(F)(F)F)c23)cn1,IC50,nM,=,3400.0,Inhibition of human hERG
4384,CHEMBL1835141,Cn1cc(-c2ccc3c(c2)[nH]c2c(C(N)=O)cnc(NC(C4CC4)C4CC4)c23)cn1,IC50,nM,=,1700.0,Inhibition of human hERG
4385,CHEMBL1835039,C[C@H](Nc1ccc(C(N)=O)c2[nH]c3cc(-c4cnn(C)c4)ccc3c12)C(C)(C)C,IC50,nM,=,29000.0,Inhibition of human hERG
4386,CHEMBL1835035,Cn1cc(-c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(NC4CCCCC4)c23)cn1,IC50,nM,=,620.0,Inhibition of human hERG
4387,CHEMBL515914,CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4388,CHEMBL1200558,CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4389,CHEMBL388590,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4390,CHEMBL1458880,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4391,CHEMBL14,C[N+](C)(C)CCOC(N)=O.[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4392,CHEMBL211501,CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4393,CHEMBL12089,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4394,CHEMBL1231530,O=C(O)CCNC(=O)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4395,CHEMBL844,Brc1c(NC2=NCCN2)ccc2nccnc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4396,CHEMBL1200396,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4397,CHEMBL3084803,CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4398,CHEMBL1095699,[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4399,CHEMBL701,NCC(CC(=O)O)c1ccc(Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4400,CHEMBL221753,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-],IC50,nM,=,108.5,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4401,CHEMBL319244,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4402,CHEMBL277474,Cc1cc(=O)n(-c2ccccc2)n1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4403,CHEMBL415690,OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4404,CHEMBL264374,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4405,CHEMBL1077,Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4406,CHEMBL894,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4407,CHEMBL108,NC(=O)N1c2ccccc2C=Cc2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4408,CHEMBL24,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4409,CHEMBL1598608,CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4410,CHEMBL1201346,O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4411,CHEMBL31184,c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4412,CHEMBL113,Cn1c(=O)c2c(ncn2C)n(C)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4413,CHEMBL1256017,N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4414,CHEMBL135,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4415,CHEMBL402794,CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4416,CHEMBL253376,CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4417,CHEMBL49,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4418,CHEMBL508102,CCOC(=O)n1ccn(C)c1=S,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4419,CHEMBL1487,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4420,CHEMBL1542,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4421,CHEMBL521589,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4422,CHEMBL1371125,c1ccc2c(c1)c1cccc3ccc4cccc2c4c31,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4423,CHEMBL820,CS(=O)(=O)OCCCCOS(C)(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4424,CHEMBL65,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4425,CHEMBL566534,CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4426,CHEMBL282575,C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4427,CHEMBL942,CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4428,CHEMBL1515611,CC(C)C(Br)C(=O)NC(N)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4429,CHEMBL499815,C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4430,CHEMBL564201,O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4431,CHEMBL270299,CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4432,CHEMBL278172,CCOC(=O)c1ccc(N)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4433,CHEMBL1016,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4434,CHEMBL567597,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4435,CHEMBL26260,O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4436,CHEMBL418971,CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4437,CHEMBL16068,Brc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4438,CHEMBL127516,CCCCOC(=O)c1ccc(N)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4439,CHEMBL517712,CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4440,CHEMBL529,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4441,CHEMBL1586,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4442,CHEMBL541,O=C(O)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4443,CHEMBL990,CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4444,CHEMBL48449,C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4445,CHEMBL36994,COc1ccc(C(=O)N2CCCC2=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4446,CHEMBL196,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4447,CHEMBL24441,CNCCc1ccccn1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4448,CHEMBL290106,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4449,CHEMBL493,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4450,CHEMBL1366,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4451,CHEMBL1537,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4452,CHEMBL838,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4453,CHEMBL508112,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4454,CHEMBL1255834,CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4455,CHEMBL294199,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4456,CHEMBL712,COc1ccc(C2C(=O)c3ccccc3C2=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4457,CHEMBL25,CC(=O)Oc1ccccc1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4458,CHEMBL1201203,CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4459,CHEMBL632,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4460,CHEMBL4649901,Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4461,CHEMBL1370,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4462,CHEMBL1489,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4463,CHEMBL158,C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4464,CHEMBL340978,CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4465,CHEMBL1476898,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4466,CHEMBL1560,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4467,CHEMBL423192,COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4468,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4469,CHEMBL720,OCc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4470,CHEMBL1201207,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4471,CHEMBL357995,Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4472,CHEMBL188921,COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4473,CHEMBL338790,Nc1ccc2c3c(cccc13)C(=O)NC2=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4474,CHEMBL1105,COc1ccc2cc(CC(=O)O)ccc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4475,CHEMBL20,CC(=O)Nc1nnc(S(N)(=O)=O)s1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4476,CHEMBL1601669,C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4477,CHEMBL267894,CCC1(CCC(C)C)C(=O)N=C(O)NC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4478,CHEMBL30327,Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4479,CHEMBL1455,CN(C)c1nc(N(C)C)nc(N(C)C)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4480,CHEMBL1370561,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4481,CHEMBL87285,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4482,CHEMBL63560,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4483,CHEMBL14192,c1ccc(Cn2ccnc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4484,CHEMBL1235242,N[C@@H](Cc1ccc(F)cc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4485,CHEMBL45245,O=c1[nH]c2ccccc2c2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4486,CHEMBL502620,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4487,CHEMBL1467,O=c1ncnc2[nH][nH]cc1-2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4488,CHEMBL1113,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4489,CHEMBL1399,CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4490,CHEMBL9419,CC(=O)Nc1cccc(O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4491,CHEMBL660,NC12CC3CC(CC(C3)C1)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4492,CHEMBL376180,Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4493,CHEMBL1082,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4494,CHEMBL13378,Cc1onc(O)c1CC(N)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4495,CHEMBL1381098,S=C=Nc1cccc2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4496,CHEMBL1308,Cc1cn[nH]c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4497,CHEMBL3215298,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4498,CHEMBL2103747,CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4499,CHEMBL234926,C=CCO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4500,CHEMBL81977,NC(=O)c1cccc(N)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4501,CHEMBL153479,Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4502,CHEMBL1169,Nc1ccc(C(=O)O)c(O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4503,CHEMBL267345,C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4504,CHEMBL117405,CC(C)NC[C@H](O)COc1cccc2[nH]ccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4505,CHEMBL156455,C=C(Cl)Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4506,CHEMBL153062,CCCCCCCCCc1ccc(O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4507,CHEMBL1566,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4508,CHEMBL184,Nc1nc(O)c2ncn(COCCO)c2n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4509,CHEMBL1110,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4510,CHEMBL40583,Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4511,CHEMBL1006,NCCCNCCSP(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4512,CHEMBL174,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4513,CHEMBL1909048,O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4514,CHEMBL77675,N=C(Nc1ccccc1)Nc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4515,CHEMBL195437,CCCCCCCCc1ccc(O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4516,CHEMBL642,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4517,CHEMBL1697694,COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4518,CHEMBL1230813,OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4519,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4520,CHEMBL291338,O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4521,CHEMBL177,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4522,CHEMBL1566249,CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4523,CHEMBL437002,O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4524,CHEMBL41543,NC(=O)N1c2ccccc2CCc2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4525,CHEMBL85728,Nc1ccc(Cc2ccc(N)cc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4526,CHEMBL93645,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4527,CHEMBL2105617,CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4528,CHEMBL1403281,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4529,CHEMBL1365675,Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4530,CHEMBL1544,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4531,CHEMBL283196,O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4532,CHEMBL945,N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4533,CHEMBL116,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4534,CHEMBL1909049,COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4535,CHEMBL1395,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4536,CHEMBL917,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4537,CHEMBL189171,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4538,CHEMBL1483,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4539,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,17589.4,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4540,CHEMBL1230333,O=C(O)CCCc1cccs1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4541,CHEMBL47,Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4542,CHEMBL1046,NCCCCCC(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4543,CHEMBL12856,Nc1cc(-c2ccncc2)c[nH]c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4544,CHEMBL426123,O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4545,CHEMBL1909050,Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4546,CHEMBL311469,CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4547,CHEMBL1425,Sc1ncnc2nc[nH]c12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4548,CHEMBL112,CC(=O)Nc1ccc(O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4549,CHEMBL870,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4550,CHEMBL1491,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4551,CHEMBL1629810,CC(O)COC[C@@H]1O[C@H]2O[C@H]3[C@H](COCC(C)O)O[C@@H](O[C@H]4[C@H](COCC(C)O)O[C@@H](O[C@H]5[C@H](COCC(C)O)O[C@@H](O[C@H]6[C@H](COCC(C)O)OC[C@@H](O[C@H]7[C@H](COCC(C)O)O[C@@H](O[C@H]8[C@H](COCC(C)O)O[C@@H](O[C@H]9[C@H](COCC(C)O)O[C@@H](O[C@@H]1[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]9O)[C@@H](O)[C@@H]8O)[C@@H](O)[C@@H]7O)[C@@H]6O)[C@@H](O)[C@@H]5O)[C@@H](O)[C@@H]4O)[C@@H](O)[C@@H]3O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4552,CHEMBL1909051,O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4553,CHEMBL661,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4554,CHEMBL488,CCC1(c2ccc(N)cc2)CCC(=O)NC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4555,CHEMBL461727,N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4556,CHEMBL558551,O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4557,CHEMBL101168,Nn1nnc2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4558,CHEMBL106,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4559,CHEMBL989,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4560,CHEMBL563,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4561,CHEMBL659,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4562,CHEMBL44,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4563,CHEMBL472,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4564,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4565,CHEMBL1752,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4566,CHEMBL241694,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4567,CHEMBL485259,CC12CCC(CC1)C(C)(C)O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4568,CHEMBL1289,Clc1cc(Cl)c(OCC#CI)cc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4569,CHEMBL389621,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4570,CHEMBL1282,CC(C)Cn1cnc2c(N)nc3ccccc3c21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4571,CHEMBL1902981,CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4572,CHEMBL2220427,CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4573,CHEMBL1297,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4574,CHEMBL1463,Nc1[nH]c(=O)ncc1F,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4575,CHEMBL1501,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4576,CHEMBL806,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4577,CHEMBL1200993,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4578,CHEMBL3039597,CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4579,CHEMBL773,NCC(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4580,CHEMBL562,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4581,CHEMBL1024,O=P1(NCCCl)OCCCN1CCCl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4582,CHEMBL305660,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,104.8,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4583,CHEMBL696,CCC1(C)CC(=O)NC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4584,CHEMBL42710,C=CCc1ccc(O)c(OC)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4585,CHEMBL433257,COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4586,CHEMBL1535,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4587,CHEMBL808,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4588,CHEMBL679,CNC[C@H](O)c1ccc(O)c(O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4589,CHEMBL768,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4590,CHEMBL32749,COc1cc(/C=C/C(=O)O)ccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4591,CHEMBL177756,O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4592,CHEMBL2220442,CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4593,CHEMBL407030,OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4594,CHEMBL64894,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4595,CHEMBL252557,O=C(O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4596,CHEMBL980,COc1ccccc1OCC(O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4597,CHEMBL941,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4598,CHEMBL1568,Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4599,CHEMBL496,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4600,CHEMBL1062,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4601,CHEMBL290916,CC1=NN(c2ccccc2)C(=O)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4602,CHEMBL417,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4603,CHEMBL193482,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4604,CHEMBL457299,OCCO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4605,CHEMBL880,CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4606,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4607,CHEMBL1200600,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4608,CHEMBL666,O=C(O)P(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4609,CHEMBL182,Nc1nc(O)c2ncn(COC(CO)CO)c2n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4610,CHEMBL25719,CC(C)=CCC/C(C)=C/CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4611,CHEMBL441687,CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4612,CHEMBL420,N=C(N)N/N=C/c1c(Cl)cccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4613,CHEMBL1130,C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4614,CHEMBL1200623,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4615,CHEMBL1201010,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4616,CHEMBL1319362,Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4617,CHEMBL467,NC(=O)NO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4618,CHEMBL50588,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4619,CHEMBL1536,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4620,CHEMBL1405,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4621,CHEMBL902,NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4622,CHEMBL710,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4623,CHEMBL185,O=c1[nH]cc(F)c(=O)[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4624,CHEMBL1103,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4625,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4626,CHEMBL427216,Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4627,CHEMBL95764,O=C(O)CNCP(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4628,CHEMBL765,NC(N)=NCCN1CCCCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4629,CHEMBL1527608,Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4630,CHEMBL1200624,C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4631,CHEMBL407,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4632,CHEMBL862,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4633,CHEMBL1255901,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4634,CHEMBL521,CC(C)Cc1ccc(C(C)C(=O)O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4635,CHEMBL578,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4636,CHEMBL1385840,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4637,CHEMBL456,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4638,CHEMBL413965,O=C(O)Cc1ccc(-c2ccccc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4639,CHEMBL1493,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,IC50,nM,=,24106.9,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4640,CHEMBL30008,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,IC50,nM,=,605.8,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4641,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,12286.4,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4642,CHEMBL35,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4643,CHEMBL888,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4644,CHEMBL1481,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4645,CHEMBL306043,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4646,CHEMBL53463,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4647,CHEMBL871,CC(O)(P(=O)(O)O)P(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4648,CHEMBL1480,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4649,CHEMBL434063,CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4650,CHEMBL276832,NNc1nncc2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4651,CHEMBL1117,CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4652,CHEMBL826,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4653,CHEMBL119443,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4654,CHEMBL44884,CC[C@@H](CO)NCCN[C@@H](CC)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4655,CHEMBL6273,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4656,CHEMBL1512,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4657,CHEMBL726,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,IC50,nM,=,5705.8,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4658,CHEMBL940,NCC1(CC(=O)O)CCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4659,CHEMBL457,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4660,CHEMBL1073,Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4661,CHEMBL1201469,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4662,CHEMBL1433,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4663,CHEMBL622,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4664,CHEMBL1200845,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4665,CHEMBL1237174,NN,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4666,CHEMBL252556,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4667,CHEMBL15511,CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4668,CHEMBL442,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4669,CHEMBL545,CCO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4670,CHEMBL37161,COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4671,CHEMBL1454946,COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4672,CHEMBL1614641,C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4673,CHEMBL1201012,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4674,CHEMBL1200431,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4675,CHEMBL34139,C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4676,CHEMBL1372,N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4677,CHEMBL289469,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4678,CHEMBL1108,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,nM,=,927.2,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4679,CHEMBL44657,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4680,CHEMBL672,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4681,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4682,CHEMBL435,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4683,CHEMBL788,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4684,CHEMBL56337,CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4685,CHEMBL532,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4686,CHEMBL691,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4687,CHEMBL452,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4688,CHEMBL1201353,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4689,CHEMBL167911,COP(=O)(OC)OC=C(Cl)Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4690,CHEMBL898,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4691,CHEMBL723,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,IC50,nM,=,4119.3,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4692,CHEMBL334255,CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4693,CHEMBL1909056,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4694,CHEMBL428880,O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4695,CHEMBL139835,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4696,CHEMBL157548,CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4697,CHEMBL657,CN(C)CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,31859.0,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4698,CHEMBL404520,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4699,CHEMBL1413,Cc1cc(C2CCCCC2)n(O)c(=O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4700,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4701,CHEMBL1626,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,IC50,nM,=,395.1,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4702,CHEMBL134,Clc1cccc(Cl)c1N=C1NCCN1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4703,CHEMBL248702,CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4704,CHEMBL139,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4705,CHEMBL404811,C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4706,CHEMBL1754,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4707,CHEMBL280998,Oc1ccccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4708,CHEMBL515,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4709,CHEMBL47244,C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4710,CHEMBL1200709,C/C=C/C(=O)N(CC)c1ccccc1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4711,CHEMBL1231107,Nc1nc(N)nc(NC2CC2)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4712,CHEMBL1201216,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4713,CHEMBL936,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4714,CHEMBL707,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,IC50,nM,=,2215.5,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4715,CHEMBL1055,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4716,CHEMBL7002,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4717,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,170.1,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4718,CHEMBL49080,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4719,CHEMBL1771,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4720,CHEMBL175,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4721,CHEMBL1466,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4722,CHEMBL254219,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4723,CHEMBL1201195,CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4724,CHEMBL130,O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4725,CHEMBL107,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4726,CHEMBL1480987,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4727,CHEMBL803,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4728,CHEMBL178,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4729,CHEMBL932,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4730,CHEMBL1628227,CN(C)CCC=C1c2ccccc2COc2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4731,CHEMBL1371,O=c1[nH]c2cc(Cl)ccc2o1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4732,CHEMBL34431,CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4733,CHEMBL11359,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4734,CHEMBL1753,CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4735,CHEMBL1902627,CC(C)NCC(O)c1ccccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4736,CHEMBL75435,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4737,CHEMBL1123,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,IC50,nM,=,20590.9,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4738,CHEMBL1751,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4739,CHEMBL44814,ClC(Cl)(Cl)Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4740,CHEMBL1730,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4741,CHEMBL451,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4742,CHEMBL2221249,CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4743,CHEMBL648,CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4744,CHEMBL504760,CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4745,CHEMBL70927,Cc1c(O)c(=O)ccn1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4746,CHEMBL487894,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4747,CHEMBL1042,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4748,CHEMBL799,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4749,CHEMBL549,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,IC50,nM,=,16675.4,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4750,CHEMBL1159650,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4751,CHEMBL12131,Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4752,CHEMBL52440,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4753,CHEMBL1460,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4754,CHEMBL1255837,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4755,CHEMBL1351,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4756,CHEMBL118,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4757,CHEMBL110691,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4758,CHEMBL1909057,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4759,CHEMBL123292,C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4760,CHEMBL1687,COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4761,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,27849.7,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4762,CHEMBL1732,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4763,CHEMBL964,CCN(CC)C(=S)SSC(=S)N(CC)CC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4764,CHEMBL205596,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4765,CHEMBL30,CN/C(=N/CCSCc1nc[nH]c1C)NC#N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4766,CHEMBL1261,O=C(O)CC(O)(CC(=O)O)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4767,CHEMBL565,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4768,CHEMBL104,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4769,CHEMBL1172,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4770,CHEMBL1201220,CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4771,CHEMBL1873703,ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4772,CHEMBL1909054,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4773,CHEMBL1727,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4774,CHEMBL44618,ClC(Cl)Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4775,CHEMBL891,Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4776,CHEMBL111861,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4777,CHEMBL88,O=P1(N(CCCl)CCCl)NCCCO1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4778,CHEMBL476,CN(C)/N=N/c1[nH]cnc1C(N)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4779,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4780,CHEMBL926,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4781,CHEMBL1567463,C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4782,CHEMBL293492,O=C/C=C/c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4783,CHEMBL510139,CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4784,CHEMBL683,CC(C)(Oc1ccc(Cl)cc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4785,CHEMBL1766,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4786,CHEMBL12,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4787,CHEMBL411,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4788,CHEMBL460499,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4789,CHEMBL1477,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4790,CHEMBL398440,Cc1cc(O)cc(C)c1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4791,CHEMBL954,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4792,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,10571.0,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4793,CHEMBL1650,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4794,CHEMBL160,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4795,CHEMBL1554,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4796,CHEMBL1200406,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4797,CHEMBL3545252,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4798,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,5827.5,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4799,CHEMBL282468,C[N+](C)(C)CCO.[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4800,CHEMBL43064,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4801,CHEMBL1619,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4802,CHEMBL384467,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4803,CHEMBL181,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4804,CHEMBL1200545,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4805,CHEMBL513,O=NN(CCCl)C(=O)NCCCl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4806,CHEMBL502896,Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4807,CHEMBL415,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4808,CHEMBL1909055,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4809,CHEMBL6466,O=c1ccc2ccccc2o1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4810,CHEMBL516,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,IC50,nM,=,17049.1,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4811,CHEMBL1479,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4812,CHEMBL504,C[S+](C)[O-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4813,CHEMBL219916,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4814,CHEMBL498,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4815,CHEMBL1200528,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4816,CHEMBL557555,CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4817,CHEMBL1741,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4818,CHEMBL19224,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4819,CHEMBL495778,C=C(C)C1(O)OC(=O)C=C1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4820,CHEMBL286398,CC(O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4821,CHEMBL7568,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4822,CHEMBL900,Cc1ccccc1C(OCCN(C)C)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4823,CHEMBL1089,NNCCc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4824,CHEMBL16,O=C1N=C(O)NC1(c1ccccc1)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4825,CHEMBL36715,NC(=O)CN1CCCC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4826,CHEMBL1198,CCCCOc1ccc(OCCCN2CCOCC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4827,CHEMBL506,COc1cc(NC(C)CCCN)c2ncccc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4828,CHEMBL103,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4829,CHEMBL54126,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4830,CHEMBL485549,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4831,CHEMBL3183075,CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4832,CHEMBL1909071,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4833,CHEMBL762,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4834,CHEMBL458019,C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4835,CHEMBL29,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4836,CHEMBL1518,CCCc1cc(=O)[nH]c(=S)[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4837,CHEMBL222863,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4838,CHEMBL711,O=C1c2ccccc2C(=O)C1c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4839,CHEMBL94,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4840,CHEMBL295416,Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4841,CHEMBL1144,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4842,CHEMBL856,CCC1(c2ccccc2)C(=O)NCNC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4843,CHEMBL316561,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4844,CHEMBL1592,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4845,CHEMBL1572,CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4846,CHEMBL56367,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4847,CHEMBL9514,COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4848,CHEMBL450895,C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4849,CHEMBL1200585,C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4850,CHEMBL490,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,IC50,nM,=,10429.3,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4851,CHEMBL55,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,IC50,nM,=,15721.5,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4852,CHEMBL600325,C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4853,CHEMBL414804,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4854,CHEMBL40,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4855,CHEMBL1200656,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4856,CHEMBL311350,CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4857,CHEMBL976,O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4858,CHEMBL897,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4859,CHEMBL564,CN(C)CCCN1c2ccccc2Sc2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4860,CHEMBL1909075,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4861,CHEMBL57,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4862,CHEMBL13341,CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4863,CHEMBL1162,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4864,CHEMBL1612004,COc1ccccc1N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4865,CHEMBL310555,Oc1cccc2cccnc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4866,CHEMBL540445,C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4867,CHEMBL628,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4868,CHEMBL643,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4869,CHEMBL469912,COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4870,CHEMBL1071,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4871,CHEMBL14060,Oc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4872,CHEMBL500,CC(C)NCC(O)COc1cccc2[nH]ccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4873,CHEMBL527,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4874,CHEMBL2,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,IC50,nM,=,24277.8,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4875,CHEMBL608,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4876,CHEMBL757,C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4877,CHEMBL573,O=C(O)c1cccnc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4878,CHEMBL1428,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4879,CHEMBL1201146,C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4880,CHEMBL3350037,C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4881,CHEMBL1517,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4882,CHEMBL267648,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4883,CHEMBL531,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4884,CHEMBL631,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4885,CHEMBL614,NC(=O)c1cnccn1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4886,CHEMBL1068,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4887,CHEMBL75880,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4888,CHEMBL828,c1ccc2c(c1)Nc1ccccc1S2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4889,CHEMBL595,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4890,CHEMBL61,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4891,CHEMBL131,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4892,CHEMBL640,CCN(CC)CCNC(=O)c1ccc(N)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4893,CHEMBL154,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4894,CHEMBL1140,NC(=O)c1cccnc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4895,CHEMBL1726,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4896,CHEMBL9,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4897,CHEMBL4,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4898,CHEMBL428647,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4899,CHEMBL1177,NC1=NC(=O)C(c2ccccc2)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4900,CHEMBL1196,CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4901,CHEMBL511,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,IC50,nM,=,12618.2,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4902,CHEMBL42442,COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4903,CHEMBL567,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,IC50,nM,=,4216.0,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4904,CHEMBL597,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,IC50,nM,=,20076.3,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4905,CHEMBL1909072,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4906,CHEMBL3559671,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4907,CHEMBL635,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4908,CHEMBL569,CCN(CC)CCOC(=O)c1ccc(N)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4909,CHEMBL783,CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4910,CHEMBL3,CN1CCC[C@H]1c1cccnc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4911,CHEMBL13209,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4912,CHEMBL2107797,C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4913,CHEMBL715,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,nM,=,100000.0,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4914,CHEMBL1371937,CC(C)(CO)C(O)C(=O)NCCCO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4915,CHEMBL1540,Nc1nc(O)c2ncn(CCC(CO)CO)c2n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4916,CHEMBL526,CC(C)c1cccc(C(C)C)c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4917,CHEMBL307145,Oc1cccc(O)c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4918,CHEMBL1503,COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4919,CHEMBL1262,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4920,CHEMBL918,NC(=O)NC(=O)Cc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4921,CHEMBL101,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4922,CHEMBL702,CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4923,CHEMBL1909074,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4924,CHEMBL1400945,CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4925,CHEMBL1321,CNNCc1ccc(C(=O)NC(C)C)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4926,CHEMBL584,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4927,CHEMBL193,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4928,CHEMBL475534,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4929,CHEMBL445,CNCCC=C1c2ccccc2CCc2ccccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4930,CHEMBL1502,COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4931,CHEMBL1430,CC(C)(S)[C@@H](N)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4932,CHEMBL27,CC(C)NCC(O)COc1cccc2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4933,CHEMBL716,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4934,CHEMBL46,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4935,CHEMBL1231,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4936,CHEMBL16073,CCOc1ccc(NC(C)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4937,CHEMBL456807,NNc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4938,CHEMBL1909073,CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4939,CHEMBL748,C[n+]1ccccc1/C=N/O.[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4940,CHEMBL1194,CCCNC(C)C(=O)Nc1ccccc1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4941,CHEMBL728,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,IC50,nM,=,1848.1,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4942,CHEMBL184618,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4943,CHEMBL63323,O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4944,CHEMBL572,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4945,CHEMBL364713,COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4946,CHEMBL580,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4947,CHEMBL689,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4948,CHEMBL58,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,IC50,nM,=,3584.9,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4949,CHEMBL534,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4950,CHEMBL141,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4951,CHEMBL1454,c1ccc([C@H]2CN3CCSC3=N2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4952,CHEMBL1447,CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4953,CHEMBL21731,CNCCCC12CCC(c3ccccc31)c1ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4954,CHEMBL686,Cc1cccc(Nc2ccccc2C(=O)O)c1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4955,CHEMBL975,O=S(=O)([O-])CCS.[Na+],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4956,CHEMBL416,COc1c2occc2cc2ccc(=O)oc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4957,CHEMBL1065,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4958,CHEMBL558,Cc1cccc(C)c1OCC(C)N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4959,CHEMBL1630579,CCN(CC)CCOCCC1=CCC2CC1C2(C)C,IC50,nM,=,5902.4,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4960,CHEMBL19019,O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4961,CHEMBL165790,CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4962,CHEMBL547,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4963,CHEMBL191,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4964,CHEMBL86,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4965,CHEMBL6437,CN1CCN2c3ccccc3Cc3ccccc3C2C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4966,CHEMBL86304,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4967,CHEMBL1618305,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4968,CHEMBL2106399,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4969,CHEMBL741,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4970,CHEMBL1201237,CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4971,CHEMBL1909064,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4972,CHEMBL1909067,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4973,CHEMBL1201139,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4974,CHEMBL1201151,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4975,CHEMBL1201024,C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4976,CHEMBL164290,CCN(CC)N=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4977,CHEMBL92401,CC(C)NNC(=O)c1ccncc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4978,CHEMBL64391,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4979,CHEMBL503,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4980,CHEMBL878,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4981,CHEMBL91,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4982,CHEMBL1373,NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4983,CHEMBL80,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4984,CHEMBL1221512,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4985,CHEMBL480,Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4986,CHEMBL1201193,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4987,CHEMBL1237,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4988,CHEMBL1909068,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4989,CHEMBL45,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4990,CHEMBL19215,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4991,CHEMBL313493,COS(C)(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4992,CHEMBL268291,CN(C)C=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4993,CHEMBL1513,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4994,CHEMBL1200633,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4995,CHEMBL19299,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4996,CHEMBL13,COCCc1ccc(OCC(O)CNC(C)C)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4997,CHEMBL1276308,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4998,CHEMBL1388,Oc1ccc(OCc2ccccc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
4999,CHEMBL2252949,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5000,CHEMBL1909062,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5001,CHEMBL1149,C[N+](C)(C)C[C@H](O)CC(=O)[O-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5002,CHEMBL157138,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5003,CHEMBL1909069,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5004,CHEMBL599,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5005,CHEMBL1431,CN(C)C(=N)NC(=N)N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5006,CHEMBL108545,COC(=O)c1ccccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5007,CHEMBL1333512,c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5008,CHEMBL406,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5009,CHEMBL481,CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5010,CHEMBL1384,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5011,CHEMBL98350,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5012,CHEMBL137,Cc1ncc([N+](=O)[O-])n1CCO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5013,CHEMBL189,Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5014,CHEMBL787,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5015,CHEMBL245416,N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5016,CHEMBL1909063,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5017,CHEMBL1009,N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5018,CHEMBL561,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5019,CHEMBL685,COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5020,CHEMBL852,N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5021,CHEMBL1411979,CN(C)CCN(Cc1cccs1)c1ccccn1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5022,CHEMBL459,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5023,CHEMBL60889,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5024,CHEMBL1070,COc1ccc2cc(CCC(C)=O)ccc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5025,CHEMBL115,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5026,CHEMBL1712923,Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5027,CHEMBL742,CNC1(c2ccccc2Cl)CCCCC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5028,CHEMBL1909065,CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5029,CHEMBL934,CC(C)(C(=O)c1cccnc1)c1cccnc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5030,CHEMBL802,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5031,CHEMBL429,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5032,CHEMBL960,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5033,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5034,CHEMBL514,O=NN(CCCl)C(=O)NC1CCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5035,CHEMBL509,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5036,CHEMBL395110,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5037,CHEMBL1515,Cn1cc[nH]c1=S,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5038,CHEMBL1201356,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5039,CHEMBL19236,COc1nc(C)nc(Cl)c1NC1=NCCN1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5040,CHEMBL649,CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5041,CHEMBL6,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5042,CHEMBL445206,C/C=C\c1ccc(O)c(OC)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5043,CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5044,CHEMBL2105807,CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5045,CHEMBL105,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5046,CHEMBL571,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5047,CHEMBL460291,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5048,CHEMBL1444,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5049,CHEMBL267044,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5050,CHEMBL841,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5051,CHEMBL1390,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5052,CHEMBL1087,Cc1cccc(C)c1NC(=O)C1CCCCN1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5053,CHEMBL1201117,COc1ccccc1OCC(O)COC(N)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5054,CHEMBL325372,COC(=O)c1ccc(O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5055,CHEMBL1200862,C[C@](N)(Cc1ccc(O)cc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5056,CHEMBL1456,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5057,CHEMBL1909070,CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5058,CHEMBL1201631,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5059,CHEMBL64,NNC(=O)c1ccncc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5060,CHEMBL1200693,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5061,CHEMBL1670,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5062,CHEMBL469,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5063,CHEMBL1200559,CC(O)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5064,CHEMBL1679,Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5065,CHEMBL79,CCN(CC)CC(=O)Nc1c(C)cccc1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5066,CHEMBL998,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,IC50,nM,=,39086.6,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5067,CHEMBL717,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5068,CHEMBL127,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5069,CHEMBL34259,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5070,CHEMBL650,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5071,CHEMBL54440,CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5072,CHEMBL866,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5073,CHEMBL895,Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5074,CHEMBL86754,Oc1c(I)cc(I)c2cccnc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5075,CHEMBL434,CC(C)NCC(O)c1ccc(O)c(O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5076,CHEMBL1489254,CC(=O)OCC(COC(C)=O)OC(C)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5077,CHEMBL422,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,IC50,nM,=,6226.0,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5078,CHEMBL56564,CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5079,CHEMBL865,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5080,CHEMBL159,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5081,CHEMBL603,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5082,CHEMBL1451,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5083,CHEMBL1490,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5084,CHEMBL428,N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5085,CHEMBL2107687,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5086,CHEMBL90555,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5087,CHEMBL1521,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5088,CHEMBL1504,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5089,CHEMBL203266,COc1ccc(CN2CCNCC2)c(OC)c1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5090,CHEMBL1566956,COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5091,CHEMBL109,CCCC(CCC)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5092,CHEMBL238071,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5093,CHEMBL28079,CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5094,CHEMBL585,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5095,CHEMBL695,CN1C(=O)OC(C)(C)C1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5096,CHEMBL76904,N#CC(C#N)=Cc1ccc(O)c(O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5097,CHEMBL1069,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5098,CHEMBL553025,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5099,CHEMBL877,NC[C@H]1CC[C@H](C(=O)O)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5100,CHEMBL129,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5101,CHEMBL24944,O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5102,CHEMBL1475,Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5103,CHEMBL141343,Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5104,CHEMBL262777,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5105,CHEMBL119385,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5106,CHEMBL415324,COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5107,CHEMBL93,CC(c1cc2ccccc2s1)N(O)C(N)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5108,CHEMBL1054,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5109,CHEMBL408,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5110,CHEMBL29292,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5111,CHEMBL1200629,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5112,CHEMBL1464,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5113,CHEMBL1386,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5114,CHEMBL1200679,[Cl-].[Cl-].[Zn+2],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5115,CHEMBL14053,O=C(O)C(Cl)(Cl)Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5116,CHEMBL1200391,NC(CO)(CO)CO,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5117,CHEMBL462547,CCOC(N)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5118,CHEMBL637,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5119,CHEMBL559147,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5120,CHEMBL621,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5121,CHEMBL1909083,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5122,CHEMBL38,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5123,CHEMBL43882,ClCC(Cl)Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5124,CHEMBL1200604,CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5125,CHEMBL1349,CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5126,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5127,CHEMBL15245,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5128,CHEMBL95,Nc1c2c(nc3ccccc13)CCCC2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5129,CHEMBL1908355,NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5130,CHEMBL1393,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5131,CHEMBL227934,O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5132,CHEMBL446,Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5133,CHEMBL453,Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5134,CHEMBL1440,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5135,CHEMBL727,Nc1nc2[nH]cnc2c(=S)[nH]1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5136,CHEMBL1630578,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5137,CHEMBL1237044,COc1cccc(C2(O)CCCCC2CN(C)C)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5138,CHEMBL413,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5139,CHEMBL959,CC(N)C12CC3CC(CC(C3)C1)C2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5140,CHEMBL1321154,O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5141,CHEMBL27577,NC(=O)c1ccccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5142,CHEMBL447,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5143,CHEMBL1909078,O=[As][O-].[Na+],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5144,CHEMBL269732,C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5145,CHEMBL302795,CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5146,CHEMBL1148,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5147,CHEMBL1909079,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5148,CHEMBL403,CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5149,CHEMBL1191,Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5150,CHEMBL15770,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5151,CHEMBL468,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5152,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,1588.0,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5153,CHEMBL1747,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5154,CHEMBL772,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5155,CHEMBL923,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5156,CHEMBL1214185,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5157,CHEMBL424,O=C(O)c1ccccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5158,CHEMBL972,C#CCN(C)[C@H](C)Cc1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5159,CHEMBL136478,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5160,CHEMBL1221,Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5161,CHEMBL83,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,IC50,nM,=,967.0,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5162,CHEMBL611,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5163,CHEMBL273348,NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5164,CHEMBL27769,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5165,CHEMBL443,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5166,CHEMBL18797,CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5167,CHEMBL190,Cn1c(=O)c2nc[nH]c2n(C)c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5168,CHEMBL84158,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5169,CHEMBL1762,Cc1cccc(C)c1NC(=O)C(C)N,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5170,CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5171,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,4190.1,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5172,CHEMBL115769,COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5173,CHEMBL1208572,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5174,CHEMBL12948,CC1CCC(NC(=O)N(CCCl)N=O)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5175,CHEMBL179166,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5176,CHEMBL1243,Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5177,CHEMBL488025,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5178,CHEMBL506247,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5179,CHEMBL822,CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5180,CHEMBL275742,CC(C)NC[C@@H](O)COc1cccc2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5181,CHEMBL2079587,C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5182,CHEMBL21,Nc1ccc(S(N)(=O)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5183,CHEMBL625,c1ccc2[nH]c(-c3cscn3)nc2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5184,CHEMBL2103774,C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5185,CHEMBL817,Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5186,CHEMBL1643,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5187,CHEMBL163,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5188,CHEMBL452861,CC(C)NC[C@H](O)COc1cccc2ccccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5189,CHEMBL154111,O=C(Oc1ccccc1C(=O)O)c1ccccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5190,CHEMBL809,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,IC50,nM,=,8317.3,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5191,CHEMBL471,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5192,CHEMBL439,Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5193,CHEMBL588119,CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5194,CHEMBL404,C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5195,CHEMBL1760,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5196,CHEMBL427526,CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5197,CHEMBL991,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5198,CHEMBL1109,Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5199,CHEMBL1306,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5200,CHEMBL1236282,CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5201,CHEMBL833,Clc1ccccc1CN1CCc2sccc2C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5202,CHEMBL1020,Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5203,CHEMBL444633,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5204,CHEMBL18701,CCCCOc1cc(CC2CNC(=O)N2)ccc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5205,CHEMBL1909076,N[C@H](CSC(=S)NCc1ccccc1)C(=O)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5206,CHEMBL114,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5207,CHEMBL1419,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5208,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,47138.4,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5209,CHEMBL62193,COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5210,CHEMBL26,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5211,CHEMBL20883,O=c1[nH]c(=O)n(C2CCCO2)cc1F,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5212,CHEMBL1219,COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5213,CHEMBL372795,CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5214,CHEMBL421,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5215,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5216,CHEMBL508338,,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5217,CHEMBL267744,O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5218,CHEMBL83668,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5219,CHEMBL81,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5220,CHEMBL374478,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5221,CHEMBL122,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5222,CHEMBL1200748,C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5223,CHEMBL37858,O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5224,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5225,CHEMBL412873,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5226,CHEMBL1539,COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5227,CHEMBL128,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5228,CHEMBL2367892,CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5229,CHEMBL1651906,CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5230,CHEMBL437,Nc1ccc(S(=O)(=O)Nc2nccs2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5231,CHEMBL386630,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5232,CHEMBL38737,CC(=N)S,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5233,CHEMBL499,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5234,CHEMBL1076211,Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5235,CHEMBL1168,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5236,CHEMBL1660,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5237,CHEMBL121,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5238,CHEMBL242273,C=CCc1ccc2c(c1)OCO2,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5239,CHEMBL10,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5240,CHEMBL1064,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5241,CHEMBL1167,CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5242,CHEMBL438,Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5243,CHEMBL983,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5244,CHEMBL277100,CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5245,CHEMBL1909080,O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2],IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5246,CHEMBL832,O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5247,CHEMBL698,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5248,CHEMBL134342,O=C(O)CCCC[C@@H]1CCSS1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5249,CHEMBL1220,CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5250,CHEMBL84,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5251,CHEMBL1790041,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5252,CHEMBL744,Nc1nc2ccc(OC(F)(F)F)cc2s1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5253,CHEMBL429023,C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5254,CHEMBL714,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5255,CHEMBL498847,Cc1ncc([N+](=O)[O-])n1CC(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5256,CHEMBL221886,CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5257,CHEMBL70586,CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1,IC50,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)
5258,CHEMBL1910114,COCCN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O,IC50,nM,>,80000.0,Inhibition of human ERG
5259,CHEMBL1910113,Cc1nc2c(c(-c3ccc(Cl)cc3Cl)c1CN)CN(CCO)C2=O,IC50,nM,>,80000.0,Inhibition of human ERG
5260,CHEMBL1910112,Cc1nc2c(c(-c3ccc(Cl)cc3Cl)c1CN)CN(CC(=O)O)C2=O,IC50,nM,>,80000.0,Inhibition of human ERG
5261,CHEMBL1910111,COC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O,IC50,nM,>,80000.0,Inhibition of human ERG
5262,CHEMBL1910111,COC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O,IC50,nM,>,80000.0,Inhibition of human ERG
5263,CHEMBL1910111,COC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O,IC50,nM,>,80000.0,Inhibition of human ERG
5264,CHEMBL1910126,Cc1nc2c(c(-c3ccc(Cl)cc3Cl)c1CN)CN(CC(=O)NCc1cccnc1)C2=O,IC50,nM,=,80000.0,Inhibition of human ERG
5265,CHEMBL1909986,Cc1nc2cn(Cc3ccccc3)cc2c(-c2ccc(Cl)cc2Cl)c1CN,IC50,nM,=,14000.0,Inhibition of human ERG by flux assay
5266,CHEMBL1915048,CN[C@@H]1CCN(c2nc(N)nc3c2oc2ncc(Cl)cc23)C1,IC50,nM,>,10000.0,Inhibition of human ERG by binding assay
5267,CHEMBL631,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,IC50,nM,=,2880.0,Inhibition of human cloned ERG channel expressed in chinese hamster CHO cells after 5 mins by patch clamp assay
5268,CHEMBL1914835,Cl.O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCC(c2ccccc2)CC1,IC50,nM,=,3460.0,Inhibition of human cloned ERG channel expressed in chinese hamster CHO cells after 5 mins by patch clamp assay
5269,CHEMBL1914844,Cc1ccc(N2CCN(CC(O)COc3ccccc3C(=O)CCc3ccccc3)CC2)cc1.Cl,IC50,nM,=,4310.0,Inhibition of human cloned ERG channel expressed in chinese hamster CHO cells after 5 mins by patch clamp assay
5270,CHEMBL1915083,Cl.O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,nM,=,2600.0,Inhibition of human cloned ERG channel expressed in chinese hamster CHO cells after 5 mins by patch clamp assay
5271,CHEMBL1915364,Cl.O=C(CCc1ccccc1)c1cc(F)ccc1OCC(O)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,nM,=,4840.0,Inhibition of human cloned ERG channel expressed in chinese hamster CHO cells after 5 mins by patch clamp assay
5272,CHEMBL1916700,CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccccc1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
5273,CHEMBL1916399,N#Cc1cc(OC(F)(F)F)cc(-c2nc(-c3ccc4c(c3)CCN4C(=O)CCC(=O)O)no2)c1,IC50,nM,>,100000.0,Displacement of [3H]astemizole from human ERG
5274,CHEMBL1916559,O=C(O)CCC(=O)N1CCc2cc(-c3noc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)ccc21,IC50,nM,>,100000.0,Displacement of [3H]astemizole from human ERG
5275,CHEMBL1917511,CC(C)(C)c1cc(C(=O)Nc2nc(CN)cs2)n(Cc2ccccc2)n1,IC50,nM,=,3700.0,Inhibition of human ERG expressed in Chinese hamster CHL cells by perforated patch clamp assay
5276,CHEMBL1916547,COc1ccc2nnc(=O)n(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG by ionworks HT assay
5277,CHEMBL1916546,COc1cc2c(ccc(=O)n2CCN2CCC(NCc3cc4c(cn3)OCCO4)CC2)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by ionworks HT assay
5278,CHEMBL1916545,COc1ccc2ccc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,40000.0,Inhibition of human ERG by ionworks HT assay
5279,CHEMBL1916544,COc1ncc2ncc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,81000.0,Inhibition of human ERG by ionworks HT assay
5280,CHEMBL1916543,COc1ncc2ccc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,206000.0,Inhibition of human ERG by ionworks HT assay
5281,CHEMBL1914480,COc1ccc2ncc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,31000.0,Inhibition of human ERG by ionworks HT assay
5282,CHEMBL1916542,COc1ccc2ncc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,19000.0,Inhibition of human ERG by ionworks HT assay
5283,CHEMBL1916541,COc1ccc2c(C)nc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG by ionworks HT assay
5284,CHEMBL1916540,COc1ccc2c(C)cc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,23000.0,Inhibition of human ERG by ionworks HT assay
5285,CHEMBL1916539,COc1ccc2ccc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,34000.0,Inhibition of human ERG by ionworks HT assay
5286,CHEMBL1916538,COc1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)OC2,IC50,nM,=,42000.0,Inhibition of human ERG by ionworks HT assay
5287,CHEMBL1916537,COc1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CC2,IC50,nM,=,29000.0,Inhibition of human ERG by ionworks HT assay
5288,CHEMBL1916536,COc1ccc2c(c1)N(CCN1CCC(NCc3cc4c(cn3)OCCO4)CC1)C(=O)CS2,IC50,nM,=,6000.0,Inhibition of human ERG by ionworks HT assay
5289,CHEMBL1824043,O=C1COc2ccc(CNC3CCN(CCN4C(=O)COc5ccc(F)cc54)CC3)nc2N1,IC50,nM,=,9000.0,Inhibition of human ERG by ionworks HT assay
5290,CHEMBL1824041,N#Cc1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,=,41000.0,Inhibition of human ERG by ionworks HT assay
5291,CHEMBL1916535,O=C1COc2ccccc2N1CCN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,20000.0,Inhibition of human ERG by ionworks HT assay
5292,CHEMBL1824044,COc1ccc2c(c1)N(CCN1CCC(NCc3ccc4c(n3)NC(=O)CO4)CC1)C(=O)CO2,IC50,nM,=,13000.0,Inhibition of human ERG by ionworks HT assay
5293,CHEMBL1916534,COc1ccc2c(c1)N(CCN1CCC(NCc3cc4c(cn3)OCCO4)CC1)C(=O)CO2,IC50,nM,=,13000.0,Inhibition of human ERG by ionworks HT assay
5294,CHEMBL1916533,COc1ccc2ncc(F)c(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2n1,IC50,nM,=,4000.0,Inhibition of human ERG by ionworks HT assay
5295,CHEMBL1916532,COc1ccc2ncc(F)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,3000.0,Inhibition of human ERG by ionworks HT assay
5296,CHEMBL1924014,O=C(NCCN1CCCCC1)c1ccc(Oc2ncc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1,IC50,nM,=,5011.87,Inhibition of human ERG
5297,CHEMBL1924024,COc1cc(C(=O)NCCN2CCCC2)ccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(C(F)(F)F)c1,IC50,nM,=,25118.86,Inhibition of human ERG
5298,CHEMBL1910292,COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)cc(OCCOC)c1,IC50,nM,=,4500.0,Inhibition of human ERG
5299,CHEMBL1922933,CCCCC[C@@H](Cc1ccc(C(=O)NCCC(=O)O)cc1)C(=O)c1cc2cc(Cl)ccc2n1-c1cccc(C(F)(F)F)c1,IC50,nM,=,3700.0,Displacement of [35S]-MK-499 from human ERG expressed in HEK cells
5300,CHEMBL1929387,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1.Cl,IC50,nM,>,500000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
5301,CHEMBL1926762,COc1ccc2nccc(NC(=O)[C@H]3CC[C@H](NCc4ccc5c(c4)OCCO5)CC3)c2c1,IC50,nM,=,25000.0,Inhibition of human ERG by whole cell patch clamp assay
5302,CHEMBL1926763,COc1ccc2nccc(NC(=O)[C@]3(O)CC[C@@H](NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,24000.0,Inhibition of human ERG by whole cell patch clamp assay
5303,CHEMBL1926764,COc1ccc2nccc(NC(=O)[C@H]3CC[C@H](NCc4ccc5c(c4)OCCO5)CC3)c2n1,IC50,,,,Inhibition of human ERG by whole cell patch clamp assay
5304,CHEMBL1926765,COc1ccc2nccc(NC(=O)[C@]3(O)CC[C@@H](NCc4ccc5c(c4)OCCO5)CC3)c2n1,IC50,nM,=,25000.0,Inhibition of human ERG by whole cell patch clamp assay
5305,CHEMBL1926766,COc1ccc2nccc(NC(=O)[C@]3(O)CC[C@@H](NCc4cnc5c(c4)OCCO5)CC3)c2n1,IC50,nM,=,52000.0,Inhibition of human ERG by whole cell patch clamp assay
5306,CHEMBL1926864,COc1ccc2nccc(NC(=O)[C@H]3CC[C@H](NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,29000.0,Inhibition of human ERG by whole cell patch clamp assay
5307,CHEMBL1926865,COc1cc(F)c2nccc(NC(=O)[C@]3(O)CC[C@@H](NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,113000.0,Inhibition of human ERG by whole cell patch clamp assay
5308,CHEMBL1926866,COc1ccc2nccc(NC(=O)[C@]3(O)CC[C@@H](NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,200000.0,Inhibition of human ERG by whole cell patch clamp assay
5309,CHEMBL1926867,Cc1ccc2cccc(NC(=O)[C@]3(O)CC[C@@H](NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,2000.0,Inhibition of human ERG by whole cell patch clamp assay
5310,CHEMBL1926868,Cc1ccc2cccc(NC(=O)[C@H]3CC[C@H](NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,,,,Inhibition of human ERG by whole cell patch clamp assay
5311,CHEMBL1926869,N#Cc1ccc2cccc(NC(=O)[C@]3(O)CC[C@@H](NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,,,,Inhibition of human ERG by whole cell patch clamp assay
5312,CHEMBL1926870,N#Cc1ccc2cccc(NC(=O)[C@@H]3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](O)C3)c2n1,IC50,,,,Inhibition of human ERG by whole cell patch clamp assay
5313,CHEMBL1926871,CO[C@@H]1C[C@H](C(=O)Nc2cccc3ccc(C)nc23)CC[C@H]1NCc1cc2c(cn1)OCCO2,IC50,,,,Inhibition of human ERG by whole cell patch clamp assay
5314,CHEMBL1926893,COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1,IC50,nM,=,250.0,Inhibition of human ERG
5315,CHEMBL548279,COc1ccc2nccc([C@@H](O)CN3CCC(NCc4ccc5c(c4)OCCO5)CC3)c2c1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5316,CHEMBL1927161,COc1ccc2nccc([C@@H](O)CN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,4000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5317,CHEMBL1927162,COc1ccc2ncc(F)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,6000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5318,CHEMBL1916532,COc1ccc2ncc(F)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5319,CHEMBL1927163,COc1ccc2ncc(Cl)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5320,CHEMBL1927164,COc1ccc2ncc(C#N)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5321,CHEMBL1927165,COc1ccc2ncc(F)c([C@@H](O)CN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,5000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5322,CHEMBL1927166,COc1ccc2ncc(F)c([C@H](O)CN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5323,CHEMBL1927167,COc1ccc2ncc(F)c(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@H](O)C3)c2n1,IC50,nM,=,3000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5324,CHEMBL1927168,COc1ccc2ncc(F)c(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](O)C3)c2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5325,CHEMBL1927169,COc1ccc2ncc(F)c(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@@H](O)C3)c2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5326,CHEMBL1927170,COc1ccc2ncc(F)c(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@H](O)C3)c2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5327,CHEMBL1235773,COc1ccc2ncc(C#N)c(CCN3CCC(NCc4cc5c(cn4)OCS5)CC3)c2c1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp electrophysiology
5328,CHEMBL548279,COc1ccc2nccc([C@@H](O)CN3CCC(NCc4ccc5c(c4)OCCO5)CC3)c2c1,IC50,nM,=,39800.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5329,CHEMBL1927161,COc1ccc2nccc([C@@H](O)CN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,25100.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5330,CHEMBL1927162,COc1ccc2ncc(F)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,5000.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5331,CHEMBL1916532,COc1ccc2ncc(F)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,15100.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5332,CHEMBL1927163,COc1ccc2ncc(Cl)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5333,CHEMBL1927164,COc1ccc2ncc(C#N)c(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,7900.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5334,CHEMBL1927165,COc1ccc2ncc(F)c([C@@H](O)CN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,79400.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5335,CHEMBL1927166,COc1ccc2ncc(F)c([C@H](O)CN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2n1,IC50,nM,=,63100.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5336,CHEMBL1927167,COc1ccc2ncc(F)c(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@H](O)C3)c2n1,IC50,nM,=,7900.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5337,CHEMBL1927168,COc1ccc2ncc(F)c(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](O)C3)c2n1,IC50,nM,=,4900.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5338,CHEMBL1927169,COc1ccc2ncc(F)c(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@@H](O)C3)c2n1,IC50,,,,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5339,CHEMBL1927170,COc1ccc2ncc(F)c(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@H](O)C3)c2n1,IC50,nM,=,29500.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5340,CHEMBL1235773,COc1ccc2ncc(C#N)c(CCN3CCC(NCc4cc5c(cn4)OCS5)CC3)c2c1,IC50,nM,=,500.0,Displacement of [3H]dofetilide from human ERG by liquid scintillation counting
5341,CHEMBL1935425,O=S1(=O)CCC(Oc2ccc3c(c2)CCC2(CCN(C4CCC4)CC2)O3)CC1,IC50,nM,=,7000.0,Inhibition of human Erg
5342,CHEMBL1935426,O=S1(=O)CCC(COc2ccc3c(c2)CCC2(CCN(C4CCC4)CC2)O3)CC1,IC50,nM,>,30000.0,Inhibition of human Erg
5343,CHEMBL1095819,CN1CCC[C@@H](c2nc3ccccc3n2Cc2ccc(F)cc2)C1,IC50,nM,=,720.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5344,CHEMBL1935439,CN(C)C(=O)CN1CCCC(c2nc3ccccc3n2CCOc2ccccc2)C1,IC50,nM,=,450.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5345,CHEMBL1935441,Cc1ccc(Cn2c([C@H]3CNCCO3)nc3ccccc32)cc1,IC50,nM,=,2300.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5346,CHEMBL1935442,Fc1ccc(Cn2c([C@H]3CNCCO3)nc3ccccc32)cc1,IC50,nM,=,3400.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5347,CHEMBL1935443,Cc1ccc(Cn2c(C3CNCCO3)nc3ccccc32)cc1C,IC50,nM,=,2100.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5348,CHEMBL1935443,Cc1ccc(Cn2c(C3CNCCO3)nc3ccccc32)cc1C,IC50,,,,Inhibition of human Erg by whole cell patch clamp electrophysiology
5349,CHEMBL1935444,Cc1ccc(Cn2c(C3CNCCS3)nc3ccccc32)cc1,IC50,,,,Inhibition of human Erg by whole cell patch clamp electrophysiology
5350,CHEMBL1935444,Cc1ccc(Cn2c(C3CNCCS3)nc3ccccc32)cc1,IC50,nM,=,930.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5351,CHEMBL1935444,Cc1ccc(Cn2c(C3CNCCS3)nc3ccccc32)cc1,IC50,,,,Inhibition of human Erg by whole cell patch clamp electrophysiology
5352,CHEMBL1935445,Fc1ccc(Cn2c(C3CNCCS3)nc3ccccc32)cc1,IC50,,,,Inhibition of human Erg by whole cell patch clamp electrophysiology
5353,CHEMBL1935446,Fc1ccc(Cn2c([C@H]3CNCCS3)nc3ccccc32)cc1,IC50,nM,=,900.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5354,CHEMBL1935445,Fc1ccc(Cn2c(C3CNCCS3)nc3ccccc32)cc1,IC50,,,,Inhibition of human Erg by whole cell patch clamp electrophysiology
5355,CHEMBL1935447,COc1ccc(Cn2c([C@H]3CNCCS3)nc3ccccc32)cc1,IC50,nM,=,1500.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5356,CHEMBL1935448,COc1ccc(Cn2c(C3CNCCS3)nc3ccccc32)cc1,IC50,,,,Inhibition of human Erg by whole cell patch clamp electrophysiology
5357,CHEMBL550818,CN(CC1CCOCC1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,IC50,nM,=,29.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5358,CHEMBL556450,Cc1cnn(C2CCN(c3nc4ccccc4n3Cc3ccc(F)cc3)CC2)c1,IC50,nM,=,809.0,Inhibition of human Erg by whole cell patch clamp electrophysiology
5359,CHEMBL1935601,O=S(=O)(c1cccc(F)c1)c1ccc2c3c(oc2c1)C1(CCCOC1)NCC3,IC50,nM,=,9600.0,Inhibition of human ERG by patch express assay
5360,CHEMBL1935601,O=S(=O)(c1cccc(F)c1)c1ccc2c3c(oc2c1)C1(CCCOC1)NCC3,IC50,nM,=,12000.0,Inhibition of human ERG by patch express assay
5361,CHEMBL1935601,O=S(=O)(c1cccc(F)c1)c1ccc2c3c(oc2c1)C1(CCCOC1)NCC3,IC50,nM,=,13600.0,Inhibition of human ERG by patch express assay
5362,CHEMBL1935599,O=S(=O)(c1cccc(F)c1)c1ccc2c3c(oc2c1)C1(CCOCC1)NCC3,IC50,nM,>,30000.0,Inhibition of human ERG by patch express assay
5363,CHEMBL1935597,CC1(C(F)F)NCCc2c1oc1cc(S(=O)(=O)c3cccc(F)c3)ccc21,IC50,nM,>,30000.0,Inhibition of human ERG by patch express assay
5364,CHEMBL1935596,CC1(C(F)(F)F)NCCc2c1oc1cc(S(=O)(=O)c3cccc(F)c3)ccc21,IC50,nM,>,30000.0,Inhibition of human ERG by patch express assay
5365,CHEMBL1935594,CC1(C)NCCc2c1oc1cc(S(=O)(=O)c3cccc(F)c3)ccc21,IC50,nM,=,1000.0,Inhibition of human ERG by patch express assay
5366,CHEMBL1935590,O=S(=O)(c1cccc(F)c1)c1ccc2c3c(oc2c1)CNCC3,IC50,nM,=,1000.0,Inhibition of human ERG by patch express assay
5367,CHEMBL1934130,CC(=O)N[C@@H]1CC2(CCN(Cc3ccc4c(c3)c3ccccc3n4C(N)=O)CC2)c2ccccc21,IC50,nM,=,2000.0,Inhibition of human ERG by rubidium [86Rb] efflux assay
5368,CHEMBL1934520,COCCS(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,7400.0,Inhibition of human ERG by patch-clamp assay
5369,CHEMBL1934521,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)CCO)cc2)cc1,IC50,nM,=,7700.0,Inhibition of human ERG by patch-clamp assay
5370,CHEMBL1934523,COCCCS(=O)(=O)c1ccc(-c2ccc(CCN3CCC[C@H]3C)cc2)cc1,IC50,nM,=,11000.0,Inhibition of human ERG by patch-clamp assay
5371,CHEMBL1934524,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)CCCO)cc2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by patch-clamp assay
5372,CHEMBL1934525,C[C@@H]1CCCN1CCc1ccc(-c2ccc(S(=O)(=O)CC3CCOCC3)cc2)cc1,IC50,nM,=,3100.0,Inhibition of human ERG by patch-clamp assay
5373,CHEMBL1934835,CC(=O)Nc1cccc(C2CCN(CCCn3nc(-c4ccc(F)c(F)c4)c4ccccc4c3=O)CC2)c1,IC50,nM,=,16000.0,Inhibition of human ERG
5374,CHEMBL1935100,C[C@@H]1CCCN1CCCOc1ccc(C2=NNC(=O)CC2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG by patch-express assay
5375,CHEMBL1935114,C[C@@H]1CCCN1CCCOc1ccc(C2=NNC(=O)C(C)(C)C2)cc1,IC50,nM,=,20000.0,Inhibition of human ERG by patch-express assay
5376,CHEMBL1939738,CN(CCO)C(=O)c1ccc([C@H](c2cccc(NC(=O)C3CC3)c2)N2CCN(Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,15000.0,Inhibition of human Erg
5377,CHEMBL1939737,CCN(CC)C(=O)c1ccc([C@H](c2cccc(NC(=O)C3CC3)c2)N2CCN(Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,11000.0,Inhibition of human Erg
5378,CHEMBL1939739,O=C(Nc1cccc([C@@H](c2ccc(C(=O)N3CCC3)cc2)N2CCN(Cc3ccc(F)cc3)CC2)c1)C1CC1,IC50,nM,=,3600.0,Inhibition of human Erg
5379,CHEMBL1939740,CCN(CC)C(=O)c1ccc([C@H](c2cccc(NC(=O)C3CC3)c2)N2CCN(Cc3ccccn3)CC2)cc1,IC50,nM,=,20000.0,Inhibition of human Erg
5380,CHEMBL1939742,CCN(C)C(=O)c1ccc([C@H](c2cccc(NC(=O)C3CC3)c2)N2CCN(Cc3nc(C)cs3)CC2)cc1,IC50,nM,=,18000.0,Inhibition of human Erg
5381,CHEMBL1939743,CCN(CC)C(=O)c1ccc([C@H](c2cccc(NC(=O)C3CC3)c2)N2CCN(CCOC)CC2)cc1,IC50,nM,>,30000.0,Inhibition of human Erg
5382,CHEMBL1939744,CCN(C)C(=O)c1ccc([C@H](c2cccc(NC(=O)C3CC3)c2)N2CCN(CCCOC)CC2)cc1,IC50,nM,=,13000.0,Inhibition of human Erg
5383,CHEMBL1939741,CCN(C)C(=O)c1ccc([C@H](c2cccc(NC(=O)C3CCC3)c2)N2CCN(Cc3cccnc3)CC2)cc1,IC50,nM,=,28000.0,Inhibition of human Erg
5384,CHEMBL1939736,CCN(CC)C(=O)c1ccc([C@H](c2cccc(NC(=O)OC)c2)N2CCN(Cc3cncs3)CC2)cc1,IC50,nM,=,14000.0,Inhibition of human Erg
5385,CHEMBL1939735,CCN(CC)C(=O)c1ccc([C@H](c2cccc(NC(=O)OC)c2)N2CCN(Cc3cccnc3)CC2)cc1,IC50,nM,=,11000.0,Inhibition of human Erg
5386,CHEMBL1939745,CCOC(=O)Nc1ccccc1[C@@H](c1ccc(C(=O)N(CC)CC)cc1)N1CCN(Cc2cscn2)CC1,IC50,nM,=,8700.0,Inhibition of human Erg
5387,CHEMBL1939746,CCOC(=O)Nc1cccc([C@@H](c2ccc(C(=O)N(CC)CC)cc2)N2CCN(Cc3cscn3)CC2)c1,IC50,nM,=,5400.0,Inhibition of human Erg
5388,CHEMBL1939747,CCOC(=O)Nc1ccc([C@@H](c2ccc(C(=O)N(CC)CC)cc2)N2CCN(Cc3cscn3)CC2)cc1,IC50,nM,=,7300.0,Inhibition of human Erg
5389,CHEMBL1939748,CCOC(=O)Nc1ccccc1[C@@H](c1ccc(C(=O)N(CC)CC)cc1)N1CCN(Cc2ccccn2)CC1,IC50,nM,=,9900.0,Inhibition of human Erg
5390,CHEMBL1939749,CCOC(=O)Nc1cccc([C@@H](c2ccc(C(=O)N(C)CC)cc2)N2CCN(Cc3nc[nH]c3C)CC2)c1,IC50,nM,>,33000.0,Inhibition of human Erg
5391,CHEMBL1939750,CCOC(=O)Nc1cccc([C@@H](c2ccc(C(=O)N(C)CC)cc2)N2CCN(Cc3c[nH]c(C)n3)CC2)c1,IC50,nM,>,33000.0,Inhibition of human Erg
5392,CHEMBL1939751,CCN(C)C(=O)c1ccc([C@H](c2cccc(NC(=O)OC)c2)N2CCN(Cc3cscn3)CC2)cc1,IC50,nM,=,17000.0,Inhibition of human Erg
5393,CHEMBL1939752,CCOC(=O)Nc1cccc([C@@H](c2ccc(C(=O)N3CCC3)cc2)N2CCN(Cc3cccnc3)CC2)c1,IC50,nM,=,11000.0,Inhibition of human Erg
5394,CHEMBL1938410,CCN(C)C(=O)c1ccc([C@H](c2cccnc2)N2CCN(Cc3cscn3)CC2)cc1,IC50,nM,=,15000.0,Inhibition of human Erg
5395,CHEMBL1939753,CCN(C)C(=O)c1ccc([C@H](c2cccnc2)N2CCN(Cc3ccccn3)CC2)cc1,IC50,nM,=,13000.0,Inhibition of human Erg
5396,CHEMBL1939754,CCN(C)C(=O)c1ccc([C@H](c2ccccn2)N2CCN(Cc3ccccn3)CC2)cc1,IC50,nM,>,33000.0,Inhibition of human Erg
5397,CHEMBL1940274,COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC,IC50,nM,=,137000.0,Inhibition of human ERG
5398,CHEMBL1940315,O=C(NC1CCCS(=O)(=O)C1)c1ccc(Oc2ccc(C#C[C@]3(O)CN4CCC3CC4)cc2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG
5399,CHEMBL1940308,CN1CCC(NC(=O)c2ccc(Oc3ccc(C#C[C@]4(O)CN5CCC4CC5)cc3)cc2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
5400,CHEMBL227875,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2,IC50,nM,>,30000.0,Inhibition of human Erg expressed in HEK293 cells by FAST patch clamp analysis
5401,CHEMBL1945829,O=C(O[C@@H]1COc2nc([N+](=O)[O-])cn2C1)N1CCN(c2ccc(OC(F)(F)F)cc2)CC1,IC50,nM,>,30000.0,Inhibition of human Erg expressed in HEK293 cells by FAST patch clamp analysis
5402,CHEMBL1945721,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3Cl)n2n(C)c1=O,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5403,CHEMBL1945723,CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5404,CHEMBL1945726,CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(F)cccc3Cl)n21,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5405,CHEMBL1945850,Cc1cccnc1-n1nc(C)c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)cc1=O,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
5406,CHEMBL1945849,Cc1cccc(-n2nc(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)cc2=O)n1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
5407,CHEMBL1945848,Cc1nn(-c2ccccn2)c(=O)cc1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
5408,CHEMBL1945845,Cc1n[nH]c(=O)cc1-c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,=,7000.0,Inhibition of human ERG by patch clamp assay
5409,CHEMBL1945844,O=c1cc(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)cn[nH]1,IC50,nM,=,2000.0,Inhibition of human ERG by patch clamp assay
5410,CHEMBL1946015,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2cccc(F)c2)cc1,IC50,nM,<,1000.0,Inhibition of human ERG
5411,CHEMBL1946016,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2ccccn2)cc1,IC50,nM,=,3900.0,Inhibition of human ERG
5412,CHEMBL1946017,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2cccnc2)cc1,IC50,nM,=,1300.0,Inhibition of human ERG
5413,CHEMBL1946019,CCN(C)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2ccccc2NC(C)=O)cc1,IC50,nM,=,12000.0,Inhibition of human ERG
5414,CHEMBL1946020,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2cccc(NC(C)=O)c2)cc1,IC50,nM,=,3000.0,Inhibition of human ERG
5415,CHEMBL1946021,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2ccc(NC(C)=O)cc2)cc1,IC50,nM,=,1300.0,Inhibition of human ERG
5416,CHEMBL1946022,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2ccccc2NC(=O)OC)cc1,IC50,nM,=,4700.0,Inhibition of human ERG
5417,CHEMBL1946023,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2cccc(NC(=O)OC)c2)cc1,IC50,nM,=,1100.0,Inhibition of human ERG
5418,CHEMBL1946024,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3ccc(F)cc3)CC2)c2ccc(NC(=O)OC)cc2)cc1,IC50,nM,=,900.0,Inhibition of human ERG
5419,CHEMBL339457,CCN(CC)C(=O)c1ccc(C(=C2CCNCC2)c2cccc(F)c2)cc1,IC50,nM,=,3000.0,Inhibition of human ERG
5420,CHEMBL1946619,CCN(CC)C(=O)c1ccc(C(=C2CCNCC2)c2ccccn2)cc1,IC50,nM,=,33000.0,Inhibition of human ERG
5421,CHEMBL1946620,CCN(CC)C(=O)c1ccc(C(=C2CCN(Cc3cscn3)CC2)c2ccccn2)cc1,IC50,nM,=,16000.0,Inhibition of human ERG
5422,CHEMBL1946621,CN(C)C(=O)c1ccc(C(=C2CCN(Cc3cscn3)CC2)c2ccccn2)cc1,IC50,nM,=,18000.0,Inhibition of human ERG
5423,CHEMBL1945199,C[N+](C)(CCCCNC(=O)Cc1ccc(OCc2ccccc2)cc1)CCNC(=O)c1nc(Cl)c(N)nc1N.[Br-],IC50,nM,=,330.0,Binding affinity to human ERG channel
5424,CHEMBL1945199,C[N+](C)(CCCCNC(=O)Cc1ccc(OCc2ccccc2)cc1)CCNC(=O)c1nc(Cl)c(N)nc1N.[Br-],IC50,nM,=,10800.0,Inhibition of human ERG channel by patch clamp assay
5425,CHEMBL1950643,O=c1ccc(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)n[nH]1,IC50,nM,=,8000.0,Inhibition of human Erg by patch clamp assay
5426,CHEMBL1950736,O=c1ccc(-c2ccc(OC3CCN(C4CCC4)CC3)nc2)n[nH]1,IC50,nM,=,9000.0,Inhibition of human Erg by patch clamp assay
5427,CHEMBL1950747,C[C@H]1CC(=O)NN=C1c1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,=,27000.0,Inhibition of human Erg by patch clamp assay
5428,CHEMBL1950743,CC1(C)CC(c2ccc(OC3CCN(C4CCC4)CC3)cc2)=NNC1=O,IC50,nM,=,21000.0,Inhibition of human Erg by patch clamp assay
5429,CHEMBL1950434,COc1cc(/C=C2\CCCN3C2=NO[C@]3(CO)c2ccc(F)cc2)ccc1-n1cnc(C)c1,IC50,nM,=,3300.0,Inhibition of human ERG by cell based voltage clamp assay
5430,CHEMBL1950433,COc1cc(/C=C2\CCCN3C2=NOC3(C)c2ccc(F)cc2)ccc1-n1cnc(C)c1,IC50,nM,=,740.0,Inhibition of human ERG by cell based voltage clamp assay
5431,CHEMBL1224151,COc1cc(/C=C2\CCCN([C@@H](C)c3ccc(F)cc3)C2=O)ccc1-n1cnc(C)c1,IC50,nM,=,1200.0,Inhibition of human ERG by cell based voltage clamp assay
5432,CHEMBL1950535,COc1cc(/C=C2\CCCN3C2=NOC[C@@H]3c2cc(F)c(F)c(F)c2)ccc1-n1cnc(C)c1,IC50,nM,=,1000.0,Inhibition of human ERG by cell based voltage clamp assay
5433,CHEMBL1951032,COc1c(Nc2ccc(S(C)(=O)=O)nc2C)ncnc1OC1CCN(C(=O)OC(C)C)CC1,IC50,nM,>,10000.0,Inhibition of human ERG
5434,CHEMBL1951032,COc1c(Nc2ccc(S(C)(=O)=O)nc2C)ncnc1OC1CCN(C(=O)OC(C)C)CC1,IC50,nM,=,13000.0,Inhibition of human ERG by patch clamp assay
5435,CHEMBL1951453,CCCOc1sc(C(=O)N2CCC(c3cccc(CN)c3)CC2)c(C)c1Br,IC50,nM,=,1000.0,Inhibition of human ERG by whole-cell patch clamp electrophysiology assay
5436,CHEMBL1230468,Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1Cl,IC50,nM,=,28000.0,Inhibition of human ERG by automated patch clamp assay
5437,CHEMBL212689,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1,IC50,nM,=,7300.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5438,CHEMBL212689,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1,IC50,nM,=,1900.0,Inhibition of human ERG by electrophysiological assay
5439,CHEMBL1951909,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)N2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,>,32.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5440,CHEMBL1951906,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,25000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5441,CHEMBL1951908,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1,IC50,nM,=,1200.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5442,CHEMBL1951898,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1,IC50,nM,=,3200.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5443,CHEMBL1951899,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1,IC50,nM,=,5800.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5444,CHEMBL1951892,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5445,CHEMBL1951893,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3ccccc3)CC2)CC1,IC50,nM,=,13000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5446,CHEMBL1951894,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3cccc(F)c3)CC2)CC1,IC50,nM,=,3200.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5447,CHEMBL1951895,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C(C)=O)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5448,CHEMBL1951896,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,25000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5449,CHEMBL1951897,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(=O)(=O)CC)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5450,CHEMBL1951900,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5451,CHEMBL1951901,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(Cc3ccccc3)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5452,CHEMBL1951902,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C(C)=O)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5453,CHEMBL1951903,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5454,CHEMBL1951904,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(Cc3ccccc3)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5455,CHEMBL1951905,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C(C)=O)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5456,CHEMBL1951907,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5457,CHEMBL1949696,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5458,CHEMBL1951910,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(S(C)(=O)=O)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5459,CHEMBL1951911,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(OC)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,32000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5460,CHEMBL1951912,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,35000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5461,CHEMBL1951913,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,,,,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5462,CHEMBL1951914,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,24000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5463,CHEMBL1951766,Cc1ccc([C@]2(O)CC[C@H](N3CC[C@@H](NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cc1,IC50,nM,=,13200.0,Displacement of dofetidine from human Erg
5464,CHEMBL1951768,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3ccccn3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5465,CHEMBL1951769,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3cccnc3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5466,CHEMBL1951770,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3ccncc3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5467,CHEMBL1951771,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3ncccn3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5468,CHEMBL1951772,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3ccncn3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5469,CHEMBL1951774,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3cccnn3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5470,CHEMBL1951775,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3ccnnc3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5471,CHEMBL1951776,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN([C@H]2CC[C@@](O)(c3cnccn3)CC2)C1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5472,CHEMBL1951777,Cc1ccc([C@]2(O)CC[C@H](N3CC[C@@H](NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5473,CHEMBL1951778,COc1ccc([C@]2(O)CC[C@H](N3CC[C@@H](NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1.CS(=O)(=O)O,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5474,CHEMBL1951779,CCOc1ccc([C@]2(O)CC[C@H](N3CC[C@@H](NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,>,30.0,Displacement of dofetidine from human Erg
5475,CHEMBL1951778,COc1ccc([C@]2(O)CC[C@H](N3CC[C@@H](NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1.CS(=O)(=O)O,IC50,nM,=,84000.0,Inhibition of human Erg by patch clamp assay
5476,CHEMBL1951612,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,IC50,nM,=,10000.0,Inhibition of human ERG by Qpatch assay
5477,CHEMBL1951595,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCC[C@H](N)C4)n3Cc3ccccc3)n(C)c2=O)c1,IC50,nM,=,100.0,Inhibition of human ERG by dofetilide binding assay
5478,CHEMBL237500,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,IC50,nM,>,30000.0,Inhibition of human ERG by dofetilide binding assay
5479,CHEMBL1951596,Cn1c(=O)n(Cc2nccc3ccccc23)c(=O)c2c1c(C#N)c(N1CCC[C@H](N)C1)n2Cc1ccccc1,IC50,nM,=,2800.0,Inhibition of human ERG by dofetilide binding assay
5480,CHEMBL1951598,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCC[C@H](N)C4)n3CC=C(C)C)n(C)c2=O)c1,IC50,nM,=,1600.0,Inhibition of human ERG by dofetilide binding assay
5481,CHEMBL1951597,Cn1c(=O)c2c(c(C#N)c(N3CCC[C@H](N)C3)n2Cc2ccccc2)n(C)c1=O,IC50,nM,=,4300.0,Inhibition of human ERG by dofetilide binding assay
5482,CHEMBL1951599,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,IC50,nM,=,9000.0,Inhibition of human ERG by dofetilide binding assay
5483,CHEMBL1951601,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1cnc3ccccc3n1)c(=O)n2C,IC50,nM,=,5000.0,Inhibition of human ERG by dofetilide binding assay
5484,CHEMBL1951600,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,IC50,nM,=,6700.0,Inhibition of human ERG by dofetilide binding assay
5485,CHEMBL1951602,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1ncccc1C#N)c(=O)n2C,IC50,nM,=,16900.0,Inhibition of human ERG by dofetilide binding assay
5486,CHEMBL1951604,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,IC50,nM,=,28200.0,Inhibition of human ERG by dofetilide binding assay
5487,CHEMBL1951603,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(CC(=O)c1cccc(OC)c1)c(=O)n2C,IC50,nM,=,1300.0,Inhibition of human ERG by dofetilide binding assay
5488,CHEMBL1951605,CC#CCn1c(N2CCC[C@@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,IC50,nM,=,21700.0,Inhibition of human ERG by dofetilide binding assay
5489,CHEMBL1951607,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCCNCC4)n3CC=C(C)C)n(C)c2=O)c1,IC50,nM,=,1100.0,Inhibition of human ERG by dofetilide binding assay
5490,CHEMBL1951606,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,IC50,nM,>,30000.0,Inhibition of human ERG by dofetilide binding assay
5491,CHEMBL1951608,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,IC50,nM,=,1900.0,Inhibition of human ERG by dofetilide binding assay
5492,CHEMBL1951610,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1cn3ccccc3n1)c(=O)n2C,IC50,nM,=,1800.0,Inhibition of human ERG by dofetilide binding assay
5493,CHEMBL1951609,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,IC50,nM,=,2000.0,Inhibition of human ERG by dofetilide binding assay
5494,CHEMBL1951611,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,IC50,nM,=,1800.0,Inhibition of human ERG by dofetilide binding assay
5495,CHEMBL1951612,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,IC50,nM,=,3400.0,Inhibition of human ERG by dofetilide binding assay
5496,CHEMBL1949693,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,IC50,nM,=,900.0,Inhibition of human ERG by dofetilide binding assay
5497,CHEMBL1951613,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,IC50,nM,=,12000.0,Inhibition of human ERG by dofetilide binding assay
5498,CHEMBL1951614,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,IC50,nM,=,4400.0,Inhibition of human ERG by dofetilide binding assay
5499,CHEMBL1951416,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,IC50,nM,=,12000.0,Inhibition of human ERG by dofetilide binding assay
5500,CHEMBL1951914,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,11000.0,Inhibition of human ERG by electrophysiological assay
5501,CHEMBL1951915,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,14000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5502,CHEMBL1951916,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(C)cc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,4000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5503,CHEMBL1951917,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,7900.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5504,CHEMBL1951918,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C(F)(F)F)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,7900.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5505,CHEMBL1952100,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(Cl)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1,IC50,nM,=,6500.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs"
5506,CHEMBL1952113,FC(F)(F)Oc1cccc(-n2nnc3ccc(NCC4CCNCC4)nc32)c1,IC50,nM,=,10000.0,Displacement of [3H]astemizole from human ERG expressed in CHO-K1 cell membranes
5507,CHEMBL1952141,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1.O=S(=O)(O)O,IC50,nM,=,3162.28,Displacement of [3H]astemizole from human ERG expressed in CHO-K1 cell membranes
5508,CHEMBL1952142,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(OC(F)(F)F)c1,IC50,nM,=,3162.28,Displacement of [3H]astemizole from human ERG expressed in CHO-K1 cell membranes
5509,CHEMBL1952143,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(N(C)C)c1,IC50,nM,=,31622.78,Displacement of [3H]astemizole from human ERG expressed in CHO-K1 cell membranes
5510,CHEMBL1952144,FC(F)(F)Oc1cccc(-n2nnc3cc(Cl)c(NCC4CCNCC4)nc32)c1,IC50,nM,=,398.11,Displacement of [3H]astemizole from human ERG expressed in CHO-K1 cell membranes
5511,CHEMBL1951431,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3ccnc4ccccc34)c(=O)c21,IC50,nM,=,4200.0,Inhibition of human ERG by dofetilide binding assay
5512,CHEMBL555563,O=C(N1CCCCC1)N1CC(O[C@@H](c2ccc(Cl)cc2)c2cccnc2Cl)C1,IC50,nM,=,30800.0,Inhibition of human ERG
5513,CHEMBL1950346,CCCS(=O)(=O)n1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(C1CCOCC1)CC2,IC50,nM,=,2000.0,Inhibition of human Erg by voltage ion flux electrophysiological assay
5514,CHEMBL1950351,CCS(=O)(=O)n1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(C1CCOCC1)CC2,IC50,nM,=,3100.0,Inhibition of human Erg by voltage ion flux electrophysiological assay
5515,CHEMBL1950487,CCCS(=O)(=O)n1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(C1CCOC1)CC2,IC50,nM,=,13000.0,Inhibition of human Erg by voltage ion flux electrophysiological assay
5516,CHEMBL1950488,CCS(=O)(=O)n1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(C1CCOC1)CC2,IC50,nM,=,25000.0,Inhibition of human Erg by voltage ion flux electrophysiological assay
5517,CHEMBL1950489,CC1CCN(C(=O)c2ccc3c(c2)c2c(n3C)CCN(C3CCOCC3)C2)CC1,IC50,nM,=,2600.0,Inhibition of human Erg by voltage ion flux electrophysiological assay
5518,CHEMBL1950490,Cn1c2c(c3cc(C(=O)N4CCCCC4)ccc31)CN(C1CCOCC1)CC2,IC50,nM,=,18000.0,Inhibition of human Erg by voltage ion flux electrophysiological assay
5519,CHEMBL1949930,COc1cc(OC(C)C)cc(S(=O)(=O)c2ccc3c(c2)O[C@H]2CNCC[C@@H]32)c1.Cl,IC50,nM,=,3300.0,Inhibition of human ERG by patch clamp assay
5520,CHEMBL1957497,CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1,IC50,nM,=,100000.0,Displacement of [3H]-astemizole from human ERG expressed in CHO-K1 cells membrane
5521,CHEMBL521851,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,nM,=,64000.0,Displacement of [3H]-astemizole from human ERG expressed in CHO-K1 cells membrane
5522,CHEMBL1957676,CC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@H]2c2ccc(F)c(F)c2)c(Cl)c1,IC50,nM,=,1100.0,Inhibition of human ERG
5523,CHEMBL1957677,CC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@H]2c2cccnc2)c(Cl)c1,IC50,nM,=,4800.0,Inhibition of human ERG
5524,CHEMBL1957790,CC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)c(Cl)c1,IC50,nM,=,5800.0,Inhibition of human ERG
5525,CHEMBL1957791,CCC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)c(Cl)c1,IC50,nM,=,2800.0,Inhibition of human ERG
5526,CHEMBL1957792,COC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)c(Cl)c1,IC50,nM,=,10300.0,Inhibition of human ERG
5527,CHEMBL1957793,CCOC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)c(Cl)c1,IC50,nM,=,3200.0,Inhibition of human ERG
5528,CHEMBL1957795,CC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)c(C)c1,IC50,nM,=,4200.0,Inhibition of human ERG
5529,CHEMBL1957796,CC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@]23OC(=O)c2cc(F)c(F)cc23)c(C)c1,IC50,nM,=,12900.0,Inhibition of human ERG
5530,CHEMBL1957788,CC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)c(C)c1,IC50,nM,=,5100.0,Inhibition of human ERG
5531,CHEMBL1957789,COCC(F)(F)COCc1ccc([C@@]2(O)CCNC[C@@H]2c2ccc(-c3ccccc3CCNC(C)=O)cc2C)cc1,IC50,nM,=,9800.0,Inhibition of human ERG
5532,CHEMBL1957797,COC[C@H](C)COCc1ccc([C@@]2(O)CCNC[C@@H]2c2ccc(-c3ccccc3CCNC(C)=O)cc2C)cc1,IC50,nM,=,9000.0,Inhibition of human ERG
5533,CHEMBL1957798,CC(=O)NCCc1ccccc1-c1ccc([C@@H](CN)Cc2ccc(OCCOc3c(Cl)cc(C)cc3Cl)cc2)c(C)c1.Cl,IC50,nM,=,6.0,Inhibition of human ERG
5534,CHEMBL1957816,O=C(c1cccn2ccnc12)N1CCN(CCc2ccc(F)cc2F)CC1,IC50,nM,=,1900.0,Inhibition of human ERG by patch-clamp assay
5535,CHEMBL1956107,CN[C@H]1CC[C@@H](N2CCc3ccc(NC(=N)c4cccs4)cc32)CC1,IC50,nM,=,13000.0,Inhibition of human Erg expressed in HEK293 cells by patch clamp assay
5536,CHEMBL1956112,CN1CCC[C@H]1CCN1CCCc2cc(NC(=N)c3cccs3)ccc21,IC50,nM,=,4700.0,Inhibition of human Erg expressed in HEK293 cells by patch clamp assay
5537,CHEMBL243001,Cc1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,1600.0,Inhibition of human Erg by patch clamp assay
5538,CHEMBL1956989,Cc1nc2ncc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,3100.0,Inhibition of human Erg by patch clamp assay
5539,CHEMBL1956988,Cc1nc2ccc(Oc3ccc(F)cc3)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,3200.0,Inhibition of human Erg by patch clamp assay
5540,CHEMBL1956991,Cc1nc2ccc(Oc3ccc(Cl)cc3F)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,1300.0,Inhibition of human Erg by patch clamp assay
5541,CHEMBL1956995,COc1ccc2cccc(Oc3ccc4nc(C)n(C[C@H]5CCCN(C(C)C)C5)c(=O)c4n3)c2n1,IC50,nM,=,13600.0,Inhibition of human Erg by patch clamp assay
5542,CHEMBL1956998,Cc1nc2cnc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,1300.0,Inhibition of human Erg by patch clamp assay
5543,CHEMBL1956999,Cc1nc2cnc(Oc3ccc(Cl)cc3F)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,130.0,Inhibition of human Erg by patch clamp assay
5544,CHEMBL1957001,Cc1nc2cnc(Oc3ccc4ncsc4c3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,2400.0,Inhibition of human Erg by patch clamp assay
5545,CHEMBL1957002,Cc1nc2cnc(Oc3ccc(F)c4cccnc34)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,9400.0,Inhibition of human Erg by patch clamp assay
5546,CHEMBL1957004,Cc1nc2ncc(Oc3ccc(F)cc3)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,16100.0,Inhibition of human Erg by patch clamp assay
5547,CHEMBL1957005,Cc1nc2ncc(Oc3ccc(Cl)cc3F)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,>,33000.0,Inhibition of human Erg by patch clamp assay
5548,CHEMBL1957008,Cc1nc2ncc(Oc3ccc(F)c4cccnc34)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,>,33000.0,Inhibition of human Erg by patch clamp assay
5549,CHEMBL1957012,Cc1nc2cnc(Oc3cccc4cccnc34)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,25100.0,Inhibition of human Erg by patch clamp assay
5550,CHEMBL243001,Cc1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,1621.81,Inhibition of human Erg by patch clamp assay
5551,CHEMBL1956989,Cc1nc2ncc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,3090.3,Inhibition of human Erg by patch clamp assay
5552,CHEMBL1956988,Cc1nc2ccc(Oc3ccc(F)cc3)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,3235.94,Inhibition of human Erg by patch clamp assay
5553,CHEMBL1956991,Cc1nc2ccc(Oc3ccc(Cl)cc3F)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,1288.25,Inhibition of human Erg by patch clamp assay
5554,CHEMBL1956995,COc1ccc2cccc(Oc3ccc4nc(C)n(C[C@H]5CCCN(C(C)C)C5)c(=O)c4n3)c2n1,IC50,nM,=,13489.63,Inhibition of human Erg by patch clamp assay
5555,CHEMBL1956998,Cc1nc2cnc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,1288.25,Inhibition of human Erg by patch clamp assay
5556,CHEMBL1956999,Cc1nc2cnc(Oc3ccc(Cl)cc3F)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,128.82,Inhibition of human Erg by patch clamp assay
5557,CHEMBL1957001,Cc1nc2cnc(Oc3ccc4ncsc4c3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,2398.83,Inhibition of human Erg by patch clamp assay
5558,CHEMBL1957002,Cc1nc2cnc(Oc3ccc(F)c4cccnc34)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,9549.93,Inhibition of human Erg by patch clamp assay
5559,CHEMBL1957004,Cc1nc2ncc(Oc3ccc(F)cc3)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,16218.1,Inhibition of human Erg by patch clamp assay
5560,CHEMBL1957005,Cc1nc2ncc(Oc3ccc(Cl)cc3F)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,33113.11,Inhibition of human Erg by patch clamp assay
5561,CHEMBL1957008,Cc1nc2ncc(Oc3ccc(F)c4cccnc34)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,33113.11,Inhibition of human Erg by patch clamp assay
5562,CHEMBL1957012,Cc1nc2cnc(Oc3cccc4cccnc34)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,25118.86,Inhibition of human Erg by patch clamp assay
5563,CHEMBL1956996,Cc1nc2ccc(Oc3ccc(F)c4cccnc34)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,129.99,Inhibition of human Erg by patch clamp assay
5564,CHEMBL1956990,Cc1nc2ncc(Oc3ccc(Br)cc3F)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,1299.87,Inhibition of human Erg by patch clamp assay
5565,CHEMBL1956992,Cc1nc2ccc(Oc3ccc4c(c3)OCO4)nc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,13598.78,Inhibition of human Erg by patch clamp assay
5566,CHEMBL2011947,Nc1ncnc(Nc2ccc(Oc3ccc(Cl)cc3)cc2)n1,IC50,nM,=,1500.0,Inhibition of human ERG by PatchXpress voltage patch clamp assay
5567,CHEMBL2010816,Nc1cncc(Nc2ccc(Oc3ccc(OC(F)(F)F)cc3)cc2)n1,IC50,nM,=,8500.0,Inhibition of human ERG by PatchXpress voltage patch clamp assay
5568,CHEMBL2012244,c1ccc(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)cc1,IC50,nM,=,760.0,Inhibition of human ERG by patchXpress assay
5569,CHEMBL2012178,Cc1c(C)n(Cc2ccccc2)c2ncnc(OC3CCN(Cc4cscn4)CC3)c12,IC50,nM,=,510.0,Inhibition of human ERG by patchXpress assay
5570,CHEMBL1234899,Cc1nc2cc(OC(F)(F)F)ccc2n1-c1ccc(C(=O)NC2CC2)s1,IC50,nM,<,2800.0,Inhibition of human ERG expressed in CHOK1 cells by whole cell voltage clamp assay
5571,CHEMBL2012951,Cc1nc2c(OC(F)F)cccc2n1-c1ccc(C(=O)NC2CC2)s1,IC50,nM,=,28800.0,Inhibition of human ERG expressed in CHOK1 cells by whole cell voltage clamp assay
5572,CHEMBL2012958,Cc1nc2c(C#N)cccc2n1-c1ccc(C(=O)NC2CC2)s1,IC50,nM,=,53000.0,Inhibition of human ERG expressed in CHOK1 cells by whole cell voltage clamp assay
5573,CHEMBL2010824,CCC(NCCCC[C@@H](Cc1cc(C)c(F)c(C)c1)C(=O)NO)c1ccc(F)cc1,IC50,nM,=,13300.0,Inhibition of human ERG by fluorescence polarization assay
5574,CHEMBL2012838,CCC(NCCCC[C@@H](C[C@@H](OC)c1ccc(F)cc1)C(=O)NO)c1ccc(F)cc1,IC50,nM,=,10000.0,Inhibition of human ERG by fluorescence polarization assay
5575,CHEMBL1760324,Cc1cc(C[C@H](CCCCNCc2ccc(F)cc2)C(=O)NO)cc(C)c1F,IC50,nM,=,4650.0,Inhibition of human ERG by fluorescence polarization assay
5576,CHEMBL2012837,CCC(NCCCC[C@@H](Oc1cc(C)c(F)c(C)c1)C(=O)NO)c1ccc(F)cc1,IC50,nM,=,2700.0,Inhibition of human ERG by fluorescence polarization assay
5577,CHEMBL1760318,CO[C@H](C[C@H](CCCCNCc1ccc(F)cc1)C(=O)NO)c1ccc(F)cc1,IC50,nM,=,2000.0,Inhibition of human ERG by fluorescence polarization assay
5578,CHEMBL1269994,Cc1cc(N[C@H](CCCCNCc2ccc(F)cc2)C(=O)NO)cc(C)c1F,IC50,nM,=,1230.0,Inhibition of human ERG by fluorescence polarization assay
5579,CHEMBL2012836,CCC(NCCCC[C@@H](Nc1cc(C)c(F)c(C)c1)C(=O)NO)c1ccc(F)cc1,IC50,nM,=,950.0,Inhibition of human ERG by fluorescence polarization assay
5580,CHEMBL1760322,Cc1cc(O[C@H](CCCCNCc2ccc(F)cc2)C(=O)NO)cc(C)c1F,IC50,nM,=,790.0,Inhibition of human ERG by fluorescence polarization assay
5581,CHEMBL2010853,CN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)[C@@H]1CCN(Cc2nc3cc(F)ccc3s2)C[C@@H]1F,IC50,nM,=,7000.0,Binding affinity to human ERG
5582,CHEMBL2010852,CN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)[C@@H]1CCN(Cc2nc3ccccc3s2)C[C@@H]1F,IC50,nM,=,16000.0,Binding affinity to human ERG
5583,CHEMBL2010851,CN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)[C@@H]1CCN(Cc2ccc(C(F)(F)F)cc2)C[C@@H]1F,IC50,nM,=,4200.0,Binding affinity to human ERG
5584,CHEMBL2010850,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)[C@@H]1CCN(Cc2nc3cc(F)ccc3s2)C[C@@H]1F,IC50,nM,=,4700.0,Binding affinity to human ERG
5585,CHEMBL2010849,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)[C@@H]1CCN(Cc2ccc(C(F)(F)F)nc2)C[C@@H]1F,IC50,nM,=,15000.0,Binding affinity to human ERG
5586,CHEMBL2010848,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)[C@@H]1CCN(Cc2ccc(C(F)(F)F)cn2)C[C@@H]1F,IC50,nM,=,10000.0,Binding affinity to human ERG
5587,CHEMBL2010847,CO[C@H]1CN(Cc2ccc(C(F)(F)F)cc2)CC[C@H]1N(C)C(=O)Cc1ccc(-n2cnnn2)cc1,IC50,nM,=,1200.0,Binding affinity to human ERG
5588,CHEMBL2010846,CO[C@@H]1CN(Cc2ccc(C(F)(F)F)cc2)CC[C@@H]1N(C)C(=O)Cc1ccc(-n2cnnn2)cc1,IC50,nM,=,2000.0,Binding affinity to human ERG
5589,CHEMBL2010845,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)[C@@H]1CCN(Cc2ccc(C(F)(F)F)cc2)C[C@@H]1F,IC50,nM,=,2000.0,Binding affinity to human ERG
5590,CHEMBL2010844,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)[C@H]1CCN(Cc2ccc(C(F)(F)F)cc2)C[C@H]1F,IC50,nM,=,3600.0,Binding affinity to human ERG
5591,CHEMBL2010843,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)C1CCN(Cc2nc3c(s2)CCCC3)CC1,IC50,nM,=,7600.0,Binding affinity to human ERG
5592,CHEMBL2010842,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)C1CCN(Cc2nc3cc(F)ccc3s2)CC1,IC50,nM,=,1300.0,Binding affinity to human ERG
5593,CHEMBL2010841,Cc1nc(-c2ccc(CN3CCC(N(C)C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)cc2)no1,IC50,nM,=,6500.0,Binding affinity to human ERG
5594,CHEMBL2010840,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)C1CCN(Cc2ccc(C(F)(F)F)c(F)c2)CC1,IC50,nM,=,2800.0,Binding affinity to human ERG
5595,CHEMBL2010839,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)C1CCN(Cc2ccc(C(F)(F)F)nc2)CC1,IC50,nM,=,13000.0,Binding affinity to human ERG
5596,CHEMBL2010838,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)C1CCN(Cc2ccc(C(F)(F)F)cn2)CC1,IC50,nM,=,4200.0,Binding affinity to human ERG
5597,CHEMBL2010837,CN(C(=O)Cc1ccccc1)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,1600.0,Binding affinity to human ERG
5598,CHEMBL2010836,CN(C(=O)Cc1ccc(-n2cnnn2)cc1)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,1200.0,Binding affinity to human ERG
5599,CHEMBL2010835,CC(=O)Nc1ccc(CC(=O)N(C)C2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1,IC50,nM,=,4500.0,Binding affinity to human ERG
5600,CHEMBL2010834,CNC(=O)c1ccc(CC(=O)N(C)C2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1,IC50,nM,=,2100.0,Binding affinity to human ERG
5601,CHEMBL2010833,CN(C(=O)Cc1ccc(S(C)(=O)=O)c(F)c1)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,2900.0,Binding affinity to human ERG
5602,CHEMBL2010832,CN(C(=O)Cc1ccc(S(C)(=O)=O)cc1F)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,2600.0,Binding affinity to human ERG
5603,CHEMBL2010831,CN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,3000.0,Binding affinity to human ERG
5604,CHEMBL2010830,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,2500.0,Binding affinity to human ERG
5605,CHEMBL2010872,CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3,IC50,nM,=,20000.0,Inhibition of human Erg expressed CHO cells
5606,CHEMBL2011528,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C[C@@H]1c1cc(F)ccc1F,IC50,nM,=,8800.0,Inhibition of human ERG
5607,CHEMBL2011534,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C[C@@H]1c1cc(F)c(F)cc1F,IC50,nM,=,6100.0,Inhibition of human ERG
5608,CHEMBL2011535,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)CC[C@@H]1c1cc(F)c(F)cc1F,IC50,,,,Inhibition of human ERG
5609,CHEMBL2011537,N[C@@H]1CCN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C1,IC50,,,,Inhibition of human ERG
5610,CHEMBL1938952,COc1ccncc1C(=O)NC(=O)Nc1ccc(-c2ccccc2)c(C(F)(F)F)c1,IC50,nM,>,10000.0,Inhibition of human ERG
5611,CHEMBL2017974,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,IC50,nM,>,30000.0,Displacement of dofetilide from human ERG
5612,CHEMBL2016731,Cc1nc(N2CCC(N3CCCC3)CC2)nc2ccc(NC(=O)COc3ccc(Cl)cc3)cc12,IC50,nM,=,450.0,Inhibition of human ERG
5613,CHEMBL2016776,Cc1nc(N2CCC(N3CCCC3=O)CC2)nc2ccc(NC(=O)COc3ccc(OC(F)(F)F)cc3)cc12,IC50,nM,=,3700.0,Inhibition of human ERG
5614,CHEMBL2017408,COc1cc(-c2cn(CC(=O)N(c3ccccc3)c3ccccc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,3050.0,Inhibition of human ERG
5615,CHEMBL2017409,COc1cc(-c2cn(CC(=O)N(c3ccccc3)C3CCCCC3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,800.0,Inhibition of human ERG
5616,CHEMBL2017410,COc1cc(-c2cn(CC(=O)Nc3cccc4ccccc34)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Inhibition of human ERG
5617,CHEMBL2017411,COc1cc(-c2cn(CC(=O)Nc3ccc4c(c3)OC(F)(F)O4)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Inhibition of human ERG
5618,CHEMBL2017412,COc1cc(-c2cn(CC(=O)NC3C4CC5CC(C4)CC3C5)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,4030.0,Inhibition of human ERG
5619,CHEMBL2017413,COc1cc(-c2cn(CC(=O)N(Cc3ccc(F)cc3)C3C4CC5CC(C4)CC3C5)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,250.0,Inhibition of human ERG
5620,CHEMBL2017414,COc1cc(-c2cn(CC(=O)N(Cc3ccccc3)Cc3ccccc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,870.0,Inhibition of human ERG
5621,CHEMBL2017415,COc1cc(-c2cn(CC(=O)N(Cc3ccccc3)[C@H](C)c3ccccc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,430.0,Inhibition of human ERG
5622,CHEMBL2017416,COc1cc(-c2cn(CC(=O)N([C@H](C)c3ccccc3)[C@H](C)c3ccccc3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,840.0,Inhibition of human ERG
5623,CHEMBL2017417,COc1cc(-c2cn(CC(=O)N(C3CCCCC3)C3CCCCC3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,1390.0,Inhibition of human ERG
5624,CHEMBL2017562,COc1cc(-c2cn(CC(=O)N3CCC(c4nc5ccccc5o4)CC3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,10300.0,Inhibition of human ERG
5625,CHEMBL2017563,COc1cc(-c2cn(CC(=O)N(Cc3ccccc3)CC(F)(F)F)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2870.0,Inhibition of human ERG
5626,CHEMBL2017564,COc1cc(-c2cn(CC(=O)N(CC(F)(F)F)c3ccc4c(c3)CCC4)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,1490.0,Inhibition of human ERG
5627,CHEMBL2017565,COc1cc(-c2cn(CC(=O)N(CC(F)(F)F)c3ccc4c(c3)OC(F)(F)O4)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,1920.0,Inhibition of human ERG
5628,CHEMBL2017566,COc1cc(-c2cn(CC(=O)N(CC(F)(F)F)c3ccc4ccccc4c3)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,630.0,Inhibition of human ERG
5629,CHEMBL2017567,COc1cc(-c2cn(CC(=O)N(CC(F)(F)F)c3cccc4ccccc34)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,800.0,Inhibition of human ERG
5630,CHEMBL2017568,COc1cc(-c2cn(C3CCCCNC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,43900.0,Inhibition of human ERG
5631,CHEMBL2017569,COc1cc(-c2cn(C3C(=O)NC4CCC3C4)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,5350.0,Inhibition of human ERG
5632,CHEMBL2017570,COc1cc(-c2cn(C3CC(C(F)(F)F)CCNC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,30000.0,Inhibition of human ERG
5633,CHEMBL2017571,COc1cc(-c2cn(C3CC(C(F)(F)F)CNC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,30000.0,Inhibition of human ERG
5634,CHEMBL2017572,COc1cc(-c2cn(C3CC(C)(C)CCNC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,20800.0,Inhibition of human ERG
5635,CHEMBL2017573,COc1cc(-c2cn(C3CC[C@H]4CCCC[C@@H]4NC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,20800.0,Inhibition of human ERG
5636,CHEMBL2017574,COc1cc(-c2cn(C3CC([Si](C)(C)C)CCNC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,6270.0,Inhibition of human ERG
5637,CHEMBL2016588,COc1cc(-c2cn(C3CCCC(C(C)(C)C)NC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,44200.0,Inhibition of human ERG
5638,CHEMBL2017575,COc1cc(-c2cn(C3CC(C4CCCCC4)CCNC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,3680.0,Inhibition of human ERG
5639,CHEMBL2017576,COc1cc(-c2cn([C@H]3C[C@@H](C(C)(C)C)CCN(CC45CC6CC(CC(C6)C4)C5)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,870.0,Inhibition of human ERG
5640,CHEMBL2017577,COc1cc(-c2cn([C@H]3C[C@@H](C(C)(C)C)CCN(CC(C)(C)C)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2100.0,Inhibition of human ERG
5641,CHEMBL2017578,COc1cc(-c2cn([C@H]3C[C@@H](C(C)(C)C)CCN(Cc4ccccc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,,,,Inhibition of human ERG
5642,CHEMBL2017579,COc1cc(-c2cn([C@H]3CC[C@H](c4ccccc4)CN(Cc4ccccc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,200.0,Inhibition of human ERG
5643,CHEMBL2017580,COc1cc(-c2cn([C@H]3C[C@@H](C(F)(F)F)CCN(Cc4ccccc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,5480.0,Inhibition of human ERG
5644,CHEMBL2017581,COc1cc(-c2cn([C@H]3C[C@@H]([Si](C)(C)C)CCN(Cc4ccccc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,40800.0,Inhibition of human ERG
5645,CHEMBL2017582,COc1cc(-c2cn([C@H]3C[C@@H](C(F)(F)F)CCN(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,31900.0,Inhibition of human ERG
5646,CHEMBL2017583,COc1cc(-c2cn([C@H]3C[C@@H](C(F)(F)F)CN(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,13100.0,Inhibition of human ERG
5647,CHEMBL2017584,COc1cc(-c2cn([C@H]3CCCCN(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,21900.0,Inhibition of human ERG
5648,CHEMBL2017585,COc1cc(-c2cn([C@H]3C[C@@H](c4ccccc4)CCN(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2220.0,Inhibition of human ERG
5649,CHEMBL2017586,COc1cc(-c2cn([C@H]3C[C@@H](C(C)(C)C)CCN(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,5400.0,Inhibition of human ERG
5650,CHEMBL2017588,Cc1nc(N2CCC(O)CC2)nc2ccc(NC(=O)/C=C/c3ccc(OC(F)(F)F)cc3)cc12,IC50,nM,=,3300.0,Inhibition of human ERG expressed in HEK293 cells by voltage clamp electrophysiology assay
5651,CHEMBL2017593,Cc1nc(N2CCC(O)(C3CC3)CC2)nc2ccc(NC(=O)/C=C/c3ccc(Cl)cc3)cc12,IC50,nM,=,5600.0,Inhibition of human ERG expressed in HEK293 cells by voltage clamp electrophysiology assay
5652,CHEMBL2017597,Cc1nc(N2CCC(O)(C3CC3)CC2)nc2ccc(NC(=O)/C=C/c3ccc(C(F)F)cc3)cc12,IC50,nM,=,2500.0,Inhibition of human ERG expressed in HEK293 cells by voltage clamp electrophysiology assay
5653,CHEMBL2017609,Cc1nc(N(C)C2CCCC2)nc2ccc(NC(=O)/C=C/c3ccc(Cl)cc3)cc12,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by voltage clamp electrophysiology assay
5654,CHEMBL2017618,Cc1nc(NCCCC(=O)NC2CC2)nc2ccc(NC(=O)/C=C/c3ccc(OC(F)(F)F)cc3)cc12,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by voltage clamp electrophysiology assay
5655,CHEMBL2017749,Cc1nc(N2CCC(N3C(=O)CCC3=O)CC2)nc2ccc(NC(=O)/C=C/c3ccc(OC(F)(F)F)cc3)cc12,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by voltage clamp electrophysiology assay
5656,CHEMBL2017760,COCC(=O)NC1CCN(c2nc(C)c3cc(NC(=O)/C=C/c4ccc(Cl)cc4)ccc3n2)CC1,IC50,nM,=,1200.0,Inhibition of human ERG expressed in HEK293 cells by voltage clamp electrophysiology assay
5657,CHEMBL1552719,COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by radioligand binding assay
5658,CHEMBL1086580,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,IC50,nM,>,30000.0,Inhibition of human ERG by radioligand binding assay
5659,CHEMBL1867804,COc1ccc(-n2c(C)nnc2SCc2nc(-c3ccc(OC)c(OC)c3)no2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by radioligand binding assay
5660,CHEMBL1898239,COc1ccc(-c2noc(CSc3nnc(C)n3-c3ccc(OC)cc3)n2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by radioligand binding assay
5661,CHEMBL2017374,CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1.Cl,IC50,nM,=,1820.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp assay
5662,CHEMBL1980297,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,IC50,nM,=,1000.0,Inhibition of human Erg by patch clamp assay in absence of plasma protein
5663,CHEMBL2022867,c1ccc(-n2cc(-c3ccnc4ccccc34)cn2)cc1,IC50,nM,=,2500.0,Inhibition of human ERG by electrophysiology assay
5664,CHEMBL2023457,COc1ccc2c(-c3cnn(-c4ccccc4)c3)ccnc2c1,IC50,nM,=,2500.0,Inhibition of human ERG by electrophysiology assay
5665,CHEMBL2023802,CCOc1cc2nccc(Oc3cnc(CC(=O)Nc4n[nH]c(CC)c4C)c(OC)c3)c2cc1OC,IC50,nM,=,76000.0,Inhibition of human ERG
5666,CHEMBL2023803,COc1ccc2c(Oc3ccc(CC(=O)Nc4cn(C)nc4C)c(OC)c3)ccnc2c1.O=S(=O)(O)O,IC50,nM,>,100000.0,Inhibition of human ERG
5667,CHEMBL2023067,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Br)c[nH]c2c1=O,IC50,nM,>,300000.0,Inhibition of human ERG
5668,CHEMBL2022467,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]c(Br)cc2c1=O,IC50,nM,>,300000.0,Inhibition of human ERG
5669,CHEMBL2023066,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]c(-c3cccnc3)cc2c1=O,IC50,nM,>,300000.0,Inhibition of human ERG
5670,CHEMBL2022464,Cc1cc2c(=O)n(Cc3ccccc3C#N)c(N3CCC[C@@H](N)C3)nc2[nH]1,IC50,nM,>,300000.0,Inhibition of human ERG
5671,CHEMBL2022935,CCN(CC)CCCNc1nnc(-c2ccc(NC(=O)c3ccccc3F)cc2)o1,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5672,CHEMBL2022499,O=C(Nc1ccc(-c2nnc(NCCCN3CCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5673,CHEMBL2022496,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5674,CHEMBL2022938,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,6309.57,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5675,CHEMBL2022497,O=C(Nc1ccc(-c2nnc(NCCCN3CCOCC3)o2)cc1)c1ccccc1F,IC50,nM,=,31622.78,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5676,CHEMBL2022939,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)c1ccccc1,IC50,nM,=,15848.93,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5677,CHEMBL2022940,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)c1ccccc1Cl,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5678,CHEMBL2022941,Cc1ccccc1C(=O)Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5679,CHEMBL2023916,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)c1cccc(F)c1,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5680,CHEMBL2021948,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)c1ccc(F)cc1,IC50,nM,=,10000.0,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5681,CHEMBL2023917,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)c1c(F)cccc1F,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5682,CHEMBL2023918,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)C1CCCC1,IC50,nM,=,25118.86,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5683,CHEMBL2023919,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)C1CCCCC1,IC50,nM,=,19952.62,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5684,CHEMBL2023920,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)C1CCCCCC1,IC50,nM,=,19952.62,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5685,CHEMBL2023921,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1F)c1ccccc1F,IC50,nM,=,6309.57,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5686,CHEMBL2023922,CCc1cc(-c2nnc(NCCCN3CCCCC3)o2)ccc1NC(=O)c1ccccc1F,IC50,nM,=,25118.86,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5687,CHEMBL2023923,Cc1cc(-c2nnc(NCCCN3CCCCC3)o2)ccc1NC(=O)c1ccccc1F,IC50,nM,=,15848.93,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5688,CHEMBL2023924,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)c(Cl)c1)c1ccccc1F,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5689,CHEMBL2023925,Cc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCCCC2)o1,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5690,CHEMBL2022495,COc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCCCC2)o1,IC50,nM,=,5011.87,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5691,CHEMBL2023926,COc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCOCC2)o1,IC50,nM,=,15848.93,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5692,CHEMBL2023927,CCOc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCCCC2)o1,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5693,CHEMBL2023928,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)c(F)c1)c1ccccc1F,IC50,nM,=,10000.0,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5694,CHEMBL2023929,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)c(C(F)(F)F)c1)c1ccccc1F,IC50,nM,=,5011.87,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5695,CHEMBL2023930,CCc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCCCC2)o1,IC50,nM,=,3981.07,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5696,CHEMBL2022495,COc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCCCC2)o1,IC50,nM,=,16982.44,Inhibition of human ERG by electrophysiology assay
5697,CHEMBL2022495,COc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCCCC2)o1,IC50,nM,=,5011.87,Binding affinity to human ERG
5698,CHEMBL2022495,COc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCN2CCCCC2)o1,IC50,nM,=,16982.44,Inhibition of human ERG by electrophysiology assay
5699,CHEMBL2022496,O=C(Nc1ccc(-c2nnc(NCCCN3CCCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5700,CHEMBL2022497,O=C(Nc1ccc(-c2nnc(NCCCN3CCOCC3)o2)cc1)c1ccccc1F,IC50,nM,=,31622.78,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5701,CHEMBL2022498,O=C(Nc1ccc(-c2nnc(NCCCN3CCCOCC3)o2)cc1)c1ccccc1F,IC50,nM,=,19952.62,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5702,CHEMBL2022499,O=C(Nc1ccc(-c2nnc(NCCCN3CCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5703,CHEMBL2022500,C[C@@H]1CC[C@@H](C)N1CCCNc1nnc(-c2ccc(NC(=O)c3ccccc3F)cc2)o1,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5704,CHEMBL2022501,CN1CCN(CCCNc2nnc(-c3ccc(NC(=O)c4ccccc4F)cc3)o2)CC1,IC50,nM,=,63095.73,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5705,CHEMBL2022502,O=C(Nc1ccc(-c2nnc(NCCCN3CCC(F)(F)CC3)o2)cc1)c1ccccc1F,IC50,nM,>,63095.73,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5706,CHEMBL2022503,O=C(Nc1ccc(-c2nnc(NCCCN3CCC(F)CC3)o2)cc1)c1ccccc1F,IC50,nM,=,7943.28,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5707,CHEMBL2022504,O=C(Nc1ccc(-c2nnc(NCCCN3C[C@@H]4CC[C@H]3C4)o2)cc1)c1ccccc1F,IC50,nM,=,6309.57,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5708,CHEMBL2021936,O=C(Nc1ccc(-c2nnc(NCCCN3CCN4CCC3CC4)o2)cc1)c1ccccc1F,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5709,CHEMBL2022729,O=C(Nc1ccc(-c2nnc(NCCCCN3CCOCC3)o2)cc1)c1ccccc1F,IC50,nM,=,63095.73,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5710,CHEMBL2022730,O=C(Nc1ccc(-c2nnc(NCCCCN3CCCOCC3)o2)cc1)c1ccccc1F,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5711,CHEMBL2022731,O=C(Nc1ccc(-c2nnc(NCCCCN3CCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5712,CHEMBL2022732,CCN(CC)CCCCNc1nnc(-c2ccc(NC(=O)c3ccccc3F)cc2)o1,IC50,nM,=,19952.62,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5713,CHEMBL2022733,O=C(Nc1ccc(-c2nnc(NCCCCN3CCCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,12589.25,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5714,CHEMBL2022734,O=C(Nc1ccc(-c2nnc(NCCCCN3CCCCC3)o2)cc1)c1ccccc1,IC50,nM,=,19952.62,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5715,CHEMBL2022735,O=C(Nc1ccc(-c2nnc(NCCCCN3CCCCC3)o2)cc1)C1CCCCC1,IC50,nM,=,25118.86,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5716,CHEMBL2022736,COc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCCN2CCCCC2)o1,IC50,nM,=,15848.93,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5717,CHEMBL2022737,O=C(Nc1ccc(-c2nnc(NCCCCN3CCCCC3)o2)c(Cl)c1)c1ccccc1F,IC50,nM,=,1995.26,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5718,CHEMBL2022738,COc1cc(NC(=O)c2ccccc2F)ccc1-c1nnc(NCCCCN2CCOCC2)o1,IC50,nM,>,63095.73,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5719,CHEMBL2022739,O=C(Nc1ccc(-c2nnc(NCCCCN3CCOCC3)o2)c(F)c1)c1ccccc1F,IC50,nM,=,39810.72,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5720,CHEMBL2022740,O=C(Nc1ccc(-c2nnc(NCCCCN3CCOCC3)o2)c(F)c1)c1ccccc1,IC50,nM,=,15848.93,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5721,CHEMBL2022741,O=C(Nc1ccc(-c2nnc(NCCCCN3CCC(F)CC3)o2)cc1)c1ccccc1F,IC50,nM,=,15848.93,Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay
5722,CHEMBL2022729,O=C(Nc1ccc(-c2nnc(NCCCCN3CCOCC3)o2)cc1)c1ccccc1F,IC50,nM,=,29512.09,Inhibition of human ERG
5723,CHEMBL2022733,O=C(Nc1ccc(-c2nnc(NCCCCN3CCCCC3)o2)cc1)c1ccccc1F,IC50,nM,=,12589.25,Inhibition of human ERG
5724,CHEMBL2022739,O=C(Nc1ccc(-c2nnc(NCCCCN3CCOCC3)o2)c(F)c1)c1ccccc1F,IC50,nM,=,18620.87,Inhibition of human ERG
5725,CHEMBL2024308,NS(=O)(=O)c1ccc(OCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5726,CHEMBL2024309,NS(=O)(=O)c1ccc(OCCN2CCCCC2)cc1,IC50,nM,=,24000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5727,CHEMBL2024310,CCOC(=O)C1CCN(CCOc2ccc(S(N)(=O)=O)cc2)CC1,IC50,nM,=,22900.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5728,CHEMBL2024311,NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,,,,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5729,CHEMBL2024378,NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,=,93200.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5730,CHEMBL2024379,CCOC(=O)C1CCN(CCCOc2ccc(S(N)(=O)=O)cc2)CC1,IC50,nM,=,76500.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5731,CHEMBL2024380,NS(=O)(=O)c1ccc(OCCCN2CCOCC2)cc1,IC50,,,,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5732,CHEMBL2024381,NS(=O)(=O)c1ccc(OCCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5733,CHEMBL2024382,NS(=O)(=O)c1ccc(OCCCCN2CCCCC2)cc1,IC50,nM,=,13600.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5734,CHEMBL2024383,CCOC(=O)C1CCN(CCCCOc2ccc(S(N)(=O)=O)cc2)CC1,IC50,nM,=,18800.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5735,CHEMBL2024384,CC(C)NC(=O)NS(=O)(=O)c1ccc(OCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5736,CHEMBL2024385,O=C(Nc1ccccc1)NS(=O)(=O)c1ccc(OCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5737,CHEMBL2024386,O=C(NC1CCCCC1)NS(=O)(=O)c1ccc(OCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5738,CHEMBL2024387,O=C(Nc1cc(Cl)ccc1Cl)NS(=O)(=O)c1ccc(OCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5739,CHEMBL2024388,O=C(Nc1ccc(C(F)(F)F)cc1)NS(=O)(=O)c1ccc(OCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5740,CHEMBL2024389,CC(C)NC(=O)NS(=O)(=O)c1ccc(OCCN2CCCCC2)cc1,IC50,nM,=,26100.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5741,CHEMBL2024390,O=C(Nc1ccccc1)NS(=O)(=O)c1ccc(OCCN2CCCCC2)cc1,IC50,nM,=,27600.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5742,CHEMBL2024391,O=C(NC1CCCCC1)NS(=O)(=O)c1ccc(OCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5743,CHEMBL2024392,O=C(Nc1cc(Cl)ccc1Cl)NS(=O)(=O)c1ccc(OCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5744,CHEMBL2024393,O=C(Nc1ccc(C(F)(F)F)cc1)NS(=O)(=O)c1ccc(OCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5745,CHEMBL2024394,CCOC(=O)C1CCN(CCOc2ccc(S(=O)(=O)NC(=O)Nc3ccccc3)cc2)CC1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5746,CHEMBL2024395,CC(C)NC(=O)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5747,CHEMBL2024396,O=C(Nc1ccccc1)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,,,,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5748,CHEMBL2024397,O=C(NC1CCCCC1)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5749,CHEMBL2024398,O=C(Nc1cc(Cl)ccc1Cl)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5750,CHEMBL2024399,O=C(Nc1ccc(C(F)(F)F)cc1)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5751,CHEMBL2024400,CC(C)NC(=O)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5752,CHEMBL2024401,O=C(Nc1ccccc1)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5753,CHEMBL2024402,O=C(NC1CCCCC1)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,,,,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5754,CHEMBL2021967,O=C(Nc1cc(Cl)ccc1Cl)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5755,CHEMBL2021968,O=C(Nc1ccc(C(F)(F)F)cc1)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5756,CHEMBL2021969,CCOC(=O)C1CCN(CCCOc2ccc(S(=O)(=O)NC(=O)Nc3ccccc3)cc2)CC1,IC50,nM,=,78700.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5757,CHEMBL2021970,CC(C)NC(=O)NS(=O)(=O)c1ccc(OCCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5758,CHEMBL2021971,O=C(Nc1ccccc1)NS(=O)(=O)c1ccc(OCCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5759,CHEMBL2021972,O=C(NC1CCCCC1)NS(=O)(=O)c1ccc(OCCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5760,CHEMBL2021973,O=C(Nc1cc(Cl)ccc1Cl)NS(=O)(=O)c1ccc(OCCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5761,CHEMBL2021974,O=C(Nc1ccc(C(F)(F)F)cc1)NS(=O)(=O)c1ccc(OCCCCN2CCCC2)cc1,IC50,nM,=,49100.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5762,CHEMBL2021975,CC(C)NC(=O)NS(=O)(=O)c1ccc(OCCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5763,CHEMBL2021976,O=C(Nc1ccccc1)NS(=O)(=O)c1ccc(OCCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5764,CHEMBL2021977,O=C(NC1CCCCC1)NS(=O)(=O)c1ccc(OCCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5765,CHEMBL2021978,O=C(Nc1cc(Cl)ccc1Cl)NS(=O)(=O)c1ccc(OCCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5766,CHEMBL2021979,O=C(Nc1ccc(C(F)(F)F)cc1)NS(=O)(=O)c1ccc(OCCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5767,CHEMBL2021980,CCOC(=O)C1CCN(CCCCOc2ccc(S(=O)(=O)NC(=O)Nc3ccccc3)cc2)CC1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5768,CHEMBL2021981,O=C(Nc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5769,CHEMBL2021982,CC(=O)c1ccc(NC(=O)NS(=O)(=O)c2ccc(OCCCN3CCCC3)cc2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5770,CHEMBL2021983,Cc1ccc(NC(=O)NS(=O)(=O)c2ccc(OCCCN3CCCC3)cc2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5771,CHEMBL2021984,O=C(Nc1cccc2ccccc12)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5772,CHEMBL2021985,CN(C)c1ccc(NC(=O)NS(=O)(=O)c2ccc(OCCCN3CCCC3)cc2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5773,CHEMBL2021986,O=C(NC(c1ccccc1)c1ccccc1)NS(=O)(=O)c1ccc(OCCCN2CCCC2)cc1,IC50,,,,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5774,CHEMBL2021987,O=C(Nc1ccccc1C(F)(F)F)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5775,CHEMBL2021988,O=C(Nc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,,,,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5776,CHEMBL2021989,COc1ccc(NC(=O)NS(=O)(=O)c2ccc(OCCCN3CCCCC3)cc2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5777,CHEMBL2021990,CC(=O)c1ccc(NC(=O)NS(=O)(=O)c2ccc(OCCCN3CCCCC3)cc2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5778,CHEMBL2021991,Cc1ccc(NC(=O)NS(=O)(=O)c2ccc(OCCCN3CCCCC3)cc2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5779,CHEMBL2021992,O=C(NC(c1ccccc1)c1ccccc1)NS(=O)(=O)c1ccc(OCCCN2CCCCC2)cc1,IC50,nM,>,100000.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells after 45 mins by scintillation counting method
5780,CHEMBL2022995,Cc1cccc(C(CC[C@H](N)C(=O)O)(c2ccccc2)c2ccccc2)c1,IC50,nM,>,25000.0,Inhibition of human ERG
5781,CHEMBL2022996,Cc1cccc(C(CC[C@@H](N)C(=O)O)(c2ccccc2)c2ccccc2)c1,IC50,nM,>,25000.0,Inhibition of human ERG
5782,CHEMBL2022997,Cc1cccc(C(CCCN)(c2ccccc2)c2ccccc2)c1,IC50,nM,=,6480.0,Inhibition of human ERG
5783,CHEMBL228814,Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1,IC50,nM,=,4810.0,Inhibition of human ERG
5784,CHEMBL1922270,C[C@H]1c2c([nH]c3ccc(C(F)(F)F)cc23)C[C@H]2CCN(CCCC3CCOCC3)C[C@@H]21,IC50,nM,=,30.0,Inhibition of human Erg expressed in HEK293 cells assessed as rubidium efflux after 4 hrs by atomic absorbance spectrometric analysis
5785,CHEMBL2032047,C[C@H]1c2c([nH]c3ccc(C(F)(F)F)cc23)C[C@H]2CCN(CCCC3(C(=O)O)CCOCC3)C[C@@H]21,IC50,nM,=,300.0,Inhibition of human Erg expressed in HEK293 cells assessed as rubidium efflux after 4 hrs by atomic absorbance spectrometric analysis
5786,CHEMBL2032048,C[C@H]1c2c([nH]c3ccc(C(F)(F)F)cc23)C[C@H]2CCN(CCC3(C(=O)O)CCOCC3)C[C@@H]21,IC50,nM,>,5000.0,Inhibition of human Erg expressed in HEK293 cells assessed as rubidium efflux after 4 hrs by atomic absorbance spectrometric analysis
5787,CHEMBL2032049,C[C@H]1c2c([nH]c3ccc(C(F)(F)F)cc23)C[C@H]2CCN(CCC3(C(=O)O)CCCCC3)C[C@@H]21,IC50,nM,>,5000.0,Inhibition of human Erg expressed in HEK293 cells assessed as rubidium efflux after 4 hrs by atomic absorbance spectrometric analysis
5788,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,56.0,Inhibition of human Erg expressed in HEK293 cells assessed as rubidium efflux after 4 hrs by atomic absorbance spectrometric analysis
5789,CHEMBL914,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,23000.0,Inhibition of human Erg expressed in HEK293 cells assessed as rubidium efflux after 4 hrs by atomic absorbance spectrometric analysis
5790,CHEMBL2029422,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,=,20000.0,Inhibition of human ERG by patch clamp assay
5791,CHEMBL2029572,O=C(N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)C1(O)CCN(c2cc(C(F)(F)F)ccn2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5792,CHEMBL2029571,N#Cc1ccnc(N2CCC(C(=O)N3CC[C@H](N[C@H]4CC[C@@](O)(c5ccc(-c6ncccn6)cn5)CC4)C3)CC2)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5793,CHEMBL2029570,O=C(C1CCN(c2cc(C(F)(F)F)ncn2)CC1)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5794,CHEMBL2029569,O=C(C1CCN(c2nccc(C(F)(F)F)n2)CC1)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1,IC50,nM,=,26000.0,Displacement of [3H]dofetilide from human ERG
5795,CHEMBL2029568,O=C(C1CCN(c2cc(C(F)(F)F)ccn2)CC1)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1,IC50,nM,=,28000.0,Displacement of [3H]dofetilide from human ERG
5796,CHEMBL2029567,O=C(C1CCN(c2cccc(C(F)(F)F)n2)CC1)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1,IC50,nM,=,10000.0,Displacement of [3H]dofetilide from human ERG
5797,CHEMBL2029566,O=C(C1CCN(c2cccc(C(F)(F)F)c2)CC1)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1,IC50,nM,=,9000.0,Displacement of [3H]dofetilide from human ERG
5798,CHEMBL2029424,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncco4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5799,CHEMBL2029423,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4nccs4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5800,CHEMBL2029422,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5801,CHEMBL2029421,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4cnccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5802,CHEMBL2029419,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ccncc4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,=,13000.0,Displacement of [3H]dofetilide from human ERG
5803,CHEMBL2029418,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4cccnc4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,=,30000.0,Displacement of [3H]dofetilide from human ERG
5804,CHEMBL2029412,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccccn3)CC2)C1)c1cccc(C(F)(F)F)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG
5805,CHEMBL2029417,Cc1ccc([C@]2(O)CC[C@H](N[C@H]3CCN(C(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)nc1,IC50,nM,=,24000.0,Displacement of [3H]dofetilide from human ERG
5806,CHEMBL2031868,CNC(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,29000.0,Inhibition of human ERG by IonWorks assay
5807,CHEMBL2031869,CCNC(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,16000.0,Inhibition of human ERG by IonWorks assay
5808,CHEMBL2031870,CC(C)NC(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,6200.0,Inhibition of human ERG by IonWorks assay
5809,CHEMBL2031871,O=C(NC1CC1)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,11000.0,Inhibition of human ERG by IonWorks assay
5810,CHEMBL2031872,O=C(NC1CCC1)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,2500.0,Inhibition of human ERG by IonWorks assay
5811,CHEMBL2031873,O=C(NC1CCCC1)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,8200.0,Inhibition of human ERG by IonWorks assay
5812,CHEMBL2031874,CN(C)C(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,11000.0,Inhibition of human ERG by IonWorks assay
5813,CHEMBL2031875,O=C(c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1)N1CCCC1,IC50,nM,=,8800.0,Inhibition of human ERG by IonWorks assay
5814,CHEMBL2031876,C[C@@H]1CCCN1C(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,10500.0,Inhibition of human ERG by IonWorks assay
5815,CHEMBL2031877,C[C@H]1CCCN1C(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1,IC50,nM,=,12000.0,Inhibition of human ERG by IonWorks assay
5816,CHEMBL2031878,O=C(c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)c(F)c1)N1CCCC1,IC50,nM,=,11300.0,Inhibition of human ERG by IonWorks assay
5817,CHEMBL2031879,O=C(c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1F)N1CCCC1,IC50,nM,=,8800.0,Inhibition of human ERG by IonWorks assay
5818,CHEMBL2031880,O=C(c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1Cl)N1CCCC1,IC50,nM,=,9300.0,Inhibition of human ERG by IonWorks assay
5819,CHEMBL2031881,CNC(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)c(F)c1,IC50,nM,=,3700.0,Inhibition of human ERG by IonWorks assay
5820,CHEMBL2031882,CN(C)C(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)c(F)c1,IC50,nM,=,32500.0,Inhibition of human ERG by IonWorks assay
5821,CHEMBL2031883,CNC(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCC[C@H]2C)C3=O)cc1,IC50,nM,=,17000.0,Inhibition of human ERG by IonWorks assay
5822,CHEMBL2031884,CCNC(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCC[C@H]2C)C3=O)cc1,IC50,nM,=,7400.0,Inhibition of human ERG by IonWorks assay
5823,CHEMBL2031885,C[C@@H]1CCCN1CCN1CCc2cc(-c3ccc(C(=O)N4CCCC4)cc3)ccc2C1=O,IC50,nM,=,9600.0,Inhibition of human ERG by IonWorks assay
5824,CHEMBL2031760,C[C@@H]1CCCN1CCN1CCc2cc(-c3ccc(F)cc3)ccc2C1=O,IC50,nM,=,300.0,Inhibition of human ERG by IonWorks assay
5825,CHEMBL2031762,C[C@@H]1CCCN1CCN1CCc2cc(-c3ccc(C#N)cc3)ccc2C1=O,IC50,nM,=,140.0,Inhibition of human ERG by IonWorks assay
5826,CHEMBL188,Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3,IC50,,,,Inhibition of human ERG
5827,CHEMBL244403,CCCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12,IC50,,,,Inhibition of human ERG
5828,CHEMBL1950351,CCS(=O)(=O)n1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(C1CCOCC1)CC2,IC50,nM,=,3100.0,Inhibition of human ERG
5829,CHEMBL2029718,CN(CCCC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CCC(C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5830,CHEMBL2029719,CCN(CCCC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CCC(C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5831,CHEMBL2029720,Cn1c2c(c3cc(C(=O)NCCCC(=O)NC4CC4)ccc31)CC(C1CCOCC1)CC2,IC50,nM,>,31000.0,Inhibition of human ERG
5832,CHEMBL2029721,CN(CC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CCC(C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5833,CHEMBL2029722,CCN(CC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CCC(C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5834,CHEMBL2029723,CN(CCC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CCC(C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5835,CHEMBL2029724,CNC(=O)CCCN(C)C(=O)c1ccc2c(c1)c1c(n2C)CCC(C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5836,CHEMBL2029725,CN(CC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5837,CHEMBL2029726,CN(CC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5838,CHEMBL2029727,CCN(CC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,,,,Inhibition of human ERG
5839,CHEMBL2029728,CCN(CC(=O)NC1CC1)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@H](C2CCOCC2)C1,IC50,,,,Inhibition of human ERG
5840,CHEMBL2029729,CNC(=O)CCCN(C)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,=,105000.0,Inhibition of human ERG
5841,CHEMBL2029730,CNC(=O)CCCN(C)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@H](C2CCOCC2)C1,IC50,,,,Inhibition of human ERG
5842,CHEMBL2029731,CCN(CC(=O)NCCF)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,,,,Inhibition of human ERG
5843,CHEMBL2029732,CN(CCCC(=O)NCCF)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,,,,Inhibition of human ERG
5844,CHEMBL2029733,CCN(CCCC(=O)NCCO)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5845,CHEMBL2029734,CN(CCCC(=O)NC1COC1)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5846,CHEMBL2029735,CN(C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1)[C@H](CO)CCC(=O)NCCF,IC50,nM,>,33000.0,Inhibition of human ERG
5847,CHEMBL2029736,CCNC(=O)CC[C@@H](CO)N(C)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5848,CHEMBL2029737,CNC(=O)CC[C@@H](CO)N(C)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5849,CHEMBL2029738,CN(CCCC(=O)NCCO)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5850,CHEMBL2029739,CN(CCCC(=O)NCC#N)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5851,CHEMBL2029899,CONC(=O)CCCN(C)C(=O)c1ccc2c(c1)c1c(n2C)CC[C@@H](C2CCOCC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG
5852,CHEMBL2030451,CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cc2)n1,IC50,nM,>,100000.0,Inhibition of human ERG by whole cell assay
5853,CHEMBL2030450,CS(=O)(=O)Cc1cc(N2CCOCC2)nc(NC(=O)c2ccno2)n1,IC50,nM,>,33000.0,Inhibition of human ERG by whole cell assay
5854,CHEMBL2030449,CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc(NS(C)(=O)=O)cc2)n1,IC50,nM,>,29000.0,Inhibition of human ERG by whole cell assay
5855,CHEMBL2030448,CS(=O)(=O)Cc1cc(N2CC3CCC(C2)O3)nc(-c2ccc3[nH]ccc3c2)n1,IC50,nM,>,32000.0,Inhibition of human ERG by whole cell assay
5856,CHEMBL2030446,C[C@H]1COCCN1c1cc(CS(C)(=O)=O)nc(-c2ccc3[nH]ccc3c2)n1,IC50,nM,>,32000.0,Inhibition of human ERG by whole cell assay
5857,CHEMBL2029359,CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2cnc3[nH]ccc3c2)n1,IC50,nM,>,32000.0,Inhibition of human ERG by whole cell assay
5858,CHEMBL2030445,CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc3[nH]cnc3c2)n1,IC50,nM,>,32000.0,Inhibition of human ERG by whole cell assay
5859,CHEMBL2030442,CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2cccc3[nH]ccc23)n1,IC50,nM,>,33000.0,Inhibition of human ERG by whole cell assay
5860,CHEMBL2030436,CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc3[nH]ccc3c2)n1,IC50,nM,>,32000.0,Inhibition of human ERG by whole cell assay
5861,CHEMBL1312643,O=S(=O)(Cc1cc(N2CCOCC2)nc(-c2ccccn2)n1)c1ccccc1,IC50,nM,>,32000.0,Inhibition of human ERG by whole cell assay
5862,CHEMBL2030402,O=c1[nH]c([C@@H]2CCCN2)nc2c1oc1ccc(Cl)cc12,IC50,nM,>,30000.0,Inhibition of human Erg
5863,CHEMBL2031465,Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O,IC50,nM,>,100000.0,Inhibition of human ERG
5864,CHEMBL2031477,O=C1CC2CCc3cc(OC4CCN(C5CCC5)CC4)ccc3C2=NN1,IC50,nM,=,18000.0,Inhibition of human ERG by patch clamp assay
5865,CHEMBL2031958,COc1cc(CN2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(OC)c1OC,IC50,nM,=,400.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5866,CHEMBL2031959,COc1cc(CN2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(OC)c1O,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5867,CHEMBL2031960,COc1cc(C(=O)N2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(OC)c1O,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5868,CHEMBL2031961,CC(C)(C)c1cc(CN2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(C(C)(C)C)c1O,IC50,nM,=,100.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5869,CHEMBL2031962,CC(C)(C)c1cc(C(=O)N2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(C(C)(C)C)c1O,IC50,nM,=,250.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5870,CHEMBL2031963,CC(C)(C)c1cc(CN2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(C(C)(C)C)c1O,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5871,CHEMBL2031964,CC(C)(C)c1cc(C(=O)N2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(C(C)(C)C)c1O,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5872,CHEMBL2031965,COc1c(C(C)(C)C)cc(CN2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1C(C)(C)C,IC50,nM,=,100.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5873,CHEMBL2031966,COc1c(C(C)(C)C)cc(C(=O)N2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1C(C)(C)C,IC50,nM,=,660.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5874,CHEMBL2031967,COc1c(C(C)(C)C)cc(CN2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1C(C)(C)C,IC50,nM,=,130.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5875,CHEMBL2031968,COc1c(C(C)(C)C)cc(C(=O)N2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1C(C)(C)C,IC50,nM,=,9000.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5876,CHEMBL2031969,CC(C)(C)c1cc(CN2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(C(C)(C)C)c1,IC50,nM,=,100.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5877,CHEMBL2031970,CC(C)(C)c1cc(C(=O)N2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(C(C)(C)C)c1,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5878,CHEMBL2031971,Fc1ccc(C(CCCCCN2CCN(Cc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)c2ccc(F)cc2)cc1,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5879,CHEMBL2031972,O=C(CCCCC(c1ccc(F)cc1)c1ccc(F)cc1)N1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC1,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5880,CHEMBL2031973,COc1c(C(C)(C)C)cc(C(=O)N2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)[C@@H](C)C2)cc1C(C)(C)C,IC50,nM,=,900.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5881,CHEMBL2031974,COc1c(C(C)(C)C)cc(C(=O)N2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C[C@@H]2C)cc1C(C)(C)C,IC50,nM,=,4900.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5882,CHEMBL2031975,CC(C)(C)c1ccc(C(=O)NCC2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc1,IC50,nM,=,820.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5883,CHEMBL2031976,CC(C)(C)c1cc(C(=O)NCC2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(C(C)(C)C)c1,IC50,nM,=,2800.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5884,CHEMBL2031977,COc1c(C(C)(C)C)cc(C(=O)NCC2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc1C(C)(C)C,IC50,nM,=,1900.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5885,CHEMBL2031978,O=C(NCC1CCN(C(=O)CCCCC(c2ccc(F)cc2)c2ccc(F)cc2)C1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,nM,=,700.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5886,CHEMBL2031979,O=C(NCC1CCN(C(=O)CCCCC(c2ccc(F)cc2)c2ccc(F)cc2)C1)c1cc(F)cc(C(F)(F)F)c1,IC50,,,,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5887,CHEMBL2031980,COc1c(C(C)(C)C)cc(C(=O)NCC2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc1C(C)(C)C,IC50,nM,=,100.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5888,CHEMBL2031981,COc1cc(C(=O)NCC2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(OC)c1OC,IC50,nM,=,100.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5889,CHEMBL2031982,O=C(NCC1CCN(CCCCCC(c2ccc(F)cc2)c2ccc(F)cc2)C1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,nM,=,100.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5890,CHEMBL2031983,COc1cc(CNCC2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(OC)c1OC,IC50,nM,=,40.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5891,CHEMBL2031984,CC(C)(C)c1cc(CNCC2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(C(C)(C)C)c1O,IC50,nM,=,870.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5892,CHEMBL2031985,CC(C)(C)c1cc(CNCC2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(C(C)(C)C)c1,IC50,nM,=,460.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5893,CHEMBL2031986,CC(C)(C)c1cc(C(=O)NC[C@H]2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(C(C)(C)C)c1,IC50,nM,=,5000.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5894,CHEMBL2031987,CC(C)(C)c1cc(C(=O)NC[C@@H]2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(C(C)(C)C)c1,IC50,nM,=,2000.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5895,CHEMBL2031988,COc1c(C(C)(C)C)cc(C(=O)NC[C@H]2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc1C(C)(C)C,IC50,nM,=,5000.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5896,CHEMBL2031989,COc1c(C(C)(C)C)cc(C(=O)NC[C@@H]2CCN(C(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc1C(C)(C)C,IC50,nM,=,2000.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5897,CHEMBL2031990,O=C(NC[C@H]1CCN(C(=O)CCCCC(c2ccc(F)cc2)c2ccc(F)cc2)C1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,nM,=,750.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5898,CHEMBL2031991,O=C(NC[C@@H]1CCN(C(=O)CCCCC(c2ccc(F)cc2)c2ccc(F)cc2)C1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,nM,=,800.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5899,CHEMBL2031996,COc1cc(C(=O)N2CCC(CNC(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(OC)c1OC,IC50,nM,=,750.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5900,CHEMBL2031997,COc1c(C(C)(C)C)cc(C(=O)N2CCC(CNC(=O)CCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc1C(C)(C)C,IC50,nM,=,650.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5901,CHEMBL2031998,COc1cc(CN2CCC(CNCCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(OC)c1OC,IC50,nM,=,100.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5902,CHEMBL2031999,CC(C)(C)c1cc(CN2CCC(CNCCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc(C(C)(C)C)c1O,IC50,nM,=,10.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5903,CHEMBL2032000,COc1c(C(C)(C)C)cc(CN2CCC(CNCCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)C2)cc1C(C)(C)C,IC50,nM,=,110.0,Inhibition of human Erg expressed in HEK293 cells by whole cell patch clamp analysis
5904,CHEMBL2036784,CN1CCN(C)C(C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,13000.0,Inhibition of human ERG
5905,CHEMBL2036783,CN1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,20000.0,Inhibition of human ERG
5906,CHEMBL2036782,CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,17000.0,Inhibition of human ERG
5907,CHEMBL2036781,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(C(=O)[C@H]2CN(C3CC3)CCN2)CC1,IC50,nM,=,19000.0,Inhibition of human ERG
5908,CHEMBL2036780,CCN1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,10000.0,Inhibition of human ERG
5909,CHEMBL2036779,CCN1CCOC(C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,5000.0,Inhibition of human ERG
5910,CHEMBL2036778,CCN1CCC[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,5000.0,Inhibition of human ERG
5911,CHEMBL2036777,CC(C)N1CCN[C@@H](CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,5600.0,Inhibition of human ERG
5912,CHEMBL2036776,CCN1CCNC(CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,8900.0,Inhibition of human ERG
5913,CHEMBL2036775,CC(C)N1CCO[C@@H](CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,6300.0,Inhibition of human ERG
5914,CHEMBL2036774,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(C[C@H]2CN(C3CC3)CCO2)CC1,IC50,nM,=,16000.0,Inhibition of human ERG
5915,CHEMBL2036773,CCN1CCO[C@@H](CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,7900.0,Inhibition of human ERG
5916,CHEMBL2036772,O=C(Nc1ccccc1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,,,,Inhibition of human ERG
5917,CHEMBL2036771,CS(=O)(=O)c1cccc(NC(=O)N2CCN(C[C@@H]3CCCN(C4CC4)C3)CC2)c1,IC50,,,,Inhibition of human ERG
5918,CHEMBL2036770,O=C(Nc1ccccc1Cl)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,,,,Inhibition of human ERG
5919,CHEMBL2036769,N#Cc1ccc(NC(=O)N2CCN(C[C@@H]3CCCN(C4CC4)C3)CC2)cc1,IC50,,,,Inhibition of human ERG
5920,CHEMBL2036768,N#Cc1cccc(NC(=O)N2CCN(C[C@@H]3CCCN(C4CC4)C3)CC2)c1,IC50,,,,Inhibition of human ERG
5921,CHEMBL2036767,O=C(Nc1ccc(C(F)(F)F)cc1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,6300.0,Inhibition of human ERG
5922,CHEMBL2036766,O=C(Nc1cccc(C(F)(F)F)c1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,13000.0,Inhibition of human ERG
5923,CHEMBL2036765,COc1ccc(NC(=O)N2CCN(C[C@@H]3CCCN(C4CC4)C3)CC2)cc1,IC50,,,,Inhibition of human ERG
5924,CHEMBL2036764,O=C(Nc1ccc(Br)cc1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,7100.0,Inhibition of human ERG
5925,CHEMBL2036763,O=C(Nc1cccc(Cl)c1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,28000.0,Inhibition of human ERG
5926,CHEMBL2035000,O=C(Nc1ccc(Cl)cc1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,14000.0,Inhibition of human ERG
5927,CHEMBL2036762,Cc1ccc(NC(=O)N2CCN(C[C@@H]3CCCN(C4CC4)C3)CC2)cc1Cl,IC50,nM,=,7100.0,Inhibition of human ERG
5928,CHEMBL2036761,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,6300.0,Inhibition of human ERG
5929,CHEMBL2036760,O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,890.0,Inhibition of human ERG
5930,CHEMBL2036759,O=C(Nc1ccc(F)c(Cl)c1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,14000.0,Inhibition of human ERG
5931,CHEMBL2036758,CC(C)N1CCC[C@@H](CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,1300.0,Inhibition of human ERG
5932,CHEMBL2036757,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(C[C@@H]2CCCN(C3CC3)C2)CC1,IC50,nM,=,2000.0,Inhibition of human ERG
5933,CHEMBL2036756,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(C[C@@H]2CCCN(CCCc3ccccc3)C2)CC1,IC50,nM,=,400.0,Inhibition of human ERG
5934,CHEMBL2036755,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(C[C@@H]2CCCN(CCc3ccccc3)C2)CC1,IC50,nM,<,300.0,Inhibition of human ERG
5935,CHEMBL2036754,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(C[C@@H]2CCCN(CC3CC3)C2)CC1,IC50,nM,=,930.0,Inhibition of human ERG
5936,CHEMBL2036753,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(C[C@@H]2CCCN(Cc3ccccc3)C2)CC1,IC50,nM,=,560.0,Inhibition of human ERG
5937,CHEMBL2036752,CCN1CCC[C@H](CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,,,,Inhibition of human ERG
5938,CHEMBL2036751,CCN1CCC[C@@H](CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,2100.0,Inhibition of human ERG
5939,CHEMBL2036750,CCN1CCCC(CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,4300.0,Inhibition of human ERG
5940,CHEMBL2036749,O=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(CC2CCCNC2)CC1,IC50,nM,=,1600.0,Inhibition of human ERG
5941,CHEMBL2036748,CN1CCCC(CN2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,1600.0,Inhibition of human ERG
5942,CHEMBL2036782,CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,60000.0,Inhibition of human ERG by electrophysiology assay
5943,CHEMBL2036268,CN[C@H]1CC[C@@H](c2c[nH]c3ccc(NC(=N)c4cccs4)cc32)CC1.Cl,IC50,nM,=,39000.0,Displacement of [3H]astemizole from human Erg expressed in HEK293 cells after 75 mins
5944,CHEMBL2036270,CCN[C@H]1CC[C@@H](c2c[nH]c3ccc(NC(=N)c4cccs4)cc32)CC1.Cl,IC50,nM,=,23000.0,Displacement of [3H]astemizole from human Erg expressed in HEK293 cells after 75 mins
5945,CHEMBL2036273,CNC1CCCC(c2c[nH]c3ccc(NC(=N)c4cccs4)cc23)C1.Cl,IC50,nM,=,33000.0,Displacement of [3H]astemizole from human Erg expressed in HEK293 cells after 75 mins
5946,CHEMBL2036275,CCN[C@H]1CCC[C@@H](c2c[nH]c3ccc(NC(=N)c4cccs4)cc23)C1.Cl,IC50,nM,=,16300.0,Displacement of [3H]astemizole from human Erg expressed in HEK293 cells after 75 mins
5947,CHEMBL1770317,CC(C)C1(c2ccc(-c3ccc4ccccc4c3)[nH]c2=O)OC(=O)NC1=O,IC50,nM,>,50118.72,Inhibition of human ERG
5948,CHEMBL1813065,C[C@@H]1CCCN1CCCOc1ccc(-c2cn[nH]c(=O)c2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG by patch clamp assay
5949,CHEMBL2035184,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2csc(c2)COC/1,IC50,,,,Displacement of dofetilide from human ERG
5950,CHEMBL2035186,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2coc(c2)COC/1,IC50,,,,Displacement of dofetilide from human ERG
5951,CHEMBL2035052,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccnc(c2)OCC/1,IC50,nM,=,2400.0,Displacement of dofetilide from human ERG
5952,CHEMBL2035183,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(s2)COC/1,IC50,nM,=,7200.0,Displacement of dofetilide from human ERG
5953,CHEMBL2035185,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1,IC50,nM,>,10000.0,Displacement of dofetilide from human ERG
5954,CHEMBL2036730,O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cc2)CC1,IC50,nM,>,30000.0,Inhibition of human Erg
5955,CHEMBL2042691,O=C(O)c1cc(CN2CCN(c3ccc(Br)cc3)CC2)c2ccccn2c1=O,IC50,nM,=,2100.0,Inhibition of human ERG
5956,CHEMBL2042692,O=C(O)c1cc(CN2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2ccccn2c1=O,IC50,nM,=,100.0,Inhibition of human ERG
5957,CHEMBL1683351,N#Cc1ccc(N2CCN(Cc3cc(C(=O)O)c(=O)n4ccccc34)CC2)cc1,IC50,nM,=,7400.0,Inhibition of human ERG
5958,CHEMBL531475,COc1ccc(-c2cc(-c3ccc(S(C)(=O)=O)cc3)cnc2N)cn1,IC50,nM,=,3000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
5959,CHEMBL2041980,CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)c2)cc1,IC50,nM,=,4700.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
5960,CHEMBL2042163,COCC1=C(C(=O)N2CCC[C@H]2c2cc(C)no2)[C@@H](c2cc3ccccc3n2C)n2nc(C(F)(F)F)cc2N1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
5961,CHEMBL2042321,CC(C)(C)Oc1cccc2nc(N)nc(N)c12,IC50,nM,=,20200.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
5962,CHEMBL2043004,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccccc3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,220.0,Binding affinity to human Erg
5963,CHEMBL2043010,COc1cc(N2C(=O)N(c3ccc(-c4ccccc4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3C(=O)O)ncn1,IC50,nM,>,30000.0,Binding affinity to human Erg
5964,CHEMBL2043011,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccc(C(=O)O)cc3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,>,30000.0,Binding affinity to human Erg
5965,CHEMBL2043168,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,6400.0,Binding affinity to human Erg
5966,CHEMBL2043169,COc1cc(N2C(=O)N(c3ccc(-c4cccc(C(=O)O)c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,7000.0,Binding affinity to human Erg
5967,CHEMBL2043170,COc1cc(N2C(=O)N(c3ccc(-c4ccccc4C(=O)O)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,2400.0,Binding affinity to human Erg
5968,CHEMBL2043171,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4Cl)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,>,60000.0,Binding affinity to human Erg
5969,CHEMBL2043172,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)c(Cl)c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,5700.0,Binding affinity to human Erg
5970,CHEMBL2043324,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4F)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,54000.0,Binding affinity to human Erg
5971,CHEMBL2043325,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4C)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,13000.0,Binding affinity to human Erg
5972,CHEMBL2043326,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)c(C)c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,23000.0,Binding affinity to human Erg
5973,CHEMBL2043327,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(C3CCCCC3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,1000.0,Binding affinity to human Erg
5974,CHEMBL2043328,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(N3CCC3=O)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,27000.0,Binding affinity to human Erg
5975,CHEMBL2040894,COCc1nc(-c2ccc(N3C(=O)N(c4cc(O)ncn4)C4(CCN(Cc5ncccc5C)CC4)C3=O)cc2)no1,IC50,nM,=,7700.0,Binding affinity to human Erg
5976,CHEMBL2040895,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-n3cccn3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,9000.0,Binding affinity to human Erg
5977,CHEMBL2040896,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccno3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,22000.0,Binding affinity to human Erg
5978,CHEMBL2040897,Cc1nc(C)c(-c2ccc(N3C(=O)N(c4cc(O)ncn4)C4(CCN(Cc5ncccc5C)CC4)C3=O)cc2)s1,IC50,nM,=,950.0,Binding affinity to human Erg
5979,CHEMBL2041010,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)s4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,12000.0,Binding affinity to human Erg
5980,CHEMBL2041164,COc1cc(N2C(=O)N(c3ccc(-c4csc(C(=O)O)c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,8000.0,Binding affinity to human Erg
5981,CHEMBL2041165,COc1cc(N2C(=O)N(c3ccc(-c4coc(C(=O)O)c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,>,60000.0,Binding affinity to human Erg
5982,CHEMBL2041166,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3cncnc3)cc1)C(=O)N2c1cc(O)ncn1,IC50,,,,Binding affinity to human Erg
5983,CHEMBL2041167,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3cnc(O)nc3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,>,60000.0,Binding affinity to human Erg
5984,CHEMBL2041168,COc1cc(N2C(=O)N(c3ccc(-c4ccc(-c5ccn[nH]5)cc4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,2000.0,Binding affinity to human Erg
5985,CHEMBL2041169,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccc(-c4ccn[nH]4)cc3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,8100.0,Binding affinity to human Erg
5986,CHEMBL2041170,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccc(N4CCOCC4)cc3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,13000.0,Binding affinity to human Erg
5987,CHEMBL2041171,COc1cc(N2C(=O)N(c3ccc(-c4ccc(-c5cc(=O)[nH][nH]5)cc4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,17000.0,Binding affinity to human Erg
5988,CHEMBL2041172,COc1cc(N2C(=O)N(c3ccc(-c4ccc5cn[nH]c5c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,720.0,Binding affinity to human Erg
5989,CHEMBL2041173,COc1cc(N2C(=O)N(c3ccc(-c4ccc5[nH]ncc5c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,4700.0,Binding affinity to human Erg
5990,CHEMBL2041174,COc1cc(N2C(=O)N(c3ccc(-c4ccc5nc[nH]c5c4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,15000.0,Binding affinity to human Erg
5991,CHEMBL2041175,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccc4scnc4c3)cc1)C(=O)N2c1cc(O)ncn1,IC50,nM,=,1500.0,Binding affinity to human Erg
5992,CHEMBL2041176,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C#N)cc4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,370.0,Binding affinity to human Erg
5993,CHEMBL2041177,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(N)=O)cc4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,650.0,Binding affinity to human Erg
5994,CHEMBL2041178,CNC(=O)c1ccc(-c2ccc(N3C(=O)N(c4cc(OC)ncn4)C4(CCN(Cc5ncccc5C)CC4)C3=O)cc2)cc1,IC50,nM,=,8500.0,Binding affinity to human Erg
5995,CHEMBL2041179,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)N(C)C)cc4)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,8900.0,Binding affinity to human Erg
5996,CHEMBL2041180,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4)nc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,46000.0,Binding affinity to human Erg
5997,CHEMBL2041181,COc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4C)nc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,7100.0,Binding affinity to human Erg
5998,CHEMBL2040854,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3cc(O)ncn3)C3(CCN(Cc4ncccc4C)CC3)C2=O)cn1,IC50,nM,=,20000.0,Binding affinity to human Erg
5999,CHEMBL2041182,Cc1cc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4C)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)ncn1,IC50,nM,=,38000.0,Binding affinity to human Erg
6000,CHEMBL2041183,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3cc(C(F)(F)F)ncn3)C3(CCN(Cc4ncccc4C)CC3)C2=O)cc1,IC50,nM,=,21000.0,Binding affinity to human Erg
6001,CHEMBL2041184,Cc1nccc(N2C(=O)N(c3ccc(-c4ccc(C(=O)O)cc4C)cc3)C(=O)C23CCN(Cc2ncccc2C)CC3)n1,IC50,nM,=,22000.0,Binding affinity to human Erg
6002,CHEMBL2041185,COc1nccnc1N1C(=O)N(c2ccc(-c3ccc(C(=O)O)cc3C)cc2)C(=O)C12CCN(Cc1ncccc1C)CC2,IC50,nM,=,1400.0,Binding affinity to human Erg
6003,CHEMBL2041186,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3nccnc3C)C3(CCN(Cc4ncccc4C)CC3)C2=O)cc1,IC50,nM,=,7800.0,Binding affinity to human Erg
6004,CHEMBL2041187,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccc(C(=O)O)cc3)cc1)C(=O)N2c1ncccn1,IC50,nM,=,19000.0,Binding affinity to human Erg
6005,CHEMBL2041188,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3ncccn3)C3(CCN(Cc4ncccc4C)CC3)C2=O)cc1,IC50,nM,=,23000.0,Binding affinity to human Erg
6006,CHEMBL2041189,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccc(C(=O)O)cc3)cc1)C(=O)N2c1cnccn1,IC50,nM,=,16000.0,Binding affinity to human Erg
6007,CHEMBL2041190,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3cnccn3)C3(CCN(Cc4ncccc4C)CC3)C2=O)cc1,IC50,nM,=,7200.0,Binding affinity to human Erg
6008,CHEMBL2041191,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3cnccn3)C3(CCN(Cc4ncccc4C)CC3)C2=O)cn1,IC50,nM,=,2500.0,Binding affinity to human Erg
6009,CHEMBL2041192,Cc1cccnc1CN1CCC2(CC1)C(=O)N(c1ccc(-c3ccc(C(=O)O)cc3)cc1)C(=O)N2c1ccncn1,IC50,nM,=,31000.0,Binding affinity to human Erg
6010,CHEMBL2041193,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3ccncn3)C3(CCN(Cc4ncccc4C)CC3)C2=O)cc1,IC50,nM,=,22000.0,Binding affinity to human Erg
6011,CHEMBL2048865,N[C@@H]1CCCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6012,CHEMBL2048866,N[C@@H]1CCCN(c2c(Cl)cccc2/C=C2\SC(=O)NC2=O)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6013,CHEMBL2048867,N[C@@H]1CCCN(c2c(Br)cccc2/C=C2\SC(=O)NC2=O)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6014,CHEMBL2048868,COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6015,CHEMBL2048869,CCOc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6016,CHEMBL2048870,CC(C)COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,nM,=,23000.0,Inhibition of human ERG
6017,CHEMBL2048871,CC(C)Oc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6018,CHEMBL2048872,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6019,CHEMBL2048873,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccncc2)C1,IC50,nM,>,30000.0,Inhibition of human ERG
6020,CHEMBL2046888,c1ccc(CCNCCC(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,2790.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6021,CHEMBL2046889,c1ccc(CCCNCCC(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,17.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6022,CHEMBL2046890,c1ccc(CCNCCN(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,62.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6023,CHEMBL2046891,c1ccc(CCCNCCN(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,580.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6024,CHEMBL2046892,Fc1ccc(N(CCNCCc2ccccc2)c2ccc(F)cc2)cc1,IC50,nM,=,44.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6025,CHEMBL2046893,Fc1ccc(N(CCNCCCc2ccccc2)c2ccc(F)cc2)cc1,IC50,nM,=,2.4,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6026,CHEMBL2046894,O=C(Cc1ccccc1)NCCN(c1ccccc1)c1ccccc1,IC50,nM,=,7860.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6027,CHEMBL2046895,O=C(CCc1ccccc1)NCCN(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,=,192.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6028,CHEMBL2046888,c1ccc(CCNCCC(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,3162.28,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6029,CHEMBL2046889,c1ccc(CCCNCCC(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,15.85,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6030,CHEMBL2046890,c1ccc(CCNCCN(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,63.1,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6031,CHEMBL2046891,c1ccc(CCCNCCN(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,630.96,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6032,CHEMBL2046892,Fc1ccc(N(CCNCCc2ccccc2)c2ccc(F)cc2)cc1,IC50,nM,=,39.81,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6033,CHEMBL2046893,Fc1ccc(N(CCNCCCc2ccccc2)c2ccc(F)cc2)cc1,IC50,nM,=,2.512,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6034,CHEMBL2046894,O=C(Cc1ccccc1)NCCN(c1ccccc1)c1ccccc1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6035,CHEMBL2046895,O=C(CCc1ccccc1)NCCN(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,=,199.53,Inhibition of human ERG expressed in HEK cells by patch clamp assay
6036,CHEMBL2047521,O=C(Nc1cnc(Cl)nc1)c1ccc(F)c(F)c1,IC50,nM,>,30000.0,Inhibition of human ERG
6037,CHEMBL2048028,CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1,IC50,nM,>,20000.0,Inhibition of human ERG
6038,CHEMBL2048293,N#Cc1cc(OC(F)(F)F)cc(-c2nc(-c3ccc4c(c3)cc3n4CCC3CC(=O)O)no2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by astemizole assay
6039,CHEMBL2048293,N#Cc1cc(OC(F)(F)F)cc(-c2nc(-c3ccc4c(c3)cc3n4CCC3CC(=O)O)no2)c1,IC50,nM,>,400000.0,Inhibition of human ERG by patch clamp assay
6040,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,1100.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6041,CHEMBL2059323,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cc(F)ccc32)CC1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6042,CHEMBL2059304,O=c1[nH]c2ccccc2n1C1CCN(CCOc2ccccc2)CC1,IC50,nM,=,2100.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6043,CHEMBL2059318,O=C1CCc2cc(F)ccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,3400.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6044,CHEMBL2059324,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3c(F)cccc32)CC1,IC50,nM,=,3400.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6045,CHEMBL2059305,O=C1CCc2ccccc2N1CCCN1CCC(c2ccc3[nH]ccc3c2)CC1,IC50,nM,=,4400.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6046,CHEMBL2059322,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccc(F)cc32)CC1,IC50,nM,=,4400.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6047,CHEMBL2059317,O=C1CCc2c(F)cccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,5300.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6048,CHEMBL2059319,O=C1CCc2ccc(F)cc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,5700.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6049,CHEMBL2059310,O=C1CCc2cccnc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,6300.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6050,CHEMBL2059321,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cccc(F)c32)CC1,IC50,nM,=,6300.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6051,CHEMBL2059311,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,6600.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6052,CHEMBL2059306,O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,7300.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6053,CHEMBL2059320,O=C1CCc2cccc(F)c2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,7900.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6054,CHEMBL2059312,O=C1CCc2ccccc2N1OCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,=,9300.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6055,CHEMBL2059313,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cccnc32)CC1,IC50,nM,=,13000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6056,CHEMBL1242923,O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1,IC50,nM,=,20000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6057,CHEMBL2059316,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ncccc32)CC1,IC50,nM,=,22000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6058,CHEMBL2059315,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cnccc32)CC1,IC50,nM,=,46000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6059,CHEMBL2059307,O=C1CCc2ncccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,>,50000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6060,CHEMBL2059308,O=C1CCc2cnccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,>,50000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6061,CHEMBL2059309,O=C1CCc2ccncc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,IC50,nM,>,50000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6062,CHEMBL2059314,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccncc32)CC1,IC50,nM,>,50000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6063,CHEMBL667,CC(=O)OCC[N+](C)(C)C,IC50,,,,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay
6064,CHEMBL2057795,CCN1CCN(c2nc(C)nc3sc(-c4ccccc4)cc23)CC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human Erg expressed in human HEK293 cells
6065,CHEMBL2058172,COCCNC(=O)c1nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn2c1C,IC50,nM,>,30000.0,Inhibition of human ERG by Herg fluorescence polarization assay
6066,CHEMBL2059066,CC1(C)NCCn2c1nc(-c1ccc(F)cc1)c2Nc1ccc(F)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6067,CHEMBL2058844,Cc1ccc(Nc2c(-c3ccc(F)cc3)nc3n2CCNC3(C)C)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6068,CHEMBL2058843,CC1(C)NC(=O)Cn2c1nc(-c1ccc(F)cc1)c2Nc1ccc(F)c(Cl)c1,IC50,nM,>,30000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6069,CHEMBL2058842,Cc1ccc(Nc2c(-c3ccc(F)cc3)nc3n2CC(=O)NC3(C)C)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6070,CHEMBL2058841,Cc1ccc(Nc2c(-c3ccc(F)cc3)nc3n2CC(=O)NC3)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6071,CHEMBL2058840,Cc1ccc(Nc2c(-c3ccc(F)cc3)nc3n2CCNC3)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6072,CHEMBL2058838,Cc1ccc(Nc2c(-c3ccc(F)cc3)nc3n2CCN(C(=O)C(C)(C)N)C3(C)C)cc1,IC50,nM,>,30000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6073,CHEMBL2058837,CC(C)(N)C(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)cc2)C1(C)C,IC50,nM,=,21900.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6074,CHEMBL1800137,CC(C)(N)C(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)cc2)C1,IC50,nM,=,5600.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6075,CHEMBL2057225,CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(F)c(F)c3)n2CCN1C(=O)CN,IC50,nM,>,30000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6076,CHEMBL2058833,CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(F)cc3)n2CCN1C(=O)CN,IC50,nM,=,13400.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6077,CHEMBL2058831,CC(C)[C@@H]1c2nc(-c3ccc(F)cc3)c(Nc3ccc(F)c(Cl)c3)n2CCN1C(=O)CN,IC50,nM,=,13400.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6078,CHEMBL1800836,NCC(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)cc2)C1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6079,CHEMBL2063167,CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)N(C)C1=O,IC50,nM,>,24000.0,Inhibition of human ERG expressed in HEK293 cells coexpressing Kir2.3 after 30 mins by FluxOR based FLIPR assay
6080,CHEMBL2063168,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)N(C)C1=O,IC50,nM,>,23400.0,Inhibition of human ERG expressed in HEK293 cells coexpressing Kir2.3 after 30 mins by FluxOR based FLIPR assay
6081,CHEMBL2063169,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)N(C)C1=O,IC50,nM,>,22700.0,Inhibition of human ERG expressed in HEK293 cells coexpressing Kir2.3 after 30 mins by FluxOR based FLIPR assay
6082,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,8.0,Inhibition of human ERG expressed in HEK293 cells coexpressing Kir2.3 after 30 mins by FluxOR based FLIPR assay
6083,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,230.0,Inhibition of human ERG expressed in HEK293 cells coexpressing Kir2.3 after 30 mins by FluxOR based FLIPR assay
6084,CHEMBL2062563,CC(=O)Nc1ccc2ccn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1,IC50,nM,=,8600.0,Inhibition of human Erg
6085,CHEMBL2062564,CC(=O)Nc1ccc2cnn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1,IC50,nM,>,33000.0,Inhibition of human Erg
6086,CHEMBL2062566,CC(=O)Nc1ccc2c(c1)N(c1cc(NC3CC3)n3ncc(C#N)c3n1)CC2,IC50,nM,>,33000.0,Inhibition of human Erg
6087,CHEMBL1642258,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(=O)N(C)C)CC2,IC50,nM,=,3900.0,Inhibition of human ERG by patch clamp assay
6088,CHEMBL2070735,Cc1nc(N)c2nnn(C[C@H]3CN(Cc4nccs4)CCO3)c2n1,IC50,nM,>,100000.0,Inhibition of human ERG
6089,CHEMBL2069397,O=C1CC(c2nc(-c3cccc(Cl)c3)no2)CN1c1ccc(F)cc1,IC50,nM,=,4000.0,Inhibition of human ERG by patch clamp assay
6090,CHEMBL2069398,Cc1cccc(-c2noc(C3CC(=O)N(c4ccc(F)cc4)C3)n2)c1,IC50,nM,=,6000.0,Inhibition of human ERG by patch clamp assay
6091,CHEMBL2069397,O=C1CC(c2nc(-c3cccc(Cl)c3)no2)CN1c1ccc(F)cc1,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp assay
6092,CHEMBL2069398,Cc1cccc(-c2noc(C3CC(=O)N(c4ccc(F)cc4)C3)n2)c1,IC50,nM,=,8000.0,Inhibition of human ERG by patch clamp assay
6093,CHEMBL2069399,CCCCOc1ccc(C(=O)N[C@@H]2COc3cccc(N4CCN(C)CC4)c3C2)cc1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6094,CHEMBL2069400,CN1CCN(c2cccc3c2C[C@H](NC(=O)c2ccc(OC(F)(F)F)cc2)CO3)CC1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6095,CHEMBL2069401,CN1CCN(c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)CC1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6096,CHEMBL2069402,CN1CCN(c2cccc3c2C[C@H](NC(=O)c2ccc(OCCC(F)(F)F)nc2)CO3)CC1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6097,CHEMBL2069403,Cc1nn(-c2ccccc2)nc1C(=O)N[C@@H]1COc2cccc(N3CCN(C)CC3)c2C1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6098,CHEMBL2069404,Cc1ccc(-n2nc(C)c(C(=O)N[C@@H]3COc4cccc(N5CCN(C)CC5)c4C3)n2)c(C)c1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6099,CHEMBL2069407,O=C(N[C@@H]1COc2cccc(-c3ccncc3)c2C1)c1ccc(OC(F)(F)F)cc1,IC50,nM,=,2511.89,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6100,CHEMBL2069408,O=C(N[C@@H]1COc2cccc(-c3cccnc3)c2C1)c1ccc(OCC(F)(F)F)nc1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6101,CHEMBL2069409,O=C(N[C@@H]1COc2cccc(-c3ccncc3)c2C1)c1ccc(OCC(F)(F)F)nc1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6102,CHEMBL2069410,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cc1F,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6103,CHEMBL2069411,O=C(N[C@@H]1COc2cccc(-c3ccc(CO)nc3)c2C1)c1ccc(OCC(F)(F)F)nc1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6104,CHEMBL2069412,O=C(N[C@@H]1COc2cccc(-c3ccnc(CO)c3)c2C1)c1ccc(OCC(F)(F)F)nc1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6105,CHEMBL2069413,O=C(N[C@@H]1COc2cccc(-c3ccc(CO)nc3)c2C1)c1ccc(OCCOCC(F)(F)F)nc1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6106,CHEMBL2069416,Cc1nn(-c2ccccc2)nc1C(=O)N[C@@H]1COc2cccc(-c3ccncc3)c2C1,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6107,CHEMBL2069420,O=C(N[C@@H]1COc2cccc(-c3cncnc3)c2C1)c1ccc(OCCC(F)(F)F)nc1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6108,CHEMBL2069421,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cn1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6109,CHEMBL2069422,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCCC(F)(F)F)nc2)CO3)cn1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6110,CHEMBL2069423,COc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(COCC(F)(F)F)nc2)CO3)cn1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6111,CHEMBL2069424,Cc1ncc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cn1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6112,CHEMBL2069425,COc1cnc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cn1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6113,CHEMBL2069426,Cc1cnc(-c2cccc3c2C[C@H](NC(=O)c2ccc(OCC(F)(F)F)nc2)CO3)cn1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6114,CHEMBL2069427,COc1cnc(-c2cccc3c2C[C@H](NC(=O)c2ccc(COCC(F)(F)F)nc2)CO3)cn1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in CHO cells by IonWorks HT assay
6115,CHEMBL2069499,CCCCC1(CCCC)N[C@@H](c2nc(-c3ccccc3)c[nH]2)Cc2c1[nH]c1ccccc21,IC50,nM,=,150.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6116,CHEMBL2069500,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCCCC4)N3)n2)cc1,IC50,nM,=,77.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6117,CHEMBL2069501,CCOCC1(COCC)N[C@@H](c2nc(-c3ccccc3)c[nH]2)Cc2c1[nH]c1ccccc21,IC50,nM,=,176.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6118,CHEMBL2069502,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,380.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6119,CHEMBL2069503,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,730.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6120,CHEMBL2069504,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCOC4)N3)n2)cc1,IC50,nM,=,64.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6121,CHEMBL2069504,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCOC4)N3)n2)cc1,IC50,nM,=,25.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6122,CHEMBL2069505,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCSCC4)N3)n2)cc1,IC50,nM,=,120.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6123,CHEMBL2069506,[O-][S+]1CCC(C2N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)CC1,IC50,nM,=,100.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6124,CHEMBL2069507,O=S1(=O)CCC(C2N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)CC1,IC50,nM,=,100.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6125,CHEMBL2069509,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCNCC4)N3)n2)cc1,IC50,nM,=,5100.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6126,CHEMBL2069510,CC(=O)N1CCC(C2N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)CC1,IC50,nM,=,9800.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6127,CHEMBL2069511,CS(=O)(=O)N1CCC(C2N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)CC1,IC50,nM,=,3500.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6128,CHEMBL2069512,COC(=O)N1CCC(C2N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)CC1,IC50,nM,=,700.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6129,CHEMBL2069513,CNC(=O)N1CCC(C2N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)CC1,IC50,nM,=,240.0,Displacement of [35S]MK499 from human Erg expressed in HEK293 cells after 60 mins by scintillation counting
6130,CHEMBL2069921,c1ccc(CN2CCN(Cc3nc(-c4ccccc4)no3)CC2)cc1,IC50,nM,=,12700.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6131,CHEMBL1504335,c1ccc(CN2CCN(Cc3nnc(-c4ccccc4)o3)CC2)cc1,IC50,nM,=,27300.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6132,CHEMBL2069922,CN(Cc1nc2ccccc2c(=O)[nH]1)Cc1nc(-c2ccccc2)no1,IC50,nM,=,26200.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6133,CHEMBL2069923,CN(Cc1nc2ccccc2c(=O)[nH]1)Cc1nnc(-c2ccccc2)o1,IC50,nM,>,33000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6134,CHEMBL2069924,c1ccc(-c2noc(CN3CCN(Cc4nc5ccccc5s4)CC3)n2)cc1,IC50,nM,=,13000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6135,CHEMBL2069925,c1ccc(-c2nnc(CN3CCN(Cc4nc5ccccc5s4)CC3)o2)cc1,IC50,nM,=,30000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6136,CHEMBL2069926,C[C@@H](Oc1nnc(-c2ccncc2)n1C)c1noc(-c2cccc(Cl)c2)n1,IC50,nM,=,11600.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6137,CHEMBL2069927,C[C@@H](Oc1nnc(-c2ccncc2)n1C)c1nnc(-c2cccc(Cl)c2)o1,IC50,nM,=,21500.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6138,CHEMBL2069928,c1cncc(-c2ccc(-c3noc(C4CN5CCC4CC5)n3)o2)c1,IC50,nM,=,6400.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6139,CHEMBL2069929,c1cncc(-c2ccc(-c3nnc(C4CN5CCC4CC5)o3)o2)c1,IC50,nM,=,20200.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6140,CHEMBL2069930,CCOC(=O)N1CCN(Cc2noc(-c3cc(Cl)ccc3F)n2)CC1,IC50,nM,=,31000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6141,CHEMBL2069931,CCOC(=O)N1CCN(Cc2nnc(-c3cc(Cl)ccc3F)o2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6142,CHEMBL1716297,CCOC(=O)N1CCN(Cc2nc(-c3cccc(Cl)c3)no2)CC1,IC50,nM,=,15500.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6143,CHEMBL2069932,CCOC(=O)N1CCN(Cc2nnc(-c3cccc(Cl)c3)o2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp assay
6144,CHEMBL2070936,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3ccc(F)cc3)CC2)CC1,IC50,nM,=,31622.78,Inhibition of human ERG
6145,CHEMBL2070937,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc4ccccc4s3)CC2)CC1,IC50,nM,=,7943.28,Inhibition of human ERG
6146,CHEMBL2070938,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nccs3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
6147,CHEMBL2070939,Cc1nc(N2CCN(C(=O)[C@@H]3CCCC[C@H]3C(=O)NC3(C#N)CC3)CC2)sc1C,IC50,nM,>,100000.0,Inhibition of human ERG
6148,CHEMBL2070940,CCc1csc(N2CCN(C(=O)[C@@H]3CCCC[C@H]3C(=O)NC3(C#N)CC3)CC2)n1,IC50,nM,>,100000.0,Inhibition of human ERG
6149,CHEMBL2070941,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc(C4CC4)cs3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
6150,CHEMBL2070942,CC(C)(C)c1csc(N2CCN(C(=O)[C@@H]3CCCC[C@H]3C(=O)NC3(C#N)CC3)CC2)n1,IC50,nM,=,6309.57,Inhibition of human ERG
6151,CHEMBL2070943,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc(C(F)(F)F)cs3)CC2)CC1,IC50,nM,=,25118.86,Inhibition of human ERG
6152,CHEMBL2070944,Cc1sc(N2CCN(C(=O)[C@@H]3CCCC[C@H]3C(=O)NC3(C#N)CC3)CC2)nc1C(F)(F)F,IC50,nM,=,15848.93,Inhibition of human ERG
6153,CHEMBL2070945,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc(C(F)(F)F)c(Cl)s3)CC2)CC1,IC50,nM,=,25118.86,Inhibition of human ERG
6154,CHEMBL2069324,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc(-c4ccccc4)cs3)CC2)CC1,IC50,nM,=,25118.86,Inhibition of human ERG
6155,CHEMBL2070947,CS(=O)(=O)c1ccc2nc(N3CCN(C(=O)[C@@H]4CCCC[C@H]4C(=O)NC4(C#N)CC4)CC3)sc2c1,IC50,nM,>,100000.0,Inhibition of human ERG
6156,CHEMBL2070948,CC(C)(C#N)c1cnc(N2CCN(C(=O)[C@@H]3CCCC[C@H]3C(=O)NC3(C#N)CC3)CC2)s1,IC50,nM,>,100000.0,Inhibition of human ERG
6157,CHEMBL2070949,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc4cccnc4s3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
6158,CHEMBL2070950,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc4ccncc4s3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
6159,CHEMBL2070951,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc4cnccc4s3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
6160,CHEMBL2071095,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc4ncccc4s3)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
6161,CHEMBL2071097,N#CC1(NC(=O)[C@@H]2CCCC[C@H]2C(=O)N2CCN(c3nc4c(s3)COCC4)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
6162,CHEMBL2071098,CC1(C)COCc2sc(N3CCN(C(=O)[C@@H]4CCCC[C@H]4C(=O)NC4(C#N)CC4)CC3)nc21,IC50,nM,>,100000.0,Inhibition of human ERG
6163,CHEMBL2070131,COc1cnc(-c2ccccn2)nc1NCc1ccccc1F,IC50,nM,>,25000.0,Inhibition of human ERG by Rb efflux assay
6164,CHEMBL2070133,COc1cnc(-c2ccccn2)nc1NCc1c(F)cc(F)cc1F,IC50,nM,>,25000.0,Inhibition of human ERG by Rb efflux assay
6165,CHEMBL2070134,COc1cnc(-c2ccccn2)nc1NCc1ccc(F)cc1C(F)(F)F,IC50,nM,>,25000.0,Inhibition of human ERG by Rb efflux assay
6166,CHEMBL2070953,COc1ccc(-c2csc(NC(=O)[C@H]3CCCCN3S(=O)(=O)c3ccc(C)cc3)n2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells after 3 mins by patch clamp assay
6167,CHEMBL2041933,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,nM,=,15000.0,Inhibition of human ERG
6168,CHEMBL495095,C=CCc1ccccc1OC(C)C1=NCCN1,IC50,nM,=,16900.0,Inhibition of human ERG expressed in HEK293 cells after 240 secs by patch clamp assay
6169,CHEMBL1956195,CC(Oc1ccccc1CC1CC1)C1=NCCN1,IC50,nM,=,8900.0,Inhibition of human ERG expressed in HEK293 cells after 240 secs by patch clamp assay
6170,CHEMBL2086582,COc1ccc(-c2cc(NC(=O)CCCCN3CCCN(C(C)=O)CC3)[nH]n2)cc1,IC50,nM,=,24200.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6171,CHEMBL2086690,CC(C)c1nc(N2CCN(c3ncc(OCc4ccncc4C#N)cn3)[C@H](C)C2)no1,IC50,nM,=,10000.0,Inhibition of human hERG
6172,CHEMBL2086760,CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1,IC50,nM,=,3367.0,Binding affinity to human ERG
6173,CHEMBL549220,Cc1cc(C(=O)OCC(N)=O)c(C)n1-c1ccc(F)cc1,IC50,nM,>,33000.0,"OSM: hERG, IC50 uM (Essen Bioscience): IonWorks patch clamp electrophysiology. 8 point concentration-response curves were generated using 3-fold serial dilutions from the maximum final assay concentration of 33 uM."
6174,CHEMBL599702,Cc1cc(/C=C2\SC(=Nc3ccccc3)NC2=O)c(C)n1-c1ccccc1,IC50,nM,>,33000.0,"OSM: hERG, IC50 uM (Essen Bioscience): IonWorks patch clamp electrophysiology. 8 point concentration-response curves were generated using 3-fold serial dilutions from the maximum final assay concentration of 33 uM."
6175,CHEMBL2147537,C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells
6176,CHEMBL1952329,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,=,980.0,Inhibition of human ERG
6177,CHEMBL2146806,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O,IC50,nM,=,50.12,Displacement of [3H]dofetilide from human ERG
6178,CHEMBL2146801,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG
6179,CHEMBL2146484,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG
6180,CHEMBL2146807,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O,IC50,nM,=,79.43,Displacement of [3H]dofetilide from human ERG
6181,CHEMBL2146808,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O,IC50,nM,=,5011.87,Displacement of [3H]dofetilide from human ERG
6182,CHEMBL2146809,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O,IC50,nM,=,158.49,Displacement of [3H]dofetilide from human ERG
6183,CHEMBL2146810,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O,IC50,nM,=,3.981,Displacement of [3H]dofetilide from human ERG
6184,CHEMBL2146811,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O,IC50,nM,=,63.1,Displacement of [3H]dofetilide from human ERG
6185,CHEMBL2146812,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG
6186,CHEMBL2146813,O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1,IC50,nM,=,158.49,Displacement of [3H]dofetilide from human ERG
6187,CHEMBL1767164,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1,IC50,nM,=,50.12,Displacement of [3H]dofetilide from human ERG
6188,CHEMBL639,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,IC50,nM,=,100.0,Displacement of [3H]dofetilide from human ERG
6189,CHEMBL1767136,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O,IC50,nM,=,199.53,Displacement of [3H]dofetilide from human ERG
6190,CHEMBL2146802,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O,IC50,nM,=,15.85,Displacement of [3H]dofetilide from human ERG
6191,CHEMBL2146803,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O,IC50,nM,=,251.19,Displacement of [3H]dofetilide from human ERG
6192,CHEMBL2146804,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O,IC50,nM,=,1258.93,Displacement of [3H]dofetilide from human ERG
6193,CHEMBL2146805,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O,IC50,nM,=,2511.89,Displacement of [3H]dofetilide from human ERG
6194,CHEMBL1223753,Cc1cc2c(cc1F)[nH]c(=O)n2C1CCN(C2CCOCC2)CC1,IC50,nM,=,12589.25,Binding affinity to human ERG
6195,CHEMBL2146599,Cc1ccc2[nH]c(=O)n(C3CCN(C4CCOCC4)CC3)c2c1,IC50,nM,=,25118.86,Binding affinity to human ERG
6196,CHEMBL2146598,O=c1[nH]c2ccccc2n1C1CCN(C2CCOCC2)CC1,IC50,nM,>,63095.73,Binding affinity to human ERG
6197,CHEMBL2146597,O=c1[nH]c2ccccc2n1C1CCN(C2CCCCC2)CC1,IC50,nM,>,63095.73,Binding affinity to human ERG
6198,CHEMBL1802360,O=c1[nH]c2ccccc2n1C1CCN(CCCOc2ccc(F)cc2)CC1,IC50,nM,=,79.43,Binding affinity to human ERG
6199,CHEMBL2146754,O=[N+]([O-])c1ccc(CCN2CCNCC2)cc1,IC50,nM,=,190.0,Displacement of [35S]MK499 from human ERG
6200,CHEMBL2146755,O=[N+]([O-])c1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,5.0,Displacement of [35S]MK499 from human ERG
6201,CHEMBL2146757,N#Cc1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,9.0,Displacement of [35S]MK499 from human ERG
6202,CHEMBL2146852,N#Cc1cccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)c1,IC50,nM,=,22.0,Displacement of [35S]MK499 from human ERG
6203,CHEMBL2146853,O=[N+]([O-])c1ccc(CCN2CCN(CCc3ccc4nonc4c3)CC2)cc1,IC50,nM,=,25.0,Displacement of [35S]MK499 from human ERG
6204,CHEMBL2146854,O=[N+]([O-])c1ccc(CCN2CCN(CCc3ccc(-c4ncco4)cc3)CC2)cc1,IC50,nM,=,47.0,Displacement of [35S]MK499 from human ERG
6205,CHEMBL2146856,O=C1OCc2c1cccc2-c1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,150.0,Displacement of [35S]MK499 from human ERG
6206,CHEMBL2146857,CCOC(=O)c1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,19.0,Displacement of [35S]MK499 from human ERG
6207,CHEMBL2146858,O=[N+]([O-])c1ccc(CCN2CCN(CCc3ccc(F)cc3)CC2)cc1,IC50,nM,=,23.0,Displacement of [35S]MK499 from human ERG
6208,CHEMBL2146861,COc1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,7.0,Displacement of [35S]MK499 from human ERG
6209,CHEMBL2146862,CS(=O)(=O)c1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,150.0,Displacement of [35S]MK499 from human ERG
6210,CHEMBL2146865,CC(CN1CCN(CCc2ccc([N+](=O)[O-])cc2)CC1)c1ccc([N+](=O)[O-])cc1,IC50,nM,=,3.1,Displacement of [35S]MK499 from human ERG
6211,CHEMBL2146866,CC(Cc1ccc([N+](=O)[O-])cc1)N1CCN(CCc2ccc([N+](=O)[O-])cc2)CC1,IC50,nM,=,3.9,Displacement of [35S]MK499 from human ERG
6212,CHEMBL2146867,CC1CN(CCc2ccc([N+](=O)[O-])cc2)CCN1CCc1ccc([N+](=O)[O-])cc1,IC50,nM,=,0.76,Displacement of [35S]MK499 from human ERG
6213,CHEMBL2146868,N#Cc1ccc(CCN2CCN(CCc3ccc(C#N)cc3)CC2)cc1,IC50,nM,=,12.0,Displacement of [35S]MK499 from human ERG
6214,CHEMBL2146869,c1cc2nonc2cc1CCN1CCN(CCc2ccc3nonc3c2)CC1,IC50,nM,=,67.0,Displacement of [35S]MK499 from human ERG
6215,CHEMBL2146870,O=C1OCc2cc(CCN3CCN(CCc4ccc5c(c4)COC5=O)CC3)ccc21,IC50,nM,=,1900.0,Displacement of [35S]MK499 from human ERG
6216,CHEMBL2146871,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1,IC50,nM,=,430.0,Displacement of [35S]MK499 from human ERG
6217,CHEMBL2146872,O=C1OCc2cc(CCN3CCN(CCc4ccc5nonc5c4)CC3)ccc21,IC50,nM,=,280.0,Displacement of [35S]MK499 from human ERG
6218,CHEMBL2146851,N#Cc1ccc(CCN2CCN(CCc3ccc4nonc4c3)CC2)cc1,IC50,nM,=,42.0,Displacement of [35S]MK499 from human ERG
6219,CHEMBL2146873,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1F,IC50,nM,=,170.0,Displacement of [35S]MK499 from human ERG
6220,CHEMBL2146874,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1Cl,IC50,nM,=,120.0,Displacement of [35S]MK499 from human ERG
6221,CHEMBL2146875,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1Br,IC50,nM,=,560.0,Displacement of [35S]MK499 from human ERG
6222,CHEMBL2146876,COc1cc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1C#N,IC50,nM,=,1600.0,Displacement of [35S]MK499 from human ERG
6223,CHEMBL2146877,CCOc1cc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1C#N,IC50,nM,=,670.0,Displacement of [35S]MK499 from human ERG
6224,CHEMBL2146878,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1OC(F)(F)F,IC50,nM,=,110.0,Displacement of [35S]MK499 from human ERG
6225,CHEMBL2146879,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1OC1CC1,IC50,nM,=,470.0,Displacement of [35S]MK499 from human ERG
6226,CHEMBL2146880,CSc1cc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1C#N,IC50,nM,=,460.0,Displacement of [35S]MK499 from human ERG
6227,CHEMBL2146881,CNc1cc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1C#N,IC50,nM,=,670.0,Displacement of [35S]MK499 from human ERG
6228,CHEMBL2146882,CS(=O)(=O)c1cc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1C#N,IC50,nM,=,4700.0,Displacement of [35S]MK499 from human ERG
6229,CHEMBL2147020,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c3ncccc23)c1,IC50,nM,=,1900.0,Inhibition of recombinant human ERG channel IKr expressed in CHO cells by patch clamp assay
6230,CHEMBL2147021,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c3nc(F)ccc23)c1,IC50,nM,=,2700.0,Inhibition of recombinant human ERG channel IKr expressed in CHO cells by patch clamp assay
6231,CHEMBL2147022,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c3nc(N)ccc23)c1,IC50,nM,=,4300.0,Inhibition of recombinant human ERG channel IKr expressed in CHO cells by patch clamp assay
6232,CHEMBL2147023,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c(-c3ccccc3)c2Cl)c1,IC50,nM,=,30000.0,Inhibition of recombinant human ERG channel IKr expressed in CHO cells by patch clamp assay
6233,CHEMBL2147024,Cc1cc(C#N)ccc1-c1ccnc(NCc2cc(-c3ccccn3)[nH]n2)c1,IC50,nM,=,1100.0,Inhibition of recombinant human ERG channel IKr expressed in CHO cells by patch clamp assay
6234,CHEMBL2147025,Cc1cc(C#N)ccc1-c1ccnc(NCc2n[nH]c(-c3ccccn3)c2Cl)c1,IC50,nM,>,30000.0,Inhibition of recombinant human ERG channel IKr expressed in CHO cells by patch clamp assay
6235,CHEMBL2147194,COCc1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1.Cl,IC50,nM,=,1810.0,Inhibition of human ERG
6236,CHEMBL2147072,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(C#N)cc21,IC50,nM,=,1200.0,Inhibition of human ERG
6237,CHEMBL2147070,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cc(F)ccc2Cl)c2ccc(C(=O)O)cc21,IC50,nM,>,10000.0,Inhibition of human ERG
6238,CHEMBL2147210,COc1ncc(-c2ccccc2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,IC50,nM,=,10000.0,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6239,CHEMBL2147211,COc1cnc(-c2ccccc2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,IC50,nM,=,19952.62,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6240,CHEMBL2147212,O=C(NCCc1ccccc1-c1cnc(OC(F)F)cn1)c1ccc(OCCC(F)(F)F)nc1,IC50,nM,=,6309.57,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6241,CHEMBL2147213,O=C(NCCc1ccccc1-c1cccnc1)c1ccc(OCCC(F)(F)F)nc1,IC50,nM,=,6309.57,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6242,CHEMBL2147214,Cc1ncc(-c2ccccc2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,IC50,nM,=,12589.25,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6243,CHEMBL2147215,O=C(NCCc1ccccc1-c1ccc(CO)nc1)c1ccc(OCCC(F)(F)F)nc1,IC50,nM,>,25118.86,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6244,CHEMBL2147217,Cc1ncc(-c2ccccc2CCNC(=O)c2ccc(OCCOCC(F)(F)F)nc2)cn1,IC50,nM,=,31622.78,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6245,CHEMBL2147219,Cc1ncc(-c2ccccc2CCNC(=O)c2ccc(C(=O)NCCCC(F)(F)F)nc2)cn1,IC50,nM,=,19952.62,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6246,CHEMBL2147221,COc1ncc(-c2cccc(C)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,IC50,nM,=,6309.57,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6247,CHEMBL2147222,COc1ncc(-c2cccc(F)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,IC50,nM,=,7943.28,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6248,CHEMBL2147223,COc1ncc(-c2cccc(Cl)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,IC50,nM,=,3981.07,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6249,CHEMBL2147225,COc1ccc(CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)c(-c2cnc(OC)nc2)c1,IC50,nM,=,6309.57,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6250,CHEMBL2147304,COc1ncc(-c2cccc(OC(F)F)c2CCNC(=O)c2ccc(OCCC(F)(F)F)nc2)cn1,IC50,nM,=,3981.07,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6251,CHEMBL2147306,COc1ncc(-c2c(C)ccc(F)c2CCNC(=O)c2ccc(OCC(F)(F)F)nc2)cn1,IC50,nM,=,12589.25,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6252,CHEMBL2147307,COc1cnc(-c2c(C)ccc(F)c2CCNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,IC50,nM,=,19952.62,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6253,CHEMBL2147308,COc1cnc(-c2c(F)ccc(F)c2CCNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,IC50,nM,=,19952.62,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6254,CHEMBL2147309,Cc1cnc(-c2c(F)ccc(F)c2CCNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,IC50,nM,>,31622.78,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6255,CHEMBL2147303,COc1ncc(-c2ccccc2C(F)(F)CNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,IC50,nM,=,19952.62,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6256,CHEMBL2147316,COc1cnc(-c2ccccc2C(F)(F)CNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,IC50,nM,=,25118.86,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6257,CHEMBL2147317,COc1cnc(-c2cccc(F)c2C(F)(F)CNC(=O)c2ccc(COCC(F)(F)F)nc2)cn1,IC50,nM,=,19952.62,Inhibition of human ERG channel by whole cell voltage-clamp electrophysiology assay
6258,CHEMBL1684954,C[C@@H](NC(=O)Cc1ccc(C2CC2)cc1)c1ccc(OCC(F)(F)F)cn1,IC50,nM,>,10000.0,Displacement of [3S]MK499 from human ERG in HEK293 cells
6259,CHEMBL2151144,C[C@@H](NC(=O)Cc1ccc(N2CC[C@H](F)C2)cc1)c1ccc(OCC(F)(F)F)cn1,IC50,nM,>,10000.0,Displacement of [3S]MK499 from human ERG in HEK293 cells
6260,CHEMBL2151145,Cc1ncoc1-c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1,IC50,nM,>,30000.0,Displacement of [3S]MK499 from human ERG in HEK293 cells
6261,CHEMBL2151146,C[C@@H](NC(=O)Cc1ccc(-c2cnn3ncccc23)cc1)c1ccc(OCC(F)(F)F)cn1,IC50,nM,>,30000.0,Displacement of [3S]MK499 from human ERG in HEK293 cells
6262,CHEMBL2151147,Cc1nccnc1-c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1,IC50,nM,>,30000.0,Displacement of [3S]MK499 from human ERG in HEK293 cells
6263,CHEMBL457614,CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)n[nH]1,IC50,nM,=,5200.0,Inhibition of human ERG
6264,CHEMBL2151319,C[C@H](Nc1ccc2ncn(-c3cc(C4CC4)[nH]n3)c2n1)c1ncc(F)cn1,IC50,nM,>,32000.0,Inhibition of human ERG
6265,CHEMBL2151320,Cc1cc(-n2cnc3ccc(N[C@@H](C)c4ncc(F)cn4)nc32)n[nH]1,IC50,nM,>,32000.0,Inhibition of human ERG
6266,CHEMBL2151321,CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1,IC50,nM,>,32000.0,Inhibition of human ERG
6267,CHEMBL2151322,CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](CO)c4ccc(F)cn4)nc32)n[nH]1,IC50,nM,=,52000.0,Inhibition of human ERG
6268,CHEMBL2151323,CC(C)Oc1cc(-n2cnc3cnc(N[C@@H](C)c4ncc(F)cn4)nc32)n[nH]1,IC50,nM,>,32000.0,Inhibition of human ERG
6269,CHEMBL2151324,CC(C)Oc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c2ccc(F)cn2)n[nH]1,IC50,nM,>,25000.0,Inhibition of human ERG
6270,CHEMBL2151325,CCOc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c2ccc(F)cn2)n[nH]1,IC50,nM,=,32000.0,Inhibition of human ERG
6271,CHEMBL2151326,COc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c2ccc(F)cn2)n[nH]1,IC50,nM,>,32000.0,Inhibition of human ERG
6272,CHEMBL2153191,CCCSc1nc(N2CCC[C@@H](CC(=O)O)C2)ccc1C(=O)NC1CCCCC1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
6273,CHEMBL2151438,c1cc(-c2cnc3c(c2)C[C@@]2(CN4CCC2CC4)O3)co1,IC50,nM,=,1600.0,Inhibition of human ERG
6274,CHEMBL597241,Clc1cnc2nc(N3CCN4CCC3CC4)oc2c1,IC50,nM,=,3300.0,Inhibition of human ERG
6275,CHEMBL603052,Cc1nc2nc(N3CCN4CCC3CC4)oc2cc1Cl,IC50,nM,=,16200.0,Inhibition of human ERG
6276,CHEMBL2152522,c1ccc([C@@H]([C@H](c2ccccc2)N2CCCCC2)N2CCCCC2)cc1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in CHOK1 cells
6277,CHEMBL2152523,c1ccc([C@H]([C@@H](c2ccccc2)N2CCCCC2)N2CCCCC2)cc1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHOK1 cells
6278,CHEMBL2152524,c1ccc([C@@H]([C@H](c2ccccc2)N2CCCC2)N2CCCC2)cc1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in CHOK1 cells
6279,CHEMBL2152525,c1ccc([C@H]([C@@H](c2ccccc2)N2CCCC2)N2CCCC2)cc1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in CHOK1 cells
6280,CHEMBL2152252,CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N,IC50,nM,=,17318.0,Inhibition of human Erg expressed in CHO cells after 5 mins
6281,CHEMBL4299173,COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O.Cl.Cl,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG
6282,CHEMBL1962378,O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,nM,=,2600.0,Inhibition of human ERG by patch clamp assay
6283,CHEMBL1963307,O=C(CCc1ccccc1)c1cc(F)ccc1OCC(O)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,nM,=,4840.0,Inhibition of human ERG by patch clamp assay
6284,CHEMBL1963280,O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCC(c2ccccc2)CC1,IC50,nM,=,3460.0,Inhibition of human ERG by patch clamp assay
6285,CHEMBL1963594,Cc1ccc(N2CCN(CC(O)COc3ccccc3C(=O)CCc3ccccc3)CC2)cc1,IC50,nM,=,4310.0,Inhibition of human ERG by patch clamp assay
6286,CHEMBL2158050,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,124000.0,Inhibition of human ERG
6287,CHEMBL2159976,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,21000.0,Inhibition of human ERG
6288,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,nM,>,30000.0,Inhibition of human ERG expressed in mammalian cells by patch clamp method
6289,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in mammalian cells by patch clamp method
6290,CHEMBL2159975,COc1ccc2nccc([C@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,<,30000.0,Inhibition of human ERG expressed in mammalian cells by patch clamp method
6291,CHEMBL2159976,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,<,30000.0,Inhibition of human ERG expressed in mammalian cells by patch clamp method
6292,CHEMBL2158041,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(CCSc4ccc[se]4)C[C@@H]3C(=O)O)c2c1,IC50,nM,<,30000.0,Inhibition of human ERG expressed in mammalian cells by patch clamp method
6293,CHEMBL2159974,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(CCSc4ccco4)C[C@@H]3C(=O)O)c2c1,IC50,nM,<,30000.0,Inhibition of human ERG expressed in mammalian cells by patch clamp method
6294,CHEMBL2158485,O=C(N[C@H]1C2CC3CC1C[C@](O)(C3)C2)c1cnc(N2CCOCC2)nc1C1CC1,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks assay
6295,CHEMBL2158221,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCNCC3)cc2C2=CCCCC2)n1.O=C(O)C(F)(F)F,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6296,CHEMBL2158222,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(c4ccccn4)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6297,CHEMBL2158223,N#CCCN1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6298,CHEMBL2158224,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(Cc4ccccn4)CC3)cc2C2=CCCCC2)n1,IC50,nM,=,7700.0,Displacement of [3H]astemizole from human ERG potassium channel
6299,CHEMBL2158225,N#Cc1cnc(C(=O)Nc2ccc(C3CCN(CCO)CC3)cc2C2=CCCCC2)[nH]1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6300,CHEMBL2158226,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(CO)CO)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6301,CHEMBL2158227,CS(=O)(=O)CCN1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6302,CHEMBL2158228,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(CC(N)=O)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6303,CHEMBL2158229,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(CC(=O)O)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6304,CHEMBL2158230,N#Cc1cnc(C(=O)Nc2ccc(C3CCN(CCN4CCOCC4)CC3)cc2C2=CCCCC2)[nH]1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6305,CHEMBL256712,CC(=O)N1CCC(c2ccc(NC(=O)c3ncc(C#N)[nH]3)c(C3=CCCCC3)c2)CC1,IC50,nM,>,3200.0,Displacement of [3H]astemizole from human ERG potassium channel
6306,CHEMBL2158231,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)c4cccnc4)CC3)cc2C2=CCCCC2)n1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6307,CHEMBL1908842,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6308,CHEMBL2158287,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)[C@H](O)CO)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6309,CHEMBL2158288,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)CNCCO)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6310,CHEMBL2158289,CN(CCO)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6311,CHEMBL2158290,CS(=O)(=O)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6312,CHEMBL2158291,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)c4ccc[n+]([O-])c4)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6313,CHEMBL2158292,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)c4cc[n+]([O-])cc4)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6314,CHEMBL2158293,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)Cc4c[nH]cn4)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6315,CHEMBL2158294,Cn1cnc(CC(=O)N2CCC(c3ccc(NC(=O)c4nc(C#N)c[nH]4)c(C4=CCCCC4)c3)CC2)c1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6316,CHEMBL2158295,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)Cc4ccccn4)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6317,CHEMBL2158296,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)Cc4cccnc4)CC3)cc2C2=CCCCC2)n1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6318,CHEMBL2158297,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)Cc4ccncc4)CC3)cc2C2=CCCCC2)n1,IC50,nM,>,3200.0,Displacement of [3H]astemizole from human ERG potassium channel
6319,CHEMBL2158298,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)CCN4CCOCC4)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6320,CHEMBL2158299,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)CN4CCOCC4)CC3)cc2C2=CCCCC2)n1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6321,CHEMBL2158300,CC(C)(N)CC(=O)N1CCC(c2ccc(NC(=O)c3ncc(C#N)[nH]3)c(C3=CCCCC3)c2)CC1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6322,CHEMBL2158301,CC(C)(N)C(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6323,CHEMBL2158302,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(=O)NCCO)CC3)cc2C2=CCCCC2)n1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel
6324,CHEMBL2158303,N#Cc1c[nH]c(C(=O)Nc2ccc(C3CCN(C(N)=O)CC3)cc2C2=CCCCC2)n1,IC50,,,,Displacement of [3H]astemizole from human ERG potassium channel
6325,CHEMBL2158562,COc1cc(Cl)c(-c2nc(SCC(=O)N(C)C)nc3[nH]cc(C#N)c23)cc1OC,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells by voltage-clamp method
6326,CHEMBL2158561,COc1cc(Cl)c(-c2nc(SCC(=O)N(C)C)nc3[nH]cc(C#N)c23)cc1O,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells by voltage-clamp method
6327,CHEMBL2158563,CCN(CC)CCOc1cc(-c2nc(SCC(=O)NC)nc3[nH]cc(C#N)c23)c(Cl)cc1Cl,IC50,nM,=,17800.0,Inhibition of human ERG expressed in HEK293 cells by voltage-clamp method
6328,CHEMBL2158562,COc1cc(Cl)c(-c2nc(SCC(=O)N(C)C)nc3[nH]cc(C#N)c23)cc1OC,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG
6329,CHEMBL2158561,COc1cc(Cl)c(-c2nc(SCC(=O)N(C)C)nc3[nH]cc(C#N)c23)cc1O,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG
6330,CHEMBL2158564,CCN(CC)CCSc1nc(-c2cc(OC)c(C#N)cc2Cl)c2c(C#N)c[nH]c2n1,IC50,nM,=,1070.0,Displacement of [3H]-dofetilide from human ERG
6331,CHEMBL2158563,CCN(CC)CCOc1cc(-c2nc(SCC(=O)NC)nc3[nH]cc(C#N)c23)c(Cl)cc1Cl,IC50,nM,=,3140.0,Displacement of [3H]-dofetilide from human ERG
6332,CHEMBL2158629,CCN(CC)CCSc1nc(-c2cc(OC)c(Cl)cc2Cl)c2c(C#N)c[nH]c2n1,IC50,nM,=,1400.0,Displacement of [3H]-dofetilide from human ERG
6333,CHEMBL2158626,CCN(CC)CCOc1cc(-c2nc(SC)nc3[nH]cc(C#N)c23)c(Cl)cc1Cl,IC50,nM,=,1710.0,Displacement of [3H]-dofetilide from human ERG
6334,CHEMBL2158625,CSc1nc(-c2cc(OCCN3CCCC3)c(Cl)cc2Cl)c2c(C#N)c[nH]c2n1,IC50,nM,=,3640.0,Displacement of [3H]-dofetilide from human ERG
6335,CHEMBL2158793,Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1,IC50,nM,>,100000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6336,CHEMBL2158792,Cc1cc(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl,IC50,nM,>,100000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6337,CHEMBL2158791,Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6338,CHEMBL2158785,Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(C#N)c1Cl,IC50,nM,=,15848.93,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6339,CHEMBL2158784,Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl,IC50,nM,>,50118.72,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6340,CHEMBL2158783,Cc1c(Cl)ccc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)c1Cl,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6341,CHEMBL2158782,Cc1cc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl,IC50,nM,>,100000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6342,CHEMBL2158781,Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1,IC50,nM,>,100000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6343,CHEMBL2158780,Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6344,CHEMBL2158779,O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3Cl)CC2)CC1,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6345,CHEMBL2158778,O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3)CC2)CC1,IC50,nM,>,100000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6346,CHEMBL2158777,O=C(O)[C@H](Cc1cccc(C(F)(F)F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,6309.57,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6347,CHEMBL2158776,COc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6348,CHEMBL2158775,COc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6349,CHEMBL2158774,Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,6309.57,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6350,CHEMBL2158773,Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,6309.57,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6351,CHEMBL2158772,Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>,25118.86,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6352,CHEMBL2158771,N#Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,5011.87,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6353,CHEMBL2158770,N#Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,12589.25,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6354,CHEMBL2158769,N#Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,25118.86,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6355,CHEMBL2158841,O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>=,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6356,CHEMBL2158840,O=C(O)[C@H](Cc1cccc(F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6357,CHEMBL2158839,O=C(O)[C@H](Cc1ccccc1F)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6358,CHEMBL2158838,O=C(O)[C@H](Cc1ccc(Cl)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,3981.07,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6359,CHEMBL2158837,O=C(O)[C@H](Cc1ccccc1Cl)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6360,CHEMBL2158836,O=C(O)[C@@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,6309.57,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6361,CHEMBL2158835,O=C(O)[C@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,15848.93,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6362,CHEMBL2158834,O=C(O)c1cccnc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6363,CHEMBL2158833,O=C(O)c1ccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6364,CHEMBL2158832,O=C(O)c1cccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,19952.62,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6365,CHEMBL2158831,O=C(O)c1ccccc1CN1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,12589.25,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6366,CHEMBL2158830,O=C(O)COc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6367,CHEMBL2158829,O=C(O)COc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6368,CHEMBL2158828,O=C(O)COc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6369,CHEMBL2158827,O=C(O)Cc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6370,CHEMBL2158826,O=C(O)Cc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6371,CHEMBL2158825,O=C(O)Cc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,12589.25,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6372,CHEMBL2158824,O=C(O)c1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6373,CHEMBL2158823,O=C(O)c1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1,IC50,nM,=,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6374,CHEMBL2158822,O=C(O)c1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,1584.89,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6375,CHEMBL2158821,O=C(O)[C@@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,15848.93,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6376,CHEMBL2158820,O=C(O)[C@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,25118.86,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6377,CHEMBL2158819,O=C(O)C(c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6378,CHEMBL2158818,O=C(O)C(c1ccccc1)N1CCO[C@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6379,CHEMBL2158816,O=C(O)C(c1ccccc1)N1CCCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1,IC50,nM,=,25118.86,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6380,CHEMBL2158814,Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,25118.86,"Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs by TopCount analysis"
6381,CHEMBL2158815,O=C(O)C(c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,5011.87,Binding affinity to human ERG by ion flux assay
6382,CHEMBL1933349,COc1ccc2cc(-c3cc(-c4cc(Cl)cc(Cl)c4)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1,IC50,nM,>,10000.0,Binding affinity to human ERG
6383,CHEMBL2159339,C[C@@H](c1ccc(C(=O)NCCC(=O)O)cc1)n1nc(-c2cc(Cl)cc(Cl)c2)cc1-c1ccc2cc(C(F)(F)F)ccc2c1,IC50,nM,<,1200.0,Binding affinity to human ERG
6384,CHEMBL2159341,Cc1ccc2cc(-c3cc(-c4cc(Cl)cc(Cl)c4)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1,IC50,nM,>,10000.0,Binding affinity to human ERG
6385,CHEMBL2159347,COc1ccc2cc(-c3cc(-c4cc(Cl)ccc4Cl)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1,IC50,nM,=,9700.0,Binding affinity to human ERG
6386,CHEMBL2164045,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2cccc(O)c2C(=O)N1CCc1ncc(F)cn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6387,CHEMBL2164044,O=C(NCc1ccc(F)c(C(F)(F)F)c1)C1c2ccccc2C(=O)N1CCc1ncc(F)cn1,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6388,CHEMBL2164043,O=C(NCc1ccc(F)c(OC(F)(F)F)c1)C1c2ccccc2C(=O)N1CCc1ncc(F)cn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6389,CHEMBL2164042,O=C(NCc1cccc(OC(F)(F)F)c1)C1c2ccccc2C(=O)N1CCc1ncc(F)cn1,IC50,nM,=,24000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6390,CHEMBL2164041,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2cccc(O)c2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6391,CHEMBL2164040,COc1cccc2c1C(=O)N(CCc1ccccn1)C2C(=O)NCc1ccc(OC(F)(F)F)cc1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6392,CHEMBL2164039,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2cccc(F)c2C(=O)N1CCc1ccccn1,IC50,nM,=,8200.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6393,CHEMBL2164038,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2c(O)cccc2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6394,CHEMBL2164037,COc1cccc2c1C(C(=O)NCc1ccc(OC(F)(F)F)cc1)N(CCc1ccccn1)C2=O,IC50,nM,=,3600.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6395,CHEMBL2164369,Cc1cccc2c1C(C(=O)NCc1ccc(OC(F)(F)F)cc1)N(CCc1ccccn1)C2=O,IC50,nM,=,5600.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6396,CHEMBL2164368,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2c(F)cccc2C(=O)N1CCc1ccccn1,IC50,nM,=,5600.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6397,CHEMBL2164367,CC1(C(=O)NCc2ccc(OC(F)(F)F)cc2)c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,11000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6398,CHEMBL2164367,CC1(C(=O)NCc2ccc(OC(F)(F)F)cc2)c2ccccc2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6399,CHEMBL2164367,CC1(C(=O)NCc2ccc(OC(F)(F)F)cc2)c2ccccc2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6400,CHEMBL2164366,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ncc(F)cn1,IC50,nM,=,5500.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6401,CHEMBL2164365,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1cnccn1,IC50,nM,=,9200.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6402,CHEMBL2164364,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ncccn1,IC50,nM,=,16000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6403,CHEMBL2164363,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CC(F)(F)c1ccccn1,IC50,nM,=,9700.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6404,CHEMBL2164362,CC(C)(CN1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC(F)(F)F)cc1)c1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6405,CHEMBL2164361,CC(C)(Cc1ccccn1)N1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC(F)(F)F)cc1,IC50,nM,=,4300.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6406,CHEMBL2164360,CC(Cc1ccccn1)N1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC(F)(F)F)cc1,IC50,nM,=,8600.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6407,CHEMBL2164359,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1Cc1ccc(C(F)(F)F)cn1,IC50,nM,=,3300.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6408,CHEMBL2164358,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCOc1ccccn1,IC50,nM,=,4900.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6409,CHEMBL2164357,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6410,CHEMBL2164356,Cc1cccc(CCN2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)n1,IC50,nM,=,6600.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6411,CHEMBL2164047,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccc(F)cn1,IC50,nM,=,5300.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6412,CHEMBL2164046,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccncc1,IC50,nM,=,5100.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6413,CHEMBL2164382,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1cccnc1,IC50,nM,=,5500.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6414,CHEMBL2164381,N#CCCN1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC(F)(F)F)cc1,IC50,nM,=,26000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6415,CHEMBL2164380,CC(CC#N)N1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC(F)(F)F)cc1,IC50,nM,=,31000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6416,CHEMBL2164379,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCOCC(F)(F)F,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6417,CHEMBL2164378,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCC(F)(F)F,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6418,CHEMBL2164377,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CC1CC(F)(F)C1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6419,CHEMBL2164376,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CC(F)(F)C1,IC50,nM,=,23000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6420,CHEMBL2164375,CC(C)(C)OC(=O)N1CC(N2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)C1,IC50,nM,=,11000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6421,CHEMBL2164374,CC(C)(C)OC(=O)N1CCC(N2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)CC1,IC50,nM,=,14000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6422,CHEMBL2163357,N#C[C@H]1CC[C@H](N2C(=O)c3ccccc3C2C(=O)NCc2ccc(OC(F)(F)F)cc2)CC1,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6423,CHEMBL2164373,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CCC(F)(F)CC1,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6424,CHEMBL2164373,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CCC(F)(F)CC1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6425,CHEMBL2164373,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CCC(F)(F)CC1,IC50,nM,=,14000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6426,CHEMBL2164372,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C[C@@H]1CCCO1,IC50,nM,=,17000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6427,CHEMBL2164371,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CCOCC1,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6428,CHEMBL2164371,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CCOCC1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6429,CHEMBL2164371,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1C1CCOCC1,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6430,CHEMBL2164370,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCN1CCOCC1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6431,CHEMBL2164397,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCC1CCOCC1,IC50,nM,=,22000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6432,CHEMBL2164396,O=C(NCc1ccc(OCCC(F)(F)F)nc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,20000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6433,CHEMBL2164395,O=C(NCc1ccc(OCC(F)(F)F)nc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,16000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6434,CHEMBL2164394,O=C(NCc1ccc(OC(F)F)nc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6435,CHEMBL2164393,CC(NC(=O)C1c2ccccc2C(=O)N1CCc1ccccn1)c1ccc(OCC(F)(F)F)cc1,IC50,nM,=,7300.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6436,CHEMBL2164392,O=C(NCc1ccc(OCC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,8900.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6437,CHEMBL2164391,O=C(NCc1ccc(CC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,14000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6438,CHEMBL2164390,O=C(NCc1cccc(OC(F)(F)F)c1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,21000.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6439,CHEMBL2164389,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6440,CHEMBL2164389,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,4600.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6441,CHEMBL2164389,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,7800.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6442,CHEMBL2164388,COc1ccc(CNC(=O)C2c3ccccc3C(=O)N2CCc2ccccn2)cc1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6443,CHEMBL2164387,O=C(NCc1ccc(C(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,8600.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6444,CHEMBL2164386,O=C(NCc1ccccc1Br)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6445,CHEMBL2164385,O=C(NCc1cccc(Br)c1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6446,CHEMBL2164384,O=C(NCc1ccc(Br)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,9300.0,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6447,CHEMBL2164383,Cc1ccc(NC(=O)C2c3ccccc3C(=O)N2CCc2ccccn2)cc1C,IC50,,,,Binding affinity to human ERG expressed in CHOK1 cells by IonWorks HT assay
6448,CHEMBL2164544,N#Cc1cc(F)cc(-c2nc(-c3ccccn3)no2)c1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWorks assay
6449,CHEMBL2164552,N#Cc1ccc(-c2noc(-c3cc(F)cc(C#N)c3)n2)nc1,IC50,nM,=,6350.0,Inhibition of human ERG by IonWorks assay
6450,CHEMBL2164551,N#Cc1cc(F)cc(-c2nc(-c3ccc(F)cn3)no2)c1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWorks assay
6451,CHEMBL2165068,N#Cc1ccc2ccc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@@H](F)C3)c2c1,IC50,nM,=,57000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by liquid scintillation counter
6452,CHEMBL2165064,N#Cc1ccc2ccc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@H](F)C3)c2c1,IC50,nM,>,200000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by liquid scintillation counter
6453,CHEMBL2165062,N#Cc1ccc2ccc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,39000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by liquid scintillation counter
6454,CHEMBL2165061,COc1ccc2ncc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@H](OC)C3)c2c1,IC50,nM,=,27000.0,Inhibition of human ERG by Ionworks assay
6455,CHEMBL2165060,COc1ccc2ncc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@@H](OC)C3)c2c1,IC50,nM,=,93000.0,Inhibition of human ERG by Ionworks assay
6456,CHEMBL2165059,CO[C@@H]1CN(CCn2c(=O)ccc3ccc(C#N)cc32)CC[C@H]1NCc1ccc2c(n1)NC(=O)CO2,IC50,nM,=,124000.0,Inhibition of human ERG by Ionworks assay
6457,CHEMBL2165058,CO[C@H]1CN(CCn2c(=O)ccc3ccc(C#N)cc32)CC[C@@H]1NCc1cc2c(cn1)OCCO2,IC50,nM,=,176000.0,Inhibition of human ERG by Ionworks assay
6458,CHEMBL2165057,COc1ccc2ncc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](OC)C3)c2c1,IC50,nM,=,88000.0,Inhibition of human ERG by Ionworks assay
6459,CHEMBL2165056,COc1ccc2ncc(=O)n(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](OC)C3)c2c1,IC50,nM,=,75000.0,Inhibition of human ERG by Ionworks assay
6460,CHEMBL2165055,CO[C@H]1CN(CCn2c(=O)ccc3ccc(C#N)cc32)CC[C@H]1NCc1ccc2c(n1)NC(=O)CO2,IC50,nM,=,189000.0,Inhibition of human ERG by Ionworks assay
6461,CHEMBL2165054,CO[C@H]1CN(CCn2c(=O)ccc3ccc(C#N)cc32)CC[C@H]1NCc1cc2c(cn1)OCCO2,IC50,nM,=,174000.0,Inhibition of human ERG by Ionworks assay
6462,CHEMBL2164748,COc1ccc2ncc(=O)n(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@H](O)C3)c2c1,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks assay
6463,CHEMBL2164747,COc1ccc2ncc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](O)C3)c2c1,IC50,nM,=,152000.0,Inhibition of human ERG by Ionworks assay
6464,CHEMBL2164746,COc1ccc2ncc(=O)n(CCN3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)[C@H](O)C3)c2c1,IC50,nM,=,172000.0,Inhibition of human ERG by Ionworks assay
6465,CHEMBL2164745,COc1ccc2ncc(=O)n(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](O)C3)c2c1,IC50,nM,=,15000.0,Inhibition of human ERG by Ionworks assay
6466,CHEMBL2164744,COc1ccc2ncc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@H](O)C3)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG by Ionworks assay
6467,CHEMBL2164743,N#Cc1ccc2ccc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](O)C3)c2c1,IC50,nM,>,333000.0,Inhibition of human ERG by Ionworks assay
6468,CHEMBL2164742,N#Cc1ccc2ccc(=O)n(CCN3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)[C@H](O)C3)c2c1,IC50,nM,=,305000.0,Inhibition of human ERG by Ionworks assay
6469,CHEMBL2164741,N#Cc1ccc2ccc(=O)n(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](O)C3)c2c1,IC50,nM,=,117000.0,Inhibition of human ERG by Ionworks assay
6470,CHEMBL2164740,N#Cc1ccc2ccc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@H](O)C3)c2c1,IC50,nM,=,156000.0,Inhibition of human ERG by Ionworks assay
6471,CHEMBL2164739,COc1ccc2ncc(=O)n(CCN3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](F)C3)c2c1,IC50,nM,=,19000.0,Inhibition of human ERG by Ionworks assay
6472,CHEMBL2165069,COc1ccc2ncc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@@H](F)C3)c2c1,IC50,nM,=,75000.0,Inhibition of human ERG by Ionworks assay
6473,CHEMBL2165068,N#Cc1ccc2ccc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@@H](F)C3)c2c1,IC50,nM,=,122000.0,Inhibition of human ERG by Ionworks assay
6474,CHEMBL2165067,COc1ccc2ncc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](F)C3)c2c1,IC50,nM,=,32000.0,Inhibition of human ERG by Ionworks assay
6475,CHEMBL2163364,COc1ccc2ncc(=O)n(CCN3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)[C@H](F)C3)c2c1,IC50,nM,=,25000.0,Inhibition of human ERG by Ionworks assay
6476,CHEMBL2165066,N#Cc1ccc2ccc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](F)C3)c2c1,IC50,nM,=,168000.0,Inhibition of human ERG by Ionworks assay
6477,CHEMBL2165065,N#Cc1ccc2ccc(=O)n(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](F)C3)c2c1,IC50,nM,=,199000.0,Inhibition of human ERG by Ionworks assay
6478,CHEMBL2165064,N#Cc1ccc2ccc(=O)n(CCN3CC[C@H](NCc4cc5c(cn4)OCCO5)[C@H](F)C3)c2c1,IC50,nM,=,233000.0,Inhibition of human ERG by Ionworks assay
6479,CHEMBL2165063,COc1ccc2ncc(=O)n(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,=,35000.0,Inhibition of human ERG by Ionworks assay
6480,CHEMBL2165062,N#Cc1ccc2ccc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,44000.0,Inhibition of human ERG by Ionworks assay
6481,CHEMBL2165819,Nc1c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)cnc2ccnn12,IC50,nM,>,300000.0,Inhibition of human ERG by manual patch clamp assay
6482,CHEMBL2165065,N#Cc1ccc2ccc(=O)n(CCN3CC[C@@H](NCc4cc5c(cn4)OCCO5)[C@@H](F)C3)c2c1,IC50,nM,>,200000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by liquid scintillation counter
6483,CHEMBL2165070,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCCCCCc3ccccc3)c2)s1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins by automated patch clamp assay
6484,CHEMBL2165094,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCCCCCc3ccccc3)c2)o1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins by automated patch clamp assay
6485,CHEMBL2165084,NC(=O)c1ccn(-c2cccc(OC(=O)NCCCCCCc3ccccc3)c2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins by automated patch clamp assay
6486,CHEMBL2165083,C#CCCCCCCCCCNC(=O)Oc1cccc(-n2ccc(C(N)=O)c2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins by automated patch clamp assay
6487,CHEMBL2164422,O=S(=O)(NCCO)c1ccc(-c2ccnc3[nH]c(C4CC4)cc23)cc1,IC50,nM,>,50118.72,Inhibition of human ERG
6488,CHEMBL2164443,CS(=O)(=O)c1ccc(C(CC2CCCC2)C(=O)Nc2nccs2)cc1F,IC50,nM,=,23000.0,Inhibition of human ERG
6489,CHEMBL2164761,CS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2cnccn2)cc1Cl,IC50,nM,=,7300.0,Inhibition of human ERG
6490,CHEMBL2164212,Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NCc2ccc(C(=O)O)cc2)CC1,IC50,nM,>,50000.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6491,CHEMBL2164211,COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1,IC50,nM,>,40000.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6492,CHEMBL2164210,CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2Cl)CC1,IC50,nM,=,10800.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6493,CHEMBL2164208,CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C(=O)NC(C)C)nc2C)CC1,IC50,nM,=,33000.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6494,CHEMBL2164207,CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2Cl)CC1,IC50,nM,=,300.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6495,CHEMBL2164206,CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1,IC50,nM,=,5500.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6496,CHEMBL2164220,Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC#N)CC1,IC50,nM,=,16000.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6497,CHEMBL2164219,COCC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1,IC50,nM,=,8400.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6498,CHEMBL2164203,CNC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1,IC50,nM,=,1600.0,Inhibition of human recombinant hERG expressed in CHO cells by automated patch clamp assay
6499,CHEMBL2164389,O=C(NCc1ccc(OC(F)(F)F)cc1)C1c2ccccc2C(=O)N1CCc1ccccn1,IC50,nM,=,4600.0,Inhibition of human ERG
6500,CHEMBL2164571,CCN(CCO)C(=O)c1cc2cccnn2c1-c1cccc(C)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6501,CHEMBL2164565,CCN(CCO)C(=O)c1cc2cccnn2c1-c1cccc(C(F)(F)F)c1,IC50,nM,=,23442.29,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6502,CHEMBL2164887,N#Cc1cccc(-c2c(C(=O)N3CCCCC3CO)cc3ccccn23)c1,IC50,nM,=,24547.09,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6503,CHEMBL2164886,COc1cccc(-c2c(C(=O)N3CCCCC3CO)cc3ccccn23)c1,IC50,nM,>,33113.11,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6504,CHEMBL2164884,CCN(CCO)C(=O)c1cc2ccccn2c1-c1cccc(OC)n1,IC50,nM,>,33113.11,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6505,CHEMBL2164883,CCN(CCO)C(=O)c1cc2ccccn2c1-c1cccc(OC)c1,IC50,nM,>,33113.11,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6506,CHEMBL2171024,O=C(O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6507,CHEMBL2170804,CS(=O)(=O)O.OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp technique
6508,CHEMBL2171013,Cc1ccc(S(=O)(=O)N(C)C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,=,316.23,Inhibition of human ERG expressed in CHO cells by IonworksHT assay
6509,CHEMBL2171014,Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)NS(=O)(=O)c4ccc(N(C)C)cc4)CC3)CC2)c1Cl,IC50,nM,>,19952.62,Inhibition of human ERG expressed in CHO cells by IonworksHT assay
6510,CHEMBL2171016,Cc1c(Cl)ccc(OC2CCN(C3CCN(S(=O)(=O)NC(=O)c4ccccc4)CC3)CC2)c1Cl,IC50,nM,=,3981.07,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6511,CHEMBL2171015,O=C(NS(=O)(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1)c1ccccc1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6512,CHEMBL2171048,Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4C)CC3)CC2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6513,CHEMBL2171040,COc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6514,CHEMBL2171038,Cc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6515,CHEMBL2171035,O=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6516,CHEMBL2158814,Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1,IC50,nM,>,15848.93,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6517,CHEMBL2171033,O=C(NS(=O)(=O)c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiological ion flux assay
6518,CHEMBL2171419,Cl.Fc1cc(C(Oc2ccccc2)C2CNC2)ccc1Cl,IC50,nM,=,1560.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp technique
6519,CHEMBL2171418,Cl.Clc1ccc(OC(c2ccc3ccccc3c2)C2CNC2)cc1Cl,IC50,nM,=,180.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp technique
6520,CHEMBL2171417,Cl.c1ccc(OC(c2ccc3ccccc3c2)C2CNC2)cc1,IC50,nM,=,830.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp technique
6521,CHEMBL2171416,CCCOC(c1ccc2ccccc2c1)C1CNC1.Cl,IC50,nM,=,980.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp technique
6522,CHEMBL2171415,CCCOC(c1ccc(Cl)c(Cl)c1)C1CNC1.Cl,IC50,nM,=,2200.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp technique
6523,CHEMBL2172192,CNc1nn2cc3c(nc2c1S(=O)(=O)c1ccccc1)CCN(C)C3,IC50,nM,=,500.0,Inhibition of human recombinant ERG channel expressed in HEK297 cells after 3 to 8 mins by voltage clamp assay
6524,CHEMBL2172186,CNc1nn2c3c(cnc2c1S(=O)(=O)c1ccccc1)CN(C)CC3,IC50,nM,=,54200.0,Inhibition of human recombinant ERG channel expressed in HEK297 cells after 3 to 8 mins by voltage clamp assay
6525,CHEMBL2170051,Cc1cc(SCCN2CCOCC2)nn1-c1ccc(Cl)c(Cl)c1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6526,CHEMBL2170070,Cc1cc(OCCN2C[C@H](C)O[C@H](C)C2)nn1-c1ccc2ccccc2c1,IC50,nM,=,7400.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6527,CHEMBL2170066,c1cn(C2CCCCC2)nc1OCCN1CCOCC1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6528,CHEMBL2170063,c1ccc2cc(-n3ccc(OCCN4CCOCC4)n3)ccc2c1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6529,CHEMBL2170062,Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6530,CHEMBL2170061,Cc1cc(OCCN2CCOCC2)nn1-c1ccc(Cl)cc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6531,CHEMBL2170213,CC(=O)C1CCN(CCOc2ccn(-c3ccc(Cl)c(Cl)c3)n2)CC1,IC50,nM,=,4500.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6532,CHEMBL2170232,CCOC(=O)N1CCN(CCOc2cc(C)n(-c3ccc(Cl)c(Cl)c3)n2)CC1,IC50,nM,=,4100.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6533,CHEMBL2170231,Cc1cc(OCCN2CCN(C)CC2)nn1-c1ccc(Cl)c(Cl)c1,IC50,nM,=,7400.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6534,CHEMBL2170225,Cc1cc(OCCN2CCOCC2)nn1-c1ccc(Cl)c(Cl)c1,IC50,nM,=,3500.0,Inhibition of human ERG transfected in HEK293 cell membranes by whole cell patch clamp assay
6535,CHEMBL2170617,Cn1ccnc1C(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6536,CHEMBL2170605,CC(C)(C)C(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,IC50,nM,=,27000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6537,CHEMBL2170608,COCC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6538,CHEMBL2170609,CCC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6539,CHEMBL2170610,CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6540,CHEMBL2170630,N#Cc1cccc(C(=O)N2CCC(c3ccc(C(=O)NC(=N)N)cc3C(F)(F)F)CC2)c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6541,CHEMBL2170611,CC(=O)N1CCC(c2cc(C)c(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,IC50,nM,=,7000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6542,CHEMBL2170629,N#Cc1ccc(C(=O)N2CCC(c3ccc(C(=O)NC(=N)N)cc3C(F)(F)F)CC2)cc1,IC50,nM,=,4000.0,Inhibition of human ERG expressed in HEK 293 cells by PatchXpress assay
6543,CHEMBL2170294,Cc1ccccc1-n1nc(-c2c(-c3ccc(F)cc3)nn3c2NC[C@@H](CO)C3)ccc1=O,IC50,nM,>,100000.0,Inhibition of human ERG by Rb ion flux assay
6544,CHEMBL2170299,C[C@H]1CCCCN1CCCNCc1ccc(CNCCCN2CCCC[C@H]2C)cc1.Cl,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells after 5 mins by whole-cell patch clamp assay
6545,CHEMBL2311028,Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells after 5 mins by whole-cell patch clamp assay
6546,CHEMBL2170444,C[C@@H]1CCCCN1CCCNCc1ccc(CNCCCN2CCCC[C@H]2C)cc1.Cl,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells after 5 mins by whole-cell patch clamp assay
6547,CHEMBL2179806,C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(C(=O)NCc4ccc(C(C)(C)C)cc4)c3)c3c(N)ncnc32)C1,IC50,nM,=,1800.0,Displacement of dofetilide from human ERG
6548,CHEMBL2179805,C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(C(=O)Nc4ccc(C(C)C)c(C)c4)c3)c3c(N)ncnc32)C1,IC50,nM,=,300.0,Displacement of dofetilide from human ERG
6549,CHEMBL2179804,C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(C(=O)Nc4ccc(C(C)C)cc4)c3)c3c(N)ncnc32)C1,IC50,nM,=,1100.0,Displacement of dofetilide from human ERG
6550,CHEMBL2181207,CCCN1CNc2cc(Nc3ccnc4cc(Cl)ccc34)ccc2C1,IC50,nM,=,22.0,Inhibition of human ERG expressed in rat after 2 to 3 days by patch clamp assay
6551,CHEMBL2177588,CN1C[C@@H](C(=O)Nc2ccc(Cl)cc2)[C@H](c2ccc(/C=C/C(=O)Nc3ccccc3N)cc2)C1,IC50,nM,=,5000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
6552,CHEMBL2177582,CN1C[C@H](c2ccc(/C=C/C(=O)Nc3ccccc3N)cc2F)[C@@H](C(=O)Nc2ccc(Cl)cc2)C1,IC50,nM,=,7000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
6553,CHEMBL2178223,CC(C)(O)CN1C[C@H](c2ccc(/C=C/C(=O)Nc3ccccc3N)cc2)[C@@H](C(=O)Nc2ccc(Cl)cc2)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells by patch clamp method
6554,CHEMBL2178221,Nc1ccccc1NC(=O)/C=C/c1ccc([C@H]2CN(CCO)C[C@@H]2C(=O)Nc2ccc(Cl)cc2)cc1,IC50,nM,=,15000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
6555,CHEMBL2177587,CN1C[C@H](c2ccc(/C=C/C(=O)Nc3ccccc3N)cc2)[C@@H](C(=O)Nc2ccc(Cl)cc2)C1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
6556,CHEMBL2181880,CO[C@H](C)C(=O)N[C@@H](Cc1ccc2c(c1)OCO2)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21,IC50,nM,=,23700.0,Inhibition of human ERG
6557,CHEMBL2164575,Cc1ccc2c(c1C)N(S(=O)(=O)c1ccc(C(C)(C)C)cc1)Cc1ccc(C(F)(F)F)nc1N2,IC50,nM,>,10000.0,Inhibition of human ERG
6558,CHEMBL2177305,CCn1cc([C@]2(c3cccc(NC(=O)c4ccc(Cl)cn4)c3)N=C(N)c3c(F)cccc32)cc(C)c1=O,IC50,nM,=,1300.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6559,CHEMBL2177304,CCn1cc([C@]2(c3cccc(C#CC4CC4)c3)N=C(N)c3c(F)cccc32)cc(C)c1=O,IC50,nM,=,8500.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6560,CHEMBL2177303,CC#Cc1cncc(-c2cccc([C@@]3(c4cc(C)c(=O)n(CC)c4)N=C(N)c4c(F)cc(F)cc43)c2)c1,IC50,nM,=,3100.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6561,CHEMBL2152903,CC#Cc1cncc(-c2cccc([C@@]3(c4cc(C)c(=O)n(CC)c4)N=C(N)c4c(F)cccc43)c2)c1,IC50,nM,=,2800.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6562,CHEMBL2177302,CCn1cc(C2(c3cccc(-c4cncc(C#N)c4)c3)N=C(N)c3c(F)cccc32)cc(C)c1=O,IC50,,,,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6563,CHEMBL2177301,CCn1cc(C2(c3cccc(-c4cncc(F)c4)c3)N=C(N)c3c(F)cccc32)cc(C)c1=O,IC50,nM,=,2700.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6564,CHEMBL2177920,CCn1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3c(F)cccc32)cc(C)c1=O,IC50,nM,=,15000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6565,CHEMBL2177919,Cc1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3c(F)cccc32)cn(C)c1=O,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6566,CHEMBL2177918,COc1c(C)cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3c(F)cccc32)cc1C#N,IC50,nM,=,2100.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6567,CHEMBL2177917,COc1c(C)cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3c(F)cccc32)nc1C,IC50,nM,=,3800.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6568,CHEMBL2177916,COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3c(F)cccc32)cc1,IC50,nM,=,500.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6569,CHEMBL2177915,CC#Cc1cncc(-c2cccc(C3(c4ccnc(C(F)F)c4)N=C(N)c4c(F)cccc43)c2)c1,IC50,nM,=,2900.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6570,CHEMBL2177914,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cc(F)cc(F)c21,IC50,nM,=,19000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6571,CHEMBL2177913,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6572,CHEMBL2177912,NC1=NC(c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,IC50,nM,=,7200.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6573,CHEMBL2177911,COc1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3c(F)cccc32)ccn1,IC50,nM,=,2200.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6574,CHEMBL2177113,NC1=NC(c2cccc(-c3cncnc3)c2)(c2ccnc(C3CC3)c2)c2cccc(F)c21,IC50,nM,=,3500.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6575,CHEMBL2177910,Cc1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3c(F)cccc32)cc(C)n1,IC50,nM,=,6400.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6576,CHEMBL2177909,NC1=N[C@](c2ccnc(C(F)(F)F)c2)(c2ccc(F)c(-c3cncnc3)c2)c2cccc(F)c21,IC50,nM,=,7900.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6577,CHEMBL2177908,NC1=NC(c2ccnc(C(F)(F)F)c2)(c2ccc(F)c(-c3cncnc3)c2)c2cccc(F)c21,IC50,nM,=,16000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6578,CHEMBL2177907,N#Cc1cncc(-c2cccc(C3(c4ccnc(C(F)(F)F)c4)N=C(N)c4c(F)cccc43)c2)c1,IC50,nM,=,1700.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6579,CHEMBL2177906,NC1=NC(c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)(F)F)c2)c2cccc(F)c21,IC50,nM,=,11000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6580,CHEMBL2177905,NC1=NC(c2ccncc2)(c2cccc(-c3cncc(F)c3)c2)c2cccc(F)c21,IC50,nM,=,1600.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6581,CHEMBL2177904,NC1=N[C@](c2ccncc2)(c2cccc(-c3cncnc3)c2)c2cccc(F)c21,IC50,nM,=,3100.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6582,CHEMBL2177309,NC1=NC(c2ccncc2)(c2cccc(-c3cncnc3)c2)c2cccc(F)c21,IC50,nM,=,5700.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6583,CHEMBL2177308,NC1=NC(c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)(F)F)c2)c2ccccc21,IC50,nM,=,5500.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6584,CHEMBL2177307,NC1=NC(c2ccncc2)(c2cccc(-c3cncnc3)c2)c2ccccc21,IC50,nM,=,16000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6585,CHEMBL2151218,COc1cc(Nc2cccc3c2nc(-c2ccc(F)cc2)n3C)ccc1-n1cnc(C)c1,IC50,nM,=,2000.0,Displacement of [3H]dofetilide to human ERG expressed in HEK293 cells
6586,CHEMBL2178524,Cc1cn(-c2ccc(Nc3cccc4c3nc(-c3ccc(F)cc3)n4C)cc2F)cn1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide to human ERG expressed in HEK293 cells
6587,CHEMBL2178523,Cc1cn(-c2ccc(Nc3cccc4c3nc(-c3ccc(F)cc3)n4C)cn2)cn1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide to human ERG expressed in HEK293 cells
6588,CHEMBL2178522,Cc1cn(-c2ccc(Nc3cccc4c3nc(-c3ccc(F)cc3)n4C)nc2)cn1,IC50,nM,=,5200.0,Displacement of [3H]dofetilide to human ERG expressed in HEK293 cells
6589,CHEMBL2178521,COc1cc(Nc2cccc3c2nc(-c2ccc(F)cc2)n3C)cnc1-n1cnc(C)c1,IC50,nM,=,1800.0,Displacement of [3H]dofetilide to human ERG expressed in HEK293 cells
6590,CHEMBL2178520,COc1cc(Nc2cccc3c2nc(-c2ccc(F)cc2)n3C)ncc1-n1cnc(C)c1,IC50,,,,Displacement of [3H]dofetilide to human ERG expressed in HEK293 cells
6591,CHEMBL2151164,COc1nc(Nc2cccc3c2nc(-c2ccc(F)cc2)n3C)ccc1-n1cnc(C)c1,IC50,nM,=,8500.0,Displacement of [3H]dofetilide to human ERG expressed in HEK293 cells
6592,CHEMBL2180528,CC(C)[C@@H](NC(=O)c1ccccc1)C(=O)N1CCC(c2ccc(Cl)cc2)CC1,IC50,nM,=,7000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current by whole cell patch clamp assay
6593,CHEMBL250689,CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1,IC50,nM,=,400.0,Inhibition of human ERG
6594,CHEMBL2180015,CC#Cc1ccnc(-c2cc(C3(C4CC4)N=C(C)C(N)=N3)ccc2O)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6595,CHEMBL2180014,CC#Cc1cncc(-c2cc(C3(C4CC4)N=C(C)C(N)=N3)ccc2O)c1,IC50,nM,=,24500.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6596,CHEMBL2180037,CC#Cc1cncc(-c2cccc(C3(C4CC4)N=C(C)C(N)=N3)c2)c1,IC50,nM,=,14400.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6597,CHEMBL2180036,COc1cccc(-c2cccc(C3(C4CCN(C(C)=O)CC4)N=C(C)C(N)=N3)c2)c1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6598,CHEMBL2180035,COc1cccc(-c2cccc(C3(C4CCOCC4)N=C(C)C(N)=N3)c2)c1,IC50,nM,=,21000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6599,CHEMBL2180034,CC1=NC(c2cccc(-c3cccnc3)c2)(C2CCCCC2)N=C1N,IC50,nM,=,28800.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6600,CHEMBL2180033,CC1=NC(c2cccc(-c3cncc(Cl)c3)c2)(C2CC2)N=C1N,IC50,nM,=,12400.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6601,CHEMBL2180032,CC1=N[C@@](Cc2ccccc2)(c2cccc(-c3cncnc3)c2)N=C1N,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6602,CHEMBL2180031,CC#Cc1cncc(-c2cccc(C3(c4cc(C)c(OC)c(C)c4)N=C(C)C(N)=N3)c2)c1,IC50,nM,=,17500.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6603,CHEMBL2180030,COc1c(C)cc([C@@]2(c3cccc(-c4cncnc4)c3)N=C(C)C(N)=N2)cc1C,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6604,CHEMBL2180029,COc1c(C)cc([C@]2(c3cccc(-c4cncnc4)c3)N=C(C)C(N)=N2)cc1C,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6605,CHEMBL2180028,COc1c(C)cc(C2(c3cccc(-c4cncnc4)c3)N=C(C)C(N)=N2)cc1C,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6606,CHEMBL2180027,COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(C)C(N)=N2)cc1C,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6607,CHEMBL2180026,COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(C)C(N)=N2)cc1,IC50,nM,=,19000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6608,CHEMBL2180025,COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(C)C(N)=N2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6609,CHEMBL2180024,CC1=NC(c2ccc(F)cc2)(c2cccc(-c3cccnc3)c2)N=C1N,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6610,CHEMBL2180023,COc1cccc(-c2cccc(C3(c4ccncc4)N=C(C)C(N)=N3)c2)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6611,CHEMBL2180022,CC1=NC(c2ccccc2)(c2cccc(-c3cccnc3)c2)N=C1N,IC50,,,,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6612,CHEMBL2180021,COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(N)C(C(C)C)=N2)cc1,IC50,nM,=,26800.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6613,CHEMBL2180020,CC(C)C1=NC(c2ccccc2)(c2cccc(-c3cncnc3)c2)N=C1N,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6614,CHEMBL2180019,CC1=NC(C)(c2cccc(-c3cccnc3)c2)N=C1N,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6615,CHEMBL2180018,COc1cccc(-c2cccc(C3(C)N=C(C)C(N)=N3)c2)c1,IC50,nM,=,16700.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6616,CHEMBL2180017,CC(C)C1=NC(C)(c2cccc(-c3cccnc3)c2)N=C1N,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6617,CHEMBL2180016,CC1(c2cccc(-c3cccnc3)c2)N=C(N)C(c2ccccc2)=N1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IonWorks assay
6618,CHEMBL2180839,CC(C)(C)c1cc(NC(=O)CCCN2CCCCC2)[nH]n1,IC50,,,,Inhibition of human ERG expressed in CHO cells
6619,CHEMBL2180842,O=C(CCCN1CCCCC1)Nc1cc(-c2cncc(F)c2)n[nH]1,IC50,nM,=,15800.0,Inhibition of human ERG expressed in CHO cells
6620,CHEMBL2180835,COc1ccc(-c2cc(NC(=O)CCCN3CCCCC3)[nH]n2)cc1,IC50,nM,=,4610.0,Inhibition of human ERG expressed in CHO cells
6621,CHEMBL2180840,COc1cccc(-c2cc(NC(=O)CCCN3CCCCC3)[nH]n2)c1,IC50,nM,=,3080.0,Inhibition of human ERG expressed in CHO cells
6622,CHEMBL2180841,O=C(CCCN1CCCCC1)Nc1cc(-c2cccc(F)c2)n[nH]1,IC50,nM,=,1290.0,Inhibition of human ERG expressed in CHO cells
6623,CHEMBL2178953,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,IC50,nM,>,32000.0,Inhibition of human ERG
6624,CHEMBL2180070,C[C@H](c1nc2c(cnn2C2CCCC2)c(=O)[nH]1)N1CC(c2ncccn2)C1,IC50,nM,=,53500.0,Inhibition of human ERG
6625,CHEMBL2179510,Cc1noc(-c2ccc3c(c2)c2c(n3CCCSc3cc(F)cc(F)c3)CCCC2)n1,IC50,nM,>,10000.0,Inhibition of human ERG
6626,CHEMBL2177609,CC(C)(C)c1c(C(=O)NC2C3CC4CC(C3)CC2C4)cnn1-c1ccc(C(=O)O)cc1,IC50,nM,>,100000.0,Inhibition of human ERG
6627,CHEMBL1258006,O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1,IC50,nM,=,54000.0,Inhibition of human ERG expressed in CHO cells by whole cell voltage clamp assay
6628,CHEMBL2179670,CC(=O)Nc1ccc(CCN2CCC(COc3nc4ccccc4c4cn(C)cc34)CC2)cc1,IC50,nM,=,20.0,Inhibition of human ERG
6629,CHEMBL2179671,COCc1ccc(CCN2CCC(COc3nc4ccccc4c4cn(C)cc34)CC2)cc1,IC50,nM,=,20.0,Inhibition of human ERG
6630,CHEMBL2179672,Cn1cc2c(OCC3CCN(CCc4ccc(CO)cc4)CC3)nc3ccccc3c2c1,IC50,nM,=,10.0,Inhibition of human ERG
6631,CHEMBL2179674,Cn1cc2c(OCC3CCN(CCc4ccc(C(=O)O)cc4)CC3)nc3ccccc3c2c1,IC50,nM,=,9960.0,Inhibition of human ERG
6632,CHEMBL2179675,Cl.Cn1cc2c(OCC3CCN(CCc4ccc(N)cc4)CC3)nc3ccccc3c2c1,IC50,nM,=,50.0,Inhibition of human ERG
6633,CHEMBL2179676,Cl.Cn1cc2c(OCC3CCN(CCN4CCOCC4)CC3)nc3ccccc3c2c1,IC50,nM,=,1220.0,Inhibition of human ERG
6634,CHEMBL2179707,CC(C)n1nc(C(=O)NCC2CCN(CCc3ccc(C(=O)O)cc3)CC2)c2ccccc21,IC50,nM,>,100000.0,Inhibition of human ERG
6635,CHEMBL3216126,CC(C)n1nc(C(=O)NCC2CCN(CCc3ccc(N)cc3)CC2)c2ccccc21.Cl.Cl,IC50,nM,=,22600.0,Inhibition of human ERG
6636,CHEMBL2179702,CC(C)n1nc(C(=O)NCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc21.Cl,IC50,nM,=,2630.0,Inhibition of human ERG
6637,CHEMBL2181486,COc1ccc(-c2cc(-c3ccc(C(=O)N4CCN(C)CC4)cc3)cnc2N)cn1,IC50,nM,=,20500.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6638,CHEMBL2181488,Nc1ncc(-c2ccc(C(=O)N3CCOCC3)cc2)cc1-c1ccc(C(F)(F)F)nc1,IC50,nM,=,20200.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6639,CHEMBL2181297,Nc1ncc(-c2ccc(C(=O)N3CCNCC3)cc2)cc1-c1ccc(C(F)(F)F)nc1,IC50,nM,=,19700.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6640,CHEMBL2181296,CN1CCN(C(=O)c2ccc(-c3cnc(N)c(-c4ccc(C(F)(F)F)cc4)c3)cc2)CC1,IC50,nM,=,16300.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6641,CHEMBL2181497,COc1ccc(-c2cc(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)cnc2N)cn1,IC50,nM,=,10400.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6642,CHEMBL2181492,COc1ccc(-c2cc(-c3ccc(S(=O)(=O)N(C)C)cc3)cnc2N)cn1,IC50,nM,=,9700.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6643,CHEMBL2181490,CN1CCN(C(=O)c2ccc(-c3cnc(N)c(-c4ccc(C(F)(F)F)nc4)c3)cc2)CC1,IC50,nM,=,8200.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6644,CHEMBL2181298,Nc1ncc(-c2ccc(C(=O)N3CCNCC3)cc2)cc1-c1ccc(C(F)(F)F)cc1,IC50,nM,=,5500.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6645,CHEMBL2181489,Nc1ncc(-c2ccc(C(=O)N3CCOCC3)cc2)cc1-c1ccc(C(F)(F)F)cc1,IC50,nM,=,3000.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6646,CHEMBL2181495,COc1ccc(-c2cc(-c3ccc(S(=O)(=O)NC4CC4)cc3)cnc2N)cn1,IC50,nM,=,2100.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6647,CHEMBL2181487,COc1ccc(-c2cc(-c3ccc(C(=O)N4CCOCC4)cc3)cnc2N)cn1,IC50,nM,>,11000.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6648,CHEMBL2181481,COc1ccc(-c2cc(-c3ccc(C(=O)N(C)C)cc3)cnc2N)cn1,IC50,nM,>,11000.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6649,CHEMBL2181496,COc1ccc(-c2cc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)cnc2N)cn1,IC50,nM,>,11000.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6650,CHEMBL2181493,CNS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(OC)nc3)c2)cc1,IC50,nM,>,11000.0,Inhibition of human ERG expressed in chinese hamster lung cells by IonWorks patch clamp electrophysiology assay
6651,CHEMBL3215681,CC(C)n1nc(C(=O)NCC2CCN(CCN3CCOCC3)CC2)c2ccccc21.Cl.Cl,IC50,nM,=,32500.0,Inhibition of human ERG
6652,CHEMBL1084000,CN(C)CCCCc1ccc(C2(C)COC2)cc1,IC50,nM,=,35000.0,Inhibition of human ERG
6653,CHEMBL1083999,CN(C)CCCCc1ccc(C(C)(C)C)cc1,IC50,nM,=,7500.0,Inhibition of human ERG
6654,CHEMBL2203713,N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1,IC50,nM,=,160000.0,Displacement of [3H]astemizole from human recombinant ERG expressed in HEK293 cells
6655,CHEMBL2203713,N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1,IC50,nM,=,13000.0,Inhibition of human recombinant ERG expressed in HEK293 cells after 5 to 10 mins by conventional whole-cell patch clamp assay
6656,CHEMBL2206288,c1cc([C@H]2C[C@@H](CN3CCOCC3)C2)ccc1CN1CCCC1,IC50,nM,=,300000.0,Inhibition of human Erg expressed in human HEK293 cells
6657,CHEMBL2203769,Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(N6CCN[C@@H](C)C6)cc5)nc34)CC2)no1,IC50,,,,Inhibition of human ERG by cell-based electrophysiology assay
6658,CHEMBL2203768,COCCN1CCN(c2ccc(-c3nc4c(N5CCN(Cc6cc(C)on6)CC5)c(Br)cnc4[nH]3)cc2)CC1,IC50,,,,Inhibition of human ERG by cell-based electrophysiology assay
6659,CHEMBL2203767,CCN1CCN(c2ccc(-c3nc4c(N5CCN(Cc6cc(C)on6)CC5)c(Cl)cnc4[nH]3)cc2)CC1,IC50,,,,Inhibition of human ERG by cell-based electrophysiology assay
6660,CHEMBL2203766,CC(=O)N1CCN(c2ccc(-c3nc4c(N5CCN(Cc6cc(C)on6)CC5)c(Br)cnc4[nH]3)cc2)CC1,IC50,,,,Inhibition of human ERG by cell-based electrophysiology assay
6661,CHEMBL2207500,Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ncon4)CC3)c(Cl)cnc2[nH]1,IC50,nM,=,11000.0,Inhibition of human ERG by cell-based electrophysiology assay
6662,CHEMBL2207501,Cc1nc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)CC2)no1,IC50,nM,=,9500.0,Inhibition of human ERG by cell-based electrophysiology assay
6663,CHEMBL2203775,Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cccc(N6CCN(C)CC6)c5)nc34)CC2)no1,IC50,nM,=,9500.0,Inhibition of human ERG by cell-based electrophysiology assay
6664,CHEMBL2207518,Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)CC2)no1,IC50,nM,=,6300.0,Inhibition of human ERG by cell-based electrophysiology assay
6665,CHEMBL1236904,Cc1cc(CN2CCN(c3c(Br)cnc4nc(-c5ccc(N6CCN(C)CC6)cc5)[nH]c34)CC2)no1,IC50,nM,=,3000.0,Inhibition of human ERG by cell-based electrophysiology assay
6666,CHEMBL2203764,Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C5CC5)nc34)CC2)no1,IC50,nM,=,2500.0,Inhibition of human ERG by cell-based electrophysiology assay
6667,CHEMBL1651456,Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(N6CCN(C)CC6)cc5)nc34)CC2)no1,IC50,nM,=,2300.0,Inhibition of human ERG by cell-based electrophysiology assay
6668,CHEMBL2203765,Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(N6CCOCC6)cc5)nc34)CC2)no1,IC50,nM,>,33000.0,Inhibition of human ERG by cell-based electrophysiology assay
6669,CHEMBL2207503,Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1,IC50,nM,>,25000.0,Inhibition of human ERG by whole-cell voltage clamping
6670,CHEMBL2204267,CSc1ncc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)s1,IC50,nM,=,6000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6671,CHEMBL2204266,CC(C)Oc1ncc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)s1,IC50,nM,=,28000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6672,CHEMBL2204265,CC(C)c1ncc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)s1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6673,CHEMBL2204264,CCc1ncc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)s1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6674,CHEMBL2204263,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6675,CHEMBL2204262,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3nc4ccccc4s3)CC2)C1,IC50,nM,=,6200.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6676,CHEMBL2204261,Cc1cnc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)s1,IC50,nM,=,28000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6677,CHEMBL2204260,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3ccns3)CC2)C1,IC50,nM,=,24000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6678,CHEMBL2204259,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3nccs3)CC2)C1,IC50,nM,=,32000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6679,CHEMBL2204258,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3cccs3)CC2)C1,IC50,nM,=,27000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6680,CHEMBL2204257,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3nncs3)CC2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6681,CHEMBL2204256,Cn1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)n1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6682,CHEMBL2204255,Cn1ccnc1[C@]1(O)CC[C@H](N2CC(NC(=O)CNC(=O)c3cccc(C(F)(F)F)c3)C2)CC1,IC50,nM,=,15000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6683,CHEMBL2204254,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3ncco3)CC2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6684,CHEMBL2204253,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3ccc(OC4CCC4)nc3)CC2)C1,IC50,nM,=,9800.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6685,CHEMBL2204252,CC(C)(C)Oc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,5500.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6686,CHEMBL2204251,CC(C)Oc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,11200.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6687,CHEMBL2204250,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3ccc(OCC(F)(F)F)nc3)CC2)C1,IC50,nM,=,7000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6688,CHEMBL2204249,CCOc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,14500.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6689,CHEMBL2204248,COc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)nc1,IC50,nM,=,25000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6690,CHEMBL2204247,COc1cccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)n1,IC50,nM,=,17500.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6691,CHEMBL2204246,COc1ncc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cc1C,IC50,nM,=,21600.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6692,CHEMBL2204245,CN(C)c1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,22500.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6693,CHEMBL2204244,COc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,37000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6694,CHEMBL2204243,Cc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,35000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6695,CHEMBL2204242,N#Cc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNC(=O)c4cccc(C(F)(F)F)c4)C3)CC2)cn1,IC50,nM,=,12500.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6696,CHEMBL2204270,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3ccc(F)nc3)CC2)C1,IC50,nM,=,10000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6697,CHEMBL2204269,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3cncnc3)CC2)C1,IC50,nM,=,43800.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 1 hr by scintillation counting analysis
6698,CHEMBL2203585,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N[C@H]3CCCC[C@@H]3O)c(=O)n3ccccc23)CC1,IC50,nM,=,16400.0,Binding affinity to human ERG
6699,CHEMBL2204278,O=C(N[C@H]1CCCC[C@@H]1O)c1cc(CN2CCN(c3cc4scnc4cn3)CC2)c2ccccn2c1=O,IC50,nM,=,13100.0,Binding affinity to human ERG
6700,CHEMBL2204276,Cc1ccc(N2CCN(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)c(=O)n4ccccc34)CC2)nc1,IC50,nM,=,11500.0,Binding affinity to human ERG
6701,CHEMBL2203589,N#CC1(c2ccccc2)CCN(Cc2cc(C(=O)N[C@H]3CCCC[C@@H]3O)c(=O)n3ccccc23)CC1,IC50,nM,=,5100.0,Binding affinity to human ERG
6702,CHEMBL2204277,O=C(N[C@H]1CCCC[C@@H]1O)c1cc(CN2CCN(c3cc4ccccc4cn3)CC2)c2ccccn2c1=O,IC50,nM,=,2000.0,Binding affinity to human ERG
6703,CHEMBL2204275,N#Cc1ccc(N2CCN(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)c(=O)n4ccccc34)CC2)cc1,IC50,nM,=,390.0,Binding affinity to human ERG
6704,CHEMBL2203846,CSc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1,IC50,nM,=,8000.0,Inhibition of human ERG overexpressed in HEK cells
6705,CHEMBL2203845,COc1cc(Nc2cnc(C#N)c(O[C@@H]3CCN(C)C3)n2)ncc1-c1cnn(C)c1,IC50,nM,=,16000.0,Inhibition of human ERG overexpressed in HEK cells
6706,CHEMBL2203844,COc1cc(Nc2cnc(C#N)c(O[C@@H]3CCNC3)n2)ncc1-c1cnn(C)c1,IC50,,,,Inhibition of human ERG overexpressed in HEK cells
6707,CHEMBL2203843,COc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1,IC50,nM,=,5000.0,Inhibition of human ERG overexpressed in HEK cells
6708,CHEMBL2203842,CNc1cc(Nc2cnc(C#N)c(O[C@H]3CCN(C)C3)n2)ncc1-c1cnn(C)c1,IC50,nM,=,19000.0,Inhibition of human ERG overexpressed in HEK cells
6709,CHEMBL2203841,CNc1cc(Nc2cnc(C#N)c(O[C@@H]3CCN(C)C3)n2)ncc1-c1cnn(C)c1,IC50,nM,=,24000.0,Inhibition of human ERG overexpressed in HEK cells
6710,CHEMBL2203838,CNc1cc(Nc2cnc(C#N)c(O[C@@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1,IC50,,,,Inhibition of human ERG overexpressed in HEK cells
6711,CHEMBL2204592,CNc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1,IC50,nM,=,12000.0,Inhibition of human ERG overexpressed in HEK cells
6712,CHEMBL2204589,C#Cc1cnc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)cc1NC,IC50,nM,=,8000.0,Inhibition of human ERG overexpressed in HEK cells
6713,CHEMBL2204588,CNc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1C1CC1,IC50,nM,=,6000.0,Inhibition of human ERG overexpressed in HEK cells
6714,CHEMBL2204587,CNc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1C(F)(F)F,IC50,nM,=,1000.0,Inhibition of human ERG overexpressed in HEK cells
6715,CHEMBL2204586,CNc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1Cl,IC50,nM,=,1000.0,Inhibition of human ERG overexpressed in HEK cells
6716,CHEMBL2204583,COC(=O)c1cnc(Nc2cnc(C#N)c(O[C@@H]3CCNC3)n2)cc1N(C)C,IC50,nM,=,30000.0,Inhibition of human ERG overexpressed in HEK cells
6717,CHEMBL2203848,CNc1cc(Nc2cnc(C#N)c(O[C@@H]3CCNC3)n2)ncc1C(=O)OC,IC50,nM,=,16000.0,Inhibition of human ERG overexpressed in HEK cells
6718,CHEMBL2203847,CNc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1C(=O)OC,IC50,nM,=,5000.0,Inhibition of human ERG overexpressed in HEK cells
6719,CHEMBL1928705,C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N,IC50,nM,=,5000.0,Inhibition of human ERG overexpressed in HEK cells
6720,CHEMBL2207751,CC(=O)NC1CC2CCC(C1)N2Cc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
6721,CHEMBL2207750,CC(=O)N1CC2CC1CN2Cc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
6722,CHEMBL2207749,CC(=O)N1CC2CN(Cc3ccc(Oc4nc5ncccc5s4)cc3)CC2C1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
6723,CHEMBL2207752,NC(=O)C1CCN(Cc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
6724,CHEMBL2207747,CC(=O)NC1CC2CCC(C1)N2CCc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,=,4300.0,Inhibition of human ERG by patch clamp assay
6725,CHEMBL2207748,O=C1CCCN1C1CCN(Cc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
6726,CHEMBL2207744,O=C1CCCN1C1CCN(CCc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,=,2800.0,Inhibition of human ERG by patch clamp assay
6727,CHEMBL2207738,O=C1CCCN1C1CCN(CCOc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,=,2500.0,Inhibition of human ERG by patch clamp assay
6728,CHEMBL2207751,CC(=O)NC1CC2CCC(C1)N2Cc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6729,CHEMBL2207750,CC(=O)N1CC2CC1CN2Cc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6730,CHEMBL2207749,CC(=O)N1CC2CN(Cc3ccc(Oc4nc5ncccc5s4)cc3)CC2C1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6731,CHEMBL2207748,O=C1CCCN1C1CCN(Cc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6732,CHEMBL2207747,CC(=O)NC1CC2CCC(C1)N2CCc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,=,8300.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6733,CHEMBL2207746,CC(=O)N1CC2CC1CN2CCc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6734,CHEMBL2207745,CC(=O)N1CC2CN(CCc3ccc(Oc4nc5ncccc5s4)cc3)CC2C1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6735,CHEMBL2207744,O=C1CCCN1C1CCN(CCc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6736,CHEMBL2207743,NC(=O)C1CCN(CCc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6737,CHEMBL2207742,c1cnc2nc(Oc3ccc(CCN4CCCCC4)cc3)sc2c1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6738,CHEMBL2207741,CC(=O)NC1CC2CCC(C1)N2CCOc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6739,CHEMBL2207740,CC(=O)N1CC2CC1CN2CCOc1ccc(Oc2nc3ncccc3s2)cc1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6740,CHEMBL2207739,CC(=O)N1CC2CN(CCOc3ccc(Oc4nc5ncccc5s4)cc3)CC2C1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6741,CHEMBL2207738,O=C1CCCN1C1CCN(CCOc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6742,CHEMBL2207737,NC(=O)C1CCN(CCOc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6743,CHEMBL2207736,c1cnc2nc(Oc3ccc(OCCN4CCCCC4)cc3)sc2c1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6744,CHEMBL2207735,Fc1cnc2nc(Oc3ccc(CN4CCCCC4)cc3)sc2c1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6745,CHEMBL2207734,Clc1cnc2nc(Oc3ccc(CN4CCCCC4)cc3)sc2c1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6746,CHEMBL2207733,Cc1ccnc2nc(Oc3ccc(CN4CCCCC4)cc3)sc12,IC50,nM,=,8100.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6747,CHEMBL2207732,c1cc2sc(Oc3ccc(CN4CCCCC4)cc3)nc2cn1,IC50,,,,Inhibition of dofetilide binding to human ERG by patch clamp assay
6748,CHEMBL2207731,c1cc2nc(Oc3ccc(CN4CCCCC4)cc3)sc2cn1,IC50,,,,Inhibition of dofetilide binding to human ERG by patch clamp assay
6749,CHEMBL2207730,c1cnc2nc(Oc3ccc(CN4CCCCC4)cc3)sc2c1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6750,CHEMBL2207729,NC(=O)C1CCN(Cc2ccc(Oc3nc4cccnc4s3)cc2)CC1,IC50,,,,Inhibition of dofetilide binding to human ERG by patch clamp assay
6751,CHEMBL2207752,NC(=O)C1CCN(Cc2ccc(Oc3nc4ncccc4s3)cc2)CC1,IC50,nM,=,8900.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6752,CHEMBL517533,NC(=O)C1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,1500.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6753,CHEMBL479383,O=C(CO)NC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,=,9900.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6754,CHEMBL481280,O=C(O)C1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of dofetilide binding to human ERG by patch clamp assay
6755,CHEMBL2206792,COCC[C@H](Oc1ncnc2c1cnn2-c1ccccc1OC)C(=O)Nc1ccc(C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG
6756,CHEMBL2206791,COCC[C@H](Oc1ncnc2c1cnn2-c1ccccc1C(F)(F)F)C(=O)Nc1ccc(C)cn1,IC50,nM,=,26000.0,Inhibition of human ERG
6757,CHEMBL2206790,COCC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccc(C)cn1,IC50,nM,=,22000.0,Inhibition of human ERG
6758,CHEMBL2207663,Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in HEK cells by ion flux assay
6759,CHEMBL2207662,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)cc1C(F)(F)F,IC50,nM,=,10000.0,Inhibition of human ERG expressed in HEK cells by ion flux assay
6760,CHEMBL2207659,Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]nc2C(F)(F)F)CC1,IC50,nM,=,1258.93,Inhibition of human ERG expressed in HEK cells by ion flux assay
6761,CHEMBL2207658,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C(F)(F)F,IC50,nM,=,3162.28,Inhibition of human ERG expressed in HEK cells by ion flux assay
6762,CHEMBL2207665,Cn1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c(C(F)(F)F)cc1=O,IC50,nM,=,12589.25,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6763,CHEMBL2207664,Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)cc3C(F)(F)F)CC2)c1Cl,IC50,nM,=,5011.87,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6764,CHEMBL2207663,Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1,IC50,nM,=,10000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6765,CHEMBL2207662,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)cc1C(F)(F)F,IC50,nM,=,5011.87,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6766,CHEMBL2207661,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C1CC1,IC50,nM,=,2511.89,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6767,CHEMBL2207660,Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]nc3C(F)(F)F)CC2)c1Cl,IC50,nM,=,1995.26,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6768,CHEMBL2207659,Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]nc2C(F)(F)F)CC1,IC50,nM,=,3162.28,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6769,CHEMBL2207658,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C(F)(F)F,IC50,nM,=,3162.28,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6770,CHEMBL2207657,Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3c(F)cccc23)CC1,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6771,CHEMBL2207656,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2c(F)cccc12,IC50,nM,=,1995.26,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6772,CHEMBL2207655,CC1(O)CN(S(=O)(=O)c2ccc3c(C(=O)NC[C@@H](O)CN4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)c[nH]c(=O)c3c2)C1,IC50,nM,=,3162.28,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6773,CHEMBL2207654,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)N3CCC3)ccc12,IC50,nM,=,1000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6774,CHEMBL2207286,CN(C)S(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1,IC50,nM,=,1000.0,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6775,CHEMBL2207285,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NC3CC3)ccc12,IC50,nM,=,794.33,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6776,CHEMBL2207284,CNS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1,IC50,nM,=,1995.26,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6777,CHEMBL2207283,Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccc(S(C)(=O)=O)cc34)CC2)c1Cl,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6778,CHEMBL2207282,NS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1,IC50,nM,>,6309.57,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6779,CHEMBL2207281,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NCCO)ccc12,IC50,nM,=,5011.87,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6780,CHEMBL2207280,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccc(F)cc12,IC50,nM,=,1258.93,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6781,CHEMBL2207277,Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3ccc(S(C)(=O)=O)cc23)CC1,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6782,CHEMBL2207276,Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(S(C)(=O)=O)ccc23)CC1,IC50,nM,=,1995.26,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6783,CHEMBL2207672,Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4cc(S(C)(=O)=O)ccc34)CC2)c1Cl,IC50,nM,>,31622.78,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6784,CHEMBL2207671,CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1,IC50,nM,=,6309.57,"Displacement of 3,7-Bis[2-(4-nitro[3,5]-[3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3hrs"
6785,CHEMBL2204663,CCn1cc2c(Oc3cnc(C(=O)N4CCC4)c(F)c3)cc(C(=O)Nc3cnc(C)cn3)cc2n1,IC50,nM,>,300000.0,Inhibition of human ERG by patch clamp assay
6786,CHEMBL2207666,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12,IC50,nM,=,6309.57,Inhibition of human ERG expressed in HEK cells by ion flux assay
6787,CHEMBL2208405,CS(=O)(=O)N(CC(=O)NCC1CC1)c1cc(C(F)(F)F)ccc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG
6788,CHEMBL2208429,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c2ccccc12,IC50,nM,=,251.19,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6789,CHEMBL2208427,COc1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)ccc1N,IC50,nM,=,251.19,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6790,CHEMBL2208431,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c(=O)c2ccccc12,IC50,nM,=,398.11,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6791,CHEMBL2208432,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)n1c(=O)[nH]c2ccccc21,IC50,nM,=,501.19,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6792,CHEMBL2208433,CN(C[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C(=O)c1c[nH]c(=O)c2ccccc12,IC50,nM,=,1995.26,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6793,CHEMBL2208430,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c2ccccc12,IC50,nM,=,1995.26,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6794,CHEMBL2208435,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cnnc2ccccc12,IC50,nM,=,6309.57,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6795,CHEMBL2207666,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12,IC50,nM,=,7943.28,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6796,CHEMBL2208434,O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cc(=O)[nH]c2ccccc12,IC50,nM,>,10000.0,Inhibition of human ERG in HEK cells by ion flux electrophysiology assay
6797,CHEMBL2216904,COc1cc2c(cc1O)[C@@H](Cc1ccc(O)c(Oc3ccc(C[C@@H]4c5cc(OC)c(OC)cc5CCN4C)cc3)c1)N(C)CC2,IC50,nM,=,9600.0,Inhibition of human ERG tail current expressed in HEK293 cells at + 60 mV holding potential by patch clamp assay
6798,CHEMBL2216904,COc1cc2c(cc1O)[C@@H](Cc1ccc(O)c(Oc3ccc(C[C@@H]4c5cc(OC)c(OC)cc5CCN4C)cc3)c1)N(C)CC2,IC50,nM,=,9100.0,Inhibition of human ERG stepped current expressed in HEK293 cells at + 20 mV holding potential by patch clamp assay
6799,CHEMBL2316211,O=C(CNc1nccc2ncc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,nM,>,50000.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6800,CHEMBL2316210,O=C(CNc1nncc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,,,,Inhibition of human ERG assessed as [3H]astemizole binding activity
6801,CHEMBL2316209,O=C(CNc1nccc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,nM,=,32900.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6802,CHEMBL2315941,O=C(CNc1ccnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,nM,=,11200.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6803,CHEMBL2315940,N#Cc1cc(NCC(=O)NC2CN([C@H]3CC[C@@](O)(c4cncs4)CC3)C2)c2cc(C(F)(F)F)ccc2n1,IC50,nM,=,35100.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6804,CHEMBL2315939,O=C(CNc1cc(C(F)(F)F)nc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,nM,=,36100.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6805,CHEMBL2315938,O=C(CNc1nc(C(F)(F)F)nc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,nM,=,32700.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6806,CHEMBL2315937,Cc1nc(NCC(=O)NC2CN([C@H]3CC[C@@](O)(c4cncs4)CC3)C2)c2cc(C(F)(F)F)ccc2n1,IC50,nM,=,25700.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6807,CHEMBL2315936,N#Cc1ccccc1[C@H]1CC[C@@H](N2CC(NC(=O)CNc3ncnc4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,2100.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6808,CHEMBL2315935,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccccc3O)CC2)C1,IC50,nM,=,6600.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6809,CHEMBL2315934,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccccn3)CC2)C1,IC50,nM,=,7500.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6810,CHEMBL2315933,Nc1cccnc1[C@H]1CC[C@@H](N2CC(NC(=O)CNc3ncnc4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,8300.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6811,CHEMBL2315932,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccc(O)cn3)CC2)C1,IC50,nM,=,12900.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6812,CHEMBL2315931,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3cccnc3)CC2)C1,IC50,nM,=,16000.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6813,CHEMBL2315930,COc1cnccc1[C@H]1CC[C@@H](N2CC(NC(=O)CNc3ncnc4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,20200.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6814,CHEMBL2315929,Nc1cnccc1[C@H]1CC[C@@H](N2CC(NC(=O)CNc3ncnc4ccc(C(F)(F)F)cc34)C2)CC1,IC50,nM,=,46000.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6815,CHEMBL2315928,COc1cccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNc4ncnc5ccc(C(F)(F)F)cc45)C3)CC2)n1,IC50,nM,=,13400.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6816,CHEMBL2315927,COc1ccc([C@]2(O)CC[C@H](N3CC(NC(=O)CNc4ncnc5ccc(C(F)(F)F)cc45)C3)CC2)cn1,IC50,nM,=,28500.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6817,CHEMBL2315926,CC(C)c1ncc([C@]2(O)CC[C@H](N3CC(NC(=O)CNc4ncnc5ccc(C(F)(F)F)cc45)C3)CC2)s1,IC50,nM,=,37500.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6818,CHEMBL2315925,Cc1ncc([C@]2(O)CC[C@H](N3CC(NC(=O)CNc4ncnc5ccc(C(F)(F)F)cc45)C3)CC2)s1,IC50,nM,>,50000.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6819,CHEMBL2315924,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1,IC50,nM,>,50000.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6820,CHEMBL2315923,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3ccns3)CC2)C1,IC50,nM,=,28400.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6821,CHEMBL2315922,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3nccs3)CC2)C1,IC50,nM,>,50000.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6822,CHEMBL2315921,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@](O)(c3ccccc3)CC2)C1,IC50,nM,=,16900.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6823,CHEMBL2315920,O=C(CNc1ncnc2ccc(C(F)(F)F)cc12)NC1CN([C@H]2CC[C@@H](c3ccccc3)CC2)C1,IC50,nM,=,5200.0,Inhibition of human ERG assessed as [3H]astemizole binding activity
6824,CHEMBL2316385,C[S+]([O-])Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12,IC50,nM,=,17000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
6825,CHEMBL2316383,C[S+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC2CCOCC2)c2ccccc12,IC50,nM,>,32000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
6826,CHEMBL2316382,COc1ccc(NC(=O)c2ccc(C[S+](C)[O-])c3ccccc23)c(C(=O)NCC2CCOCC2)n1,IC50,nM,>,32000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
6827,CHEMBL2316378,COc1ccc(NC(=O)c2ccc(Cn3ccnn3)c3ccccc23)c(C(=O)NCC2CCOCC2)n1,IC50,nM,=,11000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
6828,CHEMBL2312150,COc1ccc(Cl)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1,IC50,nM,=,20000.0,Inhibition of human ERG by patch clamp assay
6829,CHEMBL2312148,COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1,IC50,nM,=,4700.0,Inhibition of human ERG by patch clamp assay
6830,CHEMBL2312146,COc1cc(Nc2cc(-c3cccc(C#N)c3)ccn2)ccc1N1CCOCC1,IC50,nM,=,7700.0,Inhibition of human ERG by patch clamp assay
6831,CHEMBL2312142,COc1cc(Nc2cc(-c3cccc(C#N)c3)ccn2)ccc1N1CCN(C)CC1,IC50,nM,=,1300.0,Inhibition of human ERG by patch clamp assay
6832,CHEMBL2312924,O=P(NCc1ccccc1-c1cccnc1)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6833,CHEMBL2312923,O=P(Nc1cc(F)ccc1-n1cccn1)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6834,CHEMBL2312922,COc1ccc(-c2ncccc2NP(=O)(c2ccccc2)c2ccccc2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
6835,CHEMBL2312921,CCCN(c1cccc(S(C)(=O)=O)c1)P(=O)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6836,CHEMBL2312920,CCCN(c1cccc(C#N)c1)P(=O)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6837,CHEMBL2312919,N#Cc1cccc(NP(=O)(c2ccccc2)c2ccccc2)c1,IC50,nM,>,33000.0,Inhibition of human ERG
6838,CHEMBL2312918,CCCN(c1ccon1)P(=O)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6839,CHEMBL2313230,CCCN(c1cncnc1)P(=O)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6840,CHEMBL2313229,O=P(c1ccccc1)(c1ccccc1)N(Cc1ccccn1)Cc1ccccn1,IC50,nM,>,33000.0,Inhibition of human ERG
6841,CHEMBL2313228,N#CCCCN(c1cccnc1)P(=O)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6842,CHEMBL2313227,COCCN(c1cccnc1)P(=O)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6843,CHEMBL2313226,O=P(c1ccccc1)(c1ccccc1)N(Cc1ccccn1)c1cccnc1,IC50,nM,>,33000.0,Inhibition of human ERG
6844,CHEMBL2313225,O=P(c1ccccc1)(c1ccccc1)N(c1cccnc1)c1cccnc1,IC50,nM,>,33000.0,Inhibition of human ERG
6845,CHEMBL2313224,O=P(Nc1cccnc1)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6846,CHEMBL2312933,CCCN(c1cccnc1)P(=O)(c1ccccc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
6847,CHEMBL2313765,CO[C@H]1COCC[C@H]1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6848,CHEMBL2313764,CO[C@@H]1COCC[C@@H]1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6849,CHEMBL2313763,COC1COCCC1N[C@@H]1C[C@H]2C[C@@H](N(C)C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6850,CHEMBL2313762,COC1COCCC1N[C@@H]1C[C@H]2C[C@H](N(C)C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6851,CHEMBL2313761,COC1COCCC1N[C@@H]1C[C@H]2C[C@@H](OC)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6852,CHEMBL2313780,COC1COCCC1N[C@@H]1C[C@H]2C[C@H](OC)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6853,CHEMBL2313779,COC1COCCC1N[C@@H]1C[C@H]2C[C@@H](O)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6854,CHEMBL2313778,COC1COCCC1N[C@@H]1C[C@H]2C[C@H](O)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6855,CHEMBL2313777,COC1COCCC1N[C@@H]1C[C@H]2C[C@@H](C(N)=O)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6856,CHEMBL2313776,COC1COCCC1N[C@@H]1C[C@H]2C[C@H](C(N)=O)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6857,CHEMBL2313775,COC1COCCC1N[C@@H]1C[C@H]2C[C@@H](C(F)(F)F)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6858,CHEMBL2313774,COC1COCCC1N[C@@H]1C[C@H]2C[C@H](C(F)(F)F)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6859,CHEMBL2313773,COC1COCCC1N[C@@H]1C[C@H]2C[C@@H](Cl)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6860,CHEMBL2313772,COC1COCCC1N[C@@H]1C[C@H]2C[C@H](Cl)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6861,CHEMBL2313771,COC1COCCC1N[C@@H]1C[C@H]2C[C@@H](F)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6862,CHEMBL2313770,COC1COCCC1N[C@@H]1C[C@H]2C[C@H](F)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6863,CHEMBL2313769,COC1COCCC1N[C@@H]1C[C@H]2CC(F)(F)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6864,CHEMBL2313768,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ccc(OC(F)(F)F)cc3C2)C1,IC50,nM,=,7400.0,Binding affinity to human ERG
6865,CHEMBL2313767,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ccc(C#N)cc3C2)C1,IC50,nM,=,33700.0,Binding affinity to human ERG
6866,CHEMBL2314054,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ccc(C(F)(F)F)cc3C2)C1,IC50,nM,=,27600.0,Binding affinity to human ERG
6867,CHEMBL2314053,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ccc(Br)cc3C2)C1,IC50,nM,=,20300.0,Binding affinity to human ERG
6868,CHEMBL2314052,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ccc(Cl)cc3C2)C1,IC50,nM,=,42400.0,Binding affinity to human ERG
6869,CHEMBL2314051,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ccc(F)cc3C2)C1,IC50,nM,=,23500.0,Binding affinity to human ERG
6870,CHEMBL2314050,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(OC(C)C)cc3C2)C1,IC50,nM,=,46900.0,Binding affinity to human ERG
6871,CHEMBL2313786,COc1cnc2c(c1)CN(C(=O)[C@@]13CCC[C@@H]1C[C@@H](NC1CCOCC1OC)C3)CC2,IC50,nM,=,46600.0,Binding affinity to human ERG
6872,CHEMBL2313785,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc([N+](=O)[O-])cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6873,CHEMBL2313784,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6874,CHEMBL2313783,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(Br)cc3C2)C1,IC50,nM,=,48900.0,Binding affinity to human ERG
6875,CHEMBL2313782,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(Cl)cc3C2)C1,IC50,nM,=,33300.0,Binding affinity to human ERG
6876,CHEMBL2313781,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncccc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6877,CHEMBL2314065,COC1COCCC1N[C@@H]1C[C@H]2CCCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,=,40900.0,Binding affinity to human ERG
6878,CHEMBL2314064,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCCC[C@@H]1C[C@@H](NC1CCOCC1)C2,IC50,nM,=,38900.0,Binding affinity to human ERG
6879,CHEMBL2313784,COC1COCCC1N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6880,CHEMBL2314063,O=C(N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1)C1CCOCC1,IC50,nM,>,50000.0,Binding affinity to human ERG
6881,CHEMBL2314062,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCC[C@@H]1C[C@@H](NCC1CCOCC1)C2,IC50,nM,=,47000.0,Binding affinity to human ERG
6882,CHEMBL2314061,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCC[C@@H]1C[C@@H](NC1CCOCC1)C2,IC50,nM,=,25700.0,Binding affinity to human ERG
6883,CHEMBL2314060,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCC[C@@H]1C[C@@H](NC1CCS(=O)(=O)CC1)C2,IC50,nM,>,50000.0,Binding affinity to human ERG
6884,CHEMBL2314059,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCC[C@@H]1C[C@@H](NC1CCSCC1)C2,IC50,nM,=,23100.0,Binding affinity to human ERG
6885,CHEMBL2314058,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCC[C@@H]1C[C@@H](NC1CCCCCC1)C2,IC50,nM,=,14700.0,Binding affinity to human ERG
6886,CHEMBL2314057,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCC[C@@H]1C[C@@H](NC1CCCCC1)C2,IC50,nM,=,33600.0,Binding affinity to human ERG
6887,CHEMBL2314056,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCC[C@@H]1C[C@@H](NC1CCCC1)C2,IC50,nM,=,33500.0,Binding affinity to human ERG
6888,CHEMBL2314055,CCC(CC)N[C@@H]1C[C@H]2CCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
6889,CHEMBL2325202,Cc1ccc(OCC#Cc2cccc(C#CCOc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6890,CHEMBL2325205,Cc1ccc(OCCCc2cccc(CCCOc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,962.0,Inhibition of human ERG K+ channel expressed in HEK293 cells after 15 mins by patch clamp assay
6891,CHEMBL2325200,Cc1ccc(C#CCOCc2cccc(COCC#Cc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,214.0,Inhibition of human ERG K+ channel expressed in HEK293 cells after 15 mins by patch clamp assay
6892,CHEMBL2325199,Cc1ccc(CCCOCc2cccc(COCCCc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,194.0,Inhibition of human ERG K+ channel expressed in HEK293 cells after 15 mins by patch clamp assay
6893,CHEMBL2324256,Cc1ccc(OCCCc2cc(N)cc(CCCOc3ccc(C)cc3)n2)cc1,IC50,nM,=,146.0,Inhibition of human ERG K+ channel expressed in HEK293 cells after 15 mins by patch clamp assay
6894,CHEMBL2324251,C[n+]1c(CCc2ccccc2)cccc1CCc1ccccc1,IC50,nM,=,466.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6895,CHEMBL2324250,c1ccc(CCc2cccc(CCc3ccccc3)n2)cc1,IC50,nM,=,1608.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6896,CHEMBL2324248,C[n+]1c(COc2ccccc2)cccc1COc1ccccc1,IC50,nM,=,767.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6897,CHEMBL2324247,c1ccc(OCc2cccc(COc3ccccc3)n2)cc1,IC50,nM,=,74.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6898,CHEMBL2324246,C[n+]1c(CCCOc2ccccc2Cl)cccc1CCCOc1ccccc1Cl,IC50,nM,=,74.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6899,CHEMBL2324245,C[n+]1c(CCCOc2cccc(Cl)c2)cccc1CCCOc1cccc(Cl)c1,IC50,nM,=,60.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6900,CHEMBL2324244,C[n+]1c(CCCOc2ccc(Cl)cc2)cccc1CCCOc1ccc(Cl)cc1,IC50,nM,=,14.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6901,CHEMBL2324243,COc1ccc(OCCCc2cccc(CCCOc3ccc(OC)cc3)[n+]2C)cc1,IC50,nM,=,158.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6902,CHEMBL2324242,C[n+]1c(CCCOc2ccccc2)cccc1CCCOc1ccccc1,IC50,nM,=,208.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6903,CHEMBL2324239,C[n+]1c(C#CCOc2ccc(Cl)cc2)cccc1C#CCOc1ccc(Cl)cc1,IC50,nM,=,31077.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6904,CHEMBL2325217,C[n+]1c(C#CCOc2ccccc2)cccc1C#CCOc1ccccc1,IC50,nM,=,14014.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6905,CHEMBL2325216,C[n+]1c(C#Cc2ccccc2Cl)cccc1C#Cc1ccccc1Cl,IC50,nM,=,3901.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6906,CHEMBL2325215,C[n+]1c(C#Cc2cccc(Cl)c2)cccc1C#Cc1cccc(Cl)c1,IC50,nM,=,4019.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6907,CHEMBL2325214,C[n+]1c(C#Cc2ccc(Cl)cc2)cccc1C#Cc1ccc(Cl)cc1,IC50,nM,=,1159.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6908,CHEMBL2325213,COc1ccc(C#Cc2cccc(C#Cc3ccc(OC)cc3)[n+]2C)cc1,IC50,nM,=,377.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6909,CHEMBL2325212,C[n+]1c(C#Cc2ccc(-c3ccccc3)cc2)cccc1C#Cc1ccc(-c2ccccc2)cc1,IC50,nM,=,294.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6910,CHEMBL2325211,C[n+]1c(C#CC2CCCCC2)cccc1C#CC1CCCCC1,IC50,nM,=,4340.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6911,CHEMBL2325210,C[n+]1c(C#Cc2ccccc2)cccc1C#Cc1ccccc1,IC50,nM,=,554.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6912,CHEMBL2325209,Cc1ccc(OCC#Cc2cccc(CCCOc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,2908.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6913,CHEMBL2325208,CCCCCCCCc1cccc(CCCCCCCC)[n+]1C,IC50,nM,=,15.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6914,CHEMBL2325207,CCCCCCC#Cc1cccc(C#CCCCCCC)[n+]1C,IC50,nM,=,1992.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6915,CHEMBL2325206,Cc1ccc(CCOCCCc2cccc(CCCOCCc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,371.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6916,CHEMBL2325205,Cc1ccc(OCCCc2cccc(CCCOc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,86.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6917,CHEMBL2325204,Cc1ccc(CCc2cccc(CCc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,24.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6918,CHEMBL2325203,Cc1ccc(CCOCC#Cc2cccc(C#CCOCCc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,14426.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6919,CHEMBL2325201,Cc1ccc(C#Cc2cccc(C#Cc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,285.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6920,CHEMBL2325200,Cc1ccc(C#CCOCc2cccc(COCC#Cc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,40.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6921,CHEMBL2325199,Cc1ccc(CCCOCc2cccc(COCCCc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,24.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6922,CHEMBL2324264,Cc1ccc(CCOCc2cccc(COCCc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,135.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6923,CHEMBL2324263,Cc1ccc(COCc2cccc(COCc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,107.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6924,CHEMBL2324262,Cc1ccc(OCc2cccc(COc3ccc(C)cc3)[n+]2C)cc1,IC50,nM,=,53.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6925,CHEMBL2324261,Cc1ccc(Cc2cc[n+](C)c(COc3ccc(C)cc3)c2)cc1.O=S(=O)([O-])C(F)(F)F,IC50,nM,=,346.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6926,CHEMBL2324260,Cc1ccc(Cc2cccc(COc3ccc(C)cc3)[n+]2C)cc1.Cc1ccc(S(=O)(=O)[O-])cc1,IC50,nM,>,10.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6927,CHEMBL2324259,Cc1ccc(Cc2ccnc(COc3ccc(C)cc3)c2)cc1,IC50,nM,>,10.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6928,CHEMBL2324258,Cc1ccc(Cc2cccc(COc3ccc(C)cc3)n2)cc1,IC50,nM,>,10.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6929,CHEMBL2324257,Clc1ccc(OCCCc2cccc(CCCOc3ccc(Cl)cc3)n2)cc1,IC50,nM,=,9.9,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6930,CHEMBL2324256,Cc1ccc(OCCCc2cc(N)cc(CCCOc3ccc(C)cc3)n2)cc1,IC50,nM,=,170.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6931,CHEMBL2324255,Cc1ccc(OCC#Cc2cc(N)cc(C#CCOc3ccc(C)cc3)n2)cc1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6932,CHEMBL2324254,Cc1ccc(CCN(C)CCOc2ccc(C)cc2)cc1,IC50,nM,=,5.1,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6933,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,4.1,Displacement of [3H]astemizole from human ERG K+ channel expressed in HEK293 cells by scintillation spectrophotometric analysis
6934,CHEMBL2322611,COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2Cc2ccccc2)C(C)C)ccc1OC.Cl,IC50,nM,=,14500.0,Inhibition of human ERG by dofetilide binding assay
6935,CHEMBL2322875,COc1cc(N2CCN(C(=O)Cn3nc(C(F)(F)F)c(Cl)c3C)CC2)ccc1Cl,IC50,nM,=,16000.0,Binding affinity to human ERG by patch clamp assay
6936,CHEMBL2323191,N#Cc1ccc(-c2ccc3c(c2)OC[C@H]2[C@H](CO)OC(=O)N32)cn1,IC50,nM,=,18350.0,Inhibition of human ERG
6937,CHEMBL1915619,CC(=O)NC[C@@H]1OC(=O)N2c3ccc(-c4ccc(C#N)nc4)cc3OC[C@@H]12,IC50,nM,=,2780.0,Inhibition of human ERG
6938,CHEMBL2323189,CN1C[C@@H](c2ccc(-c3ccc4c(c3)OC[C@H]3[C@H](CO)OC(=O)N43)cn2)OC1=O,IC50,nM,>,40000.0,Inhibition of human ERG
6939,CHEMBL2323180,O=C1OC(CO)CN1c1ccc(-c2ccc3c(c2)OC[C@H]2[C@H](CO)OC(=O)N32)cn1,IC50,nM,>,40000.0,Inhibition of human ERG
6940,CHEMBL2321994,OCC[C@@]1(c2cc3ccccc3o2)CCCNC1,IC50,,,,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6941,CHEMBL2321993,OCC[C@]1(c2cc3ccccc3o2)CCCNC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6942,CHEMBL2321992,OCC[C@@]1(c2ccc(Cl)c(Cl)c2)CCCNC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6943,CHEMBL2321991,OCC[C@]1(c2ccc(Cl)c(Cl)c2)CCCNC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6944,CHEMBL2321990,OCC[C@@]1(c2ccc(Cl)c(Cl)c2)CCCCNC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6945,CHEMBL2326695,OCC[C@]1(c2ccc(Cl)c(Cl)c2)CCCCNC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6946,CHEMBL2326694,COCCN1CC=CC[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,5300.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6947,CHEMBL2326693,OCCN1CC=CC[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6948,CHEMBL2326692,Clc1ccc(C2CCCCNC2)cc1Cl,IC50,nM,=,6100.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6949,CHEMBL2326691,CN1CCCCC(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6950,CHEMBL2326690,C1=CCC(c2cc3ccccc3o2)CNC1,IC50,nM,=,19000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6951,CHEMBL2326689,CN1CC=CCC(c2cc3ccccc3o2)C1,IC50,nM,=,15000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6952,CHEMBL2326688,Clc1cccc(C2CC=CCNC2)c1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6953,CHEMBL2326687,Clc1ccc(C2CC=CCNC2)cc1,IC50,nM,>,31000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6954,CHEMBL2326686,Fc1ccc(C2CC=CCNC2)cc1Cl,IC50,nM,=,23000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6955,CHEMBL2326685,Cc1cc(C2CC=CCNC2)ccc1Cl,IC50,nM,=,26000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6956,CHEMBL2326684,Cc1cc(C2CC=CCN(C)C2)ccc1Cl,IC50,nM,=,26000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6957,CHEMBL2322002,Cc1ccc(C2CC=CCNC2)cc1Cl,IC50,nM,>,27000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6958,CHEMBL2322001,C1=CCC(c2ccc3ccccc3c2)CNC1,IC50,nM,=,15400.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6959,CHEMBL2322000,Clc1ccc([C@@H]2CC=CCNC2)cc1Cl,IC50,nM,=,13700.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6960,CHEMBL2321999,Clc1ccc([C@H]2CC=CCNC2)cc1Cl,IC50,nM,=,21000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6961,CHEMBL2321998,Clc1ccc(C2CC=CCNC2)cc1Cl,IC50,nM,=,11000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6962,CHEMBL2321997,CN1CC=CC[C@@H](c2ccc(Cl)c(Cl)c2)C1,IC50,,,,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6963,CHEMBL2321996,CN1CC=CC[C@H](c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6964,CHEMBL2321995,CN1CC=CCC(c2ccc(Cl)c(Cl)c2)C1,IC50,nM,=,7600.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6965,CHEMBL400964,CN1Cc2c(N)cccc2[C@@H](c2ccccc2)C1,IC50,,,,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6966,CHEMBL51697,CN1Cc2c(N)cccc2[C@H](c2ccccc2)C1,IC50,,,,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6967,CHEMBL273575,CN1Cc2c(N)cccc2C(c2ccccc2)C1,IC50,nM,>,27000.0,Inhibition of human ERG expressed in CHO-K1 cells by electrophysiological assay
6968,CHEMBL2324491,CCCS(=O)(=O)N1CCN(C2(CNC(=O)c3c(F)cccc3F)CCC(F)(F)CC2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
6969,CHEMBL2326473,Cn1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)n1,IC50,nM,>,33000.0,Inhibition of human ERG
6970,CHEMBL2326472,Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1,IC50,nM,>,33000.0,Inhibition of human ERG
6971,CHEMBL2326471,Nc1nc2cc3c(cc2s1)CCN(Cc1ncon1)CC3,IC50,nM,>,33000.0,Inhibition of human ERG
6972,CHEMBL2326470,Nc1nc2cc3c(cc2s1)CCN(Cc1cnc[nH]1)CC3,IC50,nM,>,33000.0,Inhibition of human ERG
6973,CHEMBL2326469,Nc1nc2cc3c(cc2s1)CCN(Cc1cscn1)CC3,IC50,nM,=,15000.0,Inhibition of human ERG
6974,CHEMBL2326468,Nc1nc2cc3c(cc2s1)CCN(Cc1cnco1)CC3,IC50,nM,>,33000.0,Inhibition of human ERG
6975,CHEMBL2326485,Nc1nc2cc3c(cc2s1)CCN(Cc1ccncc1)CC3,IC50,nM,>,33000.0,Inhibition of human ERG
6976,CHEMBL2326484,Nc1nc2cc3c(cc2s1)CCN(Cc1cccnc1)CC3,IC50,nM,=,21000.0,Inhibition of human ERG
6977,CHEMBL2326483,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccn1)CC3,IC50,nM,=,13000.0,Inhibition of human ERG
6978,CHEMBL2326482,CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,IC50,nM,>,33000.0,Inhibition of human ERG
6979,CHEMBL2326481,CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,IC50,nM,=,12000.0,Inhibition of human ERG
6980,CHEMBL2326480,COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,IC50,nM,=,6600.0,Inhibition of human ERG
6981,CHEMBL2326479,COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,IC50,nM,=,3300.0,Inhibition of human ERG
6982,CHEMBL2326478,Nc1nc2cc3c(cc2s1)CCN(Cc1cccc(F)c1)CC3,IC50,nM,=,6800.0,Inhibition of human ERG
6983,CHEMBL2326477,Nc1nc2cc3c(cc2s1)CCN(Cc1ccc(F)cc1)CC3,IC50,nM,=,3600.0,Inhibition of human ERG
6984,CHEMBL2326476,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccc1)CC3,IC50,nM,=,7800.0,Inhibition of human ERG
6985,CHEMBL2326475,Nc1nc2cc3c(cc2s1)CCN(C(=O)c1ccccc1)CC3,IC50,nM,>,33000.0,Inhibition of human ERG
6986,CHEMBL2326474,Nc1nc2cc3c(cc2s1)CCN(CCO)CC3,IC50,nM,>,33000.0,Inhibition of human ERG
6987,CHEMBL2326492,CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1,IC50,nM,>,33000.0,Inhibition of human ERG
6988,CHEMBL2326491,Nc1nc2cc3c(cc2s1)CCN(CC(F)(F)F)CC3,IC50,nM,>,33000.0,Inhibition of human ERG
6989,CHEMBL2326490,Nc1nc2cc3c(cc2s1)CCN(C1CC1)CC3,IC50,nM,=,13000.0,Inhibition of human ERG
6990,CHEMBL2326489,CCN1CCc2cc3nc(N)sc3cc2CC1,IC50,nM,=,29000.0,Inhibition of human ERG
6991,CHEMBL2326488,CN1CCc2cc3nc(N)sc3cc2CC1,IC50,nM,>,33000.0,Inhibition of human ERG
6992,CHEMBL2326487,Nc1nc2cc3c(cc2s1)CCNCC3,IC50,nM,>,33000.0,Inhibition of human ERG
6993,CHEMBL2324520,CC(C#N)=C1CCN(c2ccc(N3C[C@H](Cn4cc(F)nn4)OC3=O)cc2F)CC1,IC50,nM,=,21000.0,Inhibition of human hERG by automated patch clamp assay
6994,CHEMBL2324519,CC(C#N)=C1CCN(c2ccc(N3C[C@H](Cn4ccnn4)OC3=O)cc2F)CC1,IC50,nM,=,213320.0,Inhibition of human hERG by automated patch clamp assay
6995,CHEMBL2324511,N#CC=C1CCN(c2ccc(N3C[C@H](Cn4cc(F)nn4)OC3=O)cc2F)CC1,IC50,nM,=,2370.0,Inhibition of human hERG by automated patch clamp assay
6996,CHEMBL2324510,N#CC=C1CCN(c2ccc(N3C[C@H](Cn4ccnn4)OC3=O)cc2F)CC1,IC50,nM,=,49500.0,Inhibition of human hERG by automated patch clamp assay
6997,CHEMBL2325418,Cc1ccc(C(CCC(N)C(=O)O)(c2ccccc2)c2ccccc2)cc1C,IC50,nM,>,25000.0,Inhibition of human ERG channel expressed in CHO cells by Ionworks HT assay
6998,CHEMBL2325412,CCc1cc(C(SC[C@H](N)C(=O)O)(c2ccccc2)c2ccccc2)ccc1C,IC50,nM,>,25000.0,Inhibition of human ERG channel expressed in CHO cells by Ionworks HT assay
6999,CHEMBL2325410,Cc1ccc(C(SC[C@H](N)C(=O)O)(c2ccccc2)c2ccccc2)cc1C,IC50,nM,>,25000.0,Inhibition of human ERG channel expressed in CHO cells by Ionworks HT assay
7000,CHEMBL2325436,COc1ccc(C(CCCN)(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,6600.0,Inhibition of human ERG channel expressed in CHO cells by Ionworks HT assay
7001,CHEMBL392369,COc1ccc(C(SC[C@H](N)C(=O)O)(c2ccccc2)c2ccccc2)cc1,IC50,nM,>,25000.0,Inhibition of human ERG channel expressed in CHO cells by Ionworks HT assay
7002,CHEMBL2325429,Cc1ccc(C(=O)N(CCCN)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1,IC50,nM,=,1600.0,Inhibition of human ERG channel expressed in CHO cells by Ionworks HT assay
7003,CHEMBL1907089,O=C(NCCN1CCC2(CC1)C(=O)NCN2c1cccc(F)c1)c1ccc(F)c(F)c1,IC50,nM,>,20000.0,Inhibition of human ERG
7004,CHEMBL2325485,Cc1cccc(N2CNC(=O)C23CCN(C[C@H](C)NC(=O)c2ccc(Br)cc2)CC3)c1,IC50,nM,>,20000.0,Inhibition of human ERG
7005,CHEMBL2325940,COc1cc(Oc2ccccc2)ccc1-c1nc([C@H]2C[C@@](C)(O)C2)n2ccnc(N)c12,IC50,nM,>,15000.0,Inhibition of human ERG
7006,CHEMBL2325697,C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1,IC50,nM,=,50000.0,Inhibition of human ERG by whole-cell electrophysiology assay
7007,CHEMBL2325706,CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CCNCC1,IC50,nM,>,33000.0,Inhibition of human ERG by whole-cell electrophysiology assay
7008,CHEMBL2325705,CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CCOCC1,IC50,nM,>,33000.0,Inhibition of human ERG by whole-cell electrophysiology assay
7009,CHEMBL2325704,CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG by whole-cell electrophysiology assay
7010,CHEMBL2325703,CC(C)(c1cc(N2CCOCC2)nc(-c2cccc3[nH]ccc23)n1)S(C)(=O)=O,IC50,nM,>,33000.0,Inhibition of human ERG by whole-cell electrophysiology assay
7011,CHEMBL2325741,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7012,CHEMBL2325740,COCCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,=,9369.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7013,CHEMBL2325739,NC1(C(=O)NC(CCCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,57793.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7014,CHEMBL2325738,NC1(C(=O)NC(CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7015,CHEMBL2325737,NC1(C(=O)NC(CO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7016,CHEMBL2325736,CS(=O)(=O)NCCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,=,80124.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7017,CHEMBL2325735,CS(=O)(=O)NCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7018,CHEMBL2325734,NC1(C(=O)NC(CCS(N)(=O)=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7019,CHEMBL2325733,NC1(C(=O)NC(CS(N)(=O)=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7020,CHEMBL2325732,CC(=O)NCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7021,CHEMBL2325731,CN(C)C(=O)CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7022,CHEMBL2325730,NC(=O)C(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7023,CHEMBL2325729,NC1(C(=O)N[C@@H](CCN2CCCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,29367.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7024,CHEMBL2325728,NC1(C(=O)N[C@@H](CCN2CCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,21030.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7025,CHEMBL2325727,CN(C)CC[C@H](NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7026,CHEMBL2325996,NC1(C(=O)NC(CCCN2CCCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7027,CHEMBL2325995,NC1(C(=O)NC(CCCN2CCOCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,74807.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7028,CHEMBL2325994,NC1(C(=O)NC(CCCN2CCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7029,CHEMBL2325993,CN(C)CCCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7030,CHEMBL2325992,CN(C)CCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7031,CHEMBL2325991,COc1ccc(C(C)NC(=O)C2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1OC,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7032,CHEMBL2325990,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(S(C)(=O)=O)cc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7033,CHEMBL2325989,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccccn1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7034,CHEMBL2325988,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1cccnc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7035,CHEMBL2325987,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(F)cc1,IC50,nM,=,26957.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7036,CHEMBL2325986,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccccc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7037,CHEMBL2325985,NC1(C(=O)NC(Cc2ccccc2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,3500.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7038,CHEMBL2325984,NC1(C(=O)NC(c2ccccc2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,1600.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7039,CHEMBL2325983,NC1(C(=O)NC(c2ccc(Cl)cc2)C2CC2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,2600.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7040,CHEMBL2325982,CCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,=,6495.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7041,CHEMBL2325743,C[C@H](NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,=,6747.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7042,CHEMBL2325742,C[C@@H](NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,=,9092.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7043,CHEMBL2325997,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,IC50,nM,=,7200.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7044,CHEMBL598194,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,nM,=,5235.0,Inhibition of human ERG expressed in CHO cells by ionworks assay
7045,CHEMBL405821,NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1,IC50,nM,>,1000.0,Inhibition of human ERG channel
7046,CHEMBL2333615,CN1CCC(COCc2cc(C(F)(F)F)cc(C3CC3)n2)(c2cccc(F)c2)CC1,IC50,nM,=,9000.0,Inhibition of human ERG
7047,CHEMBL2333614,CN1CCC(COCc2cc(C(F)(F)F)cc(C3CC3)n2)(c2cccc(Cl)c2)CC1,IC50,nM,=,9200.0,Inhibition of human ERG
7048,CHEMBL2333613,CN1CCC(COCc2cc(C(F)(F)F)cc(C3CC3)n2)(c2ccc(Cl)cc2)CC1,IC50,nM,=,3100.0,Inhibition of human ERG
7049,CHEMBL2333612,CN1CCC(COCc2cc(C#N)cc(C3CC3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,17000.0,Inhibition of human ERG
7050,CHEMBL2333611,CN1CCC(COCc2cc(C3CC3)cc(C3CC3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,17000.0,Inhibition of human ERG
7051,CHEMBL2333610,CN1CCC(COCc2cc(C(F)(F)F)cc(C3CCCC3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,12000.0,Inhibition of human ERG
7052,CHEMBL2333609,CN1CCC(COCc2cc(C(F)(F)F)cc(C3(F)CC3)n2)(c2ccccc2)CC1,IC50,nM,=,12000.0,Inhibition of human ERG
7053,CHEMBL2333608,CN1CCC(COCc2cc(C(F)(F)F)cc(C3(F)CC3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,4300.0,Inhibition of human ERG
7054,CHEMBL2333607,CN1CCC(COCc2cc(C(F)(F)F)cc(C3CC3(C)C)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,9000.0,Inhibition of human ERG
7055,CHEMBL2333606,CC1CC1c1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,34000.0,Inhibition of human ERG
7056,CHEMBL2333605,FC(F)(F)c1cc(COCC2(c3ccccc3)CCNCC2)nc(C2CC2)c1,IC50,nM,=,5500.0,Inhibition of human ERG
7057,CHEMBL2333604,CN1CCC(COCc2cc(C(F)(F)F)cc(C3CC3)n2)(c2ccccc2)CC1,IC50,nM,=,9000.0,Inhibition of human ERG
7058,CHEMBL2333637,CN1CCC(COCc2cc(C(F)(F)F)cc(C3CC3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,13000.0,Inhibition of human ERG
7059,CHEMBL2333636,CC(C)=Cc1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,18000.0,Inhibition of human ERG
7060,CHEMBL2333635,C/C=C/c1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,13000.0,Inhibition of human ERG
7061,CHEMBL2333634,CC(C)Cc1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,12000.0,Inhibition of human ERG
7062,CHEMBL2333633,CC(C)c1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,26000.0,Inhibition of human ERG
7063,CHEMBL2333632,COc1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,9900.0,Inhibition of human ERG
7064,CHEMBL2333631,CN1CCC(COCc2cc(C(F)(F)F)cc(C#N)n2)(c2ccccc2)CC1,IC50,nM,=,33000.0,Inhibition of human ERG
7065,CHEMBL2333630,CN1CCC(COCc2cc(C(F)(F)F)ccn2)(c2ccc(F)cc2)CC1,IC50,nM,=,29000.0,Inhibition of human ERG
7066,CHEMBL2333629,CN1CCC(COCc2cc(C(F)(F)F)cc(N3CCC(C#N)CC3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,7700.0,Inhibition of human ERG
7067,CHEMBL2333628,CN1CCN(c2cc(C(F)(F)F)cc(COCC3(c4ccccc4)CCNCC3)n2)CC1,IC50,nM,=,16000.0,Inhibition of human ERG
7068,CHEMBL2333627,CN1CCC(COCc2cc(C(F)(F)F)cc(N3CCC(C#N)C3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,8300.0,Inhibition of human ERG
7069,CHEMBL2333626,CN1CCC(COCc2cc(C(F)(F)F)cc(N3CC=CC3)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,8700.0,Inhibition of human ERG
7070,CHEMBL2333625,CN1CCC(COCc2cc(C(F)(F)F)cc(N3CCC4CC43)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,12000.0,Inhibition of human ERG
7071,CHEMBL2333624,CN1CCC(COCc2cc(C(F)(F)F)cc(N3CCCC3)n2)(c2ccccc2)CC1,IC50,nM,=,7400.0,Inhibition of human ERG
7072,CHEMBL2333623,FC(F)(F)c1cc(COCC2(c3ccccc3)CCNCC2)nc(N2CCCC2)c1,IC50,nM,=,2300.0,Inhibition of human ERG
7073,CHEMBL2333622,CC(C)CN(CC(C)C)c1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,9500.0,Inhibition of human ERG
7074,CHEMBL2333621,CCN(C)c1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,6100.0,Inhibition of human ERG
7075,CHEMBL2333620,CCC(CC)Nc1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,7100.0,Inhibition of human ERG
7076,CHEMBL2333619,CCNc1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,80000.0,Inhibition of human ERG
7077,CHEMBL2333618,CCN(CC)c1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCN(C)CC2)n1,IC50,nM,=,14000.0,Inhibition of human ERG
7078,CHEMBL2333617,CN(C)c1cc(C(F)(F)F)cc(COCC2(c3ccc(F)cc3)CCNCC2)n1,IC50,nM,=,8400.0,Inhibition of human ERG
7079,CHEMBL2333616,CN1CCC(COCc2cc(Cl)cc(C(F)(F)F)n2)(c2ccccc2)CC1,IC50,nM,=,12000.0,Inhibition of human ERG
7080,CHEMBL2333648,FC(F)(F)c1cc(Cl)cc(COCC2(c3ccccc3)CCNCC2)n1,IC50,nM,=,25000.0,Inhibition of human ERG
7081,CHEMBL2333647,Clc1cc(COCC2(c3ccccc3)CCNCC2)cc(Cl)n1,IC50,nM,=,33000.0,Inhibition of human ERG
7082,CHEMBL2333646,CN1CCC(COCc2cncc(Br)c2)(c2ccccc2)CC1,IC50,nM,=,13000.0,Inhibition of human ERG
7083,CHEMBL2333645,Brc1cncc(COCC2(c3ccccc3)CCNCC2)c1,IC50,nM,=,15000.0,Inhibition of human ERG
7084,CHEMBL2333644,CN1CCC(COCc2cc(C(F)(F)F)cc(Cl)n2)(c2ccccc2F)CC1,IC50,nM,=,43000.0,Inhibition of human ERG
7085,CHEMBL2333643,CN1CCC(COCc2cc(C(F)(F)F)cc(Cl)n2)(c2ccc(F)cc2)CC1,IC50,nM,=,6000.0,Inhibition of human ERG
7086,CHEMBL2333642,Fc1ccc(C2(COCc3cc(C(F)(F)F)cc(Cl)n3)CCNCC2)cc1,IC50,nM,=,20000.0,Inhibition of human ERG
7087,CHEMBL2333641,CN1CCC(COCc2cc(C(F)(F)F)cc(Cl)n2)(c2ccc(Cl)cc2)CC1,IC50,nM,=,23000.0,Inhibition of human ERG
7088,CHEMBL2333640,CN1CCC(COCc2cc(C(F)(F)F)cc(Cl)n2)(c2ccccc2)CC1,IC50,nM,=,25000.0,Inhibition of human ERG
7089,CHEMBL2333639,FC(F)(F)c1cc(Cl)nc(COCC2(c3ccccc3)CCNCC2)c1,IC50,nM,=,28000.0,Inhibition of human ERG
7090,CHEMBL2333638,FC(F)(F)c1cc(Cl)cc(COCC2(c3ccccc3)CCNCC2)c1,IC50,nM,=,7200.0,Inhibition of human ERG
7091,CHEMBL2331648,CCNc1nc2c(c(C(N)=O)n1)CN(C(=O)CCc1ccc(OC(F)(F)F)cc1)CC2,IC50,nM,=,4600.0,Inhibition of human ERG
7092,CHEMBL2331680,CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp assay
7093,CHEMBL2331678,CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C(C)C)C3)cc1,IC50,nM,=,8500.0,Inhibition of human ERG by patch clamp assay
7094,CHEMBL2336059,CCOC(=O)N1[C@H]2CC[C@@H]1C[C@@H](CN1CC[C@H](N3C(=O)Cc4ccccc43)C1)C2,IC50,nM,=,2400.0,Inhibition of human ERG assessed as decrease in tail current amplitude measured after 5 mins by whole cell patch clamp technique
7095,CHEMBL2336058,CCOC(=O)N1CCC(CN2CC[C@H](N3C(=O)Cc4ccccc43)C2)(OC)CC1,IC50,,,,Inhibition of human ERG assessed as decrease in tail current amplitude measured after 5 mins by whole cell patch clamp technique
7096,CHEMBL2336057,CCOC(=O)N1CCC(O)(CN2CC[C@H](N3C(=O)Cc4ccccc43)C2)CC1,IC50,nM,=,3900.0,Inhibition of human ERG assessed as decrease in tail current amplitude measured after 5 mins by whole cell patch clamp technique
7097,CHEMBL2336056,CCOC(=O)N1CCC(C)(CN2CC[C@H](N3C(=O)Cc4ccccc43)C2)CC1,IC50,nM,=,3500.0,Inhibition of human ERG assessed as decrease in tail current amplitude measured after 5 mins by whole cell patch clamp technique
7098,CHEMBL2336055,CCOC(=O)N1CCC(CN2CC[C@H](N3C(=O)Cc4ccccc43)C2)CC1,IC50,nM,=,800.0,Inhibition of human ERG assessed as decrease in tail current amplitude measured after 5 mins by whole cell patch clamp technique
7099,CHEMBL2337725,COc1cc(N2Cc3ccc(Sc4ccc(F)cc4)nc3C2=O)ccc1OCCN1CCCC1,IC50,nM,=,25000.0,Inhibition of human ERG
7100,CHEMBL2338347,CS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2cnc([C@H](O)CO)cn2)cc1Cl,IC50,nM,=,70000.0,Inhibition of human ERG channel
7101,CHEMBL2336325,CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,IC50,nM,=,47500.0,Inhibition of human ERG
7102,CHEMBL1801204,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,nM,=,30400.0,Inhibition of human ERG
7103,CHEMBL2336327,COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CNCCO,IC50,nM,=,27500.0,Inhibition of human ERG
7104,CHEMBL2336323,CNC(=O)c1cc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)ccc1OC(F)F,IC50,nM,=,24200.0,Inhibition of human ERG
7105,CHEMBL2336329,CNCc1cccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)c1,IC50,nM,=,17400.0,Inhibition of human ERG
7106,CHEMBL2336334,COCC(C)Nc1nc(N2CCOC[C@@H]2C)c2ccc(-c3ccc(OC)c(CO)c3)nc2n1,IC50,nM,=,17000.0,Inhibition of human ERG
7107,CHEMBL2331605,C[C@H]1CN(c2nc(N3CCOC[C@@H]3C)c3ncc(-c4ccccc4)nc3n2)C[C@@H](C)O1,IC50,nM,=,13200.0,Inhibition of human ERG
7108,CHEMBL2336328,C[C@H]1CN(c2nc(N3CCOCC3)c3ccc(-c4cccc(CNCCO)c4)nc3n2)C[C@@H](C)O1,IC50,nM,=,13000.0,Inhibition of human ERG
7109,CHEMBL1078983,COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CO,IC50,nM,=,8300.0,Inhibition of human ERG
7110,CHEMBL2336332,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CC[C@@H](O)C4)nc3n2)cc1CO,IC50,nM,=,8000.0,Inhibition of human ERG
7111,CHEMBL2336331,C[C@H]1CN(c2nc(N3CCOC[C@@H]3C)c3ccc(-c4ccccc4)nc3n2)C[C@@H](C)O1,IC50,nM,=,4000.0,Inhibition of human ERG
7112,CHEMBL2338343,CC(C)CCOc1ccc2c(c1)[C@H]1OCCC[C@H]1[C@@H](C1CCOCC1)N2,IC50,nM,>,10000.0,Binding affinity to human ERG channel by patch clamp assay
7113,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,3300.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7114,CHEMBL2337981,CC(C)(C)NC(=O)NCCN1CCC(CO)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7115,CHEMBL2337980,CC(C)(C)NC(=O)NCCN1CCC(O)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7116,CHEMBL2337979,CC(C)(C)NC(=O)NCCN1CCCC(NC(=O)c2cc(Cl)cc(Cl)c2)C1,IC50,nM,=,4100.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7117,CHEMBL2337978,CC(C)(C)NC(=O)NCCN1CCC(NC(=O)c2cc(Cl)cc(Cl)c2)C1,IC50,nM,=,6600.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7118,CHEMBL2337977,CC(C)(C)NC(=O)NCCN1CC(NC(=O)c2cc(Cl)cc(Cl)c2)C1,IC50,nM,=,13000.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7119,CHEMBL2338409,CC(C)(C)NC(=O)NCCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)C1,IC50,nM,=,5800.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7120,CHEMBL2338408,CC(C)(C)NC(=O)NCCN1CCOC(CNC(=O)c2cc(Cl)cc(Cl)c2)C1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7121,CHEMBL2338407,CC(C)(C)NC(=O)NCCN1CCCC(CNC(=O)c2cc(Cl)cc(Cl)c2)C1,IC50,nM,=,5300.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7122,CHEMBL2338406,CC(C)(C)NC(=O)NCCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,13000.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7123,CHEMBL2338405,CC(C)(C)NC(=O)NCCN1CCN(CC(=O)Nc2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,1600.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7124,CHEMBL2338400,CC(C)(C)NC(=O)NCCN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by IONWORKS assay
7125,CHEMBL2336326,C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(-c3cccc(C(=O)NCCO)c3)nc2n1,IC50,nM,>,32000.0,Inhibition of human ERG
7126,CHEMBL2336324,C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(-c3ccc4nc[nH]c(=O)c4c3)nc2n1,IC50,nM,>,32000.0,Inhibition of human ERG
7127,CHEMBL2336322,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1C(=O)N(C)C,IC50,nM,>,32000.0,Inhibition of human ERG
7128,CHEMBL2336321,CNC(=O)c1cc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)ccc1OC,IC50,nM,>,32000.0,Inhibition of human ERG
7129,CHEMBL2336320,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1C(N)=O,IC50,nM,>,32000.0,Inhibition of human ERG
7130,CHEMBL2336319,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1C(C)O,IC50,nM,>,32000.0,Inhibition of human ERG
7131,CHEMBL2336318,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(-n4ccnc4)nc3n2)cc1CO,IC50,nM,>,32000.0,Inhibition of human ERG
7132,CHEMBL2336333,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCN(C)CC4)nc3n2)cc1CO,IC50,nM,>,32000.0,Inhibition of human ERG
7133,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1400.0,Inhibition of human ERG
7134,CHEMBL2334275,O[C@H](COc1ccc(C(F)(F)F)cc1)CN1CCN(Cc2c(F)cccc2Cl)CC1,IC50,nM,=,13970.0,Inhibition of human ERG
7135,CHEMBL2334271,COc1cccc(N2CCN(C[C@H](O)COc3ccc(C(F)(F)F)cc3)CC2)c1,IC50,nM,=,4080.0,Inhibition of human ERG
7136,CHEMBL2334265,O[C@H](COc1ccc(F)cc1)CN1CCN(Cc2ccc(Cl)c(Cl)c2)CC1,IC50,nM,=,290.0,Inhibition of human ERG
7137,CHEMBL2334264,O[C@H](COc1ccc(F)cc1)CN1CCN(Cc2ccc(Cl)cc2)CC1,IC50,nM,=,1350.0,Inhibition of human ERG
7138,CHEMBL2334620,O[C@H](COc1ccc(Cl)cc1)CN1CCN(Cc2c(F)cccc2Cl)CC1,IC50,nM,=,2070.0,Inhibition of human ERG
7139,CHEMBL2334618,O[C@H](COc1ccc(Cl)cc1)CN1CCN(Cc2ccc(Cl)cc2)CC1,IC50,nM,=,320.0,Inhibition of human ERG
7140,CHEMBL2334610,O[C@@H](COc1ccc(C(F)(F)F)cc1)CN1CCN(Cc2ccc(Cl)c(Cl)c2)CC1,IC50,nM,=,9200.0,Inhibition of human ERG
7141,CHEMBL2334606,COc1ccccc1N1CCN(C[C@@H](O)COc2ccc(C(F)(F)F)cc2)CC1,IC50,nM,=,3950.0,Inhibition of human ERG
7142,CHEMBL2334601,O[C@@H](COc1ccc(F)cc1)CN1CCN(Cc2ccc(Cl)c(Cl)c2)CC1,IC50,nM,=,870.0,Inhibition of human ERG
7143,CHEMBL2332055,CC(C)(C)C(=O)NCCC1CCN(c2ncnc3cc(C(N)=O)sc23)CC1,IC50,nM,>,50000.0,Inhibition of human ERG by dofetilide binding assay
7144,CHEMBL2332039,CCNC(=O)c1ccc(C(=O)NCCC2CCN(c3ncnc4cc(C(N)=O)sc34)CC2)s1,IC50,nM,>,50000.0,Inhibition of human ERG by dofetilide binding assay
7145,CHEMBL2331747,Cc1cn([C@H]2CCCN(S(=O)(=O)c3ccc(O)c(Oc4cccc(Cl)c4)c3)C2)c(=O)[nH]c1=O,IC50,nM,=,27000.0,Inhibition of human ERG
7146,CHEMBL2335295,Brc1cccc2nc(C#Cc3ccccn3)ccc12,IC50,nM,=,22700.0,Inhibition of human ERG
7147,CHEMBL2335291,C(#Cc1ccc2ccccc2n1)c1ccccn1,IC50,nM,=,20300.0,Inhibition of human ERG
7148,CHEMBL2335285,COc1cccc2nc(C#Cc3cccnc3)ccc12,IC50,nM,=,65300.0,Inhibition of human ERG
7149,CHEMBL2335279,COc1cccc2nc(C#Cc3ccccc3)ccc12,IC50,nM,=,61700.0,Inhibition of human ERG
7150,CHEMBL1234899,Cc1nc2cc(OC(F)(F)F)ccc2n1-c1ccc(C(=O)NC2CC2)s1,IC50,nM,<,2800.0,Inhibition of human ERG channel overexpressed in Chinese hamster CHOK1 cells by whole cell voltage clamp assay
7151,CHEMBL2347999,CN1CCC(c2nn(-c3cnc4[nH]cc(C(=O)NC(C)(C)CO)c4n3)c3ccccc23)CC1,IC50,nM,>,10000.0,Inhibition of human ERG channel
7152,CHEMBL2347996,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3ncn4c3CCCC4)nc12,IC50,nM,=,4100.0,Inhibition of human ERG channel
7153,CHEMBL2347994,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3nn(C4CCNCC4)c4cc(F)ccc34)nc12,IC50,nM,>,3000.0,Inhibition of human ERG channel
7154,CHEMBL2347993,Cc1ccc2c(-c3cnc4[nH]cc(C(=O)NC(C)(C)CO)c4n3)nn(CCCN(C)C)c2c1,IC50,nM,>,30000.0,Inhibition of human ERG channel
7155,CHEMBL2347992,CC(C)(CO)NC(=O)c1c[nH]c2ncc(-c3nn(CCCS(C)(=O)=O)c4cc(F)ccc34)nc12,IC50,nM,>,2000.0,Inhibition of human ERG channel
7156,CHEMBL2347991,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3nn(CCC(O)CO)c4cc(F)ccc34)nc12,IC50,nM,>,3000.0,Inhibition of human ERG channel
7157,CHEMBL2347989,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3nn(CCCS(C)(=O)=O)c4cc(F)ccc34)nc12,IC50,nM,>,10000.0,Inhibition of human ERG channel
7158,CHEMBL2347988,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3nn(CCC(O)CO)c4ccc(OC(F)F)cc34)nc12,IC50,nM,=,4150.0,Inhibition of human ERG channel
7159,CHEMBL2347420,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3nn(CCCS(C)(=O)=O)c4ccc(OC(F)F)cc34)nc12,IC50,nM,=,429.0,Inhibition of human ERG channel
7160,CHEMBL2347419,CN(C)CCCn1nc(-c2cnc3[nH]cc(C(=O)NC(C)(C)CO)c3n2)c2cc(OC(F)F)ccc21,IC50,nM,=,6320.0,Inhibition of human ERG channel
7161,CHEMBL2347418,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3nn(CCCN4CCOCC4)c4ccc(OC(F)F)cc34)nc12,IC50,nM,=,1440.0,Inhibition of human ERG channel
7162,CHEMBL2347417,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3nn(CCCN4CC(C#N)C4)c4ccc(OC(F)F)cc34)nc12,IC50,nM,=,414.0,Inhibition of human ERG channel
7163,CHEMBL2347416,CN1CC(Cn2nc(-c3cnc4[nH]cc(C(=O)NC(C)(C)C)c4n3)c3cc(OC(F)F)ccc32)C1,IC50,nM,=,293.0,Inhibition of human ERG channel
7164,CHEMBL2347415,CN(C)CCCn1nc(-c2cnc3[nH]cc(C(=O)NC(C)(C)C)c3n2)c2cc(OC(F)F)ccc21,IC50,nM,<,300.0,Inhibition of human ERG channel
7165,CHEMBL2347414,Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@]4(C)C[C@@H](N)C4)c3n2)c2ccc(F)cc21,IC50,nM,>,1000.0,Inhibition of human ERG channel
7166,CHEMBL2347413,Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@]4(C)C[C@H](N)C4)c3n2)c2ccc(F)cc21,IC50,nM,>,30000.0,Inhibition of human ERG channel
7167,CHEMBL2347407,CC(C)(C)NC(=O)c1c[nH]c2ncc(-c3n[nH]c4c(C(C)(C)O)cccc34)nc12,IC50,nM,>,2000.0,Inhibition of human ERG channel
7168,CHEMBL2177736,NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,IC50,nM,=,9100.0,Inhibition of human ERG channel
7169,CHEMBL2103830,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,IC50,nM,>,1000.0,Inhibition of human ERG channel
7170,CHEMBL2346976,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
7171,CHEMBL2346975,CC(=O)N1CCN(CCOc2ccc(C3(O)CCN(c4ccc5nnc(C(F)(F)F)n5n4)CC3)cc2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
7172,CHEMBL2346974,CC(=O)N1CCN(CCOc2ccc(C3CCN(c4ccc5nnc(C(F)(F)F)n5n4)CC3)cc2)CC1,IC50,nM,=,11220.18,Inhibition of human ERG by IonWorks assay
7173,CHEMBL2346973,Cn1nccc1CCOc1ccc(C2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1,IC50,nM,=,17782.79,Inhibition of human ERG by IonWorks assay
7174,CHEMBL2346972,Fc1ccc(CN2CCN(C3=Nn4c(nnc4C(F)(F)F)CC3)CC2)cc1,IC50,nM,=,29512.09,Inhibition of human ERG by IonWorks assay
7175,CHEMBL2346971,OC1(c2cccnc2)CCN(c2ccc3nnc(C(F)(F)F)n3n2)CC1,IC50,nM,=,95499.26,Inhibition of human ERG by IonWorks assay
7176,CHEMBL2346970,OC1(c2ccc(F)cc2)CCN(c2ccc3nnc(C(F)(F)F)n3n2)CC1,IC50,nM,=,18197.01,Inhibition of human ERG by IonWorks assay
7177,CHEMBL2346969,Fc1cccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)c1F,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
7178,CHEMBL2346968,Fc1ccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1,IC50,nM,=,10715.19,Inhibition of human ERG by IonWorks assay
7179,CHEMBL2346967,N#Cc1ccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1,IC50,nM,=,2238.72,Inhibition of human ERG by IonWorks assay
7180,CHEMBL2348780,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO,IC50,nM,=,20000.0,Inhibition of human ERG
7181,CHEMBL2382415,N#Cc1cnccc1COc1cnc(N2CC3CCC(C2)N3C(=O)OCC(F)(F)F)nc1,IC50,nM,=,13000.0,Inhibition of human ERG by IonWorks assay
7182,CHEMBL2086687,C[C@@H]1CN(C(=O)OCC(F)(F)F)CCN1c1ncc(OCc2ccncc2C#N)cn1,IC50,nM,=,12000.0,Inhibition of human ERG by IonWorks assay
7183,CHEMBL2382414,N#Cc1cnccc1COc1cnc(N2CCN(C(=O)OCC(F)(F)F)CC2)nc1,IC50,nM,=,10000.0,Inhibition of human ERG by IonWorks assay
7184,CHEMBL2381908,CC(C)CN1CCC(COc2ccc(NC(=O)Nc3cccnc3Oc3ccccc3C(C)(C)C)c(F)c2)CC1,IC50,nM,=,3700.0,Inhibition of human ERG by patch clamp assay
7185,CHEMBL2381898,CN(C)Cc1ccccc1-c1ccc(NC(=O)Nc2cccnc2Oc2ccccc2C(C)(C)C)c(F)c1,IC50,nM,=,5400.0,Inhibition of human ERG by patch clamp assay
7186,CHEMBL2381285,O=C(O)C[C@@H]1COc2cc3c(cc21)OC[C@@H](c1cccc(Cl)c1)O3,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
7187,CHEMBL2381282,O=C(O)C[C@@H]1COc2cc3c(cc21)OC[C@@H](c1cccc(Br)c1)O3,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
7188,CHEMBL2382372,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5cc(F)cc(F)c5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,30900.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7189,CHEMBL2382364,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5cc(F)cc(F)c5)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,7180.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7190,CHEMBL2382345,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5cc(F)ccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,9970.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7191,CHEMBL2382343,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5c(F)cccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,47600.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7192,CHEMBL2382342,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5cccc(F)c5)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,10300.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7193,CHEMBL2382341,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5ccccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,12200.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7194,CHEMBL2382287,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5ccccc5)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,24900.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7195,CHEMBL2158050,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,23600.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7196,CHEMBL2159976,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,19700.0,Inhibition of human ERG channel in HEK293 cells by voltage-gated patch clamp technique
7197,CHEMBL2380648,CC(C)(C)N1CCN(c2ccc(N3CCN(C(=O)N[C@H]4C5CC6CC4C[C@](C(N)=O)(C6)C5)c4ccccc43)nc2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG channel
7198,CHEMBL2380453,C[C@]1(c2cccc(-c3cncc(F)c3)c2)N=C(N)[C@H]2CCCCN21,IC50,,,,Inhibition of human ERG expressed in CHO cells
7199,CHEMBL2380452,C[C@]1(c2cccc(-c3cncc(F)c3)c2)N=C(N)[C@@H]2CCCCN21,IC50,,,,Inhibition of human ERG expressed in CHO cells
7200,CHEMBL2380443,COc1cccc(-c2cccc(C3(C)N=C(N)CCO3)c2)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells
7201,CHEMBL2380441,CC1(c2cccc(-c3cccnc3)c2)N=C(N)c2c(F)cccc2O1,IC50,,,,Inhibition of human ERG expressed in CHO cells
7202,CHEMBL2380457,COc1cccc(-c2cccc(C3(C)N=C(N)CN3C(C)=O)c2)c1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells
7203,CHEMBL2380445,CC1(c2cccc(-c3cncnc3)c2)N=C(N)CCS1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells
7204,CHEMBL2380458,COc1ccc(C2(c3cccc(-c4cncnc4)c3)CCC(N)=N2)cc1,IC50,nM,=,23000.0,Inhibition of human ERG expressed in CHO cells
7205,CHEMBL2380456,COc1cccc(-c2cccc(C3(c4ccncc4)N=C(N)CS3)c2)c1,IC50,nM,=,12000.0,Inhibition of human ERG expressed in CHO cells
7206,CHEMBL2380446,COc1cccc(-c2cccc(C3(C)N=C(N)CCS3)c2)c1,IC50,nM,=,11000.0,Inhibition of human ERG expressed in CHO cells
7207,CHEMBL2380455,COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)CS2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells
7208,CHEMBL2380454,COc1cccc(-c2cccc(C3(C)N=C(N)CS3)c2)c1,IC50,nM,=,9200.0,Inhibition of human ERG expressed in CHO cells
7209,CHEMBL2380448,COc1cccc(-c2cccc(C3(C)CSCC(N)=N3)c2)c1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in CHO cells
7210,CHEMBL2380440,CC1(c2cccc(-c3cncnc3)c2)N=C(N)c2c(F)cccc2O1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in CHO cells
7211,CHEMBL2380451,COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(N)n3nc(C)cc32)cc1,IC50,nM,=,8600.0,Inhibition of human ERG expressed in CHO cells
7212,CHEMBL2380447,COc1cccc(-c2cccc(C3(C)COCC(N)=N3)c2)c1,IC50,nM,=,8000.0,Inhibition of human ERG expressed in CHO cells
7213,CHEMBL2380449,COc1cccc(-c2cccc(C3(C)CCSC(N)=N3)c2)c1,IC50,nM,=,7600.0,Inhibition of human ERG expressed in CHO cells
7214,CHEMBL2380444,CC1(c2cccc(-c3cccc(Cl)c3)c2)N=C(N)CCO1,IC50,nM,=,6150.0,Inhibition of human ERG expressed in CHO cells
7215,CHEMBL2380442,CC1(c2cccc(-c3cncnc3)c2)N=C(N)c2ccccc2S1,IC50,nM,=,6000.0,Inhibition of human ERG expressed in CHO cells
7216,CHEMBL2380461,CC1(c2cccc(-c3cncnc3)c2)N=C(N)c2ccccc2O1,IC50,nM,=,5700.0,Inhibition of human ERG expressed in CHO cells
7217,CHEMBL2380459,COc1ccc(C2(c3cccc(-c4cccnc4)c3)CC(OC)C(N)=N2)cc1,IC50,nM,=,3200.0,Inhibition of human ERG expressed in CHO cells
7218,CHEMBL2380438,CC1(c2cccc(-c3cccnc3)c2)N=C(N)c2ccccc2O1,IC50,nM,=,2800.0,Inhibition of human ERG expressed in CHO cells
7219,CHEMBL2380459,COc1ccc(C2(c3cccc(-c4cccnc4)c3)CC(OC)C(N)=N2)cc1,IC50,nM,=,2500.0,Inhibition of human ERG expressed in CHO cells
7220,CHEMBL2380459,COc1ccc(C2(c3cccc(-c4cccnc4)c3)CC(OC)C(N)=N2)cc1,IC50,nM,=,2500.0,Inhibition of human ERG expressed in CHO cells
7221,CHEMBL2380459,COc1ccc(C2(c3cccc(-c4cccnc4)c3)CC(OC)C(N)=N2)cc1,IC50,nM,=,2400.0,Inhibition of human ERG expressed in CHO cells
7222,CHEMBL2380439,CCC1(c2cccc(-c3cncnc3)c2)N=C(N)c2ccccc2O1,IC50,nM,=,1600.0,Inhibition of human ERG expressed in CHO cells
7223,CHEMBL2380459,COc1ccc(C2(c3cccc(-c4cccnc4)c3)CC(OC)C(N)=N2)cc1,IC50,nM,=,1500.0,Inhibition of human ERG expressed in CHO cells
7224,CHEMBL2380450,COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(N)c3nc(C)sc32)cc1,IC50,nM,=,1500.0,Inhibition of human ERG expressed in CHO cells
7225,CHEMBL2387464,O=C(Nc1c[nH]c2ncc(-c3ccccc3F)cc12)c1cnn2ccc(NC[C@H]3CCNC[C@@H]3F)nc12,IC50,nM,=,5000.0,Inhibition of human ERG channel by patch clamp technique
7226,CHEMBL2385102,Cc1c(C)c2ccc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2oc1=O,IC50,nM,=,195.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7227,CHEMBL2387230,Cc1cc(=O)oc2c(C)c(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12,IC50,nM,=,226.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7228,CHEMBL2387229,Cc1cc(=O)oc2c(Cl)c(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12,IC50,nM,=,1591.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7229,CHEMBL2387265,O=c1cc(-c2ccccc2)c2ccc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2o1,IC50,nM,=,820.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7230,CHEMBL2387253,COc1ccccc1N1CCN(CCCCOc2ccc3c(C)cc(=O)oc3c2)CC1,IC50,nM,=,31.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7231,CHEMBL2387260,Cc1cc(=O)oc2cc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12,IC50,nM,=,159.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7232,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,581.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7233,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,650.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
7234,CHEMBL2386114,O=C(O)c1cccc(CN2C(=O)/C(=C(\c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1,IC50,nM,>,20000.0,Inhibition of human ERG
7235,CHEMBL2386558,CN(C)C(=O)[C@H]1C[C@@H]1c1ccc(-c2ncn(C)c2Sc2ccc(Cl)cn2)cc1,IC50,nM,=,37000.0,Inhibition of human ERG
7236,CHEMBL2386636,C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CCC#N)CC1,IC50,nM,=,20000.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
7237,CHEMBL2386635,C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1,IC50,nM,>,100000.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
7238,CHEMBL2386633,C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](C#N)CC1,IC50,nM,>,100000.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
7239,CHEMBL2385096,C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@@H](NCC(F)(F)F)C1,IC50,nM,>,100000.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
7240,CHEMBL2386629,C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](NCC(F)(F)F)CC1,IC50,nM,>,100000.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
7241,CHEMBL2386653,C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CCCOC1,IC50,nM,>,100000.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
7242,CHEMBL2393450,CCOC(=O)c1c(-c2ccc3c(c2)OCO3)csc1N,IC50,nM,>,10000.0,Inhibition of human ERG
7243,CHEMBL2393448,CCOC(=O)c1c(-c2ccc(N(C)C)cc2)csc1N,IC50,nM,>,10000.0,Inhibition of human ERG
7244,CHEMBL2393431,COc1cccc(COC(=O)c2c(-c3ccc(OC)c(OC)c3)csc2N)c1,IC50,nM,=,1000.0,Inhibition of human ERG
7245,CHEMBL2393423,COc1ccc(-c2csc(N)c2C(=O)OC(C)C)cc1OC,IC50,nM,>,10000.0,Inhibition of human ERG
7246,CHEMBL2392692,CNc1nc(C)nc(N2CCC(C(=O)NCc3ccc(Br)cc3OC(F)(F)F)CC2)n1,IC50,nM,>,10000.0,Inhibition of human ERG
7247,CHEMBL2391167,Cc1cc(N2CCC(N3CCCC3C)C2)ccc1NC(=O)c1cc(F)ccc1C,IC50,nM,=,480.0,Inhibition of human ERG channel
7248,CHEMBL2391166,Cc1cc(N2CCC(N3CCCC3C)C2)ccc1NC(=O)c1ccccc1F,IC50,nM,=,1000.0,Inhibition of human ERG channel
7249,CHEMBL2390995,O=C(/C=C/c1ccc2c(c1)C(=O)CC1(CCN(Cc3ccc(F)cc3)CC1)O2)NO,IC50,nM,=,2380.0,Displacement of [3H]astemizole from human ERG channel transfected in HEK293 cells after 60 mins by liquid scintillation counting analysis
7250,CHEMBL1938433,O=C(/C=C/c1ccc2c(c1)C(=O)CC1(CCN(Cc3ccccc3)CC1)O2)NO,IC50,nM,=,3810.0,Displacement of [3H]astemizole from human ERG channel transfected in HEK293 cells after 60 mins by liquid scintillation counting analysis
7251,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,2.6,Displacement of [3H]Astemizole from human recombinant ERG expressed in HEK293 cells at after 60 mins
7252,CHEMBL2391797,CN(C)[C@@H]1CCN(C(=O)c2ccc(O)cc2OC[C@@H](O)CN2CCC3(CC2)Cc2cc(Cl)ccc2O3)C1,IC50,nM,>,17500.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7253,CHEMBL2391807,CC(=O)N[C@H]1CCN(C(=O)c2ccc(O)cc2OC[C@@H](O)CN2CCC3(CC2)Cc2cc(Cl)ccc2O3)C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7254,CHEMBL2391804,O=C(c1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2)N1CC[C@H](O)C1,IC50,nM,=,22700.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7255,CHEMBL2391803,O=C(c1cc(Cl)c(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2)N1CC[C@H](O)C1,IC50,nM,=,8300.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7256,CHEMBL2391810,O=C(c1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2)N1CCC(O)CC1,IC50,nM,=,1600.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7257,CHEMBL2391935,CC(=O)NCCNC(=O)c1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2,IC50,nM,=,1200.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7258,CHEMBL2391800,O=C(c1ccc(F)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2)N1CC[C@H](O)C1,IC50,nM,=,700.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7259,CHEMBL2391795,O=C(NC1CC1)c1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2,IC50,nM,=,300.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7260,CHEMBL2391939,O=C(NC1CC1)c1ccc(F)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2,IC50,nM,=,38.0,Inhibition of human ERG expressed in HEK cells by ion flux electrophysiology method
7261,CHEMBL2391994,CC(C)(C(=O)O)c1ccc(CN2CCC(COC(=O)c3c4n(c5ccccc35)CCCO4)CC2)cc1,IC50,nM,=,69000.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch-clamp technique
7262,CHEMBL31,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,130000.0,Inhibition of human ERG current by patch clamp assay
7263,CHEMBL4,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,1420000.0,Inhibition of human ERG current by patch clamp assay
7264,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,nM,=,966000.0,Inhibition of human ERG current by patch clamp assay
7265,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,18000.0,Inhibition of human ERG current by patch clamp assay
7266,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,129000.0,Inhibition of human ERG current by patch clamp assay
7267,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,915000.0,Inhibition of human ERG current by patch clamp assay
7268,CHEMBL583,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,IC50,nM,=,50000.0,Inhibition of human ERG current by patch clamp assay
7269,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,>,250000.0,Binding affinity to human ERG F656A tetrameric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -120 mV by patch clamp method
7270,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,>,5000000.0,Binding affinity to human ERG F656A tetrameric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -120 mV by patch clamp method
7271,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,33600.0,Binding affinity to human ERG F656A tandem dimeric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -120 mV by patch clamp method
7272,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,2300000.0,Binding affinity to human ERG F656A tandem dimeric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -120 mV by patch clamp method
7273,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,46900.0,Binding affinity to human ERG S624A tetrameric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7274,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,2100000.0,Binding affinity to human ERG S624A tetrameric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7275,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,>,250000.0,Binding affinity to human ERG Y652A tetrameric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7276,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,>,5000000.0,Binding affinity to human ERG Y652A tetrameric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7277,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,127600.0,Binding affinity to human ERG Y652A tandem dimeric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7278,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,2300000.0,Binding affinity to human ERG Y652A tandem dimeric mutant expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7279,CHEMBL850,C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1,IC50,nM,=,21700.0,Binding affinity to wild type human ERG expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7280,CHEMBL33,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,IC50,nM,=,1100000.0,Binding affinity to wild type human ERG expressed in HEK293 cells assessed as inhibition of tail current measured upon repolarization to -40 mV by patch clamp method
7281,CHEMBL2403551,Cc1cc(N2CC[C@@H](N3CCC[C@H]3C)C2)ccc1NC(=O)c1cc(F)ccc1C,IC50,,,,Inhibition of human ERG transfected in CHO cells by patch clamp assay
7282,CHEMBL2403550,Cc1cc(N2CC[C@H](N3CCC[C@@H]3C)C2)ccc1NC(=O)c1cc(F)ccc1C,IC50,nM,=,1100.0,Inhibition of human ERG transfected in CHO cells by patch clamp assay
7283,CHEMBL2403549,Cc1cc(N2CC[C@@H](N3CCC[C@@H]3C)C2)ccc1NC(=O)c1cc(F)ccc1C,IC50,nM,=,1800.0,Inhibition of human ERG transfected in CHO cells by patch clamp assay
7284,CHEMBL2403548,Cc1cc(N2CC[C@H](N3CCC[C@H]3C)C2)ccc1NC(=O)c1cc(F)ccc1C,IC50,,,,Inhibition of human ERG transfected in CHO cells by patch clamp assay
7285,CHEMBL2403108,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,IC50,nM,=,46000.0,Inhibition of human ERG by patch-clamp technique
7286,CHEMBL2403842,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C(=O)CN(C)C)CC1,IC50,nM,=,24500.0,Inhibition of human ERG by dofetilide binding assay
7287,CHEMBL2403843,Cc1cc(Nc2ncc(C)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1,IC50,nM,=,20000.0,Inhibition of human ERG by patch-clamp technique
7288,CHEMBL2403845,CC(C)Oc1cc(C2CCNCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,IC50,nM,=,5300.0,Inhibition of human ERG by dofetilide binding assay
7289,CHEMBL2403849,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1,IC50,nM,=,3350.0,Inhibition of human ERG by dofetilide binding assay
7290,CHEMBL2403848,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC2CCC2)cc1C1CCNCC1,IC50,nM,=,3020.0,Inhibition of human ERG by dofetilide binding assay
7291,CHEMBL2403836,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCO)CC1,IC50,nM,=,2640.0,Inhibition of human ERG by dofetilide binding assay
7292,CHEMBL2403108,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,IC50,nM,=,1250.0,Inhibition of human ERG by dofetilide binding assay
7293,CHEMBL2403843,Cc1cc(Nc2ncc(C)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1,IC50,nM,=,1100.0,Inhibition of human ERG by dofetilide binding assay
7294,CHEMBL2403831,CC(C)Oc1nc(C2CCNCC2)ncc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,IC50,nM,=,400.0,Inhibition of human ERG by dofetilide binding assay
7295,CHEMBL2403866,Cc1nc2cc(F)ccc2n1[C@H]1CC[C@@H](NC[C@H]2Cc3ccc(C#N)cc3C2)CC1,IC50,nM,=,30.0,Inhibition of human ERG channel by patch clamp technique
7296,CHEMBL2403861,CC(C)(O)c1nc2cc(Cl)ccc2n1[C@H]1CC[C@@H](NC[C@H]2Cc3ccc(C#N)cc3C2)CC1,IC50,nM,=,60.0,Inhibition of human ERG channel by patch clamp technique
7297,CHEMBL2403858,CC(C)(O)c1nc2cc(Cl)ccc2n1[C@H]1CC[C@@H](NCC2Cc3ccc(Cl)cc3C2)CC1,IC50,nM,=,420.0,Inhibition of human ERG channel by patch clamp technique
7298,CHEMBL2403108,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,IC50,nM,=,46000.0,Inhibition of human ERG by patch clamp method
7299,CHEMBL2403316,O=c1ncn(Cc2c(F)cc(F)cc2F)c2ccc(Oc3ccccc3)cc12,IC50,nM,=,3700.0,Inhibition of human ERG
7300,CHEMBL2403338,Cc1ccc(Cn2cnc(=O)c3cc(Oc4ncccc4C(F)(F)F)ccc32)c(F)c1,IC50,nM,=,14000.0,Inhibition of human ERG
7301,CHEMBL2403327,Cc1ccc(Cn2cnc(=O)c3cc(Oc4ncccc4C(F)(F)F)ccc32)cc1,IC50,nM,=,17000.0,Inhibition of human ERG
7302,CHEMBL2409564,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,IC50,nM,>,100000.0,Binding affinity to human ERG
7303,CHEMBL2409676,C[C@]1(CS(=O)(=O)N2CCN(c3ncc(OCc4ccc(C(F)(F)F)o4)cn3)CC2)NC(=O)NC1=O,IC50,nM,=,44000.0,Inhibition of human ERG channel by electrophysiological assay
7304,CHEMBL2409707,C[C@]1(CS(=O)(=O)N2CCC(Oc3ccc(OC(F)(F)C(F)F)cc3)CC2)NC(=O)NC1=O,IC50,nM,=,40000.0,Inhibition of human ERG channel by electrophysiological assay
7305,CHEMBL2409408,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C(=O)[C@@H](C)O)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7306,CHEMBL2409407,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(CCO)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7307,CHEMBL2409406,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(S(C)(=O)=O)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7308,CHEMBL2409404,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCC(OC)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7309,CHEMBL2409403,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCOCC1,IC50,nM,>,30000.0,Inhibition of human ERG
7310,CHEMBL1683036,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7311,CHEMBL2409313,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)C(=O)C1,IC50,nM,>,30000.0,Inhibition of human ERG
7312,CHEMBL2409312,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(CCO)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7313,CHEMBL481205,COCCOc1cc2ncc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7314,CHEMBL479441,COCCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7315,CHEMBL2409401,COCCN1CCN(c2cc3c(Nc4ccc(C)cc4F)c(C(N)=O)nnc3cc2OC)CC1,IC50,nM,=,23000.0,Inhibition of human ERG
7316,CHEMBL481806,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1,IC50,nM,=,23000.0,Inhibition of human ERG
7317,CHEMBL2409400,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCC(N(C)C)CC1,IC50,nM,=,21000.0,Inhibition of human ERG
7318,CHEMBL2409399,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1C[C@H](C)N[C@H](C)C1,IC50,nM,=,20000.0,Inhibition of human ERG
7319,CHEMBL2409397,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C(C)C)CC1,IC50,nM,=,17000.0,Inhibition of human ERG
7320,CHEMBL481717,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCC(O)CC1,IC50,nM,=,17000.0,Inhibition of human ERG
7321,CHEMBL2409405,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCS(=O)(=O)CC1,IC50,nM,=,16000.0,Inhibition of human ERG
7322,CHEMBL521096,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCN(C)CC1,IC50,nM,=,15000.0,Inhibition of human ERG
7323,CHEMBL2409410,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1C1CCN(CCO)CC1,IC50,nM,=,14000.0,Inhibition of human ERG
7324,CHEMBL2409402,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCCN(CCO)CC1,IC50,nM,=,14000.0,Inhibition of human ERG
7325,CHEMBL2409409,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1C1CCN(C(C)C)CC1,IC50,nM,=,11000.0,Inhibition of human ERG
7326,CHEMBL2409309,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1C1CCN(C)CC1,IC50,nM,=,11000.0,Inhibition of human ERG
7327,CHEMBL2409311,COCCOc1cc2ncc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCOCC1,IC50,nM,=,9000.0,Inhibition of human ERG
7328,CHEMBL481008,CCOc1cc2ncc(C(N)=O)c(Nc3cccc(Cl)c3Cl)c2cc1N1CCN(C)CC1,IC50,nM,=,8000.0,Inhibition of human ERG
7329,CHEMBL2409398,COc1cc2nnc(C(N)=O)c(Nc3ccc(C)cc3F)c2cc1N1CCCN(C)CC1,IC50,nM,=,6000.0,Inhibition of human ERG
7330,CHEMBL520431,CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCCN(C)CC1,IC50,nM,=,6000.0,Inhibition of human ERG
7331,CHEMBL2409310,CCOc1cc2ncc(C(N)=O)c(Nc3cccc(Cl)c3Cl)c2cc1C1CCN(C)CC1,IC50,nM,=,4000.0,Inhibition of human ERG
7332,CHEMBL2407175,CCCN1C(=O)CC2(CCN(CC3CCN(C(=O)OCC)CC3)CC2)c2cccnc21,IC50,nM,=,670.0,Inhibition of human ERG by automated planar patch-clamp system
7333,CHEMBL2407174,CCOC(=O)N1CCC(CN2CCC3(CC2)CC(=O)N(CC)c2ncccc23)CC1,IC50,nM,=,2890.0,Inhibition of human ERG by automated planar patch-clamp system
7334,CHEMBL2407173,CCOC(=O)N1CCC(CN2CCC3(CC2)CC(=O)N(C)c2ncccc23)CC1,IC50,nM,=,2540.0,Inhibition of human ERG by automated planar patch-clamp system
7335,CHEMBL2407172,CCOC(=O)N1CCC(CN2CCC3(CC2)CC(=O)Nc2ncccc23)CC1,IC50,nM,=,2800.0,Inhibition of human ERG by automated planar patch-clamp system
7336,CHEMBL2407171,CCOC(=O)N1CCC(CN2CCC3(CC2)OC(=O)Nc2ncccc23)CC1,IC50,nM,=,920.0,Inhibition of human ERG by automated planar patch-clamp system
7337,CHEMBL2407170,CCOC(=O)N1CCC(CN2CCC3(CC2)OC(=O)N(C)c2ncccc23)CC1,IC50,nM,=,1480.0,Inhibition of human ERG by automated planar patch-clamp system
7338,CHEMBL2409198,CC(=O)Nc1cc(Nc2cc(NC3COC3)n3ncc(C#N)c3n2)c(F)cc1C1CC1,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7339,CHEMBL2409197,CC(=O)Nc1cc(Nc2cc(NC3COC3)n3ncc(C#N)c3n2)ccc1C1CC1,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7340,CHEMBL2409196,CC(=O)Nc1cc(Nc2cc(NC3COC3)n3ncc(C#N)c3n2)c(F)cc1C,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7341,CHEMBL2409195,CC(=O)Nc1cc(Nc2cc(NC3COC3)n3ncc(C#N)c3n2)ccc1C,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7342,CHEMBL2409194,CC(=O)Nc1cc(Nc2cc(NC3COC3)n3ncc(C#N)c3n2)ccc1Cl,IC50,,,,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7343,CHEMBL2409184,CC(=O)Nc1cc(Nc2cc(Nc3cn(C)cn3)n3ncc(C#N)c3n2)ccc1C,IC50,,,,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7344,CHEMBL2409183,CC(=O)Nc1cc(Nc2cc(Nc3ccn(C)n3)n3ncc(C#N)c3n2)ccc1C,IC50,,,,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7345,CHEMBL2409182,CC(=O)Nc1cc(Nc2cc(NC3CCC3)n3ncc(C#N)c3n2)c(F)cc1C,IC50,nM,=,16000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7346,CHEMBL2409181,CC(=O)Nc1cc(Nc2cc(NC3CCC3)n3ncc(C#N)c3n2)ccc1C,IC50,nM,=,11000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7347,CHEMBL2409180,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ncc1C,IC50,nM,=,19000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7348,CHEMBL2407112,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)cnc1C,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7349,CHEMBL2409179,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)c(F)cc1C1CC1,IC50,,,,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7350,CHEMBL2409178,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)c(F)cc1C,IC50,nM,=,16000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7351,CHEMBL2409177,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C1CC1,IC50,nM,=,19000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7352,CHEMBL2409176,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C(C)C,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7353,CHEMBL2409175,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,IC50,nM,=,21000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7354,CHEMBL2409174,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1Cl,IC50,nM,>,33000.0,Binding affinity to human ERG expressed in CHO cells by IonWorks assay
7355,CHEMBL2413849,Cc1ccc2[nH]c(C(=O)N3CCC(CC(C)(C)O)CC3)cc2c1,IC50,nM,>,100000.0,Inhibition of human ERG channel by Rb efflux assay
7356,CHEMBL2414670,Cc1noc(C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)n1,IC50,nM,>,30000.0,Inhibition of human ERG channel by patch clamp analysis
7357,CHEMBL2415099,COc1nc(-c2nc3n(n2)CCC[C@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG
7358,CHEMBL2415098,COc1cc(-c2nc3n(n2)CCO[C@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG
7359,CHEMBL2415097,COc1cc(-c2nc3n(n2)CCC[C@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG
7360,CHEMBL2415096,COc1cc(-c2nc3n(n2)CCC[C@@H]3c2ccc(F)cc2C)ccc1-n1cnc(C)c1,IC50,nM,=,794.0,Binding affinity to human ERG
7361,CHEMBL2415095,COc1cc(-c2nc3n(n2)CCC[C@H]3c2ccc(F)cc2C)ccc1-n1cnc(C)c1,IC50,nM,=,7900.0,Binding affinity to human ERG
7362,CHEMBL2418811,Cc1sc(Nc2ccc(Cl)cc2F)nc1C(=O)N1CCC[C@H](C)[C@@H]1C,IC50,nM,>,50000.0,Inhibition of human ERG channel by patch express-based electrophysiology assay
7363,CHEMBL2418806,Cc1ccc(Nc2nc(C(=O)N3CCCC(C)C3C)cs2)cc1,IC50,nM,>,50000.0,Inhibition of human ERG channel by patch express-based electrophysiology assay
7364,CHEMBL2420704,Cn1cc(-c2ccnc(C3COCCN3)c2)c(-c2ccc(F)cc2)n1,IC50,nM,=,25900.0,Displacement of [3H]dofetilide from human ERG channel
7365,CHEMBL2420703,Cn1cc(-c2ccnc3c2OCCNC3)c(-c2ccc(F)cc2)n1,IC50,nM,>,79600.0,Displacement of [3H]dofetilide from human ERG channel
7366,CHEMBL2420702,CNCc1cc(-c2cn(C)nc2-c2ccc(F)cc2)ccn1,IC50,nM,=,38200.0,Displacement of [3H]dofetilide from human ERG channel
7367,CHEMBL1951415,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1,IC50,nM,=,27700.0,Displacement of [3H]dofetilide from human ERG channel
7368,CHEMBL2420704,Cn1cc(-c2ccnc(C3COCCN3)c2)c(-c2ccc(F)cc2)n1,IC50,nM,=,4430.0,Inhibition of human ERG channel by electrophysiological method
7369,CHEMBL2420703,Cn1cc(-c2ccnc3c2OCCNC3)c(-c2ccc(F)cc2)n1,IC50,nM,=,25700.0,Inhibition of human ERG channel by electrophysiological method
7370,CHEMBL2420702,CNCc1cc(-c2cn(C)nc2-c2ccc(F)cc2)ccn1,IC50,nM,=,3990.0,Inhibition of human ERG channel by electrophysiological method
7371,CHEMBL2420700,Cn1cc(-c2ccncc2)c(-c2ccc(F)cc2)n1,IC50,nM,>,100000.0,Inhibition of human ERG channel by electrophysiological method
7372,CHEMBL1951415,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1,IC50,nM,=,27000.0,Inhibition of human ERG channel by electrophysiological method
7373,CHEMBL2419564,CN(C(=O)c1ccncc1)c1ccc(OCc2ccc3ccccc3n2)cc1,IC50,nM,>,50000.0,Inhibition of human ERG
7374,CHEMBL188678,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,nM,=,14000.0,Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
7375,CHEMBL2420287,CC(=O)N1CCN(CCOc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
7376,CHEMBL2420310,O=C(CN1CCN(CCO)CC1)Nc1ccc(-c2cccc3c(=O)cc(N4CCOCC4)oc23)c2sc3ccccc3c12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
7377,CHEMBL1086377,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1,IC50,nM,>,20000.0,Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
7378,CHEMBL2420425,CN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
7379,CHEMBL2425893,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3ccc(Cl)cc3n2)c1=O,IC50,nM,=,100000.0,Inhibition of human ERG
7380,CHEMBL2426288,COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,4200.0,Inhibition of human ERG
7381,CHEMBL2424936,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CN1CCO[C@@H](CNCc2cc3c(cn2)OCCO3)C1,IC50,,,,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7382,CHEMBL2424935,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CN1CCC[C@@H](CNCc2cc3c(cn2)OCCO3)C1,IC50,,,,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7383,CHEMBL2424934,O=c1c(F)cc2ncc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,,,,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7384,CHEMBL2424933,O=c1cnc2ccc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,206000.0,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7385,CHEMBL2424932,O=c1ccc2ccc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,,,,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7386,CHEMBL2424931,O=c1ccc2ncc(F)c3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,122000.0,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7387,CHEMBL2424930,O=c1ccc2ncc(F)c3c2n1C[C@@]3(F)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,,,,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7388,CHEMBL2424929,O=c1ccc2ncc(F)c3c2n1C[C@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,,,,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7389,CHEMBL2424928,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,310000.0,Inhibition of human ERG transfected in HEK293 cells by patch clamp assay
7390,CHEMBL2424936,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CN1CCO[C@@H](CNCc2cc3c(cn2)OCCO3)C1,IC50,,,,Inhibition of human ERG by patch clamp assay
7391,CHEMBL2424935,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CN1CCC[C@@H](CNCc2cc3c(cn2)OCCO3)C1,IC50,,,,Inhibition of human ERG by patch clamp assay
7392,CHEMBL2424934,O=c1c(F)cc2ncc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,289000.0,Inhibition of human ERG by patch clamp assay
7393,CHEMBL2424933,O=c1cnc2ccc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,101000.0,Inhibition of human ERG by patch clamp assay
7394,CHEMBL2424932,O=c1ccc2ccc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,,,,Inhibition of human ERG by patch clamp assay
7395,CHEMBL2424931,O=c1ccc2ncc(F)c3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,58000.0,Inhibition of human ERG by patch clamp assay
7396,CHEMBL2424930,O=c1ccc2ncc(F)c3c2n1C[C@@]3(F)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,16000.0,Inhibition of human ERG by patch clamp assay
7397,CHEMBL2424929,O=c1ccc2ncc(F)c3c2n1C[C@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,,,,Inhibition of human ERG by patch clamp assay
7398,CHEMBL2424928,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,=,239000.0,Inhibition of human ERG by patch clamp assay
7399,CHEMBL2425952,CCc1nc2c(Cc3ccc(C(=O)NO)cc3)cccc2c(=O)n1CCc1ccccc1,IC50,nM,=,4700.0,Inhibition of human ERG channel
7400,CHEMBL2425958,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,IC50,nM,>,10000.0,Inhibition of human ERG channel
7401,CHEMBL2425061,N[C@H]1C[C@@H](N2Cc3cnc(C4CC4)nc3C2)CO[C@@H]1c1cc(F)c(F)cc1F,IC50,nM,>,30000.0,Inhibition of human ERG channel
7402,CHEMBL2425060,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CO[C@@H]1c1cc(F)c(F)cc1F,IC50,nM,=,23000.0,Inhibition of human ERG channel
7403,CHEMBL2425059,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,IC50,nM,=,4800.0,Inhibition of human ERG channel
7404,CHEMBL2430983,Cn1nc(-c2ccncc2)cc1NC(=O)[C@H](Cc1ccccc1)NCC(=O)O,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
7405,CHEMBL531475,COc1ccc(-c2cc(-c3ccc(S(C)(=O)=O)cc3)cnc2N)cn1,IC50,nM,=,3500.0,Inhibition of human ERG channel expressed in Chinese hamster lung cells after 6 to 7 mins by patch clamp assay
7406,CHEMBL1800137,CC(C)(N)C(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2Nc2ccc(F)cc2)C1,IC50,nM,=,3950.0,Binding affinity to human ERG channel
7407,CHEMBL2431809,CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(Cl)cc3)n2CCN1C(=O)CN,IC50,nM,=,7200.0,Binding affinity to human ERG channel
7408,CHEMBL2436978,CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1,IC50,nM,=,21000.0,Inhibition of human ERG tail current transfected in HEK293 cells by patch clamp assay
7409,CHEMBL2435858,Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,IC50,nM,=,18000.0,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7410,CHEMBL2435853,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1,IC50,nM,=,9900.0,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7411,CHEMBL2435849,O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1,IC50,nM,>,40000.0,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7412,CHEMBL2434978,O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1,IC50,nM,>,30000.0,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7413,CHEMBL2435856,CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,IC50,nM,>,30000.0,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7414,CHEMBL2435852,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,IC50,nM,>,30000.0,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7415,CHEMBL2435845,Cc1nc(Nc2ccc(C(=O)O)cc2)ncc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7416,CHEMBL2435844,O=C(O)c1ccc(Sc2ncc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7417,CHEMBL2435843,CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)c(C)n2)cc1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7418,CHEMBL2435857,Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7419,CHEMBL2435855,Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(F)c2)CC1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7420,CHEMBL2435854,Cc1cccc([C@@H]2CN(C3CCOCC3)C(=O)N2C2CCN(Cc3ccc(Oc4ccc(C(=O)O)cc4)nc3C)CC2)c1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7421,CHEMBL2435851,O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7422,CHEMBL2435850,O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1,IC50,,,,Inhibition of human recombinant ERG expressed in CHO cells by patch-clamp technique
7423,CHEMBL2436226,CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C)ccc3ccccc23)c2ccc(C#N)cc2N(C(C)=O)[C@H]1C.Cl,IC50,nM,=,35300.0,Inhibition of human ERG
7424,CHEMBL2436225,CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(OC)ccc3ccccc23)c2ccc(C#N)cc2N(C(C)=O)[C@H]1C.Cl,IC50,nM,>,20000.0,Inhibition of human ERG
7425,CHEMBL2441565,CN(C)C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,IC50,nM,>,10000.0,Inhibition of human ERG channel by patch clamp assay
7426,CHEMBL2440388,COc1ccc2c(c1)c(/C=N/NS(=O)(=O)c1ccc(C)cc1)cn2CC(=O)Nc1ccc(F)cc1F,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7427,CHEMBL2440387,COc1ccc2c(c1)c(/C=N/NS(=O)(=O)c1ccc(C)cc1)cn2CC(=O)Nc1ccc(Cl)cc1,IC50,nM,=,418350.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7428,CHEMBL2440386,COc1ccc2c(c1)c(/C=N/NS(=O)(=O)c1ccc(C)cc1)cn2CC(=O)Nc1ccccc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7429,CHEMBL2440385,CCC(=O)Oc1ccc(NC(=O)Cn2cc(/C=N/NS(=O)(=O)c3ccc(C)cc3)c3ccccc32)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7430,CHEMBL2440384,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccc(F)cc3F)c3ccccc23)cc1,IC50,nM,=,42970.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7431,CHEMBL2440383,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccccc3Cl)c3ccccc23)cc1,IC50,nM,=,18660.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7432,CHEMBL2440382,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7433,CHEMBL2440403,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccc(OC(F)(F)F)cc3)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7434,CHEMBL2440402,COc1ccc(NC(=O)Cn2cc(/C=N/NS(=O)(=O)c3ccc(C)cc3)c3ccccc32)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7435,CHEMBL2440401,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccc(C)c(C)c3)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7436,CHEMBL2440400,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3cc(C)ccc3C)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7437,CHEMBL2440399,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccc(C)cc3C)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7438,CHEMBL2440398,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccccc3)c3ccccc23)cc1,IC50,nM,=,43620.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7439,CHEMBL2440397,CCCCOc1ccc(S(=O)(=O)NCCc2cn(CC(=O)Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7440,CHEMBL2440121,CCCCOc1ccc(S(=O)(=O)NCCc2cn(CC(=O)Nc3ccc(OC)cc3)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7441,CHEMBL2440396,COc1ccc(S(=O)(=O)NCCc2cn(CC(=O)Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,nM,=,11490.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7442,CHEMBL2440395,COc1ccc(NC(=O)Cn2cc(CCNS(=O)(=O)c3ccc(OC)cc3)c3ccccc32)cc1,IC50,nM,=,10230.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7443,CHEMBL2440394,Cc1ccc(S(=O)(=O)NCCc2cn(CC(=O)Nc3ccc(Cl)cc3)c3ccccc23)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7444,CHEMBL2440393,COc1ccc(NC(=O)Cn2cc(CCNS(=O)(=O)c3ccc(C)cc3)c3ccccc32)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7445,CHEMBL2440392,CCCCOc1ccc(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc1,IC50,nM,=,3180.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7446,CHEMBL2440391,CCCCOc1ccc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7447,CHEMBL2440390,CCCCOc1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)OC)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7448,CHEMBL2440389,COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(F)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7449,CHEMBL2440410,COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Br)cc1,IC50,nM,=,4660.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7450,CHEMBL2440409,COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7451,CHEMBL2440408,COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(OC)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7452,CHEMBL2440407,COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(OC2CCCC2)cc1,IC50,nM,=,9560.0,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7453,CHEMBL2440406,COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(OCC(C)C)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7454,CHEMBL2440405,COC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(OC(C)C)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7455,CHEMBL2440404,CCCCOc1ccc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)OC)cc1,IC50,,,,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique
7456,CHEMBL2441420,O=C1OCc2c1ccc(CCN1CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC1)c2F,IC50,nM,=,12000.0,Inhibition of human ERG by electrophysiology assay
7457,CHEMBL2441417,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,13000.0,Inhibition of human ERG by electrophysiology assay
7458,CHEMBL2441408,O=C1OCCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,18000.0,Inhibition of human ERG by electrophysiology assay
7459,CHEMBL2441437,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,4500.0,Inhibition of human ERG by electrophysiology assay
7460,CHEMBL2441428,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)cc(Cl)c21,IC50,nM,=,3400.0,Displacement of [35S]-MK499 from human ERG
7461,CHEMBL2441427,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)cc(F)c21,IC50,nM,=,13000.0,Displacement of [35S]-MK499 from human ERG
7462,CHEMBL2441426,Cc1cc(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)cc2c1C(=O)OC2,IC50,nM,=,10000.0,Displacement of [35S]-MK499 from human ERG
7463,CHEMBL2441425,COc1cc2c(cc1CCN1CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC1)COC2=O,IC50,nM,=,5600.0,Displacement of [35S]-MK499 from human ERG
7464,CHEMBL2441424,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)c(F)cc21,IC50,nM,=,26000.0,Displacement of [35S]-MK499 from human ERG
7465,CHEMBL2441423,Cc1cc2c(cc1CCN1CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC1)COC2=O,IC50,nM,=,14000.0,Displacement of [35S]-MK499 from human ERG
7466,CHEMBL2441422,COc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,40000.0,Displacement of [35S]-MK499 from human ERG
7467,CHEMBL2441421,O=C1OCc2c1ccc(CCN1CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC1)c2Cl,IC50,nM,=,17000.0,Displacement of [35S]-MK499 from human ERG
7468,CHEMBL2441420,O=C1OCc2c1ccc(CCN1CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC1)c2F,IC50,nM,=,31000.0,Displacement of [35S]-MK499 from human ERG
7469,CHEMBL2441419,O=C1OCc2c1ccc(CCN1CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC1)c2C1CC1,IC50,nM,=,12000.0,Displacement of [35S]-MK499 from human ERG
7470,CHEMBL2441418,CCc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,27000.0,Displacement of [35S]-MK499 from human ERG
7471,CHEMBL2441417,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,20000.0,Displacement of [35S]-MK499 from human ERG
7472,CHEMBL2441416,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4C(F)(F)F)CC3)ccc21,IC50,nM,=,6900.0,Displacement of [35S]-MK499 from human ERG
7473,CHEMBL2441415,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4C4CC4)CC3)ccc21,IC50,nM,=,3000.0,Displacement of [35S]-MK499 from human ERG
7474,CHEMBL2441414,Cc1cc(-n2cnnn2)ccc1CC(=O)N1CCN(CCc2ccc3c(c2)COC3=O)CC1,IC50,nM,=,1400.0,Displacement of [35S]-MK499 from human ERG
7475,CHEMBL2441413,CCc1cc(CC(=O)N2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1-n1cnnn1,IC50,,,,Displacement of [35S]-MK499 from human ERG
7476,CHEMBL2441412,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)c(C(F)(F)F)c4)CC3)ccc21,IC50,nM,=,5100.0,Displacement of [35S]-MK499 from human ERG
7477,CHEMBL2441411,N#Cc1cc(CC(=O)N2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1-n1cnnn1,IC50,nM,=,7100.0,Displacement of [35S]-MK499 from human ERG
7478,CHEMBL2441410,COc1cc(CC(=O)N2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1-n1cnnn1,IC50,nM,=,8200.0,Displacement of [35S]-MK499 from human ERG
7479,CHEMBL2441409,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)c(F)c4)CC3)ccc21,IC50,nM,=,27000.0,Displacement of [35S]-MK499 from human ERG
7480,CHEMBL2441408,O=C1OCCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,43000.0,Displacement of [35S]-MK499 from human ERG
7481,CHEMBL2441441,O=C1CCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,6500.0,Displacement of [35S]-MK499 from human ERG
7482,CHEMBL2441440,O=C(Cc1ccc(-n2cnnn2)cc1)N1CCN(CCc2ccc3c(c2)COC3)CC1,IC50,nM,=,2500.0,Displacement of [35S]-MK499 from human ERG
7483,CHEMBL2441439,O=C1NCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,,,,Displacement of [35S]-MK499 from human ERG
7484,CHEMBL2441438,O=C1OCc2ccc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)cc21,IC50,nM,=,32000.0,Displacement of [35S]-MK499 from human ERG
7485,CHEMBL2441437,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,14000.0,Displacement of [35S]-MK499 from human ERG
7486,CHEMBL2441436,O=C(Cc1ccc(-n2cnnn2)cc1)N1CCN(CCc2ccc3nonc3c2)CC1,IC50,nM,=,1300.0,Displacement of [35S]-MK499 from human ERG
7487,CHEMBL2441435,N#Cc1cccc(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)c1,IC50,nM,=,2700.0,Displacement of [35S]-MK499 from human ERG
7488,CHEMBL2441434,N#Cc1ccc(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)cc1,IC50,nM,=,420.0,Displacement of [35S]-MK499 from human ERG
7489,CHEMBL2441433,O=C(Cc1ccc(-n2cnnn2)cc1)N1CCN(CCc2ccc([N+](=O)[O-])cc2)CC1,IC50,nM,=,160.0,Displacement of [35S]-MK499 from human ERG
7490,CHEMBL2441431,O=C1OCc2cc(CC(=O)N3CCN(CCc4ccc([N+](=O)[O-])cc4)CC3)ccc21,IC50,nM,=,1300.0,Displacement of [35S]-MK499 from human ERG
7491,CHEMBL2441430,O=C(Cc1ccc([N+](=O)[O-])cc1)N1CCN(CCc2ccc([N+](=O)[O-])cc2)CC1,IC50,nM,=,46.0,Displacement of [35S]-MK499 from human ERG
7492,CHEMBL2441429,O=[N+]([O-])c1ccc(CCN2CCN(CCc3ccc(-n4cnnn4)cc3)CC2)cc1,IC50,nM,=,11.0,Displacement of [35S]-MK499 from human ERG
7493,CHEMBL2441636,Cc1cc(N2CC[C@H](N3CCC[C@@H]3C)C2)ccc1NC(=O)C1CCOCC1,IC50,nM,=,18900.0,Inhibition of human ERG expressed in CHO cells by patch-clamp technique
7494,CHEMBL2440460,CS(=O)(=O)O.O=C(O)c1ccccc1-c1ccc(CN2CCC(COC(=O)c3c4n(c5ccccc35)CCCO4)CC2)cc1,IC50,nM,=,47500.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
7495,CHEMBL2440459,COC(=O)c1ccccc1-c1ccc(CN2CCC(COC(=O)c3c4n(c5ccccc35)CCCO4)CC2)cc1.CS(=O)(=O)O,IC50,nM,=,131.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
7496,CHEMBL2440456,O=C(OCC1CCN(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)CC1)c1c2n(c3ccccc13)CCCO2,IC50,nM,=,27500.0,Inhibition of human ERG expressed in HEK293 cells by patch-clamp technique
7497,CHEMBL2443262,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1,IC50,nM,=,6200.0,Inhibition of human ERG channel expressed in HEK293 cells by whole-cell patch clamp technique
7498,CHEMBL2443278,c1ccc([C@]2(CCNCc3cccs3)CCOC3(CCCC3)C2)nc1,IC50,nM,=,2300.0,Inhibition of human ERG channel expressed in HEK293 cells by whole-cell patch clamp technique
7499,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,=,10.0,Inhibition of human ERG
7500,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,10.0,Inhibition of human ERG
7501,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,10.0,Inhibition of human ERG
7502,CHEMBL549,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,IC50,nM,=,10.0,Inhibition of human ERG
7503,CHEMBL3087669,Cc1cc(N2CC[C@H](N3CCC[C@@H]3C)C2)ccc1NC(=O)c1c(C)noc1C,IC50,nM,=,37000.0,Inhibition of human ERG current transfected in CHO cells by patch clamp assay
7504,CHEMBL3086028,CCN(CC)CC(=O)N[C@@H]1CC[C@@H](C(=O)NC(c2ccc(F)cc2)c2ccc(F)cc2)[C@H](c2ccc(Br)cc2)C1,IC50,nM,=,780.0,Inhibition of human ERG
7505,CHEMBL3086043,O=C(NC(c1ccc(Cl)cc1)c1ncccn1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,1200.0,Inhibition of human ERG
7506,CHEMBL3086042,O=C(NC(c1ccc(Cl)cc1)c1cnccn1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,1000.0,Inhibition of human ERG
7507,CHEMBL3086041,O=C(NC(c1ccc(Cl)cc1)c1ccc(F)cn1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,180.0,Inhibition of human ERG
7508,CHEMBL3086040,O=C(NC(c1ccc(Cl)cc1)c1ccnc(F)c1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,590.0,Inhibition of human ERG
7509,CHEMBL3086039,O=C(NC(c1ccc(Cl)cc1)c1ccncc1Cl)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,690.0,Inhibition of human ERG
7510,CHEMBL3086038,Cc1cc(C(NC(=O)[C@@H]2CC[C@@H](N3CCOCC3)C[C@H]2c2ccc(Br)cc2)c2ccc(Cl)cc2)ccn1,IC50,nM,=,1500.0,Inhibition of human ERG
7511,CHEMBL3086037,O=C(NC(c1ccncc1)c1ccc(Cl)cc1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,1900.0,Inhibition of human ERG
7512,CHEMBL3085780,O=C(NC(c1ccncc1)c1ccc(F)cc1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,8400.0,Inhibition of human ERG
7513,CHEMBL3086036,O=C(NC(c1ccc(F)cc1)c1ccc(F)cc1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,100.0,Inhibition of human ERG
7514,CHEMBL3086035,O=C(NC(c1ccc(Cl)cc1)c1ccc(Cl)cc1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,39.0,Inhibition of human ERG
7515,CHEMBL3086032,C[C@H](NC(=O)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1)c1ccc(F)cc1,IC50,nM,=,2200.0,Inhibition of human ERG
7516,CHEMBL3086029,O=C([C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1)N1CC(c2ccccc2)(c2ccccc2)C1,IC50,nM,=,290.0,Inhibition of human ERG
7517,CHEMBL3086048,O=C(NC(c1ccccc1)c1ccccc1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1,IC50,nM,=,530.0,Inhibition of human ERG
7518,CHEMBL3086047,O=C(NC(c1ccccc1)c1ccccc1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccccc1,IC50,nM,=,170.0,Inhibition of human ERG
7519,CHEMBL3086045,Cc1ccccc1[C@H]1C[C@@H](NCc2ccc(Cl)cc2)CC[C@@H]1C(=O)N1CC(c2ccccc2)(c2ccccc2)C1,IC50,nM,=,3.0,Inhibition of human ERG
7520,CHEMBL3092633,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1cccnc1Oc1ccccc1C1CCN(Cc2ccccc2)CC1,IC50,,,,Inhibition of human ERG flux
7521,CHEMBL3092630,CN1Cc2cccc(Oc3ncccc3NC(=O)Nc3ccc(OC(F)(F)F)cc3)c2C1,IC50,,,,Inhibition of human ERG flux
7522,CHEMBL3092628,CC(C)CN1Cc2cccc(Oc3ncccc3NC(=O)Nc3ccc(OC(F)(F)F)cc3)c2C1,IC50,,,,Inhibition of human ERG flux
7523,CHEMBL3091475,CC(C)(C)CN1Cc2cccc(Oc3ncccc3NC(=O)Nc3ccc(OC(F)(F)F)cc3)c2C1,IC50,,,,Inhibition of human ERG flux
7524,CHEMBL3092629,CN1Cc2cccc(Oc3ncccc3NC(=O)Nc3ccc(OC(F)(F)F)cc3)c2C1C(C)(C)C,IC50,nM,=,7200.0,Inhibition of human ERG flux
7525,CHEMBL3092632,CC(C)CN1CCC(c2ccccc2Oc2ncccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,IC50,nM,=,6000.0,Inhibition of human ERG flux
7526,CHEMBL3092631,CC(C)(C)CN1CCC(c2ccccc2Oc2ncccc2NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,IC50,nM,=,4600.0,Inhibition of human ERG flux
7527,CHEMBL3092198,CC(C)(C1CCN(C(=O)c2cc(F)ccc2S(C)(=O)=O)CC1)S(=O)(=O)c1cccc(C(F)(F)F)c1,IC50,nM,>,10000.0,Displacement of [35S]MK-499 from human ERG
7528,CHEMBL3092197,CC(C)(C1CCN(C(=O)c2ccc(S(C)(=O)=O)cc2OC(F)(F)F)CC1)S(=O)(=O)c1cccc(C(F)(F)F)c1,IC50,nM,>,10000.0,Displacement of [35S]MK-499 from human ERG
7529,CHEMBL3093987,CCCCCCCN(CC)CC#CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,970.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7530,CHEMBL3093949,CCCCN(CC)CC#CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,4810.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7531,CHEMBL3093950,CCCCCCCN(CC)CC#CCOCc1ccc(Cl)cc1,IC50,nM,=,834.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7532,CHEMBL3093951,CCCCN(CC)CC#CCOCc1ccc(Cl)cc1,IC50,nM,=,7372.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7533,CHEMBL3093959,CCCCCCCN(CC)CCCCc1ccc(Cl)cc1,IC50,nM,=,4.3,Inhibition of human ERG channel expressed in HEK293 cells after 15 mins by whole-cell patch clamp technique
7534,CHEMBL3093986,CCCCCCCN(CC)C/C=C/Cc1ccc(Cl)cc1,IC50,nM,<,5.0,Inhibition of human ERG channel expressed in HEK293 cells after 15 mins by whole-cell patch clamp technique
7535,CHEMBL3093982,CCCCCCCN(CC)CC#CCOc1ccc(Cl)cc1,IC50,nM,=,58.0,Inhibition of human ERG channel expressed in HEK293 cells after 15 mins by whole-cell patch clamp technique
7536,CHEMBL3093979,CCCCN(CC)CC#CC#Cc1ccc(Cl)cc1,IC50,nM,=,473.0,Inhibition of human ERG channel expressed in HEK293 cells after 15 mins by whole-cell patch clamp technique
7537,CHEMBL3093976,CCCCCCCN(CC)CC#CCCc1ccc(Cl)cc1,IC50,nM,=,53.0,Inhibition of human ERG channel expressed in HEK293 cells after 15 mins by whole-cell patch clamp technique
7538,CHEMBL3093969,CCCCCCCN(CC)CC#CCc1ccc(Cl)cc1,IC50,nM,=,4.9,Inhibition of human ERG channel expressed in HEK293 cells after 15 mins by whole-cell patch clamp technique
7539,CHEMBL598270,CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1.Cc1ccc(S(=O)(=O)[O-])cc1,IC50,nM,=,50.0,Inhibition of human ERG channel expressed in HEK293 cells after 15 mins by whole-cell patch clamp technique
7540,CHEMBL3093963,CCCCCCCN1CCC(C(=O)c2ccccc2)CC1,IC50,nM,=,124.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7541,CHEMBL3093962,CCCCCCCN1CCC(Cc2ccccc2)CC1,IC50,nM,=,58.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7542,CHEMBL3093961,CCCCCCCN(CC)CCCCCc1ccc(Cl)cc1,IC50,nM,=,123.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7543,CHEMBL3093960,CCCCN(CC)CCCCCc1ccc(Cl)cc1,IC50,nM,=,2500.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7544,CHEMBL3093959,CCCCCCCN(CC)CCCCc1ccc(Cl)cc1,IC50,nM,=,43.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7545,CHEMBL3093958,CCCCCCCN(CC)CCCCc1ccccc1,IC50,nM,=,506.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7546,CHEMBL3093957,CCCCCCC[N+](CC)(CC)C/C=C/Cc1ccc(Cl)cc1.[I-],IC50,nM,=,1.5,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7547,CHEMBL3093956,CCCCCCCN(CC)C/C=C\Cc1ccccc1,IC50,nM,=,1178.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7548,CHEMBL3093955,CCCCCCCN(CC)C/C=C/CCc1ccc(Cl)cc1,IC50,nM,=,238.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7549,CHEMBL3093954,CCCCN(CC)C/C=C/CCc1ccc(Cl)cc1,IC50,nM,=,1868.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7550,CHEMBL3093953,CCCCCCCN(CC)C/C=C/Cc1ccccc1,IC50,nM,=,176.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7551,CHEMBL3093986,CCCCCCCN(CC)C/C=C/Cc1ccc(Cl)cc1,IC50,nM,=,49.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7552,CHEMBL3093985,CCCCN(CC)C/C=C/Cc1ccc(Cl)cc1,IC50,nM,=,1127.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7553,CHEMBL3093984,CCCCCCCN(CC)C/C=C/c1ccc(Cl)cc1,IC50,nM,=,243.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7554,CHEMBL3093983,CCCCN(CC)C/C=C/c1ccc(Cl)cc1,IC50,nM,=,1050.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7555,CHEMBL3093982,CCCCCCCN(CC)CC#CCOc1ccc(Cl)cc1,IC50,nM,=,2473.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7556,CHEMBL3093981,CCCCN(CC)CC#CCOc1ccc(Cl)cc1,IC50,nM,=,14443.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7557,CHEMBL3093979,CCCCN(CC)CC#CC#Cc1ccc(Cl)cc1,IC50,nM,=,9929.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7558,CHEMBL3093978,CCCCCCCN(CC)CC#CCCc1ccc(C)cc1,IC50,nM,=,1890.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7559,CHEMBL3093977,CCCCN(CC)CC#CCCc1ccc(C)cc1,IC50,nM,=,5590.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7560,CHEMBL3093976,CCCCCCCN(CC)CC#CCCc1ccc(Cl)cc1,IC50,nM,=,765.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7561,CHEMBL3093975,CCCCN(CC)CC#CCCc1ccc(Cl)cc1,IC50,nM,=,6007.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7562,CHEMBL3093974,CCCCCCCN(CC)CC#CCCc1ccccc1,IC50,nM,=,4394.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7563,CHEMBL3093972,CCCCCCCN(CC)CC#CC(c1ccccc1)c1ccccc1,IC50,nM,=,238.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7564,CHEMBL3093971,CCCCCCCN(CC)CC#CCc1ccc(C)cc1,IC50,nM,=,5090.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7565,CHEMBL3093970,CCCCN(CC)CC#CCc1ccc(C)cc1,IC50,nM,=,3470.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7566,CHEMBL3093969,CCCCCCCN(CC)CC#CCc1ccc(Cl)cc1,IC50,nM,=,865.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7567,CHEMBL3093968,CCCCN(CC)CC#CCc1ccc(Cl)cc1,IC50,nM,=,2654.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7568,CHEMBL3093967,CCCCCCCN(CC)CC#CCc1ccccc1,IC50,nM,=,3543.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7569,CHEMBL3093966,CCCCN(CC)CC#CCc1ccccc1,IC50,nM,=,7820.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7570,CHEMBL3093965,CCCCCCC[N+](CC)(CC)CC#Cc1ccc(Cl)cc1.Cc1ccc(S(=O)(=O)[O-])cc1,IC50,nM,=,40.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7571,CHEMBL3093964,CCCCCCCN(CC)CC#Cc1ccc(Cl)cc1,IC50,nM,=,4080.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7572,CHEMBL598270,CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1.Cc1ccc(S(=O)(=O)[O-])cc1,IC50,nM,=,2.0,Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis
7573,CHEMBL3099950,NC(=O)Nc1ccc(F)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2,IC50,nM,=,400.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7574,CHEMBL3099949,NC(=O)Nc1ccccc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2,IC50,nM,=,400.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7575,CHEMBL3099948,NC(=O)Nc1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2,IC50,nM,>,8900.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7576,CHEMBL3099947,O=C(Nc1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(F)ccc1O2)NC1CC1,IC50,nM,=,3800.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7577,CHEMBL3099945,O=C(Nc1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2)NC1CC1,IC50,nM,=,2400.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7578,CHEMBL3099944,COc1ccc(NC(=O)NC2CC2)c(OC[C@@H](O)CN2CCC3(CC2)Cc2cc(Cl)ccc2O3)c1,IC50,nM,=,700.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7579,CHEMBL3099943,O=C(Nc1cc(Cl)c(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2)NC1CC1,IC50,nM,=,1000.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7580,CHEMBL3099942,CNC(=O)Nc1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2,IC50,nM,=,4600.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7581,CHEMBL3099961,CNC(=O)Nc1ccc(O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(F)ccc1O2,IC50,nM,=,13100.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7582,CHEMBL3099959,N[C@H](COc1cccc2ccc(=O)[nH]c12)CN1CCC2(CC1)Cc1cc(F)ccc1O2,IC50,nM,=,1200.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7583,CHEMBL3099958,N[C@H](COc1cccc2c1NC(=O)CO2)CN1CCC2(CC1)Cc1cc(F)ccc1O2,IC50,nM,=,1100.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7584,CHEMBL3099953,O=c1ccc2cccc(OC[C@@H](O)CN3CCC4(CC3)Cc3cc(Cl)ccc3O4)c2[nH]1,IC50,nM,=,600.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7585,CHEMBL3099952,O=C1CCc2cccc(OC[C@@H](O)CN3CCC4(CC3)Cc3cc(Cl)ccc3O4)c2N1,IC50,nM,=,500.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7586,CHEMBL3099951,O=C1COc2cccc(OC[C@@H](O)CN3CCC4(CC3)Cc3cc(Cl)ccc3O4)c2N1,IC50,nM,=,600.0,Inhibition of human ERG expressed in HEK cells after 3 hrs by ion flux electrophysiology
7587,CHEMBL3099716,CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1,IC50,nM,=,10900.0,Inhibition of human ERG
7588,CHEMBL3099899,COc1ccc(CNC(=O)c2cc(-c3cc(Cl)cc(Cl)c3)cnc2-c2cccnc2)cc1OC,IC50,nM,=,6950.0,Inhibition of human ERG
7589,CHEMBL3104879,Cc1cc2c(c(Oc3cc(NS(=O)(=O)c4ccc(Cl)cc4)ccc3F)n1)C(=O)N(C(C)C)C2=O,IC50,nM,>,30000.0,Inhibition of human ERG by patch-clamp assay
7590,CHEMBL3104250,C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O,IC50,nM,>,10000.0,Inhibition of human ERG
7591,CHEMBL3109337,COCCOc1ccn2c(-c3ccc4cccc(O[C@@H]5CCNC[C@H]5F)c4n3)cnc2c1,IC50,nM,=,3900.0,Inhibition of human ERG
7592,CHEMBL601202,Cn1cncc1[C@H](O)C1=Cc2cccnc2[C@@H](N2CCN(C(=O)OC(C)(C)C)CC2)c2ccc(Cl)cc21,IC50,nM,>,1000.0,Inhibition of human ERG
7593,CHEMBL3112967,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCn3c(nnc3C(F)(F)F)C2=O)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by dofetilide binding assay
7594,CHEMBL3112960,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2nc(-c3cccnc3)ccc2=O)CC1,IC50,nM,=,4400.0,Inhibition of human ERG by dofetilide binding assay
7595,CHEMBL3112968,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCc3c(nc(C(F)(F)F)nc3C3CC3)C2=O)CC1,IC50,nM,=,260.0,Inhibition of human ERG by dofetilide binding assay
7596,CHEMBL3115061,Cl.O=C1N[C@H](C(=O)O)Cc2cn(cn2)C/C=C/COc2ccc(Cl)c1c2,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
7597,CHEMBL3115111,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCCN3CCOCC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7598,CHEMBL3115110,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCCN3CCCC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7599,CHEMBL3115109,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCCNC(C)=O)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7600,CHEMBL3115108,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCCC3CCOCC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7601,CHEMBL3115107,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCC3CCOCC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7602,CHEMBL3115106,COCCOC(=O)N1C[C@@H]2C[C@@H](NC3CCOCC3OC)C[C@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7603,CHEMBL3115105,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCC(C)C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7604,CHEMBL3115104,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCC(C)(C)C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7605,CHEMBL3115103,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCc3ccccc3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7606,CHEMBL3115102,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)Oc3ccccc3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7607,CHEMBL3115101,COC(=O)N1C[C@@H]2C[C@@H](NC3CCOCC3OC)C[C@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7608,CHEMBL3115100,COC1COCCC1N[C@@H]1C[C@H]2CN(/C(N)=N\C#N)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7609,CHEMBL3115099,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)NCc3ccccc3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7610,CHEMBL3115098,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)NC(C)C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7611,CHEMBL3115097,CNC(=O)N1C[C@@H]2C[C@@H](NC3CCOCC3OC)C[C@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7612,CHEMBL3115096,COC1COCCC1N[C@@H]1C[C@H]2CN(C(N)=O)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7613,CHEMBL3115275,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)CCc3ccccc3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7614,CHEMBL3115274,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)C#CC3CC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,=,49600.0,Binding affinity to human ERG
7615,CHEMBL3115273,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)/C=C/C(C)(C)C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7616,CHEMBL3115272,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)/C=C/c3ccccc3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,=,24100.0,Binding affinity to human ERG
7617,CHEMBL3115271,COC1COCCC1N[C@@H]1C[C@H]2CN(C(C)=O)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7618,CHEMBL3115270,COC1COCCC1N[C@@H]1C[C@H]2CN(c3ncccn3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7619,CHEMBL3115269,COC1COCCC1N[C@@H]1C[C@H]2CN(c3nccs3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7620,CHEMBL3115268,COC1COCCC1N[C@@H]1C[C@H]2CN(c3ccccc3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,=,22900.0,Binding affinity to human ERG
7621,CHEMBL3115267,COC1COCCC1N[C@@H]1C[C@H]2CN(C3COC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7622,CHEMBL3115116,COC1COCCC1N[C@@H]1C[C@H]2CN(C3CC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,=,42100.0,Binding affinity to human ERG
7623,CHEMBL3115115,COC1COCCC1N[C@@H]1C[C@H]2CN(C(C)C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7624,CHEMBL3115114,CCN1C[C@@H]2C[C@@H](NC3CCOCC3OC)C[C@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,=,42600.0,Binding affinity to human ERG
7625,CHEMBL3115113,COC1COCCC1N[C@@H]1C[C@H]2CN(C)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7626,CHEMBL3115112,COC1COCCC1N[C@@H]1C[C@H]2CNC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Binding affinity to human ERG
7627,CHEMBL3115346,COC(=O)C(CCCN1CCC(c2ccccc2OC)CC1)(c1ccc(Br)cc1)C(C)C,IC50,nM,=,780.0,Inhibition of human ERG by whole-cell patch clamp method
7628,CHEMBL3115345,COC(=O)C(CCCN1CC=C(c2ccccc2OC)CC1)(c1ccc(Br)cc1)C(C)C,IC50,nM,=,1260.0,Inhibition of human ERG by whole-cell patch clamp method
7629,CHEMBL3115195,COC(=O)C(CCC(=O)N1CCN(c2ccccc2OC)CC1)(c1ccc(Br)cc1)C(C)C,IC50,nM,=,16800.0,Inhibition of human ERG by whole-cell patch clamp method
7630,CHEMBL3115194,COC(=O)C(CCC(=O)N(C)CCCc1nc2ccccc2[nH]1)(c1ccc(Br)cc1)C(C)C,IC50,nM,=,12500.0,Inhibition of human ERG by whole-cell patch clamp method
7631,CHEMBL3115193,COc1ccccc1N1CCN(CCCC(C(=O)O)(c2ccc(Br)cc2)C(C)C)CC1,IC50,nM,=,3960.0,Inhibition of human ERG by whole-cell patch clamp method
7632,CHEMBL3115192,CC(C)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(C(=O)O)c1ccc(Br)cc1,IC50,nM,=,2340.0,Inhibition of human ERG by whole-cell patch clamp method
7633,CHEMBL513338,COC(=O)C(CCCN1CCN(c2ccccc2OC)CC1)(c1ccc(Br)cc1)C(C)C,IC50,nM,=,1380.0,Inhibition of human ERG by whole-cell patch clamp method
7634,CHEMBL468397,COC(=O)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(c1ccc(Br)cc1)C(C)C,IC50,nM,=,178.0,Inhibition of human ERG by whole-cell patch clamp method
7635,CHEMBL3121667,Fc1ccccc1-c1nc2ccn(Cc3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)no3)cc-2n1,IC50,nM,=,794.33,Inhibition of human ERG expressed in CHO cells
7636,CHEMBL1957287,Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1,IC50,nM,=,794.33,Inhibition of human ERG expressed in CHO cells
7637,CHEMBL3121666,Fc1cccc(-c2nc3cnn(Cc4cc(-c5ccc(C(F)(F)F)cc5C(F)(F)F)no4)cc-3n2)c1F,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells
7638,CHEMBL3121096,O=C1NN=C(c2ccc(OC3CCN(C4CCC4)CC3)cc2)[C@@H]2C[C@H]12,IC50,nM,=,6000.0,Inhibition of human ERG channel by patch clamp technique
7639,CHEMBL3121095,O=C1NN=C(c2ccc(OC3CCN(C4CCC4)CC3)cc2)[C@H]2C[C@@H]12,IC50,nM,=,14000.0,Inhibition of human ERG channel by patch clamp technique
7640,CHEMBL3121151,CCN(CC)[C@@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@H](C)NC(=O)OC)[nH]4)cc3)cc2)[nH]1)c1ccccc1,IC50,nM,=,9100.0,Inhibition of human ERG by whole cell patch clamp assay
7641,CHEMBL2023898,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,IC50,nM,=,29200.0,Inhibition of human ERG by whole cell patch clamp assay
7642,CHEMBL3120293,CNc1nc(NCCCN(C)C)c2sc(-c3ccc4nonc4c3)cc2n1,IC50,nM,=,2000.0,Binding affinity to full length human ERG expressed in CHO cells after 6 to 7 mins by IonWorks assay
7643,CHEMBL3120287,CNc1nc(NCCCN(C)C)c2sc(-c3ccc(N4CCOCC4)cc3)cc2n1,IC50,nM,=,1800.0,Binding affinity to full length human ERG expressed in CHO cells after 6 to 7 mins by IonWorks assay
7644,CHEMBL3120281,CNc1nc(NCCCN(C)C)c2sc(-c3ccc(OC)nc3)cc2n1,IC50,nM,=,6800.0,Binding affinity to full length human ERG expressed in CHO cells after 6 to 7 mins by IonWorks assay
7645,CHEMBL3120280,CNc1nc(NCCCN(C)C)c2sc(-c3ccc(OC(F)(F)F)cc3)cc2n1,IC50,nM,=,2800.0,Binding affinity to full length human ERG expressed in CHO cells after 6 to 7 mins by IonWorks assay
7646,CHEMBL3120274,CNc1nc(NCCCN(C)C)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,=,2700.0,Binding affinity to full length human ERG expressed in CHO cells after 6 to 7 mins by IonWorks assay
7647,CHEMBL3120265,CNc1nc(NCCCN(C)C)c2sc(-c3ccccc3)cc2n1,IC50,nM,=,8500.0,Binding affinity to full length human ERG expressed in CHO cells after 6 to 7 mins by IonWorks assay
7648,CHEMBL3124997,C[S+]([O-])c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7649,CHEMBL3124996,CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cn1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7650,CHEMBL3124995,N#Cc1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7651,CHEMBL3124994,Nc1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cn1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7652,CHEMBL3124993,Nc1ncc(-c2ccc(C(F)(F)F)nc2)nc1-c1ccc(C(F)(F)F)nc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7653,CHEMBL3124992,Nc1ncc(-c2ccc(F)nc2)nc1-c1ccc(C(F)(F)F)nc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7654,CHEMBL3124991,Nc1ncc(-c2ccncn2)nc1-c1ccc(C(F)(F)F)nc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7655,CHEMBL3124990,Nc1ncc(-c2cccnc2)nc1-c1ccc(C(F)(F)F)nc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7656,CHEMBL3124989,Nc1ncc(-c2ccncc2)nc1-c1ccc(C(F)(F)F)nc1,IC50,nM,>,33000.0,Inhibition of human ERG by patch clamp electrophysiology
7657,CHEMBL3124988,Nc1ncc(-c2ccc(S(=O)(=O)CC3CC3)cc2)nc1-c1ccc(C(F)(F)F)nc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7658,CHEMBL3124987,Nc1ncc(-c2ccc(S(=O)(=O)C3CC3)cc2)nc1-c1ccc(C(F)(F)F)nc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7659,CHEMBL3124986,CNS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by patch clamp electrophysiology
7660,CHEMBL3124985,CCS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cc1,IC50,nM,=,3700.0,Inhibition of human ERG by patch clamp electrophysiology
7661,CHEMBL3124984,CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cc1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiology
7662,CHEMBL3124983,Nc1ncc(-c2ccc(C(=O)N3CCOCC3)cc2)nc1-c1ccc(C(F)(F)F)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by patch clamp electrophysiology
7663,CHEMBL3124982,Nc1ncc(-c2ccc(C(=O)N3CCOCC3)cc2)nc1-c1ccc(C(F)(F)F)nc1,IC50,nM,=,20200.0,Inhibition of human ERG by patch clamp electrophysiology
7664,CHEMBL3124981,CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)cc3)n2)cc1,IC50,nM,>,3700.0,Inhibition of human ERG by patch clamp electrophysiology
7665,CHEMBL3124980,CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)n2)cc1,IC50,nM,=,8100.0,Inhibition of human ERG by patch clamp electrophysiology
7666,CHEMBL3128180,Cc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1,IC50,nM,=,12000.0,Inhibition of human ERG
7667,CHEMBL3128188,O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2ccnn21,IC50,nM,>,30000.0,Inhibition of human ERG
7668,CHEMBL3128200,Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccc(F)cc3)N2)cc1,IC50,nM,=,5600.0,Inhibition of human ERG
7669,CHEMBL1684585,Nc1nc(CC(=O)Nc2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1,IC50,nM,=,11200.0,Inhibition of human ERG
7670,CHEMBL3128178,O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2scnc21,IC50,nM,=,6100.0,Inhibition of human ERG
7671,CHEMBL3128201,Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1,IC50,nM,=,23300.0,Inhibition of human ERG
7672,CHEMBL3128199,Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccc(F)c3)N2)cc1,IC50,nM,=,4000.0,Inhibition of human ERG
7673,CHEMBL3128198,Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccc(Cl)c3)N2)cc1,IC50,nM,=,1500.0,Inhibition of human ERG
7674,CHEMBL3128194,Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1,IC50,nM,=,12700.0,Inhibition of human ERG
7675,CHEMBL3125272,CCNC(=O)[C@@H]1C[C@@H](NC(=O)c2cc(CC)nn2C)CN1C(=O)c1coc2ccccc12,IC50,nM,>,50000.0,Displacement of [3H]-dofetilide from human ERG after 1 hr by liquid scintillation counting analysis
7676,CHEMBL3127404,CN1C(=O)CC[C@H]1CN(Cc1ccc(Cl)cc1)S(=O)(=O)c1cccc(C#N)c1,IC50,nM,=,30000.0,Inhibition of human ERG
7677,CHEMBL3127543,OCc1cn(-c2ccc(N3CCC(N4CCc5ccc(F)cc54)CC3)nn2)cn1,IC50,nM,<,10.0,Binding affinity to human ERG
7678,CHEMBL3127542,Cc1cn(-c2ccc(N3CCC(N4CCc5ccc(F)cc54)CC3)nn2)cn1,IC50,nM,<,10.0,Binding affinity to human ERG
7679,CHEMBL3126842,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,IC50,nM,=,24500.0,Inhibition of human ERG by fluorescence-based thallium flux assay
7680,CHEMBL3126842,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,IC50,nM,=,12400.0,Inhibition of human ERG by patch-clamp assay
7681,CHEMBL3127696,O=C(c1ccccc1)N1CCC2(CCCN(C(=O)N3CCCN(C4CCC4)CC3)C2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7682,CHEMBL3127695,O=C(c1ccccc1)N1CCC2(CC1)CCN(C(=O)C1CCN(C3CCC3)CC1)C2,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7683,CHEMBL3127694,O=C(N1CCN(C2CCC2)CC1)N1CCC2(CCN(S(=O)(=O)c3ccccc3)CC2)C1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7684,CHEMBL3127693,O=C(c1ccccc1)N1CCC2(CC1)CCN(C(=O)N1CCN(C3CCC3)CC1)C2,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7685,CHEMBL3127692,CC(C)S(=O)(=O)N1CCC2(CCN(C(=O)N3CCCN(C4CCC4)CC3)C2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7686,CHEMBL3127691,O=C(N1CCCN(C2CCC2)CC1)N1CCC2(CCN(S(=O)(=O)c3ccccc3)CC2)C1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7687,CHEMBL3127690,O=C(c1ccccc1)N1CCC2(CC1)CCN(C(=O)N1CCCN(C3CCC3)CC1)C2,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7688,CHEMBL3127689,O=C(N1CCCN(C2CCC2)CC1)N1CCC2(CCCN(S(=O)(=O)c3ccccc3)C2)C1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7689,CHEMBL3127688,O=C(c1ccccc1)N1CCCC2(CCN(C(=O)N3CCCN(C4CCC4)CC3)C2)C1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7690,CHEMBL3127687,CC(C)N1CCCN(C(=O)C2CC3(CCN(C(=O)c4ccccc4)CC3)C2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7691,CHEMBL3127686,O=C(c1ccccc1)N1CCC2(CC1)CC(C(=O)N1CCN(C3CCC3)CC1)C2,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7692,CHEMBL3127685,O=C(C1CC2(CCN(c3ccccc3)CC2)C1)N1CCN(C2CCC2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7693,CHEMBL3127684,CS(=O)(=O)N1CCC2(CC1)CC(C(=O)N1CCN(C3CCC3)CC1)C2,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7694,CHEMBL3127683,CC(C)N1CCN(C(=O)N2CCC3(CCN(C4CCOCC4)CC3)C2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7695,CHEMBL3127682,CC(C)N1CCN(C(=O)N2CCC3(CCCN(C4CCOCC4)C3)C2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7696,CHEMBL3127681,O=C(N1CCCN(C2CCC2)CC1)N1CCC2(CCCN(C3CCOCC3)C2)C1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7697,CHEMBL3127680,CC(C)N1CCN(C(=O)N2CC3(CCN(C4CCOCC4)CC3)C2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7698,CHEMBL3127679,CC(C)N1CCN(C(=O)C2CC3(CCN(C4CCOCC4)CC3)C2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7699,CHEMBL3127678,CC(C)N1CCCN(C(=O)C2CC3(CCN(C4CCOCC4)CC3)C2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7700,CHEMBL3127677,O=C(C1CC2(CCN(C3CCOCC3)CC2)C1)N1CCN2CCCCC2C1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7701,CHEMBL3127676,O=C(C1CC2(CCN(C3CCOCC3)CC2)C1)N1CCN(C2CCCCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7702,CHEMBL3127675,O=C(C1CC2(CCN(C3CCOCC3)CC2)C1)N1CCN(C2CCC2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7703,CHEMBL3127674,O=C(C1CC2(CCN(C3CCOCC3)CC2)C1)N1CCCN(C2CCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7704,CHEMBL3127673,O=C(C1CC12CCC(C1CCCCC1)CC2)N1CCN(C2CCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7705,CHEMBL3124968,CC(C)N1CCN(C(=O)[C@H]2CC23CCN(C2CCOCC2)CC3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7706,CHEMBL3127672,CC(C)N1CCN(C(=O)[C@@H]2CC23CCN(C2CCOCC2)CC3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7707,CHEMBL3127671,O=C(C1CC12CCN(c1ccncc1)CC2)N1CCN(C2CCCCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7708,CHEMBL3127670,O=C(C1CC12CCN(CCc1ccccc1)CC2)N1CCN(C2CCCCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7709,CHEMBL3127669,O=C(C1CC12CCN(Cc1ccccc1)CC2)N1CCN(C2CCCCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7710,CHEMBL3127668,O=C(C1CC12CCN(c1ccccc1)CC2)N1CCN(C2CCCCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7711,CHEMBL3127709,CC(C)N1CCC2(CC1)CC2C(=O)N1CCN(C2CCCCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7712,CHEMBL3127708,O=C(C1CC12CCN(C1CCCCC1)CC2)N1CCN(C2CCCCC2)CC1,IC50,nM,=,20800.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7713,CHEMBL3127707,O=C(C1CC12CCNCC2)N1CCN(C2CCCCC2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7714,CHEMBL3127706,O=C(C1CC12CCN(C1CCC1)CC2)N1CCN(C2CCOCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7715,CHEMBL3127705,O=C(C1CC12CCN(C1CCOCC1)CC2)N1CCN(c2ccncc2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7716,CHEMBL3127704,O=C(C1CC12CCN(C1CCOCC1)CC2)N1CCCN(C2CCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7717,CHEMBL3127703,O=C(C1CC12CCN(C1CCOCC1)CC2)N1CCN(C2CCCCCC2)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7718,CHEMBL3127702,O=C(C1CC12CCN(C1CCOCC1)CC2)N1CCN(C2CCCCC2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7719,CHEMBL3127701,O=C(C1CC12CCN(C1CCOCC1)CC2)N1CCN(C2CCCC2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7720,CHEMBL3127700,O=C(C1CC12CCN(C1CCOCC1)CC2)N1CCN(C2CCC2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7721,CHEMBL3127699,O=C(C1CC12CCN(C1CCOCC1)CC2)N1CCN(C2CC2)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7722,CHEMBL3127698,CC(C)N1CCN(C(=O)C2CC23CCN(C2CCOCC2)CC3)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7723,CHEMBL3127697,CN1CCN(C(=O)C2CC23CCN(C2CCOCC2)CC3)CC1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by electrophysiological analysis
7724,CHEMBL3127986,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1cscn1,IC50,nM,=,176600.0,Inhibition of human ERG expressed in CHO-ZG cells after 20 mins by FluxOR thallium assay
7725,CHEMBL3127992,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1cc2c(cc1Br)OCO2,IC50,nM,=,48000.0,Inhibition of human ERG expressed in CHO-ZG cells after 20 mins by FluxOR thallium assay
7726,CHEMBL3134098,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(F)cc3F)cc(Cl)c2NC1=O,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiology assay
7727,CHEMBL3133005,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cn2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG
7728,CHEMBL3181946,Cc1cccc(C(=O)Nc2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2)c1,IC50,nM,,32790.0,PubChem BioAssay. SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel TASK1 in hERG expressing cells: FluxOR Assay CRC.   (Class of assay: confirmatory) 
7729,CHEMBL3185008,CCOc1cccc(NC(=O)c2cccc(NC(=O)C3CCCC3)c2)c1,IC50,nM,,990.0,PubChem BioAssay. SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel TASK1 in hERG expressing cells: FluxOR Assay CRC.   (Class of assay: confirmatory) 
7730,CHEMBL2324344,CCCC(=O)C1CCN(c2ncnc3c2CN(C(=O)c2ccc(-c4ccccc4)cc2)CC3)CC1,IC50,nM,,7680.0,PubChem BioAssay. SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel TASK1 in hERG expressing cells: FluxOR Assay CRC.   (Class of assay: confirmatory) 
7731,CHEMBL3185736,Cc1cccc(C(=O)Nc2cccc(NC(=O)c3cccc(C)c3)c2)c1,IC50,nM,,12400.0,PubChem BioAssay. SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel TASK1 in hERG expressing cells: FluxOR Assay CRC.   (Class of assay: confirmatory) 
7732,CHEMBL148342,COc1ccc(CC(=O)NCc2ccccc2-c2ccccc2C(=O)NCc2ccc(F)cc2F)cc1,IC50,nM,,36730.0,PubChem BioAssay. SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel TASK1 in hERG expressing cells: FluxOR Assay CRC.   (Class of assay: confirmatory) 
7733,CHEMBL3188099,COc1ccccc1NC(=O)c1cccc(NC(=O)C2CCCC2)c1,IC50,nM,,43490.0,PubChem BioAssay. SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel TASK1 in hERG expressing cells: FluxOR Assay CRC.   (Class of assay: confirmatory) 
7734,CHEMBL3217922,COC[C@H](C)Oc1cc(Oc2ccc(S(C)(=O)=O)cc2)cc(C(=O)Nc2nccs2)c1,IC50,nM,=,6900.0,Inhibition of human ERG
7735,CHEMBL3217923,COC[C@H](C)Oc1cc(Oc2ccc(S(C)(=O)=O)cc2)cc(C(=O)Nc2nc(C)ns2)c1,IC50,nM,=,7500.0,Inhibition of human ERG
7736,CHEMBL3217922,COC[C@H](C)Oc1cc(Oc2ccc(S(C)(=O)=O)cc2)cc(C(=O)Nc2nccs2)c1,IC50,nM,=,6900.0,Inhibition of human ERG
7737,CHEMBL3217923,COC[C@H](C)Oc1cc(Oc2ccc(S(C)(=O)=O)cc2)cc(C(=O)Nc2nc(C)ns2)c1,IC50,nM,=,7500.0,Inhibition of human ERG
7738,CHEMBL3217925,C[C@@H](CO)Oc1cc(Oc2ccc(C(=O)N3CCC3)cc2)cc(C(=O)Nc2ccn(C)n2)c1,IC50,nM,=,70000.0,Inhibition of human ERG
7739,CHEMBL3217924,C[C@@H](CO)Oc1cc(Oc2ccc(C(=O)N(C)C)cc2)cc(C(=O)Nc2ccn(C)n2)c1,IC50,nM,>,100000.0,Inhibition of human ERG
7740,CHEMBL3217758,COC[C@H](C)Oc1cc(Oc2ccc(C(=O)N(C)C)cc2)cc(C(=O)Nc2cc[nH]n2)c1,IC50,nM,>,95000.0,Inhibition of human ERG
7741,CHEMBL2086693,C[C@@H]1CN(c2noc(C(F)(F)F)n2)CCN1c1ncc(OCc2ccncc2C#N)cn1,IC50,nM,=,7600.0,Inhibition of human ERG
7742,CHEMBL2086690,CC(C)c1nc(N2CCN(c3ncc(OCc4ccncc4C#N)cn3)[C@H](C)C2)no1,IC50,nM,>,9800.0,Inhibition of human ERG
7743,CHEMBL2087086,C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccncc2C#N)cn1,IC50,nM,=,5900.0,Inhibition of human ERG
7744,CHEMBL2087084,CC(C)c1noc(N2CCN(c3ncc(OCc4ccncc4C#N)cn3)[C@H](C)C2)n1,IC50,nM,=,11600.0,Inhibition of human ERG
7745,CHEMBL3218816,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccncc2C#N)cn1,IC50,nM,=,18000.0,Inhibition of human ERG
7746,CHEMBL3217767,CC(C)c1nnc(N2CCN(c3ncc(OCc4ccncc4C#N)cn3)[C@H](C)C2)o1,IC50,nM,>,28000.0,Inhibition of human ERG
7747,CHEMBL3220877,NCC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,18300.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7748,CHEMBL3220878,C[C@H](N)C(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,1280.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7749,CHEMBL3220879,C[C@@H](N)C(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,4920.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7750,CHEMBL3220881,O=C(/C=C/[C@@H]1CCCN1)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,86200.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7751,CHEMBL3220882,CN(C)C/C=C/C(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,92100.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7752,CHEMBL3221107,CCNC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,210.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7753,CHEMBL3221108,CCCNC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,1280.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7754,CHEMBL3218855,COc1cc(N2CCN(C)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG by automated patch-clamp assay
7755,CHEMBL3218856,COc1cc(N2CCC(N3CCOCC3)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG by automated patch-clamp assay
7756,CHEMBL3218857,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG by automated patch-clamp assay
7757,CHEMBL3221109,O=C(N1CCOCC1)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,390.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7758,CHEMBL1766528,CN1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,49.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7759,CHEMBL1766529,CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,460.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7760,CHEMBL3221110,O=[N+]([O-])c1cccc(CNc2cc(C(F)(F)F)cc3ncc(N4CCN(CCO)CC4)cc23)c1,IC50,nM,=,37.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7761,CHEMBL3221111,CN1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc(C#N)c4)c3c2)CC1,IC50,nM,=,174.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7762,CHEMBL3221113,CC(=O)c1cccc(CNc2cc(C(F)(F)F)cc3ncc(N4CCN(C)CC4)cc23)c1,IC50,nM,=,93600.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7763,CHEMBL3221123,CCNC(=O)Nc1cccc(CNc2cc(C(F)(F)F)cc3ncc(N4CCN(C)CC4)cc23)c1,IC50,nM,=,81700.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7764,CHEMBL3221125,CN1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc5nonc45)c3c2)CC1,IC50,nM,=,107.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7765,CHEMBL3221126,CN1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4ccc5cccnc5c4)c3c2)CC1,IC50,nM,=,75800.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7766,CHEMBL3221131,[2H]C(Nc1cc(C(F)(F)F)cc2ncc(N3CCN(C)CC3)cc12)c1cccc([N+](=O)[O-])c1,IC50,nM,=,1270.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7767,CHEMBL3221132,[2H]C(Nc1cc(C(F)(F)F)cc2ncc(N3CCN(C(C)=O)CC3)cc12)c1cccc([N+](=O)[O-])c1,IC50,nM,>,100000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7768,CHEMBL3221133,[2H]C([2H])(O)CN1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1,IC50,nM,=,160.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7769,CHEMBL3221134,[2H]C(Nc1cc(C(F)(F)F)cc2ncc(N3CCN(CC([2H])([2H])O)CC3)cc12)c1cccc([N+](=O)[O-])c1,IC50,nM,=,480.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells after 30 mins by FluxOR thallium assay
7770,CHEMBL3217925,C[C@@H](CO)Oc1cc(Oc2ccc(C(=O)N3CCC3)cc2)cc(C(=O)Nc2ccn(C)n2)c1,IC50,nM,=,70000.0,Inhibition of human ERG
7771,CHEMBL3219105,CCn1ccc(NC(=O)c2cc(Oc3ccc(C(=O)N4CCC4)cc3)cc(O[C@@H](C)CO)c2)n1,IC50,nM,=,54000.0,Inhibition of human ERG
7772,CHEMBL3219106,CC(C)n1ccc(NC(=O)c2cc(Oc3ccc(C(=O)N4CCC4)cc3)cc(O[C@@H](C)CO)c2)n1,IC50,nM,=,31000.0,Inhibition of human ERG
7773,CHEMBL3219107,C[C@@H](CO)Oc1cc(Oc2ccc(C(=O)N3CCC3)cc2)cc(C(=O)Nc2cc[nH]n2)c1,IC50,nM,>,100000.0,Inhibition of human ERG
7774,CHEMBL3219108,C[C@@H](CO)Oc1cc(Oc2ccc(C(=O)N3CCC3)cc2)cc(C(=O)Nc2nccs2)c1,IC50,nM,=,9000.0,Inhibition of human ERG
7775,CHEMBL3219109,Cc1nsc(NC(=O)c2cc(Oc3ccc(C(=O)N4CCC4)cc3)cc(O[C@@H](C)CO)c2)n1,IC50,nM,=,11000.0,Inhibition of human ERG
7776,CHEMBL3219110,Cc1cnc(NC(=O)c2cc(Oc3ccc(C(=O)N4CCC4)cc3)cc(O[C@@H](C)CO)c2)cn1,IC50,nM,=,38000.0,Inhibition of human ERG
7777,CHEMBL3219115,COC[C@H](C)Oc1cc(Oc2ccc(C(=O)N3CCC3)cc2)cc(C(=O)Nc2ccn(C)n2)c1,IC50,nM,=,36000.0,Inhibition of human ERG
7778,CHEMBL3219116,CC(C)Oc1cc(Oc2ccc(C(=O)N3CCC3)cc2)cc(C(=O)Nc2ccn(C)n2)c1,IC50,nM,=,27000.0,Inhibition of human ERG
7779,CHEMBL3219117,Cn1ccc(NC(=O)c2cc(Oc3ccc(C(=O)N4CCC4)cc3)cc(O[C@H]3CCOC3)c2)n1,IC50,nM,=,35000.0,Inhibition of human ERG
7780,CHEMBL3219119,Cn1ccc(NC(=O)c2cc(Oc3ccc(C(=O)N4CCC4)cc3)cc(OC(CF)CF)c2)n1,IC50,nM,=,28000.0,Inhibition of human ERG
7781,CHEMBL3219120,COC[C@H](C)Oc1cc(Oc2ccc(C(=O)N3CCC3)cc2)cc(C(=O)Nc2cnc(C)cn2)c1,IC50,nM,=,18000.0,Inhibition of human ERG
7782,CHEMBL3219121,COC[C@H](C)Oc1cc(Oc2ccc(C(=O)N3CCC3)nc2)cc(C(=O)Nc2cnc(C)cn2)c1,IC50,nM,=,40000.0,Inhibition of human ERG
7783,CHEMBL3219123,COC[C@H](C)Oc1cc(Oc2ncc(C(=O)N3CCC3)cc2Cl)cc(C(=O)Nc2cnc(C)cn2)c1,IC50,nM,=,18000.0,Inhibition of human ERG
7784,CHEMBL3219124,COC[C@H](C)Oc1cc(Oc2cnc(C(=O)N3CCC3)cn2)cc(C(=O)Nc2cnc(C)cn2)c1,IC50,nM,>,100000.0,Inhibition of human ERG
7785,CHEMBL3218479,Cc1ccc(Oc2cc(C(=O)Nc3cnc(C)cn3)cc3oc(C)cc23)cc1,IC50,,,,Inhibition of dofetilide binding to human ERG
7786,CHEMBL3218480,Cc1cnc(NC(=O)c2cc(Oc3ccc(S(C)(=O)=O)cc3)c3cc(C)oc3c2)cn1,IC50,nM,=,22000.0,Inhibition of dofetilide binding to human ERG
7787,CHEMBL3218481,Cc1cnc(NC(=O)c2cc(Oc3ccc(C#N)cc3)c3cc(C)oc3c2)cn1,IC50,nM,=,4000.0,Inhibition of dofetilide binding to human ERG
7788,CHEMBL3218482,Cc1cnc(NC(=O)c2cc(Oc3ccc(C(=O)N(C)C)cc3)c3cc(C)oc3c2)cn1,IC50,nM,=,59000.0,Inhibition of dofetilide binding to human ERG
7789,CHEMBL3218997,CC(=O)Nc1cccc(C2CCN(Cc3ccc(C(=O)c4nc5ccccc5n4-c4ccc(F)cc4)cc3)CC2)c1,IC50,nM,=,1970.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch clamp assay
7790,CHEMBL3219001,CC(=O)Nc1cccc(C2CCN(Cc3ccc(C(=O)c4nc5ccccc5n4-c4ccc(Cl)cc4)cc3)CC2)c1,IC50,nM,=,1700.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch clamp assay
7791,CHEMBL3219265,CC(=O)Nc1cccc(C2CCN(Cc3ccc(C(=O)c4nc5ccccc5n4C4CCOCC4)cc3)CC2)c1,IC50,nM,=,1200.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch clamp assay
7792,CHEMBL3219269,CC(=O)Nc1cccc(C2CCN(Cc3ccc(C(=O)c4nc5ccccc5n4-c4ccc(F)cc4)cc3F)CC2)c1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch clamp assay
7793,CHEMBL3219276,CC(=O)Nc1cccc(C2CCN(Cc3ccc(C(=O)c4nc(C)c(C)n4-c4ccc(F)cc4)cc3)CC2)c1,IC50,nM,=,1700.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch clamp assay
7794,CHEMBL3218118,N#Cc1ccc(OCC2(O)CN(S(=O)(=O)c3ccc(Cl)cc3Cl)C2)cc1F,IC50,nM,=,9670.0,Inhibition of dofetilide binding to human ERG
7795,CHEMBL1957718,CC[C@@]1(c2cccc(NS(C)(=O)=O)c2)[C@H]2CN(CC3Cc4ccccc4C3)C[C@H]21,IC50,nM,=,326.0,Inhibition of human ERG by [3H]dofetilide binding assay
7796,CHEMBL3219614,CC[C@@]1(c2cccc(NS(C)(=O)=O)c2)[C@H]2CN(CCCC3(O)CCCCC3)C[C@H]21,IC50,nM,=,710.0,Inhibition of human ERG by [3H]dofetilide binding assay
7797,CHEMBL3219615,CC[C@@]1(c2cccc(C(N)=O)c2)[C@H]2CN(CC3(O)Cc4ccccc4C3)C[C@H]21,IC50,nM,=,2200.0,Inhibition of human ERG by [3H]dofetilide binding assay
7798,CHEMBL3219616,CC[C@@]1(c2cccc(NS(C)(=O)=O)c2)[C@H]2CN(CC3(O)Cc4ccccc4C3)C[C@H]21,IC50,nM,=,1600.0,Inhibition of human ERG by [3H]dofetilide binding assay
7799,CHEMBL498260,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@@H](NCCc3cncn3C2)C1=O,IC50,nM,=,210.0,Inhibition of human ERG channel expressed in CHO cells by IonWorks assay
7800,CHEMBL55826,N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@H](NCCc3cncn3C2)C1=O,IC50,nM,=,8100.0,Inhibition of human ERG channel expressed in CHO cells by IonWorks assay
7801,CHEMBL3218645,Cc1ccccc1-c1nc2ccc(-c3ccc(Cl)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,IC50,nM,=,8700.0,Inhibition of human ERG
7802,CHEMBL3218646,Cc1ccccc1-c1nc2cc(-c3ccc(Cl)cc3)sc2c(=O)n1CC1CCCN(C(C)C)C1,IC50,nM,=,2100.0,Inhibition of human ERG
7803,CHEMBL3218647,Cc1ccccc1-c1nc2cn(-c3ccc(Cl)cc3)nc2c(=O)n1CC1CCCN(C(C)C)C1,IC50,nM,=,3500.0,Inhibition of human ERG
7804,CHEMBL3218648,COCCN1CCC[C@@H](Cn2c(-c3ccccc3C)nc3cc(-c4ccc(Cl)cc4)sc3c2=O)C1,IC50,nM,=,2100.0,Inhibition of human ERG
7805,CHEMBL3218649,COCCN1CCC[C@@H](Cn2c(-c3ccccc3C)nc3nc(-c4ccc(Cl)cc4)sc3c2=O)C1,IC50,nM,=,3700.0,Inhibition of human ERG
7806,CHEMBL3218650,COCCN1CCC[C@@H](Cn2c(-c3ccccc3C)nc3cn(-c4ccc(Cl)cc4)nc3c2=O)C1,IC50,nM,=,2500.0,Inhibition of human ERG
7807,CHEMBL3218651,Cc1ccccc1-c1nc2cn(-c3ccc(F)cc3)nc2c(=O)n1CC1CCCN(C(C)C)C1,IC50,nM,>,10000.0,Inhibition of human ERG
7808,CHEMBL3218652,Cc1ccccc1-c1nc2cn(-c3ccc(C#N)cc3)nc2c(=O)n1CC1CCCN(C(C)C)C1,IC50,nM,>,8300.0,Inhibition of human ERG
7809,CHEMBL3218884,COc1ccc(-n2cc3nc(-c4ccccc4C)n(CC4CCCN(C(C)C)C4)c(=O)c3n2)cc1,IC50,nM,=,11000.0,Inhibition of human ERG
7810,CHEMBL3218885,Cc1ccccc1-c1nc2cn(-c3cccc(Cl)c3)nc2c(=O)n1CC1CCCN(C(C)C)C1,IC50,nM,=,10000.0,Inhibition of human ERG
7811,CHEMBL3218886,COc1cccc(-n2cc3nc(-c4ccccc4C)n(CC4CCCN(C(C)C)C4)c(=O)c3n2)c1,IC50,nM,=,15000.0,Inhibition of human ERG
7812,CHEMBL3218887,Cc1ccccc1-c1nc2cn(-c3cccc(C#N)c3)nc2c(=O)n1CC1CCCN(C(C)C)C1,IC50,nM,=,22000.0,Inhibition of human ERG
7813,CHEMBL3218888,COCCN1CCCC(Cn2c(-c3cccnc3C)nc3cn(-c4ccc(C#N)cc4)nc3c2=O)C1,IC50,nM,=,21000.0,Inhibition of human ERG
7814,CHEMBL3218890,COc1cccc(-n2cc3nc(-c4cccnc4C)n(C[C@H]4CCCN(C(C)C)C4)c(=O)c3n2)c1,IC50,nM,=,47000.0,Inhibition of human ERG
7815,CHEMBL3218891,COCCN1CCC[C@H](Cn2c(-c3cccnc3C)nc3cn(-c4cccc(OC)c4)nc3c2=O)C1,IC50,nM,=,43000.0,Inhibition of human ERG
7816,CHEMBL3218892,COCCN1CCC[C@H](Cn2c(-c3cccnc3C)nc3cn(C4CCCCC4)nc3c2=O)C1,IC50,nM,>,100000.0,Inhibition of human ERG
7817,CHEMBL3218908,COc1cccc(-n2cc3nc(C)n(C[C@H]4CCCN(C[C@H]5CCCO5)C4)c(=O)c3n2)c1,IC50,nM,=,2900.0,Inhibition of human ERG
7818,CHEMBL3218909,COc1cccc(-n2cc3nc(CC(C)C)n(C[C@H]4CCCN(C[C@H]5CCCO5)C4)c(=O)c3n2)c1,IC50,nM,=,3200.0,Inhibition of human ERG
7819,CHEMBL3218910,Cc1ncccc1-c1nc2cn(-c3ccccc3)nc2c(=O)n1C[C@H]1CCCN(C[C@H]2CCCO2)C1,IC50,nM,=,12000.0,Inhibition of human ERG
7820,CHEMBL3218911,COc1ccc(-n2cc3nc(-c4cccnc4C)n(C[C@H]4CCCN(C[C@H]5CCCO5)C4)c(=O)c3n2)cc1,IC50,nM,=,4100.0,Inhibition of human ERG
7821,CHEMBL3218912,CCOc1cccc(-n2cc3nc(-c4cccnc4C)n(C[C@H]4CCCN(C[C@H]5CCCO5)C4)c(=O)c3n2)c1,IC50,nM,=,14000.0,Inhibition of human ERG
7822,CHEMBL3218913,CCCOc1cccc(-n2cc3nc(-c4cccnc4C)n(C[C@H]4CCCN(C[C@H]5CCCO5)C4)c(=O)c3n2)c1,IC50,nM,=,7300.0,Inhibition of human ERG
7823,CHEMBL3218914,Cc1ncccc1-c1nc2cn(-c3cccc(OC(C)C)c3)nc2c(=O)n1C[C@H]1CCCN(C[C@H]2CCCO2)C1,IC50,nM,=,6800.0,Inhibition of human ERG
7824,CHEMBL3218915,Cc1ncccc1-c1nc2cn(-c3cccc(OC(F)F)c3)nc2c(=O)n1C[C@H]1CCCN(C[C@H]2CCCO2)C1,IC50,nM,=,8400.0,Inhibition of human ERG
7825,CHEMBL3220543,CSc1nc(N2C[C@H]3[C@@H](C2)[C@@H]3C(=O)O)ccc1C(=O)NC12CC3CC(CC(C3)C1)C2,IC50,nM,>,30000.0,Inhibition of human ERG
7826,CHEMBL3218897,COc1cccc(-n2cc3nc(-c4cccnc4C)n(C[C@H]4CCCN(C[C@H]5CCCO5)C4)c(=O)c3n2)c1,IC50,nM,=,44000.0,Inhibition of human ERG
7827,CHEMBL3221499,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccccn1,IC50,nM,>,100000.0,Inhibition of human ERG
7828,CHEMBL3221501,CCOC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccccn1,IC50,nM,>,100000.0,Inhibition of human ERG
7829,CHEMBL3221481,COCC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C)cn1,IC50,nM,=,79432.82,Inhibition of human ERG
7830,CHEMBL3221496,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(F)cn1,IC50,nM,=,79432.82,Inhibition of human ERG
7831,CHEMBL3221485,CCOC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C)cn1,IC50,nM,=,63095.73,Inhibition of human ERG
7832,CHEMBL3221493,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(Cl)cn1,IC50,nM,=,63095.73,Inhibition of human ERG
7833,CHEMBL3221498,CCOC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(F)cn1,IC50,nM,=,63095.73,Inhibition of human ERG
7834,CHEMBL3221500,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccccn1,IC50,nM,=,63095.73,Inhibition of human ERG
7835,CHEMBL3221482,COC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccc(C)cn1,IC50,nM,=,50118.72,Inhibition of human ERG
7836,CHEMBL3221486,CCOC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1cnc(C)cn1,IC50,nM,=,50118.72,Inhibition of human ERG
7837,CHEMBL3221502,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C#N)cn1,IC50,nM,=,50118.72,Inhibition of human ERG
7838,CHEMBL3221490,Cc1ccc(NC(=O)[C@H](COC2CCC2)Oc2ncnc3c2cnn3-c2ncccc2Cl)nc1,IC50,nM,=,39810.72,Inhibition of human ERG
7839,CHEMBL3221492,Cc1cnc(NC(=O)[C@H](COC2CCC2)Oc2ncnc3c2cnn3-c2ncccc2Cl)cn1,IC50,nM,=,39810.72,Inhibition of human ERG
7840,CHEMBL3221488,Cc1ccc(NC(=O)[C@H](COC(C)C)Oc2ncnc3c2cnn3-c2ccccc2Cl)nc1,IC50,nM,=,31622.78,Inhibition of human ERG
7841,CHEMBL3221497,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccc(F)cn1,IC50,nM,=,25118.86,Inhibition of human ERG
7842,CHEMBL2206790,COCC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccc(C)cn1,IC50,nM,=,19952.62,Inhibition of human ERG
7843,CHEMBL3221504,CCOC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C#N)cn1,IC50,nM,=,19952.62,Inhibition of human ERG
7844,CHEMBL3221487,CCOC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1cnc(C)cn1,IC50,nM,=,15848.93,Inhibition of human ERG
7845,CHEMBL3221491,Cc1cnc(NC(=O)[C@H](COC2CCC2)Oc2ncnc3c2cnn3-c2ccccc2Cl)cn1,IC50,nM,=,12589.25,Inhibition of human ERG
7846,CHEMBL3221503,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccc(C#N)cn1,IC50,nM,=,12589.25,Inhibition of human ERG
7847,CHEMBL3221495,CCOC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(Cl)cn1,IC50,nM,=,10000.0,Inhibition of human ERG
7848,CHEMBL3221483,COC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C)cn1,IC50,nM,>,100000.0,Inhibition of human ERG
7849,CHEMBL3221489,Cc1ccc(NC(=O)[C@H](COC(C)C)Oc2ncnc3c2cnn3-c2ncccc2Cl)nc1,IC50,nM,>,100000.0,Inhibition of human ERG
7850,CHEMBL3217794,Cc1cnc(NC(=O)[C@H](COC(C)C)Oc2ncnc3c2cnn3-c2ccccc2Cl)cn1,IC50,nM,>,100000.0,Inhibition of human ERG
7851,CHEMBL3221484,COC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1cnc(C)cn1,IC50,nM,>,79432.82,Inhibition of human ERG
7852,CHEMBL3221493,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(Cl)cn1,IC50,nM,=,63095.73,Inhibition of human ERG by electrophysiological analysis
7853,CHEMBL3221496,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(F)cn1,IC50,nM,=,79432.82,Inhibition of human ERG by electrophysiological analysis
7854,CHEMBL3221502,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C#N)cn1,IC50,nM,=,50118.72,Inhibition of human ERG by electrophysiological analysis
7855,CHEMBL3221494,CC(C)OC[C@H](Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccc(Cl)cn1,IC50,nM,=,15848.93,Inhibition of human ERG by electrophysiological analysis
7856,CHEMBL3221506,O=C(Nc1ccc(Cl)cn1)[C@H](COCCO)Oc1ncnc2c1cnn2-c1ncccc1Cl,IC50,nM,=,50118.72,Inhibition of human ERG by electrophysiological analysis
7857,CHEMBL3221507,N#Cc1ccc(NC(=O)[C@H](COCCO)Oc2ncnc3c2cnn3-c2ncccc2Cl)nc1,IC50,nM,=,50118.72,Inhibition of human ERG by electrophysiological analysis
7858,CHEMBL3221508,O=C(Nc1ccc(Cl)cn1)[C@H](COCCO)Oc1ncnc2c1cnn2-c1ccccc1Cl,IC50,nM,=,15848.93,Inhibition of human ERG by electrophysiological analysis
7859,CHEMBL3221509,C[C@@H](CO)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(Cl)cn1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological analysis
7860,CHEMBL3221510,C[C@@H](CO)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(F)cn1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological analysis
7861,CHEMBL3221511,C[C@@H](CO)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C#N)cn1,IC50,nM,=,63095.73,Inhibition of human ERG by electrophysiological analysis
7862,CHEMBL3221512,C[C@H](CO)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(Cl)cn1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological analysis
7863,CHEMBL3221513,C[C@H](CO)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(F)cn1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological analysis
7864,CHEMBL3221514,C[C@H](CO)OC[C@H](Oc1ncnc2c1cnn2-c1ncccc1Cl)C(=O)Nc1ccc(C#N)cn1,IC50,nM,=,63095.73,Inhibition of human ERG by electrophysiological analysis
7865,CHEMBL3221515,O=C(Nc1ccc(Cl)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1ncccc1Cl,IC50,nM,=,50118.72,Inhibition of human ERG by electrophysiological analysis
7866,CHEMBL3221516,O=C(Nc1ccc(F)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1ncccc1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological analysis
7867,CHEMBL3221517,O=C(Nc1ccc(Cl)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1ccccc1Cl,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiological analysis
7868,CHEMBL3221518,O=C(Nc1ccccn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1ccccc1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological analysis
7869,CHEMBL3221519,N#Cc1ccc(NC(=O)[C@H](CN2CC(O)C2)Oc2ncnc3c2cnn3-c2ccccc2Cl)nc1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiological analysis
7870,CHEMBL3221520,O=C(Nc1ccc(F)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1ccccc1Cl,IC50,nM,=,39810.72,Inhibition of human ERG by electrophysiological analysis
7871,CHEMBL3221520,O=C(Nc1ccc(F)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1ccccc1Cl,IC50,nM,=,36000.0,Inhibition of human ERG by electrophysiological analysis
7872,CHEMBL3221521,O=C(Nc1ccc(F)cn1)[C@H](COCCO)Oc1ncnc2c1cnn2-c1ccccc1Cl,IC50,nM,=,39810.72,Inhibition of human ERG by electrophysiological analysis
7873,CHEMBL3221522,N#Cc1ccc(NC(=O)[C@H](CN2CC(O)C2)Oc2ncnc3c2cnn3-c2c(Cl)cccc2Cl)nc1,IC50,nM,=,6309.57,Inhibition of human ERG by electrophysiological analysis
7874,CHEMBL3221523,O=C(Nc1ccc(F)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1c(Cl)cccc1Cl,IC50,nM,=,19952.62,Inhibition of human ERG by electrophysiological analysis
7875,CHEMBL3221523,O=C(Nc1ccc(F)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1c(Cl)cccc1Cl,IC50,nM,=,19000.0,Inhibition of human ERG by electrophysiological analysis
7876,CHEMBL3220615,COc1ccc(N2C(=O)C(C)(C)C2c2ccccc2OC)cc1,IC50,nM,=,13000.0,Inhibition of human ERG
7877,CHEMBL3221524,O=C(Nc1ccc(F)cn1)[C@H](COCCO)Oc1ncnc2c1cnn2-c1c(Cl)cccc1Cl,IC50,nM,=,19952.62,Inhibition of human ERG by electrophysiological analysis
7878,CHEMBL3221525,N#Cc1ccc(NC(=O)[C@H](CN2CC(O)C2)Oc2ncnc3c2cnn3-c2c(Cl)cccc2C#N)nc1,IC50,nM,=,7943.28,Inhibition of human ERG by electrophysiological analysis
7879,CHEMBL3221526,N#Cc1cccc(Cl)c1-n1ncc2c(O[C@@H](CN3CC(O)C3)C(=O)Nc3ccc(F)cn3)ncnc21,IC50,nM,=,50118.72,Inhibition of human ERG by electrophysiological analysis
7880,CHEMBL3221527,N#Cc1cccc(Cl)c1-n1ncc2c(O[C@@H](COCCO)C(=O)Nc3ccc(F)cn3)ncnc21,IC50,nM,=,63095.73,Inhibition of human ERG by electrophysiological analysis
7881,CHEMBL3221528,O=C(Nc1ccccn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1c(F)cccc1Cl,IC50,nM,=,79432.82,Inhibition of human ERG by electrophysiological analysis
7882,CHEMBL3221529,O=C(Nc1ccc(F)cn1)[C@H](CN1CC(O)C1)Oc1ncnc2c1cnn2-c1c(F)cccc1Cl,IC50,nM,=,25118.86,Inhibition of human ERG by electrophysiological analysis
7883,CHEMBL3221530,O=C(Nc1ccc(F)cn1)[C@H](COCCO)Oc1ncnc2c1cnn2-c1c(F)cccc1Cl,IC50,nM,=,31622.78,Inhibition of human ERG by electrophysiological analysis
7884,CHEMBL3221531,Cc1cnc(NC(=O)[C@H](CN2CC(O)C2)Oc2ncnc3c2cnn3-c2c(Cl)cccc2Cl)cn1,IC50,nM,=,62000.0,Inhibition of human ERG by electrophysiological analysis
7885,CHEMBL3221532,Cc1cnc(NC(=O)[C@H](CO[C@H](C)CO)Oc2ncnc3c2cnn3-c2c(Cl)cccc2C#N)cn1,IC50,nM,>,100000.0,Inhibition of human ERG by electrophysiological analysis
7886,CHEMBL3234858,COc1cc(OC)cc(-c2nnc([C@@]3(Cc4ccccc4)OC(=O)N([C@H](C)c4ccccc4)C3=O)o2)c1,IC50,nM,>,13000.0,Inhibition of human ERG (unknown origin)
7887,CHEMBL3234863,C[C@H](c1ccccc1)N1C(=O)O[C@](Cc2ccccc2)(c2nnc(C3(c4ccccc4)CC3)o2)C1=O,IC50,nM,>,6000.0,Inhibition of human ERG (unknown origin)
7888,CHEMBL3233058,Cc1cccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)n1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
7889,CHEMBL3237556,CCc1cccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)n1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO cells by patch clamp method
7890,CHEMBL3237557,CCCc1cccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)n1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO cells by patch clamp method
7891,CHEMBL3237558,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)cc1Nc1cccc(C2CC2)n1,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO cells by patch clamp method
7892,CHEMBL3237559,CC(C)c1cccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)n1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by patch clamp method
7893,CHEMBL3237560,Cc1nc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)ccc1F,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHO cells by patch clamp method
7894,CHEMBL3237561,Cc1ccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)nc1C,IC50,nM,=,19952.62,Inhibition of human ERG expressed in CHO cells by patch clamp method
7895,CHEMBL3237562,Cc1nc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)ccc1Cl,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO cells by patch clamp method
7896,CHEMBL3237564,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)cc1Nc1ccc2c(n1)CCC2,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by patch clamp method
7897,CHEMBL3237565,COc1ccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)nc1OC,IC50,nM,=,5011.87,Inhibition of human ERG expressed in CHO cells by patch clamp method
7898,CHEMBL3237571,CC(C)(C)c1cccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)n1,IC50,nM,=,1258.93,Inhibition of human ERG expressed in CHO cells by patch clamp method
7899,CHEMBL3237572,CC(C)C[C@H](CN)Nc1cc(Nc2cccc(C(C)(C)C)n2)c(C(N)=O)nn1,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO cells by patch clamp method
7900,CHEMBL3237573,Cc1ccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)nc1C(C)C,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
7901,CHEMBL3237574,CCCc1nc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)ccc1OC,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO cells by patch clamp method
7902,CHEMBL3237575,COc1ccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)nc1C(C)C,IC50,nM,=,1995.26,Inhibition of human ERG expressed in CHO cells by patch clamp method
7903,CHEMBL3237576,COc1ccc(Nc2cc(N[C@@H]3CCOC[C@@H]3N)nnc2C(N)=O)nc1C(C)C,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHO cells by patch clamp method
7904,CHEMBL3237577,Cc1ccc(Nc2cc(NCCN)nnc2C(N)=O)nc1C(C)C,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO cells by patch clamp method
7905,CHEMBL3237578,COc1ccc(Nc2cc(NCCN)nnc2C(N)=O)nc1C(C)C,IC50,nM,=,12589.25,Inhibition of human ERG expressed in CHO cells by patch clamp method
7906,CHEMBL3237579,CCCc1nc(Nc2cc(NCCN)nnc2C(N)=O)ccc1OC,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
7907,CHEMBL3237580,CC(C)c1nc(Nc2cc(N[C@@H]3CCOC[C@@H]3N)nnc2C(N)=O)ccc1F,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by patch clamp method
7908,CHEMBL3237581,CC(C)c1nc(Nc2cc(NCCN)nnc2C(N)=O)ccc1F,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells by patch clamp method
7909,CHEMBL3234873,CC(C)(O)c1ccc(-c2cc(C(N)=O)c(Nc3cccc(CN4CCOCC4)n3)s2)cc1,IC50,nM,=,1400.0,Inhibition of human ERG
7910,CHEMBL3234895,CC(C)(O)COCc1cccc(Nc2sc(-c3c(F)cc(C(C)(C)O)cc3F)cc2C(N)=O)n1,IC50,nM,=,12000.0,Inhibition of human ERG
7911,CHEMBL3234874,NC(=O)c1cc(-c2ccccc2F)sc1Nc1cccc(CN2CCOCC2)n1,IC50,nM,=,161.0,Inhibition of human ERG
7912,CHEMBL473967,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
7913,CHEMBL3238274,C[C@](O)(COc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21,IC50,nM,>,100000.0,Binding affinity to human ERG by dofetilide binding assay
7914,CHEMBL1091605,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,nM,=,30000.0,Inhibition of human ERG by FLIPR assay
7915,CHEMBL3233178,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7916,CHEMBL3233179,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)n3)C2=O)[C@H](CS(C)(=O)=O)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7917,CHEMBL3233180,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)c3)C2=O)[C@H](CS(C)(=O)=O)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7918,CHEMBL3233181,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)n3)C2=O)[C@H](CS(C)(=O)=O)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7919,CHEMBL3233182,Cc1ccc(C(=O)N[C@H]2CCN([C@H]3CC[C@@H](N(C)C(C)C)C[C@H]3CS(C)(=O)=O)C2=O)cc1C(F)(F)F,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7920,CHEMBL3233183,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(OC(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7921,CHEMBL3233184,CCS(=O)(=O)C[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(F)(F)F)c2)C1=O,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7922,CHEMBL3233185,CCS(=O)(=O)C[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(-c3ccccc3)c2)C1=O,IC50,nM,=,60000.0,Inhibition of human ERG by FLIPR assay
7923,CHEMBL3233186,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)C(C)C)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7924,CHEMBL3233187,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)c3)C2=O)[C@H](CS(=O)(=O)C(C)C)C1,IC50,nM,=,77000.0,Inhibition of human ERG by FLIPR assay
7925,CHEMBL3233188,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)C(C)(C)C)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7926,CHEMBL3233189,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(OC(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)C(C)(C)C)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7927,CHEMBL3233190,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cc(F)cc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)C(C)(C)C)C1,IC50,nM,>,80000.0,Inhibition of human ERG by FLIPR assay
7928,CHEMBL3237443,Fc1nccc2c3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n(C3CCCC3)c12,IC50,nM,=,720.0,Binding affinity to human ERG
7929,CHEMBL3237444,Clc1nccc2c3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n(C3CCCC3)c12,IC50,nM,=,2000.0,Binding affinity to human ERG
7930,CHEMBL3237713,C[C@@H](O)CN(C)C1CCN(c2ccc(Nc3ncc4c5ccncc5n([C@H]5CC[C@H](C)CC5)c4n3)nn2)CC1,IC50,nM,=,920.0,Binding affinity to human ERG
7931,CHEMBL2105762,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,IC50,nM,>,30000.0,Inhibition of human ERG by MK-499 displacement binding analysis
7932,CHEMBL3263255,COC1COCCC1N[C@@H]1C[C@H]2OCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7933,CHEMBL3263279,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCO[C@@H]1C[C@@H](NC1CCOCC1)C2,IC50,nM,=,43000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7934,CHEMBL3263280,COC1COCCC1N(C)[C@@H]1C[C@H]2OCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7935,CHEMBL3263281,COC1COCCC1N(CCCO)[C@@H]1C[C@H]2OCC[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7936,CHEMBL3263282,O=C(N1CCc2ncc(C(F)(F)F)cc2C1)[C@@]12CCO[C@@H]1C[C@@H](N1CCC(c3ccccc3)CC1)C2,IC50,nM,=,5800.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7937,CHEMBL3263283,O=C(O)c1cccc(C2CCN([C@@H]3C[C@H]4OCC[C@@]4(C(=O)N4CCc5ncc(C(F)(F)F)cc5C4)C3)CC2)c1,IC50,,,,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7938,CHEMBL3263284,O=C(O)c1ccc(C2CCN([C@@H]3C[C@H]4OCC[C@@]4(C(=O)N4CCc5ncc(C(F)(F)F)cc5C4)C3)CC2)cc1,IC50,nM,>,50000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7939,CHEMBL3263285,O=C(O)c1cccc(C2CCN([C@@H]3C[C@H]4OCC[C@@]4(C(=O)N4COc5ccc(C(F)(F)F)cc5C4)C3)CC2)c1,IC50,nM,=,29000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7940,CHEMBL3263286,CNC(=O)c1cccc(C2CCN([C@@H]3C[C@H]4OCC[C@@]4(C(=O)N4COc5ccc(C(F)(F)F)cc5C4)C3)CC2)c1,IC50,nM,=,3100.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells
7941,CHEMBL2177736,NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,IC50,nM,=,8600.0,Inhibition of human ERG by Q-patch assay
7942,CHEMBL475251,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,IC50,,,,Inhibition of human ERG by Q-patch assay
7943,CHEMBL3262355,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc(-n3nccn3)c2)n1,IC50,,,,Inhibition of human ERG by Q-patch assay
7944,CHEMBL3262356,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
7945,CHEMBL3262357,Cc1c[nH]c2c(Nc3nc(N[C@@H]4CCCC[C@@H]4N)cc4nc[nH]c(=O)c34)cccc12,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
7946,CHEMBL3262358,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3c(Cl)c[nH]c23)n1,IC50,nM,=,20000.0,Inhibition of human ERG by Q-patch assay
7947,CHEMBL3262359,Cn1ccc2cccc(Nc3nc(N[C@@H]4CCCC[C@@H]4N)cc4nc[nH]c(=O)c34)c21,IC50,,,,Inhibition of human ERG by Q-patch assay
7948,CHEMBL3262616,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3[nH]ccc23)n1,IC50,,,,Inhibition of human ERG by Q-patch assay
7949,CHEMBL3262617,N[C@H]1COCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,IC50,,,,Inhibition of human ERG by Q-patch assay
7950,CHEMBL3262618,C[C@H](N)CNc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,IC50,,,,Inhibition of human ERG by Q-patch assay
7951,CHEMBL3262619,O=c1[nH]cnc2cc(N[C@@H]3CCCNC3)nc(Nc3cccc4cc[nH]c34)c12,IC50,,,,Inhibition of human ERG by Q-patch assay
7952,CHEMBL3262620,Cc1c[nH]c2c(Nc3nc(N[C@@H]4CCOC[C@@H]4N)cc4nc[nH]c(=O)c34)cccc12,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
7953,CHEMBL3262621,Cc1nc2cc(N[C@@H]3CCCC[C@@H]3N)nc(Nc3cccc4c(C)c[nH]c34)c2c(=O)[nH]1,IC50,,,,Inhibition of human ERG by Q-patch assay
7954,CHEMBL3262622,Cn1cc2c(Nc3nc(N[C@@H]4CCOC[C@@H]4N)cc4cc[nH]c(=O)c34)cccc2n1,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
7955,CHEMBL3262623,N[C@H]1CCCC[C@H]1Nc1cc2cc[nH]c(=O)c2c(Nc2cccc3c(Cl)c[nH]c23)n1,IC50,,,,Inhibition of human ERG by Q-patch assay
7956,CHEMBL3262624,N[C@H]1COCC[C@H]1Nc1cc2cc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,IC50,nM,=,24900.0,Inhibition of human ERG by Q-patch assay
7957,CHEMBL3262625,Cc1c[nH]c2c(Nc3nc(N[C@@H]4CCCC[C@@H]4N)cc4cc[nH]c(=O)c34)cccc12,IC50,nM,=,8200.0,Inhibition of human ERG by Q-patch assay
7958,CHEMBL401895,Cc1cc(C)n(-c2cc(NC(=O)COc3cccc(CN(C)C)c3)nc(-c3ccc(C)o3)n2)n1,IC50,nM,=,1200.0,Inhibition of human ERG channel by patch-clamp assay
7959,CHEMBL3263640,Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1,IC50,nM,>,80000.0,Inhibition of human ERG
7960,CHEMBL3261265,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2cnc(OC)c(N)c2)c(OC)c1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells
7961,CHEMBL3261276,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(N)n2)c(OC)c1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells
7962,CHEMBL3261277,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NS(C)(=O)=O)n2)c(OC)c1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells
7963,CHEMBL3261266,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2cnc(OC)c(NS(C)(=O)=O)c2)c(OC)c1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells
7964,CHEMBL1818341,CC(C)CNCc1ccc(-c2ccccc2S(=O)(=O)N2CCCC2)cc1,IC50,nM,=,2400.0,Inhibition of human ERG channel
7965,CHEMBL3261615,C[C@@H](N1CCn2nc(-c3ccc(C#N)nc3)nc2C1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
7966,CHEMBL3261873,C[C@@H](N1CCc2nc(-c3cncnc3)sc2C1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F.O.O=S(=O)(O)O,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
7967,CHEMBL638,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
7968,CHEMBL294029,C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,IC50,nM,=,10370.0,Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
7969,CHEMBL298817,C[C@@H](n1cnc2cc(Cl)ccc2c1=O)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,IC50,nM,=,34860.0,Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
7970,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,80.0,Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
7971,CHEMBL64391,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
7972,CHEMBL3261919,N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)[C@@H]3CCCCN3)cc2)cc1,IC50,nM,=,1400.0,Inhibition of human ERG by electrophysiology assay
7973,CHEMBL3261920,CSc1cc(-c2ccc(C[C@@H](C#N)NC(=O)[C@@H]3CCCCN3)cc2)ccc1C#N,IC50,nM,=,2700.0,Inhibition of human ERG by electrophysiology assay
7974,CHEMBL3261921,CN1Cc2cc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CCCCN4)cc3)ccc2C1=O,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
7975,CHEMBL3261922,N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)[C@@H]3C[C@@H](O)CCN3)cc2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
7976,CHEMBL3261923,CN1Cc2cc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4C[C@@H](O)CCN4)cc3)ccc2C1=O,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
7977,CHEMBL3261924,N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)C3(N)CCCCC3)cc2)cc1,IC50,nM,=,9000.0,Inhibition of human ERG by electrophysiology assay
7978,CHEMBL3261925,N#C[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)C1(N)CCOCC1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
7979,CHEMBL3261926,N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)C3(N)CCOCC3)cc2)cc1,IC50,nM,=,26000.0,Inhibition of human ERG by electrophysiology assay
7980,CHEMBL3261927,CS(=O)(=O)c1cccc(-c2ccc(C[C@@H](C#N)NC(=O)C3(N)CCOCC3)cc2)c1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
7981,CHEMBL3261928,CN1Cc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)C4(N)CCOCC4)cc3)cc2C1=O,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
7982,CHEMBL3260567,Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1,IC50,nM,=,31040.0,Inhibition of human ERG channel expressed in HEK293 cells after 3 to 5.7 mins by whole-cell patch clamp technique
7983,CHEMBL3263869,COc1ccc(Oc2cc(C)c(-c3csc(NC(=O)c4ccnc(F)c4)n3)c(C)c2)cc1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG after 60 mins by competitive binding assay
7984,CHEMBL3262028,COCCn1cc(-c2c(C)nc3c(N4CCOCC4)nccn23)cn1,IC50,nM,>,10000.0,Inhibition of human ERG
7985,CHEMBL3262132,Cl.c1cncc(OC[C@H]2CNCCN2c2nc3ncccc3o2)c1,IC50,nM,=,72000.0,Inhibition of human ERG by whole-cell voltage clamp assay
7986,CHEMBL3262163,COc1ccc(NC(=O)N2CCNC[C@@H]2COc2cccnc2)cc1.Cl,IC50,nM,=,31000.0,Inhibition of human ERG by whole-cell voltage clamp assay
7987,CHEMBL3288812,COc1ccc2ncc(F)c(C[C@@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1.Cl,IC50,,,,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
7988,CHEMBL3288854,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1,IC50,nM,=,18830.0,Inhibition of human ERG
7989,CHEMBL535,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,nM,=,500.0,Inhibition of human ERG
7990,CHEMBL3109801,COc1ncnc(Cn2cc(C(=O)NCCF)c3ncc(C)cc32)c1C,IC50,nM,>,33000.0,Inhibition of human ERG
7991,CHEMBL3109802,COc1ncnc(Cn2cc(C(=O)NCCO)c3ncc(C)cc32)c1C,IC50,nM,>,33000.0,Inhibition of human ERG
7992,CHEMBL3291422,COc1ncnc(Cn2cc(C(=O)NCC(F)F)c3ncc(C)cc32)c1C,IC50,nM,>,33000.0,Inhibition of human ERG
7993,CHEMBL3291423,Cc1cnc2c(C(=O)NCCO)cn(Cc3ncnc(N(C)C)c3C)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG
7994,CHEMBL3291424,Cc1cnc2c(C(=O)NCCO)cn(Cc3ncnc(OC(F)F)c3C)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG
7995,CHEMBL3291427,COc1cnc2c(C(=O)NCCO)cn(Cc3ncnc(OC)c3C)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG
7996,CHEMBL3291430,COc1cnc2c(C(=O)NCCO)cn(Cc3ncnc(N(C)C)c3C)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG
7997,CHEMBL3286732,Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNC(=O)O3)nc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK cells by voltage clamp assay
7998,CHEMBL3289444,CC(C)OC(=O)N1CCC(C)(CN2CCC3(CC2)CN(S(C)(=O)=O)c2ncccc23)CC1,IC50,nM,=,2750.0,Inhibition of human ERG tail current after 5 mins by patch-clamp method
7999,CHEMBL3289440,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(S(C)(=O)=O)c2ncccc23)CC1,IC50,nM,=,1900.0,Inhibition of human ERG tail current after 5 mins by patch-clamp method
8000,CHEMBL3289442,CCOC(=O)N1CCC(C)(CN2CCC3(CC2)CN(S(C)(=O)=O)c2ncccc23)CC1,IC50,nM,=,3630.0,Inhibition of human ERG tail current after 5 mins by patch-clamp method
8001,CHEMBL3289443,COC(=O)N1CCC(C)(CN2CCC3(CC2)CN(S(C)(=O)=O)c2ncccc23)CC1,IC50,nM,=,17000.0,Inhibition of human ERG tail current after 5 mins by patch-clamp method
8002,CHEMBL3289441,CCOC(=O)N1[C@H]2CC[C@@H]1C[C@@H](CN1CCC3(CC1)CN(S(C)(=O)=O)c1ncccc13)C2,IC50,,,,Inhibition of human ERG tail current after 5 mins by patch-clamp method
8003,CHEMBL3289445,CC1(CN2CCC3(CC2)CN(S(C)(=O)=O)c2ncccc23)CCN(C(=O)OC(C)(C)C)CC1,IC50,,,,Inhibition of human ERG tail current after 5 mins by patch-clamp method
8004,CHEMBL3289803,Nc1nc2ccc(C(F)(F)F)cc2n1CC(O)c1ccc(C(F)(F)F)cc1Cl,IC50,nM,>,10500.0,Inhibition of human ERG
8005,CHEMBL3289800,N#Cc1ccc2nc(N)n(CC(O)c3cccc(Cl)c3Cl)c2c1,IC50,nM,>,33300.0,Inhibition of human ERG
8006,CHEMBL3289801,CS(=O)(=O)c1ccc2nc(N)n(CC(O)c3cccc(Cl)c3Cl)c2c1,IC50,nM,>,33300.0,Inhibition of human ERG
8007,CHEMBL3289802,Nc1nc2ccc(Cl)cc2n1CC(O)c1cccc(Cl)c1Cl,IC50,nM,>,33300.0,Inhibition of human ERG
8008,CHEMBL3289805,Nc1nc2cccnc2n1CC(O)c1cccc(Cl)c1Cl,IC50,nM,>,33300.0,Inhibition of human ERG
8009,CHEMBL3289810,Nc1nc2ccc(OCC(F)(F)F)nc2n1CC(O)c1ccc(C(F)(F)F)cc1Cl,IC50,nM,>,33300.0,Inhibition of human ERG
8010,CHEMBL3289812,Nc1nc2ccc(OC3CNC3)nc2n1CC(O)c1ccc(C(F)(F)F)cc1Cl,IC50,nM,>,33300.0,Inhibition of human ERG
8011,CHEMBL3289813,CC(Oc1ccc2nc(N)n(CC(O)c3ccc(C(F)(F)F)cc3Cl)c2n1)C(F)(F)F,IC50,nM,>,33300.0,Inhibition of human ERG
8012,CHEMBL3289795,Cc1cn(CC(O)c2ccc(Cl)cc2Cl)c(N)n1,IC50,nM,>,33300.0,Inhibition of human ERG
8013,CHEMBL3289796,Cc1nc(N)n(CC(O)c2ccc(Cl)cc2Cl)c1C,IC50,nM,>,33300.0,Inhibition of human ERG
8014,CHEMBL3289807,Nc1nc2ccc(NCC(F)(F)F)nc2n1CC(O)c1ccc(Cl)cc1Cl,IC50,nM,=,3500.0,Inhibition of human ERG
8015,CHEMBL3289797,Nc1nc(C2CC2)cn1CC(O)c1ccc(Cl)cc1Cl,IC50,nM,=,4500.0,Inhibition of human ERG
8016,CHEMBL3289799,Nc1nc2ccccc2n1CC(O)c1ccc(Cl)cc1Cl,IC50,nM,=,10300.0,Inhibition of human ERG
8017,CHEMBL3289806,CN1CCN(c2ccc3nc(N)n(CC(O)c4ccc(C(F)(F)F)cc4Cl)c3n2)CC1,IC50,nM,=,12200.0,Inhibition of human ERG
8018,CHEMBL3289811,Nc1nc2ccc(OC3CCOC3)nc2n1CC(O)c1ccc(C(F)(F)F)cc1Cl,IC50,nM,=,16600.0,Inhibition of human ERG
8019,CHEMBL3289794,Nc1nccn1CC(O)c1cccc(Cl)c1Cl,IC50,nM,=,22000.0,Inhibition of human ERG
8020,CHEMBL3289798,Nc1nc(-c2ccc(F)cc2)cn1CC(O)c1ccc(C(F)(F)F)cc1Cl,IC50,nM,=,25000.0,Inhibition of human ERG
8021,CHEMBL3289792,Nc1nccn1CC(O)c1ccc(Cl)cc1F,IC50,nM,=,60000.0,Inhibition of human ERG
8022,CHEMBL3289791,Nc1nccn1CC(O)c1ccc(Cl)cc1Cl,IC50,,,,Inhibition of human ERG
8023,CHEMBL3289793,Cc1cc(Cl)ccc1C(O)Cn1ccnc1N,IC50,,,,Inhibition of human ERG
8024,CHEMBL600686,O=C(CN1C(C(=O)c2ccccc2)=C(O)c2ccccc2S1(=O)=O)c1ccccc1,IC50,nM,>,100000.0,Inhibition of human ERG
8025,CHEMBL2036234,CC1CN(CC(=O)N[C@H]2C3CC4CC2C[C@](C(N)=O)(C4)C3)S(=O)(=O)N(c2c(Cl)cc(Cl)cc2Cl)C1,IC50,nM,=,37000.0,Inhibition of human ERG
8026,CHEMBL3289804,Nc1nc2cnccc2n1CC(O)c1ccc(Cl)cc1Cl,IC50,,,,Inhibition of human ERG
8027,CHEMBL3289808,Nc1nc2ccc(C3CC3)nc2n1CC(O)c1ccc(Cl)cc1Cl,IC50,,,,Inhibition of human ERG
8028,CHEMBL3289809,Nc1nc2ccc(C(=O)NC3CC3)nc2n1CC(O)c1ccc(Cl)cc1Cl,IC50,,,,Inhibition of human ERG
8029,CHEMBL2426677,COc1ccc(CC(=O)N2CCC3(CC2)CN([C@@H]2CCc4cc(-c5ncccn5)ccc42)C3)cc1,IC50,nM,=,2900.0,Inhibition of human ERG
8030,CHEMBL3287218,Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1,IC50,nM,=,6900.0,Inhibition of human ERG
8031,CHEMBL3290012,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1,IC50,nM,=,4000.0,Inhibition of human cloned ERG expressed in CHO cells assessed as inhibition of potassium channel current by automated patch clamp assay
8032,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,89.0,Inhibition of human cloned ERG expressed in CHO cells assessed as inhibition of potassium channel current by automated patch clamp assay
8033,CHEMBL3287849,O=c1cc([C@H]2CCN[C@@H](Cc3ccccc3)C2)o[nH]1,IC50,nM,>,1000000000.0,Inhibition of human ERG
8034,CHEMBL3287851,CC(C)(C)C[C@H]1C[C@@H](c2cc(=O)[nH]o2)CCN1,IC50,nM,>,1000000000.0,Inhibition of human ERG
8035,CHEMBL3287854,O=c1cc([C@H]2CCN[C@@H](CCc3ccccc3)C2)o[nH]1,IC50,nM,>,1000000000.0,Inhibition of human ERG
8036,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,2.7,Inhibition of human cloned ERG expressed in CHO cells assessed as inhibition of potassium channel current by automated patch clamp assay
8037,CHEMBL3287739,Cc1cc(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3cccc(-c4ccc(O)cc4CN4CCOCC4)c3)CC2)nn1C,IC50,nM,=,31622.78,Inhibition of human ERG
8038,CHEMBL3288029,Cc1csc(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3cccc(-c4ccc(CN5C[C@H](C)N[C@H](C)C5)cc4CN4CCOCC4)c3)CC2)n1,IC50,nM,=,19952.62,Inhibition of human ERG
8039,CHEMBL3288030,Cc1ccc(O)c(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3cccc(-c4ccc(CN5C[C@H](C)N[C@H](C)C5)cc4CN4CCOCC4)c3)CC2)c1,IC50,nM,=,6309.57,Inhibition of human ERG
8040,CHEMBL3290766,Cn1ncc(C(=O)N2CCC(Nc3cc(=O)[nH]c4ccccc34)CC2)c1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by medium-throughput electrophysiology
8041,CHEMBL3290767,Cn1ncc(C(=O)N2CCC(Nc3cc(=O)[nH]c4ccc(F)cc34)CC2)c1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by medium-throughput electrophysiology
8042,CHEMBL3290768,Cn1ncc(C(=O)N2CCC(Nc3cc(=O)[nH]c4cc(F)c(F)cc34)CC2)c1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by medium-throughput electrophysiology
8043,CHEMBL3290772,Cn1ncc(C(=O)N2CCC(Nc3cc(=O)n(C)c4ccccc34)CC2)c1Cl,IC50,nM,>,33000.0,Inhibition of human ERG by medium-throughput electrophysiology
8044,CHEMBL3291056,Cc1onc(C(=O)N2CCC(Nc3cc(=O)n(C)c4cc(F)c(F)cc34)CC2)c1C,IC50,,,,Inhibition of human ERG by medium-throughput electrophysiology
8045,CHEMBL3291062,Cc1onc(C(=O)N2[C@H]3CC[C@@H]2C[C@H](Nc2cc(=O)n(C)c4cc(F)c(F)cc24)C3)c1C,IC50,nM,=,16000.0,Inhibition of human ERG by medium-throughput electrophysiology
8046,CHEMBL3291063,Cn1ncc(C(=O)N2[C@H]3CC[C@@H]2C[C@H](Nc2n[nH]c4ccc(F)cc24)C3)c1Cl,IC50,nM,>,33000.0,Inhibition of human ERG by medium-throughput electrophysiology
8047,CHEMBL3291065,Cn1ncc(C(=O)N2[C@H]3CC[C@@H]2C[C@H](Nc2cc(=O)n(C)c4ncccc24)C3)c1Cl,IC50,nM,>,33000.0,Inhibition of human ERG by medium-throughput electrophysiology
8048,CHEMBL3291066,Cc1onc(C(=O)N2[C@H]3CC[C@@H]2C[C@H](Nc2cc(=O)n(C)c4nccnc24)C3)c1C,IC50,nM,>,33000.0,Inhibition of human ERG by medium-throughput electrophysiology
8049,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,24.0,Inhibition of human ERG tail current by patch clamp method
8050,CHEMBL2165062,N#Cc1ccc2ccc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,44000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8051,CHEMBL3290336,COc1ccc2ccc(=O)n(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2n1,IC50,nM,=,21000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8052,CHEMBL3290337,N#Cc1ccc2ccc(=O)n(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,,,,Inhibition of human ERG by patch clamp electrophysiological analysis
8053,CHEMBL3290338,Cc1nc(CNC2CCN(CCn3c(=O)ccc4ccc(C#N)cc43)CC2)ccc1C#N,IC50,nM,=,5300.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8054,CHEMBL3290339,Cc1ncc(CNC2CCN(CCn3c(=O)ccc4ccc(C#N)cc43)CC2)cc1C#N,IC50,nM,=,26000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8055,CHEMBL3290340,Cc1ncc(CNC2CCN(CCn3c(=O)ccc4ncc(F)cc43)CC2)cc1C#N,IC50,nM,=,69000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8056,CHEMBL3290341,COc1cnc2ccc(=O)n(CCN3CCC(NCc4cnc(C)c(C#N)c4)CC3)c2c1,IC50,nM,=,50600.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8057,CHEMBL3290342,COc1ccc2c(ccc(=O)n2CCN2CCC(NCc3cnc(C)c(C#N)c3)CC2)n1,IC50,nM,=,10000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8058,CHEMBL3290343,Cc1ncc(CNC2CCN(CCn3c(=O)ccc4c3ccc(=O)n4C)CC2)cc1C#N,IC50,nM,=,33000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8059,CHEMBL3286436,COc1cc(C#N)c2ccc(=O)n(CCN3CCC(NCc4cnc(C)c(C#N)c4)CC3)c2c1,IC50,nM,=,2500.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8060,CHEMBL3290344,COc1cnc2ccc(=O)n(CCN3CCC(NC(=O)c4cnc(C)c(C#N)c4)CC3)c2c1,IC50,nM,=,74000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8061,CHEMBL3290345,COc1cnc2ccc(=O)n(CCN3CCC(NCc4cnc(OC)c(C#N)c4)CC3)c2c1,IC50,nM,=,12000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8062,CHEMBL3290346,COc1cnc2ccc(=O)n(CCN3CCC(NCc4cnc(C)c(C#N)n4)CC3)c2c1,IC50,nM,=,69000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8063,CHEMBL3290347,COc1ccc2ncc(=O)n(CCN3CCC(NCc4cnc(C)c(C#N)c4)CC3)c2n1,IC50,nM,=,13000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8064,CHEMBL3290348,COc1cnc2ncc(=O)n(CCN3CCC(NCc4cnc(C)c(C#N)c4)CC3)c2c1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8065,CHEMBL3290349,Cc1ncc(CN[C@@H]2CCN(CCn3c(=O)ccc4ccc(C#N)cc43)C[C@@H]2F)cc1C#N,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8066,CHEMBL3290350,Cc1ncc(CN[C@@H]2CCN(CCn3c(=O)ccc4ncc(F)cc43)C[C@@H]2F)cc1C#N,IC50,nM,=,133000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8067,CHEMBL3290351,COc1cnc2ccc(=O)n(CCN3CC[C@@H](NCc4cnc(C)c(C#N)c4)[C@@H](F)C3)c2c1,IC50,nM,=,90000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8068,CHEMBL3290352,COc1cnc2ccc(=O)n(CCN3CC[C@@H](NCc4cnc(C)c(C#N)c4)[C@@H](OC)C3)c2c1,IC50,nM,=,151000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8069,CHEMBL3290353,O=C1COc2ccc(CN[C@@H]3CCN(CCn4c(=O)ccc5ncc(F)cc54)C[C@@H]3F)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8070,CHEMBL3290354,O=C1COc2ccc(CN[C@H]3CCN(CCn4c(=O)ccc5ncc(F)cc54)C[C@H]3F)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8071,CHEMBL3290355,COc1cnc2ccc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](F)C3)c2c1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8072,CHEMBL3290356,COc1cnc2ccc(=O)n(CCN3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)[C@H](F)C3)c2c1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8073,CHEMBL3290357,COc1cnc2ccc(=O)n(CCN3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)[C@@H](OC)C3)c2c1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp electrophysiological analysis
8074,CHEMBL3288810,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1.Cl,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
8075,CHEMBL3288811,COc1ccc2ncc(F)c(C[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1.Cl,IC50,nM,=,18000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
8076,CHEMBL3355072,C[C@@H]1Cn2ncc(-c3ccc(S(C)(=O)=O)cc3)c2CN1c1ccnc2[nH]ccc12,IC50,nM,=,1500.0,Inhibition of human ERG by automated whole cell electrophysiology
8077,CHEMBL3355073,C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1ccnc2[nH]ccc12,IC50,nM,>,30000.0,Inhibition of human ERG by automated whole cell electrophysiology
8078,CHEMBL3355074,C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1cc(Cl)nc2[nH]ccc12,IC50,nM,=,12500.0,Inhibition of human ERG by automated whole cell electrophysiology
8079,CHEMBL3355480,C[C@@H]1COCCN1c1nc(-c2nncc3[nH]ccc23)cc2c1ncn2C,IC50,nM,>,30000.0,Inhibition of human ERG channel by dofetilide binding assay
8080,CHEMBL3355475,C[C@@H]1COCCN1c1nc(-c2cncc3[nH]ccc23)cc2c1ncn2C,IC50,nM,>,30000.0,Inhibition of human ERG channel by dofetilide binding assay
8081,CHEMBL3358687,O=C(NCCN1CCC(O)(Cc2ccc(F)cc2)CC1)Nc1ccnc2ccsc12,IC50,nM,=,5000.0,Inhibition of human ERG by patch clam assay
8082,CHEMBL3356239,COc1ccccc1CCNCC(=O)N1CCc2ccccc2C1C1CCCCC1,IC50,nM,=,8300.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8083,CHEMBL2031958,COc1cc(CN2CCN(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc(OC)c1OC,IC50,nM,=,3400.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8084,CHEMBL3356240,COc1c(OC(C)(C)C)cc(CN2CC(=O)N(CCCCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2=O)cc1OC(C)(C)C,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8085,CHEMBL3356242,O=C(CNCCc1c(Cl)cccc1Cl)N1CCc2ccccc2C1C1CCCCC1,IC50,nM,=,54700.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8086,CHEMBL3356246,O=C(CNCC1CCCCC1)N1CCc2ccccc2C1C1CCCCC1,IC50,nM,=,26000.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8087,CHEMBL3356247,O=C(CNCC1(O)CCCCC1)N1CCc2ccccc2C1C1CCCCC1,IC50,nM,=,46100.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8088,CHEMBL3356248,O=C(CNCC1(O)CCCC1)N1CCc2ccccc2C1C1CCCCC1,IC50,nM,=,78600.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8089,CHEMBL3356249,O=C(CNCC1(O)CCCCCC1)N1CCc2ccccc2C1C1CCCCC1,IC50,nM,=,50100.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8090,CHEMBL3356250,O=C(CNCCC1(O)CCCCC1)N1CCc2ccccc2C1C1CCCCC1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8091,CHEMBL3356251,O=C(CNCC1(O)CCCCC1)N1CCc2ccccc2[C@@H]1C1CCCCC1,IC50,nM,=,98000.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8092,CHEMBL3356252,O=C(CNCC1(O)CCCCC1)N1CCc2ccccc2[C@H]1C1CCCCC1,IC50,nM,=,76000.0,Inhibition of human ERG expressed in CHO cells by Rb efflux assay
8093,CHEMBL1952329,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,<,1000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
8094,CHEMBL3355544,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
8095,CHEMBL3355550,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
8096,CHEMBL3355552,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
8097,CHEMBL3355987,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
8098,CHEMBL3355541,CN1CCC(CNc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
8099,CHEMBL3354952,CC(C)(CO)NC(=O)c1nn(-c2ccc(F)cc2F)c2c1C[C@H]1C[C@@H]21,IC50,nM,>,1000000.0,Displacement of [3H]Astemizole from human ERG channel
8100,CHEMBL3354952,CC(C)(CO)NC(=O)c1nn(-c2ccc(F)cc2F)c2c1C[C@H]1C[C@@H]21,IC50,nM,>,30000.0,Inhibition of human ERG channel by patch clamp technique
8101,CHEMBL3358920,O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
8102,CHEMBL3358920,O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21,IC50,nM,>,30000.0,Displacement of [3H]astemizole from human ERG
8103,CHEMBL3358937,CC(C)(CC(O)(Cc1cc2cc(N3CCOCC3)ncc2[nH]1)C(F)(F)F)c1ccccc1S(C)(=O)=O,IC50,nM,=,20000.0,Inhibition of human ERG channel expressed in recombinant HEK293 cells by whole cell patch-clamp technique
8104,CHEMBL3358953,CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccccc3C(N)=O)C(F)(F)F)[nH]c2cn1,IC50,nM,>,30000.0,Inhibition of human ERG channel expressed in recombinant HEK293 cells by whole cell patch-clamp technique
8105,CHEMBL3358954,CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,IC50,nM,>,30000.0,Inhibition of human ERG channel expressed in recombinant HEK293 cells by whole cell patch-clamp technique
8106,CHEMBL3358925,Cc1ccc(F)cc1C(C)(C)CC(O)(Cc1cc2cc(-c3ccccc3)ncc2[nH]1)C(F)(F)F,IC50,nM,=,3800.0,Inhibition of human ERG channel expressed in recombinant HEK293 cells by whole cell patch-clamp technique
8107,CHEMBL2151164,COc1nc(Nc2cccc3c2nc(-c2ccc(F)cc2)n3C)ccc1-n1cnc(C)c1,IC50,nM,=,8500.0,Binding affinity to human ERG
8108,CHEMBL3353099,COc1nc(-c2nc(Nc3cc(C(F)(F)F)ccc3F)n(C)n2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Binding affinity to human ERG
8109,CHEMBL3326188,CCCCCc1ccc(-c2ccoc2C(=O)NNC(=O)c2ccc(O)c([N+](=O)[O-])c2)cc1,IC50,nM,>,1000.0,Inhibition of human ERG
8110,CHEMBL3310484,Fc1cc(C(CC2CNC2)Oc2ccccc2F)ccc1Cl,IC50,nM,=,1410.0,Inhibition of human ERG expressed in CHO-K1 cells by patch-clamp electrophysiology method
8111,CHEMBL3310485,Fc1cccc(OC(CC2CNC2)c2ccc(Cl)c(F)c2)c1,IC50,nM,=,1460.0,Inhibition of human ERG expressed in CHO-K1 cells by patch-clamp electrophysiology method
8112,CHEMBL2153098,CN(C)c1ccc(/C=C/c2c(F)cccc2F)cc1,IC50,nM,=,32100.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8113,CHEMBL3314417,CNc1ccc(/C=C/c2c(F)cccc2F)cc1,IC50,nM,=,49100.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8114,CHEMBL3314420,CNc1ccc(/C=C/c2c(F)cccc2Cl)cc1,IC50,nM,=,49800.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8115,CHEMBL3314423,CN(C)c1ccc(/C=C/c2c(F)cccc2F)nc1,IC50,nM,=,21100.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8116,CHEMBL3314424,CN(C)c1ccc(/C=C/c2c(F)cccc2Cl)nc1,IC50,nM,=,20700.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8117,CHEMBL3314426,CN(C)c1ccc(/C=C/c2c(F)cccc2F)cn1,IC50,nM,=,22000.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8118,CHEMBL3314429,CN(C)c1ccc(/C=C/c2c(F)cccc2Cl)cn1,IC50,nM,=,59500.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8119,CHEMBL3314430,CNc1ccc(/C=C/c2c(F)cccc2Cl)cn1,IC50,nM,=,19900.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8120,CHEMBL3314433,CN(C)c1ncc(/C=C/c2c(F)cccc2F)cn1,IC50,nM,=,40500.0,Inhibition of human ERG over-expressed in HEK293 cell membrane by [3H]dofetilide binding assay
8121,CHEMBL3356474,C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4CNC4)cc3N21,IC50,nM,>,30000.0,Inhibition of human ERG
8122,CHEMBL3355112,C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4(C)CNC4)cc3N21,IC50,nM,>,30000.0,Inhibition of human ERG
8123,CHEMBL3323084,Cn1cc([C@@]2(c3cncc(C(=O)O)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,12000.0,Inhibition of human ERG by functional patch clamp assay
8124,CHEMBL2204935,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,3400.0,Inhibition of human ERG by functional patch clamp assay
8125,CHEMBL3323084,Cn1cc([C@@]2(c3cncc(C(=O)O)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,11990.0,Inhibition of human ERG by MK-499 displacement binding analysis
8126,CHEMBL3323082,Cn1cc([C@@]2(c3cc(C(=O)O)ccn3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,19560.0,Inhibition of human ERG by MK-499 displacement binding analysis
8127,CHEMBL3323080,Cn1cc([C@@]2(c3cccc(C(=O)O)n3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,8703.0,Inhibition of human ERG by MK-499 displacement binding analysis
8128,CHEMBL3323079,CCOC(=O)c1ccc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)nc1,IC50,nM,=,2845.0,Inhibition of human ERG by MK-499 displacement binding analysis
8129,CHEMBL3323078,CCOC(=O)c1ccc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)nc1,IC50,nM,=,1611.0,Inhibition of human ERG by MK-499 displacement binding analysis
8130,CHEMBL3323077,CCOC(=O)c1cncc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)c1,IC50,nM,=,2520.0,Inhibition of human ERG by MK-499 displacement binding analysis
8131,CHEMBL3323076,CCOC(=O)c1cncc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)c1,IC50,nM,=,2257.0,Inhibition of human ERG by MK-499 displacement binding analysis
8132,CHEMBL3323075,CCOC(=O)c1ccnc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)c1,IC50,nM,=,1205.0,Inhibition of human ERG by MK-499 displacement binding analysis
8133,CHEMBL3323074,CCOC(=O)c1ccnc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)c1,IC50,nM,=,1420.0,Inhibition of human ERG by MK-499 displacement binding analysis
8134,CHEMBL3323073,CCOC(=O)c1cccc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)n1,IC50,nM,=,625.0,Inhibition of human ERG by MK-499 displacement binding analysis
8135,CHEMBL3323072,CCOC(=O)c1cccc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)n1,IC50,nM,=,707.0,Inhibition of human ERG by MK-499 displacement binding analysis
8136,CHEMBL2204935,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,1740.0,Inhibition of human ERG by MK-499 displacement binding analysis
8137,CHEMBL3329684,COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1,IC50,nM,=,9670.0,Inhibition of human ERG channel after 3 hrs by fluorescence assay
8138,CHEMBL3322590,O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1,IC50,nM,>,100000.0,Inhibition of human ERG channel by hERG Tracer Red based fluorescent assay
8139,CHEMBL3323181,CN1Cc2cc(N3CCOCC3)ccc2[C@@H](c2ccc3sccc3c2)C1,IC50,nM,=,1000.0,Inhibition of human ERG by patch-clamp assay
8140,CHEMBL3318939,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OCCCOC)c(C(C)C)cc2F)C2CC2)C1.Cl,IC50,nM,=,5500.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8141,CHEMBL3318940,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc3c(cc2F)OC(C)(C)C(=O)N3CCCOC)C2CC2)C1.Cl,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8142,CHEMBL3318941,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OCCCOC)c(C(C)C)cn2)C2CC2)C1.Cl,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8143,CHEMBL3318942,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2ccc(C(C)C)c(OCCCOC)n2)C2CC2)C1.Cl,IC50,nM,=,3300.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8144,CHEMBL3318943,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OC)c(C(C)C)cn2)C2CC2)C1.Cl,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8145,CHEMBL3318944,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OCC)c(CC)cn2)C2CC2)C1.Cl,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8146,CHEMBL3318928,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2ccc(C(C)C)cn2)C2CC2)C1.Cl,IC50,nM,=,7000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8147,CHEMBL3318929,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2ccc(C(C)C)cc2)C2CC2)C1.Cl,IC50,,,,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8148,CHEMBL3318945,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OC)c(C(C)C)cn2)C2CC2)[C@@H]1O.Cl,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8149,CHEMBL3318946,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OCC)c(CC)cn2)C2CC2)[C@@H]1O.Cl,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8150,CHEMBL3318947,CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2ccc(C(C)C)cn2)C2CC2)[C@@H]1O.Cl,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes incubated for 90 mins by beta-counting method
8151,CHEMBL3318978,Clc1ccc(C2(c3nnc4c(C5CC5)cccn34)CC2)cc1,IC50,nM,>,60000.0,Inhibition of human ERG flux
8152,CHEMBL3319003,COc1cnc2ccc(=O)n(CCN3CCC(c4c[nH]c5ccc(C#N)cc45)CC3)c2c1,IC50,nM,=,2000.0,Inhibition of human ERG by electrophysiology assay
8153,CHEMBL3319004,COc1cnc2ccc(=O)n(CCN3CCC(c4c[nH]c5cc(C(F)(F)F)ccc45)CC3)c2c1,IC50,nM,=,1800.0,Inhibition of human ERG by electrophysiology assay
8154,CHEMBL3318982,COc1cnc2ccc(=O)n(CCN3CCC(C4C(=O)Nc5ccc(Cl)cc54)CC3)c2c1,IC50,nM,=,4800.0,Inhibition of human ERG by electrophysiology assay
8155,CHEMBL3318983,COc1cnc2ccc(=O)n(CCN3CCC(c4nc5cc(C(F)(F)F)ccc5[nH]4)CC3)c2c1,IC50,nM,=,1000.0,Inhibition of human ERG by electrophysiology assay
8156,CHEMBL3318984,COc1cnc2ccc(=O)n(CCN3CCN(c4nc5cc(C(F)(F)F)ccc5[nH]4)CC3)c2c1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology assay
8157,CHEMBL3318985,COc1cnc2ccc(=O)n(CCN3CCN(c4nc5ccccc5[nH]4)CC3)c2c1,IC50,nM,=,7000.0,Inhibition of human ERG by electrophysiology assay
8158,CHEMBL3318986,O=c1ccc2ncc(F)cc2n1CCN1CCN(c2nc3cc(C(F)(F)F)ccc3[nH]2)CC1,IC50,nM,=,1000.0,Inhibition of human ERG by electrophysiology assay
8159,CHEMBL3318987,O=c1ccc2ncc(F)cc2n1CCN1CCC(c2nc3cc(C(F)(F)F)ccc3[nH]2)CC1,IC50,,,,Inhibition of human ERG by electrophysiology assay
8160,CHEMBL3318988,N#Cc1ccc2[nH]c(C3CCN(CCn4c(=O)ccc5ncc(F)cc54)CC3)nc2c1,IC50,,,,Inhibition of human ERG by electrophysiology assay
8161,CHEMBL3318989,COc1cnc2ccc(=O)n(CCN3CCC(c4nc5cc(Cl)ccc5[nH]4)CC3)c2c1,IC50,nM,=,1000.0,Inhibition of human ERG by electrophysiology assay
8162,CHEMBL3318990,COc1cnc2ccc(=O)n(CCN3CCC(c4nc5cc(C#N)ccc5[nH]4)CC3)c2c1,IC50,nM,=,4500.0,Inhibition of human ERG by electrophysiology assay
8163,CHEMBL3318991,COc1cnc2ccc(=O)n(CCN3CCC(c4nc5cc(Cl)c(F)cc5[nH]4)CC3)c2c1,IC50,nM,=,1200.0,Inhibition of human ERG by electrophysiology assay
8164,CHEMBL3318992,COc1cnc2ccc(=O)n(CCN3CCC(c4nc5cc(Cl)c(C)cc5[nH]4)CC3)c2c1,IC50,nM,=,1400.0,Inhibition of human ERG by electrophysiology assay
8165,CHEMBL3318993,Cc1cc2[nH]c(C3CCN(CCn4c(=O)ccc5ncc(F)cc54)CC3)nc2cc1Cl,IC50,nM,=,1200.0,Inhibition of human ERG by electrophysiology assay
8166,CHEMBL3318994,COc1ccc2ncc(=O)n(CCN3CCC(c4nc5cc(Cl)c(C)cc5[nH]4)CC3)c2c1,IC50,,,,Inhibition of human ERG by electrophysiology assay
8167,CHEMBL3318995,COc1cnc2ncc(=O)n(CCN3CCC(c4nc5cc(Cl)c(C)cc5[nH]4)CC3)c2c1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology assay
8168,CHEMBL3318996,Cc1cc2[nH]c(C3CCN(CCn4c(=O)ccc5ncc(F)cc54)CC3)nc2cc1C#N,IC50,,,,Inhibition of human ERG by electrophysiology assay
8169,CHEMBL3318997,COc1cnc2ccc(=O)n(CCN3CCC(c4nc5cc(C#N)c(C)cc5[nH]4)CC3)c2c1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology assay
8170,CHEMBL3318998,COc1cnc2ccc(=O)n(CCN3CCN(c4nc5cc(C#N)c(C)cc5[nH]4)CC3)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
8171,CHEMBL3318999,N#Cc1ccc2[nH]c(C3CCN(CCn4c(=O)ccc5ncc(Oc6cccnc6)cc54)CC3)nc2c1,IC50,nM,=,1400.0,Inhibition of human ERG by electrophysiology assay
8172,CHEMBL3319000,N#Cc1ccc2[nH]c(C3CCN(CCn4c(=O)ccc5ncc(Oc6ccc(S(N)(=O)=O)cc6)cc54)CC3)nc2c1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
8173,CHEMBL3319001,NS(=O)(=O)c1ccc(Oc2cnc3ccc(=O)n(CCN4CCC(c5nc6cc(C(F)(F)F)ccc6[nH]5)CC4)c3c2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
8174,CHEMBL2407174,CCOC(=O)N1CCC(CN2CCC3(CC2)CC(=O)N(CC)c2ncccc23)CC1,IC50,nM,=,2890.0,Inhibition of human ERG channel
8175,CHEMBL3310798,CCNC(=O)N1CC2(CCN(CC3CCN(C(=O)OCC)CC3)CC2)c2cccnc21,IC50,nM,=,230.0,Inhibition of human ERG channel
8176,CHEMBL3310799,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(C(=O)N(CC)CC)c2ncccc23)CC1,IC50,nM,=,2540.0,Inhibition of human ERG channel
8177,CHEMBL3310800,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(C(=O)NC)c2ncccc23)CC1,IC50,nM,=,300.0,Inhibition of human ERG channel
8178,CHEMBL3310801,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(C(N)=O)c2ncccc23)CC1,IC50,nM,=,190.0,Inhibition of human ERG channel
8179,CHEMBL3310802,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(C(=O)N(C)C)c2ncccc23)CC1.O=C(O)/C=C/C(=O)O,IC50,nM,>,10000.0,Inhibition of human ERG channel
8180,CHEMBL3310917,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(C(=O)N2CCC2)c2ncccc23)CC1,IC50,,,,Inhibition of human ERG channel
8181,CHEMBL3310918,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(C(=O)N2CCCC2)c2ncccc23)CC1,IC50,,,,Inhibition of human ERG channel
8182,CHEMBL3289440,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(S(C)(=O)=O)c2ncccc23)CC1,IC50,nM,=,1900.0,Inhibition of human ERG channel
8183,CHEMBL3310919,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(C(=O)OC)c2ncccc23)CC1,IC50,,,,Inhibition of human ERG channel
8184,CHEMBL3310920,CCOC(=O)N1CCC(CN2CCC3(CC2)CN(CC)c2ncccc23)CC1,IC50,,,,Inhibition of human ERG channel
8185,CHEMBL3311308,COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO cells by dofetilide binding assay
8186,CHEMBL3311308,COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO cells by summary (Abse5) assay
8187,CHEMBL1081188,COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
8188,CHEMBL1086899,Cc1cccc(C(=O)Nc2cccc(NC(=O)c3cccc(Cl)c3)c2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
8189,CHEMBL3188857,Cc1cccc(C(=O)Nc2cccc(NC(=O)c3ccccc3C(F)(F)F)c2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
8190,CHEMBL3183773,Cc1cccc(C(=O)Nc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
8191,CHEMBL3187891,Cc1cccc(C(=O)Nc2cccc(NC(=O)c3ccncc3)c2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
8192,CHEMBL3185736,Cc1cccc(C(=O)Nc2cccc(NC(=O)c3cccc(C)c3)c2)c1,IC50,nM,=,12400.0,Inhibition of human ERG
8193,CHEMBL3317856,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,IC50,nM,=,1400000.0,Inhibition of human ERG
8194,CHEMBL3321871,CN1CCN(c2ccc3nc(Nc4ccc(Br)cn4)[nH]c3c2)CC1,IC50,nM,=,3500.0,Inhibition of human ERG
8195,CHEMBL3321873,Cc1ccc(Nc2nc3ccc(N4CCN(C)CC4)cc3[nH]2)nc1,IC50,nM,=,12700.0,Inhibition of human ERG
8196,CHEMBL3321968,CN1CCN(c2cc(Cl)c3nc(Nc4ccc(Br)cn4)[nH]c3c2)CC1,IC50,nM,=,7300.0,Inhibition of human ERG
8197,CHEMBL3321972,CN1CCC(c2ccc3nc(Nc4ccc(C(F)(F)F)cn4)[nH]c3c2)CC1,IC50,nM,=,4300.0,Inhibition of human ERG
8198,CHEMBL3321963,CN1CCN(Cc2ccc3nc(Nc4ccc(C(F)(F)F)cn4)[nH]c3c2)CC1,IC50,nM,=,21500.0,Inhibition of human ERG
8199,CHEMBL3321980,Cc1nc(Nc2nc3cnc(N4CCN(C)CC4)cc3[nH]2)cc(C2CC2)c1F,IC50,nM,=,8800.0,Inhibition of human ERG
8200,CHEMBL3299132,O=C1NC(=O)C(Cc2coc3ccc(Cl)cc3c2=O)S1,IC50,nM,=,135.0,Inhibition of human ERG channel
8201,CHEMBL3314362,Cc1cc2c(cc1CN(C)C)CCN(C(=O)c1cc3cc(Cl)ccc3n1C)C2,IC50,nM,=,12900.0,Inhibition of human ERG expressed in CHO cells by electrophysiology assay
8202,CHEMBL3314352,CN(C)Cc1ccc2c(c1)CCN(C(=O)c1cc3cc(Br)ncc3n1C)C2,IC50,nM,=,31200.0,Inhibition of human ERG expressed in CHO cells by electrophysiology assay
8203,CHEMBL3314349,CN(C)Cc1ccc2c(c1)CCN(C(=O)c1cc3cc(Cl)ccc3n1C)C2,IC50,nM,=,4900.0,Inhibition of human ERG expressed in CHO cells by electrophysiology assay
8204,CHEMBL3355570,Cc1cc(=O)n(C[C@H](N)[C@H]2CC[C@H](NCc3ccc4c(n3)NC(=O)CO4)CC2)c2cc(F)ccc12,IC50,nM,>,333000.0,Inhibition of human ERG by cell-based patch clamp method
8205,CHEMBL3355569,Cc1cc(=O)n(C[C@H](N)[C@H]2CC[C@H](NCc3ncc4c(n3)NC(=O)CO4)CC2)c2cc(F)ccc12,IC50,nM,>,333000.0,Inhibition of human ERG by cell-based patch clamp method
8206,CHEMBL3355568,COc1ccc2ccc(=O)n(C[C@H](N)[C@H]3CC[C@H](NCc4ncc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,>,100000.0,Inhibition of human ERG by cell-based patch clamp method
8207,CHEMBL3341839,COc1ccc2ncc(=O)n(CC(N)C3(F)CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG by cell-based patch clamp method
8208,CHEMBL3355578,COc1cnc2ccc(=O)n(C[C@@H](N)[C@H]3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,>,100000.0,Inhibition of human ERG by cell-based patch clamp method
8209,CHEMBL3355577,CNC(Cn1c(=O)cnc2cc(F)c(OC)cc21)[C@H]1CC[C@H](NCc2ncc3c(n2)NC(=O)CO3)CC1,IC50,,,,Inhibition of human ERG by cell-based patch clamp method
8210,CHEMBL3341840,COc1ccc2ncc(=O)n(CC[C@]3(N)CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,,,,Inhibition of human ERG by cell-based patch clamp method
8211,CHEMBL2165063,COc1ccc2ncc(=O)n(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,=,35000.0,Inhibition of human ERG by cell-based patch clamp method
8212,CHEMBL3352849,COc1ccc2ncc(=O)n(C[C@H](N)[C@H]3CC[C@H](NCc4ncc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,>,333000.0,Inhibition of human ERG by cell-based patch clamp method
8213,CHEMBL3355571,COc1ccc2ncc(=O)n(C[C@H](N)[C@H]3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,>,333000.0,Inhibition of human ERG by cell-based patch clamp method
8214,CHEMBL3355572,N[C@@H](Cn1c(=O)cnc2ccc(F)cc21)[C@H]1CC[C@H](NCc2ccc3c(n2)NC(=O)CO3)CC1,IC50,nM,=,174000.0,Inhibition of human ERG by cell-based patch clamp method
8215,CHEMBL3355573,N[C@@H](Cn1c(=O)cnc2ccc(F)cc21)[C@H]1CC[C@H](NCc2ncc3c(n2)NC(=O)CO3)CC1,IC50,nM,>,333000.0,Inhibition of human ERG by cell-based patch clamp method
8216,CHEMBL3355574,COc1cc2c(cc1F)ncc(=O)n2C[C@H](N)[C@H]1CC[C@H](NCc2ncc3c(n2)NC(=O)CO3)CC1,IC50,nM,>,333000.0,Inhibition of human ERG by cell-based patch clamp method
8217,CHEMBL3355575,COc1cnc2ccc(=O)n(C[C@H](N)[C@H]3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,>,333000.0,Inhibition of human ERG by cell-based patch clamp method
8218,CHEMBL3355576,N[C@@H](Cn1c(=O)ccc2ncc(F)cc21)[C@H]1CC[C@H](NCc2ccc3c(n2)NC(=O)CO3)CC1,IC50,nM,>,100000.0,Inhibition of human ERG by cell-based patch clamp method
8219,CHEMBL2426288,COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,4200.0,Inhibition of human ERG
8220,CHEMBL3353410,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,16200.0,Inhibition of human ERG
8221,CHEMBL2426279,C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,IC50,nM,=,9100.0,Inhibition of human ERG
8222,CHEMBL2426277,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,IC50,nM,=,7100.0,Inhibition of human ERG
8223,CHEMBL3353403,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CC[C@@H](N(C)C)C1,IC50,nM,=,5600.0,Inhibition of human ERG
8224,CHEMBL3353404,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,6700.0,Inhibition of human ERG
8225,CHEMBL3353405,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CC(N(C)C)C1,IC50,nM,=,4000.0,Inhibition of human ERG
8226,CHEMBL3353406,C=CC(=O)Nc1cc(Nc2ncc(C#N)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,4300.0,Inhibition of human ERG
8227,CHEMBL3353407,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,7400.0,Inhibition of human ERG
8228,CHEMBL3353408,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,14800.0,Inhibition of human ERG
8229,CHEMBL3358004,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(CS(C)(=N)=O)cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8230,CHEMBL3358003,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(C[S+](C)[O-])cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8231,CHEMBL3358002,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(OS(C)(=O)=O)cc2F)cn1,IC50,nM,=,17000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8232,CHEMBL3358001,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(CS(C)(=O)=O)cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8233,CHEMBL3358000,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(-n3cnnn3)cc2F)cn1,IC50,nM,=,5700.0,Inhibition of human ERG by patch clamp based electrophysiology method
8234,CHEMBL3357999,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(C#N)cc2F)cn1,IC50,nM,=,11000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8235,CHEMBL3357998,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(CS(C)(=O)=O)cc2)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8236,CHEMBL3357997,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(S(C)(=O)=O)cc2)cn1,IC50,nM,=,9400.0,Inhibition of human ERG by patch clamp based electrophysiology method
8237,CHEMBL3357996,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(C#N)cc2C#N)cn1,IC50,nM,=,3600.0,Inhibition of human ERG by patch clamp based electrophysiology method
8238,CHEMBL3357995,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(S(C)(=O)=O)cc2C#N)cn1,IC50,nM,=,6400.0,Inhibition of human ERG by patch clamp based electrophysiology method
8239,CHEMBL3357994,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccc(S(C)(=O)=O)cc2F)cn1,IC50,nM,=,6900.0,Inhibition of human ERG by patch clamp based electrophysiology method
8240,CHEMBL3218816,C[C@@H]1CN(c2nnc(C(F)(F)F)o2)CCN1c1ncc(OCc2ccncc2C#N)cn1,IC50,nM,=,18000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8241,CHEMBL3358005,C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccc(S(C)(=O)=O)cc2F)cn1,IC50,nM,=,3600.0,Inhibition of human ERG by patch clamp based electrophysiology method
8242,CHEMBL3358006,C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccc(CS(C)(=O)=O)cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8243,CHEMBL3358007,C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccc(C[S+](C)[O-])cc2F)cn1,IC50,nM,=,28000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8244,CHEMBL3358008,C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccc(CS(C)(=N)=O)cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8245,CHEMBL3358009,C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccc(N=S(C)(C)=O)cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8246,CHEMBL3358010,C[C@@H]1CN(C(=O)OC2(C(F)(F)F)COC2)CCN1c1ncc(OCc2ccc(CS(C)(=O)=O)cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8247,CHEMBL3358011,C[C@@H]1CN(C(=O)OC2(C(F)(F)F)COC2)CCN1c1ncc(OCc2ccc(OS(C)(=O)=O)cc2F)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8248,CHEMBL3358012,C[C@@H]1CN(C(=O)OC2(C(F)(F)F)COC2)CCN1c1ncc(OCc2ccc(S(C)(=O)=O)cc2F)cn1,IC50,nM,=,11000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8249,CHEMBL3358013,CC(C)c1noc(N2CCN(c3ncc(OCc4ccc(CS(C)(=O)=O)cc4F)cn3)[C@H](C)C2)n1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp based electrophysiology method
8250,CHEMBL3358014,CC(C)c1noc(N2CCN(c3ncc(OCc4ccc(S(C)(=O)=O)cc4F)cn3)[C@H](C)C2)n1,IC50,nM,=,7400.0,Inhibition of human ERG by patch clamp based electrophysiology method
8251,CHEMBL3353409,C=CC(=O)Nc1cc(Nc2ncc(C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,15600.0,Inhibition of human ERG
8252,CHEMBL3353411,C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,17500.0,Inhibition of human ERG
8253,CHEMBL3353412,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCNC,IC50,nM,>,33000.0,Inhibition of human ERG
8254,CHEMBL3330442,O=C(NC[C@@H]1OC(=O)N2c3ccc(N4CCOCC4=O)cc3OC[C@@H]12)c1ccc(Cl)s1,IC50,nM,=,79750.0,Inhibition of human ERG by patch clamp assay
8255,CHEMBL3358509,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ncccc2c1,IC50,nM,=,10000.0,Inhibition of human ERG by whole cell based electrophysiology assay
8256,CHEMBL3330811,COc1ccc(-n2cnc3c(-c4ccccc4)csc3c2=O)cc1,IC50,nM,=,10800.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch-clamp assay
8257,CHEMBL3330817,COc1ccc(-n2cnc3c(-c4ccccc4F)csc3c2=O)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch-clamp assay
8258,CHEMBL3330823,COc1ccc(-n2cnc3c(-c4ccccc4C)csc3c2=O)cc1,IC50,nM,=,9870.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch-clamp assay
8259,CHEMBL1783876,C#CCNc1ccnc2sc3c(=O)n(-c4ccc(OC)cc4)cnc3c12,IC50,nM,=,31000.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch-clamp assay
8260,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,130.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by scintillation counting method
8261,CHEMBL3343216,OC(c1ccccc1)(c1ccccc1)C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1,IC50,nM,=,210.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by scintillation counting method
8262,CHEMBL3344385,OC(c1ccccc1)(c1ccccc1)C1CCN(CCCOc2ccc(-c3ccccc3)cc2)CC1,IC50,nM,=,140.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by scintillation counting method
8263,CHEMBL3330060,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells after 20 mins by patch clamp assay
8264,CHEMBL3330073,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells after 20 mins by patch clamp assay
8265,CHEMBL3330060,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,IC50,nM,=,97700.0,Inhibition of human ERG expressed in CHO cells after 20 mins by thallium assay
8266,CHEMBL3330073,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,IC50,nM,=,55300.0,Inhibition of human ERG expressed in CHO cells after 20 mins by thallium assay
8267,CHEMBL3329814,O=C(OCC1CCN(CC(O)CO)CC1)c1c2n(c3ccccc13)CCCO2,IC50,nM,=,81000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by patch clamp method
8268,CHEMBL3329813,CC(C(=O)O)c1ccc(CN2CCC(COC(=O)c3c4n(c5ccccc35)CCCO4)CC2)cc1,IC50,nM,=,25000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by patch clamp method
8269,CHEMBL3329812,O=C(OCC1CCN(CC2CCCC(C(=O)O)C2)CC1)c1c2n(c3ccccc13)CCCO2,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by patch clamp method
8270,CHEMBL3329811,O=C(OCC1CCN(CC2CCC(C(=O)O)C2)CC1)c1c2n(c3ccccc13)CCCO2,IC50,nM,=,209000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by patch clamp method
8271,CHEMBL3329226,O=C(OCC1CCN(CC2C3CC4C2C4C3C(=O)O)CC1)c1c2n(c3ccccc13)CCCO2,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by patch clamp method
8272,CHEMBL3331484,Clc1ccc(CN(C2CC2)C2CNC2)cc1Cl,IC50,nM,=,4710.0,Inhibition of human ERG expressed in CHO-K1 cells by automated whole-cell patch-clamp electrophysiology method
8273,CHEMBL3331502,Clc1cccc(CN(CC2CNC2)c2ccccc2)c1Cl.O=C(O)C(F)(F)F,IC50,nM,=,1880.0,Inhibition of human ERG expressed in CHO-K1 cells by automated whole-cell patch-clamp electrophysiology method
8274,CHEMBL3331503,CC(C)N(Cc1ccc(Cl)c(Cl)c1)CC1CNC1.Cl,IC50,nM,=,5500.0,Inhibition of human ERG expressed in CHO-K1 cells by automated whole-cell patch-clamp electrophysiology method
8275,CHEMBL3338194,CS(=O)(=O)c1ccc(-n2cc(Cl)c(OC3CCN(c4ncc(Cl)cn4)CC3)cc2=O)c(F)c1,IC50,nM,=,1400.0,Inhibition of human ERG by patch clamp assay
8276,CHEMBL3338895,O=C1NC(=O)/C(=C\c2ccccc2OCc2nnc(-c3ccccc3)o2)S1,IC50,nM,=,41000.0,Inhibition of human ERG
8277,CHEMBL3355597,O=C1NC(=O)/C(=C\c2ccccc2OCc2nnc(OCc3c(Cl)cccc3Cl)o2)S1,IC50,nM,=,29000.0,Inhibition of human ERG
8278,CHEMBL3355626,CS(=O)(=O)c1ccc(-c2cnc3ccc(-c4cccc(S(=O)(=O)CCCN)c4)nn23)cc1,IC50,nM,>,33000.0,Inhibition of human ERG channel by patch clamp technique
8279,CHEMBL3355629,C[S+]([O-])c1ccc(-c2cnc3ccc(-c4cccc(S(C)(=O)=O)c4)nn23)cc1,IC50,nM,=,4000.0,Inhibition of human ERG channel by patch clamp technique
8280,CHEMBL3355633,C[S+]([O-])c1ccc(-c2cnc3ccc(-c4cccc([S+](C)[O-])c4)nn23)cc1,IC50,nM,=,12000.0,Inhibition of human ERG channel by patch clamp technique
8281,CHEMBL3355636,O=S(=O)(c1cccc(-c2ccc3ncc(-c4ccc(-c5nnn[nH]5)cc4)n3n2)c1)C1CC1,IC50,nM,>,33000.0,Inhibition of human ERG channel by patch clamp technique
8282,CHEMBL3355638,C[S+]([O-])c1ccc(-c2cnc3ccc(-c4cccc(S(=O)(=O)C5CC5)c4)nn23)cc1,IC50,nM,=,400.0,Inhibition of human ERG channel by patch clamp technique
8283,CHEMBL3355639,CS(=O)(=O)c1ccc(-c2cnc3ccc(-c4cccc(S(=O)(=O)C5CC5)c4)nn23)cc1,IC50,nM,=,400.0,Inhibition of human ERG channel by patch clamp technique
8284,CHEMBL3355624,C[S+]([O-])c1cccc(-c2ccc3ncc(-c4ccc(S(C)(=O)=O)cc4)n3n2)c1,IC50,nM,=,4000.0,Inhibition of human ERG channel by patch clamp technique
8285,CHEMBL3355630,CS(=O)(=O)c1cccc(-c2ccc3ncc(-c4ccc(C(=O)N5CCC(O)C5)cc4)n3n2)c1,IC50,nM,>,33000.0,Inhibition of human ERG channel by patch clamp technique
8286,CHEMBL3301607,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,IC50,nM,>,100000.0,Inhibition of human ERG channel by patch clamp assay
8287,CHEMBL1230468,Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1Cl,IC50,nM,=,28000.0,Inhibition of human ERG
8288,CHEMBL3358114,Cc1nn(C)c(C)c1N(C(F)F)S(=O)(=O)c1c(Cl)cc(CCCC2CCN(C)CC2)cc1Cl,IC50,nM,=,600.0,Inhibition of human ERG
8289,CHEMBL3330650,O=C(NOCCO)c1ccc2cncn2c1Nc1ccc(I)cc1F,IC50,nM,=,4400.0,Inhibition of human ERG by patch clamp assay
8290,CHEMBL3330652,O=C(NOCCO)c1ccn2cncc2c1Nc1ccc(I)cc1F,IC50,nM,=,2100.0,Inhibition of human ERG by patch clamp assay
8291,CHEMBL3330653,O=C(NOCCO)c1ncc2cncn2c1Nc1ccc(I)cc1F,IC50,nM,=,3300.0,Inhibition of human ERG by patch clamp assay
8292,CHEMBL3330654,C[C@H](O)CONC(=O)c1ncc2cncn2c1Nc1ccc(I)cc1F,IC50,nM,=,3300.0,Inhibition of human ERG by patch clamp assay
8293,CHEMBL3330655,C[C@H](CO)CONC(=O)c1ncc2cncn2c1Nc1ccc(I)cc1F,IC50,nM,=,14000.0,Inhibition of human ERG by patch clamp assay
8294,CHEMBL3359220,Cc1nc(-c2ccccc2)nc(OCCCN2CCCCC2)c1Cl,IC50,nM,=,280.0,Inhibition of ERG channel in HEK293 cells by whole cell patch clamp technique
8295,CHEMBL3359230,Cc1nc(-c2ccccc2)nc(OCCCN2CCCC2)c1Cl,IC50,nM,=,3760.0,Inhibition of ERG channel in HEK293 cells by whole cell patch clamp technique
8296,CHEMBL3359234,Cc1ccc(-c2nc(C)c(Cl)c(OCCCN3CCCCC3)n2)cc1,IC50,nM,=,950.0,Inhibition of ERG channel in HEK293 cells by whole cell patch clamp technique
8297,CHEMBL3359236,Cc1nc(-c2ccc(C(F)(F)F)cc2)nc(OCCCN2CCCCC2)c1Cl,IC50,nM,=,2610.0,Inhibition of ERG channel in HEK293 cells by whole cell patch clamp technique
8298,CHEMBL3359237,Cc1nc(-c2ccc(F)cc2)nc(OCCCN2CCCCC2)c1Cl,IC50,nM,=,1540.0,Inhibition of ERG channel in HEK293 cells by whole cell patch clamp technique
8299,CHEMBL3359238,Cc1nc(-c2ccc(F)c(F)c2)nc(OCCCN2CCCCC2)c1Cl,IC50,nM,=,1400.0,Inhibition of ERG channel in HEK293 cells by whole cell patch clamp technique
8300,CHEMBL3359239,Cc1nc(-c2ccc(Cl)cc2)nc(OCCCN2CCCCC2)c1Cl,IC50,nM,=,6980.0,Inhibition of ERG channel in HEK293 cells by whole cell patch clamp technique
8301,CHEMBL3359265,Cc1nc2ccc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2[nH]1,IC50,nM,=,141000.0,Inhibition of human ERG channel by patch-clamp assay
8302,CHEMBL3359264,CC(C)n1ncc2c1C(=O)CC1(CCN(C(=O)c3cnc4cc[nH]c4c3)CC1)C2,IC50,nM,=,29000.0,Inhibition of human ERG channel by patch-clamp assay
8303,CHEMBL3359263,CCn1ncc2c1C(=O)CC1(CCN(C(=O)c3ccc4[nH]ncc4c3)CC1)C2,IC50,,,,Inhibition of human ERG channel by patch-clamp assay
8304,CHEMBL3359262,CC(C)n1ncc2c1C(=O)CC1(CCN(C(=O)c3ccc4[nH]ncc4c3)CC1)C2,IC50,nM,=,23000.0,Inhibition of human ERG channel by patch-clamp assay
8305,CHEMBL3359261,CC(C)(C)n1ncc2c1C(=O)CC1(CCN(C(=O)c3ccc4[nH]ncc4c3)CC1)C2,IC50,nM,=,21000.0,Inhibition of human ERG channel by patch-clamp assay
8306,CHEMBL3359260,CC(C)(C)n1cc2c(n1)C(=O)C(C)(C)C1(CCN(C(=O)c3ccc4[nH]ncc4c3)CC1)O2,IC50,,,,Inhibition of human ERG channel by patch-clamp assay
8307,CHEMBL3359259,CC1C(=O)c2nn(C(C)(C)C)cc2OC12CCN(C(=O)c1ccc3[nH]ncc3c1)CC2,IC50,,,,Inhibition of human ERG channel by patch-clamp assay
8308,CHEMBL3359259,CC1C(=O)c2nn(C(C)(C)C)cc2OC12CCN(C(=O)c1ccc3[nH]ncc3c1)CC2,IC50,,,,Inhibition of human ERG channel by patch-clamp assay
8309,CHEMBL2419601,CC(C)(C)n1cc2c(n1)C(=O)CC1(CCN(C(=O)c3ccc4[nH]ncc4c3)CC1)O2,IC50,nM,=,34000.0,Inhibition of human ERG channel by patch-clamp assay
8310,CHEMBL2144409,Cc1ccc(-c2ncn(-c3ccc(Nc4nccc(-c5cccc(N6CCOCC6)c5)n4)cc3)n2)cn1,IC50,nM,>,30000.0,Inhibition of human ERG
8311,CHEMBL3393706,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,nM,=,3700.0,Inhibition of human ERG
8312,CHEMBL3393710,Fc1cccnc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,nM,=,3000.0,Inhibition of human ERG
8313,CHEMBL3393716,Nc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,,,,Inhibition of human ERG
8314,CHEMBL3393717,Oc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,nM,=,800.0,Inhibition of human ERG
8315,CHEMBL3393718,NC(=O)c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,nM,=,1100.0,Inhibition of human ERG
8316,CHEMBL3393719,CS(=O)(=O)c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,nM,=,2000.0,Inhibition of human ERG
8317,CHEMBL3393720,CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,nM,=,2300.0,Inhibition of human ERG
8318,CHEMBL3393730,COC(=O)N[C@H](C(=O)N1C[C@@H](C)C[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cc5[nH]c([C@@H]6C[C@H](C)CN6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5s4)s3)cc2)[nH]1)C(C)C,IC50,nM,=,25100.0,Inhibition of human ERG by Q-patch assay
8319,CHEMBL3120454,COC(=O)N[C@H](C(=O)N1C[C@@H](C)C[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cc5[nH]c([C@@H]6C[C@H](C)CN6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5s4)cc3)cc2)[nH]1)C(C)C,IC50,nM,>,40000.0,Inhibition of human ERG by Q-patch assay
8320,CHEMBL3394201,COc1ccc(CC(=O)N2CCC3(CC2)CN([C@@H]2CCc4cc(-c5cc(C)ncn5)ccc42)C3)c(C(N)=O)c1,IC50,nM,=,47000.0,Inhibition of human ERG by patch clamp assay
8321,CHEMBL2426677,COc1ccc(CC(=O)N2CCC3(CC2)CN([C@@H]2CCc4cc(-c5ncccn5)ccc42)C3)cc1,IC50,nM,=,2900.0,Inhibition of human ERG by patch clamp assay
8322,CHEMBL3394868,COC(=O)N[C@H](C(=O)N1C[C@@H](C)C[C@H]1c1nc(-c2ccc(-c3ccc(-c4ccc5[nH]c([C@@H]6C[C@H](C)CN6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)cc3)cc2)c[nH]1)C(C)C,IC50,nM,>,30000.0,Inhibition of human ERG channel by planar technique
8323,CHEMBL3394868,COC(=O)N[C@H](C(=O)N1C[C@@H](C)C[C@H]1c1nc(-c2ccc(-c3ccc(-c4ccc5[nH]c([C@@H]6C[C@H](C)CN6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)cc3)cc2)c[nH]1)C(C)C,IC50,nM,>,30000.0,Inhibition of human ERG channel by QPatch technique
8324,CHEMBL3398175,COc1cc([C@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1,IC50,nM,=,6800.0,Inhibition of human ERG by patch clamp cellular assay
8325,CHEMBL3398171,COc1cc([C@@]2(O)CCN(CC(N)=O)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp cellular assay
8326,CHEMBL3398166,COc1cc([C@@]2(O)CCN(C)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1,IC50,,,,Inhibition of human ERG by patch clamp cellular assay
8327,CHEMBL3398269,Cc1c(-c2ccc(F)cc2F)noc1-c1ccc2c(c1)CN(C(C)C)C2=O,IC50,nM,=,1060.0,Inhibition of human ERG
8328,CHEMBL3398278,CC(C)N1Cc2cc(-c3cc(-c4ccc(Cl)nc4)no3)ccc2C1=O,IC50,nM,=,40000.0,Inhibition of human ERG
8329,CHEMBL3398280,COc1ccc(-c2cc(-c3ccc4c(c3)CN(C(C)C)C4=O)on2)cn1,IC50,nM,=,12000.0,Inhibition of human ERG
8330,CHEMBL3401350,CC(C)[C@]1(C)CC(=O)N(Cc2cc(F)cc(C(=O)N[C@@H](C)c3ccccc3)c2)C(=N)N1,IC50,nM,=,9000.0,Inhibition of human ERG by voltage clamp method
8331,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,ug.mL-1,=,0.2,Inhibition of human ERG channel
8332,CHEMBL3401424,Cl.c1ccc(C2CC3(N4CCCC4)CNCC2C(c2ccccc2)C3)cc1,IC50,nM,=,2630.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in tail current at membrane potential of +20 mV
8333,CHEMBL76,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,IC50,nM,=,2500.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in tail current at membrane potential of +20 mV
8334,CHEMBL172,O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1,IC50,nM,=,2600.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in tail current at membrane potential of +20 mV
8335,CHEMBL3403995,COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC,IC50,nM,=,13000.0,Inhibition of human ERG by dofetilide binding assay
8336,CHEMBL3305167,COc1ccc2ncc(F)c(C[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,26000.0,Inhibition of human ERG by MK499 binding assay
8337,CHEMBL3400817,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8338,CHEMBL3400818,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8339,CHEMBL3400819,O=C1COc2ccc(CNC34CCC(CC5Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,15200.0,Inhibition of human ERG by MK499 binding assay
8340,CHEMBL3400819,O=C1COc2ccc(CNC34CCC(CC5Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,12300.0,Inhibition of human ERG by MK499 binding assay
8341,CHEMBL3400819,O=C1COc2ccc(CNC34CCC(CC5Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,23000.0,Inhibition of human ERG by MK499 binding assay
8342,CHEMBL3400820,O=C1COc2ccc(CNC34CCC(CC5(F)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,13800.0,Inhibition of human ERG by MK499 binding assay
8343,CHEMBL3400821,CO[C@@]1(CC23CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC2)CO3)Cn2c(=O)ccc3ncc(F)c1c32,IC50,nM,=,7300.0,Inhibition of human ERG by MK499 binding assay
8344,CHEMBL3400822,CO[C@]1(CC23CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC2)CO3)Cn2c(=O)ccc3ncc(F)c1c32,IC50,nM,=,24500.0,Inhibition of human ERG by MK499 binding assay
8345,CHEMBL3400823,O=C1COc2ccc(CNC34CCC(C[C@]5(O)CN6C(=O)CCc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8346,CHEMBL3400824,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)CN6C(=O)CCc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8347,CHEMBL3402178,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)c(F)cc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8348,CHEMBL3402179,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)Cn6c(=O)c(F)cc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8349,CHEMBL3402180,O=C1COc2ccc(CNC34CCC(CC5(O)Cn6c(=O)c(Cl)cc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8350,CHEMBL3402181,Cc1cc(=O)n2c3c(c(F)cnc13)[C@](O)(CC13CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO3)C2,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8351,CHEMBL3402182,Cc1cc(=O)n2c3c(c(F)cnc13)[C@@](O)(CC13CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO3)C2,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8352,CHEMBL3402183,O=C1COc2ccc(CNC34CCC(CC5(O)Cn6c(=O)cc(Cl)c7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8353,CHEMBL3402184,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7nc(Cl)c(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8354,CHEMBL3402185,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(Cl)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,53300.0,Inhibition of human ERG by MK499 binding assay
8355,CHEMBL3402186,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)Cn6c(=O)ccc7ncc(Cl)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8356,CHEMBL3402187,COc1cnc2ccc(=O)n3c2c1[C@](O)(CC12CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO2)C3,IC50,nM,>,60000.0,Inhibition of human ERG by MK499 binding assay
8357,CHEMBL3402188,COc1cnc2ccc(=O)n3c2c1[C@@](O)(CC12CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO2)C3,IC50,,,,Inhibition of human ERG by MK499 binding assay
8358,CHEMBL3305167,COc1ccc2ncc(F)c(C[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,18000.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8359,CHEMBL3400817,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,174000.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8360,CHEMBL3400818,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,394000.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8361,CHEMBL3400819,O=C1COc2ccc(CNC34CCC(CC5Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,15800.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8362,CHEMBL3400819,O=C1COc2ccc(CNC34CCC(CC5Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,21600.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8363,CHEMBL3400819,O=C1COc2ccc(CNC34CCC(CC5Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,30000.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8364,CHEMBL3400820,O=C1COc2ccc(CNC34CCC(CC5(F)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8365,CHEMBL3400821,CO[C@@]1(CC23CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC2)CO3)Cn2c(=O)ccc3ncc(F)c1c32,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8366,CHEMBL3400822,CO[C@]1(CC23CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC2)CO3)Cn2c(=O)ccc3ncc(F)c1c32,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8367,CHEMBL3400823,O=C1COc2ccc(CNC34CCC(C[C@]5(O)CN6C(=O)CCc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8368,CHEMBL3400824,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)CN6C(=O)CCc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8369,CHEMBL3402178,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)c(F)cc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8370,CHEMBL3402179,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)Cn6c(=O)c(F)cc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8371,CHEMBL3402180,O=C1COc2ccc(CNC34CCC(CC5(O)Cn6c(=O)c(Cl)cc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8372,CHEMBL3402181,Cc1cc(=O)n2c3c(c(F)cnc13)[C@](O)(CC13CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO3)C2,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8373,CHEMBL3402182,Cc1cc(=O)n2c3c(c(F)cnc13)[C@@](O)(CC13CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO3)C2,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8374,CHEMBL3402183,O=C1COc2ccc(CNC34CCC(CC5(O)Cn6c(=O)cc(Cl)c7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8375,CHEMBL3402184,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7nc(Cl)c(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8376,CHEMBL3402185,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(Cl)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8377,CHEMBL3402186,O=C1COc2ccc(CNC34CCC(C[C@@]5(O)Cn6c(=O)ccc7ncc(Cl)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8378,CHEMBL3402187,COc1cnc2ccc(=O)n3c2c1[C@](O)(CC12CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO2)C3,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8379,CHEMBL3402188,COc1cnc2ccc(=O)n3c2c1[C@@](O)(CC12CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC1)CO2)C3,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8380,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,89.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel current at holding potential of 0 mV by electrophysiological method
8381,CHEMBL3409256,NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,IC50,nM,=,6200.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel current at holding potential of 0 mV by electrophysiological method
8382,CHEMBL2064645,CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC)nc(C#Cc4ccc(F)c(F)c4)nc31)[C@H](O)[C@@H]2O,IC50,nM,=,27000.0,Inhibition of human ERG by PDSP screening
8383,CHEMBL3407783,CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC)nc(C#Cc4cccs4)nc31)[C@H](O)[C@@H]2O,IC50,nM,=,11500.0,Inhibition of human ERG by PDSP screening
8384,CHEMBL3408381,N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1,IC50,nM,=,48400.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8385,CHEMBL3408382,N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1,IC50,nM,=,7600.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8386,CHEMBL3408383,CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1,IC50,nM,=,32600.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8387,CHEMBL3408384,CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1,IC50,nM,=,28700.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8388,CHEMBL3408385,COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1,IC50,nM,=,17600.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8389,CHEMBL3408386,CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1,IC50,nM,=,11500.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8390,CHEMBL3408387,CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1,IC50,nM,=,10400.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8391,CHEMBL3408388,CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1,IC50,nM,=,9300.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8392,CHEMBL3408389,CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1,IC50,nM,=,8400.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8393,CHEMBL3408390,N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1,IC50,nM,=,8400.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8394,CHEMBL3408391,N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1,IC50,nM,=,45500.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8395,CHEMBL3408392,N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1,IC50,nM,=,6800.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8396,CHEMBL3408393,N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1,IC50,nM,=,2500.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8397,CHEMBL3408394,CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1,IC50,nM,=,5700.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8398,CHEMBL3408395,CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1,IC50,nM,=,4600.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8399,CHEMBL3408396,N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1,IC50,nM,=,3400.0,Inhibition of human ERG assessed as reduction in channel current expressed in HEK cells by patch clamp assay
8400,CHEMBL3407784,CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc31)[C@H](O)[C@@H]2O,IC50,nM,=,12900.0,Inhibition of human ERG by PDSP screening
8401,CHEMBL2064657,CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(Cl)c4)nc(C#Cc4ccc(F)c(F)c4)nc31)[C@H](O)[C@@H]2O,IC50,nM,=,12200.0,Inhibition of human ERG by PDSP screening
8402,CHEMBL3410207,C(#Cc1ncn2c1COc1ccccc1-2)c1ccccc1,IC50,nM,>,1000.0,Inhibition of human ERG channel
8403,CHEMBL1946770,Cc1cc(C#Cc2cn(-c3ccc(F)cc3)c(C)n2)ccn1,IC50,nM,>,10000.0,Inhibition of human ERG channel
8404,CHEMBL3301626,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1,IC50,nM,=,7100.0,Inhibition of human ERG channel
8405,CHEMBL3410223,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1,IC50,nM,=,1000.0,Inhibition of human ERG channel
8406,CHEMBL3410224,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1F,IC50,nM,>,1000.0,Inhibition of human ERG channel
8407,CHEMBL3408617,CCOc1nc(NC(=O)C2(NC(=O)c3ccc4c(C5CCCC5)c(-c5ccc(F)cn5)n(C)c4c3)CCC2)ccc1/C=C/C(=O)O,IC50,nM,=,2100.0,Inhibition of human ERG channel
8408,CHEMBL3408622,CCOc1nc(NC(=O)C2(NC(=O)c3ccc4c(c3)c(C)c(-c3ccc(F)cn3)n4C3CCCCC3)CCC2)ccc1/C=C/C(=O)O,IC50,nM,=,1400.0,Inhibition of human ERG channel
8409,CHEMBL3408274,C[C@H](c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1,IC50,nM,=,19000.0,Inhibition of human ERG channel
8410,CHEMBL3409588,O=c1cc(-c2ccnc(NC3CCOCC3)n2)ccn1[C@H](CO)c1ccc(Cl)c(F)c1,IC50,nM,=,14500.0,Inhibition of human ERG
8411,CHEMBL1673059,NC(=O)C1CCN(c2c(Cl)cncc2Cl)CC1,IC50,nM,>,10000.0,Inhibition of human ERG
8412,CHEMBL3408214,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc3cnccc3c1)CC2,IC50,nM,>,10000.0,Inhibition of human ERG
8413,CHEMBL2170062,Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8414,CHEMBL2170054,Clc1ccc(-n2ccc(NCCN3CCCCC3)n2)cc1Cl,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8415,CHEMBL2170053,Clc1ccc(-n2ccc(NCCN3CCOCC3)n2)cc1Cl,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8416,CHEMBL3417042,Clc1ccc(-n2cc(NCCN3CCCCC3)nn2)cc1Cl,IC50,nM,=,1700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8417,CHEMBL3417043,Clc1ccc(-n2cc(NCCN3CCCCC3)nn2)c(Cl)c1,IC50,nM,=,4900.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8418,CHEMBL3417044,Clc1ccc(-n2cc(NCCN3CCCCC3)nn2)cc1,IC50,nM,=,3100.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8419,CHEMBL3417045,Fc1cccc(-n2cc(NCCN3CCCCC3)nn2)c1,IC50,nM,=,5200.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8420,CHEMBL3417046,Fc1ccc(-n2cc(NCCN3CCCCC3)nn2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8421,CHEMBL3417047,Fc1ccc(-n2cc(NCCN3CCCCC3)nn2)cc1F,IC50,nM,=,2200.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8422,CHEMBL3417048,Fc1ccc(-n2cc(NCCN3CCCCC3)nn2)c(F)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8423,CHEMBL3417049,Clc1ccc(-n2cc(NCCN3CCOCC3)nn2)cc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8424,CHEMBL3417050,Fc1cccc(-n2cc(NCCN3CCOCC3)nn2)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8425,CHEMBL3417051,Fc1ccc(-n2cc(NCCN3CCOCC3)nn2)cc1F,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8426,CHEMBL3417052,Fc1cccc(-n2cc(NCCN3CCCCCC3)nn2)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8427,CHEMBL3417053,Fc1cccc(-n2cc(NCCN3CCN(C4CCCCC4)CC3)nn2)c1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8428,CHEMBL3417054,Fc1cccc(-n2cc(NCCN3CCCOCC3)nn2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8429,CHEMBL3417055,Fc1ccc(-n2cc(NCCN3CCC(F)(F)CC3)nn2)cc1F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8430,CHEMBL3417056,CC(=O)N1CCN(CCNc2cn(-c3ccc(Cl)c(Cl)c3)nn2)CC1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8431,CHEMBL3417057,c1ccc(Cn2cc(NCCN3CCCCC3)nn2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8432,CHEMBL3417058,Clc1ccc(Cn2cc(NCCN3CCCCC3)nn2)cc1Cl,IC50,nM,=,2200.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8433,CHEMBL3417059,Fc1ccc(Cn2cc(NCCN3CCCCC3)nn2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8434,CHEMBL3417060,Fc1cccc(Cn2cc(NCCN3CCCCC3)nn2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8435,CHEMBL3417061,Fc1ccc(Cn2cc(NCCN3CCCCC3)nn2)cc1F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8436,CHEMBL3417062,c1ccc(Cn2cc(NCCN3CCOCC3)nn2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8437,CHEMBL3417063,Clc1ccc(Cn2cc(NCCN3CCOCC3)nn2)cc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8438,CHEMBL3417064,Fc1ccc(Cn2cc(NCCN3CCOCC3)nn2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8439,CHEMBL3417065,Fc1ccc(Cn2cc(NCCN3CCOCC3)nn2)cc1F,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8440,CHEMBL3417066,Clc1ccc(Cn2cc(NCCN3CCCCCC3)nn2)cc1Cl,IC50,nM,=,3900.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8441,CHEMBL3417067,c1ccc(Cn2cc(NCCN3CCCCCC3)nn2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8442,CHEMBL3417068,Clc1ccc(Cn2cc(NCCN3CCCOCC3)nn2)cc1Cl,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8443,CHEMBL3417069,Fc1ccc(Cn2cc(NCCN3CCC(F)(F)CC3)nn2)cc1F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8444,CHEMBL3417070,Fc1ccc(Cn2cc(NCCN3CCC(F)(F)CC3)nn2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8445,CHEMBL3417071,C[C@H]1CCC[C@@H](C)N1CCNc1cn(Cc2ccc(F)cc2)nn1,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8446,CHEMBL3417072,CCN(CC)CCNc1cn(Cc2ccccc2)nn1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8447,CHEMBL3417073,CN1CCN(CCNc2cn(Cc3ccccc3)nn2)CC1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8448,CHEMBL3417074,CC(=O)N1CCN(CCNc2cn(Cc3ccc(Cl)c(Cl)c3)nn2)CC1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8449,CHEMBL3417075,Clc1ccc(Cn2cc(NCCCN3CCOCC3)nn2)cc1Cl,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8450,CHEMBL3417076,Clc1ccc(-n2cc(NCCCN3CCOCC3)nn2)cc1Cl,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8451,CHEMBL3417077,c1c(NCCN2CCOCC2)nnn1C1CCCCC1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8452,CHEMBL3417078,c1c(NCCN2CCOCC2)nnn1C12CC3CC(CC(C3)C1)C2,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8453,CHEMBL3417079,CCN(CCN1CCOCC1)c1cn(-c2ccc(Cl)c(Cl)c2)nn1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8454,CHEMBL3417080,CCCN(CCN1CCOCC1)c1cn(-c2ccc(Cl)c(Cl)c2)nn1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8455,CHEMBL3417081,CCN(CCN1CCOCC1)c1cn(C23CC4CC(CC(C4)C2)C3)nn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8456,CHEMBL3417082,CC(=O)N(CCN1CCOCC1)c1cn(-c2ccc(Cl)c(Cl)c2)nn1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8457,CHEMBL3417083,CC(=O)N(CCN1CCOCC1)c1cn(Cc2ccc(Cl)c(Cl)c2)nn1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8458,CHEMBL3417084,CS(=O)(=O)N(CCN1CCOCC1)c1cn(-c2ccc(Cl)c(Cl)c2)nn1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8459,CHEMBL3417085,CCCNC(=S)N(CCN1CCOCC1)c1cn(-c2ccc(Cl)c(Cl)c2)nn1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole cell patch clamp assay
8460,CHEMBL3415610,COc1cccc2[nH]c(-c3nc(N[C@@H]4CCOC[C@@H]4N)cnc3C(N)=O)cc12,IC50,nM,=,22000.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8461,CHEMBL3415599,COc1cc(C)nc(Nc2cc(N[C@@H]3CS(=O)(=O)CC[C@@H]3N)cnc2C(N)=O)c1,IC50,nM,>,30000.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8462,CHEMBL3415598,Cc1cc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)cnc2C(N)=O)nc(-n2nccn2)n1,IC50,nM,=,44000.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8463,CHEMBL3415597,Cc1nc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)cnc2C(N)=O)cc(OCC(C)(C)O)n1,IC50,nM,=,18000.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8464,CHEMBL3415596,Cc1cc(C(C)(C)O)cc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)cnc2C(N)=O)n1,IC50,nM,=,6500.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8465,CHEMBL3415595,Cc1cc(CC(C)(C)O)cc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)cnc2C(N)=O)n1,IC50,nM,=,5900.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8466,CHEMBL3415594,Cc1cc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)cnc2C(N)=O)nc(C)c1-c1cnn(C)c1,IC50,nM,=,1000.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8467,CHEMBL3415593,COc1cc(C)nc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)cnc2C(N)=O)c1,IC50,nM,=,1700.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8468,CHEMBL3415592,NC(=O)c1ncc(N[C@@H]2CCCC[C@@H]2N)cc1Nc1cccc(C(F)(F)F)n1,IC50,nM,=,600.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8469,CHEMBL3415591,Cc1cc(C)nc(Nc2cc(NC[C@@H](N)CCS(C)(=O)=O)cnc2C(N)=O)c1,IC50,nM,=,14000.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8470,CHEMBL3415589,Cc1cc(C)nc(Nc2cc(N[C@@H]3CS(=O)(=O)CC[C@@H]3N)cnc2C(N)=O)c1,IC50,nM,=,29000.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8471,CHEMBL3415588,COC[C@H](N)CNc1cnc(C(N)=O)c(Nc2cc(C)cc(C)n2)c1,IC50,nM,=,1600.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8472,CHEMBL3415587,Cc1cc(C)nc(Nc2cc(NCC3(N)CC3)cnc2C(N)=O)c1,IC50,nM,=,1700.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8473,CHEMBL3415585,Cc1cc(C)nc(Nc2cc(NC[C@@H](N)CC(F)F)cnc2C(N)=O)c1,IC50,nM,=,5200.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8474,CHEMBL3415583,Cc1cc(C)nc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)cnc2C(N)=O)c1,IC50,nM,=,1600.0,Inhibition of ERG channel expressed in human embryonic kidney cells assessed as tail current amplitude measured for 3 to 30 mins by PatchXpress electrophysiology assay
8475,CHEMBL3415586,Cc1cc(C)nc(Nc2cc(NC[C@@H](N)C(F)(F)F)cnc2C(N)=O)c1,IC50,nM,=,42000.0,Displacement of radio-labeled MK-499 from ERG channel in human embryonic kidney cells
8476,CHEMBL3415590,Cc1cc(C)nc(Nc2cc(NC[C@@H](N)CS(C)(=O)=O)cnc2C(N)=O)c1,IC50,nM,>,60000.0,Displacement of radio-labeled MK-499 from ERG channel in human embryonic kidney cells
8477,CHEMBL3417504,C[C@@H]1CCCN1CCCOc1ccc(C2=NNC(=O)C3CC23)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp technique
8478,CHEMBL3417505,C[C@H](COc1ccc(C2=NNC(=O)C3CC23)cc1)CN1CCC[C@H]1C,IC50,nM,=,8000.0,Inhibition of human ERG by patch clamp technique
8479,CHEMBL3416028,NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8480,CHEMBL3416027,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2[nH]ccc12,IC50,nM,=,3700.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8481,CHEMBL3416026,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,IC50,nM,=,25900.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8482,CHEMBL3416025,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,IC50,nM,=,3700.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8483,CHEMBL3416024,NC(=O)c1ncc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,IC50,nM,=,8100.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8484,CHEMBL3416023,NC(=O)c1ncc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8485,CHEMBL3416022,NC(=O)c1ccc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8486,CHEMBL3416021,NC(=O)c1ccc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,IC50,nM,=,8500.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8487,CHEMBL3262624,N[C@H]1COCC[C@H]1Nc1cc2cc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,IC50,nM,=,24900.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8488,CHEMBL3262356,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8489,CHEMBL3262355,N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc(-n3nccn3)c2)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8490,CHEMBL3265032,c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8491,CHEMBL2177736,NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,IC50,nM,=,8600.0,Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay
8492,CHEMBL2177736,NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1,IC50,nM,=,10000.0,Inhibition of human ERG by manual patch clamp assay
8493,CHEMBL3416026,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,IC50,nM,=,5000.0,Inhibition of human ERG by GLP study
8494,CHEMBL3416055,Cl.NC[C@H]1C[C@@H]1c1cc(Cl)ccc1OCCF,IC50,nM,=,2000.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp method
8495,CHEMBL3416051,C=C(F)COc1ccc(Cl)cc1[C@H]1C[C@@H]1CN.Cl,IC50,nM,=,3980.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp method
8496,CHEMBL3416047,C=CCOc1ccc(Cl)cc1[C@H]1C[C@@H]1CN.O=C(O)C(F)(F)F,IC50,nM,=,270.0,Inhibition of human ERG channel expressed in CHO cells by patch clamp method
8497,CHEMBL3417742,COc1ccc(Oc2ccc(S(=O)(=O)C3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,=,37000.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8498,CHEMBL3417745,O=C(NO)C1(S(=O)(=O)c2ccc(Oc3ccc(OC(F)(F)F)cc3)cc2)CCC2(CCNCC2)C1,IC50,nM,=,100000.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8499,CHEMBL3417746,O=C(NO)C1(S(=O)(=O)c2ccc(OCc3ccc(OC(F)(F)F)cc3)cc2)CCC2(CCNCC2)C1,IC50,nM,=,50300.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8500,CHEMBL3417751,CNC(=O)c1ccc(Oc2ccc(S(=O)(=O)C3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8501,CHEMBL3417752,O=C(c1ccc(Oc2ccc(S(=O)(=O)C3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1)N1CCCC1,IC50,nM,>,100000.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8502,CHEMBL3417761,CNC(=O)c1ccc(COc2ccc(S(=O)(=O)C3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8503,CHEMBL3417767,COc1ccc(C(=O)Oc2ccc(S(=O)(=O)C3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,=,63400.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8504,CHEMBL3417769,CNC(=O)c1ccc(Oc2ccc(S(=O)(=O)[C@@]3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8505,CHEMBL3417770,CNC(=O)c1ccc(Oc2ccc(S(=O)(=O)[C@]3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG channel after 2 hrs by fluorescence polarization assay
8506,CHEMBL3417769,CNC(=O)c1ccc(Oc2ccc(S(=O)(=O)[C@@]3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG channel by patch clamp technique
8507,CHEMBL3417770,CNC(=O)c1ccc(Oc2ccc(S(=O)(=O)[C@]3(C(=O)NO)CCC4(CCNCC4)C3)cc2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG channel by patch clamp technique
8508,CHEMBL3422007,Cc1cccc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,7300.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8509,CHEMBL3422008,Cc1cncc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,4700.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8510,CHEMBL3422009,C[C@@H]1c2nnc(-c3csc(-c4ccc(F)cc4F)n3)n2CCN1C(=O)c1ccc(-c2cccs2)cc1,IC50,nM,=,1400.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8511,CHEMBL3422010,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)cs1,IC50,nM,=,24000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8512,CHEMBL3422012,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)C3)cs1,IC50,nM,=,27000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8513,CHEMBL3422015,CC(C)c1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)co1,IC50,nM,=,7300.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8514,CHEMBL3422016,Cc1csc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,17000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8515,CHEMBL3422017,Cc1noc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,5100.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8516,CHEMBL3422018,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,8000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch-clamp assay
8517,CHEMBL3305005,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2100.0,Inhibition of MK499 binding to human ERG
8518,CHEMBL3422754,COc1ccc2ncc(Cl)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,320.0,Inhibition of MK499 binding to human ERG
8519,CHEMBL3422755,COc1ccc2nccc(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,560.0,Inhibition of MK499 binding to human ERG
8520,CHEMBL3422756,COc1ccc2ncc(C#N)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,370.0,Inhibition of MK499 binding to human ERG
8521,CHEMBL3422757,COc1ccc2ncc(C(F)(F)F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,130.0,Inhibition of MK499 binding to human ERG
8522,CHEMBL3422758,COc1ccc2ncc(C(F)F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,5850.0,Inhibition of MK499 binding to human ERG
8523,CHEMBL3422759,COc1ccc2ncc(C)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,27430.0,Inhibition of MK499 binding to human ERG
8524,CHEMBL3422760,COc1ccc2ncc(CO)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1440.0,Inhibition of MK499 binding to human ERG
8525,CHEMBL3422761,COc1ccc2ncc(C(N)=O)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of MK499 binding to human ERG
8526,CHEMBL3422762,COc1ccc2ncc(S(C)(=O)=O)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1550.0,Inhibition of MK499 binding to human ERG
8527,CHEMBL3422763,COc1ccc2ncc(OC)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,4260.0,Inhibition of MK499 binding to human ERG
8528,CHEMBL3422764,COc1ccc2ncc(O)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1960.0,Inhibition of MK499 binding to human ERG
8529,CHEMBL3422765,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(O)nc56)(CC3)OC4)nc2N1,IC50,nM,=,4.83,Inhibition of MK499 binding to human ERG
8530,CHEMBL3422766,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6cccnc56)(CC3)OC4)nc2N1,IC50,,,,Inhibition of MK499 binding to human ERG
8531,CHEMBL3422767,Cc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of MK499 binding to human ERG
8532,CHEMBL3422768,COC(=O)c1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,8.75,Inhibition of MK499 binding to human ERG
8533,CHEMBL3422769,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(C(=O)O)nc56)(CC3)OC4)nc2N1,IC50,,,,Inhibition of MK499 binding to human ERG
8534,CHEMBL3422947,N#Cc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3.87,Inhibition of MK499 binding to human ERG
8535,CHEMBL3422948,Nc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3.21,Inhibition of MK499 binding to human ERG
8536,CHEMBL3422949,CN(C)c1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,8.35,Inhibition of MK499 binding to human ERG
8537,CHEMBL3422950,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(N7CCOCC7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,11.46,Inhibition of MK499 binding to human ERG
8538,CHEMBL3422951,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(N7CCS(=O)(=O)CC7)nc56)(CC3)OC4)nc2N1,IC50,,,,Inhibition of MK499 binding to human ERG
8539,CHEMBL3421646,COc1cc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2nc1OC,IC50,nM,=,13.91,Inhibition of MK499 binding to human ERG
8540,CHEMBL3422952,COc1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c(F)cnc2cc1F,IC50,nM,=,0.73,Inhibition of MK499 binding to human ERG
8541,CHEMBL3422953,COc1cc(C)c2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2.9,Inhibition of MK499 binding to human ERG
8542,CHEMBL3422954,CCOc1cc(C)c2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1.19,Inhibition of MK499 binding to human ERG
8543,CHEMBL3422955,COc1ccc2nc(N3CCNCC3)c(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of MK499 binding to human ERG
8544,CHEMBL3422956,COc1ccc2nc(N3CCN(C)CC3)c(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of MK499 binding to human ERG
8545,CHEMBL3422957,COc1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c(F)cnc2cc1C(F)(F)F,IC50,nM,=,1.7,Inhibition of MK499 binding to human ERG
8546,CHEMBL3422958,Cc1cc(S(C)(=O)=O)nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c(F)cnc12,IC50,nM,=,12.38,Inhibition of MK499 binding to human ERG
8547,CHEMBL3422959,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6cc(C(F)(F)F)cnc56)(CC3)OC4)nc2N1,IC50,nM,=,0.89,Inhibition of MK499 binding to human ERG
8548,CHEMBL3422960,CN(C)c1cnc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c(F)cnc2c1,IC50,nM,=,18.37,Inhibition of MK499 binding to human ERG
8549,CHEMBL3422961,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6cc(Cl)cnc56)(CC3)OC4)nc2N1,IC50,nM,=,3.27,Inhibition of MK499 binding to human ERG
8550,CHEMBL3422962,N#Cc1ccc2ncc(C#N)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1.66,Inhibition of MK499 binding to human ERG
8551,CHEMBL3422963,COc1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc2cc1Cl,IC50,nM,=,4.2,Inhibition of MK499 binding to human ERG
8552,CHEMBL3422964,COc1cc2nccc(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2nc1OC,IC50,nM,=,1.43,Inhibition of MK499 binding to human ERG
8553,CHEMBL3422965,COc1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc2cc1F,IC50,nM,=,2.49,Inhibition of MK499 binding to human ERG
8554,CHEMBL3422966,COc1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc2cc1C#N,IC50,nM,=,1.6,Inhibition of MK499 binding to human ERG
8555,CHEMBL3422967,COc1cc(C)c2nccc(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,5.22,Inhibition of MK499 binding to human ERG
8556,CHEMBL3422968,COc1cc(OC)c2nccc(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1.78,Inhibition of MK499 binding to human ERG
8557,CHEMBL3422969,COc1cc(CCC23CCC(NCc4ccc5c(n4)NC(=O)CO5)(CC2)CO3)c2nc(OC)ccc2n1,IC50,nM,=,4.21,Inhibition of MK499 binding to human ERG
8558,CHEMBL3422970,Cc1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc2cc1C#N,IC50,nM,=,0.87,Inhibition of MK499 binding to human ERG
8559,CHEMBL3422971,COc1cc2nccc(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2nc1C#N,IC50,nM,=,1.96,Inhibition of MK499 binding to human ERG
8560,CHEMBL3422972,COc1cc2nccc(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2nc1C(=O)O,IC50,nM,=,13.09,Inhibition of MK499 binding to human ERG
8561,CHEMBL3422973,Cc1cc(C#N)nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc12,IC50,nM,=,2.08,Inhibition of MK499 binding to human ERG
8562,CHEMBL3422974,Cc1cc(S(C)(=O)=O)nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc12,IC50,nM,=,6.71,Inhibition of MK499 binding to human ERG
8563,CHEMBL3422975,CN(C)c1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc2cc1C(F)(F)F,IC50,nM,=,2.29,Inhibition of MK499 binding to human ERG
8564,CHEMBL3422976,CN(C)c1nc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc2cc1F,IC50,nM,=,1.21,Inhibition of MK499 binding to human ERG
8565,CHEMBL3422977,O=C1COc2ccc(CNC34CCC(CCc5ccnc6ccc(C(F)(F)F)nc56)(CC3)OC4)nc2N1,IC50,nM,=,0.99,Inhibition of MK499 binding to human ERG
8566,CHEMBL3422978,O=C1COc2ccc(CNC34CCC(CCc5ccnc6cc(C(F)(F)F)cnc56)(CC3)OC4)nc2N1,IC50,nM,=,0.39,Inhibition of MK499 binding to human ERG
8567,CHEMBL3422979,COc1cnc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc2c1,IC50,nM,=,15.62,Inhibition of MK499 binding to human ERG
8568,CHEMBL3422980,O=C1COc2ccc(CNC34CCC(CCc5ccnc6cc(Cl)cnc56)(CC3)OC4)nc2N1,IC50,nM,=,4.93,Inhibition of MK499 binding to human ERG
8569,CHEMBL3422981,O=C1COc2ccc(CNC34CCC(CCc5ccnc6cc(F)cnc56)(CC3)OC4)nc2N1,IC50,nM,=,16.75,Inhibition of MK499 binding to human ERG
8570,CHEMBL3422982,CCOC(=O)c1c(OC)cnc2c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)ccnc12,IC50,nM,=,7.87,Inhibition of MK499 binding to human ERG
8571,CHEMBL3422983,COc1ccc2ncc(C#N)c(CC(O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2.13,Inhibition of MK499 binding to human ERG
8572,CHEMBL3422983,COc1ccc2ncc(C#N)c(CC(O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2.58,Inhibition of MK499 binding to human ERG
8573,CHEMBL3305005,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8574,CHEMBL3422754,COc1ccc2ncc(Cl)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8575,CHEMBL3422755,COc1ccc2nccc(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1300.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8576,CHEMBL3422756,COc1ccc2ncc(C#N)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8577,CHEMBL3422757,COc1ccc2ncc(C(F)(F)F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,730.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8578,CHEMBL3422758,COc1ccc2ncc(C(F)F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1750.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8579,CHEMBL3422759,COc1ccc2ncc(C)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1060.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8580,CHEMBL3422760,COc1ccc2ncc(CO)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,5900.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8581,CHEMBL3422761,COc1ccc2ncc(C(N)=O)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8582,CHEMBL3422762,COc1ccc2ncc(S(C)(=O)=O)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2410.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8583,CHEMBL3422763,COc1ccc2ncc(OC)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8584,CHEMBL3422764,COc1ccc2ncc(O)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Patch express assay
8585,CHEMBL3305167,COc1ccc2ncc(F)c(C[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,26.0,Inhibition of MK499 binding to human ERG
8586,CHEMBL3305167,COc1ccc2ncc(F)c(C[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,18.0,Inhibition of human ERG expressed in CHO cells by Patch express assay
8587,CHEMBL3422235,NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](c3ncco3)C[C@H]2CS1,IC50,nM,=,10600.0,Inhibition of human ERG expressed in CHO cells
8588,CHEMBL3422236,Cc1coc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1,IC50,nM,=,2300.0,Inhibition of human ERG expressed in CHO cells
8589,CHEMBL3422237,Cc1cc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1,IC50,nM,=,1600.0,Inhibition of human ERG expressed in CHO cells
8590,CHEMBL3422238,Cn1cc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)cn1,IC50,nM,=,4900.0,Inhibition of human ERG expressed in CHO cells
8591,CHEMBL3422241,Cc1coc([C@H]2C[C@H]3[C@@H](C)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHO cells
8592,CHEMBL3422242,Cc1cc([C@H]2C[C@H]3[C@@H](C)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1,IC50,nM,=,2100.0,Inhibition of human ERG expressed in CHO cells
8593,CHEMBL3422243,C[C@H]1SC(N)=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](c3cnn(C)c3)C[C@@H]12,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHO cells
8594,CHEMBL3422244,Cc1coc([C@H]2C[C@H]3[C@@H](CF)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1,IC50,nM,=,19600.0,Inhibition of human ERG expressed in CHO cells
8595,CHEMBL3422245,Cc1cc([C@H]2C[C@H]3[C@@H](CF)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1,IC50,nM,=,10100.0,Inhibition of human ERG expressed in CHO cells
8596,CHEMBL3422246,Cn1cc([C@H]2C[C@H]3[C@@H](CF)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)cn1,IC50,nM,=,13800.0,Inhibition of human ERG expressed in CHO cells
8597,CHEMBL33899,CC/C(=C(\c1ccccc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1,IC50,nM,>,33000.0,Inhibition of hERG channel by electrophysiology
8598,CHEMBL195515,CC/C(=C(\c1ccc(O)cc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1,IC50,nM,>,100000.0,Inhibition of hERG channel by electrophysiology
8599,CHEMBL3427385,O=C(O)/C=C/c1ccc(Cc2c(-c3ccccc3)c(=O)oc3cc(O)ccc23)cc1,IC50,nM,>,100000.0,Inhibition of hERG channel by electrophysiology
8600,CHEMBL3427401,Cc1cc(F)ccc1-c1c(Oc2ccc(/C=C/C(=O)O)cc2)c2ccc(O)cc2oc1=O,IC50,nM,>,100000.0,Inhibition of hERG channel by electrophysiology
8601,CHEMBL3427402,Cc1cc(OC(F)(F)F)ccc1-c1c(Oc2ccc(/C=C/C(=O)O)cc2)c2ccc(O)cc2oc1=O,IC50,nM,>,100000.0,Inhibition of hERG channel by electrophysiology
8602,CHEMBL3427414,Cc1cc(F)ccc1-c1c(Oc2ccc(/C=C/C(=O)O)cc2)c2ccccc2oc1=O,IC50,nM,>,100000.0,Inhibition of hERG channel by electrophysiology
8603,CHEMBL3400817,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8604,CHEMBL3425799,O=C1COc2cc(F)c(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8605,CHEMBL3425800,O=C1COc2cc(Cl)c(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,27700.0,Displacement of MK499 from human ERG
8606,CHEMBL3425801,Cc1cc2c(nc1CNC13CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC1)OC3)NC(=O)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8607,CHEMBL3425802,CCc1cc2c(nc1CNC13CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC1)OC3)NC(=O)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8608,CHEMBL3425803,Nc1cc2c(nc1CNC13CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC1)OC3)NC(=O)CO2,IC50,,,,Displacement of MK499 from human ERG
8609,CHEMBL3425804,O=C1COc2cc(O)c(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Displacement of MK499 from human ERG
8610,CHEMBL3425806,O=C1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)cc2N1,IC50,nM,=,11700.0,Displacement of MK499 from human ERG
8611,CHEMBL3425807,O=C1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Displacement of MK499 from human ERG
8612,CHEMBL3425809,O=C1COc2ccc(C(=O)NC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Displacement of MK499 from human ERG
8613,CHEMBL3425810,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCCO4)(CC1)CO2,IC50,nM,=,2600.0,Displacement of MK499 from human ERG
8614,CHEMBL3425811,CC1COc2cc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)ncc2O1,IC50,,,,Displacement of MK499 from human ERG
8615,CHEMBL3425811,CC1COc2cc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)ncc2O1,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8616,CHEMBL3425812,CC1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)cc2O1,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8617,CHEMBL3425812,CC1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)cc2O1,IC50,,,,Displacement of MK499 from human ERG
8618,CHEMBL3425813,N#Cc1c(CNC23CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC2)OC3)ncc2c1OCCO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8619,CHEMBL3425814,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ncc4c(c3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8620,CHEMBL3425815,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCCS4)(CC1)CO2,IC50,,,,Displacement of MK499 from human ERG
8621,CHEMBL3425816,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)SCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8622,CHEMBL3425817,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCCS4(=O)=O)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8623,CHEMBL3425818,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)S(=O)(=O)CCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8624,CHEMBL3425819,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8625,CHEMBL3425820,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(nn3)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8626,CHEMBL3425821,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ncc4c(n3)OCCO4)(CC1)CO2,IC50,,,,Displacement of MK499 from human ERG
8627,CHEMBL3425822,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(c3)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8628,CHEMBL3425823,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cc3F)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8629,CHEMBL3425514,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cc3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8630,CHEMBL3425824,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(c3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8631,CHEMBL3425827,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc(Cl)c4c(c3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8632,CHEMBL3425924,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)NCCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8633,CHEMBL3425925,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)OCCN4)(CC1)CO2,IC50,,,,Displacement of MK499 from human ERG
8634,CHEMBL3425926,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)NCCN4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8635,CHEMBL3425927,CN1CCOc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc21,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8636,CHEMBL3425928,CN1CCOc2nc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)ccc21,IC50,,,,Displacement of MK499 from human ERG
8637,CHEMBL3425930,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(c3)OCO4)(CC1)CO2,IC50,nM,>,60000.0,Displacement of MK499 from human ERG
8638,CHEMBL3425934,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NC/C=C/c3c(F)cccc3F)(CC1)CO2,IC50,nM,=,32.0,Displacement of MK499 from human ERG
8639,CHEMBL3425935,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NC/C=C/c3cc(F)ccc3F)(CC1)CO2,IC50,nM,=,8.0,Displacement of MK499 from human ERG
8640,CHEMBL3425936,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NC/C=C/c3ccc(F)cc3)(CC1)CO2,IC50,nM,=,64.0,Displacement of MK499 from human ERG
8641,CHEMBL3425937,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NC/C(F)=C\c3cc(F)ccc3F)(CC1)CO2,IC50,nM,=,16.0,Displacement of MK499 from human ERG
8642,CHEMBL3425938,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NC/C(F)=C/c3cc(F)ccc3F)(CC1)CO2,IC50,nM,=,16.0,Displacement of MK499 from human ERG
8643,CHEMBL3425939,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NC/C=C/c3ccccc3)(CC1)CO2,IC50,nM,=,64.0,Displacement of MK499 from human ERG
8644,CHEMBL3425940,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NC/C=C/c3ccccn3)(CC1)CO2,IC50,nM,=,64.0,Displacement of MK499 from human ERG
8645,CHEMBL3425941,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCCCc3cc(F)ccc3F)(CC1)CO2,IC50,nM,=,32.0,Displacement of MK499 from human ERG
8646,CHEMBL3425942,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCOc3cc(F)ccc3F)(CC1)CO2,IC50,nM,=,64.0,Displacement of MK499 from human ERG
8647,CHEMBL3425943,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc(-c4cccs4)on3)(CC1)CO2,IC50,nM,=,16.0,Displacement of MK499 from human ERG
8648,CHEMBL3400817,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,174000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8649,CHEMBL3425798,O=C1CSc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,25700.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8650,CHEMBL3425799,O=C1COc2cc(F)c(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,333000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8651,CHEMBL3425800,O=C1COc2cc(Cl)c(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,126000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8652,CHEMBL3425801,Cc1cc2c(nc1CNC13CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC1)OC3)NC(=O)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8653,CHEMBL3425802,CCc1cc2c(nc1CNC13CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC1)OC3)NC(=O)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8654,CHEMBL3425803,Nc1cc2c(nc1CNC13CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC1)OC3)NC(=O)CO2,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8655,CHEMBL3425804,O=C1COc2cc(O)c(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8656,CHEMBL3425805,O=C1COc2cc(OC(=O)c3ccccc3)c(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,30500.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8657,CHEMBL3425806,O=C1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)cc2N1,IC50,nM,=,30000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8658,CHEMBL3425807,O=C1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,nM,=,30000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8659,CHEMBL3425808,O=C1COc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)cc2N1,IC50,nM,=,7300.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8660,CHEMBL3425809,O=C1COc2ccc(C(=O)NC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8661,CHEMBL3425810,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCCO4)(CC1)CO2,IC50,nM,=,764000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8662,CHEMBL3425811,CC1COc2cc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)ncc2O1,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8663,CHEMBL3425811,CC1COc2cc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)ncc2O1,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8664,CHEMBL3425812,CC1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)cc2O1,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8665,CHEMBL3425812,CC1COc2cnc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)cc2O1,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8666,CHEMBL3425813,N#Cc1c(CNC23CCC(C[C@]4(O)Cn5c(=O)ccc6ncc(F)c4c65)(CC2)OC3)ncc2c1OCCO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8667,CHEMBL3425814,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ncc4c(c3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8668,CHEMBL3425815,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCCS4)(CC1)CO2,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8669,CHEMBL3425816,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)SCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8670,CHEMBL3425817,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCCS4(=O)=O)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8671,CHEMBL3425818,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)S(=O)(=O)CCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8672,CHEMBL3425819,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8673,CHEMBL3425820,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(nn3)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8674,CHEMBL3425821,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ncc4c(n3)OCCO4)(CC1)CO2,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8675,CHEMBL3425822,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(c3)OCCO4)(CC1)CO2,IC50,nM,=,16500.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8676,CHEMBL3425823,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cc3F)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8677,CHEMBL3425514,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cc3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8678,CHEMBL3425824,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(c3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8679,CHEMBL3425825,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3c(Cl)cc4c(c3Cl)OCCO4)(CC1)CO2,IC50,nM,=,30400.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8680,CHEMBL3425826,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(c(Cl)c3Cl)OCCO4)(CC1)CO2,IC50,nM,=,31600.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8681,CHEMBL3425827,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc(Cl)c4c(c3Cl)OCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8682,CHEMBL3425924,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)NCCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8683,CHEMBL3425925,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)OCCN4)(CC1)CO2,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8684,CHEMBL3425926,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(n3)NCCN4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8685,CHEMBL3425927,CN1CCOc2ccc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)nc21,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8686,CHEMBL3425928,CN1CCOc2nc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)ccc21,IC50,,,,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8687,CHEMBL3425929,CN1CCN(C)c2nc(CNC34CCC(C[C@]5(O)Cn6c(=O)ccc7ncc(F)c5c76)(CC3)OC4)ccc21,IC50,nM,=,30600.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8688,CHEMBL3425930,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(c3)OCO4)(CC1)CO2,IC50,nM,>,60000.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8689,CHEMBL3425931,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3ccc4c(c3)OC(F)(F)O4)(CC1)CO2,IC50,nM,=,28200.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8690,CHEMBL3425932,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCS4)(CC1)CO2,IC50,nM,=,33600.0,Inhibition of human ERG expressed in CHO cells measured over 5 mins by patch clamp assay
8691,CHEMBL3317856,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,IC50,nM,=,1400000.0,Inhibition of human ERG
8692,CHEMBL3425933,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CC12CCC(NCc3cc4c(cn3)OCCC4)(CC1)CO2,IC50,,,,Displacement of MK499 from human ERG
8693,CHEMBL2105617,CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O,IC50,nM,=,1040.0,Inhibition of hERG K channel
8694,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IC50,nM,=,30.0,Inhibition of potassium current (Ikr) measured using whole-cell patch clamp experiments in HEK-293 cells stable transfected with hERG cDNA
8695,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,3280.0,Inhibition of hERG K channel
8696,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,33.0,Inhibition of hERG K channel
8697,CHEMBL71,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,nM,=,1470.0,Inhibition of hERG K channel
8698,CHEMBL87045,c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1,IC50,nM,=,22600.0,Inhibition of hERG K channel
8699,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,6.5,Inhibition of hERG K channel
8700,CHEMBL72,CNCCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,1390.0,Inhibition of hERG K channel
8701,CHEMBL23,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,IC50,nM,=,17300.0,Inhibition of hERG K channel
8702,CHEMBL657,CN(C)CCOC(c1ccccc1)c1ccccc1,IC50,nM,=,5200.0,Inhibition of hERG K channel
8703,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,5.0,Inhibition of hERG K channel
8704,CHEMBL814,COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1,IC50,nM,=,3100.0,Inhibition of hERG K channel
8705,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,27.0,Inhibition of hERG K channel
8706,CHEMBL11,CN(C)CCCN1c2ccccc2CCc2ccccc21,IC50,nM,=,3400.0,Inhibition of hERG K channel
8707,CHEMBL558,Cc1cccc(C)c1OCC(C)N,IC50,nM,>,10000.0,Inhibition of hERG K channel
8708,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1800.0,Inhibition of hERG K channel
8709,CHEMBL193,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],IC50,nM,=,275000.0,Inhibition of hERG K channel
8710,CHEMBL475534,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,10000.0,Inhibition of hERG K channel
8711,CHEMBL16,O=C1N=C(O)NC1(c1ccccc1)c1ccccc1,IC50,nM,=,100000.0,Inhibition of hERG K channel
8712,CHEMBL1423,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,nM,=,20.0,Inhibition of hERG K channel
8713,CHEMBL24072,CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,IC50,nM,=,65.0,Inhibition of potassium current (Ikr) measured using whole-cell patch clamp experiments in HEK-293 cells stable transfected with hERG cDNA
8714,CHEMBL631,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,IC50,nM,=,440.0,Inhibition of hERG K channel
8715,CHEMBL27,CC(C)NCC(O)COc1cccc2ccccc12,IC50,nM,=,2828.0,Inhibition of hERG K channel
8716,CHEMBL716,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,IC50,nM,=,5800.0,Inhibition of hERG K channel
8717,CHEMBL1294,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,IC50,nM,=,300.0,Inhibition of hERG K channel
8718,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,150.0,Inhibition of hERG K channel
8719,CHEMBL12713,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,IC50,nM,=,14.0,Inhibition of hERG K channel
8720,CHEMBL2111110,C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1,IC50,nM,=,2500.0,Inhibition of hERG K channel
8721,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,8.9,Inhibition of hERG K channel
8722,CHEMBL479,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,nM,=,33.0,Inhibition of hERG K channel
8723,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,143.0,Inhibition of hERG K channel
8724,CHEMBL709,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,IC50,nM,=,19952.62,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8725,CHEMBL270190,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,IC50,nM,=,63095734.45,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8726,CHEMBL1111,COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O,IC50,nM,=,7943282.35,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8727,CHEMBL1346,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,IC50,nM,=,1584.89,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8728,CHEMBL1323,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,IC50,nM,=,63095.73,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8729,CHEMBL1421,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,IC50,nM,=,50118.72,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8730,CHEMBL1118,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,IC50,nM,=,19952623.15,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8731,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,125.89,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8732,CHEMBL491571,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12,IC50,nM,=,7943282.35,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8733,CHEMBL1175,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,IC50,nM,=,10000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8734,CHEMBL308954,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,IC50,nM,=,398107.17,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8735,CHEMBL1908360,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,nM,=,15848931.92,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8736,CHEMBL741,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,IC50,nM,=,398107.17,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8737,CHEMBL554,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,nM,=,100000000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8738,CHEMBL1201187,Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,IC50,nM,=,125892.54,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8739,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,398107.17,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8740,CHEMBL434394,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,IC50,nM,=,6309.57,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8741,CHEMBL584,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,IC50,nM,=,31622776.6,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8742,CHEMBL255863,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,IC50,nM,=,63095.73,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8743,CHEMBL1621,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,IC50,nM,=,1000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8744,CHEMBL1189679,O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2,IC50,nM,=,3981.07,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8745,CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,nM,=,3162277.66,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8746,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,158489.32,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8747,CHEMBL24778,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,IC50,nM,=,25118.86,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8748,CHEMBL1422,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,IC50,nM,=,1000000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8749,CHEMBL1734,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,IC50,nM,=,1584.89,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8750,CHEMBL535,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,nM,=,10000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8751,CHEMBL779,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,IC50,nM,=,79432.82,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8752,CHEMBL374731,Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O,IC50,nM,=,5011872.34,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8753,CHEMBL1382,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,IC50,nM,=,125.89,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8754,CHEMBL1520,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,IC50,nM,=,316227.77,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform
8755,CHEMBL709,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,IC50,nM,=,12589.25,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8756,CHEMBL1323,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,IC50,nM,=,100000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8757,CHEMBL1421,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,IC50,nM,=,50118.72,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8758,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,630.96,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8759,CHEMBL1175,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,IC50,nM,=,6309.57,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8760,CHEMBL461101,CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O,IC50,nM,=,1584893.19,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8761,CHEMBL308954,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,IC50,nM,=,25118.86,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8762,CHEMBL1908360,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,nM,=,794328.23,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8763,CHEMBL741,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,IC50,nM,=,251188.64,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8764,CHEMBL554,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,nM,=,630957.34,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8765,CHEMBL1201187,Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,IC50,nM,=,79432.82,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8766,CHEMBL434394,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,IC50,nM,=,6309.57,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8767,CHEMBL584,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,IC50,nM,=,501187.23,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8768,CHEMBL1621,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,IC50,nM,=,1258.93,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8769,CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,nM,=,316227.77,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8770,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,100000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8771,CHEMBL1422,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,IC50,nM,=,501187.23,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8772,CHEMBL535,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,nM,=,7943.28,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8773,CHEMBL779,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,IC50,nM,=,125892.54,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8774,CHEMBL1382,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,IC50,nM,=,158.49,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8775,CHEMBL1520,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,IC50,nM,=,79432.82,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform
8776,CHEMBL709,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,IC50,nM,=,125892.54,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8777,CHEMBL270190,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,IC50,nM,=,794328.23,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8778,CHEMBL1111,COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O,IC50,nM,=,501187.23,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8779,CHEMBL1346,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,IC50,nM,=,79.43,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8780,CHEMBL1323,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,IC50,nM,=,158489.32,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8781,CHEMBL1421,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,IC50,nM,=,15848.93,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8782,CHEMBL550348,O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1,IC50,nM,=,3981071.71,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8783,CHEMBL1118,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,IC50,nM,=,251188.64,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8784,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,10.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8785,CHEMBL491571,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12,IC50,nM,=,5011872.34,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8786,CHEMBL1175,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,IC50,nM,=,5011.87,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8787,CHEMBL461101,CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O,IC50,nM,=,630.96,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8788,CHEMBL308954,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,IC50,nM,=,158489.32,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8789,CHEMBL1908360,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,nM,=,501187.23,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8790,CHEMBL58323,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,IC50,nM,=,50118723.36,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8791,CHEMBL741,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,IC50,nM,=,251188.64,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8792,CHEMBL554,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,nM,=,1000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8793,CHEMBL1201187,Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,IC50,nM,=,39810.72,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8794,CHEMBL32,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,IC50,nM,=,79432.82,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8795,CHEMBL434394,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,IC50,nM,=,316.23,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8796,CHEMBL584,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,IC50,nM,=,12589.25,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8797,CHEMBL255863,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,IC50,nM,=,125.89,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8798,CHEMBL1621,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,IC50,nM,=,1258.93,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8799,CHEMBL1189679,O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2,IC50,nM,=,1995.26,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8800,CHEMBL254316,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,IC50,nM,=,1584893.19,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8801,CHEMBL192,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,nM,=,31622.78,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8802,CHEMBL24778,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,IC50,nM,=,7943.28,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8803,CHEMBL1422,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,IC50,nM,=,158489.32,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8804,CHEMBL1734,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,IC50,nM,=,251.19,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8805,CHEMBL535,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,nM,=,251.19,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8806,CHEMBL779,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,IC50,nM,=,100000.0,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8807,CHEMBL374731,Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O,IC50,nM,=,158489319.25,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8808,CHEMBL1382,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,IC50,nM,=,12.59,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8809,CHEMBL1520,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,IC50,nM,=,31622.78,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay
8810,CHEMBL3545059,COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O,IC50,,,,Inhibitory concentration of aliskiren hemifumarate against cloned hERG channel expressed in human embryonic kidney cell
8811,CHEMBL3577447,CC12CCC(C(NC(=O)[C@@H](CC3CCCCC3)NC(=O)N[C@@H](CCCCN)C(=O)O)C1)C2(C)C.Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp assay
8812,CHEMBL3577935,CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,=,32000.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8813,CHEMBL3577936,COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8814,CHEMBL3577937,CCCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,=,360.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8815,CHEMBL3577938,COCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8816,CHEMBL3577939,CC(C)CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1,IC50,nM,=,2700.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8817,CHEMBL3577940,CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)[C@H](CCc2ccccc2)C1,IC50,nM,=,1600.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8818,CHEMBL3577941,CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)[C@H](COc2ccccc2)C1,IC50,nM,=,5300.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8819,CHEMBL1091604,CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)[C@H](CS(=O)(=O)c2ccccc2)C1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by FLIPR based flux assay
8820,CHEMBL3577942,CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NCC)C1=O,IC50,nM,=,14000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current at holding potential of 80 mV to +20 mV by whole cell patch clamp assay
8821,CHEMBL3577945,CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O,IC50,nM,=,1800.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current at holding potential of 80 mV to +20 mV by whole cell patch clamp assay
8822,CHEMBL1783889,CC(C)N1CCN(C(=O)c2ccc(CN3CCCCC3)cc2)CC1,IC50,nM,>,30000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis
8823,CHEMBL3577955,CC(C)N1CCN(C(=O)c2ccc(CN3CCOCC3)cc2)CC1.O=C(O)/C=C\C(=O)O,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis
8824,CHEMBL3577956,O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis
8825,CHEMBL3577957,Cl.O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis
8826,CHEMBL3577958,CC(C)N1CCN(C(=O)c2ccc(CN3CCC(F)CC3)cc2)CC1,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis
8827,CHEMBL3577959,O=C(c1ccc(CN2CCC(F)CC2)cc1)N1CCN(C2CCC2)CC1,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis
8828,CHEMBL3577960,O=C(c1ccc(CN2CCC(F)CC2)cc1)N1CCN(C2CC2)CC1,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis
8829,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,40.0,Inhibition of human ERG expressed in CHO cells assessed as whole cell current by patch clamp assay
8830,CHEMBL3582240,CC1(C)CC[C@]23CC[C@]4(C)[C@](C(=O)C=C5[C@@]6(C)C=C(C#N)C(=O)C(C)(C)[C@@H]6CC[C@]54C)([C@@H]2C1)N(C1CCCCC1)C3=O,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells assessed as whole cell current by patch clamp assay
8831,CHEMBL3582294,CNC(=O)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F,IC50,nM,=,93560.0,Inhibition of human ERG channel
8832,CHEMBL2204935,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,1700.0,Inhibition of MK499 binding to human ERG
8833,CHEMBL3323086,Cn1cc([C@@]2(c3ccc(C(=O)O)cn3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,95600.0,Inhibition of MK499 binding to human ERG
8834,CHEMBL3582312,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCCCC4)N3)n2)nc1,IC50,nM,=,200.0,Inhibition of MK499 binding to human ERG
8835,CHEMBL3582313,c1cncc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCCCC4)N3)n2)c1,IC50,nM,=,190.0,Inhibition of MK499 binding to human ERG
8836,CHEMBL3582314,c1ccc2c3c([nH]c2c1)C(C1CCCCC1)N[C@@H](c1nc(-c2ccncc2)c[nH]1)C3,IC50,nM,=,90.0,Inhibition of MK499 binding to human ERG
8837,CHEMBL3582315,c1ccc2c3c([nH]c2c1)C(C1CCCCC1)N[C@@H](c1nc(-c2cnccn2)c[nH]1)C3,IC50,nM,=,340.0,Inhibition of MK499 binding to human ERG
8838,CHEMBL3582316,Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCCCC4)N3)n2)nc1,IC50,nM,=,170.0,Inhibition of MK499 binding to human ERG
8839,CHEMBL3582317,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,8540.0,Inhibition of MK499 binding to human ERG
8840,CHEMBL2204935,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,3400.0,Inhibition of human ERG by Patchexpress patch clamp assay
8841,CHEMBL3582317,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,12000.0,Inhibition of human ERG by Patchexpress patch clamp assay
8842,CHEMBL3582336,CCn1cc([C@@]2(c3nn(C)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,27000.0,Inhibition of human ERG by Patchexpress patch clamp assay
8843,CHEMBL3582318,Cc1nc([C@]2(c3cn[nH]c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,4200.0,Inhibition of MK499 binding to human ERG
8844,CHEMBL3582319,CCn1cc([C@@]2(c3noc(C)n3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,7300.0,Inhibition of MK499 binding to human ERG
8845,CHEMBL3582320,CCc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,9600.0,Inhibition of MK499 binding to human ERG
8846,CHEMBL3582321,Cc1nc([C@]2(c3cnn(CC4CC4)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,3200.0,Inhibition of MK499 binding to human ERG
8847,CHEMBL3582322,Cn1cc([C@@]2(c3noc(O)n3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,1200.0,Inhibition of MK499 binding to human ERG
8848,CHEMBL3582323,Cn1cc([C@@]2(c3noc(CN)n3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,3700.0,Inhibition of MK499 binding to human ERG
8849,CHEMBL3582324,Cc1nnc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)o1,IC50,nM,=,3200.0,Inhibition of MK499 binding to human ERG
8850,CHEMBL3582325,CCc1nnc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)o1,IC50,nM,=,4300.0,Inhibition of MK499 binding to human ERG
8851,CHEMBL3582326,CCn1cc([C@@]2(c3nnc(C)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,8500.0,Inhibition of MK499 binding to human ERG
8852,CHEMBL3582327,CCn1cc([C@@]2(c3nnc(O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,22400.0,Inhibition of MK499 binding to human ERG
8853,CHEMBL3582328,CCn1cc([C@@]2(c3nnc(S)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,10400.0,Inhibition of MK499 binding to human ERG
8854,CHEMBL3582329,CCn1cc([C@@]2(c3nnc(SC)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,1600.0,Inhibition of MK499 binding to human ERG
8855,CHEMBL3582330,Cn1cc([C@@]2(c3nnc(N)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,35400.0,Inhibition of MK499 binding to human ERG
8856,CHEMBL3582331,CCn1cc([C@@]2(c3nnc(NC)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,1100.0,Inhibition of MK499 binding to human ERG
8857,CHEMBL3582332,CCn1cc([C@@]2(c3nnc(N(C)C)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,5500.0,Inhibition of MK499 binding to human ERG
8858,CHEMBL3582333,Cn1nc([C@]2(c3cn[nH]c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)oc1=O,IC50,nM,=,21500.0,Inhibition of MK499 binding to human ERG
8859,CHEMBL3582334,Cn1cc([C@@]2(c3nn(C)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,25800.0,Inhibition of MK499 binding to human ERG
8860,CHEMBL3580681,CCn1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)oc1=O,IC50,nM,=,51500.0,Inhibition of MK499 binding to human ERG
8861,CHEMBL3582335,CC(C)n1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)oc1=O,IC50,nM,=,27900.0,Inhibition of MK499 binding to human ERG
8862,CHEMBL3582336,CCn1cc([C@@]2(c3nn(C)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,32200.0,Inhibition of MK499 binding to human ERG
8863,CHEMBL3582337,CCn1cc(C2(c3nn(C)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,39900.0,Inhibition of MK499 binding to human ERG
8864,CHEMBL3582338,CCn1cc(C2(c3nn(C)c(=O)o3)NC(c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,27100.0,Inhibition of MK499 binding to human ERG
8865,CHEMBL3582339,CCn1cc([C@@]2(c3nn(CC)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,7700.0,Inhibition of MK499 binding to human ERG
8866,CHEMBL3582340,CCn1cc([C@@]2(c3nn(C(C)C)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,7700.0,Inhibition of MK499 binding to human ERG
8867,CHEMBL3582341,CCn1cc([C@@]2(c3nn(CC4CC4)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,5500.0,Inhibition of MK499 binding to human ERG
8868,CHEMBL3582342,CCn1cc([C@@]2(c3nn(CCN(C)C)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,3400.0,Inhibition of MK499 binding to human ERG
8869,CHEMBL3582343,CCn1cc([C@@]2(c3nn(CC(=O)O)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,30500.0,Inhibition of MK499 binding to human ERG
8870,CHEMBL3582344,CCn1cc([C@@]2(c3nn(CC(N)=O)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1,IC50,nM,=,34500.0,Inhibition of MK499 binding to human ERG
8871,CHEMBL3580774,Cc1cn(-c2ccc3n(c2=O)CCN([C@@H](C)COc2ccc(F)cc2[C@@H](C)C(F)(F)F)C3=O)cn1,IC50,nM,=,9200.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
8872,CHEMBL3580775,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H]1CCc2cc(F)c(F)cc21,IC50,nM,>,20000.0,Inhibition of human ERG channel
8873,CHEMBL3580776,N[C@@H](CC(=O)N1CC(=O)Nc2ccccc2C1)[C@H]1CCc2cc(F)c(F)cc21,IC50,nM,>,20000.0,Inhibition of human ERG channel
8874,CHEMBL3580784,N[C@@H](CC(=O)N1CC(=O)Nc2cc(F)c(F)cc2C1)[C@H]1CCc2cc(F)c(F)cc21,IC50,,,,Inhibition of human ERG channel
8875,CHEMBL3580788,CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,IC50,,,,Inhibition of human ERG channel
8876,CHEMBL3580789,CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccc(F)cc21,IC50,,,,Inhibition of human ERG channel
8877,CHEMBL3581791,COC(=O)c1ccc2[nH]c(NCCCNC(=O)c3cc(Cl)cc(Cl)c3)nc2c1,IC50,nM,>,50100.0,Inhibition of human ERG by IonWorks electrophysiology
8878,CHEMBL3581790,CC(C)(C)OC(=O)N1CCC(C(=O)NCCCNc2nc3ccccc3[nH]2)CC1,IC50,nM,>,50100.0,Inhibition of human ERG by IonWorks electrophysiology
8879,CHEMBL3581789,O=C(NCCCNc1nc2ccccc2[nH]1)c1ccc(CN2CCCC2)cc1,IC50,nM,>,50100.0,Inhibition of human ERG by IonWorks electrophysiology
8880,CHEMBL3581788,O=C(NCCCNc1nc2ccccc2[nH]1)c1ccnc(C(F)(F)F)c1,IC50,nM,=,22390.0,Inhibition of human ERG by IonWorks electrophysiology
8881,CHEMBL3581787,O=C(NCCCNc1nc2ccccc2[nH]1)c1cc(Cl)cc(Cl)c1,IC50,nM,=,1170.0,Inhibition of human ERG by IonWorks electrophysiology
8882,CHEMBL3402044,O=C(Nc1cccc(-c2nc3ccccc3[nH]2)c1)c1cc(Cl)cc(Cl)c1,IC50,nM,>,14790.0,Inhibition of human ERG by IonWorks electrophysiology
8883,CHEMBL3586426,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4ccccc4-c4cccs4)C[C@H]3C2)n1,IC50,nM,>,10000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8884,CHEMBL3586432,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4ccccc4-n4nccn4)C[C@H]3C2)n1,IC50,nM,>,10000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8885,CHEMBL3586433,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4cccc(F)c4-n4nccn4)C[C@H]3C2)n1,IC50,nM,=,6000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8886,CHEMBL3586434,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4ccc(F)cc4-n4nccn4)C[C@H]3C2)n1,IC50,nM,>,10000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8887,CHEMBL3586435,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4cc(F)ccc4-n4nccn4)C[C@H]3C2)n1,IC50,nM,>,10000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8888,CHEMBL3586436,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4c(F)cccc4-n4nccn4)C[C@H]3C2)n1,IC50,nM,>,10000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8889,CHEMBL3586437,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4ccccc4-c4ncn[nH]4)C[C@H]3C2)n1,IC50,nM,>,10000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8890,CHEMBL3586438,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4cccc(C)c4-n4nccn4)C[C@H]3C2)n1,IC50,,,,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8891,CHEMBL3586439,Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc(C)cc(C)n4)C[C@@H]3C2)c1,IC50,nM,>,10000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8892,CHEMBL3586440,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4c(C)cccc4-n4nccn4)C[C@H]3C2)n1,IC50,nM,=,6900.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8893,CHEMBL3586441,COc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc(C)cc(C)n4)C[C@@H]3C2)c1,IC50,nM,=,8100.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8894,CHEMBL3586442,Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4cc(Cl)ccc4-n4nccn4)C[C@H]3C2)n1,IC50,,,,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cells
8895,CHEMBL3585946,Cc1ncc(OC[C@@]2(c3ccccc3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,IC50,nM,=,7700.0,Inhibition of human ERG
8896,CHEMBL3585951,Cc1ncc(OC[C@@]2(c3ccccc3)C[C@H]2C(=O)Nc2cc(C)c(F)cn2)c(C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
8897,CHEMBL3585953,Cc1ncc(OC[C@@]2(c3ccccc3F)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,IC50,nM,=,5900.0,Inhibition of human ERG
8898,CHEMBL3545367,Cc1ncc(OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,IC50,nM,=,6100.0,Inhibition of human ERG
8899,CHEMBL3585954,Cc1ncc(OC[C@@]2(c3ccc(F)cc3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,IC50,nM,=,2200.0,Inhibition of human ERG
8900,CHEMBL3585955,Cc1ncc(OC[C@@]2(c3cc(F)cc(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,IC50,nM,=,4800.0,Inhibition of human ERG
8901,CHEMBL3585956,Cc1ncc(OC[C@@]2(c3ccc(F)c(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,IC50,nM,=,2200.0,Inhibition of human ERG
8902,CHEMBL3585957,Cc1ncc(OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc2cc(C)c(F)cn2)c(C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
8903,CHEMBL3586573,CCN1C(=O)CNc2ncc(-c3ccc(-c4nc[nH]n4)nc3C)nc21,IC50,nM,>,33000.0,Inhibition of human ERG
8904,CHEMBL3586404,CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1,IC50,nM,=,33000.0,Inhibition of human ERG
8905,CHEMBL3589894,CNC(=O)c1ccc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1,IC50,nM,=,30000.0,Inhibition of human ERG
8906,CHEMBL3589904,COc1ccc(Cl)c(-c2ccc(NC(=O)c3ccnn3C)nc2N)c1,IC50,nM,>,30000.0,Inhibition of human ERG
8907,CHEMBL2324355,Cc1nocc1C(=O)Nc1ccc(-c2ccccc2OC(F)(F)F)c(N)n1,IC50,nM,>,30000.0,Inhibition of human ERG
8908,CHEMBL1627306,O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,IC50,nM,=,380.0,Inhibition of human ERG by PatchXpress assay
8909,CHEMBL3589152,COc1cc(N2Cc3cn(-c4ccc(Cl)cc4)nc3C2=O)ccc1N1CC[C@@H](O)C1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in CHO cells by automated whole-cell patch clamp electrophysiology system
8910,CHEMBL3589153,COc1cc(N2Cc3cn(-c4ccc(Cl)cc4)nc3C2=O)ccc1N1C[C@H](O)[C@@H](O)C1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated whole-cell patch clamp electrophysiology system
8911,CHEMBL3093972,CCCCCCCN(CC)CC#CC(c1ccccc1)c1ccccc1,IC50,nM,=,182.0,Inhibition of human Kv11.1 expressed in HEK293 cells assessed as inhibition of channel tail current at holding potential -80 mV by whole cell voltage clamp assay
8912,CHEMBL2325212,C[n+]1c(C#Cc2ccc(-c3ccccc3)cc2)cccc1C#Cc1ccc(-c2ccccc2)cc1,IC50,nM,=,107.0,Inhibition of human Kv11.1 expressed in HEK293 cells assessed as inhibition of channel tail current at holding potential -80 mV by whole cell voltage clamp assay
8913,CHEMBL3593759,COc1ccc2c(c1)CCN(C(=O)CNCC1(O)CCCCC1)[C@@H]2C(C)C,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells after 10 mins by Rb efflux assay
8914,CHEMBL3593760,COc1ccc2c(c1)CCN(C(=O)CNCC1(O)CCCCC1)[C@H]2C(C)C,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells after 10 mins by Rb efflux assay
8915,CHEMBL3593779,C[C@H]1CN(c2ccc(C#N)cn2)CC[C@H]1Nc1c(C(N)=O)cnc2[nH]ccc12,IC50,nM,=,28700.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 10 mins by Rb efflux assay
8916,CHEMBL3593778,N#Cc1ccc(N2CC[C@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@H](F)C2)nc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 10 mins by Rb efflux assay
8917,CHEMBL3593777,N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 10 mins by Rb efflux assay
8918,CHEMBL3593776,N#Cc1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)nn1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 10 mins by Rb efflux assay
8919,CHEMBL3593775,N#Cc1cnc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)cn1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 10 mins by Rb efflux assay
8920,CHEMBL3593771,N#Cc1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)nc1,IC50,nM,=,13400.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 10 mins by Rb efflux assay
8921,CHEMBL3594232,Cc1cc(C(=O)O)nc(N2C[C@H]3C[C@@H](c4ccccc4C(F)(F)F)C[C@H]3C2)n1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
8922,CHEMBL3598099,C[C@@H](OC(=O)N1CCC(O[C@H]2CC[C@H](Oc3cnc(S(C)(=O)=O)cn3)CC2)CC1)C(F)(F)F,IC50,nM,>,1000000.0,Displacement of [3H]-Astemizole from human ERG
8923,CHEMBL3598099,C[C@@H](OC(=O)N1CCC(O[C@H]2CC[C@H](Oc3cnc(S(C)(=O)=O)cn3)CC2)CC1)C(F)(F)F,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
8924,CHEMBL3596512,COc1cccc(N2CCN(Cc3nc4c5cccc(OC)c5nc(N)n4n3)[C@H](C)C2)c1,IC50,nM,=,21060.0,Inhibition of [35S]MK499 binding to human ERG channel
8925,CHEMBL3596511,COc1ccccc1N1CCN(Cc2nc3c4cccc(OC)c4nc(N)n3n2)[C@H](C)C1,IC50,nM,=,47600.0,Inhibition of [35S]MK499 binding to human ERG channel
8926,CHEMBL3596510,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ncccn4)C[C@H]3C)nc21,IC50,nM,>,60000.0,Inhibition of [35S]MK499 binding to human ERG channel
8927,CHEMBL3596509,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ccncc4)C[C@H]3C)nc21,IC50,nM,=,2184.0,Inhibition of [35S]MK499 binding to human ERG channel
8928,CHEMBL3596508,COc1cccc2c1nc(N)n1nc(CN3CCN(c4cccnc4)C[C@H]3C)nc21,IC50,nM,=,22290.0,Inhibition of [35S]MK499 binding to human ERG channel
8929,CHEMBL3596507,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ccccn4)C[C@H]3C)nc21,IC50,nM,=,25460.0,Inhibition of [35S]MK499 binding to human ERG channel
8930,CHEMBL3596506,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ccccc4)C[C@H]3C)nc21,IC50,nM,=,16940.0,Inhibition of [35S]MK499 binding to human ERG channel
8931,CHEMBL3596505,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ccc(F)cn4)C[C@H]3C)nc21,IC50,nM,=,21870.0,Inhibition of [35S]MK499 binding to human ERG channel
8932,CHEMBL3596504,COc1cccc2c1nc(N)n1nc(CN3CCN(c4cccc(F)c4)C[C@H]3C)nc21,IC50,nM,=,23830.0,Inhibition of [35S]MK499 binding to human ERG channel
8933,CHEMBL3596503,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ccccc4F)C[C@H]3C)nc21,IC50,nM,=,49970.0,Inhibition of [35S]MK499 binding to human ERG channel
8934,CHEMBL3596502,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ccc(F)cc4)C[C@H]3C)nc21,IC50,nM,=,1551.0,Inhibition of [35S]MK499 binding to human ERG channel
8935,CHEMBL3596513,COc1ccc(N2CCN(Cc3nc4c5cccc(OC)c5nc(N)n4n3)[C@H](C)C2)cc1,IC50,nM,=,20750.0,Inhibition of [35S]MK499 binding to human ERG channel
8936,CHEMBL3596514,COc1cccc2c1nc(N)n1nc(CN3CCN(c4cnn(C)c4)C[C@H]3C)nc21,IC50,nM,>,60000.0,Inhibition of [35S]MK499 binding to human ERG channel
8937,CHEMBL3596515,COc1cccc2c1nc(N)n1nc(CN3CCN(c4ncc(C)s4)C[C@H]3C)nc21,IC50,nM,=,47030.0,Inhibition of [35S]MK499 binding to human ERG channel
8938,CHEMBL3596516,COc1cccc2c1nc(N)n1nc(CN3CCN(c4cnc(C)s4)C[C@H]3C)nc21,IC50,nM,=,17880.0,Inhibition of [35S]MK499 binding to human ERG channel
8939,CHEMBL3596517,COc1cccc2c1nc(N)n1nc(CN3CCN(c4sc(C)nc4C)C[C@H]3C)nc21,IC50,nM,>,60000.0,Inhibition of [35S]MK499 binding to human ERG channel
8940,CHEMBL3596518,COc1cccc2c1nc(N)n1nc(CN3CCN(c4nsnc4Cl)C[C@H]3C)nc21,IC50,nM,=,24330.0,Inhibition of [35S]MK499 binding to human ERG channel
8941,CHEMBL3596589,CCn1cc(N2CCN(Cc3nc4c5cccc(OC)c5nc(N)n4n3)[C@H](C)C2)cn1,IC50,nM,=,39190.0,Inhibition of [35S]MK499 binding to human ERG channel
8942,CHEMBL3596590,COc1cccc2c1nc(N)n1nc(CN3CCN(c4cnn(C(C)(C)C)c4)C[C@H]3C)nc21,IC50,nM,>,60000.0,Inhibition of [35S]MK499 binding to human ERG channel
8943,CHEMBL3601324,CCC(=O)N[C@H]1CC[C@H](CN(C)c2ccc(N3C(=O)Cc4cc(OC)c(O[C@H](C)CC)cc4[C@@H]3c3ccc(Cl)cc3)cc2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by radioligand binding assay
8944,CHEMBL3601397,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCNC(=O)C4)CC3)cc1)C(=O)C2,IC50,nM,=,16000.0,Inhibition of human ERG by radioligand binding assay
8945,CHEMBL3601322,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)[C@H]2c1ccc(Cl)cc1,IC50,nM,=,1300.0,Inhibition of human ERG by radioligand binding assay
8946,CHEMBL3601331,O=C(CCCCCCC(=O)Nc1ccc2ccnc(Nc3ccc(Br)cc3F)c2c1)NO,IC50,nM,>,40000.0,Inhibition of human ERG overexpressed in CHO cells by Qpatch method
8947,CHEMBL3601332,O=C(CCCCCCC(=O)Nc1ccc2ccnc(Nc3cccc(Cl)c3F)c2c1)NO,IC50,nM,>,40000.0,Inhibition of human ERG overexpressed in CHO cells by Qpatch method
8948,CHEMBL3601333,Cc1ccc(Nc2nccc3ccc(NC(=O)CCCCCCC(=O)NO)cc23)cc1,IC50,nM,>,40000.0,Inhibition of human ERG overexpressed in CHO cells by Qpatch method
8949,CHEMBL3601334,O=C(CCCCCCC(=O)Nc1ccc2ccnc(Nc3ccc4ccccc4c3)c2c1)NO,IC50,nM,>,40000.0,Inhibition of human ERG overexpressed in CHO cells by Qpatch method
8950,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,98.0,Inhibition of human ERG overexpressed in CHO cells by Qpatch method
8951,CHEMBL3601038,CC(=O)NC1CCN(Cc2ccc(NCCCc3ccc(Oc4ccccc4)nn3)cc2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
8952,CHEMBL3601260,COc1cccc2c1[C@H](c1ccccc1)N(C(=O)CNC[C@@H](C)O)CC2,IC50,nM,>,100000.0,Inhibition of human ERG channel by Rb efflux assay
8953,CHEMBL3601377,COc1ccc(COc2cnn(CC(=O)c3ccc(CN(C)C)cc3C)c(=O)c2)nc1,IC50,nM,=,16000.0,Inhibition of human ERG by patch clamp assay
8954,CHEMBL3605277,O=C(c1ccc(F)cc1)N1CCc2nc(COc3cccc(F)c3)oc2C1,IC50,nM,>,10000.0,Inhibition of human ERG
8955,CHEMBL3604331,C[C@@H]1c2nnc(-c3ccccn3)n2CCN1C(=O)c1cccc(Cl)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG channel expressed in HEK293 cells by radioligand competition binding assay
8956,CHEMBL3604333,C[C@H]1Cn2c(nnc2-c2ccc(F)cc2)CN1C(=O)c1cccc(Cl)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG channel expressed in HEK293 cells by radioligand competition binding assay
8957,CHEMBL3604421,C[C@H]1Cn2c(nnc2-c2ccc(F)cc2)CN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG channel expressed in HEK293 cells by radioligand competition binding assay
8958,CHEMBL3604423,C[C@H]1Cn2c(nnc2-c2cnccn2)CN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG channel expressed in HEK293 cells by radioligand competition binding assay
8959,CHEMBL3604424,C[C@H]1Cn2c(nnc2-c2ccccn2)CN1C(=O)c1cccc(Cl)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG channel expressed in HEK293 cells by radioligand competition binding assay
8960,CHEMBL3604426,COc1ccnc(-c2nnc3n2C[C@H](C)N(C(=O)c2cccc(Cl)c2Cl)C3)c1,IC50,nM,>,10000.0,Displacement of [3H]-astemizole from human ERG channel expressed in HEK293 cells by radioligand competition binding assay
8961,CHEMBL3604429,C[C@H]1Cn2c(nnc2-c2cc(F)ccn2)CN1C(=O)c1cccc(Cl)c1Cl,IC50,,,,Displacement of [3H]-astemizole from human ERG channel expressed in HEK293 cells by radioligand competition binding assay
8962,CHEMBL3605557,CCn1c([C@@H](C)NS(=O)(=O)c2ccc(C#N)nc2)nc2cnc(C(F)(F)F)cc21,IC50,nM,>,200000.0,Inhibition of human ERG
8963,CHEMBL3605558,CCn1c([C@@H](C)NS(=O)(=O)c2ccc(C#N)nc2)nc2cnc(C3CC3)cc21,IC50,nM,>,200000.0,Inhibition of human ERG
8964,CHEMBL3305005,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2000.0,Inhibition of MK499 binding to human ERG
8965,CHEMBL3604687,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(cc5Cl)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,5800.0,Inhibition of MK499 binding to human ERG
8966,CHEMBL3604688,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(cc5F)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,1300.0,Inhibition of MK499 binding to human ERG
8967,CHEMBL3604690,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(cc5C)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,1000.0,Inhibition of MK499 binding to human ERG
8968,CHEMBL3604691,COc1ccc2ncc(F)c(CCC34CCC(NCc5cc(C)c6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,300.0,Inhibition of MK499 binding to human ERG
8969,CHEMBL3604692,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(c(C)c5C)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,500.0,Inhibition of MK499 binding to human ERG
8970,CHEMBL3604693,CCc1c(CNC23CCC(CCc4c(F)cnc5ccc(OC)nc45)(CC2)OC3)nc2c(c1C)OCC(=O)N2,IC50,nM,=,700.0,Inhibition of MK499 binding to human ERG
8971,CHEMBL3604694,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(c(C)c5C(C)C)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,1200.0,Inhibition of MK499 binding to human ERG
8972,CHEMBL3604797,C=Cc1c(CNC23CCC(CCc4c(F)cnc5ccc(OC)nc45)(CC2)OC3)nc2c(c1C)OCC(=O)N2,IC50,nM,=,500.0,Inhibition of MK499 binding to human ERG
8973,CHEMBL3604798,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(c(C)c5F)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,900.0,Inhibition of MK499 binding to human ERG
8974,CHEMBL3604799,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)C(C)O6)(CC3)CO4)c2n1,IC50,nM,=,800.0,Inhibition of MK499 binding to human ERG
8975,CHEMBL3604799,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)C(C)O6)(CC3)CO4)c2n1,IC50,nM,=,1800.0,Inhibition of MK499 binding to human ERG
8976,CHEMBL3604800,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)C(C)(C)O6)(CC3)CO4)c2n1,IC50,nM,=,3000.0,Inhibition of MK499 binding to human ERG
8977,CHEMBL3604801,CCOC(=O)C1(C)Oc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC)nc56)(CC3)OC4)nc2NC1=O,IC50,nM,=,2400.0,Inhibition of MK499 binding to human ERG
8978,CHEMBL3604801,CCOC(=O)C1(C)Oc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC)nc56)(CC3)OC4)nc2NC1=O,IC50,nM,=,3600.0,Inhibition of MK499 binding to human ERG
8979,CHEMBL3604802,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)N(C)C(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,800.0,Inhibition of MK499 binding to human ERG
8980,CHEMBL3604803,COc1ccc2ncc(F)c(CCC34CCC(N(C)Cc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1200.0,Inhibition of MK499 binding to human ERG
8981,CHEMBL3604804,COC(=O)N(Cc1ccc2c(n1)NC(=O)CO2)C12CCC(CCc3c(F)cnc4ccc(OC)nc34)(CC1)OC2,IC50,nM,=,6100.0,Inhibition of MK499 binding to human ERG
8982,CHEMBL3604805,COc1ccc2ncc(F)c(CCC34CCC(NC(=O)c5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,>,60000.0,Inhibition of MK499 binding to human ERG
8983,CHEMBL3604806,COc1ccc2ncc(F)c(CCC34CCC(N(C)C(=O)c5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,>,60000.0,Inhibition of MK499 binding to human ERG
8984,CHEMBL3604807,COc1ccc2ncc(F)c(C[C@H](O)C3CCC(NCc4nc5c(cc4F)OCC(=O)N5)CO3)c2n1,IC50,nM,=,2400.0,Inhibition of MK499 binding to human ERG
8985,CHEMBL3604808,COc1ccc2ncc(F)c(C[C@H](O)C3CCC(NCc4nc5c(cc4OC)OCC(=O)N5)CO3)c2n1,IC50,,,,Inhibition of MK499 binding to human ERG
8986,CHEMBL3604809,COc1ccc2ncc(F)c(C[C@H](O)C3CCC(NCc4ccc5c(n4)NC(=O)CO5)CO3)c2n1,IC50,,,,Inhibition of MK499 binding to human ERG
8987,CHEMBL3305005,COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHO cells measured for 5 mins by automated patch clamp assay
8988,CHEMBL3604690,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(cc5C)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,4300.0,Inhibition of human ERG expressed in CHO cells measured for 5 mins by automated patch clamp assay
8989,CHEMBL3604691,COc1ccc2ncc(F)c(CCC34CCC(NCc5cc(C)c6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in CHO cells measured for 5 mins by automated patch clamp assay
8990,CHEMBL3604692,COc1ccc2ncc(F)c(CCC34CCC(NCc5nc6c(c(C)c5C)OCC(=O)N6)(CC3)CO4)c2n1,IC50,nM,=,4600.0,Inhibition of human ERG expressed in CHO cells measured for 5 mins by automated patch clamp assay
8991,CHEMBL3604805,COc1ccc2ncc(F)c(CCC34CCC(NC(=O)c5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells measured for 5 mins by automated patch clamp assay
8992,CHEMBL3604806,COc1ccc2ncc(F)c(CCC34CCC(N(C)C(=O)c5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells measured for 5 mins by automated patch clamp assay
8993,CHEMBL3604735,Cc1cc(NCc2c(Cl)ccc(Cl)c2Cl)c2cccc(C(N)=O)c2n1,IC50,nM,=,501.19,Inhibition of human ERG
8994,CHEMBL3604734,Cc1cc(NCc2c(F)cccc2C(F)(F)F)c2cccc(C(N)=O)c2n1,IC50,nM,=,398.11,Inhibition of human ERG
8995,CHEMBL3604701,Cc1cc(NCc2c(C)cccc2C)c2cccc(C(N)=O)c2n1,IC50,nM,=,501.19,Inhibition of human ERG
8996,CHEMBL3605140,CCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,400.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
8997,CHEMBL3605143,CC(C)CCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
8998,CHEMBL3605145,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC7CCC7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
8999,CHEMBL3605146,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCC(F)(F)F)nc56)(CC3)OC4)nc2N1,IC50,nM,=,1100.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9000,CHEMBL3605147,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC(F)F)nc56)(CC3)OC4)nc2N1,IC50,nM,=,700.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9001,CHEMBL3605148,COCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,17300.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9002,CHEMBL3605120,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCCO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,25000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9003,CHEMBL3605121,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCCCO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,2400.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9004,CHEMBL3605122,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCCCCO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,2400.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9005,CHEMBL3605123,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCCCCCO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,700.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9006,CHEMBL3605125,CC(C)(O)CCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,7000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9007,CHEMBL3605126,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCC7(CO)CC7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,2700.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9008,CHEMBL3605127,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCC(O)CO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,2300.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9009,CHEMBL3605128,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCC(CO)CO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,10500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9010,CHEMBL3605129,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC[C@H]7C[C@H](O)[C@H](O)C7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,3100.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9011,CHEMBL3605130,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC[C@@H]7C[C@H](O)[C@H](O)C7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,2700.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9012,CHEMBL3605131,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCC7(O)COC7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,12200.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9013,CHEMBL3605132,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC7CC(O)CC(O)C7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,6300.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9014,CHEMBL3605133,NCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,17500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9015,CHEMBL3605134,NCCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,7900.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9016,CHEMBL3605135,NCCCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,8000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9017,CHEMBL3605137,NCC1(COc2ccc3ncc(F)c(CCC45CCC(NCc6ccc7c(n6)NC(=O)CO7)(CC4)CO5)c3n2)CC1,IC50,nM,=,7600.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9018,CHEMBL3605138,NC1(COc2ccc3ncc(F)c(CCC45CCC(NCc6ccc7c(n6)NC(=O)CO7)(CC4)CO5)c3n2)CC1,IC50,nM,=,3700.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9019,CHEMBL3605139,NC1CC1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,200.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9020,CHEMBL3605014,NC1COCC1Oc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3600.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9021,CHEMBL3605015,N[C@H]1COC[C@@H]1Oc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2800.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9022,CHEMBL3605016,N[C@@H]1COC[C@H]1Oc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,11300.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9023,CHEMBL3605017,N[C@@H]1CO[C@H]1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,17700.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9024,CHEMBL3605018,N[C@H]1CO[C@@H]1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,24400.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9025,CHEMBL3605019,N[C@@H]1CO[C@@H]1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3300.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9026,CHEMBL3605020,N[C@H]1CO[C@H]1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,23900.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9027,CHEMBL3605021,NCC(O)COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3300.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9028,CHEMBL3605022,N[C@H]1C(=O)N[C@@H]1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,29100.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9029,CHEMBL3605023,N[C@@H]1C(=O)NC[C@H]1Oc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,39900.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9030,CHEMBL3605024,N#CCCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,8900.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9031,CHEMBL3605025,N#CC1(COc2ccc3ncc(F)c(CCC45CCC(NCc6ccc7c(n6)NC(=O)CO7)(CC4)CO5)c3n2)CC1,IC50,nM,=,5500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9032,CHEMBL3605026,CCOC(=O)COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,8500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9033,CHEMBL3605116,O=C(O)COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,>,60000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9034,CHEMBL3605117,CCOC(=O)CCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9035,CHEMBL3605118,O=C(O)CCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,>,60000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9036,CHEMBL3605119,COC(=O)CCCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,400.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9037,CHEMBL3604999,O=C(O)CCCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,43500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9038,CHEMBL3605000,CCOC(=O)C(F)(F)CCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,25400.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9039,CHEMBL3605001,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCCC(F)(F)C(=O)O)nc56)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9040,CHEMBL3605002,COC(=O)[C@@H]1C[C@@H]1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,600.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9041,CHEMBL3605003,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC[C@H]7C[C@H]7C(=O)O)nc56)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9042,CHEMBL3605004,COC(=O)[C@H]1C[C@@H]1COc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,500.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9043,CHEMBL3605005,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC[C@H]7C[C@@H]7C(=O)O)nc56)(CC3)OC4)nc2N1,IC50,nM,=,43400.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9044,CHEMBL3605006,COC(=O)C1(COc2ccc3ncc(F)c(CCC45CCC(NCc6ccc7c(n6)NC(=O)CO7)(CC4)CO5)c3n2)CC1,IC50,nM,=,1600.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9045,CHEMBL3605007,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCC7(C(=O)O)CC7)nc56)(CC3)OC4)nc2N1,IC50,nM,>,60000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9046,CHEMBL3605010,NC(=O)C(F)(F)CCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,9200.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9047,CHEMBL3605011,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCc7cc(=O)c(O)c[nH]7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,5300.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9048,CHEMBL3605012,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCCc7cc(=O)c(O)c[nH]7)nc56)(CC3)OC4)nc2N1,IC50,nM,=,900.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9049,CHEMBL3305167,COc1ccc2ncc(F)c(C[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,26000.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9050,CHEMBL3605013,O=C1COc2ccc(CNC34CCC([C@@H](O)Cc5c(F)cnc6ccc(OCCO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,29700.0,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9051,CHEMBL3604992,O=C1COc2ccc(CNC34CCC([C@@H](O)Cc5c(F)cnc6ccc(OCCCO)nc56)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG assessed as reduction in MK499 competitive binding
9052,CHEMBL3605120,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OCCO)nc56)(CC3)OC4)nc2N1,IC50,nM,=,2900.0,Inhibition of human ERG expressed in CHO cells by patch express method based electrophysiology assay
9053,CHEMBL3605133,NCCOc1ccc2ncc(F)c(CCC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by patch express method based electrophysiology assay
9054,CHEMBL3605003,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC[C@H]7C[C@H]7C(=O)O)nc56)(CC3)OC4)nc2N1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by patch express method based electrophysiology assay
9055,CHEMBL3605005,O=C1COc2ccc(CNC34CCC(CCc5c(F)cnc6ccc(OC[C@H]7C[C@@H]7C(=O)O)nc56)(CC3)OC4)nc2N1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by patch express method based electrophysiology assay
9056,CHEMBL3305167,COc1ccc2ncc(F)c(C[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,18000.0,Inhibition of human ERG expressed in CHO cells by patch express method based electrophysiology assay
9057,CHEMBL3605013,O=C1COc2ccc(CNC34CCC([C@@H](O)Cc5c(F)cnc6ccc(OCCO)nc56)(CC3)OC4)nc2N1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by patch express method based electrophysiology assay
9058,CHEMBL3604992,O=C1COc2ccc(CNC34CCC([C@@H](O)Cc5c(F)cnc6ccc(OCCCO)nc56)(CC3)OC4)nc2N1,IC50,,,,Inhibition of human ERG expressed in CHO cells by patch express method based electrophysiology assay
9059,CHEMBL3603923,N#Cc1cc(Cl)cc(-c2cc(-c3ccc(F)cn3)ncn2)c1,IC50,nM,>,3162.28,Inhibition of human ERG
9060,CHEMBL3609819,COc1cccc2nc(CCCN(C)CC[C@]3(OC(=O)C(C)C)C[C@H]4CCC[C@@H]3c3ccccc34)[nH]c12,IC50,nM,<,400.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
9061,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1300.0,Inhibition of human ERG expressed in HEK cells by patch clamp assay
9062,CHEMBL3422009,C[C@@H]1c2nnc(-c3csc(-c4ccc(F)cc4F)n3)n2CCN1C(=O)c1ccc(-c2cccs2)cc1,IC50,nM,=,1400.0,Inhibition of human ERG
9063,CHEMBL3422010,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)cs1,IC50,nM,=,24000.0,Inhibition of human ERG
9064,CHEMBL3608680,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,IC50,nM,>,100000.0,Inhibition of human ERG
9065,CHEMBL3422018,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,8000.0,Inhibition of human ERG
9066,CHEMBL3608681,Cc1nnc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)s1,IC50,,,,Inhibition of human ERG
9067,CHEMBL3608682,Cc1noc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,IC50,,,,Inhibition of human ERG
9068,CHEMBL3608683,CC(C)c1noc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,IC50,nM,=,1600.0,Inhibition of human ERG
9069,CHEMBL3608684,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)C3)n1,IC50,nM,=,50000.0,Inhibition of human ERG
9070,CHEMBL3608685,C[C@@H]1c2nnc(-c3ncns3)n2CCN1C(=O)c1ccc(F)cc1,IC50,,,,Inhibition of human ERG
9071,CHEMBL3608686,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)C3(C)C)n1,IC50,,,,Inhibition of human ERG
9072,CHEMBL3608687,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(Cl)cc2)[C@@H]3C)n1,IC50,nM,=,66000.0,Inhibition of human ERG
9073,CHEMBL3608688,C[C@@H]1c2nnc(-c3nc(C(F)(F)F)ns3)n2CCN1C(=O)c1ccc(F)cc1,IC50,nM,=,39000.0,Inhibition of human ERG
9074,CHEMBL3608740,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccccc2)[C@@H]3C)n1,IC50,nM,=,50000.0,Inhibition of human ERG
9075,CHEMBL3608741,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3CCO)n1,IC50,nM,=,50000.0,Inhibition of human ERG
9076,CHEMBL3318989,COc1cnc2ccc(=O)n(CCN3CCC(c4nc5cc(Cl)ccc5[nH]4)CC3)c2c1,IC50,nM,=,1000.0,Inhibition of human ERG by IonWorks assay
9077,CHEMBL3608742,NS(=O)(=O)c1ccc(Oc2cnc3ccc(=O)n(CCN4CCC(c5nc6cc(Cl)ccc6[nH]5)CC4)c3c2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWorks assay
9078,CHEMBL3290336,COc1ccc2ccc(=O)n(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2n1,IC50,nM,=,23000.0,Inhibition of human ERG by IonWorks assay
9079,CHEMBL3608743,NS(=O)(=O)c1ccc(Oc2ccc3ccc(=O)n(CCN4CCC(NCc5ccc6c(n5)NC(=O)CO6)CC4)c3n2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9080,CHEMBL3608314,Cc1cc2[nH]c(C3CCN(CCn4c(=O)ccc5ncc(Oc6ccc(S(N)(=O)=O)cc6)cc54)CC3)nc2cc1C#N,IC50,nM,>,33000.0,Inhibition of human ERG by IonWorks assay
9081,CHEMBL3608744,Cc1ncc(CNC2CCN(CCn3c(=O)ccc4ncc(Oc5ccc(S(N)(=O)=O)cc5)cc43)CC2)cc1Cl,IC50,nM,=,82000.0,Inhibition of human ERG by IonWorks assay
9082,CHEMBL3608745,Cc1ncc(CNC2CCN(CCn3c(=O)ccc4ncc(Oc5ccc(S(N)(=O)=O)cc5)cc43)CC2)cc1C#N,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9083,CHEMBL3608746,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ccc(Oc6cncnc6)nc54)CC3)nc2N1,IC50,nM,>,224000.0,Inhibition of human ERG by IonWorks assay
9084,CHEMBL3608747,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ccc(Oc6ccon6)nc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9085,CHEMBL3608748,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ncc(Oc6ccon6)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9086,CHEMBL3608749,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ncc(Oc6cccnc6)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9087,CHEMBL3608750,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ncc(Oc6cncc(F)c6)cc54)CC3)nc2N1,IC50,nM,=,79000.0,Inhibition of human ERG by IonWorks assay
9088,CHEMBL3608751,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ncc(O[C@@H]6CCOC6)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9089,CHEMBL3608752,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ncc(O[C@H]6CCOC6)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9090,CHEMBL3608753,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ncc(OCc6ccccn6)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9091,CHEMBL3608754,O=C1COc2ccc(CNC3CCN(CCn4c(=O)ccc5ncc(OCc6cccnn6)cc54)CC3)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9092,CHEMBL3608755,Cn1ccc(COc2cnc3ccc(=O)n(CCN4CCC(NCc5ccc6c(n5)NC(=O)CO6)CC4)c3c2)n1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9093,CHEMBL3608756,O=C1COc2ccc(CN[C@@H]3CCN(CCn4c(=O)ccc5ncc(Oc6ccon6)cc54)C[C@@H]3F)nc2N1,IC50,nM,>,100000.0,Inhibition of human ERG by IonWorks assay
9094,CHEMBL3608757,O=C1COc2ccc(CN[C@@H]3CCN(CCn4c(=O)ccc5ncc(Oc6cccnc6)cc54)C[C@@H]3F)nc2N1,IC50,nM,=,75000.0,Inhibition of human ERG by IonWorks assay
9095,CHEMBL3609521,CN(C)C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O,IC50,nM,=,5700.0,Inhibition of dofetilide binding to human ERG
9096,CHEMBL3609622,COc1cc(-c2cn(C3CCc4ccccc4NC3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,17600.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9097,CHEMBL3609623,COc1cc(-c2cn(C3CCc4ccccc4N(C)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,4060.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9098,CHEMBL3609624,COc1cc(-c2cn(C3CCc4ccccc4N(CCF)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,3220.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9099,CHEMBL3609625,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,8960.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9100,CHEMBL3609626,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,3560.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9101,CHEMBL3609627,COc1cc(-c2cn(C3CCc4ccccc4N(CC4CC4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,1580.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9102,CHEMBL3609628,COc1cc(-c2cn(C3CCc4ccccc4N(Cc4ccccc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,1010.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9103,CHEMBL3609629,COc1cc(-c2cn(C3CCc4ccccc4N(Cc4ccccn4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,7570.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9104,CHEMBL3609630,COc1cc(-c2cn(C3CCc4ccccc4N(Cc4ccncc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,6220.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9105,CHEMBL3609631,COc1cc(-c2cn(C3CCc4ccccc4N(Cc4cccnc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,4450.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9106,CHEMBL3609632,COc1cc(-c2cn(C3CCc4ccccc4N(CC4(C)COC4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,18100.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9107,CHEMBL3609633,COc1cc(-c2cn([C@H]3C[C@H](C)c4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,6680.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9108,CHEMBL3609634,COc1cc(-c2cn(C3CSc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,4750.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9109,CHEMBL3608322,COc1cc(-c2cn(C3(C)CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,6000.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9110,CHEMBL3609635,COc1cc(-c2cn(C3CCc4c(ccc5ccccc45)N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,900.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9111,CHEMBL3609636,COc1cc(-c2cn(C3CCc4cc(F)ccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2680.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9112,CHEMBL3609637,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,2610.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9113,CHEMBL3609638,COc1cc(-c2cn(C3CCc4c(F)cc(F)cc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,1830.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9114,CHEMBL3609639,COc1cc(-c2cn(C3CCc4c(ccc(Br)c4F)N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,530.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9115,CHEMBL3609640,COc1cc(-c2cn(C3CCc4ncccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,>,50000.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9116,CHEMBL3609641,COc1cc(-c2cn(C3CCc4cccnc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,8740.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9117,CHEMBL3609642,COc1cc(-c2cn(C3CC[C@@H]4CCCC[C@H]4N(Cc4ccccc4)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,9000.0,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay
9118,CHEMBL3609637,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,IC50,nM,=,12900.0,Inhibition of human ERG expressed in HEK cells assessed as reduction in IKr current by patchXpress assay
9119,CHEMBL3612809,COc1cc([C@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,18000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9120,CHEMBL3612808,Cc1c([C@@H](O)CN2CCN(C[C@@H](O)c3ccc(C#N)cn3)CC2)ccc2c1COC2=O,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9121,CHEMBL3612807,Cc1c([C@@H](O)CN2CCN(C[C@H](O)c3ccc(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,28000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9122,CHEMBL3612806,COc1cc(C(O)CN2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,6400.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9123,CHEMBL3612805,COc1cc(C(O)CN2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,2200.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9124,CHEMBL3612804,COc1cc(C(C)(C)CN2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,1200.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9125,CHEMBL3612803,COc1cc(C(C)CN2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,1100.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9126,CHEMBL3612802,COc1cc(CC(C)N2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,1300.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9127,CHEMBL3612801,CCOC(CN1CCN(CCc2ccc(C#N)c(OC)c2)CC1)c1ccc2c(c1C)COC2=O,IC50,nM,=,3500.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9128,CHEMBL3612800,COc1cc(CCN2CCN(CC(OC)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,9000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9129,CHEMBL3612799,COc1cc(CCN2CCN(CC(O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,9000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9130,CHEMBL3612798,COc1cc(CCN2CCN(CC(F)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,2400.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9131,CHEMBL3612797,COc1cc(CCN2CCN(CC(C)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,2800.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9132,CHEMBL3612796,COc1cc(CCN2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,2100.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9133,CHEMBL2146876,COc1cc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)ccc1C#N,IC50,nM,=,1600.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9134,CHEMBL2146871,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1,IC50,nM,=,430.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9135,CHEMBL2146757,N#Cc1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,9.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9136,CHEMBL3612795,O=C1OCc2cc(CCN3CCN(CCc4ccc([N+](=O)[O-])cc4)CC3)ccc21,IC50,nM,=,150.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9137,CHEMBL3612810,COc1cc([C@@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,17000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9138,CHEMBL3612811,COc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,1700.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9139,CHEMBL3612811,COc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,5100.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9140,CHEMBL3612812,COc1nc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9141,CHEMBL3612812,COc1nc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9142,CHEMBL3612813,Cc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9143,CHEMBL3612813,Cc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9144,CHEMBL3612814,Cc1nc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,17000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9145,CHEMBL3612814,Cc1nc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9146,CHEMBL3612922,Cc1cc(C#N)cnc1C(O)CN1CCN(C[C@H](O)c2ccc3c(c2C)COC3=O)CC1,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9147,CHEMBL3612922,Cc1cc(C#N)cnc1C(O)CN1CCN(C[C@H](O)c2ccc3c(c2C)COC3=O)CC1,IC50,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9148,CHEMBL3612923,Cc1c([C@@H](O)CN2CCN(CC(O)c3ncc(C#N)cc3Cl)CC2)ccc2c1COC2=O,IC50,nM,=,5700.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9149,CHEMBL3612923,Cc1c([C@@H](O)CN2CCN(CC(O)c3ncc(C#N)cc3Cl)CC2)ccc2c1COC2=O,IC50,nM,=,16000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9150,CHEMBL3612924,Cc1c([C@@H](O)CN2CCN(CC(O)c3cc(C4CC4)c(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,11000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9151,CHEMBL3612924,Cc1c([C@@H](O)CN2CCN(CC(O)c3cc(C4CC4)c(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,10000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9152,CHEMBL3612925,COc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)nc(C)c1C#N,IC50,nM,=,5700.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9153,CHEMBL3612925,COc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)nc(C)c1C#N,IC50,nM,=,16000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9154,CHEMBL3612926,CCOc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,11000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9155,CHEMBL3612926,CCOc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,7700.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9156,CHEMBL3612927,Cc1c([C@@H](O)CN2CCN(CC(O)c3cc(C(F)(F)F)c(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,4800.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9157,CHEMBL3612927,Cc1c([C@@H](O)CN2CCN(CC(O)c3cc(C(F)(F)F)c(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,10000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9158,CHEMBL3612928,[2H]C([2H])([2H])Oc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,20000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9159,CHEMBL3612928,[2H]C([2H])([2H])Oc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,21000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9160,CHEMBL3612796,COc1cc(CCN2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,<=,1000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9161,CHEMBL3612807,Cc1c([C@@H](O)CN2CCN(C[C@H](O)c3ccc(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,12000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9162,CHEMBL3612810,COc1cc([C@@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,33000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9163,CHEMBL3612814,Cc1nc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N,IC50,nM,=,14000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9164,CHEMBL3612924,Cc1c([C@@H](O)CN2CCN(CC(O)c3cc(C4CC4)c(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,14000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9165,CHEMBL3612926,CCOc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,12000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9166,CHEMBL3612928,[2H]C([2H])([2H])Oc1cc(C(O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N,IC50,nM,=,30000.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9167,CHEMBL2441437,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,4500.0,Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
9168,CHEMBL3618335,O=c1c2cc(-c3ccc(Cl)cc3)cn2ncn1-c1ccc(N2CCC(O)CC2)nc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as channel current by Q-patch electrophysiological assay
9169,CHEMBL3618324,COc1cc(-n2cnn3cc(-c4ccc(Cl)cc4)cc3c2=O)ccc1OCCN1CCCC1,IC50,nM,=,5500.0,Inhibition of human ERG by flux assay
9170,CHEMBL3618330,CNC1CCN(c2ccc(-n3cnn4cc(-c5ccc(Cl)cc5)cc4c3=O)cn2)C1,IC50,nM,=,3000.0,Inhibition of human ERG by flux assay
9171,CHEMBL3618331,O=c1c2cc(-c3ccc(Cl)cc3)cn2ncn1-c1ccc(N2CC(O)C2)nc1,IC50,nM,=,3300.0,Inhibition of human ERG by flux assay
9172,CHEMBL3618333,O=c1c2cc(-c3ccc(Cl)cn3)cn2ncn1-c1ccc(N2CC[C@@H](O)C2)nc1,IC50,nM,>,80000.0,Inhibition of human ERG by flux assay
9173,CHEMBL3618334,O=c1c2cc(-c3ccc(Cl)cc3)cn2ncn1-c1ccc(N2CCC(N3CC(O)C3)C2)nc1,IC50,nM,=,2000.0,Inhibition of human ERG by flux assay
9174,CHEMBL3618335,O=c1c2cc(-c3ccc(Cl)cc3)cn2ncn1-c1ccc(N2CCC(O)CC2)nc1,IC50,nM,>,80000.0,Inhibition of human ERG by flux assay
9175,CHEMBL3120274,CNc1nc(NCCCN(C)C)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,=,2700.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology assay
9176,CHEMBL3617330,CNc1nc(NCCN2CCNCC2)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,=,1400.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology assay
9177,CHEMBL3617334,CNc1nc(NCC(F)(F)F)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology assay
9178,CHEMBL3617353,Nc1nc(NC2CCNCC2)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,=,900.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology assay
9179,CHEMBL3617452,Nc1nc(NC2CCNC2)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,=,2400.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology assay
9180,CHEMBL3617454,Nc1nc(NC2CCOCC2)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,=,700.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology assay
9181,CHEMBL3617456,Nc1nc(N2CCC(N)CC2)c2sc(-c3ccc(C(F)(F)F)cc3)cc2n1,IC50,nM,=,6100.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology assay
9182,CHEMBL3622203,C[C@@H](Oc1nc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,IC50,nM,>,30000.0,Inhibition of human ERG by binding assay
9183,CHEMBL3416026,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,IC50,nM,=,28000.0,Inhibition of human ERG by automated patch clamp assay
9184,CHEMBL3622203,C[C@@H](Oc1nc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
9185,CHEMBL3622175,COCc1cnc(N2CCC([C@H]3C[C@H]3COCc3ccc(S(C)(=O)=O)cc3F)CC2)nc1,IC50,nM,=,13000.0,Inhibition of human ERG by by patchXpress method
9186,CHEMBL3622956,Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1,IC50,nM,=,24200.0,Inhibition of human ERG by manual patch clamp assay
9187,CHEMBL3622957,Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC[C@@H](O)C1,IC50,,,,Inhibition of human ERG by manual patch clamp assay
9188,CHEMBL3622958,Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(C)c(C)n4C)n2)cc1CN1CC(O)C1,IC50,nM,=,12500.0,Inhibition of human ERG by manual patch clamp assay
9189,CHEMBL3623278,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCOCC1,IC50,nM,=,17000.0,Inhibition of human ERG by patch clamp assay
9190,CHEMBL3622446,Cc1nnc2n1-c1ccc(-c3cncc([C@@](C)(O)C(F)(F)F)c3)cc1CC2,IC50,nM,>,30000.0,Displacement of [35S]MK0499 from human ERG
9191,CHEMBL3627897,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@H](c3cccc(F)c3)c3ccc4[nH]c(C)nc4c3)c(Cl)c2)n1,IC50,nM,=,19900.0,Inhibition of human ERG
9192,CHEMBL3627894,COc1cc2nc([C@@H](CNC(=O)c3c(Cl)cc(-n4cnc(C)n4)cc3Cl)c3cccc(F)c3)[nH]c2cc1Cl,IC50,nM,=,10930.0,Inhibition of human ERG
9193,CHEMBL3627896,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@H](c3cccc(F)c3)c3nc4c(C)cc(Cl)cc4[nH]3)c(Cl)c2)n1,IC50,nM,=,3051.0,Inhibition of human ERG
9194,CHEMBL3627899,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@H](c3cccc(F)c3)c3nc4c(F)ccc(C)c4c(=O)[nH]3)c(Cl)c2)n1,IC50,nM,>,60000.0,Inhibition of human ERG
9195,CHEMBL3627895,Cc1ncn(-c2cc(Cl)c(C(=O)NC[C@@H](c3cccc(F)c3)c3nc4ccc(Cl)cc4[nH]3)c(Cl)c2)n1,IC50,nM,=,5351.0,Inhibition of human ERG
9196,CHEMBL3628128,N/C1=N\C(=O)[C@@H]2CCCN2c2ccc(cc2)OCCCCCCNCC(=O)Nc2c(Cl)cc(cc2Cl)CN1,IC50,nM,=,32000.0,Inhibition of human ERG by thallium flux assay
9197,CHEMBL3628127,N/C1=N\C(=O)[C@@H]2CCCN2c2ccc(cc2)OC/C=C/CCCNCC(=O)Nc2c(Cl)cc(cc2Cl)CN1,IC50,nM,>,13000.0,Inhibition of human ERG by thallium flux assay
9198,CHEMBL3628126,N/C1=N\C(=O)[C@@H]2CCCN2c2ccc(cc2)OCCCCCNCC(=O)Nc2c(Cl)cc(cc2Cl)CN1,IC50,nM,>,13000.0,Inhibition of human ERG by thallium flux assay
9199,CHEMBL3628125,N/C1=N\C(=O)[C@@H]2CCCN2c2ccc(cc2)OC/C=C/CCNCC(=O)Nc2c(Cl)cc(cc2Cl)CN1,IC50,nM,>,13000.0,Inhibition of human ERG by thallium flux assay
9200,CHEMBL3628124,N/C1=N\C(=O)[C@@H]2CCCN2c2ccc(cc2)OC/C=C/CNCC(=O)Nc2c(Cl)cc(cc2Cl)CN1,IC50,nM,>,13000.0,Inhibition of human ERG by thallium flux assay
9201,CHEMBL3234071,CS(=O)(=O)c1ccc(-c2cnc3ccc(-c4cccc(S(C)(=O)=O)c4)nn23)cc1,IC50,nM,=,900.0,Inhibition of human ERG potassium channel by ionworks patch-clamp electrophysiology assay
9202,CHEMBL3355639,CS(=O)(=O)c1ccc(-c2cnc3ccc(-c4cccc(S(=O)(=O)C5CC5)c4)nn23)cc1,IC50,nM,=,400.0,Inhibition of human ERG potassium channel by ionworks patch-clamp electrophysiology assay
9203,CHEMBL3628216,CS(=O)(=O)c1ccc(-c2cnc3ccc(-c4cccc(S(C)(=O)=O)c4)cn23)cc1,IC50,nM,=,4800.0,Inhibition of human ERG potassium channel by ionworks patch-clamp electrophysiology assay
9204,CHEMBL3628219,CS(=O)(=O)c1ccc(-c2cnn3ccc(-c4cccc(S(C)(=O)=O)c4)cc23)cc1,IC50,nM,>,33000.0,Inhibition of human ERG potassium channel by ionworks patch-clamp electrophysiology assay
9205,CHEMBL3628220,CS(=O)(=O)c1ccc(-c2cnn3ccc(-c4cccc(S(=O)(=O)C5CC5)c4)cc23)cc1,IC50,nM,=,1400.0,Inhibition of human ERG potassium channel by ionworks patch-clamp electrophysiology assay
9206,CHEMBL3628223,CS(=O)(=O)c1ccc(-c2cnn3ccc(-c4cccc(S(=O)(=O)C5CC5)c4)nc23)cc1,IC50,nM,=,500.0,Inhibition of human ERG potassium channel by ionworks patch-clamp electrophysiology assay
9207,CHEMBL3634101,O=C(Nc1cc2ncncc2cc1OCc1cccc(Cl)c1)Nc1cccc2ccccc12,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane after 1 hr
9208,CHEMBL3634812,O=C(c1ccc(F)cc1F)C1CCN(CCCOc2ccc(-c3nc4ccccc4o3)cc2)CC1,IC50,nM,=,850.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch clamp method
9209,CHEMBL3634813,Fc1ccc2c(C3CCN(CCCOc4ccc(-c5nc6ccccc6o5)cc4)CC3)noc2c1,IC50,nM,=,3760.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch clamp method
9210,CHEMBL3634821,Fc1ccc2c(C3CCN(CCCOc4ccc(Cc5nc6ccccc6o5)cc4)CC3)noc2c1,IC50,nM,=,5980.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch clamp method
9211,CHEMBL3634824,Fc1ccc2c(C3CCN(CCCOc4ccc(CCc5nc6ccccc6o5)cc4)CC3)noc2c1,IC50,nM,=,630.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch clamp method
9212,CHEMBL3634825,CC(c1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1)c1nc2ccccc2o1,IC50,nM,=,1010.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch clamp method
9213,CHEMBL3634013,COc1ccc([C@H](C)NC(=O)COc2cc(C(F)(F)F)c3c(-c4ccccc4)nn(C)c3n2)cc1,IC50,nM,>,30000.0,Binding affinity to human ERG
9214,CHEMBL3634015,Cc1n[nH]c(C)c1[C@H](C)NC(=O)COc1cc(C(F)(F)F)c2c(-c3ccccc3)nn(C)c2n1,IC50,nM,>,30000.0,Binding affinity to human ERG
9215,CHEMBL3634013,COc1ccc([C@H](C)NC(=O)COc2cc(C(F)(F)F)c3c(-c4ccccc4)nn(C)c3n2)cc1,IC50,,,,Inhibition of human ERG by QPatch assay
9216,CHEMBL3634015,Cc1n[nH]c(C)c1[C@H](C)NC(=O)COc1cc(C(F)(F)F)c2c(-c3ccccc3)nn(C)c2n1,IC50,nM,>,30000.0,Inhibition of human ERG by QPatch assay
9217,CHEMBL2425070,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)ccc1F,IC50,nM,>,30000.0,Inhibition of human ERG assessed as reduction in IKr current
9218,CHEMBL2105762,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,IC50,nM,=,39000.0,Inhibition of human ERG assessed as reduction in IKr current
9219,CHEMBL3735281,CCS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,IC50,nM,>,60000.0,Inhibition of human ERG assessed as reduction in IKr current
9220,CHEMBL3735329,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,IC50,nM,=,21000.0,Inhibition of human ERG assessed as reduction in IKr current
9221,CHEMBL3734797,Cc1noc([C@H]2C[C@@H]2C(=O)NCc2ccc(-c3cccc(OC(F)(F)F)c3)c3c2CN(C(=O)NC(C)(C)C)CC3)n1,IC50,nM,=,2340.0,Displacement of [35S]-MK-0499 from human ERG
9222,CHEMBL3736345,CC(C)(C)n1nnc2c1CCC(n1cnc(-c3ccc(F)cc3)n1)C2,IC50,nM,=,6309.57,Inhibition of human ERG
9223,CHEMBL271220,CCOC[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2,IC50,nM,=,800.0,Inhibition of human ERG by patch clamp technique
9224,CHEMBL3735203,O=C(c1ccccn1)[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp technique
9225,CHEMBL3735710,COc1cccc(S(=O)(=O)N2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3ccccn3)C2)c1,IC50,nM,>,19000.0,Inhibition of human ERG by patch clamp technique
9226,CHEMBL3736358,O=C(c1ccccn1)[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1cccc(C(F)(F)F)c1)C2,IC50,nM,>,20000.0,Inhibition of human ERG by patch clamp technique
9227,CHEMBL3735376,O=C(c1ccccn1)[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(F)cc1)C2,IC50,nM,=,980.0,Inhibition of human ERG by patch clamp technique
9228,CHEMBL3734774,O=C(c1ccccn1)[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2,IC50,nM,=,5000.0,Inhibition of human ERG by patch clamp technique
9229,CHEMBL42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,nM,=,901.0,Inhibition of human ERG
9230,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,778.0,Inhibition of human ERG
9231,CHEMBL3740256,O=S(=O)(c1ccc(C(F)(F)F)cc1)N1CCC(CN2CCC(c3noc4cc(F)ccc34)CC2)CC1,IC50,nM,=,1390.1,Inhibition of human ERG
9232,CHEMBL3741292,O=[N+]([O-])c1ccc(S(=O)(=O)N2CCC(CN3CCC(c4noc5cc(F)ccc45)CC3)CC2)cc1,IC50,nM,=,3810.2,Inhibition of human ERG
9233,CHEMBL3740472,COCCCN1C[C@H]2[C@H](CNC(=O)c3nc(C(C)C)n4ccccc34)[C@H]2C1,IC50,nM,=,5100.0,Inhibition of human ERG channel expressed in HEK293 cells after 5 mins by patch clamp assay
9234,CHEMBL3740099,COc1cc(N2C(=O)N(Cc3c(F)cc(F)cc3F)c3ncccc3S2(=O)=O)cnc1OC,IC50,nM,>,10000.0,Inhibition of human ERG
9235,CHEMBL3739712,Cc1cc(COc2ccc(F)c(F)c2F)nc(-c2ccccn2)n1,IC50,nM,>,31622.78,Inhibition of human ERG
9236,CHEMBL3740291,CC1(C#N)CN(c2cc(COc3ccc(F)c(F)c3F)nc(-c3ccccn3)n2)C1,IC50,nM,=,10000.0,Inhibition of human ERG
9237,CHEMBL3741735,Fc1ccc(OCc2cc(OCC3(F)COC3)nc(-c3ccccn3)n2)c(F)c1F,IC50,nM,=,6309.57,Inhibition of human ERG
9238,CHEMBL3741159,O=C(c1ccc(Cl)c(C(F)(F)F)c1)N1CCN(c2cc(=O)[nH]c(=O)n2Cc2ccc(OS(=O)(=O)c3cccc4cnccc34)cc2)CC1,IC50,nM,=,47800.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
9239,CHEMBL3741589,O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1,IC50,nM,=,77000.0,Displacement of doferilide from human ERG
9240,CHEMBL3746068,Nc1nc(CNC(=O)c2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1,IC50,nM,>,30000.0,Inhibition of human ERG by IKr binding assay
9241,CHEMBL3747487,CCOC(=O)C1CCN(C(=O)c2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)CC1,IC50,nM,=,8300.0,Inhibition of human ERG by IKr binding assay
9242,CHEMBL3747244,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCC2(CCOC2=O)CC1,IC50,nM,=,46000.0,Inhibition of human ERG by IKr binding assay
9243,CHEMBL3746280,CC1(C)CC2(CCN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)CC2)C(=O)O1,IC50,nM,=,31000.0,Inhibition of human ERG by IKr binding assay
9244,CHEMBL3747710,CCS(=O)(=O)C1CCN(C(=O)c2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)CC1,IC50,nM,>,60000.0,Inhibition of human ERG by IKr binding assay
9245,CHEMBL3747546,CCOC(=O)[C@@H]1[C@H]2CN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)C[C@H]21,IC50,nM,=,7000.0,Inhibition of human ERG by IKr binding assay
9246,CHEMBL3746885,CCOC(=O)[C@H]1[C@H]2CN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)C[C@H]21,IC50,nM,=,12000.0,Inhibition of human ERG by IKr binding assay
9247,CHEMBL3747356,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1C[C@H]2[C@@H](C1)[C@@H]2c1nnco1,IC50,nM,=,55000.0,Inhibition of human ERG by IKr binding assay
9248,CHEMBL3747455,CCc1nnc([C@@H]2[C@H]3CN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)C[C@H]32)o1,IC50,nM,=,36000.0,Inhibition of human ERG by IKr binding assay
9249,CHEMBL3745890,Cn1nnc([C@@H]2[C@H]3CN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)C[C@H]32)n1,IC50,nM,=,17000.0,Inhibition of human ERG by IKr binding assay
9250,CHEMBL3651966,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,nM,=,12000.0,Inhibition of human ERG by patch clamp assay
9251,CHEMBL3746457,O=C1c2cc(COc3ccccc3)nn2CCN1c1ccc(F)cn1,IC50,nM,>,10000.0,Inhibition of human ERG
9252,CHEMBL3746204,CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3ccc(F)c(C(F)(F)F)c3)c2)ncn1,IC50,nM,=,5800.0,Inhibition of human ERG channel by automated Q-patch assay
9253,CHEMBL3747226,O=C(Nc1cccc(C(F)(F)F)c1)n1ccc2cc(Oc3ncnc4c3CCNC4)ccc21,IC50,nM,=,8900.0,Inhibition of human ERG channel by automated Q-patch assay
9254,CHEMBL3747266,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cccc(C(F)(F)F)c3)c2)CN1,IC50,nM,=,10700.0,Inhibition of human ERG channel by automated Q-patch assay
9255,CHEMBL3747481,O=C(Nc1cccc(C(F)(F)F)c1)n1ccc2cc(Oc3ncnc4c3CNC4)ccc21,IC50,nM,=,15600.0,Inhibition of human ERG channel by automated Q-patch assay
9256,CHEMBL3746562,CC1(c2cc(NC(=O)n3ccc4cc(Oc5ncnc6c5CCNC6)ccc43)n[nH]2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG channel by automated Q-patch assay
9257,CHEMBL3746776,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C)CC4)[nH]n3)c2)CN1,IC50,nM,=,27400.0,Inhibition of human ERG channel by automated Q-patch assay
9258,CHEMBL3746226,CC(C)(C)c1cc(NC(=O)n2ccc3cc(Oc4ncnc5c4CCNC5)ccc32)no1,IC50,nM,=,7000.0,Inhibition of human ERG channel by automated Q-patch assay
9259,CHEMBL3747669,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C(C)(C)C)on3)c2)CN1,IC50,nM,=,11100.0,Inhibition of human ERG channel by automated Q-patch assay
9260,CHEMBL3745816,CC(C)(C)c1cc(NC(=O)n2ccc3cc(Oc4ncnc5c4CNC5)ccc32)no1,IC50,nM,=,23500.0,Inhibition of human ERG channel by automated Q-patch assay
9261,CHEMBL3746122,O=C(Nc1cc(C2CC2)on1)n1ccc2cc(Oc3ncnc4c3CNC4)ccc21,IC50,nM,>,30000.0,Inhibition of human ERG channel by automated Q-patch assay
9262,CHEMBL3663242,C[C@H]1Cn2c(nnc2-c2cnccn2)C(=O)N1Cc1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Displacement of dofetilide from human ERG channel
9263,CHEMBL3754515,Nc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cn1,IC50,nM,=,1800.0,Inhibition of human ERG transfected in HEK293 cells
9264,CHEMBL3754123,Nc1ncc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cn1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cells
9265,CHEMBL3752154,COc1ccc2ncc(F)c(CC(N)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,14000.0,Inhibition of human ERG expressed in CHO cells by patch express assay
9266,CHEMBL3754258,COc1ccc2ncc(F)c(C(=O)CC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3700.0,Inhibition of human ERG expressed in CHO cells by patch express assay
9267,CHEMBL3754299,COc1ccc2ncc(F)c(CC(=O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,9400.0,Displacement of MK499 from human ERG
9268,CHEMBL3752587,COc1ccc2ncc(F)c(C[C@H](OC)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,6000.0,Displacement of MK499 from human ERG
9269,CHEMBL3753257,COc1ccc2ncc(F)c(CC(OCCO)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1400.0,Displacement of MK499 from human ERG
9270,CHEMBL3754692,COc1ccc2ncc(F)c(CC(OCC(=O)O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3000.0,Displacement of MK499 from human ERG
9271,CHEMBL3752550,COc1ccc2ncc(F)c(CC(F)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3200.0,Displacement of MK499 from human ERG
9272,CHEMBL3752154,COc1ccc2ncc(F)c(CC(N)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,14600.0,Displacement of MK499 from human ERG
9273,CHEMBL3752154,COc1ccc2ncc(F)c(CC(N)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1200.0,Displacement of MK499 from human ERG
9274,CHEMBL3753230,COc1ccc2ncc(F)c(CC(NOC(C)=O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,18200.0,Displacement of MK499 from human ERG
9275,CHEMBL3752949,COc1ccc2ncc(F)c(CC(NS(C)(=O)=O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,3300.0,Displacement of MK499 from human ERG
9276,CHEMBL3753912,COc1ccc2ncc(F)c(C/C(=N\O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1600.0,Displacement of MK499 from human ERG
9277,CHEMBL3754022,COc1ccc2ncc(F)c(C/C(=N/O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,5400.0,Displacement of MK499 from human ERG
9278,CHEMBL3752010,CO/N=C(/Cc1c(F)cnc2ccc(OC)nc12)C12CCC(NCc3ccc4c(n3)NC(=O)CO4)(CC1)CO2,IC50,nM,=,2500.0,Displacement of MK499 from human ERG
9279,CHEMBL3753613,COc1ccc2ncc(F)c(CC(C)(O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,6100.0,Displacement of MK499 from human ERG
9280,CHEMBL3753861,COc1ccc2ncc(F)c(CC(O)(C(F)(F)F)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,2400.0,Displacement of MK499 from human ERG
9281,CHEMBL3754258,COc1ccc2ncc(F)c(C(=O)CC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1200.0,Displacement of MK499 from human ERG
9282,CHEMBL3753902,COc1ccc2ncc(F)c(C(O)CC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,4000.0,Displacement of MK499 from human ERG
9283,CHEMBL3753902,COc1ccc2ncc(F)c(C(O)CC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,1300.0,Displacement of MK499 from human ERG
9284,CHEMBL3754192,COc1ccc2ncc(F)c(C(C)(O)CC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,6500.0,Displacement of MK499 from human ERG
9285,CHEMBL3753978,COc1ccc2ncc(F)c(C(CO)CC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,11000.0,Displacement of MK499 from human ERG
9286,CHEMBL3753081,CCOC(=O)C(CC12CCC(NCc3ccc4c(n3)NC(=O)CO4)(CC1)CO2)c1c(F)cnc2ccc(OC)nc12,IC50,nM,=,8400.0,Displacement of MK499 from human ERG
9287,CHEMBL3752808,COc1ccc2ncc(F)c(C(CC34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)C(=O)O)c2n1,IC50,nM,=,1000.0,Displacement of MK499 from human ERG
9288,CHEMBL3753988,COc1ccc2ncc(F)c([C@@H](O)[C@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,60000.0,Displacement of MK499 from human ERG
9289,CHEMBL3753718,COc1ccc2ncc(F)c([C@H](O)[C@@H](O)C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,36100.0,Displacement of MK499 from human ERG
9290,CHEMBL3754125,COc1ccc2ncc(F)c([C@H]3OC(=O)O[C@@H]3C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,11200.0,Displacement of MK499 from human ERG
9291,CHEMBL3754742,COc1ccc2ncc(F)c([C@@H]3OC(=O)O[C@H]3C34CCC(NCc5ccc6c(n5)NC(=O)CO6)(CC3)CO4)c2n1,IC50,nM,=,4900.0,Displacement of MK499 from human ERG
9292,CHEMBL3758349,CC(CCNCC12CC3CC(CC(C3)C1)C2)Nc1ccnc2cc(Cl)ccc12,IC50,nM,>,5000.0,Inhibition of human ERG expressed in CHO cells by patch plate method
9293,CHEMBL3758840,CC(CCNCC12CC3CC(CC(C3)C1)C2)Nc1c(F)cnc2cc(Cl)ccc12,IC50,nM,>,5000.0,Inhibition of human ERG expressed in CHO cells by patch plate method
9294,CHEMBL1294,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,IC50,nM,=,2670.0,Inhibition of human ERG expressed in CHO cells by patch plate method
9295,CHEMBL3126842,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,IC50,nM,=,26000.0,Inhibition of human ERG by FLIPR assay
9296,CHEMBL3758288,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)C(C)C)cc21,IC50,nM,=,40900.0,Inhibition of human ERG by FLIPR assay
9297,CHEMBL3760108,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)CC(C)C)cc21,IC50,nM,=,16600.0,Inhibition of human ERG by FLIPR assay
9298,CHEMBL3759768,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)C3CCC3)cc21,IC50,nM,=,38100.0,Inhibition of human ERG by FLIPR assay
9299,CHEMBL74656,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC,IC50,nM,<,1000.0,Inhibition of human ERG channel by fluorescence polarization assay
9300,CHEMBL3758721,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCn2cccc2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9301,CHEMBL3758932,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCn2cccc2)C[C@H]1OC,IC50,nM,=,6835.0,Inhibition of human ERG channel by fluorescence polarization assay
9302,CHEMBL3758199,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCn2ccnc2)C[C@H]1OC,IC50,nM,=,7261.0,Inhibition of human ERG channel by fluorescence polarization assay
9303,CHEMBL3759601,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCn2cncn2)C[C@H]1OC,IC50,nM,=,7711.0,Inhibition of human ERG channel by fluorescence polarization assay
9304,CHEMBL3758523,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCn2ncnn2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9305,CHEMBL3758578,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCC(=O)N2CCCC2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9306,CHEMBL3758945,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCC(=O)N2CCCCC2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9307,CHEMBL3759928,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCC(=O)N2CCC(Cc3ccccc3)CC2)C[C@H]1OC,IC50,nM,=,3701.0,Inhibition of human ERG channel by fluorescence polarization assay
9308,CHEMBL3758410,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCC(=O)N2CCOCC2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9309,CHEMBL3759259,CCC(=O)N1CCC(CN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9310,CHEMBL3759348,CCC(=O)N1CCCC(CN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)C1,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9311,CHEMBL3759824,CCC(=O)N1CCC(CCN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9312,CHEMBL3759969,COC(=O)N1CCC(CN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)CC1,IC50,nM,=,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9313,CHEMBL3759362,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CC2CCN(C(C)=O)CC2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9314,CHEMBL3759546,CCCC(=O)N1CCC(CN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9315,CHEMBL3759860,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CC2CCN(C(=O)C(C)C)CC2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9316,CHEMBL3759944,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CC2CCN(C(=O)C(C)(C)C)CC2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9317,CHEMBL3758433,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CC2CCN(C(=O)CC(C)C)CC2)C[C@H]1OC,IC50,nM,=,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9318,CHEMBL3758398,CCOC(=O)N1CCC(CN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)CC1,IC50,nM,=,4580.0,Inhibition of human ERG channel by fluorescence polarization assay
9319,CHEMBL3758641,CCCOC(=O)N1CCC(CN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)CC1,IC50,nM,<,1000.0,Inhibition of human ERG channel by fluorescence polarization assay
9320,CHEMBL3758397,CCC(=S)N1CCC(CN2CC[C@H](NC(=O)c3cc(Cl)c(N)cc3OC)[C@H](OC)C2)CC1,IC50,nM,=,2862.0,Inhibition of human ERG channel by fluorescence polarization assay
9321,CHEMBL3758674,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CC2CCN(C(=S)C(C)C)CC2)C[C@H]1OC,IC50,nM,=,1132.0,Inhibition of human ERG channel by fluorescence polarization assay
9322,CHEMBL3759759,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CC2CCN(C(=O)N(C)C)CC2)C[C@H]1OC,IC50,nM,>,10000.0,Inhibition of human ERG channel by fluorescence polarization assay
9323,CHEMBL3758976,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CC2CCN(C(=O)NC(C)C)CC2)C[C@H]1OC,IC50,nM,=,7551.0,Inhibition of human ERG channel by fluorescence polarization assay
9324,CHEMBL3342693,Cc1nc(NC(=O)c2cc(CNC(=O)C(C)C)cnc2C(F)F)[nH]c1-c1ccc(C(F)(F)F)cc1,IC50,nM,=,82.6,Inhibition of human ERG
9325,CHEMBL111201,O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1,IC50,nM,=,220.0,Binding affinity to human ERG channel
9326,CHEMBL1684585,Nc1nc(CC(=O)Nc2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1,IC50,nM,=,19000.0,Binding affinity to human ERG channel
9327,CHEMBL3128178,O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2scnc21,IC50,nM,=,6100.0,Binding affinity to human ERG channel
9328,CHEMBL3128188,O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2ccnn21,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9329,CHEMBL3764774,O=C(Cn1cnc2ccccc2c1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1,IC50,nM,=,2000.0,Binding affinity to human ERG channel
9330,CHEMBL3764088,O=C(Cn1ncccc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9331,CHEMBL3764950,O=C(Cn1cnccc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9332,CHEMBL3763594,O=C(Cn1cccnc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9333,CHEMBL3764592,O=C(Cn1ccccc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9334,CHEMBL3765335,C[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)n1ncccc1=O,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9335,CHEMBL3763998,C[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)n1ncccc1=O,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9336,CHEMBL3763934,O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2cccc(=O)n21,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9337,CHEMBL2107826,O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2nccc(=O)n21,IC50,nM,>,30000.0,Binding affinity to human ERG channel
9338,CHEMBL3764650,COc1ccccc1N1CCN(CCCCCC(=O)n2c3ccccc3c3ccccc32)CC1.Cl,IC50,nM,=,2830.0,Inhibition of human ERG expressed in CHO-K1 cells by patch clamp method
9339,CHEMBL3137320,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,IC50,nM,>,100000.0,Inhibition of human ERG by cell based assay
9340,CHEMBL3764357,CN(C)Cc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1.Cl.Cl,IC50,nM,=,6300.0,Inhibition of human ERG using tracer red fluorescent probe
9341,CHEMBL3765596,O=C1CCc2c(Oc3ccc4c(c3)C[C@H](NC(=O)c3cccc(C(F)(F)F)c3)CC4)ccnc2N1,IC50,nM,>,11100.0,Inhibition of human ERG using tracer red fluorescent probe
9342,CHEMBL3764238,CNCc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1.Cl.Cl,IC50,nM,=,10000.0,Inhibition of human ERG using tracer red fluorescent probe
9343,CHEMBL3765509,CCNCc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1.Cl.Cl,IC50,nM,=,5600.0,Inhibition of human ERG using tracer red fluorescent probe
9344,CHEMBL3764101,Cl.Cl.NCc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1,IC50,nM,=,6600.0,Inhibition of human ERG using tracer red fluorescent probe
9345,CHEMBL3764895,CC(C)(N)c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1.Cl.Cl,IC50,nM,=,7400.0,Inhibition of human ERG using tracer red fluorescent probe
9346,CHEMBL3765012,Cl.Cl.NC1(c2cc(C(=O)N[C@@H]3CCc4ccc(Oc5ccnc6c5CCC(=O)N6)cc4C3)cc(C(F)(F)F)c2)CCC1,IC50,nM,=,3100.0,Inhibition of human ERG using tracer red fluorescent probe
9347,CHEMBL3763999,Cl.N[C@H](CO)c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1,IC50,nM,=,13800.0,Inhibition of human ERG using tracer red fluorescent probe
9348,CHEMBL3764870,Cl.Cl.O=C1CCc2c(Oc3ccc4c(c3)C[C@H](NC(=O)c3cc(C(F)(F)F)cc(C5(O)CNC5)c3)CC4)ccnc2N1,IC50,nM,=,4900.0,Inhibition of human ERG using tracer red fluorescent probe
9349,CHEMBL3764275,O=C1CCc2c(Oc3ccc4c(c3)C[C@H](NC(=O)c3cc(CN5CCOCC5CO)cc(C(F)(F)F)c3)CC4)ccnc2N1,IC50,nM,>,100000.0,Inhibition of human ERG using tracer red fluorescent probe
9350,CHEMBL3765355,O=C1CCc2c(Oc3ccc4c(c3)C[C@H](NC(=O)c3cc(-c5cnc[nH]5)cc(C(F)(F)F)c3)CC4)ccnc2N1,IC50,nM,>,33000.0,Inhibition of human ERG using tracer red fluorescent probe
9351,CHEMBL3765074,O=C1CCc2c(Oc3ccc4c(c3)C[C@H](NC(=O)c3cc(-c5cc[nH]n5)cc(C(F)(F)F)c3)CC4)ccnc2N1,IC50,nM,>,33000.0,Inhibition of human ERG using tracer red fluorescent probe
9352,CHEMBL3765708,Cl.O=C1CCc2c(Oc3ccc4c(c3)C[C@H](NC(=O)c3cc(-c5cn[nH]c5)cc(C(F)(F)F)c3)CC4)ccnc2N1,IC50,nM,>,11100.0,Inhibition of human ERG using tracer red fluorescent probe
9353,CHEMBL3763694,Cl.Cl.Cn1cnc(-c2cc(C(=O)N[C@@H]3CCc4ccc(Oc5ccnc6c5CCC(=O)N6)cc4C3)cc(C(F)(F)F)c2)c1,IC50,nM,>,100000.0,Inhibition of human ERG using tracer red fluorescent probe
9354,CHEMBL3764588,Cl.Cn1nccc1-c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1,IC50,nM,>,11100.0,Inhibition of human ERG using tracer red fluorescent probe
9355,CHEMBL3763646,Cl.Cn1cc(-c2cc(C(=O)N[C@@H]3CCc4ccc(Oc5ccnc6c5CCC(=O)N6)cc4C3)cc(C(F)(F)F)c2)cn1,IC50,nM,>,100000.0,Inhibition of human ERG using tracer red fluorescent probe
9356,CHEMBL3765022,O=C(O)CN(C1(c2ccc(-c3ccccc3OC(F)(F)F)cc2)CCC1)S(=O)(=O)c1ccc(OC(F)F)cc1,IC50,nM,=,15000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
9357,CHEMBL3764017,CC1(C)CCc2cc(S(=O)(=O)N(CC(=O)O)C3(c4cccc(-c5cc(Cl)cc(Cl)c5)c4)CCC3)ccc2O1,IC50,nM,=,40000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
9358,CHEMBL3764044,CC1(C)CCc2cc(S(=O)(=O)N(CC(=O)O)Cc3cccc(-c4ccccc4)c3)ccc2O1,IC50,nM,=,20000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
9359,CHEMBL3764377,O=C(O)CN(Cc1cccc(-c2ccccc2OC(F)(F)F)c1)S(=O)(=O)c1ccc(OC(F)F)cc1,IC50,nM,=,11000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
9360,CHEMBL3769968,C=CCOc1cc(F)c(F)cc1C1CC1CN.Cl,IC50,nM,=,9100.0,Inhibition of human ERG channel
9361,CHEMBL3770443,CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
9362,CHEMBL3770342,NC1=NC2(CCCCC2)NC(Nc2cccc(Br)c2)=N1,IC50,nM,>,1000.0,Inhibition of human ERG channel by patch clamp assay
9363,CHEMBL3770359,Cc1c(C2CC2)nc2ccc(-n3ccc(OCc4ccc(Cl)cc4)cc3=O)cn12,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp test
9364,CHEMBL3769933,Cc1c2c(nn1-c1nnc(-c3ccc(OC(C)C)c(Cl)c3)s1)CCN(CCC(=O)O)C2,IC50,nM,>,50118.72,Inhibition of human ERG
9365,CHEMBL461101,CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O,IC50,nM,=,690.0,Inhibition of human ERG channel tail current
9366,CHEMBL3774411,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1,IC50,nM,=,2511.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9367,CHEMBL3775718,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)[nH]c1,IC50,nM,=,1000.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9368,CHEMBL3774769,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)n(C)c1,IC50,nM,=,1258.93,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9369,CHEMBL3774769,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)n(C)c1,IC50,nM,=,251.19,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9370,CHEMBL3774769,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)n(C)c1,IC50,nM,=,1995.26,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9371,CHEMBL3775033,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1,IC50,nM,=,5011.87,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9372,CHEMBL3774569,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1ccn(C)c(=O)c1,IC50,nM,=,2511.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9373,CHEMBL3775350,Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1ccn(C)c(=O)c1,IC50,nM,>,10000.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9374,CHEMBL3775350,Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1ccn(C)c(=O)c1,IC50,nM,=,6309.57,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9375,CHEMBL3775243,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1N1CCOCC1,IC50,nM,=,125.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9376,CHEMBL3775243,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1N1CCOCC1,IC50,nM,=,501.19,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9377,CHEMBL3774649,Cn1c(SCCCN2CC3CCN(c4ccccc4)C3C2)nnc1C1CCOCC1,IC50,nM,=,3162.28,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9378,CHEMBL3774649,Cn1c(SCCCN2CC3CCN(c4ccccc4)C3C2)nnc1C1CCOCC1,IC50,nM,=,3981.07,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9379,CHEMBL3775737,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCOCC1,IC50,nM,=,794.33,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9380,CHEMBL3775737,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCOCC1,IC50,nM,=,6309.57,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9381,CHEMBL3774462,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCC1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9382,CHEMBL3774462,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCC1,IC50,nM,=,199.53,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9383,CHEMBL3774463,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCCC1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9384,CHEMBL3774463,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCCC1,IC50,nM,=,316.23,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9385,CHEMBL3774431,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCCCC1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9386,CHEMBL3774431,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCCCC1,IC50,nM,=,316.23,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9387,CHEMBL3774515,Cc1ncoc1-c1nnc(SCCCN2CC3CN(c4ccc(C(F)(F)F)cc4)C3C2)n1C,IC50,nM,=,630.96,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9388,CHEMBL3774411,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1,IC50,nM,=,1258.93,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9389,CHEMBL3775408,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1ccccn1,IC50,nM,=,630.96,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9390,CHEMBL3775214,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1ccncc1,IC50,nM,=,1584.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9391,CHEMBL3775197,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cccnc1,IC50,nM,=,1995.26,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9392,CHEMBL3775197,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cccnc1,IC50,nM,=,5011.87,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9393,CHEMBL3775554,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccccn1,IC50,nM,=,158.49,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9394,CHEMBL3774490,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccncc1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9395,CHEMBL3775604,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cccnc1,IC50,nM,=,125.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9396,CHEMBL3775482,Cc1cc(-c2nnc(SCCCN3CC4CCN(c5ccc(C(F)(F)F)cc5)C4C3)n2C)on1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9397,CHEMBL3775256,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1nccs1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9398,CHEMBL3775036,Cn1cc(-c2nnc(SCCCN3CC4CCN(c5ccc(C(F)(F)F)cc5)C4C3)n2C)cn1,IC50,nM,=,158.49,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9399,CHEMBL3775583,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cccnn1,IC50,nM,=,125.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9400,CHEMBL3774534,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccnnc1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9401,CHEMBL3775810,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccncn1,IC50,nM,=,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9402,CHEMBL3775572,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cncnc1,IC50,nM,=,158.49,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9403,CHEMBL3774519,Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1cnccn1,IC50,nM,=,501.19,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9404,CHEMBL3775771,Cn1c(SCCCN2CC3CCN(c4c(F)cccc4F)C3C2)nnc1-c1cnccn1,IC50,nM,=,2511.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9405,CHEMBL3775946,Cn1c(SCCCN2CC3CCN(c4c(F)cccc4C(F)(F)F)C3C2)nnc1-c1cnccn1,IC50,nM,=,1584.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9406,CHEMBL3774911,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4C(F)(F)F)C3C2)nnc1-c1cnccn1,IC50,nM,=,1258.93,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9407,CHEMBL3775753,COc1cc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)ccc1F,IC50,nM,=,398.11,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9408,CHEMBL3774591,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4F)C3C2)nnc1-c1cnccn1,IC50,nM,=,794.33,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9409,CHEMBL3775598,CC(C)Oc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21,IC50,nM,=,1995.26,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9410,CHEMBL3775598,CC(C)Oc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21,IC50,nM,=,1995.26,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9411,CHEMBL3775631,Cn1c(SCCCN2CC3CCN(c4ccccc4C#N)C3C2)nnc1-c1cnccn1,IC50,nM,=,199.53,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9412,CHEMBL3775667,Cn1c(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)nnc1-c1cnccn1,IC50,nM,=,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9413,CHEMBL3775097,Cn1c(SCCCN2CC3CCN(c4ccc(C#N)cc4)C3C2)nnc1-c1cnccn1,IC50,nM,=,251.19,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9414,CHEMBL3774621,Cn1c(SCCCN2CC3CCN(c4ccccc4OC(F)(F)F)C3C2)nnc1-c1cnccn1,IC50,nM,=,630.96,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9415,CHEMBL3774895,Cn1c(SCCCN2CC3CCN(c4cccc(OC(F)(F)F)c4)C3C2)nnc1-c1cnccn1,IC50,nM,=,125.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9416,CHEMBL3775386,Cn1c(SCCCN2CC3CCN(c4ccc(OC(F)(F)F)cc4)C3C2)nnc1-c1cnccn1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9417,CHEMBL3775618,COc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21,IC50,nM,=,1995.26,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9418,CHEMBL3774412,COc1cccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)c1,IC50,nM,=,794.33,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9419,CHEMBL3775023,COc1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)cc1,IC50,nM,=,794.33,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9420,CHEMBL3774927,Cc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21,IC50,nM,=,316.23,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9421,CHEMBL3775836,Cc1cccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)c1,IC50,nM,=,316.23,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9422,CHEMBL3775071,Cc1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)cc1,IC50,nM,=,398.11,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9423,CHEMBL3775294,Cn1c(SCCCN2CC3CCN(c4ccccc4F)C3C2)nnc1-c1cnccn1,IC50,nM,=,1000.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9424,CHEMBL3774869,Cn1c(SCCCN2CC3CCN(c4cccc(F)c4)C3C2)nnc1-c1cnccn1,IC50,nM,=,199.53,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9425,CHEMBL3774996,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1cnccn1,IC50,nM,=,316.23,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9426,CHEMBL3774783,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cnccn1,IC50,nM,=,1584.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9427,CHEMBL3774783,Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cnccn1,IC50,nM,=,1258.93,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9428,CHEMBL3774425,Cn1c(SCCCN2CC3CCN(c4cccc(C(F)(F)F)c4)C3C2)nnc1-c1cnccn1,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9429,CHEMBL3774683,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cnccn1,IC50,nM,=,251.19,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9430,CHEMBL3774683,Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cnccn1,IC50,nM,=,125.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9431,CHEMBL3775872,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4OC(F)(F)F)C3C2)n1C,IC50,nM,=,630.96,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9432,CHEMBL3775967,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4c(F)cccc4F)C3C2)n1C,IC50,nM,=,1000.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9433,CHEMBL3775301,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(Cl)cc4Cl)C3C2)n1C,IC50,nM,=,1258.93,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9434,CHEMBL3775338,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cc(Cl)cc(Cl)c4)C3C2)n1C,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9435,CHEMBL3775534,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)n1C,IC50,nM,=,794.33,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9436,CHEMBL3775534,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)n1C,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9437,CHEMBL3775005,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(F)c4)C3C2)n1C,IC50,nM,=,251.19,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9438,CHEMBL3775395,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(OC(F)(F)F)cc4)C3C2)n1C,IC50,nM,<,100.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9439,CHEMBL3774588,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)n1C,IC50,nM,=,794.33,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9440,CHEMBL3774588,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)n1C,IC50,nM,=,794.33,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9441,CHEMBL3775226,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C,IC50,nM,=,398.11,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9442,CHEMBL3775226,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C,IC50,nM,=,199.53,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9443,CHEMBL3775226,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C,IC50,nM,=,15848.93,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9444,CHEMBL3774540,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)n1C,IC50,nM,=,199.53,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9445,CHEMBL3774540,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)n1C,IC50,nM,=,199.53,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9446,CHEMBL3774540,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)n1C,IC50,nM,=,199.53,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9447,CHEMBL3775589,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C,IC50,nM,=,1258.93,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9448,CHEMBL3775589,Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C,IC50,nM,=,1584.89,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9449,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,630.96,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9450,CHEMBL3774996,Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1cnccn1,IC50,nM,>,1000.0,Inhibition of human ERG tail current expressed in HEK293 cells after 5 mins by patch clamp assay
9451,CHEMBL3775378,CC(C)CN1[C@H](C)Cc2cc(O)ccc2[C@H]1c1ccc(/C=C/C(=O)O)cc1,IC50,nM,>,30000.0,Inhibition of human ERG tail current by plate-based planar patch clamp system
9452,CHEMBL3582317,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,12000.0,Binding affinity to human ERG by patchXpress functional assay
9453,CHEMBL2204935,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,3400.0,Binding affinity to human ERG by patchXpress functional assay
9454,CHEMBL3775160,COc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@](c4cnn(C)c4)(c4noc(C)n4)N3)n2)n1,IC50,,,,Binding affinity to human ERG
9455,CHEMBL3774684,COc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@](c4cnn(C)c4)(c4noc(C)n4)N3)n2)n1,IC50,nM,=,3619.0,Binding affinity to human ERG
9456,CHEMBL3775061,Cc1nc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,6481.0,Binding affinity to human ERG
9457,CHEMBL3582317,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,8544.0,Binding affinity to human ERG
9458,CHEMBL3774800,Cc1nc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccccn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,4895.0,Binding affinity to human ERG
9459,CHEMBL3775760,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccccn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,5503.0,Binding affinity to human ERG
9460,CHEMBL3775630,Cc1nc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,1753.0,Binding affinity to human ERG
9461,CHEMBL3775042,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccccc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,1817.0,Binding affinity to human ERG
9462,CHEMBL2204935,Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1,IC50,nM,=,1701.0,Binding affinity to human ERG
9463,CHEMBL3775387,COc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)n1,IC50,nM,=,1025.0,Binding affinity to human ERG
9464,CHEMBL3774909,Clc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)nc1,IC50,nM,=,465.0,Binding affinity to human ERG
9465,CHEMBL3775734,Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)nc1,IC50,nM,=,1742.0,Binding affinity to human ERG
9466,CHEMBL3775411,c1ccc2c3c([nH]c2c1)[C@@H](C1CCOCC1)N[C@@H](c1nc(-c2nccs2)c[nH]1)C3,IC50,,,,Binding affinity to human ERG
9467,CHEMBL3774986,c1ccc2c3c([nH]c2c1)[C@@H](C1CCOCC1)N[C@@H](c1nc(-c2cscn2)c[nH]1)C3,IC50,nM,=,4393.0,Binding affinity to human ERG
9468,CHEMBL3774983,c1cnc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)nc1,IC50,,,,Binding affinity to human ERG
9469,CHEMBL3775018,c1ccc2c3c([nH]c2c1)[C@@H](C1CCOCC1)N[C@@H](c1nc(-c2cnccn2)c[nH]1)C3,IC50,,,,Binding affinity to human ERG
9470,CHEMBL3774851,c1cncc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c1,IC50,nM,=,2701.0,Binding affinity to human ERG
9471,CHEMBL3774903,c1ccc2c3c([nH]c2c1)[C@@H](C1CCOCC1)N[C@@H](c1nc(-c2ccncc2)c[nH]1)C3,IC50,nM,=,7518.0,Binding affinity to human ERG
9472,CHEMBL3775418,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)nc1,IC50,nM,=,4026.0,Binding affinity to human ERG
9473,CHEMBL3775643,c1ccc2c(-c3c[nH]c([C@H]4Cc5c([nH]c6ccccc56)[C@@H](C5CCOCC5)N4)n3)c[nH]c2c1,IC50,,,,Binding affinity to human ERG
9474,CHEMBL3775284,c1ccc2c3c([nH]c2c1)[C@@H](C1CCOCC1)N[C@@H](c1nc(-c2csc4ccccc24)c[nH]1)C3,IC50,nM,=,87.0,Binding affinity to human ERG
9475,CHEMBL3775055,Cc1csc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c1,IC50,,,,Binding affinity to human ERG
9476,CHEMBL3775435,Clc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)s1,IC50,nM,=,522.0,Binding affinity to human ERG
9477,CHEMBL3774626,c1ccc2c3c([nH]c2c1)[C@@H](C1CCOCC1)N[C@@H](c1nc(-c2ccsc2)c[nH]1)C3,IC50,nM,=,146.0,Binding affinity to human ERG
9478,CHEMBL3775050,Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c(F)c1,IC50,nM,=,634.0,Binding affinity to human ERG
9479,CHEMBL3775532,Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1F,IC50,nM,=,350.0,Binding affinity to human ERG
9480,CHEMBL3774500,CS(=O)(=O)c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,,,,Binding affinity to human ERG
9481,CHEMBL3774488,O=C(O)c1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c1,IC50,nM,=,839.0,Binding affinity to human ERG
9482,CHEMBL3775414,c1ccc(-c2ccc(-c3c[nH]c([C@H]4Cc5c([nH]c6ccccc56)[C@@H](C5CCOCC5)N4)n3)cc2)cc1,IC50,nM,=,17.0,Binding affinity to human ERG
9483,CHEMBL3775456,FC(F)(F)Oc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c1,IC50,nM,=,58.0,Binding affinity to human ERG
9484,CHEMBL3775316,FC(F)(F)Oc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,130.0,Binding affinity to human ERG
9485,CHEMBL3775031,COc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c1,IC50,nM,=,247.0,Binding affinity to human ERG
9486,CHEMBL3775282,COc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,69.0,Binding affinity to human ERG
9487,CHEMBL3775398,Oc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,467.0,Binding affinity to human ERG
9488,CHEMBL3775793,FC(F)(F)c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,158.0,Binding affinity to human ERG
9489,CHEMBL3774791,Cc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,101.0,Binding affinity to human ERG
9490,CHEMBL3775241,N#Cc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c1,IC50,,,,Binding affinity to human ERG
9491,CHEMBL3774861,N#Cc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,,,,Binding affinity to human ERG
9492,CHEMBL3774866,Clc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,144.0,Binding affinity to human ERG
9493,CHEMBL3774495,Fc1ccccc1-c1c[nH]c([C@H]2Cc3c([nH]c4ccccc34)[C@@H](C3CCOCC3)N2)n1,IC50,nM,=,495.0,Binding affinity to human ERG
9494,CHEMBL3774817,Fc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)c1,IC50,nM,=,258.0,Binding affinity to human ERG
9495,CHEMBL2204941,Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,377.0,Binding affinity to human ERG
9496,CHEMBL3775851,c1ccc2c3c([nH]c2c1)C(C1CCOCC1)NC(c1nc(C24CC5CC(CC(C5)C2)C4)c[nH]1)C3,IC50,nM,=,506.0,Binding affinity to human ERG
9497,CHEMBL3775825,CC(C)(C)c1c[nH]c(C2Cc3c([nH]c4ccccc34)C(C3CCOCC3)N2)n1,IC50,nM,=,2944.0,Binding affinity to human ERG
9498,CHEMBL3775580,c1ccc2c3c([nH]c2c1)C(C1CCOCC1)NC(c1nc(C2CCCCC2)c[nH]1)C3,IC50,nM,=,136.0,Binding affinity to human ERG
9499,CHEMBL3775729,CC1(c2nc(-c3ccccc3)c[nH]2)Cc2c([nH]c3ccccc23)C(C2CCOCC2)N1,IC50,nM,=,530.0,Binding affinity to human ERG
9500,CHEMBL3775729,CC1(c2nc(-c3ccccc3)c[nH]2)Cc2c([nH]c3ccccc23)C(C2CCOCC2)N1,IC50,nM,=,1634.0,Binding affinity to human ERG
9501,CHEMBL3775729,CC1(c2nc(-c3ccccc3)c[nH]2)Cc2c([nH]c3ccccc23)C(C2CCOCC2)N1,IC50,nM,=,2946.0,Binding affinity to human ERG
9502,CHEMBL3775729,CC1(c2nc(-c3ccccc3)c[nH]2)Cc2c([nH]c3ccccc23)C(C2CCOCC2)N1,IC50,nM,=,2175.0,Binding affinity to human ERG
9503,CHEMBL2069502,c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)cc1,IC50,nM,=,380.0,Binding affinity to human ERG
9504,CHEMBL3775576,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,IC50,nM,>,10000.0,Inhibition of human ERG
9505,CHEMBL3780951,Cc1cc(C)n(Cc2ccc(C(=O)NCC3(c4nc(-c5ccccc5)cs4)CCOCC3)cc2)n1,IC50,nM,=,44900.0,Inhibition of human ERG by QPatch assay
9506,CHEMBL3786542,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,=,62000.0,Inhibition of human ERG
9507,CHEMBL3786542,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9508,CHEMBL3786542,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9509,CHEMBL3786255,CC(c1ccccc1)N1C(=O)c2ccccc2C1C(=O)NCc1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9510,CHEMBL3785486,CCCCNC(=O)C1c2ccccc2C(=O)N1CC(C)c1ccc(Cl)cc1,IC50,nM,=,32000.0,Inhibition of human ERG
9511,CHEMBL3786013,O=C(NCc1ccncc1)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9512,CHEMBL3786473,CC(c1ccccc1)N1C(=O)c2ccccc2C1C(=O)NC(C)(C)CO,IC50,nM,>,33000.0,Inhibition of human ERG
9513,CHEMBL3786440,COCCOCCNC(=O)C1c2cc(F)ccc2C(=O)N1CC(C)c1ccc(Cl)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9514,CHEMBL3785865,Cc1c(O)ccc2c1C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,=,46000.0,Inhibition of human ERG
9515,CHEMBL3785865,Cc1c(O)ccc2c1C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,>,32000.0,Inhibition of human ERG
9516,CHEMBL3785865,Cc1c(O)ccc2c1C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,=,26000.0,Inhibition of human ERG
9517,CHEMBL3787069,CC(C)(C)NC(=O)C1c2ccc(O)cc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,=,45000.0,Inhibition of human ERG
9518,CHEMBL3787412,Cc1c(NS(C)(=O)=O)ccc2c1C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,>,33000.0,Inhibition of human ERG
9519,CHEMBL3787036,CC(C)(C)NC(=O)C1c2ccc(NS(C)(=O)=O)cc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,=,15000.0,Inhibition of human ERG
9520,CHEMBL3787356,CC(C)(C)NC(=O)C1c2c(O)cccc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,=,28000.0,Inhibition of human ERG
9521,CHEMBL3785621,COc1ccc2c(c1C)C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,=,24000.0,Inhibition of human ERG
9522,CHEMBL3785810,Cc1c(OC(F)F)ccc2c1C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,=,22000.0,Inhibition of human ERG
9523,CHEMBL3786683,Cc1c(OCF)ccc2c1C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,=,27000.0,Inhibition of human ERG
9524,CHEMBL3786256,Cc1c(OS(C)(=O)=O)ccc2c1C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,>,32000.0,Inhibition of human ERG
9525,CHEMBL3785555,COc1ccc2c(c1)C(=O)N(Cc1ccccc1-c1ccccc1)C2C(=O)NC(C)(C)C,IC50,nM,=,30000.0,Inhibition of human ERG
9526,CHEMBL3786868,CC(C)(C)NC(=O)C1c2cc(C#N)ccc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9527,CHEMBL3786562,CC(C)(C)NC(=O)C1c2ccc(C#N)cc2C(=O)N1Cc1ccccc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9528,CHEMBL3785335,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccc(F)cc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9529,CHEMBL3785335,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccc(F)cc1-c1ccccc1,IC50,nM,>,32000.0,Inhibition of human ERG
9530,CHEMBL3785765,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1cc(F)ccc1-c1ccc(F)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9531,CHEMBL3785765,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1cc(F)ccc1-c1ccc(F)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9532,CHEMBL3786460,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccc(F)c(F)c1,IC50,nM,>,33000.0,Inhibition of human ERG
9533,CHEMBL3786460,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccc(F)c(F)c1,IC50,nM,>,31000.0,Inhibition of human ERG
9534,CHEMBL3787088,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1cc(F)ccc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9535,CHEMBL3787088,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1cc(F)ccc1-c1ccccc1,IC50,nM,>,33000.0,Inhibition of human ERG
9536,CHEMBL3786519,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccc(F)cc1-c1ccc(F)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9537,CHEMBL3786303,CC(C)(C)NC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccc(F)cc1,IC50,nM,=,56000.0,Inhibition of human ERG
9538,CHEMBL3786775,Cc1c(O)ccc2c1C(=O)N(Cc1ccccc1-c1ccc(F)cc1)C2C(=O)NC(C)(C)C,IC50,nM,>,32000.0,Inhibition of human ERG
9539,CHEMBL3785370,Cc1c(O)ccc2c1C(=O)N(Cc1ccccc1-c1ccc(F)c(F)c1)C2C(=O)NC(C)(C)C,IC50,nM,=,27000.0,Inhibition of human ERG
9540,CHEMBL3785768,CC(C)(CN1C(=O)c2ccccc2C1C(=O)NCCCF)c1ccc(Cl)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9541,CHEMBL3786344,CCCNC(=O)C1c2ccccc2C(=O)N1CC(C)c1ccc(Cl)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9542,CHEMBL3786896,CCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCc1cc(Cl)ccc1-n1cnnn1)c1ccc(F)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9543,CHEMBL3785257,CC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCc1cc(Cl)ccc1-n1cnnn1)c1ccc(F)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
9544,CHEMBL3787339,CCCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCc1cc(Cl)ccc1-n1cnnn1)c1ccc(F)cc1,IC50,nM,=,15000.0,Inhibition of human ERG
9545,CHEMBL3787686,CCCCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCc1cc(Cl)ccc1-n1cnnn1)c1ccc(F)cc1,IC50,nM,=,14000.0,Inhibition of human ERG
9546,CHEMBL3786094,O=C(O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCc1cc(Cl)ccc1-n1cnnn1)c1ccc(F)cc1)c1ccccc1,IC50,nM,=,5600.0,Inhibition of human ERG
9547,CHEMBL3785774,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\N1CCN(C)CC1)C2(C)C,IC50,nM,=,24000.0,Inhibition of human ERG by patch clamp method
9548,CHEMBL3786892,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C,IC50,nM,=,44000.0,Inhibition of human ERG by patch clamp method
9549,CHEMBL3786375,O=C(c1nnc(-c2ccc(Cl)cc2)o1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,5500.0,Inhibition of human ERG by IonWork assay
9550,CHEMBL3787457,O=C(c1nnc(-c2ccccc2)o1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,11000.0,Inhibition of human ERG by IonWork assay
9551,CHEMBL3786572,COc1ccc(-c2nnc(C(=O)N3CCC(Oc4ccc(CN5CCCC5)cc4)CC3)o2)cc1,IC50,nM,=,11000.0,Inhibition of human ERG by IonWork assay
9552,CHEMBL3787639,O=C(c1nnc(-c2ccc(OC(F)F)cc2)o1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,4200.0,Inhibition of human ERG by IonWork assay
9553,CHEMBL3787131,O=C(c1nnc(-c2ccc(F)cc2)o1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,6200.0,Inhibition of human ERG by IonWork assay
9554,CHEMBL3786923,O=C(c1nnc(-c2ccccc2Cl)o1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,5300.0,Inhibition of human ERG by IonWork assay
9555,CHEMBL3786609,COc1ccc(-c2nnc(C(=O)N3CCC(Oc4ccc(CN5CCCC5)nc4)CC3)o2)cc1,IC50,nM,=,25000.0,Inhibition of human ERG by IonWork assay
9556,CHEMBL3785118,COc1ccc(-c2nnc(C(=O)N3CCC(Oc4ccc(CN5CCN(C)CC5)cc4)CC3)o2)cc1,IC50,nM,=,15000.0,Inhibition of human ERG by IonWork assay
9557,CHEMBL3787461,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CCN(C)CC5)c(F)c4)C3)o2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWork assay
9558,CHEMBL3787582,CN1CCN(Cc2ccc(OC3CN(C(=O)c4nnc(-c5ccccc5)o4)C3)cc2F)CC1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWork assay
9559,CHEMBL3786662,COc1ccc(-c2nnc(C(=O)N3CCC(Oc4ccc(CN5CCOCC5)cc4)CC3)o2)cc1,IC50,nM,=,16000.0,Inhibition of human ERG by IonWork assay
9560,CHEMBL3785102,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CCOCC5)c(OC)c4)C3)o2)cc1,IC50,nM,=,9800.0,Inhibition of human ERG by IonWork assay
9561,CHEMBL3787345,O=C(c1nnc(-c2ccccc2)o1)N1CCC(Oc2ccc(CN3CCC(O)C3)cc2)CC1,IC50,nM,=,31000.0,Inhibition of human ERG by IonWork assay
9562,CHEMBL3787642,COc1ccc(-c2nnc(C(=O)N3CCC(Oc4ccc(CN5CCC(O)C5)cc4)CC3)o2)cc1,IC50,nM,=,24000.0,Inhibition of human ERG by IonWork assay
9563,CHEMBL3786685,CC1(O)CCN(Cc2ccc(OC3CN(C(=O)c4nnc(-c5ccccc5)o4)C3)cc2)C1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWork assay
9564,CHEMBL3787261,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CCC(C)(O)C5)cc4)C3)o2)cc1,IC50,nM,=,26000.0,Inhibition of human ERG by IonWork assay
9565,CHEMBL3786350,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CC(OC)C5)cc4)C3)o2)cc1,IC50,nM,=,8500.0,Inhibition of human ERG by IonWork assay
9566,CHEMBL3787462,COc1ccc(-c2nnc(C(=O)N3CCC(Oc4ccc(CN5CC(O)C(C)(C)C5)cc4)CC3)o2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG by IonWork assay
9567,CHEMBL3786311,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN(C)CC5(C)COC5)cc4)C3)o2)cc1,IC50,nM,=,16000.0,Inhibition of human ERG by IonWork assay
9568,CHEMBL3785343,CN(Cc1ccc(OC2CN(C(=O)c3nnc(-c4ccccc4)o3)C2)cc1)CC1(C)COC1,IC50,nM,=,14000.0,Inhibition of human ERG by IonWork assay
9569,CHEMBL3787028,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CCCOCC5)cc4)C3)o2)cc1,IC50,nM,=,25000.0,Inhibition of human ERG by IonWork assay
9570,CHEMBL3670644,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CCCC56COC6)cc4)C3)o2)cc1,IC50,nM,=,12000.0,Inhibition of human ERG by IonWork assay
9571,CHEMBL3786841,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CC6(CCOC6)C5)cc4)C3)o2)cc1,IC50,nM,=,16000.0,Inhibition of human ERG by IonWork assay
9572,CHEMBL3670640,O=C(c1nnc(-c2ccccc2)o1)N1CC(Oc2ccc(CN3CC4(CCOC4)C3)cc2)C1,IC50,nM,=,16000.0,Inhibition of human ERG by IonWork assay
9573,CHEMBL3670638,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CC6(CCCO6)C5)cc4)C3)o2)cc1,IC50,nM,=,13000.0,Inhibition of human ERG by IonWork assay
9574,CHEMBL3786346,O=C(c1nnc(-c2ccccc2)o1)N1CC(Oc2ccc(CN3CC4(CCCO4)C3)cc2)C1,IC50,nM,=,8900.0,Inhibition of human ERG by IonWork assay
9575,CHEMBL3787394,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CC6(COC6)C5)cc4)C3)o2)cc1,IC50,nM,=,22000.0,Inhibition of human ERG by IonWork assay
9576,CHEMBL3785663,O=C(c1nnc(-c2ccccc2)o1)N1CC(Oc2ccc(CN3CC4(COC4)C3)cc2)C1,IC50,nM,=,28000.0,Inhibition of human ERG by IonWork assay
9577,CHEMBL3787333,Cc1cc(CN(C)C)ccc1OC1CN(C(=O)c2nnc(-c3ccccc3)o2)C1,IC50,nM,=,8600.0,Inhibition of human ERG by IonWork assay
9578,CHEMBL3786272,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN(C)C)c(C)c4)C3)o2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG by IonWork assay
9579,CHEMBL3787170,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN(C)C)c(F)c4)C3)o2)cc1,IC50,nM,=,15000.0,Inhibition of human ERG by IonWork assay
9580,CHEMBL3785819,COc1ccc(-c2nnc(C(=O)N3CCC(Oc4ccc(CN5CCCC5)cn4)CC3)o2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWork assay
9581,CHEMBL3787492,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN(C)C)cn4)C3)o2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG by IonWork assay
9582,CHEMBL3787134,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN(C)C)cc4)C3)o2)cc1,IC50,nM,=,21000.0,Inhibition of human ERG by IonWork assay
9583,CHEMBL3786169,COc1ccc(-c2nnc(C(=O)N3CC(Oc4ccc(CN5CCCC5)cc4)C3)o2)cc1,IC50,nM,=,5500.0,Inhibition of human ERG by IonWork assay
9584,CHEMBL3786352,O=C(c1nc(-c2ccccc2)no1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,1800.0,Inhibition of human ERG by IonWork assay
9585,CHEMBL3787237,Cc1oc(-c2ccccc2)nc1C(=O)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,3000.0,Inhibition of human ERG by IonWork assay
9586,CHEMBL3786768,Cn1nc(C(=O)N2CCC(Oc3ccc(CN4CCCC4)cc3)CC2)cc1-c1ccccc1,IC50,nM,=,7400.0,Inhibition of human ERG by IonWork assay
9587,CHEMBL3787166,O=C(c1noc(-c2ccccc2)n1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,7500.0,Inhibition of human ERG by IonWork assay
9588,CHEMBL3787417,O=C(c1cc(-c2ccccc2)on1)N1CCC(Oc2ccc(CN3CCCC3)cc2)CC1,IC50,nM,=,3300.0,Inhibition of human ERG by IonWork assay
9589,CHEMBL1614712,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,IC50,nM,=,130.0,Inhibition of human ERG by dofetilide binding assay
9590,CHEMBL3787112,Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,IC50,nM,=,420.0,Inhibition of human ERG by dofetilide binding assay
9591,CHEMBL3787614,Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,IC50,nM,=,3600.0,Inhibition of human ERG by dofetilide binding assay
9592,CHEMBL1614712,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,IC50,nM,=,130.0,Displacement of [3H]-dofetilide from human ERG channel expressed in HEK293 cells
9593,CHEMBL3785500,Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,IC50,nM,=,1100.0,Displacement of [3H]-dofetilide from human ERG channel expressed in HEK293 cells
9594,CHEMBL3786634,Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CC[S+]([O-])CC2)C1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG channel expressed in HEK293 cells
9595,CHEMBL3787636,CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OCC56CCC(CC5)O6)c4)c4c(N)ncnc43)C2)CC1,IC50,nM,=,15000.0,Displacement of [3H]-dofetilide from human ERG channel expressed in HEK293 cells
9596,CHEMBL3787662,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3[nH]ccc23)c1,IC50,nM,=,1000.0,Inhibition of dofetilide binding to human ERG
9597,CHEMBL3786973,CCN/C(=N\S(=O)(=O)c1ccc(N)cc1)N1CC2(C=N1)CCCC2,IC50,nM,>,10000.0,Inhibition of human ERG
9598,CHEMBL3786469,Cc1cc(F)ccc1C1CCN(CC2Cc3ccccc3CN2)CC1,IC50,nM,=,200.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9599,CHEMBL3785952,Cc1cc(F)ccc1C1CCN(CC2Cc3c(Cl)ccc(O)c3CN2)CC1,IC50,nM,=,970.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9600,CHEMBL3786899,c1ccc2c(c1)CNC(CN1CCC3(CCc4ccccc43)CC1)C2,IC50,nM,>,1500.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9601,CHEMBL3786486,CN1C(=O)c2ccccc2CC1CN1CCC2(CCc3ccccc32)CC1,IC50,nM,=,6960.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9602,CHEMBL3787051,CC(=O)N1Cc2ccccc2CC1CN1CCC2(CCc3ccccc32)CC1,IC50,nM,=,500.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9603,CHEMBL3785560,Oc1ccc(Cl)c2c1CNC(CN1CCC3(CCc4ccccc43)CC1)C2,IC50,nM,=,1730.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9604,CHEMBL3785095,Oc1ccc(Br)c2c1CNC(CN1CCC3(CCc4ccccc43)CC1)C2,IC50,nM,=,1000.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9605,CHEMBL3785718,Oc1cccc2c1CNC(CN1CCC3(CCc4ccccc43)CC1)C2,IC50,nM,=,940.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9606,CHEMBL3785728,Oc1ccc2c(c1)CC(CN1CCC3(CCc4ccccc43)CC1)NC2,IC50,nM,=,340.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9607,CHEMBL3785605,c1ccc2c(c1)CC(CN1CCC3(CCc4ccccc43)CC1)CO2,IC50,nM,=,1500.0,Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells after 60 mins by liquid scintillation counting method
9608,CHEMBL3792516,Cn1c(C2CC2)nc2ccc(-n3ccc(OCc4ccc(Cl)s4)cc3=O)cc21,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp test
9609,CHEMBL3578244,Cc1c2cc(-n3ccc(OCc4csc(C(F)(F)F)c4)cc3=O)ccc2nn1C1CC1,IC50,nM,>,10000.0,Inhibition of human ERG
9610,CHEMBL3793226,O=c1ccc2ccc(F)c3c2n1C[C@H]3CN1CCC(NCc2cc3c(nn2)OCCO3)CC1,IC50,nM,=,238000.0,Inhibition of human ERG
9611,CHEMBL3794265,O=c1cnc2ccc(F)c3c2n1C[C@H]3CN1CCC(NCc2cc3c(nn2)OCCO3)CC1,IC50,nM,=,42000.0,Inhibition of human ERG
9612,CHEMBL2441417,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,13000.0,Inhibition of human ERG by electrophysiology analysis
9613,CHEMBL2441417,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,20000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9614,CHEMBL3794510,O=C1OCc2cc(/C=C/C3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,1800.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9615,CHEMBL3794249,O=C1OCc2cc(CCC3C4CN(C(=O)Cc5ccc(-n6cnnn6)cc5)CC34)ccc21,IC50,nM,=,5000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9616,CHEMBL3792423,O=C1OCc2cc(CCC3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)CC3)ccc21,IC50,nM,=,2000.0,Inhibition of human ERG by electrophysiology analysis
9617,CHEMBL3792423,O=C1OCc2cc(CCC3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)CC3)ccc21,IC50,nM,=,5400.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9618,CHEMBL3793060,O=C1OCc2cc(CCC3CCN(C(=O)Cc4ccc(-n5cnnn5)cn4)CC3)ccc21,IC50,nM,=,7900.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9619,CHEMBL3794427,O=C1OCc2cc(CCC3(F)CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,2100.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9620,CHEMBL3792861,O=C1OCc2cc(CCC3(O)CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,6500.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9621,CHEMBL3792542,Cc1c(CCC2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,5900.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9622,CHEMBL3794155,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)CC3)ccc21,IC50,nM,=,4500.0,Inhibition of human ERG by electrophysiology analysis
9623,CHEMBL3794155,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)CC3)ccc21,IC50,nM,=,9300.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9624,CHEMBL3793471,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cn4)CC3)ccc21,IC50,nM,=,46000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9625,CHEMBL3794101,O=C1OCc2nc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,26000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9626,CHEMBL3793857,O=C1OCc2cc(CCC3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,6400.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9627,CHEMBL2441437,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,4500.0,Inhibition of human ERG by electrophysiology analysis
9628,CHEMBL3792966,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,33000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9629,CHEMBL3692706,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,=,29000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9630,CHEMBL3692706,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,=,17000.0,Inhibition of human ERG by electrophysiology analysis
9631,CHEMBL3793143,Cc1c(CCN2CCN(C(=O)Cc3cnc(-n4cnnn4)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,12000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9632,CHEMBL3793380,Cc1cc(-n2cnnn2)cnc1CC(=O)N1CCN(CCc2ccc3c(c2C)COC3=O)CC1,IC50,nM,=,52000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9633,CHEMBL3793380,Cc1cc(-n2cnnn2)cnc1CC(=O)N1CCN(CCc2ccc3c(c2C)COC3=O)CC1,IC50,nM,=,52000.0,Inhibition of human ERG by electrophysiology analysis
9634,CHEMBL3792700,Cc1cc(-n2cnnn2)ncc1CC(=O)N1CCN(CCc2ccc3c(c2C)COC3=O)CC1,IC50,nM,=,9100.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9635,CHEMBL3793685,Cc1nc(-n2cnnn2)ccc1CC(=O)N1CCN(CCc2ccc3c(c2C)COC3=O)CC1,IC50,nM,=,8500.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9636,CHEMBL3793717,Cc1cc(-n2cnnn2)ncc1C(C)C(=O)N1CCN(CCc2ccc3c(c2C)COC3=O)CC1,IC50,nM,=,42000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9637,CHEMBL3794533,Cc1nc(-n2cnnn2)ccc1C(C)C(=O)N1CCN(CCc2ccc3c(c2C)COC3=O)CC1,IC50,nM,=,3400.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9638,CHEMBL3793411,Cc1c(CCN2CCN(C(=O)Cc3cncc(-n4cnnn4)c3)CC2)ccc2c1COC2=O,IC50,nM,=,21000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9639,CHEMBL3794292,Cc1c(C(C)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,=,49000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9640,CHEMBL3794292,Cc1c(C(C)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,=,30000.0,Inhibition of human ERG by electrophysiology analysis
9641,CHEMBL3792978,Cc1c(C(F)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,>,100000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9642,CHEMBL3792978,Cc1c(C(F)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,=,22000.0,Inhibition of human ERG by electrophysiology analysis
9643,CHEMBL3794233,Cc1c(C(O)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,=,33000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9644,CHEMBL3792808,COC(CN1CCN(C(=O)Cc2ccc(-n3cnnn3)nc2)CC1)c1ccc2c(c1C)COC2=O,IC50,nM,>,100000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9645,CHEMBL3792410,COc1c(C(O)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)CC2)ccc2c1COC2=O,IC50,nM,=,19000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells
9646,CHEMBL3800381,O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCN(C(c2ccccc2)(c2ccccc2)c2ccccc2)CC1,IC50,nM,=,47100.0,Inhibition of wild type human ERG channel expressed in Xenopus laevis oocytes assessed as use dependent suppression of K+ current at 1 Hz equilibrated for 5 mins by two-electrode voltage clamp method
9647,CHEMBL3799831,CN(C)C(=O)c1cc(CN2CCOc3c(F)cccc32)c2oc(N3CCOCC3)cc(=O)c2c1,IC50,nM,=,94000.0,Inhibition of human ERG
9648,CHEMBL3794064,O=C(O)C1CN(Cc2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1,IC50,nM,=,18000.0,Inhibition of human ERG by patch clamp method
9649,CHEMBL3640290,COc1nc(N2C[C@H]3C(=O)N(C)C(=N)N[C@@]3(c3ccc(F)cc3F)C2)nc(C)c1F,IC50,nM,=,1900.0,Inhibition of human ERG
9650,CHEMBL3799746,CNC(=O)c1cc(Oc2ccc3nc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)sc3c2)ccn1,IC50,nM,>,100000.0,Inhibition of human ERG assessed as reduction in channel current by automated patch-clamp electrophysiology assay
9651,CHEMBL3797601,CNC(=O)c1cc(Oc2ccc3nc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)sc3c2)ccn1,IC50,nM,>,100000.0,Inhibition of human ERG assessed as reduction in channel current by automated patch-clamp electrophysiology assay
9652,CHEMBL3798983,CNC(=O)c1cc(Oc2ccc3nc(NC(=O)Nc4ccc(Cl)c(Cl)c4)sc3c2)ccn1,IC50,nM,>,100000.0,Inhibition of human ERG assessed as reduction in channel current by automated patch-clamp electrophysiology assay
9653,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,3.31,Inhibition of human ERG assessed as reduction in channel current by automated patch-clamp electrophysiology assay
9654,CHEMBL3799621,CNC(=O)c1cc(Oc2ccc3nc(NC(=O)c4cc(C(F)(F)F)cc(C(F)(F)F)c4)sc3c2)ccn1,IC50,nM,=,48380.0,Inhibition of human ERG assessed as reduction in channel current by automated patch-clamp electrophysiology assay
9655,CHEMBL3797717,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCN(C)CC3)nc21,IC50,nM,=,2100.0,Inhibition of human ERG1 expressed in CHO cells by whole cell patch clamp electrophysiology method
9656,CHEMBL3799529,CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCNCC3)nc21,IC50,nM,=,1400.0,Inhibition of human ERG1 expressed in CHO cells by whole cell patch clamp electrophysiology method
9657,CHEMBL3805993,CCCCCCNC(=O)C1C(=O)N(O)C(=O)c2ccccc21,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as inhibition of tail current after 5 mins by automated whole-cell patch clamp assay
9658,CHEMBL2407287,O=C(NCc1ccc(F)cc1)C1C(=O)N(O)C(=O)c2ccccc21,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as inhibition of tail current after 5 mins by automated whole-cell patch clamp assay
9659,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,24.0,Inhibition of human ERG expressed in CHOK1 cells assessed as inhibition of tail current after 5 mins by automated whole-cell patch clamp assay
9660,CHEMBL3804846,O=C1N[C@H](c2cncc(C#Cc3ccccc3)c2)[C@@H](c2cc(F)ccc2F)O1,IC50,nM,=,3600.0,Inhibition of human ERG by patch clamp method
9661,CHEMBL3805966,Cc1cc2ncc3c(n2n1)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,IC50,nM,=,600.0,Inhibition of human ERG
9662,CHEMBL3806029,Cc1cc2ncc3c(n2n1)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,IC50,nM,=,6400.0,Inhibition of human ERG
9663,CHEMBL3806041,N[C@H]1C[C@@H](N2Cc3cnc4nnc(C5CC5)n4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,IC50,nM,=,600.0,Inhibition of human ERG
9664,CHEMBL3806003,N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,IC50,nM,>,100000.0,Inhibition of human ERG
9665,CHEMBL3805400,Cc1ccn2nc3c(c2n1)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,IC50,nM,=,18000.0,Inhibition of human ERG
9666,CHEMBL3804950,Cc1ccnc2c3c(nn12)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,IC50,nM,=,97000.0,Inhibition of human ERG
9667,CHEMBL3806052,N[C@H]1C[C@@H](N2Cc3nn4nccnc4c3C2)CO[C@@H]1c1cc(F)ccc1F,IC50,nM,=,23000.0,Inhibition of human ERG
9668,CHEMBL3805081,O=c1ccc(OCCCN2CCCCC2)nn1-c1ccc(Cl)cc1,IC50,nM,=,1450.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9669,CHEMBL3805396,O=c1ccc(OCCCN2CCCCC2)nn1-c1ccc(Cl)c(Cl)c1,IC50,nM,=,6340.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9670,CHEMBL3806153,O=c1ccc(OCCCN2CCCCC2)nn1-c1ccc(F)c(Cl)c1,IC50,nM,=,980.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9671,CHEMBL3805989,O=c1ccc(OCCCN2CCCCC2)nn1-c1ccc(F)c(F)c1,IC50,nM,=,1890.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9672,CHEMBL3805101,CC1CCN(CCCOc2ccc(=O)n(-c3ccc(Cl)cc3)n2)CC1,IC50,nM,=,1610.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9673,CHEMBL3806193,CC1CCN(CCCOc2ccc(=O)n(-c3ccc(Cl)c(Cl)c3)n2)CC1,IC50,nM,=,1460.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9674,CHEMBL3805844,CC1CCN(CCCOc2ccc(=O)n(-c3ccc(F)c(Cl)c3)n2)CC1,IC50,nM,=,2160.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9675,CHEMBL3805216,CC1CCN(CCCOc2ccc(=O)n(-c3ccc(F)c(F)c3)n2)CC1,IC50,nM,=,2680.0,Inhibition of human ERG expressed in HEK293 cells assessed as tail current at -50 mV holding potential by whole-cell patch clamp method
9676,CHEMBL3805559,CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,IC50,nM,=,1030.0,Inhibition of human ERG after 10 mins
9677,CHEMBL1112,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,IC50,nM,=,3860.0,Inhibition of human ERG after 10 mins
9678,CHEMBL3805518,CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F,IC50,nM,=,998.0,Inhibition of human ERG after 10 mins
9679,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,1070.0,Inhibition of human ERG after 10 mins
9680,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,70.0,Inhibition of human ERG expressed in cell membranes after 4 hrs by fluorescence polarization assay
9681,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,23.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis
9682,CHEMBL3805335,CC(=O)Nc1ccc2c3c(cccc13)C(=O)N(CCCCN1CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC1)C2=O,IC50,nM,=,182.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis
9683,CHEMBL3805898,O=[N+]([O-])c1ccc(NCCCCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)c2nonc12,IC50,nM,=,25.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis
9684,CHEMBL3804918,CCN(CC)c1ccc2cc(C(=O)NCCCCN3CCC(Nc4nc5ccccc5n4Cc4ccc(F)cc4)CC3)c(=O)oc2c1,IC50,nM,=,434.0,Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis
9685,CHEMBL3805852,COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](c4c(C)noc4C)SC(N)=N3)c2)cn1,IC50,nM,=,640.0,Inhibition of human ERG by whole-cell patch clamp assay
9686,CHEMBL3808866,CNC(=O)CCCCC[C@H](NC(=O)c1cncs1)c1ncc(-c2ccc(-c3ccn[nH]3)cc2)[nH]1,IC50,nM,>,30000.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
9687,CHEMBL3809595,FC(F)(F)Oc1ccc(-c2ccc3nnc(C(F)(F)F)n3c2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG
9688,CHEMBL3809641,Cc1noc(Cn2nc3ccc(-c4ccc(OC(F)(F)F)cc4)cn3c2=O)n1,IC50,nM,>,10000.0,Inhibition of human ERG
9689,CHEMBL3103192,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
9690,CHEMBL3103191,CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN(C)C,IC50,nM,=,4000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
9691,CHEMBL3808921,C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C(F)(F)F)CC4)on3)c2)CN1,IC50,nM,=,7400.0,Binding affinity to human ERG by radioligand binding assay
9692,CHEMBL3809643,C[C@H]1Cc2c(ncnc2Oc2ccc3ccn(C(=O)Nc4cc(C5(C(F)(F)F)CC5)on4)c3c2)CN1,IC50,nM,=,8600.0,Binding affinity to human ERG by radioligand binding assay
9693,CHEMBL3808957,CC(C)(C)c1cc(NC(=O)n2ccc3ccc(Oc4ncnc5c4CNC5)cc32)no1,IC50,nM,=,21000.0,Binding affinity to human ERG by radioligand binding assay
9694,CHEMBL3809754,CC(C)(C)c1cc(NC(=O)n2ccc3ncc(Oc4ncnc5c4CNC5)cc32)no1,IC50,nM,>,30000.0,Binding affinity to human ERG by radioligand binding assay
9695,CHEMBL3808653,CC(C)(C)c1cc(NC(=O)n2ccc3nc(Oc4ncnc5c4CNC5)ccc32)no1,IC50,nM,=,26000.0,Binding affinity to human ERG by radioligand binding assay
9696,CHEMBL3809144,CC1(c2cc(NC(=O)c3ccn4cc(Oc5ncnc6c5CNC6)ccc34)n[nH]2)CC1,IC50,nM,>,30000.0,Binding affinity to human ERG by radioligand binding assay
9697,CHEMBL3808450,CC(C)(C)c1cc(NC(=O)c2cnc3cc(Oc4ncnc5c4CNC5)ccn23)no1,IC50,nM,=,9200.0,Binding affinity to human ERG by radioligand binding assay
9698,CHEMBL3810154,CC(C)(C)c1cc(NC(=O)n2ccc3cc(Oc4ncnc5c4CNC5)cnc32)no1,IC50,nM,=,5700.0,Binding affinity to human ERG by radioligand binding assay
9699,CHEMBL3810135,CC(C)(C)c1cc(NC(=O)n2ncc3cc(Oc4ncnc5c4CNC5)ccc32)no1,IC50,nM,=,7700.0,Binding affinity to human ERG by radioligand binding assay
9700,CHEMBL3687984,CN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c1c2=O,IC50,nM,=,40000.0,Displacement of [35S]MK499 from human ERG
9701,CHEMBL3814424,CN(C/C=C/c1ccc(C(F)(F)F)cc1)Cc1cccc2ccoc12.Cl,IC50,nM,=,3710.0,Inhibition of human ERG expressed in CHO cells by Qpatch-clamp method
9702,CHEMBL3814374,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC[C@H](O)CC(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,25600.0,Inhibition of recombinant human ERG expressed in HEK293 cells assessed as inhibition of peak tail current by patch clamp assay
9703,CHEMBL3813836,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC[C@@H](O)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,21000.0,Inhibition of recombinant human ERG flux expressed in HEK293 cells by patch clamp assay
9704,CHEMBL3814418,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC[C@H](O)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,12000.0,Inhibition of recombinant human ERG flux expressed in HEK293 cells by patch clamp assay
9705,CHEMBL3814374,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC[C@H](O)CC(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,28000.0,Inhibition of recombinant human ERG flux expressed in HEK293 cells by patch clamp assay
9706,CHEMBL3814963,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC[C@@H](O)CC(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,23000.0,Inhibition of recombinant human ERG flux expressed in HEK293 cells by patch clamp assay
9707,CHEMBL3819521,CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(Cl)c3Cl)c2O)CC1,IC50,nM,>,79432.82,Binding affinity to human ERG
9708,CHEMBL3819512,CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1,IC50,nM,>,100000.0,Binding affinity to human ERG
9709,CHEMBL3818331,CCN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1,IC50,nM,>,100000.0,Binding affinity to human ERG
9710,CHEMBL3823354,Cc1cc(C2C=CN=CN2)c(C)s1.Cl,IC50,nM,>,25000.0,Inhibition of human ERG
9711,CHEMBL3823297,COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9712,CHEMBL3823659,CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)cn2)CC1,IC50,nM,=,5400.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9713,CHEMBL3822858,COc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,6600.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9714,CHEMBL3823278,CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c(C)n2)CC1,IC50,nM,=,5200.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9715,CHEMBL3823007,Cc1nn(C2CCNCC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1,IC50,nM,=,29000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9716,CHEMBL3822583,CC(=O)N1CCC(n2ncc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c2C)CC1,IC50,nM,=,21000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9717,CHEMBL3822543,Cc1c(Nc2ncc(Cl)c(-c3cnc4ccccn34)n2)cnn1C1CCNCC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9718,CHEMBL3823929,CC(=O)N1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c2C)CC1,IC50,nM,=,27000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9719,CHEMBL3823522,COc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9720,CHEMBL3822989,CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c(C)n2)CC1,IC50,nM,=,7200.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9721,CHEMBL3823301,CC(=O)N1CCC(n2ncc(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9722,CHEMBL3824296,Cc1nn(C2CCNCC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,24000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9723,CHEMBL3823914,CC(=O)N1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1,IC50,nM,=,23000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9724,CHEMBL3822943,CCOc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,6400.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9725,CHEMBL3822619,CCc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,5200.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9726,CHEMBL3822962,CCc1c(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)cnn1C1CCN(C(C)=O)CC1,IC50,nM,=,17000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9727,CHEMBL3824323,Cc1nn(C2CCN(CCO)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,9300.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9728,CHEMBL3823962,CNC(=O)CN1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1,IC50,nM,=,12000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9729,CHEMBL3823095,Cc1nn(C2CCN(CC(=O)N(C)C)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,7800.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9730,CHEMBL3822587,Cc1nn(C2CCN(C(=O)CO)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,22000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9731,CHEMBL3822651,COCC(=O)N1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1,IC50,nM,=,17000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9732,CHEMBL3822947,Cc1nn(C2CCN(C(=O)[C@H](C)O)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,23000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9733,CHEMBL3823030,Cc1nn(C2CCN(C(=O)[C@@H](C)O)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,=,29000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9734,CHEMBL3823154,Cc1nn(C2CCN(C(=O)CN)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9735,CHEMBL3824103,Cc1nn(C2CCN(C(=O)[C@H](C)N)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9736,CHEMBL3822644,Cc1nn(C2CCN(C(=O)[C@@H](C)N)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9737,CHEMBL3822976,CNCC(=O)N1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHOK1 cells after 6 mins by electrophysiology assay
9738,CHEMBL3828718,COC(=O)N(CC(=O)O)Cc1cc(OCc2nc(-c3ccc(Cl)cc3)oc2C)ccc1F,IC50,nM,>,80000.0,Inhibition of human ERG by flux-based assay
9739,CHEMBL3688197,N#Cc1cc(S(=O)(=O)Nc2ccc(F)cn2)ccc1Oc1ccc(CO)c(Cl)c1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp method
9740,CHEMBL3683287,N#Cc1ccc(Oc2ccc(S(=O)(=O)Nc3ccc(F)cn3)cc2C#N)cc1Cl,IC50,nM,=,67000.0,Inhibition of human ERG by patch clamp method
9741,CHEMBL3924161,O=S(=O)(Nc1ccc(C(F)(F)F)nc1)c1ccccc1C(F)(F)F,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp method
9742,CHEMBL3929544,O=S(=O)(Nc1cncc(C(F)(F)F)c1)c1ccccc1C(F)(F)F,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp method
9743,CHEMBL3979322,CN1CCN(c2ccccc2CNC(=O)c2ccc(F)c(NC(=O)c3cnc4cc(-c5ccnn5C)ccn34)c2)CC1,IC50,nM,=,4000.0,Inhibition of human ERG
9744,CHEMBL3915941,Cc1ncc(C(=O)NCCN2CCCC2(C)C)cc1NC(=O)c1cnn2cc(-c3cnn(C)c3)ccc12,IC50,nM,>,30000.0,Inhibition of human ERG
9745,CHEMBL85606,N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,IC50,nM,=,676.08,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9746,CHEMBL3958494,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3)C2)n1C,IC50,nM,=,3981.07,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9747,CHEMBL3901211,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccccc3)C2)n1C,IC50,nM,=,3630.78,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9748,CHEMBL3913062,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3)C2)n1C,IC50,nM,=,4677.35,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9749,CHEMBL3983937,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccccc3)C2)n1C,IC50,nM,=,2884.03,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9750,CHEMBL3913607,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,190.55,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9751,CHEMBL3944642,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,371.54,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9752,CHEMBL3935692,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,407.38,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9753,CHEMBL3954568,Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,316.23,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9754,CHEMBL3953365,Cc1ncoc1-c1nnc(SCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,134.9,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9755,CHEMBL3936812,Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,524.81,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9756,CHEMBL3908862,Cc1ncoc1-c1nnc(SCCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,562.34,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9757,CHEMBL3914195,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3C(F)(F)F)C2)n1C,IC50,nM,=,1949.84,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9758,CHEMBL3975989,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccccc3C(F)(F)F)C2)n1C,IC50,nM,=,891.25,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9759,CHEMBL3963783,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3)C2)n1C,IC50,nM,=,602.56,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9760,CHEMBL3926847,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C,IC50,nM,=,758.58,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9761,CHEMBL3935776,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,251.19,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9762,CHEMBL3901587,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,446.68,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9763,CHEMBL3927895,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,691.83,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9764,CHEMBL3955505,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,IC50,nM,=,524.81,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9765,CHEMBL3985877,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C,IC50,nM,=,1202.26,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9766,CHEMBL3975147,Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C,IC50,nM,=,2691.53,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9767,CHEMBL3983121,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3cc(Cl)cc(Cl)c3)C2)n1C,IC50,nM,<,100.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9768,CHEMBL3899336,Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3cc(Cl)cc(Cl)c3)C2)n1C,IC50,nM,=,263.03,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9769,CHEMBL3923578,Cc1ncsc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,794.33,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9770,CHEMBL3914556,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1nccs1,IC50,nM,=,446.68,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9771,CHEMBL3984387,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1,IC50,nM,=,112.2,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9772,CHEMBL3905582,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9773,CHEMBL3976319,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccs1,IC50,nM,<,100.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9774,CHEMBL3896638,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccsc1,IC50,nM,<,100.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9775,CHEMBL3985419,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccoc1,IC50,nM,=,151.36,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9776,CHEMBL3956758,Cn1cc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,IC50,nM,=,467.74,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9777,CHEMBL3908174,Cn1nccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,616.6,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9778,CHEMBL3978613,Cc1cc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)on1,IC50,nM,=,204.17,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9779,CHEMBL3899125,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1,IC50,nM,=,812.83,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9780,CHEMBL3970323,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1,IC50,nM,=,2818.38,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9781,CHEMBL3959240,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(S(N)(=O)=O)cc1,IC50,nM,=,223.87,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9782,CHEMBL3979523,CC(=O)c1ccc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)cc1,IC50,nM,<,100.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9783,CHEMBL3950540,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)cc1,IC50,nM,<,100.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9784,CHEMBL3981856,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(CC(N)=O)cc1,IC50,nM,=,7585.78,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9785,CHEMBL3941818,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1,IC50,nM,=,151.36,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9786,CHEMBL3920167,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(-c2ncco2)c1,IC50,nM,=,120.23,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9787,CHEMBL3938107,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1,IC50,nM,=,1200.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9788,CHEMBL3946901,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1,IC50,nM,=,200.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9789,CHEMBL3921885,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)nnc1-c1cccnc1,IC50,nM,=,2800.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9790,CHEMBL3947961,Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1,IC50,nM,=,223.87,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9791,CHEMBL3929083,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1,IC50,nM,=,295.12,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9792,CHEMBL3938107,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1,IC50,nM,=,1230.27,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9793,CHEMBL3946901,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1,IC50,nM,=,208.93,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9794,CHEMBL3955608,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cnccn1,IC50,nM,=,257.04,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9795,CHEMBL3958309,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncn1,IC50,nM,=,144.54,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9796,CHEMBL3940897,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,IC50,nM,=,2511.89,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9797,CHEMBL3949662,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)nnc1-c1cccnc1,IC50,nM,=,933.25,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9798,CHEMBL3921885,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)nnc1-c1cccnc1,IC50,nM,=,2754.23,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9799,CHEMBL3897134,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3)C2)nnc1-c1cccnc1,IC50,nM,=,2089.3,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9800,CHEMBL3968272,Cc1ncccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,6309.57,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9801,CHEMBL3946313,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1C(F)(F)F,IC50,nM,=,1318.26,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9802,CHEMBL3958949,COc1ncccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,602.56,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9803,CHEMBL3922535,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)nc1,IC50,nM,<,100.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9804,CHEMBL3950254,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1,IC50,nM,=,660.69,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9805,CHEMBL3913542,Cc1ccc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)c(C)n1,IC50,nM,=,933.25,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9806,CHEMBL3941520,Cc1nc(C(N)=O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,2754.23,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9807,CHEMBL3964649,Cc1nc(C(=O)O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,IC50,nM,=,10000.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9808,CHEMBL3964512,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CCC(=O)N=C1,IC50,nM,=,9549.93,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9809,CHEMBL3897772,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CC=NC(=O)C1,IC50,nM,=,3467.37,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9810,CHEMBL3894853,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccn(C)c(=O)c1,IC50,nM,=,7943.28,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9811,CHEMBL3963243,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCN(C(N)=O)CC1,IC50,nM,=,3311.31,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9812,CHEMBL3912801,CC(=O)NC1CCC(c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)CC1,IC50,nM,=,6918.31,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9813,CHEMBL3948167,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCOCC1,IC50,nM,=,2951.21,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9814,CHEMBL3964512,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CCC(=O)N=C1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9815,CHEMBL3922838,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(=O)n(C)c1,IC50,nM,=,3162.28,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9816,CHEMBL3913849,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCNC(=O)C1,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9817,CHEMBL3983684,CN1CCC(c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)CC1=O,IC50,nM,>,10000.0,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9818,CHEMBL3903779,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CC2CCC(C1)O2,IC50,nM,=,2454.71,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9819,CHEMBL3958201,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1,IC50,nM,=,295.12,Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay
9820,CHEMBL3901517,O=C(Nc1ccccc1)N1N=C(c2ccc(Br)cc2)CC1c1ccc(F)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as potassium tail current measured at -40 mV holding potential after 3 mins by QPatch clamp assay
9821,CHEMBL3966141,O=C(Nc1cccc(F)c1)N1N=C(c2ccc(Br)cc2)CC1c1ccc(F)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as potassium tail current measured at -40 mV holding potential after 3 mins by QPatch clamp assay
9822,CHEMBL3941914,Cc1nc(C)c(-c2csc(Nc3ccc(C(=O)N4C5CCC4CN(c4ncc(C(F)(F)F)cn4)C5)cn3)n2)s1,IC50,nM,>,10000.0,Inhibition of human ERG
9823,CHEMBL3984425,C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1,IC50,nM,>,10000.0,Inhibition of human ERG
9824,CHEMBL2064666,COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2,IC50,nM,>,10000.0,Inhibition of human ERG
9825,CHEMBL3936443,COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@H](N1CCN(C)CC1)C2,IC50,nM,=,9100.0,Inhibition of human ERG
9826,CHEMBL3980825,COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@@H](N1CCN(C)CC1)C2,IC50,nM,=,7900.0,Inhibition of human ERG
9827,CHEMBL3972807,COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@H](N1CCN(CCO)CC1)C2,IC50,nM,>,10000.0,Inhibition of human ERG
9828,CHEMBL3943236,COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@@H](N1CCN(CCO)CC1)C2,IC50,nM,>,10000.0,Inhibition of human ERG
9829,CHEMBL3925372,COc1c(Nc2ncc(Cl)c(Nc3ccccc3N3CCCS3(=O)=O)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2,IC50,nM,=,2700.0,Inhibition of human ERG
9830,CHEMBL3918616,COc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2,IC50,nM,=,240.0,Inhibition of human ERG
9831,CHEMBL3890564,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCCC(N2CCN(CCO)CC2)C3)ncc1Cl,IC50,nM,>=,10000.0,Inhibition of human ERG
9832,CHEMBL3934099,COc1c(Nc2ncc(Cl)c(Nc3ccccc3-n3cccn3)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2,IC50,nM,=,3700.0,Inhibition of human ERG
9833,CHEMBL3972653,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@@H](N2CCN(CCO)CC2)C3)ncc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG
9834,CHEMBL3951811,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG
9835,CHEMBL3904907,C[C@@H]1c2ncn(-c3ccc(F)cc3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by competitive binding assay
9836,CHEMBL3955145,C[C@@H]1c2ncn(-c3ccccn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by competitive binding assay
9837,CHEMBL3895947,C[C@@H]1c2ncn(-c3ccc(F)cn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by competitive binding assay
9838,CHEMBL3901705,C[C@@H]1c2ncn(-c3ncc(F)cn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by competitive binding assay
9839,CHEMBL3900554,Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O,IC50,nM,=,5500.0,Inhibition of human ERG by patch clamp assay
9840,CHEMBL3906074,Cc1nc(C)c(-c2csc(Nc3ccc(C(=O)N4C5COCC4CC(=O)C5)cn3)n2)s1,IC50,nM,>,30000.0,Inhibition of human ERG
9841,CHEMBL3927522,N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)[C@@H]3CCCC[C@@H]3N)cc2)cc1,IC50,nM,=,5400.0,Inhibition of human ERG
9842,CHEMBL3970692,N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)[C@@H]3CCCCC[C@@H]3N)cc2)cc1,IC50,nM,=,3600.0,Inhibition of human ERG
9843,CHEMBL3927609,N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)[C@@H]3CNCCCO3)cc2)cc1,IC50,nM,=,17000.0,Inhibition of human ERG
9844,CHEMBL3972563,Cn1c(=O)sc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,IC50,nM,=,23000.0,Inhibition of human ERG
9845,CHEMBL3900409,Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,IC50,nM,>,33000.0,Inhibition of human ERG
9846,CHEMBL3980602,CCn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,IC50,nM,=,31000.0,Inhibition of human ERG
9847,CHEMBL3960432,Cc1cc(-c2ccc(C[C@@H](C#N)NC(=O)[C@@H]3CNCCCO3)cc2)cc2c1oc(=O)n2C,IC50,nM,>,33000.0,Inhibition of human ERG
9848,CHEMBL3891374,N#C[C@H](Cc1ccc(-c2ccc3oc(=O)n(CC(F)F)c3c2)cc1)NC(=O)[C@@H]1CNCCCO1,IC50,nM,>,33000.0,Inhibition of human ERG
9849,CHEMBL3916182,COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4,IC50,nM,=,16500.0,Inhibition of human ERG
9850,CHEMBL3892879,COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4,IC50,nM,=,13200.0,Inhibition of human ERG
9851,CHEMBL24778,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,IC50,nM,=,8200.0,Inhibition of human ERG
9852,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,200.0,Inhibition of human ERG
9853,CHEMBL3982647,CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](NC(=O)[C@H](CC1CCCCC1)NS(=O)(=O)N[C@@H](CCCCN)C(=O)O)C2.Cl,IC50,nM,>,10000.0,Inhibition of recombinant human ERG expressed in CHO cells by patch clamp method
9854,CHEMBL3907479,Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1,IC50,nM,=,6900.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9855,CHEMBL3891894,Cc1nc2ccc(-n3ncc(C(=O)c4cc5cc(CN6CCOCC6)ccc5[nH]4)c3N)cc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9856,CHEMBL3681278,Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9857,CHEMBL3681314,Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1,IC50,nM,=,8600.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9858,CHEMBL3681317,Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9859,CHEMBL3676329,Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9860,CHEMBL3895337,Cc1ccc2cc(C(=O)c3cnn(-c4ccc5nc(C)[nH]c5c4)c3N)[nH]c2c1,IC50,nM,=,6900.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9861,CHEMBL3681244,Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in channel currents at -80 mV holding potential by automated whole-cell patch clamp method
9862,CHEMBL3933212,COc1cnc(O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4CC4)C[C@H]3C3CC3)N(C(=O)[C@@H](NC(=O)O[C@H](C)C(F)(F)F)C3CCCCC3)C2)c2cc(Cl)ccc12,IC50,nM,=,12500.0,Inhibition of human ERG by patch clamp assay
9863,CHEMBL3965352,Cc1ccc2c(n1)[C@H]([C@@H](C)C(=O)Nc1ccc(Cl)c(-c3nc4ccccc4n3C)c1)CC[C@H]2C,IC50,nM,>,15000.0,Inhibition of human ERG
9864,CHEMBL3986017,C[C@@H]1CC[C@@H]([C@@H](C)C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c2nc(CN3CCOCC3)ccc21,IC50,nM,=,3310.0,Inhibition of human ERG
9865,CHEMBL3967752,Cc1ccc2c(n1)[C@H]([C@@H](C)C(=O)Nc1ccc(Cl)c(-c3ccccn3)c1)CC[C@H]2C,IC50,nM,>,15000.0,Inhibition of human ERG
9866,CHEMBL3924243,C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](CC(=O)Nc3ccc(Cl)c(-c4ccccn4)c3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,IC50,nM,>,15000.0,Inhibition of human ERG
9867,CHEMBL3919646,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,nM,=,3600.0,Inhibition of radiolabeled dofetilide binding to human ERG expressed in HEK293 cells
9868,CHEMBL3914287,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,IC50,nM,=,2800.0,Inhibition of radiolabeled dofetilide binding to human ERG expressed in HEK293 cells
9869,CHEMBL3942186,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,nM,=,1000.0,Inhibition of radiolabeled dofetilide binding to human ERG expressed in HEK293 cells
9870,CHEMBL3965757,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,nM,=,19700.0,Inhibition of radiolabeled dofetilide binding to human ERG expressed in HEK293 cells
9871,CHEMBL3950251,N[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H](N)[C@@H]1O,IC50,nM,=,10400.0,Inhibition of radiolabeled dofetilide binding to human ERG expressed in HEK293 cells
9872,CHEMBL3913540,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,IC50,nM,=,1200.0,Inhibition of radiolabeled dofetilide binding to human ERG expressed in HEK293 cells
9873,CHEMBL3904539,N[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C[C@@H](N)[C@@H]1O,IC50,nM,=,11500.0,Inhibition of radiolabeled dofetilide binding to human ERG expressed in HEK293 cells
9874,CHEMBL1738797,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,IC50,nM,>,30000.0,Inhibition of human ERG
9875,CHEMBL3735648,CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21,IC50,nM,=,2650.0,Inhibition of human ERG
9876,CHEMBL3958173,CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,IC50,nM,>,30000.0,Inhibition of human ERG
9877,CHEMBL3736267,CC1(C)c2cc(C3CCN(CC4(O)CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21,IC50,nM,>,12250.0,Inhibition of human ERG
9878,CHEMBL3915994,Cc1cc(CN(CC2CCCC2)[C@@H](CC(=O)O)c2ccc(Cl)cc2)ccc1OCCN1C(=O)CCC1=O,IC50,nM,>,10000.0,Inhibition of human ERG
9879,CHEMBL3930002,Cl.O=C(O)C[C@@H](c1ccc(Cl)c(F)c1)N(Cc1ccc(OCCN2C(=O)CCC2=O)c(F)c1)CC1CC1,IC50,nM,>,10000.0,Inhibition of human ERG
9880,CHEMBL3902046,Cl.O=C(O)C[C@@H](c1ccc(Cl)c(F)c1)N(Cc1ccc(OCCN2C(=O)CCC2=O)c(Cl)c1)CC1CC1,IC50,nM,>,10000.0,Inhibition of human ERG
9881,CHEMBL3945735,Cn1ccc(Cn2cc(-c3ccc(Cl)c(C(F)(F)F)c3)cn2)n1,IC50,nM,=,3470.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9882,CHEMBL3975087,FC(F)c1cc(-c2cnn(Cc3cc[nH]n3)c2)ccc1Cl,IC50,nM,=,4750.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9883,CHEMBL3954438,Fc1ccc(-c2cnn(Cc3cc[nH]n3)c2)cc1OC(F)F,IC50,nM,=,135000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9884,CHEMBL3983077,CCc1[nH]ncc1Cn1cc(-c2ccc(Cl)c(OC(F)F)c2)cn1,IC50,nM,=,35000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9885,CHEMBL3927856,FC(F)Oc1cc(-c2cnn(Cc3cn[nH]c3)c2)ccc1Cl,IC50,nM,=,52600.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9886,CHEMBL3897632,FC(F)Oc1cc(-c2cnn(Cc3cc[nH]n3)c2)ccc1Cl,IC50,nM,=,9560.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9887,CHEMBL3936854,Cn1cc(Cn2cc(-c3ccc(Cl)c(OC(F)F)c3)cn2)cn1,IC50,nM,=,52400.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9888,CHEMBL3966599,Cn1ccc(Cn2cc(-c3ccc(Cl)c(OC(F)F)c3)cn2)n1,IC50,nM,=,8080.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by scintillation counting
9889,CHEMBL3687538,COc1cc(C(F)(F)F)ccc1-c1ncnc2cc(S(=O)(=O)Nc3nccs3)ccc12,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cell membranes measured after 90 mins by TopCount scintillation counting method
9890,CHEMBL3903475,Cc1cn(-c2ccc(-c3cn(CC(=O)Nc4cccc(Cl)c4Cl)nn3)cc2F)cn1,IC50,nM,=,3400.0,Inhibition of human ERG
9891,CHEMBL3905835,Cc1nccn1-c1ccc(-c2cn(CC(=O)Nc3cccc(Cl)c3Cl)nn2)cc1,IC50,nM,=,2200.0,Inhibition of human ERG
9892,CHEMBL3965469,Cc1nccn1-c1ccc(-c2cn(CC(=O)Nc3cccc(Cl)c3Cl)nn2)cn1,IC50,nM,=,4500.0,Inhibition of human ERG
9893,CHEMBL3415610,COc1cccc2[nH]c(-c3nc(N[C@@H]4CCOC[C@@H]4N)cnc3C(N)=O)cc12,IC50,nM,=,22000.0,Inhibition of human ERG
9894,CHEMBL3968947,O=C(O)CCCOc1ccc(-c2cc(OC(F)(F)F)ccc2Cl)cc1,IC50,nM,>,60000.0,Inhibition of human ERG
9895,CHEMBL3909872,Cc1cc(-c2cc(OC(F)(F)F)ccc2Cl)cc(C)c1OCCCC(=O)O,IC50,nM,=,54570.0,Inhibition of human ERG
9896,CHEMBL3896657,O=C(O)CCc1cc2cc(-c3cc(OC(F)(F)F)ccc3F)ccc2o1,IC50,nM,>,60000.0,Inhibition of human ERG
9897,CHEMBL3928846,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@@H]3CO2)ccc2c1COC2=O,IC50,nM,=,53400.0,Displacement of 35S-MK499 from human ERG expressed in HEK293 cell membranes
9898,CHEMBL3929578,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc2c1COC2=O,IC50,nM,=,21100.0,Displacement of 35S-MK499 from human ERG expressed in HEK293 cell membranes
9899,CHEMBL3900159,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc2c1COC2=O,IC50,nM,=,26800.0,Displacement of 35S-MK499 from human ERG expressed in HEK293 cell membranes
9900,CHEMBL3922156,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@@H]3CO2)ccc2c1COC2=O,IC50,nM,=,59400.0,Displacement of 35S-MK499 from human ERG expressed in HEK293 cell membranes
9901,CHEMBL3921834,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CS2)ccc2c1COC2=O,IC50,nM,=,8900.0,Displacement of 35S-MK499 from human ERG expressed in HEK293 cell membranes
9902,CHEMBL3898579,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@@H]3CN2)ccc2c1COC2=O,IC50,nM,=,22000.0,Displacement of 35S-MK499 from human ERG expressed in HEK293 cell membranes
9903,CHEMBL3929578,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc2c1COC2=O,IC50,nM,=,19700.0,Inhibition of human ERG by electrophysiology method
9904,CHEMBL3900159,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc2c1COC2=O,IC50,nM,=,56500.0,Inhibition of human ERG by electrophysiology method
9905,CHEMBL3922156,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@@H]3CO2)ccc2c1COC2=O,IC50,nM,=,74900.0,Inhibition of human ERG by electrophysiology method
9906,CHEMBL3889781,O=C1OCCc2cc([C@@H]3CN4CCN(C(=O)Cc5ccc(-n6cnnn6)nc5)C[C@H]4CO3)ccc21,IC50,nM,=,75900.0,Inhibition of human ERG by electrophysiology method
9907,CHEMBL3911740,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology method
9908,CHEMBL3939330,O=C(Cc1ccc(-n2cnnn2)nc1)N1CCN2C[C@@H](c3ccc4nonc4c3)OC[C@@H]2C1,IC50,nM,>,10000.0,Inhibition of human ERG by electrophysiology method
9909,CHEMBL3922938,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc2nonc12,IC50,nM,>,10000.0,Inhibition of human ERG by electrophysiology method
9910,CHEMBL3924012,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,12500.0,Inhibition of human ERG by electrophysiology method
9911,CHEMBL3896006,Cc1c(C#N)cccc1[C@H]1CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)C[C@H]2CO1,IC50,nM,=,17600.0,Inhibition of human ERG by electrophysiology method
9912,CHEMBL3891108,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@H]3CO2)ccc2nonc12,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology method
9913,CHEMBL3943156,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nc4)C[C@@H]3CO2)ccc(F)c1C#N,IC50,nM,>,10000.0,Inhibition of human ERG by electrophysiology method
9914,CHEMBL3964139,Cc1c(C#N)cccc1[C@@H]1CN2CCN(C(=O)Cc3ccc(-n4cnnn4)nc3)C[C@@H]2CO1,IC50,nM,=,14800.0,Inhibition of human ERG by electrophysiology method
9915,CHEMBL3987135,O=C1OCCc2cc([C@@H]3CN4CCN(C(=O)Cc5ccc(-n6cnnn6)cc5)C[C@H]4CO3)ccc21,IC50,nM,>,30000.0,Inhibition of human ERG by electrophysiology method
9916,CHEMBL3942711,O=C1OCCc2cc([C@H]3CN4CCN(C(=O)Cc5ccc(-n6cnnn6)nc5)C[C@@H]4CO3)ccc21,IC50,nM,=,41500.0,Inhibition of human ERG by electrophysiology method
9917,CHEMBL3894177,O=C1OCCc2cc([C@@H]3CN4CCN(C(=O)Cc5cnc(-n6cnnn6)nc5)C[C@H]4CO3)ccc21,IC50,nM,>,90000.0,Inhibition of human ERG by electrophysiology method
9918,CHEMBL3933749,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)cn4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,20300.0,Inhibition of human ERG by electrophysiology method
9919,CHEMBL3964482,Cc1c([C@@H]2CN3CCN(C(=O)Cc4cnc(-n5cnnn5)nc4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,5900.0,Inhibition of human ERG by electrophysiology method
9920,CHEMBL3974889,Cc1c([C@@H]2CN3CCN(C(=O)Cc4cnc(-n5cnnn5)cn4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology method
9921,CHEMBL3892013,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)cn4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,19900.0,Inhibition of human ERG by electrophysiology method
9922,CHEMBL3920038,Cc1c([C@H]2CN3CCN(C(=O)Cc4cnc(-n5cnnn5)nc4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,25200.0,Inhibition of human ERG by electrophysiology method
9923,CHEMBL3900985,Cc1c([C@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)nn4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,33700.0,Inhibition of human ERG by electrophysiology method
9924,CHEMBL3928945,Cc1c([C@H]2CN3CCN(C(=O)Cc4cnc(-n5cnnn5)cn4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,12300.0,Inhibition of human ERG by electrophysiology method
9925,CHEMBL1767164,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1,IC50,nM,=,50.12,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9926,CHEMBL639,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,IC50,nM,=,100.0,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9927,CHEMBL3947980,c1cnc2c(N3CCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)cccc2c1,IC50,nM,=,7943.28,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9928,CHEMBL3921827,c1cnc2c(N3CCN(CCCc4ccc(OCCCN5CCCCCC5)cc4)CC3)cccc2c1,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9929,CHEMBL3893197,c1cnc2c(N3CCN(CCCCc4ccc(OCCCN5CCCCCC5)cc4)CC3)cccc2c1,IC50,nM,=,1584.89,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9930,CHEMBL3967709,O=C(O)c1cnc2c(N3CCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)cccc2c1,IC50,nM,=,19952.62,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9931,CHEMBL3896541,O=C(O)c1ccnc2c(N3CCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)cccc12,IC50,nM,>,63095.73,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9932,CHEMBL3953018,N#Cc1ccc(N2CCN(CCc3ccc(OCCCN4CCCCCC4)cc3)CC2)c2ncccc12,IC50,nM,>,63095.73,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9933,CHEMBL3925332,O=C(O)c1cc(N2CCN(CCc3ccc(OCCCN4CCCCCC4)cc3)CC2)c2ncccc2c1,IC50,nM,=,39810.72,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9934,CHEMBL3925977,O=C(O)c1ccc2cccnc2c1N1CCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1,IC50,nM,=,31622.78,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9935,CHEMBL3952802,O=C(O)/C=C/c1ccc2cccc(N3CCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)c2n1,IC50,nM,>,63095.73,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9936,CHEMBL3935303,O=C(O)CCc1ccc2cccc(N3CCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)c2n1,IC50,nM,=,15848.93,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9937,CHEMBL3907368,O=C(O)CCc1cnc2c(N3CCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)cccc2c1,IC50,nM,=,31622.78,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9938,CHEMBL3926412,CCc1cc(N2CCN(CCc3ccc(OCCCN4CCCCCC4)cc3)CC2)c2nc(CCC(=O)O)ccc2c1,IC50,nM,=,50118.72,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9939,CHEMBL3898341,CCCCc1cc(N2CCN(CCc3ccc(OCCCN4CCCCCC4)cc3)CC2)c2nc(CCC(=O)O)ccc2c1,IC50,nM,=,2511.89,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9940,CHEMBL3917428,O=C(O)CCc1ccc2cc(Cc3ccccc3)cc(N3CCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)c2n1,IC50,nM,=,6309.57,Displacement of [3H]-dofetilide from human ERG expressed in CHOK1 cell membranes incubated for 4 hrs in dark by luminescent assay
9941,CHEMBL3897030,Brc1ccc2c(NC3=NC[C@@]4(CN5CCC4CC5)O3)ncnn12,IC50,nM,=,2500.0,Inhibition of human ERG by patch clamp assay
9942,CHEMBL3944559,C/C(=N\NC(=N)N)c1ccc2c(c1)Cc1cc(/C(C)=N/NC(=N)N)ccc1-2.Cl.Cl,IC50,nM,=,1120.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes
9943,CHEMBL3913789,Cl.N=C(N)N/N=C/c1ccc(-c2ccc(/C=N/Nc3ccccc3Cl)cc2)cc1,IC50,nM,=,1140.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes
9944,CHEMBL3941777,Cl.N=C(N)N/N=C/c1ccc(-c2ccc(/C=N/Nc3ccccc3Br)cc2)cc1,IC50,nM,=,440.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes
9945,CHEMBL3904792,Cl.N=C(N)N/N=C/c1ccc(-c2ccc(/C=N/Nc3ccc(F)cc3)cc2)cc1,IC50,nM,=,3290.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes
9946,CHEMBL3923854,Cl.N=C(N)N/N=C/c1ccc(-c2ccc(/C=N/Nc3ccc(F)cc3F)cc2)cc1,IC50,nM,=,2240.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes
9947,CHEMBL2028019,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,IC50,nM,=,20720.0,Inhibition of recombinant human ERG expressed in CHOK1 cells at -80 mV holding potential after 2 mins by patch clamp assay
9948,CHEMBL3946995,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,IC50,nM,=,2110.0,Inhibition of recombinant human ERG expressed in CHOK1 cells at -80 mV holding potential after 2 mins by patch clamp assay
9949,CHEMBL3946960,CC(C)Cc1cc(CNS(=O)(=O)c2ccc(Cc3ccccc3)cc2)nn1-c1ccccc1,IC50,nM,=,6550.0,Inhibition of human ERG expressed in CHOK1 cells by whole-cell patch clamp method
9950,CHEMBL3919158,CC(C)Cc1cc(CNS(=O)(=O)c2ccc(CCc3ccccc3)cc2)nn1-c1ccccc1,IC50,nM,=,8730.0,Inhibition of human ERG expressed in CHOK1 cells by whole-cell patch clamp method
9951,CHEMBL3973288,CC(C)Cc1cc(CNS(=O)(=O)c2cccc(F)c2)nn1-c1ccccc1,IC50,nM,=,14500.0,Inhibition of human ERG expressed in CHOK1 cells by whole-cell patch clamp method
9952,CHEMBL3902262,CC(C)Cc1cc(CNS(=O)(=O)c2ccccc2)nn1-c1ccccc1,IC50,nM,=,21000.0,Inhibition of human ERG expressed in CHOK1 cells by whole-cell patch clamp method
9953,CHEMBL3885379,FC(F)(F)c1c(OC[C@H]2C[C@@H]2c2ccc(Cl)cc2)ccn2c(CC3CC3)nnc12,IC50,nM,=,380.0,Inhibition of human ERG by patch clamp method
9954,CHEMBL3948914,Cc1ccc(C(C)C)cc1NC(=O)Cn1c(Cc2c(Cl)cccc2Cl)nc2ccccc21,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells by automated patch clamp method
9955,CHEMBL3899686,COc1ccc(OC)c(Cc2nc3ccccc3n2CC(=O)Nc2cc(C(C)(C)C)cc(C(C)(C)C)c2)c1,IC50,nM,=,20.0,Inhibition of human ERG expressed in CHOK1 cells by automated patch clamp method
9956,CHEMBL3939039,Cc1ccc(C(C)C)cc1NC(=O)Cn1c(-c2cc(Cl)ccc2Cl)nc2ccc(Cl)cc21,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by automated patch clamp method
9957,CHEMBL3922790,CCN1CCCC1CNC(=O)c1ccc(Cn2c(Cc3c(Cl)cccc3Cl)nc3ccccc32)cc1,IC50,nM,=,1570.0,Inhibition of human ERG expressed in CHOK1 cells by automated patch clamp method
9958,CHEMBL3947919,CN(C)CCCNC(=O)c1ccc(Cn2c(Cc3c(Cl)cccc3Cl)nc3ccccc32)cc1,IC50,nM,=,4530.0,Inhibition of human ERG expressed in CHOK1 cells by automated patch clamp method
9959,CHEMBL3932821,O=C(NCCCN1CCCCC1)c1ccc(Cn2c(Cc3c(Cl)cccc3Cl)nc3ccccc32)cc1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by automated patch clamp method
9960,CHEMBL3944506,COc1ccc2nc(NC3=NC[C@@]4(CN5CCC4CC5)O3)sc2c1,IC50,nM,=,1300.0,Inhibition of human ERG by patch clamp assay
9961,CHEMBL3918431,c1ccc2cc(NC3=NC[C@@]4(CN5CCC4CC5)O3)ncc2c1,IC50,nM,=,3220.0,Inhibition of human ERG by patch clamp assay
9962,CHEMBL2107383,COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC.Cl,IC50,nM,=,7000.0,Inhibition of human ERG expressed in HEK cells by patch clamp method
9963,CHEMBL243664,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1,IC50,nM,=,32400.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9964,CHEMBL3968881,COc1ccc(C(=O)Oc2cc(O)cc3oc(-c4ccc(OC)cc4)cc(=O)c23)cc1,IC50,nM,=,4100.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9965,CHEMBL16312,COc1ccc(-c2cc(=O)c3ccccc3o2)cc1,IC50,nM,=,21900.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9966,CHEMBL301692,COc1ccc(-c2cc(=O)c3cc(Cl)ccc3o2)cc1,IC50,nM,=,13000.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9967,CHEMBL2442379,COc1ccc(-c2cc(=O)c3cc(C)ccc3o2)cc1,IC50,nM,=,57900.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9968,CHEMBL311498,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9969,CHEMBL3939799,C[C@@H]1O[C@@H](OC2C(=O)c3c(O)cc(O)cc3OC2c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9970,CHEMBL226335,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9971,CHEMBL8260,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9972,CHEMBL3948644,COc1ccc(-c2cc(=O)c3c(O)cc(OC(C)=O)cc3o2)cc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9973,CHEMBL3984354,COc1ccc(-c2cc(=O)c3c(O)cc(OC(=O)c4ccccc4)cc3o2)cc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9974,CHEMBL350958,COc1ccc(-c2cc(=O)c3c(O)cc(OC)cc3o2)cc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9975,CHEMBL3924648,CCOc1cc(O)c2c(=O)cc(-c3ccc(OC)cc3)oc2c1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in tail current amplitude by whole cell patch clamp method
9976,CHEMBL3933375,COc1ccc2c(c1)CNCCS2,IC50,nM,=,7029.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9977,CHEMBL2105757,COc1ccc2c(c1)CN(C(=O)C(=O)[O-])CCS2.[Na+],IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9978,CHEMBL3932540,COc1ccc2c(c1)CN(C(=O)c1ccc(N=[N+]=[N-])cc1O)CCS2,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9979,CHEMBL3958409,COc1ccc2c(c1)CN(C(=O)N1CCN(Cc3ccc4c(c3)OCO4)CC1)CCS2,IC50,nM,=,2496.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9980,CHEMBL3965149,COc1ccc2c(c1)CN(C(=O)N1CCCCC1)CCS2,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9981,CHEMBL3943880,COC(=O)C(=O)N1CCSc2ccc(OC)cc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9982,CHEMBL3980215,COc1ccc2c(c1)CN(C(=O)N1CCNCC1)CCS2,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9983,CHEMBL3918523,O=C(NO)N1CCSc2ccccc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9984,CHEMBL3915771,CCN(CC)C(=O)N1CCSc2ccccc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9985,CHEMBL3958287,COC(=O)C(=O)N1CCSc2ccccc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9986,CHEMBL3955655,O=C(O)C(=O)N1CCSc2ccccc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9987,CHEMBL3909873,O=C(N1CCN(Cc2ccc3c(c2)OCO3)CC1)N1CCSc2ccccc2C1,IC50,nM,=,4406.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9988,CHEMBL3963470,O=C(N1CCCCC1)N1CCSc2ccccc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9989,CHEMBL3954519,O=C(N1CCNCC1)N1CCSc2ccccc2C1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9990,CHEMBL3892659,COc1ccc2c(c1)CN(C(=O)C(=O)O)CCS2(=O)=O,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9991,CHEMBL2440854,COc1ccc2c(c1)CN(C)CCS2,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9992,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,500.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9993,CHEMBL2440857,COc1ccc2c(c1)CN(C(=O)CCN1CCC(Cc3ccccc3)CC1)CCS2.Cl,IC50,nM,=,463.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in outward tail current after 5 mins at -80 mV holding potential by patch clamp assay
9994,CHEMBL3920203,CC(C)S(=O)(=O)NCCN1CC2CN(C[C@H](O)COc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,=,1905.46,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
9995,CHEMBL3917472,CC(C)(C)NS(=O)(=O)CCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
9996,CHEMBL3980357,CC(C)(C)OC(=O)NCCN1CC2CN(CCNS(=O)(=O)c3ccc(F)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
9997,CHEMBL3976526,O=S(=O)(NCCN1CC2CN(Cc3ccccc3)CC(C1)O2)c1ccc(F)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
9998,CHEMBL3905698,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)Cc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
9999,CHEMBL3903029,CC(C)S(=O)(=O)NCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10000,CHEMBL3966988,N#Cc1ccc(CS(=O)(=O)NCCN2CC3CN(Cc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10001,CHEMBL3955115,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10002,CHEMBL3927915,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4ccc(F)cc4F)CC(C2)O3)cc1,IC50,nM,=,3235.94,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10003,CHEMBL3925260,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10004,CHEMBL3934615,CS(=O)(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10005,CHEMBL3937364,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10006,CHEMBL3974075,CS(=O)(=O)NCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10007,CHEMBL3976522,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccc(C#N)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10008,CHEMBL3913182,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4cccc(Cl)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10009,CHEMBL3973197,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4ccc(C#N)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10010,CHEMBL3957756,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)C(F)(F)F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10011,CHEMBL3960441,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)Cc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10012,CHEMBL3942367,Cn1cnc(S(=O)(=O)NCCN2CC3CN(CCOc4ccc(C#N)cc4)CC(C2)O3)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10013,CHEMBL3945049,CCCCS(=O)(=O)NCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10014,CHEMBL3909031,Cn1cnc(S(=O)(=O)NCCN2CC3CN(CCCOc4ccc(C#N)cc4)CC(C2)O3)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10015,CHEMBL3906218,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)Cc4ccc(C(F)(F)F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10016,CHEMBL3946866,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)Cc4ccc(C(F)(F)F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10017,CHEMBL3944234,Cc1noc(C)c1S(=O)(=O)NCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10018,CHEMBL3894551,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4ccccc4OC(F)(F)F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10019,CHEMBL3982681,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)Cc4cccc(Cl)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10020,CHEMBL3916089,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10021,CHEMBL3929813,N#Cc1ccc(CN2CC3CN(CCNS(=O)(=O)c4ccc(C#N)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10022,CHEMBL3986453,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10023,CHEMBL3971442,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4ccc(OC(F)F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10024,CHEMBL3912524,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10025,CHEMBL3915182,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCOc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10026,CHEMBL3966710,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10027,CHEMBL3975912,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccc5c(c4)CCO5)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10028,CHEMBL3926918,Cc1nn(C)c(Cl)c1S(=O)(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10029,CHEMBL3929590,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccccc4C#N)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10030,CHEMBL3986615,COc1ccc(S(=O)(=O)NCCN2CC3CN(CCOc4ccc(C#N)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10031,CHEMBL3891560,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4ccc5c(c4)CCO5)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10032,CHEMBL3948200,Cc1nn(C)c(Cl)c1S(=O)(=O)NCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10033,CHEMBL3950836,COc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4ccc(C#N)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10034,CHEMBL3970684,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4ccccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10035,CHEMBL3967966,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4cc(F)ccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10036,CHEMBL3931053,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4ccc(F)c(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10037,CHEMBL3934230,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCOc4ccccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10038,CHEMBL3983804,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCOc4ccc(C#N)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10039,CHEMBL3981320,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCOCc4ccccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10040,CHEMBL3945417,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4ccc(F)c(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10041,CHEMBL3942732,Cc1cc(C)n(CCN2CC3CN(CCNS(=O)(=O)c4ccc(C#N)cc4)CC(C2)O3)n1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10042,CHEMBL3905070,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4ccccc4C#N)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10043,CHEMBL3902402,Cc1noc(C)c1CN1CC2CN(CCNS(=O)(=O)c3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10044,CHEMBL3894240,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4cccc(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10045,CHEMBL3903976,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4cccc(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10046,CHEMBL3895864,Cc1oncc1S(=O)(=O)NCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10047,CHEMBL3942038,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4coc5ccccc45)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10048,CHEMBL3915705,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4c[nH]c5ccccc45)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10049,CHEMBL3918449,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4c[nH]c5ccc(F)cc45)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10050,CHEMBL3953430,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)c4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10051,CHEMBL3956052,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)c4ccc(F)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10052,CHEMBL3927756,N#Cc1ccc(OCCCN2CC3CN(CCCNS(=O)(=O)c4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10053,CHEMBL3937546,N#Cc1ccc(CN2CC3CN(CCNS(=O)(=O)Cc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10054,CHEMBL3981791,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)Cc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10055,CHEMBL3894300,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)c4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10056,CHEMBL3921864,Cc1[nH]c2ccccc2c1CN1CC2CN(CCNS(=O)(=O)c3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10057,CHEMBL3919137,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4cccc(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10058,CHEMBL3915543,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4cccc(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10059,CHEMBL3923613,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4ccc(C#N)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10060,CHEMBL3936218,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4c(F)cc(C#N)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10061,CHEMBL3933488,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCOc4c(F)cccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10062,CHEMBL3947613,CC(C)S(=O)(=O)NCCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10063,CHEMBL3938049,N#Cc1ccc(OCCCN2CC3CN(CCCNS(=O)(=O)Cc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10064,CHEMBL3920476,Cc1noc(C)c1S(=O)(=O)NCCCN1CC2CN(CCCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10065,CHEMBL3904589,Cc1noc(C)c1S(=O)(=O)NCCCN1CC2CN(CCOc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10066,CHEMBL3891938,Cc1noc(C)c1S(=O)(=O)NCCCN1CC2CN(Cc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10067,CHEMBL3894695,Cc1noc(C)c1S(=O)(=O)NCCN1CC2CN(Cc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10068,CHEMBL3985192,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4nc5ccccc5o4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10069,CHEMBL3890135,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4cccc(C#N)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10070,CHEMBL3939950,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4cccc(C#N)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10071,CHEMBL3957572,N#Cc1ccc(CN2CC3CN(CCNS(=O)(=O)c4cccc(C#N)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10072,CHEMBL3967524,N#Cc1ccc(CN2CC3CN(CCNS(=O)(=O)c4ccccc4C#N)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10073,CHEMBL3975386,N#Cc1ccc(OCCCN2CC3CN(CCNS(=O)(=O)c4ccccc4C#N)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10074,CHEMBL3946853,N#Cc1ccc(CN2CC3CN(CCS(=O)(=O)Nc4ccc(C#N)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10075,CHEMBL3944226,N#Cc1ccc(CNS(=O)(=O)CCN2CC3CN(Cc4ccccc4C#N)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10076,CHEMBL3909019,Cc1noc(C)c1CN1CC2CN(CCS(=O)(=O)N(Cc3ccc(C#N)cc3)Cc3c(C)noc3C)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10077,CHEMBL3892476,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCOc4ccc(C#N)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10078,CHEMBL3932560,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)c4ccc(F)cc4)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10079,CHEMBL3906433,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)c4ccccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10080,CHEMBL3894543,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10081,CHEMBL3982670,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)c4ccc(F)cc4F)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10082,CHEMBL3939265,N#Cc1ccc(OCCN2CC3CN(CCCNS(=O)(=O)c4ccccc4)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10083,CHEMBL3936504,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccc(F)cc4)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10084,CHEMBL3929883,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4cccc(F)c4)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10085,CHEMBL3932635,Cc1noc(C)c1S(=O)(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10086,CHEMBL3969573,N#Cc1cccc(S(=O)(=O)NCCN2CC3CN(CCOc4ccc(C#N)cc4F)CC(C2)O3)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10087,CHEMBL3972282,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccccc4)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10088,CHEMBL3908503,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4ccc(Cl)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10089,CHEMBL3918241,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4ccc(C(F)(F)F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10090,CHEMBL3953223,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4c(F)cccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10091,CHEMBL3955863,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4ccccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10092,CHEMBL3894065,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10093,CHEMBL3896742,CN(CCN1CC2CN(Cc3ccc(C#N)cc3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10094,CHEMBL3900588,CN(CCN1CC2CN(Cc3ccccc3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10095,CHEMBL3903313,CN(CCN1CC2CN(Cc3ccc(F)cc3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10096,CHEMBL3959589,CN(CCN1CC2CN(CCc3ccccc3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10097,CHEMBL3962303,CN(CCN1CC2CN(CCc3cccc(F)c3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10098,CHEMBL3940848,CN(CCN1CC2CN(CCc3ccccc3F)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10099,CHEMBL3917041,Cc1noc(C)c1CN1CC2CN(CCS(=O)(=O)NCc3ccc(C#N)cc3)CC(C1)O2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10100,CHEMBL3968314,N#Cc1ccc(CNS(=O)(=O)CCN2CC3CN(CCc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10101,CHEMBL3948224,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)Cc4ccccc4)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10102,CHEMBL3892836,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccc5c(c4)CCO5)CC(C2)O3)c(F)c1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10103,CHEMBL3895555,N#Cc1ccc(OCCN2CC3CN(CCNS(=O)(=O)c4ccc(F)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10104,CHEMBL3957375,N#Cc1ccc(CN2CC3CN(CCNS(=O)(=O)c4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10105,CHEMBL3922226,O=S(=O)(NCCN1CC2CN(Cc3ccc(F)cc3)CC(C1)O2)c1ccc(F)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10106,CHEMBL3926495,N#Cc1ccc(CCN2CC3CN(CCNS(=O)(=O)c4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10107,CHEMBL3923752,O=S(=O)(NCCN1CC2CN(CCc3ccc(F)cc3)CC(C1)O2)c1ccc(F)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10108,CHEMBL3973704,CN(CCN1CC2CN(CCOc3c(F)cccc3F)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10109,CHEMBL3971138,CN(CCCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2)S(=O)(=O)c1ccccc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10110,CHEMBL3912797,CN(CCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2)S(=O)(=O)c1ccc2c(c1)CCO2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10111,CHEMBL3910131,CN(CCN1CC2CN(CCOc3ccc(C#N)cc3)CC(C1)O2)S(=O)(=O)c1ccc2c(c1)CCO2,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10112,CHEMBL3960009,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4ccc(C#N)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10113,CHEMBL3901969,CN(CCN1CC2CN(Cc3ccc(C#N)cc3F)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10114,CHEMBL3893809,O=S(=O)(NCCN1CC2CN(CCc3cccc(F)c3)CC(C1)O2)c1ccc(F)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10115,CHEMBL3903514,O=S(=O)(NCCN1CC2CN(CCc3ccccc3F)CC(C1)O2)c1ccc(F)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10116,CHEMBL3938857,O=S(=O)(NCCN1CC2CN(CCc3ccccc3)CC(C1)O2)c1ccc(F)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10117,CHEMBL3941569,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(Cc4noc5ccccc45)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10118,CHEMBL3984870,CN(CCN1CC2CN(CCc3ccc(F)cc3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10119,CHEMBL3889836,CN(CCN1CC2CN(CCc3ccc(F)c(F)c3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10120,CHEMBL3964634,N#Cc1ccc(CN2CC3CN(CCCNS(=O)(=O)c4ccc(C#N)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10121,CHEMBL3955593,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(Cc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10122,CHEMBL3901526,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10123,CHEMBL3911351,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCc4cccc(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10124,CHEMBL3910804,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCc4ccccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10125,CHEMBL3908020,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCc4c(F)cccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10126,CHEMBL3984123,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCc4ccc(F)c(F)c4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10127,CHEMBL3959965,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(Cc4ccccc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10128,CHEMBL3925200,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCCOc4ccc(F)cc4)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10129,CHEMBL3949531,N#Cc1ccc(S(=O)(=O)NCCCN2CC3CN(CCOc4c(F)cccc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10130,CHEMBL3956117,CN(CCN1CC2CN(CCCOc3ccc(F)cc3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10131,CHEMBL3953505,CN(CCN1CC2CN(CCCOc3ccc(F)cc3F)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10132,CHEMBL3918524,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCc4ccc(F)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10133,CHEMBL3915772,N#Cc1ccc(S(=O)(=O)NCCN2CC3CN(CCCOc4ccc(F)cc4F)CC(C2)O3)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10134,CHEMBL3938661,CN(CCN1CC2CN(CCc3ccc(Cl)cc3)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10135,CHEMBL3941374,CN(CCN1CC2CN(CCc3ccc(F)cc3F)CC(C1)O2)S(=O)(=O)c1ccc(C#N)cc1,IC50,nM,<,31622.78,Inhibition of human ERG expressed in CHO cells incubated for 10 mins after 3 hrs incubation with Rb+-load buffer by atomic absorption spectrometry based Rb+ efflux assay
10136,CHEMBL1404,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,IC50,nM,=,13400.0,Inhibition of human ERG expressed in CHO cells using voltage step to -50 mV for 300 ms from -80 mV holding potential by automated patch clamp assay
10137,CHEMBL3707392,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,IC50,nM,=,5700.0,Inhibition of human ERG expressed in CHO cells using voltage step to -50 mV for 300 ms from -80 mV holding potential by automated patch clamp assay
10138,CHEMBL3696117,Clc1ccc(Cn2c(/C=C/C3CCN(CC4CCCCC4)C3)nc3cc(Br)ccc32)cc1,IC50,nM,=,1100.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10139,CHEMBL3696118,Cc1cc2nc(/C=C/C3CCCN3C)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,980.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10140,CHEMBL3696119,Cc1cc2nc(/C=C/C3CCNC3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,1600.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10141,CHEMBL3696120,Cc1cc2nc(CC3CCNCC3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,1100.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10142,CHEMBL3696121,Cc1cc2nc(CC3CC4CCC(C3)N4)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,4300.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10143,CHEMBL3699563,Cc1cc2nc(CC3CCNC(C)C3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,580.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10144,CHEMBL3699564,Cc1cc2nc(C(C)Cc3ccncc3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,8800.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10145,CHEMBL3699565,Cc1cc2nc(CC3CCCNC3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,490.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10146,CHEMBL3699566,Cc1cc2nc(CC3CCCCC3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,>,10000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10147,CHEMBL3699567,Cc1cc2nc(CCC3CCCN3C)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,260.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10148,CHEMBL3699568,Cc1cc2nc(/C=C/c3cccs3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,>,10000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10149,CHEMBL3699569,Cc1ccc2c(c1)nc(CN1CCC[C@@H]1C)n2Cc1ccc(Cl)cc1,IC50,nM,<,1000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10150,CHEMBL3699570,C/C(=C\c1cccnc1)c1nc2cc(C)c(C)cc2n1Cc1ccc(Cl)cc1,IC50,nM,>,10000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10151,CHEMBL3699571,Cc1cc2nc(COC3CCCC3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,>,10000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10152,CHEMBL1945694,Cc1cc2ncn(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,7000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10153,CHEMBL3699572,O=c1ccc(-c2nc3cc(Cl)c(Cl)cc3n2Cc2ccc(Cl)c(Cl)c2)c[nH]1,IC50,nM,=,5000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10154,CHEMBL3699573,Cc1cc2nc(/C=C/c3ccccc3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,4000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10155,CHEMBL1407943,Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1,IC50,nM,<,1000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10156,CHEMBL3699574,O=C1CCCN1Cc1nc2ccccc2n1Cc1ccc(Cl)cc1,IC50,nM,=,7000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10157,CHEMBL1537587,COc1ccc(Cn2cnc3c(NS(C)(=O)=O)c(C)c(C)cc32)cc1,IC50,nM,>,30000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10158,CHEMBL3699575,CS(=O)(=O)c1ccc2c(c1)nc(C(F)(F)F)n2Cc1ccccc1,IC50,nM,>,30000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10159,CHEMBL3699576,Cc1cc2nc(CC3CCCC3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,=,1300.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10160,CHEMBL3699577,OC[C@@H]1CCCN1Cc1nc2ccccc2n1Cc1ccc(Cl)cc1,IC50,nM,<,1000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10161,CHEMBL3699578,Cc1cc2nc(/C=C/c3ccco3)n(Cc3ccc(Cl)cc3)c2cc1C,IC50,nM,>,10000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10162,CHEMBL3699579,COc1ccc2nc(CN3CCC[C@H]3CO)n(Cc3ccc(Cl)cc3)c2c1,IC50,nM,=,5000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10163,CHEMBL1872352,OCc1nc2ccccc2n1Cc1ccc(Cl)cc1,IC50,nM,>,30000.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10164,CHEMBL3699580,Cc1ccc2nc(CN3CCCC3)n(Cc3ccc(Cl)cc3)c2c1,IC50,nM,=,650.0,"Potassium Channel Assay: Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The most common mechanism for these adverse events is the inhibition of one or more cardiac potassium channels, in particular hERG. This current is important for cardiac myocyte repolarization and is a common target for drugs that prolong the QT interval. Test articles in this study were therefore characterized to determine their ability to inhibit the hERG channel. Ion channel activity was measured using a stably transfected Chinese Hamster Ovary (CHO) cell line expressing the hERG mRNA. The pharmacology of this cloned channel expressed in the CHO cell line is very similar to that observed in native tissue."
10165,CHEMBL3703208,COCc1cnn(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10166,CHEMBL3703209,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10167,CHEMBL3703210,CC1(C)Oc2ccc(Br)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10168,CHEMBL3703214,CCC1Oc2ccc(Br)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10169,CHEMBL3703214,CCC1Oc2ccc(Br)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10170,CHEMBL3703215,NC1=NC2(CO1)c1cc(Br)ccc1OC1(CCCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10171,CHEMBL3703220,NC1=NC2(CO1)c1cc(Br)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10172,CHEMBL3703220,NC1=NC2(CO1)c1cc(Br)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,=,7930.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10173,CHEMBL3703221,NC1=NC2(CO1)c1cc(Br)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10174,CHEMBL3703221,NC1=NC2(CO1)c1cc(Br)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10175,CHEMBL3703222,NC1=NC2(CO1)c1cc(Br)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10176,CHEMBL3703232,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10177,CHEMBL3703233,CC1(C)Oc2ccc(NC(=O)c3ccc(F)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10178,CHEMBL3703234,NC1=NC2(CO1)c1cc(NC(=O)c3ncc(Cl)cc3F)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10179,CHEMBL3703235,CC1(C)Oc2ccc(NC(=O)c3ncc(Cl)cc3F)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10180,CHEMBL3703236,NC1=NC2(CO1)c1cc(NC(=O)c3ccc(F)cn3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10181,CHEMBL3703237,NC1=NC2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1OCC21CC1,IC50,nM,=,2170.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10182,CHEMBL3703239,NC1=NC2(CO1)c1cc(-c3cc(Cl)cnc3F)ccc1OCC21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10183,CHEMBL3703246,CC1(C)Oc2ccc(Br)cc2C2(CSC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10184,CHEMBL3703247,NC1=NC2(CO1)c1cc(Nc3ncccc3Cl)ccc1OCC21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10185,CHEMBL3703249,COc1cccnc1Nc1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10186,CHEMBL3703250,CC(C)Cc1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10187,CHEMBL3703253,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10188,CHEMBL3703253,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10189,CHEMBL3703254,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,4830.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10190,CHEMBL3703255,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)CO3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10191,CHEMBL3703256,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(CSC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10192,CHEMBL3703257,CC#Cc1ccnc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)CO3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10193,CHEMBL3703258,NC1=NC2(CO1)c1cc(-c3cncc(C4CC4)c3)ccc1OCC21CC1,IC50,nM,=,3480.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10194,CHEMBL3703259,NC1=NC2(CO1)c1cc(-c3cncc(OCC(F)(F)F)c3)ccc1OCC21CC1,IC50,nM,=,5810.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10195,CHEMBL3703260,NC1=NC2(CO1)c1cc(-c3cncc(OCC(F)F)c3)ccc1OCC21CC1,IC50,nM,=,6900.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10196,CHEMBL3703261,NC1=NC2(CO1)c1cc(-c3cncc(OC(F)F)c3)ccc1OCC21CC1,IC50,nM,=,2780.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10197,CHEMBL3703262,NC1=NC2(CO1)c1cc(-c3cnc4[nH]ccc4c3)ccc1OCC21CC1,IC50,nM,=,9220.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10198,CHEMBL3703263,NC1=NC2(CO1)c1cc(-c3cnc4[nH]cc(Cl)c4c3)ccc1OCC21CC1,IC50,nM,=,4430.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10199,CHEMBL3703264,CCc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,4480.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10200,CHEMBL3703265,NC1=NC2(CO1)c1cc(-c3cncc(OCC(F)(F)C(F)F)c3)ccc1OCC21CC1,IC50,nM,=,1670.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10201,CHEMBL3703266,COc1ccnc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,=,9770.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10202,CHEMBL3703267,Cc1cn2ccc(-c3ccc4c(c3)C3(COC(N)=N3)C3(COC3)C3(CCC3)O4)cc2n1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10203,CHEMBL3640021,Cc1cn2cc(-c3ccc4c(c3)C3(COC(N)=N3)C3(COC3)C3(CCC3)O4)ccc2n1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10204,CHEMBL3703268,CC#Cc1cncc(-c2ccc3c(c2)C2(CSC(N)=N2)C2(COC2)CO3)c1,IC50,nM,=,6050.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10205,CHEMBL3703253,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10206,CHEMBL3703269,NC1=NC2(CO1)c1cc(-c3cncc(F)c3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10207,CHEMBL3703270,NC1=NC2(CO1)c1cc(-c3cccnc3F)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10208,CHEMBL3703271,COc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,=,8220.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10209,CHEMBL3703274,Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10210,CHEMBL3703275,Cc1cnnc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10211,CHEMBL3954909,C[C@@H]1Oc2ccc(-c3cccnc3F)cc2[C@]2(COC(=N)N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10212,CHEMBL3953424,C[C@@H]1Oc2ccc(-c3cncnc3)cc2[C@]2(COC(=N)N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10213,CHEMBL3703278,C[C@@H]1Oc2ccc(-c3cccnc3F)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10214,CHEMBL3703279,C[C@@H]1Oc2ccc(-c3cncnc3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10215,CHEMBL3951464,COc1cncc(-c2ccc3c(c2)[C@]2(COC(=N)N2)C2(COC2)[C@H](C)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10216,CHEMBL3703281,CC1(C)Oc2ccc(-c3cccnc3F)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10217,CHEMBL3703282,COc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10218,CHEMBL3703283,CCC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10219,CHEMBL3703284,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC1(CCCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10220,CHEMBL3703285,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CC)O3)c1,IC50,nM,=,7940.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10221,CHEMBL3703286,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(C1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10222,CHEMBL3703286,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(C1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10223,CHEMBL3703287,CC(C)CC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10224,CHEMBL3703288,CCCC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10225,CHEMBL3703289,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CCC)O3)c1,IC50,nM,=,5340.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10226,CHEMBL3703287,CC(C)CC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10227,CHEMBL3703288,CCCC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10228,CHEMBL3703290,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(CCC(F)(F)F)C21CCC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10229,CHEMBL3703291,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CCC(F)(F)F)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10230,CHEMBL3703292,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CCCO1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10231,CHEMBL3703292,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CCCO1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10232,CHEMBL3703293,NC1=NC2(CO1)c1cc(-c3cncc(C(F)(F)F)c3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10233,CHEMBL3703294,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10234,CHEMBL3703295,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CCC1,IC50,nM,=,5280.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10235,CHEMBL3703296,NC1=NC2(CO1)c1cc(-c3cncnc3)c(F)cc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10236,CHEMBL3703297,NC1=NC2(CO1)c1cc(-c3cccnc3F)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10237,CHEMBL3703298,NC1=NC2(CO1)c1cc(-c3cc(Cl)cnc3F)ccc1OCC21CC1,IC50,nM,=,3250.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10238,CHEMBL3703299,COc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,7900.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10239,CHEMBL3703300,CCOc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,5750.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10240,CHEMBL3703301,NC1=NC2(CO1)c1cc(-c3cncc(Cl)c3)ccc1OCC21CC1,IC50,nM,=,2910.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10241,CHEMBL3703255,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)CO3)c1,IC50,nM,=,9400.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10242,CHEMBL3703302,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10243,CHEMBL3703303,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10244,CHEMBL3703254,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,1980.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10245,CHEMBL3703304,CC#Cc1cncc(-c2cc3c(cc2F)OCC2(CC2)C32COC(N)=N2)c1,IC50,nM,=,4320.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10246,CHEMBL3703307,N#Cc1ncccc1-c1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10247,CHEMBL3703308,Cc1cnc(F)c(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10248,CHEMBL3703309,Cc1ncncc1-c1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10249,CHEMBL3703310,NC1=NC2(CO1)c1cc(-c3cncc(C(F)F)c3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10250,CHEMBL3650774,COc1cccc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10251,CHEMBL3650786,CC1(C)Oc2ccc(-c3cc(Cl)cnc3F)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,1000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10252,CHEMBL3650819,NC1=NC2(CO1)c1cc(Br)ccc1OCC21CC(F)(F)C1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10253,CHEMBL3650820,NC1=NC2(CO1)c1cc(NC(=O)c3ncc(Br)cn3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10254,CHEMBL3650821,CC1(C)Oc2ccc(NC(=O)c3ncc(Br)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10255,CHEMBL3650822,Cc1cc(C#N)cnc1C(=O)Nc1ccc2c(c1)C1(COC(N)=N1)C1(CC1)CO2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10256,CHEMBL3650823,N#Cc1cnc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c(Cl)c1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10257,CHEMBL3650824,COc1cnc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)cn1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10258,CHEMBL3650825,Cc1cc(Cl)cnc1C(=O)Nc1ccc2c(c1)C1(COC(N)=N1)C1(CC1)CO2,IC50,nM,=,4910.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10259,CHEMBL3650826,Cc1cc(Cl)cnc1C(=O)Nc1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C(C)(C)O2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10260,CHEMBL3650827,N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)nc1,IC50,nM,=,3650.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10261,CHEMBL3650828,CC1(C)Oc2ccc(NC(=O)c3ccc(C#N)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10262,CHEMBL3650829,NC1=NC2(c3cc(-c4cncnc4)ccc3OCC23CC3)C(F)(F)CS1,IC50,nM,>,1000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10263,CHEMBL3650830,NC1=NC2(c3cc(-c4cncnc4)ccc3OCC23CC3)c2cccc(F)c21,IC50,nM,=,4250.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10264,CHEMBL3650831,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10265,CHEMBL3650831,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,=,7730.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10266,CHEMBL3650833,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10267,CHEMBL3650834,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CC2CC2)O3)c1,IC50,nM,=,5220.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10268,CHEMBL3650835,NC1=NC2(c3cc(-c4cncnc4)ccc3OCC23CC3)C(F)(F)CO1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10269,CHEMBL3650833,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10270,CHEMBL3650836,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CC(F)(F)C1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10271,CHEMBL3650837,NC1=NC2(CO1)c1cc(-c3cccnc3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10272,CHEMBL3650838,NC1=NC2(CO1)c1cc(-c3cncc4ccccc34)ccc1OC1(CCC1)C21COC1,IC50,nM,=,3700.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10273,CHEMBL3650840,NC1=NC2(CO1)c1cc(-c3cccnc3C(F)(F)F)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10274,CHEMBL3650841,Cn1cc2cc(-c3ccc4c(c3)C3(COC(N)=N3)C3(CC3)CO4)ccc2n1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10275,CHEMBL3650843,NC1=NC2(COC1)c1cc(-c3cncnc3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10276,CHEMBL3650845,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,=,20670.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10277,CHEMBL3650846,CC1(C)Oc2ccc(NC(=O)c3ccc(Br)cn3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10278,CHEMBL3650847,COc1cnc(C(=O)Nc2ccc3c(c2)[C@@]2(COC(N)=N2)C2(COC2)C(C)(C)O3)cn1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10279,CHEMBL3650848,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2[C@@]2(COC(N)=N2)C12CC2,IC50,nM,=,3250.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10280,CHEMBL3650849,CC1(C)Oc2ccc(NC(=O)c3ccc(F)cn3)cc2[C@@]2(COC(N)=N2)C12CC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10281,CHEMBL3650850,COc1cnc(C(=O)Nc2ccc3c(c2)[C@@]2(COC(N)=N2)C2(CC2)C(C)(C)O3)cn1,IC50,nM,=,20770.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10282,CHEMBL3650851,CC1(C)Oc2ccc(NC(=O)c3cnc(C(F)F)cn3)cc2[C@@]2(COC(N)=N2)C12CC2,IC50,nM,=,15100.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10283,CHEMBL3650852,COc1cnc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)cn1,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10284,CHEMBL3650845,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel.The membrane potential was held at −80 mV and repetitively (every 15 seconds) depolarized to +20 mV for 4800 milliseconds after the pulse to −50 mV for 20 milliseconds served to define the baseline, followed by repolarizing step to −50 mV for 5000 milliseconds to evaluate of the tail current amplitude. Experiments were conducted at room temperature."
10285,CHEMBL3903744,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C)n2c1COCC2)c1ccccc1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10286,CHEMBL3940749,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C)n2c1COCC2)c1cnc(OC)c(Cl)c1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10287,CHEMBL3916254,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C)n2c1COCC2)c1ccc(C(F)(F)F)c(Cl)c1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10288,CHEMBL3964723,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C)n2c1COCC2)c1ccc(Cl)c(Cl)c1,IC50,nM,=,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10289,CHEMBL3958545,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C)n2c1COCC2)c1ccc(C#N)c(Cl)c1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10290,CHEMBL3966365,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C)n2c1COCC2)c1ccc(C(F)(F)F)nc1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10291,CHEMBL4107340,CC[C@@H](NC(=O)c1cc(C(=O)N[C@H](C)c2ccc(F)cc2)n2c1COCC2)c1ccc(C(F)(F)F)cc1,IC50,nM,>,1000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10292,CHEMBL3915314,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C)n2c1COCC2)c1ccc(C(F)(F)F)cc1,IC50,nM,>,1000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10293,CHEMBL4108113,CC[C@@H](NC(=O)c1cc(C(=O)N[C@H](C)c2ccc(F)cc2)n2c1COCC2)c1ccc(C(F)(F)F)nc1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10294,CHEMBL4108024,CC[C@H](NC(=O)c1cc(C(=O)N[C@H](C)c2ccc(F)cc2)n2c1COCC2)c1ncccn1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10295,CHEMBL4107748,CC[C@@H](NC(=O)c1cc(C(=O)N[C@H](CC)c2ccccc2)n2c1COCC2)c1ccccc1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10296,CHEMBL4110602,CC[C@@H](NC(=O)c1cc(C(=O)N[C@H](CC)c2ccc(OC)nc2)n2c1COCC2)c1ccccc1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10297,CHEMBL4115511,CCOC(=O)CNC(=O)c1cc(C(=O)N[C@H](CC)c2ccccc2)c2n1CCOC2,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10298,CHEMBL3961794,CCOC(=O)[C@H](C)N(C)C(=O)c1cc(C(=O)N[C@H](CC)c2ccccc2)c2n1CCOC2,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10299,CHEMBL3947683,O=C(N[C@H](c1ccc(F)cc1)C1CC1)c1cc(C(=O)N2CCCC2)n2c1COCC2,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10300,CHEMBL4114380,CC[C@@H](NC(=O)c1cc(C(=O)N2CCC[C@@H]2C(F)(F)F)n2c1COCC2)c1ccc(C(F)(F)F)nc1,IC50,nM,>,10000.0,"hERG Inhibition Assay: The effect of compounds of the formula I on the cloned human cardiac hERG channel was evaluated in an in vitro model using a whole-cell patch-clamping technique. CHO (Chinese hamster ovary) cells stably expressing hERG, the potassium channel underlying IKr currents in human hearts, were grown in HAM's F-12 media supplemented with 10% fetal bovine serum, 1x penicillin/streptomycin and 500 ug/ml G418 (Invitrogen, Carlsbad, Calif., USA) in an atmosphere of 95% air and 5% carbon dioxide. Cells used for patch-clamping were seeded on glass or plastic coverslips 12 to 36 hours before use. hERG channel currents were recorded at room temperature using the whole-cell configuration of the patch clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, Calif., USA). Briefly, electrodes (3 to 6 MΩ resistance) were fashioned from TW150F glass capillary tubes (World Precision Instruments, Sarasota, Fla., USA) and filled with pipette solution (containing 120 mM potassium aspartate, 20 mM potassium chloride, 4 mM adenosine triphosphate disodium salt, 5 mM HEPES, 1 mM magnesium chloride; pH adjusted to 7.2 with potassium hydroxide). hERG currents were initiated by a positive voltage pulse (20 mV) followed by a negative pulse (-40 mV) and were recorded for off-line analyses. Once hERG current from a cell perfused with external solution (containing 130 mM sodium chloride, 5 mM potassium chloride, 2.8 mM sodium acetate, 1 mM magnesium chloride, 10 mM HEPES, 10 mM glucose, 1 mM calcium chloride; pH adjusted to 7.4 with sodium hydroxide) without the test compound, i.e. control solution, was stabilized, the cell was perfused with external solution containing the test compound at specific concentrations."
10301,CHEMBL3973534,NC1=N[C@@]2(c3cc(NC(=O)c4ccc(OC(F)F)cn4)ccc3F)COCC[C@H]2CS1,IC50,nM,=,500.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10302,CHEMBL3909266,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2cc(NC(=O)c3ccc(C#N)cn3)cs2)CO1,IC50,nM,=,1800.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10303,CHEMBL3983509,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)CO1,IC50,nM,=,200.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10304,CHEMBL3910757,Cc1cccc2c1N(C(=O)CSc1ccc(C(F)(F)F)cn1)CCC2,IC50,nM,>,30000.0,"Inhibition Assay: To determine whether compounds were selective for TRPV3 inhibition over inhibition of other ion channel types, the human ERG (hERG), NaV1.2, and TRPV1 (hTRPV1) channels and the rat TRPV6 (rTRPV6) channel were also stably transfected and expressed or induced to express in mammalian cell lines. The methods for measuring currents from these channels are well-established and have been described in numerous publications (See, Weerapura et al., 2002, J Physiology 540: 15-27; Rush et al., 2005, J Physiology 564: 808-815; Caterina et al., 1997, Nature 389: 816-824; Hoenderhop et al., 2001, J Physiology 537: 747-761; Clapham et al., 2003, Pharmacol Rev 55: 591-596)."
10305,CHEMBL3947726,Cc1cccc2c1N(C(=O)CSc1ccc(Cl)cn1)CCC2,IC50,nM,>,5000.0,"Inhibition Assay: To determine whether compounds were selective for TRPV3 inhibition over inhibition of other ion channel types, the human ERG (hERG), NaV1.2, and TRPV1 (hTRPV1) channels and the rat TRPV6 (rTRPV6) channel were also stably transfected and expressed or induced to express in mammalian cell lines. The methods for measuring currents from these channels are well-established and have been described in numerous publications (See, Weerapura et al., 2002, J Physiology 540: 15-27; Rush et al., 2005, J Physiology 564: 808-815; Caterina et al., 1997, Nature 389: 816-824; Hoenderhop et al., 2001, J Physiology 537: 747-761; Clapham et al., 2003, Pharmacol Rev 55: 591-596)."
10306,CHEMBL3923819,Cc1cccc2c1N(C(=O)CSc1ncccc1Cl)CCC2,IC50,nM,>,10000.0,"Inhibition Assay: To determine whether compounds were selective for TRPV3 inhibition over inhibition of other ion channel types, the human ERG (hERG), NaV1.2, and TRPV1 (hTRPV1) channels and the rat TRPV6 (rTRPV6) channel were also stably transfected and expressed or induced to express in mammalian cell lines. The methods for measuring currents from these channels are well-established and have been described in numerous publications (See, Weerapura et al., 2002, J Physiology 540: 15-27; Rush et al., 2005, J Physiology 564: 808-815; Caterina et al., 1997, Nature 389: 816-824; Hoenderhop et al., 2001, J Physiology 537: 747-761; Clapham et al., 2003, Pharmacol Rev 55: 591-596)."
10307,CHEMBL3703208,COCc1cnn(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10308,CHEMBL3703209,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10309,CHEMBL3703210,CC1(C)Oc2ccc(Br)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10310,CHEMBL3703214,CCC1Oc2ccc(Br)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10311,CHEMBL3703214,CCC1Oc2ccc(Br)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10312,CHEMBL3703215,NC1=NC2(CO1)c1cc(Br)ccc1OC1(CCCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10313,CHEMBL3703220,NC1=NC2(CO1)c1cc(Br)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10314,CHEMBL3703220,NC1=NC2(CO1)c1cc(Br)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,=,7930.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10315,CHEMBL3703221,NC1=NC2(CO1)c1cc(Br)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10316,CHEMBL3703221,NC1=NC2(CO1)c1cc(Br)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10317,CHEMBL3703222,NC1=NC2(CO1)c1cc(Br)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10318,CHEMBL3703232,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10319,CHEMBL3703233,CC1(C)Oc2ccc(NC(=O)c3ccc(F)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10320,CHEMBL3703234,NC1=NC2(CO1)c1cc(NC(=O)c3ncc(Cl)cc3F)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10321,CHEMBL3703235,CC1(C)Oc2ccc(NC(=O)c3ncc(Cl)cc3F)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10322,CHEMBL3703236,NC1=NC2(CO1)c1cc(NC(=O)c3ccc(F)cn3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10323,CHEMBL3703237,NC1=NC2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1OCC21CC1,IC50,nM,=,2170.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10324,CHEMBL3703239,NC1=NC2(CO1)c1cc(-c3cc(Cl)cnc3F)ccc1OCC21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10325,CHEMBL3703246,CC1(C)Oc2ccc(Br)cc2C2(CSC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10326,CHEMBL3703247,NC1=NC2(CO1)c1cc(Nc3ncccc3Cl)ccc1OCC21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10327,CHEMBL3703249,COc1cccnc1Nc1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10328,CHEMBL3703250,CC(C)Cc1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10329,CHEMBL3703253,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10330,CHEMBL3703253,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10331,CHEMBL3703254,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,4830.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10332,CHEMBL3703255,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)CO3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10333,CHEMBL3703256,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(CSC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10334,CHEMBL3703257,CC#Cc1ccnc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)CO3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10335,CHEMBL3703258,NC1=NC2(CO1)c1cc(-c3cncc(C4CC4)c3)ccc1OCC21CC1,IC50,nM,=,3480.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10336,CHEMBL3703259,NC1=NC2(CO1)c1cc(-c3cncc(OCC(F)(F)F)c3)ccc1OCC21CC1,IC50,nM,=,5810.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10337,CHEMBL3703260,NC1=NC2(CO1)c1cc(-c3cncc(OCC(F)F)c3)ccc1OCC21CC1,IC50,nM,=,6900.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10338,CHEMBL3703261,NC1=NC2(CO1)c1cc(-c3cncc(OC(F)F)c3)ccc1OCC21CC1,IC50,nM,=,2780.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10339,CHEMBL3703262,NC1=NC2(CO1)c1cc(-c3cnc4[nH]ccc4c3)ccc1OCC21CC1,IC50,nM,=,9220.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10340,CHEMBL3703263,NC1=NC2(CO1)c1cc(-c3cnc4[nH]cc(Cl)c4c3)ccc1OCC21CC1,IC50,nM,=,4430.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10341,CHEMBL3703264,CCc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,4480.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10342,CHEMBL3703265,NC1=NC2(CO1)c1cc(-c3cncc(OCC(F)(F)C(F)F)c3)ccc1OCC21CC1,IC50,nM,=,1670.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10343,CHEMBL3703266,COc1ccnc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,=,9770.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10344,CHEMBL3703267,Cc1cn2ccc(-c3ccc4c(c3)C3(COC(N)=N3)C3(COC3)C3(CCC3)O4)cc2n1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10345,CHEMBL3640021,Cc1cn2cc(-c3ccc4c(c3)C3(COC(N)=N3)C3(COC3)C3(CCC3)O4)ccc2n1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10346,CHEMBL3703268,CC#Cc1cncc(-c2ccc3c(c2)C2(CSC(N)=N2)C2(COC2)CO3)c1,IC50,nM,=,6050.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10347,CHEMBL3703253,CC1(C)Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10348,CHEMBL3703269,NC1=NC2(CO1)c1cc(-c3cncc(F)c3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10349,CHEMBL3703270,NC1=NC2(CO1)c1cc(-c3cccnc3F)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10350,CHEMBL3703271,COc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,=,8220.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10351,CHEMBL3703274,Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10352,CHEMBL3703275,Cc1cnnc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10353,CHEMBL3703276,C[C@H]1Oc2ccc(-c3cccnc3F)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10354,CHEMBL3703277,C[C@H]1Oc2ccc(-c3cncnc3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10355,CHEMBL3703278,C[C@@H]1Oc2ccc(-c3cccnc3F)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10356,CHEMBL3703279,C[C@@H]1Oc2ccc(-c3cncnc3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10357,CHEMBL3703280,COc1cncc(-c2ccc3c(c2)[C@@]2(COC(N)=N2)C2(COC2)[C@@H](C)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10358,CHEMBL3703281,CC1(C)Oc2ccc(-c3cccnc3F)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10359,CHEMBL3703282,COc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10360,CHEMBL3703283,CCC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10361,CHEMBL3703284,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC1(CCCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10362,CHEMBL3703285,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CC)O3)c1,IC50,nM,=,7940.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10363,CHEMBL3703286,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(C1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10364,CHEMBL3703286,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(C1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10365,CHEMBL3703287,CC(C)CC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10366,CHEMBL3703288,CCCC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10367,CHEMBL3703289,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CCC)O3)c1,IC50,nM,=,5340.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10368,CHEMBL3703287,CC(C)CC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10369,CHEMBL3703288,CCCC1Oc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10370,CHEMBL3924870,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(CCC(F)(F)F)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10371,CHEMBL3703291,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CCC(F)(F)F)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10372,CHEMBL3703292,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CCCO1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10373,CHEMBL3703292,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CCCO1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10374,CHEMBL3703293,NC1=NC2(CO1)c1cc(-c3cncc(C(F)(F)F)c3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10375,CHEMBL3703294,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10376,CHEMBL3703295,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CCC1,IC50,nM,=,5280.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10377,CHEMBL3703296,NC1=NC2(CO1)c1cc(-c3cncnc3)c(F)cc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10378,CHEMBL3703297,NC1=NC2(CO1)c1cc(-c3cccnc3F)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10379,CHEMBL3703298,NC1=NC2(CO1)c1cc(-c3cc(Cl)cnc3F)ccc1OCC21CC1,IC50,nM,=,3250.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10380,CHEMBL3703299,COc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,7900.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10381,CHEMBL3703300,CCOc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,5750.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10382,CHEMBL3703301,NC1=NC2(CO1)c1cc(-c3cncc(Cl)c3)ccc1OCC21CC1,IC50,nM,=,2910.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10383,CHEMBL3703255,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)CO3)c1,IC50,nM,=,9400.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10384,CHEMBL3703302,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10385,CHEMBL3703303,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10386,CHEMBL3703254,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c1,IC50,nM,=,1980.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10387,CHEMBL3703304,CC#Cc1cncc(-c2cc3c(cc2F)OCC2(CC2)C32COC(N)=N2)c1,IC50,nM,=,4320.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10388,CHEMBL3703307,N#Cc1ncccc1-c1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10389,CHEMBL3703308,Cc1cnc(F)c(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C2(CCC2)O3)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10390,CHEMBL3703309,Cc1ncncc1-c1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C1(CCC1)O2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10391,CHEMBL3703310,NC1=NC2(CO1)c1cc(-c3cncc(C(F)F)c3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10392,CHEMBL3650774,COc1cccc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)c1,IC50,nM,>,1000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10393,CHEMBL3650786,CC1(C)Oc2ccc(-c3cc(Cl)cnc3F)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,1000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10394,CHEMBL3650819,NC1=NC2(CO1)c1cc(Br)ccc1OCC21CC(F)(F)C1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10395,CHEMBL3650820,NC1=NC2(CO1)c1cc(NC(=O)c3ncc(Br)cn3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10396,CHEMBL3650821,CC1(C)Oc2ccc(NC(=O)c3ncc(Br)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10397,CHEMBL3650822,Cc1cc(C#N)cnc1C(=O)Nc1ccc2c(c1)C1(COC(N)=N1)C1(CC1)CO2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10398,CHEMBL3650823,N#Cc1cnc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)c(Cl)c1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10399,CHEMBL3650824,COc1cnc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)cn1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10400,CHEMBL3650825,Cc1cc(Cl)cnc1C(=O)Nc1ccc2c(c1)C1(COC(N)=N1)C1(CC1)CO2,IC50,nM,=,4910.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10401,CHEMBL3650826,Cc1cc(Cl)cnc1C(=O)Nc1ccc2c(c1)C1(COC(N)=N1)C1(COC1)C(C)(C)O2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10402,CHEMBL3650827,N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(CC2)CO3)nc1,IC50,nM,=,3650.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10403,CHEMBL3650828,CC1(C)Oc2ccc(NC(=O)c3ccc(C#N)cn3)cc2C2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10404,CHEMBL3650829,NC1=NC2(c3cc(-c4cncnc4)ccc3OCC23CC3)C(F)(F)CS1,IC50,nM,>,1000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10405,CHEMBL3650830,NC1=NC2(c3cc(-c4cncnc4)ccc3OCC23CC3)c2cccc(F)c21,IC50,nM,=,4250.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10406,CHEMBL3650831,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10407,CHEMBL3650831,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(Cc1ccccc1)C21COC1,IC50,nM,=,7730.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10408,CHEMBL3650833,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10409,CHEMBL3650834,CC#Cc1cncc(-c2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(CC2CC2)O3)c1,IC50,nM,=,5220.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10410,CHEMBL3650835,NC1=NC2(c3cc(-c4cncnc4)ccc3OCC23CC3)C(F)(F)CO1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10411,CHEMBL3650833,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OC(CC1CC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10412,CHEMBL3650836,NC1=NC2(CO1)c1cc(-c3cncnc3)ccc1OCC21CC(F)(F)C1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10413,CHEMBL3650837,NC1=NC2(CO1)c1cc(-c3cccnc3)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10414,CHEMBL3650838,NC1=NC2(CO1)c1cc(-c3cncc4ccccc34)ccc1OC1(CCC1)C21COC1,IC50,nM,=,3700.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10415,CHEMBL3650840,NC1=NC2(CO1)c1cc(-c3cccnc3C(F)(F)F)ccc1OC1(CCC1)C21COC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10416,CHEMBL3650841,Cn1cc2cc(-c3ccc4c(c3)C3(COC(N)=N3)C3(CC3)CO4)ccc2n1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10417,CHEMBL3650843,NC1=NC2(COC1)c1cc(-c3cncnc3)ccc1OCC21CC1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10418,CHEMBL3650845,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,=,20670.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10419,CHEMBL3650846,CC1(C)Oc2ccc(NC(=O)c3ccc(Br)cn3)cc2[C@@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10420,CHEMBL3650847,COc1cnc(C(=O)Nc2ccc3c(c2)[C@@]2(COC(N)=N2)C2(COC2)C(C)(C)O3)cn1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10421,CHEMBL3650848,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2[C@@]2(COC(N)=N2)C12CC2,IC50,nM,=,3250.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10422,CHEMBL3650849,CC1(C)Oc2ccc(NC(=O)c3ccc(F)cn3)cc2[C@@]2(COC(N)=N2)C12CC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10423,CHEMBL3650850,COc1cnc(C(=O)Nc2ccc3c(c2)[C@@]2(COC(N)=N2)C2(CC2)C(C)(C)O3)cn1,IC50,nM,=,20770.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10424,CHEMBL3650851,CC1(C)Oc2ccc(NC(=O)c3cnc(C(F)F)cn3)cc2[C@@]2(COC(N)=N2)C12CC2,IC50,nM,=,15100.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10425,CHEMBL3650852,COc1cnc(C(=O)Nc2ccc3c(c2)C2(COC(N)=N2)C2(COC2)C(C)(C)O3)cn1,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10426,CHEMBL3650853,CC1(C)Oc2ccc(NC(=O)c3ccc(Cl)cn3)cc2[C@]2(COC(N)=N2)C12COC2,IC50,nM,>,10000.0,"Inhibition Assay: Test Example 5: The hERG potassium current was measured in a hERG-stably-expressing Chinese hamster ovary K1 (CHO) cells. The experiments were performed using an automated planar patch-clamp system QPatch HTX (Sophion Bioscience A/S). The application of pressure for forming gigaseals and whole-cell patch clamp configuration were established using the QPatch assay software. Patch-clamp experiments were performed in voltage-clamp mode and whole-cell currents were recorded. The following stimulation protocol was applied to investigate the effects of compounds on hERG potassium channel. The test solution includes:Extracellular solution: 2 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES, 4 mM of KCl, 145 mM of NaCl, and 10 mM of glucose; and pH adjusted to 7.4 with NaOH,Intracellular solution: 5.374 mM of CaCl2, 1.75 mM of MgCl2, 10 mM of HEPES, 10 mM of EGTA, 120 mM of KCl, and 4 mM of ATP, and pH adjusted to 7.2 with KOH."
10427,CHEMBL3962108,NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)O)c12)[C@H]1CCCc2cccnc21,IC50,nM,=,2700.0,"In Vitro Assay: The in vitro effects of the selected compounds on the hERG (human ether-á-go-go-related gene) potassium channel current (a surrogate for IKr, the rapidly activating, delayed rectifier cardiac potassium current) expressed in mammalian cells were evaluated at room temperature using the PatchXpress 7000A (Molecular Devices), an automatic parallel patch clamp system. Each compound was evaluated at varying concentrations in duplicate up to 10 μM, and the duration of exposure to each test article concentration was 5 minutes."
10428,CHEMBL3903672,NCCCCN(Cc1nccc2c3ccccc3n(CCCN3CCNCC3)c12)[C@H]1CCCc2cccnc21,IC50,nM,=,4100.0,"In Vitro Assay: The in vitro effects of the selected compounds on the hERG (human ether-á-go-go-related gene) potassium channel current (a surrogate for IKr, the rapidly activating, delayed rectifier cardiac potassium current) expressed in mammalian cells were evaluated at room temperature using the PatchXpress 7000A (Molecular Devices), an automatic parallel patch clamp system. Each compound was evaluated at varying concentrations in duplicate up to 10 μM, and the duration of exposure to each test article concentration was 5 minutes."
10429,CHEMBL3906863,c1cnc2c(c1)CCCC2N(CCCN1CCNCC1)Cc1nccc2c3ccccc3n(CCN3CCOCC3)c12,IC50,nM,=,3100.0,"In Vitro Assay: The in vitro effects of the selected compounds on the hERG (human ether-á-go-go-related gene) potassium channel current (a surrogate for IKr, the rapidly activating, delayed rectifier cardiac potassium current) expressed in mammalian cells were evaluated at room temperature using the PatchXpress 7000A (Molecular Devices), an automatic parallel patch clamp system. Each compound was evaluated at varying concentrations in duplicate up to 10 μM, and the duration of exposure to each test article concentration was 5 minutes."
10430,CHEMBL3929341,OCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)C3CCCc4cccnc43)c21,IC50,nM,=,2400.0,"In Vitro Assay: The in vitro effects of the selected compounds on the hERG (human ether-á-go-go-related gene) potassium channel current (a surrogate for IKr, the rapidly activating, delayed rectifier cardiac potassium current) expressed in mammalian cells were evaluated at room temperature using the PatchXpress 7000A (Molecular Devices), an automatic parallel patch clamp system. Each compound was evaluated at varying concentrations in duplicate up to 10 μM, and the duration of exposure to each test article concentration was 5 minutes."
10431,CHEMBL3972873,NCCCCN(Cc1nccc2c3ccccc3n(CC(N)=O)c12)[C@H]1CCCc2cccnc21,IC50,nM,=,1800.0,"In Vitro Assay: The in vitro effects of the selected compounds on the hERG (human ether-á-go-go-related gene) potassium channel current (a surrogate for IKr, the rapidly activating, delayed rectifier cardiac potassium current) expressed in mammalian cells were evaluated at room temperature using the PatchXpress 7000A (Molecular Devices), an automatic parallel patch clamp system. Each compound was evaluated at varying concentrations in duplicate up to 10 μM, and the duration of exposure to each test article concentration was 5 minutes."
10432,CHEMBL3952064,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)cs2)CO1,IC50,nM,=,9900.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10433,CHEMBL3952064,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)cs2)CO1,IC50,nM,=,23600.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10434,CHEMBL3967984,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(Cl)cn3)cs2)CO1,IC50,nM,=,9000.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10435,CHEMBL3972449,Cc1cc(OC(F)F)cnc1C(=O)Nc1csc([C@]23CO[C@@H](C)C[C@H]2CSC(N)=N3)n1,IC50,nM,=,9600.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10436,CHEMBL3942279,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)CO1,IC50,nM,=,400.0,"hERG Patch Clamp Assay: All testing was carried out in CHO cells transfected with the hERG gene purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Geneticin and 1% of 1M HEPES buffer solution, and maintained at approximately 37 °C. in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3-5 days based on confluency. On the day of the experiment, 50%-80% confluent cells were harvested from a 175 cm2 culture flask using Detachin. After 10 minutes of exposure to Detachin at 37 °C., the cells were centrifuged for 1 minute at 1000 RPM. The supernatant was removed and the cell pellet was reconstituted in 5-8 mL of serum free media with 2.5% of 1M HEPES, placed on the Qstirrer, and allowed to recover. After a 30 minute recovery period, experiments were initiated."
10437,CHEMBL3977597,CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C[C@H]2CNC(=N)N2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O[C@H]1C)[C@@H](C)CC)[C@@H](C)CC,IC50,nM,>,100000.0,"Inhibition Assay: Briefly, the experiments were performed on an IonWorks™ HT instrument (Molecular Devices Corporation), which automatically performs electrophysiology measurements in 48 single cells simultaneously in a specialised 384-well plate (PatchPlate™). The cells used were Chinese hamster ovary (CHO) cells stably transfected with hERG. A single-cell suspension is prepared in extracellular solution (Dulbecco's phosphate buffered saline with calcium and magnesium pH 7-7.2) and aliquots added automatically to each well of a PatchPlate™. The cells were then positioned over a small hole at the bottom of each well by applying a vacuum beneath the plate to form an electrical seal. The vacuum was applied through a single compartment common to all wells which is filled with intracellular solution (buffered to pH 7.2 with HEPES). The resistance of each seal was measured via a common ground-electrode in the intracellular compartment and individual electrodes placed into each of the upper wells. Electrical access to the cell was achieved by circulating a perforating agent, amphotericin, underneath the PatchPlate™ and then measuring the pre-compound hERG current. An electrode was positioned in the extracellular compartment and a holding potential of −80 mV applied for 15 sec. The hERG channels were then activated by applying a depolarising step to +40 mV for 5 sec and then clamped at −50 mV for 4 sec to elicit the hERG tail current, before returning to −80 mV for 0.3 s. The test compound was then added at various concentrations (0.008, 0.04, 0.2, 1, 5 and 25 μM) to the upper wells of the PatchPlate™. The test compound was left in contact with the cells for 300 sec before recording currents using the same voltage-step protocol as in the pre-compound scan. Quinidine, an established hERG inhibitor, was included as a positive control."
10438,CHEMBL1294,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,IC50,nM,=,1440.0,"Inhibition Assay: Briefly, the experiments were performed on an IonWorks™ HT instrument (Molecular Devices Corporation), which automatically performs electrophysiology measurements in 48 single cells simultaneously in a specialised 384-well plate (PatchPlate™). The cells used were Chinese hamster ovary (CHO) cells stably transfected with hERG. A single-cell suspension is prepared in extracellular solution (Dulbecco's phosphate buffered saline with calcium and magnesium pH 7-7.2) and aliquots added automatically to each well of a PatchPlate™. The cells were then positioned over a small hole at the bottom of each well by applying a vacuum beneath the plate to form an electrical seal. The vacuum was applied through a single compartment common to all wells which is filled with intracellular solution (buffered to pH 7.2 with HEPES). The resistance of each seal was measured via a common ground-electrode in the intracellular compartment and individual electrodes placed into each of the upper wells. Electrical access to the cell was achieved by circulating a perforating agent, amphotericin, underneath the PatchPlate™ and then measuring the pre-compound hERG current. An electrode was positioned in the extracellular compartment and a holding potential of −80 mV applied for 15 sec. The hERG channels were then activated by applying a depolarising step to +40 mV for 5 sec and then clamped at −50 mV for 4 sec to elicit the hERG tail current, before returning to −80 mV for 0.3 s. The test compound was then added at various concentrations (0.008, 0.04, 0.2, 1, 5 and 25 μM) to the upper wells of the PatchPlate™. The test compound was left in contact with the cells for 300 sec before recording currents using the same voltage-step protocol as in the pre-compound scan. Quinidine, an established hERG inhibitor, was included as a positive control."
10439,CHEMBL3938841,CC(C)(O)[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(Cl)c4)n3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10440,CHEMBL3964407,O[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(Cl)c4)n3n2)CC1,IC50,nM,=,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10441,CHEMBL3355988,CO[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10442,CHEMBL426658,Clc1cccc(-c2cnc3ccc(NC4CCOCC4)nn23)c1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10443,CHEMBL3975308,CC(C)(O)[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(C(F)(F)F)c4)n3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10444,CHEMBL3912135,C[C@]1(O)CC[C@H](Nc2ccc3ncc(-c4cccc(C(F)(F)F)c4)n3n2)CC1,IC50,nM,=,12000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10445,CHEMBL3979144,O[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(C(F)(F)F)c4)n3n2)CC1,IC50,nM,=,10000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10446,CHEMBL3917577,CC(C)(O)[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10447,CHEMBL3895053,C[C@]1(O)CC[C@H](Nc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,=,26000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10448,CHEMBL3936197,CO[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10449,CHEMBL3355987,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10450,CHEMBL3355550,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10451,CHEMBL3355552,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10452,CHEMBL3355544,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,nM,>,30000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10453,CHEMBL3965204,O[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,=,16000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10454,CHEMBL3908640,O=S1(=O)CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,=,10000.0,Fast Patch Assay: Representative compounds were tested for hERG activity using the Fast Patch assay available from WuXiApptec (Shanghai China).
10455,CHEMBL4108583,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(Cl)c(Cl)c2)[C@@H]3C)n1,IC50,nM,=,42000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10456,CHEMBL4113741,CCc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,IC50,nM,=,32000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10457,CHEMBL3608687,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(Cl)cc2)[C@@H]3C)n1,IC50,nM,=,66000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10458,CHEMBL4106866,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(Cl)c(F)c2)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10459,CHEMBL3608680,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10460,CHEMBL4114280,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)c(Cl)c2)[C@@H]3C)n1,IC50,nM,=,45000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10461,CHEMBL4115594,Cc1nsc(-c2nnc3n2CCN(C(=O)c2cc(F)c(F)c(F)c2)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10462,CHEMBL4115295,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)c(F)c2F)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10463,CHEMBL4112037,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)c(F)c2)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10464,CHEMBL4113428,Cc1nsc(-c2nnc3n2CCN(C(=O)c2cc(F)c(F)c(F)c2F)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10465,CHEMBL3608741,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3CCO)n1,IC50,nM,=,50000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10466,CHEMBL4110286,CCc1noc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10467,CHEMBL4111714,Cc1nsc(-c2nnc3n2CCN(C(=O)c2cccc(F)c2)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10468,CHEMBL4110770,Cc1nsc(-c2nnc3n2CCN(C(=O)c2cccc(Cl)c2)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10469,CHEMBL4112585,Cc1nsc(-c2nnc3n2CCN(C(=O)c2cc(F)cc(F)c2)[C@@H]3C)n1,IC50,nM,=,46000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10470,CHEMBL4110224,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2F)[C@@H]3C)n1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10471,CHEMBL3608740,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccccc2)[C@@H]3C)n1,IC50,nM,=,50000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10472,CHEMBL4109584,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(C(F)(F)F)cc2)[C@@H]3C)n1,IC50,nM,=,45000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10473,CHEMBL4112608,CC[C@@H]1c2nnc(-c3nc(C)ns3)n2CCN1C(=O)c1ccc(F)cc1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10474,CHEMBL4110242,CCC[C@@H]1c2nnc(-c3nc(C)ns3)n2CCN1C(=O)c1ccc(F)cc1,IC50,nM,=,61000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10475,CHEMBL4114258,COc1cccc(C(=O)N2CCn3c(-c4nc(C)ns4)nnc3[C@H]2C)c1,IC50,nM,=,70000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10476,CHEMBL4107016,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(C#N)cc2)[C@@H]3C)n1,IC50,nM,=,59000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10477,CHEMBL4108623,CCc1noc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,32000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG). Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 μM; 3 μM; 10 μM; 30 μM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models. The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from −80 mV to a maximum value of +40 mV, starting with −40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to −55 mV, after each of these incremented steps, for 1 second and finally repolarized to −80 mV for 1 second."
10478,CHEMBL3898132,Cn1cc(-c2nc3c(N4CCN(Cc5cccnc5)CC4)c(Br)cnc3[nH]2)cn1,IC50,nM,=,5500.0,"Cell-Based Electrophysiology Assays: All hERG percentage inhibitions at 10 uM compound concentration were determined by Millipore in a high-throughput cell-based electrophysiology assay for inhibition of hERG tail current41, and values are reported as a mean of multiple determinations. 0.3% DMSO aqueous vehicle negative control gave 7-16% inhibition. Cisapride (1 uM) positive control gave 96-104% inhibition. All hERG IC50 values were determined by Millipore,41 and the hERG IC50 for Example 1 was also determined by Cyprotex plc measuring hERG tail-currents by whole-cell voltage-clamping."
10479,CHEMBL3891461,Cc1nn(C)c(C)c1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1,IC50,nM,=,10800.0,"Cell-Based Electrophysiology Assays: All hERG percentage inhibitions at 10 uM compound concentration were determined by Millipore in a high-throughput cell-based electrophysiology assay for inhibition of hERG tail current41, and values are reported as a mean of multiple determinations. 0.3% DMSO aqueous vehicle negative control gave 7-16% inhibition. Cisapride (1 uM) positive control gave 96-104% inhibition. All hERG IC50 values were determined by Millipore,41 and the hERG IC50 for Example 1 was also determined by Cyprotex plc measuring hERG tail-currents by whole-cell voltage-clamping."
10480,CHEMBL2207503,Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1,IC50,nM,>,25000.0,"Cell-Based Electrophysiology Assays: All hERG percentage inhibitions at 10 uM compound concentration were determined by Millipore in a high-throughput cell-based electrophysiology assay for inhibition of hERG tail current41, and values are reported as a mean of multiple determinations. 0.3% DMSO aqueous vehicle negative control gave 7-16% inhibition. Cisapride (1 uM) positive control gave 96-104% inhibition. All hERG IC50 values were determined by Millipore,41 and the hERG IC50 for Example 1 was also determined by Cyprotex plc measuring hERG tail-currents by whole-cell voltage-clamping."
10481,CHEMBL2207500,Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ncon4)CC3)c(Cl)cnc2[nH]1,IC50,nM,=,11000.0,"Cell-Based Electrophysiology Assays: All hERG percentage inhibitions at 10 uM compound concentration were determined by Millipore in a high-throughput cell-based electrophysiology assay for inhibition of hERG tail current41, and values are reported as a mean of multiple determinations. 0.3% DMSO aqueous vehicle negative control gave 7-16% inhibition. Cisapride (1 uM) positive control gave 96-104% inhibition. All hERG IC50 values were determined by Millipore,41 and the hERG IC50 for Example 1 was also determined by Cyprotex plc measuring hERG tail-currents by whole-cell voltage-clamping."
10482,CHEMBL2207501,Cc1nc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)CC2)no1,IC50,nM,=,9500.0,"Cell-Based Electrophysiology Assays: All hERG percentage inhibitions at 10 uM compound concentration were determined by Millipore in a high-throughput cell-based electrophysiology assay for inhibition of hERG tail current41, and values are reported as a mean of multiple determinations. 0.3% DMSO aqueous vehicle negative control gave 7-16% inhibition. Cisapride (1 uM) positive control gave 96-104% inhibition. All hERG IC50 values were determined by Millipore,41 and the hERG IC50 for Example 1 was also determined by Cyprotex plc measuring hERG tail-currents by whole-cell voltage-clamping."
10483,CHEMBL3910048,O=C(OCC12CCN(CC1)CC2)c1c[nH]c2cc(O)cc(Cl)c12,IC50,nM,>,30000.0,"Inhibition Assay: hERG study was conducted with an automated patch clamp machine, Qpatch-48HT (Sophion Biosciences, Denmark). Cultured CHO cells stably expressing hERG channels (provided by Sophion Biosciences, Denmark) were harvested from culture flasks of 70-90% cell confluence rate and prepared as cell suspension with a cell density of 3-8&timse;10^6 cells/mL in serum-free media (CHO-S-SFM II, cat#12052 Invitrogen; 25 mM HEPES). Cells in such condition were placed into a Qpatch cell stir chamber and used within 4 hours. For each run, cells were first spun down by the built-in Qpatch centrifuge and re-suspended in an extracellular solution (in mM, 2 CaCl2, 1 MgCl2, 4 KCl, 145 NaCl, 10 Glucose, 10 HEPES, pH 7.4, osmolarity ~305 mOsm). Qplate-48 that holds one cell in each of its 48 channels for the later voltage-clamped assay were primed with the extracellular solution and intracellular solution (in mM, 5.4 CaCl2, 1.75 MgCl2, 120 KCl, 10 HEPES, 5 EGTA, 4 NaATP, pH 7.25, Osmolarity ~280-295 mOsm). Cells were dispatched by Qpatch robotic dispensing guns into each Qplate channel and went through the process of giga-ohm sealing and whole cell configuration. Whole-cell recordings were performed in voltage-clamp mode at a holding potential of −80 mV. The hERG current was activated by depolarizing at +20 mV for 5 sec, after which the current was taken back to −50 mV for 5 sec to remove the inactivation and observe the deactivating tail current. The maximum amount of tail current size was used to determine the hERG current amplitude. The above voltage protocol was applied to the cells every 15 sec throughout the whole procedure. External solution containing 0.1% DMSO (vehicle) was applied to the cells to establish the baseline. Compound solution was added, and the cells were kept in the test solution until the compound's effect reached a steady state or for a maximum of 4 min. For dose response assays (0.1, 0.3, 1, 3, 10 and 30 μM), the compound was applied to the cells accumulatively from low to high concentrations. Washout with extracellular solution was performed after compound testing. Positive control cisapride 0.1 μM was used on each cell after compound testing to ensure the normal response and the good quality of the cell."
10484,CHEMBL3916655,Cc1cc(Cl)c2c(C(=O)OCC34CCN(CC3)CC4)c[nH]c2c1,IC50,nM,=,2430.0,"Inhibition Assay: hERG study was conducted with an automated patch clamp machine, Qpatch-48HT (Sophion Biosciences, Denmark). Cultured CHO cells stably expressing hERG channels (provided by Sophion Biosciences, Denmark) were harvested from culture flasks of 70-90% cell confluence rate and prepared as cell suspension with a cell density of 3-8&timse;10^6 cells/mL in serum-free media (CHO-S-SFM II, cat#12052 Invitrogen; 25 mM HEPES). Cells in such condition were placed into a Qpatch cell stir chamber and used within 4 hours. For each run, cells were first spun down by the built-in Qpatch centrifuge and re-suspended in an extracellular solution (in mM, 2 CaCl2, 1 MgCl2, 4 KCl, 145 NaCl, 10 Glucose, 10 HEPES, pH 7.4, osmolarity ~305 mOsm). Qplate-48 that holds one cell in each of its 48 channels for the later voltage-clamped assay were primed with the extracellular solution and intracellular solution (in mM, 5.4 CaCl2, 1.75 MgCl2, 120 KCl, 10 HEPES, 5 EGTA, 4 NaATP, pH 7.25, Osmolarity ~280-295 mOsm). Cells were dispatched by Qpatch robotic dispensing guns into each Qplate channel and went through the process of giga-ohm sealing and whole cell configuration. Whole-cell recordings were performed in voltage-clamp mode at a holding potential of −80 mV. The hERG current was activated by depolarizing at +20 mV for 5 sec, after which the current was taken back to −50 mV for 5 sec to remove the inactivation and observe the deactivating tail current. The maximum amount of tail current size was used to determine the hERG current amplitude. The above voltage protocol was applied to the cells every 15 sec throughout the whole procedure. External solution containing 0.1% DMSO (vehicle) was applied to the cells to establish the baseline. Compound solution was added, and the cells were kept in the test solution until the compound's effect reached a steady state or for a maximum of 4 min. For dose response assays (0.1, 0.3, 1, 3, 10 and 30 μM), the compound was applied to the cells accumulatively from low to high concentrations. Washout with extracellular solution was performed after compound testing. Positive control cisapride 0.1 μM was used on each cell after compound testing to ensure the normal response and the good quality of the cell."
10485,CHEMBL3921669,CS(=O)(=O)C1(c2nc(-c3cccc4[nH]ccc34)nc3c2OC[C@@H]2COCCN32)CCOCC1,IC50,nM,=,6000000.0,"Binding Assay: Predictor hERG Assay test kits were obtained from Invitrogen (Carlsbad, Calif.). The binding assay was carried out according to the kit instructions. Fluorescence polarization measurements were made using EnVision Microplate Reader from Perkin-Elmer Instruments."
10486,CHEMBL3985847,CNc1nc2ccccc2n1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COCCN21,IC50,nM,=,4000000.0,"Binding Assay: Predictor hERG Assay test kits were obtained from Invitrogen (Carlsbad, Calif.). The binding assay was carried out according to the kit instructions. Fluorescence polarization measurements were made using EnVision Microplate Reader from Perkin-Elmer Instruments."
10487,CHEMBL4109966,CN1C(=O)N(c2cccc(C(F)(F)F)c2)C2=C(C(=O)CC2)[C@H]1c1ccc(C#N)cc1CO,IC50,nM,>,30000.0,"Inhibition Assay: The inhibition of the hERG (human ether-a-go-go-related gene) potassium channel can be determined as described in Rast, G., & Guth, B. D., Journal of Pharmacological and Toxicological Methods (2014), http://dx.doi.org/10.1016/i.vascn.2014.08.001."
10488,CHEMBL3899311,CN1C(=O)N(c2cccc(C(F)(F)F)c2)C2=C(C(=O)CC2)[C@@H]1c1ccc(C#N)cc1S(=O)(=O)CCO,IC50,nM,>,30000.0,"Inhibition Assay: The inhibition of the hERG (human ether-a-go-go-related gene) potassium channel can be determined as described in Rast, G., & Guth, B. D., Journal of Pharmacological and Toxicological Methods (2014), http://dx.doi.org/10.1016/i.vascn.2014.08.001."
10489,CHEMBL3978111,CN1C(=O)N(c2cccc(C(F)(F)F)c2)C2=C(C(=O)CC2)[C@@H]1c1ccc(C#N)cc1[S+](C)[O-],IC50,nM,>,30000.0,"Inhibition Assay: The inhibition of the hERG (human ether-a-go-go-related gene) potassium channel can be determined as described in Rast, G., & Guth, B. D., Journal of Pharmacological and Toxicological Methods (2014), http://dx.doi.org/10.1016/i.vascn.2014.08.001."
10490,CHEMBL3945540,CN1C(=O)N(c2ccnc(C(F)(F)F)c2)C2=C(C(=O)CC2)C1c1ccc(C#N)cc1S(C)(=O)=O,IC50,nM,>,30000.0,"Inhibition Assay: The inhibition of the hERG (human ether-a-go-go-related gene) potassium channel can be determined as described in Rast, G., & Guth, B. D., Journal of Pharmacological and Toxicological Methods (2014), http://dx.doi.org/10.1016/i.vascn.2014.08.001."
10491,CHEMBL3422010,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)cs1,IC50,nM,>,30000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10492,CHEMBL4107180,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4ccccc4)cc2)[C@@H]3C)cs1,IC50,nM,>,30000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10493,CHEMBL3422012,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)C3)cs1,IC50,nM,=,26000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10494,CHEMBL3908229,O=C(c1ccc(-c2cccs2)cc1)N1CCn2c(nnc2-c2csc(C(F)(F)F)n2)C1,IC50,nM,>,30000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10495,CHEMBL4108578,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)co1,IC50,nM,>,30000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10496,CHEMBL3422016,Cc1csc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)n1,IC50,nM,=,17000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10497,CHEMBL4112613,Cc1nc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)[C@@H]3C)sc1C,IC50,nM,=,12000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10498,CHEMBL4107668,Cc1cccc(-c2nnc3n2CCN(C(=O)c2ccc(-c4ccccc4)cc2)[C@@H]3C)n1,IC50,nM,=,25000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10499,CHEMBL4114218,C[C@@H]1c2nnc(-c3cccc(O)n3)n2CCN1C(=O)c1ccc(-c2cccs2)cc1,IC50,nM,=,20000.0,"Inhibition Assay: The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKf current generated in normoxic conditions in stably transfected HEK 293 cells with the human ether-a-go-go-related gene (hERG).Whole-cell currents (acquisition by manual patch-clamp) elicited during a voltage pulse were recorded in baseline conditions and following application of tested compounds (5 minutes of exposure). The concentrations of tested compounds (0.3 uM; 3 uM; 10 uM; 30 uM) reflect a range believed to exceed the concentrations at expected efficacy doses in preclinical models.The pulses protocol applied is described as follow: the holding potential (every 3 seconds) was stepped from -80 mV to a maximum value of +40 mV, starting with -40 mV, in eight increments of +10 mV, for a period of 1 second. The membrane potential was then returned to -55 mV, after each of these incremented steps, for 1 second and finally repolarized to -80 mV for 1 second.Â  The current density recorded were normalized against the baseline conditions and corrected for solvent effect and time-dependent current run-down using experimental design in test compound free conditions.Â  Inhibition curves were obtained for compounds and the concentrations which decreased 50% of the current density determined in the baseline conditions (IC50) were determined. All compounds for which the IC50 value is above 10 uM are not considered to be potent inhibitors of the hERG channel whereas compounds with IC50 values below 1 uM are considered potent hERG channel inhibitors."
10500,CHEMBL4084106,CC(C)(N)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,=,2600.0,Inhibition of recombinant human ERG expressed in HEK293 cells at holding potential of -120 mV by PatchXpress automated electrophysiology method
10501,CHEMBL4096468,NC1(Cc2nc(-c3ccc(OC(F)(F)F)cc3)c[nH]2)COC1,IC50,nM,=,10000.0,Inhibition of recombinant human ERG expressed in HEK293 cells at holding potential of -120 mV by PatchXpress automated electrophysiology method
10502,CHEMBL4084106,CC(C)(N)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,=,1800.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10503,CHEMBL4100562,CC(C)(C)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10504,CHEMBL4073749,CC(C)(O)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10505,CHEMBL4092827,CC(=O)NC(C)(C)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10506,CHEMBL4065160,CC(C)(NC(N)=O)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10507,CHEMBL4104889,C[C@](N)(CF)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,=,14000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10508,CHEMBL4080659,NC(CF)(CF)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,=,15000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10509,CHEMBL4069225,COC[C@@](C)(N)c1nc(-c2ccc(OC(F)(F)F)cc2)c[nH]1,IC50,nM,=,3700.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10510,CHEMBL4096468,NC1(Cc2nc(-c3ccc(OC(F)(F)F)cc3)c[nH]2)COC1,IC50,nM,=,14000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10511,CHEMBL4079961,CC(C)(N)c1nc(-c2ccccc2)c[nH]1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10512,CHEMBL4104203,CC(C)(N)c1nc(-c2ccc(Cl)cc2)c[nH]1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10513,CHEMBL4087838,CC(C)(N)c1nc(-c2ccc(S(C)(=O)=O)cc2)c[nH]1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10514,CHEMBL4066520,CC(C)(N)c1nc(-c2cccc(OC(F)(F)F)c2)c[nH]1,IC50,nM,=,9000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10515,CHEMBL4095544,COc1ccc(-c2c[nH]c(C(C)(C)N)n2)cc1,IC50,nM,>,16000.0,Inhibition of Cy3B-labeled ligand binding to recombinant human ERG expressed in HEK293 cells by fluorescence polarization method
10516,CHEMBL4093905,C/C(N)=N\C(=N/S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1,IC50,nM,>=,100000.0,Inhibition of human ERG expressed in HEK293 cells measured by Qpatch assay
10517,CHEMBL3918431,c1ccc2cc(NC3=NC[C@@]4(CN5CCC4CC5)O3)ncc2c1,IC50,nM,=,3200.0,Inhibition of human ERG by patch clamp electrophysiology assay
10518,CHEMBL4102566,c1ccc(-c2cc(NC3=NC[C@@]4(CN5CCC4CC5)O3)ncn2)cc1,IC50,nM,=,4000.0,Inhibition of human ERG by patch clamp electrophysiology assay
10519,CHEMBL4083676,O=C(Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)cc1)NC1CC1,IC50,nM,>,60000.0,Inhibition of human ERG
10520,CHEMBL4089040,NC(=O)Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)cc1,IC50,,,,Inhibition of human ERG
10521,CHEMBL4060838,O=C(Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)cc1)N1CCC1,IC50,nM,=,7400.0,Inhibition of human ERG
10522,CHEMBL4081159,O=C(Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)nc1)N1CCC1,IC50,nM,=,2100.0,Inhibition of human ERG
10523,CHEMBL4099186,O=C(Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)c(F)c1)N1CCC1,IC50,nM,=,3500.0,Inhibition of human ERG
10524,CHEMBL4104464,O=C(Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)cc1F)N1CCC1,IC50,nM,=,3300.0,Inhibition of human ERG
10525,CHEMBL4080222,O=C(Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)cc1F)N1CC(O)C1,IC50,nM,=,5300.0,Inhibition of human ERG
10526,CHEMBL4070965,O=C(Cc1ccc(OCC[C@@H]2C[C@@H]2C2CCN(c3ncc(Cl)cn3)CC2)cc1F)N1CCCCC1,IC50,nM,=,3300.0,Inhibition of human ERG
10527,CHEMBL4098051,CCc1cnc(N2CCC([C@H]3C[C@H]3CCOc3ccc(CC(=O)N4CCC4)c(F)c3)CC2)nc1,IC50,nM,=,3200.0,Inhibition of human ERG
10528,CHEMBL4062339,CC1(OC(=O)N2CCC([C@H]3C[C@H]3CCOc3ccc(CC(=O)N4CCC4)c(F)c3)CC2)CC1,IC50,nM,=,23000.0,Inhibition of human ERG
10529,CHEMBL4097638,CC(C)c1noc(N2CCC([C@H]3C[C@H]3CCOc3ccc(CC(=O)N4CCC4)c(F)c3)CC2)n1,IC50,nM,=,7000.0,Inhibition of human ERG
10530,CHEMBL4077033,COCc1cnc(N2CCC([C@H]3C[C@H]3CCOc3ccc(CC(=O)N4CCC4)c(F)c3)CC2)nc1,IC50,nM,=,19000.0,Inhibition of human ERG
10531,CHEMBL4093284,COCc1cnc(N2CCC([C@H]3C[C@H]3CCOc3cc(F)c(CC(=O)N4CCC4)c(F)c3)CC2)nc1,IC50,nM,=,9100.0,Inhibition of human ERG
10532,CHEMBL4062339,CC1(OC(=O)N2CCC([C@H]3C[C@H]3CCOc3ccc(CC(=O)N4CCC4)c(F)c3)CC2)CC1,IC50,nM,=,8600.0,Inhibition of human ERG by PatchXpress method
10533,CHEMBL4093284,COCc1cnc(N2CCC([C@H]3C[C@H]3CCOc3cc(F)c(CC(=O)N4CCC4)c(F)c3)CC2)nc1,IC50,nM,=,12000.0,Inhibition of human ERG by PatchXpress method
10534,CHEMBL4084542,C[C@H](NC(=O)c1c(CN2CCC(N3CCCCC3)CC2)c(-c2cccc(C(F)(F)F)c2)nc2ccccc12)c1ccccc1,IC50,nM,=,1200.0,Inhibition of human ERG by patchXpress electrophysiology assay
10535,CHEMBL4071093,COc1cccc(/C=C/C(=O)c2cc(OC)c(OC)cc2O)c1,IC50,nM,>,100000.0,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10536,CHEMBL55,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,IC50,nM,=,18800.0,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10537,CHEMBL594853,COc1cccc(/C=C/C(=O)c2ccccc2O)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10538,CHEMBL260597,COc1cccc(/C=C/C(=O)c2ccc(OC)cc2O)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10539,CHEMBL3125824,COc1cccc(/C=C/C(=O)c2cc(OC)ccc2O)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10540,CHEMBL229907,COc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10541,CHEMBL4082217,COc1ccc(/C=C/C(=O)c2cc(OC)ccc2O)cc1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10542,CHEMBL264704,COc1ccc(C(=O)/C=C/c2c(OC)cccc2OC)c(O)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10543,CHEMBL4090067,COc1ccc(O)c(C(=O)/C=C/c2c(OC)cccc2OC)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10544,CHEMBL262597,COc1ccc(C(=O)/C=C/c2ccc(OC)c(OC)c2)c(O)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10545,CHEMBL4063079,COc1ccc(O)c(C(=O)/C=C/c2ccc(OC)c(OC)c2)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10546,CHEMBL260867,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10547,CHEMBL4071694,COc1ccc(O)c(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c1,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10548,CHEMBL4098711,COc1cc(O)c(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)cc1OC,IC50,,,,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
10549,CHEMBL4071864,CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21,IC50,nM,=,195000.0,Inhibition of human ERG expressed in HEK293 cells
10550,CHEMBL4087734,Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@]3(F)CN(c4nc5cc(Cl)ccc5o4)C[C@@]3(F)C2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
10551,CHEMBL4105616,Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@]3(F)CN(c4nc5ccccc5o4)C[C@@]3(F)C2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
10552,CHEMBL4087679,Nc1nccn2c([C@@H]3CCC[C@H](C(=O)O)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12,IC50,nM,>,60000.0,Inhibition of human ERG
10553,CHEMBL4097019,CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc(C23CCC(C(=O)O)(CC2)CC3)n2ccnc(N)c12,IC50,nM,=,26000.0,Inhibition of human ERG
10554,CHEMBL4074833,C[C@]1(C(=O)O)CCC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1,IC50,nM,>,60000.0,Inhibition of human ERG
10555,CHEMBL4068919,C[C@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1,IC50,nM,=,54000.0,Inhibition of human ERG
10556,CHEMBL4096195,CC(C)[C@@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1,IC50,nM,>,60000.0,Inhibition of human ERG
10557,CHEMBL4079697,C[C@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn32)CC1,IC50,nM,>,60000.0,Inhibition of human ERG
10558,CHEMBL4103954,C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1,IC50,nM,=,4300.0,Inhibition of human ERG
10559,CHEMBL4079081,CC(=O)NC[C@@H]1OC(=O)N2c3cc(F)c(C4=CCN(C(=O)CO)CC4)cc3OC[C@@H]12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by patch clamp method
10560,CHEMBL2105720,O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,IC50,nM,>,30000.0,Inhibition of human ERG
10561,CHEMBL2105720,O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,IC50,nM,>,30000.0,Inhibition of human ERG
10562,CHEMBL2105720,O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,IC50,nM,>,30000.0,Inhibition of human ERG
10563,CHEMBL4095361,Cc1nnc(-c2cccc(CN3CCN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)CC3)n2)o1,IC50,nM,>,60000.0,Inhibition of human ERG
10564,CHEMBL4073137,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2ccccn2)CC1,IC50,nM,>,60000.0,Inhibition of human ERG
10565,CHEMBL4074920,Cc1noc(-c2cccc(CN3CCN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)CC3)n2)n1,IC50,nM,>,60000.0,Inhibition of human ERG
10566,CHEMBL4087670,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2ncn(CC(F)F)n2)CC1,IC50,nM,=,34010.0,Inhibition of human ERG
10567,CHEMBL4066314,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2ncn(CC(F)(F)F)n2)CC1,IC50,nM,>,60000.0,Inhibition of human ERG
10568,CHEMBL4065251,CCn1nnc(CN2CCN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)CC2)n1,IC50,nM,>,60000.0,Inhibition of human ERG
10569,CHEMBL4092912,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2nnn(CC3CC3)n2)CC1,IC50,nM,=,39380.0,Inhibition of human ERG
10570,CHEMBL4103112,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2nnn(CC(F)F)n2)CC1,IC50,nM,>,60000.0,Inhibition of human ERG
10571,CHEMBL4085173,O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2nnn(CC(F)(F)F)n2)CC1,IC50,nM,=,29890.0,Inhibition of human ERG
10572,CHEMBL2146873,N#Cc1ccc(CCN2CCN(CCc3ccc4c(c3)COC4=O)CC2)cc1F,IC50,nM,=,170.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10573,CHEMBL2441437,O=C1OCc2cc(CCN3CCN(C(=O)Cc4ccc(-n5cnnn5)cc4)CC3)ccc21,IC50,nM,=,1400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10574,CHEMBL3612807,Cc1c([C@@H](O)CN2CCN(C[C@H](O)c3ccc(C#N)cn3)CC2)ccc2c1COC2=O,IC50,nM,=,18000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10575,CHEMBL3622105,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(C#N)cn2)C3)ccc2c1COC2=O,IC50,nM,=,2400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10576,CHEMBL3622104,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2ccc(C#N)cn2)C3)ccc2c1COC2=O,IC50,nM,=,1800.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10577,CHEMBL4087753,Cc1c([C@@H](O)CN2CCC3(CC2)CN(c2ccc(C#N)cn2)C3)ccc2c1COC2=O,IC50,nM,=,10500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10578,CHEMBL4066423,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cncc(C#N)c2)C3)ccc2c1COC2=O,IC50,nM,=,2400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10579,CHEMBL4079335,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2cncc(C#N)c2)C3)ccc2c1COC2=O,IC50,nM,=,1800.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10580,CHEMBL4097359,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(C#N)nc2)C3)ccc2c1COC2=O,IC50,nM,=,1200.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10581,CHEMBL4068517,CSc1ccc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2)cn1,IC50,nM,=,4600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10582,CHEMBL4089640,COc1ccc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2)cn1,IC50,nM,=,3300.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10583,CHEMBL4094901,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(C(C)(C)O)nc2)C3)ccc2c1COC2=O,IC50,nM,=,29000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10584,CHEMBL4067468,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc([S+](C)[O-])nc2)C3)ccc2c1COC2=O,IC50,nM,=,3000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10585,CHEMBL4087218,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(S(C)(=O)=O)nc2)C3)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10586,CHEMBL4105076,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2ccc(S(C)(=O)=O)nc2)C3)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10587,CHEMBL4064760,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cnc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,8900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10588,CHEMBL4086237,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2cnc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,16100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10589,CHEMBL4074870,CCS(=O)(=O)c1cnc(N2CC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)CC2=O)cn1,IC50,nM,=,6100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10590,CHEMBL4098260,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,14400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10591,CHEMBL4066256,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2ccc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,17400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10592,CHEMBL4093830,Cc1nc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2)ccc1S(C)(=O)=O,IC50,nM,=,7900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10593,CHEMBL4087218,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(S(C)(=O)=O)nc2)C3)ccc2c1COC2=O,IC50,nM,=,29600.0,Inhibition of human ERG by electrophysiology method
10594,CHEMBL4064760,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cnc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,22700.0,Inhibition of human ERG by electrophysiology method
10595,CHEMBL4086237,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2cnc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,27800.0,Inhibition of human ERG by electrophysiology method
10596,CHEMBL4098260,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,11700.0,Inhibition of human ERG by electrophysiology method
10597,CHEMBL4066256,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2ccc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,24000.0,Inhibition of human ERG by electrophysiology method
10598,CHEMBL4070123,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(C#N)cn2)CC3)ccc2c1COC2=O,IC50,nM,=,193.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10599,CHEMBL4065169,CS(=O)(=O)Nc1cccc([C@H](c2ccc(F)cc2)C(c2cccnc2)c2cccnc2)n1,IC50,nM,=,110000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in rapidly activating delayed rectifier cardiac potassium current by whole-cell voltage-patch clamp assay
10600,CHEMBL4104525,O[C@@H](c1cccnc1-c1cc(Cl)cc(Cl)c1)C(c1cccnc1)c1cccnc1,IC50,nM,=,128000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in rapidly activating delayed rectifier cardiac potassium current by whole-cell voltage-patch clamp assay
10601,CHEMBL4065169,CS(=O)(=O)Nc1cccc([C@H](c2ccc(F)cc2)C(c2cccnc2)c2cccnc2)n1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10602,CHEMBL4104525,O[C@@H](c1cccnc1-c1cc(Cl)cc(Cl)c1)C(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10603,CHEMBL4080304,CN(c1cccnc1)c1ncccc1CC(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10604,CHEMBL4089937,c1ccc(-c2ccccc2CC(c2cccnc2)c2cccnc2)cc1,IC50,nM,=,7620.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10605,CHEMBL4068841,N#Cc1cccc(-c2cc(F)ccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,=,10200.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10606,CHEMBL4100226,CN(C)C(=O)c1cccc(-c2ccccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10607,CHEMBL4060189,CS(=O)(=O)Nc1cccc(-c2cc(F)ccc2CC(c2cccnc2)c2cccnc2)n1,IC50,,,,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10608,CHEMBL4105373,CS(=O)(=O)Nc1cccc(-c2cc(F)ccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,=,1900.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10609,CHEMBL4087512,c1cncc(C(Cc2ccccc2-c2ccncc2)c2cccnc2)c1,IC50,nM,=,22100.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10610,CHEMBL4097667,c1cncc(-c2ccccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10611,CHEMBL4079636,c1cncc(C(Cc2ccccc2-c2cncc3ccccc23)c2cccnc2)c1,IC50,nM,=,12000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10612,CHEMBL4075240,Fc1ccc(CC(c2cccnc2)c2cccnc2)c(-c2cn[nH]c2)c1,IC50,,,,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10613,CHEMBL4096382,Fc1ccc(CC(c2cccnc2)c2cccnc2)c(C2CC2)c1,IC50,,,,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10614,CHEMBL4074093,Fc1ccc(CC(c2cccnc2)c2cccnc2)c(-c2cccc(C(F)(F)F)c2)c1,IC50,nM,=,2230.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10615,CHEMBL4100098,FC(F)(F)c1cccc(-c2ncccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10616,CHEMBL4075394,FC(F)(F)Oc1cccc(-c2ncccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,=,12700.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10617,CHEMBL4095750,COc1cccc(-c2ncccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10618,CHEMBL4085436,Clc1ccccc1-c1ncccc1CC(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10619,CHEMBL4062996,Clc1cccc(-c2ncccc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10620,CHEMBL4080956,CN(C)C(=O)c1cccc(-c2ncccc2CC(c2ccnc(N)n2)c2cccnc2F)c1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10621,CHEMBL4098469,N#Cc1cccc(-c2cccc(Cl)c2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,=,2560.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10622,CHEMBL4072707,Cc1cc(F)ccc1-c1ccccc1C(C#N)C(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10623,CHEMBL4081003,CC(=O)NC(c1ccccc1-c1cc(Cl)cc(Cl)c1)C(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10624,CHEMBL4105245,Clc1ccccc1-c1ncccc1CC(c1cccnc1)c1cccnc1Cl,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10625,CHEMBL4088894,Nc1cccc(C(Cc2cccnc2-c2cccc(C(F)(F)F)c2)c2cccnc2)n1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10626,CHEMBL4067665,Nc1cccc(C(Cc2cccnc2-c2cc(Cl)cc(Cl)c2)c2cccnc2)n1,IC50,nM,=,10200.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10627,CHEMBL4061731,OC(c1cccnc1-c1ccccc1Cl)C(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10628,CHEMBL4089812,OC(c1cccnc1-c1cccc(Cl)c1)C(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10629,CHEMBL4076764,O[C@@H](c1cccnc1-c1cccc(C(F)(F)F)c1)C(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10630,CHEMBL4097545,OC(c1cccnc1-c1cccc(Cl)c1Cl)C(c1cccnc1)c1cccnc1,IC50,,,,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10631,CHEMBL4094177,OC(Cc1cccnc1-c1cc(Cl)cc(Cl)c1)(c1cccnc1)c1cccnc1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10632,CHEMBL4074029,OC(c1cccnc1-c1cc(Cl)cc(Cl)c1)C(c1cccnc1)c1ccccn1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10633,CHEMBL4094570,OC(c1cccnc1-c1cccc(Cl)c1)C(c1cccnc1)c1ncco1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10634,CHEMBL4084347,OC(Cc1cccnc1-c1cccc(C(F)(F)F)c1)(c1cccnc1F)c1cccnc1F,IC50,nM,=,10000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10635,CHEMBL4102309,Nc1cccc(C(c2cccnc2)C(O)c2cccnc2-c2cc(Cl)cc(Cl)c2)n1,IC50,nM,>,30000.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10636,CHEMBL4094185,CN(C)C(=O)c1cccc(-c2ccc(F)cc2CC(c2cccnc2)c2cccnc2)c1,IC50,nM,=,26400.0,Displacement of [3H]-MK499 from human ERG IKr channel expressed in HEK293 cell membranes
10637,CHEMBL3918431,c1ccc2cc(NC3=NC[C@@]4(CN5CCC4CC5)O3)ncc2c1,IC50,nM,=,3200.0,Inhibition of human ERG potassium channel by patch clamp assay
10638,CHEMBL4102566,c1ccc(-c2cc(NC3=NC[C@@]4(CN5CCC4CC5)O3)ncn2)cc1,IC50,nM,=,4000.0,Inhibition of human ERG potassium channel by patch clamp assay
10639,CHEMBL4084621,c1cn(-c2cc(NC3=NC[C@@]4(CN5CCC4CC5)O3)ncn2)cn1,IC50,nM,>,30000.0,Inhibition of human ERG potassium channel by patch clamp assay
10640,CHEMBL3301604,O=C(O)COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
10641,CHEMBL3933704,O=C(O)COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2cccc(F)c2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
10642,CHEMBL4082978,C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1,IC50,nM,>,25000.0,Inhibition of human ERG
10643,CHEMBL4100885,O=C(NCCN1CCNCC1)Nc1ncccc1OCc1ccccc1,IC50,nM,>,28700.0,Displacement of [3H]-Astemizole from human ERG expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method
10644,CHEMBL4081497,Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cn2)n1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by patch clamp electrophysiology
10645,CHEMBL4081974,COC(=O)N[C@@H]1CC(C)(C)c2ccc(Nc3nc(NCC(F)F)c4occc4n3)cc2NC1=O,IC50,nM,>,20000.0,Inhibition of human ERG
10646,CHEMBL535,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,nM,=,500.0,Inhibition of human ERG expressed in CHO cells by Qpatch assay
10647,CHEMBL4093614,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl,IC50,nM,=,6730.0,Inhibition of human ERG expressed in CHO cells by Qpatch assay
10648,CHEMBL1729,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,nM,=,150.0,Inhibition of human ERG expressed in CHO cells by Qpatch assay
10649,CHEMBL4065484,CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by binding assay
10650,CHEMBL4065484,CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by QPatch assay
10651,CHEMBL4101809,COc1nc(C2=NOC[C@H](c3cc4ccccc4o3)N2)ccc1-n1cnc(C)c1,IC50,nM,=,15000.0,Inhibition of human ERG by patch clamp assay
10652,CHEMBL71752,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32,IC50,nM,=,39.0,Inhibition of human ERG
10653,CHEMBL431377,CN1C(=O)c2c(nc(Cc3ccc(-c4ccccc4)cc3)n2Cc2ccccc2)N2CC3(CCCC3)N=C12,IC50,nM,>,10000.0,Inhibition of human ERG
10654,CHEMBL1463540,O=c1n(Cc2ccc(Cl)cc2)c2sc3c(c2c2ncnn12)CCCC3,IC50,nM,=,6300.0,Inhibition of human ERG
10655,CHEMBL4068450,CN1CCc2c(sc3c2c2ncnn2c(=O)n3Cc2ccc(Cl)cc2)C1,IC50,nM,=,69.0,Inhibition of human ERG
10656,CHEMBL4086861,O=c1n(Cc2ccc(Cl)cc2)c2sc3c(c2c2ncnn12)CCN(CC1CC1)C3,IC50,nM,=,160.0,Inhibition of human ERG
10657,CHEMBL4074038,O=C(C1CC1)N1CCc2c(sc3c2c2ncnn2c(=O)n3Cc2ccc(Cl)cc2)C1,IC50,nM,=,490.0,Inhibition of human ERG
10658,CHEMBL4094575,COc1ccc(Cn2c(=O)n3ncnc3c3c4c(sc32)CN(C(=O)C2CC2(F)F)CC4)cc1,IC50,nM,=,4900.0,Inhibition of human ERG
10659,CHEMBL4084358,O=c1n(Cc2ccc(Cl)cc2)c2sc3c(c2c2ncnn12)CCN(C1COC1)C3,IC50,nM,=,980.0,Inhibition of human ERG
10660,CHEMBL4102318,O=c1n(Cc2ccc(Cl)cc2)c2sc3c(c2c2ncnn12)CCN(Cc1ccccc1)C3,IC50,nM,=,490.0,Inhibition of human ERG
10661,CHEMBL4069196,O=c1n(Cc2ccccc2)c2sc3c(c2c2ncnn12)CCN(CC1CCOCC1)C3,IC50,nM,=,570.0,Inhibition of human ERG
10662,CHEMBL4090245,O=c1n(Cc2ccc(Cl)cc2)c2sc3c(c2c2ncnn12)CCN(CC1CCOCC1)C3,IC50,nM,=,350.0,Inhibition of human ERG
10663,CHEMBL4078578,O=c1n(Cc2ccc(Cl)cc2F)c2sc3c(c2c2ncnn12)CCN(CC1CCOCC1)C3,IC50,nM,=,610.0,Inhibition of human ERG
10664,CHEMBL4102858,COc1ccc(Cn2c(=O)n3ncnc3c3c4c(sc32)CN(CC2CCOCC2)CC4)cc1,IC50,nM,=,2200.0,Inhibition of human ERG
10665,CHEMBL4067682,COc1ccc(Cn2c(=O)n3ncnc3c3c4c(sc32)CN(CC2CCOCC2)CC4)c(F)c1,IC50,nM,=,2700.0,Inhibition of human ERG
10666,CHEMBL4095097,COc1ccc(Cn2c(=O)n3ncnc3c3c4c(sc32)CN(CC2CCOCC2)CC4(F)F)cc1,IC50,nM,=,9200.0,Inhibition of human ERG
10667,CHEMBL4060568,COc1cc(-c2cccc(C(F)(F)F)c2)c(F)cc1-c1nccc2cc(S(=O)(=O)Nc3ccon3)ccc12,IC50,nM,>,10000.0,Inhibition of human hERG by patch clamp method
10668,CHEMBL4072731,Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp assay
10669,CHEMBL3908849,NC(=O)n1cc(NC(=O)N2CCC[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2)c2ccccc21,IC50,nM,>,30000.0,Inhibition of dofetilide binding to human ERG
10670,CHEMBL3683753,NC(=O)c1nn(CC(=O)N2[C@H](C(=O)Nc3cccc(Br)n3)C[C@H]3C[C@H]32)c2ccccc12,IC50,nM,>,30000.0,Inhibition of dofetilide binding to human ERG
10671,CHEMBL4081080,N/C(CC(O)c1cc2c(F)cc(F)cc2c2cc(C(F)(F)F)ccc12)=N\N=C\c1ccc(F)cc1,IC50,nM,=,67.0,Inhibition of human ERG by fluorescence polarization assay
10672,CHEMBL4105332,CCN(CC)Cc1cc(/C=N/N=C(\N)CC(O)c2cc3c(F)cc(F)cc3c3cc(C(F)(F)F)ccc23)ccc1O,IC50,nM,=,390.0,Inhibition of human ERG by fluorescence polarization assay
10673,CHEMBL38827,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1,IC50,nM,=,377.0,Inhibition of human ERG by fluorescence polarization assay
10674,CHEMBL1107,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,IC50,nM,=,156.0,Inhibition of human ERG by fluorescence polarization assay
10675,CHEMBL4072722,COc1ccccc1CNC[C@H]1C[C@@H]1c1cc(F)ccc1OC.Cl,IC50,nM,=,1400.0,Inhibition of human ERG expressed in CHO cells by automated patch-clamp assay
10676,CHEMBL4099219,O=c1c2ccccc2oc2c(Cc3ccc4c(c3)OCO4)[nH]c(-c3nccs3)c12,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
10677,CHEMBL4060768,O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1,IC50,nM,=,45000.0,Inhibition of human ERG
10678,CHEMBL4070064,c1ccc(CNc2nc(-c3cncnc3)nc3cccc(-c4cccc(N5CCOCC5)c4)c23)nc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10679,CHEMBL4096316,NC(=O)c1ccc(-c2cccc3nc(-c4cncnc4)nc(NCc4ccccn4)c23)cc1,IC50,nM,=,1300.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10680,CHEMBL4067350,O=C(NCC(F)(F)F)c1ccc(-c2cccc3nc(-c4cncnc4)nc(NCc4ccccn4)c23)cc1,IC50,nM,=,4900.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10681,CHEMBL4076905,Nc1ncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,nM,=,80000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10682,CHEMBL4061436,COc1ncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,nM,=,66000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10683,CHEMBL4099807,c1ccc(-c2cccc3nc(-c4cccnc4)nc(NCc4ccccn4)c23)cc1,IC50,nM,=,20000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10684,CHEMBL4081790,Oc1ccc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,nM,=,500.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10685,CHEMBL4072025,NC(=O)c1ccc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,nM,=,4600.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10686,CHEMBL4093540,NC(=O)Nc1ccc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10687,CHEMBL4071250,NC(=O)Nc1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10688,CHEMBL4076097,NS(=O)(=O)Nc1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1,IC50,nM,=,800.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10689,CHEMBL4068539,CC(=O)Nc1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10690,CHEMBL4094440,NS(=O)(=O)c1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10691,CHEMBL4102583,NS(=O)(=O)c1ccc(CCNc2nc(Cl)nc3cccc(-c4ccccc4)c23)cc1,IC50,nM,=,24000.0,Inhibition of human ERG expressed in HEK293 cells by flux assay
10692,CHEMBL4084636,O=S(=O)(c1cccc(Nc2nc(Cl)nc3cccc(-c4ccccc4)c23)c1)N1CCOCC1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by flux assay
10693,CHEMBL4104959,NS(=O)(=O)c1ccc(CCNc2nc(-c3cncnc3)nc3cccc(-c4ccccc4)c23)cc1,IC50,nM,=,5600.0,Inhibition of human ERG expressed in HEK293 cells by flux assay
10694,CHEMBL4082779,O=S(=O)(c1cccc(Nc2nc(-c3cncnc3)nc3cccc(-c4ccccc4)c23)c1)N1CCOCC1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by flux assay
10695,CHEMBL4078271,CN(C)c1ccc(-c2cccc3nc(-c4cncnc4)nc(NCc4ccccn4)c23)cc1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by flux assay
10696,CHEMBL4084304,CC(=O)Nc1ccc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by flux assay
10697,CHEMBL4077920,NS(=O)(=O)c1ccncc1-c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by flux assay
10698,CHEMBL4102183,NS(=O)(=O)c1ncccc1-c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,=,36000.0,Inhibition of human ERG expressed in HEK293 cells by flux assay
10699,CHEMBL4093031,CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)c(F)c12,IC50,nM,=,24000.0,Inhibition of human ERG by thallium flux assay
10700,CHEMBL4104000,CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)cc12,IC50,nM,=,4800.0,Inhibition of human ERG by thallium flux assay
10701,CHEMBL4078188,CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ccccn5)CC4)ccc3C)cc12,IC50,nM,=,5800.0,Inhibition of human ERG by thallium flux assay
10702,CHEMBL4093031,CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)c(F)c12,IC50,nM,=,18000.0,Inhibition of human ERG by patch clamp assay
10703,CHEMBL4102628,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1,IC50,nM,=,19700.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in tail current at -40 holding potential by automated patch-clamp assay
10704,CHEMBL4092338,CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,IC50,nM,=,30000.0,Inhibition of human ERG
10705,CHEMBL4080522,Cc1[nH]nc2c1C(c1cc(-c3cccnc3)cc(C(F)(F)F)c1)(C(C)C)C(C#N)=C(N)O2,IC50,nM,=,29000.0,Inhibition of human ERG expressed in CHO cells after 30 mins by BTC-AM dye based thallium flux assay
10706,CHEMBL4059848,CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)C(=O)C1(C)C,IC50,nM,=,17000.0,Inhibition of human ERG by patch clamp assay
10707,CHEMBL4097298,COc1cncc(Cc2cc(-c3ccccc3)no2)c1,IC50,nM,=,23000.0,Inhibition of human ERG after 3.5 hrs by fluorescence polarization assay
10708,CHEMBL4069631,CN(C)c1ccc(C(=O)N(CCCCCC(=O)NO)CC(=O)NCc2ccccc2)cc1,IC50,nM,=,50815.94,Inhibition of human ERG
10709,CHEMBL4069631,CN(C)c1ccc(C(=O)N(CCCCCC(=O)NO)CC(=O)NCc2ccccc2)cc1,IC50,nM,=,279898.13,Inhibition of human ERG
10710,CHEMBL4063658,CN(C)c1ccc(C(=O)N(CC(=O)NC2CCCCC2)Cc2ccc(C(=O)NO)cc2)cc1,IC50,nM,=,21527.82,Inhibition of human ERG
10711,CHEMBL4063658,CN(C)c1ccc(C(=O)N(CC(=O)NC2CCCCC2)Cc2ccc(C(=O)NO)cc2)cc1,IC50,nM,=,52119.47,Inhibition of human ERG
10712,CHEMBL391514,O=C(CCCCCN1C(=O)c2ccccc2N(Cc2ccccc2)C(=O)[C@@H]1Cc1ccccc1)NO,IC50,nM,=,2228.44,Inhibition of human ERG
10713,CHEMBL299499,N=C(Nc1ccc(I)cc1)NC12CC3CC(CC(C3)C1)C2,IC50,nM,=,491.4,Inhibition of human ERG
10714,CHEMBL4098778,N=C(NCCCOc1ccc(F)cc1)Nc1ccc(I)cc1,IC50,nM,=,109.1,Inhibition of human ERG
10715,CHEMBL4084182,N=C(NCCCOc1ccc(F)cc1)Nc1ccc(Cl)cc1,IC50,nM,=,216.0,Inhibition of human ERG
10716,CHEMBL4092687,COc1ccc(NC(=N)NCCCOc2ccc(F)cc2)cc1,IC50,nM,=,416.8,Inhibition of human ERG
10717,CHEMBL299499,N=C(Nc1ccc(I)cc1)NC12CC3CC(CC(C3)C1)C2,IC50,nM,=,2600.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch clamp method
10718,CHEMBL4084182,N=C(NCCCOc1ccc(F)cc1)Nc1ccc(Cl)cc1,IC50,nM,=,430.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch clamp method
10719,CHEMBL4102635,O=S(=O)(Nc1cscn1)c1cc(Cl)c(OCC2NCCC=C2c2ccc(F)cc2)cc1F,IC50,nM,=,10300.0,Inhibition of human ERG
10720,CHEMBL4076061,N[C@@H]1CCC=C(c2ccc(F)cc2)[C@H]1COc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl,IC50,nM,=,10300.0,Inhibition of human ERG
10721,CHEMBL4096341,Cc1ncn(-c2ccc(C(=O)N[C@H]3[C@H]4CC[C@H]3N(c3ncc(Cl)c5cnoc35)C4)c(Cl)c2)n1,IC50,nM,>,10000.0,Inhibition of human ERG by Whole-cell voltage clamp electrophysiology method
10722,CHEMBL4086823,COc1ccc(CN2C[C@@H]3CN(S(=O)(=O)c4ccc(Cl)cc4)CC[C@@H]3Oc3c(NC(=O)C4CC4)cccc3C2=O)cc1,IC50,nM,>,20000.0,Inhibition of human ERG
10723,CHEMBL4088312,CN(C/C=C/c1ccc2ccccc2c1)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,=,16200.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10724,CHEMBL4069757,CN(C/C=C/c1ccc(Br)cc1)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,=,1900.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10725,CHEMBL4090758,Cc1ccc(/C=C/CN(C)Cc2ccc3c(c2)OCCC3)cc1.Cl,IC50,nM,=,3800.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10726,CHEMBL4072535,CN(C/C=C/c1ccc(C(F)F)cc1)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,=,1900.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10727,CHEMBL4094016,CN(C/C=C/c1ccc(C(F)(F)F)cc1)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,=,2900.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10728,CHEMBL4084875,COC(=O)c1ccc(/C=C/CN(C)Cc2ccc3c(c2)OCCC3)cc1.Cl,IC50,nM,=,6500.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10729,CHEMBL4064940,CN(C/C=C/c1ccc(-c2ccccc2)cc1)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,=,32100.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10730,CHEMBL4065307,CN(C/C=C/c1ccc(C(F)(F)F)cc1F)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,=,3200.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10731,CHEMBL4092973,CN(C/C=C/c1ccc(C(F)(F)F)c(F)c1)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,=,200.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10732,CHEMBL4103161,COc1ccc(/C=C/CN(C)Cc2ccc3c(c2)OCCC3)c(F)c1.Cl,IC50,nM,=,3100.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10733,CHEMBL4102178,CN(C/C=C/c1ccc2ccccc2c1)Cc1ccc2c(c1)CCO2.Cl,IC50,nM,=,6700.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10734,CHEMBL4078841,CN(C/C=C/c1ccc(C(F)F)cc1)Cc1ccc2c(c1)CCO2.Cl,IC50,nM,=,1300.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10735,CHEMBL4096875,CN(C/C=C/c1ccc(C(F)(F)F)cc1)Cc1ccc2c(c1)CCO2.Cl,IC50,nM,=,2200.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10736,CHEMBL4075121,CN(C/C=C/c1ccc(-c2ccccc2)cc1)Cc1ccc2c(c1)CCO2.Cl,IC50,nM,=,11300.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10737,CHEMBL4102707,CN(C/C=C/c1ccc(C(F)(F)F)cc1F)Cc1ccc2c(c1)CCO2.Cl,IC50,nM,=,2900.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10738,CHEMBL4077944,CN(C/C=C/C=C/c1ccc(-c2ccccc2)cc1)Cc1ccc2c(c1)OCCC2.Cl,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10739,CHEMBL3827961,COc1ccc(/C=C/CN(C)Cc2ccc3c(c2)CCCCC3)cc1.Cl,IC50,nM,=,3200.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10740,CHEMBL3828585,CN(C/C=C/c1ccc(C(F)(F)F)cc1)Cc1ccc2c(c1)CCCC2.Cl,IC50,nM,=,1400.0,Inhibition of human ERG expressed in CHO cells after 3 mins at -80 mV holding potential by automated patch clamp method
10741,CHEMBL4102775,COc1ccc(CN(CC(=O)N2CCC3(CC2)CNC3)c2ccc(C#N)cc2)cc1F,IC50,nM,=,20100.0,Inhibition of human hERG by patch clamp method
10742,CHEMBL4095018,COc1ccc(CN(CC(=O)N2CCC(CN)CC2)c2ccc(C#N)cc2)cc1F,IC50,nM,=,12400.0,Inhibition of human hERG by patch clamp method
10743,CHEMBL4079933,COc1ccc(CN(CC(=O)N2CCC(N)CC2)c2ccc(C#N)cc2)cc1F,IC50,nM,>,25000.0,Inhibition of human hERG by patch clamp method
10744,CHEMBL4084845,Cc1ccc(-c2ncc(OC[C@H]3CCNC3)cc2-c2ccc(C#N)cc2)cc1,IC50,nM,=,3200.0,Inhibition of human hERG by patch clamp method
10745,CHEMBL1762621,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2,IC50,nM,>,200000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10746,CHEMBL4083511,COC(=O)[C@@H](N)CCC(=O)Nc1ccc(COC2=C(C#N)[C@H](O)[C@]3(C)C4=CC(=O)[C@@H]5[C@@H]6CC(C)(C)CC[C@]6(C(=O)OC)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)cc1,IC50,nM,>,200000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10747,CHEMBL4067401,CCCn1c(=O)c2[nH]c(-c3cnn(CC#Cc4cccc(OC(F)(F)F)c4)c3)nc2n(CC)c1=O,IC50,nM,>,25000.0,Inhibition of human ERG
10748,CHEMBL4087968,Nc1ccc(F)cc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1,IC50,nM,=,32000.0,Inhibition of recombinant human ERG expressed in HEK293 cells after 9 mins by patch clamp method
10749,CHEMBL4071757,Cc1ccc(/C=C/C(=O)N2CCN(c3ccc(C(=O)Nc4ccccc4N)cc3)CC2)cc1,IC50,nM,=,27100.0,Inhibition of recombinant human ERG expressed in HEK293 cells after 9 mins by patch clamp method
10750,CHEMBL4088425,COc1ccc(/C=C/C(=O)N2CCN(c3ccc(C(=O)Nc4ccccc4N)cc3)CC2)cc1,IC50,nM,=,25100.0,Inhibition of recombinant human ERG expressed in HEK293 cells after 9 mins by patch clamp method
10751,CHEMBL4096149,Nc1ccccc1NC(=O)c1ccc(N2CCN(C(=O)/C=C/c3ccc(F)cc3)CC2)cc1,IC50,nM,=,32600.0,Inhibition of recombinant human ERG expressed in HEK293 cells after 9 mins by patch clamp method
10752,CHEMBL4101067,CCc1cc(COc2cc(C(=O)N3CCC[C@@H](N)C3)nn2-c2ccc(C#N)cc2)on1,IC50,nM,=,5000.0,Inhibition of human ERG by patch clamp assay
10753,CHEMBL4084845,Cc1ccc(-c2ncc(OC[C@H]3CCNC3)cc2-c2ccc(C#N)cc2)cc1,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp assay
10754,CHEMBL4076989,CC(C)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,4000.0,Inhibition of [3H]-astemizole binding to human ERG after 2 hrs by scintillation counting method
10755,CHEMBL4065122,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells incubated for 3 to 5 mins by automated parallel patch clamp assay
10756,CHEMBL4078293,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
10757,CHEMBL4091875,C[C@H]1[C@@H](C)OC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N,IC50,nM,>,80000.0,Inhibition of human ERG
10758,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,1.2,Inhibition of human ERG by fluorescently labeled tracer binding method
10759,CHEMBL4087615,COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1,IC50,nM,=,2460.0,Inhibition of human ERG by fluorescently labeled tracer binding method
10760,CHEMBL4065208,Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1,IC50,nM,=,2760.0,Inhibition of human ERG by fluorescently labeled tracer binding method
10761,CHEMBL4091441,Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1,IC50,nM,=,3120.0,Inhibition of human ERG by fluorescently labeled tracer binding method
10762,CHEMBL4064608,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,IC50,nM,>,100000.0,Inhibition of human hERG
10763,CHEMBL1280,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl,IC50,nM,=,560.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
10764,CHEMBL4099387,CN(Cc1ccccn1)Cc1ccccc1CNc1ccnc2cc(Cl)ccc12,IC50,nM,=,870.96,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
10765,CHEMBL4099387,CN(Cc1ccccn1)Cc1ccccc1CNc1ccnc2cc(Cl)ccc12,IC50,nM,=,870.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp method
10766,CHEMBL4080228,COc1cc(C)[nH]c(=O)c1CN1CCc2c(Cl)cc([C@H](OC)C3COC3)c(Cl)c2C1=O,IC50,nM,>,100000.0,Inhibition of human ERG
10767,CHEMBL4063478,CCOC(=O)[C@@H]1C2CCC(C[C@@H]1OC(c1ccc(F)cc1)c1ccc(F)cc1)N2C[C@H](N)C(C)C,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10768,CHEMBL4085107,CCOC(=O)[C@@H]1C2CCC(C[C@@H]1OC(c1ccc(F)cc1)c1ccc(F)cc1)N2CCc1c[nH]c2ccccc12,IC50,nM,=,14000.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10769,CHEMBL4077089,CCOC(=O)[C@@H]1C2CCC(C[C@@H]1OC(c1ccc(F)cc1)c1ccc(F)cc1)N2CC1CC1,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10770,CHEMBL4092855,CC(C)[C@@H](N)CN1C2CCC1CC(NC(c1ccc(F)cc1)c1ccc(F)cc1)C2,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10771,CHEMBL4082578,Fc1ccc(C(NC2CC3CCC(C2)N3CCN2CCCCC2)c2ccc(F)cc2)cc1,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10772,CHEMBL4100591,Fc1ccc(C(OC2CC3CCC(C2)N3CCN2CCCCC2)c2ccc(F)cc2)cc1,IC50,nM,=,5150.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10773,CHEMBL4090416,CN(C)CCN1C2CCC1CC(NC(c1ccc(F)cc1)c1ccc(F)cc1)C2,IC50,nM,=,5480.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10774,CHEMBL4062435,CN(C)CCN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2,IC50,nM,=,8230.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10775,CHEMBL4097211,CCOC(=O)[C@@H]1C2CCC(C[C@@H]1NC(c1ccc(F)cc1)c1ccc(F)cc1)N2CCN,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10776,CHEMBL4070531,C=C[C@@H]1C2CCC(C[C@@H]1OC(c1ccc(F)cc1)c1ccc(F)cc1)N2CCN(C)C,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10777,CHEMBL429015,CC(C)[C@@H](N)CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2,IC50,nM,=,4360.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10778,CHEMBL199166,NCCN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10779,CHEMBL440272,Fc1ccc(C(OC2CC3CCC(C2)N3CC2CC2)c2ccc(F)cc2)cc1,IC50,nM,=,3960.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10780,CHEMBL199103,Fc1ccc(C(OC2CC3CCC(C2)N3CCc2c[nH]c3ccccc23)c2ccc(F)cc2)cc1,IC50,,,,Displacement of [3H]Dofetilide from human ERG expressed in HEK cells after 180 mins by scintillation counting method
10781,CHEMBL4086008,CN(C/C=C/c1ccc(-c2ccccc2)cc1)Cc1coc2ccccc12.Cl,IC50,nM,=,34800.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 3 mins by QPatch test
10782,CHEMBL4101749,CN(C/C=C/c1ccc(-c2ccccc2)cc1)Cc1cccc2cc[nH]c12.Cl,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 3 mins by QPatch test
10783,CHEMBL3814424,CN(C/C=C/c1ccc(C(F)(F)F)cc1)Cc1cccc2ccoc12.Cl,IC50,nM,=,3700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 3 mins by QPatch test
10784,CHEMBL2181928,C[C@@H]1CN(c2ccc3c(n2)NC(=O)CO3)[C@H](c2ccccc2)CO1,IC50,nM,>,100000.0,Inhibition of human ERG by patch clamp assay
10785,CHEMBL4099050,CCOC(=O)c1c(CN2CCOCC2)nc(-c2nccs2)nc1-c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10786,CHEMBL4093889,CCOC(=O)C1=C(CN2CCOC[C@H]2CCC(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10787,CHEMBL4074934,CCOC(=O)C1=C(CN2CCOC[C@@H]2CCC(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10788,CHEMBL4101622,CCOC(=O)C1=C(CN2CCO[C@@H](CCC(=O)O)C2)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10789,CHEMBL4085181,CCOC(=O)C1=C(CN2CCO[C@H](CCC(=O)O)C2)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10790,CHEMBL4063560,CCOC(=O)C1=C(CN2CC(F)(F)C[C@H]2C(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10791,CHEMBL4074324,CCOC(=O)C1=C(CN2CC(C)(C)OC[C@H]2C(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10792,CHEMBL4094822,CCOC(=O)C1=C(CN2CCO[C@H](C)[C@H]2C(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10793,CHEMBL4100106,CCOC(=O)C1=C(CN2CCOC[C@H]2CO)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,=,24200.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10794,CHEMBL4061060,CCOC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10795,CHEMBL4092352,CCOC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10796,CHEMBL4064672,COC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10797,CHEMBL4073176,COC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10798,CHEMBL4091444,CCOC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10799,CHEMBL4061904,CCOC(=O)C1=C(CN2CCOC[C@@H]2C(=O)O)NC(c2nccs2)=N[C@@H]1c1ccc(Cl)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10800,CHEMBL4083668,CCOC(=O)C1=C(CN2CCOC[C@@H]2C(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(Cl)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10801,CHEMBL4068628,CCOC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=N[C@@H]1c1ccc(Cl)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10802,CHEMBL4095407,CCOC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=N[C@H]1c1ccc(Cl)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10803,CHEMBL4095001,CCOC(=O)C1=C(CN2CCOC[C@H]2C(=O)O)NC(c2nccs2)=NC1c1ccc(Cl)cc1Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10804,CHEMBL4077526,CCOC(=O)C1=C(CN2CCOC(CCC(=O)O)C2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10805,CHEMBL4087323,CCOC(=O)C1=C(CN2CCOCC2CCC(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10806,CHEMBL4065913,CCOC(=O)C1=C(CN2CCOC(CC(=O)O)C2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10807,CHEMBL4064868,CCOC(=O)C1=C(CN2CCOCC2CC(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10808,CHEMBL4092568,CCOC(=O)C1=C(CN2CCOC(C(=O)O)C2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10809,CHEMBL4102761,CCOC(=O)C1=C(CN2CCOC(CO)C2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,7330.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10810,CHEMBL4084810,CCOC(=O)C1=C(CN2CCOCC2CO)NC(c2nccs2)=NC1c1ccc(Cl)cc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10811,CHEMBL4082545,CCOC(=O)C1=C(CN2CCOCC2C(=O)NS(C)(=O)=O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10812,CHEMBL4100564,CCOC(=O)C1=C(CN2CCOCC2C(=O)NC)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10813,CHEMBL4079166,CCOC(=O)C1=C(CN2CCOCC2C(N)=O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10814,CHEMBL4097181,CCOC(=O)C1=C(CN2CCOCC2C(=O)OC(C)C)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10815,CHEMBL4087026,CCOC(=O)C1=C(CN2CCOCC2C(=O)OC)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10816,CHEMBL4104891,CCOC(=O)C1=C(CN2CC(C)(C)OCC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10817,CHEMBL4059649,CCOC(=O)C1=C(CN2CCO[C@H](C)[C@H]2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10818,CHEMBL4081602,CCOC(=O)C1=C(CN)NC(c2nccs2)=NC1c1ccc(Cl)cc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10819,CHEMBL4068300,CCOC(=O)C1=C(CN2CCOCC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Cl,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10820,CHEMBL4089481,CCOC(=O)C1=C(CN2CCOCC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10821,CHEMBL4102843,CCOC(=O)C1=C(CN2CCN(C)CC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10822,CHEMBL4084893,CCOC(=O)C1=C(CN2CCCCC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10823,CHEMBL4079517,CCOC(=O)C1=C(CN2CCCC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10824,CHEMBL4103771,CCOC(=O)C1=C(CNC(Cc2ccccc2)C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,8680.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10825,CHEMBL4087396,CCOC(=O)C1=C(CN2CCS(=O)(=O)CC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,1070.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10826,CHEMBL4098434,CCOC(=O)C1=C(CN2CC[S+]([O-])CC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,5740.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10827,CHEMBL4060052,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nc(CC(=O)O)cs2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10828,CHEMBL4088287,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nc(CC(=O)OC)cs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,1640.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10829,CHEMBL4068707,CCOC(=O)C1=C(CN2CCOCC2)NC(c2ncc(OC)s2)=NC1c1ccc(F)cc1Br,IC50,nM,=,4190.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10830,CHEMBL4096023,CCOC(=O)C1=C(CN2CCOCC2)NC(n2ncnn2)=NC1c1ccc(F)cc1Br,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10831,CHEMBL4082519,CCOC(=O)C1=C(CN2CCOCC2)NC(n2cncn2)=NC1c1ccc(F)cc1Br,IC50,nM,=,700.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10832,CHEMBL4079561,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccn2C)=NC1c1ccc(F)cc1Br,IC50,nM,=,170.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10833,CHEMBL4070728,CCOC(=O)C1=C(CN2CCOCC2)NC(c2ccccn2)=NC1c1ccc(F)cc1Br,IC50,nM,=,3800.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10834,CHEMBL4077161,CCOC(=O)C1=C(CN2CCOCC2)NC(c2cccs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,900.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10835,CHEMBL4075908,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nncs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,3490.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10836,CHEMBL4067663,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1-c1ccccc1,IC50,nM,=,4960.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10837,CHEMBL4103602,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccccc1[N+](=O)[O-],IC50,nM,=,260.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10838,CHEMBL4062770,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccccc1Cl,IC50,nM,=,4040.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10839,CHEMBL4078766,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(Cl)cc1Cl,IC50,nM,=,300.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10840,CHEMBL4076401,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1Cl,IC50,nM,=,2310.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10841,CHEMBL4092509,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=N[C@@H]1c1ccc(F)cc1Br,IC50,nM,=,4880.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10842,CHEMBL4064808,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=N[C@H]1c1ccc(F)cc1Br,IC50,nM,=,4500.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10843,CHEMBL3742114,CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br,IC50,nM,=,860.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
10844,CHEMBL4069245,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C)n2)C3=O)ccc2c1COC2=O,IC50,nM,=,20000.0,Inhibition of human ERG by PatchXpress method
10845,CHEMBL4062576,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(-n4cnnn4)cn2)C3)ccc2c1COC2=O,IC50,nM,=,3290.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10846,CHEMBL4098260,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,14400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10847,CHEMBL4071221,Cc1nsc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2)n1,IC50,nM,=,4200.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10848,CHEMBL4059846,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccns2)C3)ccc2c1COC2=O,IC50,nM,=,1400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10849,CHEMBL4081764,Cc1c([C@@H](O)CN2CCC3(CC2)CN(c2ccns2)C3)ccc2c1COC2=O,IC50,nM,=,4500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10850,CHEMBL4067063,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2ccns2)C3)ccc2c1COC2=O,IC50,nM,=,8000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10851,CHEMBL4061345,Cc1c([C@@H](O)CN2CCC3(CC2)CN(c2ccns2)C(=O)O3)ccc2c1COC2=O,IC50,nM,=,12000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10852,CHEMBL4062753,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccns2)C3=O)ccc2c1COC2=O,IC50,nM,=,8900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10853,CHEMBL4071329,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2sncc2Cl)C3=O)ccc2c1COC2=O,IC50,nM,=,1500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10854,CHEMBL4067649,Cc1cnsc1N1CCC2(CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)C1=O,IC50,nM,=,7900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10855,CHEMBL4075906,Cc1cc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)sn1,IC50,nM,=,7400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10856,CHEMBL4093627,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cc(-c4ccccc4)ns2)C3=O)ccc2c1COC2=O,IC50,nM,=,9.5,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10857,CHEMBL4072929,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cc(-c4ccccc4)no2)C3=O)ccc2c1COC2=O,IC50,nM,=,54.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10858,CHEMBL4086822,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cnsc2)C3=O)ccc2c1COC2=O,IC50,nM,=,4900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10859,CHEMBL4076563,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cnsn2)C3=O)ccc2c1COC2=O,IC50,nM,=,6100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10860,CHEMBL4070003,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ncns2)C3=O)ccc2c1COC2=O,IC50,nM,=,12300.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10861,CHEMBL4095422,Cc1nsc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,14500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10862,CHEMBL4075319,COc1nsc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,9600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10863,CHEMBL4092262,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccncc2)C3=O)ccc2c1COC2=O,IC50,nM,=,10400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10864,CHEMBL4071345,COc1cc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)ccn1,IC50,nM,=,3800.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10865,CHEMBL4086697,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccnnc2)C3=O)ccc2c1COC2=O,IC50,nM,=,27000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10866,CHEMBL4072014,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccncn2)C3=O)ccc2c1COC2=O,IC50,nM,=,21900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10867,CHEMBL4071603,Cc1nccc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,17600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10868,CHEMBL4103004,COc1nccc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,7900.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10869,CHEMBL4078730,CNc1nccc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,9400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10870,CHEMBL4068584,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccn(C)c(=O)c2)C3=O)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10871,CHEMBL4078280,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C)c2)C3=O)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10872,CHEMBL4069245,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C)n2)C3=O)ccc2c1COC2=O,IC50,nM,=,21600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10873,CHEMBL4075427,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cnn(C)c(=O)c2)C3=O)ccc2c1COC2=O,IC50,nM,=,12000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10874,CHEMBL4093121,CCn1nc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)ccc1=O,IC50,nM,=,7600.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10875,CHEMBL4071141,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C4CCCC4)n2)C3=O)ccc2c1COC2=O,IC50,nM,=,13500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10876,CHEMBL4070542,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C(F)F)n2)C3=O)ccc2c1COC2=O,IC50,nM,=,19100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10877,CHEMBL4061173,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cc(C)c(=O)n(C)n2)C3=O)ccc2c1COC2=O,IC50,nM,=,2700.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10878,CHEMBL4102137,Cc1cc(=O)n(C)nc1N1CCC2(CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)C1=O,IC50,nM,=,21000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10879,CHEMBL4084167,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2cn(C)c(=O)cn2)C3=O)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10880,CHEMBL4082637,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C)n2)C3)ccc2c1COC2=O,IC50,nM,=,4500.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10881,CHEMBL4059965,Cc1c([C@@H](O)CN2CCC3(CC2)CC(=O)N(c2ccc(=O)n(C)n2)C3)ccc2c1COC2=O,IC50,nM,=,36400.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10882,CHEMBL4098143,Cn1nc(N2CCC3(CCN(C[C@H](O)c4ccc(-n5cnnn5)nn4)CC3)C2=O)ccc1=O,IC50,nM,=,3100.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10883,CHEMBL4071084,Cc1nc(-n2cnnn2)ccc1[C@@H](O)CN1CCC2(CC1)CCN(c1ccc(=O)n(C)n1)C2=O,IC50,nM,=,17200.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10884,CHEMBL4075868,Cc1c(CCN2CCC3(CC2)CCN(c2ccc(=O)n(C)n2)C3=O)ccc2c1COC2=O,IC50,nM,=,4700.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10885,CHEMBL4075415,Cc1c([C@@H](O)[C@H](C)N2CCC3(CCN(c4ccc(=O)n(C)n4)C3=O)CC2)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10886,CHEMBL4101783,Cc1c([C@@H](O)CN2CCC3(CC2)CN(c2ccc(=O)n(C)n2)C3)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10887,CHEMBL4076697,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C)n2)CC3)ccc2c1COC2=O,IC50,nM,=,45000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10888,CHEMBL4097415,Cc1c([C@@H](O)CN2CCC3(CC2)CN(c2ccc(=O)n(C)n2)C(=O)CO3)ccc2c1COC2=O,IC50,nM,=,46000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10889,CHEMBL4075425,Cc1c([C@@H](O)CN2CCC3(CC2)OCCN(c2ccc(=O)n(C)n2)C3=O)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10890,CHEMBL4062796,Cc1c([C@@H](O)CN2CCC3(CC2)CN(c2ccc(=O)n(C)n2)CCO3)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10891,CHEMBL4093837,Cc1c([C@@H](O)CN2CCC3(CC2)CN(c2ccc(=O)n(C)n2)C(=O)O3)ccc2c1COC2=O,IC50,nM,>,60000.0,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells
10892,CHEMBL4069245,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(=O)n(C)n2)C3=O)ccc2c1COC2=O,IC50,nM,>,90000.0,Inhibition of human ERG by Qpatch electrophysiology method
10893,CHEMBL4103004,COc1nccc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,8200.0,Inhibition of human ERG by Qpatch electrophysiology method
10894,CHEMBL4092262,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccncc2)C3=O)ccc2c1COC2=O,IC50,nM,=,19500.0,Inhibition of human ERG by Qpatch electrophysiology method
10895,CHEMBL4075319,COc1nsc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,10300.0,Inhibition of human ERG by Qpatch electrophysiology method
10896,CHEMBL4095422,Cc1nsc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)n1,IC50,nM,=,9000.0,Inhibition of human ERG by Qpatch electrophysiology method
10897,CHEMBL4075906,Cc1cc(N2CCC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)sn1,IC50,nM,=,6600.0,Inhibition of human ERG by Qpatch electrophysiology method
10898,CHEMBL4062753,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccns2)C3=O)ccc2c1COC2=O,IC50,nM,=,5000.0,Inhibition of human ERG by Qpatch electrophysiology method
10899,CHEMBL4098260,Cc1c([C@@H](O)CN2CCC3(CC2)CCN(c2ccc(S(C)(=O)=O)cn2)C3)ccc2c1COC2=O,IC50,nM,=,11700.0,Inhibition of human ERG by Qpatch electrophysiology method
10900,CHEMBL4091821,Cc1nnc2sc(C(=O)NCc3ccc(-c4cccnc4F)cc3)c(N)c2c1C,IC50,nM,>,33000.0,Inhibition of human ERG
10901,CHEMBL1773422,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1,IC50,nM,=,213000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10902,CHEMBL4075428,Cn1c([S+](C)[O-])nc(-c2ccc(F)cc2)c1-c1ccnc(N)c1,IC50,nM,=,83000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10903,CHEMBL432798,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C,IC50,nM,=,28600.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10904,CHEMBL321494,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,IC50,nM,=,2760.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10905,CHEMBL4094458,Cc1cc(CNc2nc(N)nc3ccn(Cc4ccccn4)c23)no1,IC50,nM,=,1200.0,Displacement of 3H-dofetilide from human ERG
10906,CHEMBL4073895,Nc1nc(NCc2cc(C3CC3)on2)c2c(ccn2Cc2ccccn2)n1,IC50,nM,=,200.0,Displacement of 3H-dofetilide from human ERG
10907,CHEMBL4078859,COc1ccc(Cn2ccc3nc(N)nc(NCc4cc(C)on4)c32)nc1OC,IC50,nM,=,700.0,Displacement of 3H-dofetilide from human ERG
10908,CHEMBL4103135,COc1cccc(Cn2ccc3nc(N)nc(NCc4cc(C)on4)c32)n1,IC50,nM,=,2300.0,Displacement of 3H-dofetilide from human ERG
10909,CHEMBL4072841,Cc1cc(CNc2nc(N)nc3ccn(Cc4ccc(F)cn4)c23)no1,IC50,nM,=,2000.0,Displacement of 3H-dofetilide from human ERG
10910,CHEMBL4099725,Cc1cc(CNc2nc(N)nc3ccn(Cc4ncccc4F)c23)no1,IC50,nM,=,2100.0,Displacement of 3H-dofetilide from human ERG
10911,CHEMBL4088372,Cc1cc(CNc2nc(N)nc3ccn(Cc4ccc(C(F)(F)F)cn4)c23)no1,IC50,nM,=,500.0,Displacement of 3H-dofetilide from human ERG
10912,CHEMBL4060138,Cc1cc(CNc2nc(N)nc3ccn(Cc4cc(C(F)(F)F)ccn4)c23)no1,IC50,,,,Displacement of 3H-dofetilide from human ERG
10913,CHEMBL4080513,Cc1cc(CNc2nc(N)nc3ccn(Cc4ncccc4Cl)c23)no1,IC50,nM,=,900.0,Displacement of 3H-dofetilide from human ERG
10914,CHEMBL4098533,Cc1cc(CNc2nc(N)nc3ccn(Cc4cc(Cl)ccn4)c23)no1,IC50,nM,=,500.0,Displacement of 3H-dofetilide from human ERG
10915,CHEMBL4103847,Cc1cc(COc2nc(N)nc3ccn(Cc4ccccn4)c23)no1,IC50,nM,>,50000.0,Displacement of 3H-dofetilide from human ERG
10916,CHEMBL4079597,Cc1cnc(COc2nc(N)nc3ccn(Cc4ccccn4)c23)o1,IC50,nM,>,50000.0,Displacement of 3H-dofetilide from human ERG
10917,CHEMBL4096097,Cc1cnc(COc2nc(N)nc3ccn(Cc4ccccn4)c23)s1,IC50,nM,=,44700.0,Displacement of 3H-dofetilide from human ERG
10918,CHEMBL4068797,Cc1nc(COc2nc(N)nc3ccn(Cc4ccccn4)c23)no1,IC50,nM,>,50000.0,Displacement of 3H-dofetilide from human ERG
10919,CHEMBL4074704,COc1cccnc1Cn1ccc2nc(N)nc(OCc3ncc(C)o3)c21,IC50,nM,=,2200.0,Displacement of 3H-dofetilide from human ERG
10920,CHEMBL4095178,COc1cccnc1Cn1ccc2nc(N)nc(NCc3cc(C)on3)c21,IC50,nM,=,1600.0,Displacement of 3H-dofetilide from human ERG
10921,CHEMBL4062218,CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1,IC50,nM,>,33000.0,Inhibition of human ERG
10922,CHEMBL4088721,CN(Cc1ccc(C(F)(F)F)cc1)c1cc(C(=O)Nc2ccccc2)ncn1,IC50,nM,=,3300.0,Inhibition of full length human ERG expressed in CHO cells at -70 mV holding potential by patch clamp assay
10923,CHEMBL4075071,CN(Cc1ccc(C(F)(F)F)nc1)c1cc(C(=O)Nc2ccccc2)ncn1,IC50,nM,=,5600.0,Inhibition of full length human ERG expressed in CHO cells at -70 mV holding potential by patch clamp assay
10924,CHEMBL4088719,CC(C)Oc1ccc(NC(=O)c2cc(N(C)Cc3ccc(F)cc3)ncn2)cc1,IC50,nM,=,4100.0,Inhibition of full length human ERG expressed in CHO cells at -70 mV holding potential by patch clamp assay
10925,CHEMBL4070191,CN1CCN(c2ccc(NC(=O)c3cc(N(C)Cc4ccc(C(F)(F)F)cc4)ncn3)cc2)CC1,IC50,nM,=,900.0,Inhibition of full length human ERG expressed in CHO cells at -70 mV holding potential by patch clamp assay
10926,CHEMBL4101551,CN(Cc1ccc(F)cc1)c1cc(C(=O)Nc2nncs2)ncn1,IC50,nM,=,4200.0,Inhibition of full length human ERG expressed in CHO cells at -70 mV holding potential by patch clamp assay
10927,CHEMBL4083549,CN(Cc1ccc(C(F)(F)F)nc1)c1cc(C(=O)Nc2nncs2)ncn1,IC50,nM,=,14000.0,Inhibition of full length human ERG expressed in CHO cells at -70 mV holding potential by patch clamp assay
10928,CHEMBL3703085,CN(C)[C@H]1CC[C@H](n2cc(C(N)=O)c(Nc3ccc(Cl)cc3)n2)[C@@H](C#N)C1,IC50,nM,=,12200.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10929,CHEMBL3647849,N#C[C@H]1C[C@@H](O)CC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(Cl)cc2)n1,IC50,nM,=,26000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10930,CHEMBL4094682,CN([C@H]1CC[C@H](n2cc(C(N)=O)c(Nc3ccc(Cl)cc3)n2)[C@@H](C#N)C1)C1(C)COC1,IC50,nM,=,46000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10931,CHEMBL3703025,N#C[C@H]1C[C@@H](N2CCC2)CC[C@@H]1n1cc(C(N)=O)c(Nc2ccc([C@H](O)C(F)(F)F)cc2)n1,IC50,nM,=,32000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10932,CHEMBL4076821,N#C[C@H]1CCCC[C@@H]1n1cc(C(N)=O)c(Nc2ccccc2)n1,IC50,nM,>,60000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10933,CHEMBL4100288,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccccc2)n1,IC50,nM,>,60000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10934,CHEMBL4089234,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(Cl)cc2)n1,IC50,nM,=,40000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10935,CHEMBL4104623,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(F)cc2)n1,IC50,nM,=,40000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10936,CHEMBL4077886,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(C3CC3)cc2)n1,IC50,nM,=,35000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10937,CHEMBL4102140,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(OC(F)F)cc2)n1,IC50,nM,=,25000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10938,CHEMBL4078799,Cn1cc(-c2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc2)cn1,IC50,nM,>,60000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10939,CHEMBL4096821,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(-n3ccnn3)cc2)n1,IC50,nM,=,13200.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10940,CHEMBL4067915,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccnc(F)c2)n1,IC50,nM,>,60000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10941,CHEMBL4089118,N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc([C@H](O)C(F)(F)F)cc2)n1,IC50,nM,>,60000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10942,CHEMBL4061128,N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1,IC50,nM,=,40000.0,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cell membranes
10943,CHEMBL3703085,CN(C)[C@H]1CC[C@H](n2cc(C(N)=O)c(Nc3ccc(Cl)cc3)n2)[C@@H](C#N)C1,IC50,nM,=,3000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
10944,CHEMBL4077555,C[C@@H]1CN(C(=O)c2nc(Nc3cc(C4CC4)[nH]n3)c3cc(Cl)ccc3n2)CCN1.Cl,IC50,nM,>,40000.0,Inhibition of human ERG by Qpatch assay
10945,CHEMBL3919664,C[C@H]1Cc2c(nnn2-c2ncc(F)cn2)CN1C(=O)c1cccc(C(F)(F)F)c1F,IC50,nM,>,3000.0,Inhibition of human ERG channel expressed in CHO cells at holding potential of -80 mV after 5 mins by automated patch clamp assay
10946,CHEMBL3914857,C[C@H]1Cc2c(nnn2-c2ncc(F)cn2)CN1C(=O)c1ccnc(C(F)(F)F)c1F,IC50,nM,>,3000.0,Inhibition of human ERG channel expressed in CHO cells at holding potential of -80 mV after 5 mins by automated patch clamp assay
10947,CHEMBL4099792,C[C@@H](c1ccc(Br)cc1)N1CC[C@](CCC(N)=O)(c2ccc(F)cc2)OC1=O,IC50,nM,=,6300.0,Inhibition of human ERG
10948,CHEMBL4100755,C[C@@H](c1ccc(OC(F)F)cc1)N1CC[C@](CCC(N)=O)(c2ccc(F)cc2)OC1=O,IC50,nM,=,5300.0,Inhibition of human ERG
10949,CHEMBL3664717,C[C@@H](c1ccc(-c2ccn(C)c(=O)c2)cc1)N1CC[C@](CC(C)(C)O)(c2ccccc2)OC1=O,IC50,nM,>,100000.0,Inhibition of human ERG
10950,CHEMBL4078201,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5cc(F)ccc5F)C4)C[C@@H]3C(=O)O)c2n1,IC50,nM,=,45000.0,Inhibition of human ERG
10951,CHEMBL4082602,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5ncccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,10700.0,Inhibition of human ERG
10952,CHEMBL4101570,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5ccno5)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,>,300000.0,Inhibition of human ERG
10953,CHEMBL4079869,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5cccc(F)c5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,25000.0,Inhibition of human ERG
10954,CHEMBL4097890,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5cc(F)cc(F)c5)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,14100.0,Inhibition of human ERG
10955,CHEMBL4092041,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5cc(F)ccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,85900.0,Inhibition of human ERG
10956,CHEMBL4064317,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5c(F)cccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,45300.0,Inhibition of human ERG
10957,CHEMBL4103746,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(C4CC(c5ccccc5)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,22300.0,Inhibition of human ERG
10958,CHEMBL2382345,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5cc(F)ccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,9970.0,Inhibition of human ERG
10959,CHEMBL2382343,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5c(F)cccc5F)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,47600.0,Inhibition of human ERG
10960,CHEMBL2382287,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(C4CC(c5ccccc5)C4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,24900.0,Inhibition of human ERG
10961,CHEMBL2424928,O=c1ccc2ncc(F)c3c2n1C[C@@]3(O)CN1CCC(NCc2cc3c(cn2)OCCO3)CC1,IC50,nM,>,300000.0,Inhibition of human ERG
10962,CHEMBL2158050,COc1ccc2ncc(F)c([C@@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,23600.0,Inhibition of human ERG
10963,CHEMBL2159976,COc1ccc2nccc([C@@H](O)CC[C@@H]3CCN(CCSc4cccs4)C[C@@H]3C(=O)O)c2c1,IC50,nM,=,19700.0,Inhibition of human ERG
10964,CHEMBL3317856,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,IC50,ug.mL-1,=,588.0,Inhibition of human ERG
10965,CHEMBL4062193,Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F,IC50,nM,>,100000.0,Inhibition of human ERG
10966,CHEMBL4101680,N#Cc1ccc(-c2n[nH]c3cc(OC(F)(F)F)ccc23)cc1,IC50,nM,>,30000.0,Inhibition of human ERG
10967,CHEMBL4093377,FC(F)(F)c1ccc2c(Nc3ccc(Cl)nc3)n[nH]c2c1,IC50,nM,>,100000.0,Inhibition of human ERG
10968,CHEMBL222863,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,IC50,nM,=,5800.0,Displacement of Tracer Red from human ERG expressed in cell membranes by fluorescence polarization assay
10969,CHEMBL4104102,C[C@@H]1CC[C@H](Nc2ncc(C(N)=O)c3sc(-c4ccccc4)cc23)CN1,IC50,nM,=,2450.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10970,CHEMBL4093952,C[C@@H]1N[C@H](C)CC[C@@H]1Nc1ncc(C(N)=O)c2sc(-c3ccccc3)cc12,IC50,nM,=,8400.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10971,CHEMBL4066399,NC(=O)c1cnc(N[C@H]2CCCN[C@@H]2CCO)c2cc(-c3ccccc3)sc12,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10972,CHEMBL4082801,NC(=O)c1cnc(N[C@H]2CNCC[C@@H]2O)c2cc(-c3ccccc3)sc12,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10973,CHEMBL4100776,C[C@@H]1NCCC[C@@H]1Nc1ncc(C(N)=O)c2sc(-c3ccccc3)cc12,IC50,nM,=,5900.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10974,CHEMBL4059912,C[C@H]1NCCC[C@@H]1Nc1ncc(C(N)=O)c2sc(-c3ccccc3)cc12,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10975,CHEMBL4081827,CN1CCC[C@H](Nc2ncc(C(N)=O)c3sc(-c4ccccc4)cc23)C1,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10976,CHEMBL4098331,NC(=O)c1cnc(N(CCc2ccccc2)[C@H]2CCCNC2)c2cc(-c3ccccc3)sc12,IC50,nM,=,2100.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10977,CHEMBL4076939,NC(=O)c1cnc(N(CCO)[C@H]2CCCNC2)c2cc(-c3ccccc3)sc12,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10978,CHEMBL4079391,CCN(c1ncc(C(N)=O)c2sc(-c3ccccc3)cc12)[C@H]1CCCNC1,IC50,nM,=,2400.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10979,CHEMBL4097424,CN(c1ncc(C(N)=O)c2sc(-c3ccccc3)cc12)[C@H]1CCCNC1,IC50,nM,=,2700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10980,CHEMBL4068572,NC(=O)c1cnc(SC2CCCNC2)c2cc(-c3ccccc3)sc12,IC50,nM,=,4900.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10981,CHEMBL4089699,NC(=O)c1cnc(O[C@H]2CCCNC2)c2cc(-c3ccccc3)sc12,IC50,nM,=,3800.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10982,CHEMBL4081097,NC(=O)c1cnc(N[C@H]2CCCNC2)c2cc(-c3ccccc3)oc12,IC50,,,,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10983,CHEMBL4105353,NC(=O)c1ccc(N[C@H]2CCCNC2)c2cc(-c3ccc(Cl)cc3)[nH]c12,IC50,nM,=,4100.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10984,CHEMBL4088986,NC(=O)c1ccc(N[C@H]2CCCNC2)c2cc(-c3ccc(F)cc3)[nH]c12,IC50,nM,=,6700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10985,CHEMBL4067770,NC(=O)c1ccc(N[C@H]2CCCNC2)c2cc(-c3cccc(F)c3)[nH]c12,IC50,nM,=,7700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10986,CHEMBL4096683,NC(=O)c1ccc(N[C@H]2CCCNC2)c2cc(-c3ccccc3)[nH]c12,IC50,nM,=,11600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10987,CHEMBL4079910,NC(=O)c1cnc(N[C@H]2CCCNC2)c2cc(-c3ccsc3)sc12,IC50,nM,=,28000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10988,CHEMBL4097937,NC(=O)c1cnc(N[C@H]2CCCNC2)c2cc(-c3cccs3)sc12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10989,CHEMBL4098878,NC(=O)c1cnc(N[C@H]2CCCNC2)c2cc(-c3cccc(F)c3)sc12,IC50,nM,=,14200.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10990,CHEMBL1287920,NC(=O)c1cnc(N[C@H]2CCCNC2)c2cc(-c3ccccc3)sc12,IC50,nM,=,19700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10991,CHEMBL487273,NC(=O)Nc1sc(-c2ccccc2)cc1C(=O)N[C@H]1CCCNC1,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10992,CHEMBL4082386,NC(=O)c1cnc(N[C@H]2CCCNC2)c2sc(-c3ccccc3)cc12,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10993,CHEMBL4083348,NC(=O)c1cnc(N[C@H]2CCCNC2)c2sc(-c3cccc(F)c3)cc12,IC50,nM,>,31600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10994,CHEMBL2041933,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,nM,=,15000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by patch clamp assay
10995,CHEMBL4079080,O=C(O[C@H](CO)C(F)(F)F)N1C[C@H]2[C@@H](C1)[C@@H]2c1ccn(-c2ccc(F)cc2)n1,IC50,nM,>,30000.0,Inhibition of human ERG
10996,CHEMBL2386850,Cc1cc(Oc2cncnc2)cc(C(=O)Nc2ccc(F)cn2)n1,IC50,nM,=,73600.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
10997,CHEMBL4087906,O=C(CN1CCCC2=C1C(=O)N(C1CC1)C2=O)Nc1ccc(-c2cccnc2)nn1,IC50,nM,=,48000.0,Inhibition of human ERG by patch clamp assay
10998,CHEMBL4095883,Cn1c(C#N)ccc1-c1ccc(O)cc1F,IC50,nM,>,100000.0,Inhibition of dofetilide binding to human ERG
10999,CHEMBL4105630,C[C@]12CC[C@@H]3[C@H]4CC[C@@](C)(O)C[C@H]4CC[C@H]3[C@@H]1CC[C@@H]2C(=O)Cn1cc(C#N)cn1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
11000,CHEMBL4060396,CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCCC3)c2c(=O)n1-c1ccccc1,IC50,nM,>,40000.0,Inhibition of human ERG
11001,CHEMBL4073929,CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1,IC50,nM,>,40000.0,Inhibition of human ERG
11002,CHEMBL4098370,Cc1nc(N)nc(N2CCC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCCC4)c3c(=O)n2-c2ccccc2)c1C#N,IC50,,,,Inhibition of human ERG
11003,CHEMBL4080347,N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1,IC50,nM,=,31700.0,Inhibition of human ERG
11004,CHEMBL3673194,NC1=N[C@@]2(c3cc(CNCC(F)(F)F)c(F)cc3F)CO[C@@H](CF)C[C@H]2CS1,IC50,nM,=,4300.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11005,CHEMBL4088234,C[C@@H]1C[C@@](C)(c2cc(CNC3(C(F)(F)F)CC3)c(F)cc2F)N=C(N)S1,IC50,nM,=,2600.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11006,CHEMBL4098403,C[C@@]1(c2cc(CNC3(C(F)(F)F)CC3)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,3500.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11007,CHEMBL4080380,C[C@@]1(c2cc(CNC3(C(F)(F)F)COC3)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,16500.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11008,CHEMBL4077211,C[C@@]1(c2cc(CNC3(C#N)CC3)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,28400.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11009,CHEMBL4062728,C[C@@]1(c2cc(CNC3(C(F)F)CC3)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,13700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11010,CHEMBL4064148,C[C@@]1(c2cc(CNCC3CC3)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,33000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11011,CHEMBL4085715,C[C@@]1(c2cc(CNC3CC3)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,49200.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11012,CHEMBL4084170,C[C@@]1(c2cc(CNCCC(F)(F)F)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,20400.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11013,CHEMBL4061602,C[C@@H](NCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F)C(F)(F)F,IC50,nM,=,13900.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11014,CHEMBL4094377,CC(C)(NCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F)C(F)(F)F,IC50,nM,=,11200.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11015,CHEMBL4066885,C[C@@]1(c2cc(CNCC(F)F)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,14700.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11016,CHEMBL4086633,C[C@@]1(c2cc(CNCC(F)(F)F)c(F)cc2F)CCSC(N)=N1,IC50,nM,=,6100.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 5 mins by patch clamp assay
11017,CHEMBL3675746,CCc1nc2c(C)cc(C)nc2n1Cc1ccc(/C=C/CN2CCN(C(C)C)CC2)cc1,IC50,nM,=,1000.0,Displacement of [3H]-dofetilide from recombinant human ERG expressed in HEK293 cells
11018,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,1330.0,Inhibition of human ERG
11019,CHEMBL4083333,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2,IC50,nM,=,2670.0,Inhibition of human ERG
11020,CHEMBL4102670,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2O,IC50,nM,=,4050.0,Inhibition of human ERG
11021,CHEMBL4104261,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2F,IC50,nM,=,6130.0,Inhibition of human ERG
11022,CHEMBL4087132,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(F)F.Cl,IC50,nM,=,5800.0,Inhibition of human ERG
11023,CHEMBL4094825,Cc1nc2ccccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,IC50,,,,Inhibition of human ERG
11024,CHEMBL4060556,O=C(c1ccccc1)N1CCc2oc(-c3ccc(F)cn3)nc2C1,IC50,nM,=,64000.0,Inhibition of human ERG
11025,CHEMBL4102181,O=C(c1cccc(F)c1)N1CCc2oc(-c3ccc(F)cn3)nc2C1,IC50,nM,=,74000.0,Inhibition of human ERG
11026,CHEMBL4087545,O=C(c1cc(F)cc(Cl)c1)N1CCc2oc(-c3ccc(F)cn3)nc2C1,IC50,nM,=,19000.0,Inhibition of human ERG
11027,CHEMBL4098822,O=C(c1cc(F)cc(Cl)c1)N1CCn2nc(-c3ccc(F)cn3)cc2C1,IC50,nM,=,15000.0,Inhibition of human ERG
11028,CHEMBL4104355,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n([C@H]3CCCNC3)c2n1,IC50,nM,=,2900.0,Inhibition of human ERG by patch clamp assay
11029,CHEMBL4086461,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n([C@@H]3CCCNC3)c2n1,IC50,nM,=,1500.0,Inhibition of human ERG by patch clamp assay
11030,CHEMBL4082422,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n(C3CCCNC3)c2n1,IC50,nM,=,2900.0,Inhibition of human ERG by patch clamp assay
11031,CHEMBL4100435,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CC3)n(C3CCCNC3)c2n1,IC50,nM,=,1000.0,Inhibition of human ERG by patch clamp assay
11032,CHEMBL4071991,Cc1ccc([C@@H]2CN(C(=O)[C@H]3CC[C@H](CN)CC3)C[C@H]2c2ccc(C#N)cc2)cc1,IC50,nM,=,12100.0,Inhibition of human ERG expressed in CHO cells by Ionworks electrophysiology method
11033,CHEMBL3134377,Cc1ccc(-c2ncc(OC[C@@H]3CCNC3)cc2-c2ccc(C#N)cc2)cc1,IC50,nM,=,3200.0,Inhibition of human ERG expressed in CHO cells by Ionworks electrophysiology method
11034,CHEMBL4102051,O=C(CCCCCCNc1ncnc2ccc(Cl)cc12)NO,IC50,nM,>,30000.0,Inhibition of recombinant human ERG expressed in HEK293 cells at -80 mV holding potential measured for 9 mins by Qpatch clamp method
11035,CHEMBL4094315,O=C(CCCCCCNc1ncnc2ccc(F)cc12)NO,IC50,nM,>,30000.0,Inhibition of recombinant human ERG expressed in HEK293 cells at -80 mV holding potential measured for 9 mins by Qpatch clamp method
11036,CHEMBL98,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,nM,>,30000.0,Inhibition of recombinant human ERG expressed in HEK293 cells at -80 mV holding potential measured for 9 mins by Qpatch clamp method
11037,CHEMBL639,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,IC50,nM,=,100.0,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11038,CHEMBL4060529,COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O.Cl.Cl,IC50,nM,=,398.11,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11039,CHEMBL4085417,CCCCc1cc(OC2CCN(CCS(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,1659.59,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11040,CHEMBL4098917,CCCCc1cc(OC2CCN(CCCS(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,75.86,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11041,CHEMBL4080880,CCCCc1cc(OC2CCN(CCCS(=O)(=O)CCC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,28.84,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11042,CHEMBL4102287,CCCCc1cc(OC2CCN(CCCS(=O)(=O)C(C)C)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,91.2,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11043,CHEMBL4084325,CCCCc1cc(OC2CCN(CCCS(=O)(=O)C(C)(C)C)CC2)c2ncccc2c1,IC50,nM,=,467.74,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11044,CHEMBL4095759,CCCCc1cc(OC2CCN(CCCCS(=O)(=O)C(C)(C)C)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,302.0,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11045,CHEMBL4068414,CCCCc1cc(OC2CCN(CCC(C)S(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,199.53,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11046,CHEMBL4068414,CCCCc1cc(OC2CCN(CCC(C)S(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,131.83,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11047,CHEMBL4079248,CCCCc1cc(OC2CCN(CCNS(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,75.86,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11048,CHEMBL4080166,CCCCc1cc(OC2CCN(CCCNS(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,63.1,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11049,CHEMBL4098192,CCCCc1cc(OC2CCN(CCCCNS(C)(=O)=O)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,19.95,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11050,CHEMBL4088036,CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,77.62,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11051,CHEMBL4059750,CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CCC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,87.1,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11052,CHEMBL4060765,CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)C(C)C)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,128.82,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11053,CHEMBL4082646,CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC(C)C)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,43.65,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11054,CHEMBL4088039,CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)C3CCCCC3)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,18.2,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11055,CHEMBL4065123,CCCCc1cc(OC2CCN(CCCCN(C)S(=O)(=O)CC)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,251.19,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11056,CHEMBL4090136,CCCCc1cc(OC2CCN(CCS(=O)(=O)NC(C)(C)C)CC2)c2ncccc2c1,IC50,nM,=,630.96,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11057,CHEMBL4069073,CCCCc1cc(OC2CCN(CCCS(=O)(=O)NC(C)(C)C)CC2)c2ncccc2c1.Cl.Cl,IC50,nM,=,281.84,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11058,CHEMBL4063163,CCCCc1cc(OC2CCN(CCCCS(=O)(=O)NCCC)CC2)c2ncccc2c1,IC50,nM,=,95.5,Displacement of [3H]-Dofetilide from recombinant human ERG expressed in CHOK1 cell membranes incubated for 4 hrs under dark condition by luminescence assay
11059,CHEMBL4062161,CCN1CCc2c(sc(NC(=O)Nc3ccc(Cl)cc3)c2C(N)=O)C1.Cl,IC50,nM,=,3260.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11060,CHEMBL4101684,NC(=O)c1c(NC(=O)Nc2ccc(Cl)cc2)sc2c1CCN(CCCNC(=O)CCc1c[nH]c3ccccc13)C2,IC50,nM,=,20100.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11061,CHEMBL4074997,CC[N+]1(C)CCc2c(sc(NC(=O)Nc3ccc(Cl)cc3)c2C(N)=O)C1.[I-],IC50,nM,=,3380.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11062,CHEMBL4085169,NC(=O)c1c(NC(=O)Nc2ccc(Cl)cc2)sc2c1CC[N+]1(CCCC1)C2.[Br-],IC50,nM,=,3510.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11063,CHEMBL4101606,NC(=O)c1c(NC(=O)Nc2ccc(Cl)cc2)sc2c1CC[N+]1(CCOCC1)C2.[I-],IC50,nM,=,12400.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11064,CHEMBL4074914,CC[N+]1(C)Cc2sc(NC(=O)Nc3ccc(Cl)cc3)c(C(N)=O)c2C1.[I-],IC50,nM,=,3290.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11065,CHEMBL4072149,CC1(C)Cc2c(sc(NC(=O)Nc3ccc(Cl)cc3)c2C(N)=O)C(C)(C)N1.Cl,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11066,CHEMBL4096279,CN1[C@H]2CC[C@@H]1Cc1sc(NC(=O)Nc3ccc(Cl)cc3)c(C(N)=O)c12.Cl,IC50,nM,=,5600.0,Inhibition of human ERG expressed in HEK293 cells assessed as decrease in peak tail current amplitude by path clamp method
11067,CHEMBL4079206,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(/C=C/c4c(Cl)cccc4Cl)oc23)[C@H](O)C1,IC50,nM,>,50000.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11068,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,14.0,Inhibition of [3H]-astemizole binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11069,CHEMBL4085364,[2H]C1([2H])OC(N)=N[C@]12c1cc(-c3cncnc3)ccc1C[C@]21C[C@H](C)[C@@H](OC)[C@H](C)C1,IC50,,,,Inhibition of human ERG
11070,CHEMBL4103296,[2H]C1([2H])OC(N)=N[C@]12c1cc(-c3cncnc3)ccc1C[C@]21CC[C@@H](OC)[C@H](C)C1,IC50,nM,>,33000.0,Inhibition of human ERG
11071,CHEMBL4070299,[2H]C1([2H])OC(N)=N[C@]12c1cc(-c3cncnc3)ccc1C[C@@]21CC[C@H](OC)[C@@H](C)C1,IC50,nM,>,33000.0,Inhibition of human ERG
11072,CHEMBL4072602,CCc1ccn2ccnc2c1N1CCCN(CC2CCN(C(=O)[C@H]3C[C@@H]4CC[C@H]3O4)CC2)CC1,IC50,nM,=,1300.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
11073,CHEMBL4084050,CCc1ccn2ccnc2c1N1CCCN([C@@H](CC(N)=O)C2CCN(C(=O)[C@H]3C[C@@H]4CC[C@H]3O4)CC2)CC1,IC50,nM,=,8300.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
11074,CHEMBL4091946,O=C(O)c1ccc2c(c1)C(=O)OC21CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,IC50,nM,=,560.0,Inhibition of MK499 binding to human ERG
11075,CHEMBL4100640,O=C(O)CC1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,IC50,nM,=,5400.0,Inhibition of MK499 binding to human ERG
11076,CHEMBL4105361,O=C(O)CN1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,IC50,nM,=,4800.0,Inhibition of MK499 binding to human ERG
11077,CHEMBL4067085,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CO1,IC50,,,,Inhibition of MK499 binding to human ERG
11078,CHEMBL4069786,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,IC50,nM,=,14700.0,Inhibition of MK499 binding to human ERG
11079,CHEMBL4075203,O=C(O)CC1CCOC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,IC50,nM,=,4300.0,Inhibition of MK499 binding to human ERG
11080,CHEMBL4060355,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,IC50,nM,=,7800.0,Inhibition of MK499 binding to human ERG
11081,CHEMBL4082282,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,IC50,nM,>,60000.0,Inhibition of MK499 binding to human ERG
11082,CHEMBL4087688,O=C(O)CC1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,IC50,nM,=,19500.0,Inhibition of MK499 binding to human ERG
11083,CHEMBL4066339,O=C(O)C[C@@H]1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,IC50,nM,=,4400.0,Inhibition of MK499 binding to human ERG
11084,CHEMBL4079801,O=C(O)C[C@H]1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,IC50,nM,=,4900.0,Inhibition of MK499 binding to human ERG
11085,CHEMBL4075203,O=C(O)CC1CCOC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,IC50,nM,=,2900.0,Inhibition of MK499 binding to human ERG
11086,CHEMBL4075203,O=C(O)CC1CCOC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,IC50,nM,=,6600.0,Inhibition of MK499 binding to human ERG
11087,CHEMBL4060355,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,IC50,nM,=,800.0,Inhibition of MK499 binding to human ERG
11088,CHEMBL4060355,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,IC50,nM,=,1200.0,Inhibition of MK499 binding to human ERG
11089,CHEMBL4082282,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,IC50,nM,=,16000.0,Inhibition of MK499 binding to human ERG
11090,CHEMBL4082282,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,IC50,nM,=,17400.0,Inhibition of MK499 binding to human ERG
11091,CHEMBL4080076,Cc1c(-c2ccc(N3CCC(F)(F)C3)cc2)[nH]c2cc(F)cc(F)c2c1=O,IC50,nM,>,25000.0,Inhibition of human ERG
11092,CHEMBL4061934,COc1ccc2ncc(F)c(C[C@H](N)[C@@H]3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)CO3)c2n1,IC50,nM,=,5000.0,Inhibition of human ERG assessed as reduction of K+ current
11093,CHEMBL4088118,COc1ccc2ccc(=O)n(C[C@H](O)[C@@H]3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)CO3)c2n1,IC50,nM,=,15000.0,Inhibition of human ERG assessed as reduction of K+ current
11094,CHEMBL4094942,COc1ccc2ccc(=O)n(C[C@H](N)[C@@H]3CC[C@@H](NCc4ccc5c(n4)NC(=O)CO5)CO3)c2n1,IC50,nM,=,52000.0,Inhibition of human ERG assessed as reduction of K+ current
11095,CHEMBL3828074,CCc1nc2c(C)cc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1,IC50,nM,=,15000.0,Inhibition of human ERG by manual patch clamp assay
11096,CHEMBL4063869,CCc1nc2ccc(C3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)cs1,IC50,nM,=,5600.0,Inhibition of human ERG by manual patch clamp assay
11097,CHEMBL3828074,CCc1nc2c(C)cc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1,IC50,nM,=,15000.0,Inhibition of human ERG by automated patch clamp assay
11098,CHEMBL4098810,CCc1nc2ccc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)cs1,IC50,nM,>,33000.0,Inhibition of human ERG by automated patch clamp assay
11099,CHEMBL4084282,CCc1nc2ccc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1,IC50,nM,>,11000.0,Inhibition of human ERG by automated patch clamp assay
11100,CHEMBL4061747,CCc1nc2ccc(C3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1,IC50,nM,=,2900.0,Inhibition of human ERG by automated patch clamp assay
11101,CHEMBL4066553,CC1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,IC50,nM,=,3800.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp method
11102,CHEMBL4069220,O=[N+]([O-])c1cn2c(n1)O[C@@H](COc1ccc(-c3ccc(F)cc3)nc1)CC2,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp method
11103,CHEMBL218974,C[C@]1(COc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,IC50,nM,=,10500.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp method
11104,CHEMBL4094163,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,IC50,nM,=,186.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
11105,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,22.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
11106,CHEMBL4104658,C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,8460.0,Inhibition of human ERG expressed in HEK293 cells by lonWorks Quattro analysis
11107,CHEMBL3353410,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,nM,=,570.0,Inhibition of human ERG expressed in HEK293 cells by lonWorks Quattro analysis
11108,CHEMBL4079239,C[C@@H]1c2nnn(-c3ncc(F)cn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cells
11109,CHEMBL4095741,Cc1ccnc(-n2nnc3c2CCN(C(=O)c2cccc(C(F)(F)F)c2Cl)[C@@H]3C)n1,IC50,nM,>,10000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cells
11110,CHEMBL4068397,C[C@@H]1c2nnn(-c3ncccn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cells
11111,CHEMBL4074304,C[C@@H]1c2nnn(-c3cnccn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cells
11112,CHEMBL4094806,C[C@@H]1c2nnn(-c3cc(F)ccn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,IC50,nM,>,10000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cells
11113,CHEMBL4096145,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,IC50,nM,=,300.0,Inhibition of human ERG by patch clamp method
11114,CHEMBL4080797,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp method
11115,CHEMBL4096145,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,IC50,nM,=,3800.0,Inhibition of human ERG by flux-based assay
11116,CHEMBL4068856,Cc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1,IC50,nM,=,4900.0,Inhibition of human ERG by flux-based assay
11117,CHEMBL4087655,Cc1cccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)c1,IC50,nM,=,7700.0,Inhibition of human ERG by flux-based assay
11118,CHEMBL4071255,COc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1,IC50,nM,=,7500.0,Inhibition of human ERG by flux-based assay
11119,CHEMBL4076794,COc1cccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)c1,IC50,nM,=,7200.0,Inhibition of human ERG by flux-based assay
11120,CHEMBL4078773,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cc1,IC50,nM,=,13800.0,Inhibition of human ERG by flux-based assay
11121,CHEMBL4076191,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4F)cc23)CC[C@]1(C)N,IC50,nM,=,9600.0,Inhibition of human ERG by flux-based assay
11122,CHEMBL4071806,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(F)c4)cc23)CC[C@]1(C)N,IC50,nM,=,7600.0,Inhibition of human ERG by flux-based assay
11123,CHEMBL4077508,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(F)cc4)cc23)CC[C@]1(C)N,IC50,nM,=,10200.0,Inhibition of human ERG by flux-based assay
11124,CHEMBL4076823,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(Cl)c4)cc23)CC[C@]1(C)N,IC50,nM,=,6000.0,Inhibition of human ERG by flux-based assay
11125,CHEMBL4091582,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)cc4)cc23)CC[C@]1(C)N,IC50,nM,=,12000.0,Inhibition of human ERG by flux-based assay
11126,CHEMBL3671804,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccnc4)cc23)CC[C@]1(C)N,IC50,nM,>,80000.0,Inhibition of human ERG by flux-based assay
11127,CHEMBL4063870,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccncc4)cc23)CC[C@]1(C)N,IC50,nM,>,80000.0,Inhibition of human ERG by flux-based assay
11128,CHEMBL4089164,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cncnc4)cc23)CC[C@]1(C)N,IC50,nM,=,8500.0,Inhibition of human ERG by flux-based assay
11129,CHEMBL4060984,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cc[nH]n4)cc23)CC[C@]1(C)N,IC50,nM,>,80000.0,Inhibition of human ERG by flux-based assay
11130,CHEMBL4084341,Cc1cnccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1,IC50,nM,>,80000.0,Inhibition of human ERG by flux-based assay
11131,CHEMBL4073562,Cc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1,IC50,nM,=,30000.0,Inhibition of human ERG by flux-based assay
11132,CHEMBL4079880,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccncc4F)cc23)CC[C@]1(C)N,IC50,nM,>,80000.0,Inhibition of human ERG by flux-based assay
11133,CHEMBL4104127,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccnc(F)c4)cc23)CC[C@]1(C)N,IC50,nM,=,41000.0,Inhibition of human ERG by flux-based assay
11134,CHEMBL4069127,COc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1,IC50,,,,Inhibition of human ERG by flux-based assay
11135,CHEMBL3671805,Cc1ccncc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1,IC50,nM,=,18000.0,Inhibition of human ERG by flux-based assay
11136,CHEMBL4060444,Cc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,IC50,nM,=,8000.0,Inhibition of human ERG by flux-based assay
11137,CHEMBL4088673,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cncc(F)c4)cc23)CC[C@]1(C)N,IC50,nM,=,5000.0,Inhibition of human ERG by flux-based assay
11138,CHEMBL4098840,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(F)nc4)cc23)CC[C@]1(C)N,IC50,nM,=,35000.0,Inhibition of human ERG by flux-based assay
11139,CHEMBL4080797,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,IC50,nM,>,80000.0,Inhibition of human ERG by flux-based assay
11140,CHEMBL4091096,CCOc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,IC50,nM,=,17000.0,Inhibition of human ERG by flux-based assay
11141,CHEMBL4070136,CC(C)Oc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,IC50,nM,=,5300.0,Inhibition of human ERG by flux-based assay
11142,CHEMBL4096795,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)nc4)cc23)CC[C@]1(C)N,IC50,nM,=,4100.0,Inhibition of human ERG by flux-based assay
11143,CHEMBL4077394,Cc1c(CNS(=O)(=O)c2ccccc2)nn(-c2ccccc2)c1CC(C)C,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by whole cell patch clamp method
11144,CHEMBL4075532,CC(C)c1cc(CN2Cc3ccccc3S2(=O)=O)nn1-c1ccccc1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by whole cell patch clamp method
11145,CHEMBL4102649,CC(C)c1cc(CN2Cc3ccccc3S2(=O)=O)nn1-c1ccc(F)cc1,IC50,nM,=,14700.0,Inhibition of human ERG expressed in CHOK1 cells by whole cell patch clamp method
11146,CHEMBL4080064,CC(C)c1cc(CN2Cc3ccccc3S2(=O)=O)nn1C(C)(C)C,IC50,nM,=,19300.0,Inhibition of human ERG expressed in CHOK1 cells by whole cell patch clamp method
11147,CHEMBL4060757,Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12,IC50,nM,=,4600.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11148,CHEMBL4077588,Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12,IC50,nM,=,100.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11149,CHEMBL4062498,COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1,IC50,nM,=,24000.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11150,CHEMBL4076024,COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1,IC50,nM,=,4500.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11151,CHEMBL4075954,CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1,IC50,nM,=,15000.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11152,CHEMBL4069387,CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1,IC50,nM,=,2800.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11153,CHEMBL4065907,CC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1,IC50,nM,=,19000.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11154,CHEMBL4079820,CC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1,IC50,nM,=,2400.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11155,CHEMBL4059723,CC1(C(=O)N2CCO[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)CCC1,IC50,nM,=,14000.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11156,CHEMBL4081661,CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)CCC1,IC50,,,,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11157,CHEMBL4087095,COCCC(=O)N1CCN[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1,IC50,,,,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11158,CHEMBL4104951,COCCC(=O)N1CCS(=O)(=O)C(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1,IC50,,,,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11159,CHEMBL4079225,COCCC(=O)N1CCSC(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1,IC50,nM,=,1800.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11160,CHEMBL4097247,COCCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1,IC50,nM,=,5800.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11161,CHEMBL4075605,CC1(C(=O)N2CCO[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1,IC50,nM,=,14400.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11162,CHEMBL4099975,CC1(C(=O)N2CCCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1,IC50,,,,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11163,CHEMBL4096526,CC1(C(=O)N[C@@H]2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1,IC50,,,,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11164,CHEMBL4078497,CC1(C(=O)N2CCC(c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC2)COC1,IC50,,,,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11165,CHEMBL4104254,CC1(C(=O)N2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1,IC50,nM,=,2500.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11166,CHEMBL4086348,CC1(C(=O)N2CC(c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1,IC50,nM,=,400.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11167,CHEMBL4066585,Nc1nccn2c(CN3CCOCC3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12,IC50,,,,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11168,CHEMBL4094125,CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1,IC50,nM,=,3500.0,Inhibition of human ERG by [35S]-MK499 displacement or iKr channel assay
11169,CHEMBL3911908,CC(C)Cc1cc(CNS(=O)(=O)c2cccc3cccnc23)nn1-c1ccccc1,IC50,nM,=,4670.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp method
11170,CHEMBL4081529,CC(C)Cc1cc(CNS(=O)(=O)c2cccc3cccnc23)nn1-c1ccc(F)cc1,IC50,nM,=,1600.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp method
11171,CHEMBL4127190,C[C@]12CCCC[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,=,7700.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11172,CHEMBL4125756,C[C@]12CC[C@@H](O)C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11173,CHEMBL4129913,C[C@]12CC[C@H](O)C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11174,CHEMBL4126989,CO[C@@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11175,CHEMBL4127992,CO[C@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11176,CHEMBL4126938,CC1(O)CC[C@@]2(C)[C@H](C[C@@H](N3CCC[C@@H](N)C3)[C@@H]2Oc2ccc(C#N)cc2)C1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11177,CHEMBL4128079,C[C@]12CCC(F)(F)C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,=,13000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11178,CHEMBL4129456,C[C@]12CCC(F)=C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,=,8600.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11179,CHEMBL4128782,CO/N=C1\CC[C@@]2(C)[C@@H](C1)C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,=,25000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11180,CHEMBL4126435,CN(C)C(=O)/C=C1\CC[C@@]2(C)[C@@H](C1)C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11181,CHEMBL4129002,C[C@]12CC[C@H](C(F)F)C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,=,15000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11182,CHEMBL4127600,C[C@]12CCC(=O)C[C@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11183,CHEMBL4130214,N#Cc1ccc(O[C@@H]2[C@@H]3CC(=O)[C@@H]3C[C@H]2N2CCC[C@@H](N)C2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11184,CHEMBL4126041,N#Cc1ccc(O[C@@H]2[C@@H]3CCC(=O)[C@@H]3C[C@H]2N2CCC[C@@H](N)C2)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11185,CHEMBL4126528,C[C@@]12CCC(=O)C[C@@H]1C[C@@H](N1CCC[C@@H](N)C1)[C@@H]2Oc1ccc(C#N)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11186,CHEMBL4129805,N#Cc1ccc(O[C@@H]2[C@H]3[C@@H]4C[C@@H](CC4=O)[C@H]3C[C@H]2N2CCC[C@@H](N)C2)cc1,IC50,nM,=,17000.0,Inhibition of human ERG expressed in CHOK1 cells at holding potential of -80 mV after 5 mins by patch clamp assay
11187,CHEMBL3186509,O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1,IC50,nM,=,2700.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells after 45 mins by scintillation counting method
11188,CHEMBL3931791,CN(CCC1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)C(=O)c1c[nH]c(=O)o1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells after 45 mins by scintillation counting method
11189,CHEMBL3931791,CN(CCC1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)C(=O)c1c[nH]c(=O)o1,IC50,nM,=,7300.0,Inhibition of human ERG expressed in CHO-K1 cells at -90 mV holding potential by Qpatch clamp assay
11190,CHEMBL3974814,CN(CCC1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)C(=O)c1c[nH]nn1,IC50,nM,=,8600.0,Inhibition of human ERG expressed in CHO-K1 cells at -90 mV holding potential by Qpatch clamp assay
11191,CHEMBL3906229,O=C(CCc1c[nH]nn1)NC1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,8800.0,Inhibition of human ERG expressed in CHO-K1 cells at -90 mV holding potential by Qpatch clamp assay
11192,CHEMBL3827512,O=C(CCCc1c[nH]nn1)NC1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,20900.0,Inhibition of human ERG expressed in CHO-K1 cells at -90 mV holding potential by Qpatch clamp assay
11193,CHEMBL3890736,O=C(CCCCc1c[nH]nn1)NC1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1,IC50,nM,=,9300.0,Inhibition of human ERG expressed in CHO-K1 cells at -90 mV holding potential by Qpatch clamp assay
11194,CHEMBL4126773,COc1cc(-c2ccc3c(n2)[C@@H](C)N(c2cnn(CC(F)(F)F)c2)C3=O)cnc1OC,IC50,nM,>,30000.0,Inhibition of human ERG
11195,CHEMBL4129600,CNS(=O)(=O)c1cc(-c2sc(NC(C)=O)nc2C)cc2c1C(=O)N([C@@H](C)C1CC1)C2,IC50,nM,>,31622.78,Inhibition of human ERG
11196,CHEMBL4126156,CC(=O)Nc1nc(C)c(-c2cc3c(c(S(C)(=O)=O)c2)C(=O)N([C@@H](C)C2CC2)C3)s1,IC50,nM,=,31622.78,Inhibition of human ERG
11197,CHEMBL4127396,CC(=O)Nc1nc(C)c(-c2cc3c(c(NS(C)(=O)=O)c2)C(=O)N([C@@H](C)C2CC2)C3)s1,IC50,nM,=,19952.62,Inhibition of human ERG
11198,CHEMBL4109308,O=C(c1ccc(-n2nnc3cccnc32)cc1)N(c1ncccc1Cl)[C@@H]1CCCNC1,IC50,nM,=,8500.0,Inhibition of human ERG by patch clamp method
11199,CHEMBL4107559,Cc1cnc2c(c1)nnn2-c1ccc(C(=O)N(c2ncccc2Cl)[C@@H]2CCCNC2)nc1,IC50,nM,=,3600.0,Inhibition of human ERG by patch clamp method
11200,CHEMBL4127311,CN(C)c1cncc(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2)n1,IC50,nM,=,43200.0,Inhibition of human ERG by patch clamp method
11201,CHEMBL4127458,Cc1cncc(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2)n1,IC50,nM,=,59800.0,Inhibition of human ERG by patch clamp method
11202,CHEMBL4127879,NS(=O)(=O)c1cccc(-c2ccc3nccc(-c4ccncc4F)c3n2)c1,IC50,nM,>,10000.0,Inhibition of full length human ERG expressed in HEK293 cells assessed as reduction in tail current at holding potential of -70 mV after 6 to 7 mins by IonWork patch clamp method
11203,CHEMBL4128198,O=S(=O)(NCCO)c1cccc(Nc2ccc3nccc(-c4ccncc4)c3n2)c1,IC50,nM,>,10000.0,Inhibition of full length human ERG expressed in HEK293 cells assessed as reduction in tail current at holding potential of -70 mV after 6 to 7 mins by IonWork patch clamp method
11204,CHEMBL4127800,O=S(=O)(NCc1ccccc1)c1cccc(Nc2ccc3nccc(-c4ccncc4)c3n2)c1,IC50,nM,=,1200.0,Inhibition of full length human ERG expressed in HEK293 cells assessed as reduction in tail current at holding potential of -70 mV after 6 to 7 mins by IonWork patch clamp method
11205,CHEMBL4129258,NS(=O)(=O)c1cccc(-c2ccc3nccc(-c4ccnc(C(F)(F)F)c4)c3n2)c1,IC50,nM,>,10000.0,Inhibition of full length human ERG expressed in HEK293 cells assessed as reduction in tail current at holding potential of -70 mV after 6 to 7 mins by IonWork patch clamp method
11206,CHEMBL4171419,O=C1S/C(=C\c2ccc3c(cnn3Cc3ccc(Cl)cc3C(F)(F)F)c2)C(=O)N1[C@@H]1CCNC[C@H]1F,IC50,nM,=,21000.0,Displacement of [3H]astemizole from human ERG
11207,CHEMBL4177457,CS(=O)(=O)c1nn(Cc2nc3cc(Cl)ccc3n2CC2COC2)c2cnccc12,IC50,nM,>,20000.0,Inhibition of human ERG
11208,CHEMBL4165366,O=C(O)CCc1cc(F)c(OCc2c(-c3ccc(Cl)cc3F)nsc2C(F)(F)F)c(F)c1,IC50,nM,>,50000.0,Inhibition of human ERG
11209,CHEMBL12089,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],IC50,nM,=,3100.0,Inhibition of human ERG by patch clamp assay
11210,CHEMBL4169575,CCc1cc2c(s1)CCN1Cc3ccccc3CC21,IC50,nM,=,10500.0,Inhibition of human ERG by patch clamp assay
11211,CHEMBL4161395,c1ccc(Cc2cc3c(s2)CCN2Cc4ccccc4CC32)cc1,IC50,nM,=,21300.0,Inhibition of human ERG by patch clamp assay
11212,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,1600.0,Inhibition of human ERG
11213,CHEMBL4162672,COc1nc2ccccc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,1600.0,Inhibition of human ERG
11214,CHEMBL4159307,COc1nc2ccc(Cl)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,6900.0,Inhibition of human ERG
11215,CHEMBL4169545,COc1nc2ccc(C)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,4300.0,Inhibition of human ERG
11216,CHEMBL4162513,CC#Cc1ccc2nc(OC)c(C(c3ccccc3)C(O)(CCN(C)C)c3cccc4ccccc34)cc2c1,IC50,nM,=,7900.0,Inhibition of human ERG
11217,CHEMBL4169823,COc1nc2ccc(/C=N/O)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,3500.0,Inhibition of human ERG
11218,CHEMBL4176516,CO/N=C/c1ccc2nc(OC)c([C@@H](c3ccccc3)[C@](O)(CCN(C)C)c3cccc4ccccc34)cc2c1,IC50,nM,=,2200.0,Inhibition of human ERG
11219,CHEMBL4166400,COc1nc2ccc(CN(C)C)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,4800.0,Inhibition of human ERG
11220,CHEMBL4177019,COc1nc2ccc(CN)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,1700.0,Inhibition of human ERG
11221,CHEMBL4167910,COc1nc2ccc(CO)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,10000.0,Inhibition of human ERG
11222,CHEMBL4159990,COc1nc2ccc(CC(C)=O)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,10000.0,Inhibition of human ERG
11223,CHEMBL4159957,COc1nc2ccc(C(=O)N(C)C)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,6300.0,Inhibition of human ERG
11224,CHEMBL4170272,COc1nc2ccc(C(=O)O)cc2cc1C(c1ccccc1)C(O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,10000.0,Inhibition of human ERG
11225,CHEMBL4170680,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@@H]2CN2CCN(C)CC2)cc1)c1ccccc1,IC50,nM,=,1.4,Inhibition of human ERG
11226,CHEMBL4171244,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@H]2CN2CCN(C)CC2)cc1)c1ccccc1,IC50,nM,=,0.95,Inhibition of human ERG
11227,CHEMBL502835,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,IC50,nM,=,2.6,Inhibition of human ERG
11228,CHEMBL4168811,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCOCC1)CC2)c1ccccc1,IC50,nM,>,30.0,Inhibition of human ERG
11229,CHEMBL4161551,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cccn1)CC2)c1ccccc1,IC50,nM,>,30.0,Inhibition of human ERG
11230,CHEMBL4172155,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cncn1)CC2)c1ccccc1,IC50,nM,>,30.0,Inhibition of human ERG
11231,CHEMBL4165455,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCCC1=O)CC2)c1ccccc1,IC50,nM,>,30.0,Inhibition of human ERG
11232,CHEMBL4173370,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CC(C)OC(C)C1)CC2)c1ccccc1,IC50,nM,>,30.0,Inhibition of human ERG
11233,CHEMBL3634342,C[C@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)CO[C@@H]1F,IC50,nM,=,8000.0,Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assay
11234,CHEMBL4175845,C[C@]1(c2cc(NC(=O)c3ncc(C#N)cc3F)ccc2F)N=C(N)CO[C@@H]1F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assay
11235,CHEMBL4161795,C[C@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)N=C(N)CO[C@@H]1F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assay
11236,CHEMBL3634125,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)CO[C@@H]3F)c2)cn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assay
11237,CHEMBL4165629,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)CO[C@H]3C(F)(F)F)c2)cn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assay
11238,CHEMBL4170106,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)COC3=C(F)F)c2)cn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assay
11239,CHEMBL4162197,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)CO[C@H]3C(F)F)c2)cn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cell membranes by radioligand binding assay
11240,CHEMBL4175534,COCCNCCC(=O)N[C@H]1c2ccccc2C[C@@H]1NC(=O)c1cc2ccccc2n1C,IC50,nM,=,1584.89,Inhibition of human ERG expressed in CHO cells
11241,CHEMBL4167669,CN(C)CCC(=O)N[C@H]1c2ccccc2C[C@@H]1NC(=O)c1cc2cc(F)c(F)cc2[nH]1,IC50,nM,=,3981.07,Inhibition of human ERG expressed in CHO cells
11242,CHEMBL4160434,O=C(N[C@H]1Cc2ccccc2[C@@H]1NC(=O)[C@H]1CCNC1)c1cc2cc(F)ccc2[nH]1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells
11243,CHEMBL4171040,Cc1ccc2[nH]c(C(=O)N[C@H]3Cc4ccccc4[C@@H]3NC(=O)CCN(C)C)cc2c1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHO cells
11244,CHEMBL4163811,Cc1ccc2[nH]c(C(=O)N[C@@H]3Cc4ccccc4[C@H]3NC(=O)CCN(C)C)cc2c1,IC50,nM,=,2511.89,Inhibition of human ERG expressed in CHO cells
11245,CHEMBL4174476,Cc1ccc2[nH]c(C(=O)N[C@H]3Cc4ccccc4[C@H]3NC(=O)CCN(C)C)cc2c1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHO cells
11246,CHEMBL4167267,Cc1ccc2[nH]c(C(=O)N[C@@H]3Cc4ccccc4[C@@H]3NC(=O)CCN(C)C)cc2c1,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO cells
11247,CHEMBL4164328,CN(C)CCNC(=O)[C@H]1c2ccccc2C[C@@H]1NC(=O)c1cc2ccccc2[nH]1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in CHO cells
11248,CHEMBL4172217,CN(C)CCNC(=O)[C@@H]1c2ccccc2C[C@H]1NC(=O)c1cc2ccccc2[nH]1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in CHO cells
11249,CHEMBL4162255,CCC[C@@H](CCO)Nc1nc(N)nc2ccccc12,IC50,nM,=,6800.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11250,CHEMBL4170169,CCCC[C@@H](CCO)Nc1nc(N)nc2ccccc12,IC50,nM,=,2700.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11251,CHEMBL4175502,CCC[C@@H](CCO)Nc1nc(N)nc2cccc(C)c12,IC50,nM,=,5500.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11252,CHEMBL4162750,CCCC[C@@H](CCO)Nc1nc(N)nc2cccc(C)c12,IC50,nM,=,600.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11253,CHEMBL4173454,CCC[C@@H](CCO)Nc1nc(N)nc2cccc(F)c12,IC50,nM,=,8900.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11254,CHEMBL4166194,CCCC[C@@H](CCO)Nc1nc(N)nc2cccc(F)c12,IC50,nM,>,10000.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11255,CHEMBL4176810,CCC[C@@H](CCO)Nc1nc(N)nc2ccc(C)cc12,IC50,nM,=,7200.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11256,CHEMBL4174506,CCCC[C@@H](CCO)Nc1nc(N)nc2ccc(C)cc12,IC50,nM,=,5400.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11257,CHEMBL4166593,CCC[C@@H](CCO)Nc1nc(N)nc2ccc(F)cc12,IC50,nM,=,9300.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11258,CHEMBL4159383,CCCC[C@@H](CCO)Nc1nc(N)nc2ccc(F)cc12,IC50,nM,=,5800.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11259,CHEMBL4170014,CCC[C@@H](CCO)Nc1nc(N)nc2ccc(OC)cc12,IC50,,,,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11260,CHEMBL4176397,CCCC[C@@H](CCO)Nc1nc(N)nc2ccc(OC)cc12,IC50,nM,=,6000.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11261,CHEMBL4168533,CCC[C@@H](CCO)Nc1nc(N)nc2cc(C)ccc12,IC50,nM,=,8100.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11262,CHEMBL4160103,CCCC[C@@H](CCO)Nc1nc(N)nc2cc(C)ccc12,IC50,nM,=,1800.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11263,CHEMBL4168028,CCC[C@@H](CCO)Nc1nc(N)nc2cc(F)ccc12,IC50,nM,=,9100.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11264,CHEMBL4163469,CCCC[C@@H](CCO)Nc1nc(N)nc2cc(F)ccc12,IC50,nM,=,4900.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11265,CHEMBL4171368,CCC[C@@H](CCO)Nc1nc(N)nc2cc(OC)ccc12,IC50,nM,>,10000.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11266,CHEMBL4166919,CCCC[C@@H](CCO)Nc1nc(N)nc2cc(OC)ccc12,IC50,nM,=,3200.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11267,CHEMBL4174813,CCC[C@@H](CCO)Nc1nc(N)nc2c(F)cccc12,IC50,nM,>,10000.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11268,CHEMBL4170320,CCCC[C@@H](CCO)Nc1nc(N)nc2c(F)cccc12,IC50,nM,=,4470.0,Inhibition of radioligand binding to human ERG expressed in HEK293 cell membranes by scintillation counting method
11269,CHEMBL3186509,O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1,IC50,nM,=,480.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11270,CHEMBL4169912,O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(Cl)cc(Cl)c3)C[C@H]12)c1ccc2[nH]c(=O)oc2c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11271,CHEMBL4162641,O=C(NC[C@H]1[C@@H]2CN(C(=O)/C=C/c3cc(Cl)cc(Cl)c3)C[C@H]12)c1ccc2[nH]c(=O)oc2c1,IC50,nM,=,4200.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11272,CHEMBL4173341,O=C(NC[C@H]1[C@@H]2CN(C(=O)CCc3cc(Cl)cc(Cl)c3)C[C@H]12)c1ccc2[nH]c(=O)oc2c1,IC50,nM,=,8100.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11273,CHEMBL4170966,O=C(NC[C@H]1[C@@H]2CN(C(=O)C3CC3c3cc(Cl)cc(Cl)c3)C[C@H]12)c1ccc2[nH]c(=O)oc2c1,IC50,nM,=,4700.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11274,CHEMBL4163050,O=C(NC[C@H]1[C@@H]2CN(C(=O)NCc3cc(Cl)cc(Cl)c3)C[C@H]12)c1ccc2[nH]c(=O)oc2c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11275,CHEMBL4164658,CC(OC(=O)N1C[C@H]2[C@H](CNC(=O)c3ccc4[nH]c(=O)oc4c3)[C@H]2C1)c1cc(Cl)cc(Cl)c1,IC50,nM,=,8500.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11276,CHEMBL4174042,O=C(NC[C@H]1[C@@H]2CN(C(=O)N3CCc4c(Cl)cc(Cl)cc4C3)C[C@H]12)c1ccc2[nH]c(=O)oc2c1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11277,CHEMBL4169550,O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]c(=O)oc2c1,IC50,nM,=,5200.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11278,CHEMBL4168498,N#Cc1cc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]c(=O)oc5c4)[C@H]3C2)cc(OC(F)(F)F)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11279,CHEMBL4159308,CC(C)(C)OC(=O)N1CCCC(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]c(=O)oc5c4)[C@H]3C2)C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11280,CHEMBL4171105,Cc1ccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]c(=O)oc5c4)[C@H]3C2)nc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11281,CHEMBL4162674,Cc1cc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]c(=O)oc5c4)[C@H]3C2)no1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11282,CHEMBL4173049,N#Cc1cc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)cc(C(=O)OC(F)(F)F)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11283,CHEMBL4172309,N#Cc1cc(COC(=O)N2C[C@H]3[C@H](CNC(=O)N4CCc5[nH]nnc5C4)[C@H]3C2)cc(C(=O)OC(F)(F)F)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11284,CHEMBL4169136,N#Cc1cc(COC(=O)N2C[C@H]3[C@H](CNC(=O)NCCCc4cnn[nH]4)[C@H]3C2)cc(C(=O)OC(F)(F)F)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11285,CHEMBL4164935,N#Cc1cc(COC(=O)N2C[C@H]3[C@H](CNC(=O)N4CCc5c(O)noc5C4)[C@H]3C2)cc(C(=O)OC(F)(F)F)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11286,CHEMBL4165749,O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
11287,CHEMBL4163616,O[C@H]1CNCCC[C@@H]1n1c2ccc(C(F)(F)F)cc2c2cc(C(F)(F)F)ccc21,IC50,nM,=,1180.0,Inhibition of human ERG
11288,CHEMBL4175981,CC(C)(C)[C@@H](CO)NC(=O)c1nn(-c2c[n+]([O-])ccn2)c2c1C[C@@H]1C[C@H]21,IC50,nM,>,30000.0,Inhibition of [3H]-astemizole binding to human ERG
11289,CHEMBL4175981,CC(C)(C)[C@@H](CO)NC(=O)c1nn(-c2c[n+]([O-])ccn2)c2c1C[C@@H]1C[C@H]21,IC50,nM,>,30000.0,Inhibition of human ERG by patch-clamp method
11290,CHEMBL4166742,Cl.O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12,IC50,nM,>,100000.0,Inhibition of human ERG expressed in HEK293 cells at holding potential of -80 mV by whole cell patch clamp method
11291,CHEMBL4173715,O=C(O)C[C@]1(CC(F)(F)F)CCc2cc(-c3cnc(NC(=O)Nc4ccc(F)c(F)c4)cn3)ccc2C1=O,IC50,nM,>,10000.0,Inhibition of human ERG by QPatch assay
11292,CHEMBL4159471,Cc1cc(NC(=O)c2cccc(S(=O)(=O)N[C@H]3CCOC3)c2)ccc1F,IC50,nM,>,10000.0,Inhibition of human ERG
11293,CHEMBL4162120,CN(C/C=C/C=C/c1ccc(C(F)(F)F)cc1F)Cc1ccc2c(c1)OCO2.Cl,IC50,nM,=,14.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by whole cell Qpatch assay
11294,CHEMBL4161555,CN(C/C=C/c1ccc(F)cc1C(F)(F)F)Cc1ccc2c(c1)OCO2.Cl,IC50,nM,=,4.22,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by whole cell Qpatch assay
11295,CHEMBL2041193,Cc1cc(C(=O)O)ccc1-c1ccc(N2C(=O)N(c3ccncn3)C3(CCN(Cc4ncccc4C)CC3)C2=O)cc1,IC50,nM,=,22000.0,Inhibition of human ERG
11296,CHEMBL4161899,Cc1ccc(CN2CC[C@@H](N3CC[C@@H](c4ccc(O)cc4)[C@@H](F)C3)C2=O)cc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11297,CHEMBL4115649,Cc1ccc(CN2CC[C@@H](N3CC[C@H](c4ccc(O)cc4)[C@@H](F)C3)C2=O)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11298,CHEMBL4170867,Cc1ccc(CN2CC[C@@H](N3CC[C@H](c4ccc(O)cc4)[C@H](F)C3)C2=O)cc1,IC50,nM,=,7800.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11299,CHEMBL4168402,Cc1ccc(CN2CC[C@@H](N3CCC(c4ccc(O)cc4)C(F)(F)C3)C2=O)cc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11300,CHEMBL3911371,O=C1[C@H](N2CC[C@@H](c3ccc(O)cc3)[C@H](F)C2)CCN1Cc1ccc(F)cc1,IC50,nM,>,5000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11301,CHEMBL4111330,O=C1[C@H](N2CCC(c3ccc(O)cc3)CC2)CCN1Cc1ccc(F)cc1,IC50,nM,=,620.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11302,CHEMBL4115628,Cc1ccc(CN2CC[C@@H](N3CCC(c4ccc(O)cc4)CC3)C2=O)cc1,IC50,nM,=,400.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11303,CHEMBL3892956,Cc1ccc(CN2CC[C@@H](N3CC[C@@H](c4ccc(O)cc4)[C@H](F)C3)C2=O)cc1,IC50,nM,=,28000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in peak tail current after 2 to 5 mins by patch clamp based electrophysiology assay
11304,CHEMBL4166144,COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cell membranes by patch clamp method
11305,CHEMBL4176771,COc1ncc(-c2cc(O[C@@H]3CCOC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cell membranes by patch clamp method
11306,CHEMBL4166594,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(OC3CCOCC3)c2n1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cell membranes by patch clamp method
11307,CHEMBL4174909,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(O[C@@H]3CCOC3)c2n1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cell membranes by patch clamp method
11308,CHEMBL4169829,Cn1cnc(S(=O)(=O)NCCOc2ccc3c(c2)[C@@H](Cc2ccccc2)[C@@H](N2CCC2)CC3)c1,IC50,nM,=,15000.0,Inhibition of human ERG
11309,CHEMBL4173253,O=S(=O)(CC1CC1)NCCOc1ccc2c(c1)[C@@H](Cc1ccccc1)[C@@H](N1CCC1)CC2,IC50,nM,=,80.0,Inhibition of human ERG
11310,CHEMBL4164744,Cn1cnc(S(=O)(=O)NCCOc2ccc3c(c2)[C@@H](Cc2ccccc2)[C@@H](N2CCC2)CO3)c1,IC50,,,,Inhibition of human ERG
11311,CHEMBL4168181,O=S(=O)(CC1CC1)NCCOc1ccc2c(c1)[C@@H](Cc1ccccc1)[C@@H](N1CCC1)CO2,IC50,,,,Inhibition of human ERG
11312,CHEMBL4160909,CCCS(=O)(=O)NCc1ccc2c(c1)[C@@H](Cc1ccccc1)[C@@H](N1CCC1)CC2,IC50,,,,Inhibition of human ERG
11313,CHEMBL4171521,O=S(=O)(CC1CC1)NC1CN(c2ccc3c(c2)[C@@H](Cc2ccccc2)[C@@H](N2CCC2)CC3)C1,IC50,nM,=,4400.0,Inhibition of human ERG
11314,CHEMBL4164312,O=S(=O)(CC1CC1)NC1CN(c2ccc3c(c2)[C@@H](Cc2ccccc2)[C@@H](N2CCC2)CO3)C1,IC50,nM,=,11400.0,Inhibition of human ERG
11315,CHEMBL4174959,CCCS(=O)(=O)NC1CN(c2ccc3c(c2)[C@@H](Cc2ccccc2)[C@@H](N2CCC2)CC3)C1,IC50,nM,=,6800.0,Inhibition of human ERG
11316,CHEMBL4167754,CCCS(=O)(=O)NC1CN(c2ccc3c(c2)[C@@H](Cc2ccccc2)[C@@H](N2CCC2)CO3)C1,IC50,,,,Inhibition of human ERG
11317,CHEMBL4159833,CCCS(=O)(=O)N[C@@H]1CCN(c2ccc3c(c2)[C@@H](Cc2ccccc2)[C@@H](N2CCC2)CC3)C1=O,IC50,nM,=,4500.0,Inhibition of human ERG
11318,CHEMBL4171264,COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3CC[C@H](OC)CC3)c(=O)n2C)cn1,IC50,nM,=,27000.0,Inhibition of human ERG by electrophysiology assay
11319,CHEMBL3898577,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1,IC50,nM,=,22000.0,Inhibition of human ERG by electrophysiology assay
11320,CHEMBL4174323,NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NC1CCOCC1,IC50,nM,=,2100.0,Inhibition of human ERG by electrophysiology assay
11321,CHEMBL3950905,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11322,CHEMBL4173181,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCN(C)C)nc5)cc4c32)C1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11323,CHEMBL4172761,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(CS(C)(=O)=O)nc5)cc4c32)C1,IC50,nM,=,14000.0,Inhibition of human ERG by electrophysiology assay
11324,CHEMBL4164853,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(CO)nc5)cc4c32)C1,IC50,nM,=,23000.0,Inhibition of human ERG by electrophysiology assay
11325,CHEMBL4161022,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(NC(=O)CCCN(C)C)nc5)cc4c32)C1,IC50,nM,=,18000.0,Inhibition of human ERG by electrophysiology assay
11326,CHEMBL4171626,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(C(=O)NCCN(C)C)nc5)cc4c32)C1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11327,CHEMBL4164430,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(N(C)CCN(C)C)nc5)cc4c32)C1,IC50,nM,=,5700.0,Inhibition of human ERG by electrophysiology assay
11328,CHEMBL4175071,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(NCCN(C)C)nc5)cc4c32)C1,IC50,nM,=,24000.0,Inhibition of human ERG by electrophysiology assay
11329,CHEMBL4170883,COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@@H](C)C3CCOCC3)c(=O)n2C)cn1,IC50,nM,=,15000.0,Inhibition of human ERG by electrophysiology assay
11330,CHEMBL3986918,CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n(C3CCOCC3)c(=O)n2C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11331,CHEMBL4162952,COCc1ccc(-c2cc3c(cc2F)ncc2c3n(C3CCOCC3)c(=O)n2C)cn1,IC50,nM,=,27000.0,Inhibition of human ERG by electrophysiology assay
11332,CHEMBL4176135,COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3C[C@@H](O)C3)c(=O)n2C)cn1,IC50,nM,=,15000.0,Inhibition of human ERG by electrophysiology assay
11333,CHEMBL4168290,COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3C[C@H](OC)C3)c(=O)n2C)cn1,IC50,nM,=,8900.0,Inhibition of human ERG by electrophysiology assay
11334,CHEMBL4160664,COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3C[C@@H](OC)C3)c(=O)n2C)cn1,IC50,nM,=,9000.0,Inhibition of human ERG by electrophysiology assay
11335,CHEMBL4169828,Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4cccnc4)ccc3ncc21,IC50,nM,=,11000.0,Inhibition of human ERG by electrophysiology assay
11336,CHEMBL3924247,CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2COC2)c(=O)n4C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11337,CHEMBL3936734,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11338,CHEMBL3958682,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11339,CHEMBL3954517,CNCCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2C[C@@H](OC)C2)c(=O)n4C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11340,CHEMBL3979811,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCC6)nc5)cc4c32)C1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11341,CHEMBL3936943,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCC6)nc5)cc4c32)C1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11342,CHEMBL3960323,CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCCC6)nc5)cc4c32)C1,IC50,nM,=,14000.0,Inhibition of human ERG by electrophysiology assay
11343,CHEMBL3972724,Cn1c(=O)n([C@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)c(F)cc3ncc21,IC50,nM,=,18000.0,Inhibition of human ERG by electrophysiology assay
11344,CHEMBL3890490,CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2CCCOC2)c(=O)n4C)cn1,IC50,nM,=,27000.0,Inhibition of human ERG by electrophysiology assay
11345,CHEMBL4111966,CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@@H]2CCCOC2)c(=O)n4C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11346,CHEMBL3889770,CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2C[C@@H](O)C2)c(=O)n4C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11347,CHEMBL4167508,COCc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11348,CHEMBL3946515,Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)c(F)cc3ncc21,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11349,CHEMBL3960662,CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1,IC50,nM,>,33000.0,Inhibition of human ERG by electrophysiology assay
11350,CHEMBL3091687,NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21,IC50,nM,=,8920.0,Displacement of [3H]astemizole from human ERG expressed in HEK cell membranes
11351,CHEMBL4172669,CN(C[C@H]1Cc2c(cccc2N2CCNCC2)CN1)[C@H]1CCCc2cccnc21,IC50,nM,=,20300.0,Displacement of [3H]astemizole from human ERG expressed in HEK cell membranes
11352,CHEMBL4162011,CN(C[C@@H]1Cc2c(cccc2N2CCNCC2)CN1)[C@H]1CCCc2cccnc21,IC50,,,,Displacement of [3H]astemizole from human ERG expressed in HEK cell membranes
11353,CHEMBL4064619,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 600 secs at -80 mV holding potential by automated patch clamp assay
11354,CHEMBL4173974,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1,IC50,nM,=,69000.0,Inhibition of human ERG expressed in CHOK1 cells incubated for 600 secs at -80 mV holding potential by automated patch clamp assay
11355,CHEMBL4169479,O[C@H]1Cc2ccccc2C2(CCC(N3CCN(C4CCCCC4)CC3)CC2)O1,IC50,nM,=,3207.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
11356,CHEMBL4159233,CCOC(=O)C[C@H]1Cc2ccccc2C2(CCC(N3CCN(C4CCCCC4)CC3)CC2)O1,IC50,nM,=,1753.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
11357,CHEMBL4170683,FCC[C@@H]1Cc2ccccc2C2(CCC(N3CCN(C4CCCCC4)CC3)CC2)O1,IC50,nM,=,2620.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
11358,CHEMBL3989970,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F,IC50,nM,>,100000.0,Inhibition of human ERG
11359,CHEMBL3675743,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(-c2nnc(C3CCNCC3)o2)cc1,IC50,nM,=,19000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11360,CHEMBL4204864,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(-c2nnc(N3CCNCC3)o2)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11361,CHEMBL4210921,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(/C=C/CN2CCNC(=O)C2)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11362,CHEMBL4207309,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(/C=C/CN2CCNCC2=O)cc1,IC50,nM,=,25000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11363,CHEMBL4212656,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(CCC(=O)N2CCNCC2)cc1,IC50,nM,=,23000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11364,CHEMBL4217603,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(/C=C/CN2CCN(C[C@@H](O)CO)CC2)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11365,CHEMBL4208267,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(CCC(O)C2CCNCC2)cc1,IC50,nM,=,5300.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11366,CHEMBL4213196,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(CCCC2(O)CCNCC2)cc1,IC50,nM,=,24000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11367,CHEMBL4211343,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(CCCC2(O)CCN(C(C)C)CC2)cc1,IC50,nM,=,5700.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11368,CHEMBL3639746,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(CCCN2CCN(C(C)C)CC2)cc1,IC50,nM,=,4500.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11369,CHEMBL4209248,CCc1nn2c(C)cc(C)nc2c1Cc1ccc(/C=C/CN2CCN(C(C)C)CC2)cc1,IC50,nM,=,2100.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11370,CHEMBL4205308,CCc1nc2c(C)cc(C)nn2c1Cc1ccc(/C=C/CN2CCN(C(C)C)CC2)cc1,IC50,nM,=,2300.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11371,CHEMBL3675746,CCc1nc2c(C)cc(C)nc2n1Cc1ccc(/C=C/CN2CCN(C(C)C)CC2)cc1,IC50,nM,=,1000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method
11372,CHEMBL4212439,CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
11373,CHEMBL4217392,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
11374,CHEMBL4208064,CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
11375,CHEMBL4212973,CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
11376,CHEMBL4205584,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by Tracer Red dye based fluorescence polarization assay
11377,CHEMBL4217988,N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1,IC50,nM,>,25151.8,Inhibition of human ERG by PatchXpress electrophysiology method
11378,CHEMBL4076061,N[C@@H]1CCC=C(c2ccc(F)cc2)[C@H]1COc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl,IC50,nM,=,10300.0,Inhibition of human ERG by Qpatch clamp assay
11379,CHEMBL4203948,CCN[C@@H]1CCC=C(c2ccc(F)cc2)[C@H]1COc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl.Cl,IC50,nM,=,4400.0,Inhibition of human ERG by Qpatch clamp assay
11380,CHEMBL4210866,Cl.N[C@@H]1CCC=C(c2ccc(F)cc2)[C@H]1CNc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl,IC50,nM,=,4600.0,Inhibition of human ERG by Qpatch clamp assay
11381,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,304.7,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11382,CHEMBL4208355,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3F)CC2)cc1,IC50,nM,=,178.0,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11383,CHEMBL4213322,COc1ccc(CCN2CCC(Nc3nc4ccccc4[nH]3)CC2)cc1,IC50,nM,=,163.9,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11384,CHEMBL4217209,CCCCCCn1c(NC2CCN(CCc3ccc(OC)cc3)CC2)nc2ccccc21,IC50,nM,=,29.96,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11385,CHEMBL4205490,CCCCCCCCn1c(NC2CCN(CCc3ccc(OC)cc3)CC2)nc2ccccc21,IC50,nM,=,3270.0,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11386,CHEMBL4204991,CCCCCCCCCCn1c(NC2CCN(CCc3ccc(OC)cc3)CC2)nc2ccccc21,IC50,nM,=,2069.0,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11387,CHEMBL4217155,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3CCC(C)C)CC2)cc1,IC50,nM,=,211.7,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11388,CHEMBL4207128,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3CC3CCCCC3)CC2)cc1,IC50,nM,=,3.27,Inhibition of human ERG expressed in Xenopus laevis oocytes by two-electrode voltage clamp assay
11389,CHEMBL4202587,CC(C)OCc1ccccc1CNC(=O)c1c2c(c(Cl)n1C)CC(C)(C)CC2,IC50,nM,=,16500.0,Inhibition of human ERG
11390,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,370.0,Inhibition of human ERG
11391,CHEMBL4206467,COc1nc2ccc(Br)cc2cc1[C@@H](c1cc(C)c(C)s1)[C@@](O)(CCN(C)C)c1cccc(F)c1,IC50,nM,=,880.0,Inhibition of human ERG
11392,CHEMBL4204414,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccc(N(C)C)nc1)[C@@](O)(CCN(C)C)c1cccc(F)c1,IC50,nM,=,890.0,Inhibition of human ERG
11393,CHEMBL4212501,CCSc1ccc([C@H](c2cc3cc(Br)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cccc(F)c2)cn1,IC50,nM,=,460.0,Inhibition of human ERG
11394,CHEMBL4218132,COc1cc([C@H](c2cc3cc(Br)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cccc(F)c2)cnc1OC,IC50,nM,=,1900.0,Inhibition of human ERG
11395,CHEMBL4213428,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1cccc(C)c1,IC50,nM,=,530.0,Inhibition of human ERG
11396,CHEMBL4217292,N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1,IC50,nM,=,5500.0,Inhibition of human ERG by patch clamp method
11397,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,580.0,Inhibition of human ERG
11398,CHEMBL4210894,N[C@H]1CCN(c2cc3c(cc2F)n2ccnc2c(=O)n3C2CC2)C1,IC50,nM,>,30000.0,Inhibition of human ERG transfected in CHO cells by patch clamp method
11399,CHEMBL4218256,N[C@H]1CCN(c2cc3c(cc2F)n2ncnc2c(=O)n3C2CC2)C1,IC50,nM,>,30000.0,Inhibition of human ERG transfected in CHO cells by patch clamp method
11400,CHEMBL4203118,O=c1c2nccn2c2cc(F)c(-c3ccncc3)cc2n1C1CC1,IC50,nM,>,30000.0,Inhibition of human ERG transfected in CHO cells by patch clamp method
11401,CHEMBL4210352,Cc1cc(C2C[C@H]3[C@@H](C)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1,IC50,nM,=,2100.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11402,CHEMBL4204559,Cc1cc(C2C[C@H]3[C@@H](CF)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1,IC50,nM,=,2100.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11403,CHEMBL3414707,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccc(F)cc2F)CO1,IC50,nM,=,15800.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11404,CHEMBL4209994,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccccc2C(F)(F)F)CO1,IC50,nM,=,55400.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11405,CHEMBL4207711,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccccc2)CO1,IC50,nM,=,85700.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11406,CHEMBL4209354,COc1ccccc1[C@]12CO[C@@H](C)C[C@H]1CSC(N)=N2,IC50,nM,=,85600.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11407,CHEMBL4214603,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ncccc2F)CO1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11408,CHEMBL4203347,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccsc2)CO1,IC50,nM,=,39900.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11409,CHEMBL4204215,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2cccs2)CO1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11410,CHEMBL4214785,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nccs2)CO1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11411,CHEMBL4217023,COc1ccc(C(=O)Nc2csc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)n2)cc1,IC50,nM,=,18400.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11412,CHEMBL3922902,COc1ccc(C(=O)Nc2csc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)n2)nc1,IC50,nM,=,13100.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11413,CHEMBL3979124,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(F)cn3)cs2)CO1,IC50,nM,=,10700.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11414,CHEMBL3983988,Cc1cc(F)cnc1C(=O)Nc1csc([C@]23CO[C@@H](C)C[C@H]2CSC(N)=N3)n1,IC50,nM,=,17900.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11415,CHEMBL3917530,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(C(F)(F)F)cn3)cs2)CO1,IC50,nM,=,11700.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11416,CHEMBL3967984,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(Cl)cn3)cs2)CO1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11417,CHEMBL3947194,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)(F)F)cn3)cs2)CO1,IC50,nM,=,10100.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11418,CHEMBL4211913,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(C#N)cn3)cs2)CO1,IC50,nM,=,12100.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11419,CHEMBL3952064,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)cs2)CO1,IC50,nM,=,9900.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11420,CHEMBL3972449,Cc1cc(OC(F)F)cnc1C(=O)Nc1csc([C@]23CO[C@@H](C)C[C@H]2CSC(N)=N3)n1,IC50,nM,=,9600.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11421,CHEMBL3941301,COc1cnc(C(=O)Nc2csc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)n2)cn1,IC50,nM,=,43000.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11422,CHEMBL4204163,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3cnc(OC(F)F)cn3)cs2)CO1,IC50,nM,=,23600.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11423,CHEMBL4215837,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccn(C(F)F)n3)cs2)CO1,IC50,nM,=,9300.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11424,CHEMBL4203860,COc1cccc(NC(=O)c2cnc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)s2)c1,IC50,nM,=,6200.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11425,CHEMBL4212046,COc1cccc(NC(=O)c2cnc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)s2)n1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHOK1 cells for 5 mins at -80 mV holding potential by patch clamp method
11426,CHEMBL4205708,CCN(CC)CCNC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1,IC50,nM,=,1170.0,Inhibition of human ERG
11427,CHEMBL4217261,CCN(CC)[C@@H](C)CNC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1,IC50,nM,=,718.0,Inhibition of human ERG
11428,CHEMBL4209443,CCc1cc(C(=O)NC[C@H](C)N(CC)CC)cc(-c2cnn3ccc(-c4cccs4)nc23)n1,IC50,nM,=,3280.0,Inhibition of human ERG
11429,CHEMBL4215300,CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CC(OC)C2)c1,IC50,nM,=,4160.0,Inhibition of human ERG
11430,CHEMBL4210359,CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CC(O)C2)c1,IC50,nM,>,30000.0,Inhibition of human ERG
11431,CHEMBL1627,CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,IC50,nM,=,245.0,Inhibition of human ERG expressed in HEK293 cells at holding potential of -80 mV by whole cell patch clamp assay
11432,CHEMBL841,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,IC50,nM,=,33.0,Inhibition of human ERG expressed in HEK293 cells at holding potential of -80 mV by whole cell patch clamp assay
11433,CHEMBL4215407,Cc1cc(COc2ccc(S(=O)(=O)N(C)C3(C(=O)NO)CN(C(=O)C(C)C)C3)cc2)c2ccccc2n1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO-K1 cells assessed as reduction in tail current amplitude by patch clamp assay
11434,CHEMBL4208519,Cc1cc(COc2ccc(S(=O)(=O)N(C)C3(C(=O)NO)CN(C(=O)CC(C)C)C3)cc2)c2ccccc2n1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO-K1 cells assessed as reduction in tail current amplitude by patch clamp assay
11435,CHEMBL4212482,COc1ccccc1CCN1CCC(CCc2ccccc2OCCF)CC1.Cl,IC50,nM,=,430.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11436,CHEMBL4208760,Cl.FCCOc1ccccc1CCC1CCN(CCc2ccccc2)CC1,IC50,nM,=,760.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11437,CHEMBL4213543,COc1ccc(CCN2CCC(CCc3cccc(OCCF)c3)CC2)cc1.Cl,IC50,nM,=,280.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11438,CHEMBL4218476,COc1ccccc1CCN1CCC(CCc2cccc(OCCF)c2)CC1.Cl,IC50,nM,=,800.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11439,CHEMBL4209141,Cl.FCCOc1cccc(CCC2CCN(CCc3ccccc3)CC2)c1,IC50,nM,=,750.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11440,CHEMBL4203660,COc1ccc(CCN2CCC(CCc3ccccc3OCCF)CC2)cc1.Cl,IC50,nM,=,350.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11441,CHEMBL4210865,Cl.FCCOc1ccccc1CCC1CCN(CCc2ccccc2Cl)CC1,IC50,nM,=,690.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11442,CHEMBL4204715,Cl.FCCOc1ccccc1CCC1CCN(CCc2ccc(F)cc2)CC1,IC50,nM,=,380.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11443,CHEMBL4212262,Cl.FCCOc1ccc(CCC2CCN(CCc3ccccc3Cl)CC2)cc1,IC50,nM,=,2200.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11444,CHEMBL4209058,Cl.FCCOc1ccc(CCN2CCC(CCc3ccccc3)CC2)cc1,IC50,nM,=,350.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11445,CHEMBL4213979,Cl.FCCOc1cccc(CCN2CCC(CCc3ccccc3)CC2)c1,IC50,nM,=,410.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11446,CHEMBL4212474,Cl.Cl.FCCOc1ccccc1CCN1CCN(CCc2ccccc2)CC1,IC50,nM,=,5490.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11447,CHEMBL4217431,Cl.Cl.FCCOc1cccc(CCN2CCN(CCc3ccccc3)CC2)c1,IC50,nM,=,4310.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11448,CHEMBL4206313,Cl.Cl.FCCOc1ccc(CCN2CCN(CCc3ccccc3)CC2)cc1,IC50,nM,=,3050.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11449,CHEMBL4202598,Cl.Cl.FCCOc1ccccc1CCN1CCN(CCc2ccccc2Cl)CC1,IC50,nM,=,850.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11450,CHEMBL4210347,Cl.Cl.FCCOc1ccccc1CCN1CCN(CCc2ccc(F)cc2)CC1,IC50,nM,=,1120.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11451,CHEMBL4206622,Cl.Cl.FCCOc1ccc(CCN2CCN(CCc3ccccc3Cl)CC2)cc1,IC50,nM,=,1400.0,Displacement of [3H]Dofetilide from human ERG expressed in HEK293 cells after 60 mins by scintillation spectrometry
11452,CHEMBL3301610,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,IC50,nM,=,10900.0,Inhibition of human ERG
11453,CHEMBL4208172,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc6n(c5c4)C(C)(C)CC6)n3)nc2)CC1,IC50,nM,=,6380.0,Inhibition of human ERG
11454,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,3290.0,Inhibition of human ERG
11455,CHEMBL4215911,COCCCN1CCC(c2nnc(-c3cccc4cc(C(C)C)nn34)o2)CC1,IC50,nM,=,2300.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
11456,CHEMBL4205936,CC(C)c1cc2cccc(-c3nnc(C4CCN(CC5CCOCC5)CC4)o3)n2n1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp method
11457,CHEMBL4211068,CCN(CC)CC.NC(=O)c1ccc(-c2cc(C(=O)O)cc(-n3cc(-c4ccc(C(F)(F)F)cc4)nn3)c2)cc1,IC50,nM,=,166.0,Inhibition of human ERG
11458,CHEMBL4206892,CS(=O)(=O)N1CCN(C(=O)c2cnc3ccc(F)cc3c2N2CCC(C#N)(c3ccccc3)CC2)CC1,IC50,nM,=,5460.0,Inhibition of human ERG
11459,CHEMBL4206272,CS(=O)(=O)N1CCN(C(=O)c2cnc3ccc(F)cc3c2-c2ccc(C3(C#N)CC3)cc2)CC1,IC50,nM,=,10940.0,Inhibition of human ERG
11460,CHEMBL4208555,O=C(NC[C@@H](Cc1ccccc1)N1CCC(O)(C(F)(F)F)CC1)C1(c2ccc(Cl)cc2)CCCC1,IC50,nM,>,3000.0,Inhibition of human ERG
11461,CHEMBL4210362,O=S1(=O)N(CCCCCOc2ccc(-c3ccc(Cl)cc3)cc2)CCN1c1ccncc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay
11462,CHEMBL4218176,O=C1CN(c2ccncc2)CCN1CCCCCOc1ccc(-c2ccc(Cl)cc2)cc1,IC50,nM,=,370.0,Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay
11463,CHEMBL4215737,CCO/N=C/c1ccc(OCCCCCN2CCN(c3ccnc(N)c3)S2(=O)=O)cc1,IC50,nM,=,9000.0,Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay
11464,CHEMBL4216835,O=C1N(CCCCC2CCc3cc(-c4ccc(Cl)cc4)ccc3O2)CCN1c1ccncc1,IC50,nM,=,1750.0,Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay
11465,CHEMBL4204909,CCO/N=C1\CCc2cc(OCCCCCN3CCN(c4ccnc(N)c4)S3(=O)=O)ccc21,IC50,nM,=,6000.0,Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay
11466,CHEMBL4210399,CCO/N=C/c1ccc(OCCC(C)CCN2CCN(c3ccnc(N)c3)C2=O)cc1,IC50,nM,=,800.0,Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay
11467,CHEMBL4210100,COc1cc2c(cc1OC)Nc1ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c1NC2,IC50,nM,>,40000.0,Inhibition of human ERG at holding potential of -80 mV by cell based automated Qpatch method
11468,CHEMBL4215501,COc1cc2nccc(Oc3ccc(NC(=O)C(C)(C)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,IC50,nM,>,40000.0,Inhibition of human ERG at holding potential of -80 mV by cell based automated Qpatch method
11469,CHEMBL4208552,CC1=C[C@@](CF)(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)O1,IC50,nM,=,3900.0,Inhibition of human ERG expressed in HEK293 cells by manual patch clamp assay
11470,CHEMBL4213486,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)C=C(CF)OC(N)=N1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in HEK293 cells by manual patch clamp assay
11471,CHEMBL4206403,CCS(=O)(=O)c1ccc(O[C@@H](C)C(F)(F)F)c(C(=O)N2Cc3cn(-c4ccnc(C)c4)nc3C2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11472,CHEMBL4211293,CC(C)S(=O)(=O)c1ccc(O[C@@H](C)C(F)(F)F)c(C(=O)N2Cc3cn(-c4ccccc4)nc3C2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11473,CHEMBL4210589,C[C@H](Oc1ccc(C#N)cc1C(=O)N1Cc2cn(-c3ccccc3F)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11474,CHEMBL4205726,C[C@H](Oc1ccc(C#N)cc1C(=O)N1Cc2cn(-c3cncc(F)c3)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11475,CHEMBL4215015,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2O[C@@H](C)C(F)(F)F)C3)ccn1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11476,CHEMBL4210095,C[C@H](Oc1ccc(C#N)cc1C(=O)N1Cc2cn(C3CCCC3)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11477,CHEMBL4202824,CC(C)Oc1ccc(C#N)cc1C(=O)N1Cc2cn(-c3ccccc3)nc2C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11478,CHEMBL4214486,CC(C)Oc1ccc(C#N)cc1C(=O)N1Cc2cn(-c3cncc(F)c3)nc2C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11479,CHEMBL4207171,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2OC(C)C)C3)ccn1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11480,CHEMBL4218903,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2OCC2CC2)C3)ccn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11481,CHEMBL4211535,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2N2CCC(F)(F)CC2)C3)ccn1,IC50,nM,=,6900.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11482,CHEMBL4206650,N#Cc1ccc(-c2cccc(F)c2)c(C(=O)N2Cc3cn(-c4cncc(F)c4)nc3C2)c1,IC50,nM,=,8800.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11483,CHEMBL4212425,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2-c2cccc(F)c2)C3)ccn1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11484,CHEMBL4214756,CCS(=O)(=O)c1ccc(O[C@@H](C)C(F)(F)F)c(C(=O)N2Cc3cn(-c4cncc(F)c4)nc3C2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11485,CHEMBL4209849,CCS(=O)(=O)c1ccc(O[C@@H](C)C(F)(F)F)c(C(=O)N2Cc3cn(-c4ccccc4F)nc3C2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11486,CHEMBL4202565,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(S(C)(=O)=O)ccc2-c2cccc(F)c2)C3)ccn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11487,CHEMBL4214250,CS(=O)(=O)c1ccc(-c2cccc(F)c2)c(C(=O)N2Cc3cn(-c4cncc(F)c4)nc3C2)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11488,CHEMBL4205995,CS(=O)(=O)c1ccc(-c2cccc(F)c2)c(C(=O)N2Cc3cn(-c4ccccc4F)nc3C2)c1,IC50,nM,=,4500.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11489,CHEMBL4217712,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(S(C)(=O)=O)ccc2N2CCC(F)(F)CC2)C3)ccn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11490,CHEMBL4210353,CS(=O)(=O)c1ccc(N2CCC(F)(F)CC2)c(C(=O)N2Cc3cn(-c4cncc(F)c4)nc3C2)c1,IC50,nM,=,6700.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11491,CHEMBL4205471,CS(=O)(=O)c1ccc(N2CCC(F)(F)CC2)c(C(=O)N2Cc3cn(-c4ccccc4F)nc3C2)c1,IC50,nM,=,4300.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11492,CHEMBL4211426,CS(=O)(=O)c1ccc(OCC2CC2)c(C(=O)N2Cc3cn(-c4ccccc4F)nc3C2)c1,IC50,nM,=,9900.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11493,CHEMBL4216391,CC(C)(C)Oc1ccc(S(C)(=O)=O)cc1C(=O)N1Cc2cn(-c3ccccc3F)nc2C1,IC50,nM,=,8100.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11494,CHEMBL4213968,CC(C)Oc1ccc(S(C)(=O)=O)cc1C(=O)N1Cc2cn(-c3ccccc3F)nc2C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11495,CHEMBL4218894,C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1Cc2cn(C3CCCC3)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11496,CHEMBL4218366,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(S(C)(=O)=O)ccc2O[C@@H](C)C(F)(F)F)C3)ccn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11497,CHEMBL4206639,C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1Cc2cn(-c3cncc(F)c3)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11498,CHEMBL4206122,Cc1cccc(-n2cc3c(n2)CN(C(=O)c2cc(S(C)(=O)=O)ccc2O[C@@H](C)C(F)(F)F)C3)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11499,CHEMBL4211012,C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1Cc2cn(-c3ccccc3F)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11500,CHEMBL4210484,C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1Cc2cn(-c3ccccc3)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at 10 nM to 10 uM at holding potential of -80 mV measured after 5 mins by QPatch automated patch clamp electrophysiology method
11501,CHEMBL4170114,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11502,CHEMBL4217332,COc1cc2c(NC3CCN(C)C(=O)C3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11503,CHEMBL4212905,CCc1ccc(-c2cc(NCC3CCN(C)CC3)c3cc(OC)c(OCCCN4CCCC4)cc3n2)o1,IC50,,,,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11504,CHEMBL4206035,COc1cc2c(NC3CC4(CCN(C)CC4)C3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11505,CHEMBL4208812,COc1cc2c(NC3CCC34CCN(C)CC4)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,,,,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11506,CHEMBL4205373,COc1cc2c(NC3CC4CCC(C3)N4C)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,,,,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11507,CHEMBL4215377,Cc1ccc(-c2cc(NC3CCN(C)CC3)c3cc(Cl)c(OCCCN4CCCC4)cc3n2)o1,IC50,,,,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11508,CHEMBL4215326,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OC1CC2(C1)CN(C)C2,IC50,,,,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11509,CHEMBL4170114,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11510,CHEMBL4217332,COc1cc2c(NC3CCN(C)C(=O)C3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11511,CHEMBL4212905,CCc1ccc(-c2cc(NCC3CCN(C)CC3)c3cc(OC)c(OCCCN4CCCC4)cc3n2)o1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11512,CHEMBL4206035,COc1cc2c(NC3CC4(CCN(C)CC4)C3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11513,CHEMBL4208812,COc1cc2c(NC3CCC34CCN(C)CC4)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11514,CHEMBL4205373,COc1cc2c(NC3CC4CCC(C3)N4C)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11515,CHEMBL4215377,Cc1ccc(-c2cc(NC3CCN(C)CC3)c3cc(Cl)c(OCCCN4CCCC4)cc3n2)o1,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11516,CHEMBL4215326,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OC1CC2(C1)CN(C)C2,IC50,nM,>,100000.0,Inhibition of Tracer Red binding to human ERG in membranes after 2 hrs by fluorescence polarization assay
11517,CHEMBL4218103,Cn1cc(-c2ccc(OC3CCN(C(=O)Nc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)cn1,IC50,nM,=,3800.0,Inhibition of human ERG by fluorescence polarization assay
11518,CHEMBL4204174,Cn1cc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)cn1,IC50,nM,=,4500.0,Inhibition of human ERG by fluorescence polarization assay
11519,CHEMBL4215846,Cn1cnc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)c1,IC50,nM,=,18000.0,Inhibition of human ERG by fluorescence polarization assay
11520,CHEMBL4208510,Cn1cc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)n2)cn1,IC50,nM,=,5300.0,Inhibition of human ERG by fluorescence polarization assay
11521,CHEMBL4211921,Cn1cc(-c2ccc(O[C@@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C3)c(C(N)=O)n2)cn1,IC50,nM,=,6800.0,Inhibition of human ERG by fluorescence polarization assay
11522,CHEMBL4207042,CNC(=O)c1cnc(N)c(O[C@H]2CN(C(=O)Cc3ccc(OC(F)(F)F)cc3)CC2(F)F)c1,IC50,nM,=,79000.0,Inhibition of human ERG by fluorescence polarization assay
11523,CHEMBL4216371,CCNC(=O)c1cnc(N)c(O[C@H]2CN(C(=O)Cc3ccc(OC(F)(F)F)cc3)CC2(F)F)c1,IC50,nM,=,43000.0,Inhibition of human ERG by fluorescence polarization assay
11524,CHEMBL4211826,C[C@H](C(=O)N1CCC(Oc2ccc(-c3cn(C)cn3)cc2C(N)=O)CC1)c1ccc(OC(F)(F)F)cc1,IC50,nM,=,6500.0,Inhibition of human ERG by fluorescence polarization assay
11525,CHEMBL4212366,C[C@@H](C(=O)N1CCC(Oc2ccc(-c3cn(C)cn3)cc2C(N)=O)CC1)c1ccc(OC(F)(F)F)cc1,IC50,nM,=,4200.0,Inhibition of human ERG by fluorescence polarization assay
11526,CHEMBL4207464,Cn1cnc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)c(F)c4)CC3)c(C(N)=O)c2)c1,IC50,,,,Inhibition of human ERG by fluorescence polarization assay
11527,CHEMBL4208942,Cn1cnc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC5CC5)c(F)c4)CC3)c(C(N)=O)c2)c1,IC50,nM,>,40000.0,Inhibition of human ERG by fluorescence polarization assay
11528,CHEMBL4204070,Cn1cnc(-c2cnc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)c1,IC50,nM,=,4500.0,Inhibition of human ERG by fluorescence polarization assay
11529,CHEMBL4204606,Cn1cnc(-c2cnc(O[C@@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1,IC50,nM,=,7000.0,Inhibition of human ERG by fluorescence polarization assay
11530,CHEMBL4216273,Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@@H]3F)c(C(N)=O)c2)c1,IC50,nM,=,24000.0,Inhibition of human ERG by fluorescence polarization assay
11531,CHEMBL4215848,Cn1cnc(-c2cnc(O[C@@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@@H]3F)c(C(N)=O)c2)c1,IC50,nM,=,9000.0,Inhibition of human ERG by fluorescence polarization assay
11532,CHEMBL4210892,Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1,IC50,nM,=,14000.0,Inhibition of human ERG by fluorescence polarization assay
11533,CHEMBL4212493,Cn1cnc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3(F)F)c(C(N)=O)c2)c1,IC50,,,,Inhibition of human ERG by fluorescence polarization assay
11534,CHEMBL4217454,CC(C)(O)COc1ccc(C(N)=O)c(O[C@@H]2CCN(C(=O)Cc3ccc(OC(F)(F)F)cc3)C[C@H]2F)c1,IC50,nM,=,29000.0,Inhibition of human ERG by fluorescence polarization assay
11535,CHEMBL4216925,CC(C)(O)COc1ccc(C(N)=O)c(O[C@H]2CCN(C(=O)Cc3ccc(OC(F)(F)F)cc3)C[C@@H]2F)c1,IC50,nM,=,38000.0,Inhibition of human ERG by fluorescence polarization assay
11536,CHEMBL4206532,CC(C)(O)COc1ccc(C(N)=O)c(O[C@@H]2CCN(C(=O)Cc3ccc(OC(F)(F)F)cc3)C[C@@H]2F)c1,IC50,nM,=,38000.0,Inhibition of human ERG by fluorescence polarization assay
11537,CHEMBL4203759,CC(C)(O)COc1ccc(C(N)=O)c(O[C@H]2CCN(C(=O)Cc3ccc(OC(F)(F)F)cc3)C[C@H]2F)c1,IC50,nM,=,42000.0,Inhibition of human ERG by fluorescence polarization assay
11538,CHEMBL4208638,CC(C)(CO)Oc1ccc(C(N)=O)c(O[C@@H]2CCN(C(=O)Cc3ccc(OC(F)(F)F)cc3)C[C@@H]2F)c1,IC50,nM,=,35000.0,Inhibition of human ERG by fluorescence polarization assay
11539,CHEMBL4208124,Cn1cnc(-c2cnc(N)c(O[C@H]3CN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@@H]3F)c2)c1,IC50,nM,=,16000.0,Inhibition of human ERG by fluorescence polarization assay
11540,CHEMBL4213038,Cn1cnc(-c2cnc(N)c(O[C@@H]3CN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c2)c1,IC50,nM,=,15000.0,Inhibition of human ERG by fluorescence polarization assay
11541,CHEMBL4211534,Cn1cnc(-c2cnc(N)c(O[C@@H]3CN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3(F)F)c2)c1,IC50,nM,=,21000.0,Inhibition of human ERG by fluorescence polarization assay
11542,CHEMBL4216500,Cn1cnc(-c2cnc(N)c(O[C@H]3CN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3(F)F)c2)c1,IC50,nM,=,11000.0,Inhibition of human ERG by fluorescence polarization assay
11543,CHEMBL4204174,Cn1cc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)cn1,IC50,,,,Inhibition of human ERG by patch express assay
11544,CHEMBL4215846,Cn1cnc(-c2ccc(OC3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3)c(C(N)=O)c2)c1,IC50,nM,=,9500.0,Inhibition of human ERG by patch express assay
11545,CHEMBL4207042,CNC(=O)c1cnc(N)c(O[C@H]2CN(C(=O)Cc3ccc(OC(F)(F)F)cc3)CC2(F)F)c1,IC50,nM,=,88000.0,Inhibition of human ERG by patch express assay
11546,CHEMBL4216371,CCNC(=O)c1cnc(N)c(O[C@H]2CN(C(=O)Cc3ccc(OC(F)(F)F)cc3)CC2(F)F)c1,IC50,,,,Inhibition of human ERG by patch express assay
11547,CHEMBL4216500,Cn1cnc(-c2cnc(N)c(O[C@H]3CN(C(=O)Cc4ccc(OC(F)(F)F)cc4)CC3(F)F)c2)c1,IC50,nM,=,7700.0,Inhibition of human ERG by patch express assay
11548,CHEMBL4204633,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)CC2C)cc1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11549,CHEMBL4211181,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4c3cnn4C)[C@@H](C)C2)c(C)c1,IC50,nM,>,30000.0,Inhibition of human ERG by cell based automated patch clamp method
11550,CHEMBL4206816,Cc1ccc(NC(=O)N2CCN(c3nc(N)nc4sc(-c5cccnc5)nc34)CC2)cc1,IC50,nM,=,2000.0,Inhibition of human ERG by cell based automated patch clamp method
11551,CHEMBL4217096,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)CC2)cc1,IC50,nM,=,28000.0,Inhibition of human ERG by cell based automated patch clamp method
11552,CHEMBL4209793,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4c3ncn4C)[C@@H](C)C2)c(C)c1,IC50,nM,>,30000.0,Inhibition of human ERG by cell based automated patch clamp method
11553,CHEMBL1652677,Nc1nc(N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)c2nc(-c3cccnc3)sc2n1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11554,CHEMBL4205416,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4sc(-c5cccnc5)nc34)CC2)cc1,IC50,nM,=,2200.0,Inhibition of human ERG by cell based automated patch clamp method
11555,CHEMBL4210308,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4sc(-c5ccccc5)nc34)CC2)cc1,IC50,nM,=,1700.0,Inhibition of human ERG by cell based automated patch clamp method
11556,CHEMBL4203041,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)[C@@H](C)C2)cc1,IC50,nM,=,17000.0,Inhibition of human ERG by cell based automated patch clamp method
11557,CHEMBL4207928,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)[C@@H](C)C2)c(C)n1,IC50,nM,>,30000.0,Inhibition of human ERG by cell based automated patch clamp method
11558,CHEMBL4215244,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4sccc34)[C@@H](C)C2)c(C)c1,IC50,nM,=,8000.0,Inhibition of human ERG by cell based automated patch clamp method
11559,CHEMBL4203566,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4sncc34)[C@@H](C)C2)c(C)c1,IC50,nM,=,8000.0,Inhibition of human ERG by cell based automated patch clamp method
11560,CHEMBL4204100,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)C(C)C2)cc1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11561,CHEMBL4208976,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)C(C)C2C)cc1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11562,CHEMBL4208440,COc1ccc(NC(=O)N2C[C@H](C)N(c3nc(N)nc4scnc34)[C@H](C)C2)cc1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11563,CHEMBL4213363,COc1ccc(NC(=O)N2C[C@H](C)N(c3nc(N)nc4scnc34)C[C@H]2C)cc1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11564,CHEMBL4212822,COc1ccc(NC(=O)N2CC3CCC(C2)N3c2nc(N)nc3scnc23)cc1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11565,CHEMBL4217771,COc1ccc(NC(=O)N2C3CCC2CN(c2nc(N)nc4scnc24)C3)cc1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11566,CHEMBL4215340,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)[C@@H](C)C2)c(C)c1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11567,CHEMBL4203671,COc1ccc(NC(=O)N2CCN(c3nc(N)nc4scnc34)[C@H](C)C2)c(C)c1,IC50,,,,Inhibition of human ERG by cell based automated patch clamp method
11568,CHEMBL55,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,IC50,nM,=,18700.0,Inhibition of human ERG incubated for 2 hrs by fluorescence polarisation assay
11569,CHEMBL110,O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1,IC50,nM,>,100000.0,Inhibition of human ERG incubated for 2 hrs by fluorescence polarisation assay
11570,CHEMBL125,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,IC50,nM,>,100000.0,Inhibition of human ERG incubated for 2 hrs by fluorescence polarisation assay
11571,CHEMBL267345,C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2,IC50,nM,>,100000.0,Inhibition of human ERG incubated for 2 hrs by fluorescence polarisation assay
11572,CHEMBL4203179,CCN1CCC(N2CCc3nc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)ccc3C2)CC1,IC50,nM,>,50000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by automated Q-patch method
11573,CHEMBL4203703,CN1CCN(c2cc(CN(C)[C@H]3CCCc4cccnc43)ncn2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells after 4 mins at -80 mV holding potential by Qpatch assay
11574,CHEMBL4215835,CC(CC(=O)O)c1cccc(-n2c(C(N)=O)cc3ccc(OC(F)(F)F)cc32)n1,IC50,nM,>,33000.0,Inhibition of human ERG expressed in CHO cells by ionworks patch clamp assay
11575,CHEMBL4205624,O=c1c2cc(Cc3cccnc3)c3ccccc3c2ncn1[C@H]1CCCC[C@@H]1O,IC50,nM,=,12000.0,Inhibition of human ERG
11576,CHEMBL4078588,Cc1ccc(Cc2cc3c(=O)n([C@H]4CCCC[C@@H]4O)cnc3c3ccccc23)cn1,IC50,nM,=,60000.0,Inhibition of human ERG
11577,CHEMBL4206036,O=c1c2cc(Cc3ccc(Cl)nc3)c3ccccc3c2ncn1[C@H]1CCCC[C@@H]1O,IC50,nM,=,13000.0,Inhibition of human ERG
11578,CHEMBL4213206,COc1ccc(Cc2cc3c(=O)n([C@H]4CCCC[C@@H]4O)cnc3c3ccccc23)cn1,IC50,nM,=,6400.0,Inhibition of human ERG
11579,CHEMBL4218135,CSc1ccc(Cc2cc3c(=O)n([C@H]4CCCC[C@@H]4O)cnc3c3ccccc23)cn1,IC50,nM,=,7500.0,Inhibition of human ERG
11580,CHEMBL4211915,C[C@H]1COCCN1c1nc(-c2cnc(N)cc2F)cc(C2(S(C)(=O)=O)CC2)n1,IC50,nM,>,30000.0,Inhibition of recombinant human ERG expressed in CHO cells by automated whole cell patch clamp Qpatch method
11581,CHEMBL4217549,C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc12)C1CCOCC1,IC50,nM,=,24000.0,Inhibition of recombinant human ERG expressed in CHOK1 cells at -70 mV holding potential by patch clamp electrophysiology method
11582,CHEMBL4218854,CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1,IC50,nM,=,15000.0,Inhibition of recombinant human ERG expressed in CHOK1 cells at -70 mV holding potential by patch clamp electrophysiology method
11583,CHEMBL4217428,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cccc(CN2CCOCC2)c1,IC50,nM,=,3700.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11584,CHEMBL3954214,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CC[C@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,9600.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11585,CHEMBL3954214,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CC[C@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,4200.0,Inhibition of human ERG by automated patch clamp assay
11586,CHEMBL3954214,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CC[C@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,4500.0,Inhibition of human ERG by manual patch clamp assay
11587,CHEMBL3956542,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cccc(-c2cncnc2)c1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11588,CHEMBL3913939,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cncc(-c2cncnc2)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11589,CHEMBL3915183,COc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1-c1cncnc1,IC50,nM,=,1100.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11590,CHEMBL3908521,O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccc(OCCN2CCCC2)c(-c2cncnc2)c1,IC50,nM,=,9.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11591,CHEMBL3892952,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(NCCCO)c(-c2cncnc2)c1,IC50,nM,=,1500.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11592,CHEMBL3910823,CN1CCN(c2ncc(C(=O)Nc3ccc(OC(F)(F)F)cc3)cc2-c2cncnc2)CC1,IC50,nM,=,310.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11593,CHEMBL4115154,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,17000.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11594,CHEMBL4106732,O=C(Nc1ccc(SC(F)(F)F)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,10500.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11595,CHEMBL4106732,O=C(Nc1ccc(SC(F)(F)F)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,1500.0,Inhibition of human ERG by automated patch clamp assay
11596,CHEMBL4110570,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,3600.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11597,CHEMBL4110570,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,1800.0,Inhibition of human ERG by automated patch clamp assay
11598,CHEMBL4110570,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,=,5000.0,Inhibition of human ERG by manual patch clamp assay
11599,CHEMBL3898258,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2C[C@H](O)[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11600,CHEMBL3898258,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2C[C@H](O)[C@@H](O)C2)c(-c2cncnc2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
11601,CHEMBL4217559,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2ccn[nH]2)c1,IC50,nM,>=,23000.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11602,CHEMBL4217559,O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2ccn[nH]2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
11603,CHEMBL4114922,C[C@@]1(O)CCN(c2ncc(C(=O)Nc3ccc(OC(F)(F)F)cc3)cc2-c2ccn[nH]2)C1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11604,CHEMBL4114922,C[C@@]1(O)CCN(c2ncc(C(=O)Nc3ccc(OC(F)(F)F)cc3)cc2-c2ccn[nH]2)C1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
11605,CHEMBL4213152,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2[nH]ncc2F)c1,IC50,nM,>=,18500.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11606,CHEMBL4213152,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2[nH]ncc2F)c1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
11607,CHEMBL4208229,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG by high throughput assay
11608,CHEMBL4208229,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1,IC50,nM,=,26000.0,Inhibition of human ERG by automated patch clamp assay
11609,CHEMBL4218772,COCCNc1cc(O)c2c(=O)c3c(-c4nccs4)[nH]c(Cc4ccc5c(c4)OCO5)c3oc2c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp assay
11610,CHEMBL4205724,COc1cncc(NC(C(=O)c2c[nH]c3ccccc23)c2ccccc2)c1,IC50,nM,=,3500.0,Inhibition of human ERG
11611,CHEMBL4203720,COc1cccc(NC(C(=O)c2c[nH]c3ccccc23)c2nc3ccccc3o2)c1,IC50,,,,Inhibition of human ERG
11612,CHEMBL4203293,COc1cc(NC(C(=O)c2c[nH]c3ccccc23)c2ccccc2)cc(OCCO)c1,IC50,nM,>,50000.0,Inhibition of human ERG
11613,CHEMBL4212403,COc1cc(NC(C(=O)c2c[nH]c3ccccc23)c2ccccc2)cc(OC)c1,IC50,,,,Inhibition of human ERG
11614,CHEMBL4212403,COc1cc(NC(C(=O)c2c[nH]c3ccccc23)c2ccccc2)cc(OC)c1,IC50,,,,Inhibition of human ERG
11615,CHEMBL4212403,COc1cc(NC(C(=O)c2c[nH]c3ccccc23)c2ccccc2)cc(OC)c1,IC50,nM,>,50000.0,Inhibition of human ERG
11616,CHEMBL4211062,Cc1c[nH]c2ncnc(O[C@H]3CC[C@H](N4CCOCC4)CC3)c12,IC50,nM,>,39810.72,Inhibition of human ERG
11617,CHEMBL4203802,Cc1c[nH]c2ncnc(O[C@H]3CC[C@H](N4CCO[C@H](C)C4)CC3)c12,IC50,nM,>,39810.72,Inhibition of human ERG
11618,CHEMBL4215476,Cc1c[nH]c2ncnc(O[C@H]3CC[C@H](N4CCO[C@@H](C)C4)CC3)c12,IC50,nM,=,25118.86,Inhibition of human ERG
11619,CHEMBL4209118,Cc1c[nH]c2ncnc(O[C@H]3CC[C@H](N4C[C@@H]5C[C@H]4CO5)CC3)c12,IC50,nM,>,39810.72,Inhibition of human ERG
11620,CHEMBL4204251,Cc1c[nH]c2ncnc(O[C@H]3CC[C@H](N4C[C@H]5C[C@@H]4CO5)CC3)c12,IC50,nM,>,39810.72,Inhibition of human ERG
11621,CHEMBL4216473,COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1,IC50,nM,>,33300.0,Inhibition of human ERG
11622,CHEMBL4217816,Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11623,CHEMBL4214343,Nc1nc(Nc2cn[nH]c2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11624,CHEMBL4209441,Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1,IC50,nM,=,24000.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11625,CHEMBL4216862,Nc1nc(Nc2cnn(C3CC3)c2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1,IC50,nM,=,9500.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11626,CHEMBL4211893,CC(C1CC1)n1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1,IC50,nM,=,13500.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11627,CHEMBL4204675,Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N,IC50,nM,=,2600.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11628,CHEMBL4216339,CCn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N,IC50,nM,=,7800.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11629,CHEMBL4208062,CC(C)n1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N,IC50,nM,=,30000.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11630,CHEMBL4203192,N#Cc1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1C1CC1,IC50,nM,=,30000.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11631,CHEMBL4212436,COCCOCCn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N,IC50,,,,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
11632,CHEMBL4224807,CN(c1ncnc2[nH]ccc12)[C@@H]1CCN(C(=O)CC#N)C1,IC50,nM,=,93000.0,Inhibition of human ERG expressed in HEK293 cells by automated patch clamp method
11633,CHEMBL3301607,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,IC50,nM,=,85000.0,Inhibition of human ERG expressed in HEK293 cells by automated patch clamp method
11634,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,1600.0,Inhibition of human ERG by patch clamp assay
11635,CHEMBL4227218,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccsc12,IC50,nM,=,12000.0,Inhibition of human ERG by patch clamp assay
11636,CHEMBL4227597,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2c1CCC2,IC50,nM,=,3800.0,Inhibition of human ERG by patch clamp assay
11637,CHEMBL4227161,COc1cc2ccc(C#N)cc2cc1[C@@H](c1cccc(OC)c1OC)[C@@](O)(CCN(C)C)c1cccc2c1CCC2,IC50,nM,=,1000.0,Inhibition of human ERG by patch clamp assay
11638,CHEMBL4228012,COc1cc2ccc(Br)cc2cc1[C@@H](c1cccc(OC)c1F)[C@@](O)(CCN(C)C)c1cccc2c1CCC2,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp assay
11639,CHEMBL4224771,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccoc12,IC50,nM,=,800.0,Inhibition of human ERG by patch clamp assay
11640,CHEMBL4229114,COc1cc2ccc(C#N)cc2cc1[C@@H](c1cccc(F)c1)[C@@](O)(CCN(C)C)c1cccc2ccoc12,IC50,nM,=,600.0,Inhibition of human ERG by patch clamp assay
11641,CHEMBL4229127,COc1cc2ccc(Br)cc2cc1[C@@H](c1cccnc1OC)[C@@](O)(CCN(C)C)c1cccc2ccoc12,IC50,,,,Inhibition of human ERG by patch clamp assay
11642,CHEMBL4227762,COc1cc2ccc(Br)cc2cc1[C@@H](c1cnc(OC)c(OC)c1)[C@@](O)(CCN(C)C)c1cccc2ccoc12,IC50,nM,=,1000.0,Inhibition of human ERG by patch clamp assay
11643,CHEMBL4228130,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1cccc2ccoc12,IC50,nM,=,900.0,Inhibition of human ERG by patch clamp assay
11644,CHEMBL4227669,CCOc1cc([C@H](c2cc3cc(Br)ccc3cc2OC)[C@@](O)(CCN(C)C)c2cccc3ccoc23)cc(OCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
11645,CHEMBL4225190,CCOc1cc([C@H](c2cc3cc(C#N)ccc3cc2OC)[C@@](O)(CCN(C)C)c2cccc3ccoc23)cc(OCC)n1,IC50,nM,=,3300.0,Inhibition of human ERG by patch clamp assay
11646,CHEMBL4227403,CCOc1cc([C@H](c2cc3cc(Br)ccc3cc2OC)[C@@](O)(CCN(C)C)c2cccc3ccoc23)cc(OC)n1,IC50,nM,=,7500.0,Inhibition of human ERG by patch clamp assay
11647,CHEMBL4228555,CCOc1cc([C@H](c2cc3cc(C#N)ccc3cc2OC)[C@@](O)(CCN(C)C)c2cccc3ccoc23)cc(OC)n1,IC50,nM,<,1000.0,Inhibition of human ERG by patch clamp assay
11648,CHEMBL4227141,COc1cc([C@H](c2cc3cc(Br)ccc3cc2OC)[C@@](O)(CCN(C)C)c2cccc3ccoc23)cc(OC(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
11649,CHEMBL4227994,COc1cc([C@H](c2cc3cc(C#N)ccc3cc2OC)[C@@](O)(CCN(C)C)c2cccc3ccoc23)cc(OC(C)C)n1,IC50,nM,>,2000.0,Inhibition of human ERG by patch clamp assay
11650,CHEMBL4226881,CCCOc1cc([C@H](c2cc3cc(Br)ccc3cc2OC)[C@@](O)(CCN(C)C)c2cccc3ccoc23)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp assay
11651,CHEMBL4226478,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1ccc2occc2c1,IC50,nM,=,400.0,Inhibition of human ERG by patch clamp assay
11652,CHEMBL4226743,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1ccc2occc2c1,IC50,nM,=,600.0,Inhibition of human ERG by patch clamp assay
11653,CHEMBL4225899,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1cccc2occc12,IC50,nM,=,1000.0,Inhibition of human ERG by patch clamp assay
11654,CHEMBL4227540,COc1cc2ccc(C#N)cc2cc1[C@@H](c1cccc(F)c1)[C@@](O)(CCN(C)C)c1cc2ccccc2o1,IC50,nM,=,900.0,Inhibition of human ERG by patch clamp assay
11655,CHEMBL4226688,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1cc2ccccc2o1,IC50,nM,=,800.0,Inhibition of human ERG by patch clamp assay
11656,CHEMBL4225217,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1ccc2c(c1)N(C)CC2,IC50,nM,<,1000.0,Inhibition of human ERG by patch clamp assay
11657,CHEMBL4228122,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2c1CCN2C,IC50,nM,=,1300.0,Inhibition of human ERG by patch clamp assay
11658,CHEMBL4225886,COc1cc2ccc(C#N)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1cccc2c1OCC2,IC50,nM,>,1000.0,Inhibition of human ERG by patch clamp assay
11659,CHEMBL4225434,COc1cc2ccc(Br)cc2cc1[C@@H](c1cccc(C)c1)[C@@](O)(CCN(C)C)c1cccc2c1OCO2,IC50,nM,=,500.0,Inhibition of human ERG by patch clamp assay
11660,CHEMBL4228918,COc1cc2ccc(C#N)cc2cc1[C@@H](c1cccc(C)c1)[C@@](O)(CCN(C)C)c1cccc2c1OCO2,IC50,nM,=,300.0,Inhibition of human ERG by patch clamp assay
11661,CHEMBL4228396,COc1cc2ccc(Br)cc2cc1[C@@H](c1cccc(C)c1)[C@@](O)(CCN(C)C)c1cccc2c1OCCO2,IC50,,,,Inhibition of human ERG by patch clamp assay
11662,CHEMBL4225136,COc1cc2ccc(Br)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1ccnc2c1OCCO2,IC50,nM,>,3000.0,Inhibition of human ERG by patch clamp assay
11663,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,370.0,Inhibition of human ERG assessed as prolongation of QT interval
11664,CHEMBL3604734,Cc1cc(NCc2c(F)cccc2C(F)(F)F)c2cccc(C(N)=O)c2n1,IC50,nM,=,398.11,Inhibition of human ERG
11665,CHEMBL4227839,C[C@@H]1c2n[nH]cc2CN1C1=NC(NCc2c(F)cccc2C(F)(F)F)c2cccc(C(N)=O)c2N1,IC50,nM,=,3162.28,Inhibition of human ERG
11666,CHEMBL4226243,Cc1n[nH]c2c1CN(C1=NC(NCc3c(F)cccc3C(F)(F)F)c3cccc(C(N)=O)c3N1)C2,IC50,nM,=,12589.25,Inhibition of human ERG
11667,CHEMBL4229220,N#Cc1cnccc1COc1cnc(N2CCN(c3nnc(C(F)(F)F)o3)CC2)nc1,IC50,nM,=,19952.62,Inhibition of human ERG
11668,CHEMBL4225726,N#Cc1cnccc1COc1cnc(N2CCN(c3nc(C(F)(F)F)no3)CC2)nc1,IC50,nM,=,6309.57,Inhibition of human ERG
11669,CHEMBL4224878,N#Cc1cnccc1COc1cnc(N2CCN(c3noc(C(F)(F)F)n3)CC2)nc1,IC50,nM,=,6309.57,Inhibition of human ERG
11670,CHEMBL1957287,Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1,IC50,nM,=,794.33,Inhibition of human ERG
11671,CHEMBL4229151,COc1ccc(-n2cc(Cn3ccc4nc(-c5ccccc5F)nc-4c3)nn2)cc1,IC50,nM,=,6309.57,Inhibition of human ERG
11672,CHEMBL44657,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11673,CHEMBL560739,COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC,IC50,nM,=,12.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11674,CHEMBL4227060,COc1ccc2nccc(CCN3CCC(NCc4ccc(Cl)c(Cl)c4)CC3)c2c1,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11675,CHEMBL4229191,COc1ccc2nccc(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,=,3800.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11676,CHEMBL4227550,COc1ccc2nccc(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11677,CHEMBL4228387,COc1ccc2nccc(CCN3CCC(NCc4ccc5c(c4)OCCO5)CC3)c2c1,IC50,nM,=,810.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11678,CHEMBL4226360,COc1ccc2nccc(CC[C@H]3CC[C@H](NCc4ccc(Cl)c(Cl)c4)CC3)c2c1,IC50,nM,=,2300.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11679,CHEMBL4228129,COc1ccc2nccc(CC[C@H]3CC[C@H](NCc4ccc5c(n4)NC(=O)CO5)CC3)c2c1,IC50,nM,=,410.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11680,CHEMBL4225277,COc1ccc2nccc(CC[C@H]3CC[C@H](NCc4cc5c(cn4)OCCO5)CC3)c2c1,IC50,nM,=,940.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11681,CHEMBL4228889,COc1ccc2nccc(CC[C@H]3CC[C@H](NCc4ccc5c(c4)OCCO5)CC3)c2c1,IC50,nM,=,260.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11682,CHEMBL8,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11683,CHEMBL4228182,COc1ccc2nccc(CC[C@H]3OC[C@H](NCc4ccc(Cl)cc4)CO3)c2c1,IC50,nM,=,2000.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11684,CHEMBL4226251,COc1ccc2nccc(CC[C@H]3OC[C@H](NCc4ccc(Cl)c(Cl)c4)CO3)c2c1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11685,CHEMBL4224881,COc1ccc2nccc(CC[C@H]3OC[C@H](NCc4ccc5c(n4)NC(=O)CO5)CO3)c2c1,IC50,nM,=,2500.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11686,CHEMBL4225469,COc1ccc2nccc(CC[C@H]3OC[C@H](NCc4ccc5c(n4)NC(=O)CS5)CO3)c2c1,IC50,nM,=,1300.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11687,CHEMBL4229223,COc1ccc2nccc(CC[C@H]3OC[C@H](NCc4cc5c(cn4)OCCC5)CO3)c2c1,IC50,nM,=,12000.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11688,CHEMBL4228258,COc1ccc2nccc(CC[C@H]3OC[C@H](NCc4cc5c(cn4)OCCO5)CO3)c2c1,IC50,nM,=,9500.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11689,CHEMBL4229089,COc1ccc2nccc(CC[C@H]3OC[C@H](NCc4ccc5c(c4)OCCO5)CO3)c2c1,IC50,nM,=,5100.0,Inhibition of human ERG expressed in CHOK1 cells by patch clamp assay
11690,CHEMBL3317856,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,IC50,ug.mL-1,=,588.0,Inhibition of human ERG expressed in CHO cells using -80 mV holding potential measured after 3 mins
11691,CHEMBL4243419,Cc1cc(SC(Cc2ccccc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)ccc1OCC(=O)O,IC50,nM,>,10000.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
11692,CHEMBL4241707,COc1cc(OC)cc(C(=O)N[C@H]2CC[C@H](Nc3nc(C)cc(N(C)C)n3)CC2)c1,IC50,nM,=,3981.07,Inhibition of human ERG
11693,CHEMBL4241692,COc1cc(Nc2nc(C)cc(N(C)C)n2)ccc1F,IC50,nM,=,5011.87,Inhibition of human ERG
11694,CHEMBL4242822,CC(C)Cc1ccc2ncccc2c1NS(=O)(=O)c1ccc(CCCN2CCN3CCC[C@@H]3C2)cc1,IC50,nM,=,1300.0,Inhibition of human ERG by patch clamp assay
11695,CHEMBL4237244,CC(C)Cc1ccc2ncccc2c1NS(=O)(=O)c1ccc(CCCO[C@H]2C[C@@H]3CC[C@H](C2)N3C)cc1,IC50,nM,=,1600.0,Inhibition of human ERG by patch clamp assay
11696,CHEMBL4240867,CC(C)Cc1ccc2nn(C)cc2c1NS(=O)(=O)c1ccc(CCCCC2CCN(C)CC2)cc1,IC50,nM,=,3700.0,Inhibition of human ERG by patch clamp assay
11697,CHEMBL4249236,CC(C)Cc1ccc2nn(C)cc2c1NS(=O)(=O)c1ccc(CCCOC[C@@H]2CCCN2C)cc1,IC50,nM,=,3000.0,Inhibition of human ERG by patch clamp assay
11698,CHEMBL4243933,CC(C)Cc1ccc2nn(C)cc2c1NS(=O)(=O)c1ccc(CCCO[C@H]2C[C@@H]3CC[C@H](C2)N3C)cc1,IC50,nM,=,3300.0,Inhibition of human ERG by patch clamp assay
11699,CHEMBL4247729,CC(C)Cc1ccc2nn(C)cc2c1NS(=O)(=O)c1ccc(CCCOC[C@H]2COCCN2C)cc1,IC50,nM,=,3100.0,Inhibition of human ERG by patch clamp assay
11700,CHEMBL4243499,CC(C)Cc1ccc2nn(C)cc2c1NS(=O)(=O)c1ccc(CCCOC[C@@H]2CN(C)CCO2)cc1,IC50,nM,=,5600.0,Inhibition of human ERG by patch clamp assay
11701,CHEMBL4250740,CC(C)Cc1ccc2nn(C)cc2c1NS(=O)(=O)c1ccc(CCCOC[C@H]2CN(C)CCO2)cc1,IC50,nM,=,6700.0,Inhibition of human ERG by patch clamp assay
11702,CHEMBL4246475,CC(C)Cc1ccc2nn(C)cc2c1N(C(F)F)S(=O)(=O)c1ccc(CCCCC2CCN(C)CC2)cc1,IC50,nM,=,6000.0,Inhibition of human ERG by patch clamp assay
11703,CHEMBL4242175,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(Br)c1,IC50,nM,=,1258.93,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11704,CHEMBL4242635,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(C2CC2)c1,IC50,nM,=,5011.87,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11705,CHEMBL4238909,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(N2CCOCC2)c1,IC50,nM,>,63095.73,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11706,CHEMBL4251444,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2cccn2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11707,CHEMBL4247149,Cc1ccn(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,=,39810.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11708,CHEMBL4247617,Cc1cnn(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)c1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11709,CHEMBL4243367,Cc1ccnn1-c1cccc([C@H](CC(=O)O)CN2CC[C@@H](CCc3ccc4c(n3)NCCC4)C2)c1,IC50,nM,>,63095.73,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11710,CHEMBL4241824,Cc1cc(C)n(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11711,CHEMBL4240155,Cc1cc(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)[nH]n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11712,CHEMBL4250148,Cc1cnn(C)c1-c1cccc([C@H](CC(=O)O)CN2CC[C@@H](CCc3ccc4c(n3)NCCC4)C2)c1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11713,CHEMBL4246111,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2cnnc2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11714,CHEMBL4243686,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2cncn2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11715,CHEMBL4237868,Cc1nc(C)n(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11716,CHEMBL4237919,Cc1nncn1-c1cccc([C@H](CC(=O)O)CN2CC[C@@H](CCc3ccc4c(n3)NCCC4)C2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11717,CHEMBL4241584,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2ccnn2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11718,CHEMBL4245829,O=C(O)CC(CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2ccnc2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11719,CHEMBL4245368,Cc1cn(C)c(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11720,CHEMBL4249629,Cc1nc(C)c(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)[nH]1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11721,CHEMBL4249172,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(O[C@H]2CCOC2)c1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11722,CHEMBL4239085,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(O[C@@H]2CCOC2)c1,IC50,nM,=,39810.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11723,CHEMBL4237498,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(OC2COC2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11724,CHEMBL4242732,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(OC2CCOCC2)c1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11725,CHEMBL4244784,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(C2CCOC2)c1,IC50,nM,=,39810.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11726,CHEMBL4244784,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(C2CCOC2)c1,IC50,nM,=,39810.72,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11727,CHEMBL4248589,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cc(C2CC2)cc(N2CCOCC2)c1,IC50,nM,>,63095.73,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11728,CHEMBL4242263,Cc1cc(C)n(-c2cc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)cc(N3CCOCC3)c2)n1,IC50,nM,>,63095.73,Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay
11729,CHEMBL4242635,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(C2CC2)c1,IC50,nM,=,1995.26,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11730,CHEMBL4238909,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(N2CCOCC2)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11731,CHEMBL4251444,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2cccn2)c1,IC50,nM,=,794.33,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11732,CHEMBL4247149,Cc1ccn(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11733,CHEMBL4243367,Cc1ccnn1-c1cccc([C@H](CC(=O)O)CN2CC[C@@H](CCc3ccc4c(n3)NCCC4)C2)c1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11734,CHEMBL4241824,Cc1cc(C)n(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11735,CHEMBL4240155,Cc1cc(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)[nH]n1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11736,CHEMBL4250148,Cc1cnn(C)c1-c1cccc([C@H](CC(=O)O)CN2CC[C@@H](CCc3ccc4c(n3)NCCC4)C2)c1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11737,CHEMBL4246111,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2cnnc2)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11738,CHEMBL4243686,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2cncn2)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11739,CHEMBL4237868,Cc1nc(C)n(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11740,CHEMBL4237919,Cc1nncn1-c1cccc([C@H](CC(=O)O)CN2CC[C@@H](CCc3ccc4c(n3)NCCC4)C2)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11741,CHEMBL4241584,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2ccnn2)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11742,CHEMBL4245829,O=C(O)CC(CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(-n2ccnc2)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11743,CHEMBL4245368,Cc1cn(C)c(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11744,CHEMBL4249629,Cc1nc(C)c(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)[nH]1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11745,CHEMBL4249172,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(O[C@H]2CCOC2)c1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11746,CHEMBL4239085,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(O[C@@H]2CCOC2)c1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11747,CHEMBL4237498,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(OC2COC2)c1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11748,CHEMBL4242732,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(OC2CCOCC2)c1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11749,CHEMBL4244784,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(C2CCOC2)c1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11750,CHEMBL4244784,O=C(O)C[C@H](CN1CC[C@@H](CCc2ccc3c(n2)NCCC3)C1)c1cccc(C2CCOC2)c1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11751,CHEMBL4242263,Cc1cc(C)n(-c2cc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)cc(N3CCOCC3)c2)n1,IC50,nM,>,31622.78,Inhibition of human ERG expressed in HEK293 cells by Q-patch assay
11752,CHEMBL4244935,Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1,IC50,nM,=,3500.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV after 60 secs by patch clamp assay
11753,CHEMBL4248282,Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1,IC50,nM,=,3380.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV after 60 secs by patch clamp assay
11754,CHEMBL4242114,Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1,IC50,nM,=,2060.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV after 60 secs by patch clamp assay
11755,CHEMBL4238063,Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1,IC50,nM,=,1520.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV after 60 secs by patch clamp assay
11756,CHEMBL4249798,Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV after 60 secs by patch clamp assay
11757,CHEMBL4280986,Cc1cn(-c2ccc3n(c2=O)CCN(C[C@@]24C[C@@H]2C(C)(C)Oc2ccc(C(F)(F)F)cc24)C3=O)cn1,IC50,nM,=,15600.0,Inhibition of human ERG expressed in CHOK1 cells by QPatch automated patch-clamp method
11758,CHEMBL4289783,Fc1ccc(N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)c(-c2ccccc2)c1,IC50,nM,=,16660.0,Inhibition of human ERG expressed in CHO-K1 cells assessed as reduction in tail current amplitude at -80 mV holding potential after 2 mins by path clamp assay
11759,CHEMBL4284346,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,IC50,nM,=,7520.0,Inhibition of human ERG by auomated patch clamp assay
11760,CHEMBL4277101,O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,IC50,nM,=,7850.0,Inhibition of human ERG by auomated patch clamp assay
11761,CHEMBL4286717,CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,IC50,nM,=,6210.0,Inhibition of human ERG by auomated patch clamp assay
11762,CHEMBL4294617,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,IC50,nM,=,2630.0,Inhibition of human ERG by auomated patch clamp assay
11763,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,1330.0,Inhibition of human ERG by auomated patch clamp assay
11764,CHEMBL1112,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,IC50,nM,=,3860.0,Inhibition of human ERG by auomated patch clamp assay
11765,CHEMBL4292234,Cc1c(CN2CCOCC2)cc(-c2ccc(C(F)(F)F)cc2)n1-c1ccc(F)cc1,IC50,nM,>,50000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11766,CHEMBL4288827,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1-c1ccc(F)cn1,IC50,nM,=,8000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11767,CHEMBL4277084,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1Cc1ccc(F)cc1,IC50,nM,=,5000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11768,CHEMBL4294266,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1C(C)C,IC50,nM,=,16000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11769,CHEMBL4280239,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1CC(C)C,IC50,nM,=,16000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11770,CHEMBL4290873,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1C1CC1,IC50,nM,=,8000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11771,CHEMBL4290458,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1C1CCC1,IC50,nM,=,8000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11772,CHEMBL4282585,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1C1CCCCC1,IC50,nM,=,50000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11773,CHEMBL4291770,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1C1CCCOC1,IC50,nM,=,10000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11774,CHEMBL4069395,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1-c1ccc(F)cc1,IC50,nM,=,10000.0,Inhibition of human ERG by [3H]dofetilide binding displacement assay
11775,CHEMBL3828585,CN(C/C=C/c1ccc(C(F)(F)F)cc1)Cc1ccc2c(c1)CCCC2.Cl,IC50,nM,=,1400.0,Inhibition of recombinant human ERG expressed in CHO cells at -80 mV holding potential measured after 3 minutes by automated whole cell patch clamp Qpatch method
11776,CHEMBL4284707,CN(C/C=C/C=C/C=C/c1ccc(C(F)(F)F)cc1)Cc1ccc2c(c1)OCCO2.Cl,IC50,nM,=,8700.0,Inhibition of recombinant human ERG expressed in CHO cells at -80 mV holding potential measured after 3 minutes by automated whole cell patch clamp Qpatch method
11777,CHEMBL4288408,CN(C/C=C/C=C/c1ccc(C(F)(F)F)cc1)Cc1ccc2c(c1)OCCO2.Cl,IC50,nM,=,12100.0,Inhibition of recombinant human ERG expressed in CHO cells at -80 mV holding potential measured after 3 minutes by automated whole cell patch clamp Qpatch method
11778,CHEMBL3827961,COc1ccc(/C=C/CN(C)Cc2ccc3c(c2)CCCCC3)cc1.Cl,IC50,nM,=,3200.0,Inhibition of recombinant human ERG expressed in CHO cells at -80 mV holding potential measured after 3 minutes by automated whole cell patch clamp Qpatch method
11779,CHEMBL4278050,CN(C/C=C/c1ccc(C(F)(F)F)cc1)Cc1ccc2c(c1)OCCO2.Cl,IC50,nM,=,3900.0,Inhibition of recombinant human ERG expressed in CHO cells at -80 mV holding potential measured after 3 minutes by automated whole cell patch clamp Qpatch method
11780,CHEMBL4288709,Cc1ccc(/C=C/CN(C)Cc2ccc3c(c2)OCCO3)cc1.Cl,IC50,nM,=,4600.0,Inhibition of recombinant human ERG expressed in CHO cells at -80 mV holding potential measured after 3 minutes by automated whole cell patch clamp Qpatch method
11781,CHEMBL4276884,O=C(NCc1ccc(OC(F)(F)F)c(Cl)c1)c1ccc(S(=O)(=O)Nc2nccs2)c(F)c1,IC50,nM,=,17700.0,Inhibition of human ERG
11782,CHEMBL4293085,O=C(NCc1ccc(OC(F)(F)F)c(Cl)c1)c1ccc(S(=O)(=O)Nc2ncns2)c(F)c1,IC50,nM,>,100000.0,Inhibition of human ERG
11783,CHEMBL4276813,O=S(=O)(Nc1ncns1)c1ccc(OCc2ccc(OC(F)(F)F)c(Cl)c2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG
11784,CHEMBL4279819,CN(c1ncnc2[nH]ccc12)[C@H]1CN(C(=O)CC#N)CC12CC2,IC50,nM,=,120000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by automated planar patch clamp method
11785,CHEMBL3301607,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,IC50,nM,=,85000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by automated planar patch clamp method
11786,CHEMBL4281310,Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CCC(N(C)C(=O)N[C@@H](C)c3ccc(C#CC4CC4)c(Cl)c3Cl)CC2)ncn1,IC50,nM,=,3160.0,Inhibition of human ERG expressed in HEK293 cells by manual patch clamp assay
11787,CHEMBL4279774,COc1ccccc1-n1nc(C2CC(C)(C)OC(C)(C)C2)cc1-c1ccc(Cl)cc1,IC50,nM,=,20000.0,Inhibition of human ERG
11788,CHEMBL4277584,COc1ccccc1-n1nc(C2CC(C)(C)OC(C)(C)C2)cc1-c1csc(Cl)c1,IC50,nM,=,26000.0,Inhibition of human ERG
11789,CHEMBL4281315,CN(c1ccc(-c2cc3ccccc3s2)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,110.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11790,CHEMBL4289183,CC1(C)CC(Nc2ccc(-c3cc4ccccc4s3)nn2)CC(C)(C)N1,IC50,nM,=,600.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11791,CHEMBL4285798,CC1(C)CC(Nc2ccc(-c3ccc4ccccc4c3)nn2)CC(C)(C)N1,IC50,nM,=,1500.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11792,CHEMBL4277857,CC1(C)CC(Nc2ccc(-c3cccc4ccccc34)nn2)CC(C)(C)N1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11793,CHEMBL4282391,CN(c1ccc(-c2ccc(F)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,2200.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11794,CHEMBL4292990,CN(c1ccc(-c2cc3ccccc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,80.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11795,CHEMBL4283397,CN(c1ccc(-c2ccc(C#N)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,300.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11796,CHEMBL4280558,CN(c1ccc(-c2ccc(-n3cccn3)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,300.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11797,CHEMBL4288439,CC1(C)CC(Oc2ccc(-c3ccc(-n4cccn4)cc3O)nn2)CC(C)(C)N1,IC50,nM,=,230.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11798,CHEMBL4290774,Oc1cc(-n2cccn2)ccc1-c1ccc(OC2CCNCC2)nn1,IC50,nM,=,6000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11799,CHEMBL4278935,Oc1cc(-n2cccn2)ccc1-c1ccc(OC2CCNCC2(F)F)nn1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11800,CHEMBL4287358,CC1(C)CC(Oc2ccc(-c3ccc(-n4cccn4)cc3O)nn2)CC(C)(C)N1CC(F)(F)F,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11801,CHEMBL4277023,CN(c1ccc(-c2cc3cccnc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,4500.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11802,CHEMBL4279018,CN(c1ccc(-c2cc3cnccc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,14000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11803,CHEMBL4286948,CN(c1ccc(-c2ccc(-n3ccc(N)n3)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,16000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11804,CHEMBL4291213,CN(c1ccc(-c2ccc(-n3cc(CO)cn3)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,16000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11805,CHEMBL4283367,CN(c1ccc(-c2ccc(-c3cn[nH]c3)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,IC50,nM,=,6000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11806,CHEMBL4294614,Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2CCC3(CCCNC3)C2)nn1,IC50,nM,=,270.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11807,CHEMBL4286715,Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2C[C@@H]3CNC[C@@H]3C2)nn1,IC50,nM,=,2500.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11808,CHEMBL4279463,CC1(C)CC(Cc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,IC50,nM,=,17000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11809,CHEMBL4290141,CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,IC50,nM,=,6300.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cell membranes after 90 mins by micro-beta counting
11810,CHEMBL4277264,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,IC50,nM,=,12000.0,Inhibition of human ERG
11811,CHEMBL4288117,FC(F)(F)Oc1ccc(Oc2ccc(N3CCC4(CC3)OCCc3sccc34)cc2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO-S1 cells by automated planar chip-based electrophysiology
11812,CHEMBL4280886,Brc1ccc(Nc2ccc(CN3CCC4(CC3)OCCc3sccc34)cc2)cc1,IC50,nM,=,7900.0,Inhibition of human ERG expressed in CHO-S1 cells by automated planar chip-based electrophysiology
11813,CHEMBL4292051,FC(F)(F)Oc1ccc(Oc2ccc(CN3CCC4(CCCCO4)CC3)cc2)cc1,IC50,nM,=,2500.0,Inhibition of human ERG expressed in CHO-S1 cells by automated planar chip-based electrophysiology
11814,CHEMBL4293735,CC(C)(C)c1ccc(CN2CCC3(CCCCO3)CC2)cc1,IC50,nM,=,15800.0,Inhibition of human ERG expressed in CHO-S1 cells by automated planar chip-based electrophysiology
11815,CHEMBL4288117,FC(F)(F)Oc1ccc(Oc2ccc(N3CCC4(CC3)OCCc3sccc34)cc2)cc1,IC50,nM,=,1500.0,Inhibition of human ERG expressed in CHO-S1 cells by Qpatch clamp assay
11816,CHEMBL4280886,Brc1ccc(Nc2ccc(CN3CCC4(CC3)OCCc3sccc34)cc2)cc1,IC50,nM,=,2300.0,Inhibition of human ERG expressed in CHO-S1 cells by Qpatch clamp assay
11817,CHEMBL4292051,FC(F)(F)Oc1ccc(Oc2ccc(CN3CCC4(CCCCO4)CC3)cc2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO-S1 cells by Qpatch clamp assay
11818,CHEMBL4293735,CC(C)(C)c1ccc(CN2CCC3(CCCCO3)CC2)cc1,IC50,nM,=,8100.0,Inhibition of human ERG expressed in CHO-S1 cells by Qpatch clamp assay
11819,CHEMBL4294221,NC1=N[C@@]2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(C3=CCCOC3)cc12,IC50,nM,=,900.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by PatchXpress automated electrophysiology method
11820,CHEMBL4290066,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)NC(C)(C)C)cc3)n2)C1,IC50,nM,>,10000.0,Inhibition of human ERG
11821,CHEMBL4245727,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)C1,IC50,nM,>,10000.0,Inhibition of human ERG
11822,CHEMBL4286628,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCOCC4)nc3)n2)C1,IC50,nM,=,1500.0,Inhibition of human ERG
11823,CHEMBL4278717,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCCCC4)nc3)n2)C1,IC50,nM,=,260.0,Inhibition of human ERG
11824,CHEMBL4278321,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCCCC4)cc3)n2)C1,IC50,nM,=,3300.0,Inhibition of human ERG
11825,CHEMBL4288997,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCC(F)(F)CC4)cc3)n2)C1,IC50,nM,>,10000.0,Inhibition of human ERG
11826,CHEMBL4285083,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CC(C)OC(C)C4)cc3)n2)C1,IC50,nM,>,10000.0,Inhibition of human ERG
11827,CHEMBL4282893,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)nc3)n2)C1,IC50,nM,=,10000.0,Inhibition of human ERG
11828,CHEMBL4281335,C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)cc3)n2)C1,IC50,nM,>,10000.0,Inhibition of human ERG
11829,CHEMBL1873475,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,IC50,nM,=,1100.0,Inhibition of human ERG
11830,CHEMBL4295247,C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](CCCN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,IC50,nM,>,40000.0,Inhibition of human ERG
11831,CHEMBL4288614,C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](OCCN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,IC50,nM,>,40000.0,Inhibition of human ERG
11832,CHEMBL4288001,CC#C[C@@H](CC(=O)O)c1ccc(OC[C@H]2COc3ccc(Cl)cc3O2)cc1,IC50,nM,>,40000.0,Inhibition of human ERG by patch-clamp assay
11833,CHEMBL4291468,COc1cccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)c1,IC50,nM,>,20000.0,Inhibition of human ERG
11834,CHEMBL146624,CCc1ccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1,IC50,nM,>,100000.0,Inhibition of human ERG
11835,CHEMBL1236904,Cc1cc(CN2CCN(c3c(Br)cnc4nc(-c5ccc(N6CCN(C)CC6)cc5)[nH]c34)CC2)no1,IC50,nM,=,3000.0,Inhibition of human ERG
11836,CHEMBL4281089,CCCCNc1nc(N)nc2c1CN(C(=O)c1cccs1)CC2,IC50,nM,=,900.0,Displacement of 3H-dofetilide from human ERG
11837,CHEMBL4285364,CCCCNc1nc(N)nc2c1CN(C(=O)c1csc(C)n1)CC2,IC50,nM,=,1300.0,Displacement of 3H-dofetilide from human ERG
11838,CHEMBL4276988,CCC[C@@H](CCO)Nc1nc(N)nc2c1CN(C(=O)c1csc(C)n1)CC2,IC50,nM,=,22000.0,Displacement of 3H-dofetilide from human ERG
11839,CHEMBL4284935,CCCC[C@@H](CCO)Nc1nc(N)nc2c1CN(C(=O)c1csc(C)n1)CC2,IC50,nM,>,50000.0,Displacement of 3H-dofetilide from human ERG
11840,CHEMBL4290212,CCC[C@@H](CCO)Nc1nc(N)nc2c1CN(C(=O)c1cccs1)CC2,IC50,nM,=,7600.0,Displacement of 3H-dofetilide from human ERG
11841,CHEMBL4279547,CCCC[C@@H](CCO)Nc1nc(N)nc2c1CN(C(=O)c1cccs1)CC2,IC50,nM,=,6900.0,Displacement of 3H-dofetilide from human ERG
11842,CHEMBL4288964,CCCCc1nc(C(C)C)c(CC(=S)N2CCCC2)c(=O)n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,IC50,nM,=,7000.0,Inhibition of human ERG
11843,CHEMBL3823499,CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1,IC50,nM,=,7445.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11844,CHEMBL4278565,CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ncc(F)cc34)c2c1,IC50,nM,=,12140.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11845,CHEMBL4286477,CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4c3CCCC4)c2c1,IC50,nM,=,8635.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11846,CHEMBL4293701,CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3cc[nH]n3)c2c1,IC50,nM,=,8305.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11847,CHEMBL4283104,Cc1cc(Nc2ccnc3ccc(S(=O)(=O)C(C)(C)C)cc23)n[nH]1,IC50,nM,=,6371.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11848,CHEMBL4285462,Cc1[nH]nc(Nc2ccnc3ccc(S(=O)(=O)C(C)(C)C)cc23)c1C,IC50,nM,=,15500.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11849,CHEMBL4293287,COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C,IC50,nM,=,14500.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11850,CHEMBL4282034,CCOc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11851,CHEMBL4289904,Cc1[nH]nc(Nc2ccnc3cc(OCCO)c(S(=O)(=O)C(C)(C)C)cc23)c1C,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11852,CHEMBL4292228,COCCOc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C,IC50,nM,=,30000.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11853,CHEMBL4281602,Cc1[nH]nc(Nc2ccnc3cc(OC(F)(F)F)c(S(=O)(=O)C(C)(C)C)cc23)c1C,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11854,CHEMBL4285837,CCc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C,IC50,nM,=,23990.0,Inhibition of human ERG expressed in CHO cells by Qpatch clamp assay
11855,CHEMBL2325697,C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1,IC50,nM,=,50000.0,Inhibition of human ERG by whole cell electrophysiology analysis
11856,CHEMBL4285417,C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2cc[nH]c3nccc2-3)n1,IC50,nM,=,166000.0,Inhibition of human ERG by whole cell electrophysiology analysis
11857,CHEMBL4281240,C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cncc3[nH]ccc23)n1,IC50,nM,=,15000.0,Inhibition of human ERG by whole cell electrophysiology analysis
11858,CHEMBL4291436,CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1,IC50,nM,=,4600.0,Inhibition of human ERG by whole cell electrophysiology analysis
11859,CHEMBL3648329,CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2([S@](C)(=N)=O)CC2)n1,IC50,nM,=,15000.0,Inhibition of human ERG by whole cell electrophysiology analysis
11860,CHEMBL1210207,CCOc1cc(CN2CCC(NC(=O)c3cncc(C)c3)CC2)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,1690.0,Inhibition of MK-499 binding to human ERG
11861,CHEMBL4277106,CCOc1cc(CN2CC[C@H]3C(Nc4nc5ccc(C(=O)O)cc5o4)CC[C@H]32)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,15000.0,Inhibition of MK-499 binding to human ERG
11862,CHEMBL4288417,CCOc1cc(CN2CCC(c3ncc(-c4ccc(F)cc4)[nH]3)CC2)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,260.0,Inhibition of MK-499 binding to human ERG
11863,CHEMBL4280531,CCOc1cc(CN2CCC3(CC2)CCN(S(=O)(=O)c2cccnc2)CC3)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,210.0,Inhibition of MK-499 binding to human ERG
11864,CHEMBL4278161,CCOc1cc(CN2CCC(C3CCN(S(=O)(=O)c4ccccc4)CC3)CC2)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,220.0,Inhibition of MK-499 binding to human ERG
11865,CHEMBL4288848,CCOc1cc(CN2CCC(COc3cccc4cccnc34)CC2)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,210.0,Inhibition of MK-499 binding to human ERG
11866,CHEMBL4281620,CCOc1cc(CN2CCC(Oc3nccc(Cl)n3)CC2)cc(OCC)c1-c1ccc(F)cc1,IC50,,,,Inhibition of MK-499 binding to human ERG
11867,CHEMBL4292255,CCOc1cc(CN2CCC3(CC2)CC(Cc2ccc(F)cc2)C(=O)O3)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,950.0,Inhibition of MK-499 binding to human ERG
11868,CHEMBL4289922,CCOc1cc(CN2CCC3(CC2)NC(=O)NC3=O)cc(OCC)c1-c1ccc(F)cc1,IC50,nM,=,25000.0,Inhibition of MK-499 binding to human ERG
11869,CHEMBL4282052,CCOc1cc(CN2CCC3(CC2)CC(=O)N(c2ccc(C(=O)O)cc2)C3)cc(OCC)c1-c1ccc(F)cc1.O=C(O)C(F)(F)F,IC50,nM,=,45000.0,Inhibition of MK-499 binding to human ERG
11870,CHEMBL4287248,O=C(O)c1ccc(N2CC3(CCN(Cc4cc(Cl)c(-c5ccc(F)cc5F)c(C5CC5)c4)CC3)OC2=O)cc1,IC50,nM,>,10000.0,Inhibition of human ERG
11871,CHEMBL4289325,O=C(O)c1ccc(N2CC3(CCN(Cc4cc(C(F)(F)F)ccc4C4CC4)CC3)OC2=O)cc1,IC50,nM,>,10000.0,Inhibition of human ERG
11872,CHEMBL4284867,CC1(C)CCOc2c(Cl)cc(CN3CCC4(CC3)CC(=O)N(c3ccc(C(=O)O)cc3)C4)cc21,IC50,nM,>,10000.0,Inhibition of human ERG
11873,CHEMBL4278328,CC(C)n1cc(CN2CCC3(CC2)CC(=O)N(c2ccc(C(=O)O)cc2)C3)c2c(C3CC3)cccc21,IC50,nM,>,10000.0,Inhibition of human ERG
11874,CHEMBL4281494,Cc1sc([C@@H]2CCCN2C(=O)CN(C)C)cc1C(=O)Nc1ncc(Cl)s1.Cl,IC50,nM,<,300.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
11875,CHEMBL4283796,CCN(CC(=O)O)CC(=O)N1CCC[C@H]1c1cc(C(=O)Nc2ncc(F)s2)c(C)s1,IC50,nM,>,300000.0,Inhibition of human ERG expressed in HEK293 cells at -80 holding potential by whole patch clamp assay
11876,CHEMBL4293473,O=C(Nc1ccc(Cl)c(Cl)c1)Nc1nccnc1OCc1ccccc1,IC50,nM,=,11300.0,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cell membranes after 1 hr by microbeta counting method
11877,CHEMBL4279795,O=C1S/C(=C\c2ccc(Oc3ccc([N+](=O)[O-])cc3)cc2)C(=O)N1c1ccc(OCCCCN2CCN(CC3CC3)CC2)cc1,IC50,nM,=,55300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current at -80 holding potential after 100 to 200 secs by whole cell automated patch-clamp electrophysiology assay
11878,CHEMBL4287698,O=C1S/C(=C\c2ccc(Oc3ccc(F)cc3)cc2)C(=O)N1c1ccc(OCCCCN2CCN(CC3CC3)CC2)cc1,IC50,nM,=,3400.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current at -80 holding potential after 100 to 200 secs by whole cell automated patch-clamp electrophysiology assay
11879,CHEMBL4279373,O=C1S/C(=C\c2ccc(Oc3ccc(Br)cc3)cc2)C(=O)N1c1ccc(OCCCCN2CCN(CC3CC3)CC2)cc1,IC50,nM,=,27500.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current at -80 holding potential after 100 to 200 secs by whole cell automated patch-clamp electrophysiology assay
11880,CHEMBL4282148,CCOC(=O)C1CCN(c2ccc3c(Nc4cc(C)[nH]n4)nc(-c4ccccc4)nc3c2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole-cell patch clamp method
11881,CHEMBL3945880,O=c1cc(NC2CCN(S(=O)(=O)C(F)(F)F)CC2)c2cc(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)ccc2[nH]1,IC50,nM,>,50000.0,Inhibition of human ERG
11882,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,167.1,Inhibition of human ERG expressed in HEK293 cells at -50 mV holding potential by patch clamp assay
11883,CHEMBL4289498,O=C(CCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,IC50,nM,=,823.7,Inhibition of human ERG expressed in HEK293 cells at -50 mV holding potential by patch clamp assay
11884,CHEMBL4293999,O=C(CCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,IC50,nM,=,2905.4,Inhibition of human ERG expressed in HEK293 cells at -50 mV holding potential by patch clamp assay
11885,CHEMBL4294799,O=C1CCc2cc(C(O)CCCN3CCC(c4noc5cc(F)ccc45)CC3)cc3c2N1CC3,IC50,nM,=,1899.6,Inhibition of human ERG expressed in HEK293 cells at -50 mV holding potential by patch clamp assay
11886,CHEMBL4441173,CS(=O)(=O)c1cc(-c2ccccc2)cc(S(=O)(=O)c2ccc(CN)s2)c1,IC50,nM,=,25000.0,Inhibition of human ERG expressed in CHOK1 cells by Q-patch electrophysiology method
11887,CHEMBL4564517,Cc1ccc(-c2cc(S(C)(=O)=O)cc(S(=O)(=O)c3ccc(CN)s3)c2)cc1,IC50,nM,=,4600.0,Inhibition of human ERG expressed in CHOK1 cells by Q-patch electrophysiology method
11888,CHEMBL4434955,Cc1ccc(-c2cc(S(=O)(=O)c3ccc(CN)s3)ccc2S(C)(=O)=O)cc1.Cl,IC50,nM,=,68000.0,Inhibition of human ERG expressed in CHOK1 cells by Q-patch electrophysiology method
11889,CHEMBL4463039,N#Cc1ccc2nnc(C(=O)N3CCC(c4ccccc4C(F)(F)F)CC3)n2c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by PatchXpress automated electrophysiology method
11890,CHEMBL3954871,N#Cc1ccc2nnc(C(=O)N3CCC(c4cccc(F)c4C(F)(F)F)CC3)n2c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by PatchXpress automated electrophysiology method
11891,CHEMBL4448494,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHO cells at - 80 mV holding potential by Q-patch clamp electrophysiology assay
11892,CHEMBL4470753,Cc1cc(Cc2cc(-c3ccc(Br)cc3)on2)cc(C)c1OC(C)(C)C(=O)O,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO-K1 cells by whole-cell patch clamp assay
11893,CHEMBL4522177,COC1CCN(Cc2cc(-c3ccc(C(C)C)cc3)n(-c3ccc(F)cc3)n2)CC1,IC50,nM,=,6310.0,Inhibition of human ERG
11894,CHEMBL4069395,Cc1c(CN2CCOCC2)cc(-c2ccc(C(C)C)cc2)n1-c1ccc(F)cc1,IC50,nM,=,10000.0,Inhibition of human ERG
11895,CHEMBL4591121,CC(C)c1ccc(-c2cc(CN3CCN(c4ccccn4)CC3)nn2-c2ccc(F)cc2)cc1,IC50,nM,=,25100.0,Inhibition of human ERG
11896,CHEMBL4558187,CC(C)c1ccc(-c2cc(CN3CC[Si](C)(C)CC3)nn2-c2ccc(F)cc2)cc1,IC50,nM,=,2000.0,Inhibition of human ERG
11897,CHEMBL4529897,CC(C)c1ccc(-c2cc(CN3CCOCC3)nn2C2CCCCC2)cc1,IC50,nM,>,50000.0,Inhibition of human ERG
11898,CHEMBL4554211,CC(C)c1ccc(-c2cc(CN3CCN(c4ccccn4)CC3)nn2C2CCCCC2)cc1,IC50,nM,>,50000.0,Inhibition of human ERG
11899,CHEMBL4476297,CC(C)c1ccc(-c2cc(CN3CCOCC3)nn2C2CCC2)cc1,IC50,nM,=,32000.0,Inhibition of human ERG
11900,CHEMBL4474294,COC1CCN(Cc2cc(-c3ccc(C(F)(F)F)cc3)n(-c3ccc(F)cc3)n2)CC1,IC50,nM,=,3200.0,Inhibition of human ERG
11901,CHEMBL4543679,C[Si]1(C)CCN(Cc2cc(-c3ccc(C(F)(F)F)cc3)n(-c3ccc(F)cc3)n2)CC1,IC50,nM,=,1260.0,Inhibition of human ERG
11902,CHEMBL4515914,C[Si]1(C)CCN(Cc2cc(-c3ccc(C(F)(F)F)cc3)n(C3CCCCC3)n2)CC1,IC50,nM,=,2500.0,Inhibition of human ERG
11903,CHEMBL4443434,CC(C)c1ccc(-c2cc(CN3CC[Si](C)(C)CC3)nn2C2CCCCC2)cc1,IC50,nM,=,8000.0,Inhibition of human ERG
11904,CHEMBL4471705,FC(F)(F)c1cccc(Nc2cc3[nH]c(Nc4ccc(N5CCNCC5)cn4)nc3cn2)c1,IC50,nM,=,30000.0,Inhibition of human ERG by patch clamp electrophysiology
11905,CHEMBL4545990,FC(F)(F)c1cccc(Nc2cc3[nH]c(Nc4ccc(N5CCOCC5)cn4)nc3cn2)c1,IC50,nM,=,500.0,Inhibition of human ERG by patch clamp electrophysiology
11906,CHEMBL4575250,C[C@H]1CN(C(=O)c2ccnc(Nc3nc4cnc(Nc5ccc(F)c(C(F)(F)F)c5)cc4[nH]3)c2)C[C@@H](C)N1,IC50,nM,=,13000.0,Inhibition of human ERG by patch clamp electrophysiology
11907,CHEMBL4447741,C[C@H]1CN(C(=O)c2ccnc(Nc3nc4cnc(Nc5ccc(F)c(C(F)(F)F)c5)cc4[nH]3)c2)C[C@@H](C)O1,IC50,nM,=,5300.0,Inhibition of human ERG by patch clamp electrophysiology
11908,CHEMBL4456445,O=C(NO)C(c1ccc(-c2ncc(C(F)(F)F)cn2)cc1)c1ccccc1F,IC50,nM,>,100000.0,Displacement of [3H]dofetilide from recombinant human ERG after 60 mins by scintillation counting method
11909,CHEMBL4437833,Cc1ncc(-c2ccc(C(C(=O)NO)c3ccccc3F)cc2)cn1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG after 60 mins by scintillation counting method
11910,CHEMBL4590062,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(C)S(C)(=O)=O)c(-c3ccc4ncn5c6cccc(F)c6cc5c4n3)cc12,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
11911,CHEMBL4435877,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(C)S(C)(=O)=O)c(-c3ccc4c(n3)-c3cc5c(F)cccc5n3CN4)cc12,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
11912,CHEMBL3901713,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(C)S(C)(=O)=O)c(-c3ccc4ccn5c6cccc(F)c6cc5c4n3)cc12,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
11913,CHEMBL3947779,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(C)S(C)(=O)=O)c(-c3ccc4c(n3)-c3cc5c(F)cccc5n3CC4)cc12,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
11914,CHEMBL4536105,COc1ncc(-c2cc(OCCCCCCC(=O)NO)c3ncnc(C)c3c2)cc1F,IC50,nM,>,30000.0,Inhibition of human ERG stably expressed in CHO cells by whole cell patch clamp method
11915,CHEMBL4462577,COc1ccc(-c2cc(OCCN(C)c3ncc(C(=O)NO)cn3)c3ncnc(C)c3c2)cn1,IC50,nM,>,30000.0,Inhibition of human ERG stably expressed in CHO cells by whole cell patch clamp method
11916,CHEMBL4585668,CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F,IC50,nM,>,50000.0,Inhibition of human ERG expressed in mammalian expression system by Q-patch clamp electrophysiology method
11917,CHEMBL4461925,Nc1n[nH]c(N2CCC(N3CCOC[C@@H]3Cc3ccc(Cl)cc3)CC2)n1,IC50,nM,=,12000.0,Inhibition of human ERG expressed in CHO-K1 cells by automated Patch Clamp method
11918,CHEMBL4461925,Nc1n[nH]c(N2CCC(N3CCOC[C@@H]3Cc3ccc(Cl)cc3)CC2)n1,IC50,nM,=,39000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11919,CHEMBL4470253,CO[C@@H]1C[C@H](Cc2ccc(Cl)cc2)N(C2CCN(c3nc(N)n[nH]3)CC2)C1,IC50,nM,=,15800.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11920,CHEMBL4547227,Nc1n[nH]c(N2CCC(N3C[C@H](O)C[C@@H]3Cc3ccc(Cl)cc3)CC2)n1,IC50,nM,=,55000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11921,CHEMBL4537828,CO[C@H]1C[C@H](Cc2ccc(Cl)cc2)N(C2CCN(c3nc(N)n[nH]3)CC2)C1,IC50,nM,=,19000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11922,CHEMBL4442663,Nc1n[nH]c(N2CCC(N3C[C@@H](O)C[C@@H]3Cc3ccc(Cl)cc3)CC2)n1,IC50,nM,=,13200.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11923,CHEMBL4466293,CO[C@H]1CN(C2CCN(c3nc(N)n[nH]3)CC2)[C@H]1Cc1ccc(Cl)cc1,IC50,nM,=,340.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11924,CHEMBL4580568,Nc1n[nH]c(N2CCC(N3CCCC[C@@H]3Cc3ccc(Cl)cc3)CC2)n1,IC50,nM,=,8300.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11925,CHEMBL4588384,Nc1n[nH]c(N2CCC(N3CCC[C@@H]3Cc3ccc(Cl)cc3)CC2)n1,IC50,nM,=,4000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11926,CHEMBL4441922,Nc1n[nH]c(N2CCC(N3CCCC(c4ccc(Cl)cc4)C3)CC2)n1,IC50,,,,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11927,CHEMBL4583636,Nc1n[nH]c(N2CCC(N3CCC(c4ccc(Cl)cc4)C3)CC2)n1,IC50,,,,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11928,CHEMBL4464754,Nc1n[nH]c(N2CCC(N(CCc3ccc(Cl)cc3)CC3CCCCO3)CC2)n1,IC50,nM,=,11000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11929,CHEMBL4541831,Nc1n[nH]c(N2CCC(N(CCc3ccc(Cl)cc3)CC3CCCO3)CC2)n1,IC50,nM,=,15000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11930,CHEMBL4440077,Nc1n[nH]c(N2CCC(N(CCc3ccc(Cl)cc3)C3COC3)CC2)n1,IC50,nM,=,4400.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11931,CHEMBL4546929,COC(C)(C)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,3500.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11932,CHEMBL4446970,CC(C)(O)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,19000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11933,CHEMBL4520755,CO[C@@H](C)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,17600.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11934,CHEMBL4464943,C[C@H](O)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,14000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11935,CHEMBL4442416,CO[C@H](C)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,6400.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11936,CHEMBL4460797,C[C@@H](O)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,6100.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11937,CHEMBL4521547,COCCN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,2800.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11938,CHEMBL4577776,Nc1n[nH]c(N2CCC(N(CCO)CCc3ccc(Cl)cc3)CC2)n1,IC50,nM,=,6300.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11939,CHEMBL4555101,CNC(=O)NCCN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,1800.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11940,CHEMBL4453964,CNS(=O)(=O)CCN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,16000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11941,CHEMBL4457342,CS(=O)(=O)NCCN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,7200.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11942,CHEMBL4472377,CC(=O)NCCN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,3300.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11943,CHEMBL4524503,CNC(=O)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,2600.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11944,CHEMBL4542155,Nc1n[nH]c(N2CCC(N(CCc3ccc(Cl)cc3)CC(=O)O)CC2)n1,IC50,nM,=,8000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
11945,CHEMBL4586512,Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3-c3ccccc3)c(C)c2c1,IC50,nM,=,19530.0,Inhibition of human ERG by patch-clamp method
11946,CHEMBL4446835,C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1,IC50,nM,>,40000.0,Inhibition of human ERG by patch-clamp method
11947,CHEMBL4463714,Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3-c3ccc(NC(=O)/C=C/CN(C)C)cc3)c(C)c2c1,IC50,nM,=,32850.0,Inhibition of human ERG by patch-clamp method
11948,CHEMBL4462946,Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12,IC50,nM,>,40000.0,Inhibition of human ERG by patch-clamp method
11949,CHEMBL4537540,Cc1c(C(=O)CC#N)oc2ccccc12,IC50,nM,=,30.0,Inhibition of human ERG by patch-clamp method
11950,CHEMBL4577458,Cc1ccc2oc(C(=O)CC#N)c(C)c2c1,IC50,nM,=,30.0,Inhibition of human ERG by patch-clamp method
11951,CHEMBL4443436,Cc1c(C(=O)CC#N)oc2ccc(Cl)cc12,IC50,nM,=,30.0,Inhibition of human ERG by patch-clamp method
11952,CHEMBL4592743,Cc1c(C(=O)CC#N)oc2ccc(Br)cc12,IC50,nM,=,30.0,Inhibition of human ERG by patch-clamp method
11953,CHEMBL4553144,COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl,IC50,nM,=,13070.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
11954,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,21.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
11955,CHEMBL4526734,CC(C)C(=O)c1c(Nc2ccc(F)c(F)c2F)[nH]c2c(F)cc(F)cc2c1=O,IC50,nM,=,6900.0,Binding affinity to human ERG
11956,CHEMBL4441783,O=C(CSc1nc2cc([N+](=O)[O-])ccc2[nH]1)Nc1ccc(Oc2ccccc2)cc1,IC50,nM,=,8240.0,Inhibition of human ERG
11957,CHEMBL3235396,CCCCCCCc1[nH]c2ccc([N+](=O)[O-])cc2c(=O)c1CO,IC50,nM,=,12870.0,Inhibition of human ERG
11958,CHEMBL4577906,Cc1ccc(NC(=O)c2ccc3c(c2)CC(c2ccc(Cl)cc2)OC3=O)cc1C,IC50,nM,=,6770.0,Inhibition of human ERG
11959,CHEMBL4453859,Cc1ccc(N(C)C(=O)c2ccc3c(c2)CC(c2ccc(Cl)cc2)OC3=O)cc1C,IC50,nM,=,2920.0,Inhibition of human ERG
11960,CHEMBL4547348,CCC(C)c1ccc(OCCOc2ccc(Cl)cc2CNn2cnnc2)cc1,IC50,nM,=,1408.0,Inhibition of human ERG
11961,CHEMBL4440009,O=C(c1cn(CCCNCc2ccc(Oc3ccc(Cl)cc3)cc2)nn1)N1CCOCC1,IC50,nM,=,678.0,Inhibition of human ERG
11962,CHEMBL4444525,CCCCOc1ccc(Cl)c(OCCCC)c1/N=N/c1c(O)ccc2ccccc12,IC50,nM,=,380.0,Inhibition of human ERG
11963,CHEMBL4469841,CCCCOc1cc(Cl)cc(OCCCC)c1/N=N/c1c(O)ccc2ccccc12,IC50,nM,=,400.0,Inhibition of human ERG
11964,CHEMBL4451572,CCCCOc1cc(Cl)c(/N=N/c2c(O)ccc3ccccc23)c(OCCCC)c1,IC50,nM,=,400.0,Inhibition of human ERG
11965,CHEMBL4589017,O=C(CCCC(=O)c1cccc([N+](=O)[O-])c1)NC1CCCC1,IC50,nM,=,20380.0,Inhibition of human ERG
11966,CHEMBL4579589,O=C(CCNC(=O)c1cccc([N+](=O)[O-])c1)NC1CCOC1=O,IC50,nM,=,904350.0,Inhibition of human ERG
11967,CHEMBL4517913,O=C(CCNC(=O)c1cccc([N+](=O)[O-])c1)Nc1nc(=O)[nH]cc1F,IC50,nM,=,356180.0,Inhibition of human ERG
11968,CHEMBL4586478,O=C(CCCS(=O)(=O)c1ccccc1)NC1CCOC1=O,IC50,nM,=,109010.0,Inhibition of human ERG
11969,CHEMBL4520260,O=C(CCCS(=O)(=O)c1ccccc1)Nc1cc[nH]c(=O)n1,IC50,nM,=,67800.0,Inhibition of human ERG
11970,CHEMBL4445189,O=C(CCCS(=O)(=O)c1ccccc1)Nc1nc(=O)[nH]cc1F,IC50,nM,=,40477.0,Inhibition of human ERG
11971,CHEMBL4533341,C[C@@H]1O[C@H](C)CN2c3c(cc4c(N5CC6(CC6)OC5=O)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@@H]12,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells in at -80 mV holding potential by automated Qpatch clamp assay
11972,CHEMBL4435962,C[C@@H]1O[C@H](C)CN2c3c(cc4c(N5CCSC5=O)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@@H]12,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells in at -80 mV holding potential by automated Qpatch clamp assay
11973,CHEMBL4460834,C[C@@H]1O[C@H](C)CN2c3c(cc4c(N5C[C@@H](C)SC5=O)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@@H]12,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells in at -80 mV holding potential by automated Qpatch clamp assay
11974,CHEMBL4447387,C[C@H]1CN(c2noc3c(F)c4c(cc23)CC2(C(=O)NC(=O)NC2=O)[C@H]2[C@H](C)O[C@H](C)CN42)C(=O)S1,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells in at -80 mV holding potential by automated Qpatch clamp assay
11975,CHEMBL4559406,COC[C@H]1CN(c2noc3c(F)c4c(cc23)CC2(C(=O)NC(=O)NC2=O)[C@H]2[C@H](C)O[C@H](C)CN42)C(=O)S1,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells in at -80 mV holding potential by automated Qpatch clamp assay
11976,CHEMBL74656,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC,IC50,nM,=,190.0,Inhibition of human ERG expressed in CHO cells in at -80 mV holding potential by automated Qpatch clamp assay
11977,CHEMBL3648680,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1,IC50,nM,=,2700.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by patch clamp assay
11978,CHEMBL4544141,O=C1OCc2cc(C3CN4CCN(C(=O)Cc5ccc(-n6cnnn6)cc5)CC4CO3)ccc21,IC50,nM,=,21100.0,Inhibition of human ERG
11979,CHEMBL3987135,O=C1OCCc2cc([C@@H]3CN4CCN(C(=O)Cc5ccc(-n6cnnn6)cc5)C[C@H]4CO3)ccc21,IC50,nM,=,75900.0,Inhibition of human ERG
11980,CHEMBL4451354,Cc1c(C#N)cccc1[C@@H]1CN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)C[C@H]2CO1,IC50,nM,=,14800.0,Inhibition of human ERG
11981,CHEMBL3933749,Cc1c([C@@H]2CN3CCN(C(=O)Cc4ccc(-n5cnnn5)cn4)C[C@H]3CO2)ccc(F)c1C#N,IC50,nM,=,20300.0,Inhibition of human ERG
11982,CHEMBL4550510,N#Cc1ccc(O[C@H]2CN(S(=O)(=O)c3ccc(Cl)cn3)C[C@@]2(O)CN)cc1F,IC50,nM,=,20000.0,Inhibition of human ERG by electrophysiology
11983,CHEMBL4517101,N#Cc1ccc(O[C@H]2CN(S(=O)(=O)c3ccc(Cl)cc3Cl)C[C@@]2(O)CN)cc1F,IC50,nM,=,3000.0,Inhibition of human ERG by electrophysiology
11984,CHEMBL4557670,C[C@H]1SC(N)=N[C@](C)(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)[C@H]1F,IC50,nM,=,5100.0,Inhibition of human ERG at -80 mV holding potential by automated Qpatch clamp assay
11985,CHEMBL4537998,O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@@H]1c1ccc(Cl)cc1,IC50,nM,=,3000.0,Inhibition of human ERG expressed in HEK293 cells at holding potential -80 mV by whole-cell voltage-clamp method
11986,CHEMBL4458424,O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1,IC50,nM,=,10600.0,Inhibition of human ERG expressed in HEK293 cells at holding potential -80 mV by whole-cell voltage-clamp method
11987,CHEMBL4447631,Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1,IC50,nM,=,28000.0,Inhibition of human ERG
11988,CHEMBL4458562,Cc1cnc(Nc2ccnn2C)nc1-c1cn2c(n1)C(=O)N(Cc1ccc(F)c(F)c1)CC2,IC50,nM,=,23000.0,Inhibition of human ERG
11989,CHEMBL4587118,Cc1cnc(Nc2ccnn2C)nc1-c1cc2n(c1)CCN(Cc1ccc(F)c(F)c1)C2=O,IC50,,,,Inhibition of human ERG
11990,CHEMBL4551714,COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)cc2C(=O)N1Cc1cccc(C)n1,IC50,nM,=,20000.0,Inhibition of human ERG
11991,CHEMBL4440109,Cc1cnc(Nc2ccnn2C)nc1-c1cn2c(n1)C(=O)N(Cc1ccc(F)c(F)c1)[C@@H](C)C2,IC50,nM,=,23000.0,Inhibition of human ERG
11992,CHEMBL4482864,COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1,IC50,nM,=,11000.0,Inhibition of human ERG
11993,CHEMBL4521594,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,IC50,nM,>,10000.0,Inhibition of human ERG
11994,CHEMBL4587968,Cn1cc(-c2ccc3c(c2)CC[C@]32NC(=O)N(CC(=O)N3Cc4cc(F)ccc4OC[C@H]3C(F)(F)F)C2=O)cn1,IC50,nM,>,40000.0,Inhibition of human ERG
11995,CHEMBL4455404,Cc1cc([C@@H]2C[C@@H]3CC[C@H]2C3)n(O)c(=O)c1.NCCO,IC50,nM,>,40000.0,Inhibition of human ERG stably expressed in CHO cells at -80 mV by automated Qpatch electrophysiological assay
11996,CHEMBL242580,Cc1cc(C2CCCCC2)n(O)c(=O)c1.NCCO,IC50,nM,>,40000.0,Inhibition of human ERG stably expressed in CHO cells at -80 mV by automated Qpatch electrophysiological assay
11997,CHEMBL4576115,Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N,IC50,nM,>,40000.0,Inhibition of human ERG by Qpatch automatic patch-clamp assays
11998,CHEMBL4444503,C[S+]([O-])c1ccc(-c2ccc3ncc(-c4ccc([S+](C)[O-])cc4)n3n2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
11999,CHEMBL4528812,C[S+]([O-])c1ccc(-c2ccc3ncc(-c4ccc(S(C)(=O)=O)cc4)n3n2)cc1,IC50,nM,=,17900.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12000,CHEMBL4513767,C[S+]([O-])c1ccc(-c2cnc3ccc(-c4ccc(S(C)(=O)=O)cc4)nn23)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12001,CHEMBL4483664,CCN(CC)Cc1cc(-c2ccc3ncc(-c4ccc([S+](C)[O-])cc4)n3n2)ccc1F,IC50,nM,=,590.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12002,CHEMBL4442584,CCN(CC)Cc1ccc(-c2ccc3ncc(-c4ccc(S(C)(=O)=O)cc4)n3n2)cc1F,IC50,nM,=,5200.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12003,CHEMBL4587589,CCN(CC)Cc1cc(-c2cnc3ccc(-c4cccc([S+](C)[O-])c4)nn23)ccc1F,IC50,,,,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12004,CHEMBL4476063,C[S+]([O-])c1cccc(-c2ccc3ncc(-c4cccc([S+](C)[O-])c4)n3n2)c1,IC50,nM,=,8450.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12005,CHEMBL4465203,C[S+]([O-])c1ccc(-c2cnc3ccc(Nc4cccc(S(C)(=O)=O)c4)nn23)cc1,IC50,nM,=,2360.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12006,CHEMBL4562181,C[S+]([O-])c1ccc(-c2cnc3ccc(Nc4cccc([S+](C)[O-])c4)nn23)cc1,IC50,nM,=,18200.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12007,CHEMBL4443635,C[S+]([O-])c1ccc(Nc2ccc3ncc(-c4ccc([S+](C)[O-])cc4)n3n2)cc1,IC50,nM,=,32300.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12008,CHEMBL4444857,C[S+]([O-])c1ccc(-c2cnc3ccc(Nc4ccc(S(C)(=O)=O)cc4)nn23)cc1,IC50,nM,=,26100.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12009,CHEMBL4562638,C[S+]([O-])c1ccc(-c2cnc3ccc(Nc4cnccn4)nn23)cc1,IC50,nM,=,7840.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12010,CHEMBL4445885,C[S+]([O-])c1ccc(-c2cnc3ccc(NC4CCS(=O)(=O)CC4)nn23)cc1,IC50,nM,=,28800.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12011,CHEMBL4445827,C[S+]([O-])c1ccc(-c2cnc3ccc(NC4CCN(S(C)(=O)=O)CC4)nn23)cc1,IC50,nM,=,25900.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12012,CHEMBL4582849,CCN(CC)Cc1cc(Nc2ccc3ncc(-c4ccc([S+](C)[O-])cc4)n3n2)ccc1O,IC50,nM,=,7830.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12013,CHEMBL4558874,CS(=O)(=O)c1cccc(-c2ccc3ncc(-c4cccc(S(C)(=O)=O)c4)n3n2)c1,IC50,nM,=,2350.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12014,CHEMBL4444105,CS(=O)(=O)c1ccc(-c2ccc3ncc(-c4cccc(S(C)(=O)=O)c4)n3n2)cc1,IC50,nM,=,4000.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12015,CHEMBL4554895,C[S+]([O-])c1ccc(-c2ccc3ncc(-c4cccc(S(C)(=O)=O)c4)n3n2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12016,CHEMBL4451616,C[S+]([O-])c1ccc(-c2ccc3ncc(-c4cccc([S+](C)[O-])c4)n3n2)cc1,IC50,nM,=,21100.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by QPatch clamp method
12017,CHEMBL4456608,CCN(CC)/[N+]([O-])=N/OCOC(=O)/C=C/c1ccc(OC(=O)OCN2C(=O)SC(Cc3ccc(OCCN(C)c4ccccn4)cc3)C2=O)c(OC)c1,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
12018,CHEMBL121,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,IC50,nM,=,29500.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
12019,CHEMBL4577928,O=C(O)CNC(=O)c1c(O)c2c(n(Cc3ccc(C(F)(F)F)cc3)c1=O)COC2,IC50,nM,>,60000.0,Inhibition of iKr (unknown origin)
12020,CHEMBL4518465,O=[N+]([O-])c1ccc2c(c1)ncn2Cc1ccc(O)c2ncccc12,IC50,nM,=,22000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 2.5 mins by Qpatch clamp assay
12021,CHEMBL4448093,Oc1ccc(Cn2c(-c3cscn3)nc3ccccc32)c2cccnc12,IC50,nM,=,18000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential after 2.5 mins by Qpatch clamp assay
12022,CHEMBL4452291,C[C@@H](C(N)=O)[C@H](N)c1cn2cc(C(C)(C)C)ccc2n1,IC50,nM,>,72000.0,Inhibition of human ERG
12023,CHEMBL4466809,CC(C)(C)c1ccc2[nH]c(C(C)(C)N)nc2c1,IC50,nM,=,41000.0,Inhibition of human ERG
12024,CHEMBL4297317,C[C@@H](C(N)=O)[C@H](N)c1nc2ccc(C(C)(C)C)cc2[nH]1,IC50,nM,>,30000.0,Inhibition of human ERG
12025,CHEMBL4465428,Cl.O=S(=O)(/C=C/c1ncccc1F)c1ccc(OCCCN2CCOCC2)cc1,IC50,nM,=,112100.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12026,CHEMBL4445670,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,IC50,nM,>,10000.0,Inhibition of recombinant human ERG expressed in HEK293 cells at -80 mV holding potential by automated voltage-clamp assay
12027,CHEMBL4546437,CCCCc1nc(C(C)C)c(CC(=O)OCC)c(=O)n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,IC50,nM,=,8100.0,Inhibition of human ERG by automated patch clamp method
12028,CHEMBL4441094,CS(=O)(=O)c1cc(CNC(=O)c2cncc3c2cnn3-c2ccc(F)cc2)ccn1,IC50,nM,=,30000.0,Inhibition of human ERG by patch clamp method
12029,CHEMBL4456123,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,IC50,nM,=,68000.0,Inhibition of human ERG by patch clamp method
12030,CHEMBL4464625,CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp method
12031,CHEMBL4457118,O=C(c1ccc(-c2ccc(F)c(F)c2)o1)N1CCN(Cc2ccc(OC3CCNCC3)c(Cl)c2)CC1,IC50,nM,=,4000.0,Binding affinity to human ERG
12032,CHEMBL4447340,CC1=C(c2cccc(O)c2)[C@H](c2ccc(OCCN3CC(CF)C3)cc2)Oc2ccc(O)cc21,IC50,nM,=,4600.0,Inhibition of human ERG by patch clamp method
12033,CHEMBL4463663,Nc1cc(F)c(S(=O)(=O)N2CCC(O)CC2)cc1C(=O)Nc1cc(F)c(F)c(F)c1,IC50,nM,=,8780.0,Inhibition of human ERG expressed in human HEK293 cells by patch clamp assay
12034,CHEMBL4463663,Nc1cc(F)c(S(=O)(=O)N2CCC(O)CC2)cc1C(=O)Nc1cc(F)c(F)c(F)c1,IC50,nM,=,10900.0,Inhibition of human ERG by competitive fluorescence polarization assay
12035,CHEMBL4514379,N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12,IC50,nM,>,10000.0,Inhibition of human ERG by electrophysiology analysis
12036,CHEMBL4462496,CN(C)C(=O)Cn1ccc2ncc(-c3ccc(C(F)(F)F)cc3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12037,CHEMBL4571666,CN(C)C(=O)Cn1ccc2ncc(-c3cccc(C(F)(F)F)c3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12038,CHEMBL4515350,O=C(Cn1ccc2ncc(-c3cccc(C(F)(F)F)c3)cc21)N1CCC1,IC50,nM,=,5300.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12039,CHEMBL4463483,CN(C)C(=O)Cn1ccc2ncc(-c3ccccc3C(F)(F)F)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12040,CHEMBL4462073,CN(C)C(=O)Cn1ccc2ncc(-c3cccc(C(F)(F)F)n3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12041,CHEMBL4442512,CN(C)C(=O)Cn1ccc2ncc(-c3cncc(C(F)(F)F)c3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12042,CHEMBL4513602,CN(C)C(=O)Cn1ccc2ncc(-c3ccnc(C(F)(F)F)c3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12043,CHEMBL4451099,CN(C)C(=O)Cn1ccc2ncc(-c3cccc(Cl)c3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12044,CHEMBL4474982,Cc1cccc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)c1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12045,CHEMBL4593473,CN(C)C(=O)Cn1ccc2ncc(-c3ccc(F)c(Cl)c3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12046,CHEMBL4547576,CN(C)C(=O)Cn1ccc2ncc(-c3ccc(F)c(C(F)F)c3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12047,CHEMBL4467491,O=C(Cn1ccc2ncc(-c3ccc(F)c(C(F)F)c3)cc21)N1CCC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12048,CHEMBL4591770,CN(C)C(=O)Cn1ccc2ncc(-c3ccc(F)c(F)c3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12049,CHEMBL4531750,CN(C)C(=O)Cn1ccc2ncc(-c3ccc(C(F)(F)F)s3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12050,CHEMBL4575739,Cc1ccc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)s1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12051,CHEMBL4529810,Cc1csc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)c1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12052,CHEMBL4211247,CN(C)C(=O)Cn1ccc2ncc(-c3ccc(Cl)s3)cc21,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12053,CHEMBL4529074,Cc1cc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)sc1Cl,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12054,CHEMBL4451514,Cc1cc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)ccc1Cl,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis
12055,CHEMBL4518161,Cc1nn(-c2ccc(CN)cc2)c(C)c1-c1ccc(F)cc1,IC50,nM,>,30000.0,Inhibition of human ERG incubated for 4 hrs by fluorescence polarization assay
12056,CHEMBL4587871,Cc1nn(-c2ccc3c(c2)CNC3)c(C)c1-c1ccc(F)cc1,IC50,nM,>,30000.0,Inhibition of human ERG incubated for 4 hrs by fluorescence polarization assay
12057,CHEMBL4442568,Cc1nn(-c2ncnc3c2CNC3)c(C)c1-c1ccc(F)cc1,IC50,nM,>,30000.0,Inhibition of human ERG incubated for 4 hrs by fluorescence polarization assay
12058,CHEMBL4468395,CN1CCC(Nc2cccc3ccc(-c4nnc5c6c(cnn45)N(C)CCO6)nc23)CC1,IC50,nM,>,20000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12059,CHEMBL4543342,CN1CCC(CNc2cccc3ccc(-c4nnc5c6c(cnn45)N(C)CCO6)nc23)CC1,IC50,nM,>,20000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12060,CHEMBL4576509,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,nM,=,19700.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12061,CHEMBL4547383,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCCCC5)c4n3)nnc21,IC50,nM,>,20000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12062,CHEMBL4556293,COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,IC50,nM,>,20000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12063,CHEMBL4483071,CN1CCOc2c1cnn1c(-c3ccc4ccc(Cl)c(NCC5(F)CCNCC5)c4n3)nnc21,IC50,nM,=,2100.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12064,CHEMBL4526558,CN1CCOc2c1cnn1c(-c3ccc4c(F)c(F)cc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,nM,>,20000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12065,CHEMBL4527736,CN1CCOc2c1cnn1c(-c3ccc4c(F)ccc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,nM,>,20000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12066,CHEMBL4460019,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NCC5(F)CCNCC5)c4c3)nnc21,IC50,nM,>,20000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12067,CHEMBL4521827,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NC5CCCCC5)c4c3)nnc21,IC50,nM,=,4000.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12068,CHEMBL4449598,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCCCC5)c4c3)nnc21,IC50,nM,=,6060.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12069,CHEMBL1952142,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(OC(F)(F)F)c1,IC50,nM,=,2100.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12070,CHEMBL1952329,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,nM,=,511.0,Inhibition of human ERG incubated for 1 hr by Fluorescence polarization binding assay
12071,CHEMBL4590082,Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2,IC50,nM,>,30000.0,Inhibition of human ERG
12072,CHEMBL4443422,Cc1sc(-c2ccccc2Cl)cc1C(=O)N[C@@H](CN)c1ccccc1,IC50,nM,=,6700.0,Inhibition of human ERG by QPatch assay
12073,CHEMBL4445556,NC[C@H](Oc1noc2ccc(-c3ccccc3Cl)cc12)c1ccccc1,IC50,nM,=,23000.0,Inhibition of human ERG by QPatch assay
12074,CHEMBL4471339,NC[C@H](Oc1noc2ncc(-c3ccccc3Cl)cc12)c1ccccc1,IC50,,,,Inhibition of human ERG by QPatch assay
12075,CHEMBL4528547,NC[C@H](Oc1noc2ccc(-c3ccccc3Cl)nc12)c1ccccc1,IC50,nM,=,3600.0,Inhibition of human ERG by QPatch assay
12076,CHEMBL4467227,NCC(Oc1noc2ccc(-c3ccccc3Cl)cc12)c1ccccn1,IC50,,,,Inhibition of human ERG by QPatch assay
12077,CHEMBL4592805,N=C(N)NC[C@H](Oc1noc2ccc(-c3ccccc3Cl)cc12)c1ccccc1,IC50,nM,=,9500.0,Inhibition of human ERG by QPatch assay
12078,CHEMBL3952064,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)cs2)CO1,IC50,nM,=,9900.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
12079,CHEMBL4574502,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ncc(NC(=O)c3ccc(OC(F)F)cn3)s2)CO1,IC50,nM,=,11970.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
12080,CHEMBL4483673,C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2cc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)CO1,IC50,nM,=,400.0,Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by patch clamp method
12081,CHEMBL4583691,Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1,IC50,nM,>,10000.0,Inhibition of human ERG by patch clamp method
12082,CHEMBL4560579,C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(C)N=C(N)S[C@@]4(COC)C[C@H]43)c2)cn1,IC50,nM,=,6900.0,Inhibition of human ERG
12083,CHEMBL4570428,Nc1nc2cccc(-c3cccc(Cl)c3Cl)n2n1,IC50,nM,>,25000.0,Inhibition of human ERG
12084,CHEMBL4472275,Cc1noc(C)c1NC(=O)[C@@H]1CCCC[C@H]1C(=O)c1ccc(-c2cc[nH]n2)cc1,IC50,nM,>,12589.25,Inhibition of human ERG by high-throughput electrophysiology assay
12085,CHEMBL4554389,Cc1nn(C)cc1NC(=O)[C@@H]1CCCC[C@H]1C(=O)c1ccc(-c2cc[nH]n2)cc1,IC50,nM,>,12589.25,Inhibition of human ERG by high-throughput electrophysiology assay
12086,CHEMBL4528928,Cc1cc(-c2ccc(C(=O)[C@@H]3CCCC[C@H]3C(=O)Nc3cn(C)nc3C)cc2)n[nH]1,IC50,nM,>,100000.0,Inhibition of human ERG by high-throughput electrophysiology assay
12087,CHEMBL4528662,COc1cc(NC(=O)[C@@H]2CCCC[C@H]2C(=O)c2ccc(-c3cc[nH]n3)cc2)ncn1,IC50,nM,=,12589.25,Inhibition of human ERG by high-throughput electrophysiology assay
12088,CHEMBL4533700,O=C(Nc1cnn2cccnc12)[C@@H]1CCCC[C@H]1C(=O)c1ccc(-c2cc[nH]n2)cc1,IC50,nM,>,31622.78,Inhibition of human ERG by high-throughput electrophysiology assay
12089,CHEMBL4463314,Cn1cc(NC(=O)[C@@H]2CCCC[C@H]2C(=O)c2ccc(-c3cc[nH]n3)cc2)c(C(F)(F)F)n1,IC50,nM,>,31622.78,Inhibition of human ERG by high-throughput electrophysiology assay
12090,CHEMBL4450838,Cc1cc(-c2ccc(C(=O)[C@@H]3CCCC[C@H]3C(=O)Nc3cn(C)nc3C(N)=O)cc2)[nH]n1,IC50,nM,>,31622.78,Inhibition of human ERG by high-throughput electrophysiology assay
12091,CHEMBL4554158,Cc1nn(C)cc1NC(=O)[C@@H]1CCCC[C@H]1C(=O)c1ccc(-c2cc[nH]n2)cc1F,IC50,nM,>,12589.25,Inhibition of human ERG by high-throughput electrophysiology assay
12092,CHEMBL4442899,Cc1cc(-c2ccc(C(=O)[C@@H]3CCCC[C@H]3C(=O)Nc3cn(C)nc3C(N)=O)c(F)c2)[nH]n1,IC50,nM,>,31622.78,Inhibition of human ERG by high-throughput electrophysiology assay
12093,CHEMBL4472842,Cc1cc(-c2ccc3c([C@@H]4CCCC[C@H]4C(=O)Nc4cn(C)nc4C(N)=O)noc3c2)n[nH]1,IC50,nM,>,31622.78,Inhibition of human ERG by high-throughput electrophysiology assay
12094,CHEMBL3647536,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21,IC50,nM,=,26800.0,Inhibition of human ERG by electrophysiology method
12095,CHEMBL4545044,CCn1cnc2c(-c3ccc(F)c(-c4cc5c(cc4OC)C(=O)N(C)C5)c3)cnnc21,IC50,nM,>,30000.0,Inhibition of human ERG by electrophysiology method
12096,CHEMBL3989870,CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1,IC50,nM,=,3000.0,Inhibition of human ERG
12097,CHEMBL3545369,NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,IC50,nM,>,40000.0,Inhibition of human ERG
12098,CHEMBL4589417,O=S1(=O)NCCN1CCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,IC50,nM,>,40000.0,Inhibition of human ERG
12099,CHEMBL4451860,O=S1(=O)CCCN1CCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,IC50,nM,=,17270.0,Inhibition of human ERG
12100,CHEMBL4443777,O=C1OCCN1CCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,IC50,nM,=,31120.0,Inhibition of human ERG
12101,CHEMBL4447439,COCCN1CCN(CCNc2nonc2/C(=N/O)Nc2ccc(F)c(Br)c2)S1(=O)=O,IC50,nM,=,16630.0,Inhibition of human ERG
12102,CHEMBL4558162,Cc1ccc2c(c1)nc(CCN1C(=O)c3cccc4cccc(c34)C1=O)n2-c1ccncc1,IC50,nM,=,4700.0,Inhibition of human ERG expressd in CHO-hERG cells after 2.5 hrs by Rb+ efflux assay
12103,CHEMBL4469488,O=C(NCCc1cc(C(=O)NO)no1)c1ccc(Cl)c(Cl)c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells by manual-patch clamp assay
12104,CHEMBL1213603,CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12105,CHEMBL4570378,CCNC1=N[C@H]2[C@H](O[C@H](COC)[C@@H](O)[C@@H]2O)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12106,CHEMBL4577980,CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](OC)[C@@H]2O)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12107,CHEMBL4519186,CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2OC)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12108,CHEMBL4483089,CCN(C)C1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12109,CHEMBL4110677,CCNC1=N[C@H]2[C@H](O[C@H](C)[C@@H](O)[C@@H]2O)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12110,CHEMBL4520749,CCNC1=N[C@@H]2[C@@H](O)C[C@@H](CO)O[C@@H]2S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12111,CHEMBL4107048,CCNC1=N[C@@H]2C[C@H](O)[C@@H](CO)O[C@@H]2S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12112,CHEMBL4543991,CCNC1=N[C@H]2[C@H](O[C@H](CF)[C@@H](O)[C@@H]2O)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12113,CHEMBL4554360,CCNC1=N[C@H]2[C@H](O[C@H](CO)C(F)[C@@H]2O)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12114,CHEMBL4448352,CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2F)S1,IC50,nM,>,30000.0,Displacement of MK-0499 from human ERG
12115,CHEMBL4588734,CC(C)(C)OC(=O)n1c2c(c3ccccc31)C[C@H]1C(=O)N3C[C@@H](CC(=O)O)C[C@H]3[C@@H]2N1C(=O)CC1CCC(F)(F)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
12116,CHEMBL4541206,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,400.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12117,CHEMBL4467749,C[C@@H]1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12118,CHEMBL4450665,C[C@H]1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,1200.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12119,CHEMBL4515812,CCC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,400.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12120,CHEMBL4436170,CC(C)C1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,1200.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12121,CHEMBL4439285,COCC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,1900.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12122,CHEMBL4459117,O=C1C(CO)OC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1,IC50,nM,=,1100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12123,CHEMBL4528962,O=C1C(COCc2ccccc2)OC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1,IC50,nM,=,100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12124,CHEMBL4446209,COC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,200.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12125,CHEMBL4546076,O=C(O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12126,CHEMBL4458456,CN(C)C(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12127,CHEMBL4516327,CC1(C)OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12128,CHEMBL4438550,O=C1N(c2ccccc2)CC2(CCN(CCc3ccccc3)CC2)OC12CC2,IC50,nM,=,1200.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12129,CHEMBL4452042,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2Cl)C1=O,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12130,CHEMBL4584335,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2F)C1=O,IC50,nM,=,1200.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12131,CHEMBL4526087,COc1ccccc1N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12132,CHEMBL4592081,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccc2O)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12133,CHEMBL4550656,COc1cccc(N2CC3(CCN(CCc4ccccc4)CC3)OC(C)C2=O)c1,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12134,CHEMBL4471711,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cccc(O)c2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12135,CHEMBL4457602,COc1ccc(N2CC3(CCN(CCc4ccccc4)CC3)OC(C)C2=O)cc1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12136,CHEMBL4513933,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccc(O)cc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12137,CHEMBL4578955,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccccn2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12138,CHEMBL4440055,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cccnc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12139,CHEMBL4448710,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccncc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12140,CHEMBL4439718,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cnccn2)C1=O,IC50,nM,=,100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12141,CHEMBL4538620,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cccc(C(F)(F)F)n2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12142,CHEMBL4483643,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ncccc2F)C1=O,IC50,nM,=,1200.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12143,CHEMBL4448670,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ncccc2C(F)(F)F)C1=O,IC50,nM,=,8200.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12144,CHEMBL4470425,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cncc(F)c2)C1=O,IC50,nM,=,1100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12145,CHEMBL4560624,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2ccc(C(F)(F)F)nc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12146,CHEMBL4460762,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cnccc2C(F)(F)F)C1=O,IC50,nM,=,3300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12147,CHEMBL4535897,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cccnc2C(F)(F)F)C1=O,IC50,nM,=,3800.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12148,CHEMBL4593220,CC1OC2(CCN(CCc3ccccc3)CC2)CN(c2cncc(C(F)(F)F)c2)C1=O,IC50,nM,=,500.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12149,CHEMBL4536259,CC1OC2(CCN(CCc3ccccc3F)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,800.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12150,CHEMBL4534193,CC1OC2(CCN(CCc3cccc(F)c3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12151,CHEMBL4544352,CC1OC2(CCN(CCc3ccc(F)cc3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12152,CHEMBL4451838,CC(=O)Nc1ccccc1CCN1CCC2(CC1)CN(c1ccccc1)C(=O)C(C)O2,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12153,CHEMBL4573960,CC(=O)Nc1cccc(CCN2CCC3(CC2)CN(c2ccccc2)C(=O)C(C)O3)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12154,CHEMBL4463901,CC(=O)Nc1ccc(CCN2CCC3(CC2)CN(c2ccccc2)C(=O)C(C)O3)cc1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12155,CHEMBL4463621,CC1OC2(CCN(CCc3cccc(C#N)c3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12156,CHEMBL4473746,CC1OC2(CCN(CCc3ccccn3)CC2)CN(c2ccccc2)C1=O,IC50,nM,=,2000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12157,CHEMBL4571738,CC1OC2(CCN(CCc3cccnc3)CC2)CN(c2ccccc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12158,CHEMBL4445578,CC1OC2(CCN(CCc3ccncc3)CC2)CN(c2ccccc2)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12159,CHEMBL4540888,CC1OC2(CCN(CCc3ccccn3)CC2)CN(c2cnccc2C(F)(F)F)C1=O,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12160,CHEMBL4576031,C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(c2cnccc2C(F)(F)F)C1=O,IC50,nM,=,6300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12161,CHEMBL4522004,C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(c2ncccc2C(F)(F)F)C1=O,IC50,nM,=,6600.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12162,CHEMBL4525653,CC(=O)Nc1cccc(CCN2CCC3(CC2)CN(c2ccccc2)C(=O)[C@@H](C)O3)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12163,CHEMBL4461774,O=C1N(c2cccnc2C(F)(F)F)CC2(CCN(CCc3ccccc3F)CC2)OC12CC2,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in channel current at -80 mV holding potential by whole cell patch clamp assay
12164,CHEMBL4537231,C=CC(=O)N1CCC[C@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C,IC50,nM,=,49.0,Inhibition of dofetilide binding to flag-tagged human ERG
12165,CHEMBL4483575,C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C,IC50,nM,=,1400.0,Inhibition of human ERG by Qpatch clamp method
12166,CHEMBL4468719,CCC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C,IC50,nM,=,2900.0,Inhibition of human ERG by Qpatch clamp method
12167,CHEMBL4526732,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2sccc12,IC50,nM,=,979.0,Inhibition of human ERG expressed in HEK293 cells by whole cell electrophysiology assay
12168,CHEMBL4094163,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,IC50,nM,=,186.0,Inhibition of human ERG expressed in HEK293 cells by whole cell electrophysiology assay
12169,CHEMBL175691,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,IC50,nM,=,500.0,Inhibition of human ERG expressed in HEK293 cells by whole cell electrophysiology assay
12170,CHEMBL3929927,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,IC50,nM,=,130.0,Inhibition of human ERG expressed in HEK293 cells by whole cell electrophysiology assay
12171,CHEMBL4473213,CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1,IC50,nM,=,7570.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
12172,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,27.0,Inhibition of human ERG expressed in HEK293 cells by patch clamp assay
12173,CHEMBL4451408,COc1nc(N[C@@H](C)c2cc3cc(Cl)ccc3[nH]c2=O)ncc1C#N,IC50,nM,=,3200.0,Inhibition of human ERG by patch clamp method
12174,CHEMBL4437106,CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(c3cccnn3)C2)s1)c1ccccc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by Ionworks electrophysiology assay
12175,CHEMBL3808443,CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(c3nccnn3)C2)s1)c1ccccc1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by Ionworks electrophysiology assay
12176,CHEMBL4475126,CON=C1CCC(CN2CCN(c3nc(=O)c4cc(C(F)(F)F)cc([N+](=O)[O-])c4s3)CC2)CC1,IC50,nM,=,47980.0,Inhibition of human ERG transfected in HEK293 cells by whole-cell patch clamp method
12177,CHEMBL4571987,CCON=C1CCC(CN2CCN(c3nc(=O)c4cc(C(F)(F)F)cc([N+](=O)[O-])c4s3)CC2)CC1,IC50,nM,=,38920.0,Inhibition of human ERG transfected in HEK293 cells by whole-cell patch clamp method
12178,CHEMBL3330226,O=c1nc(N2CCN(CC3CCCCC3)CC2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12,IC50,nM,=,101700.0,Inhibition of human ERG transfected in HEK293 cells by whole-cell patch clamp method
12179,CHEMBL3109802,COc1ncnc(Cn2cc(C(=O)NCCO)c3ncc(C)cc32)c1C,IC50,nM,>,33000.0,Inhibition of human ERG
12180,CHEMBL4473847,COc1ncnc(Cn2cnc3c(C(=O)NCCF)cccc32)c1C,IC50,nM,>,33000.0,Inhibition of human ERG
12181,CHEMBL4515785,COc1cc(C(=O)NCCF)c2ncn(Cc3ncnc(N(C)C)c3C)c2c1,IC50,nM,>,33000.0,Inhibition of human ERG
12182,CHEMBL4563408,O=C(Nc1ccc(OC(F)F)nc1)NC1CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1,IC50,nM,>,10000.0,Displacement of [3H]dofetilide from recombinant human ERG after 60 mins by scintillation counting analysis
12183,CHEMBL4436115,O=C(CC(O)(C(F)(F)F)C(F)(F)F)N[C@@](Cc1ccccc1)(c1cc(F)cc(C(F)(F)F)c1)c1ccc(Cl)cn1,IC50,nM,=,22000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12184,CHEMBL4448253,NC(C(=O)N[C@@](Cc1ccccc1)(c1cc(F)cc(OC(F)(F)C(F)F)c1)c1ccc(Cl)cn1)C(O)(C(F)(F)F)C(F)(F)F,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12185,CHEMBL4448253,NC(C(=O)N[C@@](Cc1ccccc1)(c1cc(F)cc(OC(F)(F)C(F)F)c1)c1ccc(Cl)cn1)C(O)(C(F)(F)F)C(F)(F)F,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12186,CHEMBL4473304,NC(C(=O)N[C@](Cc1ccccc1)(c1ccc(F)cc1)c1cc(F)cc(C(F)(F)F)c1)C(O)(C(F)(F)F)C(F)(F)F,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12187,CHEMBL4545593,CNC(C(=O)N[C@](Cc1ccccc1)(c1ccc(F)cc1)c1cc(F)cc(C(F)(F)F)c1)C(O)(C(F)(F)F)C(F)(F)F,IC50,nM,=,13000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12188,CHEMBL4452514,CC(C)NC(C(=O)N[C@](Cc1ccccc1)(c1ccc(F)cc1)c1cc(F)cc(C(F)(F)F)c1)C(O)(C(F)(F)F)C(F)(F)F,IC50,nM,=,63000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12189,CHEMBL4468680,CN(C)C(C(=O)N[C@](Cc1ccccc1)(c1ccc(F)cc1)c1cc(F)cc(C(F)(F)F)c1)C(O)(C(F)(F)F)C(F)(F)F,IC50,nM,=,16000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12190,CHEMBL4457286,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC(=O)C(N)C(O)(C(F)(F)F)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,44000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12191,CHEMBL4439823,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC(=O)C(O)C(O)(C(F)(F)F)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,11000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12192,CHEMBL4552555,CC(C)Oc1cc([C@@](Cc2ccccc2)(NCC(O)C(O)(C(F)(F)F)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,=,12000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12193,CHEMBL4468692,CC(C)Oc1cc([C@@](Cc2ccccc2)(NCC(N)C(O)(C(F)(F)F)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12194,CHEMBL4574163,NC(C(=O)N[C@@](Cc1ccccc1)(c1cc(F)cc(OC(F)(F)C(F)F)c1)c1ccc(F)c(OC2CC2)c1)C(O)(C(F)(F)F)C(F)(F)F,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12195,CHEMBL4439856,CC(C)Oc1cc([C@@](Cc2ccccc2)(NC(=O)C(N)C(O)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12196,CHEMBL4469874,CC(C)(C)Oc1cc([C@@](Cc2ccccc2)(NC(=O)C(N)C(O)(C(F)(F)F)C(F)(F)F)c2cc(F)cc(OC(F)(F)C(F)F)c2)ccc1F,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12197,CHEMBL4475826,O=C(N[C@@](Cc1ccccc1)(c1cc(F)cc(C(F)(F)F)c1)c1ccc(Cl)cn1)C(O)C(O)(C(F)(F)F)C(F)(F)F,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method
12198,CHEMBL4464246,CCOCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1,IC50,nM,=,6100.0,Inhibition of human ERG
12199,CHEMBL4591825,COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1,IC50,nM,=,16000.0,Inhibition of human ERG
12200,CHEMBL4514780,CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO,IC50,nM,>,30000.0,Inhibition of human ERG (1159 residues) expressed in CHOK1 cells at -80 mV holding potential measured after 5 mins by QPatch electrophysiology method
12201,CHEMBL4516875,CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCOP(=O)(O)O.[CaH2],IC50,nM,>,30000.0,Inhibition of human ERG (1159 residues) expressed in CHOK1 cells at -80 mV holding potential measured after 5 mins by QPatch electrophysiology method
12202,CHEMBL4473105,COc1cc2ncnc(Nc3ccc4scnc4c3)c2cc1S(=O)(=O)C(C)(C)C,IC50,nM,>,30000.0,Inhibition of human ERG (1159 residues) expressed in CHOK1 cells at -80 mV holding potential measured after 5 mins by QPatch electrophysiology method
12203,CHEMBL63560,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells by whole-cell voltage-clamp analysis
12204,CHEMBL4473164,CC(O)(COc1cccc(S(F)(F)(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells by whole-cell voltage-clamp analysis
12205,CHEMBL4581912,CC(O)(COc1ccccc1C(F)(F)F)C(=O)Nc1ccc(S(F)(F)(F)(F)F)cc1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells by whole-cell voltage-clamp analysis
12206,CHEMBL4472931,CC(O)(COc1ccc(S(F)(F)(F)(F)F)cc1)C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,nM,>,25000.0,Inhibition of human ERG expressed in CHO cells by whole-cell voltage-clamp analysis
12207,CHEMBL4516798,COc1ccccc1-c1n[nH]c2nc(N[C@H]3CC[C@H](NS(=O)(=O)CCC(F)(F)F)CC3)nc(OC)c12,IC50,nM,=,17500.0,Inhibition of human ERG by patch clamp assay
12208,CHEMBL4563818,C[C@H]1CN(c2n[nH]c3nc(N[C@H]4CC[C@H](NS(=O)(=O)CCC(F)(F)F)CC4)ncc23)CCO1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
12209,CHEMBL4572962,COc1nc(N[C@H]2CC[C@H](NS(=O)(=O)CCC(C)C)CC2)nc2[nH]nc(N3CCOC[C@H]3C)c12,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
12210,CHEMBL4533718,OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O,IC50,nM,>,30000.0,Inhibition of human ERG by fluorescence polarization assay
12211,CHEMBL4514678,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(C(N)=O)cc3)CC2)nc2c1COC2,IC50,nM,=,830.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual patch clamp assay
12212,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,86.0,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual patch clamp assay
12213,CHEMBL4568404,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5(C)CC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,nM,>,30000.0,Inhibition of human ERG
12214,CHEMBL4593911,Cl.Cl.O=C(CN1CCOCC1)Nc1ccc(OC2CCN(C3CCC3)CC2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch clamp assay
12215,CHEMBL4448852,C[C@@H]1Cc2c(ccc3[nH]ncc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F,IC50,nM,>,100000.0,Inhibition of human ERG by plate based planar patch clamp assay
12216,CHEMBL4436187,C[C@@H]1Cc2c(ccc3[nH]ncc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(F)F,IC50,nM,>,100000.0,Inhibition of human ERG by plate based planar patch clamp assay
12217,CHEMBL4564985,CC(C)(O)c1cccc(-c2ccc3nc(-c4ccc(Cl)cc4)cn3c2)c1,IC50,nM,=,1500.0,Inhibition of human ERG
12218,CHEMBL4546649,O=C(CCn1ccnc1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12219,CHEMBL4455137,Cc1nccn1CCC(=O)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12220,CHEMBL4581097,Cc1cn(CCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)cn1,IC50,nM,>,1000.0,Inhibition of human ERG
12221,CHEMBL4476726,O=C(CCn1cnc2ccccc21)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12222,CHEMBL4441884,O=C(CCn1cccn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12223,CHEMBL4471609,Cc1cc(C)n(CCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12224,CHEMBL4559166,O=C(CCn1cncn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12225,CHEMBL4542854,O=C(CCn1ccnn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12226,CHEMBL4577335,O=C(CCn1nccn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12227,CHEMBL4514784,Cc1nnn(CCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12228,CHEMBL4450305,Cc1nnnn1CCC(=O)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12229,CHEMBL4450984,Nc1nnn(CCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12230,CHEMBL4518911,Nc1nnc(SCCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)s1,IC50,nM,>,1000.0,Inhibition of human ERG
12231,CHEMBL4462854,O=C(Cn1ccnc1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12232,CHEMBL4591582,Cc1nccn1CC(=O)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12233,CHEMBL4581466,Cc1cn(CC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)cn1,IC50,nM,>,1000.0,Inhibition of human ERG
12234,CHEMBL4564334,O=C(Cn1cnc2ccccc21)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12235,CHEMBL4467510,O=C(Cn1cccn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12236,CHEMBL4471357,Cc1cc(C)n(CC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12237,CHEMBL4587961,Nc1ccn(CC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12238,CHEMBL4472494,O=C(Cn1cncn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12239,CHEMBL4472076,O=C(Cn1ccnn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12240,CHEMBL4459430,O=C(Cn1nccn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12241,CHEMBL4540852,O=C(Cn1nnc2ccccc21)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12242,CHEMBL4457580,O=C(Cn1cnnn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12243,CHEMBL4544970,O=C(Cn1ncnn1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12244,CHEMBL4475032,Cc1nnnn1CC(=O)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12245,CHEMBL4574208,Cc1nnn(CC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12246,CHEMBL4539776,Nc1nnn(CC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12247,CHEMBL4473388,Nc1nnc(SCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)s1,IC50,nM,>,1000.0,Inhibition of human ERG
12248,CHEMBL4459336,O=C(CSc1nc2ccccc2[nH]1)NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,IC50,nM,>,1000.0,Inhibition of human ERG
12249,CHEMBL4562852,COc1ccc2[nH]c(SCC(=O)NC3CCN(c4c(F)cc5c(=O)c(C(=O)O)cn(C6CC6)c5c4Cl)C3)nc2c1,IC50,nM,>,1000.0,Inhibition of human ERG
12250,CHEMBL4563297,Nc1n[nH]c(SCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12251,CHEMBL4560645,Cn1nnc(SCC(=O)NC2CCN(c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3Cl)C2)n1,IC50,nM,>,1000.0,Inhibition of human ERG
12252,CHEMBL4448579,COCCN1CCN(c2ccc(OCc3ccccc3)c(C(=O)Nc3ccnnc3)c2)CC1,IC50,nM,=,7943.28,Inhibition of human ERG by IonWork assay
12253,CHEMBL4457647,O=C(Nc1ccnnc1)c1cc(N2CCOCC2)ccc1OCc1ccccc1,IC50,nM,>,63095.73,Inhibition of human ERG by IonWork assay
12254,CHEMBL4483816,Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1,IC50,nM,>,50000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12255,CHEMBL4540910,COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,nM,=,3.0,Inhibition of human ERG
12256,CHEMBL4457529,COCC(C)(C)C#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,nM,=,1.1,Inhibition of human ERG
12257,CHEMBL4541837,COC(C)(C)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,nM,=,4.0,Inhibition of human ERG
12258,CHEMBL4518492,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCCO3)n([C@H]3CCCNC3)c2n1,IC50,nM,=,5.0,Inhibition of human ERG
12259,CHEMBL4518492,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCCO3)n([C@H]3CCCNC3)c2n1,IC50,nM,=,10.0,Inhibition of human ERG
12260,CHEMBL4528544,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCOCC3)n([C@H]3CCCNC3)c2n1,IC50,nM,=,1.7,Inhibition of human ERG
12261,CHEMBL4466764,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3COCCO3)n([C@H]3CCCNC3)c2n1,IC50,nM,=,1.4,Inhibition of human ERG
12262,CHEMBL4470576,CC1(C#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)COC1,IC50,nM,=,3.0,Inhibition of human ERG
12263,CHEMBL4457389,CC1(CC#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)COC1,IC50,nM,=,5.0,Inhibition of human ERG
12264,CHEMBL4563802,CN1CC(C#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)CC1=O,IC50,nM,>,20.0,Inhibition of human ERG
12265,CHEMBL4446498,NC(=O)c1cc(Cl)c2c(Cl)c(C#CCN3CCCC3=O)n([C@H]3CCCNC3)c2n1,IC50,nM,>,20.0,Inhibition of human ERG
12266,CHEMBL4445116,CC(C)(C#N)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,nM,=,3.0,Inhibition of human ERG
12267,CHEMBL4533366,CC(C)(CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1)C(N)=O,IC50,nM,>,10.0,Inhibition of human ERG
12268,CHEMBL4583118,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CNCCO3)n([C@H]3CCCNC3)c2n1,IC50,nM,=,6.0,Inhibition of human ERG
12269,CHEMBL4583118,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CNCCO3)n([C@H]3CCCNC3)c2n1,IC50,nM,>,20.0,Inhibition of human ERG
12270,CHEMBL4576616,N#Cc1c(C(F)(F)F)cc(Nc2ccc(OC(F)(F)F)cc2)n2c1nc1ccccc12,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in peak channel current by IonWork patch-clamp electrophysiology method
12271,CHEMBL4466654,N#Cc1c(C(F)(F)F)cc(NCc2ccco2)n2c1nc1cc(Cl)c(Cl)cc12,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in peak channel current by IonWork patch-clamp electrophysiology method
12272,CHEMBL4457843,N#Cc1c(C(F)(F)F)cc(NCc2cccs2)n2c1nc1cc(Cl)c(Cl)cc12,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in peak channel current by IonWork patch-clamp electrophysiology method
12273,CHEMBL4459380,N#Cc1c(C(F)(F)F)cc(NCc2ccccc2F)n2c1nc1cc(Cl)c(Cl)cc12,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in peak channel current by IonWork patch-clamp electrophysiology method
12274,CHEMBL4468890,N#Cc1c(C(F)(F)F)cc(NCc2cccc(F)c2)n2c1nc1cc(Cl)c(Cl)cc12,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in peak channel current by IonWork patch-clamp electrophysiology method
12275,CHEMBL1280,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl,IC50,nM,=,200.0,Inhibition of human ERG expressed in CHO cells assessed as reduction in peak channel current by IonWork patch-clamp electrophysiology method
12276,CHEMBL4456157,COc1cc(F)cc2c1nnc1c2c(-c2ccncc2C)nn1C,IC50,nM,=,17300.0,Inhibition of human ERG expressed in HEK293 cells by Qpatch method
12277,CHEMBL4556703,COc1cc(OC)c2nnc3c(c(-c4cccnc4C)nn3C)c2c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells by Qpatch method
12278,CHEMBL2042259,C/C1=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCCC3)[C@@H]2CC1,IC50,nM,>,100000.0,Inhibition of full length human ERG expressed in Chinese hamster ovary cells at -70 mV holding potential by patch clamp method
12279,CHEMBL4562467,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCC(c4cc(O)nc(C)n4)CC3)[C@@H]2CC1,IC50,nM,>,100000.0,Inhibition of full length human ERG expressed in Chinese hamster ovary cells at -70 mV holding potential by patch clamp method
12280,CHEMBL1270635,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(CN(C)C)[C@@H]2CC1,IC50,nM,>,100000.0,Inhibition of full length human ERG expressed in Chinese hamster ovary cells at -70 mV holding potential by patch clamp method
12281,CHEMBL3317856,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,IC50,nM,=,1400000.0,Inhibition of human ERG
12282,CHEMBL4468357,Cc1cc(C)n(-c2cccc([C@H](CC(=O)[O-])C[N@@+]3(C)CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO-K1 cells at -80 mV holding potential by IonWorks barracuda automated electrophysiology method
12283,CHEMBL4435170,[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,IC50,nM,>,80000.0,Inhibition of human ERG by in vitro patch clamp method
12284,CHEMBL4469750,CNC(=O)c1cnc(Nc2ccc(C#N)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,IC50,nM,=,6700.0,Inhibition of human ERG by in vitro patch clamp method
12285,CHEMBL4559585,CNC(=O)c1cnc(Nc2ccc(C(F)(F)F)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,IC50,nM,=,16000.0,Inhibition of human ERG by in vitro patch clamp method
12286,CHEMBL4580625,CNC(=O)c1cnc(Nc2cc(C)nc(C)n2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,IC50,nM,>,80000.0,Inhibition of human ERG by in vitro patch clamp method
12287,CHEMBL4476261,CNC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,IC50,nM,>,80000.0,Inhibition of human ERG by in vitro patch clamp method
12288,CHEMBL4571117,[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,IC50,nM,>,80000.0,Inhibition of human ERG by in vitro patch clamp method
12289,CHEMBL4557190,CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,IC50,nM,=,38000.0,Inhibition of human ERG by in vitro patch clamp method
12290,CHEMBL1082723,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,>=,30000.0,Inhibition of human ERG by binding assay
12291,CHEMBL1082723,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,IC50,nM,>=,30000.0,Inhibition of human ERG by patch clamp method
12292,CHEMBL1956285,Cc1cc(Nc2ccc(S(F)(F)(F)(F)F)cc2)n2nc(C(C)(F)F)nc2n1,IC50,ug.mL-1,=,0.66,Inhibition of human ERG by patch clamp method
12293,CHEMBL2041980,CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)c2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG
12294,CHEMBL4537673,C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1,IC50,nM,=,4700.0,Inhibition of human ERG
12295,CHEMBL4280095,CCCCCOc1cccc(CCNCC(=O)N(C)C)c1.Cl,IC50,nM,=,1800.0,Inhibition of human ERG assessed as reduction in channel tail current by plate-based planar patch clamp assay
12296,CHEMBL4575754,CN(C)C(=O)CNCCc1cccc(OCCCC(F)(F)CF)c1.Cl,IC50,nM,=,15000.0,Inhibition of human ERG assessed as reduction in channel tail current by plate-based planar patch clamp assay
12297,CHEMBL4291394,CN(C)C(=O)CNCCc1cccc(OCCCC(C)(F)F)c1.Cl,IC50,nM,=,7600.0,Inhibition of human ERG assessed as reduction in channel tail current by plate-based planar patch clamp assay
12298,CHEMBL4555166,CN(C)C(=O)CNCCc1cccc(OCCCCC(F)(F)F)c1.Cl,IC50,nM,=,9600.0,Inhibition of human ERG assessed as reduction in channel tail current by plate-based planar patch clamp assay
12299,CHEMBL4463136,CN(C)C(=O)CNCCc1cccc(OCCCC(F)(F)F)c1.Cl,IC50,nM,=,18000.0,Inhibition of human ERG assessed as reduction in channel tail current by plate-based planar patch clamp assay
12300,CHEMBL4286909,CCCCOc1cccc(CCNCC(=O)N(C)C)c1.Cl,IC50,nM,=,9400.0,Inhibition of human ERG assessed as reduction in channel tail current by plate-based planar patch clamp assay
12301,CHEMBL4587832,CC(C)Oc1cc(-c2cncc(-c3cnn(C4COC4)c3)c2)ccc1C(N)=O,IC50,nM,>,30000.0,Inhibition of human ERG by manual patch clamp method
12302,CHEMBL4442209,Cc1n[nH]c(C)c1-c1cncc(-c2ccc(C(N)=O)c(OC(C)C)c2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by manual patch clamp method
12303,CHEMBL175691,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,IC50,nM,=,500.0,Inhibition of human ERG
12304,CHEMBL3929927,Cc1cc(C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)nc2ccsc12,IC50,nM,=,130.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by whole cell patch clamp assay
12305,CHEMBL4442726,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)c(F)c2)nc2ccsc12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by whole cell patch clamp assay
12306,CHEMBL4520763,Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2F)nc2sccc12,IC50,nM,=,180.0,Inhibition of human ERG expressed in HEK293 cells assessed as reduction in channel tail current by whole cell patch clamp assay
12307,CHEMBL4459971,CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12,IC50,nM,=,1800.0,Inhibition of human ERG at 37 degC
12308,CHEMBL4476621,O=C(NNC(=S)Nc1ccc(Cl)c(Cl)c1)c1ccccc1O,IC50,nM,=,80.0,Displacement of [3H]-Dofetilide from recombinant human ERG after 60 mins by scintillation counting analysis
12309,CHEMBL4586075,O=c1cc(N2CCN(CC3CCCCC3)CC2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells by whole-cell patch clamp assay
12310,CHEMBL4461911,COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1,IC50,nM,=,17100.0,Inhibition of red tracer binding to human ERG expressed in membranes preincubated for 10 to 15 mins followed by tracer addition measured after 3 hrs by fluorescence polarization assay
12311,CHEMBL536480,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl,IC50,nM,=,10.0,Inhibition of red tracer binding to human ERG expressed in membranes preincubated for 10 to 15 mins followed by tracer addition measured after 3 hrs by fluorescence polarization assay
12312,CHEMBL103,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,,,,Inhibition of red tracer binding to human ERG expressed in membranes preincubated for 10 to 15 mins followed by tracer addition measured after 3 hrs by fluorescence polarization assay
12313,CHEMBL190,Cn1c(=O)c2nc[nH]c2n(C)c1=O,IC50,,,,Inhibition of red tracer binding to human ERG expressed in membranes preincubated for 10 to 15 mins followed by tracer addition measured after 3 hrs by fluorescence polarization assay
12314,CHEMBL4466173,CC1(c2ccc(C#N)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12315,CHEMBL4557053,CC1(c2ccccc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12316,CHEMBL4476371,CC1(c2ccc(OC(F)F)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,=,5011.87,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12317,CHEMBL4535475,CC1(c2ccc(-n3cnnn3)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,=,6309.57,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12318,CHEMBL4463635,CC1(c2ccc(N3CCOC3=O)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12319,CHEMBL4470743,CC1(c2ccc(S(C)(=O)=O)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12320,CHEMBL4534405,CC1(c2ccc(NS(C)(=O)=O)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,=,39810.72,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12321,CHEMBL4457226,CC1(c2ccc(C#N)cc2)NC(=O)N(CC(=O)c2ncc(F)cc2F)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO-K1 cells by Patch clamp assay
12322,CHEMBL4439190,N#Cc1ccc(S(=O)(=O)N2C[C@H](S(=O)(=O)c3ccc(Cl)cc3)[C@](O)(CO)C2)c(Cl)c1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by Qpatch assay
12323,CHEMBL4456312,N#Cc1ccc(S(=O)(=O)N2C[C@H](S(=O)(=O)c3ccc(Cl)cc3)[C@](O)(CN)C2)c(Cl)c1,IC50,nM,=,5300.0,Inhibition of human ERG expressed in CHO cells by Qpatch assay
12324,CHEMBL4547537,N#Cc1ccc(S(=O)(=O)N2C[C@H](S(=O)(=O)c3ccc(Cl)cn3)[C@](O)(CN)C2)c(Cl)c1,IC50,nM,=,8000.0,Inhibition of human ERG expressed in CHO cells by Qpatch assay
12325,CHEMBL4461475,N#Cc1ccc(S(=O)(=O)N2C[C@H](S(=O)(=O)c3ccc(Cl)cn3)[C@@](O)(CN)C2)c(Cl)c1,IC50,nM,=,8000.0,Inhibition of human ERG expressed in CHO cells by Qpatch assay
12326,CHEMBL4435246,COc1ncc(C2=CCOCC2)cc1NS(=O)(=O)c1cn(Cc2ccccc2)c(C)n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHO cells after 75 mins by fluorescence polarization assay
12327,CHEMBL939,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,,,,Inhibition of human ERG
12328,CHEMBL4453748,C=CC(=O)N(c1ccc(F)c(Cl)c1)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,IC50,nM,>,10000.0,Inhibition of human ERG
12329,CHEMBL4580164,C[C@@H](Nc1nc2c(cnn2C2CCCC2)c(=O)[nH]1)C(=O)N1CC[C@H](F)C1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
12330,CHEMBL4558749,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CCC(=O)N1CCCCCCC(=O)O,IC50,nM,=,29000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current amplitude by automated patch-clamp method
12331,CHEMBL3918816,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,IC50,nM,=,25900.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current amplitude by automated patch-clamp method
12332,CHEMBL97797,COc1ccc2nc(N)sc2c1,IC50,nM,<,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12333,CHEMBL744,Nc1nc2ccc(OC(F)(F)F)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12334,CHEMBL2386433,Nc1nc2ccc(OCc3ccccc3)cc2s1,IC50,nM,<,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12335,CHEMBL4465714,Nc1nc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12336,CHEMBL4468228,N#Cc1ccc(COc2ccc3nc(N)sc3c2)cc1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12337,CHEMBL4540341,COC(=O)c1ccc(COc2ccc3nc(N)sc3c2)cc1,IC50,nM,=,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12338,CHEMBL4566383,COC(=O)C1CCN(C(=O)c2ccc(COc3ccc4nc(N)sc4c3)cc2)CC1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12339,CHEMBL4592124,CSc1ccc2nc(N)sc2c1,IC50,nM,<,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12340,CHEMBL95463,Nc1nc2ccc(SC(F)(F)F)cc2s1,IC50,nM,=,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12341,CHEMBL4475811,Nc1nc2ccc(SCc3ccccc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12342,CHEMBL4439011,Nc1nc2ccc(SCc3ccc(Cl)c(Cl)c3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12343,CHEMBL4564287,N#Cc1ccc(CSc2ccc3nc(N)sc3c2)cc1,IC50,nM,<,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12344,CHEMBL4577695,COC(=O)c1ccc(CSc2ccc3nc(N)sc3c2)cc1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12345,CHEMBL4441552,COC(=O)C1CCN(C(=O)c2ccc(CSc3ccc4nc(N)sc4c3)cc2)CC1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12346,CHEMBL4562350,Nc1nc2ccc(SCc3ccc(C(=O)NCc4ccccc4)cc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12347,CHEMBL432942,CS(=O)(=O)c1ccc2nc(N)sc2c1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12348,CHEMBL4440584,Nc1nc2ccc(S(=O)(=O)Cc3ccccc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12349,CHEMBL4581441,Nc1nc2ccc(S(=O)(=O)Cc3ccc(Cl)c(Cl)c3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12350,CHEMBL4464690,N#Cc1ccc(CS(=O)(=O)c2ccc3nc(N)sc3c2)cc1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12351,CHEMBL4446494,COC(=O)c1ccc(CS(=O)(=O)c2ccc3nc(N)sc3c2)cc1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12352,CHEMBL4476655,COC(=O)C1CCN(C(=O)c2ccc(CS(=O)(=O)c3ccc4nc(N)sc4c3)cc2)CC1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12353,CHEMBL4469761,Nc1nc2ccc(C(=O)NCc3ccccc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12354,CHEMBL4458858,Nc1nc2ccc(C(=O)NCc3ccc(Cl)c(Cl)c3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12355,CHEMBL4561783,N#Cc1ccc(CNC(=O)c2ccc3nc(N)sc3c2)cc1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12356,CHEMBL4579215,COC(=O)c1ccc(CNC(=O)c2ccc3nc(N)sc3c2)cc1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12357,CHEMBL4452155,COC(=O)C1CCN(C(=O)c2ccc(CNC(=O)c3ccc4nc(N)sc4c3)cc2)CC1,IC50,nM,<,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12358,CHEMBL4581650,Nc1nc2ccc(C(=O)NCc3ccc(C(=O)NCc4ccccc4)cc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12359,CHEMBL4554726,COc1cc(CNC(=O)c2ccc3nc(N)sc3c2)cc(OC)c1OC,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12360,CHEMBL4582026,Nc1nc2ccc(C(=O)NCc3ccccc3[N+](=O)[O-])cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12361,CHEMBL4460492,Nc1nc2ccc(C(=O)NCc3ccccc3N)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12362,CHEMBL4435791,Nc1nc2ccc(C(=O)NC(c3ccccc3)c3ccccc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12363,CHEMBL4545398,COC(=O)C1CCN(C(=O)c2ccc3nc(N)sc3c2)CC1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12364,CHEMBL4554707,Nc1nc2ccc(C(=O)NCCc3cccs3)cc2s1,IC50,nM,<,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12365,CHEMBL4528355,Nc1nc2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12366,CHEMBL4444333,Nc1nc2ccc(C(=O)N(Cc3ccccc3)Cc3ccc(Cl)c(Cl)c3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12367,CHEMBL4452773,Nc1nc2ccc(C(=O)N(CCO)Cc3ccccc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12368,CHEMBL4462566,COc1ccc(CN(Cc2ccc(Cl)c(Cl)c2)C(=O)c2ccc3nc(N)sc3c2)cc1OC,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12369,CHEMBL4552119,Nc1nc2c(O)cc(C(=O)NCc3ccccc3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12370,CHEMBL4549839,Nc1nc2c(O)cc(C(=O)NCc3ccc(Cl)c(Cl)c3)cc2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12371,CHEMBL4583705,Nc1nc2c(C(=O)N(Cc3ccccc3)Cc3ccc(Cl)c(Cl)c3)cc(O)c(O)c2s1,IC50,nM,<,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12372,CHEMBL4453795,Nc1nc2c(C(=O)NCc3ccc(Cl)c(Cl)c3)cc(O)c(O)c2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12373,CHEMBL4456198,Nc1nc2c(C(=O)NCc3ccccc3)cc(O)c(O)c2s1,IC50,nM,>,25000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12374,CHEMBL55,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,IC50,nM,=,10000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
12375,CHEMBL4451760,COc1c(C#N)ccc2[nH]c(-c3cn4c(n3)[C@H](c3cccc(F)c3C)OCC4)cc12,IC50,nM,=,5290.0,Inhibition of human ERG by receptor binding assay
12376,CHEMBL4466805,COc1nc(-c2nc(Nc3cc(F)cc(C(F)(F)F)c3)n(C)n2)ccc1-n1cnc(C)c1,IC50,nM,>,10000.0,Inhibition of human ERG by receptor binding assay
12377,CHEMBL4528447,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(c3ccc(B(O)O)c(Cl)c3)S(C)(=O)=O)c(C3CC3)cc12,IC50,nM,=,1600.0,Inhibition of human ERG by patch clamp electrophysiology method
12378,CHEMBL4467259,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(c3cc(Cl)c4c(c3)COB4O)S(C)(=O)=O)c(C3CC3)cc12,IC50,nM,=,16000.0,Inhibition of human ERG by patch clamp electrophysiology method
12379,CHEMBL4536433,Cc1ccc(CNC(=O)[C@@H]2CNC[C@H]2c2ccc(C(F)(F)F)cc2)cc1,IC50,nM,=,8950.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12380,CHEMBL4435264,CN(C)c1ccc(CNC(=O)[C@H]2CNC[C@@H]2c2ccc(C(F)(F)F)cc2)cc1,IC50,nM,=,9410.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12381,CHEMBL4515188,CCN(CC)c1ccc(CNC(=O)[C@@H]2CNC[C@H]2c2ccc(C(F)(F)F)cc2)cc1,IC50,nM,=,4740.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12382,CHEMBL4483725,CN(C)c1ccc(CNC(=O)[C@@H]2CNC[C@H]2c2ccc(C(F)(F)F)c(F)c2)cc1,IC50,nM,=,8540.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12383,CHEMBL4567098,CN(C)c1ccc(CNC(=O)[C@@H]2CNC[C@H]2c2ccc(C(F)(F)F)c(Cl)c2)cc1,IC50,nM,=,7560.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12384,CHEMBL4453475,CN(C)c1ccc(CNC(=O)[C@@H]2CNC[C@H]2c2ccc(Oc3ccccc3)cc2)cc1,IC50,nM,=,2110.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12385,CHEMBL4475207,CN(C)c1ccc(CNC(=O)[C@H]2CNC[C@@H]2c2ccc(C(F)(F)F)nc2)cc1,IC50,nM,=,21700.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12386,CHEMBL4576672,CN(C)c1ccc(CNC(=O)[C@H]2CNC[C@@H]2c2cnc(C(F)(F)F)nc2)cc1,IC50,nM,>,50000.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12387,CHEMBL4438229,C[C@H](NC(=O)[C@H]1CNC[C@@H]1c1ccc(C(F)(F)F)nc1)c1ccc(N(C)C)cc1,IC50,nM,>,50000.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12388,CHEMBL4436020,C[C@H](NC(=O)[C@H]1CNC[C@@H]1c1ccc(C(F)(F)F)cc1)c1ccc(N(C)C)cc1,IC50,nM,=,32000.0,Inhibition of Tracer Red binding to human ERG expressed in membranes by fluorescence polarization assay
12389,CHEMBL4560054,COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1,IC50,nM,>,30000.0,Inhibition of human ERG
12390,CHEMBL4475999,CCCN(CCC)[C@H](c1ccccn1)[C@@H](c1ccccn1)N(CCC)C[C@H](O)CO,IC50,nM,>,33000.0,Inhibition of human ERG
12391,CHEMBL4437013,CCCN(CC)[C@H](c1ccccn1)[C@@H](c1ccccn1)N(CC)CCC,IC50,nM,>,33000.0,Inhibition of human ERG
12392,CHEMBL4476275,CCCN(CCC)[C@H](c1ccccn1)[C@@H](c1ccccn1)N(CCC)CCC,IC50,nM,=,6300.0,Inhibition of human ERG
12393,CHEMBL4438854,c1ccc([C@H]([C@@H](c2ccccn2)N2CCCCC2)N2CCCCC2)nc1,IC50,nM,>,33000.0,Inhibition of human ERG
12394,CHEMBL2152523,c1ccc([C@H]([C@@H](c2ccccc2)N2CCCCC2)N2CCCCC2)cc1,IC50,nM,>,33000.0,Inhibition of human ERG
12395,CHEMBL4465699,CC(C)c1cc(C(=O)NC[C@H]2CCNC2)on1,IC50,,,,Inhibition of human ERG by whole-cell patch clamp method
12396,CHEMBL4448317,CC(C)c1cc(C(=O)NC[C@H]2CCN(CCC(C)(C)C)C2)on1,IC50,,,,Inhibition of human ERG by whole-cell patch clamp method
12397,CHEMBL4459597,CC(C)c1cc(C(=O)NC[C@H]2CCN(C(=O)CC(C)(C)C)C2)on1,IC50,,,,Inhibition of human ERG by whole-cell patch clamp method
12398,CHEMBL4451029,CC(C)c1cc(C(=O)NC[C@H]2CCN(Cc3cccnc3)C2)on1,IC50,,,,Inhibition of human ERG by whole-cell patch clamp method
12399,CHEMBL4467412,CC(C)c1cc(C(=O)NC[C@H]2CCN(CCc3ccc(C(F)(F)F)cc3)C2)on1,IC50,nM,=,410.0,Inhibition of human ERG by whole-cell patch clamp method
12400,CHEMBL4593748,CC(C)c1cc(C(=O)NC[C@H]2CCN(CCc3ccc(Cl)c(Cl)c3)C2)on1,IC50,nM,=,1530.0,Inhibition of human ERG by whole-cell patch clamp method
12401,CHEMBL4454058,CC(C)c1cc(C(=O)NC[C@H]2CCN(CCc3ccc(Cl)c(F)c3)C2)on1,IC50,nM,=,1520.0,Inhibition of human ERG by whole-cell patch clamp method
12402,CHEMBL4574825,CC(C)c1cc(C(=O)NC[C@H]2CCN(CCc3ccc(OC(F)(F)F)c(F)c3)C2)on1,IC50,nM,=,160.0,Inhibition of human ERG by whole-cell patch clamp method
12403,CHEMBL4461512,Cc1ccc(CCN2CC[C@H](CNC(=O)c3cc(C(C)C)no3)C2)cc1C(F)(F)F,IC50,nM,=,1900.0,Inhibition of human ERG by whole-cell patch clamp method
12404,CHEMBL4453177,COC(=O)C1=C(C)NC(C)=C(C(=O)NC[C@H]2CCNC2)C1c1cccc([N+](=O)[O-])c1,IC50,,,,Inhibition of human ERG by whole-cell patch clamp method
12405,CHEMBL4466934,COC(=O)C1=C(C)NC(C)=C(C(=O)NC[C@H]2CCN(CCc3ccc(C(F)(F)F)cc3)C2)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,1480.0,Inhibition of human ERG by whole-cell patch clamp method
12406,CHEMBL4459378,COC(=O)C1=C(C)NC(C)=C(C(=O)NC[C@H]2CCN(CCc3ccc(Cl)c(Cl)c3)C2)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,650.0,Inhibition of human ERG by whole-cell patch clamp method
12407,CHEMBL4561491,COC(=O)C1=C(C)NC(C)=C(C(=O)NC[C@H]2CCN(CCc3ccc(C)c(C(F)(F)F)c3)C2)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,2700.0,Inhibition of human ERG by whole-cell patch clamp method
12408,CHEMBL4555422,COC(=O)C1=C(C)NC(C)=C(C(=O)NC[C@H]2CCN(CCc3ccc(Cl)c(F)c3)C2)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,330.0,Inhibition of human ERG by whole-cell patch clamp method
12409,CHEMBL4476467,COC(=O)C1=C(C)NC(C)=C(C(=O)NC[C@H]2CCN(CCc3ccc(OC(F)(F)F)c(F)c3)C2)C1c1cccc([N+](=O)[O-])c1,IC50,nM,=,1470.0,Inhibition of human ERG by whole-cell patch clamp method
12410,CHEMBL45816,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,IC50,nM,=,1340.0,Inhibition of human ERG by whole-cell patch clamp method
12411,CHEMBL4563459,Cc1cc(-c2ccc(C(=O)[C@@H]3CCCC[C@H]3C(=O)Nc3cnn(C)c3C(=O)NOC(C)(C)C)cc2)[nH]n1,IC50,nM,>,33000.0,Inhibition of human ERG by Ion-work assay
12412,CHEMBL4474619,Cc1cc(-c2ccc(C(=O)[C@@H]3CCCC[C@H]3C(=O)Nc3cnn(C)c3S(N)(=O)=O)cc2)n[nH]1,IC50,nM,>,33000.0,Inhibition of human ERG by Ion-work assay
12413,CHEMBL4542281,Cc1cc(-c2ccc(C(=O)[C@@H]3CCCC[C@H]3C(=O)Nc3cnn4c3C(=O)NCC4)cc2)n[nH]1,IC50,nM,>,33000.0,Inhibition of human ERG by Ion-work assay
12414,CHEMBL4441529,Cc1ccc(NCc2ccnn2-c2nnc(N3CCC(C(=O)N[C@H]4CCCC[C@H]4C)CC3)s2)nc1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp method
12415,CHEMBL4448921,CNc1nc(Nc2cnc(C#N)c(O[C@@H]3CCCNC3)c2)ncc1-c1cnn(C)c1,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by automated patch clamp assay
12416,CHEMBL3039517,Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1,IC50,nM,=,28100.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by automated patch clamp assay
12417,CHEMBL3544911,COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1,IC50,nM,=,20000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by automated patch clamp assay
12418,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,<,300.0,Inhibition of tracer Red binding to human ERG expressed in membranes after 3 hrs by fluorescence polarization assay
12419,CHEMBL327980,Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1,IC50,nM,=,7.82,Inhibition of fluorescently labeled tracer binding to human ERG by competitive binding assay
12420,CHEMBL4457961,COc1ccc2c(c1)CCN(CCC(F)Cc1ccccc1)CC2,IC50,nM,=,553.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by automated patch clamp electrophysiology assay
12421,CHEMBL4575948,FC(CCN1CCc2ccccc2CC1)Cc1ccccc1,IC50,nM,=,1183.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by automated patch clamp electrophysiology assay
12422,CHEMBL4571835,CCN(C)C(=O)Oc1cc(C(C)N(C)C)cc2cccnc12,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells incubated for 1 min at -80 mV holding potential by manual patch clamp assay
12423,CHEMBL451887,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,IC50,nM,=,92100.0,Inhibition of human ERG in HEK293 cells assessed as effect on QT interval
12424,CHEMBL4541964,O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1,IC50,nM,>,10000.0,Inhibition of human ERG
12425,CHEMBL4527894,COc1cc2c(cc1OC)[C@H](CCc1c[nH]c3cc(C)ccc13)N(C=O)CC2,IC50,nM,>,40000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential measured after 3 mins by QPatch automated patch-clamp assay
12426,CHEMBL74656,COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC,IC50,nM,=,70.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential measured after 3 mins by QPatch automated patch-clamp assay
12427,CHEMBL4590477,Cc1cc(-c2ccnc3[nH]nc(C(F)(F)F)c23)cc(C2(CN)CCC2)c1,IC50,nM,=,700.0,Inhibition of human ERG
12428,CHEMBL4589844,NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CCC1,IC50,nM,=,3000.0,Inhibition of human ERG
12429,CHEMBL4457150,NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CCOCC1,IC50,nM,>,10000.0,Inhibition of human ERG
12430,CHEMBL4587816,Cc1cc(-c2ccnc3[nH]nc(C(F)(F)F)c23)cc(C2(CN)COC2)c1,IC50,nM,>,10000.0,Inhibition of human ERG
12431,CHEMBL4461649,NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)COC1,IC50,nM,>,10000.0,Inhibition of human ERG
12432,CHEMBL4451680,C[C@]12CC[C@@H]3c4ccc(OCCCN5CCCC5)cc4CC[C@H]3[C@@H]1CC[C@@H]2N1CCCC1,IC50,nM,=,7500.0,Inhibition of human ERG
12433,CHEMBL4466132,CCNC(=O)[C@H]1CC[C@@]2(C)CC[C@@H]3c4ccc(OCCCN5CCC[C@H]5C)cc4CC[C@H]3[C@H]12,IC50,nM,=,4100.0,Inhibition of human ERG
12434,CHEMBL4515933,C[C@@H]1CCCN1CCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)CC[C@H](C(=O)NCC3CC3)[C@@H]12,IC50,nM,=,4100.0,Inhibition of human ERG
12435,CHEMBL4447048,CCNC(=O)[C@H]1C[C@H](OC)[C@@]2(C)CC[C@@H]3c4ccc(OCCCN5CCC[C@H]5C)cc4CC[C@H]3[C@H]12,IC50,nM,=,11400.0,Inhibition of human ERG
12436,CHEMBL4457100,CCNC(=O)[C@H]1CC(=O)[C@@]2(C)CC[C@@H]3c4ccc(OCCCN5CCC[C@H]5C)cc4CC[C@H]3[C@H]12,IC50,nM,=,17500.0,Inhibition of human ERG
12437,CHEMBL4474244,C[C@H]1CCCN1CCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)C[C@@H](C(=O)N3CCCC3)[C@@H]12,IC50,nM,=,80000.0,Inhibition of human ERG
12438,CHEMBL4452711,O=C(Nc1ccncc1)c1cn(Cc2ccc(Cl)c(Cl)c2)c(=O)c2cnn(C3CCNCC3)c12,IC50,nM,>,25000.0,Inhibition of human ERG
12439,CHEMBL4457629,NCc1ncc(S(=O)(=O)c2ccc3ccccc3c2)s1,IC50,nM,=,51000.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12440,CHEMBL4568508,CS(=O)(=O)c1cc(-c2ccccc2)cc(S(=O)(=O)c2cnc(CN)s2)c1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12441,CHEMBL4564074,CCc1cc(-c2ccccc2)cc(S(=O)(=O)c2cnc(CN)s2)c1,IC50,nM,=,36000.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12442,CHEMBL4515085,Cc1ccc(-c2cc(S(C)(=O)=O)cc(S(=O)(=O)c3cnc(CN)s3)c2)cc1,IC50,nM,=,3200.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12443,CHEMBL4457897,Cn1cc(-c2cc(S(C)(=O)=O)cc(S(=O)(=O)c3cnc(CN)s3)c2)cn1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12444,CHEMBL4444163,CCc1cc(-c2cnn(C)c2)cc(S(=O)(=O)c2cnc(CN)s2)c1,IC50,nM,=,47000.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12445,CHEMBL4460845,Cn1cc(-c2cc(F)cc(S(=O)(=O)c3cnc(CN)s3)c2)cn1,IC50,nM,=,66000.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12446,CHEMBL4550042,CS(=O)(=O)c1cc(-c2ccccc2)cc(S(=O)(=O)c2csc(CN)n2)c1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12447,CHEMBL4574361,Cn1cc(-c2cc(S(C)(=O)=O)cc(S(=O)(=O)c3csc(CN)n3)c2)cn1,IC50,,,,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12448,CHEMBL4463882,CCc1cc(-c2cnn(C)c2)cc(S(=O)(=O)c2csc(CN)n2)c1,IC50,nM,=,29000.0,Inhibition of human ERG expressed in CHOK1 cells by Qpatch electrophysiological assay
12449,CHEMBL4474647,Cc1cc2nccn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C,IC50,nM,=,8100.0,Inhibition of human ERG stably expressed in CHO cells at -90 mV holding potential by electrophysiological assay
12450,CHEMBL4439259,Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C,IC50,nM,>,198000.0,Inhibition of human ERG stably expressed in CHO cells at -90 mV holding potential by electrophysiological assay
12451,CHEMBL4513701,Cc1cc2ncnn2cc1Nc1ncc2c(n1)n([C@H]1CC[C@@](C)(O)CC1)c(=O)n2C,IC50,nM,>,198000.0,Inhibition of human ERG stably expressed in CHO cells at -90 mV holding potential by electrophysiological assay
12452,CHEMBL4471352,COc1c(OCCCCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology
12453,CHEMBL4440028,[O-][S@@+](/C=C/CCN=C=S)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in human HEK293 cells by whole cell patch clamp assay
12454,CHEMBL4557050,COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1,IC50,nM,>,30000.0,Inhibition of human ERG
12455,CHEMBL4449567,Cc1cnc(Nc2cccnc2C)nc1-c1c[nH]c2c(NC(=O)[C@@H](C)N3CCN(C)CC3)cccc12,IC50,nM,>,33000.0,Inhibition of human ERG
12456,CHEMBL4466590,Cc1cnc(Nc2cccnc2F)nc1-c1c[nH]c2c(NC(=O)[C@@H](C)N3CCN(C)CC3)cccc12,IC50,nM,=,10000.0,Inhibition of human ERG
12457,CHEMBL4450982,COc1nn(C)cc1Nc1ncc(C)c(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,IC50,nM,>,100000.0,Inhibition of human ERG
12458,CHEMBL4064366,COc1nn(C)cc1Nc1ncc(Cl)c(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,IC50,nM,=,22000.0,Inhibition of human ERG
12459,CHEMBL4541637,COc1nn(C)cc1Nc1ncc(F)c(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,IC50,nM,>,33000.0,Inhibition of human ERG
12460,CHEMBL4577393,COc1nn(C)cc1Nc1ncc(Br)c(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,IC50,nM,=,15000.0,Inhibition of human ERG
12461,CHEMBL4577523,COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,IC50,nM,>,100000.0,Inhibition of human ERG
12462,CHEMBL4441087,CC1(c2ccc(S(N)(=O)=O)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2F)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1/ HEK293 cells at -80 mV holding potential by IonWorks patch-clamp assay
12463,CHEMBL4554896,CC1(c2ccc(S(N)(=O)=O)cc2)NC(=O)N(CC(=O)c2ccc(F)cc2O)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1/ HEK293 cells at -80 mV holding potential by IonWorks patch-clamp assay
12464,CHEMBL4438645,CC1(c2ccc(S(N)(=O)=O)cc2)NC(=O)N(CC(=O)c2cccc(C(F)(F)F)c2)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1/ HEK293 cells at -80 mV holding potential by IonWorks patch-clamp assay
12465,CHEMBL4468599,CC1(c2ccc(S(N)(=O)=O)cc2)NC(=O)N(CC(=O)c2cccc(OC(F)(F)F)c2)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1/ HEK293 cells at -80 mV holding potential by IonWorks patch-clamp assay
12466,CHEMBL4590127,CC1(c2ccc(S(N)(=O)=O)cc2)NC(=O)N(CC(=O)C2CCCCC2)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1/ HEK293 cells at -80 mV holding potential by IonWorks patch-clamp assay
12467,CHEMBL4452592,CC1(c2ccc(S(N)(=O)=O)cc2)NC(=O)N(CC(=O)c2ncc(F)cc2F)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1/ HEK293 cells at -80 mV holding potential by IonWorks patch-clamp assay
12468,CHEMBL4459602,CC1(c2ccc(S(N)(=O)=O)cc2)NC(=O)N(CC(=O)c2ccc(Cl)s2)C1=O,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1/ HEK293 cells at -80 mV holding potential by IonWorks patch-clamp assay
12469,CHEMBL4575655,COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells measured after 5 mins by whole cell patch clamp method
12470,CHEMBL4548795,COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells measured after 5 mins by whole cell patch clamp method
12471,CHEMBL4434717,COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O,IC50,nM,=,19000.0,Inhibition of human ERG expressed in HEK293 cells measured after 5 mins by whole cell patch clamp method
12472,CHEMBL3183703,CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1,IC50,nM,>,30000.0,Inhibition of human ERG by high throughput automated patch clamp method
12473,CHEMBL184238,NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12474,CHEMBL4473519,NC(=O)c1ccn(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)c1,IC50,nM,=,5300.0,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12475,CHEMBL4446507,NC(=O)c1ccn(-c2cccc(NC(=O)NCCN3CCN(c4ccccc4)CC3)c2)c1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12476,CHEMBL4471658,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)o1,IC50,nM,<,100.0,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12477,CHEMBL4565200,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)s1,IC50,nM,=,280.0,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12478,CHEMBL4520982,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)n1C,IC50,,,,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12479,CHEMBL4449756,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)[nH]1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12480,CHEMBL4520184,NC(=O)c1cn(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)nn1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12481,CHEMBL4517296,Cn1c(C(N)=O)ccc1-c1cccc(OC(=O)NCCN2CCN(c3ccccc3)CC2)c1,IC50,nM,=,6400.0,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12482,CHEMBL4554053,NC(=O)c1ccn(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)c1,IC50,nM,=,3500.0,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12483,CHEMBL4540218,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)o1,IC50,nM,=,1100.0,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12484,CHEMBL4473519,NC(=O)c1ccn(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)c1,IC50,nM,=,5248.07,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12485,CHEMBL4471658,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)o1,IC50,nM,<,100.0,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12486,CHEMBL4565200,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)s1,IC50,nM,=,281.84,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12487,CHEMBL4517296,Cn1c(C(N)=O)ccc1-c1cccc(OC(=O)NCCN2CCN(c3ccccc3)CC2)c1,IC50,nM,=,6456.54,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12488,CHEMBL4554053,NC(=O)c1ccn(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)c1,IC50,nM,=,3548.13,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12489,CHEMBL4540218,Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)o1,IC50,nM,=,1071.52,Inhibition of human ERG expressed in HEK293 cells incubated for 72 hrs by patch clamp assay
12490,CHEMBL4465132,O=C1c2ccccc2C(Cc2ccnnc2)(Cc2c(F)cncc2F)c2ccccc21,IC50,nM,>,32000.0,Inhibition of ERG in human HEK293 cells incubated for 1 hr by thallium flux assay
12491,CHEMBL4447214,Cc1cc(CC2(Cc3ccnc(C)c3)c3ccccc3C(=O)c3ccccc32)ccn1,IC50,,,,Inhibition of ERG in human HEK293 cells incubated for 1 hr by thallium flux assay
12492,CHEMBL4473641,O=C1c2ccccc2C(Cc2ccnnc2)(Cc2ccnnc2)c2ccccc21,IC50,,,,Inhibition of ERG in human HEK293 cells incubated for 1 hr by thallium flux assay
12493,CHEMBL4471453,O=C1c2ccccc2C(Cc2c(F)cncc2F)(Cc2c(F)cncc2F)c2ccccc21,IC50,nM,=,12000.0,Inhibition of ERG in human HEK293 cells incubated for 1 hr by thallium flux assay
12494,CHEMBL4444584,O=C1c2ccccc2C(Cc2ccnc(C(F)(F)F)c2)(Cc2ccnc(C(F)(F)F)c2)c2ccccc21,IC50,,,,Inhibition of ERG in human HEK293 cells incubated for 1 hr by thallium flux assay
12495,CHEMBL343822,O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21,IC50,nM,=,32000.0,Inhibition of ERG in human HEK293 cells incubated for 1 hr by thallium flux assay
12496,CHEMBL342375,O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc21,IC50,nM,>,32000.0,Inhibition of ERG in human HEK293 cells incubated for 1 hr by thallium flux assay
12497,CHEMBL4297615,CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1,IC50,nM,=,75000.0,Inhibition of human ERG expressed in HEK293 cells by voltage patch clamp assay
12498,CHEMBL4530872,O=C1CN(c2cn[nH]c(=O)c2Cl)CCN1Cc1ccccc1C(F)(F)F,IC50,nM,=,8700.0,Inhibition of human ERG stably expressed in HEK293 cells measured at holding potential of -90 mV by manual patch clamp assay
12499,CHEMBL4534119,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1,IC50,nM,>,40000.0,Inhibition of human ERG by automated patch clamp electrophysiology assay
12500,CHEMBL4586372,Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12,IC50,nM,>,50000.0,Binding affinity to human ERG by fluorescence polarization assay
12501,CHEMBL4436282,COc1ccc(N/N=C/c2ccc(-c3cccc(/C=N/Nc4ccc(OC)cc4)c3)cc2)cc1,IC50,nM,>,30000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method
12502,CHEMBL4475377,COc1ccc(N/N=C/c2ccc(-c3ccc(/C=N/Nc4ccc(OC)cc4)cc3)cc2)cc1,IC50,nM,>,30000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method
12503,CHEMBL4435876,Fc1ccc(N/N=C/c2ccc(-c3cccc(/C=N/Nc4ccc(F)cc4)c3)cc2)cc1,IC50,nM,>,30000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method
12504,CHEMBL4550376,C/C(=N\Nc1ccc(F)cc1)c1ccc(-c2ccc(/C(C)=N/Nc3ccc(F)cc3)cc2)cc1,IC50,nM,>,30000.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method
12505,CHEMBL3990823,N=C(N)N/N=C/c1ccc(-c2cccc(/C=N/NC(=N)N)c2)cc1,IC50,nM,=,4660.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method
12506,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,9600.0,Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method
12507,CHEMBL4551786,CCOC(=O)N1CC/C(=C\C#Cc2cccc(C)n2)C1,IC50,nM,>,30000.0,Inhibition of human ERG
12508,CHEMBL4469773,CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](F)(Br)[C@H]1O)Oc1ccccc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole-cell patch clamp assay
12509,CHEMBL4455349,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](F)(Br)[C@H]1O)Oc1ccccc1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole-cell patch clamp assay
12510,CHEMBL629,CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,nM,=,3000.0,Inhibition of human ERG expressed in CHO cells at -80 mV holding potential by whole-cell patch clamp assay
12511,CHEMBL3932162,CN(C)CCOc1ccc(/C(=C(/CCCO)c2ccccc2)c2ccc(O)cc2)cc1.Cl,IC50,nM,>,30000.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12512,CHEMBL4585424,Cl.Cl.OCCC/C(=C(\c1ccc(Br)cc1)c1ccc(N2CCNCC2)cc1)c1ccccc1,IC50,,,,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12513,CHEMBL4443694,Cc1ccc(/C(=C(\CCCO)c2ccccc2)c2ccc(N3CCNCC3)cc2)cc1.Cl.Cl,IC50,nM,=,7100.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12514,CHEMBL4472718,Cc1ccc(/C(=C(\CCCO)c2ccccc2)c2ccc(N3CCN(C)CC3)cc2)cc1.Cl.Cl,IC50,nM,=,18900.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12515,CHEMBL4436391,CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3ccc(O)cc3)cc2)CC1.Cl.Cl,IC50,nM,=,18700.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12516,CHEMBL4541589,CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3ccc(Br)cc3)cc2)CC1.Cl.Cl,IC50,nM,=,15300.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12517,CHEMBL4437929,Cc1ccc(/C(=C(\CCCO)c2ccccc2)c2ccc(N3CCN(C(C)C)CC3)cc2)cc1.Cl.Cl,IC50,nM,>,30000.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12518,CHEMBL4580171,CCN1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3ccc(C)cc3)cc2)CC1.Cl.Cl,IC50,nM,=,17000.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12519,CHEMBL4451327,CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3cccc(O)c3)cc2)CC1.Cl.Cl,IC50,nM,=,24600.0,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12520,CHEMBL4579002,CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3cccc(Br)c3)cc2)CC1.Cl.Cl,IC50,,,,Inhibition of human ERG after 4 hrs by fluorescence polarization assay
12521,CHEMBL3932162,CN(C)CCOc1ccc(/C(=C(/CCCO)c2ccccc2)c2ccc(O)cc2)cc1.Cl,IC50,,,,Inhibition of human ERG assessed as reduction in channel current by cell based assay
12522,CHEMBL4451327,CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3cccc(O)c3)cc2)CC1.Cl.Cl,IC50,nM,>,30000.0,Inhibition of human ERG assessed as reduction in channel current by cell based assay
12523,CHEMBL4476848,C[C@@H]1OCC2(CCN(c3nc(N)c(Sc4cccnc4C(F)(F)F)c(=O)n3C)CC2)[C@@H]1N,IC50,nM,>,30000.0,Inhibition of human ERG
12524,CHEMBL4533113,Cn1c(N2CCC(C)(CN)CC2)nc(N)c(Sc2cccc(Cl)c2Cl)c1=O,IC50,nM,=,6000.0,Inhibition of human ERG
12525,CHEMBL4546378,C[C@@H]1OCC2(CCN(c3nc(N)c(Sc4cccc(Cl)c4Cl)c(=O)n3C)CC2)[C@@H]1N,IC50,nM,=,4000.0,Inhibition of human ERG
12526,CHEMBL4442335,Cc1nccc(Sc2c(N)nc(N3CCC4(CC3)CO[C@@H](C)[C@H]4N)n(C)c2=O)c1Cl,IC50,nM,>,30000.0,Inhibition of human ERG
12527,CHEMBL4578698,C[C@@H]1OCC2(CCN(c3nc(N)c(Sc4ccnc(C5CC5)c4Cl)c(=O)n3C)CC2)[C@@H]1N,IC50,nM,=,9800.0,Inhibition of human ERG
12528,CHEMBL4531137,C[C@@H]1OCC2(CCN(c3ncc(Sc4cccnc4C(F)(F)F)c(=O)n3C)CC2)[C@@H]1N,IC50,nM,>,30000.0,Inhibition of human ERG
12529,CHEMBL4447768,C[C@@H]1OCC2(CCN(c3ncc(Sc4cccnc4C(F)(F)F)c(=O)[nH]3)CC2)[C@@H]1N,IC50,nM,>,30000.0,Inhibition of human ERG
12530,CHEMBL4468062,C[C@@H]1OCC2(CCN(c3ccc(Sc4cccnc4C(F)(F)F)c(=O)n3C)CC2)[C@@H]1N,IC50,,,,Inhibition of human ERG
12531,CHEMBL4546245,C[C@@H]1OCC2(CCN(c3cc(N)c(Sc4cccnc4C(F)(F)F)c(=O)n3C)CC2)[C@@H]1N,IC50,,,,Inhibition of human ERG
12532,CHEMBL4581388,C[C@H]1C[C@@H](N)C2(CCN(c3nc(N)c(Sc4cccnc4C(F)(F)F)c(=O)n3C)CC2)C1,IC50,nM,>,30000.0,Inhibition of human ERG
12533,CHEMBL4537504,C[C@@H]1CC2(CCN(c3nc(N)c(Sc4cccnc4C(F)(F)F)c(=O)n3C)CC2)[C@H](N)[C@H]1F,IC50,nM,>,30000.0,Inhibition of human ERG
12534,CHEMBL4469071,Cn1c(N2CCC(C)(N)CC2)nc2[nH]nc(-c3cccc(Cl)c3Cl)c2c1=O,IC50,nM,=,200.0,Inhibition of human ERG by Q-patch assay
12535,CHEMBL4539145,Cn1c(N2CCC(C)(CN)CC2)nc2[nH]nc(-c3cccc(Cl)c3Cl)c2c1=O,IC50,nM,=,980.0,Inhibition of human ERG by Q-patch assay
12536,CHEMBL4437876,Cn1c(N2CCC3(CCC[C@H]3N)CC2)nc2[nH]nc(-c3cccc(Cl)c3Cl)c2c1=O,IC50,nM,=,250.0,Inhibition of human ERG by Q-patch assay
12537,CHEMBL4459445,Cn1c(N2CCC3(CC2)COC[C@H]3N)nc2[nH]nc(-c3cccc(Cl)c3Cl)c2c1=O,IC50,nM,=,930.0,Inhibition of human ERG by Q-patch assay
12538,CHEMBL4455446,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(-c5cccc(Cl)c5Cl)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,=,290.0,Inhibition of human ERG by Q-patch assay
12539,CHEMBL4475043,C[C@@H]1OCC2(CCN(c3cnc4c(-c5cccc(Cl)c5Cl)n[nH]c4n3)CC2)[C@@H]1N,IC50,nM,=,4.0,Inhibition of human ERG by Q-patch assay
12540,CHEMBL4475081,C[C@@H]1OCC2(CCN(c3cnc4c(-c5cccc(Cl)c5Cl)c[nH]c4n3)CC2)[C@@H]1N,IC50,nM,=,7.0,Inhibition of human ERG by Q-patch assay
12541,CHEMBL4461938,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(-c5ccnc(Cl)c5Cl)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,=,1200.0,Inhibition of human ERG by Q-patch assay
12542,CHEMBL4452417,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(-c5ccncc5)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
12543,CHEMBL4539178,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(-c5ccnc(N)c5Cl)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
12544,CHEMBL4436233,CNc1nccc(-c2n[nH]c3nc(N4CCC5(CC4)CO[C@@H](C)[C@H]5N)n(C)c(=O)c23)c1Cl,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
12545,CHEMBL4450282,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(-c5ccnc(NC6CCC6)c5Cl)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,=,1900.0,Inhibition of human ERG by Q-patch assay
12546,CHEMBL4471006,Cc1nc(N)ccc1-c1n[nH]c2nc(N3CCC4(CC3)CO[C@@H](C)[C@H]4N)n(C)c(=O)c12,IC50,nM,=,6600.0,Inhibition of human ERG by Q-patch assay
12547,CHEMBL4570587,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(Sc5ccnc(N)c5Cl)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,>,30000.0,Inhibition of human ERG by Q-patch assay
12548,CHEMBL4439006,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(-c5ccnc(NC6CC6)c5Cl)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,=,17000.0,Inhibition of human ERG by Q-patch assay
12549,CHEMBL4439006,C[C@@H]1OCC2(CCN(c3nc4[nH]nc(-c5ccnc(NC6CC6)c5Cl)c4c(=O)n3C)CC2)[C@@H]1N,IC50,nM,=,17000.0,Inhibition of human ERG
12550,CHEMBL4526283,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,=,25000.0,Inhibition of human ERG by fluorescence polarization assay
12551,CHEMBL4548200,CNC(=O)c1cnc(Nc2cc(C)ccn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,=,16000.0,Inhibition of human ERG by fluorescence polarization assay
12552,CHEMBL4472802,CNC(=O)c1cnc(Nc2ccc(N3CCOCC3)cn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,=,40000.0,Inhibition of human ERG by fluorescence polarization assay
12553,CHEMBL4453545,CNC(=O)c1cnc(Nc2ccc(C)nn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,=,43000.0,Inhibition of human ERG by fluorescence polarization assay
12554,CHEMBL4544320,CNC(=O)c1cnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,=,36000.0,Inhibition of human ERG by fluorescence polarization assay
12555,CHEMBL4444606,CNC(=O)c1cnc(Nc2ccc(OC)cn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,=,17000.0,Inhibition of human ERG by fluorescence polarization assay
12556,CHEMBL4438202,CNC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,>,80000.0,Inhibition of human ERG by fluorescence polarization assay
12557,CHEMBL4526283,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,=,2500.0,Inhibition of human ERG by patch clamp assay
12558,CHEMBL4444178,[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
12559,CHEMBL4460028,CC1(C)CCN1Cc1cccc(F)c1CNc1cc(F)c(S(=O)(=O)Nc2cscn2)c(F)c1,IC50,nM,=,22200.0,Inhibition of human ERG expressed in HEK293 cells by IonWorks barracuda patch clamp method
12560,CHEMBL4471825,CN(Cc1cccc(F)c1CNc1cc(F)c(S(=O)(=O)Nc2cscn2)c(F)c1)C(C)(C)C,IC50,nM,=,26300.0,Inhibition of human ERG expressed in HEK293 cells by IonWorks barracuda patch clamp method
12561,CHEMBL4435054,CC(C)N(C)Cc1cccc(F)c1CNc1cc(F)c(S(=O)(=O)Nc2cscn2)c(F)c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in HEK293 cells by IonWorks barracuda patch clamp method
12562,CHEMBL4286841,CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1,IC50,nM,=,1340.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12563,CHEMBL4288103,CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1,IC50,nM,=,28200.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12564,CHEMBL4531058,CN1CCN(c2ccc(Nc3nccc(-c4sc(C5CCNCC5)nc4-c4ccc(F)cc4)n3)cc2)CC1,IC50,nM,=,13200.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12565,CHEMBL4464676,CCOC(=O)N1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCN(C)CC5)cc4)n3)s2)CC1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12566,CHEMBL4531226,Fc1ccc(-c2nc(N3CCOCC3)sc2-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)cc1,IC50,nM,=,5400.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12567,CHEMBL4455587,Fc1ccc(-c2nc(N3CCCC3)sc2-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)cc1,IC50,nM,=,5600.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12568,CHEMBL4585607,CN1CCN(c2ccc(Nc3nccc(-c4sc(N)nc4-c4ccc(F)cc4)n3)cc2)CC1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12569,CHEMBL4459320,Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1,IC50,nM,=,35500.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12570,CHEMBL4462111,Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12571,CHEMBL4451783,CC(=O)Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1,IC50,nM,=,38000.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12572,CHEMBL4567664,O=C(Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1)C1CC1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12573,CHEMBL4459919,CN1CCC(C(=O)Nc2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1,IC50,nM,=,50100.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12574,CHEMBL4460574,CCCS(=O)(=O)Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12575,CHEMBL4532321,O=S(=O)(Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1)C1CCNCC1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12576,CHEMBL4566588,Fc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(Nc3nncs3)n2)cc1,IC50,nM,=,2500.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12577,CHEMBL4444451,Cc1nnc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)s1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12578,CHEMBL4593717,Cc1csc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12579,CHEMBL4572858,Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)on1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12580,CHEMBL4469667,Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)nn1C,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12581,CHEMBL4583048,Fc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(Nc3ccn(C4CCNCC4)n3)n2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12582,CHEMBL4446024,Fc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(Nc3ccccn3)n2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12583,CHEMBL4446015,Fc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(Nc3cnccn3)n2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12584,CHEMBL4546641,Fc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(Nc3cccnn3)n2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12585,CHEMBL4572065,Fc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(Nc3ccncn3)n2)cc1,IC50,nM,=,600.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12586,CHEMBL4438004,Cc1nccc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12587,CHEMBL4513311,CCOc1nccc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12588,CHEMBL4591417,Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)ccn1,IC50,nM,=,1000.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12589,CHEMBL4473609,Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)cc(C)n1,IC50,nM,=,1500.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12590,CHEMBL4526454,Oc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)ccn1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12591,CHEMBL4519443,COc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)cc(C)n1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12592,CHEMBL4585479,Cc1nc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)ccc1F,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12593,CHEMBL4449947,CCc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)nc(C)c1F,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12594,CHEMBL4461276,Cc1nc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)cc(C2CC2)c1F,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12595,CHEMBL4548154,Cc1nc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)cc(C2CCC2)c1F,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12596,CHEMBL4586918,Fc1ccc(-c2nc(C3CCNCC3)sc2-c2ccnc(NCc3ccncc3)n2)cc1,IC50,nM,=,1500.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12597,CHEMBL4436765,OC(CNc1nccc(-c2sc(C3CCNCC3)nc2-c2ccc(F)cc2)n1)c1ccncc1,IC50,nM,=,28200.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12598,CHEMBL4516715,Fc1ccc(-c2nc(C3CCNCC3)oc2-c2ccnc(Nc3ccncn3)n2)cc1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12599,CHEMBL4461043,c1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3C3CC3)n2)ncn1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12600,CHEMBL4453994,Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3C3CC3)n2)ccn1,IC50,nM,=,4200.0,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12601,CHEMBL4566303,Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3CN3CCCCC3)n2)ccn1,IC50,,,,Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay
12602,CHEMBL4592045,CCc1cc(F)c2nc(N3CCC(NC4CCOCC4)CC3)c(-c3nc(C)no3)c(C)c2c1,IC50,nM,=,1.0,Inhibition of human ERG expressed in HEK293 cells at 10 uM by Qpatch clamp assay
12603,CHEMBL4539279,CCc1ccc(COc2ccc(C3CN(C(=O)c4cc(OCCN5C[C@@H](O)[C@H](O)C5)ccn4)C3)cc2OC)cc1,IC50,nM,>,10000.0,Inhibition of recombinant human ERG expressed in HEK293 cells by whole-cell patch-clamp method
12604,CHEMBL4460662,CCc1ccc(COc2ccc(C3CN(C(=O)c4cc(OCCN5C[C@H](O)[C@H](O)C5)ccn4)C3)cc2OC)cc1,IC50,nM,>,3000.0,Inhibition of recombinant human ERG expressed in HEK293 cells by whole-cell patch-clamp method
12605,CHEMBL4574414,CCc1ccc(COc2ccc(C3CN(C(=O)c4cc(OCCN5CCNC(=O)C5)ccn4)C3)cc2OC)cc1,IC50,nM,>,3000.0,Inhibition of recombinant human ERG expressed in HEK293 cells by whole-cell patch-clamp method
12606,CHEMBL4458575,O=C(O)C[C@H]1CCCN(C[C@@H](O)c2ccc(-c3noc(-c4onc(-c5ccccc5)c4C(F)(F)F)n3)cc2)C1,IC50,nM,=,4100.0,Inhibition of human ERG by patch clamp method
12607,CHEMBL2408789,Cc1cc(-c2n[nH]c3cc(NC(=O)N[C@H](C)c4ccccc4)ncc23)ccn1,IC50,nM,>,20000.0,Inhibition of human ERG
12608,CHEMBL3654680,C[C@@H](NC(=O)Nc1cc2[nH]nc(-c3cnn(C)c3)c2cn1)c1ccccc1,IC50,nM,>,20000.0,Inhibition of human ERG
12609,CHEMBL3654682,Cc1cc(-c2n[nH]c3cc(NC(=O)N[C@H](C)c4ccccc4)ncc23)cc(C)n1,IC50,nM,>,20000.0,Inhibition of human ERG
12610,CHEMBL3663084,C[C@@H](NC(=O)Nc1cc2[nH]nc(-c3ccnc(F)c3)c2cn1)c1ccccc1,IC50,nM,>,20000.0,Inhibition of human ERG
12611,CHEMBL4098822,O=C(c1cc(F)cc(Cl)c1)N1CCn2nc(-c3ccc(F)cn3)cc2C1,IC50,nM,=,15000.0,Inhibition of human ERG
12612,CHEMBL3696477,Cc1c([C@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,>,30000.0,Inhibition of human ERG after 6 mins by electrophysiological assay
12613,CHEMBL3696476,Cc1c([C@H](O)CN2CCN(C[C@@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,22000.0,Inhibition of human ERG after 6 mins by electrophysiological assay
12614,CHEMBL3696475,Cc1c([C@@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,22000.0,Inhibition of human ERG after 6 mins by electrophysiological assay
12615,CHEMBL4573466,Cc1c(C(F)CN2CCN(CC(F)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,>,90000.0,Inhibition of human ERG after 6 mins by electrophysiological assay
12616,CHEMBL4559965,Cc1c(C(O)CN2CCN(CC(O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,28000.0,Inhibition of human ERG after 6 mins by electrophysiological assay
12617,CHEMBL3696477,Cc1c([C@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,100000.0,Displacement of [35S]MK-499 from human ERG
12618,CHEMBL3696476,Cc1c([C@H](O)CN2CCN(C[C@@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,47000.0,Displacement of [35S]MK-499 from human ERG
12619,CHEMBL3696475,Cc1c([C@@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,23000.0,Displacement of [35S]MK-499 from human ERG
12620,CHEMBL4573466,Cc1c(C(F)CN2CCN(CC(F)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,40000.0,Displacement of [35S]MK-499 from human ERG
12621,CHEMBL4559965,Cc1c(C(O)CN2CCN(CC(O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,23000.0,Displacement of [35S]MK-499 from human ERG
12622,CHEMBL3696479,Cc1c(CCN2CCN(CC(O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,5200.0,Displacement of [35S]MK-499 from human ERG
12623,CHEMBL4534171,Cc1c(CCN2CCN(CCc3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O,IC50,nM,=,3000.0,Displacement of [35S]MK-499 from human ERG
12624,CHEMBL2146870,O=C1OCc2cc(CCN3CCN(CCc4ccc5c(c4)COC5=O)CC3)ccc21,IC50,nM,=,1900.0,Displacement of [35S]MK-499 from human ERG
12625,CHEMBL2146755,O=[N+]([O-])c1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1,IC50,nM,=,7.0,Displacement of [35S]MK-499 from human ERG
12626,CHEMBL4566857,Cc1c(C(F)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,68000.0,Displacement of [35S]MK-499 from human ERG
12627,CHEMBL4438583,Cc1c(C(O)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,100000.0,Displacement of [35S]MK-499 from human ERG
12628,CHEMBL4522413,Cc1c(C(C)CN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,60000.0,Displacement of [35S]MK-499 from human ERG
12629,CHEMBL2441417,Cc1c(CCN2CCN(C(=O)Cc3ccc(-n4cnnn4)cc3)CC2)ccc2c1COC2=O,IC50,nM,=,20000.0,Displacement of [35S]MK-499 from human ERG
12630,CHEMBL4443722,CNC(=O)[C@@H]1C[C@H](N2CCc3c(ncnc3OCCc3ccccc3)C2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12631,CHEMBL4475942,CNC(=O)[C@@H]1C[C@H](N2CCc3c(ncnc3OCCC3CC3)C2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12632,CHEMBL4435231,CNC(=O)[C@@H]1C[C@H](N2CCc3c(cccc3OCCc3ccccc3)C2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,=,4000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12633,CHEMBL4528713,CNC(=O)[C@@H]1C[C@H](N2CCc3c(cccc3OCCC3CC3)C2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,=,11000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12634,CHEMBL4550207,CNC(=O)[C@@H]1C[C@H](N2CCc3c(cccc3OCCOC)C2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12635,CHEMBL4472682,CNC(=O)[C@@H]1C[C@H](N2CCc3c(cccc3OC)C2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12636,CHEMBL4515510,CNC(=O)[C@@H]1C[C@H](N2CCc3ccccc3C2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12637,CHEMBL4457012,CNC(=O)[C@@H]1C[C@H](n2cc(C3CC3)nn2)CN1C(=O)c1ccc(CN)c(OC)c1,IC50,nM,>,30000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12638,CHEMBL4441232,COc1cc(C(=O)N2C[C@@H](n3cc(C4CC4)nn3)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2c2ccccc2)ccc1CN,IC50,nM,=,12000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12639,CHEMBL4466010,COc1cc(C(=O)N2C[C@@H](n3cc(C4CC4)nn3)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)ccc1CN,IC50,nM,=,22000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12640,CHEMBL4448473,NCc1ccc(C(=O)N2C[C@@H](n3cc(C4CC4)nn3)C[C@H]2C(=O)NCC(c2ccccc2)c2ccccc2)cc1,IC50,nM,=,500.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12641,CHEMBL4476255,COc1cc(C(=O)N2C[C@@H](n3cc(C4CC4)nn3)C[C@H]2C(=O)NCC(c2ccccc2)c2ccccc2)ccc1CN,IC50,nM,=,2400.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12642,CHEMBL4557806,COc1cc(C(=O)N2C[C@@H](n3cc(C4CC4)nn3)C[C@H]2C(=O)NCCc2ccccc2)ccc1CN,IC50,,,,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12643,CHEMBL4475317,COc1cc(C(=O)N2C[C@@H](n3cc(C4CC4)nn3)C[C@H]2C(=O)N2CC[C@H](c3ccccc3)C2)ccc1CN,IC50,nM,=,14000.0,Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells measured after 90 mins by scintillation proximity assay
12644,CHEMBL4447180,Cn1cc(NC(=O)c2cccc(-c3ccnc(N)c3)n2)c(C(N)=O)n1,IC50,nM,=,25000.0,Inhibition of MK499 binding to human ERG
12645,CHEMBL4436908,Cn1cc(NC(=O)c2cccc(-c3ccc(C4CC4)nc3)n2)c(C(N)=O)n1,IC50,nM,>,60000.0,Inhibition of MK499 binding to human ERG
12646,CHEMBL3353206,Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1,IC50,nM,>,60000.0,Inhibition of MK499 binding to human ERG
12647,CHEMBL4518357,CN(C)[C@H]1CN(C(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C[C@@H]1O,IC50,nM,>,60000.0,Inhibition of MK499 binding to human ERG
12648,CHEMBL4434908,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CC(CN)C2)n1,IC50,nM,=,40000.0,Inhibition of MK499 binding to human ERG
12649,CHEMBL4466893,CN1CCCC(CNC(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C1,IC50,nM,=,12000.0,Inhibition of MK499 binding to human ERG
12650,CHEMBL4535152,Cn1cc(NC(=O)c2ccnc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1,IC50,nM,=,1900.0,Inhibition of MK499 binding to human ERG
12651,CHEMBL4473656,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1,IC50,nM,=,6100.0,Inhibition of MK499 binding to human ERG
12652,CHEMBL4523017,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1,IC50,nM,=,2900.0,Inhibition of MK499 binding to human ERG
12653,CHEMBL4467839,Cn1cc(NC(=O)c2cncc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1,IC50,nM,=,5200.0,Inhibition of MK499 binding to human ERG
12654,CHEMBL4459066,Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(N)=O)n1,IC50,nM,>,60000.0,Inhibition of MK499 binding to human ERG
12655,CHEMBL4438330,CCn1nc(C(C)(C)C)cc1Nc1nc(-c2ccc(-n3cnc(C)c3)c(F)c2)cs1,IC50,nM,>,30000.0,Inhibition of human ERG channel expressed in HEK293 cells by patch-clamp assay
12656,CHEMBL3918580,Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O,IC50,nM,=,10000.0,Inhibition of human ERG by patch clamp assay
12657,CHEMBL4463436,Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cc4)CC3)c(C(N)=O)cn2)n1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12658,CHEMBL4466236,Cc1nccc(Nc2cc(N[C@@H]3CCN(c4ccc(C#N)cn4)C[C@@H]3F)c(C(N)=O)cn2)n1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12659,CHEMBL4523034,Cc1nc2ccc(Nc3cc(NC4CCN(c5ccc(C#N)cn5)CC4)c(C(N)=O)cn3)cc2o1,IC50,,,,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12660,CHEMBL4476828,Cc1nc2cc(Nc3cc(NC4CCN(c5ccc(C#N)cn5)CC4)c(C(N)=O)cn3)ccc2o1,IC50,nM,=,6600.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12661,CHEMBL4591633,Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cn4)CC3)c(C(N)=O)cn2)n1,IC50,nM,=,8100.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12662,CHEMBL4471707,Cc1cnc(Nc2cc(NC3CCN(c4ccc(C#N)cn4)CC3)c(C(N)=O)cn2)cn1,IC50,nM,=,4800.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12663,CHEMBL4470355,Cc1cncc(Nc2cc(NC3CCN(c4ccc(C#N)cn4)CC3)c(C(N)=O)cn2)n1,IC50,nM,=,5400.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12664,CHEMBL4463043,N#Cc1ccc(N2CCC(Nc3cc(Nc4ccncn4)ncc3C(N)=O)CC2)nc1,IC50,nM,=,17000.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12665,CHEMBL4454640,N#Cc1ccc(N2CCC(Nc3cc(Nc4cnccn4)ncc3C(N)=O)CC2)nc1,IC50,nM,=,7700.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12666,CHEMBL4455068,N#Cc1ccc(N2CCC(Nc3cc(Nc4ccccn4)ncc3C(N)=O)CC2)nc1,IC50,nM,=,360.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12667,CHEMBL4474752,N#Cc1ccc(N2CCC(Nc3cc(Nc4ccccc4)ncc3C(N)=O)CC2)nc1,IC50,,,,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12668,CHEMBL3593777,N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12669,CHEMBL3593771,N#Cc1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)nc1,IC50,nM,=,13400.0,Inhibition of human ERG expressed in CHO-K1 cells after 10 mins by Rb efflux assay
12670,CHEMBL4448986,CC(NC(=O)c1ccc(C(F)(F)F)cc1Cl)C1(N2CCN(S(=O)(=O)c3cn(C)nn3)CC2)CCC(F)(F)CC1.Cl,IC50,nM,=,20200.0,Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay
12671,CHEMBL4437791,CN1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1,IC50,nM,=,2600.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12672,CHEMBL4588314,COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1OC,IC50,nM,=,1900.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12673,CHEMBL4467868,COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C#N,IC50,nM,=,11000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12674,CHEMBL4453497,COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C(F)(F)F,IC50,nM,=,1600.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12675,CHEMBL4581278,COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1,IC50,nM,=,12000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12676,CHEMBL4460621,COc1ccc(-c2ccc3ncnc(-c4cncc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1,IC50,nM,=,26000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12677,CHEMBL4454454,COc1ccc(-c2ccc3ncnc(N4CCC[C@H](C(=O)N5CCN(C)CC5)C4)c3c2)cn1,IC50,nM,=,1500.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12678,CHEMBL4469006,CC(=O)N1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12679,CHEMBL3944013,COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12680,CHEMBL3947814,COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12681,CHEMBL4521888,COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C(F)(F)F,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12682,CHEMBL3977066,COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from recombinant human ERG transfected in HEK293 cell membranes after 60 mins by scintillation counting
12683,CHEMBL4566705,CC(C)Cc1cc(CNC(=O)C2C3CN(CCC(C)(C)C)CC32)nn1-c1ccccc1,IC50,nM,=,2600.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch clamp method
12684,CHEMBL4560282,CC(C)Cc1cc(CNC(=O)C2C3CN(Cc4ccccc4)CC32)nn1-c1ccccc1,IC50,nM,=,1430.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch clamp method
12685,CHEMBL4463242,CC(C)Cc1cc(CNC(=O)C2C3CN(C(=O)c4ccccc4)CC32)nn1-c1ccccc1,IC50,nM,=,15000.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch clamp method
12686,CHEMBL4451905,CC(C)Cc1cc(CNC(=O)C2C3CN(C(=O)Cc4ccccc4)CC32)nn1-c1ccccc1,IC50,nM,=,20800.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch clamp method
12687,CHEMBL4524656,CC(C)Cc1cc(C(=O)NCC2C3CN(CCC(C)(C)C)CC23)nn1-c1ccccc1,IC50,nM,=,3130.0,Inhibition of human ERG expressed in CHO-K1 cells by whole cell patch clamp method
12688,CHEMBL4474081,COCCNc1ncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12689,CHEMBL4061436,COc1ncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1,IC50,nM,=,1900.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12690,CHEMBL4521294,c1ccc(-c2cccc3nc(-c4ccncc4)nc(NCc4ccccn4)c23)cc1,IC50,nM,=,6700.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12691,CHEMBL4449766,COc1cncc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)c1,IC50,nM,=,8400.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12692,CHEMBL4099807,c1ccc(-c2cccc3nc(-c4cccnc4)nc(NCc4ccccn4)c23)cc1,IC50,nM,=,20000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12693,CHEMBL4453428,Cc1n[nH]c(C)c1-c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12694,CHEMBL4576889,Cc1noc(C)c1-c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,=,3100.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12695,CHEMBL4458197,Cn1cncc1-c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,=,2700.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12696,CHEMBL4532101,c1ccc(-c2cccc3nc(-c4cncs4)nc(NCc4ccccn4)c23)cc1,IC50,nM,=,6200.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12697,CHEMBL4521058,FC(F)(F)c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12698,CHEMBL4446165,NC(=O)c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12699,CHEMBL4590051,c1ccc(-c2cccc3nc(C4CC4)nc(NCc4ccccn4)c23)cc1,IC50,,,,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12700,CHEMBL4561733,Cc1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,=,4600.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12701,CHEMBL4450487,N#Cc1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12702,CHEMBL4441179,CN(C)c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,=,2500.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12703,CHEMBL4483629,Clc1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1,IC50,nM,>,80000.0,Inhibition of human ERG expressed in HEK293 cells by thallium flux assay
12704,CHEMBL4457557,NC(=O)c1ccc(Cc2ccccc2)cc1-c1cccc(CCC(=O)O)c1,IC50,nM,>,33300.0,Inhibition of human ERG expressed in CHO cells by patch clamp assay
12705,CHEMBL2078876,CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2c1,IC50,nM,=,400.0,Inhibition of human ERG
12706,CHEMBL4587540,CCOc1ccc2cc(-c3nn(CC4CNC4)c4ncnc(N)c34)ccc2c1,IC50,nM,=,1700.0,Inhibition of human ERG
12707,CHEMBL4558606,CCOc1ccc2cc(-c3nn(CC4CN(C)C4)c4ncnc(N)c34)ccc2c1,IC50,nM,=,1400.0,Inhibition of human ERG
12708,CHEMBL4445679,CCOc1ccc2cc(-c3nn(CC4CCN(C(C)C)CC4)c4ncnc(N)c34)ccc2c1,IC50,nM,=,300.0,Inhibition of human ERG
12709,CHEMBL2078877,CCOc1ccc2cc(-c3nn(CC4CCN(C(C)=O)CC4)c4ncnc(N)c34)ccc2c1,IC50,nM,>,10000.0,Inhibition of human ERG
12710,CHEMBL4582694,CCOc1ccc2cc(-c3nn(CC4CN(C(C)=O)C4)c4ncnc(N)c34)ccc2c1,IC50,nM,>,10000.0,Inhibition of human ERG
12711,CHEMBL4572930,CN1CCC(Cn2nc(-c3ccc4cc(OCC5CC5)ccc4c3)c3c(N)ncnc32)CC1,IC50,nM,=,900.0,Inhibition of human ERG
12712,CHEMBL4444685,CN1CCC(Cn2nc(-c3ccc4cc(OC5CCC5)ccc4c3)c3c(N)ncnc32)CC1,IC50,nM,=,200.0,Inhibition of human ERG
12713,CHEMBL4543259,CN1CCC(Cn2nc(-c3ccc4cc(OC5CC5)ccc4c3)c3c(N)ncnc32)CC1,IC50,nM,=,370.0,Inhibition of human ERG
12714,CHEMBL4576165,CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2n1,IC50,nM,=,10000.0,Inhibition of human ERG
12715,CHEMBL4450160,CN1CCC(Cn2nc(-c3ccc4nc(OCC(F)(F)F)ccc4c3)c3c(N)ncnc32)CC1,IC50,nM,=,500.0,Inhibition of human ERG
12716,CHEMBL4517731,CN1CCC(Cn2nc(-c3ccc4nc(OC5CC5)ccc4c3)c3c(N)ncnc32)CC1,IC50,nM,=,1700.0,Inhibition of human ERG
12717,CHEMBL4443394,CN(C)CC(C)(C)Cn1nc(-c2ccc3nc(OC4CC4)ccc3c2)c2c(N)ncnc21,IC50,nM,=,82.0,Inhibition of human ERG
12718,CHEMBL4591429,CCOc1ccc2cc(-c3nn(CC(C)C)c4ncnc(N)c34)ccc2c1,IC50,nM,>,10000.0,Inhibition of human ERG
12719,CHEMBL4455656,CC(C)Cn1nc(-c2ccc3cc(OC4CC4)ccc3c2)c2c(N)ncnc21,IC50,nM,>,10000.0,Inhibition of human ERG
12720,CHEMBL4558168,CC(C)Cn1nc(-c2ccc3nc(OC4CC4)ccc3c2)c2c(N)ncnc21,IC50,nM,=,10000.0,Inhibition of human ERG
12721,CHEMBL4439120,CC1(Cn2nc(-c3ccc4cc(OC5CC5)ccc4c3)c3c(N)ncnc32)COC1,IC50,nM,=,1900.0,Inhibition of human ERG
12722,CHEMBL4556402,CC1(Cn2nc(-c3ccc4nc(OC5CC5)ccc4c3)c3c(N)ncnc32)COC1,IC50,nM,>,10000.0,Inhibition of human ERG
12723,CHEMBL4537636,CCOc1ccc2cc(-c3nn(CC4CCOCC4)c4ncnc(N)c34)ccc2c1,IC50,nM,>,10000.0,Inhibition of human ERG
12724,CHEMBL4573817,CCOc1ccc2cc(-c3nn(CC4CCOCC4)c4ncnc(N)c34)ccc2n1,IC50,nM,>,10000.0,Inhibition of human ERG
12725,CHEMBL4572244,Nc1ncnc2c1c(-c1ccc3cc(OC4CC4)ccc3c1)nn2CC1CCOCC1,IC50,nM,>,10000.0,Inhibition of human ERG
12726,CHEMBL4476674,Nc1ncnc2c1c(-c1ccc3nc(OC4CC4)ccc3c1)nn2CC1CCOCC1,IC50,nM,>,10000.0,Inhibition of human ERG
12727,CHEMBL4445333,CCOc1ccc2cc(-c3nn(CC(C)(C)O)c4ncnc(N)c34)ccc2n1,IC50,nM,>,10000.0,Inhibition of human ERG
12728,CHEMBL4571877,CC(C)(O)Cn1nc(-c2ccc3cc(OC4CC4)ccc3c2)c2c(N)ncnc21,IC50,nM,>,10000.0,Inhibition of human ERG
12729,CHEMBL4536241,CC(C)(O)Cn1nc(-c2ccc3nc(OC4CC4)ccc3c2)c2c(N)ncnc21,IC50,nM,>,10000.0,Inhibition of human ERG
12730,CHEMBL4553699,CC(C)(CO)Cn1nc(-c2ccc3cc(OC4CC4)ccc3c2)c2c(N)ncnc21,IC50,nM,>,10000.0,Inhibition of human ERG
12731,CHEMBL4471923,CC(C)(CO)Cn1nc(-c2ccc3nc(OC4CC4)ccc3c2)c2c(N)ncnc21,IC50,nM,>,10000.0,Inhibition of human ERG
12732,CHEMBL4464764,O=c1c(O)c(-c2cccc(O)c2)oc2ccc(O)cc12,IC50,nM,=,99300.0,Inhibition of human ERG in membranes incubated for 2 hrs by fluorescence polarization assay
12733,CHEMBL237067,CC(C)=CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,IC50,nM,=,200.0,Inhibition of human ERG channel
12734,CHEMBL4577549,CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(n2)C(C)(C)S(=O)(=O)C3)cc1,IC50,nM,=,48000.0,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp assay
12735,CHEMBL4436576,Cc1ccc(-c2cc3nccnc3c(NCCCCN)n2)cc1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12736,CHEMBL4437415,CN(C)c1ccc(-c2cc3nccnc3c(NCCCCN)n2)cn1,IC50,nM,=,39810.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12737,CHEMBL4444533,CN(C)c1ccc(-c2cc3nccnc3c(NCC(F)(F)F)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12738,CHEMBL4439653,CN(C)c1ccc(-c2cc3nccnc3c(NCCCCO)n2)cn1,IC50,nM,=,31622.78,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12739,CHEMBL4469541,CN(C)c1ccc(-c2cc3nccnc3c(NCCC(N)=O)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12740,CHEMBL4528289,CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)cn1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12741,CHEMBL4570588,CN(C)c1ccc(-c2cc3nccnc3c(NC[C@@H]3CNCCO3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12742,CHEMBL4448695,CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CNCCO3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12743,CHEMBL4460676,CN(C)c1ccc(-c2cc3nccnc3c(NC[C@@H]3CNCCC3(F)F)n2)cn1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12744,CHEMBL4556378,CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CNCCC3(F)F)n2)cn1,IC50,nM,=,19952.62,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12745,CHEMBL4571227,CN(C)c1ccc(-c2cc3nccnc3c(NCC3CNCC(F)(F)C3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12746,CHEMBL4469408,CN(C)c1ccc(-c2cc3nccnc3c(NC[C@@H]3CNCCN3C)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12747,CHEMBL4468195,CN(C)c1ccc(-c2cc3nccnc3c(NC[C@H]3CNCCN3C)n2)cn1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12748,CHEMBL4455268,Cc1ccc(-c2cc3ncccc3c(NC[C@H]3CCCNC3)n2)cc1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12749,CHEMBL4570737,Cc1ccc(-c2cc3ncncc3c(NC[C@H]3CCCNC3)n2)cc1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12750,CHEMBL4449815,Cc1ccc(-c2cc3nc[nH]c(=O)c3c(NC[C@H]3CCCNC3)n2)cc1,IC50,nM,=,7943.28,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12751,CHEMBL4526150,Cc1ccc(-c2cc3ncn(C)c(=O)c3c(NC[C@H]3CCCNC3)n2)cc1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12752,CHEMBL4468047,CN(C)c1ccc(-c2cc3ncccc3c(NC[C@H]3CCCNC3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12753,CHEMBL4472827,CN(C)c1ccc(-c2cc(NC[C@H]3CCCNC3)c3cccnc3c2)cn1,IC50,nM,=,39810.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12754,CHEMBL4560963,CN(C)c1ccc(-c2cc3nccnc3c(CCC3CCCNC3)n2)cn1,IC50,nM,=,15848.93,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12755,CHEMBL3546703,CN(C)c1ccc(-c2cc3nccnc3c(OC[C@H]3CCCNC3)n2)cn1,IC50,nM,=,10000.0,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12756,CHEMBL4583779,CN(C)c1ccc(-c2cc3nccnc3c(OC[C@@H]3CCCNC3)n2)cn1,IC50,nM,=,12589.25,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12757,CHEMBL4454171,c1cnc2c(NC[C@H]3CCCNC3)nc(N3CCNCC3)cc2n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12758,CHEMBL4436508,O=C1CN(c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)CCN1,IC50,nM,=,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12759,CHEMBL4584789,Cc1ccc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)s1,IC50,nM,=,5011.87,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12760,CHEMBL4453218,Cc1ccc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)o1,IC50,nM,=,19952.62,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12761,CHEMBL4445992,c1cnc2c(NC[C@H]3CCCNC3)nc(-c3cc[nH]n3)cc2n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12762,CHEMBL4570285,c1cnc2c(NC[C@H]3CCCNC3)nc(-c3cn[nH]c3)cc2n1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12763,CHEMBL4458845,Cn1cc(-c2cc3nccnc3c(NC[C@H]3CCCNC3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12764,CHEMBL4590420,Cn1cc(-c2cc3nccnc3c(OC[C@H]3CCCNC3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12765,CHEMBL4466696,Cn1cc(-c2cc3nccnc3c(NC[C@@H]3CNCCO3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12766,CHEMBL4439328,Cn1cc(-c2cc3nccnc3c(NC[C@@H]3CNCCC3(F)F)n2)cn1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12767,CHEMBL4561098,Cn1cc(-c2cc3nccnc3c(OCC3CNCCC3(F)F)n2)cn1,IC50,nM,=,25118.86,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12768,CHEMBL4520397,Cn1cc(-c2cc3nccnc3c(NCC3CNCC(F)(F)C3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12769,CHEMBL4473150,Cn1cc(-c2cc3nccnc3c(OCC3CNCC(F)(F)C3)n2)cn1,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12770,CHEMBL4455149,CN1CCNC[C@H]1CNc1nc(-c2cnn(C)c2)cc2nccnc12,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12771,CHEMBL4455093,CN1CCNC[C@H]1COc1nc(-c2cnn(C)c2)cc2nccnc12,IC50,nM,>,50118.72,Inhibition of human ERG expressed in CHOK1 cell membranes after 2 hrs by cy3b-dofetilide-based fluorescence polarization assay
12772,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,530.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by patch clamp method
12773,CHEMBL462605,Clc1ccc(CCCOCCCN2CCCCC2)cc1,IC50,nM,=,1700.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by patch clamp method
12774,CHEMBL4586133,O=C(O)C(=O)O.c1ccc(-c2ccc(OCCCCCN3CCCCCC3)cc2)cc1,IC50,nM,=,2030.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by patch clamp method
12775,CHEMBL4540849,O=C(O)C(=O)O.c1ccc(-c2ccc(OCCCCCN3CCCCC3)cc2)cc1,IC50,nM,=,1750.0,Inhibition of human ERG expressed in CHO cells at holding potential of -90 mV by patch clamp method
12776,CHEMBL4450031,COc1ccc2c(=O)c(O)c(-c3ccc4c(c3)OCO4)oc2c1,IC50,nM,>,100000.0,Inhibition of human ERG after 2 hrs by fluorescence polarization assay
12777,CHEMBL4593348,CCC(CC)CNc1c(C(N)=O)cnc2ccc(C#N)cc12,IC50,nM,=,2300.0,Inhibition of human ERG by electrophysiology assay
12778,CHEMBL4543897,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12,IC50,nM,=,670.0,Inhibition of human ERG by electrophysiology assay
12779,CHEMBL4576684,CCC(CC)COc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12,IC50,nM,=,2100.0,Inhibition of human ERG by electrophysiology assay
12780,CHEMBL4578468,NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NC1CCCC1,IC50,nM,=,570.0,Inhibition of human ERG by electrophysiology assay
12781,CHEMBL4581380,NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1SC1CCCC1,IC50,nM,=,5100.0,Inhibition of human ERG by electrophysiology assay
12782,CHEMBL4174323,NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NC1CCOCC1,IC50,nM,=,2100.0,Inhibition of human ERG by electrophysiology assay
12783,CHEMBL4550293,NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NCC1CCCCC1,IC50,nM,=,830.0,Inhibition of human ERG by electrophysiology assay
12784,CHEMBL4531643,NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NCC1CCOCC1,IC50,nM,=,2300.0,Inhibition of human ERG by electrophysiology assay
12785,CHEMBL4544394,C[C@@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)C1CCOCC1,IC50,nM,=,4300.0,Inhibition of human ERG by electrophysiology assay
12786,CHEMBL4548199,C[C@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)C1CCOCC1,IC50,nM,=,3600.0,Inhibition of human ERG by electrophysiology assay
12787,CHEMBL4552140,C[C@@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)c1ccn(C)n1,IC50,nM,=,2800.0,Inhibition of human ERG by electrophysiology assay
12788,CHEMBL4591401,C[C@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)c1ccn(C)n1,IC50,nM,=,11000.0,Inhibition of human ERG by electrophysiology assay
12789,CHEMBL4569880,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccncc3)cc12,IC50,nM,=,620.0,Inhibition of human ERG by electrophysiology assay
12790,CHEMBL4585977,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cccnn3)cc12,IC50,nM,=,2300.0,Inhibition of human ERG by electrophysiology assay
12791,CHEMBL4535526,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccnnc3)cc12,IC50,nM,=,1600.0,Inhibition of human ERG by electrophysiology assay
12792,CHEMBL4585489,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cncnc3)cc12,IC50,nM,=,760.0,Inhibition of human ERG by electrophysiology assay
12793,CHEMBL4567042,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(C)nc3)cc12,IC50,nM,=,3300.0,Inhibition of human ERG by electrophysiology assay
12794,CHEMBL4551177,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(COC)cc3)cc12,IC50,nM,=,18000.0,Inhibition of human ERG by electrophysiology assay
12795,CHEMBL4519670,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(CS(C)(=O)=O)cc3)cc12,IC50,nM,=,2100.0,Inhibition of human ERG by electrophysiology assay
12796,CHEMBL4588822,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(CO)nc3)cc12,IC50,nM,=,3100.0,Inhibition of human ERG by electrophysiology assay
12797,CHEMBL4560522,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(COC)nc3)cc12,IC50,nM,=,2500.0,Inhibition of human ERG by electrophysiology assay
12798,CHEMBL4576302,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(CS(C)(=O)=O)nc3)cc12,IC50,nM,=,1900.0,Inhibition of human ERG by electrophysiology assay
12799,CHEMBL4574647,CCC(CC)CNc1c(C(N)=O)c(C)nc2ccc(-c3cccnc3)cc12,IC50,nM,=,680.0,Inhibition of human ERG by electrophysiology assay
12800,CHEMBL4543599,CCC(CC)CNc1c(C(N)=O)cnc2c(C)cc(-c3cccnc3)cc12,IC50,nM,=,360.0,Inhibition of human ERG by electrophysiology assay
12801,CHEMBL4532124,NC(=O)c1cnc2ccc(-c3cccnc3)c(F)c2c1NC1CCOCC1,IC50,nM,=,13000.0,Inhibition of human ERG by electrophysiology assay
12802,CHEMBL4540906,NC(=O)c1cnc2cc(F)c(-c3cccnc3)cc2c1NC1CCOCC1,IC50,nM,=,2000.0,Inhibition of human ERG by electrophysiology assay
12803,CHEMBL4543236,NC(=O)c1cnc2cc(Cl)c(-c3cccnc3)cc2c1NC1CCOCC1,IC50,nM,=,1200.0,Inhibition of human ERG by electrophysiology assay
12804,CHEMBL4584911,NC(=O)c1cnc2c(F)cc(-c3cccnc3)cc2c1NC1CCOCC1,IC50,nM,=,10000.0,Inhibition of human ERG by electrophysiology assay
12805,CHEMBL4536989,NC(=O)c1cnc2c(Cl)cc(-c3cccnc3)cc2c1NC1CCOCC1,IC50,nM,=,1100.0,Inhibition of human ERG by electrophysiology assay
12806,CHEMBL4218734,COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1,IC50,nM,=,4500.0,Inhibition of human ERG by electrophysiology assay
12807,CHEMBL4533539,COCc1ccc(-c2cc3c(N[C@@H](C)C4CCOCC4)c(C(N)=O)cnc3cc2F)cn1,IC50,nM,=,8900.0,Inhibition of human ERG by electrophysiology assay
12808,CHEMBL4166405,COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1,IC50,nM,=,22000.0,Inhibition of human ERG by electrophysiology assay
12809,CHEMBL4548927,COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)c4ccn(C)n4)c3c2)c(F)n1,IC50,nM,=,14000.0,Inhibition of human ERG by electrophysiology assay
12810,CHEMBL4563993,COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)c(F)n1,IC50,nM,=,24000.0,Inhibition of human ERG by electrophysiology assay
12811,CHEMBL4517663,COCc1ccc(-c2cc3c(N[C@@H](C)c4nn(C)cc4F)c(C(N)=O)cnc3cc2F)cn1,IC50,nM,>,27000.0,Inhibition of human ERG by electrophysiology assay
12812,CHEMBL4215266,COCc1ccc(-c2cc3c(N[C@@H](C)c4nn(C)cc4C)c(C(N)=O)cnc3cc2F)cn1,IC50,nM,=,17000.0,Inhibition of human ERG by electrophysiology assay
12813,CHEMBL4549865,CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cnn(C)c3)cc12,IC50,nM,=,1200.0,Inhibition of human ERG by electrophysiology assay
12814,CHEMBL4464873,C[C@H]1[C@H](NC(=O)c2cc3c(F)cc(F)cc3[nH]2)C[C@@H]2C[C@H]1C2(C)C,IC50,nM,>,30000.0,Inhibition of human ERG
12815,CHEMBL3979678,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,nM,>,30000.0,Inhibition of human ERG
12816,CHEMBL4534573,CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)N(C)C)c2cn[nH]c2c1,IC50,nM,>,100000.0,Binding affinity to human ERG
12817,CHEMBL4483364,CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CC)c2cn[nH]c2c1,IC50,nM,>,100000.0,Binding affinity to human ERG
12818,CHEMBL4526887,CCc1c(-c2ccc(N3CCC(N(C)C)C3)cc2)[nH]c(=O)c2c(=O)[nH]sc12,IC50,nM,=,20000.0,Inhibition of human ERG channel by automated patch clamp assay
12819,CHEMBL4550812,COc1cc2c3c(ccc2cc1C#N)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,IC50,nM,>,40000.0,Inhibition of human ERG by patch clamp assay
12820,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,1600.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12821,CHEMBL4563167,COc1cccc(C(O)(CCN(C)C)C(c2cc3cc(Br)ccc3nc2OC)c2cccc3c2OCO3)n1,IC50,nM,=,240.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12822,CHEMBL4528706,COc1cccc(C(c2cc3cc(Br)ccc3nc2OC)C(O)(CCN(C)C)c2cc(C)cnc2C)c1OC,IC50,nM,=,1100.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12823,CHEMBL4520823,COc1cccc(C(c2cc3cc(Br)ccc3nc2OC)C(O)(CCN(C)C)c2cnc(C)cc2C)c1OC,IC50,nM,=,3900.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12824,CHEMBL4535649,COc1nc2ccc(Br)cc2cc1C(c1cccc(C)c1)C(O)(CCN(C)C)c1cccnc1OC,IC50,nM,=,450.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12825,CHEMBL4575859,COc1nc2ccc(C#N)cc2cc1C(c1cccc(C)c1)C(O)(CCN(C)C)c1cccnc1OC,IC50,nM,=,300.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12826,CHEMBL4514254,COc1cnc(OC)c(C(O)(CCN(C)C)C(c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)c1,IC50,nM,=,2900.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12827,CHEMBL4521403,COc1cc(C(O)(CCN(C)C)C(c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cnc1OC,IC50,nM,=,3600.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12828,CHEMBL4483435,COc1cc(C(O)(CCN(C)C)C(c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)c(OC)nc1OC,IC50,nM,=,2700.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12829,CHEMBL4564401,COc1cccc(C(c2cc3cc(C#N)ccc3nc2OC)C(O)(CCN(C)C)c2cc(C)nc(C)c2)c1OC,IC50,nM,=,5200.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12830,CHEMBL4522192,COc1cc(C(O)(CCN(C)C)C(c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)c(OC)cn1,IC50,nM,=,1700.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12831,CHEMBL4534128,CCOc1cc(C(O)(CCN(C)C)C(c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC(C)C)n1,IC50,nM,=,7800.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12832,CHEMBL4541578,CCOc1cc(C(O)(CCN(C)C)C(c2cc(OC)nc(OC)c2)c2cc3cc(Br)ccc3nc2OC)cc(OC(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG by manual patch clamp electrophysiology assay
12833,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,1600.0,Inhibition of human ERG
12834,CHEMBL4586271,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc3c2CCC3)cc(OC)n1,IC50,nM,=,4500.0,Inhibition of human ERG
12835,CHEMBL4524270,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc3c2CCCC3)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12836,CHEMBL4530550,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(C)c2F)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12837,CHEMBL4569766,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(C)c2F)cc(OCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12838,CHEMBL4555888,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc(C)c2F)cc(OCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12839,CHEMBL4529465,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OC)n1,IC50,nM,=,13000.0,Inhibition of human ERG
12840,CHEMBL4565089,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OCC)n1,IC50,nM,=,10000.0,Inhibition of human ERG
12841,CHEMBL4560398,COc1cc([C@](O)(CCN(C)C)[C@H](c2ccc(OC)c(F)c2)c2cc3cc(Br)ccc3nc2OC)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12842,CHEMBL4519972,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2OC)cc(OC)n1,IC50,nM,=,2200.0,Inhibition of human ERG
12843,CHEMBL4532620,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2OC)cc(OCC)n1,IC50,nM,=,5500.0,Inhibition of human ERG
12844,CHEMBL4543900,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc3c2OCO3)cc(OC)n1,IC50,nM,=,1600.0,Inhibition of human ERG
12845,CHEMBL4519008,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc3c2OCCO3)cc(OC)n1,IC50,nM,=,4400.0,Inhibition of human ERG
12846,CHEMBL4554862,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc3c2OCCO3)cc(OCC)n1,IC50,nM,=,13300.0,Inhibition of human ERG
12847,CHEMBL4561342,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc3c2OCCO3)cc(OCC)n1,IC50,nM,=,4500.0,Inhibition of human ERG
12848,CHEMBL4531693,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc3ccoc23)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12849,CHEMBL4574425,COc1cc([C@](O)(CCN(C)C)[C@H](c2cccnc2OC)c2cc3cc(Br)ccc3nc2OC)cc(OC)n1,IC50,nM,=,1700.0,Inhibition of human ERG
12850,CHEMBL4534204,CCOc1cc([C@](O)(CCN(C)C)[C@H](c2ccc(N(CC)CC)nc2)c2cc3cc(Br)ccc3nc2OC)cc(OCC)n1,IC50,nM,=,9900.0,Inhibition of human ERG
12851,CHEMBL4593713,COc1cnc(OC)c([C@H](c2cc3cc(Br)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(OC)nc(OC)c2)c1,IC50,nM,=,2200.0,Inhibition of human ERG
12852,CHEMBL4553350,COc1cnc(OC)c([C@H](c2cc3cc(C#N)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(OC)nc(OC)c2)c1,IC50,nM,=,3100.0,Inhibition of human ERG
12853,CHEMBL4570895,COc1cc([C@](O)(CCN(C)C)[C@H](c2cc(OC(C)C)cnc2OC)c2cc3cc(C#N)ccc3nc2OC)cc(OC)n1,IC50,nM,=,2400.0,Inhibition of human ERG
12854,CHEMBL4537029,COc1cc([C@](O)(CCN(C)C)[C@H](c2cc(OC)c(OC)nc2OC)c2cc3cc(Br)ccc3nc2OC)cc(OC)n1,IC50,nM,=,5900.0,Inhibition of human ERG
12855,CHEMBL4578975,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC)n1,IC50,nM,=,2600.0,Inhibition of human ERG
12856,CHEMBL4542973,COc1cc([C@](O)(CCN(C)C)[C@H](c2cc(SC)nc(SC)c2)c2cc3cc(Br)ccc3nc2OC)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12857,CHEMBL4550410,COc1cc([C@](O)(CCN(C)C)[C@H](c2cc(OC)nc(OC(C)C)c2)c2cc3cc(C#N)ccc3nc2OC)cc(OC)n1,IC50,nM,=,10600.0,Inhibition of human ERG
12858,CHEMBL4530411,CCCOc1cc([C@H](c2cc3cc(Br)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(OC)nc(OC)c2)cc(OC)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12859,CHEMBL4551182,CCOc1cc([C@H](c2cc3cc(C#N)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(OC)nc(OC)c2)cc(OC(C)C)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12860,CHEMBL4553146,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cc(OC)nc(OC)c2OC)cc(OC)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12861,CHEMBL4543668,COc1cc([C@](O)(CCN(C)C)[C@H](c2cc(OC)nc(N(C)C)c2)c2cc3cc(Br)ccc3nc2OC)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12862,CHEMBL4591849,COc1cc([C@](O)(CCN(C)C)[C@H](c2cc(OC)nc(N(C)C)c2)c2cc3cc(C#N)ccc3nc2OC)cc(OC)n1,IC50,nM,=,9400.0,Inhibition of human ERG
12863,CHEMBL4580150,CCOc1cc([C@H](c2cc3cc(C#N)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(OC)nc(OC)c2)cc(N(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12864,CHEMBL4525464,CCSc1cc([C@H](c2cc3cc(Br)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(OC)nc(OC)c2)cc(N(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12865,CHEMBL4548735,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2F)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12866,CHEMBL4590996,COc1cc(C(O)(CCn2ccnc2)C(c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2OC)cc(OC)n1,IC50,nM,=,11000.0,Inhibition of human ERG
12867,CHEMBL4585644,COc1cc(C(O)(CCn2ccnc2)C(c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC)n1,IC50,nM,=,5800.0,Inhibition of human ERG
12868,CHEMBL4634634,C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C,IC50,nM,=,23000.0,Inhibition of human ERG
12869,CHEMBL4642118,Cl.Clc1ccc(OC[C@@H]2C[C@H]3C[C@H]3N2)cn1,IC50,nM,>,10000.0,Inhibition of recombinant human ERG expressed in HEK293 at -80 mV holding potential by whole-cell patch clamp method
12870,CHEMBL4634969,CC(C)Cn1cc(-c2ccncc2)c2ccncc21,IC50,nM,=,30000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12871,CHEMBL4648945,c1cc(-c2cn(CC3CC3)c3cnccc23)ccn1,IC50,nM,=,15500.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12872,CHEMBL4091320,COCCn1cc(-c2ccncc2)c2ccncc21,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12873,CHEMBL4644898,CC1(Cn2cc(-c3ccncc3)c3ccncc32)COC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12874,CHEMBL4640598,c1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12875,CHEMBL4638460,c1ccc(Cn2cc(-c3ccncc3)c3ccncc32)cc1,IC50,nM,=,5700.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12876,CHEMBL4648742,c1ccc(-n2cc(-c3ccncc3)c3ccncc32)cc1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12877,CHEMBL4640465,Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1,IC50,nM,=,590.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12878,CHEMBL4648047,O=C(Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1)C1CC1,IC50,nM,=,130.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12879,CHEMBL4645474,O=C(Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1)NC1CC1,IC50,nM,=,1200.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12880,CHEMBL4641631,O=C(Nc1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1)NC1CC1,IC50,nM,=,4600.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12881,CHEMBL4649473,CC1(C)CN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)C1,IC50,nM,=,3800.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12882,CHEMBL4641672,O=C(Nc1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1)N1CCOCC1,IC50,nM,=,11000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12883,CHEMBL4641839,C[C@H]1CN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)C[C@@H](C)O1,IC50,nM,=,24000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12884,CHEMBL4640031,C[C@H]1CN(C(=O)Nc2cc(-c3cn([C@H]4CC[C@@](C)(O)CC4)c4cnccc34)ccn2)C[C@@H](C)O1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12885,CHEMBL4636064,CCN1CCN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)CC1,IC50,nM,>,30000.0,Displacement of [3H]dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12886,CHEMBL4636064,CCN1CCN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by Qpatch S8 assay
12887,CHEMBL4640031,C[C@H]1CN(C(=O)Nc2cc(-c3cn([C@H]4CC[C@@](C)(O)CC4)c4cnccc34)ccn2)C[C@@H](C)O1,IC50,nM,>,30000.0,Inhibition of human ERG by Qpatch S8 assay
12888,CHEMBL4641839,C[C@H]1CN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)C[C@@H](C)O1,IC50,nM,=,6600.0,Inhibition of human ERG by Qpatch S8 assay
12889,CHEMBL4641672,O=C(Nc1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1)N1CCOCC1,IC50,nM,=,24100.0,Inhibition of human ERG by Qpatch S8 assay
12890,CHEMBL4645474,O=C(Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1)NC1CC1,IC50,nM,=,600.0,Inhibition of human ERG by Qpatch S8 assay
12891,CHEMBL4640598,c1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1,IC50,nM,>,30000.0,Inhibition of human ERG by Qpatch S8 assay
12892,CHEMBL4647401,CC1(NC(=O)COc2cccc(-c3nc4c(c(Nc5ccc(-c6cn[nH]c6)cc5)n3)CN(C3CCC3)CC4)c2)CC1,IC50,nM,>,10000.0,Inhibition of human ERG by manual patch clamp assay
12893,CHEMBL4643577,COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,IC50,nM,=,30000.0,Inhibition of human ERG
12894,CHEMBL4641666,COc1nn(C)cc1C(=O)Nc1cccc(-c2cncn2C(C)C)n1,IC50,nM,=,15000.0,Inhibition of human ERG
12895,CHEMBL4632672,COc1nn(-c2cnccn2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12896,CHEMBL4640297,Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12,IC50,nM,=,5020.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12897,CHEMBL4637502,COCCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5cccnn45)c3)cc2C2CC2)CC1,IC50,nM,=,80.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12898,CHEMBL4642144,Cc1ccc(C(=O)Nc2ccc(CN3CCN(CCO)CC3)c(Cl)c2)cc1C#Cc1cnc2cccnn12,IC50,nM,=,100.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12899,CHEMBL4632471,Cc1ccc(C(=O)Nc2ccc(CN3CCN(CCO)CC3)c(C3CC3)c2)cc1C#Cc1cnc2cccnn12,IC50,nM,=,340.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12900,CHEMBL4638981,Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12,IC50,nM,=,12100.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12901,CHEMBL4633367,Cc1ccc(C(=O)Nc2ccc(CN3Cc4ccc(O)cc4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12,IC50,nM,=,780.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12902,CHEMBL255863,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,IC50,nM,=,450.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12903,CHEMBL1171837,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,nM,=,770.0,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay
12904,CHEMBL4643578,COC(=O)N1CCN(C(=O)c2ccc(-c3cnn4c(N)c(-c5ccccc5)c(NC5CC(C)(C)N(C)C(C)(C)C5)nc34)cc2)CC1,IC50,,,,Inhibition of human ERG expressed in human embryonic kidney cells by manual patch clamp assay
12905,CHEMBL4639022,CN1C(C)(C)CC(Nc2nc3c(-c4ccc(C(=O)N5CCN(S(C)(=O)=O)CC5)cc4)cnn3c(N)c2-c2ccccc2)CC1(C)C,IC50,,,,Inhibition of human ERG expressed in human embryonic kidney cells by manual patch clamp assay
12906,CHEMBL4644274,COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(NC4CC(C)(C)N(C)C(C)(C)C4)nc23)cc1OC,IC50,nM,=,1200.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12907,CHEMBL4636056,CN1C(C)(C)CC(Nc2nc3c(-c4ccc(C(=O)N5C[C@@H]6C[C@H]5CO6)cc4)cnn3c(N)c2-c2ccccc2)CC1(C)C,IC50,nM,=,4700.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12908,CHEMBL4643578,COC(=O)N1CCN(C(=O)c2ccc(-c3cnn4c(N)c(-c5ccccc5)c(NC5CC(C)(C)N(C)C(C)(C)C5)nc34)cc2)CC1,IC50,nM,=,7500.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12909,CHEMBL4639022,CN1C(C)(C)CC(Nc2nc3c(-c4ccc(C(=O)N5CCN(S(C)(=O)=O)CC5)cc4)cnn3c(N)c2-c2ccccc2)CC1(C)C,IC50,nM,=,14000.0,Displacement of [3H]-dofetilide from human ERG expressed in CHO cells incubated for 90 mins by microbeta scintillation counting method
12910,CHEMBL4644274,COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(NC4CC(C)(C)N(C)C(C)(C)C4)nc23)cc1OC,IC50,nM,=,500.0,Inhibition of human ERG expressed in human embryonic kidney cells by manual patch clamp assay
12911,CHEMBL4636056,CN1C(C)(C)CC(Nc2nc3c(-c4ccc(C(=O)N5C[C@@H]6C[C@H]5CO6)cc4)cnn3c(N)c2-c2ccccc2)CC1(C)C,IC50,nM,=,2800.0,Inhibition of human ERG expressed in human embryonic kidney cells by manual patch clamp assay
12912,CHEMBL4635160,Cc1cc(Cl)cc(-c2ccnc3cc(CN4C(=O)C5C(C4=O)C5(C)C)sc23)c1O[C@@H]1CCNC[C@@H]1C,IC50,nM,=,400.0,Inhibition of human ERG
12913,CHEMBL4638458,Cc1cc(Cl)cc(-c2ccnc3cc(CN4C(=O)CCC4=O)sc23)c1CN1[C@@H](C)CNC[C@@H]1C,IC50,nM,=,2700.0,Inhibition of human ERG
12914,CHEMBL4634092,Cc1cc(Cl)cc(-c2ccnc3cc(CN4C(=O)C5CC5C4=O)sc23)c1C[C@@H]1CNCCO1,IC50,nM,=,8000.0,Inhibition of human ERG
12915,CHEMBL4647217,Cc1cc(Cl)cc(-c2ccnc3cc(CN4C(=O)C5C(C4=O)C5(C)C)sc23)c1C[C@@H]1CNCCO1,IC50,nM,=,4200.0,Inhibition of human ERG
12916,CHEMBL4642567,CC(C)CCNC1=CC(=O)c2ccccc2C1=O,IC50,nM,>,30000.0,Inhibition of human ERG
12917,CHEMBL6966,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,nM,=,400.0,Inhibition of human ERG
12918,CHEMBL4640366,O=C(CCCCCCC(=O)Nc1ccccc1)NOC(c1ccccc1)(c1ccccc1)c1ccccc1,IC50,nM,=,96220.0,Inhibition of human ERG expressed in HEK293 cells measured after 30 mins by FluxOR dye based FLIPR TETRA assay
12919,CHEMBL296419,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,nM,=,2600.0,Inhibition of human ERG expressed in HEK293 cells measured after 30 mins by FluxOR dye based FLIPR TETRA assay
12920,CHEMBL1008,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,IC50,nM,=,1400.0,Inhibition of human ERG expressed in HEK293 cells measured after 30 mins by FluxOR dye based FLIPR TETRA assay
12921,CHEMBL54,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,nM,=,1160.0,Inhibition of human ERG expressed in HEK293 cells measured after 30 mins by FluxOR dye based FLIPR TETRA assay
12922,CHEMBL17157,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,IC50,nM,=,1200.0,Inhibition of human ERG expressed in HEK293 cells measured after 30 mins by FluxOR dye based FLIPR TETRA assay
12923,CHEMBL4634455,Nc1ncnc2c1c(Oc1cc(C(F)(F)F)ccn1)nn2C1CC1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells by patch-clamp electrophysiology assay
12924,CHEMBL4646408,Nc1ncnc2c1c(Oc1cc(C(F)(F)F)ccn1)nn2[C@@H]1CCCC[C@H]1O,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells by patch-clamp electrophysiology assay
12925,CHEMBL4642579,N#Cc1ccnc(Oc2nn([C@H]3C[C@H](F)C3)c3ncnc(N)c23)c1,IC50,nM,>,30000.0,Inhibition of human ERG expressed in CHOK1 cells by patch-clamp electrophysiology assay
12926,CHEMBL376488,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12,IC50,nM,=,1600.0,Inhibition of human ERG
12927,CHEMBL4529465,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OC)n1,IC50,nM,=,13000.0,Inhibition of human ERG
12928,CHEMBL4553146,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cc(OC)nc(OC)c2OC)cc(OC)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12929,CHEMBL4641813,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OC)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12930,CHEMBL4639462,CCOc1cc([C@](O)(CCN(C)C)[C@H](c2cccc(C)c2)c2cc3cc(Br)ccc3nc2OC)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12931,CHEMBL4647327,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC)n1,IC50,nM,=,3300.0,Inhibition of human ERG
12932,CHEMBL4634170,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OC(C)C)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12933,CHEMBL4640836,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC(C)C)n1,IC50,nM,=,17000.0,Inhibition of human ERG
12934,CHEMBL4634438,COc1cc([C@](O)(CCN(C)C)[C@H](c2cccc(C)c2)c2cc3cc(Br)ccc3nc2OC)cc(OC(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12935,CHEMBL4643771,CCCOc1cc([C@](O)(CCN(C)C)[C@H](c2cccc(C)c2)c2cc3cc(Br)ccc3nc2OC)cc(OC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12936,CHEMBL4645301,CCCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC)n1,IC50,nM,=,7800.0,Inhibition of human ERG
12937,CHEMBL4633038,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC2CCC2)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12938,CHEMBL4633025,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc3c2OCO3)cc(OC(F)F)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12939,CHEMBL4645781,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc3c2OCO3)cc(OC(F)F)n1,IC50,nM,=,4800.0,Inhibition of human ERG
12940,CHEMBL4639550,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc(C)c2F)cc(OC(F)F)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12941,CHEMBL4639824,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OC(F)F)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12942,CHEMBL4645820,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc(OC)c2F)cc(OC(F)F)n1,IC50,nM,=,5300.0,Inhibition of human ERG
12943,CHEMBL4639062,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC(F)F)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12944,CHEMBL4634074,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC(F)F)n1,IC50,nM,=,7000.0,Inhibition of human ERG
12945,CHEMBL4643476,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(SC)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12946,CHEMBL4641396,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc(OC)c2F)cc(SC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12947,CHEMBL4646329,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(S(C)(=O)=O)n1,IC50,nM,=,1800.0,Inhibition of human ERG
12948,CHEMBL4641664,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(N(C)C)n1,IC50,,,,Inhibition of human ERG
12949,CHEMBL4645910,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2ccnc(OC)c2OC)cc(N(C)C)n1,IC50,nM,=,3400.0,Inhibition of human ERG
12950,CHEMBL4634936,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(OC(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12951,CHEMBL4649701,CCOc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2c(OC)cncc2OC)cc(OC(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12952,CHEMBL4645626,COc1cccc([C@H](c2cc3cc(Br)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(SC)nc(SC)c2)c1F,IC50,nM,>,10000.0,Inhibition of human ERG
12953,CHEMBL4637995,COc1cccc([C@H](c2cc3cc(C#N)ccc3nc2OC)[C@@](O)(CCN(C)C)c2cc(SC)nc(SC)c2)c1F,IC50,nM,=,5100.0,Inhibition of human ERG
12954,CHEMBL4637257,COc1nc2ccc(Br)cc2cc1[C@@H](c1ccnc(OC)c1OC)[C@@](O)(CCN(C)C)c1cc(SC)nc(SC)c1,IC50,nM,=,2800.0,Inhibition of human ERG
12955,CHEMBL4648576,COc1nc2ccc(Br)cc2cc1[C@@H](c1cccc2c1OCO2)[C@@](O)(CCN(C)C)c1cc(SC)nc(SC)c1,IC50,nM,>,10000.0,Inhibition of human ERG
12956,CHEMBL4642317,COc1nc2ccc(C#N)cc2cc1[C@@H](c1cccc2c1OCO2)[C@@](O)(CCN(C)C)c1cc(SC)nc(SC)c1,IC50,nM,=,5900.0,Inhibition of human ERG
12957,CHEMBL4633704,COc1nc2ccc(C#N)cc2cc1[C@@H](c1cccc(C)c1F)[C@@](O)(CCN(C)C)c1cc(SC)nc(SC)c1,IC50,nM,>,10000.0,Inhibition of human ERG
12958,CHEMBL4634386,CCSc1cc([C@](O)(CCN(C)C)[C@H](c2ccccc2)c2cc3cc(Br)ccc3nc2OC)cc(SCC)n1,IC50,nM,>,30000.0,Inhibition of human ERG
12959,CHEMBL4647399,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(SCC)n1,IC50,nM,=,9200.0,Inhibition of human ERG
12960,CHEMBL4641177,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(SCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12961,CHEMBL4641852,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc(OC)c2F)cc(SCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12962,CHEMBL4638967,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc(C)c2F)cc(SCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12963,CHEMBL4647766,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc3c2OCO3)cc(SCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12964,CHEMBL4647741,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2cccc3c2OCO3)cc(SCC)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12965,CHEMBL4638334,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2ccnc(OC)c2OC)cc(SCC)n1,IC50,nM,=,1500.0,Inhibition of human ERG
12966,CHEMBL4648337,CCS(=O)(=O)c1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(C#N)ccc3nc2OC)c2ccnc(OC)c2OC)cc(S(=O)(=O)CC)n1,IC50,,,,Inhibition of human ERG
12967,CHEMBL4642509,CCSc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2ccnc(OC)c2OC)cc(N(C)C)n1,IC50,nM,>,10000.0,Inhibition of human ERG
12968,CHEMBL473417,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,IC50,nM,>,33000.0,Inhibition of human ERG
12969,CHEMBL4632769,Cc1cc(C)c(-c2ncc[nH]2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1,IC50,nM,>=,25000.0,Inhibition of human ERG
12970,CHEMBL4637222,Cc1cc(C)c(-c2cn(C)cn2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1,IC50,nM,=,21000.0,Inhibition of human ERG
12971,CHEMBL4640840,Cc1ncc(-c2cc(NC(=O)c3ccc(OCc4ccccn4)cc3)c(C)cc2C)[nH]1,IC50,nM,=,12000.0,Inhibition of human ERG
12972,CHEMBL4636326,Cc1cc(F)c(-c2ncc[nH]2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG
12973,CHEMBL4638476,Cc1ccc(-c2ncc[nH]2)c(C)c1NC(=O)c1ccc(OCc2ccccn2)cc1,IC50,nM,>,100000.0,Inhibition of human ERG
12974,CHEMBL4640515,Cc1cnc(-c2ccc(-c3ccco3)cc2)n1Cc1ccccc1OCCCCCC(=O)O,IC50,nM,=,5500.0,Inhibition of human ERG expressed in HEK293 cells by semi-automatic patch clamp assay
12975,CHEMBL4649683,Cc1cnc(-c2ccc(OC(F)(F)F)cc2)n1Cc1ccccc1OCCC[C@@H](C)CC(=O)O,IC50,nM,=,10000.0,Inhibition of human ERG expressed in HEK293 cells by semi-automatic patch clamp assay
12976,CHEMBL4635232,CCOC(=O)Cc1nn(CNC(=O)CCCN2CCN(c3cccc(C)c3C)CC2)c(=O)c2c(F)cccc12,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
12977,CHEMBL4646426,CCOC(=O)Cc1nn(CNC(=O)CCCN2CCN(c3cccc(C)c3C)CC2)c(=O)c2cc(F)ccc12,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
12978,CHEMBL41,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,IC50,nM,>,10000.0,Displacement of [3H]astemizole from human ERG
12979,CHEMBL4643134,CCn1nnc2c(C)c([C@@H](CC(=O)O)c3ccc4c(c3)CN(C(=O)c3c(C)c(C)cc(C)c3C)CC4)ccc21,IC50,nM,>,30000.0,Inhibition of human ERG
12980,CHEMBL4637258,CCS(=O)(=O)Nc1cc(-c2cn(C)c3c(=O)[nH]ccc23)cc2c1ccn2C(C)(c1ccccn1)c1ccccn1.Cl,IC50,nM,=,29258.0,Inhibition of human ERG stably expressed in HEK293 cells
12981,CHEMBL473,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,IC50,nM,=,15.0,Inhibition of human ERG stably expressed in HEK293 cells
12982,CHEMBL4647810,C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1,IC50,nM,>,10000.0,Inhibition of recombinant human ERG stably expressed in HEK293 cells at -80 mV by whole cell voltage clamp method
12983,CHEMBL4640028,CS(=O)(=O)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1,IC50,nM,=,5800.0,Inhibition of recombinant human ERG stably expressed in HEK293 cells at -80 mV by whole cell voltage clamp method
12984,CHEMBL4636208,CC(C)[C@@H](NC(=O)c1cc(C(F)(F)F)ccc1F)C(=O)N1CCC2(CC1)C(=O)N(C)C(=O)N2c1ccc2[nH]ncc2c1,IC50,nM,>,50000.0,Inhibition of human ERG by manual patch clamp assay
12985,CHEMBL4636208,CC(C)[C@@H](NC(=O)c1cc(C(F)(F)F)ccc1F)C(=O)N1CCC2(CC1)C(=O)N(C)C(=O)N2c1ccc2[nH]ncc2c1,IC50,nM,>,50000.0,Inhibition of human ERG by GLP based assay
12986,CHEMBL4644729,C[C@@H](Nc1nc2c(cnn2C(C)(C)C)c(=O)n1Cc1ccc(F)cc1)c1ccc(Cl)cc1,IC50,nM,=,11000.0,Inhibition of human ERG
12987,CHEMBL1373,NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1,IC50,,,,Inhibition of human ERG
12988,CHEMBL4635958,OC(Cc1ccc(F)cc1)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
12989,CHEMBL4636336,OC(Cc1ccc(C(F)(F)F)cc1)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
12990,CHEMBL4635589,COc1ccc(CC(O)CN2CCN(CCSC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,IC50,,,,Inhibition of human ERG
12991,CHEMBL4647914,O[C@@H](Cc1ccccc1)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
12992,CHEMBL4643955,O[C@H](Cc1ccccc1)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
12993,CHEMBL4643380,O=C(CCc1ccccc1)N1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
12994,CHEMBL4641869,CC(=O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
12995,CHEMBL4642082,[O-][S+](CCN1CCN(CC(O)Cc2ccc(F)cc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,IC50,,,,Inhibition of human ERG
12996,CHEMBL4645184,[O-][S+](CCN1CCN(CC(O)Cc2ccc(C(F)(F)F)cc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,IC50,,,,Inhibition of human ERG
12997,CHEMBL4648300,COc1ccc(CC(O)CN2CCN(CC[S+]([O-])C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,IC50,,,,Inhibition of human ERG
12998,CHEMBL4649604,[O-][S+](CCN1CCN(C[C@@H](O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,IC50,,,,Inhibition of human ERG
12999,CHEMBL4633748,[O-][S+](CCN1CCN(C[C@H](O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,IC50,,,,Inhibition of human ERG
13000,CHEMBL4638977,C[C@H](O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
13001,CHEMBL4647283,C[C@@H](O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
13002,CHEMBL4643859,Fc1ccc(C(SCCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1,IC50,,,,Inhibition of human ERG
13003,CHEMBL4638203,CCC(=O)N1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
13004,CHEMBL4648586,C[C@H](O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
13005,CHEMBL4647526,C[C@@H](O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,IC50,,,,Inhibition of human ERG
13006,CHEMBL4645855,[O-][S+](CCCN1CCN(CCCc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,IC50,,,,Inhibition of human ERG
13007,CHEMBL4634934,C[C@H]1CN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)C[C@@H](C)N1,IC50,,,,Inhibition of human ERG
13008,CHEMBL4636778,CC(O)CN1[C@@H](C)CN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)C[C@H]1C,IC50,nM,=,635.0,Inhibition of human ERG
13009,CHEMBL4647200,C[C@H](O)CN1[C@@H](C)CN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)C[C@H]1C,IC50,,,,Inhibition of human ERG
13010,CHEMBL4640152,C[C@H]1CN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)C[C@@H](C)N1C[C@@H](C)O,IC50,,,,Inhibition of human ERG
13011,CHEMBL4640772,C[C@H]1CN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)C[C@@H](C)N1CC(O)Cc1ccccc1,IC50,,,,Inhibition of human ERG
13012,CHEMBL4634776,CC(O)CN1[C@@H](C)CN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)C[C@H]1C,IC50,nM,=,7300.0,Inhibition of human ERG
13013,CHEMBL4639814,C[C@H]1CN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)C[C@@H](C)N1CC(O)Cc1ccccc1,IC50,nM,=,91.5,Inhibition of human ERG
13014,CHEMBL4640372,OC(CN1CCC2(CCN(CCSC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1)c1ccccc1,IC50,,,,Inhibition of human ERG
13015,CHEMBL4634263,CC(O)CN1CCC2(CCN(CC[S+]([O-])C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,IC50,,,,Inhibition of human ERG
13016,CHEMBL4636550,Cc1cc(Br)c(NC2=NCCN2)c2ccccc12,IC50,nM,=,7100.0,Inhibition of human ERG by radioligand binding assay
13017,CHEMBL4644994,Cc1cc(C)c2[nH]ccc2c1CN1CCCCC1c1ccc(C(=O)O)cc1,IC50,nM,>,30000.0,Inhibition of human ERG by radioligand binding assay
13018,CHEMBL4634827,CO[C@H]1CCN(Cc2c(C)cc(C)c3[nH]ccc23)[C@H](CO)C1,IC50,nM,=,14000.0,Inhibition of human ERG by radioligand binding assay
13019,CHEMBL4637717,C[C@@H](NC(=O)c1nc(-c2cc(C(F)(F)F)ccn2)nc(O)c1O)C1CCCCC1,IC50,nM,>,30000.0,Displacement of Tracer Red from human ERG measured after 4 hrs by fluorescence polarization assay
13020,CHEMBL4637524,COc1ccnc(-c2nc(O)c(O)c(C(=O)N[C@H](C)C3CCCCC3)n2)c1,IC50,nM,>,30000.0,Displacement of Tracer Red from human ERG measured after 4 hrs by fluorescence polarization assay
13021,CHEMBL4633550,C[C@@H](NC(=O)c1nc(-c2cc(Cl)ccn2)nc(O)c1O)C1CCCCC1,IC50,nM,>,30000.0,Displacement of Tracer Red from human ERG measured after 4 hrs by fluorescence polarization assay
13022,CHEMBL4635907,C[C@@H](NC(=O)c1nc(-c2nccc3ccccc23)nc(O)c1O)C1CCCCC1,IC50,nM,>,30000.0,Displacement of Tracer Red from human ERG measured after 4 hrs by fluorescence polarization assay
13023,CHEMBL3735506,COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1,IC50,nM,=,44.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13024,CHEMBL4641082,O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,4100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13025,CHEMBL4635680,O=C(NCC1CCCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,22300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13026,CHEMBL4634867,O=C(NCC1CCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,4300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13027,CHEMBL4635900,O=C(NCC1CCCO1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,11000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13028,CHEMBL4633727,O=C(NC1CCOCC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,1800.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13029,CHEMBL4633607,O=C(NC1CCCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,6600.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13030,CHEMBL4633141,O=C(NC1CCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,13300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13031,CHEMBL4645145,O=C(NC1CCS(=O)(=O)CC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,2100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13032,CHEMBL4633136,O=C(NC1CCS(=O)(=O)C1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12,IC50,nM,=,14500.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13033,CHEMBL4638321,O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cccnc3)cc12,IC50,nM,=,49300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13034,CHEMBL4632807,CC(C)Oc1cncc(-c2ccc3[nH]nc(C(=O)NCC4CCOCC4)c3c2)c1,IC50,nM,=,860.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13035,CHEMBL4643920,COCc1cncc(-c2ccc3[nH]nc(C(=O)NCC4CCOCC4)c3c2)c1,IC50,nM,=,5700.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13036,CHEMBL4640019,O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cncc(CO)c3)cc12,IC50,nM,>,100000.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13037,CHEMBL4636306,COCc1ccncc1-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1,IC50,nM,=,47100.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13038,CHEMBL4641148,O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cnccc3CO)cc12,IC50,nM,=,41300.0,Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarization to +20 mV for 2s followed by 1s pulse to -40 mV by whole cell patch clamp assay
13039,CHEMBL4646510,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,IC50,nM,>,30000.0,Inhibition of human ERG by manual whole-cell patch-clamp assay
13040,CHEMBL4632904,COc1cncc2c1[C@]1(O)[C@H](O)[C@H](CN(C)C)[C@@H](c3ccccc3)[C@]1(c1ccc(C#N)cc1)O2,IC50,nM,>,10000.0,Inhibition of human ERG by patch-clamp assay
13041,CHEMBL4645423,COc1nc(C#N)cc2c1[C@]1(O)[C@H](O)[C@H](CN(C)C)[C@@H](c3ccccc3)[C@]1(c1ccc(C#N)cc1)O2,IC50,nM,>,10000.0,Inhibition of human ERG by patch-clamp assay
13042,CHEMBL4303782,COc1cc2c(c(OC)n1)[C@]1(O)[C@H](O)[C@H](CN(C)C)[C@@H](c3ccccc3)[C@]1(c1ccc(C#N)cc1)O2,IC50,nM,>,10000.0,Inhibition of human ERG by patch-clamp assay
13043,CHEMBL4297674,CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1,IC50,nM,=,11000.0,Inhibition of human ERG by patch clamp assay
13044,CHEMBL3317856,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,IC50,ug.mL-1,=,588.0,Inhibition of human ERG
13045,CHEMBL4636169,CCCSc1nc(=O)cc(O)n1-c1ccccc1OC,IC50,nM,>,80000.0,Inhibition of human ERG
13046,CHEMBL4632688,CCCCc1nc(=O)cc(O)n1-c1c(C)cccc1OC,IC50,nM,>,80000.0,Inhibition of human ERG
13047,CHEMBL4648137,O=C(CCCCCc1ccccc1)N[C@H]1CC[C@H](O)CC1,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
13048,CHEMBL4633637,CCOc1ccc(-c2nnc([C@H]3C[C@H](NC(=O)c4ccccn4)C3)n2-c2ccccc2F)nc1,IC50,nM,>,25000.0,Displacement of [3H]dofetilide from recombinant human ERG measured after 60 mins by scintillation counting method
13049,CHEMBL4076989,CC(C)CN(CCc1ccc(Cl)cc1)C1CCN(c2nc(N)n[nH]2)CC1,IC50,nM,=,8000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13050,CHEMBL4637417,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3ccccc3O)CC2)n[nH]1,IC50,nM,=,100.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13051,CHEMBL4634943,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3cccc(O)c3)CC2)n[nH]1,IC50,nM,=,150.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13052,CHEMBL4077644,Nc1n[nH]c(N2CCC(N(CCc3ccc(Cl)cc3)Cc3ccccc3Cl)CC2)n1,IC50,nM,=,2000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13053,CHEMBL4649081,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3cccc(Cl)c3)CC2)n[nH]1,IC50,nM,=,3700.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13054,CHEMBL4646309,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,400.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13055,CHEMBL4632547,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3ccc(F)cc3Cl)CC2)n[nH]1,IC50,nM,=,4000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13056,CHEMBL4642053,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3cccc(C(F)(F)F)c3)CC2)n[nH]1,IC50,nM,=,2700.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13057,CHEMBL4646247,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3cc(F)ccc3F)CC2)n[nH]1,IC50,nM,=,3400.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13058,CHEMBL4637250,Nc1nc(N2CCC(N(CCc3ccc(Cl)cc3)Cc3ccncc3Cl)CC2)n[nH]1,IC50,nM,=,6400.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13059,CHEMBL4640857,Nc1nc(N2CCC(N3Cc4ccccc4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,22000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13060,CHEMBL4648962,Nc1nc(N2CCC(N3Cc4cc(F)ccc4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,6700.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13061,CHEMBL4638897,Nc1nc(N2CCC(N3Cc4cc(Cl)ccc4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,6700.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13062,CHEMBL4647895,N#Cc1ccc2c(c1)CN(C1CCN(c3n[nH]c(N)n3)CC1)[C@@H](Cc1ccc(Cl)cc1)CO2,IC50,nM,=,23000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13063,CHEMBL4637576,Nc1nc(N2CCC(N3Cc4cc(Cl)cc(Cl)c4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,6000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13064,CHEMBL4648844,Nc1nc(N2CCC(N3Cc4cnccc4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,17000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13065,CHEMBL4648162,Nc1nc(N2CCC(N3Cc4ccncc4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,50000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13066,CHEMBL4648998,Nc1nc(N2CCC(N3Cc4cccnc4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,>,50000.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13067,CHEMBL4644320,Nc1nc(N2CCC(N(Cc3ccccc3)[C@H](CO)Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,2900.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13068,CHEMBL4635305,CN1C[C@H](Cc2ccc(Cl)cc2)N(C2CCN(c3n[nH]c(N)n3)CC2)Cc2ccccc21,IC50,nM,=,3200.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13069,CHEMBL4643001,CN1C[C@H](Cc2ccc(Cl)cc2)N(C2CCN(c3n[nH]c(N)n3)CC2)Cc2cc(Cl)ccc21,IC50,nM,=,800.0,Displacement of Tracer Red from human ERG by fluorescence polarization assay
13070,CHEMBL4640857,Nc1nc(N2CCC(N3Cc4ccccc4OC[C@@H]3Cc3ccc(Cl)cc3)CC2)n[nH]1,IC50,nM,=,23000.0,Inhibition of human ERG expressed in CHO-K1 cells by automated Qpatch-clamp assay
13071,CHEMBL4647791,Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(C#N)c3)cc2n1-c1ccnc2c(F)ccc(F)c12,IC50,nM,>,25000.0,Inhibition of human ERG
13072,CHEMBL4470860,Cc1nc2c(-c3nnc[nH]3)cc(-c3ccnc(N)c3F)cc2n1-c1ccnc2c(F)ccc(F)c12,IC50,nM,>,25000.0,Inhibition of human ERG
13073,CHEMBL4647524,COc1cc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3n(n2)CCCCC3c2ccc(F)c(F)c2F)ncn1,IC50,nM,=,550.0,Inhibition of human ERG
13074,CHEMBL4645821,Cc1cc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3n(n2)CCCN3c2cc(F)cc(F)c2)ncn1,IC50,nM,=,700.0,Inhibition of human ERG
13075,CHEMBL4638559,COc1cc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3n(n2)CCCN3c2ccc(F)c(F)c2)ccn1,IC50,nM,>,2000.0,Inhibition of human ERG
13076,CHEMBL4644426,Cc1cc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3n(n2)CCCC[C@H]3c2ccc(F)c(F)c2F)ncn1,IC50,nM,=,1400.0,Inhibition of human ERG
13077,CHEMBL4641354,C[C@H](CN[C@@H](C(=O)Nc1ccc(-c2cnn(C)c2)cn1)c1ccccc1)c1ccc(C#N)cc1,IC50,nM,=,10400.0,Inhibition of human ERG
13078,CHEMBL4640061,Cc1c(N2CC[C@@H]([C@H](C)N)C2)c(F)cc2ccc(=O)n(C3CC3)c12,IC50,nM,=,48800.0,Inhibition of human ERG expressed in HEK293 cells measured after 10 mins by manual patch clamp electrophysiology method
13079,CHEMBL4638390,Cc1c(N2CC[C@@H]([C@H](C)N)C2)c(F)cc2c(CN)cc(=O)n(C3CC3)c12,IC50,nM,>,300000.0,Inhibition of human ERG expressed in CHOK1 cells by QPatch automated patch-clamp assay
13080,CHEMBL4634552,Cc1c(N2CC3CC3(N)C2)c(F)cc2c(CN)c(F)c(=O)n(C3CC3)c12,IC50,nM,=,114000.0,Inhibition of human ERG expressed in CHOK1 cells measured for 10 mins by QPatch automated patch-clamp assay
13081,CHEMBL4638599,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,IC50,nM,=,3010.0,Inhibition of human ERG
13082,CHEMBL4644352,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cccn12,IC50,nM,=,2200.0,Inhibition of human ERG
13083,CHEMBL4644391,N#Cc1ccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n2c1,IC50,nM,=,1050.0,Inhibition of human ERG
13084,CHEMBL85,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,nM,=,1330.0,Inhibition of human ERG
13085,CHEMBL4634009,COc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,IC50,,,,Inhibition of human ERG
13086,CHEMBL4643996,C[C@H](NS(=O)(=O)c1ccc(-c2sc(C(=O)NCC(C)(C)O)nc2C(=O)N2CCC(F)CC2)c(Cl)c1Cl)C(F)(F)F,IC50,nM,>,50000.0,Inhibition of human ERG
13087,CHEMBL4643996,C[C@H](NS(=O)(=O)c1ccc(-c2sc(C(=O)NCC(C)(C)O)nc2C(=O)N2CCC(F)CC2)c(Cl)c1Cl)C(F)(F)F,IC50,nM,>,30000.0,Inhibition of human ERG by patch clamp assay
13088,CHEMBL4468000,NCc1cccc(-c2cccc(COc3ccccc3CC(=O)O)c2)c1,IC50,nM,>,30000.0,Inhibition of human ERG by Qpatch assay
13089,CHEMBL4643449,CC(C)c1cc(COc2ccccc2CC(=O)O)cc(-c2ccc3c(c2)[C@H](N)CO3)c1,IC50,nM,=,24000.0,Inhibition of human ERG by Qpatch assay
13090,CHEMBL4632970,CNC(=O)[C@H](C)Cn1cnc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4Cl)c3)cc2c1=O,IC50,nM,=,27500.0,Inhibition of human ERG
13091,CHEMBL4649825,Cc1nsc(N2CC3CCC(C2)C3Nc2nc3c(-c4ccc(F)c(F)c4F)cccn3n2)n1,IC50,nM,<,2000.0,Inhibition of human ERG
13092,CHEMBL4639184,Cc1nsc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3c(OCC(F)(F)F)cccn3n2)n1,IC50,nM,>,10000.0,Inhibition of human ERG
13093,CHEMBL4635478,Cc1cc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3c(OCC(F)(F)F)cccn3n2)sn1,IC50,nM,=,2900.0,Inhibition of human ERG
13094,CHEMBL4649550,Cc1noc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3c(OCC(F)(F)F)ccc(C(F)(F)F)n3n2)n1,IC50,nM,=,8750.0,Inhibition of human ERG
13095,CHEMBL4642178,Cc1cc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3c(OCC(F)F)ccc(C(F)(F)F)n3n2)ncn1,IC50,nM,=,4500.0,Inhibition of human ERG
13096,CHEMBL4638913,Cc1nnc(N2C[C@@H]3CC[C@H](C2)[C@H]3Nc2nc3c(O[C@@H](C)C(F)(F)F)ccc(C(F)(F)F)n3n2)o1,IC50,nM,>,20000.0,Inhibition of human ERG
13097,CHEMBL4645216,O=C(O)c1cc(-c2ccc(C34CCN(CC3)CC4)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,IC50,nM,=,16400.0,Inhibition of human ERG
13098,CHEMBL4646514,O=C(O)c1cc(-c2ccc(C34CCN(CC3)CC4)cc2)cc(-n2cc(-c3ccc(C(F)(F)F)cc3)nn2)c1,IC50,nM,=,16800.0,Inhibition of human ERG
13099,CHEMBL4637298,CNC(=O)c1cc(C(=O)N[C@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1,IC50,nM,>,50118.72,Inhibition of human ERG
13100,CHEMBL4648439,Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O,IC50,nM,>,10000.0,Inhibition of human ERG by automated patch clamp assay
13101,CHEMBL4634904,Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O,IC50,nM,=,1300.0,Inhibition of human ERG by automated patch clamp assay
13102,CHEMBL4643319,Cn1cc(-c2cc(F)cc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O,IC50,nM,=,1600.0,Inhibition of human ERG by automated patch clamp assay
13103,CHEMBL4638277,Cn1cc(-c2cc(F)cc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O,IC50,nM,>,10000.0,Inhibition of human ERG by automated patch clamp assay
13104,CHEMBL4065122,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1,IC50,nM,>,30000.0,Inhibition of human ERG by automated patch clamp assay
13105,CHEMBL4632675,Cn1nccc1[C@H]1CCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ncns2)cc1F,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13106,CHEMBL4642571,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ncns2)cc1F,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13107,CHEMBL4641238,Cc1nsc(NS(=O)(=O)c2cc(F)c(O[C@H]3CCC[C@@H]3c3ccnn3C)cc2F)n1,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13108,CHEMBL4633573,Cn1nccc1[C@H]1CCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2nccs2)cc1F,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13109,CHEMBL4635030,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1F,IC50,nM,=,94000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13110,CHEMBL4642726,Cn1nccc1[C@H]1CCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1F,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13111,CHEMBL4640756,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1F,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13112,CHEMBL4647897,Cn1nccc1[C@H]1CCC[C@@H]1Oc1c(F)cc(S(=O)(=O)Nc2ccncn2)cc1F,IC50,,,,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13113,CHEMBL4648771,Cn1nccc1[C@H]1CCC[C@@H]1Oc1ccc(S(=O)(=O)Nc2ccncn2)c(F)c1F,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13114,CHEMBL4645788,Cn1nccc1[C@H]1CCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)c(F)c1,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13115,CHEMBL4648397,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)c(F)c1,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13116,CHEMBL4642940,Cn1nccc1[C@H]1CCCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)c(F)c1,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13117,CHEMBL4637909,Cn1nccc1[C@H]1CCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13118,CHEMBL4633566,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13119,CHEMBL4633566,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1Cl,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13120,CHEMBL4637488,Cc1cc(S(=O)(=O)Nc2ccncn2)c(F)cc1O[C@H]1CCC[C@@H]1c1ccnn1C,IC50,nM,>,100000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13121,CHEMBL4639987,Cc1cc(S(=O)(=O)Nc2ccncn2)c(F)cc1O[C@H]1CCCC[C@@H]1c1ccnn1C,IC50,nM,=,90000.0,Inhibition of human ERG by Ionworks high-throughput electrophysiology method
13122,CHEMBL4633566,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1Cl,IC50,nM,>,100000.0,Inhibition of human ERG expressed in HEK293 cells with -80 mV holding potential by whole cell manual patch clamp method
13123,CHEMBL4637728,Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)cn2-c1ccc(OCCNCCO)cc1,IC50,nM,=,2800.0,Inhibition of human ERG
13124,CHEMBL4645343,CN(C)Cc1ccc(-n2cc(-c3ccc4cc[nH]c4c3)c3c(Cl)ccnc32)cc1,IC50,nM,=,1700.0,Inhibition of human ERG
13125,CHEMBL4641455,NCc1ccc(-n2cc(-c3ccc4cc[nH]c4c3)c(C(F)(F)F)n2)cc1,IC50,nM,=,4000.0,Inhibition of human ERG
13126,CHEMBL4633000,FC(F)(F)c1nn(-c2ccc(Cc3nc[nH]n3)cc2)cc1-c1ccc2cc[nH]c2c1,IC50,nM,>,30000.0,Inhibition of human ERG
13127,CHEMBL4641477,N[C@@H](c1ccc(-n2cc(-c3ccc4cc[nH]c4c3)c(C(F)(F)F)n2)cc1)C(F)(F)F,IC50,nM,>,30000.0,Inhibition of human ERG
13128,CHEMBL4649237,NCCCCn1cc(-c2ccc3cc[nH]c3c2)c(C(F)(F)F)n1,IC50,nM,=,1900.0,Inhibition of human ERG
13129,CHEMBL4637559,N[C@@H]1CC[C@@H](n2cc(-c3ccc4cc[nH]c4c3)c(C(F)(F)F)n2)C1,IC50,nM,=,17000.0,Inhibition of human ERG
13130,CHEMBL4641724,CS(=O)(=O)c1ccc(/C(=N\N2CCCC2)C(=O)Nc2nccs2)cc1,IC50,,,,Inhibition of human ERG
13131,CHEMBL4645293,O=C(Nc1nccs1)/C(=N/N1CCCC1)c1ccc(S(=O)(=O)C2CC2)cc1,IC50,nM,=,17500.0,Inhibition of human ERG
13132,CHEMBL4641678,O=C(Nc1ncc(Cl)s1)/C(=N/N1CCCC1)c1ccc(S(=O)(=O)C2CC2)cc1,IC50,nM,=,16700.0,Inhibition of human ERG
13133,CHEMBL4638344,O=C(Nc1ccccn1)/C(=N/N1CCCC1)c1ccc(S(=O)(=O)C2CC2)cc1,IC50,,,,Inhibition of human ERG
13134,CHEMBL4649482,O=C(Nc1ncns1)/C(=N/N1CCCC1)c1ccc(S(=O)(=O)C2CC2)cc1,IC50,nM,=,5300.0,Inhibition of human ERG
13135,CHEMBL4632835,Cc1cnc(NC(=O)/C(=N/N2CCCC2)c2ccc(S(=O)(=O)C3CC3)cc2)s1,IC50,nM,>,100000.0,Inhibition of human ERG
13136,CHEMBL4637653,Cc1nnc(NC(=O)/C(=N/N2CCCC2)c2ccc(S(=O)(=O)C3CC3)cc2)s1,IC50,nM,>,100000.0,Inhibition of human ERG
13137,CHEMBL4646396,CN1CCN(Cc2cnc(NC(=O)/C(=N/N3CCCC3)c3ccc(S(=O)(=O)C4CC4)cc3)s2)CC1,IC50,nM,=,16900.0,Inhibition of human ERG
13138,CHEMBL4644080,CC(=O)N1CCN(Cc2cnc(NC(=O)/C(=N/N3CCCC3)c3ccc(S(=O)(=O)C4CC4)cc3)s2)CC1,IC50,nM,>,100000.0,Inhibition of human ERG
13139,CHEMBL4207171,Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2OC(C)C)C3)ccn1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13140,CHEMBL4644636,C[C@H](Oc1ccc(C#N)c(Cl)c1C(=O)N1Cc2cn(-c3ccc(F)cn3)nc2C1)C(F)(F)F,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13141,CHEMBL4639407,COc1c(C#N)ccc(O[C@@H](C)C(F)(F)F)c1C(=O)N1Cc2cn(-c3ccc(F)cn3)nc2C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13142,CHEMBL4638182,COc1c(S(C)(=O)=O)ccc(O[C@@H](C)C(F)(F)F)c1C(=O)N1Cc2cn(-c3ccc(F)cn3)nc2C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13143,CHEMBL4646639,COc1c(S(C)(=O)=O)ccc(O[C@@H](C)C(F)(F)F)c1C(=O)N1CC(c2ccc(C(F)(F)F)cc2)C1,IC50,nM,=,2400.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13144,CHEMBL4639102,C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CC(c2ccc(C(F)(F)F)cc2)C1)C(F)(F)F,IC50,nM,=,5900.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13145,CHEMBL4645731,COc1c(S(C)(=O)=O)ccc(O[C@@H](C)C(F)(F)F)c1C(=O)N1CC(c2ccccc2)C1,IC50,nM,=,6800.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13146,CHEMBL4638896,COc1c(S(C)(=O)=O)ccc(O[C@@H](C)C(F)(F)F)c1C(=O)N1CC(c2ccc(C(F)(F)F)cn2)C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13147,CHEMBL4634285,COc1c(S(C)(=O)=O)ccc(O[C@@H](C)C(F)(F)F)c1C(=O)N1CC(c2ncc(C(F)(F)F)cc2F)C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13148,CHEMBL4640428,COc1c(S(C)(=O)=O)ccc(O[C@@H](C)C(F)(F)F)c1C(=O)N1CC(c2ncc(C(F)(F)F)cc2Cl)C1,IC50,nM,>,10000.0,Inhibition of human ERG expressed in CHO cells by electrophysiology QPatch assay
13149,CHEMBL4646566,NS(=O)(=O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccc1F,IC50,nM,>,30000.0,Inhibition of human ERG
13150,CHEMBL4635134,CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O,IC50,nM,>,50118.72,Inhibition of human ERG
13151,CHEMBL4648431,CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2cccc3[nH]ccc23)c1=O,IC50,nM,>,50118.72,Inhibition of human ERG
13152,CHEMBL4517408,COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC,IC50,nM,=,8300.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13153,CHEMBL4642165,COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2Cl)cc(OC)c1OC,IC50,nM,=,2700.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13154,CHEMBL4638273,COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1OC,IC50,nM,=,6000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13155,CHEMBL4636120,COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F,IC50,nM,=,2500.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13156,CHEMBL4644571,COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1OC,IC50,nM,=,3100.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13157,CHEMBL4634857,COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2C)cc(OC)c1OC,IC50,nM,=,5900.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13158,CHEMBL4638544,COc1cc(-c2cncc(-c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)c2C)cc(OC)c1OC,IC50,nM,>,50000.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13159,CHEMBL4633241,COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC,IC50,nM,=,4800.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13160,CHEMBL4641530,COc1cc(-c2cncc(-c3ccc(C4=CCNCC4)cc3)c2C)cc(OC)c1OC,IC50,nM,=,3400.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13161,CHEMBL4648102,COc1cc(-c2cncc(-c3ccc(OC4CCNCC4)cc3)c2C)cc(OC)c1OC,IC50,nM,=,8100.0,Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp method
13162,CHEMBL4647983,NC(=O)[C@H]1CC[C@@H](c2ccc(OCc3ccccc3F)cc2)N1,IC50,nM,=,10000.0,Inhibition of human ERG
13163,CHEMBL4644276,NC(=O)[C@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1,IC50,nM,=,6309.57,Inhibition of human ERG
13164,CHEMBL4634427,NC(=O)[C@@H]1CC[C@@H](c2ccc(OCc3ccccc3F)cc2)N1,IC50,nM,=,5011.87,Inhibition of human ERG
13165,CHEMBL3544912,Cl.NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1,IC50,nM,=,12589.25,Inhibition of human ERG
13166,CHEMBL4637074,NC(=O)[C@@H]1CCC[C@H](c2ccc(OCc3cccc(F)c3)cc2)N1,IC50,nM,=,31622.78,Inhibition of human ERG
13167,CHEMBL4647249,NC(=O)[C@H]1CCC[C@@H](c2ccc(OCc3cccc(F)c3)cc2)N1,IC50,nM,=,3162.28,Inhibition of human ERG
13168,CHEMBL4649796,NC(=O)[C@@H]1CSC[C@H](c2ccc(OCc3cccc(F)c3)cc2)N1,IC50,nM,=,25118.86,Inhibition of human ERG
13169,CHEMBL4644347,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3cccc(F)c3)cc2)N1,IC50,nM,=,3162.28,Inhibition of human ERG
13170,CHEMBL4644773,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3)cc2)N1,IC50,nM,=,7943.28,Inhibition of human ERG
13171,CHEMBL4642930,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccc(F)cc3)cc2)N1,IC50,nM,=,7943.28,Inhibition of human ERG
13172,CHEMBL4645734,N#Cc1ccc(COc2ccc([C@H]3CC[C@@H](C(N)=O)N3)cc2)cc1,IC50,nM,=,7943.28,Inhibition of human ERG
13173,CHEMBL4637902,N#Cc1cccc(COc2ccc([C@H]3CC[C@@H](C(N)=O)N3)cc2)c1,IC50,nM,=,12589.25,Inhibition of human ERG
13174,CHEMBL4635121,N#Cc1ccccc1COc1ccc([C@H]2CC[C@@H](C(N)=O)N2)cc1,IC50,nM,=,15848.93,Inhibition of human ERG
13175,CHEMBL4634692,C[C@@H](Oc1ccc([C@H]2CC[C@@H](C(N)=O)N2)cc1)c1ccccc1,IC50,nM,=,3981.07,Inhibition of human ERG
13176,CHEMBL4634636,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2F)N1,IC50,nM,=,12589.25,Inhibition of human ERG
13177,CHEMBL4633318,CN1[C@H](C(N)=O)CC[C@@H]1c1ccc(OCc2ccccc2F)cc1,IC50,nM,=,50118.72,Inhibition of human ERG
13178,CHEMBL4638413,CNC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1,IC50,nM,=,25118.86,Inhibition of human ERG
13179,CHEMBL4646446,COc1cc([C@H]2CC[C@@H](C(N)=O)N2)ccc1OCc1ccccc1F,IC50,nM,=,3981.07,Inhibition of human ERG
13180,CHEMBL4637843,N#Cc1cc([C@H]2CC[C@@H](C(N)=O)N2)ccc1OCc1ccccc1F,IC50,nM,=,15848.93,Inhibition of human ERG
13181,CHEMBL4648908,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cn2)N1,IC50,nM,=,15848.93,Inhibition of human ERG
13182,CHEMBL4635448,NC(=O)[C@@H]1CC[C@H](c2ccc(Oc3ccccc3)cc2)N1,IC50,nM,=,12589.25,Inhibition of human ERG
13183,CHEMBL4635537,NC(=O)[C@@H]1CC[C@H](c2ccc(Oc3ccc(F)cc3)cc2)N1,IC50,nM,=,5011.87,Inhibition of human ERG
13184,CHEMBL4648552,NC(=O)[C@@H]1CC[C@H](c2ccc(Oc3cccc(F)c3)cc2)N1,IC50,nM,=,7943.28,Inhibition of human ERG
13185,CHEMBL4634823,N#Cc1ccccc1Oc1ccc([C@H]2CC[C@@H](C(N)=O)N2)cc1,IC50,nM,=,3981.07,Inhibition of human ERG
13186,CHEMBL4646990,NC(=O)[C@@H]1CC[C@H](c2cccc(Oc3ccccc3)c2)N1,IC50,nM,=,63095.73,Inhibition of human ERG
13187,CHEMBL4632663,NC(=O)[C@@H]1CC[C@H](c2cccc(OCc3ccccc3)c2)N1,IC50,nM,=,25118.86,Inhibition of human ERG
13188,CHEMBL4637181,C[C@@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)CCC(F)(F)C(N)=N1,IC50,nM,>,10000.0,Inhibition of human ERG
13189,CHEMBL4643511,NC1=N[C@](CF)(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)CCC1(F)F,IC50,nM,>,10000.0,Inhibition of human ERG
13190,CHEMBL4637358,NC1=N[C@@]2(c3cc(NC(=O)c4cnc(OCF)cn4)ccc3F)COCC[C@H]2CC1(F)F,IC50,nM,>,10000.0,Inhibition of human ERG
13191,CHEMBL4635770,NC1=N[C@@]2(c3cc(NC(=O)c4cnc(OCF)cn4)ccc3F)CCOC[C@H]2CC1(F)F,IC50,nM,>,10000.0,Inhibition of human ERG
13192,CHEMBL4648883,C[C@H]1C[C@H]2CC(F)(F)C(N)=N[C@@]2(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)CO1,IC50,nM,>,10000.0,Inhibition of human ERG
13193,CHEMBL4636350,NC1=N[C@@]2(c3cc(NC(=O)c4cnc(OCF)cn4)ccc3F)CO[C@@H](CF)C[C@H]2CC1(F)F,IC50,nM,>,10000.0,Inhibition of human ERG
13194,CHEMBL4640712,CC(C)(C#N)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)(C)C#N)c1,IC50,nM,=,7100.0,Inhibition of human ERG by Ionworks electrophysiology assay
13195,CHEMBL4635883,CC(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)C)n1,IC50,nM,=,3700.0,Inhibition of human ERG by Ionworks electrophysiology assay
13196,CHEMBL4643105,COc1cc(/C=C2\CCCN3C2=NO[C@H](c2cc(F)cc(F)c2)[C@@H]3C)ccc1-n1cnc(C)c1,IC50,nM,=,2007.0,Inhibition of MK499 binding to human ERG
13197,CHEMBL4634921,COc1cc(/C=C2\CCCN3C2=NO[C@H](c2cc(F)c(F)c(F)c2)[C@@H]3C)ccc1-n1cnc(C)c1,IC50,nM,=,1607.0,Inhibition of MK499 binding to human ERG
13198,CHEMBL4634696,COc1cc(C2=CC3=NO[C@H](c4cc(F)c(F)c(F)c4)CN3CCC2)ccc1-n1cnc(C)c1,IC50,nM,=,3352.0,Inhibition of MK499 binding to human ERG
13199,CHEMBL4642697,COc1cc(C2=CC3=NOC[C@H](c4cc(F)c(F)c(F)c4)N3CCC2)ccc1-n1cnc(C)c1,IC50,nM,=,2608.0,Inhibition of MK499 binding to human ERG
